<SEC-DOCUMENT>0000950170-23-063734.txt : 20231114
<SEC-HEADER>0000950170-23-063734.hdr.sgml : 20231114
<ACCEPTANCE-DATETIME>20231114161751
ACCESSION NUMBER:		0000950170-23-063734
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		100
CONFORMED PERIOD OF REPORT:	20230930
FILED AS OF DATE:		20231114
DATE AS OF CHANGE:		20231114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Taysha Gene Therapies, Inc.
		CENTRAL INDEX KEY:			0001806310
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				843199512
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39536
		FILM NUMBER:		231406595

	BUSINESS ADDRESS:	
		STREET 1:		3000 PEGASUS PARK DRIVE
		STREET 2:		SUITE 1430
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75247
		BUSINESS PHONE:		(214) 612-0000

	MAIL ADDRESS:	
		STREET 1:		3000 PEGASUS PARK DRIVE
		STREET 2:		SUITE 1430
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75247
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>tsha-20230930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-11-14T16:15:08.8988+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:tsha="http://tayshagtx.com/20230930" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:srt="http://fasb.org/srt/2023" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>10-Q</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_669a90f6-b4ec-40ad-8075-b945710aa163" name="dei:CurrentFiscalYearEndDate" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017">--12-31</ix:nonNumeric><ix:nonNumeric id="F_47737c52-79d8-4291-b3bf-6af71ead65de" name="dei:EntityCentralIndexKey" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017">0001806310</ix:nonNumeric><ix:nonNumeric id="F_b232171e-663f-4173-a902-2f5bad93ae1b" name="dei:DocumentFiscalPeriodFocus" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017">Q3</ix:nonNumeric><ix:nonNumeric id="F_d9c132d3-6f22-4bd6-86e3-44211bb85b64" name="dei:AmendmentFlag" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017">false</ix:nonNumeric><ix:nonFraction id="F_8d3f62bc-18eb-44df-b73a-6f99476c53f5" name="us-gaap:CommitmentsAndContingencies" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_3ce03d57-ef16-429a-a038-f0a3ac29261c" name="us-gaap:CommitmentsAndContingencies" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_097186ba-8243-4d01-97b1-6cb2253b2a70" name="us-gaap:PreferredStockValue" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_a4badc19-7056-4e60-a745-d3a4681c7b4e" name="us-gaap:PreferredStockValue" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_95731e73-590b-4d8b-bc53-eed7708f5dfe" name="us-gaap:AccountingStandardsUpdateExtensibleList" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909">http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201602Member</ix:nonNumeric><ix:nonNumeric id="F_c235bfe5-b369-4c89-8e3c-24a2b2c671cb" name="us-gaap:AccountingStandardsUpdateExtensibleList" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909">http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201602Member</ix:nonNumeric><ix:nonNumeric id="F_3d5ea955-cb63-460e-9ac4-0cc91b6e0847" name="us-gaap:AccountingStandardsUpdateExtensibleList" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14">http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201602Member</ix:nonNumeric><ix:nonNumeric id="F_3e78f387-05e6-4d7c-88d4-c13b0a4b78ec" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c">http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities</ix:nonNumeric><ix:nonNumeric id="F_dbeee014-7927-4ce5-8253-ba65a26dca89" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c">http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities</ix:nonNumeric><ix:nonNumeric id="F_b7b24932-76e0-4234-83dc-e0defb7581aa" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric id="F_1ede665f-e147-4c30-a4ac-9f4f220b3eda" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c">http://fasb.org/us-gaap/2023#Liabilities</ix:nonNumeric><ix:nonNumeric id="F_a612bde1-69ec-4545-8cd9-0a74e9778ed1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_d41a29de-53a9-4a5a-96ba-31f6e55605f3">P1Y</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="tsha-20230930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_4232a358-a09c-4ded-8c53-c1c79684fc22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_245eca74-de86-4efc-a7d0-3ed028ab318b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2db1cf9d-e412-454a-abb7-673182786e9b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9758b5a2-ae6e-4588-8d02-3e34f18b2c5c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c89eb35b-aaf3-4ca8-943d-735991153287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:SsiWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_19b223c2-858d-4c13-823b-7fac0db24551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4c88705b-93a0-4d16-a99d-3dbf7a0c78c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6c73f75e-0143-4c42-88c1-9f83877c234e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-16</xbrli:startDate><xbrli:endDate>2020-09-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ebb6d69e-99d0-4437-b8b8-87ca448aa0d2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c883f68e-7f40-4df1-9893-6348c141e5e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_afb7066a-ec3f-492c-abdf-4728d171d8a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5e5e45fa-c545-46e3-838a-10c5bb7a8a1d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-12</xbrli:startDate><xbrli:endDate>2021-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_268fe9ab-86f1-47ea-8103-b41a53f40e03"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b15937e2-c5c7-42c8-90fd-354de23b40f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2d977a75-9f73-4edb-9392-84ff074a6057"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tsha:AssetsCapitalizedAsFinanceLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2c7a64a4-5c6c-45c0-a89a-29ee6d67a457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3643e8c7-ca2c-41ba-88d7-153c48cfb65c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7c39cbeb-fc40-4194-9257-c31ad0395ba2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7b13f58d-8442-4d48-a92e-3e9c2f531ffc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">tsha:TrinityLendersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TrinityTermLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TrinityTermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-13</xbrli:startDate><xbrli:endDate>2023-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_52565164-9ede-4417-8be6-ba6aecffc735"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7e3ec4c7-5cbb-4cfd-9e66-965a4caa80c9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-14</xbrli:startDate><xbrli:endDate>2023-08-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5142e56d-a1ef-405d-ada4-47c2a8ad2e32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:UTSouthwesternAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f346f496-91c4-40a5-b151-c5aa7e20a131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_99018103-c6e5-46d7-86c2-6f53ea9bbe0b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tsha:AugustTwoThousandAndTwentyThreePrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_80322908-dd6f-45f1-92a0-5b56754ba105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6310a863-a521-49ae-9a54-5fdd0104f020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_40e64b85-0bd6-43d7-85ac-e8176005098e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_24c41917-d26a-4624-8e85-a10244e4a9a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b930a776-4755-4d30-be4d-477d007415b3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b1703001-53ce-4fd2-a321-a0b32037899b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1fb76a57-582e-46ab-b8bd-4287ba306f26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9e4fa149-1f8c-4521-8d30-073662fd12c2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_173d420c-3a82-453d-854d-b15fa055eec3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d38e6bea-f6ec-49da-b364-707ab055ad3c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fe9c5e2c-7fc2-459d-a948-657f1b1df93e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_04ff6dd0-0334-40e9-88c7-2032acec21a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:SsiStrategyHoldingsLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ded5d2d0-56e4-4b8d-b636-71c37d47e597"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3dc1a85a-2423-47a1-852c-f4579e03847b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fc047aed-6e3c-4d6e-8708-d9135d555669"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8d03e9bb-23a1-464b-940a-dd1c8ec2a91b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_15407518-9c8f-475c-9932-cccfb6f73f94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AstellasSecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tsha:AstellasPrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_788446ba-8777-48e6-8377-1f4a2176149f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_513161af-679d-453e-bcb3-fe06753ed420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5fe22845-b517-4024-bf3c-a463c9c5382c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0169fb3b-514c-413b-8951-2aa1318d1f3e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-11-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_27149336-d352-41a8-8d0e-18408512989e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dbe9d225-ee5e-4b8b-b0c9-9b23ae056e8c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e15af869-8ce3-412a-8b1c-4c46b2d2bba7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d4e0f467-0a9d-4677-822d-01e528375bf1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c9c85128-8f32-4f62-b33e-e8c28c2b5969"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_27aa3cc4-7b79-4c00-b3a7-7e63aea84451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_224db9b6-cf69-4025-8ace-07a34716e87d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7ff33646-2760-47df-b89c-a551eb67ee08"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ef3c29aa-a25c-41d7-ad90-3c2283143f19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_41f81af9-f063-4fcb-9aee-fe6cb9bc2fc8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-21</xbrli:startDate><xbrli:endDate>2022-10-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_151eb485-8164-452f-8e8d-d530d960d3b9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_de722255-5e4d-4b90-b918-c5cb3d32e39a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">tsha:TrinityLendersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">tsha:ClosingDateThroughNovember132024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TrinityTermLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TrinityTermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-13</xbrli:startDate><xbrli:endDate>2023-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f6908048-c889-4f93-869e-3dd5fb923ea5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:PerformanceAndMarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dbe2a760-59ec-4506-ae61-53a963aae53f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d6b67c53-c7b5-4cb3-a237-27c8b3f18659"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_312a5395-35e7-4a3b-845a-3e7f7d95509c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a8165939-afd1-4d28-97a4-17ac213a88aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3d602e83-3144-42f0-b3b2-264b04cf5dbb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_14267a27-65cc-48af-8835-a0a763940651"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_80f023fb-4c4f-4913-a8f0-25a04332f88c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5effed74-1ac1-4896-81fb-36ffc78da0fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_41509e45-2fbe-49bb-bd92-c66a85232c95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ba166f8a-c9a3-4db9-b638-31d38de73008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bcabd00a-3c24-4571-bd95-b51d333d5e34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3c5342a3-7cee-4f48-b5b3-8beff925816b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:PerformanceAndMarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_349ea30b-6a31-4c2d-af3c-94a43b0e6e4e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-12</xbrli:startDate><xbrli:endDate>2021-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c50b3cb1-c0e2-4765-8d8d-617b504675a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_84a4182e-9ee0-43f3-b998-badcbf3028a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b4dd4b5f-778b-4ec9-8faf-8068d96c92af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6ea481f7-b42d-41cf-8579-8896b25d1f78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9f8d2f91-99fe-4b86-b976-930ef584b76d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:LicenseAgreementForCLN7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3253dca9-a154-4e6e-add3-61c9afd96cb4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ec26563e-4690-407e-a176-41017d5c4238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_27463c1c-a3d9-4df6-9af4-17d723f972fa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5f9fb3b0-fe97-419b-bdc6-be3820e2ea68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-12</xbrli:startDate><xbrli:endDate>2021-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_23bd83df-eede-42ec-9c51-05585993a9e0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:PresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_95c66cb1-2fc7-4423-a36f-6e539db9b9ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d239af67-cf01-4921-a72c-010606f8efdb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a19561be-07c5-4bcb-9000-74a3fb2fa74a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7f6e1c72-16bb-483e-8cd7-a7a20b74ede0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:MarketBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_01b23b59-342a-4659-a799-48ef1e2fa7a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c46c3bce-3fb6-4de8-b570-c0f54c0a4d18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fe9362b3-8b1b-412f-a9cb-c0083a836950"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_162c443b-2d6f-4ca9-a115-4b08a2c7a8c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9ddff924-68e1-4fa1-9bb2-4276e2baedd2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f899ecab-1c91-4d92-99fb-b948b9803592"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2a31a044-252b-446e-9552-0e90214b5729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tsha:AugustTwoThousandAndTwentyThreePrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_997ec0ed-2c41-4632-ae98-d747ae5dbab5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">tsha:ExitAndDisposalActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_09805d8b-419c-40f4-b6d8-e5976d919ebd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_10334e6e-f910-467c-a8bf-bccc2eb4ec31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">tsha:TrinityLendersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TrinityTermLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TrinityTermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-13</xbrli:startDate><xbrli:endDate>2023-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f438b467-3326-45e8-9282-1549429f210e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b0d18d87-5486-439a-b80d-f6f9cd2a928a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-16</xbrli:startDate><xbrli:endDate>2020-09-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3fe65adb-4ffe-4988-98fd-276d9f0de168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c3b5bdf8-5491-4876-b736-c28be19cc6fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_773e89ba-c62d-4d26-a9c3-69efc4d4d04e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:LicenseAgreementForCLN7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f91f76fc-5e39-4eee-9c56-7105b8b287f2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f938f988-ce4c-4a96-9c9e-d18ca55eb075"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_15353d77-7cae-498e-95ff-53e56b3c8df9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_afe869c3-1801-4581-a6f5-b8768beaf0e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:LicenseAgreementForCLN7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_33b1b61d-afdf-4871-8372-0ac5c4985bb3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a3d12033-f85a-468b-8d86-8048a97ad7ff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">tsha:TrinityLendersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">tsha:November132024ThroughNovember132025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TrinityTermLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TrinityTermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-13</xbrli:startDate><xbrli:endDate>2023-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_52fa6299-e193-4168-a292-1d334991839a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DallasLeaseAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PegasusParkLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0d813ec3-e8bb-4190-af8b-be115e142cd4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aa7f77ea-a48d-42e3-9e4f-5074456c1eb3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2e51a9e4-9e0b-4c3b-97d0-34a783d596e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bafc0748-9e47-4fe0-8057-f224262368a9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b0061a32-1c5e-4190-b750-44c408af1f14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7b453598-4699-4830-9fe7-728f5848fb84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-12</xbrli:startDate><xbrli:endDate>2021-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_29c4a552-4734-47bc-be8c-3e643d34d362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a36762fa-d31c-45ad-af2e-461829666801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dbdfd311-3825-4ad7-b403-58287d7548a7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_386cd9a0-f7f8-4dec-8608-31eb57cc80ff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_90d0d226-40ec-4b9a-8519-b099afecfa5a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">tsha:ExitAndDisposalActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_02cd1c3a-1c6e-4efe-a03e-b7815be0c062"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SalesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tsha:SalesAgentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e2ae4188-b729-4bb9-a810-c77a789712b1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:MarketBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3d08f4c0-b2de-4b5c-a77e-bed99023b07d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9be26314-5dbf-4dea-ac67-93410907efad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_29b5ff44-bd12-407c-9c1b-ed72f20b73c9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0f464446-8753-4ba1-9363-45ea238784a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aa916425-81f6-46a9-9211-8a2744be8acf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_49ea514f-2749-4ec3-b1be-bc456b767a33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2d3969b3-1904-49b7-9987-89bee52040f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_879840b7-9535-4ff6-b76f-43c8c0b8f843"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tsha:AstellasPrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AstellasSecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f73dfe04-8e13-4f73-9796-2fc971735968"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e679b79d-3341-4675-987e-dcc562289f26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d2c65442-11b0-4704-bbf6-bea92b060507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tsha:AssetsCapitalizedAsFinanceLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2453238f-62d1-4664-a753-3e1fa2683010"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-12</xbrli:startDate><xbrli:endDate>2021-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8bc60dc0-3547-4346-8f8c-627b12b9404c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:UTSouthwesternAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ecf42b20-4d10-4df6-8173-984ab0bc4b7a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a5a9cdf2-731c-430f-9ea7-2e1cfb949e8a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SalesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tsha:SalesAgentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-05</xbrli:startDate><xbrli:endDate>2021-10-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_be79abbe-9cb7-450a-89c0-09810beac69c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bda073bb-c8f5-46f9-ba1e-59d7b6cce834"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1004e87a-1fce-46e3-ac6d-39787b2f2454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tsha:AstellasPrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AstellasSecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aca6a365-8b8d-47ba-b0c6-cb825ca992cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7f2b298a-2b65-407d-9b6b-4e8ad3ab3b4a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8e476623-2cf0-4fe3-b12e-9c905fead252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8ef3dae4-92a8-4848-bc8b-7d6ee1d2bca5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:SsiStrategyHoldingsLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2ac01888-0938-41c1-b387-fb08d1afdae5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5248d7d9-3cd0-4735-865f-dda80ba32b79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d73f002d-37aa-4ddd-8f3a-08970ba84984"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9cb3becb-0241-4438-9d16-a477e9cdad37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9eccec65-aa13-4b7b-8210-aa887edfcc29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PegasusParkLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DallasLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fb426d7d-a58c-4a86-b783-cad0e1d55c63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_11f479fa-8bc0-462f-aae7-eb345d89a6d2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SsiWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_31bb6c1a-64e4-43f2-ac13-da2509eeeef2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f36491bb-eacf-4acf-ac52-472ebe8b3169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-16</xbrli:startDate><xbrli:endDate>2023-08-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c21847ad-1728-4953-9228-368c4f2998f2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tsha:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6a80be52-6387-4afd-9538-c38ccf4297dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:MarketBasedStockOptionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e42d8932-a6cb-47d7-883a-506fc278ba6a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_41099a59-f81f-47bf-96a8-c4997b89b7b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughAugustThirteenTwentyTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-12</xbrli:startDate><xbrli:endDate>2021-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3e6ad8f3-e3b2-4766-81e6-638c50b9a854"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tsha:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8da9a80f-388d-49d3-9c46-6ca3616d641d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_29b986aa-0e5f-4fce-8696-e82fa25305c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SsiWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-05</xbrli:startDate><xbrli:endDate>2023-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0263ef18-95c0-4f1d-a160-663af20e3c36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6fdb1bde-2709-45b1-a9e2-787a87ee5614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e6e5f371-c876-4258-be9b-7f8411f4ff7e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_451c5407-a741-4c7e-bd00-1970b0bc0851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4bcd5e18-554d-46bd-8387-2b416ade3f02"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4c721f5c-334b-4fe7-802b-653db955a9ef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-14</xbrli:startDate><xbrli:endDate>2023-08-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_715ad203-ffe8-49ff-9388-adf38b8f0cef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d374b9c6-f352-4efa-81b7-539cd0b063c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6aeab603-0bae-4f76-9690-07fdf336dce4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">tsha:TrinityLendersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TrinityTermLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TrinityTermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cf8b3b2d-3381-4c33-97b3-0a49e5fa0576"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:GiantAxonalNeuropathyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_27c18364-0175-4f13-b9fc-bed49be4dac2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">tsha:ExitAndDisposalActivitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_63dd2c50-f529-4540-bf31-b0caef7db5c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_467bb9bb-f5c8-46b2-9e83-49a77c2c5e47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_18d9db4b-0220-483d-b698-33462a0d1d11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f2bd8525-6258-4ee1-bf3e-0b623f59864b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b40906ab-540f-4d66-babc-185d6edc1657"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5a369e84-71ee-4265-82bd-b5c3255f95c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_58fa74f2-e180-43b6-b5c7-e1e48ea4adbf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d41a29de-53a9-4a5a-96ba-31f6e55605f3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_865be14a-e277-45f2-b305-9aa13e3a0315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DallasLeaseAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PegasusParkLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-14</xbrli:startDate><xbrli:endDate>2021-12-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8267f30d-8810-477f-a104-32649ca7a65d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fd17c3d9-bde3-44a4-b00f-89b6c9cd0d15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_51f1008f-8fa9-4508-a0ff-0b2d61656244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f5f51dd5-7ef2-471d-bd94-707e6e8d06e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cd7537ff-48e9-472a-86b6-01bf17d9a102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_56aba35a-c830-45c9-adb0-37ddf0bc7d62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2baf5077-feb2-430c-8618-bc9ab6c792fa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_220cf9fa-9710-4b12-8b10-b837e62d8c09"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8786aa0e-05e3-4061-9f46-80d5e9b63b63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1247712d-baca-4aef-85fb-e3036cdde096"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_73e2f837-a7da-4610-a8b8-b300a337c6b9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5ff63508-7308-4b13-b74d-9cf9982f8736"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PegasusParkLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DallasLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-11</xbrli:startDate><xbrli:endDate>2021-01-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_407b4a6b-c691-4b3a-9a19-64936d532af0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4747c8da-f859-4b04-947f-581d35ec592c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:PresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7a0ba426-b372-4bb2-a6ce-f8a55df6817b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f72dceba-fcca-4fdd-bb14-6b5646b92d1e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4e3d744a-95f2-48c1-8ae4-8a48d4233bb0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c880fb70-98ec-4743-b3ec-50abce55fb61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_287d5758-9445-46a9-a9b4-4f0e72d6bc05"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:LicenseForRettMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_36b0de8a-1c04-40e9-bda7-6a7e96088f0e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d3115968-7432-4bb2-8241-e0b51c3126b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5bdf589d-7a91-4625-927d-1d6ee35dde2c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_247c1361-9891-4d77-8855-fdadd0f3d730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-12</xbrli:startDate><xbrli:endDate>2021-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_afb73dc0-9840-43ad-9af7-f5a3c969493a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dd649981-9002-4b1a-8b61-880d7062b373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_85b1368b-9750-457e-87f0-e98f7d80ece8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3826a1af-5558-42d4-951c-d3a6f47c100b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5d53cb28-f1c8-45d3-aaa3-c5feece6f465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_72ee41ab-a948-4033-acce-533b6eca774e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:GiantAxonalNeuropathyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c061af20-6853-41e3-a4ad-c8a519ad7164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9b53dc51-ef56-4848-a5a0-e8634b747a3a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0ed2ccbf-6260-463b-bb8f-3005a6425089"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:PerformanceAndMarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5d0c08dd-ca08-469f-b519-b8ead4c58f61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6b959717-546d-4082-a216-54b72a00c5df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eda542a6-c47a-464c-9bfb-8cc6ae934ce2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_07daf6b0-f34a-4741-b184-8a1f541a9c89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SsiWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7a6e813a-84dc-4c50-933b-18e61eccc073"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ffe2668b-14a2-48c0-b393-270f102a3ad6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:LicenseForGanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c8ed76c8-0f36-44af-8fd2-f083fa2a50c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_386d4b0c-dbb1-4cd6-9f1e-31bdfd623c2f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tsha:AstellasPrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AstellasSecuritiesPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-21</xbrli:startDate><xbrli:endDate>2022-10-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c6f58321-0fb7-430f-a653-4f529d5145cb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f68841e2-9812-4928-9cd8-bc1e4d7385dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6de550d8-31ef-460a-ab24-a8f077bb2101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-17</xbrli:startDate><xbrli:endDate>2020-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3cb6925a-8272-4205-b6cf-61f911a340b6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d99997ac-c0d1-4216-92e6-c6f95f327fe8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_df655a6c-a1e2-4b8b-b36e-5e7362c2c0fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">tsha:TrinityLendersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">tsha:November132025ThroughButExcludingTheMaturityDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TrinityTermLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TrinityTermLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-13</xbrli:startDate><xbrli:endDate>2023-11-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_81a7b536-c0bb-453e-bcc6-30eb806c1470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_860f05e5-09f2-4dfd-b455-5e8e3432983f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_10cb884e-9a48-40ed-b56b-6772d0af148c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_89723ac2-2fad-4cb4-b5fc-51a86fd96b12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e482ef1c-238b-4c33-805a-cf73ba22ae2b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5063c218-0805-481c-bd11-cdcf2eae0406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001806310</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Product"><xbrli:measure>tsha:Product</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_Program"><xbrli:measure>tsha:Program</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U_Y"><xbrli:measure>utr:Y</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <p style="text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, DC 20549</span></p>
  <p style="margin-left:40%;text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1811ec9d-7a62-451e-b167-8fc8560b0f2a" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">10-Q</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(Mark One)</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4%;"></td>
    <td style="width:96%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_23da2b02-760e-4e0a-a02b-0d62def5a1fe" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the quarterly period ended </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d808408d-889e-470b-bf3a-703b9cc96c1f" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e15c83b8-e4a1-4a64-b2a6-20fe6c9f20d7" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:DocumentFiscalYearFocus"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></ix:nonNumeric></span></ix:nonNumeric></span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">OR</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4%;"></td>
    <td style="width:96%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_5bd1b79b-7ef7-47c5-b390-c0c6a1149b2e" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the transition period from ___________ to ___________</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Commission File Number: </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5a96f874-6ccf-4b34-9b43-0454dbc5d85a" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">001-39536</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_36905c67-dbc8-4d28-8990-65859ba549e3" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">Taysha Gene Therapies, Inc.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Exact Name of Registrant as Specified in its Charter)</span></p>
  <p style="margin-left:40%;text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50%;"></td>
    <td style="width:50%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_42275103-565c-4753-9996-ab1ab09a8ddd" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_41411fb5-b11b-4224-9bdd-d6ea6af65aac" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">84-3199512</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">( State or other jurisdiction of</span></p><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">incorporation or organization)</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(I.R.S. Employer<br />Identification No.)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fe28bd1c-1768-4a19-a257-7ae67ca39894" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3000 Pegasus Park Drive</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1e2b55da-abbc-439e-9d8d-5dc6025a4fda" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Ste 1430</span></ix:nonNumeric></span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0ff203f1-29ec-4990-98d4-361d09e61d56" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Dallas</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_706fb4a4-ad08-4324-a6e5-a9d8fc5f6db6" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Texas</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f55b937b-e844-4403-a79a-6b02b9aa7553" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">75247</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7pt;font-family:Times New Roman;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registrant&#x2019;s telephone number, including area code: (</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dd5ff52b-6924-40ef-acad-e65d677378d7" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">214</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_814e30f2-b437-4ec1-8769-740eb0fd9e53" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">612-0000</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:40%;"></td>
    <td style="width:1%;"></td>
    <td style="width:18%;"></td>
    <td style="width:1%;"></td>
    <td style="width:40%;"></td>
   </tr>
   <tr style="height:8pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Title of each class</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Trading</span></p><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Symbol(s)</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:9pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4bcf1e44-afab-4225-b330-5e9fe504000a" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Common stock, par value $0.00001 per share</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1ab6b6fd-45e9-4ae5-8d26-d6dbbf07331a" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">TSHA</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f8206ca9-8837-45d1-92c6-d8acd4ee5b6d" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8ddc9340-9209-40ca-9d53-39e7e757b4f0" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityCurrentReportingStatus"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">    No  </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_70f293f3-52de-4a74-b597-ebaa51ddec10" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityInteractiveDataCurrent"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">  </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">    No  </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company,&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:18.9%;"></td>
    <td style="width:1%;"></td>
    <td style="width:55.84%;"></td>
    <td style="width:1.06%;"></td>
    <td style="width:20.08%;"></td>
    <td style="width:1%;"></td>
    <td style="width:2.12%;"></td>
   </tr>
   <tr style="height:10.8pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Large accelerated filer</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">  </span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Accelerated filer</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</span></p></td>
   </tr>
   <tr style="height:3.6pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_56244417-4b22-4705-a811-bcea4329d3d3" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9746;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">  </span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Smaller reporting company</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_6b1eacc8-82a2-4a60-b67a-c5a02d5564ec" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_b351223b-c321-4de7-afcc-dfe1198bba5d" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_b5f207b5-1520-44f7-aaa4-fd533a6858e4" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">    No </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_858f396a-50e0-4a4d-b854-de38cb95f54f" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityShellCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="text-indent:5.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">As of November 14, 2023, the registrant had </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_22945b03-662c-4fe1-9de9-011a9666b5f4" contextRef="C_0169fb3b-514c-413b-8951-2aa1318d1f3e" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">186,960,193</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock, $0.00001 par value per share, outstanding.</span></p>
  <p style="text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Table of Contents</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:10.1%;"></td>
    <td style="width:82.82%;"></td>
    <td style="width:7.08%;"></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PART I.</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#part_ifinancial_information"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">FINANCIAL INFORMATION</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 1.</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1_financial_statements"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed Consolidated Financial Statements (Unaudited)</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_balance_sheets"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Balance Sheets</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_statements_operat"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Statements of Operations</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_statements_stockh"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Statements of Stockholders&#x2019; (Deficit) Equity</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_statements_cash_f"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Statements of Cash Flows</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#note_1organization_description_business_"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Notes to Financial Statements</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 2.</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_2_managements_discussion_analysis_f"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 3.</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_3_quantitative_qualitative_disclosu"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">51</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 4.</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_4_controls_procedures"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Controls and Procedures</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">51</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PART II.</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#part_iior_information"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">OTHER INFORMATION</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 1.</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1_legal_proceedings"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">53</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 1A.</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1a_risk_factors"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk Factors</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">53</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 2.</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_2_unregistered_sales_equity_securit"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">55</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 3.</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_3_defaults_upon_senior_securities"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Defaults Upon Senior Securities</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">55</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 4.</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">55</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 5.</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_5_or_information"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">55</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 6.</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_6_exhibits"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibits</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">57</span></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td colspan="2" style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#signatures"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Signatures</span></a></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">58</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">i</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_ifinancial_information"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PART I&#x2014;FINANCI</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">AL INFORMATION</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 1. Financi</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">al Statements.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Taysha Gene Therapies, Inc.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_consolidated_balance_sheets"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed Consolida</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ted Balance Sheets</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(in thousands, except share and per share data)</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Unaudited)</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:67.08%;"></td>
    <td style="width:1.622%;"></td>
    <td style="width:1%;"></td>
    <td style="width:12.837%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1.622%;"></td>
    <td style="width:1%;"></td>
    <td style="width:12.837%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br />2023</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">December 31,<br />2022</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASSETS</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Current assets:</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_15ddbf0d-21c4-415b-9991-37ec94b0fbfe" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">164,278</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_31674c0c-21fa-4b6e-ae39-443a6e1d8be7" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">87,880</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_75996035-61d2-4821-833b-0c58bd10425d" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,529</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f74ca653-af62-421c-8518-87f1ac38df19" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,537</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assets held for sale</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f6caa6d9-d16b-4f09-a760-8459ccbdd436" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,000</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total current assets</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_46b96967-3b31-4b3b-a053-fa23482a59f0" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">171,807</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_db0ca990-edb6-4ef7-bf22-f4966f754f99" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">96,417</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Restricted cash</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a0853b86-abbe-4155-8e06-6d4924b4aa1e" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:RestrictedCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,637</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_085f986a-ff34-47de-abbf-557f20913a92" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:RestrictedCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,637</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property, plant and equipment, net</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a667b4e7-6f89-4066-801e-5abe9affcb6e" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,169</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c1dd473d-e057-4378-bf1b-8de620b88b86" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,963</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_cabb8c6b-b662-42f3-bf9f-eb6d9d58a380" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,852</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0bfc2d4d-598b-4e1c-a83d-7bba78b8bd65" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,943</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other non-current assets</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_523d635d-bfb5-4877-aeb9-ea2aede93404" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">304</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_77fd5254-4e8e-44da-ade3-96655dbb8fd3" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total assets</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dcb9023a-132d-45cf-bf57-83f9474795a5" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">195,769</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1d873396-95ad-42c6-9863-f8a67b62f905" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">126,276</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Current liabilities</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_75e48267-20bb-4a4e-92ed-ec10182c92ef" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,520</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a62514ed-7be2-4824-9e9d-6ebaf608b137" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,946</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d47dbf94-8283-4328-87a4-6fcd75a0f2c8" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,638</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1136a7b8-b05b-447b-b461-448420a540a7" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,287</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Deferred revenue</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f67d38ff-5222-4773-b6f3-0c42db10d3f4" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:DeferredRevenueCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,759</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f0408399-ca7c-4999-96e1-3cbf5c1ca791" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:DeferredRevenueCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,557</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant liability</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_fbc87160-e8bc-4339-bcf8-d20235315b99" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:DerivativeLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">140,534</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_14a644b0-d99c-49fb-a69c-ec5c82063ffe" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">180,451</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_99825810-0138-4b0d-8493-92647b6e8e6b" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62,790</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Deferred revenue, net of current portion</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6fc2bb24-873e-4eee-8768-b11cf3b06858" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:DeferredRevenueNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,951</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Term loan, net</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1956e90a-b275-432d-a248-0a545b61e23a" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,548</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7263d603-aec5-40c5-9daf-56de9c9d822b" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37,967</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating lease liability, net of current portion</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_64cd877a-6e08-4a0e-b6fc-49bffff0a119" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,101</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dba9101b-bd7e-4a05-8513-05c5a8980b68" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,440</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other non-current liabilities</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0d289983-16d8-42ef-9651-3c2e3cafdeeb" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,832</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ebfa3254-6994-463a-8db8-6be1dc69da59" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,130</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total liabilities</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6ac3a5e8-b769-4439-984c-473f715c2cb8" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">244,883</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c41cd85e-4f4a-420e-9717-9c37e9b3483b" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">125,327</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_8d3f62bc-18eb-44df-b73a-6f99476c53f5;"><span style="-sec-ix-hidden:F_3ce03d57-ef16-429a-a038-f0a3ac29261c;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Commitments and contingencies - Note 13</span></span></span></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Stockholders' (deficit) equity</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Preferred stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_18f43d51-a909-4b10-b990-e8e95f35a0ab" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a9edb114-de90-49fa-9e3a-13fa2e86b99c" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.00001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;par value per share; </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5e4a0cec-1fb2-4b9d-9374-3c95b602f8e8" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9de760de-3176-4582-bd75-3989f6338ebc" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;shares authorized and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_26ca3392-06b8-41e1-a55c-210252de804e" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_b76e2daf-6d3c-433a-976f-80e2676c6913" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_a4e30397-0645-42c0-be86-565adf9aa787" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_4d1e9ec7-a060-4aa8-9180-d8abaca8e543" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;shares issued and outstanding as of September 30, 2023 and December 31, 2022</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_097186ba-8243-4d01-97b1-6cb2253b2a70;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></span></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_a4badc19-7056-4e60-a745-d3a4681c7b4e;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></span></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Common stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_03fc1444-8fc0-442a-b159-297b0205b043" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_634b014f-1d38-4f58-9965-997121637b3b" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.00001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;par value per share; </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d737af77-16b3-4eac-a0d1-7fc542c6ff43" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_05a0ad2d-859d-48b3-9640-e08fbf2dc9ae" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">200,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;shares authorized and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2096f63e-70b2-4d91-a9e4-a5a00b63f58e" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_18b69774-1835-4c02-a390-832ab16f694c" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">186,960,193</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f0fe94df-9de1-4c48-8c26-ceb67a0c416c" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fec9abe7-7f8b-4238-b6cb-0f0741e7d1a3" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">63,207,507</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;issued and outstanding as of September 30, 2023 and December 31, 2022, respectively</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2f08af14-7baa-4e97-aeaa-7b57d6881df0" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0794c31b-52d0-4ae5-86f9-882cf32e9d8f" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_756362b7-eae4-4441-b8c8-684048d00b88" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">511,632</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1e78b8ba-4c3a-456a-b576-974149fd9c2c" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">402,389</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_532218c7-701e-476b-82ef-ec8a4b9af634" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">560,748</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_44ed63cc-932f-4d59-8586-cc06a62bde37" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">401,441</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total stockholders&#x2019; (deficit) equity</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9cc6d0b9-6aa1-4606-b475-fe11cd657e39" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">49,114</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0d5ef7bc-f1c9-4d4f-aa01-3b4bd3dcec8c" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">949</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total liabilities and stockholders' (deficit) equity</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_724b5420-1017-4a63-9196-976db7103450" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">195,769</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e39afbab-292a-4a0a-802c-ec3c2c4ca1d2" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">126,276</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Taysha Gene Therapies, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_consolidated_statements_operat"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed Consolidated St</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">atements of Operations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(in thousands, except share and per share data)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Unaudited)</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:52.074%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:1%;"></td>
    <td style="width:9.421%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1.262%;"></td>
    <td style="width:1%;"></td>
    <td style="width:8.74%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1.062%;"></td>
    <td style="width:1%;"></td>
    <td style="width:8.74%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1.262%;"></td>
    <td style="width:1%;"></td>
    <td style="width:8.439%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Three Months<br />Ended September 30,</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months<br />Ended September 30,</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenue</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d3f935ef-5c7e-4417-b5a3-ef94426e939f" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,746</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_61040eb4-8df7-402e-9bd3-0f4084a85eeb" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,847</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c7b69474-4270-4630-b457-c371e39046f5" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,791</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2f30d144-cecf-4a30-ab31-27e7289a5b8d" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,774</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c291665c-07d6-4e59-97d0-b0668321b76b" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,096</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8568d068-c982-475f-871a-a3ec512af048" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78,462</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_90970647-97d1-44b8-94a5-bba40fc8c29d" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,589</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7b6663e9-865a-4fe9-8426-948b85b7e7ff" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,683</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_85a29c59-75e0-4711-a2cb-e1ec1f724d40" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,328</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5bcf15b7-3b24-491e-be29-8478daa0db7f" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,019</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Impairment of long-lived assets</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6bb73656-a6a7-4c11-8daa-d0a6001f465a" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">616</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c5359fef-6386-431f-b78e-672155e33ae3" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">616</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2aa2eb03-5fd3-4d57-aa62-c40745819e81" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,996</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_674be32a-e6ed-4810-afa2-cebe183d104b" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,457</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_cc16bb60-9c78-4f1b-8587-6c2206b4bcac" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,040</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_91a47dd0-f6ba-4c94-9ef1-51d972f38914" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">108,481</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_65e5a731-578a-4bc7-b7f2-6e62ae4adc03" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">16,250</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a7913c2e-9e2c-42f2-bfa4-9df11dc5e8ad" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">25,457</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e6c4ada4-ffd7-48e6-aa27-e988671cd5de" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">56,193</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_71fc9dc5-95b1-4656-acf9-8304984f67a8" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">108,481</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other income (expense):</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Change in fair value of warrant liability</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_81185aa5-d2d6-4545-917e-e94ddd6ec9a0" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="tsha:ChangeInFairValueOfWarrantLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100,456</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2b8c8c91-6b9f-45e6-b034-0eda67b694e4" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ChangeInFairValueOfWarrantLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100,456</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest income</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7e567cfd-d8c8-4333-81b6-7fc8dd0e6104" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:InterestIncomeExpenseNonoperatingNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,109</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9467724f-f364-4651-ada0-aaccb8210d85" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:InterestIncomeExpenseNonoperatingNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e41c13ed-f08c-4920-af7a-71dfdc0ba9c8" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:InterestIncomeExpenseNonoperatingNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,651</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3e968b7b-3af7-4393-bb08-59a27c7f1c81" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:InterestIncomeExpenseNonoperatingNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3961148e-55ac-4d20-91ae-317f7de1dbd4" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,471</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_af8dcb54-7b45-4690-811b-0b9f21f83be2" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,078</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8307644d-0844-4884-8eca-b8d9af5ae0ab" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,285</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ee87c7a4-4018-4087-b9ce-4fa689efdd4a" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,493</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other expense</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_67727ba1-005b-4240-a52f-f4ade1ad886d" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">19</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8d73978e-711a-46d9-813b-5ab7ceff193b" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6eeefc68-1f79-45eb-9d7a-93cf4d507d51" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">24</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b42c7c68-9bb8-444e-80f3-e4e841ca39c6" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">12</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total other income (expense), net</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_54a4ee3c-f8c7-4dd4-840a-992452bd3947" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">100,837</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_04492d99-14f9-424d-bc69-a05668e4b5c2" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,070</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e83acb7a-12a1-42b0-816a-1cbc0509d69b" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">103,114</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9e948b5d-feb7-4dcb-8dc7-ceb5b40dfede" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,455</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_68c18e4a-0ff0-4635-a8b1-1de6ad26042e" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">117,087</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5dff1b59-dce7-4937-a51d-d8cd95793ebf" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">26,527</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0d39384e-21ec-4ef9-9b6e-0d4d8d30e462" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">159,307</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c2309640-3e8f-4eda-bf0d-c452cb4a330f" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">110,936</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss per common share, basic and diluted</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d16815ad-6ed6-40a0-8708-77310476a397" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_58dd17d7-d881-47e3-977e-1de7aad46548" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.93</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f187561b-c0ba-4b98-81e6-3e8ccfe2796a" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_43ffbf65-0f47-4091-8959-7d635eeb885c" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.65</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_edf095de-9690-4f04-8dac-4bd468720e1a" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6c287adb-251a-4814-b95c-4e522ec91cb6" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.88</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_df3ac2f0-ece8-458e-a283-e3d1a4ffe8a7" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f1bf78d7-9991-4fba-9e10-b6f3c4b5f761" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">2.79</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted average common shares outstanding, basic and diluted</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_319e7abb-49da-4c62-a75d-e30f0c60d9f6" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_175b9d31-cc92-4b57-95be-04e35e6bb13a" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">125,700,799</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ae971ffc-4b1a-48b6-84f7-9fbbf7f0960d" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_8d6bb7e4-e0fb-4df8-8f6d-c564dad1f02d" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">40,937,808</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d9500cb0-23b5-4125-a2c9-d9b807ec79a4" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_c351466c-2e45-4880-883b-eba6e5595d59" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">84,630,796</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_121480ee-cef5-437f-8cd7-425543be0d51" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_bf8c0978-cfb5-41bb-bf11-e564fd85183a" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">39,761,764</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Taysha Gene Therapies, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_consolidated_statements_stockh"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed Consolidated Statem</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ents of Stockholders&#x2019; (Deficit) Equity</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(in thousands, except share data)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Unaudited)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the Three Months Ended September 30, 2023</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:46.92%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.96%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.38%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.54%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.54%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.66%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr style="height:7pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Additional</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Common Stock</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Paid-in</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Stockholders'</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Amount</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Capital</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Deficit</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Deficit</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Balance as of June 30, 2023</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_91e0a81a-4ef7-48c5-ab09-be18f287abbd" contextRef="C_4232a358-a09c-4ded-8c53-c1c79684fc22" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">64,432,637</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ae6a9fca-094c-4d04-8088-d4b83f224a6b" contextRef="C_4232a358-a09c-4ded-8c53-c1c79684fc22" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4452fb35-7d7a-4be8-99f2-983830de2db7" contextRef="C_aca6a365-8b8d-47ba-b0c6-cb825ca992cc" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">406,546</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2d524c56-72b9-43ab-a678-a3f51ff5e115" contextRef="C_c061af20-6853-41e3-a4ad-c8a519ad7164" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">443,661</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a61c0b39-753b-453f-8362-4e2b848daa64" contextRef="C_3dc1a85a-2423-47a1-852c-f4579e03847b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">37,114</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0a1ec276-4e42-4c98-8cc5-ebb819db0b48" contextRef="C_dbe2a760-59ec-4506-ae61-53a963aae53f" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,040</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3ce377be-a989-4def-b2f2-ff85c0ebbdf5" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,040</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Issuance of common stock in private placement, net of placement agent commission and offering costs of $</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ef56d5ad-b2f9-4f84-a669-e8e9f453530e" contextRef="C_5bdf589d-7a91-4625-927d-1d6ee35dde2c" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,098</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_67525041-61d2-43a6-a471-65029dd0e62e" contextRef="C_f938f988-ce4c-4a96-9c9e-d18ca55eb075" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">122,412,376</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ec5cdc7d-6a7b-4c96-b1b5-37378f7dbf58" contextRef="C_f938f988-ce4c-4a96-9c9e-d18ca55eb075" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2e5b9d19-2d9b-4b3b-bd7e-88a842607a41" contextRef="C_7ff33646-2760-47df-b89c-a551eb67ee08" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103,028</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_fb361efa-b3bb-42a4-a00e-615471240d07" contextRef="C_5bdf589d-7a91-4625-927d-1d6ee35dde2c" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103,029</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Issuance of common stock upon vesting and settlement of restricted stock units</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d5581a3e-ddde-4c46-8c13-3a99401eea4f" contextRef="C_b4dd4b5f-778b-4ec9-8faf-8068d96c92af" name="tsha:IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">82,780</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Issuance of common stock under ESPP</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_cf49e83d-ce08-434c-8282-ece2bbac5af7" contextRef="C_b4dd4b5f-778b-4ec9-8faf-8068d96c92af" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">32,400</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_cf402109-f2b8-4588-812d-e6c66a1397b9" contextRef="C_dbe2a760-59ec-4506-ae61-53a963aae53f" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_712f9ad1-8672-43ea-925c-6320828288d6" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5cb4be66-8f17-43a4-a1ab-16d81f69a578" contextRef="C_80322908-dd6f-45f1-92a0-5b56754ba105" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">117,087</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c79d2388-ad6d-4db8-ba09-68adc1e19542" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">117,087</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Balance as of September 30, 2023</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ec2b1cf2-93b2-4c19-9ce5-aac324c6483f" contextRef="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">186,960,193</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1f8d6d1e-e706-47d7-add7-b121a57132e3" contextRef="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_52e0f445-8819-4520-83ae-c602747258bc" contextRef="C_451c5407-a741-4c7e-bd00-1970b0bc0851" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">511,632</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_bb26db7d-e201-4aec-bd5c-ec01db683938" contextRef="C_715ad203-ffe8-49ff-9388-adf38b8f0cef" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">560,748</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a3f6648f-0304-461b-a2a7-0dfa9cd32806" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">49,114</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the Three Months Ended September 30, 2022</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:46.92%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.96%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.38%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.54%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.54%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.66%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr style="height:7pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Additional</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Common Stock</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Paid-in</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Stockholders'</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Amount</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Capital</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Deficit</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Equity</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Balance as of June 30, 2022</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b7647c69-c66a-439a-a54b-50487d18e91c" contextRef="C_14267a27-65cc-48af-8835-a0a763940651" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">41,020,086</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1e273e5b-2af3-4b2d-980d-159f5e4841b0" contextRef="C_14267a27-65cc-48af-8835-a0a763940651" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ca04e855-ba3d-422f-b2f3-1344f1d7fe0c" contextRef="C_9758b5a2-ae6e-4588-8d02-3e34f18b2c5c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">352,342</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_78f8ab95-76f1-425e-9356-9036a8aa561d" contextRef="C_8267f30d-8810-477f-a104-32649ca7a65d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">319,836</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_738c8aa2-35ed-4da3-a346-570a39ce537e" contextRef="C_41509e45-2fbe-49bb-bd92-c66a85232c95" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,507</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f092634b-0dc1-4baf-8cb1-ba718f161ef0" contextRef="C_ba166f8a-c9a3-4db9-b638-31d38de73008" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,470</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7a0f86ca-38ba-4e89-85c6-de25686d925c" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,470</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Issuance of common stock upon vesting and settlement of restricted stock units</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e86c035c-0741-4d27-b8e1-9e067cb59022" contextRef="C_3d08f4c0-b2de-4b5c-a77e-bed99023b07d" name="tsha:IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">82,780</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Issuance of common stock under ESPP</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3e7a11d6-653c-4e91-9ee4-b8acdff9479a" contextRef="C_3d08f4c0-b2de-4b5c-a77e-bed99023b07d" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">73,073</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5ed5df10-3d03-4fbc-924c-ca9555abb8d1" contextRef="C_ba166f8a-c9a3-4db9-b638-31d38de73008" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">253</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6c8c0c4c-8265-4227-81f6-cf7ec7a17d66" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">253</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3ce63c2b-3541-4724-ab34-6b0335a6f147" contextRef="C_e679b79d-3341-4675-987e-dcc562289f26" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">26,527</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6ec593cc-adb0-437b-8a2d-4afc86c50270" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">26,527</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Balance as of September 30, 2022</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9adad259-62c8-42ad-8d35-9374f31f431f" contextRef="C_c9c85128-8f32-4f62-b33e-e8c28c2b5969" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">41,175,939</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_78549080-1f45-4587-abcd-da03ec440a1f" contextRef="C_c9c85128-8f32-4f62-b33e-e8c28c2b5969" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a38e3bde-a3cb-4a80-bfed-00b04f5f3410" contextRef="C_c8ed76c8-0f36-44af-8fd2-f083fa2a50c3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">357,065</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_21a425e7-67ff-435d-a0c3-a8d96dc5ef37" contextRef="C_3fe65adb-4ffe-4988-98fd-276d9f0de168" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">346,363</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2a66cd98-1ea7-4481-8d2d-fa78055cab7a" contextRef="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,703</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Taysha Gene Therapies, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed Consolidated Statements of Stockholders&#x2019; (Deficit) Equity</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(in thousands, except share data)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Unaudited)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30, 2023</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:46.92%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.96%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.38%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.54%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.54%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.66%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr style="height:7pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Additional</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Common Stock</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Paid-in</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Stockholders'</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Amount</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Capital</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Deficit</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Equity (Deficit)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Balance as of December 31, 2022</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3d3fc4c3-34d6-412a-95bf-ebb31da9c77e" contextRef="C_f91f76fc-5e39-4eee-9c56-7105b8b287f2" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">63,207,507</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_638275d2-3b3b-40a1-a735-f7bdca51b3cd" contextRef="C_f91f76fc-5e39-4eee-9c56-7105b8b287f2" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a118a347-68b6-4270-9076-baeae49cf0c9" contextRef="C_0263ef18-95c0-4f1d-a160-663af20e3c36" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">402,389</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_24c6658e-9abe-4a8e-afdd-b66b64f6219a" contextRef="C_ec26563e-4690-407e-a176-41017d5c4238" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">401,441</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6e41b5cb-7e8b-4f6e-a526-52292b6f524b" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">949</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e2274d8d-81d9-40d0-bd6b-dbb6999cacd9" contextRef="C_cd7537ff-48e9-472a-86b6-01bf17d9a102" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,937</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b117104d-2695-47b4-8d2f-00538cbe7da5" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,937</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Issuance of common stock in private placement, net of placement agent commission and offering costs of $</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_fcbf2112-69b8-407b-a111-0675939965bd" contextRef="C_15353d77-7cae-498e-95ff-53e56b3c8df9" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,138</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a05fec02-19ee-479a-bd6c-43e4f4f66ccb" contextRef="C_7a6e813a-84dc-4c50-933b-18e61eccc073" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">123,117,594</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7dcddb0e-4499-4ff1-8966-bad198fca9ee" contextRef="C_7a6e813a-84dc-4c50-933b-18e61eccc073" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ce5d1263-0d28-4ec0-8170-b6083df0a74d" contextRef="C_ef3c29aa-a25c-41d7-ad90-3c2283143f19" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103,238</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_aab15f8c-32a7-4d5d-ab59-63692fa24821" contextRef="C_15353d77-7cae-498e-95ff-53e56b3c8df9" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">103,239</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Issuance of common stock upon vesting and settlement of restricted stock units, net</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dbbf366c-922c-423c-98c9-a7193d184e9e" contextRef="C_80f023fb-4c4f-4913-a8f0-25a04332f88c" name="tsha:IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">566,772</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Issuance of common stock under ESPP</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5fff56f2-a334-4186-8c84-335ceb1d2cd6" contextRef="C_80f023fb-4c4f-4913-a8f0-25a04332f88c" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">68,320</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_18b4aaa3-fc8d-4b33-946e-940d7561ec89" contextRef="C_cd7537ff-48e9-472a-86b6-01bf17d9a102" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ac13f7df-08f7-4bd1-9086-a387e64f22d1" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_602ff705-4908-4cdb-b685-9f4b221c4958" contextRef="C_5effed74-1ac1-4896-81fb-36ffc78da0fd" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">159,307</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e17f26a4-8403-4913-acc9-f4195536d693" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">159,307</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Balance as of September 30, 2023</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2f2b23aa-bcee-4609-a6d6-0b68e09bb60f" contextRef="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">186,960,193</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1b1a9296-e7de-4bda-88d6-29054364b4fe" contextRef="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9b18d519-cc79-442d-9895-fe8a6e78dabb" contextRef="C_451c5407-a741-4c7e-bd00-1970b0bc0851" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">511,632</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_81822b0a-7381-4728-a8f2-1b02c2aa0994" contextRef="C_715ad203-ffe8-49ff-9388-adf38b8f0cef" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">560,748</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_671e9f7c-c1cd-42c0-815c-5f97752ef047" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">49,114</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30, 2022</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:46.92%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.96%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.38%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.54%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.54%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1%;"></td>
    <td style="width:7.66%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Additional</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Common Stock</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Paid-in</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Stockholders'</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Amount</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Capital</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Deficit</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">Equity (Deficit)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Balance as of December 31, 2021</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f917292d-1f6e-41d6-9d61-1db2f29eb211" contextRef="C_5d0c08dd-ca08-469f-b519-b8ead4c58f61" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">38,473,945</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2ab44f11-bde7-4e23-8b87-42eb75870a30" contextRef="C_f5f51dd5-7ef2-471d-bd94-707e6e8d06e9" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">331,032</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f60ab6bc-6913-45ed-89c3-b012a781ca82" contextRef="C_58fa74f2-e180-43b6-b5c7-e1e48ea4adbf" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">235,649</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c4eb95b3-f277-4e48-8c23-b641e606525d" contextRef="C_9b53dc51-ef56-4848-a5a0-e8634b747a3a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">95,383</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Adjustment to beginning accumulated deficit from the </span><span style="font-size:8pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_95731e73-590b-4d8b-bc53-eed7708f5dfe;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">adoption of ASC 842</span></span></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_fa7558f3-5f31-4426-966c-430558c10cc6" contextRef="C_407b4a6b-c691-4b3a-9a19-64936d532af0" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">222</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8d0bd0cc-4058-4055-8376-7dd14f1f98ef" contextRef="C_6ea481f7-b42d-41cf-8579-8896b25d1f78" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">222</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_386ec145-d68f-4a6b-ab04-0262a71b72a4" contextRef="C_c6f58321-0fb7-430f-a653-4f529d5145cb" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,172</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_bdc5d700-5afb-4b92-9dd9-0022136564e1" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,172</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Issuance of common stock upon vesting and settlement of restricted stock units</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c02fb7f1-86b9-4328-8f9a-39f207af2944" contextRef="C_513161af-679d-453e-bcb3-fe06753ed420" name="tsha:IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">628,921</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Issuance of common stock, net of sales commissions and other offering costs of $</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3f830d23-6081-449a-8198-53f31072473c" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="tsha:PaymentOfSalesCommissionsAndOtherOfferingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">392</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_66551b7f-ac42-463f-8663-f1091fa16ece" contextRef="C_513161af-679d-453e-bcb3-fe06753ed420" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,000,000</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_fa2c3941-a7af-432a-828f-fc96606a4d57" contextRef="C_513161af-679d-453e-bcb3-fe06753ed420" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3c3916af-bc97-43e6-82fd-ec5314cc5ff7" contextRef="C_c6f58321-0fb7-430f-a653-4f529d5145cb" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,608</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4f2ce7d4-94e0-4a86-8098-16113b2b9dd4" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,609</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Issuance of common stock under ESPP</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7b6d6fc9-9c42-4324-a3b0-9e16e6174073" contextRef="C_513161af-679d-453e-bcb3-fe06753ed420" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">73,073</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2e7213ce-75e3-4dd4-a32c-aa913e1c7ccd" contextRef="C_c6f58321-0fb7-430f-a653-4f529d5145cb" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">253</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_75afba98-b57f-4edd-ba55-f0ac6aa3d2f0" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">253</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8870923a-7441-4a52-8394-efb7b99c1de4" contextRef="C_09805d8b-419c-40f4-b6d8-e5976d919ebd" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">110,936</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0d8c8ad6-e492-4034-ad01-e393946676a5" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">110,936</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Balance as of September 30, 2022</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_33fcad05-de5d-4d3c-a9c5-2c7e51260ea0" contextRef="C_c9c85128-8f32-4f62-b33e-e8c28c2b5969" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">41,175,939</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5ac1013c-825e-449d-aa55-443355e81b33" contextRef="C_c9c85128-8f32-4f62-b33e-e8c28c2b5969" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_bdf1f50e-44a6-4abe-aaac-5384dc313f77" contextRef="C_c8ed76c8-0f36-44af-8fd2-f083fa2a50c3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">357,065</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_51b6efcd-e00d-40c4-a1fe-9646f51c8313" contextRef="C_3fe65adb-4ffe-4988-98fd-276d9f0de168" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">346,363</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c3351ec4-4b2b-42d2-a900-114c81007b38" contextRef="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,703</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Taysha Gene Therapies, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="condensed_consolidated_statements_cash_f"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed Consolidated St</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">atements of Cash Flows</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(in thousands)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Unaudited)</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:67.901%;"></td>
    <td style="width:1.642%;"></td>
    <td style="width:1%;"></td>
    <td style="width:12.876999999999999%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1.642%;"></td>
    <td style="width:1%;"></td>
    <td style="width:11.936%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months<br />Ended September 30,</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash flows from operating activities</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a8f13be1-9ac3-4366-a3cb-8cd85e878cde" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">159,307</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_cf14486d-60f7-4423-92cb-624f800b7786" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">110,936</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Depreciation expense</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ac3543b8-054f-470c-be45-20f46b568a11" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,005</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2e3e62f6-4587-4a82-afc8-d6e70feef072" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">810</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development license expense</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ec81b5dd-6c8d-49cd-80c9-8d15542f9df0" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ResearchAndDevelopmentLicenseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,500</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3cd03697-6cbb-440d-b3c8-e5aa4a1db120" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="tsha:ResearchAndDevelopmentLicenseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,250</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_50be4c4e-ad13-491a-b1e5-4f75b10d68fa" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,937</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d0af85d4-502b-4705-952b-1ab53124e74f" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,940</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Change in fair value of warrant liability</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3a2234f1-c3bb-4230-b5ab-471df8866120" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100,456</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Issuance costs for pre-funded warrant liability</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_89d01131-8c58-42e0-aae8-de3e7acbe780" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:IssuanceCostsForPreFundedWarrantLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,567</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Impairment of long-lived assets</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_cb9216d1-e445-414a-b62b-c5e82b1e7006" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">616</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Non-cash lease expense</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2a4cbf84-38b4-4097-ba9b-344536bcfe08" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">908</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0a40be2a-b01a-4995-b3f2-13f0f57fcb0a" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,031</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d3e93223-37cf-4c5b-8370-91b71a86d321" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:OtherNoncashIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">581</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2bf6ebbd-8c52-49e8-9044-3f9286967d90" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:OtherNoncashIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">616</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:20pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid expenses and other assets</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3a0b7ae6-8fbc-4fd0-9efc-bc0ef8cacc49" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,008</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c3711008-9715-4711-bba6-ed0ce7e880e4" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,980</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:20pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_72b69ce4-5dc5-4c6d-ae8b-c1eb2c6ef119" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,065</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_12bd5b97-dda6-469a-b427-2c6f1a219834" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,217</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:20pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued expenses and other liabilities</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_daefd5d1-3650-42ae-a456-2445664e9d01" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,260</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b7493215-6611-4436-bffd-648fdfdf9218" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="tsha:IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">8,576</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:20pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Deferred revenue</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b2f247d0-3a3e-44d7-9ac1-ac2c59f91279" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">11,847</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f923c27d-9bcb-44b1-a9e8-a69cfde3f9dc" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">56,901</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ee24f4f5-8066-418e-9ca6-041ef6501c7f" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">103,102</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash flows from investing activities</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Purchase of research and development license</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_33adfbf0-8320-4e36-b0ec-700db2be9c04" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,500</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9df576c6-8a25-46a7-b71c-c74d6b94e265" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,250</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Purchase of property, plant and equipment</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3822ff4f-b161-40cc-9e8e-ffdbd257cf0a" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,852</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d9c9171b-335c-478d-8f65-f12d54a264f3" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,310</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_457f81a8-0704-4590-8ade-de67edcb9934" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">10</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net cash used in investing activities</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8a90202c-5864-410a-9a0f-1e6436d2dcc0" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,342</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7297cdc0-46ee-4a50-acd6-cdb712d53546" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">22,560</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash flows from financing activities</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Proceeds from issuance of common stock, net of sales commissions</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e4a1b2e4-47b8-4d64-b1c4-3c83e7ace361" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,640</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Proceeds from issuance of common stock and pre-funded warrants from private placement, net of placement agent commissions and other offering costs</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f6719ec0-e481-4793-b5c9-45b758b0d328" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">140,713</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Proceeds from issuance of common stock from private placement, net of sales commissions</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a36333de-2991-485a-96a1-e452857b0e8b" contextRef="C_15353d77-7cae-498e-95ff-53e56b3c8df9" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">500</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Payment of shelf registration costs</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_243e989a-2a08-458b-bfc9-70c41dca1e78" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:PaymentOfShelfRegistrationCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">387</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3ad40c31-0a13-46e2-b989-a483a474aa30" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="tsha:PaymentOfShelfRegistrationCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">319</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Proceeds from common stock issuances under ESPP</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f44d5adf-7855-446d-874c-d5af70f58645" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ProceedsFromStockPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8e3499f3-ae51-4be1-8ea8-277bf5826e57" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:ProceedsFromStockPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">253</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6cdee9b1-c7c2-4945-9a79-8b8b301c7833" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">253</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a876e13c-4e0c-482e-b7e1-ca083d9b7b65" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">709</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_94aa1965-bdfc-49d3-8b5d-14578e1ed543" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">140,641</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4551e776-589a-4939-9547-431a966ee5bb" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,865</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net increase (decrease) in cash, cash equivalents and restricted cash</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4d8a88b0-deaf-4121-a678-850668ae5b8b" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,398</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d3ab6378-b5a1-4510-af6f-4d311b35f792" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">114,797</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash, cash equivalents and restricted cash at the beginning of the period</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_db78b6e7-4cfd-4893-b96e-0060aeedd2df" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">90,517</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a196705b-24e7-4d2d-a79f-4719228267a5" contextRef="C_9b53dc51-ef56-4848-a5a0-e8634b747a3a" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">151,740</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash, cash equivalents and restricted cash at the end of the period</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9167cfc2-13a8-4f3e-86d9-2e511cad4b0c" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">166,915</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1aab7023-08ef-402a-ad8e-9f187961494c" contextRef="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,943</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:20pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8fd1f4b2-8169-4a53-8e2f-43374888436b" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">164,278</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_289d1fed-2dbb-4d96-9a18-383e078d6167" contextRef="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34,306</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:20pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Restricted cash</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_81c769e7-92a5-4058-9071-c70e30025a84" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:RestrictedCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,637</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d9795842-a4fd-45e8-8cfb-56b35208f408" contextRef="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf" name="us-gaap:RestrictedCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,637</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash, cash equivalents and restricted cash at the end of the period</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2988e45c-a2e3-493f-b3dd-0fab2d86b5cd" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">166,915</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4d7c2e03-4e54-4de7-873e-24fcc668aff2" contextRef="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,943</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Supplemental disclosure of cash flow information:</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash paid for interest</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f87fad18-9ba2-4b81-9f5c-5a8b086d50b3" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,665</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_23bfd193-c5b7-4e88-9141-771abc883787" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,758</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Supplemental disclosure of noncash investing and financing activities:</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property, plant and equipment in accounts payable and accrued expenses</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1118f970-9f92-4a21-88da-c38997bcfe46" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a6271304-1072-4ba1-acb0-3e34c9360022" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="tsha:PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,366</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Right-of-use assets obtained in exchange for lease liabilities</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3feb8c27-1871-4673-be19-9f34cd933a03" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,035</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Offering costs not yet paid</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0cef183d-4e88-4274-95f8-f63ebda51c1b" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">423</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3666aa39-b5ee-44f9-a45b-7b16788934de" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Issuance of warrants in connection with private placement</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_90bf28ad-5fa2-4c2b-9e33-073988f58120" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:IssuanceOfWarrantsInConnectionWithPrivatePlacement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">252</ix:nonFraction></span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c7ac8d7e-9c38-40d2-b72a-2bc13be41a09" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="note_1organization_description_business_"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 1&#x2014;Organization and Descr</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">iption of Business Operations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Taysha Gene Therapies, Inc. (the &#x201c;Company&#x201d; or &#x201c;Taysha&#x201d;) was originally formed under the laws of the State of Texas on September 20, 2019 (&#x201c;Inception&#x201d;). Taysha converted to a Delaware corporation on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f9b7a97f-fbb2-4a5b-951e-a927b9786181" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="dei:EntityIncorporationDateOfIncorporation" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">February 13, 2020</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, which had no impact to the Company&#x2019;s par value or issued and authorized capital structure.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Taysha is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Sales Agreement</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 5, 2021, the Company entered into a Sales Agreement (the &#x201c;Sales Agreement&#x201d;) with SVB Securities LLC (f/k/a SVB Leerink LLC) and Wells Fargo Securities, LLC (collectively, the &#x201c;Sales Agents&#x201d;), pursuant to which the Company may issue and sell, from time to time in its sole discretion, shares of its common stock having an aggregate offering price of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2c1a4810-7ad2-4c9f-8fb6-459690e2cd27" contextRef="C_02cd1c3a-1c6e-4efe-a03e-b7815be0c062" name="tsha:AggregateOfferingPriceFromSaleOfCommonStock" unitRef="U_USD" scale="6" decimals="INF" format="ixt:num-dot-decimal">150.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million through the Sales Agents. In March 2022, the Company amended the Sales Agreement to, among other things, include Goldman Sachs &amp; Co. LLC as an additional Sales Agent. The Sales Agents may sell common stock by any method permitted by law deemed to be an &#x201c;at-the-market offering&#x201d; as defined in Rule 415(a)(4) of the Securities Act, including sales made directly on or through the Nasdaq Global Select Market or any other existing trade market for the common stock, in negotiated transactions at market prices prevailing at the time of sale or at prices related to prevailing market prices, or any other method permitted by law. Any shares of the Company&#x2019;s common stock will be issued pursuant to the Company&#x2019;s shelf registration statement on Form S-3 (File No. 333-260069) (the &#x201c;Shelf Registration Statement&#x201d;), which the Securities and Exchange Commission (&#x201c;SEC&#x201d;) declared effective on October 14, 2021; however the Company&#x2019;s use of the Shelf Registration Statement will be limited for so long as the Company is subject to General Instruction I.B.6 of Form S-3, which limits the amounts that the Company may sell under the Shelf Registration Statement and in accordance with the Sales Agreement. The Sales Agents are entitled to receive </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_cb9936d2-313e-4e73-84fb-3704ff8825d2" contextRef="C_a5a9cdf2-731c-430f-9ea7-2e1cfb949e8a" name="tsha:PercentageOfSalePricePerShareOfCommonStock" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the gross sales price per share of common stock sold under the Sales Agreement. In April 2022, the Company sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a6b031af-6166-451a-ade4-6a9e309b03f1" contextRef="C_27463c1c-a3d9-4df6-9af4-17d723f972fa" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock under the Sales Agreement and received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_50f767fb-5a9b-4648-bf50-e3882c45f0ef" contextRef="C_27463c1c-a3d9-4df6-9af4-17d723f972fa" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">11.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in net proceeds. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9172715e-dfd4-4173-8966-b56cbe7dae9d" contextRef="C_9cb3becb-0241-4438-9d16-a477e9cdad37" name="tsha:CommonStockSharesIssuedAndSold" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> other shares of common stock have been issued and sold pursuant to the Sales Agreement as of September 30, 2023.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Liquidity and Capital Resources</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to ASC 205, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Presentation of Financial Statements</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company is required to and does evaluate at each annual and interim period whether there are conditions or events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. In its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, the Company concluded that due to inherent uncertainties in the Company&#x2019;s forecast, and after considering both quantitative and qualitative factors that were known or reasonably knowable as of the date that such condensed consolidated financial statements were issued, there were conditions present in the aggregate that raised substantial doubt about the Company&#x2019;s ability to continue as a going concern.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Following the closing of the Private Placement (as defined below) in August 2023 (see Note 10), the Company has concluded that after considering both qualitative and quantitative factors, there are no longer conditions present in the aggregate that raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. The Company has sufficient liquidity to satisfy its obligations for at least twelve months following the date of the issuance of these condensed consolidated financial statements. Accordingly, the Company has concluded that there is no longer substantial doubt about the Company&#x2019;s ability to continue as a going concern.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has incurred operating losses since inception and expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As of September 30, 2023, the Company had an accumulated deficit of </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_85839cb4-c79d-4408-a126-af3ab10ff1fd" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">560.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">million. Losses are expected to continue as the Company continues to invest in its research and development activities. Future capital requirements will depend on many factors, including the timing and extent of spending on research and development and the market acceptance of the Company&#x2019;s products. As of September 30, 2023, the Company had cash and cash equivalents of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2b9f3ef3-84fb-4c64-a094-814dda0a4976" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">164.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which the Company believes will be sufficient to fund its planned operations for a period of at least twelve months from the date of issuance of these condensed consolidated financial statements.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_55e3016b-4944-4093-a164-41e899a2cc36" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 2&#x2014;Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_927d9dad-f597-44a8-8bc7-af4da5721662" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) as determined by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X and are consistent in all material respects with those included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 28, 2023 (the &#x201c;2022 Annual Report&#x201d;). In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The consolidated balance sheet as of December 31, 2022, is derived from audited financial statements, however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in the Company&#x2019;s 2022 Annual Report.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b4b9d143-84fb-47e9-b7f5-9ee642750d02" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ConsolidationPolicyTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Principles of Consolidation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying interim condensed consolidated financial statements include the accounts of Taysha and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9419a0a0-b27b-464c-bc3c-c46914e44ae6" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:UseOfEstimates" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The most significant estimates and assumptions in the Company&#x2019;s financial statements relate to the determination of the fair value of the common stock prior to the initial public offering (&#34;IPO&#34;) (as an input into stock-based compensation), estimating manufacturing accruals and accrued or prepaid research and development expenses, the measurement of impairment of long-lived assets, the fair value of the warrant liability, and the allocation of consideration received in connection with the Astellas Transactions (as defined below) at contract inception. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#x2019;s future results of operations will be affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></ix:nonNumeric></div><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There have been no changes in the Company&#x2019;s significant accounting policies as disclosed in Note 2 to the audited consolidated financial statements included in the 2022 Annual Report, except as described below.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5d115043-0b83-4040-94d6-7b540af6bb38" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash and cash equivalents consist of funds held in a standard checking account, a standard savings account and a money market fund. The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_18d5e842-6af5-4e2c-819d-c685028e7ccc" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Assets Held for Sale</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assets and liabilities are classified as held for sale when all of the following criteria for a plan of sale have been met: (1) management, having the authority to approve the action, commits to a plan to sell the assets; (2) the assets are available for immediate sale, in their present condition, subject only to terms that are usual and customary for sales of such assets; (3) an active program to locate a buyer and other actions required to complete the plan to sell the assets have been initiated; (4) the sale of the assets is probable and is expected to be completed within one year; (5) the assets are being actively marketed for a price that is reasonable in relation to their current fair value; and (6) actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or the plan will be withdrawn. When all of these criteria have been met, the assets and liabilities are classified as held for sale in the balance sheet. Assets classified as held for sale are reported at </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the lower of their carrying value or fair value less costs to sell. The Company recorded a partial impairment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f90d1bd6-ef0b-4a0f-acf8-948c611a2632" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million during the three months ended September 30, 2023 in connection with the classification of certain assets to assets held for sale. Depreciation and amortization of assets ceases upon designation as held for sale.</span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a95962eb-2365-4517-8e27-a238692e1277" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:WarrantsPolicyPolicyTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Warrants</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s specific terms and applicable authoritative guidance in FASB ASC 480, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (&#x201c;ASC 480&#x201d;) and ASC 815,</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> Derivatives and Hedging</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#x2019;s own common shares and whether the warrant holders could potentially require &#x201c;net cash settlement&#x201d; in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period while the warrants are outstanding.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to remeasurement at each balance sheet date until the warrants are exercised or expire, and any change in fair value is recognized in the Company&#x2019;s condensed consolidated statement of operations.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_95925d93-dce1-4762-b13b-39e08c63f329" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Comprehensive Loss</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Comprehensive loss is equal to net loss as presented in the accompanying condensed consolidated statements of operations.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5c97f90a-3058-44e8-9525-bd2462761b67" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), as amended, with guidance regarding the accounting for and disclosure of leases. This update requires lessees to recognize the liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheets. This update also requires lessees and lessors to disclose key information about their leasing transactions.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_32c9359a-e9a8-4fc7-a3f3-73b9d5a4cf3b" contextRef="C_afb73dc0-9840-43ad-9af7-f5a3c969493a" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2022</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_46c772b8-901a-425a-a18f-7a5729cc8b31" contextRef="C_afb73dc0-9840-43ad-9af7-f5a3c969493a" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">adopted</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> ASU 2016-02 using the modified retrospective approach and utilizing the effective date as its date of initial application.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The Company has retrospectively changed its previously issued condensed consolidated financial statements as of September 30, 2022 as presented within the Company&#x2019;s September 30, 2022 Quarterly Report on Form 10-Q to reflect the adoption of ASC 842 on January 1, 2022. The condensed consolidated financial statements for the three and nine months ended September 30, 2022 presented herein differ from the Company&#x2019;s condensed consolidated financial statements included in the Company&#x2019;s September 30, 2022 Quarterly Report on Form 10-Q as those condensed consolidated financial statements were prepared using the former accounting standard referred to as ASC Topic 840, Leases.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company elected the following practical expedients, which must be elected as a package and applied consistently to all of its leases at the transition date (including those for which the entity is a lessee or a lessor): i) the Company did not reassess whether any expired or existing contracts are or contain leases; ii) the Company did not reassess the lease classification for any expired or existing leases (that is, all existing leases that were classified as operating leases in accordance with ASC 840 are classified as operating leases, and all existing leases that were classified as capital leases in accordance with ASC 840 are classified as finance leases); and iii) the Company did not reassess initial direct costs for any existing leases. For leases that existed prior to the date of initial application of ASC 842 (which were previously classified as operating leases), a lessee may elect to use either the total lease term measured at lease inception under ASC 840 or the remaining lease term as of the date of initial application of ASC 842 in determining the period for which to measure its incremental borrowing rate. In transition to ASC 842, the Company utilized the remaining lease term of its leases in determining the appropriate incremental borrowing rates.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The adoption of this standard resulted in the recognition of operating lease right-of-use assets and operating lease liabilities of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5064d37c-f65f-43ed-a30f-9dc78f71328a" contextRef="C_afb73dc0-9840-43ad-9af7-f5a3c969493a" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">18.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f1ad92e5-323d-4469-bc63-af3e27764c73" contextRef="C_afb73dc0-9840-43ad-9af7-f5a3c969493a" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">19.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, on the Company&#x2019;s condensed consolidated balance sheet at adoption relating to its operating leases. The lease liabilities were determined based on the present value of the remaining minimum lease payments. Upon adoption of ASC 842, the Company also (i) derecognized the build-to-suit lease asset of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ef560271-daf5-4c83-ba76-a434a2c5cb46" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">26.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million previously presented in property, plant and equipment, (ii) derecognized the build-to-suit lease liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4cfa970f-9fb6-4a11-866e-79f2fa23e7ce" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:DerecognizedBuildToSuitLeaseLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">26.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, and (iii) eliminated $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_87360ca5-9820-40f4-8bf6-5b50b1dc069c" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:DeferredRentLiabiilitiesAndTenantImprovementAllowances" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of deferred rent liabilities and tenant improvement allowances as of January 1, 2022, as these liabilities are reflected in the operating lease right-of-use assets. In adopting ASU 2016-02, the Company recorded a total one-time adjustment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c58b3dc9-f3ef-4622-a70c-4d76ce3c11bc" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:CumulativeEarningsDeficit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million to the opening balance of accumulated deficit as of January 1, 2022, related to the de-recognition of the build-to-suit lease asset and related build-to-suit lease obligation. The adoption </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a1660a95-a59c-43e9-bd21-a30eff4d9fc6" contextRef="C_afb73dc0-9840-43ad-9af7-f5a3c969493a" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">did not</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> have a material impact on accumulated deficit and on the condensed consolidated statements of operations and cash flows.</span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c511b058-9aab-427d-a0c3-2c7e503df1dd" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations and statement of cash flows for the nine months ended September 30, 2022 (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:54.498%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:12.366%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre ASC 842 Nine Months Ended<br />September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASC 842 Adjustments</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">After ASC 842 Nine Months Ended<br />September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_c235bfe5-b369-4c89-8e3c-24a2b2c671cb;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed</span></span></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Consolidated Statement of Operations</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating expenses:</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0c3cbcb6-e7be-4991-a71a-8453f7433904" contextRef="C_f346f496-91c4-40a5-b151-c5aa7e20a131" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77,308</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2eaca8fc-a0bc-42bf-a128-6e64e8767352" contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,154</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_25e4f396-b102-4c1e-9d6e-0541930e7646" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78,462</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other income (expense):</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f6dffa40-0c32-4fbe-85f9-ed28585ebbbb" contextRef="C_f346f496-91c4-40a5-b151-c5aa7e20a131" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,002</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8f99f1c8-108f-4efd-b95d-924ad1840e81" contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">509</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_565fa6c7-c51e-4d4e-9cf6-f02285b5fd27" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,493</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0b44acad-ca44-4c4d-8390-f1f26da3dd37" contextRef="C_f346f496-91c4-40a5-b151-c5aa7e20a131" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">110,291</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1ee04bcc-ecfc-4678-97f4-bc18f57e0359" contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">645</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1405e0d8-7b7b-4b9f-8c3f-6c8cb4df9a8c" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">110,936</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed Consolidated Statement of Cash Flows</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Depreciation expense</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6b881678-78da-47bf-89bc-3cab1cbd41bf" contextRef="C_f346f496-91c4-40a5-b151-c5aa7e20a131" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">808</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_070e5678-9cbb-48e6-b503-fb3a4a7867d8" contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_740ab599-5810-43c9-af41-b0a28cab4d86" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">810</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Non-cash lease expense</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_104598ce-7836-4445-96d1-b50be7e52cb4" contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,031</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6b7ee46e-fc16-4038-a00b-50ace86de29b" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,031</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;&#160;Accrued expenses and other current liabilities</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_38039a88-ff71-46ef-b55e-de573c2a5496" contextRef="C_f346f496-91c4-40a5-b151-c5aa7e20a131" name="tsha:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,753</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_632def47-773a-4ac7-98ef-bf2a2e475fb8" contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4" name="tsha:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">823</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_24f0400d-537f-404c-9de6-1cbc6c1b84c6" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="tsha:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">8,576</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash flows from financing activities</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2c0e4160-8b0b-448a-a9c0-9d421acfca20" contextRef="C_f346f496-91c4-40a5-b151-c5aa7e20a131" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,144</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0d22f4cc-c0c7-416b-ab27-3b9415eb1583" contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">435</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0aa3a5c6-1c01-4cc9-91ac-779f2b019912" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">709</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Supplemental disclosure of noncash investing and financing activities:</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Right-of-use assets obtained in exchange for lease liabilities</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5ddb2696-3923-4b84-8a7e-e8d33e5a7cdc" contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,035</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_de38802d-cd6c-4295-af22-413d0de6e65d" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,035</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations for the three months ended September 30, 2022 (in thousands):</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:54.498%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:12.366%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre ASC 842 Three Months Ended<br />September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASC 842 Adjustments</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">After ASC 842 Three Months Ended<br />September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_3d5ea955-cb63-460e-9ac4-0cc91b6e0847;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed</span></span></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Consolidated Statement of Operations</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating expenses:</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_67d63899-1bb0-484d-8c87-edd6e26ab89e" contextRef="C_10334e6e-f910-467c-a8bf-bccc2eb4ec31" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,391</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a8839044-1d15-42a1-a604-d9b04a324017" contextRef="C_e42d8932-a6cb-47d7-883a-506fc278ba6a" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">383</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_79cf2757-ba9f-463d-8cee-2a4a9e0b7300" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,774</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other income (expense):</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f2c4878a-58ef-44a3-a1ed-5fdf63bf69cf" contextRef="C_10334e6e-f910-467c-a8bf-bccc2eb4ec31" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,241</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_441b8914-31de-46e0-b2ae-78b47d20ebb8" contextRef="C_e42d8932-a6cb-47d7-883a-506fc278ba6a" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">163</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_53592727-a99d-406b-8b02-1866c7e7bad2" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,078</ix:nonFraction></span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1336323d-b76c-4b3a-8e14-2f0da68361b3" contextRef="C_10334e6e-f910-467c-a8bf-bccc2eb4ec31" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">26,307</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d8871b70-d164-4464-88df-3861fd4f35fb" contextRef="C_e42d8932-a6cb-47d7-883a-506fc278ba6a" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">220</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_83e95a2f-690d-4082-a718-d1692630f49c" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">26,527</ix:nonFraction></span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
        </table></ix:nonNumeric></div></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_add60778-1e81-4881-a327-cc2241132f20" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:FairValueDisclosuresTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 3&#x2014;Fair Value Measurements</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e62f40d1-1418-450e-8660-ffe3d7eb2546" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following tables present information about the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values (in thousands):</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.487%;"></td>
        <td style="width:1%;"></td>
        <td style="width:11.149%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.263%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.525%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.263%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.525%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.263%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.525%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assets:</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;&#160;&#160;Cash equivalents &#x2013; money market funds</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e7edd8bc-f81b-463b-b2ba-a0a7e604a8ac" contextRef="C_89723ac2-2fad-4cb4-b5fc-51a86fd96b12" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150,514</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_105d961a-c975-4b67-90db-d51b37abc001" contextRef="C_f438b467-3326-45e8-9282-1549429f210e" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150,514</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ae0e6e94-6d42-449a-98d1-1d5e970a3352" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150,514</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e6b0c43d-20da-4899-8de8-f434e8ba1db5" contextRef="C_29c4a552-4734-47bc-be8c-3e643d34d362" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150,514</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Liabilities:</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant liability</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;&#160;&#160;SSI Warrants</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_32f283cd-7278-4c51-828f-eb0a08917984" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:SsiWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">701</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_adef2980-a607-4f66-9666-720b5ae81d21" contextRef="C_8e476623-2cf0-4fe3-b12e-9c905fead252" name="tsha:SsiWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">701</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;&#160;&#160;Pre-funded warrants</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7895aff2-9e30-462d-a8c1-35ce88cc9ddc" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:PreFundedWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">139,833</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b899e91f-c1b0-4747-b7ea-7db78bb8e7cc" contextRef="C_8786aa0e-05e3-4061-9f46-80d5e9b63b63" name="tsha:PreFundedWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">139,833</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total liabilities</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_422d3738-e8fd-4f6d-acac-153378794476" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">140,534</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_14081e8d-b4f6-4ead-b1ff-24985a8fd61c" contextRef="C_8786aa0e-05e3-4061-9f46-80d5e9b63b63" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">139,833</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a2b849af-155e-449c-b892-48385f907fad" contextRef="C_8e476623-2cf0-4fe3-b12e-9c905fead252" name="us-gaap:LiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">701</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company classifies its money market funds, which are valued based on quoted market prices in an active market with no valuation adjustment, as Level 1 assets within the fair value hierarchy.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company uses the Black-Scholes-Merton option pricing model to determine the fair value of the SSI Warrants (as defined below). The Company classifies its Pre-Funded Warrants (as defined below), which are valued using quoted prices of similar financial instruments in the market, as Level 2 liabilities. S</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ee Note 10 for additional information on the SSI Warrants and the Pre-Funded Warrants.</span></p></ix:nonNumeric></div>
  <div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3ae8ed67-8a3c-4455-9074-07d573d42104" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 4&#x2014;Balance Sheet Components</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2369e6a5-30c7-4416-a984-cb053cab1a04" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br />2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31,<br />2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid research and development</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c6e26e63-0620-4844-8c3c-c4462846eccc" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:PrepaidResearchAndDevelopmentContracts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,672</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2b122f53-2bae-46e6-9423-085632cb0960" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="tsha:PrepaidResearchAndDevelopmentContracts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,840</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid clinical trial</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_22d35b4c-559f-40ed-b4a2-4881ece7845d" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:PrepaidClinicalTrial" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,392</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a8d3ec45-efdc-4da1-a8d0-9c6358ad666b" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="tsha:PrepaidClinicalTrial" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,119</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Deferred offering costs</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c45924eb-0db3-4d45-a2fc-72c3078a347f" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:DeferredOfferingCosts" unitRef="U_USD" scale="3" decimals="-3">724</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b9ed8917-1320-4149-80cc-6f80b391a557" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:DeferredOfferingCosts" unitRef="U_USD" scale="3" decimals="-3">724</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid insurance</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2b395e23-5869-4831-830d-a234750a5b26" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:PrepaidInsurance" unitRef="U_USD" scale="3" decimals="-3">337</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7b59eb06-c1ea-43ef-ab5e-8145e8017b79" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:PrepaidInsurance" unitRef="U_USD" scale="3" decimals="-3">388</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_10164f86-8c37-434a-93af-4c6cb534b172" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3">404</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_800baabb-e847-4919-9ad5-b49b9c571c88" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3">466</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total prepaid expenses and other current assets</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7aabf20f-97e3-49ad-bc47-85dcf25c0c62" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,529</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c08eb56c-c799-4a6b-9040-03fa2ab7c993" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,537</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_02046928-70ff-4d0f-bd3e-a0ddb14d1c86" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property, plant and equipment, net consisted of the following (in thousands):	</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br />2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31,<br />2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_05d1a5b2-d61f-4a33-b46b-3680e91d32c3" contextRef="C_2d3969b3-1904-49b7-9987-89bee52040f5" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,091</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9edeb595-b3ed-40be-8110-5cc727cf5e4c" contextRef="C_afb7066a-ec3f-492c-abdf-4728d171d8a0" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,091</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Laboratory equipment</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ac532878-9a7a-4593-a0c9-e54996995090" contextRef="C_c21847ad-1728-4953-9228-368c4f2998f2" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,868</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f3b25d27-36e5-4c57-8db6-14e2ab630206" contextRef="C_3e6ad8f3-e3b2-4766-81e6-638c50b9a854" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,868</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e94707b8-fd3d-4834-b6c6-d0b5ef4ca0e8" contextRef="C_31bb6c1a-64e4-43f2-ac13-da2509eeeef2" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,115</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b5a8cc82-8f4c-45e9-88a8-2c04a716e819" contextRef="C_a8165939-afd1-4d28-97a4-17ac213a88aa" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,115</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2ec41ad1-ea9d-4566-bf61-5a5db2f5ac3e" contextRef="C_2db1cf9d-e412-454a-abb7-673182786e9b" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3">864</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_97837f61-722f-4f99-984f-2653be955b92" contextRef="C_c880fb70-98ec-4743-b3ec-50abce55fb61" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3">898</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Construction in progress</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dfe9e20d-3dc9-41c5-b78c-5c9a3a3304a4" contextRef="C_63dd2c50-f529-4540-bf31-b0caef7db5c3" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,874</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2e9457ae-6c2c-4435-85a5-162205f60ab6" contextRef="C_49ea514f-2749-4ec3-b1be-bc456b767a33" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,633</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_aadc76bd-44ce-47be-840d-c3bdae021f34" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,812</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_27cb081f-b114-4278-998c-bfd26533d88b" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,605</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accumulated depreciation</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dc7f2e6a-0510-4477-87ca-42e63cfcd496" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,643</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_466dfb04-14cc-4ccc-8e5f-efa43f9abddb" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,642</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property, plant and equipment, net</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5df56936-5d93-4a8b-b666-b697bb5ff012" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,169</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_75d6ee6c-5a31-4e08-8d84-06365d5f1c41" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,963</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In November 2022, the Company recognized a non-cash impairment charge of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_08015c26-338f-43e7-9eb0-1947514a1dd0" contextRef="C_7f2b298a-2b65-407d-9b6b-4e8ad3ab3b4a" name="us-gaap:AssetImpairmentCharges" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">36.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the manufacturing facility asset group, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9b4f9619-281e-43ed-b73f-ecdb7631ee19" contextRef="C_3826a1af-5558-42d4-951c-d3a6f47c100b" name="tsha:ConstructionInProgressAndFinanceLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">26.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million relates to construction in progress and finance lease right-of-use assets. The impairment charge was estimated using a discounted cash flow model and recorded in the consolidated statements of operations for the year ended December 31, 2022. Property, plant and equipment, net includes </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b0082228-dfef-4e74-9eae-0727e7ba1e2c" contextRef="C_2d977a75-9f73-4edb-9392-84ff074a6057" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> mi</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">llion and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c9c1fcab-ded5-445b-b7be-add53d2c0ebc" contextRef="C_d2c65442-11b0-4704-bbf6-bea92b060507" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of assets capitalized as finance leases as of September 30, 2023 and December 31, 2022, respectively.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Depreciation expense w</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">as $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a3da04ba-90c1-4593-b200-860c31ea7ad0" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:Depreciation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b460b74c-d46e-41b3-b29b-f8c50ae4c655" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:Depreciation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the three months ended September 30, 2023 and 2022, respectively. Depreciation expense was</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8debac72-7b6b-415c-bb23-7cc945c177c6" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:Depreciation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> milli</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">on and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_18bb08a0-0cd9-4c01-bcff-f807769e4ba0" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:Depreciation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the nine months ended September 30, 2023 and 2022, respectively.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the three months ended September 30, 2023, the Company committed to a plan to sell specific pieces of equipment originally intended for use in the Company&#x2019;s manufacturing facility in Durham, NC. The Company determined that this equipment met the requirements to be classified as held for sale. The sale is expected to be completed within one year. During the three and nine</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">months </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ended September 30, 2023, the Company recorded an impairment loss of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_733ba1af-f372-4ab7-b40f-940ae31a87b0" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_15debbcd-1453-42d4-9d27-8298598e41c6" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">0.6</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which was the difference between the carrying value and fair value less cost to sell.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_da9dc036-0cca-44b3-9b49-c355a08a1e1c" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued expenses and other current liabilities consisted of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br />2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31,<br />2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued research and development</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ab37fa38-8476-4e50-9dcf-1400cdaee42c" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:AccruedResearchAndDevelopmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,699</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_fddf0e6a-7fc7-41ec-b427-65b84206155c" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="tsha:AccruedResearchAndDevelopmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,190</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued compensation</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_38fb16cd-6005-4872-9c94-a35bc6798d71" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,745</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_da6da6ea-e2c5-427e-bf64-ae9ba08281ab" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,519</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lease liabilities, current portion</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_41186d13-85e0-430c-9c34-c40820da46c8" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:LeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,538</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c46ca0ac-16a8-447c-9ced-42a511b3970c" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="tsha:LeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,521</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued clinical trial</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8c36c8bb-8cac-4d86-8491-dd9031fc1ed7" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:AccruedClinicalTrialCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,359</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5e77389f-ee99-4be5-8258-f9506fd9c639" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="tsha:AccruedClinicalTrialCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,473</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued severance</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ee31d2a3-b349-4fc8-ada3-84d8559def74" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:AccruedSeverance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">992</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c6ec0734-a0bf-4f0a-96e6-9256fe4e300e" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="tsha:AccruedSeverance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,463</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued professional and consulting fees</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dfcf3534-99e3-4d49-8205-597bdfc52299" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">579</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9716097f-524a-4316-bb74-897da6dfbae8" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">390</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued property, plant and equipment</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_99c387af-9fe3-40fe-a20a-dfbbdbfea3af" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:AccruedPropertyPlantAndEquipmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_106b3755-2cf8-4abe-b701-222072f6e1ef" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="tsha:AccruedPropertyPlantAndEquipmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,081</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8362be7c-dfa9-4bcc-9d80-9efc2de29f71" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">681</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_87602525-d00c-4ae3-a2bc-809d3d0c369d" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">650</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total accrued expenses and other current liabilities</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1af54469-7bbb-4755-9ba9-1fd046c001d9" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,638</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9c574ba1-4fb0-4c05-89af-7438838090b1" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,287</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f717141a-ce61-4066-a3f9-5b84c5da78f9" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:LesseeOperatingLeasesTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 5&#x2014; Leases</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company leases certain office, laboratory, and manufacturing space.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Dallas Lease</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On January 11, 2021, the Company entered into a lease agreement (the &#x201c;Dallas Lease&#x201d;) with Pegasus Park, LLC, a Delaware limited liability company (the &#x201c;Dallas Landlord&#x201d;), pursuant to which the Company will lease approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_837a0ae3-728a-4fcc-84a9-9fd898dbbc68" contextRef="C_9eccec65-aa13-4b7b-8210-aa887edfcc29" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" unitRef="U_sqft" decimals="0" format="ixt:num-dot-decimal">15,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square feet of office space at 3000 Pegasus Park Drive, Dallas, Texas 75247 (the &#x201c;Office Space&#x201d;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Dallas Lease commenced on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_93803869-f59b-4751-b83f-114b385d74b1" contextRef="C_5ff63508-7308-4b13-b74d-9cf9982f8736" name="us-gaap:OperationsCommencedDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">May 27, 2021</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, and has a term of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_67318a11-065a-44bb-bdb0-57150b9c493f" contextRef="C_9eccec65-aa13-4b7b-8210-aa887edfcc29" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c9528032-3fe9-48d1-9bed-510d99603420" contextRef="C_5ff63508-7308-4b13-b74d-9cf9982f8736" name="us-gaap:LesseeOperatingLeaseOptionToExtend"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company has an option to extend the term of the Dallas Lease for one additional period of five years.</span></ix:nonNumeric></span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Dallas Landlord has the right to terminate the Dallas Lease, or the Company&#x2019;s right to possess the Office Space without terminating the Dallas Lease, upon specified events of default, including the Company&#x2019;s failure to pay rent in a timely manner and upon the occurrence of certain events of insolvency with respect to the Company.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Dallas Lease Expansion</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On December 14, 2021, the Company amended the Dallas Lease (the &#x201c;Dallas Lease Amendment&#x201d;) with the Dallas Landlord, pursuant to which the Company will lease approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_95c70711-0670-4936-ab63-2ed50fda6347" contextRef="C_52fa6299-e193-4168-a292-1d334991839a" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" unitRef="U_sqft" decimals="0" format="ixt:num-dot-decimal">18,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square feet of office space adjacent to the Office Space at 3000 Pegasus Park Drive, Dallas, Texas 75247 (the &#x201c;Expansion Premises&#x201d;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The Dallas Lease Amendment commenced on July 1, 2022, and has a term of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fe587f63-d525-48bd-954b-5674456790c7" contextRef="C_52fa6299-e193-4168-a292-1d334991839a" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is obligated to pay operating costs and utilities applicable to the Expansion Premises. Total future minimum lease payments under the Dallas Lease Amendment over the initial </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ccba435e-1d9f-4298-8ef0-508f801381b7" contextRef="C_52fa6299-e193-4168-a292-1d334991839a" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> term are approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f5b112a4-c288-49fb-913d-76a817c57c19" contextRef="C_52fa6299-e193-4168-a292-1d334991839a" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. The Company will be responsible for costs of constructing interior improvements within the Expansion Premises that exceed a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b2fdf68b-9e21-473c-ad50-e513b5d4def7" contextRef="C_865be14a-e277-45f2-b305-9aa13e3a0315" name="tsha:MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" unitRef="U_sqft" scale="0" decimals="2" format="ixt:num-dot-decimal">40.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per rentable square foot construction allowance provided by the Dallas Landlord.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has a right of first refusal with respect to certain additional office space on the 15</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">th</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> floor at 3000 Pegasus Park Drive, Dallas, Texas 75247 before the Dallas Landlord accepts any offer for such space.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Durham Lease</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On December 17, 2020, the Company entered into a lease agreement (the &#x201c;Durham Lease&#x201d;) with Patriot Park Partners II, LLC, a Delaware limited liability company (the &#x201c;Durham Landlord&#x201d;), pursuant to which the Company agreed to lease approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_496bb1f4-1d99-480b-9594-1f154bb2824e" contextRef="C_8d03e9bb-23a1-464b-940a-dd1c8ec2a91b" name="us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" unitRef="U_sqft" decimals="0" format="ixt:num-dot-decimal">187,500</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square feet of a manufacturing facility located at 5 National Way, Durham, North Carolina (the &#x201c;Facility&#x201d;). The Durham Lease commenced on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d50a21c1-6d0c-4e4a-b934-f5cf8d12b3ba" contextRef="C_6de550d8-31ef-460a-ab24-a8f077bb2101" name="us-gaap:OperationsCommencedDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">April 1, 2021</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and is expected to have a term of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c7467d0a-c9ed-424a-aa67-e01809c2f821" contextRef="C_8d03e9bb-23a1-464b-940a-dd1c8ec2a91b" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">fifteen years and six months</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_46146595-d4bb-4171-badd-5fb0d6f94c41" contextRef="C_b1703001-53ce-4fd2-a321-a0b32037899b" name="us-gaap:LesseeOperatingLeaseOptionToExtend"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company has two options to extend the term of the Durham Lease, each for a period of an additional </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6cd6e812-ab5d-410e-b800-5168832d9a44" contextRef="C_8d03e9bb-23a1-464b-940a-dd1c8ec2a91b" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">five years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></ix:nonNumeric></span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company was not required to provide a security deposit in connection with its entry into the Durham Lease. The Company will be responsible for constructing interior improvements within the Facility. The Company was required to place $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e2de3653-a2c0-4345-9d18-51575bed0434" contextRef="C_a36762fa-d31c-45ad-af2e-461829666801" name="us-gaap:EscrowDeposit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in an escrow account which will be released when the improvements are substantially complete. The escrow funds are recorded as restricted cash on the condensed consolidated balance sheet as of September 30, 2023. The Durham Landlord has the right to terminate the Durham Lease upon specified events of default, including the Company&#x2019;s failure to pay rent in a timely manner and upon the occurrence of certain events of insolvency with respect to the Company.</span></p><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Summary of all lease costs recognized under ASC 842</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e56107ae-a440-4c05-9381-5e2e21c989fc" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the lease costs recognized under ASC 842 and other information pertaining to the Company&#x2019;s operating leases for the three and nine months ended September 30, 2023 and 2022 (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:36.628%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.314%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.314%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.223%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.937%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.764%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.817%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="5" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Three Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating lease cost</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a75347cc-611d-4750-b8d1-5c7569e4db08" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">696</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0fd5dec8-a695-4393-9983-91d65cb4ca61" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">794</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_42d01fdf-6b34-4ef3-b296-21bbee7fa212" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,088</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_78980256-de87-4f7a-9094-5ad955ffffc7" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,079</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Variable lease cost</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d4ada43a-1a88-4526-a086-6787e3edb350" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">243</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f9898f54-3e9a-449b-b8df-3ecb4e0c2ab4" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">229</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3f7f45fa-77b1-4df8-b3ab-713c348dc01a" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">729</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a461db72-1637-4da1-9c9e-70739719790a" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">617</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total lease cost</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_12b7cb8e-3eb8-42fe-9af2-f56967239780" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">939</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_fd5e0ba5-fd72-4e33-ab1d-16d671c23eab" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,023</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_57468358-1da4-4c90-a076-95e98a7dae96" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,817</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4059405f-0136-463d-bcfa-61ee2620b8fb" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,696</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_12657e78-4713-4243-8997-a5add12171fe" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Supplemental information related to the remaining lease term and discount rate are as follows:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:54.052%;"></td>
        <td style="width:1.545%;"></td>
        <td style="width:1%;"></td>
        <td style="width:22.212%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:18.19%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted average remaining lease term (in years) &#x2013; Finance leases</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_603d8ed2-1fa8-464f-a77c-5d5c345f286f" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.13</span></ix:nonNumeric></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_16b8fcaf-0b5b-4a93-89e4-dd8a09f46b63" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.88</span></ix:nonNumeric></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted average remaining lease term (in years) &#x2013; Operating leases</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0851ca30-2c62-4879-8e3d-307dd918935b" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10.97</span></ix:nonNumeric></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_48705012-0381-466b-a22a-8040b0385853" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11.45</span></ix:nonNumeric></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted average discount rate &#x2013; Finance leases</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3c2a6ed8-9a88-4ffd-a9ab-4f97af601e7c" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">10.52</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7276c2d4-2a66-431a-8af5-e20bf562e06c" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">10.51</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted average discount rate &#x2013; Operating leases</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_40fffc75-286d-406a-8ca1-b5a835a71559" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">7.79</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_08cb5bd0-8592-4b07-a817-ee77973312f8" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">7.72</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><ix:nonNumeric id="F_958f357b-0c54-4045-9498-f6bdf656b147" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Supplemental cash flow information related to the Company&#x2019;s operating leases are as follows (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:52.723%;"></td>
        <td style="width:1%;"></td>
        <td style="width:20.627%;"></td>
        <td style="width:1%;"></td>
        <td style="width:2.022%;"></td>
        <td style="width:1%;"></td>
        <td style="width:20.627%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating cash flows for operating leases</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a8aa0785-6a4e-4860-8fd1-3d8e25cee974" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,109</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ea846e0a-8e17-4aff-885f-1cb5dbf545a1" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">847</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_89fdf85e-f685-46d5-953b-5c3508977aca" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023, future minimum commitments under ASC 842 under the Company&#x2019;s operating and finance leases were as follows (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:51.682%;"></td>
        <td style="width:1%;"></td>
        <td style="width:22.389%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:21.927999999999997%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Year Ending December 31,</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Finance</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_31dc40f7-a309-4b33-8ed1-10b53b240e43" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">686</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6fb4f3e1-6d52-4780-8a4b-dad7ba6adee6" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">114</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_94844b45-35c7-41e3-83ce-1e6ef9b0e088" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,810</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_fa9e1c51-a22e-4db6-9998-aea499400f68" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">454</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1d6b035c-99df-4eb3-a7ec-9e80854d058d" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,910</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f3ae3c9e-8b63-48fb-8815-73396a8f880c" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">454</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_bc9fcae9-ceca-4412-85c0-1392a85d482e" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,485</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c6c8e510-87df-4106-a963-c15073ae182b" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">399</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_53588910-8b07-4942-a952-2fd6fe1ef52d" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,577</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Thereafter</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e8c897f3-7a50-46d8-b36f-f37a4b9c96d8" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,721</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total lease payments</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d173bea5-d699-4e18-990a-0004f74d2af4" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,189</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e94173e3-cd36-466a-926b-823479c3a80c" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,421</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_276af2f8-7fb2-463f-8d61-dc522f2b3a13" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,895</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4cc208aa-37a0-475e-9eb2-bc84a4d61b89" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">242</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total lease liabilities</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6ac980d4-e064-4ef7-a808-9748a5e22176" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,294</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dd7de99e-4e39-4968-88c2-fd3c4b3804f3" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:FinanceLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,179</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_3e78f387-05e6-4d7c-88d4-c13b0a4b78ec;"><span style="-sec-ix-hidden:F_dbeee014-7927-4ce5-8253-ba65a26dca89;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lease liabilities, current</span></span></span></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e53b50fd-82bf-4967-a769-c5cca9a57140" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,193</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b29d2a7d-7132-4237-a9b3-194c173e1e38" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">345</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b7b24932-76e0-4234-83dc-e0defb7581aa;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lease liabilities, non-current</span></span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_05d86439-b904-452a-8371-c74e0f4fe7e1" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,101</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_accc5487-7c3e-4059-bfbd-8a1c1752c012" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">834</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1ede665f-e147-4c30-a4ac-9f4f220b3eda;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total lease liabilities</span></span></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_90c4cc56-e66f-4080-93b1-9c96a6558b3d" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,294</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e87e6cd1-f653-4e33-a409-920e9c8263c7" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:FinanceLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,179</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div>
  <p style="margin-left:2.133%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">12</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_873fc97c-d77d-4b49-9fc3-6f4208731867" contextRef="C_e6e5f371-c876-4258-be9b-7f8411f4ff7e" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 6&#x2014;Astellas Agreements</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 21, 2022 (the &#x201c;Effective Date&#x201d;), the Company entered into the Option Agreement (the &#x201c;Option Agreement&#x201d;) with Audentes Therapeutics, Inc. (d/b/a Astellas Gene Therapy)(&#x201c;Astellas&#x201d;), pursuant to which the Company granted to Astellas an exclusive option to obtain an exclusive, worldwide, royalty and milestone-bearing right and license (A) to research, develop, make, have made, use, sell, offer for sale, have sold, import, export and otherwise exploit, or, collectively, exploit, the product known, as of the Effective Date, as TSHA-120 (the &#x201c;120 GAN Product&#x201d;), and any backup products with respect thereto for use in the treatment of Giant Axonal Neuropathy (&#x201c;GAN&#x201d;) or any other gene therapy product for use in the treatment of GAN that is controlled by Taysha or any of its affiliates or with respect to which the Company or any of its affiliates controls intellectual property rights covering the exploitation thereof, or a GAN Product, and (B) under any intellectual property rights controlled by Taysha or any of its affiliates with respect to such exploitation (the &#x201c;GAN Option&#x201d;). Subject to certain extensions, the GAN Option was exercisable from the Effective Date through a specified period of time following Astellas&#x2019; receipt of (i) the formal minutes from the Type B end-of-Phase 2 meeting between Taysha and the FDA in response to the Company&#x2019;s meeting request sent to the FDA on September 19, 2022 for the 120 GAN Product (the &#x201c;Type B end-of-Phase 2 Meeting&#x201d;), (ii) all written feedback from the FDA with respect to the Type B end-of-Phase 2 Meeting, and (iii) all briefing documents sent by Taysha to the FDA with respect to the Type B end-of-Phase 2 Meeting.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Option Agreement, the Company also granted to Astellas an exclusive option to obtain an exclusive, worldwide, royalty and milestone-bearing right and license (A) to exploit any Rett Product (as defined below), and (B) under any intellectual property rights controlled by Taysha or any of its affiliates with respect to such exploitation (the &#x201c;Rett Option,&#x201d; and together with the GAN Option, each, an &#x201c;Option&#x201d;). Subject to certain extensions, the Rett Option is exercisable from the Effective Date through a specified period of time following Astellas&#x2019; receipt of (i) certain clinical data from the female pediatric trial and (ii) certain specified data with respect to TSHA-102, such period, the Rett Option Period, related to (i) the product known, as of the Effective Date, as TSHA-102 and any backup products with respect thereto for use in the treatment of Rett syndrome, and (ii) any other gene therapy product for use in the treatment of Rett syndrome that is controlled by Taysha or any of its affiliates or with respect to which the Company or any of its affiliates controls intellectual property rights covering the exploitation thereof (a &#x201c;Rett Product&#x201d;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The parties have agreed that, if Astellas exercises an Option, the parties will, for a specified period, negotiate a license agreement in good faith on the terms and conditions outlined in the Option Agreement, including payments by Astellas of a to be determined upfront payment, certain to be determined milestone payments, and certain to be determined royalties on net sales of GAN Products and/or Rett Products, as applicable.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the Rett Option Period, the Company has agreed to (A) not solicit or encourage any inquiries, offers or proposals for, or that could reasonably be expected to lead to, a Change of Control (as defined in the Option Agreement), or (B) otherwise initiate a process for a potential Change of Control, in each case, without first notifying Astellas and offering Astellas the opportunity to submit an offer or proposal to the Company for a transaction that would result in a Change of Control. If Astellas fails or declines to submit any such offer within a specified period after the receipt of such notice, the Company will have the ability to solicit third party bids for a Change of Control transaction. If Astellas delivers an offer to the Company for a transaction that would result in a Change of Control, the Company and Astellas will attempt to negotiate in good faith the potential terms and conditions for such potential transaction that would result in a Change of Control for a specified period, which period may be shortened or extended by mutual agreement.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As partial consideration for the rights granted to Astellas under the Option Agreement, Astellas paid the Company an upfront payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9e14ae18-f2a5-4d76-95e4-2edd9b70d236" contextRef="C_41f81af9-f063-4fcb-9aee-fe6cb9bc2fc8" name="tsha:UpfrontPayment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million (the &#x201c;Upfront Payment&#x201d;). Astellas or any of its affiliates shall have the right, in its or their discretion and upon written notice to the Company, to offset the amount of the Upfront Payment (in whole or in part, until the full amount of the Upfront Payment has been offset) against (a) any payment(s) owed to Taysha or any of its affiliates (or to any third party on behalf of the Company) under or in connection with any license agreement entered into with respect to any GAN Product or Rett Product, including, any upfront payment, milestone payment or royalties owed to Taysha or any of its affiliates (or to any third party on behalf of the Company) under or in connection with any such license agreement or (b) any amount owed to Taysha or any of its affiliates in connection with a Change of Control transaction with Astellas or any of its affiliates. As further consideration for the rights granted to Astellas under the Option Agreement, the Company and Astellas also entered into the Astellas Securities Purchase Agreement (as defined below).</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Astellas Securities Purchase Agreement</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 21, 2022, the Company entered into a securities purchase agreement with Astellas (the &#x201c;Astellas Securities Purchase Agreement&#x201d; and, together with the Option Agreement, the &#x201c;Astellas Transactions&#x201d;), pursuant to which the Company agreed to issue and sell to Astellas in a private placement (the &#x201c;Astellas Private Placement&#x201d;), an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4538443d-15bb-4d72-8170-f6925356956f" contextRef="C_879840b7-9535-4ff6-b76f-43c8c0b8f843" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">7,266,342</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares (the &#x201c;Astellas Private Placement Shares&#x201d;), of its common stock, for aggregate gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f762dc07-d5b8-43c2-876e-79afd877fcd8" contextRef="C_386d4b0c-dbb1-4cd6-9f1e-31bdfd623c2f" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Astellas Private Placement closed on October 24, 2022. Pursuant to the Astellas Securities Purchase Agreement, in connection with the Astellas Private</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Placement, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Astellas has the right to designate one individual to attend all meetings of the Board in a non-voting observer capacity. The Company also granted Astellas certain registration rights with respect to the Astellas Private Placement Shares.</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounting Treatment</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In October 2022, upon closing of the Astellas Private Placement and transferring the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_24f53afe-d516-4da1-a031-5a59442c2c5e" contextRef="C_1004e87a-1fce-46e3-ac6d-39787b2f2454" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">7,266,342</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares to Astellas, the Company recorded the issuance of shares at fair value. Fair value of the shares transferred to Astellas was calculated in accordance with ASC 820, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value Measurement </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">by analyzing the Company&#x2019;s stock price for a short period of time prior to and after the transaction date as traded on the NASDAQ. The NASDAQ trading data is considered an active market and a Level 1 measurement under ASC 820. The fair value was determined to be approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7972229e-0f27-420b-9fa6-aabfb04446da" contextRef="C_15407518-9c8f-475c-9932-cccfb6f73f94" name="tsha:FairValueOfSharesTransferredValue" unitRef="U_USD" scale="6" decimals="-4" format="ixt:num-dot-decimal">13.95</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million or $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a2aee87b-b2e0-4f2c-8138-a759608ecded" contextRef="C_1004e87a-1fce-46e3-ac6d-39787b2f2454" name="us-gaap:SharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.92</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share. The $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e5814aad-872e-4425-b94c-8072ef5fd8d7" contextRef="C_15407518-9c8f-475c-9932-cccfb6f73f94" name="tsha:TransactionPrice" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">16.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million difference between the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_388de720-b97b-47d3-9012-a646047fbdb8" contextRef="C_15407518-9c8f-475c-9932-cccfb6f73f94" name="tsha:DifferenceOfMarketValuePaid" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million paid by Astellas and the fair market value of shares issued was allocated to the transaction price of the Option Agreement.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company determined that the Option Agreement falls within the scope of ASC 606, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> as the development of TSHA-102 for the treatment of Rett Syndrome and TSHA-120 for the treatment of GAN are considered ordinary activities for the Company. In accordance with ASC 606, the Company evaluated the Option Agreement and identified three separate performance obligations: (1) option to obtain licensing right to GAN, (2) option to obtain licensing right to Rett and (3) performance of research and development activities in the Rett development plan. The transaction price is determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_123427fc-7bea-4119-985d-77a0949900d6" contextRef="C_be79abbe-9cb7-450a-89c0-09810beac69c" name="tsha:TransactionPrice" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">36.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which is comprised of the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c2a9e23e-289d-42ab-8e28-3c62a2fb2533" contextRef="C_be79abbe-9cb7-450a-89c0-09810beac69c" name="tsha:UpfrontPayment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million Upfront Payment and the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dc0fac12-b1cb-4cc9-b7ec-07d8a42e7cb8" contextRef="C_7a0ba426-b372-4bb2-a6ce-f8a55df6817b" name="tsha:TransactionPrice" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">16.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million allocated from the Astellas Private Placement.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To determine the standalone selling price (&#x201c;SSP&#x201d;) of the Rett and GAN options, which the Company concluded to be material rights, the Company utilized the probability-weighted expected return (&#x201c;PWERM&#x201d;) method. The PWERM method contemplates the probability and timing of an option exercise. At contract inception, the Company estimated that the probability of exercise was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3b9f8e35-53a3-4faf-95f7-6fd46a129f18" contextRef="C_24c41917-d26a-4624-8e85-a10244e4a9a4" name="tsha:ProbabilityOfAnOptionExercise" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% for each of the GAN and Rett options. The SSP of the Rett research and development activities was estimated using an expected cost plus margin approach. The standalone selling prices of the material rights and Rett research and development activities were then used to proportionately allocate the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4db9ea2c-969c-4901-ad4f-a411aea34860" contextRef="C_ded5d2d0-56e4-4b8d-b636-71c37d47e597" name="tsha:TransactionPrice" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">36.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million transaction price to the three performance obligations. The $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b5dbb0b5-6bf3-4776-96b7-aba1ec52ce4b" contextRef="C_9ddff924-68e1-4fa1-9bb2-4276e2baedd2" name="us-gaap:DeferredRevenue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">36.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million transaction price was recorded as deferred revenue on the condensed consolidated balance sheet at the inception of the Astellas Transactions.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6473d355-9a3c-4637-88ed-eacff20a89e8" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:SummaryOfTransactionPriceAllocationTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the allocation of the transaction price to the three performance obligations at contract inception (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.653%;"></td>
        <td style="width:1.02%;"></td>
        <td style="width:1.02%;"></td>
        <td style="width:29.288%;"></td>
        <td style="width:1.02%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Transaction Price Allocation</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Option to obtain license for Rett</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0adfb1f0-7878-46af-a10d-0556f1a58ba3" contextRef="C_287d5758-9445-46a9-a9b4-4f0e72d6bc05" name="tsha:TransactionPrice" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,485</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Option to obtain license for GAN</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5b9b4855-88ba-4a21-9d78-daf26ab1a611" contextRef="C_ffe2668b-14a2-48c0-b393-270f102a3ad6" name="tsha:TransactionPrice" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,317</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rett research and development activities</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_83fd814f-4f75-4132-8b02-1706cc4a83da" contextRef="C_9be26314-5dbf-4dea-ac67-93410907efad" name="tsha:TransactionPrice" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,257</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_be7c5311-2478-47b3-8300-5817643b6f41" contextRef="C_e6e5f371-c876-4258-be9b-7f8411f4ff7e" name="tsha:TransactionPrice" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,059</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenue allocated to the material rights will be recognized at a point in time when each option period expires or when a decision is made by Astellas to exercise or not exercise each option. Revenue from the Rett research and development activities will be recognized as activities are performed using an input method, according to the costs incurred as related to the total costs expected to be incurred to satisfy the performance obligation. The transfer of control occurs over this time period and is a reliable measure of progress towards satisfying the performance obligation.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the three and six months ended June 30, 2023, the Company determined that the total estimated costs to be incurred to satisfy the performance obligation associated with Rett research and development activities had increased from the cost estimate used for the year ended December 31, 2022, and the three months ended March 31, 2023. The cumulative impact of this change would have resulted in a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_48083b02-7224-4cbf-8374-765028641971" contextRef="C_c883f68e-7f40-4df1-9893-6348c141e5e9" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_52fd2d46-5af0-4d7c-85d7-f88525ce9b3c" contextRef="C_40e64b85-0bd6-43d7-85ac-e8176005098e" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.1</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million decrease related to revenue previously recognized based on prior cost estimates. Subsequent changes during the three months ended September 30, 2023 to total estimated costs were not material, and did not have a material impact on cumulative revenue earned.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recognized revenue of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7aca2aeb-936b-4f85-8e28-aca07621984d" contextRef="C_d6b67c53-c7b5-4cb3-a237-27c8b3f18659" name="us-gaap:Revenues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_bdedd799-28be-400a-83db-6f87a49ac62b" contextRef="C_5248d7d9-3cd0-4735-865f-dda80ba32b79" name="us-gaap:Revenues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million from Rett research and development activities for the three and nine months ended September 30, 2023, respectively. In September 2023, Astellas provided written notice of its decision not to exercise the GAN Option. The Company recognized revenue of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a4a114f3-11e0-45d7-85d2-f80ec8981104" contextRef="C_cf8b3b2d-3381-4c33-97b3-0a49e5fa0576" name="us-gaap:Revenues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_aad91a8a-04c4-48a6-95d4-5d2448e68c11" contextRef="C_72ee41ab-a948-4033-acce-533b6eca774e" name="us-gaap:Revenues" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.3</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million from the GAN Option during the three and nine months ended September 30, 2023.</span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">14</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023, the Company recorded deferred revenue of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0c3c38b8-4255-440b-bb01-c60a43b2abfe" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:DeferredRevenueCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">18.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within current liabilities and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dd6c2d76-f911-40c2-b21b-f2f39f138cdb" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:DeferredRevenueNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within long-term liabilities in the accompanying consolidated balance sheet. The Company will recognize revenues for these performance obligations as they are satisfied.</span></p></ix:nonNumeric></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9e335a34-b9cb-4ffe-b076-01db55fd8b7e" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:DebtDisclosureTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 7&#x2014;Loan with Silicon Valley Bank	</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 12, 2021 (the &#x201c;Closing Date&#x201d;), the Company entered into a Loan and Security Agreement (the &#x201c;Term Loan Agreement&#x201d;), by and among the Company, the lenders party thereto from time to time (the &#x201c;Lenders&#x201d;) and Silicon Valley Bank, as administrative agent and collateral agent for the Lenders (&#x201c;Agent&#x201d;). The Term Loan Agreement provided for (i) on the Closing Date, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_305658ad-cc4a-4d04-8822-de0863c817c7" contextRef="C_01b23b59-342a-4659-a799-48ef1e2fa7a6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5">40.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million aggregate principal amount of term loans available through </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ebc49b91-cc3c-456e-9fc8-80a4549b14aa" contextRef="C_7b453598-4699-4830-9fe7-728f5848fb84" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, (ii) from </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_40de76cc-5eea-4bea-8808-f7256b2b0e85" contextRef="C_5f9fb3b0-fe97-419b-bdc6-be3820e2ea68" name="us-gaap:DebtInstrumentMaturityDateRangeStart1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 1, 2022</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> until </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_33d58575-c7a2-4f31-a252-7df69f54faba" contextRef="C_5f9fb3b0-fe97-419b-bdc6-be3820e2ea68" name="us-gaap:DebtInstrumentMaturityDateRangeEnd1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30, 2022</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, an additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5b54960e-87fb-4fb6-9540-bb2e3b647840" contextRef="C_56aba35a-c830-45c9-adb0-37ddf0bc7d62" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5">20.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million term loan facility available at the Company&#x2019;s option upon having </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_05b502fe-b6a9-4a90-957f-a48ea434b728" contextRef="C_5f9fb3b0-fe97-419b-bdc6-be3820e2ea68" name="tsha:NumberOfDistinctAndActiveClinicalStage" unitRef="U_Program" decimals="INF" format="ixt-sec:numwordsen">three</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> distinct and active clinical stage programs, determined at the discretion of the Agent, at the time of draw, (iii) from </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4e2b5bee-826b-493d-b99c-9dd3bcf9c671" contextRef="C_247c1361-9891-4d77-8855-fdadd0f3d730" name="us-gaap:DebtInstrumentMaturityDateRangeStart1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">October 1, 2022</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> until </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_74c17aae-e175-466a-a98d-62ce7f9ecde6" contextRef="C_247c1361-9891-4d77-8855-fdadd0f3d730" name="us-gaap:DebtInstrumentMaturityDateRangeEnd1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, an additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_32dbd640-5a09-4dcc-a8b7-fa7325f2204b" contextRef="C_0f464446-8753-4ba1-9363-45ea238784a0" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5">20.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million term loan facility available at the Company&#x2019;s option upon having </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_71607e46-d1b1-4d45-953f-d0571982c6da" contextRef="C_247c1361-9891-4d77-8855-fdadd0f3d730" name="tsha:NumberOfDistinctAndActiveClinicalStage" unitRef="U_Program" decimals="INF" format="ixt-sec:numwordsen">three</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> distinct and active clinical stage programs, determined at the discretion of the Agent, at the time of draw and (iv) from </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7a6603fa-161f-4ac0-bb94-a0111fc2ab27" contextRef="C_5e5e45fa-c545-46e3-838a-10c5bb7a8a1d" name="us-gaap:DebtInstrumentMaturityDateRangeStart1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">April 1, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> until </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2a77a0a5-3c25-46fb-8da5-d899817ad0ec" contextRef="C_5e5e45fa-c545-46e3-838a-10c5bb7a8a1d" name="us-gaap:DebtInstrumentMaturityDateRangeEnd1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, an additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_33a7b2ad-6de7-4631-82af-167a1d8aea1a" contextRef="C_268fe9ab-86f1-47ea-8103-b41a53f40e03" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5">20.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million term loan facility available upon approval by the Agent and the Lenders (collectively, the &#x201c;Term Loans&#x201d;). The Company drew $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_729672f8-c8b8-4d4f-9d5e-35093ff52314" contextRef="C_b40906ab-540f-4d66-babc-185d6edc1657" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in term loans on the Closing Date and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_18890225-77c5-45b5-8696-84e8fe413800" contextRef="C_6b959717-546d-4082-a216-54b72a00c5df" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5">10.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in term loans in December 2021. The Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_01b256c4-a4a8-4575-89ef-9fc46082381b" contextRef="C_3d602e83-3144-42f0-b3b2-264b04cf5dbb" name="tsha:ProceedsFromTermLoan" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_81e44b8f-cf66-4880-bc6b-c92745c5202e" contextRef="C_5063c218-0805-481c-bd11-cdcf2eae0406" name="tsha:ProceedsFromTermLoan" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">t draw on the two additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f82a132f-2eec-465f-873d-8b6ae88eeb63" contextRef="C_2c7a64a4-5c6c-45c0-a89a-29ee6d67a457" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4ca15537-a718-4d7b-9db2-61ce1c8a2972" contextRef="C_6fdb1bde-2709-45b1-a9e2-787a87ee5614" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million tranches prior to expiration on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_77742d47-ad35-4962-a738-44d717d3790f" contextRef="C_3d602e83-3144-42f0-b3b2-264b04cf5dbb" name="us-gaap:DebtInstrumentMaturityDateRangeEnd1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30, 2022</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_91282fb7-95ea-463f-8b13-233507214c33" contextRef="C_5063c218-0805-481c-bd11-cdcf2eae0406" name="us-gaap:DebtInstrumentMaturityDateRangeEnd1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The interest rate applicable to the Term Loans was the greater of (a) the WSJ (&#x201c;Wall Street Journal&#x201d;) Prime Rate plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f9bdbb9e-61c7-4f1c-97c2-f4ab0216728b" contextRef="C_2453238f-62d1-4664-a753-3e1fa2683010" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="4">3.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% or (b) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b1e85a80-3c3e-4cee-a941-cfae7b344b49" contextRef="C_ebb6d69e-99d0-4437-b8b8-87ca448aa0d2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="INF">7.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% per annum. The Term Loans were interest only from the Closing Date through August 31, 2024, after which the Company was required to pay equal monthly installments of principal through </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0056571b-d3cb-4081-bc28-5988ed7bc695" contextRef="C_349ea30b-6a31-4c2d-af3c-94a43b0e6e4e" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">August 1, 2026</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the maturity date.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Term Loans could have been prepaid in full through August 12, 2023, with payment of a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_00a6c529-90fe-4571-ab9f-ed121ecd3bc0" contextRef="C_41099a59-f81f-47bf-96a8-c4997b89b7b2" name="tsha:PercentageOfPrepaymentPremium" unitRef="U_pure" scale="-2" decimals="4">1.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% prepayment premium, after which they could be prepaid in full with no prepayment premium. An additional final payment of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e5329074-01c5-4b18-b666-ba1c3fea4941" contextRef="C_349ea30b-6a31-4c2d-af3c-94a43b0e6e4e" name="tsha:PercentageOfPrepaymentOfFacility" unitRef="U_pure" scale="-2" decimals="3">7.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the amount of Terms Loans advanced by the Lenders (&#x201c;Exit Fee&#x201d;) was due upon prepayment or repayment of the Term Loans in full. The Exit Fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e3d7ae0a-fe18-40a5-8bfb-2d77ae36a79a" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million was recorded as debt discount and has also been fully accrued within non-current liabilities as of September 30, 2023. The debt discount was being accreted using the effective interest method over the term of the Term Loans within interest expense in the condensed consolidated statements of operations.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The obligations under the Term Loan Agreement were secured by a perfected security interest in all of the Company&#x2019;s assets except for intellectual property and certain other customarily excluded property pursuant to the terms of the Term Loan Agreement. There were no financial covenants and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_10f90984-82f8-4822-86cd-82487fe33831" contextRef="C_ebb6d69e-99d0-4437-b8b8-87ca448aa0d2" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> warrants associated with the Term Loan Agreement. The Term Loan Agreement contained various covenants that limited the Company&#x2019;s ability to engage in specified types of transactions without the consent of the Lenders which included, among others, incurring or assuming certain debt; merging, consolidating or acquiring all or substantially all of the capital stock or property of another entity; changing the nature of the Company&#x2019;s business; changing the Company&#x2019;s organizational structure or type; licensing, transferring or disposing of certain assets; granting certain types of liens on the Company&#x2019;s assets; making certain investments; and paying cash dividends.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Term Loan Agreement also contained customary representations and warranties, and also included customary events of default, including payment default, breach of covenants, change of control, and material adverse effects. The Company was in compliance with all covenants under the Term Loan Agreement as of September 30, 2023. Upon the occurrence of an event of default, a default interest rate of an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d02d091d-d93a-45f0-bd1f-967fdc6f9ce9" contextRef="C_349ea30b-6a31-4c2d-af3c-94a43b0e6e4e" name="tsha:PercentageOfAnnualDefaultInterestRate" unitRef="U_pure" scale="-2" decimals="2">5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% per annum could have been applied to the outstanding loan balances, and the Lenders could have declared all outstanding obligations immediately due and payable and exercised all of its rights and remedies as set forth in the Term Loan Agreement and under applicable law.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the three and nine months ended September 30, 2023, the Company recognized interest expense related to the Term Loan </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c98a9017-2b11-4950-aaec-7c4a5305ca07" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:InterestExpenseLongTermDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> mi</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">llion and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dac8474d-466d-4f62-ba5b-e30167d402f8" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:InterestExpenseLongTermDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. During the three and nine months ended September 30, 2022, the Company recognized interest expense related to the Term Loan of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_55528caa-1777-4e8a-b308-67b5c7f7dab2" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:InterestExpenseLongTermDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1a9b1afa-67cc-4ee5-a583-3a1b272f1381" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:InterestExpenseLongTermDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.</span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f2451d69-ce4e-464f-965f-c679f4bfb06f" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Future principal debt payments on the loan payable as of September 30, 2023 are as follows (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:83.83%;"></td>
        <td style="width:1.801%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.369%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Year Ending December 31,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_82ffae77-c327-4bbc-8534-fa00a1d2c793" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,667</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ffc8c6dc-b8a2-4be0-a0d7-1b4b05220337" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,000</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_01ec527c-c98d-4bf3-807a-baec23eaa47c" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,333</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total principal payments</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7bcb53c4-d7a2-4c05-9b20-14ddc5859e91" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,000</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unamortized debt discount</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_79767910-1412-48cd-b3da-351edff13bf8" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:DebtInstrumentUnamortizedDiscount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,452</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Term Loan, net</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ac945a17-d09a-4e8c-adaa-74ab90cfda76" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,548</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Term Loan is considered long-term debt because it has been refinanced on a long-term basis, subsequent to September 30, 2023 but before the issuance of these condensed consolidated financial statements, using the proceeds of the Trinity Term Loan Agreement (as defined in Note 16).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On March 10, 2023, Silicon Valley Bank, based in Santa Clara, California, was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) as receiver. On March 27, 2023, First Citizens Bank purchased the remaining assets, deposits and loans of Silicon Valley Bank. As a result, the portion of the Company&#x2019;s term loans previously held by Silicon Valley Bank is now held by Silicon Valley Bank as a division of First-Citizen&#x2019;s Bank &amp; Trust Company. The remaining portion of the Company&#x2019;s term loans are still held by SVB Capital, which is currently in bankruptcy proceedings.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_08c3790e-b980-43ee-a82d-e811b3fa3289" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 8&#x2014;Research, Collaboration and License Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">UT Southwestern Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 19, 2019, the Company entered into a research, collaboration and license agreement (&#x201c;UT Southwestern Agreement&#x201d;) with the Board of Regents of the University of Texas System on behalf of The University of Texas Southwestern Medical Center (&#x201c;UT Southwestern&#x201d;). Under the UT Southwestern Agreement, UT Southwestern is primarily responsible for preclinical development activities with respect to licensed products for use in certain specified indications (up to investigational new drug application-enabling studies), and the Company is responsible for all subsequent clinical development and commercialization activities with respect to the licensed products. UT Southwestern will conduct such preclinical activities for a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f7b63a28-c457-4eae-9f82-f4c3ae43af69" contextRef="C_8bc60dc0-3547-4346-8f8c-627b12b9404c" name="tsha:PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">two-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> period under mutually agreed upon sponsored research agreements that were entered into beginning in April 2020. During the initial research phase, the Company has the right to expand the scope of specified indications under the UT Southwestern Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the UT Southwestern Agreement, the Company obtained an exclusive, worldwide, royalty-free license under certain patent rights of UT Southwestern and a non-exclusive, worldwide, royalty-free license under certain know-how of UT Southwestern, in each case to make, have made, use, sell, offer for sale and import licensed products for use in certain specified indications. Additionally, the Company obtained a non-exclusive, worldwide, royalty-free license under certain patents and know-how of UT Southwestern for use in all human uses, with a right of first refusal to obtain an exclusive license under certain of such patent rights and an option to negotiate an exclusive license under other of such patent rights. The Company is required to use commercially reasonable efforts to develop, obtain regulatory approval for, and commercialize at least </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6db483e6-b714-424b-9970-81878f495a48" contextRef="C_8bc60dc0-3547-4346-8f8c-627b12b9404c" name="tsha:MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" unitRef="U_Product" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> licensed product.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 2, 2020, the Company amended the UT Southwestern Agreement to include the addition of another licensed product and certain indications, and a right of first refusal to the Company over certain patient dosing patents. No additional consideration was transferred in connection with this amendment. In March 2022, the Company and UT Southwestern mutually agreed to revise the payment schedules and current performance expectations of the current sponsored research agreements under the UT Southwestern Agreement and defer payments by fifteen months.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The UT Southwestern Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last valid claim of a licensed patent in such country for such licensed product. After the initial research term, the Company may terminate the agreement, on an indication-by-indication and licensed product-by-licensed product basis, at any time upon specified written notice to UT Southwestern. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In November 2019, as partial consideration for the license rights granted under the UT Southwestern Agreement, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_724cf76a-a7e0-4608-b438-ad2e26678ce3" contextRef="C_5142e56d-a1ef-405d-ada4-47c2a8ad2e32" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,179,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of its common stock, or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3a200027-7c12-437a-be39-e883c1c446d7" contextRef="C_5142e56d-a1ef-405d-ada4-47c2a8ad2e32" name="tsha:PercentageOfFullyDilutedCommonStockSharesOutstanding" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">20</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of its then outstanding fully-diluted common stock, to UT Southwestern. The Company does not have any future milestone or royalty obligations to UT Southwestern under the UT Southwestern Agreement other than costs related to maintenance of patents.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Abeona CLN1 Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In August 2020, the Company entered into license and inventory purchase agreements (collectively, the &#x201c;Abeona Agreements&#x201d;) with Abeona Therapeutics Inc. (&#x201c;Abeona&#x201d;) for worldwide exclusive rights to certain intellectual property rights and know-how relating to the research, development and manufacture of ABO-202, an AAV-based gene therapy for CLN1 disease (also known as infantile Batten disease). Under the terms of the Abeona Agreements, the Company made initial cash payments to Abeona of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_cf5a9166-2a0a-43e0-bb05-c0c038e7021b" contextRef="C_fe9362b3-8b1b-412f-a9cb-c0083a836950" name="tsha:PaymentOfLicenseFee" unitRef="U_USD" scale="6" decimals="-5">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the license fee and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_67df01a7-b473-4c29-8b39-af011792cac0" contextRef="C_fb426d7d-a58c-4a86-b783-cad0e1d55c63" name="tsha:PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" unitRef="U_USD" scale="6" decimals="-5">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for purchase of clinical materials and reimbursement for previously incurred development costs in October 2020. In exchange for the license rights, the Company recorded an aggregate of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6b902e6a-fa9c-48bd-b78a-bda0bf06949c" contextRef="C_d38e6bea-f6ec-49da-b364-707ab055ad3c" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="6" decimals="-5">7.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within research and development expenses in the consolidated statements of operations for the year ended December 31, 2020, since the acquired license or acquired inventory do not have an alternative future use. The Company is obligated to make up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_08843b8f-1043-4250-8502-dea516eadb19" contextRef="C_eda542a6-c47a-464c-9bfb-8cc6ae934ce2" name="tsha:LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" unitRef="U_USD" scale="6" decimals="INF">26.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in regulatory-related milestones and up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_95f9c2f9-6e45-4bcc-941f-af4cf4f31662" contextRef="C_eda542a6-c47a-464c-9bfb-8cc6ae934ce2" name="tsha:LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" unitRef="U_USD" scale="6" decimals="INF">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in sales-related milestones per licensed CLN1 product. The Company will also pay an annual earned royalty in the high single digits on net sales of any licensed CLN1 products. The license agreement with Abeona (the &#x201c;Abeona License Agreement&#x201d;) expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the Abeona License Agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the Abeona License Agreement for convenience upon specified prior written notice to Abeona.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2021, a regulatory milestone was triggered in connection with this agreement and therefore the Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c1ef85d0-2862-494d-9d82-14437214b218" contextRef="C_386cd9a0-f7f8-4dec-8608-31eb57cc80ff" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within research and development expenses in the consolidated statements of operations for the year ended December 31, 2021. The milestone fee was paid in January 2022 and classified as an investing cash outflow in the condensed consolidated statements of cash flows for the nine months ended September 30, 2022. No additional milestone payments were made or triggered in connection with this agreement during the nine months ended September 30, 2023.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Abeona Rett Agreement</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 29, 2020, the Company entered into a license agreement (the &#x201c;Abeona Rett Agreement&#x201d;) with Abeona pursuant to which the Company obtained an exclusive, worldwide, royalty-bearing license, with the right to grant sublicenses under certain patents, know-how and materials originally developed by the University of North Carolina at Chapel Hill, the University of Edinburgh and Abeona to research, develop, manufacture, have manufactured, use, and commercialize licensed products for gene therapy and the use of related transgenes for Rett syndrome.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Subject to certain obligations of Abeona, the Company is required to use commercially reasonable efforts to develop at least one licensed product and commercialize at least one licensed product in the United States.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the Abeona Rett Agreement, the Company paid Abeona a one-time upfront license fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3d2cf173-5f11-40a5-8eaa-e5f706ccd103" contextRef="C_fc047aed-6e3c-4d6e-8708-d9135d555669" name="tsha:PaymentOfOneTimeUpfrontLicenseFee" unitRef="U_USD" scale="6" decimals="-5">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which was recorded in research and development expenses in the consolidated statements of operations for the year ended December 31, 2020, since the acquired license does not have an alternative future use. The Company is obligated to pay Abeona up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_47e60a4b-7e5f-41a5-9501-4462406da6fc" contextRef="C_ecf42b20-4d10-4df6-8173-984ab0bc4b7a" name="tsha:RegulatoryRelatedMilestonesObligationPayable" unitRef="U_USD" scale="6" decimals="INF">26.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in regulatory-related milestones and up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_faed1faa-b08e-4697-9b17-89ee6a88490a" contextRef="C_ecf42b20-4d10-4df6-8173-984ab0bc4b7a" name="tsha:SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" unitRef="U_USD" scale="6" decimals="INF">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in sales-related milestones per licensed Rett product and high single-digit royalties on net sales of licensed Rett products. Royalties are payable on a licensed product-by-licensed product and country-by-country basis until the latest of the expiration or revocation or complete rejection of the last licensed patent covering such licensed product in the country where the licensed product is sold, the loss of market exclusivity in such country where the product is sold, or, if no licensed product exists in such country and no market exclusivity exists in such country, ten years from first commercial sale of such licensed product in such country.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Abeona Rett Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the agreement for convenience upon specified prior written notice to Abeona.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2022, the Company&#x2019;s clinical trial application (&#x201c;CTA&#x201d;) filing for TSHA-102 for the treatment of Rett Syndrome was approved by Health Canada and therefore triggered a regulatory milestone payment in connection with the Abeona Rett Agreement. The Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7505dfd7-ab06-4e36-a8ed-0339a4418699" contextRef="C_b930a776-4755-4d30-be4d-477d007415b3" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="6" decimals="-5">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within research and development expenses in the condensed consolidated statements of operations for the nine months ended September 30, 2022. The $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7c88b796-fca6-4ce3-aea7-8eeb24e4c6c5" contextRef="C_f68841e2-9812-4928-9cd8-bc1e4d7385dd" name="tsha:RegulatoryMilestoneFeePaid" unitRef="U_USD" scale="6" decimals="-5">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million regulatory milestone fee was paid in July 2022. In May 2023, the Company dosed the first patient with TSHA-102 in the Phase 1/2 REVEAL trial evaluating the safety and preliminary efficacy of TSHA-102 in adult patients with Rett syndrome and therefore triggered a milestone payment in connection with the Abeona Rett Agreement. The Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4eafcc20-9b15-4aee-ab71-281b01b14af5" contextRef="C_85b1368b-9750-457e-87f0-e98f7d80ece8" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">within research and development expenses in the condensed consolidated statements of operations for the nine months ended September 30, 2023. This milestone fee was paid in August 2023 and classified as an investing cash outflow in the condensed consolidated statements of cash flows for the nine months ended September 30, 2023. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f732e8d9-a4d6-47e5-a8cf-a9047f355f5f" contextRef="C_85b1368b-9750-457e-87f0-e98f7d80ece8" name="tsha:AdditionalMilestonePayments" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> additional milestone payments were made or triggered in connection with the Abeona Rett Agreement during the nine months ended September 30, 2023.</span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">17</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Acquisition of Worldwide Rights for TSHA-120 for the treatment of GAN</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2021, the Company acquired the exclusive worldwide rights to a clinical-stage AAV9 gene therapy program, now known as TSHA-120, for the treatment of GAN. TSHA-120 is an intrathecally dosed AAV9 gene therapy currently being evaluated in a clinical trial for the treatment of GAN. The trial is being conducted by the National Institutes of Health (&#x201c;NIH&#x201d;) in close collaboration with a leading patient advocacy group focused on finding treatments and cures for GAN. TSHA-120 has received rare pediatric disease and orphan drug designations from the U.S. Food and Drug Administration for the treatment of GAN. The worldwide rights were acquired through a license agreement, effective March 29, 2021, between Hannah&#x2019;s Hope Fund for Giant Axonal Neuropathy, Inc. (&#x201c;HHF&#x201d;) and the Company (the &#x201c;GAN Agreement&#x201d;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the terms of the GAN Agreement, in exchange for granting the Company the exclusive worldwide rights to TSHA-120, HHF received an upfront payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_82d0f882-b02b-4552-ab7f-f4a4d27dcbb2" contextRef="C_a19561be-07c5-4bcb-9000-74a3fb2fa74a" name="tsha:UpfrontPayment" unitRef="U_USD" scale="6" decimals="-5">5.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and will be eligible to receive clinical, regulatory and commercial milestones totaling up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ad1c0d18-7f9f-4d9a-968f-21112e098464" contextRef="C_c50b3cb1-c0e2-4765-8d8d-617b504675a8" name="tsha:ClinicalRegulatoryAndCommercialMilestonesToBeReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">19.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, as well as a low, single-digit royalty on net sales upon commercialization of the product. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3d8f05e2-660c-4da4-9319-4b22454ef055" contextRef="C_c46c3bce-3fb6-4de8-b570-c0f54c0a4d18" name="tsha:AdditionalMilestonePayments" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> additional milestone payments were made or triggered in connection with the GAN Agreement during the nine months ended September 30, 2023.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">License Agreement for CLN7</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2022, the Company entered into a license agreement with UT Southwestern (the &#x201c;CLN7 Agreement&#x201d;) pursuant to which the Company obtained an exclusive worldwide, royalty-bearing license with right to grant sublicenses to develop, manufacture, use, and commercialize licensed products for gene therapy for CLN7, a form of Batten Disease. In connection with the CLN7 Agreement, the Company paid a one-time upfront license fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3fcb6dc6-ca1b-425b-87e5-dc7555cf5645" contextRef="C_afe869c3-1801-4581-a6f5-b8768beaf0e4" name="tsha:PaymentOfOneTimeUpfrontLicenseFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. The Company recorded the upfront license fee in research and development expense in the condensed consolidated statements of operations since the acquired license does not have an alternative future use. The Company is obligated to pay UT Southwestern up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_aac0c73c-c07c-402b-a7f3-6b00f720197c" contextRef="C_9f8d2f91-99fe-4b86-b976-930ef584b76d" name="tsha:LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in regulatory-related milestones and up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_34e74be1-b72a-4b9e-91b9-3a2228f40ce3" contextRef="C_9f8d2f91-99fe-4b86-b976-930ef584b76d" name="tsha:LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in sales-related milestones, as well as a low, single-digit royalty on net sales upon commercialization of the product. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2d9d7810-8c55-4a2b-8f1e-9f4b73be551f" contextRef="C_773e89ba-c62d-4d26-a9c3-69efc4d4d04e" name="tsha:AdditionalMilestonePayments" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> additional milestone payments were made or triggered in connection with the CLN7 Agreement during the nine months ended September 30, 2023.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_81d1ce0d-774d-4a7c-8a8a-114d528712a9" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 9&#x2014;Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On July 1, 2020, the Company&#x2019;s board of directors approved the 2020 Equity Incentive Plan (&#x201c;Existing Plan&#x201d;) which permits the granting of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards (&#x201c;RSAs&#x201d;), restricted stock units (&#x201c;RSUs&#x201d;) and other stock-based awards to employees, directors, officers and consultants. As of September 16, 2020, the approval date of the New Plan (as defined below), no additional awards will be granted under the Existing Plan. The terms of the Existing Plan will continue to govern the terms of outstanding equity awards that were granted prior to approval of the New Plan.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On September 16, 2020, the Company&#x2019;s stockholders approved the 2020 Stock Incentive Plan (&#x201c;New Plan&#x201d;), which became effective upon the execution of the underwriting agreement in connection with the IPO. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_044dd7b4-b7b6-4116-bb1b-2501bb774ab5" contextRef="C_5a369e84-71ee-4265-82bd-b5c3255f95c4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The number of shares of common stock reserved for issuance under the New Plan automatically increases on January 1 of each year, for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c8bff56c-f5a0-4f15-a300-4270ad65d7bb" contextRef="C_6c73f75e-0143-4c42-88c1-9f83877c234e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, from </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_811c04e3-6044-4824-b0f5-27ef92ac1590" contextRef="C_6c73f75e-0143-4c42-88c1-9f83877c234e" name="tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 1, 2021</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, continuing through </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_85805a2b-5890-424c-a868-8ce7ae5a3ee7" contextRef="C_6c73f75e-0143-4c42-88c1-9f83877c234e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 1, 2030</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ca7b195d-5fe4-4a77-a7b0-f3b4001641bd" contextRef="C_6c73f75e-0143-4c42-88c1-9f83877c234e" name="tsha:PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company&#x2019;s board of directors.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> On January 1, 2023, the Company&#x2019;s board of directors increased the number of shares of common stock reserved for issuance under the New Plan by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_70fc3ac3-ec7c-4ce6-b3c2-7d1ed4b8e70f" contextRef="C_95c66cb1-2fc7-4423-a36f-6e539db9b9ac" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,160,375</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Furthermore, on September 16, 2020, the Company&#x2019;s stockholders approved the Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;), which became effective upon the execution of the underwriting agreement in connection with the IPO. The maximum number of shares of common stock that may be issued under the ESPP will not exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c443ee12-c63f-47fc-8024-eb9c47806e6c" contextRef="C_e482ef1c-238b-4c33-805a-cf73ba22ae2b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">362,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock, plus </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6d2392a4-2e92-4073-91a6-acd3bdbe3270" contextRef="C_224db9b6-cf69-4025-8ace-07a34716e87d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the number of shares of common stock that are automatically added on January 1st of each year for a period of up to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_93913759-339e-43a6-b0f5-b2ef8cc2ebaf" contextRef="C_b0d18d87-5486-439a-b80d-f6f9cd2a928a" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, commencing on the first January 1 following the IPO and ending on (and including) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c3f63bcf-2195-4d8b-a6ba-64acae60e270" contextRef="C_b0d18d87-5486-439a-b80d-f6f9cd2a928a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 1, 2030</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, in an amount equal to the lesser of (i) one percent (</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_19834e73-31b5-4cd8-a5df-5dff8faa7a10" contextRef="C_b0d18d87-5486-439a-b80d-f6f9cd2a928a" name="tsha:PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" unitRef="U_pure" scale="-2" decimals="INF">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year, and (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4b6edc71-84b7-41cd-b992-34375e44fbda" contextRef="C_245eca74-de86-4efc-a7d0-3ed028ab318b" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">724,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7d9ce19d-cb20-49ce-8993-0e92c98d6fb4" contextRef="C_b0d18d87-5486-439a-b80d-f6f9cd2a928a" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">were added to the ESPP in 2021. On January 1, 2022 and 2023, the Company&#x2019;s board of directors</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">incre</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ased the number of shares of common stock reserved for issuance under the ESPP by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_eb9cea34-8c57-4cc6-adcb-4e5a64a16b56" contextRef="C_173d420c-3a82-453d-854d-b15fa055eec3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">384,739</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d63320a1-c624-4bba-b4cc-32260ccb7a29" contextRef="C_27aa3cc4-7b79-4c00-b3a7-7e63aea84451" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">632,075</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> respectively. The Company has issued an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_439c6df3-dd2e-4501-bd56-ecc7704781df" contextRef="C_224db9b6-cf69-4025-8ace-07a34716e87d" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">141,393</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock under the ESPP as of September 30, 2023.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5b430549-cff9-4b87-9faa-ca1ed412727f" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The number of shares available for grant under the Company&#x2019;s incentive plans were as follows:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.21%;"></td>
        <td style="width:1.18%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.943%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.743%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.18%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.743%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Existing</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">New</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Plan</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Plan</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Available for grant - December 31, 2022</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_16b83f56-ee4d-42ba-8e7b-b0ac17442d8a" contextRef="C_1247712d-baca-4aef-85fb-e3036cdde096" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,067,682</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_29239a0c-2cce-46e0-8a1b-a14c2327eefe" contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,067,682</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Plan adjustments and amendments</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_305d9063-3756-4628-8783-0f8c5edb5976" contextRef="C_3cb6925a-8272-4205-b6cf-61f911a340b6" name="tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">667,828</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6a4e7de2-3176-46cf-890b-615dd16717a4" contextRef="C_5a369e84-71ee-4265-82bd-b5c3255f95c4" name="tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,828,203</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a90d80df-0545-447d-8c10-bad0056a4f92" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,160,375</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Grants</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9ae8cd8e-eb97-4348-8a74-9b9667968c68" contextRef="C_5a369e84-71ee-4265-82bd-b5c3255f95c4" name="tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">5,241,357</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3e98dfce-b73a-4341-8b06-32fc3704fc0d" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">5,241,357</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Forfeitures</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_24445621-9051-4f72-86ff-e0510b94845b" contextRef="C_3cb6925a-8272-4205-b6cf-61f911a340b6" name="tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">667,828</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7336a14f-f695-47f6-9b55-4440eec3b7a0" contextRef="C_5a369e84-71ee-4265-82bd-b5c3255f95c4" name="tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">2,918,614</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_346614ba-edb7-4ddc-a844-f6c5f496ee40" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">3,586,442</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Available for grant - September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_fc5b9f4c-b248-4ce9-be9f-35b909b679f4" contextRef="C_d99997ac-c0d1-4216-92e6-c6f95f327fe8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,573,142</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f63bb8c8-5528-4f8f-8206-854c4b5a15b7" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,573,142</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock Options</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the three months ended September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c07ef100-f7c1-466a-adb3-dfa899e6caad" contextRef="C_2baf5077-feb2-430c-8618-bc9ab6c792fa" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">50,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock under the New Plan were awarded with a weighted-average grant date fair value per sh</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">are of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c5649c61-a48a-4659-b5b7-39b113b1a5f1" contextRef="C_2baf5077-feb2-430c-8618-bc9ab6c792fa" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. For the nine months ended September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_731f2365-3848-4d1b-afe5-404f5104b3ed" contextRef="C_d3115968-7432-4bb2-8241-e0b51c3126b8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,520,471</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock under the New Plan were awarded with a weighted-average grant date fair value per share of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b00d0845-adcf-484c-900c-ce2544f029b6" contextRef="C_d3115968-7432-4bb2-8241-e0b51c3126b8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.64</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The stoc</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">k options vest over </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_a612bde1-69ec-4545-8cd9-0a74e9778ed1;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">one</span></span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_875d8156-3d37-434c-9b8a-7f56cb5ffa59" contextRef="C_b15937e2-c5c7-42c8-90fd-354de23b40f1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">four years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and have a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_312d1777-ef8a-4a65-a06e-f5ea03e43202" contextRef="C_d3115968-7432-4bb2-8241-e0b51c3126b8" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ten-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> contractual term.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7a2b4a43-50d5-4243-8fdf-fe26aa1014d3" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following weighted-average assumptions were used to estimate the fair value of time-based vesting stock options that were granted during the three and nine months ended September 30, 2023 and 2022:</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:53.008%;"></td>
        <td style="width:1.003%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.349%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.003%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.93%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.003%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.349%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.003%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.352%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Three Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_778c79f4-e0b4-4c7e-be9b-aacd1addbb3f" contextRef="C_36b0de8a-1c04-40e9-bda7-6a7e96088f0e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.22</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d58bfebb-55bb-4253-a3c7-fdaeed25cc8a" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.61</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a35153de-a83e-4db4-9dd1-1ac32fac46bc" contextRef="C_fe9c5e2c-7fc2-459d-a948-657f1b1df93e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.16</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5919e379-74b8-4f9d-805a-04a6e5a6d81a" contextRef="C_36b0de8a-1c04-40e9-bda7-6a7e96088f0e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></ix:nonNumeric></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ad93611b-bde7-41f4-b0af-2e50b256875d" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></ix:nonNumeric></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7cf7c32a-22c0-416f-a645-1c6f48e9b569" contextRef="C_fe9c5e2c-7fc2-459d-a948-657f1b1df93e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6.1</span></ix:nonNumeric></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_eff53df5-8d7d-4873-a09a-58536314888d" contextRef="C_36b0de8a-1c04-40e9-bda7-6a7e96088f0e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">81</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7abbe73f-5fbb-49f1-8d41-44ff756ced2a" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">81</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_63a3daa1-201c-47b4-94ce-0a0cac92a2a0" contextRef="C_fe9c5e2c-7fc2-459d-a948-657f1b1df93e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">76</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9cba1451-0750-413c-a25c-9a0d0c394c1e" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes time-based vesting stock option activity, during the nine months ended September 30, 2023:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.18%;"></td>
        <td style="width:1.001%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.674%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.221%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.893%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.001%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.674%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.221%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.133%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Aggregate</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Remaining</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Intrinsic</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Stock</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Exercise</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Contractual</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Options</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Price</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Life (in years)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Outstanding at December 31, 2022</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9db26c3b-6f6b-4751-af43-0e92afc3be1b" contextRef="C_788446ba-8777-48e6-8377-1f4a2176149f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,158,078</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_77951a1e-5482-4e1d-850a-7962789f0982" contextRef="C_788446ba-8777-48e6-8377-1f4a2176149f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">11.84</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_af3cd7ba-e05f-40e4-ba35-06176b75865d" contextRef="C_220cf9fa-9710-4b12-8b10-b837e62d8c09" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8.9</span></ix:nonNumeric></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7302ca05-e560-4f4a-bcfb-2ab45a74cdf4" contextRef="C_788446ba-8777-48e6-8377-1f4a2176149f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">62</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options granted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f5ccf08d-492b-49c5-9624-8441d3992bb6" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,520,471</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_48d3424f-ab2f-4d59-86d7-66b2e2eaefa5" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.90</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options cancelled or forfeited</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9eb403a9-f954-492f-9261-bf194727bd91" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,013,500</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_78561fe5-81b4-4544-8f9f-1fa606ad7e37" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">10.88</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options expired</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a8275811-58ee-40cc-8d56-262178add0bd" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">857,557</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6cbace24-952c-4590-999a-928014ab4e35" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">22.26</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Outstanding at September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_cda1acf1-71d4-48b9-b6c6-5d2212ffbe14" contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,807,492</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0b46072b-b662-4b6a-bacc-8c175937769a" contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.89</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_47e9a754-2128-4a13-bec3-c725ac21efba" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8.9</span></ix:nonNumeric></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_cd732caa-daf5-4004-8a70-6e1769a37675" contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,851</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options exercisable at September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_33375baf-5846-46f8-8182-da4bd82cf3c0" contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,036,300</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8fd7cc89-ab28-464a-ad5e-0d7534f28630" contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">18.48</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e4433fbe-0311-42a3-a453-25b04f0d771d" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.5</span></ix:nonNumeric></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6c944c98-a1e3-4e7c-a695-02e757115cb7" contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The aggregate intrinsic value in the above table is calculated as the difference between the fair value of the Company&#x2019;s common stock at the respective reporting date and the exercise price of the stock options. As of September 30, 2023, the total unrecognized compensation related to unvested time-based vesting stock option awards granted was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d8eb2b5d-2d7f-447d-a284-910280d82cae" contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, which the Company expects to recognize over a weighted-average period of approximately</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_51994655-e561-4c91-b3e6-8bcc8f9c77da" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.1</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> y</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ears. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_40cc1e49-de9b-493d-9638-d9b0e66c4575" contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> stock options were exercised during the period.</span></p><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Performance Stock Options</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2023, the Company issued options to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4366ab82-5bc5-4ad3-b4fc-966a19a7b594" contextRef="C_52565164-9ede-4417-8be6-ba6aecffc735" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">70,235</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock to employees under the New Plan that contain performance-based vesting conditions, subject to continued employment through each anniversary and achievement of the performance c</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">onditions. The grant date fair value of these awards was not material. As of September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0b095a16-bb51-469e-bac3-cb7b1430501a" contextRef="C_5d53cb28-f1c8-45d3-aaa3-c5feece6f465" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">58,346</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of the shares subject to the performance-based options were outstanding, all of which vested during the period. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9bcdc1d8-fc35-460e-8f69-6070085bfc38" contextRef="C_e15af869-8ce3-412a-8b1c-4c46b2d2bba7" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> stock options were exercised during the period.</span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">19</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In May 2023, the Company issued options to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7ded1995-fb1a-4f9b-b4c4-7ca816586446" contextRef="C_dbe9d225-ee5e-4b8b-b0c9-9b23ae056e8c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,166,653</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock to employees under the New Plan that contain both service and performance-based vesting conditions with a weighted average grant date fair value per share of</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_be8357b0-4587-4bae-972f-78976bb522fc" contextRef="C_dbe9d225-ee5e-4b8b-b0c9-9b23ae056e8c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. T</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">he stock options have a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5e82dde4-59d1-4047-a357-96aca8a7b34e" contextRef="C_dbe9d225-ee5e-4b8b-b0c9-9b23ae056e8c" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> contractual term and vest over </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_22fa820d-3d2f-466d-b4bc-62a8bbf469e9" contextRef="C_dbe9d225-ee5e-4b8b-b0c9-9b23ae056e8c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.6</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years if a combination of clinical, regulatory and financing performance conditions are achieved. As of September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c548c0eb-85a0-48e3-8555-731cfa758f04" contextRef="C_e15af869-8ce3-412a-8b1c-4c46b2d2bba7" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> compensation expense was recorded related to the awards as achievement of the performance conditions was not considered probable. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dcd68353-2aff-4023-9797-c3cbd527cb36" contextRef="C_3253dca9-a154-4e6e-add3-61c9afd96cb4" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true" continuedAt="F_dcd68353-2aff-4023-9797-c3cbd527cb36_1"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following assumptions were used to estimate the fair value of performance and service-based stock options that were granted during the nine months ended September 30, 2023:</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_dcd68353-2aff-4023-9797-c3cbd527cb36_1"><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.449%;"></td>
        <td style="width:0.998%;"></td>
        <td style="width:1%;"></td>
        <td style="width:17.552999999999997%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the nine months ended September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6b2cb829-2808-4c57-a375-bd1ad9fe190c" contextRef="C_3253dca9-a154-4e6e-add3-61c9afd96cb4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.02</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bccf195d-fd23-45bf-95fb-08ca81f9be31" contextRef="C_3253dca9-a154-4e6e-add3-61c9afd96cb4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6.0</span></ix:nonNumeric></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4c9c53d5-963e-469d-8bda-229b60f625c7" contextRef="C_3253dca9-a154-4e6e-add3-61c9afd96cb4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">81</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Market-based Stock Options</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2023, the Company issued options to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8620624e-17da-4c8c-85af-7d82979ce453" contextRef="C_7f6e1c72-16bb-483e-8cd7-a7a20b74ede0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">70,233</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock to employees under the New Plan that contain a market-based vesting condition, subject to continued employment through each anniversary and achievement of the market c</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ondition. The grant date fair value of the stock options that contain market-based vesting conditions was not material. As of September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_90f6b43a-e351-4fa3-9b34-ccd55bcf6a4c" contextRef="C_e2ae4188-b729-4bb9-a810-c77a789712b1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">58,344</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of the shares subject to the stock options that contain a market-based vesting condition were outstanding, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_bde5fe73-360a-4cb7-a9d3-311248741367" contextRef="C_6a80be52-6387-4afd-9538-c38ccf4297dd" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> options vested during the period.</span></p><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Restricted Stock Units</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5ef62eef-db65-4279-acc9-aedd1661906e" contextRef="C_51f1008f-8fa9-4508-a0ff-0b2d61656244" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">81,236</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> RSUs to employees under the New Plan. </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">T</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">he RSUs are subject to a service-based vesting condition. The service-based RSUs vest in equal annual installments over a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3fb623fe-c601-4a61-b82d-5aebf1893c8c" contextRef="C_51f1008f-8fa9-4508-a0ff-0b2d61656244" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">four-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> period. The Company at any time may accelerate the vesting of the RSUs. Such shares are not accounted for as out</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">standing until they vest.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#x2019;s default tax withholding method for RSUs granted prior to 2023 is the sell-to-cover method, in which shares with a market value equivalent to the tax withholding obligation are sold on behalf of the holder of the RSUs upon vesting and settlement to cover the tax withholding liability and the cash proceeds from such sales are remitted by the Company to taxing authorities. For RSUs granted in 2023, the Company&#x2019;s tax withholding policy allows the RSU holder to choose to either pay cash to the Company for the tax withholding obligation or elect the net withholding method, in which shares with a market equivalent to the tax withholding obligation are withheld and the net shares are issued to the RSU holder.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c189d623-fd4c-4136-921a-f234127238d2" contextRef="C_4747c8da-f859-4b04-947f-581d35ec592c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">251,296</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> RSUs to the former President and Chief Executive officer of the Company in connection with his resignation from the Company and Board of Directors. The RSUs vested immediately.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1bfa979e-1bd8-4626-9c61-6b2757b3cf55" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#x2019;s RSU activity for the nine months ended September 30, 2023 was as follows:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.02%;"></td>
        <td style="width:1.161%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.370000000000001%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.621%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.829999999999998%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Grant Date</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Number</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">of Shares</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">per Share</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonvested at December 31, 2022</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_eac1036b-58b0-4014-ab92-f24ed3c9abab" contextRef="C_f2bd8525-6258-4ee1-bf3e-0b623f59864b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,257,844</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c91fb5c4-2014-4ca6-be80-7d3a9caf42e2" contextRef="C_f2bd8525-6258-4ee1-bf3e-0b623f59864b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">6.52</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Restricted units granted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a9e1b30a-b560-4be5-afe7-1d84ae889784" contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">332,532</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dd1a5808-56b6-40f4-970e-5d4f3a51894f" contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">1.06</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0092c5b1-d2c9-4efc-ba24-f09ec584d456" contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">556,989</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ec3de5d6-682f-455f-a45e-e9644ded3d15" contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">4.78</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cancelled or forfeited</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_88fc5d72-16b1-4c7e-8167-c8148f43b068" contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">658,343</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2a3268ff-8777-478b-a3b6-ea18755d8523" contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.18</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonvested at September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8e5fa4b7-e01c-411c-926e-39f3c8207093" contextRef="C_dbdfd311-3825-4ad7-b403-58287d7548a7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">375,044</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dc46b9b9-89f2-4452-9846-80d04c25dbf8" contextRef="C_dbdfd311-3825-4ad7-b403-58287d7548a7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">6.63</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023, the total unrecognized compensation related to unvested RSUs granted was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3a84d598-f8e3-47e9-aa0c-c3d53f5cddad" contextRef="C_dbdfd311-3825-4ad7-b403-58287d7548a7" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which is expected to be amortized on a straight-line basis over a weighted-average period of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8ef19aa3-dad1-4a34-a2af-ff5b088b180d" contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.9</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years.</span></p></ix:nonNumeric></div><p style="text-indent:0;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Performance and Market-based Restricted Stock Units</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6f8fc3cc-0e3d-483c-a765-a49670c5ce14" contextRef="C_0ed2ccbf-6260-463b-bb8f-3005a6425089" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">81,233</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> RSUs to employees under the New Plan that contain a combination of performance and market-based vesting conditions, subject to continued employment through each anniversary and achievement of market and performance conditions. The grant date fair value of the RSUs that contain performance and market-based vesting conditions was not material. As of September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_041f60e2-5000-4d9d-909f-7d803317e271" contextRef="C_3c5342a3-7cee-4f48-b5b3-8beff925816b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">34,673</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of the RSUs were unvested and still outstanding and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3c995765-6a60-464a-a96e-54d9a29982ec" contextRef="C_f6908048-c889-4f93-869e-3dd5fb923ea5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">34,671</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> RSUs vested and were settled during the period.</span></p><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Restricted Stock Awards</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#x2019;s former President and Chief Executive Officer, was awarded </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3f8b0414-16e0-4760-a42b-8bc0896b75f0" contextRef="C_23bd83df-eede-42ec-9c51-05585993a9e0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">769,058</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> RSAs under the Existing Plan on July 1, 2020, which vested over a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0ea41303-bbd6-43d5-8791-899ecdb91403" contextRef="C_23bd83df-eede-42ec-9c51-05585993a9e0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> term, subject to continuous employment. The fair value of these RSAs at the grant date of July 1, 2020, was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3705bb68-b4ac-4d76-9982-2d1f87da63c7" contextRef="C_f72dceba-fcca-4fdd-bb14-6b5646b92d1e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">5.28</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share. On March 2, 2023, the Company&#x2019;s former President and Chief Executive Officer resigned from the Board of Directors, therefore cancelling any remaining unvested tranches.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cd100d8d-8db1-484f-9fe9-adb0ac60bd8c" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#x2019;s RSA activity for the nine months ended September 30, 2023 was as follows:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.02%;"></td>
        <td style="width:1.161%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.370000000000001%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.621%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.829999999999998%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Grant Date</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Number</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">of Shares</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">per Share</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonvested at December 31, 2022</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_baf52c9e-a14d-4bdd-905b-639280de3cfd" contextRef="C_84a4182e-9ee0-43f3-b998-badcbf3028a8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">85,494</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7d6926f9-f179-44a8-97ad-5a126c5175be" contextRef="C_84a4182e-9ee0-43f3-b998-badcbf3028a8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.28</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Restricted stock granted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7fb42317-be3b-4916-874c-7a048b1116d9" contextRef="C_d374b9c6-f352-4efa-81b7-539cd0b063c1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">64,120</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9fa4fb33-bde1-4d38-83e9-1e4ead293315" contextRef="C_d374b9c6-f352-4efa-81b7-539cd0b063c1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.28</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cancelled or forfeited</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_60c88455-64ea-4fb9-89bc-86bceffa8e23" contextRef="C_d374b9c6-f352-4efa-81b7-539cd0b063c1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">21,374</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2ebcd611-920e-4511-9bbc-981bb0ed5390" contextRef="C_d374b9c6-f352-4efa-81b7-539cd0b063c1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.28</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonvested at September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Employee Stock Purchase Plan</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2022, the Company&#x2019;s board of directors authorized the first offering under the ESPP. Under the ESPP, eligible employees may purchase shares of Taysha common stock through payroll deductions at a price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_58e6230e-e16d-41d4-9a62-83511e9f243c" contextRef="C_312a5395-35e7-4a3b-845a-3e7f7d95509c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" unitRef="U_pure" scale="-2" decimals="2">85</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the lower of the fair market values of the stock as of the beginning or the end of six-month offering periods. An employee&#x2019;s payroll deductions under the ESPP are limited to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3ff8bf16-ebe9-4e92-96d2-4d64a17f9cf6" contextRef="C_81a7b536-c0bb-453e-bcc6-30eb806c1470" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" unitRef="U_pure" scale="-2" decimals="2">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the employee&#x2019;s compensation and employees may not purchase more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_bf81007a-ec6c-4394-8292-e99d299bd523" contextRef="C_81a7b536-c0bb-453e-bcc6-30eb806c1470" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,800</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of shares of Taysha common stock during any offering period. During the nine months ended September 30, 2023 and 2022, stock-based compensation expense related to the ESPP was not material.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock-based Compensation Expense</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_346dd76b-f298-49c0-83c5-6be343195470" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the total stock-based compensation expense for the stock options, ESPP, RSAs and RSUs recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and 2022 (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.225%;"></td>
        <td style="width:1.905%;"></td>
        <td style="width:1%;"></td>
        <td style="width:15.741999999999999%;"></td>
        <td style="width:1%;"></td>
        <td style="width:2.807%;"></td>
        <td style="width:1%;"></td>
        <td style="width:11.772%;"></td>
        <td style="width:1%;"></td>
        <td style="width:2.506%;"></td>
        <td style="width:1%;"></td>
        <td style="width:14.138%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.764%;"></td>
        <td style="width:1%;"></td>
        <td style="width:14.138%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Three Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development expense</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_498bdc8f-e0af-4b50-a40a-52f6fbadcebe" contextRef="C_73e2f837-a7da-4610-a8b8-b300a337c6b9" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">705</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7c89e4cd-f286-4a2f-ac78-6a8899e031ea" contextRef="C_2e51a9e4-9e0b-4c3b-97d0-34a783d596e7" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,001</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d247639d-b0d8-4a28-8c89-0e4a8d089911" contextRef="C_aa916425-81f6-46a9-9211-8a2744be8acf" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,524</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_35952651-37ca-4e79-b99a-8f9f79108572" contextRef="C_151eb485-8164-452f-8e8d-d530d960d3b9" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,894</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_231da254-44d4-4020-a098-211c63c63b5e" contextRef="C_bcabd00a-3c24-4571-bd95-b51d333d5e34" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,335</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_eb2456b7-99da-44ea-9a16-eb7cd4866c9a" contextRef="C_c3b5bdf8-5491-4876-b736-c28be19cc6fb" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,469</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_089f4fb2-ec6d-4603-8ec9-4ef87980e922" contextRef="C_27149336-d352-41a8-8d0e-18408512989e" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,413</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9a114797-0c3e-44b6-8e1b-c4e022b4696d" contextRef="C_5fe22845-b517-4024-bf3c-a463c9c5382c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,046</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_80380664-e109-425c-be9e-6eb7569a998b" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,040</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_02a96fa6-4090-4dbf-9fe3-0ce88c786c04" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,470</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9e843bfb-178a-4cb0-acee-511e37195f6d" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,937</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_93f71f9a-7fde-44ed-9a51-4058464d90b7" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,940</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_660d0472-e7f0-4e21-8b02-9aa2d9fcf00e" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:WarrantsNoteDisclosureTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 10&#x2014;Warrants</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Pre-Funded Warrants</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 14, 2023, the Company entered into a Securities Purchase Agreement (the &#x201c;August 2023 Purchase Agreement&#x201d;) with certain institutional and other accredited investors (the &#x201c;Purchasers&#x201d;), pursuant to which the Company agreed to sell and issue to the Purchasers in a private placement transaction (the &#x201c;August 2023 Private Placement&#x201d;) (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dca234d0-7ab3-4204-aee3-e219a877dd9d" contextRef="C_99018103-c6e5-46d7-86c2-6f53ea9bbe0b" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">122,412,376</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares (the &#x201c;PIPE Shares&#x201d;) of the Company&#x2019;s common stock, and (ii) with respect to certain Purchasers, pre-funded warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6d64e9cb-5361-4f7f-be80-03390b7d980a" contextRef="C_2a31a044-252b-446e-9552-0e90214b5729" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">44,250,978</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company&#x2019;s common stock (the &#x201c;Pre-Funded Warrants&#x201d;) in lieu of shares of the Company&#x2019;s common stock. The purchase price per share of common stock was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e10476e5-3e7d-40c0-9c61-0a3322037830" contextRef="C_2a31a044-252b-446e-9552-0e90214b5729" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.90</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share (the &#x201c;Purchase Price&#x201d;), and the purchase price for the Pre-Funded Warrants was the Purchase Price minus $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2cfe4120-7260-46ab-b8a3-2fcb7a189a3a" contextRef="C_2a31a044-252b-446e-9552-0e90214b5729" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per Pre-Funded Warrant.</span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">21</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Pre-Funded Warrants have a per share exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9fa7aad7-ef2b-4312-8a6a-330d87d8e3d5" contextRef="C_4bcd5e18-554d-46bd-8387-2b416ade3f02" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, subject to proportional adjustments in the event of stock splits or combinations or similar events. The Pre-Funded Warrants will not expire until exercised in full. The Pre-Funded Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation; provided, however, that a holder may increase or decrease the beneficial ownership limitation by giving </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_18c6d9d3-5fc2-4723-8163-dae66a1f360c" contextRef="C_4c721f5c-334b-4fe7-802b-653db955a9ef" name="tsha:BeneficialOwnershipLimitationNoticePeriod" format="ixt-sec:durday"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">61</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> days&#x2019; notice to the Company, but not to any percentage in excess of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_221f66fb-5761-4f79-8c67-7eb7a0d9efeb" contextRef="C_4c721f5c-334b-4fe7-802b-653db955a9ef" name="tsha:IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">19.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%. The Pre-Funded Warrants will only be exercisable upon receipt of stockholder approval of an increase in the authorized shares of the Company&#x2019;s common stock (the &#x201c;Stockholder Approval&#x201d;), which the Company will first seek to obtain at a special meeting of stockholders scheduled to be held on November 15, 2023. If the Company does not obtain Stockholder Approval by December 31, 2023, it is required to pay liquidated damages of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_61f98c13-4d3d-4f94-8a0f-358138df5a16" contextRef="C_7e3ec4c7-5cbb-4cfd-9e66-965a4caa80c9" name="tsha:PaymentsToInvestorsAsLiquidatedDamages" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the aggregate purchase price paid by each holder of Pre-Funded Warrants. For any subsequent failure to obtain Stockholder Approval, the Company is required to pay an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a4cb185d-28ca-4bad-92d9-4e492bea0bd2" contextRef="C_7e3ec4c7-5cbb-4cfd-9e66-965a4caa80c9" name="tsha:PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% as liquidated damages.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The closing of the August 2023 Private Placement occurred on August 16, 2023 (the &#x201c;Closing&#x201d;). The total gross proceeds to the Company at the Closing were approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d22af962-d34a-4ffb-add8-e07ea27c280d" contextRef="C_f36491bb-eacf-4acf-ac52-472ebe8b3169" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">150.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, and after deducting placement agent commissions and offering expenses payable by the Company, net proceeds were approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0f3e8848-1fcc-40a1-b57a-9fcf25eb07b2" contextRef="C_f36491bb-eacf-4acf-ac52-472ebe8b3169" name="tsha:ProceedsFromIssuanceOfCommonStockNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">140.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. The Company used the with-and-without method to allocate the total gross proceeds by first allocating the portion of the proceeds equal to the fair value of the Pre-Funded Warrants on the Closing date with the remaining proceeds allocated to the PIPE Shares on a residual basis.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company concluded that the Pre-Funded Warrants do not meet the criteria for equity classification under the guidance of ASC 815 as the Company does not have sufficient authorized and unissued shares to satisfy the warrants if exercised. The Company recorded the Pre-Funded Warrants as liabilities at their fair value. This liability is subject to remeasurement at each balance sheet date and any change in fair value is recognized in the Company&#x2019;s condensed consolidated statement of operations. The Company incurred $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_41e180ee-8a45-4875-85d9-495940c58fc5" contextRef="C_d4e0f467-0a9d-4677-822d-01e528375bf1" name="tsha:IncurredPlacementAgentCommissionsAndOtherIssuanceCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of placement agent commissions and other issuance costs in connection with the August 2023 Private Placement. The placement agent commissions and other issuance costs were allocated between the PIPE Shares and the Pre-Funded Warrants on a systematic basis. The Company allocated $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d206a09b-ffd9-472c-ac06-578e4202e871" contextRef="C_d4e0f467-0a9d-4677-822d-01e528375bf1" name="tsha:AllocatedToSharesDeductionToAdditionalPaidInCapital" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million to the PIPE Shares which was recorded as a deduction to Additional paid-in capital. The remaining $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a0329215-34db-4a54-9c85-fe1d51ef9bff" contextRef="C_d4e0f467-0a9d-4677-822d-01e528375bf1" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million allocated to the Pre-Funded Warrants were recorded within general and administrative expense in the consolidated statements of operations for the nine months ended September 30, 2023. The issuance costs allocated to the Pre-Funded Warrants have been added back to net loss when deriving cash flows used in operations, and have been classified as a financing cash outflow in the condensed consolidated statement of cash flows for the nine months ended September 30, 2023.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company measured the fair value of the PIPE Shares and Pre-Funded Warrants based on the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_dcd9f868-b16c-41ca-826b-ecbef21aa376" contextRef="C_33b1b61d-afdf-4871-8372-0ac5c4985bb3" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.90</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share Purchase Price. </span><span><ix:nonNumeric id="F_73cb2e9a-dda9-4648-8f59-ab366784501e" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock" escape="true" continuedAt="F_73cb2e9a-dda9-4648-8f59-ab366784501e_1"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company used the relative fair value method to allocate the net proceeds received from the sales of the PIPE Shares and the Pre-Funded Warrants on the condensed consolidated balance sheet as follows (in thousands):</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_73cb2e9a-dda9-4648-8f59-ab366784501e_1"><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:60.997%;"></td>
        <td style="width:4.503%;"></td>
        <td style="width:1%;"></td>
        <td style="width:32.501000000000005%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Purchase Price Allocation</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PIPE Shares</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5c1e9a69-7edc-4c24-ab6f-c035026066b8" contextRef="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d" name="tsha:CommonStockAndWarrantsFairValueDisclosure" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">110,127</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-Funded Warrants</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_85a4b906-424e-4f1b-8bc3-3a81ef27b5cd" contextRef="C_18d9db4b-0220-483d-b698-33462a0d1d11" name="tsha:CommonStockAndWarrantsFairValueDisclosure" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">39,826</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_40b47110-7cab-4a6b-ad06-57193de9e760" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:CommonStockAndWarrantsFairValueDisclosure" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">149,953</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company remeasured the fair value of the Pre-Funded Warrants using the closing price of the Company&#x2019;s common stock on the Nasdaq Global Market as of September 30, 2023 of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f3bfb88f-d97f-4f4d-b9dc-61fb97f2dda9" contextRef="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d" name="us-gaap:SharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">3.16</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per common share. The Company recorded a fair value adjustment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ae683f19-777c-4950-8fde-d848579831ef" contextRef="C_4c88705b-93a0-4d16-a99d-3dbf7a0c78c1" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_8f01855d-d36c-4cbd-9a22-1ea34f1bbc91" contextRef="C_4e3d744a-95f2-48c1-8ae4-8a48d4233bb0" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">100.0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">SSI Warrants</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In April 2023, the Company entered into a securities purchase agreement (the &#x201c;SSI Securities Purchase Agreement&#x201d;), with two affiliates of SSI Strategy Holdings LLC (&#x201c;SSI&#x201d;), named therein (the &#x201c;SSI Investors&#x201d;) pursuant to which the Company agreed to issue and sell to the SSI Investors in a private placement (the &#x201c;SSI Private Placement&#x201d;), </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_5d58a253-d764-42fa-a51a-a7b5e04c5c95" contextRef="C_8ef3dae4-92a8-4848-bc8b-7d6ee1d2bca5" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">705,218</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of its common stock (the &#x201c;SSI Shares&#x201d;) and warrants (the &#x201c;SSI Warrants&#x201d;) to purchase an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_009c671d-3943-4277-b882-29cc6d06b526" contextRef="C_8ef3dae4-92a8-4848-bc8b-7d6ee1d2bca5" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">525,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company&#x2019;s common stock (the &#x201c;Warrant Shares&#x201d;). SSI provides certain consulting services to the Company. Each SSI Warrant has an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_eb9e77d5-bd11-4912-bc15-78c94dfa8e81" contextRef="C_8ef3dae4-92a8-4848-bc8b-7d6ee1d2bca5" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.7090</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per Warrant Share, which was the closing price of the Company&#x2019;s common stock on the Nasdaq Global Market on April 4, 2023. The SSI Warrants issued in the SSI Private Placement provide that the holder of the SSI Warrants will not have the right to exercise any portion of its SSI Warrants until the achievement of certain clinical and regulatory milestones related to the Company&#x2019;s clinical programs. The SSI Private Placement closed on April 5, 2023. Gross proceeds of the SSI Private Placement were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9c23db95-f09f-4806-8e98-390571f046ca" contextRef="C_04ff6dd0-0334-40e9-88c7-2032acec21a2" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company concluded that the SSI Warrants do not meet the criteria for equity classification under the guidance of ASC 815 due to settlement provisions that permit the holder to receive a variable number of shares in the event of a specified fundamental transaction as well as provisions that permit the holder to participate in dividends. As the SSI Warrants do not meet the criteria for equity classification, the Company recorded the warrants as liabilities at their fair value. This liability is subject to remeasurement at each balance sheet date until the warrants are exercised or expire, and any change in fair value is recognized in the Company&#x2019;s condensed consolidated statement of operations.</span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">22</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company determined the fair value of the SSI Warrants at issuance was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_e14584b4-87ee-4409-b56c-0595f1011bed" contextRef="C_29b986aa-0e5f-4fce-8696-e82fa25305c3" name="tsha:IssuanceOfFairValueWarrant" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million using the Black-Scholes-Merton option pricing model. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ed0ea81d-6850-4959-b3b5-ba8a15aba4e8" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock" escape="true" continuedAt="F_ed0ea81d-6850-4959-b3b5-ba8a15aba4e8_1"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following assumptions were used to estimate the fair value of the warrants at issuance:</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_ed0ea81d-6850-4959-b3b5-ba8a15aba4e8_1" continuedAt="F_ed0ea81d-6850-4959-b3b5-ba8a15aba4e8_2"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.853%;"></td>
        <td style="width:2.092%;"></td>
        <td style="width:1%;"></td>
        <td style="width:15.054%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a2bde128-4913-43fd-9365-e650a9f7688d" contextRef="C_bafc0748-9e47-4fe0-8057-f224262368a9" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" unitRef="U_pure" scale="0" decimals="2" format="ixt:num-dot-decimal">3.46</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_608a22a1-b921-4091-ac09-3a38c787c736" contextRef="C_467bb9bb-f5c8-46b2-9e83-49a77c2c5e47" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" unitRef="U_Y" scale="0" decimals="1" format="ixt:num-dot-decimal">5.2</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6a907542-f134-4de2-a429-46a613e8d902" contextRef="C_2ac01888-0938-41c1-b387-fb08d1afdae5" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" unitRef="U_pure" decimals="0" format="ixt:num-dot-decimal">81</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Market value of common stock</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f05c1ca2-d0e8-45b9-9427-4ef1e769d039" contextRef="C_aa7f77ea-a48d-42e3-9e4f-5074456c1eb3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">0.71</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The fair value adjustment as of September 30, 2023 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_90942d6b-1d82-44f4-927e-a784cc8d5170" contextRef="C_07daf6b0-f34a-4741-b184-8a1f541a9c89" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million using the Black-Scholes-Merton option pricing model with probability weights applied to each of the SSI Warrants where vesting is contingent upon the achievement of certain clinical and regulatory milestones related to the Company&#x2019;s clinical programs. As of September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_eff766fe-7d24-414d-a9fe-f1dbf3198e6f" contextRef="C_11f479fa-8bc0-462f-aae7-eb345d89a6d2" name="tsha:ClassOfWarrantOrRightVestedAndExercisable" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">200,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of the SSI Warrants have vested and are exercisable. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9323706a-7e4f-451c-ba3c-f851db29f254" contextRef="C_11f479fa-8bc0-462f-aae7-eb345d89a6d2" name="us-gaap:ClassOfWarrantOrRightUnissued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> warrants were exercised during the period.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_ed0ea81d-6850-4959-b3b5-ba8a15aba4e8_2"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company estimated the fair value of the SSI Warrant liability using the following assumptions as of September 30, 2023:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:72.285%;"></td>
        <td style="width:4.901%;"></td>
        <td style="width:1%;"></td>
        <td style="width:20.812%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_563d603f-fd5f-4510-8b9b-f83866df9231" contextRef="C_f73dfe04-8e13-4f73-9796-2fc971735968" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" unitRef="U_pure" scale="0" decimals="2" format="ixt:num-dot-decimal">3.46</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_0af00a57-f31c-49a9-907a-6dc414640b6b" contextRef="C_7c39cbeb-fc40-4194-9257-c31ad0395ba2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" unitRef="U_Y" scale="0" decimals="1" format="ixt:num-dot-decimal">4.8</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_82183d37-b260-4b1e-a526-763f11253614" contextRef="C_19b223c2-858d-4c13-823b-7fac0db24551" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" unitRef="U_pure" decimals="0" format="ixt:num-dot-decimal">81</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Market value of common stock</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d02f8e22-dd3c-40d2-bea2-8f52e37cc3a0" contextRef="C_3643e8c7-ca2c-41ba-88d7-153c48cfb65c" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" unitRef="U_USD" scale="0" decimals="2" format="ixt:num-dot-decimal">3.16</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6adfa201-5aa0-4a89-b87c-34b201e2d341" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ScheduleOfWarrantLiabilityTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the Company&#x2019;s warrant liability (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.499%;"></td>
        <td style="width:3.962%;"></td>
        <td style="width:1%;"></td>
        <td style="width:28.538999999999998%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Warrant Liability</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Balance at January 1, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Issuance of SSI Warrants</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_360a56ab-c147-4bc6-934e-c16805a65db0" contextRef="C_c89eb35b-aaf3-4ca8-943d-735991153287" name="tsha:IssuanceOfWarrantLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">252</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Issuance of Pre-Funded Warrants</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_fe75c879-3d63-447c-aaa4-89174bd92cd3" contextRef="C_4e3d744a-95f2-48c1-8ae4-8a48d4233bb0" name="tsha:IssuanceOfWarrantLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,826</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Change in fair value</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_bccdaa89-7fa4-4946-b426-5471a12dacc3" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ChangeInFairValueOfWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100,456</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Balance at September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_87050d92-85c6-472a-926d-8c94251f13d0" contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c" name="tsha:WarrantLiabilityFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">140,534</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e99a3168-daf5-4006-a2ed-551d0b1be580" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 11&#x2014;Net Loss Per Common Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Since the Company had a net loss in all periods presented, basic and diluted net loss per common share are the same.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In August 2023, the Company issued liability-classified Pre-Funded Warrants with a nominal exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_494d45c3-1c3b-4eeb-9b97-a559a832fff6" contextRef="C_4bcd5e18-554d-46bd-8387-2b416ade3f02" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share (see Note 10). In accordance with ASC 260 </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Earnings Per Share, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">shares issuable for little to no cash consideration should be included in the number of outstanding shares used to calculate basic earnings per share as long as all conditions necessary for exercise are met. As the Company does not have enough authorized shares to satisfy the warrants, the requirement that all conditions necessary for exercise are not met, and the Pre-Funded Warrants are not included in the calculation of basic net loss per share for the three and nine months ended September 30, 2023.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_db55f184-d6f5-4bb1-a6a8-7122da3db1f6" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table represents the calculation of basic and diluted net loss per common share (in thousands, except share and per share data):</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.158%;"></td>
        <td style="width:1.484%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.954%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.384%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.954%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.183%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.851%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.183%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.851%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Three Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d620a975-1bf2-46ee-b718-bf841f9258f1" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">117,087</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_21930559-da14-408b-bb10-b57b7658875b" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">26,527</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_60dd379e-dd60-4ea1-8c80-47dc65114a56" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">159,307</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_61f744e5-c040-4b5e-88d3-6f82aee57848" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">110,936</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted-average shares of common stock outstanding used to compute net loss per common share, basic and diluted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f0e19d0e-973d-471e-8bd1-62593a06683a" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_77d85fe1-0860-40cc-b34a-bb703da4b9f7" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">125,700,799</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_b29869cd-c405-40a1-b461-7f876c38a7df" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ffd36926-beb1-42fd-9892-92e36a3816c0" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">40,937,808</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_83d65c74-80fe-4fff-ad14-97437a144015" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4a989680-1761-4e33-b95a-e7f8bafdbc26" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">84,630,796</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_30e720ce-214f-44db-8806-4ed0d201775c" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_7be8fcd7-7c59-4cfb-8e6a-52b1a145ec7e" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">39,761,764</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss per common share, basic and diluted</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4b1e48fa-2e7b-4157-b2d6-d311db92b78d" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_f38e8912-1bef-41c6-b39b-abe65bc91437" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.93</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_7cb4c5b4-3656-4f78-9817-80a9884e1da8" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_1b2ecd13-6f62-40dd-8291-89dab0c89a57" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.65</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_327a0837-f826-4449-89ef-21b26d32257b" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_8b2e7849-1f95-4750-82d4-9ce74305e8b9" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.88</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_34837c66-aade-49a2-88b2-e74a12b606e1" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_3bee20d9-e0b1-467e-9f91-872428bb850f" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">2.79</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">23</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1854a085-665c-40d3-99ba-5ad9598829ec" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following common stock equivalents outstanding as of September 30, 2023 and 2022 were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti&#x2011;dilutive:</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.96%;"></td>
        <td style="width:1.16%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.36%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.16%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.36%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br />2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br />2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unvested RSUs</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3faafbe7-b0d6-416a-a578-460283a0e7bb" contextRef="C_29b5ff44-bd12-407c-9c1b-ed72f20b73c9" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">409,717</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_99f8134e-c5cf-4325-992a-f6b09f1a9c35" contextRef="C_dd649981-9002-4b1a-8b61-880d7062b373" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,257,844</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unvested RSAs</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4355b4b2-668c-4a46-b1c5-5dd36c437081" contextRef="C_bda073bb-c8f5-46f9-ba1e-59d7b6cce834" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">149,614</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Stock options</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4e9be5b3-30f1-44e9-8cea-2d372e4b7b02" contextRef="C_9e4fa149-1f8c-4521-8d30-073662fd12c2" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">8,090,835</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_2c025c7d-fdf2-4f8d-8346-50e4a15c6022" contextRef="C_1fb76a57-582e-46ab-b8bd-4287ba306f26" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">4,547,733</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SSI Warrants</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_931188a6-db0b-4cdf-af73-04625b9fef8f" contextRef="C_162c443b-2d6f-4ca9-a115-4b08a2c7a8c0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">525,000</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-Funded Warrants</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_46a463ef-4f08-435b-a55c-b97ca7ba5b7b" contextRef="C_8da9a80f-388d-49d3-9c46-6ca3616d641d" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">44,250,978</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_83d6761d-0fb0-4fae-a9e6-5b817794c6b2" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">53,276,530</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3f728cb0-5ee1-40cb-9ac6-474e48dc2b86" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,955,191</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5fc1b327-691b-4706-8eed-9e5be6834808" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 12&#x2014;Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are provided if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets. There is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_a4954892-c11a-4875-972e-16d839175703" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> provision for income taxes because the Company has incurred operating losses and capitalized certain items for income tax purposes since its inception and maintains a full valuation allowance against its net deferred tax assets. The reported amount of income tax expense for the period differs from the amount that would result from applying the federal statutory tax rate to net loss before taxes primarily because of the change in valuation allowance.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023, there were no material changes to either the nature or the amounts of the uncertain tax positions previously determined for the year ended December 31, 2022.</span></p></ix:nonNumeric></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4f12cb32-4aa9-4d4a-9590-adf4c1e7c3b5" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 13&#x2014;Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Litigation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is not a party to any material legal proceedings and is not aware of any pending or threatened claims. From time to time, the Company may be subject to various legal proceedings and claims that arise in the ordinary course of its business activities.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Commitments</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the normal course of business, the Company enters into contracts that contain a variety of indemnifications with its employees, licensors, suppliers and service providers. The Company&#x2019;s maximum exposure under these arrangements is unknown at September 30, 2023. The Company does not anticipate recognizing any significant losses relating to these arrangements.</span></p></ix:nonNumeric></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_04e72515-9aa7-40ae-a650-a0b6688b4c62" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 14 &#x2013; Strategic Reprioritization</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2022, the Company implemented changes to the Company&#x2019;s organizational structure as well as a broader operational cost reduction plan to enable the Company to focus on specific clinical-stage programs for GAN and Rett syndrome. Substantially all other research and development activities have been paused to increase operational efficiency.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with prioritization of programs, the Company reduced headcount by approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_3eba7946-471b-4d74-b856-416807851a50" contextRef="C_27c18364-0175-4f13-b9fc-bed49be4dac2" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" unitRef="U_pure" scale="-2" decimals="2">35</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% across all functions in March 2022. In accordance with ASC 420,</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> Exit and Disposal Activities,</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the Company recorded one-time severance and termination-related costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_4c3e1801-e577-4b29-a599-062037a4ee7c" contextRef="C_90d0d226-40ec-4b9a-8519-b099afecfa5a" name="us-gaap:SeveranceCosts1" unitRef="U_USD" scale="6" decimals="-5">2.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in the condensed consolidated statements of operations for the nine months ended September 30, 2022, primarily within research and development expenses. Throughout the first quarter of 2023, the Company further reduced headcount and recorded additional one-time severance and termination related costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_152a82aa-5bbc-4089-bd39-831236f18a97" contextRef="C_997ec0ed-2c41-4632-ae98-d747ae5dbab5" name="us-gaap:SeveranceCosts1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within research and development and general and administrative expenses.</span></p><ix:exclude><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">24</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1abc8484-0280-4c88-95e6-c95fb3103ffd" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="tsha:ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock" escape="true"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company expects payment of these costs to be complete by March 31, 2024. The amount of accrued severance recorded as of September 30, 2023 is as follows (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.8%;"></td>
        <td style="width:4.122%;"></td>
        <td style="width:1%;"></td>
        <td style="width:27.078%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued severance balance as of December 31, 2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_58a9ed5f-bba5-45df-9481-6e64e22d0f10" contextRef="C_d73f002d-37aa-4ddd-8f3a-08970ba84984" name="tsha:AccruedSeveranceBalance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,463</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Severance recorded</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_f886e981-890b-4f09-b3ce-79130facf450" contextRef="C_fd17c3d9-bde3-44a4-b00f-89b6c9cd0d15" name="tsha:SeveranceCostRecorded" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,691</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Severance paid</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d3bf96ca-0d01-4425-95d1-d3ae4863accd" contextRef="C_fd17c3d9-bde3-44a4-b00f-89b6c9cd0d15" name="us-gaap:SeveranceCosts1" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,162</ix:nonFraction></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued severance balance as of September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_bfa06cbc-dc73-4017-b668-ee4b3eb4df36" contextRef="C_6310a863-a521-49ae-9a54-5fdd0104f020" name="tsha:AccruedSeveranceBalance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">992</ix:nonFraction></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a36a7b3d-d478-4641-b0ae-17573cb23e2e" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 15 &#x2013; Retirement Plan</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In July 2021, the Company adopted a 401(k) retirement savings plan that provides retirement benefits to all full-time employees. Eligible employees may</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> contribute a percentage of their annual compensation, subject to Internal Revenue Service limitations. The Company contributed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_ef8a227a-9353-4d92-b4d5-b20388fafc46" contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_c0c9a06b-e51f-47ff-93bf-2281c4171ed9" contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million to the 401(k) retirement savings plan for the three months ended September 30, 2023 and 2022, respectively. The Company contributed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_1c0c965a-2945-4150-9576-b311c52789dc" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_9c900c96-dc88-4bfe-ae1b-7f8b43e1383f" contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million to the 401(k) retirement savings plan for the nine months ended September 30, 2023 and 2022, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fb48c0fe-5b00-4bf3-9f98-0d54ea11d3b6" contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017" name="us-gaap:SubsequentEventsTextBlock" escape="true"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 16&#x2013; Subsequent Events</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 13, 2023 (the &#x201c;Trinity Closing Date&#x201d;), the Company entered into a Loan and Security Agreement (the &#x201c;Trinity Term Loan Agreement&#x201d;), by and among the Company, the lenders party thereto from time to time (the &#x201c;Trinity Lenders&#x201d;) and Trinity Capital Inc., as administrative agent and collateral agent for the Trinity Lenders (&#x201c;Trinity&#x201d;). The Trinity Term Loan Agreement provides for, on the Trinity Closing Date, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_cda83925-daf9-4916-95ca-6cd7296f9e1b" contextRef="C_6aeab603-0bae-4f76-9690-07fdf336dce4" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="INF" format="ixt:num-dot-decimal">40.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million aggregate principal amount of term loans (collectively, the &#x201c;Trinity Term Loans&#x201d;). The Company drew the Trinity Term Loans in full on the Trinity Closing Date.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d2c96810-1873-4afd-8b0d-e60ae2d68ff3" contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd" name="us-gaap:DebtInstrumentInterestRateTerms"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The interest rate applicable to the Trinity Term Loans is the greater of (a) the WSJ Prime Rate plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_bf8c5ab5-ecc1-4808-b14a-0a5f92ae0670" contextRef="C_7b13f58d-8442-4d48-a92e-3e9c2f531ffc" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% or (b) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_bfe80533-da64-492e-ab39-b873b42da718" contextRef="C_6aeab603-0bae-4f76-9690-07fdf336dce4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">12.75</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% per annum. The Trinity Term Loans are interest only from the Trinity Closing Date through </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ac428606-dfd5-45a7-b41f-fbd4b9f940aa" contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd" name="tsha:InterestRatePeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">36 months</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> from the Trinity Closing Date, which may be extended to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dc455359-a684-4d81-a4a8-4314226f3ebb" contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd" name="tsha:InterestRateExtensionPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">48 months</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> from the Trinity Closing Date upon the satisfaction of certain milestones set forth in the Trinity Term Loan Agreement, after which the Company is required to pay equal monthly installments of principal through </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_45818241-e07b-4c41-b3b3-78ad2d89da69" contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">November 13, 2028</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (the &#x201c;Maturity Date&#x201d;).</span></ix:nonNumeric></span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Trinity Term Loans may be prepaid in full (i) from the Trinity Closing Date through November 13, 2024, with payment of a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_6f1c9bf3-a0d8-4d54-9c1a-ea88d47a38eb" contextRef="C_de722255-5e4d-4b90-b918-c5cb3d32e39a" name="tsha:PercentageOfPrepaymentPremium" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% prepayment premium, (ii) from November 13, 2024 through November 13, 2025, with payment of a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_20037e57-5782-46c6-b3f7-8b793cb60ea6" contextRef="C_a3d12033-f85a-468b-8d86-8048a97ad7ff" name="tsha:PercentageOfPrepaymentPremium" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% prepayment premium, and (iii) from November 13, 2025 through, but excluding, the Maturity Date, with payment of a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_fec0b5ad-5b1f-47ca-ba40-7d455f4cb73b" contextRef="C_df655a6c-a1e2-4b8b-b36e-5e7362c2c0fb" name="tsha:PercentageOfPrepaymentPremium" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% prepayment premium.  On the Trinity Closing Date, the Company paid to Trinity a commitment fee of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_eed2b33f-2fe3-43f7-a7a0-b80a3dcdc9ed" contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">1.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the original principal amount of the Trinity Term Loans. Upon repayment in full of the Trinity Term Loans, the Company will pay to Trinity an end of term payment equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_8186d173-79fa-49bc-a52c-3a11add28542" contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd" name="tsha:EndOfTermPaymentPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">5.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the original principal amount of the Trinity Term Loans.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The obligations under the Trinity Term Loan Agreement are secured by a perfected security interest in all of the Company&#x2019;s assets except for certain customarily excluded property pursuant to the terms of the Trinity Term Loan Agreement. There are no financial covenants and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_d2346482-df09-4bea-8dc2-472cbcca3c20" contextRef="C_6aeab603-0bae-4f76-9690-07fdf336dce4" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> warrants associated with the Trinity Term Loan Agreement. The Trinity Term Loan Agreement contains various covenants that limit the Company&#x2019;s ability to engage in specified types of transactions without the consent of Trinity and the Trinity Lenders which include, among others, incurring or assuming certain debt; merging, consolidating or acquiring all or substantially all of the capital stock or property of another entity; changing the nature of the Company&#x2019;s business; changing the Company&#x2019;s organizational structure or type; licensing, transferring or disposing of certain assets; granting certain types of liens on the Company&#x2019;s assets; making certain investments; and paying cash dividends.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Trinity Term Loan Agreement also contains customary representations and warranties, and also includes customary events of default, including payment default, breach of covenants, change of control, and material adverse effects. Upon the occurrence of an event of default, a default interest rate of an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><ix:nonFraction id="F_23baa426-7a97-4b6d-8358-0e95ea38bf82" contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd" name="tsha:PercentageOfAnnualDefaultInterestRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% per annum may be applied to the outstanding loan balances, and the Trinity Lenders may declare all outstanding obligations immediately due and payable and exercise all of its rights and remedies as set forth in the Trinity Term Loan Agreement and under applicable law.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The proceeds of the Trinity Term Loans were used to repay the Company&#x2019;s obligations under the Term Loan Agreement with Silicon Valley Bank in full. The Term Loan Agreement with Silicon Valley Bank was terminated concurrently with entry into the Trinity Term Loan Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">25</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_2_managements_discussion_analysis_f"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 2. Management&#x2019;s Discussion and Analysis of </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial Condition and Results of Operations.</span><span style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and the audited financial statements and notes thereto as of and for the year ended December 31, 2022 and the related Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations, included in our Annual Report on Form 10-K for the year ended December 31, 2022, or Annual Report, filed with the Securities and Exchange Commission, or the SEC, on March 28, 2023. Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q to &#x201c;we,&#x201d; &#x201c;us,&#x201d; and &#x201c;our&#x201d; refer to Taysha Gene Therapies, Inc. together with its consolidated subsidiaries.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Forward-Looking Statements</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">The information in this discussion contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which are subject to the &#x201c;safe harbor&#x201d; created by those sections. These forward-looking statements include, but are not limited to, statements concerning our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans and objectives of management. The words &#x201c;anticipates,&#x201d; &#x201c;believes,&#x201d; &#x201c;estimates,&#x201d; &#x201c;expects,&#x201d; &#x201c;intends,&#x201d; &#x201c;may,&#x201d; &#x201c;plans,&#x201d; &#x201c;projects,&#x201d; &#x201c;will,&#x201d; &#x201c;would&#x201d; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation, the risks set forth in</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Part II, Item 1A, &#x201c;Risk Factors&#x201d; in this Quarterly Report on Form 10-Q and Part II, Item 1A, &#x201c;Risk Factors&#x201d; in our Annual Report. The forward-looking statements are applicable only as of the date on which they are made, and we do not assume any obligation to update any forward-looking statements.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note Regarding Trademarks</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All brand names or trademarks appearing in this report are the property of their respective holders. Unless the context requires otherwise, references in this report to the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; and &#x201c;our&#x201d; refer to Taysha Gene Therapies, Inc.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Overview</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system, or CNS. We were founded in partnership with The University of Texas Southwestern Medical Center, or UT Southwestern, to develop and commercialize transformative gene therapy treatments. Together with UT Southwestern, we possess a portfolio of gene therapy product candidates, with exclusive options to acquire several additional development programs at no cost. By combining our management team&#x2019;s proven experience in gene therapy drug development and commercialization with UT Southwestern&#x2019;s world-class gene therapy research capabilities, we believe we have created a powerful engine to develop transformative therapies to dramatically improve patients&#x2019; lives. In March 2022, we announced strategic pipeline prioritization initiatives focused on giant axonal neuropathy, or GAN, and Rett syndrome, and we have subsequently further paused substantially all other research and development activities to increase operational efficiency. Further, in September 2023, we announced that subsequent to the receipt of Type C meeting feedback from the United States Food and Drug Administration, or FDA, regarding a registrational path for TSHA-120, we were discontinuing the development of our TSHA-120 program in evaluation for the treatment of GAN.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are evaluating TSHA-102 in the REVEAL Phase 1/2 clinical trial, which is an open-label, dose escalation, randomized, multicenter study that is examining the safety and efficacy of TSHA-102 in adult female patients with Rett syndrome. We dosed the first two adult patients with Rett syndrome in 2023. There have been no treatment-emergent serious adverse events as of the 20-week assessment post-treatment for the first Rett adult patient treated. In addition, there have been no treatment-emergent serious adverse events as of the six-week assessment post-treatment for the second Rett adult patient treated. The independent data monitoring committee, or IDMC, meeting to review the clinical data from the first two patients took place in November 2023 at which time the IDMC provided clearance to dose the third patient. Further updates on available clinical data from low dose cohort 1 are expected in the first quarter of 2024. We submitted a clinical trial application, or CTA, to the United Kingdom&#x2019;s Medicines and Healthcare Products Regulatory Agency, or MHRA, for pediatric patients with Rett syndrome and submitted an IND application for pediatric patients with Rett syndrome to the FDA for TSHA-102 early in the third quarter of 2023. In August 2023, we received clearance from the FDA on our IND for TSHA-102 in pediatric patients with Rett syndrome and are planning on dosing the first Rett syndrome pediatric patient in the first quarter of 2024. The FDA has granted Fast Track Designation to TSHA-102 for Rett syndrome.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have a limited operating history. Since our inception, our operations have focused on organizing and staffing our company, business planning, raising capital and entering into collaboration agreements for conducting preclinical and clinical development activities for our product candidates. Both of our lead product candidates are still in the clinical stage. We do not have any product candidates approved for sale and have not generated any revenue from product sales. Through September 30, 2023, we have funded our operations primarily through: (i) the sale of equity, raising an aggregate of $589.0 million of gross proceeds from our initial public offering, or the IPO, sales of common stock pursuant to our Sales Agreement (as defined below), our October 2022 follow-on offering and our 2023 private placements; (ii) pre-IPO private placements of our convertible preferred stock and other private placements of our common stock; (iii) our Term Loan Agreement (as defined below); and (iv) the Astellas Transactions (as defined below).</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 12, 2021, or the Closing Date, we entered into a Loan and Security Agreement, or the Term Loan Agreement, with the lenders party thereto from time to time, or the Lenders and Silicon Valley Bank, as administrative agent and collateral agent for the Lenders, or the Agent. We drew $30.0 million in term loans on the Closing Date and drew an additional $10.0 million term loan on December 29, 2021. We did not draw any of the additional $20.0 million tranches prior to their expiration on September 30, 2022 and March 31, 2023. On November 13, 2023, we entered into the Trinity Term Loan Agreement (as defined below). The proceeds of the Trinity Term Loans (as defined below) were used to repay our obligations under the Term Loan Agreement. The Term Loan Agreement was terminated concurrently with entry into the Trinity Term Loan Agreement.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Since our inception, we have incurred significant operating losses. Our net losses were $159.3 million for the nine months ended September 30, 2023 and $110.9 million for the nine months ended September 30, 2022. As of September 30, 2023, we had an accumulated deficit of $560.7 million. We expect to continue to incur significant expenses and operating losses for the foreseeable future. We anticipate that our expenses will increase significantly in connection with our ongoing activities, as we:</span></p>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">continue to advance the clinical development of our product candidates and, if we determine to do so in the future, reprioritize the advancement of our preclinical and discovery programs;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">conduct our ongoing clinical trials of TSHA-102 and any other future product candidates that we advance;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">seek regulatory approval for any product candidates that successfully complete clinical trials; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">continue to develop our gene therapy product candidate pipeline; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">scale up our clinical and regulatory capabilities; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">work with CMOs for the manufacture current GMP material for clinical trials or potential commercial sales;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">establish a commercialization infrastructure and scale up internal and external manufacturing and distribution capabilities to commercialize any product candidates for which we may obtain regulatory approval; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">adapt our regulatory compliance efforts to incorporate requirements applicable to marketed products; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">maintain, expand and protect our intellectual property portfolio;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">hire additional clinical, manufacturing quality control, regulatory, manufacturing and scientific and administrative personnel; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">add operational, financial and management information systems and personnel, including personnel to support our product development and planned future commercialization efforts; and </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">incur additional legal, accounting and other expenses in operating as a public company.</span></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">27</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our Pipeline</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We possess a portfolio of gene therapy product candidates for monogenic diseases of the CNS in both rare and large patient populations, with exclusive options to acquire several additional development programs at no cost. Our portfolio of gene therapy candidates targets broad neurological indications across three distinct therapeutic categories: neurodegenerative diseases, neurodevelopmental disorders and genetic epilepsies. Our current pipeline, including the stage of development of each of our product candidates, is represented in the table below:</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img38651418_0.jpg" alt="img38651418_0.jpg" style="width:720px;height:159px;" />&#160;</p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">TSHA-102 for Rett Syndrome</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TSHA-102 is a self-complementary intrathecally delivered AAV9 gene transfer therapy product candidate in clinical evaluation for Rett syndrome, a neurodevelopmental disorder and one of the most common genetic causes of severe intellectual disability, characterized by rapid developmental regression and in many cases caused by heterozygous loss of function mutations in MECP2, a gene essential for neuronal and synaptic function in the brain. TSHA-102 has been designed to prevent gene overexpression-related toxicity by inserting microRNA, or miRNA target binding sites into the 3&#x2019; untranslated region of viral genomes. This overexpression of MECP2 is seen clinically in patients with a condition known as MECP2 duplication syndrome, where elevated levels of MECP2 result in a clinical phenotype similar to Rett syndrome both in terms of symptoms and severity. TSHA-102 is constructed from a neuronal specific promoter, MeP426, coupled with the miniMECP2 transgene, a truncated version of MECP2, and miRNA-Responsive Auto-Regulatory Element, or miRARE, our novel miRNA target panel, packaged in self-complementary AAV9, which enables cellular regulation of both endogenous and exogenous MECP2 expression. According to the Rett Syndrome Research Trust, Rett syndrome affects more than 350,000 patients worldwide. The estimated addressable patient population with typical Rett syndrome caused by a pathogenic/likely pathogenic MECP2 mutation is between 15,000 and 20,000 patients in the United States, European Union and United Kingdom.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Phase 1/2 REVEAL Clinical Trial</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We submitted a CTA for TSHA-102 in November 2021 and announced initiation of clinical development under a CTA approved by Health Canada in March 2022. We are advancing TSHA-102 in the REVEAL Phase 1/2 clinical trial, which is an open-label, dose escalation and dose-expansion, randomized, multicenter study that is evaluating the safety and efficacy of TSHA-102 in up to 18 adult female patients with Rett syndrome. Participants will receive a single lumbar intrathecal injection of TSHA-102. Dose escalation will evaluate two dose levels of TSHA-102 sequentially. In cohort 1, the first two patients were dosed with a dose of 5.7x10</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> total vg, and the remaining patients in cohort 1 will receive the same dose, and the second cohort will be given a dose of 1x10</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> total vg. The maximum tolerated dose or maximum administered dose established will then be administered during dose expansion. Key assessments will include Rett-specific and global assessments, quality of life, biomarkers, and neurophysiology and imaging assessments.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> We dosed the first adult patient with Rett syndrome in the first half of 2023. The second adult patient was dosed in September 2023. We plan to complete dosing of the low dose cohort in the fourth quarter of 2023 or first quarter of 2024. TSHA-102 demonstrated a well-tolerated safety profile with no treatment-emergent serious adverse events as of the week 20 post-treatment assessment for patient 1 and as of the week six post-treatment assessment for patient 2. The IDMC meeting to review the updated clinical data took place in November 2023 at which time the IDMC provided clearance to dose the third patient.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">TSHA-102 REVEAL Clinical Trial Safety and Efficacy Endpoints</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Primary efficacy endpoints are patient assessments by clinicians using the Clinical Global Impressions Scale &#x2013; Improvement, or CGI-I, Rett Syndrome Hand Function Scale, or RSHFS, and Revised Motor Behavior Assessment, or R-MBA. Secondary</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">28</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">endpoints include patient assessments by clinicians and caregivers using the Clinical Global Impressions Scale &#x2013; Severity, or CGI-S, the Rett Syndrome Behavior Questionnaire, or RSBQ, and other clinical assessment scales.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the first adult patient dosed, TSHA-102 demonstrated a well-tolerated safety profile with no treatment-emergent serious adverse events as of the 20-week assessment post-treatment. In addition, the Principal Investigator observed significant clinical improvement in multiple domains, including autonomic function (improved breathing patterns, sleep quality and duration), socialization (improved social interest and vocalization), as well as gross motor skills (gained ability to move legs and sit unassisted for up to 15 minutes at week 12) and fine motor skills (improved hand function and the gained ability to grasp two different objects in her non-dominant hand for the first time since infancy), supported by clinical data.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the second adult patient dosed, TSHA-102 demonstrated a well-tolerated safety profile with no treatment-emergent serious adverse events as of the six-week assessment post-treatment. The Principal Investigator observed clinical improvement in multiple domains, including autonomic function (reduced seizures and improved breathing patterns, including significant reduction in hyperventilation), socialization (improved social interest), gross motor skills (improved posture, gait and stability) and fine motor skills (improved hand stereotypies) and significant reduction in seizure frequency, supported by initial clinical data and Seizure Diaries.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The first patient dosed in the REVEAL trial demonstrated a sustained clinical improvement in the first 12 weeks post-TSHA-102 administration as depicted in the graph below. The second patient dosed in the REVEAL trial demonstrated a clinical improvement at the week four post-TSHA-102 administration as depicted in the graphs below.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img38651418_1.jpg" alt="img38651418_1.jpg" style="width:720px;height:296px;" />&#160;</p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">29</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">TSHA-102 REVEAL Trial Patient 1</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The first adult patient dosed with TSHA-102 demonstrated a sustained clinical improvement in RSBQ Total Score at week 12 post-TSHA-102 administration as depicted in the chart below.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img38651418_2.jpg" alt="img38651418_2.jpg" style="width:626px;height:299px;" />&#160;</p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Patient 1 demonstrated a sustained clinically significant improvement assessed 12 weeks post-TSHA-102 administration. A 22-point improvement was shown in total RSBQ score through week 12, which was mostly driven by improvements in hand behaviors, night-time behavior, breathing problems and facial expressions.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Patient 1 demonstrated an improvement in the R-MBA Total Score at week 12 post-TSHA-102 administration as depicted in the graph below.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img38651418_3.jpg" alt="img38651418_3.jpg" style="width:720px;height:480px;" />&#160;</p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For patient 1, improvements were seen at week 12 post-TSHA-102 administration. A six-point improvement was demonstrated by the R-MBA through week 12, which was driven by improvements in motor dysfunction and social skills.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Patient 1 has been on phenytoin as antiepileptic therapy, which she has continued following treatment with TSHA-102. Prior to treatment and per medical history, the patient required phenytoin levels of &gt;100 umol/L to control her seizures. Patient 1 was seizure-free at six weeks post-treatment with TSHA-102. As of 20 weeks following treatment, the patient has seizures at phenytoin levels of  60-80 umol/L, which is substantially lower than her therapeutic levels before TSHA-102 treatment. Per the Seizure Diary, the patient experienced a total of seven seizures post-treatment, when her phenytoin levels were sub-therapeutic. Specifically, one seizure corresponded with a phenytoin level of 45.9 umol/L. The last reported seizure occurred on Day 82, when the patient&#x2019;s phenytoin level was 35.9 umol/L.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The RSHFS is a scale designed to evaluate hand function in patients with Rett syndrome. The patient's hand function is evaluated by an experienced independent physical therapist with expertise in the hand function of Rett patients, based on videotaped sessions in which the patient&#x2019;s caregiver hands her both large (e.g. a toy, cup, or spoon) and small (e.g. a grape or small piece of sandwich) objects so that the patient may demonstrate her ability to grasp, pick up, and hold the objects. The physical therapist then</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">31</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">codes the demonstrated hand function in each video at one of four levels of hand function, ranging from no active grasping of any objects to independent grasping.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Patient 1 demonstrated a significant improvement in RSHFS at 11 weeks post TSHA-102 administration as depicted in the chart below.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img38651418_4.jpg" alt="img38651418_4.jpg" style="width:720px;height:274px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Loss of hand function is a hallmark characteristic of Rett syndrome and a key area of concern for caregivers. It impacts a patient&#x2019;s ability to communicate and impedes daily activities, which ultimately limits independence. Per the RSHFS independent assessor, in the week 11 assessment, patient 1 demonstrated the ability to use use her non-dominant hand for some basic grasping whereas previously, she was not able to grasp at all. Patient 1&#x2019;s non-dominant hand went from a score of one at baseline (no active grasping) to the second highest level rating of three (holding objects for at least two seconds) at week 11. At baseline, she could hold no objects with her non-dominant hand and at week 11 post-treatment, she could hold two different objects (spoon and toy) for at least two seconds. Patient 1&#x2019;s dominant hand function improved following treatment as she was able to grasp two different objects (spoon and toy) rather than just one object (spoon) at baseline.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">TSHA-102 REVEAL Trial Patient 2</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">While the two patients dosed to date in our REVEAL trial both have the most advanced stage of Rett Syndrome, Stage, IV, they possess different genetic backgrounds and mutation types, which appears to manifest in dramatically different phenotypes and clinical severity.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Patient 1 has a large deletion within the MECP2 gene as these deletions have been reported to cause Rett Syndrome. This patient's phenotypic manifestation is more severe, with complete loss of ambulation (patient is wheelchair-bound) and scoliosis, which is consistent with the previously discussed correlation between truncating defects and severity of presenting phenotype.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Patient 2 has a missense mutation in the MECP2 gene, which has been reported in over 25 publications to cause Rett syndrome. This patient's phenotypic manifestation is milder, with only partial loss of ambulation, which is consistent with the correlation between missense defects and milder phenotypes, as demonstrated by the baseline scores of each patient.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">32</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Patient 2 demonstrated a clinical improvement in RSBQ Total Score four weeks post-TSHA-102 administration as depicted in the chart below.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img38651418_5.jpg" alt="img38651418_5.jpg" style="width:651px;height:315px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A four-point improvement at week four was shown in RSBQ Total Score which was mostly driven by improvements in body rocking/facial expressions, walking/standing and improvements in breathing abnormalities.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">33</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Patient 2 demonstrated improvements in the R-MBA Total Score at four weeks post-TSHA-102 administration as depicted in the graph below.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img38651418_6.jpg" alt="img38651418_6.jpg" style="width:720px;height:447px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A seven-point improvement through week four was demonstrated by the R-MBA, mostly driven by improvements in social skills and respiratory behaviors including less frequent hyperventilating and breath-holding.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Patient 2 had only a single seizure event that was detected on day 13 post TSHA-102 administration (two seizures reported in pre-study screening period). The seizure was an unknown type, motor and less than one minute duration. The Principal Investigator describes a reduction in seizures from pre-treatment to post-therapy treatment based on caregiver reported patient history.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">34</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Patient 2 hand function data is shown in the chart below. There was no observed improvement in RSHFS at four weeks post-treatment.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img38651418_7.jpg" alt="img38651418_7.jpg" style="width:720px;height:175px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Preclinical in vitro data on TSHA-102</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We presented new preclinical in vitro data on TSHA-102 in Rett syndrome as part of a poster presentation at the ESGCT 30th Annual Congress in October 2023. The preclinical study used human (2v6.11) and mouse (N2a) cell culture models to explore the function of miRARE and its impact on MECP2 transgene and protein expression in the presence or absence of cellular MeCP2 using both viral AAV9 transduction and plasmid transfection containing either miRARE-regulated or SV40 (unregulated) elements.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In vitro data showed that post-transcriptional gene silencing by miRARE in response to cellular MeCP2 levels can be recapitulated in human and mouse cell lines. Specifically, the data demonstrated miRARE controlled dose-dependent transgene expression of MeCP2 protein via a similar mechanism in both human and mouse cell lines. In addition, the miRARE technology partially silenced transgene expression in neuronal and non-neuronal cell lines, and the expression and subsequent downregulation were four to five-fold higher in neuronal cell lines, supporting tissue-specific expression of MeCP2.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img38651418_8.jpg" alt="img38651418_8.jpg" style="width:462px;height:316px;" />&#160;</p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Transgene protein expression was highest in homozygous cells and slightly greater than wild-type in heterozygous cells, demonstrating that transgene expression of MeCP2 protein is sensitive to cellular levels of MeCP2 and increases in human cells with both endogenous MECP2 copies disrupted. The data support that miRARE regulation of the MECP2 transgene is sensitive to cellular levels of MeCP2.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">35</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img38651418_9.jpg" alt="img38651418_9.jpg" style="width:668px;height:426px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The data also showed that transgene silencing occurred in part by inducing mRNA decay but more substantially by reducing miniMeCP2 protein accumulation. Specifically, cells transduced with TSHA-102 miRARE were associated with 49% reduced transgene mRNA as well as 197% reduced protein expression over TSHA-102 SV40 3&#x2019;UTR transfected cells, suggesting that the miRARE technology also acts in cis to prevent translation.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img38651418_10.jpg" alt="img38651418_10.jpg" style="width:670px;height:290px;" />&#160;</p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In vitro data recapitulate our in vivo neonatal mouse and further our mechanistic understanding of how miRARE controls post-transcriptional MECP2 expression. Overall, in vitro study results clearly demonstrated that miRARE controls the expression of MeCP2 protein in the most relevant cell background.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">36</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Deprioritized Programs</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have at this time deprioritized the evaluation of our preclinical and clinical product candidates TSHA-120 for GAN, TSHA-105 for SLC13A5, TSHA-118 for CLN1 and TSHA-121 for CLN7. Although we are not currently evaluating the potential of TSHA-105, TSHA-118 and TSHA-121, we may again evaluate any of these in the future as a product candidate as a component of our pipeline expansion plans, or pursue partnerships to advance these programs.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">TSHA-120 for Giant Axonal Neuropathy (GAN)</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">GAN is an ultra-rare autosomal recessive, progressive neurodegenerative disease of the central, peripheral and autonomic nervous systems caused by deficiency or complete loss-of-function of gigaxonin and the accumulation of intermediate filaments. Epidemiology studies indicate there are between 1,000 and 1,500 treatable GAN patients in the United States, European Union and United Kingdom.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There is an early (classical) and late-onset (non-classical) phenotype associated with the disease, with shared pathophysiology due to accumulation of intermediate filaments. Symptoms and features of children with classical GAN usually develop before the age of five years with distal muscle weakness and sensory loss due to axonal sensory motor neuropathy, manifesting as bilateral foot drop and difficulties with fine motor coordination. An abnormal, wide based, unsteady gait due to CNS and cerebellar involvement is also a common initial clinical manifestation. Children with the classical phenotype typically have dull, tightly curled, coarse hair (&#x201c;kinky&#x201d; hair), &#x201c;giant&#x201d; axons pathognomonic on a nerve biopsy due to accumulation of intermediate filaments, and progressive spinal cord atrophy and white matter abnormalities, initially around the cerebellar dentate nucleus, on MRI images. Symptoms progress and, as the children grow older, they develop progressive proximal muscle weakness, resulting in difficulties raising their arms and standing from the floor or a chair, scoliosis, distal contractures, progressive gait and limb ataxia, leading to loss of ambulation by the second decade. Progressive optic nerve atrophy, seen early in the disease, results in increasing deterioration of visual acuity in later stages and has been more recently described. Indeed, decreased visual acuity was seen at baseline in approximately half of GAN patients aged 3-21 years, enrolled in a natural history study [Brain. 2021 Nov 29;144(10):3239-3250]. Due to increased respiratory muscle weakness and restrictive respiratory failure as a result of severe scoliosis, assisted ventilation is required in adolescents. GAN patients often die during their late teens or early twenties, typically due to respiratory failure.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The late-onset, or non-classical, phenotype is often categorized as Charcot-Marie-Tooth Type 2, or CMT2, as it presents as a typical early onset axonal sensory motor neuropathy without the typical kinky hair and CNS involvement of the classical phenotype and has a relatively slow progression. This phenotype might represent up to 6% of all CMT2 diagnosis. In the late-onset population, patients have poor quality of life and significantly compromised activities of daily living. The disease is life limiting but not as severely as classic GAN. In classic GAN, symptomatic treatments attempt to maximize physical development and minimize the rate of deterioration. Currently, there are no approved disease-modifying therapies available, only palliative treatments.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2021, we acquired the exclusive worldwide rights to a clinical-stage, intrathecally dosed AAV9 gene therapy program, now known as TSHA-120, for the treatment of GAN, pursuant to a license agreement with Hannah&#x2019;s Hope Fund for Giant Axonal Neuropathy, Inc., or HHF. Under the terms of the agreement, HHF received an upfront payment of $5.5 million and will be eligible to receive clinical, regulatory and commercial milestones totaling up to $19.3 million, as well as a low, single-digit royalty on net sales upon commercialization of TSHA-120. We received orphan drug designation and rare pediatric disease designation from the FDA for TSHA-120 for the treatment of GAN. In April 2022, we received orphan drug designation from the European Commission for TSHA-120 for the treatment of GAN.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In September 2023, subsequent to the receipt of Type C meeting feedback from the FDA regarding a registrational path for TSHA-120, we announced that we would discontinue the development of our TSHA-120 program in the evaluation for the treatment of GAN. We are pursuing external strategic options for the TSHA-120 program to potentially enable further program development.</span></p>
  <p style="margin-left:6.667%;text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">TSHA-118 for CLN1 Disease</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CLN1 disease (one of the forms of Batten disease), a lysosomal storage disorder, is a progressive, fatal neurodegenerative disease with early childhood onset that has an estimated incidence of approximately 1 in 138,000 live births worldwide. The estimated prevalence of CLN1 disease is 1,000 patients in the United States and European Union. CLN1 disease is caused by loss-of-function mutations in the CLN1 gene that encodes the enzyme palmitoyl-protein thioesterase-1, a small glycoprotein involved in the degradation of certain lipid-modified proteins. Loss of function mutations in the CLN1 gene causes accumulation of these lipid-modified proteins in cells, eventually leading to aggregation, neuronal cellular dysfunction and ultimately neuronal cell death.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the infantile-onset form of CLN1 disease, clinical symptoms appear between six to 24 months and include rapid deterioration of speech and motor function, refractory epilepsy, ataxia and visual failure. Infantile-onset CLN1 patients are typically poorly responsive by five years of age and remain noncommunicative until their death, which usually occurs by seven years of age.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">37</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Late-infantile-onset CLN1 disease begins between two to four years of age with initial visual and cognitive decline followed by the development of ataxia and myoclonus, or quick, involuntary muscle jerks. Juvenile-onset CLN1 disease patients present between the ages of five to ten years old, with vision loss as a first symptom followed by cognitive decline, seizures and motor decline. Approximately 60% of the children diagnosed with CLN1 disease in the United States present with early-onset infantile forms, with the remaining 40% experiencing later-onset childhood forms.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All currently available therapeutic approaches for patients with CLN1 disease are targeted towards the treatment of symptoms, and no disease-modifying therapies have been approved. Gene therapy has shown promise in correcting forms of neuronal ceroid lipofuscinoses diseases that involve mutations in soluble enzymes, in part, due to cross-correction of neighboring non-transduced cells.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We believe that the introduction of a functional </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">CLN1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> gene using an AAV9 vector delivered intrathecally to the CNS offers the potential of a disease-modifying therapeutic approach for this disease. TSHA-118 is a self-complementary AAV9 viral vector that expresses human codon-optimized CLN1 complementary deoxyribonucleic acid under control of the chicken &#xdf;-actin hybrid promoter. We acquired exclusive worldwide rights to certain intellectual property rights and know-how relating to the research, development and manufacture of TSHA-118 (formerly ABO-202) in August 2020 pursuant to a license agreement with Abeona Therapeutics Inc., or Abeona.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TSHA-118 has been granted orphan drug designation, rare pediatric disease designation and fast track designation from the FDA and orphan drug designation from the European Medicines Agency for the treatment of CLN1 disease.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There is currently an open IND for the CLN1 program. We submitted a CTA filing for TSHA-118 which was approved by Health Canada in 2021. Clinical trial material has been manufactured and released and is now ready for use in a clinical trial setting.</span></p>
  <p style="margin-left:6.667%;text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">TSHA-105 for SLC13A5 Deficiency</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are developing TSHA-105 for the treatment of SLC13A5 deficiency, a rare autosomal recessive epileptic encephalopathy characterized by the onset of seizures within the first few days of life. SLC13A5 deficiency is caused by bi-allelic loss-of function mutations in the SLC13A5 gene, which codes for a sodium dependent citrate transporter, or NaCT, that is largely expressed in the brain and liver. To date, all tested mutations result in no or a greatly reduced amount of the citrate in the cells. Diminished NaCT function leads to loss of neuronal uptake of citrate and other metabolites such as succinate that are critical to brain energy metabolism and function. Affected children have impairments in gross motor function and speech production with relative preservation of fine motor skills and receptive speech. Currently, there are no approved therapies for SLC13A5 deficiency, and treatment is largely to address symptoms. The estimated prevalence of SLC13A5 deficiency is 1,900 patients in the United States and European Union.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are developing TSHA-105 as a gene replacement therapy for SLC13A5 deficiency. TSHA-105 is constructed from a codon-optimized human SLC13A5 gene packaged in a self-complementary AAV9 capsid.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have received orphan drug designation and rare pediatric disease designation from the FDA and orphan drug designation from the European Commission for TSHA-105 for the treatment of epilepsy caused by SLC13A5 deficiency. Clinical trial material has been manufactured and released and is now ready for use in a clinical trial setting.</span></p>
  <p style="margin-left:6.667%;text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">TSHA-113 for Tauopathies</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are developing TSHA-113 for the treatment of tauopathies. Tauopathies comprise a large subset of neurodegenerative diseases involving the aggregation of microtubule associated protein tau, or MAPT, protein into neurofibrillary or gliofibrillary tangles in the human brain. These include MAPT-associated frontotemporal dementia, or FTD, progressive supranuclear palsy, or PSP, corticobasal degeneration, or CD, and Alzheimer&#x2019;s disease. There are an estimated 11,000 patients in United States and Europe affected by MAPT mediated FTD and 2,000 to 2,500 are affected with MAPT-mediated PSP. and CD</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">,</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and Alzheimer&#x2019;s disease affects an estimated 6.2 million Americans and 7.8 million Europeans.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Intrathecal delivery of an antisense oligonucleotide, or ASO, targeting Tau mRNA by Biogen/Ionis in a Phase 1 study demonstrated durable, robust, time and dose dependent lowering of tau protein and phospho-tau in cerebrospinal fluid of Alzheimer&#x2019;s disease patients. Buoyed by these results, in August 2022, Biogen started a Phase 2 trial in people with mild cognitive impairment or mild dementia due to Alzheimer&#x2019;s disease. This ASO target validation paved the way for other approaches targeting intercellular tau mRNA (reduce tau protein production), for treating Tauopathies.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unlike an ASO treatment, which would require repeat lifelong administration, we are developing a one-time treatment for Tauopathies. TSHA-113 is an AAV9 capsid that packages a tau-specific miRNA and is delivered in the cerebrospinal fluid for the treatment of tauopathies. This miRNA targets all six isoforms of tau mRNA.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">38</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We tested the efficacy of TSHA-113 in PS19 mice, a validated mouse model for tauopathies. These mice express human MAPT, and they exhibit significant tau pathology, neurodegeneration, loss of body weight and progressive hind-limb paralysis around nine to 12 months of age. We tested efficacy of our treatment by delivering TSHA-113 to PS19 mice at three months, six months and nine months of age via intracisterna magna injection. We found that the tau mRNA and protein levels were significantly reduced by TSHA-113 treatment. Consistently, the tau seeding assay showed reduced levels of pathological tau in brains from PS19 mice treated with TSHA-113. In addition, TSHA-113 treatment was able to rescue the survival rate, loss in body weight, and the hind limb clasping phenotype in the PS19 mice when treated at three months, six months and nine months of age. Taken together, these results demonstrate that a one-time, vectorized delivery of a tau-specific miRNA is a promising approach for treatment for tauopathies. Ongoing and future work is focused on optimal dose determination for IND-enabling studies.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">TSHA-106 for Angelman syndrome</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are developing TSHA-106 for the treatment of Angelman syndrome, a neurodevelopmental disorder caused by a maternal deficiency of the UBE3A gene. Angelman syndrome is characterized by profound developmental delay, ataxia and gait disturbance, sleep disorder, seizures, heightened anxiety, aggression and severe speech impairments. Angelman syndrome affects approximately one per 12,000 to 20,000 patients worldwide.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Angelman syndrome is an imprinting disorder in which the maternal gene is deficient and the paternal copy of UBE3A is intact but silenced by a long non-coding RNA, UBE3A antisense transcript, or UBE3A-ATS. Delivery of an ASO targeting UBE3A-ATS showed promising results in ameliorating Angelman syndrome symptoms in a transgenic mouse model.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We have in-licensed a novel gene replacement therapy from University of North Carolina. This novel construct is designed to express two isoforms of UBE3A mRNA from the same codon optimized transgene cassette and could potentially be a one-time treatment for the disease. The unique design feature allows short and long hUBE3A isoforms expression at a near-endogenous 3:1 (short/long) ratio, a feature that could help to support optimal therapeutic outcomes. Additionally, this construct uses human Synapsin 1 promoter, to limit UBE3A expression primarily in neurons, the primary therapeutic target for treating Angelman syndrome.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In a published study, this dual isoform expressing cassette was packaged into PHP.B capsids and administered by intracerebroventricular injections in neonatal mice models. This treatment significantly improved motor learning and innate behaviors in Angelman syndrome mice (PMID: 34676830). It rendered Angelman syndrome mice resilient to epileptogenesis and associated hippocampal neuropathologies induced by seizure kindling. These results demonstrated the feasibility, tolerability, and therapeutic potential for dual-isoform hUBE3A gene transfer in the treatment of AS.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To advance these findings into translatable interventions, our collaborators packaged the dual isoform expressing cassette into AAV9 capsids and undertook animal proof of concept studies. Overall, these results are highly consistent with the published data describing neonatal ICV delivery of a similar dose of the PHP.B/hUBE3Aopt vector (PMID: 34676830) and support continued development. Ongoing and future work is focused on optimal dose and route of administration determination for IND enabling studies.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There are an estimated 55,000 patients with Angelman syndrome in the United States and Europe.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">TSHA-114 for Fragile X Syndrome</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are developing TSHA-114 for the treatment of Fragile X syndrome, the most common single gene cause of autism and cognitive impairment, affecting about one in 6,000 individuals worldwide. Fragile X syndrome is diagnosed around three years of age and characterized by anxiety, aggression, hyperactivity, attention deficits and sleep and communication disruption.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Fragile X syndrome is caused by a pathological expansion of a CGG triplet repeat in the 5&#x2019; untranslated region of the FMR1 gene. Expansion of the triplet above the normal 5&#x2013;55 repeats to 200 or more causes hypermethylation of the gene promoter, and shutdown of transcription and translation of the encoded protein, fragile X mental retardation protein, or FMRP. The expanded repeat also induces formation of RNA: DNA heteroduplexes that induces epigenetic gene silencing. Although most patients with Fragile X syndrome do not express FMRP, some individuals with the full mutation produce low amounts of the protein (less than 10% of normal levels). FMRP expression in unaffected persons varies greatly from person to person. Current pharmacotherapeutic treatments for Fragile X syndrome are solely directed towards symptom relief.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We conducted proof of concept studies in animal models of Fragile X (Fmr1 KO) with TSHA-114. No significant adverse effects were observed in behavioral, serological or pathohistological markers up to 12 months after intrathecal administration of TSHA-114 in wild-type mice. TSHA-114 treated FMRKO showed widespread FMRP expression was observed throughout brain post administration. TSHA-114 treated FMRKO mice showed robust suppression of audiogenic seizures and normalization of fear conditioning behavior. In addition, assessment of circadian locomotor activity revealed restoration of hyperactivity and sleep.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">39</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assessment of transgene expression and behavioral responses in individual mice demonstrated correlations between the level of FMRP expression and drug efficacy.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The results from the study strongly support continued development. Ongoing and future work is focused on optimal dose and route of administration determination for IND enabling studies.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There are an estimated 75,000 patients with Fragile X syndrome in the United States and Europe.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">License Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Research, Collaboration and License Agreement with The University of Texas Southwestern Medical Center</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In November 2019, we entered into a research, collaboration and license agreement, or the UT Southwestern Agreement, with The Board of Regents of the University of Texas System on behalf of UT Southwestern, as amended in April 2020.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the UT Southwestern Agreement, we obtained an exclusive, worldwide, royalty-free license under certain patent rights of UT Southwestern and a non-exclusive, worldwide, royalty-free license under certain know-how of UT Southwestern, in each case to make, have made, use, sell, offer for sale and import licensed products for use in certain specified indications. Additionally, we obtained a non-exclusive, worldwide, royalty-free license under certain patents and know-how of UT Southwestern for use in all human uses, with a right of first refusal to obtain an exclusive license under certain of such patent rights and an option to negotiate an exclusive license under other of such patent rights. We are required to use commercially reasonable efforts to develop, obtain regulatory approval for, and commercialize at least one licensed product.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the UT Southwestern Agreement, we issued to UT Southwestern 2,179,000 shares of our common stock. We do not have any future milestone or royalty obligations to UT Southwestern under the UT Southwestern Agreement, other than costs related to the maintenance of patents.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The UT Southwestern Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last valid claim of a licensed patent in such country for such licensed product. After the initial research term, we may terminate the agreement, on an indication-by-indication and licensed product-by-licensed product basis, at any time upon specified written notice to UT Southwestern. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">License Agreement with Abeona (CLN1 Disease)</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In August 2020, we entered into a license agreement, or the Abeona CLN1 Agreement, with Abeona Therapeutics Inc., or Abeona. In connection with the Abeona CLN1 Agreement, we obtained an exclusive, worldwide, royalty-bearing license, with the right to grant sublicenses under certain patents, know-how and materials originally developed by the University of North Carolina at Chapel Hill and Abeona to research, develop, manufacture, have manufactured, use, and commercialize licensed products for gene therapy for the prevention, treatment, or diagnosis of CLN1 Disease (one of the forms of Batten disease) in humans.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the license grant, we paid Abeona a one-time upfront license fee of $3.0 million during fiscal year 2020. We are obligated to pay Abeona up to $26.0 million in regulatory-related milestones and up to $30.0 million in sales-related milestones per licensed product and high single-digit royalties on net sales of licensed products. Royalties are payable on a licensed product-by-licensed product and country-by-country basis until the latest of the expiration or revocation or complete rejection of the last licensed patent covering such licensed product in the country where the licensed product is sold, the loss of market exclusivity in such country where the product is sold, or, if no licensed product exists in such country and no market exclusivity exists in such country, ten years from first commercial sale of such licensed product in such country. In addition, concurrent with the Abeona CLN1 Agreement, we entered into a purchase and reimbursement agreement with Abeona, pursuant to which we purchased specified inventory from Abeona and reimbursed Abeona for certain research and development costs previously incurred for total consideration of $4.0 million paid in fiscal year 2020.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2021 the Company&#x2019;s CTA filing for TSHA-118 for the treatment of CLN1 disease was approved by Health Canada and therefore triggered a regulatory milestone payment in connection with the Abeona CLN1 Agreement. We recorded $3.0 million within research and development expenses in the consolidated statements of operations for the year ended December 31, 2021. The milestone fee was paid in January 2022 and has been classified as an investing outflow in the condensed consolidated statements of cash flows for the nine months ended September 30, 2022. No additional milestone payments were made or triggered during the nine months ended September 30, 2023.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">40</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Abeona CLN1 Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. We may terminate the agreement for convenience upon specified prior written notice to Abeona.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">License Agreement with Abeona (Rett Syndrome)</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In October 2020, we entered into a license agreement, or the Abeona Rett Agreement, with Abeona pursuant to which we obtained an exclusive, worldwide, royalty-bearing license, with the right to grant sublicenses under certain patents, know-how and materials originally developed by the University of North Carolina at Chapel Hill, the University of Edinburgh and Abeona to research, develop, manufacture, have manufactured, use, and commercialize licensed products for gene therapy and the use of related transgenes for Rett syndrome.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Subject to certain obligations of Abeona, we are required to use commercially reasonable efforts to develop at least one licensed product and commercialize at least one licensed product in the United States.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the Abeona Rett Agreement, we paid Abeona a one-time upfront license fee of $3.0 million during fiscal year 2020. We are obligated to pay Abeona up to $26.5 million in regulatory-related milestones and up to $30.0 million in sales-related milestones per licensed product and high single-digit royalties on net sales of licensed products. Royalties are payable on a licensed product-by-licensed product and country-by-country basis until the latest of the expiration or revocation or complete rejection of the last licensed patent covering such licensed product in the country where the licensed product is sold, the loss of market exclusivity in such country where the product is sold, or, if no licensed product exists in such country and no market exclusivity exists in such country, ten years from first commercial sale of such licensed product in such country.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2022, our CTA filing for TSHA-102 for the treatment of Rett Syndrome was approved by Health Canada and therefore triggered a regulatory milestone payment in connection with the Rett Agreement. We recorded $1.0 million within research and development expenses in the condensed consolidated statements of operations for the nine months ended September 30, 2022. This milestone fee was paid in July 2022. In May 2023, we dosed the first patient with TSHA-102 in the Phase 1/2 REVEAL trial evaluating the safety and preliminary efficacy of TSHA-102 in adult patients with Rett syndrome and therefore triggered a milestone payment in connection with this agreement. We recorded $3.5 million within research and development expenses in the condensed consolidated statements of operations for the nine months ended September 30, 2023. This milestone fee was paid in August 2023 and has been classified as an investing cash outflow in the condensed consolidated statements of cash flows for the nine months ended September 30, 2023. No additional milestone payments were made or triggered in connection with this agreement during the nine months ended September 30, 2023.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Abeona Rett Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. We may terminate the agreement for convenience.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Option Agreement with Astellas</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 21, 2022, or the Effective Date, we entered into an Option Agreement, or the Option Agreement, with Audentes Therapeutics, Inc. (d/b/a Astellas Gene Therapy), or Astellas.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">TSHA-120 Giant Axonal Neuropathy</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Option Agreement, we granted to Astellas an exclusive option to obtain an exclusive, worldwide, royalty and milestone-bearing right and license (A) to research, develop, make, have made, use, sell, offer for sale, have sold, import, export and otherwise exploit, or, collectively, Exploit or the Exploitation, the product known, as of the Effective Date, as TSHA-120, or the 120 GAN Product, and any backup products with respect thereto for use in the treatment of GAN or any other gene therapy product for use in the treatment of GAN that is controlled by us or any of our affiliates or with respect to which we or any of our affiliates controls intellectual property rights covering the Exploitation thereof, or a GAN Product, and (B) under any intellectual property rights controlled by us or any of our affiliates with respect to such Exploitation, or the GAN Option. Following the receipt of Type C meeting feedback from the FDA regarding a registrational path for TSHA-120 in September 2023, Astellas elected not to exercise the GAN Option.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">41</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">TSHA-102 Rett Syndrome</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Option Agreement, we also granted to Astellas an exclusive option to obtain an exclusive, worldwide, royalty and milestone- bearing right and license (A) to Exploit any Rett Product (as defined below), and (B) under any intellectual property rights controlled by us or any of our affiliates with respect to such Exploitation, or the Rett Option, and together with the GAN Option, each, an Option. In September 2023, Astellas elected not to exercise its Option to obtain an exclusive license to TSHA-120.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Recent Developments</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">August 2023 Private Placement and Proposed Charter Amendment</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 14, 2023, we entered into a Securities Purchase Agreement, or the August 2023 Securities Purchase Agreement, with certain institutional and other accredited investors, or the Purchasers, pursuant to which we agreed to sell and issue to the Purchasers in a private placement transaction, or the August 2023 Private Placement, that closed on August 16, 2023: (i) 122,412,376 shares of our common stock and (ii) with respect to certain Purchasers, pre-funded warrants, or the Pre-Funded Warrants, to purchase 44,250,978 shares of common stock in lieu of shares of common stock. The closing of the August 2023 Private Placement, or the Closing, occurred on August 16, 2023. The total gross proceeds to us at the Closing were approximately $150.0 million, and after deducting placement agent commissions and offering expenses payable by us, net proceeds were approximately $140.3 million.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Pre-Funded Warrants are only exercisable into common stock upon the approval by our stockholders of an increase in the number of authorized shares of common stock available under our Amended and Restated Certificate of Incorporation and our filing of a Certificate of Amendment to our Amended and Restated Certificate of Incorporation, or the Certificate of Amendment, with the Secretary of State of the State of Delaware. Our Board of Directors has approved an amendment to our Amended and Restated Certificate of Incorporation, as amended to date, to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000, or the Authorized Shares Amendment, and on October 5, 2023, we filed a definitive proxy statement on Schedule 14A with respect to seeking stockholder approval of the Authorized Shares Amendment at a special meeting of the stockholders to be held on November 15, 2023. Pursuant to the August 2023 Securities Purchase Agreement, we agreed to seek to obtain stockholder approval of the Authorized Shares Amendment by December 31, 2023. If we do not obtain such stockholder approval by December 31, 2023, we are required to pay liquidated damages of 2.0% of the aggregate purchase price paid by each holder of Pre-Funded Warrants, and we are obligated to cause an additional stockholder meeting to be held every three months thereafter until stockholder approval of the Authorized Shares Amendment is obtained, or a Subsequent Stockholder Approval Deadline. For any subsequent failure to obtain such stockholder approval by any Subsequent Stockholder Approval Deadline, we are required to pay an additional 2.0% as liquidated damages.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Trinity Term Loans</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 13, 2023, or the Trinity Closing Date, we entered into a Loan and Security Agreement, or the Trinity Term Loan Agreement, by and among us, the lenders party thereto from time to time, or the Trinity Lenders, and Trinity Capital Inc., as administrative agent and collateral agent for the Trinity Lenders, or Trinity. The Trinity Term Loan Agreement provides for, on the Trinity Closing Date, $40.0 million aggregate principal amount of term loans (collectively, the &#x201c;Trinity Term Loans&#x201d;). We drew the Trinity Term Loans in full on the Trinity Closing Date.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The interest rate applicable to the Trinity Term Loans is the greater of (a) the WSJ (&#x201c;Wall Street Journal&#x201d;) Prime Rate plus 4.50% or (b) 12.75% per annum. The Trinity Term Loans are interest only from the Trinity Closing Date through 36 months from the Trinity Closing Date, which may be extended to 48 months from the Trinity Closing Date upon the satisfaction of certain milestones set forth in the Trinity Term Loan Agreement, after which we are required to pay equal monthly installments of principal through November 13, 2028, or the Maturity Date.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Trinity Term Loans may be prepaid in full (i) from the Trinity Closing Date through November 13, 2024, with payment of a 3.00% prepayment premium, (ii) from November 13, 2024 through November 13, 2025, with payment of a 2% prepayment premium, and (iii) from November 13, 2025 through, but excluding, the Maturity Date, with payment of a 1% prepayment premium.  On the Trinity Closing Date, we paid to Trinity a commitment fee of 1.00% of the original principal amount of the Trinity Term Loans. Upon repayment in full of the Trinity Term Loans, we will pay to Trinity an end of term payment equal to 5.00% of the original principal amount of the Trinity Term Loans.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The obligations under the Trinity Term Loan Agreement are secured by a perfected security interest in all of our assets except for certain customarily excluded property pursuant to the terms of the Trinity Term Loan Agreement. There are no financial covenants and no warrants associated with the Trinity Term Loan Agreement. The Trinity Term Loan Agreement contains various covenants that limit our ability to engage in specified types of transactions without the consent of Trinity and the Trinity Lenders which include,</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">42</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">among others, incurring or assuming certain debt; merging, consolidating or acquiring all or substantially all of the capital stock or property of another entity; changing the nature of our business; changing our organizational structure or type; licensing, transferring or disposing of certain assets; granting certain types of liens on our assets; making certain investments; and paying cash dividends.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Trinity Term Loan Agreement also contains customary representations and warranties, and also includes customary events of default, including payment default, breach of covenants, change of control, and material adverse effects. Upon the occurrence of an event of default, a default interest rate of an additional 5% per annum may be applied to the outstanding loan balances, and the Trinity Lenders may declare all outstanding obligations immediately due and payable and exercise all of its rights and remedies as set forth in the Trinity Term Loan Agreement and under applicable law.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The proceeds of the Trinity Term Loans were used to repay our obligations under the Term Loan Agreement (as defined below) with Silicon Valley Bank in full. The Term Loan Agreement with Silicon Valley Bank was terminated concurrently with entry into the Trinity Term Loan Agreement.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Components of Results of Operations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenue for the nine months ended September 30, 2023 was derived from the Astellas Transactions. We recognize revenue as research and development activities related to our Rett program are performed. Revenue related to the material rights associated with the Rett Option and the GAN Option must be recognized at a point in time when the options are exercised or the option period expires. In September 2023, Astellas elected not to exercise the GAN Option, therefore we recognized revenue related to the GAN Option during the nine months ended September 30, 2023.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To date, we have not recognized any revenue from product sales, and we do not expect to generate any revenue from the sale of products, if approved, in the foreseeable future. If our development efforts for our product candidates are successful and result in regulatory approval, or license agreements with third parties, we may generate revenue in the future from product sales. However, there can be no assurance as to when we will generate such revenue, if at all.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Operating Expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="margin-left:6.667%;text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Research and Development Expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development expenses primarily consist of clinical and preclinical development of our product candidates and discovery efforts, including conducting preclinical studies, manufacturing development efforts, preparing for clinical trials and activities related to regulatory filings for our product candidates. Research and development expenses are recognized as incurred and payments made prior to the receipt of goods or services to be used in research and development are capitalized until the goods or services are received. Costs incurred in obtaining technology licenses through asset acquisitions are charged to research and development expense if the licensed technology has not reached technological feasibility and has no alternative future use. Research and development expenses include or could include:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">employee-related expenses, including salaries, bonuses, benefits, stock-based compensation, severance costs and other related costs for those employees involved in research and development efforts; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">license maintenance fees and milestone fees incurred in connection with various license agreements;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">external research and development expenses incurred under agreements with consultants, contract research organizations, or CROs, investigative sites and consultants to conduct our preclinical studies; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">costs related to manufacturing material for our preclinical studies and clinical trials, including fees paid to contract manufacturing organizations, or CMOs; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">laboratory supplies and research materials; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">costs related to compliance with regulatory requirements; and </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">facilities, depreciation and other allocated expenses, which include direct and allocated expenses for rent, maintenance of facilities, insurance and equipment. </span></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development activities are central to our business model. Product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. We reduced our research and development and general and administrative spend from 2021 to 2022 but plan to increase our research and development expenses, particularly with respect to the Rett clinical</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">43</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">trials, for the foreseeable future as we continue the development of our product candidates and manufacturing processes and conduct discovery and research activities for our preclinical programs. We cannot determine with certainty the timing of initiation, the duration or the completion costs of current or future preclinical studies and clinical trials of our product candidates due to the inherently unpredictable nature of preclinical and clinical development. Clinical and preclinical development timelines, the probability of success and development costs can differ materially from expectations. We anticipate that we will make determinations as to which product candidates to pursue and how much funding to direct to each product candidate on an ongoing basis in response to the results of ongoing and future preclinical studies and clinical trials, regulatory developments and our ongoing assessments as to each product candidate&#x2019;s commercial potential. We will need to raise substantial additional capital in the future. Our clinical development costs are expected to increase significantly as we commence clinical trials. Our future expenses may vary significantly each period based on factors such as:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">expenses incurred to conduct preclinical studies required to advance our product candidates into clinical development; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">per patient trial costs, including based on the number of doses that patients received; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the number of patients who enroll in each trial; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the number of trials required for approval; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the number of sites included in the trials; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the countries in which the trials are conducted; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the length of time required to enroll eligible patients; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the drop-out or discontinuation rates of patients; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">potential additional safety monitoring requested by regulatory agencies; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the duration of patient participation in the trials and follow-up; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the phase of development of the product candidate; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">third-party contractors failing to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the ability to manufacture of our product candidates;</span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">regulators or institutional review boards requiring that we or our investigators suspend or terminate clinical development for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks; and </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the efficacy and safety profile of our product candidates. </span></div></div>
  <p style="margin-left:6.667%;text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">General and Administrative Expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General and administrative expenses consist principally of salaries and related costs for personnel in executive and administrative functions, including stock-based compensation, severance costs, travel expenses and recruiting expenses. Other general and administrative expenses include professional fees for legal, consulting, accounting and audit and tax-related services and insurance costs.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We anticipate that certain of our general and administrative expenses will decrease in the future as a result of the reductions in our headcount in 2022 and 2023 to support our infrastructure and focus on our Rett program. We also anticipate that our general and administrative expenses as a result of payments for accounting, audit, legal, consulting services, as well as costs associated with maintaining compliance with Nasdaq listing rules and SEC requirements, director and officer liability insurance, investor and public relations activities and other expenses associated with operating as a public company will stay constant for the near future but may increase over time.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:6.667%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Impairment of Long-lived Assets</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Impairment of long-lived assets are the result of an asset group's carrying value exceeding the fair value. In November 2022, we decided not to continue building out our manufacturing facility in North Carolina. We recorded a non-cash, non-recurring impairment charge related to the construction in progress and right-of-use lease assets at the manufacturing facility.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">44</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Results of Operations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Results of Operations for the Three Months ended September 30, 2023 and 2022</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes our results of operations for the three months ended September 30, 2023 and 2022 (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:67.08%;"></td>
    <td style="width:1.622%;"></td>
    <td style="width:1%;"></td>
    <td style="width:12.837%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1.622%;"></td>
    <td style="width:1%;"></td>
    <td style="width:12.837%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Three Months Ended September 30,</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenue</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4,746</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11,791</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16,774</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8,589</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8,683</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Impairment of long-lived assets</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">616</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20,996</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">25,457</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(16,250</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(25,457</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other income (expense):</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Change in fair value of warrant liability</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(100,456</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest income</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,109</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(1,471</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(1,078</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other expense</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(19</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(1</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total other income (expense), net</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(100,837</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(1,070</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(117,087</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(26,527</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:6.667%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenue related to the Astellas Transactions was $4.7 million for the three months ended September 30, 2023, which was executed in November 2022. The revenue recorded is the result of Rett research and development activities performed during the third quarter of 2023 and the expiration of the material right associated with the GAN Option.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Research and Development Expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development expenses were $11.8 million for the three months ended September 30, 2023, compared to $16.8 million for the three months ended September 30, 2022. The net change was due to a $9.3 million decrease due to lower compensation expense as a result of reduced headcount, lower licensing milestone fees, fewer manufacturing batches and fewer raw material purchases. This was partially offset by a $4.3 million increase in activity surrounding ongoing clinical trial efforts in the Rett REVEAL adult and pediatric studies.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">General and Administrative Expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General and administrative expenses were $8.6 million for the three months ended September 30, 2023, compared to $8.7 million for the three months ended September 30, 2022. The decrease of $0.1 million was due to reduced compensation expense due to lower headcount of $2.0 million, reduced consulting and professional fees of $0.7 million, partially offset by $2.6 million issuance costs allocated to the liability-classified pre-funded warrants issued in connection with the August 2023 Private Placement.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Impairment of Long-lived Assets</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We recorded a non-cash impairment charge of $0.6 million related to assets held for sale for the three months ended September 30, 2023.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Other Income (Expense)</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Change in fair value of warrant liability</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Change in fair value of warrant liability was $100.5 million for the three months ended September 30, 2023 due to the substantial increase in the fair value of the underlying common stock underlying the SSI Warrants and the Pre-Funded Warrants.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">45</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Interest Income</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest income was $1.1 million for the three months ended September 30, 2023. The increase in income is primarily attributable to higher interest earned on our savings account and dividends earned from our money market fund following the receipt of the August 2023 Private Placement proceeds.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Interest Expense</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense was $1.5 million for the three months ended September 30, 2023, compared to $1.1 million for the three months ended September 30, 2022. The increase of approximately $0.4 million was primarily attributable to higher interest expense incurred under the Term Loan Agreement due to higher interest rates on our Term Loan during the three months ended September 30, 2023 compared to the comparative period in the prior year.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Results of Operations for the Nine Months ended September 30, 2023 and 2022</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes our results of operations for the nine months ended September 30, 2023 and 2022 (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:67.441%;"></td>
    <td style="width:1.362%;"></td>
    <td style="width:1%;"></td>
    <td style="width:12.916999999999998%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1.362%;"></td>
    <td style="width:1%;"></td>
    <td style="width:12.916999999999998%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months<br />Ended September 30,</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenue</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11,847</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">44,096</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">78,462</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">23,328</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30,019</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Impairment of long-lived assets</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">616</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">68,040</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">108,481</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(56,193</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(108,481</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other income (expense):</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Change in fair value of warrant liability</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(100,456</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest income</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,651</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">50</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(4,285</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(2,493</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other expense</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(24</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(12</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total other income (expense), net</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(103,114</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(2,455</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(159,307</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(110,936</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="margin-left:6.667%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:6.667%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenue related to the Astellas Transactions was $11.8 million for the nine months ended September 30, 2023, which was executed in November 2022. The revenue recorded is the result of Rett research and development activities performed during the nine months ended September 30, 2023 and the expiration of the material right associated with the GAN Option.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Research and Development Expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development expenses were $44.1 million for the nine months ended September 30, 2023, compared to $78.5 million for the nine months ended September 30, 2022. The $34.4 million decrease was driven by the effects of the strategic reprioritization efforts taken in March 2022, which resulted in a reduction of $19.7 million in compensation expense due to reduced R&amp;D headcount. We also incurred $10.9 million less research and development manufacturing and other raw material purchases through the first nine months of 2023. Additionally, we incurred $11.7 million in lower expenses in third-party research and development consulting fees, mainly related to pre-clinical studies, and IND-enabling toxicology studies. This was partially offset by an increase in of $7.9 million in expense related to ongoing clinical trial efforts in the Rett REVEAL adult and pediatric studies.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">General and Administrative Expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General and administrative expenses were $23.3 million for the nine months ended September 30, 2023, compared to $30.0 million for the nine months ended September 30, 2022. The decrease of approximately $6.7 million was primarily due to a $6.5 million reduction in compensation expenses as a result of reduced headcount and $2.8 million in lower professional, consulting and other general and administrative expenses. This was partially offset by $2.6 million of issuance costs allocated to the liability-classified pre-funded warrants issued in connection with the August 2023 Private Placement.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">46</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Impairment of Long-lived Assets</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We recorded a non-cash impairment charge of $0.6 million related to assets held for sale for the nine months ended September 30, 2023.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Other Income (Expense)</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Change in fair value of warrant liability</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Change in fair value of warrant liability was $100.5 million for the nine months ended September 30, 2023 due to the substantial increase in the fair value of the common stock underlying the SSI Warrants and the Pre-Funded Warrants.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Interest Income</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest income was $1.7 million for the nine months ended September 30, 2023, compared to less than $0.1 million for the nine months ended September 30, 2022. The increase in income is primarily attributable to higher interest earned on our savings account and dividends earned from our money market fund following the receipt of the August 2023 Private Placement proceeds.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Interest Expense</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense was $4.3 million for the nine months ended September 30, 2023, compared to $2.5 million for the nine months ended September 30, 2022. The increase of approximately $1.8 million was primarily attributable to higher interest expense incurred under the Term Loan Agreement due to higher interest rates on our Term Loan during the nine months ended September 30, 2023 compared to the comparative period in the prior year.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Liquidity and Capital Resources</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Overview</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Since our inception, we have not generated any revenue from product sales and have incurred significant operating losses. As of September 30, 2023, we had cash and cash equivalents of $164.3 million. Through September 30, 2023, we have funded our operations primarily through (i) the sale of equity, raising an aggregate of $589.0 million in gross proceeds from our IPO, sales of common stock pursuant to the Sales Agreement (as defined below), our October 2022 follow-on offering and our 2023 private placements, (ii) pre-IPO private placements of our convertible preferred stock and other private placements of our common stock, (iii) our Term Loan Agreement (as defined below) and (iv) the Astellas Transactions. Specifically, between March and July 2020, we closed on the sale of an aggregate of 10,000,000 shares of Series A convertible preferred stock for gross proceeds of $30.0 million. In July and August 2020, we closed on the sale of an aggregate of 5,647,048 shares of Series B convertible preferred stock for gross proceeds of $96.0 million. In September 2020, we raised gross proceeds of $181.0 million in our initial public offering.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 12, 2021, or the Closing Date, we entered into a Loan and Security Agreement, or the Term Loan Agreement, with the lenders party thereto from time to time, or the Lenders and Silicon Valley Bank, as administrative agent and collateral agent for the Lenders, or the Agent. We drew $30.0 million in term loans on the Closing Date and an additional $10.0 million in term loans on December 29, 2021. We did not draw on any of the additional $20.0 million tranches prior to their expiration on September 30, 2022 and March 31, 2023. The loan repayment schedule provided for interest only payments until August 31, 2024, followed by consecutive monthly payments of principal and interest. All unpaid principal and accrued and unpaid interest with respect to each term loan was due and payable in full on August 1, 2026.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 13, 2023, we entered into the Trinity Term Loan Agreement. The proceeds of the Trinity Term Loans were used to repay our obligations under the Term Loan Agreement. Pursuant to the terms of the Trinity Term Loan Agreement, on the Trinity Closing Date, we received the Trinity Term Loans of $40.0 million, which we drew in full on the Trinity Closing Date. The Trinity Term Loans are interest only from the Trinity Closing Date through 36 months from the Trinity Closing Date, which may be extended to 48 months from the Trinity Closing Date upon the satisfaction of certain milestones set forth in the Trinity Term Loan Agreement, after which we are required to pay equal monthly installments of principal through November 13, 2028, or the Maturity Date. The proceeds of the Trinity Term Loans were used to repay our Term Loan Agreement, and the Term Loan Agreement was terminated concurrently with entry into the Trinity Term Loan Agreement.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 5, 2021, we filed a shelf registration statement on Form S-3 with the SEC in relation to the registration of common stock, preferred stock, debt securities, warrants and units or any combination thereof up to a total aggregate offering price of $350.0 million. We also simultaneously entered into a Sales Agreement, or the Sales Agreement, with SVB Leerink LLC and Wells Fargo Securities, LLC, or the Sales Agents, pursuant to which we may issue and sell, from time to time at our discretion, shares of our common stock having an aggregate offering price of up to $150.0 million through the Sales Agents. In March 2022, we amended the Sales Agreement to, among other things, include Goldman Sachs &amp; Co. LLC as an additional Sales Agent. Any shares of our common</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">47</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">stock will be issued pursuant to our shelf registration statement on Form S-3 (File No. 333-260069), or the Shelf Registration Statement, which the SEC declared effective on October 14, 2021. In April 2022, we sold 2,000,000 shares of common stock pursuant to the Sales Agreement and received net proceeds of $11.6 million. No other shares of common stock have been issued and sold pursuant to the Sales Agreement as of September 30, 2023.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 21, 2022, we entered into the Option Agreement with Astellas granting Astellas an exclusive option to obtain exclusive, worldwide, royalty and milestone-bearing rights and licenses related to TSHA-120 and TSHA-102. As partial consideration for the rights granted to Astellas under the Option Agreement, Astellas paid us a one-time payment in the amount of $20.0 million, or the Upfront Payment, in November 2022.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Also on October 21, 2022, we entered into a securities purchase agreement with Astellas, or the Astellas Securities Purchase Agreement, and together with the Option Agreement, the Astellas Transactions, pursuant to which we agreed to issue and sell to Astellas in a private placement, or the Astellas Private Placement, an aggregate of 7,266,342 shares of our common stock, or the Astellas Private Placement Shares, for aggregate proceeds of approximately $30.0 million. The Astellas Private Placement closed on October 24, 2022. Pursuant to the Astellas Securities Purchase Agreement, in connection with the Private Placement, Astellas has the right to designate one individual to attend all meetings of the Board in a non-voting observer capacity. We also granted Astellas certain registration rights with respect to the Astellas Private Placement Shares.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 26, 2022, we entered into an underwriting agreement, or the Underwriting Agreement, with Goldman Sachs &amp; Co. LLC, or the Underwriter, to issue and sell 14,000,000 shares of our common stock, par value $0.00001 per share, in an underwritten public offering pursuant to an effective registration statement on Form S-3 and a related prospectus and prospectus supplement. The offering price to the public was $2.00 per share and the Underwriter purchased the shares from us pursuant to the Underwriting Agreement at a price of $1.88 per share. In addition, we granted the Underwriter an option to purchase, for a period of 30 days, up to an additional 2,100,000 shares of our common stock. The Follow-on Offering closed on October 31, 2022 and we received net proceeds of $26.0 million after deducting underwriting discounts, commissions and offering expenses. On November 10, 2022, the Underwriter exercised their option to purchase an additional 765,226 shares of our common stock and we received net proceeds of $1.4 million after deducting underwriting discounts and commissions.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In April 2023, we entered into a securities purchase agreement, or the SSI Securities Purchase Agreement, with two affiliates of SSI Strategy Holdings LLC, or SSI, named therein, or the SSI Investors, pursuant to which we agreed to issue and sell to the SSI Investors in a private placement, or the SSI Private Placement, 705,218 shares of our common stock, or the SSI Shares, and warrants, or the SSI Warrants, to purchase an aggregate of 525,000 shares of our common stock, or the Warrant Shares. SSI provides certain consulting services to the Company. Each SSI Warrant has an exercise price of $0.7090 per Warrant Share, which was the closing price of our common stock on the Nasdaq Global Market on April 4, 2023. The SSI Warrants issued in the SSI Private Placement provide that the holder of the SSI Warrants will not have the right to exercise any portion of its SSI Warrants until the achievement of certain clinical and regulatory milestones related to our clinical programs. The SSI Private Placement closed on April 5, 2023. Gross proceeds of the SSI Private Placement were $0.5 million.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In August 2023, we entered into the August 2023 Securities Purchase Agreement with the Purchasers pursuant to which we agreed to sell and issue to the Purchasers in the August 2023 Private Placement, (i) 122,412,376 shares of common stock and (ii) with respect to certain Purchasers, Pre-Funded Warrants to purchase 44,250,978 shares of common stock in lieu of shares of common stock. The purchase price was $0.90 per share, or the Purchase Price, and the purchase price for the Pre-Funded Warrants was the Purchase Price minus $0.001 per Pre-Funded Warrant. The August 2023 Private Placement closed on August 16, 2023. We received total net proceeds of $140.3 million after deducting placement agent commissions and offering expenses.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Funding Requirements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To date, we have not generated any revenues from the commercial sale of approved drug products, and we do not expect to generate substantial revenue for at least the next few years. If we fail to complete the development of our product candidates in a timely manner or fail to obtain their regulatory approval, our ability to generate future revenue will be compromised. We do not know when, or if, we will generate any revenue from our product candidates, and we do not expect to generate significant revenue unless and until we obtain regulatory approval of, and commercialize, our product candidates. Our expenses decreased from 2021 to 2022 as a result of our program prioritization efforts and reduced headcount. We have reduced and anticipate further reductions in spending in 2023 compared to 2022 levels due to the strategic pipeline prioritization initiatives focused on developing Rett and GAN. In September 2023, we announced that we intended to discontinue development of, and seek external strategic options for, our GAN clinical program, which we anticipate will further reduce spending during the remainder of 2023. If we obtain approval for any of our product candidates, we expect to incur significant commercialization expenses related to sales, marketing, manufacturing and distribution. We anticipate that we will need substantial additional funding in connection with our continuing operations. If we are</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">48</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">unable to raise capital when needed or on attractive terms, we could be forced to delay, reduce or eliminate our research and development programs or future commercialization efforts.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023, our material cash requirements consisted of $32.6 million in total lease payments under our noncancelable leases for equipment, laboratory space and office space. These leases are described in further detail in Note 5 to our unaudited condensed consolidated financial statements located in &#x201c;Part I &#x2013; Financial Information, Item 1. Financial Statements&#x201d; in this Quarterly Report on Form 10-Q. Our most significant purchase commitments consist of approximately $13.9 million in cancellable purchase obligations to our CROs and other clinical trial vendors.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We believe that our existing cash and cash equivalents will enable us to fund our operating expenses and capital requirements into 2026. We will require additional capital to fund the research and development of our product candidates, to fund our manufacturing activities, to fund precommercial activities of our programs and for working capital and general corporate purposes. The assessment of our ability to meet our future obligations is inherently judgmental, subjective and susceptible to change. Based on our current forecast, we believe that we will have sufficient cash to maintain our planned operations for the next twelve months following the issuance of these condensed consolidated financial statements.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Because of the numerous risks and uncertainties associated with research, development and commercialization of biological products, we are unable to estimate the exact amount of our operating capital requirements. Our future funding requirements will depend on many factors, including, but not limited to:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the scope, progress, costs and results of discovery, preclinical development, laboratory testing and clinical trials for TSHA-102 and any current and future product candidates that we advance; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our ability to access sufficient additional capital on a timely basis and on favorable terms; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the extent to which we develop, in-license or acquire other product candidates and technologies in our gene therapy product candidate pipeline; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the costs and timing of process development and manufacturing scale-up activities associated with our product candidates and other programs as we advance them through preclinical and clinical development; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the number and development requirements of product candidates that we may pursue; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the costs, timing and outcome of regulatory review of our product candidates; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">our headcount growth and associated costs as we expand our research and development capabilities and establish a commercial infrastructure; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the costs and timing of future commercialization activities, including product manufacturing, marketing, sales, and distribution, for any of our product candidates for which we receive marketing approval; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending any intellectual property-related claims; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the revenue, if any, received from commercial sales of our product candidates for which we receive marketing approval; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the costs of operating as a public company. </span></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Identifying potential product candidates and conducting preclinical studies and clinical trials is a time-consuming, expensive and uncertain process that takes many years to complete, and we may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, our product candidates, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of product candidates that we do not expect to be commercially available in the near term, if at all. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives. Adequate additional financing may not be available to us on acceptable terms, or at all. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the terms of these equity securities or this debt may restrict our ability to operate. The Term Loan Agreement contains negative covenants, including, among other things, restrictions on indebtedness, liens investments, mergers, dispositions, prepayment of other indebtedness and dividends and other distributions. Any future additional debt financing and equity financing, if available, may involve agreements that include covenants limiting and restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, entering into profit-sharing or other arrangements or declaring dividends. If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may be required to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or to grant licenses on terms that may not be favorable to us.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">49</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash Flows</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table shows a summary of our cash flows for the nine months ended September 30, 2023 and 2022 (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:67%;"></td>
    <td style="width:1.62%;"></td>
    <td style="width:1%;"></td>
    <td style="width:12.88%;"></td>
    <td style="width:1%;"></td>
    <td style="width:1.62%;"></td>
    <td style="width:1%;"></td>
    <td style="width:12.88%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months<br />Ended September 30,</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(56,901</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(103,102</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net cash used in investing activities</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(7,342</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(22,560</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">140,641</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10,865</span></p></td>
    <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net change in cash, cash equivalents and restricted cash</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">76,398</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(114,797</span></p></td>
    <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Operating Activities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the nine months ended September 30, 2023, our net cash used in operating activities of $56.9 million primarily consisted of a net loss of $159.3 million, primarily attributable to the loss recorded on the change in fair value of our warrant liability. The net loss of $159.3 million was offset by $115.6 million of adjustments for non-cash items, primarily due to the change in fair value of warrant liability of $100.5 million and stock-based compensation expense of $5.9 million. Additional cash used in operating activities of $13.2 million was primarily due to a decrease in deferred revenue.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the nine months ended September 30, 2022, our net cash used in operating activities of $103.1 million primarily consisted of a net loss of $110.9 million, primarily attributable to our spending on research and development expenses. The net loss of $110.9 million was partially offset by adjustments for non-cash items, primarily stock-based compensation, research and development license fees and depreciation expense of $17.6 million. Additional cash used in operating activities of $11.8 million was primarily due to a decrease in accounts payable and accrued expenses which was partially offset by an increase in prepaid expenses and other assets of $2.0 million.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Investing Activities</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the nine months ended September 30, 2023, investing activities used $7.3 million of cash primarily attributable to capital expenditures related to the close out of our in-house manufacturing facility project and payment of a $3.5 million milestone license fee. During the nine months ended September 30, 2022, investing activities used $22.6 million of cash primarily attributable to research and development license payments of $4.3 million, including regulatory milestone payments paid to Abeona pursuant to the Rett and CLN1 Agreements and $18.3 million in capital expenditures related to our in-house manufacturing facility and research and development lab.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Financing Activities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the nine months ended September 30, 2023, financing activities provided approximately $140.6 million of cash, which is primarily attributable to the proceeds from the August 2023 Private Placement, partially offset by the payment of shelf registration costs and other financing transactions. During the nine months ended September 30, 2022, financing activities provided $10.9 million of cash, which is primarily attributable to $11.6 million net proceeds from the sale of 2,000,000 shares of common stock pursuant to the Sales Agreement and partially offset by cash used in other financing activities.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Off-Balance Sheet Arrangements</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Critical Accounting Policies and Significant Judgments and Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There were no material changes to our critical accounting policies that are disclosed in our audited consolidated financial statements for the year ended December 31, 2022 filed with the SEC on March 28, 2023.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Recent Accounting Pronouncements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">See Note 2 to our unaudited condensed consolidated financial statements located in &#x201c;Part I &#x2013; Financial Information, Item 1. Financial Statements&#x201d; in this Quarterly Report on Form 10-Q for a description of recent accounting pronouncements applicable to our condensed consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">50</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging Growth Company and Smaller Reporting Company Status</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In April 2012, the Jumpstart Our Business Startups Act of 2012, or JOBS Act, was enacted. Section 107 of the JOBS Act provides that an &#x201c;emerging growth company&#x201d; can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended, for complying with new or revised accounting standards. Thus, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We elected the extended transition period for complying with new or revised accounting standards, which delays the adoption of these accounting standards until they would apply to private companies.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, as an emerging growth company, we may take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. These provisions include:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">an exception from compliance with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">reduced disclosure about our executive compensation arrangements in our periodic reports, proxy statements and registration statements; </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">exemptions from the requirements of holding non-binding advisory votes on executive compensation or golden parachute arrangements; and </span></div></div>
  <div style="margin-left:6.667%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.571084182443509%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">an exemption from compliance with the requirements of the Public Company Accounting Oversight Board regarding the communication of critical audit matters in the auditor&#x2019;s report on financial statements. </span></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We may take advantage of these provisions until we no longer qualify as an emerging growth company. We will cease to qualify as an emerging growth company on the date that is the earliest of: (i) December 31, 2025, (ii) the last day of the fiscal year in which we have more than $1.235 billion in total annual gross revenues, (iii) the date on which we are deemed to be a &#x201c;large accelerated filer&#x201d; under the rules of the SEC, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th, or (iv) the date on which we have issued more than $1.0 billion of non-convertible debt over the prior three-year period. We may choose to take advantage of some but not all of these reduced reporting burdens. We have taken advantage of certain reduced reporting requirements in this Quarterly Report on Form 10-Q and our other filings with the SEC. Accordingly, the information contained herein may be different than you might obtain from other public companies in which you hold equity interests.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are also a &#x201c;smaller reporting company,&#x201d; meaning that the market value of our shares held by non-affiliates is less than $700 million and our annual revenue was less than $100 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our shares held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100 million during the most recently completed fiscal year and the market value of our shares held by non-affiliates is less than $700 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company, we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_3_quantitative_qualitative_disclosu"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 3. Quantitative and Qualitati</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ve Disclosures About Market Risk.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this Item.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_4_controls_procedures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 4. Controls </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and Procedures.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act ), as of the end of the period covered by this Form 10-Q. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of September 30, 2023, our disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed by us in this Form 10-Q was (a) reported</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">within the time periods specified by SEC rules and regulations, and (b) communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding any required disclosure.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">51</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Changes in Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There were no changes in our internal control over financial reporting identified in management&#x2019;s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Inherent Limitations on Effectiveness of Internal Controls</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs. Our management, including our Chief Executive Officer and Chief Financial Officer, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">52</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_iior_information"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PART II&#x2014;OTHER</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> INFORMATION</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1_legal_proceedings"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 1. Legal </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Proceedings.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are not subject to any material legal proceedings. From time to time, we may be involved in various claims and legal proceedings relating to claims arising out of our operations. We are not currently a party to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1a_risk_factors"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 1A. Ris</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">k Factors.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Our business is subject to risks and events that, if they occur, could adversely affect our financial condition and results of operations and the trading price of our securities. In addition to the other information set forth in this quarterly report on Form 10-Q, you should carefully consider the factors described in Part I, Item 1A. &#x201c;Risk Factors&#x201d; of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission on March 28, 2023. Other than as described below, there have been no material changes to the risk factors described in that report.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks Related to the Development of our Product Candidates</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Interim &#x201c;top-line&#x201d; and preliminary results from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">From time to time, we may publish interim top-line or preliminary results from our clinical trials. Interim results from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Preliminary or top-line results also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, interim and preliminary data should be viewed with caution until the final data are available. For example, in August 2023 we announced initial clinical observations from the first adult patient treated in the Phase 1/2 REVEAL trial of TSHA-102. However, those observations may not endure or be repeated in subsequently dosed patients or any age or disease severity, including patients receiving higher doses of TSHA-102. Initial clinical observations also may not translate into success on primary endpoints of the REVEAL trial through week 52. Differences between preliminary or interim data and final data could significantly harm our business prospects and may cause the trading price of our common stock to fluctuate significantly.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks Related to Ownership of our Common Stock</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">If we fail to comply with our obligations in our current and future intellectual property licenses with third parties, we could lose rights that are important to our business.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are heavily reliant upon licenses to certain patent rights and proprietary technology for the development of our product candidates, in particular the UT Southwestern Agreement and our license agreements with Abeona. These license agreements impose diligence, development and commercialization timelines and milestone payment, royalty, insurance and other obligations on us. If we fail to comply with our obligations, our licensors may have the right to terminate our licenses, in which event we might not be able to develop, manufacture or market any product that is covered by the intellectual property we in-license from such licensor and may face other penalties. Such an occurrence would materially adversely affect our business prospects. For example, in July 2023 we received a notice from Hannah's Hope Foundation that alleges we are in breach of our license agreement relating to TSHA-120 for the treatment of GAN. We believe we are not in breach of such agreement and intend to pursue all avenues with Hannah's Hope Foundation to resolve this dispute; however, there is no guarantee that we will be successful in such effort.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Licenses to additional third-party technology and materials that may be required for our development programs may not be available in the future or may not be available on commercially reasonable terms, or at all, which could have a material adverse effect on our business and financial condition. Although we control the prosecution, maintenance and enforcement of the licensed and sublicensed intellectual property relating to our product candidates, we may require the cooperation of our licensors and any upstream licensor, which may not be forthcoming. Therefore, we cannot be certain that the prosecution, maintenance and enforcement of these patent rights will be in a manner consistent with the best interests of our business. If we or our licensor fail to maintain such patents, or if we or our licensor lose rights to those patents or patent applications, the rights we have licensed may be reduced or eliminated and our right to develop and commercialize any of our product candidates that are the subject of such licensed rights could be adversely affected. In addition to the foregoing, the risks associated with patent rights that we license from third parties will also apply to patent rights we may own in the future. Further, if we fail to comply with our development obligations under our license agreements, we may lose our patent rights with respect to such agreement on a territory-by-territory basis, which would affect our patent rights worldwide.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">53</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Termination of our current or any future license agreements would reduce or eliminate our rights under these agreements and may result in our having to negotiate new or reinstated agreements with less favorable terms or cause us to lose our rights under these agreements, including our rights to important intellectual property or technology. Any of the foregoing could prevent us from commercializing our other product candidates, which could have a material adverse effect on our operating results and overall financial condition.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In addition, intellectual property rights that we in-license in the future may be sublicenses under intellectual property owned by third parties, in some cases through multiple tiers. The actions of our licensors may therefore affect our rights to use our sublicensed intellectual property, even if we are in compliance with all of the obligations under our license agreements. Should our licensors or any of the upstream licensors fail to comply with their obligations under the agreements pursuant to which they obtain the rights that are sublicensed to us, or should such agreements be terminated or amended, our ability to develop and commercialize our product candidates may be materially harmed.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">If we are unable to obtain stockholder approval for the Charter Amendment to increase the number of authorized shares of our common stock, we will be required to pay liquidated damages to holders of the Pre-Funded Warrants.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We are required to hold a special meeting of stockholders for the purpose of obtaining stockholder approval of the Charter Amendment to increase the number of authorized shares of our common stock no later than December 31, 2023. We have agreed to use our best efforts to obtain such stockholder approval and to cause our board of directors to recommend to the stockholders that they approve such matter. If such stockholder approval is not obtained by December 31, 2023, we are required to hold an additional stockholder meeting every three months thereafter until such stockholder approval is obtained.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If we do not obtain stockholder approval of the Charter Amendment by December 31, 2023, we are required to pay liquidated damages of 2.0% of the aggregate purchase price paid by each holder of Pre-Funded Warrants. For any subsequent failure to obtain such stockholder approval, we are required to pay an additional 2.0% of such aggregate purchase price as liquidated damages.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risks Related to our Financial Position and Capital Needs</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Our existing indebtedness contains restrictions that potentially limit our flexibility in operating our business. In addition, we may be required to make a prepayment or repay our outstanding indebtedness earlier than we expect, or we may be unable to draw down the remaining tranches under our Term Loan Agreement if we are unable to satisfy certain conditions.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 13, 2023, we entered into a Loan and Security Agreement, or the Trinity Term Loan Agreement, with the lenders party thereto from time to time, or the Trinity Lenders, and Trinity Capital Inc., as administrative agent and collateral agent for the Trinity Lenders, or Trinity, which provides for term loans of up to $40.0 million in the aggregate available in a single tranche. The Trinity Term Loan Agreement contains various covenants that limit our ability to engage in specified types of transactions. These covenants limit our ability to, among other things:</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">incur or assume certain debt;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">merge or consolidate or acquire all or substantially all of the capital stock or property of another entity;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">change the nature of our business;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">change our organizational structure or type;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">license, transfer, or dispose of certain assets;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">grant certain types of liens on our assets;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">make certain investments;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">pay cash dividends; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">enter into material transactions with affiliates.</span></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">A breach of any of these covenants could result in an event of default under the Trinity Term Loan Agreement. An event of default will also occur if, among other things, a material adverse change in our business, operations, or condition occurs, which could potentially include a material impairment of the prospect of our repayment of any portion of the amounts we owe under the Trinity Term Loan Agreement. In the case of a continuing event of default under the Trinity Term Loan Agreement, the Trinity Lenders could elect to declare all amounts outstanding to be immediately due and payable, proceed against the collateral in which we granted the Trinity Lenders a security interest under the Trinity Term Loan Agreement, or otherwise exercise the rights of a secured creditor.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">54</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amounts outstanding under the Trinity Term Loan Agreement are secured by all of our existing and future assets, including intellectual property.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">At closing, we drew the full $40.0 million.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">We may not have enough available cash to repay or refinance our indebtedness at the time any such repayment is required. In such an event, we may be required to delay, limit, reduce, or terminate our preclinical and clinical product development or commercialization efforts or grant others rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. Our business, financial condition, and results of operations could be materially adversely affected as a result.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_2_unregistered_sales_equity_securit"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 2. Unregistered Sales of Equit</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">y Securities and Use of Proceeds.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) Recent Sales of Unregistered Equity Securities</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">None.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) Use of Proceeds</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">None.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(c) Issuer Purchases of Equity Securities</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_3_defaults_upon_senior_securities"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 3. Defaults Upo</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">n Senior Securities.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Not applicable.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_4_mine_safety_disclosures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 4. Mine Safe</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ty Disclosures.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Not applicable.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_5_or_information"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 5. Other </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Information.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Trinity Term Loans</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 13, 2023, we entered into the Trinity Term Loan Agreement, by and among us, Trinity Lenders, and Trinity, as administrative agent and collateral agent for the Trinity Lenders. The Trinity Term Loan Agreement provides for, on November 13, 2023, $40.0 million aggregate principal amount of Trinity Term Loans. We drew the Trinity Term Loans in full on the Trinity Closing Date.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The interest rate applicable to the Trinity Term Loans is the greater of (a) the WSJ Prime Rate plus 4.50% or (b) 12.75% per annum. The Trinity Term Loans are interest only from the Trinity Closing Date through 36 months from the Trinity Closing Date, which may be extended to 48 months from the Trinity Closing Date upon the satisfaction of certain milestones set forth in the Trinity Term Loan Agreement, after which we are required to pay equal monthly installments of principal through November 13, 2028, or the Maturity Date.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Trinity Term Loans may be prepaid in full (i) from the Trinity Closing Date through November 13, 2024, with payment of a 3.00% prepayment premium, (ii) from November 13, 2024 through November 13, 2025, with payment of a 2% prepayment premium, and (iii) from November 13, 2025 through, but excluding, the Maturity Date, with payment of a 1% prepayment premium.  On the Trinity Closing Date, we paid to Trinity a commitment fee of 1.00% of the original principal amount of the Trinity Term Loans. Upon repayment in full of the Trinity Term Loans, we will pay to Trinity an end of term payment equal to 5.00% of the original principal amount of the Trinity Term Loans.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The obligations under the Trinity Term Loan Agreement are secured by a perfected security interest in all of our assets except for certain customarily excluded property pursuant to the terms of the Trinity Term Loan Agreement. There are no financial covenants and no warrants associated with the Trinity Term Loan Agreement. The Trinity Term Loan Agreement contains various covenants that limit our ability to engage in specified types of transactions without the consent of Trinity and the Trinity Lenders which include, among others, incurring or assuming certain debt; merging, consolidating or acquiring all or substantially all of the capital stock or</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">55</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">property of another entity; changing the nature of our business; changing our organizational structure or type; licensing, transferring or disposing of certain assets; granting certain types of liens on our assets; making certain investments; and paying cash dividends.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Trinity Term Loan Agreement also contains customary representations and warranties, and also includes customary events of default, including payment default, breach of covenants, change of control, and material adverse effects. Upon the occurrence of an event of default, a default interest rate of an additional 5% per annum may be applied to the outstanding loan balances, and the Trinity Lenders may declare all outstanding obligations immediately due and payable and exercise all of its rights and remedies as set forth in the Trinity Term Loan Agreement and under applicable law.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The foregoing description of the Trinity Term Loan Agreement does not purport to be complete and is qualified in its entirety by reference to the text of the Trinity Term Loan Agreement, a copy of which is filed herewith as Exhibit 10.2 and incorporated by reference herein.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Termination of Silicon Valley Bank Term Loan</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 13, 2023, in connection with the closing of the Trinity Term Loan, the existing Loan and Security Agreement by and among us, the lenders party thereto from time to time and Silicon Valley Bank, as administrative agent and collateral agent for the Lenders, dated as of August 12, 2021, or the Closing Date, which provided for provided for (i) on the Closing Date, $40.0 million aggregate principal amount of term loans available through December 31, 2021, (ii) from January 1, 2022 until September 30, 2022, an additional $20.0 million term loan facility available at our option upon having three distinct and active clinical stage programs at the time of draw, (iii) from October 1, 2022 until March 31, 2023, an additional $20.0 million term loan facility available at our option upon having three distinct and active clinical stage programs at the time of draw and (iv) from April 1, 2023 until December 31, 2023, an additional $20.0 million term loan facility available upon approval by the Agent and the Lenders, or, collectively, the Term Loans, was terminated and the Term Loans were repaid in full. All subsidiary guarantees of the Term Loans were automatically released upon the termination of the Loan and Security Agreement.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">56</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_6_exhibits"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 6. E</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">xhibits.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The exhibits listed on the Exhibit Index are either filed or furnished with this report or incorporated herein by reference.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8%;"></td>
    <td style="width:1%;"></td>
    <td style="width:91%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Number</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.1</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1806310/000119312520257858/d78879dex31.htm"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company&#x2019;s Current Report on Form 8-K (File No. 001-39536), filed with the Securities and Exchange Commission on September 29, 2020).</span></a></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.2</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1806310/000119312520247565/d938924dex34.htm"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Amended and Restated Bylaws (incorporated by reference to Exhibit 3.4 to the Company&#x2019;s Current Report on Form 8-K (File No. 001-39536), filed with the Securities and Exchange Commission on September 29, 2020).</span></a></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4.1</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1806310/000119312523211456/d497848dex41.htm"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Form of Pre-Funded Warrant to Purchase Common Stock (incorporated by reference to Exhibit 4.1 to the Company&#x2019;s Current Report on Form 8-K (File No. 001-39536), filed with the Securities and Exchange Commission on August 14, 2023).</span></a></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1806310/000119312523211456/d497848dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Form of Securities Purchase Agreement, dated August 14, 2023, by and among the Company and the Purchasers (incorporated by reference to Exhibit 4.1 to the Company&#x2019;s Current Report on Form 8-K (File No. 001-39536), filed with the Securities and Exchange Commission on August 14, 2023).</span></a></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10.2*&#134;</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tsha-ex10_2.htm"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Loan and Security Agreement, dated November 13, 2023 by and among the Company,</span></a></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tsha-ex10_2.htm"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">and the lenders from time to time party thereto as lenders, and Trinity Capital, Inc. as administrative agent and collateral</span></a></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tsha-ex10_2.htm"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">agent.</span></a></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">31.1*</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tsha-ex31_1.htm"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">31.2*</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tsha-ex31_2.htm"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">32.1#</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tsha-ex32_1.htm"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">32.2#</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tsha-ex32_2.htm"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">101.INS</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">101.SCH</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema Document</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">101.CAL</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">101.DEF</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">101.LAB</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">101.PRE</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">104</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:77.778%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">* Filed herewith.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"># These certifications are being furnished solely to accompany this quarterly report pursuant to 18 U.S.C. Section 1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#134; Portions of this agreement (indicated by asterisks) have been omitted because the registrant has determined they are not material and are the type of information that the registrant treats as private or confidential.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">57</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="signatures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TURES</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45%;"></td>
    <td style="width:1%;"></td>
    <td style="width:4%;"></td>
    <td style="width:50%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td colspan="2" style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Taysha Gene Therapies, Inc.</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Date: November 14, 2023</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">/s/ Sean Nolan</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Sean Nolan</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Chief Executive Officer</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Principal Executive Officer)</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Date: November 14, 2023</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">/s/ Kamran Alam</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Kamran Alam</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Chief Financial Officer</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Principal Financial and Accounting Officer)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">58</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>tsha-ex10_2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html>
 <head>
  <title>EX-10.2</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 10.2</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">	</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS AGREEMENT (INDICATED BY &#x201c;[***]&#x201d;) BECAUSE TAYSHA GENE THERAPIES, INC. HAS DETERMINED SUCH INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">LOAN AND SECURITY AGREEMENT</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">THIS LOAN AND SECURITY AGREEMENT is made as of November 13, 2023 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Closing Date</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;), by and among TAYSHA GENE THERAPIES, INC., a Delaware corporation (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;), the lenders from time to time party hereto (each, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Lender</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; and collectively, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Lenders</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;) and TRINITY CAPITAL INC., a Maryland corporation, as administrative agent and collateral agent for the Lenders (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Administrative Agent</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">RECITALS</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, Borrower may, from time to time, desire to borrow from Lenders, and Lenders, may, from time to time, make available to Borrower, term loans (each a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Loan</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; and collectively the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Loans</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;); and</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">WHEREAS</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, Borrower and Lenders desire that this Agreement shall serve as a master agreement which sets forth the terms and conditions governing any Loan by Lenders to Borrower.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">NOW, THEREFORE</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, in consideration of the agreements and covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.533%;">Article 1</font><div style="width:100%;display:inline;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;"><br><br>DEFINITIONS</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">As used herein, all capitalized terms shall have the meanings set forth below.  All other capitalized terms used but not defined herein shall have the meaning given to such terms in the UCC.  Any accounting term used but not defined herein shall be construed in accordance with GAAP and all calculations shall be made in accordance with GAAP. The term &#x201c;financial statements&#x201d; shall include the accompanying notes and schedules.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Account Control Agreement</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any deposit account control agreement or securities account control agreement in a form acceptable to Administrative Agent required to perfect Administrative Agent&#x2019;s security interest in all Deposit Accounts and Securities Accounts of Borrower and each of its Subsidiaries. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Administrative Agent</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means Trinity Capital Inc., in its capacity as administrative agent and collateral agent under the Loan Documents, or any successor administrative agent and collateral agent appointed in accordance with Article 5.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Administrative Agent&#x2019;s Account</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means an account at a bank designated by the Administrative Agent from time to time in a written notice to Borrower as the account into which the Borrower shall make all payments to the Administrative Agent for the benefit of the Administrative Agent and the Lenders under this Agreement and the other Loan Documents.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Administrative Agent&#x2019;s Expenses</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means all reasonable and documented out of pocket costs or expenses (including reasonable and documented attorneys&#x2019; fees and expenses) incurred by Administrative Agent in connection with the preparation, negotiation, documentation, drafting, amendment, modification, administration, perfection and funding of the Loan Documents; and all of Administrative Agent&#x2019;s reasonable and documented attorneys&#x2019; fees, costs and expenses incurred in enforcing or defending the Loan Documents (including fees and expenses of appeal or review) and the rights of Administrative Agent in and to the Loans and the Collateral or otherwise hereunder, including the exercise of any rights or remedies afforded hereunder or under applicable law, whether or not suit is brought, whether before or after bankruptcy or insolvency, including all fees and costs incurred by Administrative Agent in connection with </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">1</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">its enforcement of its rights in a bankruptcy or insolvency proceeding filed by or against Borrower, any Subsidiary or their respective Property.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Advance</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any Loan funds advanced under this Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means, with respect to any Person, any other Person that owns or controls directly or indirectly ten percent (10%) or more of the stock of another entity of such Person, any other Person that controls or is controlled by or is under common control with such Person and each of such Person&#x2019;s officers, directors, managers, joint venturers or partners.  For purposes of this definition, the term &#x201c;control&#x201d; of a Person means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting Equity Securities, by contract or otherwise and the terms &#x201c;controlled by&#x201d; and &#x201c;under common control with&#x201d; shall have correlative meanings.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Agreement</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means this Loan and Security Agreement and all Schedules and Exhibits annexed hereto and made a part hereof, as the same may be amended, supplemented and or modified from time to time by the parties hereto.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Amortization Date</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; has the meaning provided in </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.1(a)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Amortization Schedule</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; has the meaning provided in </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.1(a)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Anti-Terrorism Laws</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any laws relating to terrorism or money laundering, including Executive Order No. 13224 (effective September 24, 2001), the USA PATRIOT Act, the laws comprising or implementing the Bank Secrecy Act, and the laws administered by OFAC.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Applicable Rate</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means a variable annual interest rate equal to the greater of (i) the Prime Rate plus four and one-half percent (4.50%) or (ii) twelve and three-quarters percent (12.75%).</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Assignment and Acceptance</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means an assignment and acceptance entered into by an assigning Lender and an eligible assignee and, to the extent required, consented to by the Administrative Agent and Borrower in accordance with Section 5.4 hereof and substantially in form reasonably acceptable to the Administrative Agent and Borrower.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">BLA</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means Biologics License Application.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Blocked Person</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">means any Person:  (a) listed in the annex to, or is otherwise subject to the provisions of, Executive Order No. 13224, (b) owned or controlled by, or acting for or on behalf of, any Person that is listed in the annex to, or is otherwise subject to the provisions of, Executive Order No. 13224, (c) with which any Lender is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law, (d) that commits, threatens or conspires to commit or supports &#x201c;terrorism&#x201d; as defined in Executive Order No. 13224, or (e) that is named a &#x201c;specially designated national&#x201d; or &#x201c;blocked person&#x201d; on the most current list published by OFAC or other similar list.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Business Day</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means a day when the banks in Phoenix, Arizona are open for business.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Change of Control</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means the closing of any transaction or series of transactions by which Borrower shall merge with (whether or not Borrower is the surviving entity) or consolidate into any other Person or lease or sell substantially all of its and its subsidiaries&#x2019; assets substantially as an entirety to any other Person or by which any Person, entity or group (within the meaning of Rule 13d-5 under the Securities Exchange Act of 1934) acquires, directly or indirectly, forty-nine percent (49%) or more of Borrower&#x2019;s outstanding capital stock that has ordinary voting power for the election of directors of Borrower (determined </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">2</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">on a fully diluted basis), unless in each case, as a condition to the closing and consummation of such transaction that would otherwise constitute a &#x201c;Change of Control,&#x201d; the Obligations will be paid in full.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Closing Date</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; has the meaning set forth in the preamble hereto.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Collateral</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; has the meaning provided in </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Article 3</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Commitments</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means, with respect to each Lender, such Lender&#x2019;s obligation to make Loans to the Borrower hereunder in a principal amount equal to the amount set forth under the heading &#x201c;Commitment&#x201d; opposite such Lender&#x2019;s name on </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Schedule 2</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Commitment Fee</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; is for each Advance the fully earned and non-refundable commitment fee equal to one percent (1.00%) of the aggregate principal amount of such Advance. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Compliance Certificate</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; is that certain certificate in substantially the form attached hereto as Exhibit D.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Debt</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means (a) all indebtedness for borrowed money; (b) all indebtedness for the deferred purchase price of property or services (other than (i) trade payables and accrued expenses incurred in the Ordinary Course of Business, (ii) any earn-out, purchase price adjustment or similar obligation until such obligation appears in the liabilities section of the balance sheet and (iii) any amounts being disputed in good faith by Borrower where such dispute would not cause, or be reasonably expected to cause, a Material Adverse Change); (c) all obligations evidenced by notes, bonds, debentures or other similar instruments; (d) all indebtedness created or arising under any conditional sale or other title retention agreement with respect to property acquired (even though the rights and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such property); (e) equity securities subject to repurchase or redemption by the holder of such equity securities (other than in connection with a Change of Control or asset sale) prior to 91 days after the Maturity Date, (f) all obligations, contingent or otherwise, as an account party or applicant under acceptance, letter of credit or similar facilities in respect of obligations of the kind referred to in subsections (a) through (e) of this definition; and (g) all obligations of the kind referred to in subsections (a) through (f) above secured by (or which the holder of such obligation has an existing right, contingent or otherwise, to be secured by) any Lien on property (including accounts and contract rights). Notwithstanding anything herein to the contrary, operating leases shall not constitute Debt hereunder.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Default Rate</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.2(c)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Defaulting Lender</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any Lender that (a) has failed to (i) fund all or any portion of its Loans within two Business Days of the date such Loans were required to be funded hereunder unless such Lender notifies the Administrative Agent and the Borrower in writing that such failure is the result of such Lender&#x2019;s determination that one or more conditions precedent to funding (each of which conditions precedent, together with any applicable default, shall be specifically identified in such writing) has not been satisfied, or (ii) pay to the Administrative Agent or any other Lender any other amount required to be paid by it hereunder within two Business Days of the date when due, (b) has notified the Borrower, or the Administrative Agent in writing that it does not intend to comply with its funding obligations hereunder, or has made a public statement to that effect (unless such writing or public statement relates to such Lender&#x2019;s obligation to fund a Loan hereunder and states that such position is based on such Lender&#x2019;s determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied), (c) has failed, within three Business Days after written request by the Administrative Agent or the Borrower, to confirm in writing to the Administrative Agent and the Borrower that it will comply with its prospective funding obligations hereunder (</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon receipt of such written confirmation by the Administrative Agent and the Borrower), or (d) has, or has a direct or indirect parent company that has, (i) become the subject of a proceeding under any debtor relief law, (ii) had appointed for it a receiver, custodian, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or assets, including the </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">3</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Federal Deposit Insurance Corporation or any other state or federal regulatory authority acting in such a capacity or (iii) become the subject of a bail-in action.  Notwithstanding anything to the contrary herein, a Lender shall not be a Defaulting Lender solely by virtue of the ownership or acquisition of any Equity Security in that Lender or any direct or indirect parent company thereof by a Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permits such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made with such Lender.  Any determination by the Administrative Agent that a Lender is a Defaulting Lender under clauses (a) through (d) above shall be conclusive and binding absent manifest error, and such Lender shall be deemed to be a Defaulting Lender upon delivery of written notice of such determination to the Borrower and each Lender.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Deposit Account</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any &#x201c;deposit account&#x201d; as defined in the UCC with such additions to the term as may hereafter be made, and includes any checking account, savings account, or certificate of deposit.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Documentation and Funding Fees</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.1(c)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">End of Term Payment</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; has the meaning set forth in </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.9</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Equity Securities</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; of any Person means (a) all common stock, preferred stock, participations, shares, partnership interests, membership interests or other equity interests in and of such Person (regardless of how designated and whether or not voting or non-voting) and (b) all warrants, options and other rights to acquire any of the foregoing, but excluding any debt securities convertible into such shares or other such equity interests unless such debt securities are converted into such shares or other such equity interests. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Event of Default</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any of the following events and conditions at any time, unless waived in writing by Administrative Agent, and shall constitute an Event of Default:</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">failure on the part of Borrower to remit to Administrative Agent (i) any payment of principal or interest when due or (ii) any other amounts required to be remitted under this Agreement or any Loan Documents on or before such amount is due, and such failure continues for three (3) Business Days (which three (3) Business Day cure period shall not apply to payments due on the Maturity Date). During such cure period, the failure to make or pay any payment specified under clause (ii) is not an Event of Default (but no Advance will be made during the cure period);</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">failure on the part of Borrower: (A) to perform any obligation arising under </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 4.2</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> or to comply with any covenants of </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 4.3</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> or (B) duly to observe or perform in any other of its respective covenants or agreements in this Agreement or any other Loan Document, which failure continues for a period of ten (10) Business Days after the occurrence of such breach; </font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">there is (a) a default in any agreement to which Borrower or any of its Subsidiaries is a party with a third party or parties resulting in the acceleration of the maturity of any Debt in an amount in excess of One Million Dollars ($1,000,000.00) provided, however, that the Event of Default under this clause (c) caused by the occurrence of a breach or default under such other agreement shall be cured or waived for purposes of this Agreement upon Administrative Agent receiving written notice from the party asserting such breach or default of such cure or waiver of the breach or default under such other agreement, if at the time of such cure or waiver under such other agreement (x) Administrative Agent has not declared an Event of Default under this Agreement and/or exercised any rights with respect thereto; and (y) any such cure or waiver does not result in an Event of Default under any other provision of this Agreement or any Loan Document;</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">4</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">if any representation or warranty of Borrower made in this Agreement or in any certificate or other writing delivered pursuant hereto or any other related document is materially incorrect or misleading as of the time when the same shall have been made;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">any provision of this Agreement or any Lien or security interest of Administrative Agent in the Collateral ceases for any reason to be valid, binding and in full force and effect other than as expressly permitted hereunder;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">any bankruptcy, insolvency or other similar proceeding is filed by Borrower or any of its Subsidiaries;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">any involuntary bankruptcy, insolvency or other similar proceeding is filed against Borrower or any of its Subsidiaries and such proceeding or petition shall not be dismissed within forty-five (45) days after filing;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">any assignment is made by Borrower or any attempt by Borrower to assign any of its duties or rights hereunder;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower is consolidated with, merged with (other than if a Subsidiary merges into Borrower and Borrower is the surviving entity), or sells its properties and assets substantially as an entity to another entity without Lender&#x2019;s prior written consent, provided that no consent of Lender shall be required if, in connection with such merger or sale of properties and assets the Obligations will be paid in full;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(i) If any material portion of Borrower&#x2019;s or any of its Subsidiaries&#x2019; assets (A) is attached, seized, subjected to a writ or distress warrant, or is levied upon or (B) comes into the possession of any trustee, receiver or person acting in a similar capacity and such attachment, seizure, writ or distress warrant or levy has not been removed, discharged or rescinded within ten (10) Business Days, (ii) if Borrower or any of its Subsidiaries is enjoined, restrained or in way prevented by court order from continuing to conduct all or any material part of its business affairs, (iii) if a judgment or other claim becomes a Lien or encumbrance upon any material portion of Borrower&#x2019;s or any of its Subsidiaries&#x2019; assets or (iv) if a notice of Lien, levy or assessment if filed of record with respect to any material portion of Borrower&#x2019;s or any of its Subsidiaries&#x2019; assets by the United States Government, or any department agency or instrumentality thereof, or by any state, county municipal, or governmental agency, and the same is not paid within ten (10) Business Days after Borrower or any Subsidiary receives notice thereof; </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> that none of the foregoing shall constitute an Event of Default where such action or event is stayed or an adequate bond has been posted pending a good faith contest by Borrower;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(k)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">If any of the Loan Documents shall cease to be, or Borrower shall assert that any of the Loan Documents is not, a legal, valid and binding obligation of Borrower enforceable in accordance with its terms;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(l)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">If there occurs a Material Adverse Change to Borrower;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(m)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">there is  a Change of Control, unless, as a condition to the closing of such change of control the Obligations will be paid in full; or</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(n)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">a final, non-appealable judgment which is not covered by insurance is entered against Borrower or any Subsidiary for an amount in excess of One Million Dollars ($1,000,000.00), which is not paid or bonded within twenty (20) days of entry.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Excluded Account</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means (a) any account specifically used, and identified in writing as such to Administrative Agent, for payroll, payroll taxes, workers&#x2019; compensation or unemployment compensation premiums or benefits, pension benefits, and other employee wage and benefit payments to or for the benefit of the employees of the Borrower and its Subsidiaries, not to exceed the amounts to fund the next two (2) succeeding payroll periods, (b) any deposit account, securities account, commodities account or other </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">5</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">account to the extent solely used to hold any cash or cash equivalents pledged as a Permitted Lien, as may be designated in writing to Administrative Agent from time to time after the Closing Date, (c) deposits held as cash collateral with Metro Title Company, LLC, as escrow agent and  (d) any Deposit Account used exclusively to maintain deposits or cash collateral for the benefit of unaffiliated third parties as expressly permitted by this Agreement, as may be designated in writing to Administrative Agent from time to time after the Closing Date.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Excluded Taxes</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any of the following Taxes imposed on or with respect to a Lender or Administrative Agent or required to be withheld or deducted from a payment to a Lender or Administrative Agent: (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes and branch profits Taxes, in each case, (i) imposed as a result of such Lender or Administrative Agent being organized under the laws of, or having its principal office or, in the case of any Lender, its applicable lending office located in, the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are Other Connection Taxes, (b) in the case of a Lender, any U.S. federal withholding Taxes imposed on amounts payable to or for the account of such Lender with respect to an applicable interest in a Loan or Commitment pursuant to a law in effect on the date on which such Lender acquires the applicable interest in such Loan or Commitment or changes its lending office, except in each case to the extent that, pursuant to Section 2.11, additional amounts with respect to such Taxes were payable either to such Lender&#x2019;s assignor immediately before such Lender became a party hereto or to such Lender immediately before it changes its lending office, (c) Taxes attributable to such Lender&#x2019;s or Administrative Agent&#x2019;s failure to comply with Section 2.11(g), and (d) any Taxes imposed under FATCA.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">FATCA</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version to the extent such version is substantively comparable and not materially more onerous to comply with), any current or future Treasury Regulations or official administrative interpretations thereof, any agreements entered into pursuant to current Section 1471(b)(1) of the Code (or any amended or successor version described above), any intergovernmental agreement, treaty or convention among Governmental Authorities (and any related fiscal or regulatory legislation, rules or official practices) implementing the foregoing.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">GAAP</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means generally accepted accounting principles, consistently applied, as in effect from time to time in the United States.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Good Faith Deposit</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; is the fully earned and non-refundable deposit in the amount of Seventy-Five Thousand Dollars ($75,000.00), which will be applied toward Administrative Agent&#x2019;s Expenses on the Closing Date.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Governmental Approval</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; is any consent, authorization, approval, order, license, franchise, permit, certificate, accreditation, registration, filing or notice, of, issued by, from or to, or other act by or in respect of, any Governmental Authority.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Governmental Authority</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; is any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions of or pertaining to government, any securities exchange and any self-regulatory organization.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Inactive Subsidiary</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means each Subsidiary identified by Borrower as &#x201c;inactive&#x201d; on the Perfection Certificate. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Indemnified Taxes</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means (a) all Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on account of any obligation of any Borrower under any Loan Document and (b) to the extent not otherwise described in (a), Other Taxes. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Intellectual Property</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any and all intellectual property, including copyrights, copyright licenses, patents, patent licenses, trademarks, trademark licenses, technology, know-how and processes, </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">6</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">all rights therein, and all rights to sue at law or in equity for any past present or future infringement, violation, misuse, misappropriation or other impairment thereof, whether arising under United States, multinational or foreign laws or otherwise, including the right to receive injunctive relief and all proceeds and damages therefrom.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Interest Only Milestone</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means [***]. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Interest Only Period</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means the period from and including the Closing Date and through but excluding the thirty-seventh (37</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Arial;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">) Payment Date following the Closing Date, provided that if Borrower achieves the Interest Only Milestone, the Interest Only Period  shall be the period beginning on the Closing Date and through but excluding the forty-ninth (49</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Arial;min-width:fit-content;">th</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">) Payment Date following the Closing Date.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Investment</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means the purchase or acquisition of any capital stock, equity interest, or any obligations or other securities of, or any interest in, any Person, or the extension of any advance, loan, extension of credit or capital contribution to, or any other investment in, or deposit with, any Person.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">IP Security Agreement</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means the Intellectual Property Security Agreement, dated as of the date hereof, by and among Administrative Agent and each grantor party thereto (as amended, amended and restated, supplemented or otherwise modified from time to time).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Key Person</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; is each of Borrower&#x2019;s (i) Chief Executive Officer, who is Sean P. Nolan as of the Closing Date and (ii) Chief Financial Officer, who is Kamran Alam as of the Closing Date.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Knowledge&#x201d; or &#x201c;Knowledge of Borrower</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means the actual knowledge of the chief executive officer, chief operating officer or chief financial officer of Borrower and such knowledge that would be obtained upon due inquiry and reasonable investigation by such Persons.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Lender&#x2019;s Expenses</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means all reasonable and documented out of pocket costs or expenses (including reasonably and documented attorneys&#x2019; fees and expenses) incurred in connection with the preparation, negotiation, documentation, drafting, amendment, modification, administration, perfection and funding of the Loan Documents; and all of Lenders&#x2019; reasonable and documented attorneys&#x2019; fees, costs and expenses incurred in enforcing or defending the Loan Documents (including fees and expenses of appeal or review) and the rights of a Lender in and to the Loans and the Collateral or otherwise hereunder, including the exercise of any rights or remedies afforded hereunder or under applicable law, whether or not suit is brought, whether before or after bankruptcy or insolvency, including all reasonable and documented fees and costs incurred by any Lender in connection with such Lender&#x2019;s enforcement of its rights in a bankruptcy or insolvency proceeding filed by or against Borrower, any Subsidiary or their respective Property.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Lien</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means a claim, mortgage, deed of trust, levy, charge, pledge, security interest or other encumbrance of any kind, whether voluntarily incurred or arising by operation of law or otherwise against any property.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;Loan Advance Request Form</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; is that certain form attached hereto as </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Exhibit E</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Loan Documents</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means this Agreement and any schedules, exhibits, certificates, notices, and any other documents related to this Agreement, the Notes (if any), [***], every Account Control Agreement, the IP Security Agreement, and any other intercreditor agreement, or subordination agreement, any documents pertaining to a mortgage, any landlord waivers and bailee waivers, the Perfection Certificate, each Compliance Certificate, each Loan Advance Request Form and every other document evidencing, securing or relating to the Loans, in each case as amended, amended and restated, supplemented or otherwise modified from time to time.  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Loans</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; has the meaning set forth in the preamble above.</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">7</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Material Adverse Change</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means (i) a materially adverse effect on the business, financial condition, operations, performance or Property of Borrower and its Subsidiaries, taken as a whole, or (ii) a material impairment of the ability of Borrower to perform its obligations under or remain in compliance with this Agreement and the other Loan Documents, or any documents executed in connection therewith.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Maturity Date</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; November 13, 2028. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Notes</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means a promissory note or notes in the form of </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> hereto.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Obligations</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means all present and future obligations owing by Borrower to Administrative Agent and the Lenders governed or evidenced by the Loan Documents whether or not for the payment of money, whether or not evidenced by any note or other instrument, whether direct or indirect, absolute or contingent, due or to become due, joint or several, primary or secondary, liquidated or unliquidated, secured or unsecured, original or renewed or extended, whether arising before, during or after the commencement of any bankruptcy case in which Borrower is a debtor (specifically including interest accruing after the commencement of any bankruptcy, insolvency or similar proceeding with respect to Borrower, whether or not a claim for such post-commencement interest is allowed), including but not limited to any obligations arising pursuant to letters of credit or acceptance transactions or any other financial accommodations.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">OFAC</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means the United States Department of the Treasury&#x2019;s Office of Foreign Assets Control.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Operating Documents</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means, for any Person, such Person&#x2019;s formation documents, as certified by the Secretary of State (or equivalent agency) of such Person&#x2019;s jurisdiction of organization on a date that is no earlier than thirty (30) days prior to the Closing Date, and, (a) if such Person is a corporation, its bylaws in current form, (b) if such Person is a limited liability company, its limited liability company agreement (or similar agreement), and (c) if such Person is a partnership, its partnership agreement (or similar agreement), each of the foregoing with all current amendments or modifications thereto.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Ordinary Course of Business</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means, in respect of any transaction involving any Person, the ordinary course of such Person&#x2019;s business as conducted by any such Person in accordance with the usual and customary customs and practices in the kind of business in which such Person is engaged, and  undertaken by such Person in good faith and not for purposes of evading any covenant or restriction in any Loan Document.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Other Connection Taxes</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means, with respect to any Lender or Administrative Agent, Taxes imposed as a result of a present or former connection between such Lender or Administrative Agent and the jurisdiction imposing such Tax (other than connections arising from such Lender or Administrative Agent having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Other Taxes</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means all present or future stamp, court or documentary, intangible, recording, filing or similar Taxes that arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Payment Date</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means the first (1st) day of each month, or if such day is not a Business Day, the next Business Day.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Perfection Certificate</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means the perfection certificate delivered to Administrative Agent dated as of the Closing Date.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Permitted Debt</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means and includes:</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">8</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Debt of Borrower to Lenders under this Agreement;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Debt of Borrower in an aggregate principal amount not to exceed One Million Dollars ($1,000,000.00) at any time, secured by Liens permitted under clause (g) of the definition of Permitted Liens;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Debt consisting of reimbursement obligations with respect to letters of credit  in an aggregate face amount not to exceed Two Hundred Fifty Thousand Dollars ($250,000.00) at any time, and any other letters of credit, provided that any such letters of credit are designated in writing to the Administrative Agent and approved by Administrative Agent from time to time after the Closing Date; </font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Debt incurred on corporate credit cards in the Ordinary Course of Business with JP Morgan Chase Bank, N.A., provided that the aggregate outstanding principal amount shall not exceed Two Hundred Fifty Thousand Dollars ($250,000.00);</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Debt of Borrower existing on the date hereof and set forth on the Perfection Certificate;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">extensions, refinancings, modifications, amendments and restatements of any items of Permitted Debt under subsections (a)-(c) above; </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> that the principal amount thereof is not increased or the terms thereof are not modified to impose materially more burdensome terms upon Borrower; </font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Debt of Borrower subordinated to the Obligations pursuant to a subordination, intercreditor, or similar agreement in form and substance, and on terms, satisfactory to Administrative Agent in Administrative Agent&#x2019;s sole reasonable discretion; </font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">unsecured Debt to trade creditors incurred in the Ordinary Course of Business;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Debt incurred as a result of endorsing negotiable instruments received in the Ordinary Course of Business;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Debt incurred in connection with insurance premium financings in the Ordinary Course of Business; provided that any Lien securing such Indebtedness is limited to the unearned premium of such insurance;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(k)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">other unsecured Debt not otherwise permitted hereunder in an aggregate outstanding principal amount not to exceed Five Hundred Thousand Dollars ($500,000); and</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(l)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">to the extent constituting Debt, investments permitted in clause (g) of the definition of &#x201c;Permitted Investments&#x201d;; provided that intercompany Debt shall be subject to a subordination agreement in favor of, and in form and substance reasonably acceptable to, Agent; and</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(m)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Debt in respect of performance bonds, bid bonds, appeal bonds, surety bonds and similar obligations incurred in the Ordinary Course of Business.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Permitted Investment</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Deposits and Deposit Accounts (which shall be subject to Account Control Agreements as required herein) with commercial banks organized under the laws of the United States or a state thereof to the extent: (i) the Deposit Accounts of each such institution are insured by the Federal Deposit Insurance Corporation up to the legal limit; and (ii) each such institution has an aggregate capital and surplus of not less than One Hundred Million Dollars ($100,000,000.00);</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">9</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Investments in marketable obligations issued or fully guaranteed by the United States and maturing not more than one (1) year from the date of issuance;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Investments in open market commercial paper rated at least &#x201c;A1&#x201d; or &#x201c;P1&#x201d; or higher by a national credit rating agency and maturing not more than one (1) year from the creation thereof; </font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">other highly liquid investments consistent with Borrower&#x2019;s investment policy approved by Borrower&#x2019;s board of directors as in effect, and as provided to and reviewed and approved by Administrative Agent, prior to the Closing Date (together with Amendments thereto, as provided to and reviewed and approved in writing by Administrative Agent);</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of Borrower;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Investments outstanding on the date hereof and set forth on the Perfection Certificate; </font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Investments (i) from one Borrower into another Borrower, (ii) by Borrower in Subsidiaries that are not Guarantors not to exceed Fifty Thousand Dollars ($50,000.00) in the aggregate in any fiscal year, and (iii) by Subsidiaries that are not Guarantors in other Subsidiaries that are not Guarantors;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the Ordinary Course of Business; </font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to customers and suppliers who are not Affiliates, in the Ordinary Course of Business; provided that this paragraph shall not apply to Investments of Borrower in any Subsidiary; and</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Investments accepted in connection with transfers permitted by this Agreement, in accordance with Section 4.3 (d); </font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(k)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Investments consisting of (i) travel advances and employee relocation loans and other employee loans and advances in the Ordinary Course of Business, and (ii) loans to employees, officers or directors relating to the purchase of equity securities of Borrower or its Subsidiaries pursuant to employee stock purchase plans or agreements approved by Borrower&#x2019;s board of directors; not to exceed Two Hundred Fifty Thousand Dollars ($250,000.00) in the aggregate in any fiscal year;</font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(l)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Investments consisting of deposits to secure the performance of bids, trade contracts, statutory obligations, surety and appeal bonds (other than bonds related to judgments or litigation) or performance bonds, in each case in the Ordinary Course of Business; </font></div></div>
  <div style="text-indent:12.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:12.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.933%;">(m)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Other Investments aggregating not in excess of Five Hundred Thousand Dollars ($500,000.00) per year.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Permitted License</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means (A) licenses of over-the-counter software that is commercially available to the public, and (B) non-exclusive and exclusive licenses for the use of the Intellectual Property of Borrower or any of its Subsidiaries entered into in the Ordinary Course of Business, provided, that, with respect to each such license described in clause (B), (i) no Event of Default has occurred or is continuing at the time of such license; (ii) the license constitutes an arm&#x2019;s length transaction, the terms of which, on their face, do not provide for a sale or assignment of any Intellectual Property and do not restrict the ability of Borrower or any of its Subsidiaries, as applicable, to pledge, grant a security interest in or lien on, or assign or otherwise Transfer any Intellectual Property; (iii) in the case of any exclusive license, (x) Borrower delivers ten (10) days&#x2019; prior written notice and a brief summary of the terms of the proposed license to </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">10</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Lender and delivers to Lender copies of the final executed licensing documents in connection with the exclusive license promptly upon consummation thereof, and (y) any such license could not result in a legal transfer of title of the licensed property but may be exclusive in respects other than territory and may be exclusive as to territory only as to discrete geographical areas outside of the United States; and (iv) all upfront payments, royalties, milestone payments or other proceeds arising from the licensing agreement that are payable to Borrower or any of its Subsidiaries are paid to a Deposit Account that is governed by an Account Control Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Permitted Liens</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any of the following: </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Liens of the Administrative Agent pursuant to this Agreement;</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Liens outstanding on the date hereof and set forth on the Perfection Certificate;</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Liens for taxes and assessments not yet due and payable or, if due and payable, those being contested in good faith by appropriate proceedings and for which appropriate reserves are maintained in accordance with GAAP; </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Liens arising in the Ordinary Course of Business (such as Liens of carriers, warehousemen, mechanics, and materialmen) and other similar Liens imposed by law for sums not yet due and payable or, if due and payable, those being contested in good faith by appropriate proceedings and for which appropriate reserves are maintained in accordance with GAAP; </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">easements, rights of way, restrictions, minor defects or irregularities in title or other similar Liens which alone or in the aggregate do not interfere in any material way with the ordinary conduct of the business of Borrower; </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Liens consisting of Permitted Licenses;</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Liens consisting of purchase money security interests for new equipment financing not to exceed the amount permitted in clause (b) of the definition of &#x201c;Permitted Debt&#x201d;; </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Liens on cash collateral securing letters of credit that constitute Permitted Debt; </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Liens to secure payment of workers&#x2019; compensation, employment insurance, old-age pensions, social security and other like obligations incurred in the Ordinary Course of Business (other than Liens imposed by ERISA); </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Liens to secure leases or subleases of real property granted in the ordinary course of Borrower&#x2019;s business (or, if referring to another Person, in the ordinary course of such Person&#x2019;s business), and leases, subleases, non-exclusive licenses or sublicenses of personal property (other than Intellectual Property) granted in the ordinary course of Borrower&#x2019;s business (or, if referring to another Person, in the ordinary course of such Person&#x2019;s business), if the leases, subleases, licenses and sublicenses do not prohibit granting Lender a security interest therein;</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(k)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Liens arising from attachments or judgments, orders, or decrees in circumstances not constituting an Event of Default; </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(l)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Liens arising from the filing of any precautionary financing statement on operating leases covering the leased property, to the extent such operating leases are permitted under this Agreement; </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(m)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Liens in favor or other financial institutions arising in connection with Borrower&#x2019;s deposit or investment accounts held at such institutions to secure customary fees and charges (but not </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">11</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">credit/debt relationships or margin accounts), provided that Administrative Agent has a perfected security interest in the amounts held in such deposit accounts to the extent required by this Agreement;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(n)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Liens on insurance proceeds granted solely as a security for financed premiums to the extent the Debt qualifies as Permitted Debt; and</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(o)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(n) cash pledges and deposits to secure the performance of bids, trade, commercial and government contracts, tenders, leases, statutory or regulatory obligations (including ERISA obligations and bonds), surety and appeal bonds, performance bonds and other obligations of a like nature, in each case in the Ordinary Course of Business; in any case other than statutory or regulatory obligations, such as but not limited to ERISA and ERISA bonds, not representing an obligation for borrowed money.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means and includes any individual, any partnership, any corporation, any business trust, any joint stock company, any limited liability company, any unincorporated association or any other entity and any domestic or foreign national, state or local government, foregoing.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Potential Event of Default</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any event or circumstance, which, with the giving of notice or lapse of time or both, would become an Event of Default. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Prime Rate</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means, at any time, the greater of (i) the rate of interest noted in The Wall Street Journal, Money Rates section, as the &#x201c;Prime Rate.&#x201d; In the event that The Wall Street Journal quotes more than one rate, or a range of rates, as the Prime Rate, then the Prime Rate shall mean the average of the quoted rates. In the event that The Wall Street Journal ceases to publish a Prime Rate, then the Prime Rate shall be as announced by Lender.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Pro Rata Share</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means, with respect to:</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(a)	a Lender&#x2019;s obligation to make Loans and the right to receive payments of interest, fees and principal with respect thereto, the percentage obtained by dividing (i) such Lender&#x2019;s Commitments, by (ii) the Total Commitments, </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> that if the Total Commitments have been reduced to zero, the numerator shall be the aggregate unpaid principal amount of such Lender&#x2019;s portion of the Loans and the denominator shall be the aggregate unpaid principal amount of the Loans, and </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(b)	all other matters (including, without limitation, the indemnification obligations arising under </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 5.7</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">), the percentage obtained by dividing (i) the sum of the unpaid principal amount of such Lender&#x2019;s portion of the Loans, by (ii) the sum of the aggregate unpaid principal amount of the Loans.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Property</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any interest in any kind of property or asset, whether real, personal or mixed, whether tangible or intangible.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Responsible Officer</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means each of the chief executive officer, the chief operating officer, the chief financial officer, president, treasurer, vice president of finance and the controller of Borrower, as well as any other officer or employee identified as an authorized officer in the corporate resolution delivered by Borrower to Administrative Agent in connection with this Agreement.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Restricted License</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any license or other agreement with respect to which Borrower is the licensee and such license or agreement is material to Borrower&#x2019;s business and that prohibits or otherwise restricts Borrower from granting a security interest in Borrower&#x2019;s interest in such license or agreement or any other property.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Required Lenders</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means Lenders (other than Defaulting Lenders) whose Pro Rata Shares (without giving effect to the Pro Rata Share of Defaulting Lenders) aggregate at least fifty and one-tenth percent (50.1%); provided that such Lenders must include Administrative Agent (unless Administrative Agent is a Defaulting Lender).</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">12</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Secured Parties</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means the Lenders, Administrative Agent, each other Indemnified Person and any other holder of any Obligation.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Securities Account</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any &#x201c;securities account&#x201d; as defined in the UCC with such additions to such term as may hereafter be made.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Solvent</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; with respect to any person or entity as of any date of determination, means that on such date (a) the present fair salable value of the property and assets of such person or entity exceeds the debts and liabilities, including contingent liabilities, of such person or entity, (b) the present fair salable value of the property and assets of such person or entity is greater than the amount that will be required to pay the probable liability of such person or entity on its debts and other liabilities, including contingent liabilities, as such debts and other liabilities become absolute and matured, (c) such person or entity does not intend to incur, or believe (nor should it reasonably believe) that it will incur, debts and liabilities, including contingent liabilities, beyond its ability to pay such debts and liabilities as they become absolute and matured, and (d) such person or entity does not have unreasonably small capital with which to conduct the business in which it is engaged as such business is now conducted and is proposed to be conducted. The amount of contingent liabilities at any time shall be computed as the amount that, in the light of all the facts and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or matured liability.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Subsidiary</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; as to any Person, means any corporation, partnership, limited liability company, joint venture, trust or estate of or in which more than fifty percent (50%) of (a) the issued and outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether at the time capital stock of any other class of such corporation may have voting power upon the happening of a contingency), (b) the interest in the capital or profits of such partnership, limited liability company, or joint venture or (c) the beneficial interest in such trust or estate is at the time directly or indirectly owned or controlled through one or more intermediaries, or both, by such Person. Unless otherwise qualified, all references to a &#x201c;Subsidiary&#x201d; or to &#x201c;Subsidiaries&#x201d; in this Agreement shall refer to a Subsidiary or Subsidiaries of the Borrower.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">[***]. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">[***].</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Taxes</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges in the nature of a tax imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Tranche A Loan</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; shall have the meaning provided in </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.1(b).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Total Commitments</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means the sum of the amounts of the Lenders&#x2019; Commitments.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Transfer</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means to convey, sell, lease, transfer, assign, or otherwise dispose of.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">UCC</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means the Uniform Commercial Code as the same may from time to time be in effect in the State of California; provided, however, in the event, by reason of mandatory provisions of law, any and all of the attachment, perfection or priority of the security interest of Administrative Agent in and to the Collateral is governed by the Uniform Commercial Code as in effect in a jurisdiction other than California, the term &#x201c;UCC&#x201d; shall mean the Uniform Commercial Code as in effect in such other jurisdiction for purposes of the provisions relating to such attachment, perfection or priority and for purposes of definitions related to such provisions; provided, further, that the term &#x201c;UCC&#x201d; shall include Article 9 thereof as in effect on the Closing Date.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">U.S. Person</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d; means any Person that is a &#x201c;United States person&#x201d; as defined in Section 7701(a)(30) of the Code.</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">13</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.533%;">Article 2</font><div style="width:100%;display:inline;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;"><br><br>THE LOANS</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">The Loans</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Subject to the terms and conditions of this Agreement, each Lender severally hereby agrees to make a Loan to the Borrower in a principal amount not to exceed the amount of such Lender&#x2019;s Commitments.  If the aggregate outstanding principal amount of Loans at any time exceeds the Total Commitments, Borrower shall immediately repay such excess in full.  The Obligations of Borrower under this Agreement shall at all times be absolute and unconditional.  Borrower acknowledges and agrees that any obligation of any Lender to make any Loan hereunder is strictly contingent upon the satisfaction of the conditions set forth in Sections 2.4 and 2.5 (as applicable).  For each Loan, Borrower shall make (i) monthly payments of interest only in arrears at the Applicable Rate during the Interest Only Period, and (ii) beginning on the first Payment Date after expiration of the Interest Only Period (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Amortization Date</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;), equal monthly payments on each subsequent Payment Date in an amount determined through a calculation fully amortizing the outstanding principal balance due under each Loan at the Applicable Rate over the period from the Amortization Date through (and including) the Maturity Date. For clarity, the payment schedule with respect to the Tranche A Loan as of the Closing Date is reflected in Exhibit B attached hereto, and Administrative Agent may update such payment schedule from time to time in accordance with the terms of the Loan Documents (as amended from time to time, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Amortization Schedule</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;). In the event of any inconsistency between the Amortization Schedule and the terms of the Loan Documents (including this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.1</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">), the terms of the Loan Documents shall prevail. Borrower shall continue to comply with all of the terms and provisions hereof until all of the Obligations are paid and satisfied in full.  </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">The initial Advance hereunder, to be funded on the date hereof upon satisfaction of the conditions in </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Sections 2.4</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> and 2.5, shall be an amount equal to Forty Million Dollars ($40,000,000.00) (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Tranche A Loan</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;).</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">At the time of the Advance of the Tranche A Loan, Borrower will pay Administrative Agent and the Lenders for all reasonable and documented out of pocket costs related to the Tranche A Loan including travel, UCC search, filing, insurance, and legal costs for the Tranche A Loan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Tranche A Documentation and Funding Fee</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;). At the time of any additional Advance of any Loans, Borrower will pay Administrative Agent and the Lenders for all reasonable costs related to such additional Loans, including travel, UCC search, filing, insurance, and legal costs. The Tranche A Documentation and Funding Fee and any such additional costs due related to additional Loans shall be collectively referred to hereunder as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Documentation and Funding Fees</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.&#x201d; </font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Advances and Interest</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">All Loans requested by Borrower must be requested by 11:00 A.M. Arizona time, five (5) Business Days prior to the date of such requested Loan.  All requests or confirmations of requests for a Loan are to be in writing to Administrative Agent and may be sent by telecopy or facsimile transmission or by email provided that Administrative Agent shall have the right to require that receipt of such request not be effective unless confirmed via telephone with Lender.  Borrower may not request more than one (1) Loan per calendar month.  As express conditions precedent to Lender making each Loan to Borrower, Borrower shall deliver to Administrative Agent the documents, instruments and agreements required pursuant to </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Sections 2.4</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">2.5</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, and </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">2.6</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> (as applicable) of this Agreement (including, without limitation, the Loan Advance Request Form). Except as otherwise provided in this Section </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">2.2(a)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, all Loans under this Agreement shall be made by the Lenders simultaneously and proportionately to their Pro Rata Shares of the Total Commitments, as the case may be, it being understood that no Lender shall be responsible for any default by any other Lender in that other Lender&#x2019;s obligations to make a Loan requested hereunder, nor shall the Commitment of any Lender be increased or decreased as a result of the default by any other Lender in that other Lender&#x2019;s obligation to make a Loan requested hereunder, and each Lender shall be </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">14</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">obligated to make the Loans required to be made by it by the terms of this Agreement regardless of the failure by any other Lender.</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">The following amounts shall be deducted from the Tranche A Loan advanced hereunder: the applicable Commitment Fee and the Tranche A Documentation and Funding Fee.  </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Beginning on the date of each Advance, the unpaid principal balance of all advanced Loans and all other Obligations hereunder shall bear interest, subject to the terms hereof, at the Applicable Rate.  All payments shall be due to Administrative Agent on the applicable Payment Date, or if such day is not a Business Day, the next succeeding Business Day.  If Borrower fails to make a monthly payment due within five (5) Business Days after the date such payment is due, Administrative Agent, on behalf of the Lenders, shall have the right to require Borrower to pay to Lender a late charge equal to five percent (5%) of the past due payment.  After the occurrence and during the continuance of an Event of Default hereunder, Administrative Agent, on behalf of the Lenders, shall have the right to increase the per annum effective rate of interest on all Loans outstanding hereunder to a rate equal to 500 basis points in excess of the Applicable Rate (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Default Rate</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;).  All contractual rates of interest chargeable on outstanding Loans, shall continue to accrue and be paid even after default, maturity, acceleration, judgment, bankruptcy, insolvency proceedings of any kind or the happening of any event or occurrence similar or dissimilar.  In no contingency or event whatsoever shall the aggregate of all amounts deemed interest hereunder and charged or collected pursuant to the terms of this Agreement exceed the highest rate permissible under any law which a court of competent jurisdiction shall, in a final determination, deem applicable hereto.  In the event that such court determines Lenders have charged or received interest hereunder in excess of the highest applicable rate, Administrative Agent, shall in its sole discretion and acting on behalf of the Lenders, apply and set off such excess interest received by Lenders against other Obligations hereunder due or to become due and such rate shall automatically be reduced to the maximum rate permitted by such law.</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Interest shall be computed on the basis of a 360-day year, and twelve 30-day months. For any partial month interest periods, interest will be charged for the actual number of days elapsed. In computing interest, (i) all payments received after 12:00 p.m. Arizona time on any day shall be deemed received at the opening of business on the next Business Day, and (ii) the date of the making of the Loans shall be included and the date of payment shall be excluded. Changes to the Applicable Rate based on changes to the Prime Rate, shall be effective as of the day immediately following the date of such change, and to the extent, of such change.</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Upon the occurrence and during the continuance of an Event of Default and/or the maturity of any portion of the Obligations, any moneys on deposit with Administrative Agent may, at the direction of the Required Lenders, be applied against the Obligations in such order and manner as Administrative Agent may elect or as may otherwise be required under this Agreement.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Administrative Agent Accounts</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. Administrative Agent shall maintain accounts in which it shall record (i) the amount of each Loan made hereunder, (ii) the amount of any principal or interest due and payable or to become due and payable from the Borrower to each Lender hereunder, and (iii) the amount of any sum received by Administrative Agent hereunder for the account of the Lenders and each Lender&#x2019;s share thereof.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Conditions Precedent to Each Advance</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. It shall be an express condition precedent to each Lender&#x2019;s obligation to make an Advance of each Loan that (i) the representations and warranties contained in Section 4.1 shall be true and correct in all material respects as of the date of such Advance (provided, however, that those representations and warranties expressly referring to another date shall be true and correct in all material respects as of such other date), (ii) no Event of Default or Potential Event of Default shall have occurred and be continuing, (iii) receipt by Administrative Agent of an executed Loan Advance Request Form in the form of Exhibit E attached hereto, (iv) no circumstance shall exist that could reasonably be expected to have a Material Adverse Change, (v) all governmental and third party approvals necessary in connection with the Loan and this Agreement shall have been obtained and be in full force and effect, and (vi) Administrative Agent&#x2019;s satisfaction, in Administrative </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">15</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:1.731%;text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Agent&#x2019;s sole discretion, with the results of Administrative Agent&#x2019;s due diligence investigation, including, without limitation, review of the financial statements of Borrower dated no more than thirty (30) days prior to the funding of such Advance.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.5</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Conditions Precedent to the Tranche A Loan</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. It shall be an express condition precedent to a Lender&#x2019;s obligation to make an Advance of the Tranche A Loan that Borrower shall provide or cause to be provided to Administrative Agent all of the following items:</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">UCC-1 financing statements designating Borrower, as debtor, and Administrative Agent, as secured party for the benefit of Lenders, for filing in the state of Borrower&#x2019;s incorporation or formation, as applicable, the state of Borrower&#x2019;s chief executive office, the place where Borrower transacts business or in any other state required by Administrative Agent with respect to all Collateral which may be perfected under the UCC by the filing of a UCC-1 financing statement, together with any other documents Administrative Agent deems necessary to evidence or perfect Lenders&#x2019; security interest with respect to the Collateral;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">a certificate as to authorizing resolutions and Operating Documents of Borrower with specimen signatures, substantially in the form of </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Exhibit C</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">the Operating Documents of Borrower and good standing certificates from each of Borrower&#x2019;s jurisdiction of organization and chief executive office location, and each jurisdiction in which Borrower is qualified to conduct business where the failure to be so qualified could reasonably be expected to result in a Material Adverse Change;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">landlord waivers and bailee waivers in the form reasonably acceptable to Administrative Agent for each location where the Collateral in excess of $200,000 is located, if any;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">insurance certificates and endorsements evidencing that the Borrower, its Subsidiaries, and the Collateral are insured in accordance with the requirements of </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 4.2(q)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> hereof;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">a recent Lien search in each of the jurisdictions where the Borrower and each Subsidiary is organized and the assets of Borrower and each Subsidiary are located, and such searches reveal no Liens on any of the assets of Borrower or any Subsidiary, except for Permitted Liens;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">payment in full of the applicable Commitment Fee, the Good Faith Deposit, and the Tranche A Documentation and Funding Fees;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">a fully executed copy of this Agreement;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">[reserved];</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">fully executed copies of each other Loan Document; </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(k)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">a duly executed legal opinion of counsel to Borrower dated as of the Closing Date;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(l)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">a copy of each applicable stockholders&#x2019; agreement, investors rights agreement, voting agreement, or other similar equity financing documents of Borrower, and any amendments thereto;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(m)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">a completed Perfection Certificate for Borrower and each of its Subsidiaries; </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(n)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">a payoff letter executed by Silicon Valley Bank together with a release of any Liens created in connection therewith on Borrower and its assets and properties (such Indebtedness to be satisfied, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Existing Indebtedness</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;), in each case in form and substance satisfactory to Administrative Agent; and</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">16</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(o)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">such other documents and completion of such other matters as Administrative Agent may reasonably deem necessary and appropriate.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.6</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Reserved</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. </font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.7</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Voluntary Prepayment</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. Borrower may prepay in whole or in part, the Loans at any time, subject to payment of the premium set forth below (&#x201c;Prepayment Premium&#x201d;). The calculated pre-payment amount shall include the outstanding principal due under each Loan at the time of retirement, any partially accrued interest thereon, and a Prepayment Premium based on the following schedule: </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> On or before the first anniversary of the Closing Date the Prepayment Premium shall be equal to three percent (3.00%) of the principal being repaid.</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">After the first anniversary of the Closing Date and on or before the second anniversary of the Closing Date the Prepayment Premium shall be equal to two percent (2.00%) of the principal being repaid.</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">After the second anniversary of the Closing Date and before the Maturity Date the Prepayment Premium shall be equal to 	one percent (1.00%) of the principal repaid. </font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.8</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Mandatory Prepayment</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. If a Change of Control occurs or the Loans are accelerated following the occurrence of an Event of Default, Borrower shall immediately pay to Administrative Agent, for the benefit of Lenders, an amount equal to the sum of: (i) all outstanding principal of the Loans plus accrued and unpaid interest thereon through the prepayment date, (ii) the Prepayment Premium, plus (iii) all other Obligations that are due and payable, including, without limitation, Administrative Agent Expenses and Lender&#x2019;s Expenses and interest at the rate set forth in Section 2.2(c) with respect to any past due amounts. </font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.9</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">End of Term Payment</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. On the Maturity Date or on the date of the earlier prepayment of the Loans by Borrower pursuant to </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.6</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> or </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.7</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> or acceleration of the balance of the Loans by Administrative Agent pursuant to </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 7.1</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, Borrower shall pay to Administrative Agent, for the benefit of Lenders, the amount equal to five percent (5.00%) of the original principal amount of the Loans in addition to all sums payable hereunder (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">End of Term Payment</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;).</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.10</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Proceeds of Collateral</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. Following the occurrence and during the continuance of an Event of Default, upon the written notice of Administrative Agent, all proceeds from the Collateral shall be immediately delivered to Administrative Agent, at the direction of the Required Lenders, may apply such proceeds and payments to any of the Obligations in such order as Administrative Agent may decide in its sole discretion.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.11</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Tax Matters</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Withholding</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. Payments received by the Administrative Agent or a Lender from Borrower hereunder will be made free and clear of and without deduction for any Taxes, except as required by any Governmental Authority, law, regulation or international agreement. If (i) at any time any Governmental Authority, law, regulation or international agreement requires Borrower to make any withholding or deduction of any Tax from any such payment or other sum payable hereunder to the Administrative Agent or a Lender, and (ii) such Tax is an Indemnified Tax, Borrower hereby covenants and agrees that the amount due from Borrower with respect to such payment or additional amounts payable pursuant to this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.11(a)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> will be increased to the extent necessary to ensure that, after the making of such required withholding or deduction for Indemnified Taxes, Administrative Agent or such Lender receives a net sum equal to the sum which it would have received had no withholding or deduction for Indemnified Taxes been required and Borrower shall pay the full amount withheld or deducted to the relevant Governmental Authority. Borrower will, upon request, furnish the Administrative Agent with proof reasonably satisfactory to the Administrative Agent indicating that Borrower has made such withholding </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">17</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">payment; provided, however, that Borrower need not make any withholding payment if the amount or validity of such withholding payment is contested in good faith by appropriate and timely proceedings and as to which payment in full is bonded or reserved against by Borrower. The agreements and obligations of Borrower contained in this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.11</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> shall survive the termination of this Agreement.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower shall timely pay to the relevant Governmental Authority in accordance with applicable law, or at the option of the Administrative Agent timely reimburse it for the payment of, any Other Taxes.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">The Borrower shall indemnify each Lender and Administrative Agent, within 10 days after demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.11</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">) payable or paid by such Lender or Administrative Agent, or required to be withheld or deducted from a payment to such Lender or Administrative Agent, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. The relevant Lender or Administrative Agent shall notify the Borrower of the imposition of any Indemnified Tax reasonably promptly after becoming aware of the imposition of such Tax.  A certificate as to the amount of such payment or liability delivered to the Borrower by a Lender (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of a Lender, shall be conclusive absent manifest error.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Each Lender shall severally indemnify the Administrative Agent, within 10 days after demand therefor, for (i) any Indemnified Taxes attributable to such Lender (but only to the extent that Borrower has not already indemnified the Administrative Agent for such Indemnified Taxes and without limiting the obligation of Borrower to do so), (ii) any Taxes attributable to such Lender&#x2019;s failure to comply with the provisions of Section 8.18 relating to the maintenance of a Participant Register and (iii) any Excluded Taxes attributable to such Lender, in each case, that are payable or paid by the Administrative Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority.  A certificate as to the amount of such payment or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error.  Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by the Administrative Agent to the Lender from any other source against any amount due to the Administrative Agent under this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.11(d)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">As soon as practicable after any payment of Taxes by Borrower to a Governmental Authority pursuant to this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.11</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, Borrower shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">If any Lender or the Administrative Agent determines, in its sole discretion exercised in good faith, that it has received a refund of any Indemnified Taxes as to which it has been indemnified pursuant to Section 2.11 (including by the payment of additional amounts pursuant to </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.11(a))</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, it shall pay to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.11</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> with respect to the Indemnified Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of such indemnifying party and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund). Such indemnifying party, upon the request of such indemnified party, shall promptly repay to such indemnified party the amount paid over pursuant to this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.11(f)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) in the event that such indemnified party is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.11(f)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant to this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.11(f)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> the payment of which would place the indemnified party in a less favorable net after-Tax position than the indemnified party would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">18</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">additional amounts with respect to such Tax had never been paid. This </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.11(f)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> shall not be construed to require any indemnified party to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to the indemnifying party or any other Person.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> (i) Any Lender that is entitled to an exemption from or reduction of withholding Tax with respect to any payments made under any Loan Document shall deliver to the Borrower and the Administrative Agent, at the time or times reasonably requested by the Borrower or the Administrative Agent, such properly completed and executed documentation reasonably requested by the Borrower or the Administrative Agent as will permit such payments to be made without withholding or at a reduced rate of withholding. In addition, any Lender, if reasonably requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting requirements. Notwithstanding anything to the contrary in the preceding two sentences, the completion, execution and submission of such documentation (other than such documentation set forth in Section 2.11(g)(ii)(A), (ii)(B), (ii)(D) and (ii)(E) below) shall not be required if in the Lender&#x2019;s reasonable judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender.</font></div></div>
  <div style="margin-left:6.667%;text-indent:14.286%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.8575102053935906%;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Without limiting the generality of the foregoing,</font></div></div>
  <div style="text-indent:26.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:26.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:5.067%;">(A)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">any Lender that is a U.S. Person shall deliver to the Borrower and the Administrative Agent (in such number of copies as shall be reasonably requested by the recipient) on or prior to the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent) executed copies of Internal Revenue Service (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">IRS</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;) Form W-9 (or any successor form) certifying that such Lender is exempt from U.S. federal backup withholding tax; </font></div></div>
  <div style="margin-left:6.667%;text-indent:21.429%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:5.428947960528431%;">(B)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">any Lender that is not a U.S. Person (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Non-U.S. Lender</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;) shall, to the extent it is legally entitled to do so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be reasonably requested by the recipient) on or prior to the date on which such Non-U.S. Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), whichever of the following is applicable:</font></div></div>
  <div style="margin-left:13.333%;text-indent:23.077%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:3.384217753008642%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">in the case of a Non-U.S. Lender claiming the benefits of an income tax treaty to which the United States is a party, (x) with respect to payments of interest under any Loan Document, executed copies of IRS Form W-8BEN or IRS Form W-8BEN-E establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the &#x201c;interest&#x201d; article of such tax treaty and (y) with respect to any other applicable payments under any Loan Document, IRS Form W-8BEN or IRS Form W-8BEN-E establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the &#x201c;business profits&#x201d; or &#x201c;other income&#x201d; article of such tax treaty;</font></div></div>
  <div style="margin-left:13.333%;text-indent:23.077%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:3.384217753008642%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">executed copies of IRS Form W-8ECI (or any successor form);</font></div></div>
  <div style="margin-left:13.333%;text-indent:23.077%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:3.384217753008642%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">in the case of a Non-U.S. Lender claiming the benefits of the exemption for portfolio interest under Section 871(h) or Section 881(c) of the Code, (x) a certificate substantially in the form of Exhibit G-1 to the effect that such Non-U.S. Lender is not a &#x201c;bank&#x201d; within the meaning of Section 881(c)(3)(A) of the Code, a &#x201c;10-percent shareholder&#x201d; of the Borrower within the meaning of Section 881(c)(3)(B) of the Code, a &#x201c;controlled foreign corporation&#x201d; related to Borrower as described in Section 881(c)(3)(C) of the Code (a &#x201c;U.S. Tax Compliance Certificate&#x201d;) and (y) executed copies of IRS Form W-8BEN or IRS Form W-8BEN-E, as applicable (or any successor form); or</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">19</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:13.333%;text-indent:23.077%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:3.384217753008642%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">to the extent a Non-U.S. Lender is not the beneficial owner, executed copies of IRS Form W-8IMY, accompanied by IRS Form W-8ECI, IRS Form W-8BEN, IRS Form W-8BEN-E, a certificate substantially in the form of Exhibit G-2 or Exhibit G-3, IRS Form W-9, and/or other certification documents from each beneficial owner, as applicable; provided that if the Non-U.S. Lender is a partnership and one or more direct or indirect partners of such Non-U.S. Lender are claiming the portfolio interest exemption, such Non-U.S. Lender may provide a certificate substantially in the form of Exhibit G-4 on behalf of each such direct and indirect partner;</font></div></div>
  <div style="margin-left:6.667%;text-indent:21.429%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:5.428947960528431%;">(C)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">any Non-U.S. Lender shall, to the extent it is legally entitled to do so, deliver to the Borrower or the Administrative Agent (in such number of copies as shall be reasonably requested by the recipient) on or prior to the date on which such Non-U.S. Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), executed copies of any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be prescribed by applicable law to permit the Borrower or the Administrative Agent to determine the withholding or deduction required to be made;</font></div></div>
  <div style="margin-left:6.667%;text-indent:21.429%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:5.428947960528431%;">(D)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">each Lender and the Administrative Agent shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to (i) comply with their obligations under FATCA and (ii) determine whether such Lender (or the Administrative Agent, as applicable) has complied with such Lender&#x2019;s (or the Administrative Agent&#x2019;s, as applicable) obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this clause (D), &#x201c;FATCA&#x201d; shall include any amendments made to FATCA after the date of this Agreement; and</font></div></div>
  <div style="margin-left:6.667%;text-indent:21.429%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:5.428947960528431%;">(E)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">the Administrative Agent, and any successor or supplemental Administrative Agent, shall deliver to the Borrower (in such number of copies as shall be requested by the recipient) on or prior to the date on which the Administrative Agent becomes the administrative agent hereunder or under any other Loan Document (and from time to time thereafter upon the reasonable request of the Borrower) executed copies of either (i) IRS Form W-9 (or any successor form) or (ii) a U.S. branch withholding certificate on IRS Form W-8IMY (or any successor form) evidencing its agreement with the Borrower to be treated as a U.S. Person (with respect to amounts received on account of any Lender) and IRS Form W-8ECI (with respect to amounts received on its own account), with the effect that, in either case, the Borrower will be entitled to make payments hereunder to the Administrative Agent without withholding or deduction on account of U.S. federal withholding Tax.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Each Lender and the Administrative Agent agrees that if any documentation it previously delivered expires or becomes obsolete or inaccurate in any respect, it shall promptly update and deliver such form or certification to the Borrower and the Administrative Agent or promptly notify the Borrower and the Administrative Agent in writing of its legal ineligibility to do so.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">For the avoidance of doubt, the term &#x201c;applicable law&#x201d; includes FATCA.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">The agreements and obligations of Borrower contained in this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.11</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> shall survive the termination of this Agreement, the resignation and/or replacement of the Administrative Agent, any assignment of rights by, or the replacement of, a Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all other Obligations.</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">20</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower and the Lenders hereby acknowledge and agree that, for U.S. federal income tax purposes, the issue price (within the meaning of Section 1273(b) of the Code) of the Loan will be determined pursuant to Section 1272 through 1275 of the Code and the Treasury Regulations thereunder, including Section 1.1273-2(h)(1) of the Treasury Regulations. Furthermore, within 30 days of the Closing Date (or such longer period of time as Administrative Agent may agree to in its sole discretion) Borrower and Administrative Agent shall mutually agree as to the fair market value of the property right represented by the Warrants with respect to the Loan. The parties hereto agree to report all income tax matters with respect to the Warrant consistent with the provisions of this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.11(j</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">) unless otherwise required due to a change in applicable law or pursuant to a &#x201c;determination&#x201d; within the meaning of Section 1313 of the Internal Revenue Code.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.12</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Apportionment of Payments</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. All payments of principal and interest in respect of outstanding Loans, all payments of fees and all other payments in respect of any other Obligations, shall be allocated by the Administrative Agent among such of the Lenders as are entitled thereto, in proportion to their respective Pro Rata Shares, or as otherwise provided herein.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.13</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Defaulting Lenders</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. Notwithstanding anything to the contrary contained in this Agreement, if any Lender becomes a Defaulting Lender, then, until such time as such Lender is no longer a Defaulting Lender, to the extent permitted by applicable law:</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Such Defaulting Lender&#x2019;s right to approve or disapprove any amendment, waiver or consent with respect to this Agreement shall be restricted as set forth in </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 5.10</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Administrative Agent shall not be obligated to transfer to such Defaulting Lender any payments made by Borrower to Administrative Agent for such Defaulting Lender&#x2019;s benefit, and, in the absence of such transfer to such Defaulting Lender, the Administrative Agent shall transfer any such payments to each other non-Defaulting Lender ratably in accordance with their Pro Rata Shares (without giving effect to the Pro Rata Shares of such Defaulting Lender) (but only to the extent that such Defaulting Lender&#x2019;s Loans were funded by the other Lenders).</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">The operation of this Section shall not be construed to increase or otherwise affect the Commitments of any Lender, to relieve or excuse the performance by such Defaulting Lender or any other Lender of its duties and obligations hereunder, or to relieve or excuse the performance by the Borrower of its duties and obligations hereunder to Administrative Agent or to the Lenders other than such Defaulting Lender.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">2.14</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Post-Closing Conditions</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Notwithstanding any provision herein or in any other Loan Document to the contrary, Borrower shall (i) within one (1) Business Day of the Closing Date (or such later date as Administrative Agent may agree to in its sole discretion) deliver to Administrative Agent a fully executed Account Control Agreement in respect of each of Borrower&#x2019;s Deposit Accounts and Securities Accounts at Silicon Valley Bank, a division of First-Citizens Bank &amp; Trust Company (other than for any Excluded Account and (ii) within five (5) Business Days of the Closing Date (or such later date as Administrative Agent may agree to in its sole discretion) deliver to Administrative Agent a fully executed Account Control Agreement in respect of each of Borrower&#x2019;s Deposit Accounts and Securities Accounts at JPMorgan (other than for any Excluded Account. </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.533%;">Article 3</font><div style="width:100%;display:inline;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;"><br><br><br>CREATION OF SECURITY INTEREST; COLLATERAL</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">3.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Grant of Security Interests</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Borrower grants to Administrative Agent, for the benefit of the Lenders, a valid, continuing security interest in all presently existing and hereafter acquired or arising </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">21</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:1.731%;text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Collateral in order to secure prompt, full and complete payment of any and all Obligations and in order to secure prompt, full and complete performance by Borrower of each of its covenants and duties under each of the Loan Documents. The &#x201c;Collateral&#x201d; shall mean and include all right, title, interest, claims and demands of Borrower in the following:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">All goods (and embedded computer programs and supporting information included within the definition of &#x201c;goods&#x201d; under the UCC) and equipment now owned or hereafter acquired, including all laboratory equipment, computer equipment, office equipment, machinery, fixtures, vehicles (including motor vehicles and trailers), and other equipment and any interest in any of the foregoing, and all attachments, accessories, accessions, replacements, substitutions, additions, and improvements to any of the foregoing, wherever located;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">All inventory now owned or hereafter acquired, including all merchandise, raw materials, parts, supplies, packing and shipping materials, work in process and finished products including such inventory as is temporarily out of Borrower&#x2019;s custody or possession or in transit and including any returns upon any accounts or other proceeds, including insurance proceeds, resulting from the sale or disposition of any of the foregoing and any documents of title representing any of the above, and Borrower&#x2019;s books relating to any of the foregoing;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">All contract rights and general intangibles (including Intellectual Property), now owned or hereafter acquired, including goodwill, license agreements, franchise agreements, blueprints, drawings, purchase orders, customer lists, route lists, infringements, claims, software, computer programs, computer disks, computer tapes, literature, reports, catalogs, design rights, income tax refunds, payment intangibles, commercial tort claims, payments of insurance and rights to payment of any kind;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">All now existing and hereafter arising accounts, contract rights, royalties, license rights, license fees and all other forms of obligations owing to Borrower arising out of the sale or lease of goods, the licensing of technology or the rendering of services by Borrower (subject, in each case, to the contractual rights of third parties to require funds received by Borrower to be expended in a particular manner), whether or not earned by performance, and any and all credit insurance, guaranties, and other security therefor, as well as all merchandise returned to or reclaimed by Borrower and Borrower&#x2019;s books relating to any of the foregoing;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">All documents, cash, Deposit Accounts, letters of credit and letters of credit rights (whether or not the letter of credit is evidenced by a writing) and other supporting obligations, certificates of deposit, instruments, promissory notes, chattel paper (whether tangible or electronic) and investment property, including all securities, whether certificated or uncertificated, security entitlements, Securities Accounts, commodity contracts and commodity accounts, and all financial assets held in any Securities Account or otherwise, wherever located, now owned or hereafter acquired and Borrower&#x2019;s books relating to the foregoing; and</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">To the extent not covered by clauses (a) through (e), all other personal property of the Borrower, whether tangible or intangible, and any and all rights and interests in any of the above and the foregoing and, any and all claims, rights and interests in any of the above and all substitutions for, additions and accessions to and proceeds thereof, including insurance, condemnation, requisition or similar payments and proceeds of the sale or licensing of Intellectual Property and all of Borrower&#x2019;s books and records related to any items of other Collateral.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Notwithstanding the foregoing, or anything to the contrary herein, the Collateral does not include (i) any Excluded Account, (ii) the assets to be sold in connection with the Brady Equipment Sale, (iii) &#x201c;intent-to-use&#x201d; trademarks at all times prior to the first use thereof, whether by the actual use thereof in commerce, the recording of a statement of use with the United States Patent and Trademark Office or otherwise, but only to the extent and solely during such period that granting a security interest in the &#x201c;intent-to-use&#x201d; trademarks would be contrary to applicable law or may interfere with Borrower&#x2019;s rights to obtain and maintain such trademarks; provided that after such period, Borrower acknowledges that such interest in such trademark application or trademark shall be subject to a security interest in favor of Administrative</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">22</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Agent and shall be included in the Collateral, (iv) (x) rights of Borrower held under a license that are not assignable by their terms without the consent of the licensor thereof (but only to the extent such restriction on assignment is enforceable under applicable law), and (y) any interest of Borrower as a lessee or sublessee under a real property lease or an Equipment lease if Borrower is prohibited by the terms of such lease from granting a security interest in such lease or under which such an assignment or Lien would cause a default to occur  under such lease (but only to the extent that such prohibition is enforceable under all applicable laws including, without limitation, the UCC); provided, however, that upon termination of such prohibition, such interest shall immediately become Collateral without any action by Borrower or Administrative Agent; provided, in each case, that no asset or property shall be excluded from the Collateral to the extent the restriction described in the foregoing clauses (x) and (y) would be rendered ineffective pursuant to Section 9-406, 9-407, 9-408 or 9-409 of the UCC or any other applicable law or principles of equity, or to the extent that any necessary consents or waivers have been obtained to allow the security interest in such asset or property notwithstanding such restriction, (v) leased equipment or equipment financed (and related software) by indebtedness with a third party (and any accessions, attachments, replacements or improvements thereon) and specifically identifiable sale proceeds thereof (but only in the amount of the lien secured thereby) that is subject to a lien that is permitted pursuant to the definition of &#x201c;Permitted Liens&#x201d;, provided, that (a) the foregoing exclusion shall apply only to the extent the applicable documents relating to such financing prohibits the granting of a security interest in favor of Administrative Agent and (b) upon the release of any such lien, such equipment (and any accessions, attachments, replacements or improvements thereon), software and specifically identifiable sale proceeds shall automatically be deemed to be Collateral hereunder and shall be subject to the security interest granted herein and (vi) with respect to stock in foreign Subsidiaries and so long as Borrower identifies to Administrative Agent a present and existing adverse tax consequence as a direct result of a grant of more than sixty-five percent (65.0%), more than sixty-five percent (65.0%) of the presently existing and hereafter arising issued and outstanding shares of capital stock owned by Borrower of any foreign Subsidiary which shares entitle the holder thereof to vote for directors or any other matter.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">3.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">After-Acquired Property</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  If Borrower shall at any time acquire a commercial tort claim with a value in excess of $500,000, as defined in the UCC, Borrower shall promptly notify Administrative Agent in writing signed by Borrower of the brief details thereof and grant to Administrative Agent in such writing a security interest therein and in the proceeds thereof, all upon the terms of this Agreement, with such writing to be in form and substance reasonably satisfactory to Administrative Agent.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">3.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Location and Possession of Collateral</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  The Collateral is and shall remain in the possession of Borrower or its bailee at its location as set forth in the Perfection Certificate (the &#x201c;Permitted Locations&#x201d;) or any other location as long as Borrower provides Administrative Agent with notice of such new location within 10 days of entry into such location and, in the event that the Collateral at any new location is valued in excess of Two Hundred Thousand Dollars ($200,000.00) in the aggregate, at Administrative Agent&#x2019;s election, Borrower shall use commercially reasonable efforts to cause such bailee or landlord, as applicable, to execute and deliver a bailee waiver or landlord waiver, as applicable, in form and substance reasonably satisfactory to Administrative Agent.  Borrower shall remain in full possession, enjoyment and control of the Collateral (except only as may be otherwise required by Administrative Agent for perfection of the security interests therein created hereunder) and so long as no Event of Default has occurred and is continuing, shall be entitled to manage, operate and use the same and each part thereof with the rights and franchises appertaining thereto; </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> that the possession, enjoyment, control and use of the Collateral shall at all times be subject to the observance and performance of the terms of this Agreement.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">3.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Delivery of Additional Documentation Required</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Borrower shall from time to time execute and deliver to Administrative Agent, at the request of Administrative Agent, all financing statements and other documents Administrative Agent may reasonably request, in form satisfactory to Administrative Agent, to perfect and continue Lender&#x2019;s perfected security interests in the Collateral and in order to consummate fully all of the transactions contemplated under the Loan Documents.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">3.5</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Right to Inspect</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Administrative Agent (through any of its officers, employees, or agents) shall have the right, upon reasonable prior notice, from time to time during Borrower&#x2019;s usual business hours, to inspect the books and records of Borrower and Subsidiaries and to make copies thereof and to </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">23</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:1.731%;text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">inspect, test, and appraise the Collateral in order to verify Borrower&#x2019;s financial condition or the amount, condition of, or any other matter relating to, the Collateral up to once per year (unless an Event of Default has occurred and is continuing, in which case such inspections and appraisals are in Lender&#x2019;s discretion).</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">3.6</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Intellectual Property</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Borrower shall notify Administrative Agent before the federal registration or filing by Borrower of any copyright or copyright application and shall promptly execute and deliver to Lender any grants of security interests in same, in form acceptable to Administrative Agent, to file with the United States Copyright Office.  In addition, Borrower shall deliver to Administrative Agent within 30 days after the end of each calendar quarter, a report (each, a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Patent and Trademark Report</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;) reflecting (i) the patents, patent applications, trademarks and trademark applications that were registered or filed by Borrower during such quarter and (ii) Intellectual Property that Borrower deems &#x201c;immaterial&#x201d; to its business, if any, and shall promptly execute and deliver to Administrative Agent, on behalf of the Lenders, any grants of security interests in same, in form reasonably acceptable to Administrative Agent, to file with the United States Patent and Trademark Office.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">3.7</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Protection of Intellectual Property</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  With respect to Intellectual Property that is material to the Borrower&#x2019;s business, Borrower shall and shall cause its Subsidiaries to: </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">protect, defend and maintain the validity and enforceability of its Intellectual Property and promptly advise Administrative Agent in writing of material infringements;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">not allow any Intellectual Property material to Borrower&#x2019;s or its Subsidiaries business to be abandoned, forfeited or dedicated to the public without Administrative Agent&#x2019;s written consent;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">provide written notice to the Administrative Agent within ten (10) days of entering or becoming bound by any Restricted License (other than over-the-counter software that is commercially available to the public); and</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">take such commercially reasonable steps as  Administrative Agent requests to obtain the consent of, or waiver by, any person whose consent or waiver is necessary for (i) any Restricted License to be deemed &#x201c;Collateral&#x201d; and for Administrative Agent to have a security interest in it that might otherwise be restricted or prohibited by law or by the terms of any such Restricted License, whether now existing or entered into in the future, and (ii) Administrative Agent to have the ability in the event of a liquidation of any Collateral to dispose of such Collateral in accordance with the Administrative Agent&#x2019;s rights and remedies under this Agreement and the other Loan Documents.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">   [***]</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.533%;">Article 4</font><div style="width:100%;display:inline;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;"><br><br>REPRESENTATIONS, WARRANTIES AND COVENANTS</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">4.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Representations and Warranties</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Borrower hereby warrants, represents and covenants that:</font></p>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower and each Subsidiary is duly organized, validly existing and in good standing under the laws of the state set forth in the Perfection Certificate.  Borrower and each Subsidiary is duly qualified to do business and is in good standing in every other jurisdiction where the nature of its business requires it to be qualified, except where failure to be so qualified would not result in a Material Adverse Change, and is not subject to any bankruptcy, insolvency or other similar proceedings.  Borrower&#x2019;s and each Subsidiary&#x2019;s chief executive office, principal place of business and the place where Borrower maintains its records concerning the Collateral are located at the addresses set forth in the Perfection Certificate. The Collateral is presently located at the address set forth on the Perfection Certificate or as otherwise agreed by Administrative Agent pursuant to </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 3.3</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">;</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">24</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower and each Subsidiary has full power, authority and legal right to execute, deliver and perform each Loan Document to which it is a party, and the execution, delivery and performance hereof and thereof have been duly authorized by all necessary action;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Each Loan Document has been duly executed and delivered by Borrower and each constitutes a legal, valid and binding obligation of Borrower and each Subsidiary party thereto, enforceable in accordance with its terms, except as enforceability may be limited by bankruptcy, insolvency or other laws affecting enforcement of creditors&#x2019; rights generally and general equitable principles;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">The execution, delivery and performance of the Loan Documents (i) are not in contravention of any material agreement or indenture by which Borrower or any Subsidiary is bound, or by which its properties may be affected, (ii) do not require any shareholder approval, or any approval or consent of, or filing or registration with, any governmental body or regulatory authority or agency (other than the filing of UCC financing statements and filings with the United States Patent and Trademark Office and United States Copyright Office, in connection with the registration of the security interest granted hereunder), or any approval or consent of any trustees or holders of any of its indebtedness or obligations, unless such approval or consent has been obtained and (iii) do not contravene any material law, regulation, judgment or decree applicable to it or its Operating Documents;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower is not a &#x201c;bank holding company&#x201d; or a direct or indirect subsidiary of a &#x201c;bank holding company&#x201d; as defined in the Bank Holding Company Act of 1956, as amend, and Regulation Y thereunder of the Board of Governors of the Federal Reserve System.  Borrower is not an &#x201c;investment company&#x201d; or a company controlled by an &#x201c;investment company&#x201d; under the Investment Company Act of 1940.  Borrower is not engaged in the business of extending credit for the purpose of purchasing or carrying margin stock (as defined in Regulation U of the Board of Governors of the Federal Reserve System) and no proceeds of any Loan will be used to purchase or carry margin stock or to extend credit to others for the purpose of purchasing or carrying any margin stock;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">To Borrower&#x2019;s Knowledge, Borrower and each Subsidiary is in compliance with all requirements of law and orders, rules or regulations of any regulatory authority except to the extent that failure to be in compliance would not reasonably be expected to cause a Material Adverse Change, and no such requirement applicable to Borrower or any Subsidiary or any item of Collateral could reasonably be expected to cause a Material Adverse Change;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower is the owner and holder of all right, title and interest in and to the Collateral (other than the right, title and interests granted under the Permitted Liens), and Borrower has not assigned or pledged and hereby covenants that it will not assign or pledge, so long as this Agreement shall remain in effect, the whole or any part of the rights in the Collateral hereby and thereby assigned, to anyone other than Administrative Agent, its designee, its successors or assigns, other than Permitted Liens;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower has good and marketable title to the Collateral, and the Collateral is free and clear of all Liens, claims and encumbrances, other than Permitted Liens;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower has delivered to Administrative Agent copies of the most recent annual reviewed financial statements and most recent monthly and quarterly unaudited financial statements required to be delivered pursuant to </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 4.2(f)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> hereof, or as may hereafter be delivered in connection with the Loans (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Financial Statements</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;). Since the date of the last Financial Statement provided to Lender, no event has occurred which would have a Material Adverse Change on Borrower or any Subsidiary.  The Financial Statements are true and correct and fairly present in all material respects the financial condition of Borrower and its Subsidiaries;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No default or event of default has occurred and is continuing under or with respect to any contractual obligation, loan or indenture of Borrower or any Subsidiary in which the default could reasonably be expected to result in a Material Adverse Change;</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">25</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(k)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Other than customary prosecution proceedings before the USPTO and customary licensing application proceedings with federal and state regulatory authorities, no action, suit, litigation, or proceeding of or before any arbitrator or governmental or regulatory authority is pending or, to the Knowledge of Borrower threatened, by or against Borrower or against any of its property or assets which could reasonably be expected to result in a Material Adverse Change;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(l)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">To Borrower&#x2019;s Knowledge, no facilities or properties leased or operated by Borrower contains any &#x201c;hazardous materials&#x201d; in amount or concentrations that could constitute a violation of any federal, state or local law, rule, regulation, order or permit (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Environmental Laws</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;).  Borrower has not received notice of any suspected or actual violations of any material Environmental Laws and Borrower&#x2019;s business has been operated in conformity with all Environmental Laws in all material respects;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(m)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower has no Subsidiaries other than those listed on the Perfection Certificate. Neither Borrower nor any Subsidiary has done business in the past 5 years under any name other than that specified on the Perfection Certificate;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(n)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">To the best of Borrower&#x2019;s Knowledge, as of the date hereof and at all times throughout the term of this Agreement, including after giving effect to any transfers of interests permitted pursuant to the Loan Documents, (1) none of the funds or other assets of Borrower, any of their Affiliates constitute (or will constitute) property of, or are (or will be) beneficially owned, directly or indirectly, by any Blocked Person; (2) no Blocked Person has (or will have) any interest of any nature whatsoever in Borrower, in their Affiliates, with the result that the investment in the respective party (whether directly or indirectly), is prohibited by applicable law or the Loans are in violation of applicable law; and (3) none of the funds of Borrower, or of their Affiliates have been (or will be) derived from any unlawful activity with the result that the investment in the respective party (whether directly or indirectly), is prohibited by applicable law or the Loans are in violation of applicable law;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(o)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">To Borrower&#x2019;s Knowledge, the Property of Borrower and the Collateral are insured with financially sound and reputable insurance companies in such amounts, with such deductibles and covering such risks as are customarily carried by companies engaged in similar businesses and owning similar properties in localities where the Borrower operates;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(p)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">To Borrower&#x2019;s Knowledge, Borrower owns, or is licensed to use, all Intellectual Property necessary for the conduct of its business as currently conducted or proposed to be conducted.  No material claim has been asserted and is pending by any other person or entity challenging the use, validity or effectiveness of any Intellectual Property, nor does the Borrower have Knowledge of any basis for any such claim;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(q)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower and each Subsidiary has filed all federal, state and other tax returns that are required to be filed and has paid all taxes shown thereon to be due, together with applicable interest and penalties, and all other taxes, fees or other charges imposed on it or any of its property by any governmental or regulatory authority except (a) to the extent such taxes, fees and/or other charges are being contested in good faith by appropriate proceedings promptly instituted and diligently conducted, so long as such reserve or other appropriate provision, if any, as shall be required in conformity with GAAP shall have been made therefor, or (b) if such taxes, assessments, deposits and contributions do not, individually or in the aggregate, exceed $250,000 at any time.  No tax Liens have been filed, and, to the Knowledge of Borrower, no claim is being asserted, with respect to any such tax, fee or other charge other than Permitted Liens. Neither Borrower nor any Subsidiary is a party to any tax sharing agreement;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(r)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">This Agreement creates in favor of Administrative Agent, for the benefit of the Lenders, a legal, valid and continuing and enforceable security interest in the Collateral, the enforceability of which is subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditor&#x2019;s rights generally and subject to general principles of equity.  To the Knowledge of Borrower, upon Administrative Agent filing UCC-1 financing statements with the central filing location in the state of Borrower&#x2019;s formation or incorporation and/or the obtaining of &#x201c;control&#x201d; (as defined under the UCC) through </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">26</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">an Account Control Agreement or otherwise, Administrative Agent, for the benefit of the Lenders, will have a perfected first priority Lien on and security interest in the Collateral subject to Permitted Liens;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(s)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower and its Subsidiaries, on a consolidated basis are, and after giving effect to the incurrence of the debt evidenced by this Agreement and all obligations hereunder will be, Solvent; </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(t)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(i) The Perfection Certificate lists all of Borrower&#x2019;s and each Subsidiary&#x2019;s patents and pending applications, registered trademarks and pending applications, registered domain names, registered copyrights and pending applications and material Intellectual Property licenses owned by Borrower and each Subsidiary; (ii) all of Borrower&#x2019;s and each Subsidiary&#x2019;s Intellectual Property that is material to its business is valid, subsisting, unexpired and enforceable and has not been abandoned; (iii) except as described on the Perfection Certificate and except for Permitted Liens, Borrower and each Subsidiary is the exclusive owner of all right, title and interest in and to, or has the right to use, all of such Borrower&#x2019;s or Subsidiary&#x2019;s Intellectual Property that is material to its business; (iv) consummation and performance of this Agreement will not result in the invalidity, unenforceability or impairment of any of Borrower&#x2019;s or any Subsidiary&#x2019;s Intellectual Property that is material to its business, or in default or termination of any material Intellectual Property license of Borrower or any Subsidiary; (v) except as described on the Perfection Certificate or in connection with customary prosecution proceedings before the USPTO, there are no outstanding holdings, decisions, consents, settlements, decrees, orders, injunctions, rulings or judgments that would limit, cancel or question the validity or enforceability of any of Borrower&#x2019;s or any Subsidiary&#x2019;s Intellectual Property that is material to its business or Borrower&#x2019;s or such Subsidiary&#x2019;s rights therein or use thereof; (vi) to Borrower&#x2019;s Knowledge, except as described on the Perfection Certificate, the operation of Borrower&#x2019;s and each Subsidiary&#x2019;s business and Borrower&#x2019;s or such Subsidiary&#x2019;s use of Intellectual Property material to its business in connection therewith, does not infringe or misappropriate the intellectual property rights of any other person or entity; (vii) except as described in the Perfection Certificate or in connection with customary prosecution proceedings before the USPTO, no action or proceeding is pending or, to Borrower&#x2019;s Knowledge, threatened (1) seeking to limit, cancel or question the validity of any of Borrower&#x2019;s or any Subsidiary&#x2019;s Intellectual Property, (2) which, if adversely determined, could be reasonably expected to cause a Material Adverse Change on the value of any such Intellectual Property or (3) alleging that any such Intellectual Property, or Borrower&#x2019;s or such Subsidiary&#x2019;s use thereof in the operation of its business, infringes or misappropriates the intellectual property rights of any person or entity and (viii) to Borrower&#x2019;s Knowledge, there has been no Material Adverse Change on Borrower&#x2019;s or any Subsidiary&#x2019;s rights in its material trade secrets as a result of any unauthorized use, disclosure or appropriation by or to any person, including Borrower&#x2019;s and each Subsidiary&#x2019;s current and former employees, contractors and agents; and</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(u)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No statement or information contained in this Agreement or any document or certificate executed or delivered, or hereafter delivered, in connection with this Agreement or the Loans contains or will contain any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained herein or therein not misleading (it being recognized by Lender that projections and forecasts provided by Borrower in good faith and based upon reasonable assumptions are not to be viewed as facts and that actual results during the period or periods covered by any such projections and forecasts may differ from the projected or forecasted results).</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">4.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Affirmative Covenants of Borrower</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Borrower shall, and shall cause each of its Subsidiaries to, do all of the following, so long as any of the Loan Documents remain outstanding:</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">maintain its corporate existence and its good standing in its jurisdiction of incorporation and maintain qualification in each jurisdiction in which the failure to so qualify could reasonably be expected to cause a Material Adverse Change;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">maintain in force all licenses, approvals, agreements and Governmental Approvals, the loss of which could reasonably be expected to cause a Material Adverse Change;</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">27</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">comply with all statutes, laws, ordinances and government rules and regulations to which it is subject, noncompliance with which could reasonably be expected to cause a Material Adverse Change;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">if required by applicable law, pay and discharge or cause to be paid and discharged, all sales, use, rental and personal property or similar taxes and fees (excluding any taxes on any Lender&#x2019;s net income) which arise and are due prior to each Advance in connection with the Collateral except (a) to the extent such taxes are being contested in good faith by appropriate proceedings promptly instituted and diligently conducted, so long as such reserve or other appropriate provision, if any, as shall be required in conformity with GAAP shall have been made therefor, or (b) if such taxes, assessments, deposits and contributions do not, individually or in the aggregate, exceed $250,000 at any time;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">assist Administrative Agent in obtaining and filing UCC-1 financing statements against the Collateral and Account Control Agreements to the extent that Administrative Agent deems such action necessary or desirable;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">deliver the following to Administrative Agent: </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">as soon as available, but no later than thirty (30) days after the last day of each month:</font></div></div>
  <div style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.667%;">(A)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">copies of Borrower&#x2019;s bank statements on all Deposit Accounts</font></div></div>
  <div style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.667%;">(B)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">copies of any material Governmental Approvals obtained by Borrower or any of its Subsidiaries;</font></div></div>
  <div style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.667%;">(C)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">written notice of the commencement of, and any material development in, the proceedings contemplated by </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 4.2(i)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> hereof;</font></div></div>
  <div style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.667%;">(D)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">a duly completed Compliance Certificate signed by a Responsible Officer of Borrower, certifying that as of the end of such month Borrower was in full compliance with all of the terms and conditions of this Agreement;</font></div></div>
  <div style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.667%;">(E)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">written notice of any litigation or governmental proceedings pending or threatened (in writing) against Borrower or any of its Subsidiaries, which could reasonably be expected to result in damages or costs to Borrower or any of its Subsidiaries in excess of One Million Dollars ($1,000,000.00); and</font></div></div>
  <div style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.667%;">(F)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">written notice of all returns, recoveries, disputes and claims regarding Inventory that involve more than One Million Dollars ($1,000,000.00) individually or in the aggregate in any calendar year;</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">within forty five (45) days after the end of each fiscal quarter:</font></div></div>
  <div style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.667%;">(A)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">unaudited financial statements pertaining to the results of operations for the month then ended covering the consolidated operations of Borrower and its Subsidiaries for such month and certified as true and correct by a Responsible Officer of Borrower, consisting of a consolidated balance sheet, income statement and cash flow statement, prepared in accordance with GAAP applied on a consistent basis subject to normal year end audit adjustments and the absence of footnotes; </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> that to the extent the foregoing documents are included in materials otherwise filed with the Securities and Exchange Commission, such documents shall be deemed to have been delivered on the date on which Borrower posts such documents, or provides a link thereto, on Borrower&#x2019;s website;</font></div></div>
  <div style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.667%;">(B)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">any updates to Sections 4 (Encumbrances and Liens) and 13 (Indebtedness) of the Perfection Certificate to reflect amendments, modifications and updates to these sections to the </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">28</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">extent such amendments, modifications and updates are permitted by one or more specific provisions in the Agreement;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></div></div>
  <div style="text-indent:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:20%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.667%;">(C)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">together with the quarterly financial reports, reports as to the following, in a form acceptable to Administrative Agent: accounts receivable, accounts payable aging, and primary key performance indicators, in each case, in form and substance satisfactory to Administrative Agent; </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> that to the extent the foregoing documents are included in materials otherwise filed with the Securities and Exchange Commission, such documents shall be deemed to have been delivered on the date on which Borrower posts such documents, or provides a link thereto, on Borrower&#x2019;s website;</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">within one hundred eighty (180) days following the end of each fiscal year, a copy of Borrower&#x2019;s annual, audited financial statements consisting of a consolidated balance sheet, income statement and cash flow statement prepared in conformity with GAAP applied on a basis consistent with that of the preceding fiscal year and presenting fairly Borrower&#x2019;s financial condition as at the end of that fiscal year and the results of its operations for the twelve (12) month period then ended and certified as true and correct by Borrower&#x2019;s chief financial officer, together with an unqualified opinion (other than a qualification as to a going concern typical for venture backed companies similar to Borrower)  on the financial statements from an independent certified public accounting firm acceptable to Administrative Agent in its reasonable discretion; provided that Borrower&#x2019;s certified public accounting firm as of the Closing Date, and any such firm of national recognized standing, is acceptable to Administrative Agent; provided further that to the extent the foregoing documents are included in materials otherwise filed with the Securities and Exchange Commission, such documents shall be deemed to have been delivered on the date on which Borrower posts such documents, or provides a link thereto, on Borrower&#x2019;s website;</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">within thirty (30) days of the effective date or filing date thereof, a copy of any amendment to Borrower&#x2019;s Operating Documents; provided that to the extent the foregoing documents are included in materials otherwise filed with the Securities and Exchange Commission, such documents shall be deemed to have been delivered on the date on which Borrower posts such documents, or provides a link thereto, on Borrower&#x2019;s website; </font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(v)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">as requested by Administrative Agent, have Borrower&#x2019;s chief financial or chief operating officer participate in quarterly management update calls with Administrative Agent to discuss such information about the operations and financial condition of the business of the Borrower as Administrative Agent shall reasonably inquire into, at such times reasonably scheduled by Administrative Agent; and</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(vi)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">deliver such other financial information as Administrative Agent shall reasonably request from time-to-time.</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">deliver to Administrative Agent within ten (10) days after approval by the Borrower&#x2019;s board of directors, and in any event no later than within sixty (60) days after the end of each fiscal year of Borrower, annual operating budgets and financial projections approved by the Borrower&#x2019;s board of directors, in a form acceptable to Administrative Agent;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">deliver to Administrative Agent, promptly as they are available and in any event: (i) at the time of filing of Borrower&#x2019;s Form 10&#x2011;K with the Securities and Exchange Commission after the end of each fiscal year of Borrower, the financial statements of Borrower filed with such Form 10&#x2011;K; and (ii) at the time of filing of Borrower&#x2019;s Form 10&#x2011;Q with the Securities and Exchange Commission after the end of each of the first three fiscal quarters of Borrower, the consolidated financial statements of Borrower filed with such Form 10&#x2011;Q; </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> that to the extent the foregoing documents are included in materials otherwise filed with the Securities and Exchange Commission, such documents shall be deemed to have been delivered on the date on which Borrower posts such documents, or provides a link thereto, on Borrower&#x2019;s website;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">deliver to Administrative Agent (A) promptly upon becoming available, copies of all statements, reports and notices sent or made available generally by Borrower to its security holders and (B) immediately upon receipt of written notice thereof, a report of any material legal actions pending or </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">29</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">threatened against Borrower or any of its Subsidiaries or the commencement of any action, proceeding or governmental investigation involving Borrower or any of its Subsidiaries is commenced that is reasonably expected to result in damages or costs to Borrower or any of its Subsidiaries in excess of One Million Dollars ($1,000,000.00); </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> that to the extent the foregoing documents are included in materials otherwise filed with the Securities and Exchange Commission, such documents shall be deemed to have been delivered on the date on which Borrower posts such documents, or provides a link thereto, on Borrower&#x2019;s website;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">deliver the following to Administrative Agent: (i) as of the date of each Compliance Certificate, a list of all Intellectual Property owned or licensed to Borrower and a list of items within the definition of Collateral hereunder since the date of the last Compliance Certificate in such form as reasonably required by Administrative Agent; (ii) promptly after the same are sent by Administrative Agent, copies of any statements, reports, or correspondence required to be delivered to any other Lender; (iii) promptly upon receipt of the same, copies of all notices, requests and other documents received by any other party pursuant any other material contract, instrument, indenture regarding or relating to any breach or default alleged by or against any party thereto or any other event that could materially impair the value of the interests or rights of Administrative Agent or any Lender or could otherwise be reasonably expected to cause a Material Adverse Change; and (iv) such other information respecting the business, condition (financial or otherwise), operations, performance, properties or prospects of Borrower as Administrative Agent may from time to time reasonably request;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(k)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">make due and timely payment or deposit of all federal, state, and local taxes, assessments, or contributions required of it by law or imposed upon any Property belonging to it, and will execute and deliver to Administrative Agent, on demand, appropriate certificates attesting to the payment or deposit thereof; and Borrower will make timely payment or deposit of all tax payments and withholding taxes required of it by applicable laws, including those laws concerning F.I.C.A., F.U.T.A., state disability, and local, state, and federal income taxes, and will, upon request, furnish Administrative Agent with proof satisfactory to Administrative Agent indicating that Borrower and each Subsidiary has made such payments or deposits; </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> that Borrower need not make any payment if the amount or validity of such payment is contested in good faith by appropriate proceedings which suspend the collection thereof  (provided that such proceedings do not involve any substantial danger of the sale, forfeiture or loss of any material item of Collateral or Collateral which in the aggregate is material to Borrower and that Borrower has adequately bonded such amounts or reserves sufficient to discharge such amounts have been provided on the books of Borrower); provided further that Borrower shall not change its respective jurisdiction of residence for taxation purposes, without the prior written consent of Administrative Agent or if such contested taxes, assessments, deposits and contributions do not, individually or in the aggregate, exceed $250,000 at any time;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(l)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">make or cause to be made all filings in respect of, and pay or cause to be paid when due, all taxes, assessments, fines, fees and other liabilities (including all taxes and other claims in respect of the Collateral) unless being contested in good faith and for which Borrower maintains adequate reserves or if such contested taxes, assessments, deposits and contributions do not, individually or in the aggregate, exceed $250,000 at any time;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(m)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">perform all of Borrower&#x2019;s and each Subsidiary&#x2019;s obligations imposed by applicable law, rule or regulation in all material respects with respect to the Collateral;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(n)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">as soon as possible, and in any event within two (2) Business Days after Borrower having obtained Knowledge of the occurrence of any Event of Default or Potential Event of Default, provide a written notice setting forth the details of such Event of Default or Potential Event of Default and the action, if any is permitted, which is proposed to be taken by Borrower with respect thereto;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(o)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">as soon as possible, and in any event, no later than three (3) Business Days after receipt, provide Administrative Agent with a copy of any notice of default, notice of termination or similar notice pertaining to a lease of real property where any Collateral is located with a value in excess of $200,000;</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">30</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(p)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">from time to time execute and deliver such further documents and do such further acts and things as Administrative Agent may reasonably request in order to fully effect the purposes of this Agreement and to protect Administrative Agent&#x2019;s security interest in the Collateral, and Borrower hereby authorizes Administrative Agent to execute and deliver on behalf of Borrower and to file such financing statements (including an indication that the financing statement covers &#x201c;all assets or all personal property&#x201d; of Borrower in accordance with Section 9-504 of the UCC), collateral assignments, notices, control agreements, security agreements and other documents without the signature of Borrower either in Administrative Agent&#x2019;s name or in the name of Administrative Agent as agent and attorney-in-fact for Borrower;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(q)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">keep Borrower&#x2019;s and its Subsidiaries&#x2019; business and the Collateral insured for risks and in amounts standard for companies in Borrower&#x2019;s and its Subsidiaries&#x2019; industry and location and as Administrative Agent may reasonably request, including, but not limited to, D&amp;O insurance reasonably satisfactory to Administrative Agent.  Insurance policies shall be in a form, with companies, and in amounts that are reasonably satisfactory to Administrative Agent.  All property policies shall have a lender&#x2019;s loss payable endorsement showing Administrative Agent as lender loss payee and waive subrogation against Administrative Agent, and all liability policies shall show, or have endorsements showing Administrative Agent, as additional insured.  Administrative Agent shall be named as lender loss payee and/or additional insured with respect to any such insurance providing coverage in respect of any Collateral, and each provider of any such insurance shall agree, by endorsement upon the policy or policies issued by it or by independent instruments furnished to Administrative Agent, that it will give Administrative Agent thirty (30) days prior written notice before any such policy or policies shall be materially altered by a decrease in coverage or exclusion to coverage or canceled (other than cancellation for non-payment of premiums, for which ten (10) days&#x2019; prior written notice shall be required).  At Administrative Agent&#x2019;s request, Borrower shall deliver certified copies of policies and evidence of all premium payments.  Proceeds payable under any policy shall, at Administrative Agent&#x2019;s option, be payable to Administrative Agent, on account of the Obligations.  If Borrower or any of its Subsidiaries fails to obtain insurance as required under this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 4.2(q)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> or to pay any amount or furnish any required proof of payment to third persons, Administrative Agent may make (but has no obligation to do so), at Borrower&#x2019;s expense, all or part of such payment or obtain such insurance policies required in this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 4.2(q)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, and take any action under the policies Administrative Agent deems prudent;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(r)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">during all times any amounts remain due from Borrower to Administrative Agent or Lenders under this Agreement or Borrower has any Obligations under the Loan Documents, (i) preserve, renew and maintain in full force and effect its corporate existence and take all commercially reasonable action to maintain all rights, privileges and franchises necessary or desirable in the normal course of business; (ii) perform and observe all the terms and provisions of any material contract, instrument, or indenture to be performed or observed by it, maintain each such contract, instrument, or indenture in full force and effect, and enforce such rights under any material contract instrument, or indenture, unless the failure to do so could not be reasonably expected to cause a Material Adverse Change; (iii) keep proper books and records and accounts in which in all material respects full, true and correct entries in conformity with GAAP and all requirements of any governmental or regulatory authorities shall be made of all dealings and transactions and assets in relations to its business and activities; and (iv) permit Administrative Agent to visit and inspect any of its assets and properties and examine and make abstracts from any of its books and records at any time with or without prior written notice and as often as may be reasonably desired at any time during an Event of Default or upon prior written notice at reasonable times when no Event of Default is continuing up to two (2) times per year, and to discuss its business operations, properties and financial and other conditions with its officers and employees and accountants; </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(s)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">make available to the Administrative Agent, without expense to the Administrative Agent, Borrower and each of Borrower&#x2019;s officers, employees and agents and Borrower&#x2019;s books, to the extent that the Administrative Agent may reasonably deem them necessary to prosecute or defend any third party suit or proceeding instituted by or against the Administrative Agent or any Lender with respect to any Collateral or relating to Borrower; </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">31</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(t)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">If, after the Closing Date, any Borrower intends to form any direct or indirect Subsidiary, or acquire any direct or indirect Subsidiary, the Borrower shall (or shall cause such Borrower to): (i) ten (10) Business Days prior to such formation or acquisition, provide written notice to Administrative Agent of the formation of such Subsidiary, and, upon Administrative Agent&#x2019;s request, copies of the Operating Documents of such Subsidiary, and (ii) promptly upon Administrative Agent&#x2019;s request, and in any event within thirty (30) days of such request (or such later date as Administrative Agent may agree in its sole discretion) of such formation or creation: (A) take all such action as may be reasonably required by Administrative Agent to cause such new Subsidiary to either: (x) provide to Administrative Agent a joinder to this Agreement pursuant to which such Subsidiary becomes a Borrower hereunder, or (y) guarantee the Obligations of Borrowers under the Loan Documents, (B) grant a security interest in and to the assets which constitute Collateral of such Subsidiary (substantially in accordance with this Agreement), in each case together with such Account Control Agreements and other documents, instruments and agreements reasonably requested by Administrative Agent in accordance with the terms of this Agreement, all in form and substance reasonably satisfactory to Administrative Agent (including being sufficient to grant Administrative Agent a first priority Lien, subject to Permitted Liens) and (C) to pledge all of the direct or beneficial Equity Securities in such Subsidiary to the extent constituting Collateral; and</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(u)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Use the proceeds of the Loan solely to refinance Existing Indebtedness, as working capital and to fund its general corporate purposes.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">4.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Negative Covenants of Borrower</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. Borrower shall not, and shall not permit any of its Subsidiaries to, do any of the following without the prior written consent, which may be conditioned or withheld in its sole discretion:</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">change its name, jurisdiction of incorporation, chief executive office, or principal place of business without ten (10) days&#x2019; prior written notice to Administrative Agent;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(i) create, incur, assume, or permit to exist any Lien or security interest on any Property or Collateral now or hereafter acquired by Borrower or any Subsidiary or on any income or rights in respect of any thereof, (including sale of any accounts) except Liens and security interests created pursuant to this Agreement or Permitted Liens or (ii) or enter into any agreement with any Person other than Administrative Agent not to grant a security interest in. or otherwise encumber, any of its property, or permit any Subsidiary to do so except for agreements governing Permitted Liens;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(i) merge into or consolidate with any other entity, or permit any other entity to merge or consolidate with Borrower or any Subsidiary; provided that any Subsidiary may merge or consolidated with Borrower, (ii) liquidate or dissolve; provided that any Subsidiary may liquidate or dissolve as long as any assets of such Subsidiary are transferred to Borrower prior to liquidation or dissolution, (iii) acquire, or permit any of its Subsidiaries to acquire, all or substantially all of the capital stock, shares or property of another Person other than Permitted Investments or (iv) engage in any business other than the business of the type conducted by Borrower on the date hereof and business reasonably related, supplemental or ancillary thereto;  </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Transfer any of its Property, whether now owned or hereafter acquired except: (i) dispositions of worn-out, obsolete or surplus Equipment or assets in the Ordinary Course of Business that is, in the reasonable judgment of such Borrower or Subsidiary as applicable, no longer economically practicable to maintain or useful; (ii) the sale of Inventory in the Ordinary Course of Business; (iii) in connection with Permitted Liens, Permitted Investments and Permitted Licenses; (iv) consisting of Borrower&#x2019;s or its Subsidiaries&#x2019; use or transfer of money or Cash Equivalents in the ordinary course of its business for the payment of ordinary course business expenses in a manner that is not prohibited by the terms of this Agreement or the other Loan Documents; (v) other assets in an aggregate amount not to exceed $500,000 per year; (vi) the sale of assets pursuant to that certain Letter of Intent, dated as of [***], 2023, by and between Borrower and Brady Trane Service, Inc. (the &#x201c;Brady Equipment Sale&#x201d;) and provided to Agent prior to the date hereof; and (vii) the termination of Intellectual Property licenses for Borrower&#x2019;s de-prioritized or immaterial programs and the transfer of assets back to the licensor in connection </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">32</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">therewith, so long as any such Intellectual Property licenses are identified to Administrative Agent in writing, in advance of any transfer;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">amend, supplement or otherwise modify (pursuant to waiver or otherwise) its Operating Documents , in any respect that would reasonably be expected to result in a Material Adverse Change;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">move any Collateral from the Permitted Locations except in compliance with </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 3.3</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> above;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(i) pay any dividends or make any distributions, on its Equity Securities; (ii) purchase,  redeem, retire, defease or otherwise acquire, for value any of its Equity Securities (other than repurchases pursuant to the terms of employee stock purchase plans, employee restricted stock agreements or similar arrangements in an aggregate amount not to exceed One Hundred Thousand Dollars ($100,000.00) in any fiscal year); (iii) return any capital to any holder of its Equity Securities as such; (iv) make, any distribution of Property, Equity Securities, obligations or securities to any holder of its Equity Securities; or (v) set apart any sum for any such purpose; provided, however, that Borrower may (A) convert any of its convertible securities into other securities pursuant to the terms of such convertible securities or otherwise in exchange thereof, (B) pay dividends solely in the form of common stock; (C) pay cash in lieu of fractional shares upon exercise or conversion of any option, warrant or other convertible security; and (D) pay dividends and distributions by any Subsidiary to Borrower or another Subsidiary that is a co-Borrower;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">any Key Person to cease to be actively engaged in the management of Borrower unless written notice thereof is provided to Administrative Agent within ten (10) days;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">enter into any contractual obligation with any Affiliate or engage in any other transaction with any Affiliate except (i) upon terms at least as favorable to Borrower as an arms-length transaction with Persons who are not Affiliates of Borrower, (ii) sales of equity securities to its investors in bona fide equity financings so long as a Change in Control does not occur, (iii) transactions between Borrower and its Subsidiaries permitted under this Agreement, (d) reasonable and customary compensation arrangements and benefit plans for officers and other employees of Borrower entered into or maintained in the Ordinary Course of Business and approved by Borrower&#x2019;s board of directors, and (e) reasonable and customary fees paid to independent members of Borrower&#x2019;s board of directors in the Ordinary Course of Business;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(i) prepay, redeem, purchase, defease or otherwise satisfy in any manner prior to the scheduled repayment thereof any subordinated Debt for borrowed money other than as permitted by the applicable subordination or intercreditor agreement applicable thereto), or (ii) amend, modify or otherwise change the terms of any subordinated Debt for borrowed money or capital lease obligations so as to accelerate the scheduled repayment thereof except pursuant to the terms of any subordination or intercreditor agreement applicable thereto or (iii) repay any notes to officers, directors or shareholders, provided that Borrower may convert any such notes into Borrower&#x2019;s Equity Securities or repay or otherwise satisfy such notes by the issuance of Borrower&#x2019;s Equity Securities except pursuant to the terms of any subordination or intercreditor agreement applicable thereto;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(k)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">create, incur, assume or permit to exist any Debt except Permitted Debt; provided however, notwithstanding any Debt that is permitted under the definition of Permitted Debt, Borrower shall not create, incur, assume to exist any Debt involving the sale or financing of its accounts receivables or any Debt secured or supported by its accounts receivables without the prior written consent of Administrative Agent;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(l)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">make, or permit any Subsidiary to make, any Investment except for Permitted Investments;</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">33</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(m)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(i) become an &#x201c;investment company&#x201d; or a company controlled by an &#x201c;investment company&#x201d; under the Investment Company Act of 1940 or undertake as one of its important activities extending credit to purchase or carry margin stock (as defined in Regulation U of the Board of Governors of the Federal Reserve System), or use the proceeds of any Loan for that purpose; (ii) become subject to any other federal or state law or regulation which purports to restrict or regulate its ability to borrow money; or  (iii) fail to meet the minimum funding requirements of the Employment Retirement Income Security Act of 1974, and its regulations, as amended from time to time (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">ERISA</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;), permit, or permit any Subsidiary to permit, a Reportable Event or Prohibited Transaction, as defined in ERISA, to occur; (iv) fail to comply with the Federal Fair Labor Standards Act or violate any other law or regulation, if the violation could reasonably be expected to have a Material Adverse Change;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(n)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(x) directly or indirectly, enter into any documents, instruments, agreements or contracts with any Blocked Person or (y) directly or indirectly, (A) conduct any business or engage in any transaction or dealing with any Blocked Person, including the making or receiving of any contribution of funds, goods or services to or for the benefit of any Blocked Person, (B) deal in, or otherwise engage in any transaction relating to, any property or interests in property blocked pursuant to Executive Order No. 13224, any similar executive order or other Anti-Terrorism Law or (C) engage in or conspire to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in Executive Order No. 13224 or other Anti-Terrorism Law.  Each Lender hereby notifies Borrower that pursuant to the requirements of Anti-Terrorism Laws and such Lender&#x2019;s policies and practices, such Lender is required to obtain, verify and record certain information and documentation that identifies Borrower and its principals, which information includes the name and address of Borrower and its principals and such other information that will allow each Lender to identify such party in accordance with Anti-Terrorism Laws.  Borrower shall immediately notify Administrative Agent if Borrower has knowledge that Borrower is listed on the OFAC Lists or (i) is convicted on, (ii) pleads nolo contendere to, (iii) is indicted on or (iv) is arraigned and held over on charges involving money laundering or predicate crimes to money laundering;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(o)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(i) maintain any Deposit Account or Securities Account except accounts with respect to which Administrative Agent is able to take such actions as Administrative Agent deems necessary to obtain a perfected security interest in such accounts through one or more Account Control Agreements or other agreements giving Administrative Agent &#x201c;control&#x201d; as defined under the UCC (other than with respect to any Excluded Account) or (ii) grant or allow any other Person (other than a Lender) to perfect a security interest in, or enter into any agreements with any Persons (other than Lender) accomplishing perfection via control as to, any of its Deposit Accounts or Securities Accounts, other with respect to any Excluded Account; or</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(p)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Cause or permit any Inactive Subsidiary to maintain cash or assets in excess of Fifty Thousand Dollars ($50,000) at any time or to own or maintain any Intellectual Property.  </font></div></div>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.533%;">Article 5</font><div style="width:100%;display:inline;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;"><br><br>agent</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;">5.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Appointment.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Each Lender hereby irrevocably designates and appoints Trinity Capital Inc., or its successor or assignee, as Administrative Agent under this Agreement and the other Loan Documents, and each such Lender irrevocably authorizes the Administrative Agent, in such capacity, to take such action on its behalf under the provisions of this Agreement and the other Loan Documents (including without limitation any subordination and intercreditor agreements (or similar agreements)) and to exercise such rights, powers and perform such duties as are expressly delegated to the Administrative Agent by the terms of this Agreement and the other Loan Documents (including without limitation any subordination and intercreditor agreements (or similar agreements)), together with such other powers as are reasonably incidental thereto.  Notwithstanding any provision to the contrary elsewhere in this Agreement, the Administrative Agent shall not have any duties or responsibilities, except those expressly set forth herein and in the other Loan </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">34</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Documents, or any fiduciary relationship with any Lender, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Agreement or any other Loan Document or otherwise exist against the Administrative Agent.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Each of the Lenders hereby irrevocably appoints and authorizes the Administrative Agent to act as the agent of such Lender for purposes of acquiring, holding and enforcing any and all Liens on Collateral granted by any Borrower to secure any of the Obligations and to take all other actions, exercise all powers and perform such duties as are delegated to Administrative Agent under the Loan Documents, together with such powers and discretion as are reasonably incidental thereto.  In furtherance thereof, the Administrative Agent and any co-agents, sub-agents and attorneys-in-fact appointed by the Administrative Agent pursuant to </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 5.2</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> for purposes of holding or enforcing any Lien on the Collateral (or any portion thereof) granted under this Agreement or any other Loan Document, or for exercising any rights and remedies thereunder (at the direction of the Administrative Agent), shall be entitled to the benefits of all provisions of this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Article 5</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, as though such co-agents, sub-agents and attorneys-in-fact were the &#x201c;collateral agent&#x201d; under the Loan Documents as if set forth in full herein with respect thereto.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;">5.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Delegation of Duties</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.	Administrative Agent may execute any of its duties under this Agreement and the other Loan Documents by or through its agents or attorneys-in-fact shall be entitled to advice of counsel concerning all matters pertaining to such duties.  The exculpatory and indemnification provisions of this Article 5 shall apply to attorney-in-fact and shall apply to their respective activities in connection with the syndication of the Loans as well as activities as the Administrative Agent.  The Administrative Agent shall not be responsible for the negligence or misconduct of any agents or attorneys-in-fact selected by it with reasonable care. </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;">5.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Exculpatory Provisions</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.	Neither Administrative Agent nor any of its Affiliates nor any of their respective officers, directors, employees, agents, advisors or attorneys-in-fact shall be (i) liable for any action taken or omitted to be taken, (including the making of (or omitting to make) any determination, calculations, selection, request or providing any approval or consent or enter into any amendments, modifications or supplements) by it or such Person under or in connection with this Agreement or any other Loan Document (except to the extent that any of the foregoing are found by a final and nonappealable judgment of a court of competent jurisdiction to have resulted from its or such Person&#x2019;s own gross negligence or willful misconduct; provided, that no action taken or not taken in accordance with the directions of the Required Lenders or such other percentage of Lenders as shall be necessary hereunder, as applicable, shall be deemed to constitute gross negligence or willful misconduct) or (ii) responsible in any manner to any of the Lenders for (A) any recitals, statements, representations or warranties made by Borrower or any officer thereof contained in this Agreement or any other Loan Document or in any certificate, report, instrument, statement or other document referred to or provided for in, or received by the Administrative Agent or Lenders under or in connection with, this Agreement or any other Loan Document or the transactions contemplated herein or therein, (B) the value, validity, effectiveness, genuineness, enforceability, execution, collectability or sufficiency of this Agreement or any other Loan Document or for any failure of any Borrower a party thereto to perform its obligations hereunder or thereunder, (C) the financial condition or business affairs of Borrower or any other Person liable for the payment of any Obligations or (D) the attachment, creation and/or perfection of the Liens granted or purported to be granted in the Collateral pursuant to this Agreement or the continuation and/or amendment of any financing statements filed to perfect the Liens in the applicable Collateral (other than to the extent expressly directed by the Required Lenders).  The Administrative Agent shall not be under any obligation to any Lender (i) to ascertain or to inquire as to the observance or performance of any of the agreements, terms, covenants or provisions contained in, or conditions of, this Agreement or any other Loan Document, (ii) to inspect the properties, books or records of any Borrower, (iii) to ascertain or to inquire as to the use of the proceeds of the Loans, (iv) to ascertain or to inquire as to the existence or possible existence of any Event of Default, (v) to ascertain or to inquire as to any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (vi) to ascertain or to inquire as to the contents of any certificate, report or other document delivered hereunder or under any Loan Documents or in connection herewith or therewith, (vii) to ascertain or to inquire as to the validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document, or the creation, perfection or priority of any Lien purported to be created by this Agreement, (viii) </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">35</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">to ascertain or to inquire as to the value or the sufficiency of any Collateral, or (ix) to ascertain or to inquire as to the satisfaction of any condition set forth in Article 2 or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent or (x) to make any disclosures with respect to the foregoing or otherwise relating to any Borrower unless expressly required herein.  Anything contained herein to the contrary notwithstanding, the Administrative Agent shall not have any liability to the Lenders arising from confirmations of the amount of outstanding Loans or the component amounts thereof.  Additionally, the Administrative Agent shall not be responsible or have any liability for, or have any duty to ascertain, inquire into, monitor or enforce, compliance with the provisions hereof relating to Defaulting Lenders, Affiliates of a Lender (or otherwise determine whether a Person qualifies as a Defaulting Lender or Affiliate of a Lender).  Without limiting the generality of the foregoing, the Administrative Agent shall not (x) be obligated to ascertain, monitor or inquire as to whether any Lender or participant or prospective Lender or participant qualifies as a Defaulting Lender or Affiliate of a Lender and, absent actual knowledge to the contrary (which may be by written notice), shall be permitted to treat each Lender, participant, prospective Lender or prospective participant as if it is not a Defaulting Lender or Affiliate of a Lender or (y) have any liability with respect to or arising out of any assignment or participation of Loans, or disclosure of confidential information, to any Defaulting Lender or Affiliate of a Lender.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">  </font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;">5.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Reliance by the Administrative Agent</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. Administrative Agent shall be entitled to rely, and shall be fully protected in relying, upon (and shall not be liable for so relaying upon) any communication, request, instrument, writing, resolution, notice, consent, certificate, affidavit, letter, telecopy or email message, internet or intranet website posting, statement, order or other document (or other writing) or conversation believed by it to be genuine and correct and to have been signed, sent or made (or authenticated) by the proper Person or Persons and upon advice and statements of legal counsel (including counsel to the Borrower), independent accountants and other experts and professional advisors selected by the Administrative Agent.  In determining compliance with any condition hereunder to the making of a Loan, that by its terms must be fulfilled to the satisfaction of a Lender, the Administrative Agent may presume that such condition is satisfactory to such Lender unless the Administrative Agent shall have received notice to the contrary from such Lender prior to the making of such Loan.  The Administrative Agent may request instructions from the Required Lenders (or such number or percentage of the Lenders as shall be necessary under the circumstances as provided for herein or in the other Loan Documents) prior to taking any action or enter into any amendments, modifications or supplements, making any determination (including as to whether any agreement, document or instrument is in form and substance satisfactory to the Administrative Agent), making any calculation (which may be confirmed by the Required Lenders), sending any notice, making a selection or request (including failing to make a selection or request), exercising any voting rights or powers (including failing to exercise any voting rights or powers) or providing any consent or approval (including failing to provide any consent or approval) in connection with this Agreement or any of the other Loan Documents and may refrain (and shall incur no liability from so refraining) from taking or omitting to take any act or making any such determination, calculation, selection, request, exercising such voting rights or powers or providing such notice, approval or consent or entering into or any amendments, modifications or supplements until it receives such instruction (or calculation, as applicable) from the Required Lenders (or such number or percentage of the Lenders as shall be necessary under the circumstances as provided for herein or in the other Loan Documents), in each case as it reasonably deems appropriate (and until such instructions and indemnity, as applicable, are received, the Administrative Agent may (but shall not be obligated to) act, or refrain from acting, as it deems advisable in good faith in the interests of the Lenders).  The Administrative Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement and the other Loan Documents in accordance with a request of the Required Lenders (or such number or percentage of the Lenders as shall be necessary under the circumstances as provided for herein or in the other Loan Documents), and such request and any action taken or failure to act pursuant thereto shall be binding upon all the Lenders and all future holders of the Loans.  Notwithstanding any other provisions set forth in this Agreement or any other Loan Documents, the Administrative Agent shall not be required to take any action that is in its opinion contrary to applicable requirement of law (including, for the avoidance of doubt, any action that may be in violation of the automatic stay under the Bankruptcy Code (or any similar laws)) or that may effect a forfeiture, modification or termination of property of a Defaulting Lender in violation of Bankruptcy Code (or any similar laws) or the terms of any of the Loan Documents or that would in its reasonable opinion subject it or any of its officers, employees or directors to personal liability.  Each Lender, by delivering its signature </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">36</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">page to this Agreement, an Assignment and Acceptance and/or funding its Loans, shall be deemed to have acknowledged receipt of, and consented to and approved, each Loan Document and each other document required to be approved by the Administrative Agent, Required Lenders or Lenders, as applicable on the Closing Date or as of the date of funding such Loan.  On any applicable date of determination, upon request, the Administrative Agent shall be required to calculate whether a particular group of Lenders constitutes the Required Lenders.  The Administrative Agent shall not be required to remit payments, the proceeds of Collateral or any other funds to the Lenders or any other Secured Parties herein except in accordance with the Loan Documents.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;">5.5</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Notice of Default</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. Administrative Agent shall not be deemed to have knowledge or notice of the occurrence of any Potential Event of Default or Event of Default unless the Administrative Agent has received written notice from a Lender or the Borrower referring to this Agreement, describing such Potential Event of Default or Event of Default and stating that such notice is a &#x201c;notice of default&#x201d;.  In the event that the Administrative Agent receives such a notice, the Administrative Agent shall give notice thereof to the Lenders.  The Administrative Agent shall take such action with respect to such Potential Event of Default or Event of Default as shall be reasonably directed by the Required Lenders (or, if so specified by this Agreement, all Lenders or such number or percentage of the Lenders as shall be necessary under the circumstances as provided for herein or in the other Loan Documents); provided that unless and until the Administrative Agent shall have received such directions, the Administrative Agent may (but shall not be obligated to) take such action, or refrain from taking such action, with respect to such Potential Event of Default or Event of Default as it shall deem advisable in good faith in the interests of the Lenders.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;">5.6</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Non-Reliance on Administrative Agent and Other Lenders</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. Each Lender expressly acknowledges that neither the Administrative Agent nor any of its Affiliates nor any of their respective officers, directors, employees, agents, advisors or attorneys in fact have made any representations or warranties to it and that no act by the Administrative Agent hereafter taken, including any review of the affairs of a Borrower or any affiliate of a Borrower, shall be deemed to constitute any representation or warranty by the Administrative Agent to any Lender.  Each Lender represents to the Administrative Agent that it has, independently and without reliance upon the Administrative Agent or any other Lender, and based on such documents and information as it has deemed appropriate, made its own appraisal of an investigation into the business, operations, property, financial and other condition and creditworthiness of the Borrower and its affiliates and made its own decision to make its Loans and other extensions of credit hereunder and enter into this Agreement.  Each Lender also represents that it will, independently and without reliance upon the Administrative Agent or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under this Agreement and the other Loan Documents, and to make such investigation as it deems necessary to inform itself as to the business, operations, property, financial and other condition and creditworthiness of the Borrower and its affiliates.  Except for notices, reports and other documents expressly required hereunder or otherwise requested by the Borrower in writing to be furnished to the Lenders by the Administrative Agent, the Administrative Agent shall not have any duty or responsibility to provide any Lender with any credit or other information concerning the business, operations, property, condition (financial or otherwise), prospects or creditworthiness of Borrower or any affiliate of Borrower that may come into the possession of the Administrative Agent or any of its officers, directors, employees, agents, advisors, attorneys in fact or affiliates.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;">5.7</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Indemnification</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.	The Lenders agree to indemnify, hold harmless and defend the Administrative Agent and its Affiliates and their respective officers, directors, employees, agents, advisors and controlling persons (each, an &#x201c;Agent Indemnitee&#x201d;) (to the extent not timely reimbursed by the Borrower and without limiting the obligation of the Borrower to do so), ratably according to their respective Pro Rata Shares in effect on the date on which indemnification is sought under this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 5.7</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> (or, if indemnification is sought after the date upon which the Commitments shall have terminated and the Loans shall have been paid in full, ratably in accordance with such Pro Rata Shares immediately prior to such date), from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind whatsoever that may at any time (whether before or after the payment of the Loans) be imposed on, incurred by or asserted against such Agent Indemnitee in any way relating to or arising out of, the Commitments, this Agreement, any of the other Loan Documents or any </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">37</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">documents contemplated by or referred to herein or therein or the transactions contemplated hereby or thereby or any action taken or omitted by such Agent Indemnitee under or in connection with any of the foregoing including without limitation, exercising any of the Administrative Agent&#x2019;s powers, rights, and remedies and performing their duties hereunder and thereunder (or omitting to do the same); provided that no Lender shall be liable to any Agent Indemnitee for the payment of any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements that are found by a final and nonappealable decision of a court of competent jurisdiction to have resulted from such Agent Indemnitee&#x2019;s bad faith, gross negligence or willful misconduct, provided, however, no action taken or not taken in accordance with the directions of the Administrative Agent, Required Lenders or such other percentage of Lenders as shall be necessary hereunder, as applicable, shall be deemed to constitute gross negligence or willful misconduct.  The agreements in this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 5.7</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;">5.8</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Administrative Agent in Its Individual Capacity</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.	Administrative Agent and its affiliates may make loans to, accept deposits from and generally engage in any kind of business with Borrower as though the Administrative Agent were not the Administrative Agent.  With respect to its Loans made or renewed by it, the Administrative Agent shall have the same rights and powers under this Agreement and the other Loan Documents as any Lender and may exercise the same as though it were not the Administrative Agent, and the terms &#x201c;Lender&#x201d; and &#x201c;Lenders&#x201d; shall include the Administrative Agent in its individual capacity.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;">5.9</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Successor Administrative Agent</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.	  Administrative Agent may resign as Administrative Agent (which shall include the Administrative Agent&#x2019;s capacities as administrative agent and collateral agent) upon 30 days&#x2019; notice to the Lenders and the Borrower.  If the Administrative Agent shall resign as Administrative Agent under this Agreement and the other Loan Documents, then the Required Lenders shall appoint from among the Lenders a successor agent for the Lenders, which successor agent shall (unless an Event of Default with respect to the Borrower shall have occurred and be continuing) be subject to written approval by the Borrower (which approval shall not be unreasonably withheld or delayed), whereupon such successor agent shall succeed to the rights, powers and duties of the Administrative Agent (other than any rights to indemnity payments or other amounts owed to the retiring Administrative Agent as of the Resignation Effective Date), and the term &#x201c;Administrative Agent&#x201d; shall mean such successor agent effective upon such appointment and approval, and the former Administrative Agent&#x2019;s rights, powers and duties as Administrative Agent shall be terminated, without any other or further act or deed on the part of such former Administrative Agent or any of the parties to this Agreement or any holders of the Loans.  Any successor Administrative Agent appointed pursuant to this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 5.9</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> shall, upon its acceptance of such appointment, become the successor Administrative Agent for all purposes hereunder unless otherwise agreed.  If no successor agent has accepted appointment as Administrative Agent by the date that is 30 days following a retiring Administrative Agent&#x2019;s delivery of its notice of resignation, the retiring Administrative Agent may (but shall not be obligated to), on behalf of the Lenders and with the written consent of the Borrower (such consent not to be unreasonably withheld or delayed or required if an Event of Default shall have occurred and be continuing) appoint a successor Administrative Agent, which shall be a commercial bank organized or licensed under the laws of the United States of America or of any State thereof and having a combined capital and surplus of at least Five Hundred Million Dollars ($500,000,000.00).  If no successor agent has accepted appointment as Administrative Agent by the date that is 30 days following a retiring Administrative Agent&#x2019;s notice of resignation (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Resignation Effective Date</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;), the retiring Administrative Agent&#x2019;s resignation shall nevertheless thereupon become effective in accordance with such notice, and (i) the Lenders shall assume and perform all of the duties of the Administrative Agent hereunder until such time, if any, as the Required Lenders appoint a successor agent as provided for above, (ii) the retiring Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents and (iii) except for any indemnity payments or other amounts then owed to the retiring Administrative Agent, all payments, communications and determinations provided to be made by, to or through the Administrative Agent shall instead be made by or to each Lender directly, until such time, if any, as the successor Administrative Agent is appointed as provided for above.  After any retiring Administrative Agent&#x2019;s resignation as Administrative Agent, the provisions of this Article 5 shall continue to inure to its benefit as to any actions taken or omitted to be taken </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">38</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">by it while it was Administrative Agent.  Notwithstanding anything to the contrary, in no event shall a successor agent be a Defaulting Lender.</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;">5.10</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Authorization for Intercreditor Agreement and Subordination Agreement</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.	 The Lenders irrevocably authorize the Administrative Agent to enter into and perform its obligations under any Subordination Agreement or other similar arrangement permitted under this Agreement and any amendments, restatements, supplements or other modifications thereto approved in accordance with the terms thereof (without limiting the provisions set forth in Section 5.4 hereof).</font></div></div>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;">5.11</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Administrative Agent May File Proofs of Claim</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.	In case of the pendency of any receivership, insolvency, liquidation, bankruptcy, reorganization, arrangement, adjustment, composition or other judicial proceeding relative to any Borrower, the Administrative Agent (on behalf of the Lenders) (irrespective of whether the principal of any Loan shall then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent shall have made any demand on the Borrower) shall be entitled and empowered, by intervention in such proceeding or otherwise:</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">To file a verified statement pursuant to rule 2019 of the Federal Rules of Bankruptcy Procedure that, in its sole opinion, complies with such rule&#x2019;s disclosure requirements for entities representing more than one creditor;</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">To file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Loans and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Secured Parties (including any claim for the reasonable compensation, expenses, disbursements and advances of the Secured Parties and their respective agents and counsel and all other amounts due the Secured Parties hereunder) allowed in such judicial proceeding;</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">To collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same; and</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each applicable Lender to make such payments to the Administrative Agent, as applicable, and, in the event that the Administrative Agent shall consent to the making of such payments directly to the Lenders, to pay to the Administrative Agent any amount due for the reasonable compensation, expenses, disbursements and advances of the Administrative Agent and their respective agents and counsel, and any other amounts due to the Administrative Agent.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Each Lender further agrees that it shall not propose, vote in favor of, or otherwise support any plan of reorganization that is in contravention of any plan of reorganization that is proposed or supported by the Administrative Agent, and shall affirmatively vote to &#x201c;reject&#x201d; any plan of reorganization that is not affirmatively supported by the Administrative Agent.</font></p>
  <div style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.4%;">5.12</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Collateral Matters</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Administrative Agent is hereby authorized on behalf of the Lenders, without the necessity of any notice to or further consent from the Lenders, from time to time (but without any obligation) to take any action with respect to the Collateral and this Agreement or any other Loan Document that may be necessary to perfect and maintain perfected Liens upon the Collateral granted pursuant to this Agreement or any other Loan Document if required or expressly permitted under the terms of any of the other Loan Documents.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Each of the Lenders hereby irrevocably authorize and instruct the Administrative Agent to, and the Administrative Agent shall:</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">39</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:6.667%;text-indent:14.286%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.8575102053935906%;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Release (or confirm any release) any Lien granted to or held by the Administrative Agent upon any Collateral (A) upon the date on which all Obligations have been repaid in full, (B) constituting property sold or to be sold or otherwise disposed of as part of or in connection with any disposition permitted hereunder or under any other Loan Document or to which the Required Lenders have consented, (C) that does not constitute (or ceases to constitute) Collateral, (D) otherwise pursuant to and in accordance with the provisions of any applicable Loan Document or (E) subject to </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 5.11</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, if approved, authorized or ratified in writing by the Required Lenders, provided, however, that if any action is required by the Administrative Agent to so release such Lien, upon the request of the Administrative Agent, the Borrower shall have delivered to the Administrative Agent a certificate certifying to the permissibility of such release hereunder (and the Administrative Agent shall be permitted to rely upon such certificate without incurring any liability therefor);</font></div></div>
  <div style="margin-left:6.667%;text-indent:14.286%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:2.8575102053935906%;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Enter into any Subordination Agreement and/or similar agreement contemplated hereunder, including with respect to Debt that is (i) required or permitted to be subordinated in right of payment hereunder and/or (ii) secured by Liens and required or permitted to be pari passu with or junior to the Liens securing the Obligations, and with respect to which Debt, a Subordination Agreement or similar agreement is contemplated under this Agreement.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Anything contained in any of the Loan Documents to the contrary notwithstanding, the Borrower, the Administrative Agent and each Lender hereby agree that (i) no Lender (other than the Administrative Agent) shall have any right individually to realize upon any of the Collateral, (ii) no Lender shall have any right to enforce the Obligations, it being understood and agreed that all powers, rights and remedies hereunder and under any of the Loan Documents may be exercised solely by the Administrative Agent for the benefit of the Lenders in accordance with the terms hereof and thereof, and (iii) in the event of a foreclosure or similar enforcement action by the Administrative Agent on any of the Collateral pursuant to a public or private sale or other disposition (including pursuant to Section 363(k), Section 1129(b)(2)(a)(ii) or otherwise of the Bankruptcy Code), the Administrative Agent (or any Lender, except with respect to a &#x201c;credit bid&#x201d; pursuant to Section 363(k), Section 1129(b)(2)(a)(ii) or otherwise of the Bankruptcy Code), may be the purchaser or licensor of any or all of such Collateral at any such sale or other disposition and the Administrative Agent, as agent for and representative of Lenders (but not any Lender or the Lenders in its or their respective individual capacities) shall be entitled, upon instructions from Required Lenders, for the purpose of bidding and making settlement or payment of the purchase price for all or any portion of the Collateral sold at any such sale or disposition, to use and apply any of the Obligations as a credit on account of the purchase price for any collateral payable by the Administrative Agent at such sale or other disposition.</font></div></div>
  <div style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.8%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Administrative Agent shall not be responsible for or have a duty to ascertain or inquire into any representation or warranty regarding the existence or collectability of the Collateral, the existence, priority or perfection of the Administrative Agent&#x2019;s Lien thereon, or any certificate prepared by Borrower in connection therewith, nor shall the Administrative Agent be responsible or liable to the Lenders for any failure to monitor or maintain any portion of the Collateral, Liens therein or financing statements filed in connection therewith. Upon request by the Administrative Agent at any time, the Lenders will confirm in writing the Administrative Agent&#x2019;s authority to release or subordinate its interest in particular types or items of property, or to release any Borrower from its obligations under the Loan Documents or its Lien on any Collateral pursuant this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 5.12</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  In each case as specified in this Article 5, the Administrative Agent will (and each Lender hereby authorizes the Administrative Agent to, at the Borrower&#x2019;s expense, promptly execute and deliver to Borrower such documents, filings and recordings as Borrower may reasonably request to evidence the release of such item of Collateral from the assignment and security interest granted under this Agreement or any other Loan Document or to subordinate its interest therein, in accordance with the terms of the Loan Documents and this Article 5.  Additionally, upon the reasonable request of the Borrower, the Administrative Agent will return possessory Collateral held by it that is released from the security interests of the Loan Documents pursuant to this Article 5; provided that, in the event that any possessory collateral in the possession of the Administrative Agent gets lost or misplaced upon the reasonable request of the Borrower, the Administrative Agent shall provide a loss affidavit to the Borrower in the form customarily provided by the Administrative Agent in such circumstances.</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">40</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.533%;">Article 6</font><div style="width:100%;display:inline;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;"><br><br>BORROWER&#x2019;S INDEMNITY</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">6.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Indemnity By Borrower</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Borrower covenants and agrees, at its sole cost and expense and without limiting any other rights which Administrative Agent and Lenders have hereunder, to indemnify, protect and save Administrative Agent, each Lender, and each of their directors, officers, employees, consultants, agents, attorneys, or any other Person affiliated with or representing Administrative Agent or any Lender (each, an &#x201c;Indemnified Person&#x201d;) harmless against and from any and all claims, damages, losses, liabilities, obligations, demands, defenses, judgments, costs, disbursements Administrative Agent&#x2019;s Expenses or Lender Expenses of any kind or of any nature whatsoever which may be imposed upon, incurred by or asserted or awarded against Administrative Agent or a Lender and related to or arising from the following, unless such claim, loss or damage shall be based upon the gross negligence or willful misconduct of Administrative Agent or such Lender:</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">the transactions contemplated by the Loan Documents (including reasonable attorneys&#x2019; fees and expenses);</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">any investigative, response, remedial, administrative or judicial matter or proceeding, whether or not such Indemnified Person shall be designated a party thereto and including any such proceeding initiated by or on behalf of Borrower, and the reasonable expenses of investigation by engineers, environmental consultants and similar technical personnel and any commission, fee or compensation claimed by any broker (other than any broker retained by a Lender) asserting any right to payment for the transactions contemplated hereby which may be imposed on, incurred by or asserted against such Indemnified Person as a result of or in connection with the transactions contemplated hereby and the use or intended use of the proceeds of the loan proceeds;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">any breach by Borrower of the representations, warranties, covenants, or other obligations or agreements made by Borrower in this Agreement or in any agreement related hereto or thereto;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">the violation by Borrower of any state or federal law, rule or regulation; </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">a material misrepresentation made by Borrower to Administrative Agent or a Lender; and </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">any governmental fees, charges, taxes or penalties levied or imposed in respect to any Collateral.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">6.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Defense of Claims</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Borrower agrees to pay all amounts due under this Article 6 promptly on notice thereof from Administrative Agent.  To the extent that Borrower may make or provide, to Administrative Agent&#x2019;s satisfaction, for payment of all amounts due under this Article 6, Borrower shall be subrogated to Administrative Agent&#x2019;s rights with respect to such events or conditions.  So long as no Event of Default has occurred and is continuing, Borrower may defend any claims with counsel of its own choosing reasonably acceptable to Administrative Agent, provided if the claim creates a significant exposure for the Lenders in Administrative Agent&#x2019;s its sole judgment, or attempts to establish legal principle adverse to any Lender or Administrative Agent, Administrative Agent, on behalf of Lenders, shall select the defense counsel.  Borrower may settle any claims against Administrative Agent or a Lender, provided such settlement includes a complete release of Administrative Agent and Lenders from any claims at no cost to Administrative Agent or Lenders.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">6.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Survival</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  All of the indemnities and agreements contained in this Article 6 shall survive and continue in full force and effect notwithstanding termination of this Agreement, the full payment of any Loans or Borrower&#x2019;s performance of all Obligations.</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">41</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.533%;">Article 7</font><div style="width:100%;display:inline;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;"><br><br>DEFAULT</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">7.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Lender&#x2019;s Rights on Default</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  If an Event of Default occurs and is continuing, Administrative Agent, on behalf of Lenders, shall be entitled to:</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">declare the unpaid balance of the Loans and this Agreement immediately due and payable, whether then due or thereafter arising;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">modify the terms and conditions upon which the Lenders may be willing to consider making Loans hereunder or immediately and automatically terminate any further obligations to make Loans under this Agreement; </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">require Borrower to, and Borrower hereby agrees that it will at its expense and upon request of Administrative Agent, assemble the Collateral or any part thereof, as directed by Administrative Agent and make it available to Administrative Agent at a place and time to be designated by Administrative Agent, for cash, on credit or for future delivery, and upon such other terms as the Administrative Agent deems commercially reasonable;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">ship, reclaim, recover, store, finish, maintain, repair, prepare for sale, advertise for sale, and sell (in the manner provided for herein) the Collateral.  Administrative Agent and its agents and any purchasers at or after foreclosure are hereby granted a non-exclusive, irrevocable, perpetual, fully paid, royalty-free license or other right, solely pursuant to the provisions of this </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 7.1</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, to use, without charge, Borrower&#x2019;s Intellectual Property, including labels, patents, copyrights, rights of use of any name, trade secrets, trade names, trademarks, service marks, and advertising matter, or any Property of a similar nature, now or at any time hereafter owned or acquired by Borrower or in which Borrower now or at any time hereafter has any rights; </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> that such license shall only be exercisable in connection with the disposition of Collateral upon Administrative Agent&#x2019;s exercise of its remedies hereunder;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(e)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">without notice except as specified below, sell, resell, assign and deliver or grant a license to use or otherwise dispose of the Collateral or any part thereof, in one or more parcels at public or private sale, at any place designated by Administrative Agent;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(f)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">occupy any premises owned or leased by Borrower where the Collateral or any part thereof is assembled or located for a reasonable period in order to effectuate its rights and remedies hereunder or under law, without obligation to Borrower in respect of such occupation; </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(g)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">commence and prosecute any bankruptcy, insolvency or other similar proceeding or consent to Borrower commencing any bankruptcy, insolvency or other similar proceeding;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(h)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">place a &#x201c;hold&#x201d; on any account maintained with Administrative Agent and/or deliver a notice of exclusive control, any entitlement order, or other directions or instructions pursuant to any Account Control Agreement or similar agreements providing control of any Collateral;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">exercise any and all rights and remedies of Borrower under or in connection with the Collateral, or otherwise in respect of the Collateral, including without limitation, (A) any and all rights of Borrower to demand or otherwise require payment of any amount under, or performance of any provision of, the accounts receivables and the other Collateral, (B) withdraw, or cause or direct the withdrawal, of all funds with respect to any Deposit Accounts, (C) exercise all other rights and remedies with respect to the accounts receivables and the other Collateral, including without limitation, those set forth in Section 9-607 of the UCC and (D) exercise any and all voting, consensual and other rights with respect to any Collateral; and</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">42</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(j)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">exercise all rights and remedies available to Administrative Agent and Lenders under the Loan Documents or at law or equity, including all remedies provided under the UCC (including disposal of the Collateral pursuant to the terms thereof).</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower agrees that, to the extent notice of sale shall be required by law, at least ten (10) days&#x2019; notice to Borrower of the time and place of any public sale or the time after which any private sale is to be made shall constitute reasonable notification. At any sale of the Collateral, if permitted by applicable law, the Administrative Agent and Lenders may be the purchaser, licensee, assignee or recipient of the  Collateral or any part thereof and shall be entitled, for the purpose of bidding and making settlement or payment of the purchase price for all or any portion of the Collateral sold, assigned or licensed at such sale, to use and apply any of the Obligations as a credit on account of the purchase price of the Collateral or any part thereof payable at such sale. To the extent permitted by applicable law, Borrower waives all claims, damages and demands it may acquire against the Administrative Agent and Lenders arising out of the exercise by it of any rights hereunder.  Borrower hereby waives and releases to the fullest extent permitted by law any right or equity of redemption with respect to the Collateral, whether before or after sale hereunder, and all rights, if any, of marshalling the Collateral and any other security for the Obligations or otherwise. The Administrative Agent and Lenders shall not be liable for failure to collect or realize upon any or all of the Collateral or for any delay in so doing nor shall it be under any obligation to take any action with regard thereto. The Administrative Agent and Lenders shall not be obligated to make any sale of the Collateral regardless of notice of sale having been given. The Administrative Agent and Lenders may adjourn any public or private sale from time to time by announcement at the time and place fixed therefore, and such sale may, without further notice, be made at the time and place to which it was so adjourned. The Administrative Agent and Lenders shall not be obligated to clean-up or otherwise prepare the Collateral for sale.</font></p>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(k)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">all payments received by Borrower in respect of the  Collateral shall be received in trust for the benefit of the Administrative Agent and Lenders, shall be segregated from other funds of Borrower and shall be forthwith paid over the Administrative Agent, for the benefit of the Lenders, in the same form as so received (with any necessary endorsement);</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(l)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">the Administrative Agent may, without notice to Borrower except as required by law and at any time or from time to time, charge, set off and otherwise apply all or part of the Obligations against any funds deposited with it or held by it;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(m)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">upon the written demand of the Administrative Agent, Borrower shall execute and deliver to the Administrative Agent a collateral assignment or assignments of any or all of Borrower&#x2019;s Intellectual Property and such other documents and take such other actions as are necessary or appropriate to carry out the intent and purposes hereof;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(n)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">if Borrower fails to pay any amounts or furnish any required proof of payment due to third persons or entities, as required under the terms of this Agreement, then Administrative Agent may do any or all of the following:  (a) make payment of the same or any part thereof; or (b) obtain and maintain insurance policies of the type discussed in </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 4.2(q)</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> of this Agreement, and take any action with respect to such policies as Administrative Agent deems prudent.  Any amounts paid or deposited by Administrative Agent shall constitute Administrative Agent&#x2019;s Expenses, shall be immediately due and payable, shall bear interest at the Default Rate and shall be secured by the Collateral.  Any payments made by Administrative Agent shall not constitute an agreement by Administrative Agent to make similar payments in the future or a waiver by Administrative Agent of any Event of Default under this Agreement.  Borrower shall pay all reasonable fees and expenses, including Administrative Agent&#x2019;s Expenses, incurred by Administrative Agent in the enforcement or attempt to enforce any of the Obligations hereunder not performed when due; </font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(o)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Lenders&#x2019; rights and remedies under this Agreement, the Loan Documents, and all other agreements shall be cumulative. Lenders shall have all other rights and remedies not inconsistent herewith as provided under the UCC, by law, or in equity.  No exercise by Administrative Agent or any Lender of one right or remedy shall be deemed an election, and no waiver by Administrative Agent or any </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">43</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:0.796%;text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Lender of any Event of Default on Borrower&#x2019;s part shall be deemed a continuing waiver.  No delay by Administrative Agent or any Lender shall constitute a waiver, election, or acquiescence by it.  The Obligations of Borrower to any Lender may be enforced against Borrower in accordance with the terms of this Agreement and the other Loan Documents and, to the fullest extent permitted by applicable law, it shall not be necessary for any other party to be joined as an additional party in any proceeding to enforce such Obligations;</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(p)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">the proceeds and/or avails of the Collateral, or any part thereof, and the proceeds and the avails of any remedy hereunder (as well as any other amounts of any kind held by Administrative Agent, for the benefit of Lenders, at the time of or received by Administrative Agent after the occurrence of an Event of Default hereunder) shall be paid to and applied as follows:</font></div></div>
  <p style="margin-left:6.667%;text-indent:21.429%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">First</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, to the payment of out-of-pocket costs and expenses, including all amounts expended to preserve the value of the Collateral, of foreclosure or suit, if any, and of such sale and the exercise of any other rights or remedies, and of all proper fees, expenses, liability and advances, including reasonable legal expenses and attorneys&#x2019; fees, incurred or made hereunder by Administrative Agent, including Administrative Agent&#x2019;s Expenses;</font></p>
  <p style="margin-left:6.667%;text-indent:21.429%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Second</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, to the payment to Administrative Agent, on behalf of the Lenders of the amount then owing or unpaid on the Loans for any accrued and unpaid interest, the amounts which would have otherwise come due under </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Sections  2.6</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">2.7</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> or </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">2.8</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, if the Loans had been voluntarily prepaid, the principal balance of the Loans, and all other Obligations with respect to the Loans (provided, however, if such proceeds shall be insufficient to pay in full the whole amount so due, owing or unpaid upon the Loans, then first, to the unpaid interest thereon ratably, second, to the amounts which would have otherwise come due under </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Section 2.6</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">2.7</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, or </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">2.8</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> ratably, if the Loans had been voluntarily prepaid, third, to the principal balance of the Loans ratably, and fourth, to the ratable payment of other amounts then payable to Lenders under any of the Loan Documents); and</font></p>
  <p style="margin-left:6.667%;text-indent:21.429%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Third</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, to the payment of the surplus, if any, to Borrower, its successors and assigns or to the Person lawfully entitled to receive the same;</font></p>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(q)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Administrative Agent shall have proceeded to enforce any right under this Agreement or any other of the Loan Documents by foreclosure, sale, entry or otherwise, and such proceedings shall have been discontinued or abandoned for any reason or shall have been determined adversely, then and in every such case (unless otherwise ordered by a court of competent jurisdiction), Administrative Agent shall be restored to its former position and rights hereunder with respect to the Property subject to the security interest created under this Agreement.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">7.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Rights Cumulative; Waivers</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  All rights, remedies and powers granted to Administrative Agent and Lenders hereunder are irrevocable and cumulative, and not alternative or exclusive, and shall be in addition to all other rights, remedies and powers given hereunder, or in or by any other instrument, or available in law or equity.  Administrative Agent&#x2019;s and Lender&#x2019;s knowledge at any time of any breach of, or non-compliance with, any representations, warranties, covenants or agreements hereunder shall not constitute or be deemed a waiver of any of such rights or remedies hereunder, and any waiver of any default shall not constitute a waiver of any other default. Notwithstanding any foreclosure or sale of any item of Collateral by Administrative Agent as permitted under this Agreement, Borrower shall remain liable for any deficiency.  All amounts realized by Administrative Agent in furtherance of its rights to sell or foreclose upon the Collateral shall first be applied to all costs of the action and all costs of enforcement or interpretation of this Agreement, including any court costs, legal or expert fees and filing fees, then to any outstanding interest or penalties payable under this Agreement, then to repayment of principal of all Loans.</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">44</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0;font-size:0;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.533%;">Article 8</font><div style="width:100%;display:inline;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;"><br><br>MISCELLANEOUS</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.1</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Costs and Expenses</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Borrower will pay all Administrative Agent&#x2019;s Expenses and Lender&#x2019;s Expenses on demand.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.2</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Power of Attorney</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Borrower hereby irrevocably constitutes and appoints Administrative Agent as Borrower&#x2019;s attorney-in-fact with full power of substitution, for Borrower and any of its Subsidiary&#x2019;s and in Borrower&#x2019;s or any of its Subsidiary&#x2019;s name to do, at Administrative Agent&#x2019;s option and at Borrower&#x2019;s expense upon the occurrence and during the continuance of an Event of Default, to (a) ask, demand, collect (including, but not limited to the execution, in Borrower&#x2019;s or any Subsidiary&#x2019;s name, of notification letters), sue for, compound and give acquittance for any and all payments assigned hereunder and to endorse, in writing or by stamp, Borrower&#x2019;s name or otherwise on all checks for any monies in respect of the Collateral; (b) sign Borrower&#x2019;s or any of its Subsidiaries&#x2019; name on any invoice or bill of lading for any account or drafts against Account Debtors; (c) settle and adjust disputes and claims about any accounts directly with Account Debtors, for amounts and on terms Administrative Agent determines reasonable; (d) make, settle, and adjust all claims under Borrower&#x2019;s insurance policies; (e) pay, contest or settle any Lien, charge, encumbrance, security interest, and adverse claim in or to the Collateral, or any judgment based thereon, or otherwise take any action to terminate or discharge the same; and (f) transfer the Collateral into the name of Administrative Agent or a third party as the UCC or any applicable law permits.  Borrower hereby appoints Administrative Agent as its lawful attorney&#x2011;in&#x2011;fact to sign Borrower&#x2019;s or any of its Subsidiaries&#x2019; name on any documents necessary to perfect or continue the perfection of Administrative Agent&#x2019;s security interest in the Collateral regardless of whether an Event of Default has occurred until all Obligations (other than inchoate indemnity obligations) have been satisfied in full and Lenders are under no further obligation to make extend Loans hereunder.  Administrative Agent&#x2019;s foregoing appointment as Borrower&#x2019;s or any of its Subsidiaries&#x2019; attorney in fact, and all of Administrative Agent&#x2019;s and Lenders&#x2019; rights and powers, coupled with an interest, are irrevocable until all Obligations (other than inchoate indemnity obligations) have been fully repaid and performed and Lenders&#x2019; obligation to provide Loans terminates.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.3</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Survival</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  All representations, warranties and indemnities contained in this Agreement (and any and each other agreement or instrument delivered pursuant hereto) shall survive (i) the execution and delivery of this Agreement, (ii) the consummation of the transactions contemplated hereby, (iii) the payment of the Loans, (iv) the performance of all Obligations, and (v) termination of this Agreement.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.4</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Assignments</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Except as herein provided, this Agreement shall be binding upon and inure to the benefit of Administrative Agent, Lenders, and Borrower and their respective representatives, successors and assigns.  Any Lender may assign this Agreement and the Notes (if any) in whole or in part or sell participations therein without notice to Borrower or Borrower&#x2019;s consent.  Notwithstanding the foregoing, Borrower may not assign, transfer or otherwise convey this Agreement, in whole or in part, without Administrative Agent&#x2019;s and each Lender&#x2019;s prior written consent. Notwithstanding the foregoing, so long as no Event of Default shall have occurred and is continuing, no Lender shall assign its interests in the Loan Documents to any Person who, in the reasonable estimation of such Lender, is (a) a direct competitor of Borrower or (b) a vulture fund or distressed debt fund.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.5</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">No Brokers</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Borrower represents to Lenders that no brokers or advisors have been or will be retained in connection with the transactions contemplated herein.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.6</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Notice</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. All notices, consents, requests, instructions, approvals and communications provided herein shall be validly given, made or served, effective only if in writing, except as otherwise provided herein, and sent by overnight courier, certified U.S. mail, postage prepaid, or by electronic mail, and shall be deemed received within five (5) Business Days from the date of posting if sent by mail, one Business Day after delivery thereto if sent by overnight courier service, or on the day of transmission if sent by electronic mail with a confirmation receipt obtained, or if such day is not a Business Day, then on the following Business Day.  All such notices, consents, requests, instructions, approvals and </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">45</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:1.731%;text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">communications shall be sent to a party at the address set forth for such party on the signature pages hereto, or to such other address as such party may designate in writing.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.7</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Governing Law; Consent to Jurisdiction and Service of Process</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  THIS AGREEMENT SHALL BE SUBJECT TO AND GOVERNED BY THE LAWS OF THE STATE OF CALIFORNIA (WITHOUT REGARD TO THE CONFLICT OF LAW PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY LAWS OTHER THAN THE LAWS OF SUCH STATE).  IN THE EVENT THAT ADMINISTRATIVE AGENT OR ANY LENDER INITIATES AGAINST BORROWER ANY DISPUTE, CLAIM, OR SUIT WHETHER DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR ANY OTHER LOAN DOCUMENT OR ANY OF BORROWER&#x2019;S OBLIGATIONS OR INDEBTEDNESS HEREUNDER OR THEREUNDER, EACH PARTY DOES HEREBY IRREVOCABLY SUBMIT TO THE JURISDICTION AND VENUE OF ANY COURTS (FEDERAL, STATE OR LOCAL) HAVING A LOCATION IN THE STATE OF CALIFORNIA.  IN THE EVENT THAT BORROWER INITIATES AGAINST ADMINISTRATIVE AGENT OR ANY LENDER ANY DISPUTE, CLAIM, OR SUIT WHETHER DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR ANY RELATED ASSIGNMENT OR ANY OF BORROWER&#x2019;S OBLIGATIONS OR INDEBTEDNESS HEREUNDER, EACH PARTY DOES HEREBY IRREVOCABLY SUBMIT TO THE JURISDICTION AND VENUE OF ANY COURTS (FEDERAL, STATE OR LOCAL) HAVING A LOCATION IN THE STATE OF CALIFORNIA.  EACH PARTY EXPRESSLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO SERVICE BY CERTIFIED MAIL, POSTAGE PREPAID, DIRECTED TO ITS LAST KNOWN ADDRESS WHICH SERVICE SHALL BE DEEMED COMPLETED WITHIN FIVE (5) DAYS AFTER THE DATE OF MAILING THEREOF.  EACH PARTY HEREBY IRREVOCABLY WAIVES ANY CLAIM THAT THE STATE OF CALIFORNIA IS AN INCONVENIENT FORUM OR AN IMPROPER FORUM BASED ON LACK OF VENUE AS WELL AS ANY RIGHT IT MAY NOW OR HEREAFTER HAVE TO REMOVE ANY SUCH ACTION OR PROCEEDING, ONCE COMMENCED TO ANOTHER COURT ON THE GROUNDS OF FORUM NON CONVENIENS OR OTHERWISE.  THE EXCLUSIVE CHOICE OF FORUM SET FORTH HEREIN SHALL NOT BE DEEMED TO PRECLUDE THE ENFORCEMENT BY EITHER PARTY OF ANY JUDGMENT OBTAINED IN SUCH FORUM OR THE TAKING OF ANY ACTION BY SUCH PARTY TO ENFORCE THE SAME IN ANY OTHER APPROPRIATE JURISDICTION.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.8</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Other Documents</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Borrower shall execute such other documents and shall otherwise cooperate with Administrative Agent as Administrative Agent reasonably requires to effectuate the transactions contemplated hereby.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.9</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  If any part of this Agreement shall be contrary to any law which a party might seek to apply or enforce or should otherwise be defective, the other provisions hereof shall not be affected thereby but shall continue in full force and effect, to which end they are hereby declared severable.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.10</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Entirety; Amendments</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  This Agreement and the Exhibits referred to herein constitute the entire agreement between Administrative Agent, Lenders, and Borrower as to the subject matter contemplated herein, and supersedes all prior agreements and understandings relating thereto. Each of the parties hereto acknowledges that no party hereto nor any agent of any other party whomsoever has made any promise, representation or warranty whatsoever, express or implied, not contained herein, concerning the subject matter hereof, to induce it to execute this Agreement.  No other agreements will be effective to change, modify or terminate this Agreement in whole or in part unless such agreement is in writing and duly executed by the party to be charged except as expressly set forth herein.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.11</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">WAIVER OF JURY TRIAL</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  EACH PARTY HEREBY UNCONDITIONALLY WAIVES ITS RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF, DIRECTLY OR INDIRECTLY, THIS AGREEMENT, ANY RELATED DOCUMENTS, ANY DEALINGS BETWEEN THE PARTIES RELATING TO THE SUBJECT MATTER OF THIS AGREEMENT, AND/OR THE RELATIONSHIP THAT IS BEING ESTABLISHED BY THE PARTIES.  THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT (INCLUDING, WITHOUT LIMITATION, TRANSACTION CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS).  </font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">46</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:1.731%;text-indent:0;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">THIS WAIVER IS IRREVOCABLE AND MAY NOT BE MODIFIED ORALLY OR IN WRITING, AND SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS AND MODIFICATIONS TO THIS AGREEMENT.  IN THE EVENT OF LITIGATION, THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO TRIAL BY THE COURT.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">WITHOUT INTENDING IN ANY WAY TO LIMIT THE PARTIES&#x2019; AGREEMENT TO WAIVE THEIR RESPECTIVE RIGHT TO A TRIAL BY JURY, if the above waiver of the right to a trial by jury is not enforceable, any disputes or controversies of any nature between them arising at any time shall be decided by a reference to a private judge, mutually selected by the parties (or, if they cannot agree, by the Presiding Judge of the Santa Clara County, California Superior Court) appointed in accordance with California Code of Civil Procedure Section 638 (or pursuant to comparable provisions of federal law if the dispute falls within the exclusive jurisdiction of the federal courts), sitting without a jury, in Santa Clara County, California; and the parties hereby submit to the jurisdiction of such court.  The reference proceedings shall be conducted pursuant to and in accordance with the provisions of California Code of Civil Procedure &#167;&#167; 638 through 645.1, inclusive.  The private judge shall have the power to decide all issues in the action or proceeding, whether of fact or of law, and shall report a statement of decision thereon pursuant to California Code of Civil Procedure &#167; 644(a).  Nothing in this paragraph shall limit the right of any party at any time to exercise self-help remedies, foreclose against collateral, or obtain provisional remedies.  The private judge shall also determine all issues relating to the applicability, interpretation, and enforceability of this paragraph.</font></p>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.12</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Publicity</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Each Lender will have the right to (a) make a public announcement and include on its website, social media sites, and other marketing materials information related to this transaction; provided that Lender and Borrower shall mutually agree on the timing and content of any publicity permitted by this Section 8.12(a), and (b) include information about this transaction, including but not limited to Borrower&#x2019;s name, the type of investment, principal amount, interest rate and maturity date, in its periodic reports with the Securities and Exchange Commission (&#x201c;SEC&#x201d;), to the extent required by SEC rules and regulations.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.13</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Demand Waiver</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Borrower waives, to the fullest extent permitted by law, demand, notice of default or dishonor, notice of payment and nonpayment, notice of any default, nonpayment at maturity, release, compromise, settlement, extension, or renewal of accounts, documents, instruments, chattel paper, and guarantees held by the Lenders on which Borrower or any Subsidiary is liable.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.14</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Counterparts</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  This Agreement may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Agreement.  Delivery of an executed counterpart of a signature page of this Agreement by facsimile, portable document format (.pdf) or other electronic transmission will be as effective as delivery of a manually executed counterpart hereof.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.15</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Electronic Execution of Certain Other Documents.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">  The words &#x201c;execution,&#x201d; &#x201c;execute&#x201d;, &#x201c;signed,&#x201d; &#x201c;signature,&#x201d; and words of like import in or related to any document to be signed in connection with this Agreement and the transactions contemplated hereby (including without limitation assignments, assumptions, amendments, waivers and consents) shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic platforms approved by the Administrative Agent, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the California Electronic Transactions Act, or any other similar state laws based on the Uniform Electronic Transactions Act.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.16</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Correction of Loan Documents</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. Administrative Agent, on behalf of Lenders, may correct patent errors and fill in any blanks in the Loan Documents consistent with the agreement of the parties so long as Administrative Agent provides Borrower with notice of such correction.</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">47</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.17</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Right of Set Off</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.  Borrower hereby grants to Administrative Agent, for the benefit of Lenders, a Lien, security interest and right of set off as security for all Obligations to Lenders hereunder, whether now existing or hereafter arising upon and against all deposits, credits, collateral and property, now or hereafter in the possession, custody, safekeeping or control of the Administrative Agent or any entity under the control of the Lenders (including a Lender affiliate) or in transit to any of them.  At any time after the occurrence and during the continuance of an Event of Default, without demand or notice, the Administrative Agent, on behalf of Lenders, may set off the same or any part thereof and apply the same to any liability or obligation of Borrower even though unmatured and regardless of the adequacy of any other collateral securing the Obligations.  ANY AND ALL RIGHTS TO REQUIRE LENDERS TO EXERCISE THEIR RIGHTS OR REMEDIES WITH RESPECT TO ANY OTHER COLLATERAL WHICH SECURES THE OBLIGATIONS, PRIOR TO EXERCISING THEIR RIGHT OF SETOFF WITH RESPECT TO SUCH DEPOSITS, CREDITS OR OTHER PROPERTY OF BORROWER ARE HEREBY KNOWINGLY, VOLUNTARILY AND IRREVOCABLY WAIVED BY BORROWER.</font></div></div>
  <div style="margin-left:1.731%;text-indent:6.784%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:0.6807843775758378%;">8.18</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Registers</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Register</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. The Administrative Agent, acting solely for this purpose as an agent of the Borrower, shall maintain a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amounts (and stated interest) of the Loans owing to, each Lender pursuant to the terms hereof from time to time (the &#x201c;Register&#x201d;).  The entries in the Register shall be conclusive absent manifest error, and the Borrower, the Administrative Agent and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement.  The Register shall be available for inspection by the Borrower and any Lender, at any reasonable time and from time to time upon reasonable prior notice.</font></div></div>
  <div style="margin-left:0.796%;text-indent:13.44%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Arial;justify-content:flex-start;min-width:4.036127575500988%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Participant Register</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">. Each Lender that sells a participation shall, acting solely for this purpose as a non-fiduciary agent of the Borrower, maintain a register on which it enters the name and address of each participant and the principal amounts (and stated interest) of each participant&#x2019;s interest in the Loans or other obligations under the Loan Documents (the &#x201c;Participant Register&#x201d;); provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any participant or any information relating to a participant&#x2019;s interest in any commitments, loans, its other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such commitment, loan, letter of credit or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations.  The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary.  For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register.  Borrower agrees that each participant shall be entitled to the benefits of the provisions in Section 2.11 (subject to the requirements and limitations therein, including the requirements under Section 2.11(g) (it being understood that the documentation required under Section 2.11(g) shall be delivered to the participating Lender)) to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to Section 8.4; provided that such participant shall not be entitled to receive any greater payment under Section 2.11, with respect to any participation, than its participating Lender would have been entitled to receive, except to the extent such entitlement to receive a greater payment results from a change in law that occurs after the participant acquired the applicable participation.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">8.19 Confidentiality.   In handling any confidential information of Borrower, the Lenders and Administrative Agent shall exercise the same degree of care that it exercises for their own proprietary information, but disclosure of information may be made: (a) subject to the terms and conditions of this Agreement, to the Lenders&#x2019; and Administrative Agent&#x2019;s Subsidiaries or Affiliates; (b) to prospective transferees (other than those identified in (a) above) or purchasers of any interest in the Loans (provided, however, the Lenders and Administrative Agent shall, except upon the occurrence and during the continuance of an Event of Default, obtain such prospective transferee&#x2019;s or purchaser&#x2019;s agreement to the terms of this provision or to similar confidentiality terms); (c) as required by law, regulation, subpoena, or</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">48</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">other order; (d) to Lenders&#x2019; or Administrative Agent&#x2019;s regulators or as otherwise required in connection with an examination or audit; (e) as Administrative Agent reasonably considers appropriate in exercising remedies under the Loan Documents; and (f) to third party service providers of the Lenders and/or Administrative Agent so long as such service providers have executed a confidentiality agreement with the Lenders and Administrative Agent with terms no less restrictive than those contained herein. Confidential information does not include information that either: (i) is in the public domain or in the Lenders&#x2019; and/or Administrative Agent&#x2019;s possession when disclosed to the Lenders and/or Administrative Agent, or becomes part of the public domain after disclosure to the Lenders and/or Administrative Agent; or (ii) is disclosed to the Lenders and/or Administrative Agent by a third party, if the Lenders and/or Administrative Agent does not know that the third party is prohibited from disclosing the information.  Administrative Agent and the Lenders may use confidential information for any purpose, including, without limitation, for the development of client databases, reporting purposes, and market analysis.  The provisions of the immediately preceding sentence shall survive the termination of this Agreement.  The agreements provided under this Section 8.19 supersede all prior agreements, understanding, representations, warranties, and negotiations between the parties about the subject matter of this Section 8.19.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">[SIGNATURES ON FOLLOWING PAGE]</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">49</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 10.2</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">	</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS AGREEMENT (INDICATED BY &#x201c;[***]&#x201d;) BECAUSE TAYSHA GENE THERAPIES, INC. HAS DETERMINED SUCH INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">IN WITNESS WHEREOF</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, the parties hereto have caused this Loan and Security Agreement to be duly executed as of the day and year first above written.</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:53.58%;"></td>
    <td style="width:6.58%;"></td>
    <td style="width:39.84%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">LENDER:</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">TRINITY CAPITAL INC.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">,</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">a Maryland corporation</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">By: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">/s/ Sarah Stanton</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Name:  Sarah Stanton</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Its: General Counsel and Chief Compliance Officer</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Address for Notices:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Trinity Capital Inc.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">1 N. 1</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Arial;position:relative;min-width:fit-content;">st</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;Street, Floor 3</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Phoenix, AZ 85004</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Attention: Legal Department</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Telephone: (480) 374-5350</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Email: legal@trincapinvestment.com</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">BORROWER</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">:</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">TAYSHA GENE THERAPIES, INC., <br>a Delaware corporation</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"><br><br>By: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">/s/ Kamran Alam</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Name: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Kamran Alam</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Its:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;Chief Financial Officer</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Address for Notices:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">3000 Pegasus Park Dr., Suite 1430</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Dallas, Texas 75247</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Attention: Kamran Alam</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Telephone: [***]</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Email Address: kalam@tayshagtx.com</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Arial;min-width:fit-content;">[</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Arial;font-style:italic;min-width:fit-content;">Signature Page to Loan And Security Agreement</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Arial;min-width:fit-content;">]</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Arial;min-width:fit-content;">DMS 40285223</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 10.2</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">	</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CERTAIN INFORMATION HAS BEEN EXCLUDED FROM THIS AGREEMENT (INDICATED BY &#x201c;[***]&#x201d;) BECAUSE TAYSHA GENE THERAPIES, INC. HAS DETERMINED SUCH INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:53.58%;"></td>
    <td style="width:6.58%;"></td>
    <td style="width:39.84%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">ADMINISTRATIVE AGENT:</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">TRINITY CAPITAL INC.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">,</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">a Maryland corporation</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">By: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">/s/ Sarah Stanton</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Name:  Sarah Stanton</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Its: General Counsel and Chief Compliance Officer</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Address for Notices:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Trinity Capital Inc.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">1 N. 1</font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Arial;position:relative;min-width:fit-content;">st</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;Street, Floor 3</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Phoenix, AZ 85004</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Attention: Legal Department</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Telephone: (480) 374-5350</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Email: legal@trincapinvestment.com</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Arial;min-width:fit-content;">[</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Arial;font-style:italic;min-width:fit-content;">Signature Page to Loan And Security Agreement</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Arial;min-width:fit-content;">]</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Arial;min-width:fit-content;">DMS 40285223</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">EXHIBIT A</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">FORM OF PROMISSORY NOTE</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;margin-right:0.037%;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;margin-right:0.037%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">$40,000,000.00	                November 13, 2023</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">FOR VALUE RECEIVED, TAYSHA GENE THERAPIES, INC.,a Delaware corporation</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Maker</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;), having an office at 3000 Pegasus Park Dr., Suite 1430, Dallas, Texas  75247, hereby promises to pay to the order of TRINITY CAPITAL INC</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, a Maryland corporation  the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Payee</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;), at 1 N 1</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Arial;min-width:fit-content;">st</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> Street, Floor 3, Phoenix, AZ  85004, or at such other place as the holder may, from time to time, designate, the sum of Forty Million Dollars ($40,000,000.00) or such other principal amount as Payee has advanced to Maker, together with interest at a rate set forth in the Loan Agreement.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">   </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">This Note is issued pursuant to a certain Loan and Security Agreement between Maker and Payee dated as of November 13, 2023 (as the same may be amended, amended and restated, supplemented or otherwise modified from time to time, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Loan Agreement</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;) and is subject to all of the terms thereof.  All defined terms used herein shall have the meanings ascribed to them in the Loan Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">This Note is secured by the Collateral described in the Loan Agreement.  This Note is cross-defaulted with all other Notes issued by Maker pursuant to the Loan Agreement.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">The Maker waives demand, presentment, protest and notice of any kind and consents to the extension of time of payments, the release, surrender or substitution of any and all security or guarantees for the obligations evidenced hereby or other indulgence with respect to this Note, all without notice.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">This Note may not be changed, modified or terminated orally, except only by an agreement in writing, signed by the party to be charged.  The Maker hereby authorizes the Payee to complete this Note and any particulars relating thereto according to the terms of the indebtedness evidenced hereby.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">This Note shall be governed by and construed in accordance with the laws of the State of California. The Maker hereby irrevocably consents to the jurisdiction of any state or federal court located in the State of California with respect to any action brought in respect of this Note.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Maker hereby WAIVES THE RIGHT TO A TRIAL BY JURY and all rights of setoff and to interpose permissive counterclaims and cross claims by any such actions.  Maker further agrees to pay to holder the costs and expenses of enforcement and collection of this Note, including attorneys&#x2019; fees and expenses and court costs.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">This Note shall be binding upon the successors, assigns and legal representatives of the Maker and inure to the benefit of the Payee, any holder and their successors, endorsees, assigns and legal representatives.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">TAYSHA GENE THERAPIES, INC.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">By: 	</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">/s/ Kamran Alam</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Name:	</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Kamran Alam</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Its: 	</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Chief Financial Officer</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">A-</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">1</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">EXHIBIT B</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">AMORTIZATION SCHEDULE</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">B-</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">1</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">EXHIBIT C</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">SECRETARY&#x2019;S CERTIFICATE<br></font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20.47%;"></td>
    <td style="width:41.784%;"></td>
    <td style="width:10.353%;"></td>
    <td style="width:27.393%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">BORROWER</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">:</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">TAYSHA GENE THERAPIES, INC.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p></td>
    <td colspan="2" style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Date</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">: November 13, 2023</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">ADMINISTRATIVE AGENT:</font></p></td>
    <td colspan="2" style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Trinity Capital Inc., as Administrative Agent</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Pursuant to the Loan and Security Agreement, dated as of November 13, 2023, by and among Borrower the Lenders party thereto, and Trinity Capital Inc., as administrative agent and collateral agent for the Lenders (&#x201c;Administrative Agent&#x201d;) (the &#x201c;Loan Agreement&#x201d;, unless otherwise defined herein, terms defined in the Loan Agreement and used herein shall have the meanings given to them in the Loan Agreement), I hereby certify as follows, as of the date set forth above:</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">1.	I am the Secretary or other Responsible Officer of Borrower.  My title is as set forth below.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">2.	Borrower&#x2019;s exact legal name is set forth above.  Borrower is a corporation existing under the laws of the State of Delaware.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">3.	Attached hereto as </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Annex I</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> and </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Annex II</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">, respectively, are true, correct and complete copies of (i) Borrower&#x2019;s Articles of Incorporation (including amendments), as filed with the Secretary of State of the state in which Borrower is incorporated as set forth in paragraph 2 above; and (ii) Borrower&#x2019;s Bylaws.  Neither such Articles of Incorporation nor such Bylaws have been amended, annulled, rescinded, revoked or supplemented, and such Articles of Incorporation and such Bylaws remain in full force and effect as of the date hereof.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">4.	The resolutions attached hereto as </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Annex III </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">were duly and validly adopted by Borrower&#x2019;s board of directors at a duly held meeting of such directors (or pursuant to a unanimous written consent or other authorized corporate action).  Such resolutions are in full force and effect as of the date hereof and have not been in any way modified, repealed, rescinded, amended or revoked, and the Lenders may rely on them until each Lender receives written notice of revocation from Borrower.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">5. 	Any one of the following officers or employees of Borrower, whose names, titles and signatures are below, may act on behalf of Borrower:</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:28.26%;"></td>
    <td style="width:28.26%;"></td>
    <td style="width:28.26%;"></td>
    <td style="width:15.22%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Name</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Title</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Signature</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Authorized to Add or Remove</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;Signatories</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x25a1;</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x25a1;</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x25a1;</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x25a1;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">[</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Balance of Page Intentionally Left Blank</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">]</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">C-</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">1</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">IN WITNESS WHEREOF, the undersigned has executed and delivered this Secretary&#x2019;s Certificate on behalf of TAYSHA GENE THERAPIES, INC. as of the date first set forth above.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">						By:_______________________________</font></p>
  <p style="margin-left:40%;text-indent:11.111%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Name:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">						</font></p>
  <p style="margin-left:40%;text-indent:11.111%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Title:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">						</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;margin-right:0.037%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">The undersigned, [___], [___] of TAYSHA GENE THERAPIES, INC., does hereby certify that [___] is the duly elected and presently incumbent [___] of TAYSHA GENE THERAPIES, INC., and that the statements and signatures in the foregoing Secretary&#x2019;s Certificate are true and correct on the date hereof.		</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;margin-right:0.037%;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40%;text-indent:11.111%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">By:_______________________________</font></p>
  <p style="margin-left:40%;text-indent:11.111%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Name:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">						</font></p>
  <p style="margin-left:40%;text-indent:11.111%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Title:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">						</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;margin-right:0.037%;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;margin-right:0.037%;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Arial;min-width:fit-content;">[Signature Page to Secretary&#x2019;s Certificate]</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">ANNEX I<br><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Articles of Incorporation (including amendments)</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">[see attached]</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">ANNEX II<br><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Bylaws</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">[see attached]</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">ANNEX III<br><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Resolutions</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">[see attached]</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">EXHIBIT D</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">FORM OF COMPLIANCE CERTIFICATE</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.66%;"></td>
    <td style="width:86.34%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">TO:</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Trinity Capital Inc., as Administrative Agent</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">FROM:</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">TAYSHA GENE THERAPIES, INC.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">The undersigned authorized officer (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Officer</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;) of TAYSHA GENE THERAPIES, INC. (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Borrower</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;), hereby certifies that in accordance with the terms and conditions of the Loan and Security Agreement dated as of November 13, 2023 , by and among Borrower, the Lenders party thereto, and Trinity Capital Inc., as administrative agent and collateral agent for the Lenders (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Administrative Agent</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;) (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Loan Agreement</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">;&#x201d; capitalized terms used but not otherwise defined herein shall have the meanings given them in the Loan Agreement),</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(a)	Borrower is in complete compliance for the period ending _______________ with all required covenants except as noted below;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(b)	There are no Potential Events of Default or Events of Default, except as noted below;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(c)	Except as noted below, all representations and warranties of Borrower stated in the Loan Documents are true and correct in all material respects on this date and for the period described in (a), above; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(d)	Borrower and each Subsidiary has filed all federal, state and other tax returns that are required to be filed and has paid all taxes shown thereon to be due, together with applicable interest and penalties, and all other taxes, fees or other charges imposed on it or any of its property by any governmental or regulatory authority in accordance with the terms of the Loan Agreement.  No tax Liens have been filed, and, to the Knowledge of Borrower, no claim is being asserted, with respect to any such tax, fee or other charge.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(e)	No Liens have been levied or claims made against Borrower or any of its Subsidiaries relating to unpaid employee payroll or benefits of which Borrower has not previously provided written notification to Administrative Agent.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Attached are the required documents, if any, supporting our certification(s).  The Officer, on behalf of Borrower, further certifies that the attached financial statements are prepared in accordance with GAAP applied on a consistent basis from one period to the next except as explained in an accompanying letter or footnotes and except, in the case of unaudited financial statements, for the absence of footnotes and subject to year&#x2011;end audit adjustments as to the interim financial statements.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">  </font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;margin-right:0.037%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Please indicate compliance status since the last Compliance Certificate by circling Yes, No, or N/A under &#x201c;Complies&#x201d; column.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;margin-right:0.037%;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">D-</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">1</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:5.261%;"></td>
    <td style="width:28.946%;"></td>
    <td style="width:30.706%;"></td>
    <td style="width:12.282%;"></td>
    <td style="width:7.602%;"></td>
    <td style="width:7.602%;"></td>
    <td style="width:7.602%;"></td>
   </tr>
   <tr style="height:29.5pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Reporting Covenant</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Requirement</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Actual</font></p></td>
    <td colspan="3" style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Complies</font></p></td>
   </tr>
   <tr style="height:14.4pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">1.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Quarterly financial statements</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Quarterly within 45 days</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">N/A</font></p></td>
   </tr>
   <tr style="height:33.1pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">2.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Compliance Certificate</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Quarterly within 45 days</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">N/A</font></p></td>
   </tr>
   <tr style="height:22.3pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">3.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Annual (CPA Audited) statements</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Within 180 days after FYE</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">N/A</font></p></td>
   </tr>
   <tr style="height:22.3pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">4.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Annual Financial Projections</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Within 10 days of board of directors Approval but no later than 60 days after FYE</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">N/A</font></p></td>
   </tr>
   <tr style="height:18pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">5.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">8&#x2011;K, 10&#x2011;K and 10&#x2011;Q Filings</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">At time of filing</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">N/A</font></p></td>
   </tr>
   <tr style="height:18pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">6.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">IP Report</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Concurrently with Compliance Certificate</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">N/A</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">*To the extent the foregoing documents are included in materials otherwise filed with Securities and Exchange Commission, such documents shall be deemed to have been delivered on the date on which Borrower posts such documents, or provides a link thereto, on Borrower&#x2019;s website.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Deposit and Securities Accounts</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">(Please list all accounts; attach separate sheet if additional space needed)</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:5.261%;"></td>
    <td style="width:22.805%;"></td>
    <td style="width:26.625%;"></td>
    <td style="width:7.301%;"></td>
    <td style="width:7.301%;"></td>
    <td style="width:17.664%;"></td>
    <td style="width:13.043%;"></td>
   </tr>
   <tr style="height:20.9pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Institution Name</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Account Number</font></p></td>
    <td colspan="2" style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">New Account?</font></p></td>
    <td colspan="2" style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Account Control Agreement in place?</font></p></td>
   </tr>
   <tr style="height:20.9pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">1.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
   </tr>
   <tr style="height:20.9pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">2.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
   </tr>
   <tr style="height:20.9pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">3.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
   </tr>
   <tr style="height:20.9pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">4.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Other Matters</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:7.061%;"></td>
    <td style="width:72.775%;"></td>
    <td style="width:9.642%;"></td>
    <td style="width:10.522%;"></td>
   </tr>
   <tr style="height:14.4pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">1.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Have there been any changes in Key Persons since the last Compliance Certificate?</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
   </tr>
   <tr style="height:11.5pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:17.3pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">2.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Have there been any transfers/sales/dispositions/retirement of Collateral or IP prohibited by the Loan Agreement?</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
   </tr>
   <tr style="height:12.95pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:29.5pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">3.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Have there been any new or pending material claims or causes of action against Borrower?</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
   </tr>
   <tr style="height:14.4pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:29.5pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">4.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Has Borrower provided the Administrative Agent with all notices required to be delivered under Sections 3.2, 3.7, 3.8(c), 4.2 and 4.3 of the Loan Agreement?</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
   </tr>
   <tr style="height:15.85pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:29.5pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">5.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Have there been any material updates to the contents of the Perfection Certificate last delivered?  If yes, please explain.</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Yes</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:middle;padding-right:0.075in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">No</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">D-</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">2</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;margin-right:0.037%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Exceptions</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;margin-right:0.037%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Please explain any exceptions with respect to the certification above: (If no exceptions exist, state &#x201c;No exceptions.&#x201d;  Attach separate sheet if additional space needed.)</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;margin-right:0.037%;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;margin-right:0.037%;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">TAYSHA GENE THERAPIES, INC.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">By:  </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">				</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Name: Kamran Alam</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Title:  </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">Chief Financial Officer</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Date:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">				</font></p>
  <p style="margin-left:40%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:37.667%;border-spacing:0;table-layout:fixed;width:63.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:66.16%;"></td>
    <td style="width:33.84%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td colspan="2" style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">ADMINISTRATIVE AGENT USE ONLY</font></p></td>
   </tr>
   <tr>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Received by:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Date:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">  </font></p></td>
   </tr>
   <tr>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Verified by:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">  </font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Date:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">  </font></p></td>
   </tr>
   <tr>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td colspan="2" style="word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Compliance Status:	Yes		No</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">D-</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">3</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">EXHIBIT E<br><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Loan Advance Request Form</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Email To:  	Date: _____________________</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-top:0.75pt solid #000000;border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">LOAN PAYMENT</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">:</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">TAYSHA GENE THERAPIES, INC.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">From Account #________________________________	To Account #______________________________</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:13.333%;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(Deposit Account #)						(Loan Account #)</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Principal $____________________________________	and/or Interest $____________________________</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Authorized Signature:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">	Phone Number: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Print Name/Title: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-top:0.75pt solid #000000;border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">LOAN ADVANCE:</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Complete </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Outgoing Wire Request</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> section below if all or a portion of the funds from this loan advance are for an outgoing wire.</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">From Account #________________________________	To Account #_______________________________</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:13.333%;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">(Loan Account #)						(Deposit Account #)</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Amount of Advance $___________________________ to be paid in accordance with the amortization schedule delivered pursuant to Section 2.1 of the Loan and Security Agreement.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">All Borrower&#x2019;s representations and warranties in the Loan and Security Agreement are true, correct and complete in all material respects on the date of the request for an advance; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date:</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Authorized Signature:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">	Phone Number: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Print Name/Title: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-top:0.75pt solid #000000;border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">OUTGOING WIRE REQUEST:</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Complete only if all or a portion of funds from the loan advance above is to be wired.</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Beneficiary Name: _____________________________	Amount of Wire: $</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Beneficiary Bank: ______________________________	Account Number: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">City and State: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Beneficiary Bank Transit (ABA) #: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">	Beneficiary Bank Code (Swift, Sort, Chip, etc.): </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:46.667%;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">(For International Wire Only)</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Intermediary Bank: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">	Transit (ABA) #: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">For Further Credit to: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Special Instruction: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">	</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">By signing below, I (we) acknowledge and agree that my (our) funds transfer request shall be processed in accordance with and subject to the terms and conditions set forth in the agreements(s) covering funds transfer service(s), which agreements(s) were previously received and executed by me (us).</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> DOCPROPERTY iManageFooter \* MERGEFORMAT #294081348v2&lt;NAACTIVE&gt; - Trinity - Taysha Gene - Loan and Security Agreement [REDACTED]</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="border-top:0.75pt solid #000000;border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Authorized Signature: _____________________	2</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Arial;min-width:fit-content;">nd</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> Signature (if required): ___________________________</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Print Name/Title: _________________________	Print Name/Title: __________________________________</font></p>
  <p style="border-right:0.75pt solid #000000;text-indent:0;border-left:0.75pt solid #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">Telephone #: </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">			</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;">		Telephone #:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Arial;min-width:fit-content;">			</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Arial;min-width:fit-content;"> DOCPROPERTY iManageFooter \* MERGEFORMAT #294081348v2&lt;NAACTIVE&gt; - Trinity - Taysha Gene - Loan and Security Agreement [REDACTED]</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>tsha-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 31.1</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">I, Sean Nolan, certify that:</font></p>
  <div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">I have reviewed this Quarterly Report on Form 10-Q of Taysha Gene Therapies, Inc.;</font></div></div>
  <div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in exchange act rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49%;"></td>
    <td style="width:1%;"></td>
    <td style="width:4%;"></td>
    <td style="width:46%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Date: November 14, 2023</font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">/s/ Sean Nolan</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Sean Nolan</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Chief Executive Officer</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>tsha-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 31.2</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">I, Kamran Alam, certify that:</font></p>
  <div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">I have reviewed this Quarterly Report on Form 10-Q of Taysha Gene Therapies, Inc.;</font></div></div>
  <div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in exchange act rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div style="text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49%;"></td>
    <td style="width:1%;"></td>
    <td style="width:4%;"></td>
    <td style="width:46%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Date: November 14, 2023</font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">/s/ Kamran Alam</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Kamran Alam</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Chief Financial Officer</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Principal Financial Officer and Principal Accounting Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>tsha-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 32.1</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350), Sean Nolan, Chief Executive Officer of Taysha Gene Therapies, Inc. (the &#x201c;Company&#x201d;) hereby certifies that, to the best of his knowledge:</font></p>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#x2019;s Quarterly Report on Form 10-Q for the period ended September 30, 2023, to which this Certification is attached as Exhibit 32.1 (the &#x201c;Periodic Report&#x201d;) fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.46%;"></td>
    <td style="width:5.04%;"></td>
    <td style="width:4%;"></td>
    <td style="width:45.5%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Date: November 14, 2023</font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">/s/ Sean Nolan</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Sean Nolan</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Chief Executive Officer</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>tsha-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32.2</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 32.2</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350), Kamran Alam, Chief Financial Officer of Taysha Gene Therapies, Inc. (the &#x201c;Company&#x201d;) hereby certifies that, to the best of his knowledge:</font></p>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#x2019;s Quarterly Report on Form 10-Q for the period ended September 30, 2023, to which this Certification is attached as Exhibit 32.2 (the &#x201c;Periodic Report&#x201d;) fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.46%;"></td>
    <td style="width:5.04%;"></td>
    <td style="width:4%;"></td>
    <td style="width:45.5%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Date: November 14, 2023</font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">/s/ Kamran Alam</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Kamran Alam</font></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Chief Financial Officer</font></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">(Principal Financial Officer and Principal Accounting Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img38651418_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img38651418_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $*!+@# 2(  A$! Q$!_\0
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M% '0?\)SXG_Z#-S^8_PH_P"$Y\3_ /09N?S'^%<_10!T'_"<^)_^@S<_F/\
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M)SXG_P"@S<_F/\*Z\V6DZAK>EV#V,#V>JVLD?VR&UC@<2)(QR$7A67&TX/S
M@UY[JUW%?ZK<W,%K%:PNY\N&)0%11P!QWP.3W/-*Y31I_P#"<^)_^@S<_F/\
M*/\ A.?$_P#T&;G\Q_A7/T4Q'0?\)SXG_P"@S<_F/\*/^$Y\3_\ 09N?S'^%
M<_10!T'_  G/B?\ Z#-S^8_PJUIWC3Q)/J=I#+J]RT;S(K*2.06 (Z5RM7-)
M_P"0S8_]?$?_ *$* -B;QOXF6:11K-R &( R/7Z5'_PG/B?_ *#-S^8_PK#G
M_P"/B7_?/\ZCH Z#_A.?$_\ T&;G\Q_A1_PG/B?_ *#-S^8_PKGZ* .@_P"$
MY\3_ /09N?S'^%'_  G/B?\ Z#-S^8_PKGZ* .@_X3GQ/_T&;G\Q_A1_PG/B
M?_H,W/YC_"NAA.CVOA33$O(;%I+NS/EQ"U'GM-]H($GF;?NA0006YQC%=-/I
M6F3Z^%MM-M9DBGOH28].B!B98LI'Y0XDQC<I/)Z<4WI^/X"6OX?B><?\)SXG
M_P"@S<_F/\*/^$Y\3_\ 09N?S'^%=#<Z?<IH[2V.CQ7-VUTZZA]JTV.%X(PB
M[-R#B!2"QW CIG=3Y-"1->LIFTI5L)=%W!S;XB>7[,S$YQ@MD9]<C-)NRO\
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M![#N>&I];,/,Z#_A.?$__09N?S'^%'_"<^)_^@S<_F/\*Y^B@#H/^$Y\3_\
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MG>21%GFM[@/%,_G(3]F+HZDQH.N>FX9'#9!I-V3?;_@_Y#MK8Y3_ (3GQ/\
M]!FY_,?X4?\ "<^)_P#H,W/YC_"N?HH Z#_A.?$__09N?S'^%'_"<^)_^@S<
M_F/\*Y^B@#H/^$Y\3_\ 09N?S'^%'_"<^)_^@S<_F/\ "N?HH Z#_A.?$_\
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M7_DW_ //:*]"HH_LK^_^'_!#_67_ *=?^3?\ \]HKT*BC^RO[_X?\$/]9?\
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M_?\ P_X(?ZR_].O_ ";_ (!Y[6AH7_(?T_\ Z^$_]"%=E0"0<@X(H_LK^_\
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M^Y)_Z U=E0"0<@XH_LK^_P#A_P $/]9?^G7_ )-_P#SVBO0J*/[*_O\ X?\
M!#_67_IU_P"3?\ \]HKT*BC^RO[_ .'_  0_UE_Z=?\ DW_ //:*]"HH_LK^
M_P#A_P $/]9?^G7_ )-_P#SVBO0J*/[*_O\ X?\ !#_67_IU_P"3?\ \]HKT
M*BC^RO[_ .'_  0_UE_Z=?\ DW_ //:*]"HH_LK^_P#A_P $/]9?^G7_ )-_
MP#SVBO0J*/[*_O\ X?\ !#_67_IU_P"3?\ \]HKT*BC^RO[_ .'_  0_UE_Z
M=?\ DW_ //:*]"HH_LK^_P#A_P $/]9?^G7_ )-_P#SVBO0J*/[*_O\ X?\
M!#_67_IU_P"3?\ XW6/^/J#_ *](/_12UGUZ$23U.:*/[*_O_A_P0_UE_P"G
M7_DW_ //:*]"HH_LK^_^'_!#_67_ *=?^3?\ \]HKT*BC^RO[_X?\$/]9?\
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MCKH3OJ<#33LPHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^L:9K%G>:WY<-G!X:FN_+@OGF$S*T6'<,B /SC^+[QYI*K)]7_2?^0WAZ?\
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M/^@58_\ @.G^%']A:1_T"K'_ ,!T_P *QO!&GI'I?]I?:=1E:ZDE,8NM0GG
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MG^%']A:1_P! JQ_\!T_PKDI_$6L0Z)IO]DJLEW(EQ+)"UN;@^7&^TOOEN8@
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M2?=A["E_*ON1QW]EZ?\ \^%K_P!^5_PH_LO3_P#GPM?^_*_X5YG17K_V=/\
MY^/^OF?*_P!O4O\ GPOO7_R)Z9_9>G_\^%K_ -^5_P */[+T_P#Y\+7_ +\K
M_A7F=%']G3_Y^/\ KYA_;U+_ )\+[U_\B>F?V7I__/A:_P#?E?\ "C^R]/\
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MX6O_ 'Y7_"I(-,T\3QD6-L"&'/E+_A7E]%+^SI_\_/Z^\?\ ;]+_ )\+[_\
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M(4Z6SMIKF"XEMX9)X-WDRN@+1Y&#M/49'!Q4=@H_LZVZ_P"J7N?058V#U/\
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M(QA8G<2F1\I)YR._-6FL;1_,W6L#>;(LLF8P=[KC:Q]2-JX/4;1Z5-L'J?\
MOHT;!ZG_ +Z- &=!X<T.U>=[?1M.A>?/G-':HIDR03NP.<D \^E7FM;=I9)6
M@B,DJ".1B@RZ#.%)[@;FX]SZT_8/4_\ ?1HV#U/_ 'T: ,V[\-:#?P6T%YHF
MFW,-JNRWCFM$=85X&$!&%' X'H*DGT+2+J_2_N-*L9;Q%"K<26Z-(H!R &(R
M #S5[8/4_P#?1HV#U/\ WT: *-YH6CZC9PV=]I5C=6L&/*@GMT=(\# VJ1@8
M''%5X?"^CQ:Q-JS6%O-?22B5)I849X2(UCQ&V,J,(._4FM;8/4_]]&C8/4_]
M]&CS S$\,Z!$+D1Z'IJ"Z#"X"VD8\X,<D/Q\V2!G/I5M-,L(X3"EC;+$61RB
MQ* 63:$.,=5V+@]MHQT%6-@]3_WT:-@]3_WT: *=EI5M87NH7D6XSW\JRS,V
M.JHJ # Z */S-7J;L'J?^^C1L'J?^^C0 ZBF[!ZG_OHT;!ZG_OHT <+_ ,(U
MI'_/I_Y$?_&C_A&M(_Y]/_(C_P"-;/FMZ)_WP/\ "CS6]$_[X'^%;?6*W\[^
M]G+]1PO_ #ZC]R_R,;_A&M(_Y]/_ "(_^-'_  C6D?\ /I_Y$?\ QK9\UO1/
M^^!_A1YK>B?]\#_"CZQ6_G?WL/J.%_Y]1^Y?Y&-_PC6D?\^G_D1_\:/^$:TC
M_GT_\B/_ (UL^:WHG_? _P */-;T3_O@?X4?6*W\[^]A]1PO_/J/W+_(QO\
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M][#ZCA?^?4?N7^1C?\(UI'_/I_Y$?_&C_A&M(_Y]/_(C_P"-;/FMZ)_WP/\
M"CS6]$_[X'^%'UBM_._O8?4<+_SZC]R_R,;_ (1K2/\ GT_\B/\ XT?\(UI'
M_/I_Y$?_ !K9\UO1/^^!_A1YK>B?]\#_  H^L5OYW][#ZCA?^?4?N7^1C?\
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MT3_O@?X4?6*W\[^]A]1PO_/J/W+_ ",;_A&M(_Y]/_(C_P"-'_"-:1_SZ?\
MD1_\:V?-;T3_ +X'^%'FMZ)_WP/\*/K%;^=_>P^HX7_GU'[E_D8W_"-:1_SZ
M?^1'_P :/^$:TC_GT_\ (C_XUL^:WHG_ 'P/\*/-;T3_ +X'^%'UBM_._O8?
M4<+_ ,^H_<O\C&_X1K2/^?3_ ,B/_C1_PC6D?\^G_D1_\:V?-;T3_O@?X4>:
MWHG_ 'P/\*/K%;^=_>P^HX7_ )]1^Y?Y&-_PC6D?\^G_ )$?_&C_ (1K2/\
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M_P!\#_"CS6]$_P"^!_A69N,HI_FMZ)_WP/\ "CS6]$_[X'^% #**?YK>B?\
M? _PH\UO1/\ O@?X4 ,HI_FMZ)_WP/\ "CS6]$_[X'^% #**?YK>B?\ ? _P
MH\UO1/\ O@?X4 ,HI_FMZ)_WP/\ "CS6]$_[X'^% #**?YK>B?\ ? _PH\UO
M1/\ O@?X4 ,HI_FMZ)_WP/\ "CS6]$_[X'^% #**?YK>B?\ ? _PH\UO1/\
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M_P"-'_"-:1_SZ?\ D1_\:/[3H]G^'^8?ZN8K^:/WO_(\^HKT'_A&M(_Y]/\
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M_P#/JG_??_UJ/^$LE_Y]4_[[_P#K5SM%']JXO^?\%_D'U*A_+^9T7_"62_\
M/JG_ 'W_ /6H_P"$LE_Y]4_[[_\ K5SM%']JXO\ G_!?Y!]2H?R_F=%_PEDO
M_/JG_??_ -:C_A+)?^?5/^^__K5SM%']JXO^?\%_D'U*A_+^9T7_  EDO_/J
MG_??_P!:C_A+)?\ GU3_ +[_ /K5SM%']JXO^?\ !?Y!]2H?R_F=%_PEDO\
MSZI_WW_]:C_A+)?^?5/^^_\ ZU<[11_:N+_G_!?Y!]2H?R_F=%_PEDO_ #ZI
M_P!]_P#UJ/\ A+)?^?5/^^__ *U<[11_:N+_ )_P7^0?4J'\OYG1?\)9+_SZ
MI_WW_P#6H_X2R7_GU3_OO_ZU<[11_:N+_G_!?Y!]2H?R_F=%_P )9+_SZI_W
MW_\ 6H_X2R7_ )]4_P"^_P#ZU<[11_:N+_G_  7^0?4J'\OYG1?\)9+_ ,^J
M?]]__6H_X2R7_GU3_OO_ .M7.T4?VKB_Y_P7^0?4J'\OYG1?\)9+_P ^J?\
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M:N+_ )_P7^0?4J'\OYFK_;"_\^W_ )$_^M1_;"_\^W_D3_ZU95%']JXO^?\
M!?Y!]2H?R_F:O]L+_P ^W_D3_P"M1_;"_P#/M_Y$_P#K5E44?VKB_P"?\%_D
M'U*A_+^9J_VPO_/M_P"1/_K4?VPO_/M_Y$_^M6511_:N+_G_  7^0?4J'\OY
MFK_;"_\ /M_Y$_\ K4?VPO\ S[?^1/\ ZU95%']JXO\ G_!?Y!]2H?R_F:O]
ML+_S[?\ D3_ZU*NLJK _9NAS_K/_ *U9-%']JXO^?\%_D'U*A_+^9JG6%)S]
MF_\ (G_UJ/[87_GV_P#(G_UJRJ*/[5Q?\_X+_(/J5#^7\S5_MA?^?;_R)_\
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M)*__ #ZK_P!]_P#UJ/\ A)7_ .?5?^^__K5STMQ#!CSI8X\]-[ 9J/[?9_\
M/W!_W\%-9GC7M+\%_D+ZGA_Y?Q9TO_"2O_SZK_WW_P#6H_X25_\ GU7_ +[_
M /K5@/+'$F^1U1/[S' I&EC2/S'D58^NXG _.E_:F,_G_!?Y#^I8?^7\SH/^
M$E?_ )]5_P"^_P#ZU'_"2O\ \^J_]]__ %JP58,H92"I&01WIJS1.7"2HVSA
ML,#M^OI1_:F,_G_!?Y!]2P_\OYG0?\)*_P#SZK_WW_\ 6H_X25_^?5?^^_\
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M?_(B_P"-'U/$?\^Y?<P^L4OYE]Z,RBM/_A']4_Y]?_(B_P"-'_"/ZI_SZ_\
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M/]GW7_/+_P >'^-']GW7_/+_ ,>'^-'U/$?\^Y?<P^L4OYE]Z*U%6?[/NO\
MGE_X\/\ &C^S[K_GE_X\/\:/J>(_Y]R^YA]8I?S+[T5J*L_V?=?\\O\ QX?X
MTHTZ[8@"+D_[0_QH^IXC_GW+[F'UBE_,OO15HJS_ &?=?\\O_'A_C1_9]U_S
MR_\ 'A_C1]3Q'_/N7W,/K%+^9?>BM15G^S[K_GE_X\/\:/[/NO\ GE_X\/\
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M2-#%QBX1A*SWT?0SG+#3DI2:;5[:KKN8\4"PP^4I;;G/)YJ2-1%&43(!??\
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M_P :/98W^67W,.?#]U]Z.6'AS3U=&177:",;L@Y&#G.:T+2V2SM8[>-G9$&
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MNT_Y&']F3_F1T%%<_P#:9_\ GM)_WT:/M,__ #VD_P"^C1_;M/\ D8?V9/\
MF1T%%<_]IG_Y[2?]]&C[3/\ \]I/^^C1_;M/^1A_9D_YD=!3X?\ 7)_O"N<^
MTS_\]I/^^C0+F<'(GD!_WS1_;M/^1A_9D_YD=!17/_:9_P#GM)_WT:/M,_\
MSVD_[Z-']NT_Y&']F3_F1T%%8<%Y/'*#N>0'C:3G-;8.0#C'L:]'!8Z&+3<5
M:QRXC#2H-)N]Q:***[3F"BBB@ HHHH **** "BBB@ HHHH **** "GQ?ZP?0
M_P J93XO]8/H?Y4 ,HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH W=/_X\8_Q_F:LU6T__ (\8_P ?YFK- !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% %>P_P"0=:_]<D_D*=+9VTUS!<2V\,D\
M&[R970%H\C!VGJ,C@XKB8/B!'!;QPC3V;8@7/F8S@8]*D_X6(G_0.;_O[_\
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M\+$3_H'-_P!_?_K4OKE#^;\Q^VAW.LU'2-,UBW6WU/3K2^A5MZQW,*RJ&Z9
M8$9Y-20V%G;+&L%I!$L40AC"1A0D8Z(,#A>.G2N/_P"%B)_T#F_[^_\ UJ/^
M%B)_T#F_[^__ %J/KE#^;\P]M#N=C'96L)A,5M"A@C,4)6,#RT.,JOH/E7@>
M@]*GKA_^%B)_T#F_[^__ %J/^%B)_P! YO\ O[_]:G]=H?S?F'MH=SN**X?_
M (6(G_0.;_O[_P#6H_X6(G_0.;_O[_\ 6I?7*'\WYA[:'<[BBN'_ .%B)_T#
MF_[^_P#UJ/\ A8B?] YO^_O_ -:CZY0_F_,/;0[G<45P_P#PL1/^@<W_ ']_
M^M1_PL1/^@<W_?W_ .M1]<H?S?F'MH=SN*KI8VD0A$=K @A0QQ!8P-BG&57T
M!P.!Z"N/_P"%B)_T#F_[^_\ UJ/^%B)_T#F_[^__ %J/KE#^;\P]M#N=';>&
M/#]G;7-M:Z%ID$%TH6XBBM(U68#. X PPY/7UJU!I>G6MS]IM["UBN/*6#S8
MX55O+7HF0,[1V'2N2_X6(G_0.;_O[_\ 6H_X6(G_ $#F_P"_O_UJ/KE#^;\Q
M>UAW-]O"NB)I&H:99:=;:?;W\;17'V*!(BX((.<#!.">3ZU?_LVQ\IXC9P%)
M(1;NK1@[XAG"'/51N;@\<GUKD?\ A8B?] YO^_O_ -:C_A8B?] YO^_O_P!:
MG]=H?S?F/VT.YU,NB:3-J U"72[*2]50HN7MT,@ .0-V,X! (IUSI&F7EB]C
M=:=:3V;L7:WE@5HV8MN)*D8)W<Y]>:Y3_A8B?] YO^_O_P!:C_A8B?\ 0.;_
M +^__6I?7*'\WYA[:'<Z^+3K&&&*&*SMXXHHC#&BQ*%2,XR@&.%.!QTX%(^F
M6$D4D3V-LT<L(@D5HE(>(9PA&.5&YN.G)]:Y'_A8B?\ 0.;_ +^__6H_X6(G
M_0.;_O[_ /6H^N4/YOS#VT.YUFFZ3INC6[6^EZ?:6,+-O:.UA6)2V ,D* ,X
M Y]JN5P__"Q$_P"@<W_?W_ZU'_"Q$_Z!S?\ ?W_ZU/Z[0_F_,7M8=SN**X?_
M (6(G_0.;_O[_P#6H_X6(G_0.;_O[_\ 6I?7*'\WYC]M#N=Q17#_ /"Q$_Z!
MS?\ ?W_ZU'_"Q$_Z!S?]_?\ ZU'URA_-^8>VAW.XHKA_^%B)_P! YO\ O[_]
M:C_A8B?] YO^_O\ ]:CZY0_F_,/;0[G<45P__"Q$_P"@<W_?W_ZU'_"Q$_Z!
MS?\ ?W_ZU'URA_-^8>VAW+/]GVO_ #R_\>/^-']GVO\ SR_\>/\ C6/_ ,)?
M;_\ /E+_ -_1_A1_PE]O_P ^4O\ W]'^%<]\!_+'_P !_P" :_79?SO[V;']
MGVO_ #R_\>/^-']GVO\ SR_\>/\ C6/_ ,)?;_\ /E+_ -_1_A1_PE]O_P ^
M4O\ W]'^%%\!_+'_ ,!_X ?79?SO[V;']GVO_/+_ ,>/^-']GVO_ #R_\>/^
M-8__  E]O_SY2_\ ?T?X4?\ "7V__/E+_P!_1_A1? ?RQ_\  ?\ @!]=E_._
MO9L?V?:_\\O_ !X_XT?V?:_\\O\ QX_XUC_\)?;_ //E+_W]'^%'_"7V_P#S
MY2_]_1_A1? ?RQ_\!_X ?79?SO[V;']GVO\ SR_\>/\ C1_9]K_SR_\ 'C_C
M6/\ \)?;_P#/E+_W]'^%'_"7V_\ SY2_]_1_A1? ?RQ_\!_X ?79?SO[V;']
MGVO_ #R_\>/^-']GVO\ SR_\>/\ C6/_ ,)?;_\ /E+_ -_1_A1_PE]O_P ^
M4O\ W]'^%%\!_+'_ ,!_X ?79?SO[V;']GVO_/+_ ,>/^-']GVO_ #R_\>/^
M-8__  E]O_SY2_\ ?T?X4?\ "7V__/E+_P!_1_A1? ?RQ_\  ?\ @!]=E_._
MO9L?V?:_\\O_ !X_XT?V?:_\\O\ QX_XUC_\)?;_ //E+_W]'^%'_"7V_P#S
MY2_]_1_A1? ?RQ_\!_X ?79?SO[V;']GVO\ SR_\>/\ C1_9]K_SR_\ 'C_C
M6/\ \)?;_P#/E+_W]'^%'_"7V_\ SY2_]_1_A1? ?RQ_\!_X ?79?SO[V;']
MGVO_ #R_\>/^-.33K4R*#%P2/XC_ (UB_P#"7V__ #Y2_P#?T?X4J>,+974F
MREP"#_K!_A1? ?RQ_P# ?^ 'UV7\[^]FN=/M03^Z_P#'C_C1_9]K_P \O_'C
M_C6.?%]L23]BE_[^C_"C_A+[?_GRE_[^C_"B^ _EC_X#_P  /KLOYW][-C^S
M[7_GE_X\?\:/[/M?^>7_ (\?\:Q_^$OM_P#GRE_[^C_"C_A+[?\ Y\I?^_H_
MPHO@/Y8_^ _\ /KLOYW][-C^S[7_ )Y?^/'_ !H_L^U_YY?^/'_&L?\ X2^W
M_P"?*7_OZ/\ "C_A+[?_ )\I?^_H_P *+X#^6/\ X#_P ^NR_G?WLV/[/M?^
M>7_CQ_QH_L^U_P">7_CQ_P :Q_\ A+[?_GRE_P"_H_PH_P"$OM_^?*7_ +^C
M_"B^ _EC_P" _P# #Z[+^=_>S8_L^U_YY?\ CQ_QH_L^U_YY?^/'_&L?_A+[
M?_GRE_[^C_"C_A+[?_GRE_[^C_"B^ _EC_X#_P  /KLOYW][-C^S[7_GE_X\
M?\:/[/M?^>7_ (\?\:Q_^$OM_P#GRE_[^C_"C_A+[?\ Y\I?^_H_PHO@/Y8_
M^ _\ /KLOYW][-C^S[7_ )Y?^/'_ !H_L^U_YY?^/'_&L?\ X2^W_P"?*7_O
MZ/\ "C_A+[?_ )\I?^_H_P *+X#^6/\ X#_P ^NR_G?WLV/[/M?^>7_CQ_QH
M_L^U_P">7_CQ_P :Q_\ A+[?_GRE_P"_H_PH_P"$OM_^?*7_ +^C_"B^ _EC
M_P" _P# #Z[+^=_>S8_L^U_YY?\ CQ_QH_L^U_YY?^/'_&L?_A+[?_GRE_[^
MC_"C_A+[?_GRE_[^C_"B^ _EC_X#_P  /KLOYW][-C^S[7_GE_X\?\:='IUH
MTJ@Q<$_WC_C6+_PE]O\ \^4O_?T?X4Z/QA;+(K&REP#G_6 _THO@/Y8_^ _\
M /KLOYW][-;^S[7_ )Y?^/'_ !H_L^U_YY?^/'_&L?\ X2^W_P"?*7_OZ/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]_\  =_\*/[$U;_H&7O_ (#O_A7LM%']FP_F#ZNNYXU_8FK?] R]_P# =_\
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MO^@9>_\ @._^%>RT4?V;#^8/JZ[GC7]B:M_T#+W_ ,!W_P */[$U;_H&7O\
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MW/._[-O_ /GRN?\ OTW^%']FW_\ SY7/_?IO\*]$HH_LV'\P?5UW/._[-O\
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MY+/!!&25B4-&5*\GE@6]ZU]"T.U\/Z<;.V>63?*\\LLQ!>61V+,S8 &23T
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M*>:[EL#?BXM(Y++[-+!+:B698V5T=B6P&.V085B,@8Z]JZ"1&0D@,""5)!_
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MR1[MR( ^\DA&Q\N#C&<\587PBELR/INL:EI\@C\N1X/)8RKO9P&$D;#@NV"
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M7_R(W^-:%A:0612*WC")NS@<Y/UK:AA:U.:E*6A<*4XRNV/HHHKT3H"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *?%_K!]#_*F4^+_ %@^A_E0
M RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#=T_\
MX\8_Q_F:LU6T_P#X\8_Q_F:LT %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 5[$A;"V5N"(E!![<"I]R_WA^= 4*    .  *7 ]* $W+_>
M'YT;E_O#\Z7 ]*,#TH 3<O\ >'YT;E_O#\Z7 ]*,#TH 3<O]X?G1N7^\/SI<
M#THP/2@!-R_WA^=&Y?[P_.EP/2C ]* $W+_>'YT;E_O#\Z7 ]*,#TH 3<O\
M>'YT;E_O#\Z7 ]*,#TH 3<O]X?G1N7^\/SI<#THP/2@!-R_WA^=&Y?[P_.EP
M/2C ]* $W+_>'YT;E_O#\Z7 ]*,#TH 3<O\ >'YT;E_O#\Z7 ]*,#TH 3<O]
MX?G1N7^\/SI<#THP/2@!-R_WA^=&Y?[P_.EP/2C ]* $W+_>'YT;E_O#\Z7
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B*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img38651418_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img38651418_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (S!58# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYI/F),C 'C.?R&*R;.VO+OQ3?S+_ &E/!)I)@CN+VV$.Y]Y.T (GKW&>O;%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*@\F;_GZ?_OE?\*/)F_Y^G_[Y7_"@">BH/)F_P"?I_\ OE?\*/)F_P"?I_\
MOE?\* )Z*@\F;_GZ?_OE?\*/)F_Y^G_[Y7_"@">BH/)F_P"?I_\ OE?\*/)F
M_P"?I_\ OE?\* )Z*@\F;_GZ?_OE?\*/)F_Y^G_[Y7_"@">BH/)F_P"?I_\
MOE?\*/)F_P"?I_\ OE?\* )Z*@\F;_GZ?_OE?\*/)F_Y^G_[Y7_"@">BH/)F
M_P"?I_\ OE?\*/)F_P"?I_\ OE?\* )Z*@\F;_GZ?_OE?\*/)F_Y^G_[Y7_"
M@">BH/)F_P"?I_\ OE?\*/)F_P"?I_\ OE?\* )Z*@\F;_GZ?_OE?\*/)F_Y
M^G_[Y7_"@">BH/)F_P"?I_\ OE?\*/)F_P"?I_\ OE?\* )Z*@\F;_GZ?_OE
M?\*/)F_Y^G_[Y7_"@">BH/)F_P"?I_\ OE?\*/)F_P"?I_\ OE?\* )Z*@\F
M;_GZ?_OE?\*/)F_Y^G_[Y7_"@">BH/)F_P"?I_\ OE?\*/)F_P"?I_\ OE?\
M* )Z*@\F;_GZ?_OE?\*/)F_Y^G_[Y7_"@">BH/)F_P"?I_\ OE?\*/)F_P"?
MI_\ OE?\* )Z*@\F;_GZ?_OE?\*/)F_Y^G_[Y7_"@">BH/)F_P"?I_\ OE?\
M*/)F_P"?I_\ OE?\* )Z*@\F;_GZ?_OE?\*/)F_Y^G_[Y7_"@">BH/)F_P"?
MI_\ OE?\*/)F_P"?I_\ OE?\* )Z*@\F;_GZ?_OE?\*/)F_Y^G_[Y7_"@">B
MF1JR AY"Y]2 /Y4^@ HHJIJ>IV>C:9<:CJ$X@M+="\LA!.U?H.3^% %NBN-_
MX6MX(_Z#L?\ WXE_^)H_X6MX(_Z#L?\ WXE_^)H [*BN-_X6MX(_Z#L?_?B7
M_P")H_X6MX(_Z#L?_?B7_P")H [*BN-_X6MX(_Z#L?\ WXE_^)H_X6MX(_Z#
ML?\ WXE_^)H [*BN-_X6MX(_Z#L?_?B7_P")H_X6MX(_Z#L?_?B7_P")H [*
MBN-_X6MX(_Z#L?\ WXE_^)H_X6MX(_Z#L?\ WXE_^)H [*BN-_X6MX(_Z#L?
M_?B7_P")H_X6MX(_Z#L?_?B7_P")H [*BN-_X6MX(_Z#L?\ WXE_^)H_X6MX
M(_Z#L?\ WXE_^)H [*BN-_X6MX(_Z#L?_?B7_P")H_X6MX(_Z#L?_?B7_P")
MH [*BN-_X6MX(_Z#L?\ WXE_^)H_X6MX(_Z#L?\ WXE_^)H [*BN-_X6MX(_
MZ#L?_?B7_P")H_X6MX(_Z#L?_?B7_P")H [*BN-_X6MX(_Z#L?\ WXE_^)H_
MX6MX(_Z#L?\ WXE_^)H [*BN-_X6MX(_Z#L?_?B7_P")H_X6MX(_Z#L?_?B7
M_P")H [*BN+'Q9\#&0I_;T>X $CR)>G_ 'S[4[_A:W@C_H.Q_P#?B7_XF@#L
MJ*XW_A:W@C_H.Q_]^)?_ (FC_A:W@C_H.Q_]^)?_ (F@#LJ*XW_A:W@C_H.Q
M_P#?B7_XFC_A:W@C_H.Q_P#?B7_XF@#LJ*XW_A:W@C_H.Q_]^)?_ (FC_A:W
M@C_H.Q_]^)?_ (F@#LJ*XW_A:W@C_H.Q_P#?B7_XFC_A:W@C_H.Q_P#?B7_X
MF@#LJ*XW_A:W@C_H.Q_]^)?_ (FC_A:W@C_H.Q_]^)?_ (F@#LJ*XW_A:W@C
M_H.Q_P#?B7_XFC_A:W@C_H.Q_P#?B7_XF@#LJ*XW_A:W@C_H.Q_]^)?_ (FC
M_A:W@C_H.Q_]^)?_ (F@#LJ*XW_A:W@C_H.Q_P#?B7_XFC_A:W@C_H.Q_P#?
MB7_XF@#LJ*XW_A:W@C_H.Q_]^)?_ (FC_A:W@C_H.Q_]^)?_ (F@#LJ*XW_A
M:W@C_H.Q_P#?B7_XFC_A:W@C_H.Q_P#?B7_XF@#LJ*XW_A:W@C_H.Q_]^)?_
M (FC_A:W@C_H.Q_]^)?_ (F@#LJ*XQOBQX'1"S:]& !D_N)?_B:!\6/ [*"-
M>CP1D?N)?_B: .SHKC?^%K>"/^@['_WXE_\ B:/^%K>"/^@['_WXE_\ B: .
MRHKC?^%K>"/^@['_ -^)?_B:/^%K>"/^@['_ -^)?_B: .RHKC?^%K>"/^@[
M'_WXE_\ B:/^%K>"/^@['_WXE_\ B: .RHKC?^%K>"/^@['_ -^)?_B:/^%K
M>"/^@['_ -^)?_B: .RHKC?^%K>"/^@['_WXE_\ B:/^%K>"/^@['_WXE_\
MB: .RHKC?^%K>"/^@['_ -^)?_B:/^%K>"/^@['_ -^)?_B: .RHKC?^%K>"
M/^@['_WXE_\ B:/^%K>"/^@['_WXE_\ B: .RHKC?^%K>"/^@['_ -^)?_B:
M/^%K>"/^@['_ -^)?_B: .RHKC?^%K>"/^@['_WXE_\ B:/^%K>"/^@['_WX
ME_\ B: .RHKC?^%K>"/^@['_ -^)?_B:/^%K>"/^@['_ -^)?_B: .RHKC?^
M%K>"/^@['_WXE_\ B:/^%K>"/^@['_WXE_\ B: .RHKC?^%K>"/^@['_ -^)
M?_B:T=#\<^&_$FHO8:1J:W-TD1F:,1.N$! )RR@=6'YT =#1110 4444 %%%
M% !1110 4444 0WEP+2RGN2NX0QM(1GK@9KG_#NJ75U<0KJ#WZ3W5M]HCBFC
MA6$C*Y\LIEN-RC#'.#FNDEC2:)XI%#(ZE6![@]:R]-T"#39HY?M-S<M##Y$'
MGLI\F/\ NKA1GH.3D\#F@#6J!TDF8JQ*1#C@\M_@*GHH 155%"J  .PKR#XG
M3S7/B(6<LTAMHHE9(@<*">IQW->P5XW\1_\ D;I/^N*?RKNR])UM>QS8IM4]
M#BOL<']T_G67J:+%.J)PNW.,]\FMRL75_P#C[3_<'\S7L54E'0X8-W/IS1/^
M0!IW_7K%_P"@BK]4-$_Y &G?]>L7_H(J_7S4MSUEL%%%%(84444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBK$,T=Q!'-$VZ.10ZG&,@C(H$/HHHH **** "BBB@ HHHH R_$O_ "*NL?\
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M + <G_H]*EJ+PQ_R5@_]@.3_ -'I28T>GT444B@HHHH **** "BBB@ HHHH
M**** "BBB@ KQOXC_P#(W2?]<4_E7LE>-_$?_D;I/^N*?RKOR[^-\CFQ7\,Y
M*L75_P#C[3_<'\S6U6+J_P#Q]I_N#^9KV*WPG!3W/IS1/^0!IW_7K%_Z"*OU
M0T3_ ) &G?\ 7K%_Z"*OU\S+<]=;!1112&%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7)?%#_DF
M/B+_ *\WKK:Y+XH?\DQ\1?\ 7F] &!'_ *M/H*=38_\ 5I]!3JH@**** "BB
MB@ HHHH *X?7O*_X6EX=_M#;]E^SR?9?,^[]HSVSQG&S'OCOBNXJCJNC:=KE
MF;34K2.YASD!N"I]01R#[B@9EZA_8_\ ;5X+4V__  DIL6$>#^\VX.W';.?Q
MQCM7.^$;A8/AM$VE:3%J5RSNE_;O.D1)).XN6]L<'L176:+X6T3P\TC:781V
M[R##/N9V(]-S$D#@<=*J:CX#\,:K>O>7>DQM/(<NR2/'N.<DD*0"3GKU-(#@
MSJ%GJ.F^#7L=-33K>/7$B6!)?,'#+SNP,YSU_6N]'B.&]FOK&YTC6;6"**7S
M+J>T*Q%5X)5@23D<CCFKLGAK1I([&/[!$D=C,)[9(LQK&X.=V%(!Y]<UJD C
M!&10!XZ$DT/1=)GE>QUWPK'>J]FZEX;B)B6Y &,D,6)!W9QV[>Q5SD'@/PQ;
M:FNH0Z1"ERK^8IW-L5O4)G:,=N..U='0 4444Q!1110 4444 %%%% '.VW_)
M0]0_[!L'_HR2NBKG;;_DH>H?]@V#_P!&25T5 PHHHH$%%%% !1110 4444 <
M-?\ E_\ "WM.^W[?)_LYOL>_[OG;SG'^UC^E7]7_ +)^UZ\-+,'_  DYTYMV
MP_O<;3LQ[_=Z<_=SQBMK5]#TS7K46VIV<=S$#E=V05/LPP1T[&HM%\-:/X>6
M1=*L4MS(<NVYF8^VYB3CVZ4#.1T&YAM_A?9_V1H]OJD;HR7\)N4A"G:?,9V;
MOP/?!':LF+4+74I/ $]EIZ6%L+N>-+=7WA0I49S@9)ZDGG)YS7:7O@#PMJ%X
M]W<:1&9G.6*2/&"?7:I S^'-:4GA[29)+!_L,2'3V9[58LQK$3UPJX';N*0'
M'>-/$7]J^$-;L_[&U>S\N-6\Z[M?+C;$J#"MDY)SD>P-=OHW_(#T_P#Z]H__
M $$4[4M-M-7T^6POHO-MI0 Z;BN<$$<@@]0*L0PQV\$<,2[8XU"*,YP ,"@!
M]%%%,04444 %%%% !1110!E^)?\ D5=8_P"O*;_T U-HO_("T_\ Z]H__014
M/B7_ )%76/\ KRF_] -3:+_R M/_ .O:/_T$4#+U%%% @HHHH **** "BBB@
M"*Z_X])O^N;?RKRGPIIWBK5_A]%IUF^BII5R)8R\ZR&=07;<<#Y<YSC\*]:=
M0Z,C#*L,$54TO2K+1=/CL-/A\FVC)*)N+8R23R23U)H&<);:=;Z1\1]&T^_D
M\RWM])$5@\W ,P;D@= V,^_3VJU_;('Q"M[74/#$-KJ%S#*D-[]L61S$JL0V
MP#C.TCG!ZCMBNMU?0],UZT^S:G9QW,0.1NR&4^S#!'3L:J:1X1T#0G>33M-B
MAD88,A+.X&,8#,20/I2 X_P)KO\ 8G@'3S_96IW_ )LTW%A;^;LPW\7(QG/'
MT-7_  M+Y_Q(\3S>7)'YD-LVR1<,N4!P1V-=?I6D6.B6"V.G0>3;*2P3>S8)
M.3RQ)I+?1["TU2[U*"#9>7843R;V._:,#@G _ 4 7J***8@HHHH **** "BB
MB@ J+PQ_R5@_]@.3_P!'I4M1>&/^2L'_ + <G_H]*3&CT^BBBD4%%%% !111
M0 4444 %%%% !1110 4444 %>-_$?_D;I/\ KBG\J]DKQOXC_P#(W2?]<4_E
M7?EW\;Y'-BOX9R58NK_\?:?[@_F:VJQ=7_X^T_W!_,U[%;X3@I[GTYHG_( T
M[_KUB_\ 015^J&B?\@#3O^O6+_T$5?KYF6YZZV"BBBD,**** "BBB@ HHHH
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MJXW#UR<\XIOA7P]K]CXAM)8],DT/2XD8W5K_ &C]HBG<KC*IDE3G'4G@#GU
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MX2AB/VS,:'[G\(_VJ\3%YS7H495%K;T[GWM;+Z-.FY6V]36'B6T*C=IK XY
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MXU/10!!]BM_^>?\ X\:/L5O_ ,\__'C4]% $'V*W_P">?_CQH^Q6_P#SS_\
M'C4]% $'V*W_ .>?_CQH^Q6__//_ ,>-3T4 0?8K?_GG_P"/&C[%;_\ //\
M\>-3T4 0?8K?_GG_ ./&C[%;_P#//_QXU/10!!]BM_\ GG_X\:/L5O\ \\__
M !XU/10!!]BM_P#GG_X\:/L5O_SS_P#'C4]% $'V*W_YY_\ CQH^Q6__ #S_
M /'C4]% $'V*W_YY_P#CQH^Q6_\ SS_\>-3T4 0?8K?_ )Y_^/&C[%;_ ///
M_P >-3T4 0?8K?\ YY_^/&C[%;_\\_\ QXU/10!!]BM_^>?_ (\:/L5O_P \
M_P#QXU/10!!]BM_^>?\ X\:/L5O_ ,\__'C4]% $'V*W_P">?_CQH^Q6_P#S
MS_\ 'C4]% $'V*W_ .>?_CQH^Q6__//_ ,>-3T4 0?8K?_GG_P"/&C[%;_\
M//\ \>-3T4 0?8K?_GG_ ./&C[%;_P#//_QXU/10!!]BM_\ GG_X\:/L5O\
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M8/'/_0JV?_@V7_XBBX6+E%4_L'CG_H5;/_P;+_\ $4?8/'/_ $*MG_X-E_\
MB*+A8R;;_DH>H?\ 8-@_]&25T5<G;6?BX^/[]%\.VQO!IT!>'^TE 5-\F&W;
M.<G/&.,>]=!]@\<_]"K9_P#@V7_XBBX6+E06]G:VC2M;6T,+3.9)3&@4NQZL
MV.I]S47V#QS_ -"K9_\ @V7_ .(H^P>.?^A5L_\ P;+_ /$47"Q<HJG]@\<_
M]"K9_P#@V7_XBC[!XY_Z%6S_ /!LO_Q%%PL7**I_8/'/_0JV?_@V7_XBC[!X
MY_Z%6S_\&R__ !%%PL7**I_8/'/_ $*MG_X-E_\ B*/L'CG_ *%6S_\ !LO_
M ,11<+%RBJ?V#QS_ -"K9_\ @V7_ .(H^P>.?^A5L_\ P;+_ /$47"Q<HJG]
M@\<_]"K9_P#@V7_XBC[!XY_Z%6S_ /!LO_Q%%PL7*@CL[6*ZENH[:%+F8 2S
M*@#N ,#<>IQ[U%]@\<_]"K9_^#9?_B*/L'CG_H5;/_P;+_\ $47"Q<HJG]@\
M<_\ 0JV?_@V7_P"(H^P>.?\ H5;/_P &R_\ Q%%PL7**I_8/'/\ T*MG_P"#
M9?\ XBC[!XY_Z%6S_P#!LO\ \11<+%RBJ?V#QS_T*MG_ .#9?_B*/L'CG_H5
M;/\ \&R__$47"Q<HJG]@\<_]"K9_^#9?_B*/L'CG_H5;/_P;+_\ $47"Q7\2
M_P#(JZQ_UY3?^@&IM%_Y 6G_ /7M'_Z"*S_$=EXS7PQJS7/AFUB@%E,9)!JB
ML478<G&SG [5+H]CXU;1+ P^&+22(VT91SJJJ67:,'&SCZ47"QLU!=6=K>QK
M'=VT-PBL'"RH' 8=#@]ZB^P>.?\ H5;/_P &R_\ Q%'V#QS_ -"K9_\ @V7_
M .(HN%BY15/[!XY_Z%6S_P#!LO\ \11]@\<_]"K9_P#@V7_XBBX6+E%4_L'C
MG_H5;/\ \&R__$4?8/'/_0JV?_@V7_XBBX6+E%4_L'CG_H5;/_P;+_\ $4?8
M/'/_ $*MG_X-E_\ B*+A8N453^P>.?\ H5;/_P &R_\ Q%'V#QS_ -"K9_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8T4L,A22Q([ @\1+>ZC)I=SIVHNQ.G^++".)&O&NS$K-&Y3SG 9\%CRW(Z=
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M5[_7T9K:)5.\VB?)&H'7+1[VQW,GO1I-S#JWB;PL=/US2[X6*.5ATC2VC-M
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M#0W:R(23&@N&*." RB)5X##%8-KH5FWAO1B9M1^?Q?)"<:C<#Y?/E&1\_#8
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ML"_!_P!XUN?;;;_GLM9/@[_D5[7ZO_Z&:W:_7\%_NU/_  K\C@ENR#[;;?\
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MQ\:>))/#VF^(+R+2ELY=02PN+6*.0R,?/,#2I(7POS\A"IX'WLGC<\.>"_\
MA'[S39_[0^T?8M(32]OD[-^U]V_[QQZ8Y^M1IX'V>#[;0/[1SY&H"^\_R/O?
MZ29]NW=QUVYS[X[4 9H\3^+9[#Q%JUO#I'V/1KVXB2V>*3S+N*%OFQ)OQ&VT
M$ [6&1T JS;>+-4U7Q+>06,EC;Z1:65K?O+/;N\KQRAF*\2*%.U3@\X]#6=I
M/A?7=1M/$UA-J<EAI>H:M=B6&2R)F:)GY,,A8!5=>,E'ZDCVZG3?"MOINO:E
MJ$<BFVO+.WM%M/+P(TB#@?-GG(;T&,=Z .?3QEKL/ANP\77D-@-%NY8MUDD;
MBXAAE<(C^;O*NV60E=B\$\\<RW'C34K;0-4C:"T;Q%:ZF--A@VL(Y7D=3"^W
M=G!C<,>?X6J:#P'<IIMGH4^M";P]9SI+%:_9=L[+&VZ.)YM^"@8+T0,=H&>N
M;UUX+M[KQ[:^*#<LODQ /:;/EDE4.J2DYZJLCCIW'I0!SM_\191J.M);ZSX:
ML8]*E,"VNHS;9[V1!F3;^\7RES\JDJ^2"?:M/3_%FI^*[L1^'#96L$=A;WDT
MU]"\Q9I@62-55TQ@*<MD\D #O5J3PGJ5I=ZH=#UU=/L]4E,\\3VGFO%*PP[P
MOO786 !PP<!N0.<4Z3PG=V6HG4-!UC[+=2VD=I<M?0M=B<1Y\N0_.K>8,L,E
MB#GD=Z (?A?YO_" VGG($E^U7N]%;<%;[5+D \9^M=A6-X5T$^&?#T.E&\>\
M,4LTAGD0*S^9*\G('&?GQGOC.!TK9H **** "BBB@ HHHH **** "BBB@ HH
MHH P_&G_ "(GB'_L&7/_ **:K'AK_D5M(_Z\H?\ T 57\:?\B)XA_P"P9<_^
MBFJQX:_Y%;2/^O*'_P! % &A/#'<V\D$J[HY%*.N<9!&"*BT^PM=*TVVT^RB
M\JUMHEBACW%MJ*, 9))/ [U9HH **** ,"^\%Z%J$]U-+;7$9NP1<I:WL]ND
M^1@F1(W57)'!)!)'!JS>^&='O[.TM9;)8HK,YM?LKM;M;\8_=M&59!CC (XX
MK6HH Q8_">B1V=M:+8_NK>\%^A,KEC< Y\QV)W.V3R6)SWS4E_X9T?4Y[R:]
MLEFDO+=+:<L[?-&C%DQ@_*0S$AAA@<'/ K6HH P$\%Z$([Y)+:XN#?6QM)Y+
MJ\FGD:$YR@=W+*IR3A2.>>PJ2^\(Z+J+P//:RK)#!]E5X+F6%FA_YYN48%T_
MV6R.3ZFMNB@#!/@S0/[,LM/2Q,,%@S/:&">2*2 MG=LD5@Z@Y.0#C''2I(_"
M>B1V=M:+8_NK>\%^A,KEC< Y\QV)W.V3R6)SWS6U10!BZCX3T;5-0:_N;>9;
MEXQ#*]O=2P>:@SA9!&RAQR>&SUQ5/_A7WA@0V44>G/ MB93:&WNIHF@\QM[[
M&5P5R1V/ ) P"17344 8R>%-$CLK6T6R_=6UX+Z/,KEC< EO,9B=SMDDDL3G
MOFJ5IX?N9O',_B;4H;2*2*T^PV:02-(3'O+EW)5<$\ *,@?-R<UTU% &?K.B
M:=XATYM/U6U6YM&=7:)F(!*D,,X(R,@<=#WJ#3O#.DZ6\\D$$LDMQ&(I9;NX
MDN7:,9PFZ5F.WD_+G')XK7HH PM.\':%I5[!=VEI()+=66V66YEE2W#?>\I'
M8K'D<?*!QQTXIK^"]">"X@-K.L4]R+LJEY,GES!BV^/#CRCEB3LVYSS6_10!
M@7O@O0=0NY;FXM)3).J)<*EU+&ER$^[YR*P67CCYP<C@\<5HPZ/86VJRZG#;
MA+R6!+=W#'!C0DJNW.!C<>@J]10 5Q[_ /)98/\ L7Y/_2A*["N/?_DLL'_8
MOR?^E"4 =A1110 4444 <'I0T\6T@6"_$7F:>]O)/(C,83/B$* /E0%3P><&
MN\K@-!/AR:YLYY'O([UF0"S83&&.0,=H4$8VAF8KDX&<\=N_H **** "BBB@
M"&Z%P;.<6I07)C;RC)]T/CC/MG%<OX=T_4M/\1W*W%G&D)LXE:=9WD#OOD9F
MR47<Q9B2.,9'7-==10 4Q8D61G RQ[FGT4 %>-_$?_D;I/\ KBG\J]DKQOXC
M_P#(W2?]<4_E7?EW\;Y'-BOX9R5.7I3:<O2NK-O]V?JCY_,?X'S%K5TK_52?
M[U95:NE?ZJ3_ 'J^+QG\%FO"?_(TAZ2_)FA73>$?^7S_ (!_[-7,UTWA'_E\
M_P" ?^S5\OFG^Z3^7YH_4L9_!E_74Z:N;\8?\>EM_P!=#_*NDKF_&'_'I;?]
M=#_*OF<'_'B>%+8Z3P=_R*]K]7_]#-;M87@[_D5[7ZO_ .AFMVOU_!?[M3_P
MK\C@ENPHHHKJ)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C?B9_R*J?]?*?R:O(*]?^
M)G_(JI_U\I_)J\@KW<N_@_,\W%?Q!1UIU-'6G5X^<_[PO3]6?,YE_&7I_F5=
M1_X\)?P_F*[_ ."/^IUO_>A_D]<!J/\ QX2_A_,5W_P1_P!3K?\ O0_R>N"C
MN=F2_P 5>K_(]9HHHKJ/K HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "N2^*'_),?$7_7F]=;7(_%($
M_##Q#AB/]#;D?44 =7#_ *F/_='\J?7&1^$=?,2$>/=8'RCC[/;?_&Z?_P (
MAK__ $/VL_\ @/;?_&Z .PHKC_\ A$-?_P"A^UG_ ,![;_XW1_PB&O\ _0_:
MS_X#VW_QN@#L**X__A$-?_Z'[6?_  'MO_C='_"(:_\ ]#]K/_@/;?\ QN@#
ML**X_P#X1#7_ /H?M9_\![;_ .-T?\(AK_\ T/VL_P#@/;?_ !N@#L**X_\
MX1#7_P#H?M9_\![;_P"-T?\ "(:__P!#]K/_ (#VW_QN@#L**X__ (1#7_\
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M-785Y1:^&=9;XFZG;#QEJBS)I5N[7(@@WNIDE 4C9C P3TSR:Z?_ (1#7_\
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M_&Z/^$0U_P#Z'[6?_ >V_P#C= '845Q__"(:_P#]#]K/_@/;?_&Z/^$0U_\
MZ'[6?_ >V_\ C= '845Q_P#PB&O_ /0_:S_X#VW_ ,;H_P"$0U__ *'[6?\
MP'MO_C= '845Q_\ PB&O_P#0_:S_ . ]M_\ &Z/^$0U__H?M9_\  >V_^-T
M=A7'O_R66#_L7Y/_ $H2C_A$-?\ ^A^UG_P'MO\ XW65HVEWVE_%Y8[W6[O5
M6?09"KW,<:E!YZ<#8HH ]%HHHH **** .#L-0D,]@1JNHRZU).BW=C(I\M 6
MQ(-N,*JC)!![#UKO*Y.VN=8,>GZ5+:7D=[#-&\]V\Z&.1 V7(^;<P89 7'&1
M_=KK* "BBB@ HHHH **** "BBB@ KQOXC_\ (W2?]<4_E7LE>-_$?_D;I/\
MKBG\J[\N_C?(YL5_#.2IR]*;3EZ5U9M_NS]4?/YC_ ^8M:NE?ZJ3_>K*K5TK
M_52?[U?%XS^"S7A/_D:0])?DS0KIO"/_ "^?\ _]FKF:Z;PC_P OG_ /_9J^
M7S3_ '2?R_-'ZEC/X,OZZG35S?C#_CTMO^NA_E725S?C#_CTMO\ KH?Y5\S@
M_P"/$\*6QTG@[_D5[7ZO_P"AFMVL+P=_R*]K]7_]#-;M?K^"_P!VI_X5^1P2
MW84445U$A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!QOQ,_Y%5/^OE/Y-7D%>O\ Q,_Y
M%5/^OE/Y-7D%>[EW\'YGFXK^(*.M.IHZTZO'SG_>%Z?JSYG,OXR]/\RKJ/\
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MJ>5M#GN#'+;2FV9_+<C?&VW."5)&1[$CC@FO'HM8MX/AA9:K#J7BJ+7_ +-
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M@^T2?\^TGYC_ !H^T2?\^TGYC_&@">BH/M$G_/M)^8_QH^T2?\^TGYC_ !H
MGHJ#[1)_S[2?F/\ &C[1)_S[2?F/\: )Z*@^T2?\^TGYC_&C[1)_S[2?F/\
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M?F/\: )Z*@^T2?\ /M)^8_QH^T2?\^TGYC_&@">BH/M$G_/M)^8_QH^T2?\
M/M)^8_QH GHJ#[1)_P ^TGYC_&C[1)_S[2?F/\: )Z*@^T2?\^TGYC_&C[1)
M_P ^TGYC_&@">BH/M$G_ #[2?F/\:/M$G_/M)^8_QH GHJ#[1)_S[2?F/\:/
MM$G_ #[2?F/\: )Z*@^T2?\ /M)^8_QH^T2?\^TGYC_&@">BH/M$G_/M)^8_
MQH^T2?\ /M)^8_QH GHJ#[1)_P ^TGYC_&C[1)_S[2?F/\: )Z*@^T2?\^TG
MYC_&C[1)_P ^TGYC_&@">BF1NSJ2T;)[-BGT %<E\4/^28^(O^O-ZZVN2^*'
M_),?$7_7F] '50_ZF/\ W1_*N-\8:!K_ (@U>RB2'3KKP] /-FL)[V2W-U,#
M\OF[8GW1KC.S@$\G. *[*'_4Q_[H_E3Z *>FM?M:#^T;2UM9@<".UN&F0+V^
M9D0_AC\:SYO"6FW$\DSW.LAI&+D)K5XB@DYX590 /8  5N44 5);/_B4/8PL
MQ_<&%&ED9S]W +,V6)]2<D^]<-#X:\6M\/8O!TEOHD$1LEL9;];Z65E3 5G$
M1A7)VYP-XYQS7HE% '&IX<UCP]K5Y>^&TT^Y@OK:&*6"_G>(Q20IL1U9$?<"
MN 5('W00>3B+0_ UQH>L:#<)=Q3PV%I=QW#L"CR2SR+(650" N=W4\#'6NWH
MH \_U#PEXCAT#Q!X>T:73&L-5-Q)%<7<LBR6_G;B\>Q4(<98@-N!&[.&V_,R
M]\ .NNRZK%HWA_6C=VD,4\.K+CR98EVAXW\M\JR\%2!RH.>2*]#HH XG2?!5
MWI>L^'+H36)BTZVNX[@6]NMNI>9D8>7&B[0HVD<G/0G))-5CX'U,W3R^?:;6
M\5+K0^=L^0(PFW[OW\CIT]Z[^B@#@IO!.I2?#_Q)H GM/M>IW=U/"Y=MBK+(
M67<=N0<=< _C4>I^ F'B#5=2M=#\.:N-2(E_XG"?/;2A0ORD1OO0X!V_+@YY
MYX]!HH SM!TK^Q-!LM-\R.4V\85I([=(%=NI(C0!5!)/ _7K7$:-\/M6TZQT
M"":XLF;3M(N[&4H[D-)*5*E<KRO!SG!]C7I%% &1X6TN?1/">D:5<O&\]G9Q
M02-&25+*H!() ../2M>BB@ HHHH **** "BBB@#C[+_DK^K_ /8%M?\ T;-7
M579N19SFS6)KH1MY*S,50OCY0Q ) SC. :Y6R_Y*_J__ &!;7_T;-784 <+X
M5T/Q+HMR]SJ.GZ3>:C>2 W^IG4Y#*RYZ(GV<!54?=3<![]ZZ_4=.@U2V^SW#
MW2)N#9MKJ6W;(_VHV5L>V<5;HH RM/\ #UEIEU]HMY]3=]I7%SJES<)@_P"S
M)(RY]\9JCJGAR74O&6G:HYA:Q@L;FUGB8G<_FE,8&,8PISR*Z.B@#SN+P%JP
M\%KI5Q>VL^H_;K65IV9MI@MVC"#."=WEQY/&-S-ZYJQJ/A7Q"J>*[+2FTMK3
M7]\@GN99%DMW>$1L-BH0X.T$'<,9/#8P>\HH XNT\.Z[H%_]NTA=.NWN=/M[
M6[@NIWA"RPJ561'5')!#$%2HZ YZBK&C>&]7L_%PUK4]0AO6;2([*614\MFE
M$SR$A ,! ' '.>.?4]910!A>$-%N= T(V-T\3RFZN9LQ$E=LDSNO4#G##/O7
M/Z3X)U*QU;2[J6>T,=IK.H7[A7;)CG214 ^7[P+C/;K@FN]HH XZ?PG?RZ9X
MXMEEMM^O>9]E)9L)NMEB&_CCY@3QGC\JQ=(C\16'C3Q#:Z3%IEPT5C81R+=S
MO$JR")@&5E1BPX.5(&>,$<Y]+HH XG1/ T^AZOX?FCO([BWTZSNXIY'!6266
M>19"P7D ;MW&>,@<U%)X6\06=AK>B:5+IO\ 9FK332K<W$CB6S$Q/F@1A2LF
M,DKEUY.#TY[NB@#@_$?P];4VT.#3[E(+.UA2POTE)W7%FK(^S@8SF,#L,.WT
MI^N>"!=>+)]=BT?0]8%W;I#/:ZNN/+9,[7C?RY,9!(*[>< YXQ7<T4 <'9>"
MM2T0Z1J6FOI;ZG9I/'/;)"+.UE25@Q5/+0E-I5<,58G'/)R-?PIHVK:;=ZY>
M:Q)9M/J5XMRJVK,5C41(@4E@,D;<9[]<#.!TM% !1110 4444 8?C3_D1/$/
M_8,N?_1358\-?\BMI'_7E#_Z *K^-/\ D1/$/_8,N?\ T4U6/#7_ "*VD?\
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MK_\ H9K=K"\'?\BO:_5__0S6[7Z_@O\ =J?^%?D<$MV%%%%=1(4444 %%%%
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MFV?+4,14G-)L^C_"DLD_A'1Y97:21[.)F=SDL=HY)K7K%\(?\B9HO_7E#_Z
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M\W_QJNPHH X_[5\1?^@3X:_\#YO_ (U1]J^(O_0)\-?^!\W_ ,:KL** ./\
MM7Q%_P"@3X:_\#YO_C5'VKXB_P#0)\-?^!\W_P :KL** ./^U?$7_H$^&O\
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M\W_QJNPHH X_[5\1?^@3X:_\#YO_ (U1]J^(O_0)\-?^!\W_ ,:KL** ./\
MM7Q%_P"@3X:_\#YO_C5'VKXB_P#0)\-?^!\W_P :KL** ./^U?$7_H$^&O\
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M"?#7_@?-_P#&J/M7Q%_Z!/AK_P #YO\ XU7844 <?]J^(O\ T"?#7_@?-_\
M&J/M7Q%_Z!/AK_P/F_\ C5=A10!Q_P!J^(O_ $"?#7_@?-_\:H^U?$7_ *!/
MAK_P/F_^-5V%% ''_:OB+_T"?#7_ ('S?_&J/M7Q%_Z!/AK_ ,#YO_C5=A10
M!Q_VKXB_] GPU_X'S?\ QJC[5\1?^@3X:_\  ^;_ .-5V%% ''_:OB+_ - G
MPU_X'S?_ !JC[5\1?^@3X:_\#YO_ (U7844 <?\ :OB+_P! GPU_X'S?_&J/
MM7Q%_P"@3X:_\#YO_C5=A10!Q_VKXB_] GPU_P"!\W_QJC[5\1?^@3X:_P#
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M/K'^NB_W37+'<^5PW\1'T9X0_P"1,T7_ *\H?_0!6U6+X0_Y$S1?^O*'_P!
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MBT$K <@H3DJ3VS^-><>,VWCQ\^U5W:5I1PHP!^\;I0![71110 4444 %%%%
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M7S_@'_LU?+YI_ND_E^:/U+&?P9?UU.FKF_&'_'I;?]=#_*NDKF_&'_'I;?\
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MP0>,:T/^IC_W1_*GT 8_AO0$\/:=) ;E[JZN9WNKNY=0OG3/]Y@HX4< !1T
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M5\7C/X+->$_^1I#TE^3-"NF\(_\ +Y_P#_V:N9KIO"/_ "^?\ _]FKY?-/\
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M]IP_]!"P_P"_@_QJ2&[^T.4@NK.5@,D(VXX_ UR=UHL,%G/,LLA:.-F .,9
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MX4_Y^[[_ ,%5U_\ &Z/^%H>%/^?N^_\ !5=?_&Z["B@#C_\ A:'A3_G[OO\
MP577_P ;H_X6AX4_Y^[[_P %5U_\;KL** ./_P"%H>%/^?N^_P#!5=?_ !NC
M_A:'A3_G[OO_  577_QNNPHH X__ (6AX4_Y^[[_ ,%5U_\ &Z/^%H>%/^?N
M^_\ !5=?_&Z["B@#C_\ A:'A3_G[OO\ P577_P ;H_X6AX4_Y^[[_P %5U_\
M;KL** ./_P"%H>%/^?N^_P#!5=?_ !NC_A:'A3_G[OO_  577_QNNPHH X__
M (6AX4_Y^[[_ ,%5U_\ &Z/^%H>%/^?N^_\ !5=?_&Z["B@#C_\ A:'A3_G[
MOO\ P577_P ;H_X6AX4_Y^[[_P %5U_\;KL** ./_P"%H>%/^?N^_P#!5=?_
M !NC_A:'A3_G[OO_  577_QNNPHH X__ (6AX4_Y^[[_ ,%5U_\ &Z/^%H>%
M/^?N^_\ !5=?_&Z["B@#SCQ7\1_#%YX/UNU@NKTS36$\:!M,N5!8QL!DF, <
MGJ>*GT'XE>%[;P]ID$MU>B2.TB1@-,NF&0@!Y$>#^%=)XT_Y$3Q#_P!@RY_]
M%-5CPU_R*VD?]>4/_H H P_^%H>%/^?N^_\ !5=?_&Z/^%H>%/\ G[OO_!5=
M?_&Z["B@#C_^%H>%/^?N^_\ !5=?_&Z/^%H>%/\ G[OO_!5=?_&Z["B@#C_^
M%H>%/^?N^_\ !5=?_&Z/^%H>%/\ G[OO_!5=?_&Z["B@#C_^%H>%/^?N^_\
M!5=?_&Z/^%H>%/\ G[OO_!5=?_&Z["B@#C_^%H>%/^?N^_\ !5=?_&Z/^%H>
M%/\ G[OO_!5=?_&Z["B@#C_^%H>%/^?N^_\ !5=?_&Z/^%H>%/\ G[OO_!5=
M?_&Z["B@#C_^%H>%/^?N^_\ !5=?_&Z/^%H>%/\ G[OO_!5=?_&Z["B@#C_^
M%H>%/^?N^_\ !5=?_&Z/^%H>%/\ G[OO_!5=?_&Z["B@#C_^%H>%/^?N^_\
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M\Q_@?,6M72O]5)_O5E5JZ5_JI/\ >KXO&?P6:\)_\C2'I+\F:%=-X1_Y?/\
M@'_LU<S73>$?^7S_ (!_[-7R^:?[I/Y?FC]2QG\&7]=3IJYOQA_QZ6W_ %T/
M\JZ2N;\8?\>EM_UT/\J^9P?\>)X4MCI/!W_(KVOU?_T,UNUA>#O^17M?J_\
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M]3V\P^->A6U'_D&7?_7%_P#T$UA^ /\ D+77_7#_ -F%;FH_\@R[_P"N+_\
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MV?G+?<7;7<CW+SC&T!VD+,P X )P 3ZU?^VVG_/U#_W\%'VVT_Y^H?\ OX*
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M6][Z>&XN#YKC?)#M\L\'C&U>!@''.:V:@^VVG_/U#_W\%'VVT_Y^H?\ OX*
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M 'U74?6$]%0?9O\ IO-_WU1]F_Z;S?\ ?5 $]%0?9O\ IO-_WU1]F_Z;S?\
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MC'SI1FRBX#<?<%;/V;_IO-_WU7<MC[VG\"]">BH/LW_3>;_OJC[-_P!-YO\
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MFF>($1'/W0L852,GH,<DD$G- &/%XINO#!NUU&8SV1T*+4--C**IW1J%DB!
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M=L?&Y&5U9&4D*>5."H(Q4^B:':Z%:RPV[2RR3RM/<7$[!I)Y#U=B !G@#
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MX(.36CI'AV#2KZZU"2[NK_4;I526[NRF_8OW44(JJJC). HR22<F@#8HHHH
M**** "BBB@ KCW_Y++!_V+\G_I0E=A7'O_R66#_L7Y/_ $H2@#L**** "BBB
M@ HHHH **** "BBB@ HHHH **** "O&_B/\ \C=)_P!<4_E7LE>-_$?_ )&Z
M3_KBG\J[\N_C?(YL5_#.2IR]*;3EZ5U9M_NS]4?/YC_ ^8M:NE?ZJ3_>K*K5
MTK_52?[U?%XS^"S7A/\ Y&D/27Y,T*Z;PC_R^?\  /\ V:N9KIO"/_+Y_P
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M GX8>(<,1_H;<CZB@#JX?]3'_NC^5/KC(_ ]\8D/_"<>)Q\HX$L'_P :I_\
MP@U]_P!#SXG_ ._T'_QJ@#L**X__ (0:^_Z'GQ/_ -_H/_C5'_"#7W_0\^)_
M^_T'_P :H ["BN/_ .$&OO\ H>?$_P#W^@_^-4?\(-??]#SXG_[_ $'_ ,:H
M ["BN/\ ^$&OO^AY\3_]_H/_ (U1_P (-??]#SXG_P"_T'_QJ@#L**X__A!K
M[_H>?$__ '^@_P#C5'_"#7W_ $//B?\ [_0?_&J .PHKC_\ A!K[_H>?$_\
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MJD-6LFUI]'$_^GI;K=-%L;B(L5#9QCJI&,YXH NT444 %%%% !1110 4444
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M]+EV7PP-+V<7=Z7?H<TY\SN-^S0?\\(_^^!1]F@_YX1_]\"I:*] DB^S0?\
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M?9H/^>$?_? J6F1,70D]=S#\B10 W[-!_P \(_\ O@4?9H/^>$?_ 'P*EHH
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M +51_;?CO_H3-._\'7_VJ@#L**X_^V_'?_0F:=_X.O\ [51_;?CO_H3-._\
M!U_]JH ["BN/_MOQW_T)FG?^#K_[51_;?CO_ *$S3O\ P=?_ &J@#L**X_\
MMOQW_P!"9IW_ (.O_M5']M^._P#H3-._\'7_ -JH ++_ )*_J_\ V!;7_P!&
MS5V%>46NK>,!\3=3E7PM9->'2K=7@.JX54$DN&W^7R221C'&.O-=/_;?CO\
MZ$S3O_!U_P#:J .PHKC_ .V_'?\ T)FG?^#K_P"U4?VWX[_Z$S3O_!U_]JH
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MW_@Z_P#M5']M^._^A,T[_P '7_VJ@#L**X_^V_'?_0F:=_X.O_M5']M^._\
MH3-._P#!U_\ :J .PHKC_P"V_'?_ $)FG?\ @Z_^U4?VWX[_ .A,T[_P=?\
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MA/=R[KC2K2=H@J!&W!^/NYP#DC!SD\DCB@#LZ*YS7K:(>(O#USAC*;MDR7)
M'E2'@9P/? YP,]!71T %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 1-_Q]1_[C?S6I:B;_ (^H_P#<;^:U+0 4444 %%%% !1110 4444
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M>=F7_2;E0BD.R@;VVC)VYK3?6])CTZ+47U.R6QE_U=RUP@C?@GALX/ )_ T
M7J*R)O%7AVVL[>\GU_2XK6YW>1.]Y&J2[3AMK$X;!ZXZ54U/QCI^E:SIMK<S
M6L=A>VLMS_:$MRJ1(J&,+R>"&\P8.1VZYH Z*BN?U;Q7:V-EH]Y9>3J%MJ>H
M0V230S@H!(2-X8 AL8Z?K6F-7TQM,;4QJ-H=/4,6NA.OE  D'+YQP00>>HH
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M/_SSC_[^'_"I:* (MT__ #SC_P"_A_PHW3_\\X_^_A_PJ6B@"+=/_P \X_\
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M_A_PJ6B@"+=/_P \X_\ OX?\*:\DT<;.8H\*"3B0_P"%3U%<_P#'K-_N'^5
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M_"C=/_SSC_[^'_"I:* ( 9#=)O55^1L;6SW7V%3U$W_'U'_N-_-:EH ****
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M<HV&N(P1D=B"0?8UP^J?\?6N_P#8Z:?_ "AH ]EHHHH **** "BBB@ HHHH
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M2UD:.YU&6'3XG7JIFD6,D>^UFKI+*S@T^QM[*UC$=O;Q+%$@Z*JC 'Y"IZ*
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MGY+_ (4>4_\ S\2?DO\ A0!+147E/_S\2?DO^%'E/_S\2?DO^% $M%1>4_\
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MEVN <B1W)W.V>[$YXSTJG:>'[F;QS/XFU*&TBDBM/L-FD$C2$Q[RY=R57!/
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M?^A\U[_OBW_^-T?\(;K/_0^:]_WQ;_\ QN@#L**X_P#X0W6?^A\U[_OBW_\
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M +XM_P#XW0!V%%<?_P (;K/_ $/FO?\ ?%O_ /&Z/^$-UG_H?->_[XM__C=
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M.P/GG.,=>?7F@#6HHHH **** (F_X^H_]QOYK4M1-_Q]1_[C?S6I: "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVC9!&2Q&TY8YSC(/'0\5M4 1>:__ #[R?FO^-'FO_P ^\GYK_C4M% $7FO\
M\^\GYK_C4=Q(YMI08)!\AY)7CCZU9J*Y_P"/6;_</\J #S7_ .?>3\U_QH\U
M_P#GWD_-?\:EHH B\U_^?>3\U_QH\U_^?>3\U_QJ6B@"+S7_ .?>3\U_QH\U
M_P#GWD_-?\:EK$UJ_P!3TUDN8OLC6IFBB$!1C+*78*<-D $9Z;6Z$Y] #6\U
M_P#GWD_-?\:/-?\ Y]Y/S7_&I:* (O-?_GWD_-?\:/-?_GWD_-?\:EHH B\U
M_P#GWD_-?\:CCD?S)OW$AR_JO'RCWJS447^LG_WQ_P"@B@ \U_\ GWD_-?\
M&CS7_P"?>3\U_P :EHH B\U_^?>3\U_QH\U_^?>3\U_QJ6B@"+S7_P"?>3\U
M_P :/-?_ )]Y/S7_ !J6B@"+S7_Y]Y/S7_&CS7_Y]Y/S7_&I:* (O-?_ )]Y
M/S7_ !H\U_\ GWD_-?\ &I:* *S2/]I0^1)]QN,KZCWJ3S7_ .?>3\U_QH;_
M (^H_P#<;^:U+0!%YK_\^\GYK_C1YK_\^\GYK_C4M% $7FO_ ,^\GYK_ (T>
M:_\ S[R?FO\ C4M% $7FO_S[R?FO^-'FO_S[R?FO^-2T4 1>:_\ S[R?FO\
MC1YK_P#/O)^:_P"-2T4 1>:__/O)^:_XU'<2.;:4&"0?(>25XX^M6:BN?^/6
M;_</\J #S7_Y]Y/S7_&CS7_Y]Y/S7_&I:* (O-?_ )]Y/S7_ !H\U_\ GWD_
M-?\ &I:* (O-?_GWD_-?\:/-?_GWD_-?\:EHH B\U_\ GWD_-?\ &CS7_P"?
M>3\U_P :EHH B\U_^?>3\U_QH\U_^?>3\U_QJ6B@"+S7_P"?>3\U_P :C@D<
M1G]Q(?G;NO\ >/O5FHH/]6?]]_\ T(T 'FO_ ,^\GYK_ (T>:_\ S[R?FO\
MC4M% $7FO_S[R?FO^-'FO_S[R?FO^-2T4 1>:_\ S[R?FO\ C1YK_P#/O)^:
M_P"-2T4 1>:__/O)^:_XT>:__/O)^:_XU+10!%YK_P#/O)^:_P"-'FO_ ,^\
MGYK_ (U+10! '+729C9/D;[V.>5]#4]1-_Q]1_[C?S6I: "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^>D?_?L_XTUXYI(V0RQX8$'$9_QH GHJ+;/_ ,](_P#OV?\ &C;/_P ](_\
MOV?\: ):*BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&@"6BHML_\ STC_ ._9
M_P :-L__ #TC_P"_9_QH EHJ+;/_ ,](_P#OV?\ &C;/_P ](_\ OV?\: ):
M*BVS_P#/2/\ []G_ !HVS_\ /2/_ +]G_&@"6HH/]6?]]_\ T(T;9_\ GI'_
M -^S_C34CF12!+'U)YC/<Y]: )Z*BVS_ //2/_OV?\:-L_\ STC_ ._9_P :
M ):*BVS_ //2/_OV?\:-L_\ STC_ ._9_P : ):*BVS_ //2/_OV?\:-L_\
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M>4;HY87#HX]01P14U !14*7=M+=36L=Q$]Q"%:6)7!>,-G:6'4 X.,]<&IJ
M"BH?MEM]M^Q?:(?M?E^;Y&\;]F<;MO7&>,],T^::*V@DGGE2*&-2\DCL%5%
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M8((T5020"6().T=N*GD\(*US;WL.M:G;:E%!]GDOH?(WW$>20LBF,QG!/!"
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MI4@G"Y>%@KH58,&4D'!! .<517P5I":]H^L*LHN-)M/LEL@8;-F"H)&.2 6
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M!-,@_M;5I+/2KE;FQM'EC\N J3A<A S* <#>S$#H1S0!S$NO^)D\(>(O$_\
M;LF[2=1N8X+,6T/E2Q138V2'9O)*Y7*LN.#R<DZ7B#7=7T[7=4_M'4]5T73X
M CV-W;Z8MU9.F%R9V",ZMO+ C=&-H!!YR=]_!.FR>&-6T SW?V34YIIYG#KO
M5I7W-M.W &>F0?QJ35/"AU1[Q3KVL6]I>C;<6D4L;1L",, 71G0$<$(RCN,$
MDT 9@O-6\3>(]6L=/UU],M--AA5);.&*0W$LJ>9O8R*XV ;<!<$Y.6Z5C65C
MKNH?$R]2XU4:9>KHEH;M]-1) \F^480S(V$SDX*YZ<\'/57/@ZU-S]HTO4=0
MT:5K9;64V#1XEC080,)$< J,@,,-@GD\8ET;PCI6@:BUYIRRQ9LXK(0ELHL<
M98@\C)8ESDDG- '#VWCK5=0M/#EC->7-K-=07,U[>:=IS7,S"&7RALC"2!=Q
MY)*D#H,9%6T\5Z\84TG?=1S76KI86FK7FG-;N\#1-(7\MU4&1=K)G:%)P=N.
M#T47@33[:PT^"SO;^UN=/>5K>]B=/.42N6=3E"C*2>A4] >HS3_^$&TMM,N+
M:66[ENI[H7KZBT@^T_:!PL@8 *I4  *%"@<;<$@@'%^()-9\-:]XJOH]7ENK
MNW\-1RVMS+#'YB8EE/S!5"-@[N=HXP"#C)Z[5M7OH=>\,6<<^+>_@NC<IL7]
MX5A#+SC(P3VQ4D7@6P:ZU.YU&^U#4Y=3L_L-T;MT :+G@"-5"_>/W<>O7)):
M>"((-2TZ_NM9U:_GTZ*2&W-U)'A4=-I!"1KDX&=Q^8]R>E ' >%O$EU#X?\
M"&@07E_8P?V1]MN9]/T]KN=_G*(B@1R!%SN)8J>@ QFMVT\4:_>OINA-+<VE
MS=ZE+;)JEQ8&"66VCB\WS%BD4 2-]S)7:"&(7H!OV_@+3[&QTB'3[_4+*ZTJ
M!K:"]A>,RM$WWD<,A1U) ."O! (QSF7_ (0;2QIZ0+-=K>)=_;AJ0D'VG[1T
M,A.-IR/E*[=NWC;CB@#,\*6EW9?$3Q9%>7[WS_9; I/)&J.5_?X#! %R.1D
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MPC! ?<AY!&<KM_+BMFT@DMK6.&6ZFNI$&#/,$#O[D(JK^0% $U%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
&4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img38651418_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img38651418_2.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +S!BD# 2(  A$! Q$!_\0
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M2[MVXC@U8_LNW_V_^^J32O\ CU;_ 'S5Z@"E_9=O_M_]]4?V7;_[?_?57:*
M*7]EV_\ M_\ ?5']EV_^W_WU5VB@"E_9=O\ [?\ WU1_9=O_ +?_ 'U5VB@"
ME_9=O_M_]]4?V7;_ .W_ -]5=HH I?V7;_[?_?5']EV_^W_WU5VB@"E_9=O_
M +?_ 'U1_9=O_M_]]5=HH I?V7;_ .W_ -]4?V7;_P"W_P!]5=HH I?V7;_[
M?_?5']EV_P#M_P#?57:* *7]EV_^W_WU1_9=O_M_]]5=HH I?V7;_P"W_P!]
M4?V7;_[?_?57:* *7]EV_P#M_P#?5']EV_\ M_\ ?57:* *7]EV_^W_WU1_9
M=O\ [?\ WU5VB@"E_9=O_M_]]4?V7;_[?_?57:* *7]EV_\ M_\ ?5']EV_^
MW_WU5VB@"E_9=O\ [?\ WU1_9=O_ +?_ 'U5VB@"E_9=O_M_]]4?V7;_ .W_
M -]5=HH I?V7;_[?_?5']EV_^W_WU5VB@"E_9=O_ +?_ 'U1_9=O_M_]]5=H
MH I?V7;_ .W_ -]4?V7;_P"W_P!]5=HH I?V7;_[?_?5']EV_P#M_P#?57:*
M *7]EV_^W_WU1_9=O_M_]]5=HH I?V7;_P"W_P!]4?V7;_[?_?57:* *7]EV
M_P#M_P#?5']EV_\ M_\ ?57:* *7]EV_^W_WU1_9=O\ [?\ WU5VB@"E_9=O
M_M_]]4?V7;_[?_?57:* *7]EV_\ M_\ ?5']EV_^W_WU5VB@"E_9=O\ [?\
MWU1_9=O_ +?_ 'U5VB@"E_9=O_M_]]4?V7;_ .W_ -]5=HH I?V7;_[?_?5'
M]EV_^W_WU5VB@"E_9=O_ +?_ 'U1_9=O_M_]]5=HH I?V7;_ .W_ -]4?V7;
M_P"W_P!]5=HH I?V7;_[?_?5']EV_P#M_P#?57:* *7]EV_^W_WU1_9=O_M_
M]]5=HH I?V7;_P"W_P!]4?V7;_[?_?57:* *7]EV_P#M_P#?5']EV_\ M_\
M?57:* *7]EV_^W_WU1_9=O\ [?\ WU5VB@"E_9=O_M_]]4?V7;_[?_?57:*
M*7]EV_\ M_\ ?5']EV_^W_WU5VB@"E_9=O\ [?\ WU1_9=O_ +?_ 'U5VB@"
ME_9=O_M_]]4?V7;_ .W_ -]5=HH I?V7;_[?_?5']EV_^W_WU5VB@"E_9=O_
M +?_ 'U1_9=O_M_]]5=HH I?V7;_ .W_ -]4?V7;_P"W_P!]5=HH I?V7;_[
M?_?5']EV_P#M_P#?57:* *7]EV_^W_WU1_9=O_M_]]5=HH I?V7;_P"W_P!]
M4?V7;_[?_?57:* *7]EV_P#M_P#?5']EV_\ M_\ ?57:* *7]EV_^W_WU1_9
M=O\ [?\ WU5VB@"E_9=O_M_]]4?V7;_[?_?57:* *7]EV_\ M_\ ?5']EV_^
MW_WU5VB@"E_9=O\ [?\ WU1_9=O_ +?_ 'U5VB@"E_9=O_M_]]4?V7;_ .W_
M -]5=HH I?V7;_[?_?5']EV_^W_WU5VB@"E_9=O_ +?_ 'U1_9=O_M_]]5=H
MH I?V7;_ .W_ -]4?V7;_P"W_P!]5=HH I?V7;_[?_?5']EV_P#M_P#?57:*
M *7]EV_^W_WU1_9=O_M_]]5=HH I?V7;_P"W_P!]4?V7;_[?_?57:* *7]EV
M_P#M_P#?5']EV_\ M_\ ?57:* *7]EV_^W_WU1_9=O\ [?\ WU5VB@"E_9=O
M_M_]]4?V7;_[?_?57:* *7]EV_\ M_\ ?5']EV_^W_WU5VB@"E_9=O\ [?\
MWU1_9=O_ +?_ 'U5VB@"E_9=O_M_]]4?V7;_ .W_ -]5=HH I?V7;_[?_?5'
M]EV_^W_WU5VB@"E_9=O_ +?_ 'U1_9=O_M_]]5=HH I?V7;_ .W_ -]4?V7;
M_P"W_P!]5=HH I?V7;_[?_?5']EV_P#M_P#?57:* *7]EV_^W_WU1_9=O_M_
M]]5=HH I?V7;_P"W_P!]4?V7;_[?_?57:* *7]EV_P#M_P#?5']EV_\ M_\
M?57:* *7]EV_^W_WU1_9=O\ [?\ WU5VB@"E_9=O_M_]]4?V7;_[?_?57:*
M*7]EV_\ M_\ ?5']EV_^W_WU5VB@"E_9=O\ [?\ WU1_9=O_ +?_ 'U5VB@"
ME_9=O_M_]]4?V7;_ .W_ -]5=HH I?V7;_[?_?5']EV_^W_WU5VB@"E_9=O_
M +?_ 'U1_9=O_M_]]5=HH I?V7;_ .W_ -]4?V7;_P"W_P!]5=HH I?V7;_[
M?_?5']EV_P#M_P#?57:* *7]EV_^W_WU1_9=O_M_]]5=HH I?V7;_P"W_P!]
M4?V7;_[?_?57:* *7]EV_P#M_P#?5']EV_\ M_\ ?57:* *7]EV_^W_WU1_9
M=O\ [?\ WU5VB@"E_9=O_M_]]4?V7;_[?_?57:* *7]EV_\ M_\ ?5']EV_^
MW_WU5VB@"E_9=O\ [?\ WU1_9=O_ +?_ 'U5VB@"E_9=O_M_]]4?V7;_ .W_
M -]5=HH I?V7;_[?_?5']EV_^W_WU5VB@"E_9=O_ +?_ 'U1_9=O_M_]]5=H
MH I?V7;_ .W_ -]4?V7;_P"W_P!]5=HH I?V7;_[?_?5']EV_P#M_P#?57:*
M *7]EV_^W_WU1_9=O_M_]]5=HH I?V7;_P"W_P!]4?V7;_[?_?57:* *7]EV
M_P#M_P#?5']EV_\ M_\ ?57:* *7]EV_^W_WU1_9=O\ [?\ WU5VB@"E_9=O
M_M_]]4?V7;_[?_?57:* ,RZL(8+9Y$W;ATR:S_-?U/YUM:A_QXR?A_.L*@#8
MTK_CU;_?-7JHZ5_QZM_OFKU !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!6U#_CQD_#^=85;NH?\>,GX?SK"H V-*_X]6_WS5ZJ.E?\ 'JW^^:O4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:2"&5DA9CG QT'M5@?#EYV":CXEU2]MOXH)'(#?K776&F6FF6"65G"L4"K@
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M\B;8_P"[6KJ>DIJ>ARZ8TS1K)&$\P#)&,<X_"DT+2$T/2(=/29IEB& [#!-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@"MJ'_'C)^'\ZPJW=0_X\9/P_G6%
M0!L:5_QZM_OFKU4=*_X]6_WS5Z@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH K:A_P >,GX?SK"K=U#_ (\9/P_G6%0!L:5_QZM_OFKU4=*_X]6_WS5Z
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ,]1^1H M455_M&U_P">H_(T?VC:_P#/4?D: +5%5?[1M?\ GJ/R-']HVO\
MSU'Y&@"U157^T;7_ )ZC\C1_:-K_ ,]1^1H M455_M&U_P">H_(T?VC:_P#/
M4?D: +5%5?[1M?\ GJ/R-']HVO\ SU'Y&@"U157^T;7_ )ZC\C1_:-K_ ,]1
M^1H M455_M&U_P">H_(T?VC:_P#/4?D: +5%5?[1M?\ GJ/R-']HVO\ SU'Y
M&@"U157^T;7_ )ZC\C1_:-K_ ,]1^1H M455_M&U_P">H_(T?VC:_P#/4?D:
M +5%5?[1M?\ GJ/R-']HVO\ SU'Y&@"U157^T;7_ )ZC\C1_:-K_ ,]1^1H
MM455_M&U_P">H_(T?VC:_P#/4?D: +5%5?[1M?\ GJ/R-']HVO\ SU'Y&@"U
M157^T;7_ )ZC\C1_:-K_ ,]1^1H M455_M&U_P">H_(T?VC:_P#/4?D: +5%
M5?[1M?\ GJ/R-']HVO\ SU'Y&@"U157^T;7_ )ZC\C1_:-K_ ,]1^1H M455
M_M&U_P">H_(T?VC:_P#/4?D: +5%5?[1M?\ GJ/R-']HVO\ SU'Y&@"U157^
MT;7_ )ZC\C1_:-K_ ,]1^1H M455_M&U_P">H_(T?VC:_P#/4?D: +5%5?[1
MM?\ GJ/R-']HVO\ SU'Y&@"U157^T;7_ )ZC\C1_:-K_ ,]1^1H M455_M&U
M_P">H_(T?VC:_P#/4?D: +5%5?[1M?\ GJ/R-']HVO\ SU'Y&@"U157^T;7_
M )ZC\C1_:-K_ ,]1^1H M455_M&U_P">H_(T?VC:_P#/4?D: +5%5?[1M?\
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M ,]1^1H M455_M&U_P">H_(T?VC:_P#/4?D: +5%5?[1M?\ GJ/R-']HVO\
MSU'Y&@"U157^T;7_ )ZC\C1_:-K_ ,]1^1H M455_M&U_P">H_(T?VC:_P#/
M4?D: +5%5?[1M?\ GJ/R-']HVO\ SU'Y&@"U157^T;7_ )ZC\C1_:-K_ ,]1
M^1H M455_M&U_P">H_(T?VC:_P#/4?D: +5%5?[1M?\ GJ/R-']HVO\ SU'Y
M&@"U157^T;7_ )ZC\C1_:-K_ ,]1^1H M455_M&U_P">H_(T?VC:_P#/4?D:
M +5%5?[1M?\ GJ/R-']HVO\ SU'Y&@"U157^T;7_ )ZC\C1_:-K_ ,]1^1H
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M\T_[Y%'DQ_\ /-/^^13Z* &>3'_SS3_OD4>3'_SS3_OD4^B@!GDQ_P#/-/\
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M\T_[Y%'DQ_\ /-/^^13Z* &>3'_SS3_OD4>3'_SS3_OD4^B@!GDQ_P#/-/\
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MH 145?NJ!]!2T44 %%%% !1110 4444 5M0_X\9/P_G6%6[J'_'C)^'\ZPJ
M-C2O^/5O]\U>JCI7_'JW^^:O4 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !111TH *BGN(X%RYY[ =34,MVS2&*V7>_=NPIT-F$;S)6\R4]2>E
M$0BFO&W39CB[(.I^M7(XUB0(B@*.PIU% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M *VH?\>,GX?SK"K=U#_CQD_#^=85 &QI7_'JW^^:O51TK_CU;_?-7J "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "N#TE]-\/>(=8M]8\BW-Q()H)KC 61><X)XR,UWE,>&.7
M'F1H^.FY0: .%TVS_M;6M>N-.3;IMS;&)' Q'-)_>7U'3D5:\->(M-TG0UT_
M5;J*RN[,>6\,S!6('0@'J#79*JHH55"J.P&*8UO"[;GAC9O4J": .9\&6=P/
M[1U2XB:'[?.9(XV&"%P "1^%=51THH *,#.<<T44 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 5M0_P"/&3\/YUA5NZA_QXR?
MA_.L*@#8TK_CU;_?-7JHZ5_QZM_OFKU !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 44FX>HHW#U% "T4FX>HHW#U% "T4FX>HHW#U% "T4FX>HHW#U% "T4FX>H
MHW#U% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,R3WAQ%F.'^_W-68;>.W7"+CU/<T 0Q6A9O-N3OD[#LM6Z** "BBB@ HHHH
M**** "BBB@ HHHH \[^*G_'MI_\ O-_2O,J]-^*G_'MI_P#O-_2O,J^@P/\
M 1YF)_B,****[#G"BBB@ HHHH **** *.J_\>GXUB5MZK_QZ?C6)7+6^(WI[
M!111619]0>$/^12TS_KB*VJQ?"'_ "*6F?\ 7$5M5XD_B9Z$=D%%%%2,****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M =*["H+2TM[&U2VM8EBA0855& *GH *@DM4FF$DA+ #A3TJ>B@  P,"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#SOXJ?\>VG_[S?TKS*O3?BI_Q[:?_
M +S?TKS*OH,#_ 1YF)_B,****[#G"BBB@ HHHH **** *.J_\>GXUB5MZK_Q
MZ?C6)7+6^(WI[!111619]0>$/^12TS_KB*VJQ?"'_(I:9_UQ%;5>)/XF>A'9
M!1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH K:A_P >,GX?SK"K=U#_ (\9
M/P_G6%0!L:5_QZM_OFKU4=*_X]6_WS5Z@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@"MJ'_'C)^'\ZPJW=0_X\9/P_G6%0!L:5_QZM_OFKU4=*_X]6_WS5Z@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CEF2%"
MSMC^M0S7FU_*@7S)/;H*2*S._P VX;S)/T% #?[0]+>7\J/[0_Z=Y?RJ[10!
M2_M#_IWE_*C^T/\ IWE_*KM% %+^T/\ IWE_*C^T/^G>7\JNT4 >:_$VX\ZV
ML!Y;IAF^\/I7G%>F_%3_ (]M/_WF_I7F5?08'^ CS,3_ !&%%%%=ASA1110
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MZ=Y?RH_M#_IWE_*KM% %+^T/^G>7\J/[0_Z=Y?RJ[10!2_M#_IWE_*C^T/\
MIWE_*KM% %+^T/\ IWE_*C^T/^G>7\JNT4 4O[0_Z=Y?RH_M#_IWE_*KM% %
M+^T/^G>7\J/[0_Z=Y?RJ[10!2_M#_IWE_*C^T/\ IWE_*KM% %+^T/\ IWE_
M*C^T/^G>7\JNT4 4O[0_Z=Y?RH_M#_IWE_*KM% %+^T/^G>7\J/[0_Z=Y?RJ
M[10!2_M#_IWE_*C^T/\ IWE_*KM% %+^T/\ IWE_*C^T/^G>7\JNT4 4O[0_
MZ=Y?RH_M#_IWE_*KM% %+^T/^G>7\J/[0_Z=Y?RJ[10!2_M#_IWE_*C^T/\
MIWE_*KM% %+^T/\ IWE_*C^T/^G>7\JNT4 4O[0_Z=Y?RH_M#_IWE_*KM% %
M+^T/^G>7\J/[0_Z=Y?RJ[10!2_M#_IWE_*C^T/\ IWE_*KM% %+^T/\ IWE_
M*C^T/^G>7\JNT4 4O[0_Z=Y?RH_M#_IWE_*KM% %+^T/^G>7\J/[0_Z=Y?RJ
M[10!2_M#_IWE_*C^T/\ IWE_*KM% %+^T/\ IWE_*C^T/^G>7\JNT4 4O[0_
MZ=Y?RH_M#_IWE_*KM% %+^T/^G>7\J/[0_Z=Y?RJ[10!2_M#_IWE_*C^T/\
MIWE_*KM% %+^T/\ IWE_*C^T/^G>7\JNT4 4O[0_Z=Y?RH_M#_IWE_*KM% %
M+^T/^G>7\J/[0_Z=Y?RJ[10!2_M#_IWE_*C^T/\ IWE_*KM% %+^T/\ IWE_
M*C^T/^G>7\JNT4 4O[0_Z=Y?RH_M#_IWE_*KM% %+^T/^G>7\J/[0_Z=Y?RJ
M[10!2_M#_IWE_*C^T/\ IWE_*KM% %+^T/\ IWE_*C^T/^G>7\JNT4 4O[0_
MZ=Y?RH_M#_IWE_*KM% %+^T/^G>7\J/[0_Z=Y?RJ[10!2_M#_IWE_*C^T/\
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MXR?A_.L*MW4/^/&3\/YUA4 ;&E?\>K?[YJ]5'2O^/5O]\U>H **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% %;4/\ CQD_#^=85;NH?\>,GX?SK"H
MV-*_X]6_WS5ZJ.E?\>K?[YJ]0 4444 %%%% !1110 4444 <;XJ2._\ $VDZ
M5?2%=.E!=HP^T2/SA2?3%/O_  %X7MM/N)H;".SD2-F6X21E,9QUSFM#Q+'H
MEXMK8:JC22SOB!8P2ZM@\C'(^M8%Q\.]%TZ![N[O]7N+>(;Y(FF+AE'4$ 9(
MH Z+P?>SZAX9M9[ABTGS)O/\04D _B!6Y533)+.73;=[ *+4H/+"C  ]*MT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YW\5/^/;3_P#>
M;^E>95Z;\5/^/;3_ />;^E>95]!@?X"/,Q/\1A11178<X4444 %%%% !1110
M!1U7_CT_&L2MO5?^/3\:Q*Y:WQ&]/8****R+/J#PA_R*6F?]<16U6+X0_P"1
M2TS_ *XBMJO$G\3/0CL@HHHJ1A1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M44 %%->18T+.0 .YJF9)[PXBS'#W<]2/:@"[N'J*-R^HJI_9L'^W_P!]4O\
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M_P#OJ@"UN7U%&Y?455_LV#_;_P"^J/[-@_V_^^J +6Y?44;E]157^S8/]O\
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M157^S8/]O_OJC^S8/]O_ +ZH M;E]11N7U%5?[-@_P!O_OJC^S8/]O\ [ZH
MM;E]11N7U%5?[-@_V_\ OJC^S8/]O_OJ@"UN7U%&Y?455_LV#_;_ .^J/[-@
M_P!O_OJ@"UN7U%&Y?455_LV#_;_[ZH_LV#_;_P"^J +6Y?44;E]157^S8/\
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MF*6_RQC@R'^E6(+6.W'RC+'JQZF@"".U>9O,NCD]D'05=  &!P*** "BBB@
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M **** "BBB@ KD/B)J5YIVA1?8YVA::;RW9>NW!Z5U]<-\4?^0%9_P#7R/\
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M-%1%"JHP !P!3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M\[^*G_'MI_\ O-_2O,J]-^*G_'MI_P#O-_2O,J^@P/\  1YF)_B,****[#G"
MBBB@ HHHH **** *.J_\>GXUB5MZK_QZ?C6)7+6^(WI[!111619]0>$/^12T
MS_KB*VJQ?"'_ "*6F?\ 7$5M5XD_B9Z$=D%%%%2,**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KAOBC_P @*S_Z^1_Z":[FN&^*/_("L_\ KY'_
M *":SJ_ SAS/_=)^AY51117$?"A1110 4444 %%%% !534O^/)OK5NJFI?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!2,P52S' '4U%/=1VX^8Y8]%'6JZP373;KDE4[1@_P Z %:XDN3LMAA?XI#_
M $J:"U2 9^\YZL>M3*JHH50 !V%+0 4444 %%%% !1110!YW\5/^/;3_ />;
M^E>95Z;\5/\ CVT__>;^E>95]!@?X"/,Q/\ $84445V'.%%%% !1110 4444
M 4=5_P"/3\:Q*V]5_P"/3\:Q*Y:WQ&]/8****R+/J#PA_P BEIG_ %Q%;58O
MA#_D4M,_ZXBMJO$G\3/0CL@HHHJ1A1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<-\4?^0%9_\ 7R/_ $$UW-<-\4?^0%9_]?(_]!-9U?@9PYG_
M +I/T/*J***XCX4**** "BBB@ HHHH *J:E_QY-]:MU4U+_CR;ZTUN:4OC1@
M4445J>N!Z5])^ /^1*TW_KD/Y5\V'I7TGX _Y$K3?^N0_E6E+<]++/XC]#I:
M***W/;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .:\;_\
M@4?[XKSNO1/&_P#R!1_OBO.Z^<S/_>/DCZ7*O]W^;"BBBO./2"BBB@ HHHH
M**** *FJ?\@V?Z#^=<I75ZI_R#9_H/YURE=F'^%G'B/B04445N8'N_P[_P"1
M%TW_ '7_ /0S745R_P ._P#D1=-_W7_]#-=17NT?X<?1'S];^)+U84445H9A
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5[W_CW/UJQ5>]_P"/
M<_6O.S;_ '&K_A9=/XD95%%%?CQZ 4444 %%%% !1110 54U3_D%77_7)OY5
M;JIJG_(*NO\ KDW\JNG\:]1,\X'044#H**^F,0KTWP5_R+R_]=&_I7F5>F^"
MO^1>7_KHW]*]G(O]Y^3,ZNQT5%%%?8'.%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% %;4/^/&3\/YUA5NZA_QXR?A_.L*@#8TK_CU
M;_?-7JHZ5_QZM_OFKU !1110 4444 %%%% !5'6;Q]/T6]O(P"\,+.H/J!Q5
MZJFIV2:CIES9R2&-)HRA<=0".M '"PZ#KT.D_P!OKXDO#>&,S"VDYAY[8],4
M^S\#Z=J^A)K&H27$NJSQ>=]I$K HV,C:,XXIT?P[>:VV1>+]5D@QMVK("N/3
MKBL>XTC1M-O!I4WQ U&&4800!S@9[<<"@#O/"%[-?^&K::=VDD!:,NW5MK$9
M/Y5N5E^'M(CT/18+"*X:X1,D2MC+9.<\?6M2@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***BFN(X%RYY[
M =30!*2 ,DX%4I+IYF,=J,D=7/04@BFO#NE)CA_N#J?K5Q(TC7:BA1Z"@"&"
MT6([W.^4]6-6*** "BBB@ HHHH **** "BBB@#SOXJ?\>VG_ .\W]*\RKTWX
MJ?\ 'MI_^\W]*\RKZ# _P$>9B?XC"BBBNPYPHHHH **** "BBB@"CJO_ !Z?
MC6)6WJO_ !Z?C6)7+6^(WI[!111619]0>$/^12TS_KB*VJQ?"'_(I:9_UQ%;
M5>)/XF>A'9!1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MX;XH_P#("L_^OD?^@FNYKAOBC_R K/\ Z^1_Z":SJ_ SAS/_ '2?H>54445Q
M'PH4444 %%%% !1110 54U+_ (\F^M6ZJ:E_QY-]::W-*7QHP****U/7 ]*^
MD_ '_(E:;_UR'\J^;#TKZ3\ ?\B5IO\ UR'\JTI;GI99_$?H=+1116Y[8444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S7C?_D"C_?%>=UZ
M)XW_ .0*/]\5YW7SF9_[Q\D?2Y5_N_S84445YQZ04444 %%%% !1110!4U3_
M )!L_P!!_.N4KJ]4_P"0;/\ 0?SKE*[,/\+./$?$@HHHK<P/=_AW_P B+IO^
MZ_\ Z&:ZBN7^'?\ R(NF_P"Z_P#Z&:ZBO=H_PX^B/GZW\27JPHHHK0S"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *KWO\ Q[GZU8JO>_\ 'N?K
M7G9M_N-7_"RZ?Q(RJ***_'CT HHHH **** "BBB@ JIJG_(*NO\ KDW\JMU4
MU3_D%77_ %R;^573^->HF><#H**!T%%?3&(5Z;X*_P"1>7_KHW]*\RKTWP5_
MR+R_]=&_I7LY%_O/R9G5V.BHHHK[ YPHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH K:A_QXR?A_.L*MW4/^/&3\/YUA4 ;&E?\>K?
M[YJ]5'2O^/5O]\U>H **** "BBB@ HHHH *I:O'--HU[';9\]X7$>/[V.*NU
M!>74=C93W<V?+A0NV/0#- 'GECXQTO2?"2:79,W]L &,6@C;?YA)R>GXUKV/
MAC3M+\&S'5K:"2Y:%Y;F:9 SAB.?F/-9L?B#5!.-<?PA:C3,[S=KM\\)TW8Z
M_P#UJOW'BVZUU9+?P[HAU&$$"2:Z 2$@^F>30!J>!FF;PC9F8L3\VPMUV;CM
M_3%=%6?HD%];:5#%J4D+W(SN,";4 SP ,=AQ6A0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5AW7B&:.YFBM-'OKQ(>'DCVJ ?0;B"?P
MK<K/UG5[;1=/>ZN6Z<(@Y9V[ #UH 31]:M-;T\7EJQ"@E75QAD8=0:SW\4F1
MYSIVE7FH00DJ\\)0+N'4#<03CV%9VDV%YIG@[5+FX3R[N\$EPT7_ #SRN,?D
M*T_!:JOA*P*@ M&&;'<GK0!I:5JMKK%BMW:/N0\$$8*GN"/6KM<=X,^36/$,
M2<1+=Y51T'RBNQH *.E%5IX9IY-I?;#CG'4T ,ENV=_*MAO?NW84^&S"-YLI
M\R4]SV^E311)"FU% %/H **** "BBB@ HHHH **** "BBB@ HHHH \[^*G_'
MMI_^\W]*\RKTWXJ?\>VG_P"\W]*\RKZ# _P$>9B?XC"BBBNPYPHHHH ****
M"BBB@"CJO_'I^-8E;>J_\>GXUB5RUOB-Z>P4445D6?4'A#_D4M,_ZXBMJL7P
MA_R*6F?]<16U7B3^)GH1V04445(PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "N&^*/_("L_P#KY'_H)KN:X;XH_P#("L_^OD?^@FLZOP,X<S_W
M2?H>54445Q'PH4444 %%%% !1110 54U+_CR;ZU;JIJ7_'DWUIK<TI?&C HH
MHK4]<#TKZ3\ ?\B5IO\ UR'\J^;#TKZ3\ ?\B5IO_7(?RK2EN>EEG\1^ATM%
M%%;GMA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '->-_\
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MK:KQ)_$ST([(****D84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#/-?RJ2B@"/R(?^>:_E1Y$/_/-?RJ2B@#E_&L4::,"J*#O'05Y]7HGC?\
MY H_WQ7G=?.9G_O'R1]+E7^[_-A1117G'I!1110 4444 %%%% %35/\ D&S_
M $'\ZY2NKU3_ )!L_P!!_.N4KLP_PLX\1\2"BBBMS ]T^'L4;^!M-+(I.'Y(
M_P!LUT_D0_\ /-?RKF_AW_R(NF_[K_\ H9KJ*]VC_#CZ(^?K?Q)>K(_(A_YY
MK^5'D0_\\U_*I**T,R/R(?\ GFOY4>1#_P \U_*I** (_(A_YYK^5'D0_P#/
M-?RJ2B@"/R(?^>:_E1Y$/_/-?RJ2B@"/R(?^>:_E1Y$/_/-?RJ2B@"/R(?\
MGFOY4>1#_P \U_*I** (_(A_YYK^5'D0_P#/-?RJ2B@"/R(?^>:_E1Y$/_/-
M?RJ2B@"/R(?^>:_E1Y$/_/-?RJ2B@"/R(?\ GFOY5!=Q1K 2J*#GL*MU7O?^
M/<_6O.S;_<:O^%ET_B1E4445^/'H!1110 4444 %%%% !535/^05=?\ 7)OY
M5;JIJG_(*NO^N3?RJZ?QKU$SS@=!10.@HKZ8Q"O2O!D4;^'U+(I/F-U'TKS6
MO3?!7_(O+_UT;^E>SD7^\_)F=78WO(A_YYK^5'D0_P#/-?RJ2BOL#G(_(A_Y
MYK^5'D0_\\U_*I** (_(A_YYK^5'D0_\\U_*I** (_(A_P">:_E1Y$/_ #S7
M\JDHH C\B'_GFOY4>1#_ ,\U_*I** (_(A_YYK^5'D0_\\U_*I** (_(A_YY
MK^5'D0_\\U_*I** &K&B?=4#/H*=110 4444 %%%% !1110!6U#_ (\9/P_G
M6%6[J'_'C)^'\ZPJ -C2O^/5O]\U>JCI7_'JW^^:O4 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5'-/' FYSCT'<U!+=DN8K=?,DZ9["E
MAL\-YDS>9)ZGH* (]DU[R^8H>RCJ:MQQI$@5%  I]% !1110 4444 %%%% !
M1110!YW\5/\ CVT__>;^E>95Z;\5/^/;3_\ >;^E>95]!@?X"/,Q/\1A1117
M8<X4444 %%%% !1110!1U7_CT_&L2MO5?^/3\:Q*Y:WQ&]/8****R+/J#PA_
MR*6F?]<16U6+X0_Y%+3/^N(K:KQ)_$ST([(****D84444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7#?%'_D!6?\ U\C_ -!-=S7#?%'_ ) 5G_U\
MC_T$UG5^!G#F?^Z3]#RJBBBN(^%"BBB@ HHHH **** "JFI?\>3?6K=5-2_X
M\F^M-;FE+XT8%%%%:GK@>E?2?@#_ )$K3?\ KD/Y5\V'I7TGX _Y$K3?^N0_
ME6E+<]++/XC]#I:***W/;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** .:\;_\ (%'^^*\[KT3QO_R!1_OBO.Z^<S/_ 'CY(^ERK_=_FPHH
MHKSCT@HHHH **** "BBB@"IJG_(-G^@_G7*5U>J?\@V?Z#^=<I79A_A9QXCX
MD%%%%;F![O\ #O\ Y$73?]U__0S745R_P[_Y$73?]U__ $,UU%>[1_AQ]$?/
MUOXDO5A1116AF%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 57O?
M^/<_6K%5[W_CW/UKSLV_W&K_ (673^)&51117X\>@%%%% !1110 4444 %5-
M4_Y!5U_UR;^56ZJ:I_R"KK_KDW\JNG\:]1,\X'044#H**^F,0KTWP5_R+R_]
M=&_I7F5>F^"O^1>7_KHW]*]G(O\ >?DS.KL=%1117V!SA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!6U#_CQD_#^=85;NH?\>,GX
M?SK"H V-*_X]6_WS5ZJ.E?\ 'JW^^:O4 %%%% !1110 4444 %%%% !1110
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M** "BBB@ HHHH **** "BBB@ HHHH *X;XH_\@*S_P"OD?\ H)KN:X;XH_\
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M* "J][_Q[GZU8JO>_P#'N?K7G9M_N-7_  LNG\2,JBBBOQX] **** "BBB@
MHHHH *J:I_R"KK_KDW\JMU4U3_D%77_7)OY5=/XUZB9YP.@HH'045],8A7IO
M@K_D7E_ZZ-_2O,J]-\%?\B\O_71OZ5[.1?[S\F9U=CHJ***^P.<**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *VH?\>,GX?SK"K=U
M#_CQD_#^=85 &QI7_'JW^^:O51TK_CU;_?-7J "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#SOXJ?\>VG_[S?TKS*O3?BI_Q[:?_ +S?TKS*OH,#_ 1YF)_B,****[#G
M"BBB@ HHHH **** *.J_\>GXUB5MZK_QZ?C6)7+6^(WI[!111619]0>$/^12
MTS_KB*VJQ?"'_(I:9_UQ%;5>)/XF>A'9!1114C"BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBF2S)"NYV % #ZJ2WA9S%;+O?N>PJ/$]]US%
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MS]M^57:* *7V6Z_Y^V_*C[+=?\_;?E5VB@"E]ENO^?MORH^RW7_/VWY5=HH
MI?9;K_G[;\J/LMU_S]M^57:* *7V6Z_Y^V_*C[+=?\_;?E5VB@"E]ENO^?MO
MRH^RW7_/VWY5=HH I?9;K_G[;\JXOXE0S1Z):&2<R#[3T(_V37H-<-\4?^0%
M9_\ 7R/_ $$UG5^!G#F?^Z3]#RJBBBN(^%"BBB@ HHHH **** "JFI?\>3?6
MK=5-2_X\F^M-;FE+XT8%%%%:GK@>E?1/@6WG?P;IQ2Y*@QCC'3BOG8]*^D_
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MRW7_ #]M^5'V6Z_Y^V_*KM%:&92^RW7_ #]M^5'V6Z_Y^V_*KM% %+[+=?\
M/VWY4?9;K_G[;\JNT4 4OLMU_P _;?E1]ENO^?MORJ[10!2^RW7_ #]M^5'V
M6Z_Y^V_*KM% %+[+=?\ /VWY4?9;K_G[;\JNT4 4OLMU_P _;?E1]ENO^?MO
MRJ[10!2^RW7_ #]M^5'V6Z_Y^V_*KM% %+[+=?\ /VWY4?9;K_G[;\JNT4 4
MOLMU_P _;?E44\$\<6Y[@NOIBM*J][_Q[GZUYV;?[C5_PLNG\2,JBBBOQX]
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MA5'858HK>,5$]RAAH45:.X44451T!1110 4444 %%%% !1110 4444 %%%%
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ME:"T[]#GE)1.=T/PK=:KB:8&&VSU/5OI7HMA8P:;:);6Z[8U]>I/J:L !0
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MH_X0*3_G]'_?-=Q167]G8?\ E_%FO]I8G^;\$</_ ,(%)_S^C_OFC_A I/\
MG]'_ 'S7<44?V=A_Y?Q8?VEB?YOP1P__  @4G_/Z/^^:/^$"D_Y_1_WS7<44
M?V=A_P"7\6']I8G^;\$</_P@4G_/Z/\ OFC_ (0*3_G]'_?-=Q11_9V'_E_%
MA_:6)_F_!'"3?#LW,1ADO]J-C<53G%=3H^@Z=H5MY-A;K'D ,_5F^I[UI45O
M1PU*C\",*V*JUOC84445N<X4444 %%%% !1110 4444 %%%% !1110 4444
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MG#[\\8Q6C)&DT;1R(KHPPRL,@BL%?!FD*0N+HP!]_P!G-RYB^FS.,>V* (/
M,$D'A*U\Q2I<LP!ZX)-=/2*JHH50 H& !VI: "L^1/.U41R$L@7<%SQ6A5'_
M )C/_;.@"Z %& , =A2T44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1103@9- !147VF#RC+YT?E@X+;AC/UJ0$$ @Y!Z$4 +1110 4444 %%%% !
M1110 4444 %%%% !1110!2N'<:C;J&(4@Y /!J[5&Y_Y"EM]#5Z@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBFK+&[,J.K%3A@#G'UH =11
M10 4444 %%%% !1110 4444 %%%% !1110 529W_ +61-QVE,[<\5=JB_P#R
M&8_^N9H O4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44T
MRQK(J,ZAV^ZI/)IU !1110 4444 %%%% !1110 4444 %%%% !1110!2NG=;
MZV56(4GD ]:NU0N_^0A:?4U?H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HILDL<0!D=4!.,L<4Z@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *I:@[IY.UBN7P<'K5VJ&I=(/\ KH* +]%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!6U#_ (\9/P_G6%6[J'_'C)^'\ZPJ -C2O^/5O]\U
M>JCI7_'JW^^:O4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4?\ F,_]
MLZO51_YC/_;.@"]1110 4444 %%%% !1110 4444 %<7XND+>(]%M9;R>WM)
M682^7<&('@XR017:5Q'B];5_%F@+>B$VY=]PGQL/RGKGB@!+:06/C.SL='U"
M:[MI8F:ZCDN#.$ Q@@L3CK717VM/;7!@M=-N[Z11E_)"@+^+$9_"N9UE-/AU
MO1SX=6W2],X$@L@ IB_BW[>/SJW/K-[>>(KVP_M5-(AM%&TM&C--[C>.GTH
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MJ2Q 'YUE>,"!JOA\]#]JX/Y5FS1W%MXZU(OJ[:6+A%,,C0HRR  9&YQ@<]J
M.JTC7(-7\^,12V]S VV6WF #I^1(Q]*U*YC0=/@37;R^_MI]1NGB5)"(E5
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MHHH **** "BBB@ HHHH **** "J+_P#(9C_ZYFKU47_Y#,?_ %S- %ZBBB@
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MR* (/[1M?^>P_(T?VC:_\]A^1J?R8O\ GDG_ 'R*/)B_YY)_WR* (/[1M?\
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M4 5M0_X\9/P_G6%6[J'_ !XR?A_.L*@#8TK_ (]6_P!\U>JCI7_'JW^^:O4
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M )-=\26^EZ$VHP$3[HRT)5&=&..Y7H/K3M%\1VFK62S?O(G6,/+OA=$7UPS
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M>U[3[:YU!M0M+]O+_?(JO&PQR-H&1S6[K6M6VB6)N)SES\L<2\M(W8 4 4]
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M)F\JV!YQ&.X_,UV% !1110 4444 %%%% !1110 4444 %%%% !1110!0N_\
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M\FC^TK7_ )Z'_ODT 6Z*J?VE:_\ /0_]\FC^TK7_ )Z'_ODT 6Z*J?VE:_\
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M^%UGNX9]4U&ZU(0'=%'.$55;UP@&3]:U/[2M?^>A_P"^31_:5K_ST/\ WR:
M*NKZ#;ZL89?-EMKJ YAN(2 Z?GP?QJ*S\.I#J*W][?7&H7,8VQ/.% C'? 4
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HO;^\WYT;V_O-^=%% !O;^\WYT;V_O-^=%% !N8\%B1]:=@444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img38651418_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img38651418_3.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (S TL# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6
M3XETN?6= N;"W:-992A4R$A>'5CG /85K44 86HZ%)=:_#?0NBPRVLEI>J3A
MGC;E2O!Y!SU[&J.D>%VT[['#)I.AM]F8?Z<(LS.%^ZVW8-K\#G>><GFNKHH
MYJ3PW.WBK[:)(O[-:5+N2'D,;A4* XQC'(;KU%21:-?VUYKEQ&ME.M_+&RPS
M%MK($"LK<<9Y[,/:NAHH XS_ (0V:73+R)ULH2]XEY;V2;I+:,K_  '(&5;G
M. ,9X'&*O)X:2XL[^VETO2=-6YMV@#6*[GY[EMJ<#CY<=NM=+10!RC:)KEW)
MH@NGL$BTV9';RW=C-A2I;E1M/3Y>>IYXYT_$NE3ZSI:6MN\:NMQ%+F0D#"L"
M>@//%;%% ',2^%I9/&2ZJ)D_L\E9Y+;G)N%4JK8QCH<]>HIC^%[MK#4$6XA2
MZ?53J-HW)4$%2H?CV(.,]>_2NJHH Q(M-O[S7K;4]1%O"MI$Z006\K299\;F
M9BJ]@ !CU.>U9D?AB_\ ^$:;16DMD^S3&>SN4=B2PD+KO3:,=<'!-==10!AQ
MZ=J-[K=GJ.IK:P+9(XABMI6DWNXPS,65< #H .YYXQ4WAG2Y]&\/6FGW#1M+
M"&#&,DJ<L3QD#UK6HH P;W3M27Q1'J]E%:3(+)K9HYIVB.2X;((1O2LV;P?/
M=6%P]PUI)?3:@+_RG4M!D#:(SD9(P3DX[]*["B@#EY/#DDVD:G;PZ9H^G2W5
MLT$?V4$Y)SRSA%XZ<;3TSGL+4^BW,DWA]P\6-..9LD_-^[*_+QSSZXK>HH X
M2X\&:A-%)&T6F2W!O!<?VC*6,[H'!V?=^7 &.&(P,8YR-;4/#<]WXD2\CEB&
MGRM%+=Q,3N=XMVS QC'*YR?X172T4 <U>>&)-0NO$'G3K'#J<4"1,F2T;1@\
MD<#J1QGGGI4ATS5M3O=-DU7['#%8OYY6VE9S-*%P#RJ[0,DXYZUT-% &/X<T
MJ?1]/GM[AXV>2ZEF!C)(VLV1U YJ*_T!]4\1P7MW(PL[6W98%AG>.02,?F8E
M<$#: .OK6[10!S4'AZ[TO5-1GTUX7M;R%"T5Y+)(6E4X.2<G!4D9R<''!'%-
MT[0;W3TU1X;;38DO'0C3E9FMPH7:_.T8+#KA,?*.#73U$+F!KEK99HS.BAFB
M#C<%/0D=<4 <C_PADTNG74;K90EKU;RWL5#26R%1C8<@<-SG"C&> <8K5L-*
MGLOM$UMI6BZ?.8]L8MT+;CG/S.%0XZ<8/KSTK>HH Y?3M O;"XU&Z@M=-M5N
M4C1;")F: X^\6.U<%AD<+QP3GI51_"-X^D:O;0K96?VZ>"2*TA=C##L92Q!V
MCEMO91T%=G10!EMILQ\5QZINC\A;%[<KD[MQ=6STQC />L%_!T\FEF*7['-/
M'J<E]%'*"T4BL3\C\<9!ZX.".]=E10!R\WAN2?0]4M8=-TC3I[J'RHQ:J<?5
MW"*2/;;QCJ<\79='N'OM G#Q;=.W^:"3ELQ%!MXYY/?'%;=% &+HFFWFEW>H
MQR+;O:7-U)=1R+(WF N0=I3;CUYW>G%5[X-9>.=-O& \F\MI+(L?X7!\Q1GW
M ;'TKHJ* .9_X1B6;1=?L+B2+.H7<MQ"RDG9G:4)XZAE!XK2@T:VGAMI]5L+
M"?4DC023^4KG<!U#$9Z\UJ44 <I/X5N9[#7(C/"D]W>?:[2123Y; +M)XX.5
M[9X-.C\,7$6DZ);++"T]I?K>W<A)'F-ARY'')RW&<<"NIHH YF'3-;L-1UF:
MTAT^5+^421M-<.I3Y O*B,@_G4%EX,,-SIL5Q<M)9:=:-% 89GAD,K-EW.T@
M@8XQN-=;10!RZZ=_PBU[J^K13#^S9+7S9$FF>23SDSSELD@CCKG..*T/"MC+
MIOA?3[6==LRQ;I%QC:S$L1^!-;%% '%6$*ZII7BO2(+B 7DU[<@1N_*A@ &(
M&2!GOBNKMK:2'2H;4R!94@$>]><$+C(JU10!Q%IX0OXIM*:2WTM9;.Z\Z>]5
MF:>Z^]DL2@()SD@ELGN,<ZD6BZA;G7+:/[*UKJ+RS)(9&#H[H%P5VD$9'7/X
M5T=% '(OX2=8]'F:UTZ_GL[%;*:WN\^4P 'S(VUL$$'JO(/:K,WAZ:6QTZ*&
MWTZS,&I1WDD5LI1 JGD @?,V,<X7/M72T4 8MQHTMQX@NKUI$%O/IPL\ G<&
MWL2<=,88=ZD\.V=]INC6]A>K;YMHUB1X9&;> ,9(*C:?;FM:B@#GM?T_5]1N
MK'[+!8^39W:72M+=.K2;5(*D",@?>ZY/3I577K@/KWABWE:%;S[29'@CEW%1
MY;#(X!*Y!&<#I75T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %<;J^AZ0/&.@1C2K$1SBZ,JBW3$A"
MC<,<X/K795G7FE?:];TS4?.V?81*/+VYW[U ZYXQCWH Q8-2U&2PU"?1H-/M
M[#3Y)(HK=X6S+Y>=V"K (#T'!]ZJMJ>IZEXGT2:POHX+:\L7G6&2)V4<*3N
M<!CSP>,>]:;^&[N-;^VL=36WL;Z1I)(S;;W0O]_8VX 9]U.,U--X=\NYTN?3
M9X[9]/A:!%EA,BO&0!@X93D;>N?6@"CXB\2SZ&+B8WVD_N"K"P9CY\J9&2&W
M#:<$X&T].I[26?\ R4?4_P#KPA_]":H[[PA<W-KJMG!JB06FHSM/(#:[Y Q
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 444C,J*68X H 6H3(TAVP].[GH/I
MZT8:?ELK$1]WN?K_ (5*    , 4 (D:QC ZGDD]33J** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNC\J-J_W1^5 #//A_P">J?\ ?0H\^'_GJG_?0I^U?[H_*C:O]T?E0 SSX?\
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MK_='Y4 ,\^'_ )ZI_P!]"CSX?^>J?]]"G[5_NC\J-J_W1^5 #//A_P">J?\
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M@ HI&=44LQP!46UI_OY6/^[W;Z_X4 !D:0[8NG=^P^GK3XXUC&%[\DGJ:>
M, 8%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"$R\0_]!2;\E_PH_M&GV8?V;4[H]QHKP[_ (3+Q#_T%)OR7_"C_A,O$/\
MT%)OR7_"C^T:?9A_9M3NCW&BO#O^$R\0_P#04F_)?\*/^$R\0_\ 04F_)?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ,67J2T5%Y _YZ2?]]FCR!_STD_[[-:F1+147D#_ )Z2?]]FCR!_STD_[[-
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MG_H9KK:Y+X;?\B3:?[\G_H9KK:]RC_#CZ'@5_P"++U"BBBM3(**** "BBB@
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MJ::L1+!Y2&8=!V7_ #ZT )AI_O92/TZ%OKZ5* %  & .@%+10 4444 %%%%
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MGC_GG)_WS0!+7S=7T9YX_P"><G_?-?.=>ME?V_E^IQ8S[/S"BBBO6.$****
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MHH **** "E'6DI1UKGQ?^[S]'^1CB/X,O1CJ***^*/F HHHH **** "BBB@
MHHHH **** "BBB@#3TGI+^']:TJS=)Z2_A_6M*O%Q?\ &?\ 70_8.%_^132^
M?_I3"BBBN8]\**** "BBB@ HHHH **** "BBB@ KNM _Y EM]&_]"-<+7=:!
M_P @2V^C?^A&O(SK^!'U_1G#C_X:]32HHHKY@\D**** "BBB@ HHHH ****
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MUI*4=:Y\7_N\_1_D8XC^#+T8ZBBBOBCY@**** "BBB@ HHHH **** "BBB@
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MI%@D<%CT7_$TZ.,1Y/)8]6/4T -$.\[IL,>R]A2^1#_SR3_OD5)10!'Y$/\
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M5  '0"EHHH **** "OFZOI&OFZO6RO[?R_4XL9]GYA1117K'"%%%% !1110
M4444 %%%% !1110 4HZTE*.M<^+_ -WGZ/\ (QQ'\&7HQU%%%?%'S 4444 %
M%%% !1110 4444 %%%% !1110!IZ3TE_#^M:59ND])?P_K6E7BXO^,_ZZ'[!
MPO\ \BFE\_\ TIA1117,>^%%%% !1110 4444 %%%% !1110 5W6@?\ ($MO
MHW_H1KA:[K0/^0);?1O_ $(UY&=?P(^OZ,X<?_#7J:5%%%?,'DA1110 4444
M %%%% !1110 4444 %(WW#]*6D;[A^E,#RZBBBOJ# **** "O;4_U:_05XE7
MMJ?ZM?H*^DX>WJ?+]3&KT'4445]*8A1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(2%!)( '4FHLO/
M]W*1^O0M_A0 K2DL4B&6'4GHO^?2G1Q!,G)9CU8]33E544*H  ["EH ****
M"BBB@ HHHH *^;J^D:^;J];*_M_+]3BQGV?F%%%%>L<(4444 %%%% !1110
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M--DE6/&<ECT4=335B9VW38)!RJCHO^)H 3,DQX)C3L<?,?SZ4ODM_P ]Y/\
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MR0HHHH **** "BBB@ HHHH **** "D;[A^E+2-]P_2F!Y=1117U!@%%%'6@
MKVU/]6OT%<'X?\&//MNM45DB(RL'1F_WO3Z=:[X#  '05]9DF%JT82G45N:U
MOE<PJ23V"BBBO=,@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *IS:5IUQ>)>3:?:R72$%9GA4NI'3#$9&*N44 5[>PL[6>:>WM((
M99SNEDCC"M(<YRQ YY)Z^M6*** "BBB@ HHHH ***B:4EMD8#-W/9?K_ (4
M.>18\9Y)Z*.IIJQLY#R]1R$'0?XFG1Q!"6)+.>K&GT %%%% !1110 4444 %
M?-U?2-?-U>ME?V_E^IQ8S[/S"BBBO6.$**** "BBB@ HHHH **** "BBB@ I
M1UI*4=:Y\7_N\_1_D8XC^#+T8ZBBBOBCY@**** "BBB@ HHHH **** "BBB@
M HHHH T])Z2_A_6M*LW2>DOX?UK2KQ<7_&?]=#]@X7_Y%-+Y_P#I3"BBBN8]
M\**** "BBB@ HHHH **** "BBB@ KNM _P"0);?1O_0C7"UW6@?\@2V^C?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:/(3^])_W\;_ !J6B@"+R$_O2?\ ?QO\:/(3^])_W\;_ !J6B@"+R$_O2?\
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M/(3^])_W\;_&I:* (O(3^])_W\;_ !H\A/[TG_?QO\:EHH B\A/[TG_?QO\
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M?FO^-2T4 1>:_P#S[R?FO^-'FO\ \^\GYK_C4M% $7FO_P ^\GYK_C1YK_\
M/O)^:_XU+10!%YK_ //O)^:_XT6QS$201\[<'M\QJ6HH/]6?]]__ $(T 2T4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% $3?\?4?^XW\UK%M_!7AZ
MTN8KF#3]LL3B1&\Z0X8'(."WK6S(B27,8=58;&.",]UJJEYH\CJB7-BSL0%5
M9$))]!4R<?M$RP\:NLHWMY7L+=Z1;7FI65_+O$MINV!2,-G^]QS@@$>]5(?#
M-E;Z<]E#+<(#<"Y20,-\;C&W'&, *  0>!SFI[J_TFR2\>X,:+9JKSDQ$[ W
M0\#G\,U81K&2Z:V1(FE6-92 F1M8D*<XQSM/Y5114?1'>6*<:K?+=QHT?V@"
M+<R$@[2/+V\$#!"@^].AT&V@U-M0CEF%R\A>1LK^\!55*GC[OR ^H.<'!(J_
M]F@_YXQ_]\BH8#97+SI$D;-!)Y4@\O&UL!L=.>&'YT 5I?#FDRZI!J/V&W2Z
MB=I-Z1("[$=6.,DCJ#GK6I64=2T@:A]APOG>9Y6?L[;-^W=MW[=N['.,YK0^
MS0?\\8_^^10 0?ZL_P"^_P#Z$:EJM!;PF,DPQGYV'*C^\:D^S0?\\8_^^10!
M+147V:#_ )XQ_P#?(H^S0?\ /&/_ +Y% $M%1?9H/^>,?_?(H^S0?\\8_P#O
MD4 2T5%]F@_YXQ_]\BC[-!_SQC_[Y% $M%1?9H/^>,?_ 'R*/LT'_/&/_OD4
M 2T5%]F@_P">,?\ WR*/LT'_ #QC_P"^10!+147V:#_GC'_WR*/LT'_/&/\
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MX?\ "@"6BHMT_P#SSC_[^'_"C=/_ ,\X_P#OX?\ "@"6D)P"0"?8=ZCW3_\
M/./_ +^'_"C=/_SSC_[^'_"@#G])M;K39IY+;3=0AL$@5$LIKI)69PQY3,C*
MH"GIN&?3BM#PU#<VWAZRMKNVDMYH(EC9'96R0.H*DC'ZUH;I_P#GG'_W\/\
MA1NG_P"><?\ W\/^% $M%1;I_P#GG'_W\/\ A1NG_P"><?\ W\/^% $M%1;I
M_P#GG'_W\/\ A1NG_P"><?\ W\/^% $M%1;I_P#GG'_W\/\ A1NG_P"><?\
MW\/^% $M%1;I_P#GG'_W\/\ A1NG_P"><?\ W\/^% $M%1;I_P#GG'_W\/\
MA1NG_P"><?\ W\/^% $M%1;I_P#GG'_W\/\ A1NG_P"><?\ W\/^% $M%1;I
M_P#GG'_W\/\ A1NG_P"><?\ W\/^% $M%1;I_P#GG'_W\/\ A1NG_P"><?\
MW\/^% $M%1;I_P#GG'_W\/\ A1NG_P"><?\ W\/^% $M%1;I_P#GG'_W\/\
MA1NG_P"><?\ W\/^% $M%1;I_P#GG'_W\/\ A1NG_P"><?\ W\/^% $M%1;I
M_P#GG'_W\/\ A1NG_P"><?\ W\/^% $M%1;I_P#GG'_W\/\ A1NG_P"><?\
MW\/^% $M%1;I_P#GG'_W\/\ A1NG_P"><?\ W\/^% $M%1;I_P#GG'_W\/\
MA1NG_P"><?\ W\/^% $M%1;I_P#GG'_W\/\ A1NG_P"><?\ W\/^% $M%1;I
M_P#GG'_W\/\ A1NG_P"><?\ W\/^% $M%1;I_P#GG'_W\/\ A1NG_P"><?\
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M!+147VF#_GM'_P!]"C[3!_SVC_[Z% $M%1?:8/\ GM'_ -]"C[3!_P ]H_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
4B@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img38651418_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img38651418_4.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *P!PP# 2(  A$! Q$!_\0
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MQ_\  6.C[#\6_P#H/6/_ ("QT >KT5Y1]A^+?_0>L?\ P%CH^P_%O_H/6/\
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MQ_\  6.C[#\6_P#H/6/_ ("QT >KT5Y1]A^+?_0>L?\ P%CH^P_%O_H/6/\
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MQ_\  6.C[#\6_P#H/6/_ ("QT >KT5Y1]A^+?_0>L?\ P%CH^P_%O_H/6/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH 9+_J7_W37EGPD_U7B+_L*S_^A5ZG+_J7_P!TUY9\
M)/\ 5>(O^PK/_P"A4 >CT444Q!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4V7_4R?[A_E3J;+_J9/\ </\ *@#@/@U_J_%/_86?_P!!%>H5Y?\
M!K_5^*?^PL__ *"*]0I#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** &2_ZE_\ =->6?"3_ %7B+_L*S_\ H5>IR_ZE_P#=
M->6?"3_5>(O^PK/_ .A4 >CT444Q!1110 4444 %%%% !1110 4444 %%%%
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MO$.E>([%KK2;Q+B'!RP&"/J.M &J5(&2"!25YCX*9#\2=7 \8/J;>4^=.*2
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!DO^I?\
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M_%/_ &%G_P#017J%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 R7_4O_ +IKRSX2?ZKQ%_V%9_\ T*O4Y?\ 4O\ [IKR
MSX2?ZKQ%_P!A6?\ ]"H ]'HHHIB"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH XW7_A9X3\2WIO+^SD2=CEFMWV;
MCZGUJQX;^'/AGPG.9],LV,Q&/,G;>P^AKJJ* "BBB@ HHHH **** "L_7-%L
MO$6BW.DZBKM:7  D"-M;@Y&#6A10!SWACP3H?@^)X]'MW3S/O/(VYC^-=#11
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[+_P'7_"@#@O^%P>%O\ I]_[]?\ UZ/^%P>%O^GW_OU_]>N]_L/2?^@79?\
M@.O^%']AZ3_T"[+_ ,!U_P * ."_X7!X6_Z??^_7_P!>C_A<'A;_ *??^_7_
M ->N]_L/2?\ H%V7_@.O^%']AZ3_ - NR_\  =?\* ."_P"%P>%O^GW_ +]?
M_7H_X7!X6_Z??^_7_P!>N]_L/2?^@79?^ Z_X4?V'I/_ $"[+_P'7_"@#@O^
M%P>%O^GW_OU_]>C_ (7!X6_Z??\ OU_]>N]_L/2?^@79?^ Z_P"%']AZ3_T"
M[+_P'7_"@#@O^%P>%O\ I]_[]?\ UZ/^%P>%O^GW_OU_]>N]_L/2?^@79?\
M@.O^%']AZ3_T"[+_ ,!U_P * ."_X7!X6_Z??^_7_P!>C_A<'A;_ *??^_7_
M ->N]_L/2?\ H%V7_@.O^%']AZ3_ - NR_\  =?\* ."_P"%P>%O^GW_ +]?
M_7H_X7!X6_Z??^_7_P!>N]_L/2?^@79?^ Z_X4?V'I/_ $"[+_P'7_"@#@O^
M%P>%O^GW_OU_]>C_ (7!X6_Z??\ OU_]>N]_L/2?^@79?^ Z_P"%']AZ3_T"
M[+_P'7_"@#@O^%P>%O\ I]_[]?\ UZ/^%P>%O^GW_OU_]>N]_L/2?^@79?\
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M%V7_ (#K_A0!P7_"X/"W_3[_ -^O_KT?\+@\+?\ 3[_WZ_\ KUWO]AZ3_P!
MNR_\!U_PH_L/2?\ H%V7_@.O^% '!?\ "X/"W_3[_P!^O_KT?\+@\+?]/O\
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M .O1_P +@\+?]/O_ 'Z_^O7>_P!AZ3_T"[+_ ,!U_P */[#TG_H%V7_@.O\
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M.O\ A0!P7_"X/"W_ $^_]^O_ *]'_"X/"W_3[_WZ_P#KUWO]AZ3_ - NR_\
M =?\*/[#TG_H%V7_ (#K_A0!P7_"X/"W_3[_ -^O_KT?\+@\+?\ 3[_WZ_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]><__H(KU&O+M6_Y+]H'_7G/_P"@BO4: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F3?ZB3_=/\J?3)O]1)
M_NG^5 'FGP=Z>*_^PN__ *"*].KS'X.]/%?_ &%W_P#017IU !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)?]2_^Z:\T
M^#O_ ![^(O\ L+3_ /H5>ER_ZE_]TUYI\'?^/?Q%_P!A:?\ ]"H ].HHHH *
M*** "BBB@ HHHH ***IOJVG1WJV3W]JMV_W8&F4.?HN<T 7***H1ZYI,OG>7
MJ=F_DG$NV=3L_P![GB@"_14%I?6E_#YUG<PW$6<;X7#KGZBIZ "BJEUJFGV,
MT<-W?6T$LAPB2RJI;Z GFK?7I0 4444 %%%% !1110 4444 %%%% 'EVL?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!DO\ J7_W37FGP=_X]_$7
M_86G_P#0J]+E_P!2_P#NFO-/@[_Q[^(O^PM/_P"A4 >G4444 %%%% !1110
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MMM53Z<CFO1#XMTF/PLOB*:Y6.P:/S-[?R^M>4?&NRLO#'PYTC0["%$C:X"8
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MG0XY;^(Z?=--;2&.-$;<9O<8''XUD?"0)H'P>U/6)DVN[2<_[. !_.JO[/\
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M .>/H,56^"ZC5/&'B?Q3(1ME=H]Q[<@YKD->O)OAK\4-:C4D6VH1.[8]'#$
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%% !1110!Y=K'_)>M$_Z\)OYBO4:\NUC_DO6B?\ 7A-_,5ZC0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% 'EVK?\E^T#_KSG_]!%>HUY=JW_)?M _Z\Y__ $$5ZC0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4R;_ %$G^Z?Y4^F3?ZB3_=/\J /-/@[T\5_]A=__ $$5Z=7F/P=Z>*_^PN__
M *"*].H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!Y=JW_)?M _Z\Y_\ T$5ZC7EVK?\ )?M _P"O.?\
M]!%>HT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P"^8Z/+^+O_ #WT[_OF.@#U&BO+O+^+O_/?3O\ OF.CR_B[_P ]]._[YCH
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M^^8Z /4:*\N\OXN_\]]._P"^8Z/+^+O_ #WT[_OF.@#U&BO+O+^+O_/?3O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'EVK?\E^T#_KSG_]!%>HUY=JW_)?
MM _Z\Y__ $$5ZC0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4R;_ %$G^Z?Y4^F3?ZB3_=/\J /-/@[T\5_]
MA=__ $$5Z=7F/P=Z>*_^PN__ *"*].H **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH 9+_J7_W37FGP=_X]_$7_ &%I_P#T
M*O2Y?]2_^Z:\T^#O_'OXB_["T_\ Z%0!Z=1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y=K'_ "7K1/\ KPF_
MF*]1KR[6/^2]:)_UX3?S%>HT %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y=JW_)?M _Z\Y_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!DO^I?_ '37FGP=_P"/?Q%_
MV%I__0J]+E_U+_[IKS3X._\ 'OXB_P"PM/\ ^A4 >G4444 %%%% !2.,HP'I
M2T4 ?+]AXDN_ OQ8U_4WT2\O4DE>/;$"O?KG%7[^36OBWX[T>_M= FTZSLG
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M>E '#?"GPQ?>&/!\<.I+Y=W<.TTD.0?*R3@9'M7<T44 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH 9+_J7_W37FGP=_X]_$7_ &%I_P#T*O2Y?]2_^Z:\T^#O
M_'OXB_["T_\ Z%0!Z=1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!Y=K'_ "7K1/\ KPF_F*]1KR[6/^2]:)_U
MX3?S%>HT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!Y=JW_)?M _Z\Y_\ T$5ZC7EVK?\ )?M
M_P"O.?\ ]!%>HT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %,F_U$G^Z?Y4^F3?ZB3_=/\J /-/@[T\5_P#8
M7?\ ]!%>G5YC\'>GBO\ ["[_ /H(KTZ@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@!DO^I?\ W37FGP=_X]_$7_86G_\
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M_,5ZC7CFJ^(M%?XV:/>KJMH;5+&57E$HVJ21@$UZ/_PF?AK_ *#NG_\ ?]:
M-RBL/_A,_#7_ $'=/_[_ *T?\)GX:_Z#NG_]_P!: -RBL/\ X3/PU_T'=/\
M^_ZT?\)GX:_Z#NG_ /?]: -RBL/_ (3/PU_T'=/_ ._ZT?\ "9^&O^@[I_\
MW_6@#<HK#_X3/PU_T'=/_P"_ZT?\)GX:_P"@[I__ '_6@#<HK#_X3/PU_P!!
MW3_^_P"M'_"9^&O^@[I__?\ 6@#<HK#_ .$S\-?]!W3_ /O^M'_"9^&O^@[I
M_P#W_6@#<HK#_P"$S\-?]!W3_P#O^M'_  F?AK_H.Z?_ -_UH W**P_^$S\-
M?]!W3_\ O^M'_"9^&O\ H.Z?_P!_UH W**P_^$S\-?\ 0=T__O\ K1_PF?AK
M_H.Z?_W_ %H W**P_P#A,_#7_0=T_P#[_K1_PF?AK_H.Z?\ ]_UH W**P_\
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M -_UH W**P_^$S\-?]!W3_\ O^M'_"9^&O\ H.Z?_P!_UH W**P_^$S\-?\
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M]!W3_P#O^M'_  F?AK_H.Z?_ -_UH W**P_^$S\-?]!W3_\ O^M'_"9^&O\
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MP8ECGA\42Q.LD;ZLQ5U.01M%>HT %%%% !1110 4444 %%%% !1110 4444
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M XC_ (5-X/\ ^@<W_?PT?\*F\'_] YO^_AKMZ* .(_X5-X/_ .@<W_?PT?\
M"IO!_P#T#F_[^&NWHH XC_A4W@__ *!S?]_#1_PJ;P?_ - YO^_AKMZ* .(_
MX5-X/_Z!S?\ ?PT?\*F\'_\ 0.;_ +^&NWHH XC_ (5-X/\ ^@<W_?PT?\*F
M\'_] YO^_AKMZ* .(_X5-X/_ .@<W_?PT?\ "IO!_P#T#F_[^&NWHH XC_A4
MW@__ *!S?]_#1_PJ;P?_ - YO^_AKMZ* .(_X5-X/_Z!S?\ ?PT?\*F\'_\
M0.;_ +^&NWHH XC_ (5-X/\ ^@<W_?PT?\*F\'_] YO^_AKMZ* .(_X5-X/_
M .@<W_?PT?\ "IO!_P#T#F_[^&NWHH XC_A4W@__ *!S?]_#1_PJ;P?_ - Y
MO^_AKMZ* .(_X5-X/_Z!S?\ ?PT?\*F\'_\ 0.;_ +^&NWHH XC_ (5-X/\
M^@<W_?PT?\*F\'_] YO^_AKMZ* .(_X5-X/_ .@<W_?PT?\ "IO!_P#T#F_[
M^&NWHH XC_A4W@__ *!S?]_#1_PJ;P?_ - YO^_AKMZ* .(_X5-X/_Z!S?\
M?PT?\*F\'_\ 0.;_ +^&NWHH XC_ (5-X/\ ^@<W_?PT?\*F\'_] YO^_AKM
MZ* .(_X5-X/_ .@<W_?PT?\ "IO!_P#T#F_[^&NWHH XC_A4W@__ *!S?]_#
M1_PJ;P?_ - YO^_AKMZ* .(_X5-X/_Z!S?\ ?PT?\*F\'_\ 0.;_ +^&NWHH
M XC_ (5-X/\ ^@<W_?PT?\*F\'_] YO^_AKMZ* .(_X5-X/_ .@<W_?PT?\
M"IO!_P#T#F_[^&NWHH XC_A4W@__ *!S?]_#1_PJ;P?_ - YO^_AKMZ* .(_
MX5-X/_Z!S?\ ?PTV7X3^$%B<C3FX4G_6&NYIDW^HD_W3_*@#R[X)VT5G:>)K
M:!=L46JLJ#/0;17JE>8_!WIXK_["[_\ H(KTZ@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!DO^I?_=->:?!W_CW\1?\
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M>Z49:%95+@>ZYS5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'5+BPTEXE>VOHL$(<#YAGC&:NV%KX;\1?$FPA7Q)K_B&\MQO%VJ1&W08Z,0
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M =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB2UNVS(!(?,W=V'S9Y(KP-4O'L6CB^'-U'KLN =2(E(#D\MY97:,\^U?6E%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %,F_P!1)_NG^5/IDW^HD_W3_*@#S3X.]/%?_87?
M_P!!%>G5YC\'>GBO_L+O_P"@BO3J "BBB@#-U_51H>@7VJ,AD%K"TI4=\"O%
MQ^TA;XYT>7/U'^->K?$'_DG^N_\ 7G)_*OB2@#Z&_P"&D+;_ *!$OYC_ !H_
MX:0MO^@1+^8_QKYYHH ^AO\ AI"V_P"@1+^8_P :/^&D+;_H$2_F/\:^>:*
M/H;_ (:0MO\ H$2_F/\ &C_AI"V_Z!$OYC_&OGFB@#Z&_P"&D+;_ *!$OYC_
M !H_X:0MO^@1+^8_QKYYHH ^AO\ AI"V_P"@1+^8_P :/^&D+;_H$2_F/\:^
M>:* /H;_ (:0MO\ H$2_F/\ &D_X:0M_^@/+^8_QKYZHH ^K-8^,4.E>#=)\
M0'3W=;^5XQ'W7: ?7WKF?^&D+;_H$2_F/\:XOQE_R1?PE_U]S?\ H(KRV@#Z
M&_X:0MO^@1+^8_QH_P"&D+;_ *!$OYC_ !KYYHH ^AO^&D+;_H$2_F/\:/\
MAI"V_P"@1+^8_P :^>:* /H;_AI"V_Z!$OYC_&C_ (:0MO\ H$2_F/\ &OGF
MB@#Z&_X:0MO^@1+^8_QH_P"&D+;_ *!$OYC_ !KYYHH ^AO^&D+;_H$2_F/\
M:/\ AI"V_P"@1+^8_P :^>:* /H;_AI"V_Z!$OYC_&C_ (:0MO\ H$2_F/\
M&OGFB@#Z&_X:0MO^@1+^8_QH_P"&D+;_ *!$OYC_ !KYYHH ^AO^&D+;_H$2
M_F/\:/\ AI"V_P"@1+^8_P :^>:* /H;_AI"V_Z!$OYC_&C_ (:0MO\ H$2_
MF/\ &OGFB@#Z&_X:0MO^@1+^8_QH_P"&D+;_ *!$OYC_ !KYYHH ^AO^&D+;
M_H$2_F/\:/\ AI"V_P"@1+^8_P :^>:* /H;_AI"V_Z!$OYC_&C_ (:0MO\
MH$2_F/\ &OGFB@#Z&_X:0MO^@1+^8_QH_P"&D+;_ *!$OYC_ !KYYHH ^AO^
M&D+;_H$2_F/\:/\ AI"V_P"@1+^8_P :^>:* /H;_AI"V_Z!$OYC_&C_ (:0
MMO\ H$2_F/\ &OGFB@#Z&_X:0MO^@1+^8_QH_P"&D+;_ *!$OYC_ !KYYHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\*/^$]\>?]"4/^^G_P *]2HH \M_X3WQY_T)0_[Z?_"C_A/?'G_0E#_OI_\
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M  GOCS_H2A_WT_\ A7J5% 'EO_">^//^A*'_ 'T_^%'_  GOCS_H2A_WT_\
MA7J5% 'EO_">^//^A*'_ 'T_^%'_  GOCS_H2A_WT_\ A7J5% 'EO_">^//^
MA*'_ 'T_^%'_  GOCS_H2A_WT_\ A7J5% 'EO_">^//^A*'_ 'T_^%'_  GO
MCS_H2A_WT_\ A7J5% 'EO_">^//^A*'_ 'T_^%'_  GOCS_H2A_WT_\ A7J5
M% 'EO_">^//^A*'_ 'T_^%'_  GOCS_H2A_WT_\ A7J5% 'EO_">^//^A*'_
M 'T_^%'_  GOCS_H2A_WT_\ A7J5% 'EO_">^//^A*'_ 'T_^%'_  GOCS_H
M2A_WT_\ A7J5% 'EO_">^//^A*'_ 'T_^%'_  GOCS_H2A_WT_\ A7J5% 'E
MO_">^//^A*'_ 'T_^%'_  GOCS_H2A_WT_\ A7J5% 'EO_">^//^A*'_ 'T_
M^%'_  GOCS_H2A_WT_\ A7J5% 'EO_">^//^A*'_ 'T_^%'_  GOCS_H2A_W
MT_\ A7J5% 'EO_">^//^A*'_ 'T_^%'_  GOCS_H2A_WT_\ A7J5% 'SO?\
MBKQ3)\5M*OY/#034(K>58[3+?."HR?7BNV_X3WQY_P!"4/\ OI_\*=JQ/_"_
MM Y_Y<Y__017J% 'EO\ PGOCS_H2A_WT_P#A1_PGOCS_ *$H?]]/_A7J5% '
MEO\ PGOCS_H2A_WT_P#A1_PGOCS_ *$H?]]/_A7J5% 'EO\ PGOCS_H2A_WT
M_P#A1_PGOCS_ *$H?]]/_A7J5% 'EO\ PGOCS_H2A_WT_P#A1_PGOCS_ *$H
M?]]/_A7J5% 'EO\ PGOCS_H2A_WT_P#A1_PGOCS_ *$H?]]/_A7J5% 'EO\
MPGOCS_H2A_WT_P#A1_PGOCS_ *$H?]]/_A7J5% 'EO\ PGOCS_H2A_WT_P#A
M1_PGOCS_ *$H?]]/_A7J5% 'EO\ PGOCS_H2A_WT_P#A1_PGOCS_ *$H?]]/
M_A7J5% 'EO\ PGOCS_H2A_WT_P#A1_PGOCS_ *$H?]]/_A7J5% 'EO\ PGOC
MS_H2A_WT_P#A1_PGOCS_ *$H?]]/_A7J5% 'EO\ PGOCS_H2A_WT_P#A1_PG
MOCS_ *$H?]]/_A7J5% 'EO\ PGOCS_H2A_WT_P#A1_PGOCS_ *$H?]]/_A7J
M5% 'EO\ PGOCS_H2A_WT_P#A1_PGOCS_ *$H?]]/_A7J5% 'EO\ PGOCS_H2
MA_WT_P#A1_PGOCS_ *$H?]]/_A7J5% 'EO\ PGOCS_H2A_WT_P#A1_PGOCS_
M *$H?]]/_A7J5% 'EO\ PGOCS_H2A_WT_P#A1_PGOCS_ *$H?]]/_A7J5% '
MEO\ PGOCS_H2A_WT_P#A1_PGOCS_ *$H?]]/_A7J5% 'EO\ PGOCS_H2A_WT
M_P#A1_PGOCS_ *$H?]]/_A7J5% 'EO\ PGOCS_H2A_WT_P#A1_PGOCS_ *$H
M?]]/_A7J5% 'EO\ PGOCS_H2A_WT_P#A1_PGOCS_ *$H?]]/_A7J5% 'EO\
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M<G\J^)*^[?$.D_V[X?O]+\WR?M4+1>9C.W(QG%>(_P##-)QSXD'_ (#?_94
M>  X.179VWQ7\:VEI':Q:TWD1C"(T,; #\5KTS_AFD_]#)_Y+?\ V5'_  S2
M?^AD_P#);_[*@#R+6?'7B/7VMFU'4#*ULV^$K$B%3Z_*!5Z]^*?C/4-/EL;G
M6Y7@E38X$:*67TW 9_6O3_\ AFD_]#)_Y+?_ &5'_#-)_P"AD_\ );_[*@#Q
M'1M<U+P_J*ZAI=T]O=*"!(H!/ZTS5M8O]=U*34=2N6N+N3&^1L G'TKW'_AF
MD_\ 0R?^2W_V5'_#-)_Z&3_R6_\ LJ /,;;XI^,[33XK&'6Y5@BB$*#RT+!
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MGXS-A]C.M2>28O)_U2;MF,8W8ST]Z]._X9I/_0R?^2W_ -E1_P ,TG_H9/\
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M_);_ .RH \ HKW__ (9I/_0R?^2W_P!E1_PS2?\ H9/_ "6_^RH \ HKW_\
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M:3_T,G_DM_\ 94?\,TG_ *&3_P EO_LJ / **]__ .&:3_T,G_DM_P#94?\
M#-)_Z&3_ ,EO_LJ / **]_\ ^&:3_P!#)_Y+?_94?\,TG_H9/_);_P"RH \
MHKW_ /X9I/\ T,G_ )+?_94?\,TG_H9/_);_ .RH \ HKW__ (9I/_0R?^2W
M_P!E1_PS2?\ H9/_ "6_^RH \ HKW_\ X9I/_0R?^2W_ -E1_P ,TG_H9/\
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M9?\ GFM']NR_\\UK)HH UO[=E_YYK1_;LO\ SS6LFB@#6_MV7_GFM']NR_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/#>H7]V]P@)9Y5$0S]X\G.*3XP:+'8?$RVUK5=-ENM#FAC1UC)&T*H!R1TH
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M"E15W^RKO^XOYT?V5=_W%_.@"E1VJ[_95W_<7\Z3^RKO^XOYT 277_(*MO\
M>-9];-Q8SOI\$2J-RL2>:I_V5=_W%_.@"E15W^RKO^XOYT?V5=_W%_.@"E15
MW^RKO^XOYT?V5=_W%_.@"E15W^RKO^XOYT?V5=_W%_.@"E15W^RKO^XOYT?V
M5=_W%_.@"E15W^RKO^XOYT?V5=_W%_.@"E15W^RKO^XOYT?V5=_W%_.@"E15
MW^RKO^XOYT?V5=_W%_.@"E15W^RKO^XOYT?V5=_W%_.@"E15W^RKO^XOYT?V
M5=_W%_.@"E61XA\/6_B2RAM;F>6%8ITG#1@9)4Y Y[5TG]E7?]Q?SH_LJ[_N
M+^= %%%V(J Y"C%+5W^RKO\ N+^=']E7?]Q?SH I5@ZYX736+VWOK?4;K3;Z
M#.+BVQN88Q@YXKJ_[*N_[B_G1_95W_<7\Z .6\/>&+?0&NI_M4]]>W3[Y;JX
MQO;VXXQ6Y5W^RKO^XOYT?V5=_P!Q?SH I45=_LJ[_N+^=']E7?\ <7\Z *5%
M7?[*N_[B_G1_95W_ '%_.@"E15W^RKO^XOYT?V5=_P!Q?SH I45=_LJ[_N+^
M=']E7?\ <7\Z *5%7?[*N_[B_G1_95W_ '%_.@"E15W^RKO^XOYT?V5=_P!Q
M?SH I45=_LJ[_N+^=']E7?\ <7\Z *5%7?[*N_[B_G1_95W_ '%_.@"E15W^
MRKO^XOYT?V5=_P!Q?SH I45=_LJ[_N+^=']E7?\ <7\Z *5%7?[*N_[B_G1_
M95W_ '%_.@"E15W^RKO^XOYT?V5=_P!Q?SH I45=_LJ[_N+^=']E7?\ <7\Z
M *5%7?[*N_[B_G1_95W_ '%_.@"E15W^RKO^XOYT?V5=_P!Q?SH I45=_LJ[
M_N+^=']E7?\ <7\Z *5%7?[*N_[B_G1_95W_ '%_.@"E15W^RKO^XOYT?V5=
M_P!Q?SH I45=_LJ[_N+^=']E7?\ <7\Z *5%7?[*N_[B_G1_95W_ '%_.@"E
M15W^RKO^XOYT?V5=_P!Q?SH I4Y/]8OUJW_95W_<7\Z5=+N@ZDHO7UH Z.+_
M %*?[HI]-C!6-0>H IU #)?]2_\ NFO-/@[_ ,>_B+_L+3_^A5Z7+_J7_P!T
MUYI\'?\ CW\1?]A:?_T*@#TZBBB@ HHHH **** ,R_\ #NBZI<K<7^E6=U.H
MP))H59@/3)%7GMX9;9K9XD:!EV&,KE2O3&/2I:* ,[3M TC2'=].TRTM'<89
MH(50GZX%6;RPM-1A\F]MHKB+^Y*@8?D:L44 9MAX?T;2Y#)I^EV=JYZM#"JD
M_D*MW=E:W\)AN[>*>(]4D4,/R-3T4 9ECX=T72Y?-L-*L[:3^]#"JG]!4MWH
MVF7]W!=WEA;3W$'^JEEB#-']">E7J* *-_HNEZJT3:AI]M=&(YC,T0?9],]*
MN(B11JD:A448"@8 %.HH S-0\.Z+JLRS:AI5G=2J,!YH5<@?4BJ\7@[PU!*D
ML6@Z:DB$,K+;("I'<<5MT4 5[VPL]1@\F]M8;B+^Y*@8?D:K:?H.D:2[/I^F
M6EJS=3#"J$_D*T:* "BBB@ HHHH **** /+M8_Y+UHG_ %X3?S%>HUY=K'_)
M>M$_Z\)OYBO4: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** &2Q1SQ-%*BO&XPRL,@CT-8D7@GPM#(LD7A[3$=3E66
MU0$'\JWJ* #I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!Y=JW_)?M _Z\Y__ $$5ZC7EVK?\E^T#_KSG_P#0
M17J- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %4]0TK3]6A$.H65O=1@Y"31AQGZ&KE% '/GP+X3/7PWI1S_TZ)_A6S9V
M=KI]K':V=O%;V\8PD42A54>P%3T4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4R;_ %$G^Z?Y4^F3?ZB3_=/\J /-/@[T
M\5_]A=__ $$5Z=7F/P=Z>*_^PN__ *"*].H **** &3<0N1Z5F>8_P#>/YUI
MS?ZE_I65VH =YC_WC^='F/\ WC^=-_IS7"7/Q2L4O-1AT_0M6U6#3SB>ZLU4
MQCC/>@#O?,?^\?SH\Q_[Q_.J&D:M9:YI<&HV$RRV\HSD'[I[J?<5=H =YC_W
MC^='F/\ WC^=-HH =YC_ -X_G1YC_P!X_G3:* '>8_\ >/YT>8_]X_G3:* '
M>8_]X_G1YC_WS^=-HH LRLPMHSN.<U!YC_WC^=32_P#'K']35>@!WF/_ 'C^
M='F/_>/YTVN<O?&FF6/C&W\,RI*;N9-YE&/+C!&1N^M '2^8_P#>/YT>8_\
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MZ\Y__017J->7:M_R7[0/^O.?_P!!%>HT %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %,F_P!1)_NG^5/IDW^H
MD_W3_*@#S3X.]/%?_87?_P!!%>G5YC\'>GBO_L+O_P"@BO3J "BBB@!DW^I?
MZ5E=JU9O]2_TK*[4 %<%\2_&&G>$?#US9PQQ?;[Z,QI%&H4\_P 1QUKO3]TX
MZX./KCBO!H_!OC.Z\=R>(]?\+OJD8<M';"\1%!'W?7CCI[T =]\(M'O-(\"0
M"^#)//(\NP]E8Y!_&N[K.T6\U&]L!)J6CG2I@=HM_-$F .G(XK1H **** "B
MBB@ HHHH **** +$O_'K']35>K$O_'K']35>@".>=+6WEN93B.%"[GV'6O%V
MN]&U;PYK6KW&N:?!K,ET3!FX7>L*/N48]2.*],\9V^JWOAY[+2+?SI;EQ%+\
MX79$>&//H*++P7X=M]+M[270]-D>.$1-*ULI8G&,YQUH Q-=\:7)^&UMK^E+
M(#=(-\\:;VM1_?V]_H:3PM?ZO)K,42^+;'Q'9R6YDD&Y$EA? P J]1Z^E4].
MT'Q7H.F:SI^G6UO):+=&6U@F 9;F' 'E#/W>><FH['PWJNI>*K#4O^$8B\++
M:1,'>"1&$S$@X(3''UH SX_$NNZI<7S'QC#HE_;W1C32;J-%62,-@$,W/S"N
MCUO7-3M_&/ABT!AB2[8?:(U4.#P>%8\]NU9>LZ9XCOTO+34/!5CJUU*[+'JZ
M-'&40GY?E/.5J=?!VL6NJ>#R";M-, %U<L_< \X//<4 9;>)M<U'4]8?_A+8
M="NK24+#I%VB(DG' #MS@^O;-)X^M-6N]=\'SR:J+>2;)"1('2-L#<5;^(&M
M#7-.\1WS:E8W_@RQUJ293'#JZF.(@$==IYR/Z4[4_"&M6NC^&3:0MJ5UI;$O
M&TH4@-CC)],4 +XA\47S^+8_#5OXE@T..VMA/<:E.$!F;.-@5N/>DT/X@O:6
M7B"'4+V'5Y-'0O'>Q$;;I0,\[>!Z<4[Q!X8OT\61^);3PY;:TMS;B"YTVX*9
MB(.=ZLW'M5O3/"]_JVC:Q:ZII6GZ+!?(8X+6VA7?"",99U^]0!S.O0^+KOP#
M)KMWKQN;>Y(D_LQH55%1CE?G'/ ->E>%!GP?I !P3:* ?3BN"NM-\=7?A'_A
M%/[#1%B^1-2,ZE71?NC9U!(KT3P]:S6'AW3;2X39/# J2+G."* /-/"-O?:=
M\2/&%U=:U)-':R;KC]RH\[Y0<GTP..*MQ:EXSUKP_=>+++6C9VT,CLFEB%65
MXXR<Y<\C(%:MEX>U.U\=^()I--,NE:Q\S7(E V?*!C;UK,ATOQCHN@W7A2ST
M87EG/(ZIJ8G5 D<A.<H>3@&@#O/#NLIXA\/V.JI%Y7VF)9#'_=)[5QZ@:G\;
MBEX!(EEISF"-NBG</FQZUV'A[1D\/>'[+2HY?-%M$L9DQC<1WQVK$\3^'+^3
M6K;Q-H3*-4M(C$UN>!<QYR4ST!/J: (?&7BOP_:F?2]?TC5KJWBVR/+#:%HA
MW!#^U9?B#Q#J'VKPE9>&KYK.RU5?D9D#,$V9&<]ZFUN7QSXLTM]%_P"$=&AP
MW"[9KN6Y695'<;1ZTMYX/U.#5O!26R"YMM&7R[B<$+P$P#@^IH NZZ=<TS3K
M"S?Q9:V>6'VC5KG8CM_LA#P:RO"OBO5'USQ!I3ZH/$*VD(EL[H(J>:=N2HV\
M=>*N>.- U.]\2:;JUIHT>MVMO'Y<FGR.JJ3G._YN*J^'?#>OV7B_4=4_LZVT
MR&\@(@$879;.%P,J.O- &5I/B37M2C6_A\96HO?M)C?0KT1P[>>5W?>X[>M;
M?BK5_$G_  L?3_#NC:@+2VNK$23.4#&([L%P#U/M63JV@^(M=T^;3+SP59QW
MTDJ[M=A>-"<,"7"CYAG'KWIGB)=5TSXK:&NFQ?VA=6^DC?$S!3. _0,>A]Z
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MFG261%Z6Z*>2W]TXY%=9K\VJP:)<OH=LMQJ6PB!&( #>IS7!^%T\5>'8G9_
M<US?W#;KF\DU%"[GZGG ]* /2+.#[)96]OG/DH$SZXKA;W1O%7AGQ9J.N>'[
M2UU*SOHS)-#<2^4R29_AQR1@5WL#O);QO-$8I&4%X\YV'N,UQ/D>+?"^N:A+
MIUC)X@TV^D,R1-<"-K9NFT,W;V% #?#7B+0]=\0?;;O2KK3O$D4+B5)D*[D'
M4KG[P]ZYV/Q?J>O-J>I1^-;+08;65XH--?RRTNP]3NY&ZNGTS0]4UOQ<OB77
M;(Z888'MX[,2AV*MU)8?2N=M_"FK>')]0L8/!=AK\$\[SV]_+Y:M$7/W6#<L
M%H T9OB'=7?@72KZSA6/4]4F%HA!RL<F,Y'J,"MBRM/%FB7B7.H:V-8TSR#)
M<&6-8FA;T4#[U4=5\(:K?^$--0_9$UC3IA=1Q6T0BC:3&-N!P.*N6USXPUN[
MCM;[18]%TWRBERTDJS&;_=Q]W- &!#J'C'Q%HU]XETW6S8VUO,XBTX0JRR)&
M>26/(R*-<\<:O?Z-X3OM$E%E)JTX2:,@,!\I.,GZ4^WTWQAX>TF^\-Z=HOV^
MSN)7,6H"=4$22'D%3R<"I=0\"7UG9>#[#3E^U1Z5<A[F;.WC:1NP?K0!/::A
MXAT#X@Z;H>JZX^KVVHVKS*7A6,QL"!CCK45MJ/B+QEJ6L3:5KC:5I]B3%'$D
M*R>>ZY# D]!D5JZWH6I7?Q(T#6+>WWV5G:/'-)N VL6! Q69:Z3XD\(:MJT6
MCZ0-5T[46,D;B98_L[L26)S]X9/3VH Y3P]KNK:#\.M=N85>*Y?69$N+F%?,
M-MP/G Z'\:[?PK>ZK)K@@_X2RQ\16#P&1V5D66%^,#8O4>]97A[P]XOT/PAJ
ML7V:UFOI=1>X>TD566\C( P#T7GGFI-*\.:E?>,++56\,1>&(;6(JX@E0^><
MYP=G]: /2:*"<DFB@ HHHH **** "BBB@ HHHH **** "BBB@ I1]X?6DI1]
MX?6@#63[@^E+2)]P?2EH 9+_ *E_]TUYG\'B!;^(LL!_Q-I^_P#M5Z9-S"_^
MZ:\$\$?#VS\5W&OWD]_=6[+J<R!8F('#?6@#WSS$_OK^='F)_?7\Z\Q_X4II
MG_08U#_OL_XT?\*4TS_H,:A_WV?\: /3O,3^^OYT>8G]]?SKS'_A2FF?]!C4
M/^^S_C1_PI33/^@QJ'_?9_QH ].\Q/[Z_G1YB?WU_.O,?^%*:9_T&-0_[[/^
M-'_"E-,_Z#&H?]]G_&@#T[S$_OK^='F)_?7\Z\Q_X4IIG_08U#_OL_XT?\*4
MTS_H,:A_WV?\: /3O,3^^OYT>8G]]?SKS'_A2FF?]!C4/^^S_C1_PI33/^@Q
MJ'_?9_QH ].\Q/[Z_G1YB?WU_.O,?^%*:9_T&-0_[[/^-'_"E-,_Z#&H?]]G
M_&@#T[S$_OK^='F)_?7\Z\Q_X4IIG_08U#_OL_XT?\*4TS_H,:A_WV?\: /3
MO,3^^OYT>8G]]?SKS'_A2FF?]!C4/^^S_C1_PI33/^@QJ'_?9_QH ].\Q/[Z
M_G1YB?WU_.O,?^%*:9_T&-0_[[/^-'_"E-,_Z#&H?]]G_&@#T[S$_OK^='F)
M_?7\Z\Q_X4IIG_08U#_OL_XT?\*4TS_H,:A_WV?\: /3O,3^^OYT>8G]]?SK
MS'_A2FF?]!C4/^^S_C1_PI33/^@QJ'_?9_QH ].\Q/[Z_G1YB?WU_.O,?^%*
M:9_T&-0_[[/^-'_"E-,_Z#&H?]]G_&@#T[S$_OK^='F)_?7\Z\Q_X4IIG_08
MU#_OL_XT?\*4TS_H,:A_WV?\: $U<C_A?.B'<N/L$W<>HKT_S$_OK^=?/6H?
M#6Q@^*FF:(-2NS%/:R2F4L=P((X'-=O_ ,*4TS_H,:A_WV?\: /3O,3^^OYT
M>8G]]?SKS'_A2FF?]!C4/^^S_C1_PI33/^@QJ'_?9_QH ].\Q/[Z_G1YB?WU
M_.O,?^%*:9_T&-0_[[/^-'_"E-,_Z#&H?]]G_&@#T[S$_OK^='F)_?7\Z\Q_
MX4IIG_08U#_OL_XT?\*4TS_H,:A_WV?\: /3O,3^^OYT>8G]]?SKS'_A2FF?
M]!C4/^^S_C1_PI33/^@QJ'_?9_QH ].\Q/[Z_G1YB?WU_.O,?^%*:9_T&-0_
M[[/^-'_"E-,_Z#&H?]]G_&@#T[S$_OK^='F)_?7\Z\Q_X4IIG_08U#_OL_XT
M?\*4TS_H,:A_WV?\: /3O,3^^OYT>8G]]?SKS'_A2FF?]!C4/^^S_C1_PI33
M/^@QJ'_?9_QH ].\Q/[Z_G1YB?WU_.O,?^%*:9_T&-0_[[/^-'_"E-,_Z#&H
M?]]G_&@#T[S$_OK^='F)_?7\Z\Q_X4IIG_08U#_OL_XT?\*4TS_H,:A_WV?\
M: /3O,3^^OYT>8G]]?SKS'_A2FF?]!C4/^^S_C1_PI33/^@QJ'_?9_QH ].\
MQ/[Z_G1YB?WU_.O,?^%*:9_T&-0_[[/^-'_"E-,_Z#&H?]]G_&@#T[S$_OK^
M='F)_?7\Z\Q_X4IIG_08U#_OL_XT?\*4TS_H,:A_WV?\: /3O,3^^OYT>8G]
M]?SKS'_A2FF?]!C4/^^S_C1_PI33/^@QJ'_?9_QH ].\Q/[Z_G1YB?WU_.O,
M?^%*:9_T&-0_[[/^-'_"E-,_Z#&H?]]G_&@#T[S$_OK^='F)_?7\Z\Q_X4II
MG_08U#_OL_XT?\*4TS_H,:A_WV?\: /3O,3^^OYT>8G]]?SKS'_A2FF?]!C4
M/^^S_C1_PI33/^@QJ'_?9_QH ].\Q/[Z_G1YB?WU_.O,?^%*:9_T&-0_[[/^
M-'_"E-,_Z#&H?]]G_&@#T[S$_OK^='F)_?7\Z\Q_X4IIG_08U#_OL_XT?\*4
MTS_H,:A_WV?\: /3O,3^^OYT>8G]]?SKS'_A2FF?]!C4/^^S_C1_PI33/^@Q
MJ'_?9_QH ].\Q/[Z_G1YB?WU_.O,?^%*:9_T&-0_[[/^-'_"E-,_Z#&H?]]G
M_&@#T[S$_OK^='F)_?7\Z\Q_X4IIG_08U#_OL_XT?\*4TS_H,:A_WV?\: /3
MO,3^^OYT>8G]]?SKS'_A2FF?]!C4/^^S_C1_PI33/^@QJ'_?9_QH ].\Q/[Z
M_G1YB?WU_.O,?^%*:9_T&-0_[[/^-'_"E-,_Z#&H?]]G_&@#T[S$_OK^='F)
M_?7\Z\Q_X4IIG_08U#_OL_XT?\*4TS_H,:A_WV?\: /3O,3^^OYT>8G]]?SK
MS'_A2FF?]!C4/^^S_C1_PI33/^@QJ'_?9_QH ].\Q/[Z_G1YB?WU_.O,?^%*
M:9_T&-0_[[/^-'_"E-,_Z#&H?]]G_&@!-6(_X7[H!W+C['/W_P!D5Z?YB?WU
M_.OGO4/AM90?%?2M#&HW9BN+>60RECN!50<#FNV_X4IIG_08U#_OL_XT >G>
M8G]]?SH\Q/[Z_G7F/_"E-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]
M?SH\Q/[Z_G7F/_"E-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\
MQ/[Z_G7F/_"E-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z
M_G7F/_"E-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z_G7F
M/_"E-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z_G7F/_"E
M-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z_G7F/_"E-,_Z
M#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z_G7F/_"E-,_Z#&H?
M]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z_G7F/_"E-,_Z#&H?]]G_
M !H_X4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z_G7F/_"E-,_Z#&H?]]G_ !H_
MX4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z_G7F/_"E-,_Z#&H?]]G_ !H_X4II
MG_08U#_OL_XT >G>8G]]?SH\Q/[Z_G7F/_"E-,_Z#&H?]]G_ !H_X4IIG_08
MU#_OL_XT >G>8G]]?SH\Q/[Z_G7F/_"E-,_Z#&H?]]G_ !H_X4IIG_08U#_O
ML_XT >G>8G]]?SH\Q/[Z_G7F/_"E-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT
M >G>8G]]?SH\Q/[Z_G7F/_"E-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>
M8G]]?SH\Q/[Z_G7F/_"E-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]
M?SH\Q/[Z_G7F/_"E-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\
MQ/[Z_G7F/_"E-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z
M_G7F/_"E-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z_G7F
M/_"E-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z_G7F/_"E
M-,_Z#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z_G7F/_"E-,_Z
M#&H?]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z_G7F/_"E-,_Z#&H?
M]]G_ !H_X4IIG_08U#_OL_XT >G>8G]]?SH\Q/[Z_G7F/_"E-,_Z#&H?]]G_
M !H_X4IIG_08U#_OL_XT >G>8G]]?SIDSH8)/G7[I[^U>:?\*4TS_H,:A_WV
M?\:;)\%M,6)V_MC4.%)^^?\ &@"3X.]/%?\ V%W_ /017IU>4_ ZT6PT_P 2
M6B.SK#JC(&;J?E%>K4 %%%% #)O]2_TK*[5JRC,3#U'>L_[.W]]/SH BHJ7[
M.W]]/SH^SM_?3\Z (J*E^SM_?3\Z/L[?WT_.@"*BI?L[?WT_.C[.W]]/SH B
MHJ7[.W]]/SH^SM_?3\Z (J*E^SM_?3\Z/L[?WT_.@"*BI?L[?WT_.C[.W]]/
MSH ?+_QZQ_4U7JW)$3;HNY>#ZU#]G;^^GYT 145+]G;^^GYT?9V_OI^= $5%
M2_9V_OI^='V=O[Z?G0!%14OV=O[Z?G1]G;^^GYT 145+]G;^^GYT?9V_OI^=
M $5%2_9V_OI^='V=O[Z?G0!%14OV=O[Z?G1]G;^^GYT 145+]G;^^GYT?9V_
MOI^= $5%2_9V_OI^='V=O[Z?G0!%14OV=O[Z?G1]G;^^GYT 145+]G;^^GYT
M?9V_OI^= $58USX9L[KQ7;^(WEF%W!;_ &=4!&PKG.3[UO?9V_OI^='V=O[Z
M?G0!"ZK(K*X!5A@@]Q3(+>&VB\J"-8XP<[5Z59^SM_?3\Z/L[?WT_.@"*BI?
ML[?WT_.C[.W]]/SH BHJ7[.W]]/SH^SM_?3\Z (J*E^SM_?3\Z/L[?WT_.@"
M*BI?L[?WT_.C[.W]]/SH BHJ7[.W]]/SH^SM_?3\Z (J*E^SM_?3\Z/L[?WT
M_.@"*BI?L[?WT_.C[.W]]/SH BHJ7[.W]]/SH^SM_?3\Z (J*E^SM_?3\Z/L
M[?WT_.@"*BI?L[?WT_.C[.W]]/SH BHJ7[.W]]/SH^SM_?3\Z (J*E^SM_?3
M\Z/L[?WT_.@"*BI?L[?WT_.C[.W]]/SH BHJ7[.W]]/SH^SM_?3\Z (J*E^S
MM_?3\Z/L[?WT_.@"*BI?L[?WT_.C[.W]]/SH BHJ7[.W]]/SH^SM_?3\Z (J
M*E^SM_?3\Z/L[?WT_.@"*BI?L[?WT_.C[.W]]/SH BHJ7[.W]]/SH^SM_?3\
MZ (J*E^SM_?3\Z/L[?WT_.@"*BI?L[?WT_.C[.W]]/SH BI1]X?6I/L[?WT_
M.E$#9'SI^= &BGW!]*6D7A1]*6@!DO\ J7_W37FGP=_X]_$7_86G_P#0J]+E
M_P!2_P#NFO-/@[_Q[^(O^PM/_P"A4 >G4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 >7:Q_R7K1/^O";^8KU&
MO+M8_P"2]:)_UX3?S%>HT %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y=JW_)?M _Z\Y__ $$5
MZC7EVK?\E^T#_KSG_P#017J- !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !3)O]1)_NG^5/IDW^HD_P!T_P J
M /-/@[T\5_\ 87?_ -!%>G5YC\'>GBO_ +"[_P#H(KTZ@ HHHH @O2193$==
MIKE!))C[[?G75WO_ !Y3?[AKDATH =YDG]]OSH\R3^^WYTVN)O/B1;P7E_':
M:)?7UK8G_2+N(@(HQDGGF@#N/,D_OM^='F2?WV_.J6F:E:ZOIT-_9R"2"500
M1V]JMT .\R3^^WYT>9)_?;\Z;10 [S)/[[?G1YDG]]OSIM% #O,D_OM^='F2
M?WV_.FT4 .\R3^^WYT>9)_?;\Z;1VH TKIV&E6QW'.X\YK/\R3^^WYU>NO\
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MZ'8V;9:":-$8_P 1! _6M8Z3X@\1Z_I\VOV,-A9Z8_G1".42&X<C!SC[O'-
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M^F1?ZE/]T4^@!DO^I?\ W37FGP=_X]_$7_86G_\ 0J]+E_U+_P"Z:\T^#O\
MQ[^(O^PM/_Z%0!Z=1110 4444 %<G\2DU%_ 6I?V5=36UVJATEA8JP ()Y'M
M765!?6XN["XMV (EC9,'W&* ///@KXENO$/@=I+ZYEGN;:4QN\K;F/ .<UY-
M:?$S6Y?BTDO]IW1TV6]6$VYD/EJN0#@=*N^"-:;P1_PG&D2-M%E"\D8SR6R%
MQ^58UYX8-I\&[+Q3&N+J2]$F0.0-S<_3B@#V/XU>)KG1/!B1Z;=26]W>R*L4
ML+%6P""<'\:V] UJ#PW\/M*N_$VJ%)3;J9IKAB69L<^]>2^+-1_X3C7? ^C0
M-O:...64#GG:I/\ *J/Q5N[[4/BK:Z9;Z=_:45LBI#IPSMDQGL* /==#\?>%
M_$=T;;2=7@N)@,[ "I_4"M35];TW0;-KO4[R.V@7JSFOF<>'/%-UXITF^L?
M$NB+;3(6^RQOM.#U.XUH_%Z^U34?BA::2+$ZBMM;QNEESAV906R!0![CHGQ!
M\*^(KO[)I6L07$_78 RG]0*\P^,7_)6/!?T'_HRN&OO#OBV[U6QN]+^'TNBR
M6[@[K2-_F^NXUUOQJFN;;X@>#YH(?-N8X RQG^)M_2@#V#5O&OA[P]=6MCJN
MIQ6]U<8$<9#,6)P.P..M= K!T#*<@C(KYX^$T=GXP\?ZIJGB1Q-JUNW^CV\O
M;&>@]L5]$4 ><?$F[\:"&XAT$1VFGQVS2S7K?>!'\*X.0:Q_@-K6JZSI.J/J
MFHW-Z\<JJK3R%L=>F:]#\9?\B9K'_7J_\J\O_9T_Y ^L?]=U_K0!V_CJ7Q?*
MBV?AI(8(G1FFO)>?+ !/'.<\5POP&U_6=9GU0:KJ=U>;#A1-(6 Z=,U[/?\
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M4 %%%% $%[_QY3?[AKDATKK[F,RVTB @%E(R:P1HL^/];#^= &=16E_8L_\
MSUA_.C^Q9_\ GK#^= &;16E_8L__ #UA_.C^Q9_^>L/YT 9M%:7]BS_\]8?S
MH_L6?_GK#^= &;16E_8L_P#SUA_.C^Q9_P#GK#^= &;16E_8L_\ SUA_.C^Q
M9_\ GK#^= &;1VK2_L6?_GK#^=)_8L__ #UA_.@!+K_D%6W^\:SZW)]-EDL8
M81)&&1B22>*J_P!BS_\ /6'\Z ,VBM+^Q9_^>L/YT?V+/_SUA_.@#-HK2_L6
M?_GK#^=']BS_ //6'\Z ,VBM+^Q9_P#GK#^=']BS_P#/6'\Z ,VBM+^Q9_\
MGK#^=']BS_\ /6'\Z ,VBM+^Q9_^>L/YT?V+/_SUA_.@#-HK2_L6?_GK#^='
M]BS_ //6'\Z ,VBM+^Q9_P#GK#^=']BS_P#/6'\Z ,VBM+^Q9_\ GK#^=']B
MS_\ /6'\Z ,VBM+^Q9_^>L/YT?V+/_SUA_.@#-HK2_L6?_GK#^=']BS_ //6
M'\Z ,VLN?P_97'B.'77:7[9#!Y"@-\FW.>1ZUTW]BS_\]8?SH_L6?_GK#^=
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M?_GK#^=']BS_ //6'\Z ,VBM+^Q9_P#GK#^=']BS_P#/6'\Z ,VBM+^Q9_\
MGK#^=']BS_\ /6'\Z ,VBM+^Q9_^>L/YT?V+/_SUA_.@#-HK2_L6?_GK#^='
M]BS_ //6'\Z ,VBM+^Q9_P#GK#^=']BS_P#/6'\Z ,VBM+^Q9_\ GK#^=']B
MS_\ /6'\Z ,VBM+^Q9_^>L/YT?V+/_SUA_.@#-HK2_L6?_GK#^=']BS_ //6
M'\Z ,VG)_K%^M:']BS_\]8?SI5T:<.#YL7!]: -Z+_4I_NBGTU!MC4>@Q3J
M&2_ZE_\ =->:?!W_ (]_$7_86G_]"KTN7_4O_NFO-/@[_P >_B+_ +"T_P#Z
M%0!Z=1110 4444 %%%% '@'Q&^#WB/6_&5UJ>A) ;6\^:8O.$);/(([CI7IF
MI^#/M/PR?PU"J><MJ5B!.%\S!QS]379T4 >&_"SX4>(?#GBU=8U]80+>+9!L
MF$F<@C\.*W/B)\,]4UCQ%;>)O#-XMOJL  "L< D9YS^->K44 >/:7X7^*6L:
MK9MXGUN&VLK659=EL5S)CL=N*O?$?X97_B#6K?Q%X?NQ;ZO H!W' ?'W>>U>
MIT4 >-V'ACXK:U>0Q>)-;AM;%&!86Q4L^.WRXK1^('@77/$/COPSJNG)"]II
MX G=Y0K##YX'?BO4Z* /'_%7PWUVV\?6/BCP<((Y"0+J-W"#' /UR,UZY"TC
M0(TR!)"HW*#D _6I** /-/B-IGQ%U2Z:T\,2V@TJ: QS)*R!B3UY(STKB_!'
M@;XJ>#[M(;1K&&PFG1[I?-1R5!YQD9Z9Z5[_ $4 <%X_MOB!<2PIX/FM4MV0
MK,)BF3D=MPKS/PC\/?BKX0NV;3#80Q3N#/F5'R._45]$T4 1P>8+>/SL>;M&
M_'KCFI*** "BBB@ HHHH \NUC_DO6B?]>$W\Q7J->7:Q_P EZT3_ *\)OYBO
M4: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** ,W7H=4GTB5='N4M[X8:-G4,#@Y*G/KTS7&W>H?$V_T^2S3PYIUC+*
MNS[6NH!_+]6"XYKT2B@#G/!/A*#P;X<ATN*4SR@EIIRNWS&))SCMUKHZ** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** /+M6_Y+]H'_7G/_Z"*]1KR[5O^2_:!_UYS_\ H(KU&@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L+Q0/$*64<_AWR
M9;J-P6MIB%65<\_,>E;M% 'FFL6OC_Q?9_V+>Z19:-87!Q<W45X)W"CG 7 Z
MXQ7=Z'I%OH.B6FE6H/D6T8C3/I6A10 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !3)O]1)_NG^5/IDW^HD_P!T_P J /-/
M@[T\5_\ 87?_ -!%>G5YC\'>GBO_ +"[_P#H(KTZ@ HHHH 9-_J7^E963ZFM
M6;_4O]*RNU !D^IHR?4T5@>,/%EGX,T)M5O(S*N\(D2MAG8T ;^3ZFC)]36?
MHFJIK>C6VI)"T*SH&$;')6M"@ R?4T9/J:** #)]31D^IHHH ,GU-&3ZFBB@
M R?4T9/J:** +$N?LT?/>J^3ZFK$O_'K']35>@ R?4T9/J:J:I?+I>D7NHO&
M9%M8'F* X+!1G%5_#NLIXBT*UU6*!H4N$#B-CDKD9ZT :>3ZFC)]32D$=0:5
M4+L .YH ;D^IHR?4U@>&/%47B<7_ )5H]O\ 8[E[=M[ [BIQD5T!!'4&@!,G
MU-&3ZFEP3T!I,8H ,GU-&3ZFEP<9P:,$]J $R?4T9/J:"".HJKJ=Z-,TNXOG
MB:185W%1QF@"UD^IHR?4UF^'M83Q%H%IJT4#0I<J6$3')7!QU_"M,@CJ* $R
M?4T9/J:7:?0U0U76-/T2"*;4;CR(YI1"C%2<N>@XH O9/J:,GU-(K!T5EY5A
MD'VKGM?\76^C7L.F6MK)J.KSC,5C$VTL.N2QX'XT =%D^IHR?4UQUGX[F37+
M;2_$'A^YT-KOY;:6:99%E?LGR]#]:[+:?3\J $R?4T9/J:7!/0&DP1VH ,GU
M-&3ZFEP1U!HP3V- "9/J:,GU-'2B@ R?4T9/J:Y+7O&MQI/B*'0[#P_<:I=R
MIO BF5.,9[TVR\<77]M6NF:[X<N=%>[.RVDFF619'_N_+TXH Z_)]31D^IK#
MTGQ(-5U[5=*%C- =/=4,S_=ER,Y%;H4GL: $R?4T9/J:P=.\41:CXJO]!6U=
M)+.+S3,6!#<XP!6\01U% !D^IHR?4U@:KXIBTKQ+I6B/:/))J(<K*& ";1GD
M=ZG\4^((_"WA^YU>6W>X2#&8T;!.2!U_&@#8R?4T9/J:ALY_MEG#<JA42J&"
MGMFIB".HQ0 9/J:,GU-%8/B7Q1%X:;31+:O<?;KI;9=C ;">YH WLGU-&3ZF
MJ>J:BNEZ/=:D\9D6WA:4H#@L ,XJ'P_K">(-"M-5B@:%+F,2"-CDKD=,T :6
M3ZFC)]32[3W&*P?#GB>+Q'/J,45J\!LI!&Q9@=^>X_*@#=R?4T9/J:Q?%?B*
M/PIH,FJS6KW"(Z+Y:':3N8#J?K6M;S"XMXY@-H=0V#VH DR?4T9/J:4 GH#5
M#5M8L-"L6OM3G\BV5E4N5)P2<#I[T 7LGU-&3ZFFHZR1JZ'*L,@^HK"TCQ3%
MJ_B+5M'2T>)]-=5:5F!$F1G@=J -_)]31D^II<'T-( 3T% !D^IHR?4T$$=1
MBEP?0T )D^IHR?4U0DUK3HM:31WN,:A)&)5AVGE3WS5JZN8;*TFNKERD$*%Y
M&"DX Z\#K0!+D^IHR?4UP<GQ%OK:W&H7?A&]@T<RA!?M.I&TG ;9UP>M=Q;W
M$-W;17%NXDAE4,CC^('O0!)D^IHR?4US.M>+VT_6%T?2M)FUC4C&97MXI!'L
M0'!))X_"C0_&/]I:O)H^IZ7+H^J!=R6TT@<R+C)((XXH Z;)]31D^II0">@-
M)0 9/J:,GU-*01U!H )Z T )D^IHR?4T8I2".H- "9/J:,GU-* 3T!K T#Q1
M%K^I:M91VCPMIUP;=F9L[R!G(].M &]D^IHR?4TI!'4&DH ,GU-*I.X<FDI1
M]X?6@#67[@^E+2)]P?2EH 9+_J7_ -TUYI\'?^/?Q%_V%I__ $*O2Y?]2_\
MNFO-/@[_ ,>_B+_L+3_^A4 >G4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 >7:Q_R7K1/^O";^8KU&O+M8_Y+
MUHG_ %X3?S%>HT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!Y=JW_)?M _Z\Y__017J->7:M_R
M7[0/^O.?_P!!%>HT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAV(/05IQ^&;^+XC6>M#RSI\%HT!;=\Y.T <?A0!G>*K@V5]9V%_XX.C6D,
MDC?%U</CDOQC%9GACQ1KMWX5\3K97$FJWFG2E+.67EY5P.N._-:NL>&]>@\<
MS:]I6G6&J0W%ND+1WL@7R<?Q*"#GK47AWPAXET@>(2MY#:W%_,9K>YC"M@X
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MVH:5I^FW/VJ:6^0*7X(VKBMVX\/:A)\2K37D$?V&*(HQW_-G;CI76EB>I)H
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M97>BZC.[ZG,X>%1CD].: />:*\Q_X719?]"[J_\ WPO^-'_"Z++_ *%W5_\
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MPM_>% %6BK7V%O[PH^PM_>% %6BK7V%O[PH^PM_>% %6BK7V%O[PH^PM_>%
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MA'_WP*/LT'_/"/\ [X%4]$U-M8TJ*^:W, EY52V[*]CFM&@"+[-!_P \(_\
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M*&/3I"RJC 98D@'=D50;POXYU+2+;PYJ*:6FF6\J;;Z.5FGV(P*_*1C) P:
M*WB_QLT?B2S\+ZCKPT:*.!9;^^M@P:1CD;8B =O..HJWX!\3Q2>*+W0].U^X
MUVQ,!N([N[+,T1&!M)(''>M/5?"^O:5XB;6/#,&GWGGVZV\UMJ#E57!SO! )
MR:M1>$]7U?PYJEKK]_''/J,1006J*([,XQ\C8!;UYH X>.;5#J3+XB\2:WX?
MU=[S%G%+/FSNU#<!54$XQC.3WKI_'AU]IM,#2ZE!ID8W7MSHTHC=&QR6W?P^
MG>JC^&/&^M6%AH.LII46FVDL;"]AE9IW6,@KP1@9QS6A>^'?%.A^)+S4O#"V
M5Y;7L022VOYF58V!)++@'.: ,:7Q?)X1\$7>J6OB%=;M;BX$&GW-SN=XV*])
M>!GD'H*Y]?%=KI3:=?Z9X]OM8U6:YC2?3YR[0E78;]J[1C;VYKL!\.[^3PFY
MFD@&O->#4A&#^X6X4$!1Q]W'M6CI>F^-+Z_MY-7_ ++TF"W(9AIX$IG/HVY>
M!]/6@"E<2ZGX]\236=EJM[I.D:?]Z:SDV332\@J3R,#BJ?@*PO4^(6M&^O7O
MSIL?V&*ZE.9"N0V'/<UHW&A^+="\1W]SX8ATZXL+_P"=TNYF1HI"?F*X'-:/
M@'PMJ/AM-6DU6Y2ZN[^[\]IP>6X YH N>.M8&C>&Y)O[4MM,\UUB-S.&.Q6X
M)4+SN]*\XTKQ!867B?1;?0?'&IZ_-<2-'<6]Y*S)C;U *C%=UXX\-ZGJL^GZ
MGHPMIKZQ?Y;:[8B&0$C).,\C%8UGX4\4ZAXXT;Q%K46F6T=EYBFUM&)5<J0&
M!(!).><T 5]#\/?VE\6]6UM=;U(FQD\DQ"7Y#T/EGC[G.<5V'CNZ>W\'W\<2
MJTMU&;:,-TW."!6=X/T/7-$U[73>067V"^N3=1S12,968@## C X%6_'?A_4
M/$FCV]GI\R02174=QYC''*'.* .$U32M;\"^#],U^/Q!?/=6H@ADT]Y,VS!B
M%("]<C-;'C?7K!]:M[+4?&3:#9K$)3%:%UN7?/=@"-F.W7-67\.>*O%&HVD7
MBC[#;Z59/Y@BLY"YNB.F_(XP0#Q4=UX=\5:-XGU._P!!LM)U&WU&3SG_ +0D
M96B8\;5P#QQ0!7\ Z_/?R>([/2=9FUFTLPOV*[O'+,SE<X)(&1FL73CJG]HI
M#>^)]8TKQ))<;HK'4I]UK,N[YMJJ.F,XR?2MK2OAQJD?AW7;._O4-[?3K<PW
M$)VD.H. <#H"<5+'X=\9:[<Z7:>(8-+M["Q(+7%K*SS2E0-N<CC)'/UH Q/$
MGCFSU7QC=:)?>*)_#UAIIVR26I999IAP1N (VX[4_1?%LEQX5\66$.JS:K;V
M:&.POI<^9+N3.&) R<UO7?AWQ-H?B+4;OPW8Z3?6>I2&YG74'*LDIX.W /&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MP_Q*S=:?I>F)RUQJ$)9?5 WS5W%,>&*1E9XT9E^Z64$CZ4 <1XN5)/$/A308
MT'V:>:3S%4<(J("OZBN5U77I9_%FM0:OXTF\+1VLYCM88P@^T1@<298'Z<5[
M"T,32+(T:&1?NL5&1]#5>YTK3KR0275A:SR 8#2PJQ_,B@#Q+PU,P\+>*KV_
MN[JYGU>ZBL_.ND"RN&4J,@<<CI79>+[!(/ VD>&H!Y33- B[1C C*D_RKO\
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M %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img38651418_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img38651418_5.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ HL# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_OLT?9Q_STE_[[- $U%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 0^5-_S\M_WP*/*F_P"?EO\ O@5-10!#Y4W_ #\M_P!\"CRIO^?EO^^!4U%
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MZ34?L*SMY^]HQF)PC.HR5#XVEAW .>#Z4 :-%%(S!%+,0 .I- "U"TK.Q2$
MD=6/1?\ $TGSW'JD7Y,W^ J955%"J  .@% #(XECR<EF/5CU-2444 %%,>6.
M+&]PN>F33/M4'_/5/SH FHJ'[5!_SU3\Z/M4'_/5/SH FHJ'[5!_SU3\Z/M4
M'_/5/SH FHJ'[5!_SU3\Z/M4'_/5/SH FHJ'[5!_SU3\ZBN=4L;.W>XN;J**
M%!EG9L 4 6ZX_6?B5H.CWS6;--=2)]\VZAE4^F21S]*X3QC\2KG5O,L='+V]
MB?E:7I)*/_91[=?Y5Y]7H4<'=7J'-4K](GMG_"WM!_Y];_\ [X3_ .*H_P"%
MO:#_ ,^M_P#]\)_\57B=%;_4Z1G[>9[9_P +>T'_ )];_P#[X3_XJC_A;V@_
M\^M__P!\)_\ %5XG11]3I![>9[9_PM[0?^?6_P#^^$_^*K2T'XB:3XAU>/3;
M2"[29U9@9%4  #/8FOGN2;'"?G77?"F14\=V[.P \F3D_P"[657#4XP;14*L
MW))GT)14/VJ#_GJGYT?:H/\ GJGYUYIUDU%0_:H/^>J?G1]J@_YZI^= $U%0
M_:H/^>J?G1]J@_YZI^= $U%0_:H/^>J?G1]J@_YZI^= $U%0_:H/^>J?G1]J
M@_YZI^= $U%0_:H/^>J?G1]J@_YZI^= $U%0_:H/^>J?G1]J@_YZI^= $U%0
M_:H/^>J?G1]J@_YZI^= $U%0_:H/^>J?G1]J@_YZI^= $U%0_:H/^>J?G1]J
M@_YZI^= $U%0_:H/^>J?G1]J@_YZI^= $U%0_:H/^>J?G1]J@_YZI^= $U%0
M_:H/^>J_G2_:H/\ GJOYT 2T5%]J@_YZK^='VJ#_ )ZK^= $M%1?:H/^>J_G
M1]J@_P">J_G0!+147VJ#_GJOYTGVJ#_GJGYT 345#]J@_P">J?G1]J@_YZI^
M= $U%0_:H/\ GJGYT?:H/^>J?G0!-14/VJ#_ )ZI^='VJ#_GJGYT 345#]J@
M_P">J?G1]J@_YZI^= $U%0_:H/\ GJGYT?:H/^>J?G0!-14/VJ#_ )ZI^='V
MJ#_GJGYT 34452U=;Q](NET\XNS&1'@@'/L3P#Z$]Z .*:;3C#S<L+LWW_($
M\]MN?,Z>7G/^UG&S/;%>A5R$UOK%X7U15O[65)(HK.T,@^X"-S2@$@@_-U)P
M!ZFNOH **** "BBB@ HHHH **** .8\4:'J6I>;/9SP.?*2.."2$DK\X9F5M
MX )P,Y'10!UJ&RTS4PVGZ?<6A$=G?R737N]-DBDR%=J[BP)+@$$<8/)KK:*
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M:\_B>VU.SMGAT35A/YAQ& R0LIE#%68_P@C..W(KT"@ HHHH **** "BBB@
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M[*":673K,V5REU;ZG-=33O;LJ%"9#N#D8.X,HQU]0,4 =I1143Q&5L.W[O\
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M _\ H1K@JXJOQL^&S3_>Y^OZ!11169P!1110!0U?_CT7_?%8E;>K_P#'HO\
MOBL2M(['I87^&=;\-/\ D?\ 3/J__H#5]%U\Z?#3_D?],^K_ /H#5]%UTTMC
MZ7+/X3]?\@HHHK0]$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP#ZM4['EM9VL?ZB/_>_I7L?_  JNQ_Z"5Q_WP*DMOA9HZ7D,UW-+=QQ'<(7
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M%,[2P'<C/ H T:@.^9F4'9&IP2.I_P *GJ*'K+_OG^E $B(J*%4  =A2T44
M%%%% !1110 4444 %%%% !1110 45ROB#Q%?Z9JD\%L(C'#:)<$-:22;B7<$
M%U8+& $SN88Z^E6KCQAIUK?S6<J2!XHWDRDD3[E5=Q^57+#*\C<!0!T%%<[>
M>,;&P@@>Y@EB>=#*D;30 F,8^8-YFT@YX ))]*2'Q#F\F<S>9:M=%8L19)C^
MR)-P<C')8Y(/7''4 '1T5S__  E]BEJ]Q<V]S:KY4<T8GV+YJNVU2#NP.<9W
M%<9R<#)J_HVLVNN6CW%KG;'(8G!9&PP /5"RG@@\$]?6@#1HHHH **** "BB
MB@ HHHH **** "BBB@!H<,[*,Y7&:=44?^OF_#^52T %%%% !1110 4444 %
M%%% !1110 445GZO?RZ=!;W"*AA^T1QSE@?E1CMR/HQ7UXS0!H45RB>*;F9;
M^-(81.+E(K'.2)4:0QAB,]BCGC'&/QF3QSHK33(9BJ1([^9O1MP3K\JL6'MN
M49H Z6BN3E\9V<\=O-!/Y"1WB1W(+QR_(R.1@QLPY*] =V1TY&=JYU5X=*CN
M5M94N;@A(+:; 8R'.T-@G XR?0 ^F* -*BLW0;Z?4M%M[NY$8F?<'\L$+D,1
MP"2>WK6E0 4444 %%%% !1110 4444 %%%% !3=X\PISD#-.J(?\?3?[@_F:
M ):*** "BBB@ HHHH 9YL?\ ST7\Z/-C_P">B?\ ?0JOYMM:V7GW4D,,2_>D
ME(51DXY)]Z;:ZCI=]*8K2\L[B0#<5AE5R!ZX!Z<BGRMJ]A76Q:\V/_GHG_?0
MH\V/_GHG_?0K'N]?M;.^GMY+&X:.W,8FN%5-D>_A<C=N/X*:0>(+0VMW=_8+
MK[);1S/]H"(4D\HD.%^;(.0<;@,XXI#-GS8_^>B?]]"CS8_^>B?]]"L0>([1
M8K@S6%U#-"8P+=D1GD,F=@7:Q&3@]2,=\"K5IJD5U<3VKV%Q;7<*"3[/,J;G
M4]"I5BI&01UX/7% &CYL?_/1/^^A1YL?_/1/^^A61::W'<W=S!)I5U:BU_X^
M)9S"$B^7<,E9">A'(!]Z6Y\1Z';06\YOK-X9YO)61)D*AL9.3G&!QGZB@#6\
MV/\ YZ)_WT*/-C_YZ)_WT*S;C6M,2"]-O<VES<6D+RO;QS*7&T<Y R1S@=.]
M+<ZI#;1V6+.2>XO/]5!#LW'"[CRQ48 ]Z -'S8_^>B?]]"CS8_\ GHG_ 'T*
MJ#4=.$EO#+/!!<W"!X[>9E24@_[!YSU'X4V/5='FAEFBU"Q>*(A9'69"J$G
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M_(T(C^:SN5Y4 !: ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
' **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img38651418_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img38651418_6.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '! M(# 2(  A$! Q$!_\0
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M&$1/^L)!;+8[$8I!JVIZMK6C06UX;*VO=,%W*$C1F4DJ?E+ \\XYR,9XS@T
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MEY UIX2\'QVJ*[B\M659'*AF*,3D@'&2?0T =I9WUGJ$1ELKN"YC#;2\,@<
M]<9'?D?G1=WUI81++>74%M&S;0\T@0%O3)[\'\JYK1I_^*BU_4;V)X+N(10R
MVL"-*-@!*R J-S[LG'RC &*A\7_9=>T_2+<I.()M52%Q- \3<QOR X![]?\
M"@#L7=(HVDD941069F.  .I)JL=5TX6 OC?VHLR<"X,R^6><?>SCKQ7'KJ%Q
MJGAVQ\.R,POYKAM/NRIP1'%_K6S[IM_[[K,P4^&<(B5<C5/E4G _X^#@>PH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=0A8\M@[=Z@GLK#J<8S6Q10!1CTJ"+6Y]55Y//FA6%E)&T*I)&!C.>?6J?\
MPC-F-#BTI9KA8X9_M$4P8>8C^89 0<8X)/4=*VJ* *YM!)8-:3S23AXS&\C[
M0S C!SM 'Y"L33-"EET'2K/5/,2;3+@/&R.I$GEDA#W^4J1QP:Z.B@"@-)@7
M76U='D6=X! Z@C8Z@Y!(QG(]<]*=J.EP:FUFTS2*;2Y6YCV$#+*" #D=/F-7
M:* ,JW\/6%MXAN=;C5Q=W$8C<$C:.G(&."<#//:JS>$[)M!&D">Z6$3_ &@2
M!EWAM^_NN,9]JWJ* ,;_ (1R*2>2XNK^]NKEH&MXYI"BF%6^\4"J%R>.2#T%
M61HUFN@C1@A^Q_9_L^.,[<8S]>^?6M"B@#GFT6?^V-#B'F/8:7"[>=*ZEI),
M!%! QR!DYQZ5+XFM+NYATU[2V>X:VOXKAXT958HN<XW$#OZUN44 4(]-A.L?
MVP?-6Y>U6W,;$;0H8MV[Y/KBDU/2(M3DM9C//;W-JY>&> KN7(P1A@001ZBM
M"B@#$@\,64-EJ5K)-<W"ZB2;AIG!8DJ%)! &.F?0=L#BG_\ "/1.NG">]N[A
MK"7S87D* GY=H#;5&1C\?>MBB@#'/A^-+BYDM=0OK2*Y<R300.H5V/WB"5+*
M3W*D>HP>:M+I4"ZT=5#R>>;86VTD%=H8MGIG.3ZU>HH Q#X7L3HTNF>9<")Y
MS<"0,-Z.7WY!QC@^H-:L4,D=J(6N99'"D><X7>3ZX"A<_A4U% &'I7AK^QXT
MBM=7U#R1(971UA;S&)R=S>7N.>YSGWI-)M;L>)=:OY[22W@N%@2+S&0E]@<$
MX5C@<CKBMVB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **RI/$NC1R
M-&]_$&4D$<GD?A15^RG_ "LCVD.Z-6BBBH+"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** .9\;?\@[3O^PG;?\ H=6=9OKLZUIFCVDY
MMC=B266X559E1,<*&!&23U(.!5_5-*@U>&&*X>15AG2=?+(!+(<@'(/%-U+2
M(=2DMIC--;W-LQ:&> @.F1@CY@001U!!H X_Q%=7S:/XFTBYOI9OL<,<\<VR
M,-(C@_(^%QP1U !Z5NR2G3M(L(IM<NHVFQM*VR2SO\N=J*J$8'4G8QQW'6KB
M>'+/[%?V\\D]R^H BYGE8>8XQ@=   !T   IC^'$>.Q)U*^^TV);R+K]WO56
M7:5(V;2,8ZKGCK0!RNHZG<:EX4NA<2O*;768X$EEB\IW0.C NN!AL-CH.G2N
ML\2Z3<:OIT4=I)"L\%Q'<(LX)CD*'.U\<X-0#PC9?V=-9-<WDBS7:WDDCR N
M9!M[XZ':./<XQ6K?6;7L2(EW<VKHX=9+=@#GD8((((YZ$$?B!0!R]WXIDM[#
M4O\ B6"PUR,PI(C[9%.]MJ/O&-X .><8/%7M6N-2\.Z-<79U%K^1O+BC%S$B
MA)&8+NR@7Y><X.3QUJS_ ,(O8R6]\EW)<7<M\%$UQ*P#X7[H&T +@\C '/7-
M2-X?BN+.XM;^^O;Z*>,1D3NHV@'(("*HSG!R<G@4 4GN-1T;7=)M;C4I;^"_
MWQ/YT4:E'5=P9=BC@X(P<_6LW3-:U1/"M]X@OKYI_L_GB*V6-%1MK$+N(7.<
M\<$# '!.<]!:Z#'#?0WMS?7=]/ A2!KED_= \$@*JC)'!)R:?9:#966CR:5A
MYK64R;UE()8.22. /4T 86FZKJ?V_2QYVH7T=R"+L3:<T,<)*Y#(WEKP#QR6
MSD5/H6J7DNJ"UU2]G@OV,I-C-;JL;*#PT+@#< ,=68]>!UK6L-&-B\.=3O[B
M*%=L4,SKM48QSM4%L#^\3Z]>:9!H,<5_;7D]]>7;VJLMNL[J1'N !.0H+' Q
MEBQZ]^: -:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YR7P3H\LKR$3@NQ8@2<#
M/X45T=%;>WJ_S,R]A3_E04445B:A1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1T&337D6-<L?IZFHO+:;F483M'Z_7_"@!?M4/9B?<*3_
M $H^U1>K?]\'_"IJ* (?M47JW_?!_P */M47JW_?!_PJ:B@"'[5%ZM_WP?\
M"C[5%ZM_WP?\*FHH A^U1>K?]\'_  H^U1>K?]\'_"IJ* (?M47JW_?!_P *
M/M47JW_?!_PJ:B@"'[5%ZM_WP?\ "C[5%ZM_WP?\*FHH A^U1>K?]\'_  H^
MU1>K?]\'_"IJ* (?M47JW_?!_P */M47JW_?!_PJ:B@"'[5%ZM_WP?\ "C[5
M%ZM_WP?\*FHH A^U1>K?]\'_  H^U1>K?]\'_"IJ* (?M47JW_?!_P */M47
MJW_?!_PJ:B@"'[5%ZM_WP?\ "C[5%ZM_WP?\*FHH A^U1>K?]\'_  H^U1>K
M?]\'_"IJ* (?M47JW_?!_P */M47JW_?!_PJ:B@"'[5%ZM_WP?\ "C[5%ZM_
MWP?\*FHH A^U1>K?]\'_  H^U1>K?]\'_"IJ* (?M47JW_?!_P */M47JW_?
M!_PJ:B@"'[5%ZM_WP?\ "C[5%ZM_WP?\*FHH A^U1>K?]\'_  H^U1>K?]\'
M_"IJ* (?M47JW_?!_P */M47JW_?!_PJ:B@"'[5%ZM_WP?\ "C[5%ZM_WP?\
M*FHH A^U1>K?]\'_  H^U1>K?]\'_"IJ* (?M47JW_?!_P */M47JW_?!_PJ
M:B@"'[5%ZM_WP?\ "C[5%ZM_WP?\*FHH A^U1>K?]\'_  H^U1>K?]\'_"IJ
M* (?M47JW_?!_P */M47JW_?!_PJ:B@"'[5%ZM_WP?\ "C[5%ZM_WP?\*FHH
M A^U1>K?]\'_  H^U1>K?]\'_"IJ* (?M47JW_?!_P */M47JW_?!_PJ:B@"
M'[5%ZM_WP?\ "C[5%ZM_WP?\*FHH A^U1>K?]\'_  H^U1>K?]\'_"IJ* (?
MM47JW_?!_P */M47JW_?!_PJ:B@"'[5%ZM_WP?\ "C[5%ZM_WP?\*FHH A^U
M1>K?]\'_  H^U1>K?]\'_"IJ* (TF21L*3G&>5(J2BB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ J*2;:VQ!OD]/3W-)YC3'$1PG>3_
M  _QJ1(UC7"CZGN: &1Q8;>YW2>O8?2I:** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBHY)=K;$&Z0_PCM]?2@!SR+&NYC@?SJ+8\YS*"
ML?9/7Z_X4Y(L-OD.Y_7L/I4M !T&!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%5=1OX=+TZ>^N-WE0H78*.3[#W/2@"U17-VWB6XO/L\5M;Z;<7,
M[-M6#4?,C154%M[B/@_,HP >O6M?2=175=+@O5B:+S =T;')5@2",]^0>: +
MM%-=UC7<QP*BVO/S("L?9.Y^O^% "F1I3MA.%[R?X>M/CC6-<*.O))ZGZT\
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M (T?98O1O^^S_C4U% $/V6+T;_OL_P"-'V6+T;_OL_XU-10!#]EB]&_[[/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ IDDJQ@9R6/11U-,:4LQCB 9AU)Z+_GTIT<03))+.>K'J
M: &K$SL'FP2.B#H/\34U%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !116!XF\7:;X7MMUR_F7+#,=LA^9O<^@]
M_P"=5&+D[(3:2NS6O]0M-+LY+N]G2&",?,[']/<^U<C_ ,+6\,_W[K_OS_\
M7KR3Q'XHU+Q->>=>R8B4GRH$^Y&/8>OO6+7H4\%&WO[G++$._NGNO_"UO#/]
M^[_[\_\ UZ/^%K>&?[]W_P!^?_KUX516GU*EYD_6)GNO_"UO#/\ ?N_^_/\
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MLU-10!#]I7_GG+_W[-'VE?\ GG+_ -^S4U% $/VE?^><O_?LT?:5_P"><O\
MW[-344 0_:5_YYR_]^S1]I7_ )YR_P#?LU-10!#]I7_GG+_W[-'VE?\ GG+_
M -^S4U% $/VE?^><O_?LT?:5_P"><O\ W[-344 0_:5_YYR_]^S1]I7_ )YR
M_P#?LU-10!#]I7_GG+_W[-'VE?\ GG+_ -^S4U% $/VE?^><O_?LT?:5_P">
M<O\ W[-344 0_:5_YYR_]^S1]I7_ )YR_P#?LU-10!#]I7_GG+_W[-'VE?\
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M"DKBDECDG)I***DH^GO"\ZKX3T<;).+*'HA_N"M;[2O_ #SE_P"_9K.\*_\
M(HZ-_P!>4/\ Z *UZ\27Q,]".Q#]I7_GG+_W[-'VE?\ GG+_ -^S4U%2,A^T
MK_SSE_[]FC[2O_/.7_OV:FHH A^TK_SSE_[]FC[2O_/.7_OV:FHH A^TK_SS
ME_[]FC[2O_/.7_OV:FHH A^TK_SSE_[]FC[2O_/.7_OV:FHH A^TK_SSE_[]
MFC[2O_/.7_OV:FHH A^TK_SSE_[]FC[2O_/.7_OV:FHH A^TK_SSE_[]FC[2
MO_/.7_OV:FHH A^TK_SSE_[]FC[2O_/.7_OV:FHH A^TK_SSE_[]FC[2O_/.
M7_OV:FHH A^TK_SSE_[]FC[2O_/.7_OV:FHH A^TK_SSE_[]FC[2O_/.7_OV
M:FHH A^TK_SSE_[]FC[2O_/.7_OV:FHH A^TK_SSE_[]FC[2O_/.7_OV:FHH
M A^TK_SSE_[]FC[2O_/.7_OV:FHH C242-@*XXS\RD5)110 4444 %%%% $-
MX0+&X)E:(>6V9%&2G'4?2N,T+0+\36[B"RAL2\-SYL,A)EV(0"%*CEB=Q)/'
M/6NSNW2.SG>169%C8LJ]2,=![UP^DZ?%83Z3?R6%DEO=R*(!;W4S/&S L,[C
MM;ISP* .^HHHH *IZK=RV&EW%S#;R7$J+\D4:%BS'@<+DXR><#IFKE% 'G^D
M7DM_K TJXU#4I(FNYW=W,MLSD1QD*#\I499VV C''&,9ZGPQ<377ARTEGF:9
MR&7S&Y+J&(4D]\@#GO5R?2]/NHGCN+"UFC>3S662%6#/C&X@CDXXS5E$2*-8
MXU5$4!551@ #H * "0N%_=@%O<\"FQQ!"6)W.>K'_/%244 %%%% !1102 ,D
MX H *B>4[O+C&Y^_HOUIN]Y^(R5C_O\ <_3_ !J5$6-=JC H ;'$$.]CND/5
MC_3TJ2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *\3\??\CE??\  /\ T!:]LKQ/Q]_R.5]_P#_T!:]#+?XK]/\ (Y<7\"]3
MFJ***]P\X**** "BBB@ HHHH **** ,/5?\ C]_X"*I5=U7_ (_?^ BJ5<4_
MB9TQV04^.-I#QT]:?% 6Y;@?SJR  , 8%>;B<:H>[#5G%B,8H>[#5G>Z=\5-
M5TW3+6QCL;-DMX5B5F#9(4 9//M5G_A<.L?] ^Q_)_\ XJO.J*\AU)/J<?U[
M$?SGHO\ PN'6/^@?8_D__P 51_PN'6/^@?8_D_\ \57G5%'/+N'U[$?SGHO_
M  N'6/\ H'V/Y/\ _%4?\+AUC_H'V/Y/_P#%5YU11SR[A]>Q'\YZ+_PN'6/^
M@?8_D_\ \51_PN'6/^@?8_D__P 57G5%'/+N'U[$?SGHO_"X=8_Z!]C^3_\
MQ5'_  N'6/\ H'V/Y/\ _%5YU4<DP3@<FCGEW!8W$O:1Z._QDU9!DZ?8_D__
M ,57J7AO5)=:\.V.I3(B27$>]E3.!R>F:^72Q8Y)R:^E/ 7_ "(ND?\ 7#^I
MK6G)MZGJ9=6JU)M3E?0Z.BBBM3UPHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@".<RK;R&!5:4*2@;H6QQG\:XW2HK>
M.]TQ[+298M3WXOGDL#$J*5.\[L!0<]-A.>^:Z36[2ZN[!5M-C21RI*8G<HLH
M4Y*%@#C/T^O%9$'A^\%[::E.$_M-[HRW,RR$K'%@@1+GJ,;1TZY- '4T444
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M8* ><>QZUSEA<:B^HV[O<:S/(+T1;9[*2.)K?& [ H%#9YSD'/Y4 =S1110
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M8.2-V1C/'>L71M)NH=05[[2+R18YB;9IKU9$MH^P"[CDCGGD]*[&B@ HHHH
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M]\U-10!#]H/_ #QE_P"^:/M!_P">,O\ WS4U% $/V@_\\9?^^:/M!_YXR_\
M?-344 0_:#_SQE_[YH^T'_GC+_WS4U% $:2[VQY;KQU85)110 4444 %%%%
M!1110 4444 %0W9@%G,;F7R8-A\R3S3'M7N=P(*_7(J:B@#SK3;K1I;/1H+N
M>R?2XIKP2K(ZF%'+L8@V>!E=Y7/X5UGA02+X8L1)O^ZVSS,YV;CLZ_[.VMFB
M@!LF_;B/&3W/:DCB6/)Y+'JQZFGT4 %%%% !112$A022 !U)H 6HFE+,4B 9
MAU8]%_SZ4W+W'W<I%Z]V^GH*F5510J@ #L* &1Q!,G)9SU8]34E%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XGX^_Y'*^_X
M!_Z M>V5XGX^_P"1ROO^ ?\ H"UZ&6_Q7Z?Y'+B_@7J<U1117N'G!1110 44
M44 %%%% !1110 Y>E+2+TI:^,QO^\3]6?-8K^-+U"BBBN4YPHHHH **** "B
MBB@ K&UC_CXC_P!S^M;-8VL?\?$?^Y_6JCN=&%_B&=114UK:W%[<QVUK"\TT
MAVHB#))^E:'I[D-?2_@5&C\#Z0KJ5;R!P1CN:Y7P5\+;?3?+U#752XO!\R6_
M5(OK_>/Z?6O2^E;PBUJSV\!A9TKSGUZ!1116AZ04444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44@(;H<\XI: "BBB@
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M3[V3@MDB@#?;7-)6-)&U2R$;N8U8W"89AU4'/)Y'%/O+\6ES9VX0.]S(5Y;
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M*MZ+IUS;:L[3M(XMK&&T$KKCS&!9F(P "!E1G'KW!H Z&BBB@ HHHH ****
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M]]4>3_TTD_[ZJ6B@"+R?^FDG_?5'D_\ 323_ +ZJ6B@"+R?^FDG_ 'U1Y/\
MTTD_[ZJ6B@"+R?\ II)_WU1Y/_323_OJI:* (O)_Z:2?]]4>3_TTD_[ZJ6B@
M"+R?^FDG_?5'D_\ 323_ +ZJ6B@"+R?^FDG_ 'U1Y/\ TTD_[ZJ6B@"+R?\
MII)_WU1Y/_323_OJI:* (O)_Z:2?]]4>3_TTD_[ZJ6B@"+R?^FDG_?5'D_\
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MLT>0/[\G_?9H 6"-X8$C>>2=E&#)(%#-]=H _("I*B\@?WY/^^S1Y _OR?\
M?9H EHJ+R!_?D_[[-'D#^_)_WV: ):*B\@?WY/\ OLT>0/[\G_?9H EHJ+R!
M_?D_[[-'D#^_)_WV: ):*B\@?WY/^^S1Y _OR?\ ?9H EHJ+R!_?D_[[-'D#
M^_)_WV: ):*B\@?WY/\ OLT>0/[\G_?9H EHJ+R!_?D_[[-'D#^_)_WV: ):
M*B\@?WY/^^S1Y _OR?\ ?9H EHJ+R!_?D_[[-'D#^_)_WV: ):*B\@?WY/\
MOLT>0/[\G_?9H EHJ+R!_?D_[[-'D#^_)_WV: ):*B\@?WY/^^S1Y _OR?\
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+ 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img38651418_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img38651418_7.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &W!PP# 2(  A$! Q$!_\0
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M *"]K_WW0!MT5B?\)?X>_P"@O:_]]T?\)?X>_P"@O:_]]T ;=%8G_"7^'O\
MH+VO_?='_"7^'O\ H+VO_?= &W16)_PE_A[_ *"]K_WW1_PE_A[_ *"]K_WW
M0!MT5B?\)?X>_P"@O:_]]T?\)?X>_P"@O:_]]T ;=%8G_"7^'O\ H+VO_?='
M_"7^'O\ H+VO_?= &W16)_PE_A[_ *"]K_WW1_PE_A[_ *"]K_WW0!MT5B?\
M)?X>_P"@O:_]]T?\)?X>_P"@O:_]]T ;=%8G_"7^'O\ H+VO_?='_"7^'O\
MH+VO_?= &W16)_PE_A[_ *"]K_WW1_PE_A[_ *"]K_WW0!MT5B?\)?X>_P"@
MO:_]]T?\)?X>_P"@O:_]]T ;=%8G_"7^'O\ H+VO_?='_"7^'O\ H+VO_?=
M&W16)_PE_A[_ *"]K_WW1_PE_A[_ *"]K_WW0!MT5B?\)?X>_P"@O:_]]T?\
M)?X>_P"@O:_]]T ;=%8G_"7^'O\ H+VO_?='_"7^'O\ H+VO_?= &W16)_PE
M_A[_ *"]K_WW1_PE_A[_ *"]K_WW0!MT5B?\)?X>_P"@O:_]]T?\)?X>_P"@
MO:_]]T ;=%8G_"7^'O\ H+VO_?='_"7^'O\ H+VO_?= &W16)_PE_A[_ *"]
MK_WW1_PE_A[_ *"]K_WW0!MT5B?\)?X>_P"@O:_]]T?\)?X>_P"@O:_]]T ;
M=%8G_"7^'O\ H+VO_?='_"7^'O\ H+VO_?= &W16)_PE_A[_ *"]K_WW1_PE
M_A[_ *"]K_WW0!MT5B?\)?X>_P"@O:_]]T?\)?X>_P"@O:_]]T ;=%8G_"7^
M'O\ H+VO_?='_"7^'O\ H+VO_?= &W16)_PE_A[_ *"]K_WW1_PE_A[_ *"]
MK_WW0!MT5B?\)?X>_P"@O:_]]T?\)?X>_P"@O:_]]T ;=%8G_"7^'O\ H+VO
M_?='_"7^'O\ H+VO_?= &W16)_PE_A[_ *"]K_WW1_PE_A[_ *"]K_WW0!MT
M5B?\)?X>_P"@O:_]]T?\)?X>_P"@O:_]]T ;=%8G_"7^'O\ H+VO_?='_"7^
M'O\ H+VO_?= &W16)_PE_A[_ *"]K_WW1_PE_A[_ *"]K_WW0!MT5B?\)?X>
M_P"@O:_]]T?\)?X>_P"@O:_]]T ;=%8G_"7^'O\ H+VO_?='_"7^'O\ H+VO
M_?= &W16)_PE_A[_ *"]K_WW1_PE_A[_ *"]K_WW0!MT5B?\)?X>_P"@O:_]
M]T?\)?X>_P"@O:_]]T ;=%8G_"7^'O\ H+VO_?='_"7^'O\ H+VO_?= &W16
M)_PE_A[_ *"]K_WW1_PE_A[_ *"]K_WW0!MT5B?\)?X>_P"@O:_]]T?\)?X>
M_P"@O:_]]T ;=%8G_"7^'O\ H+VO_?='_"7^'O\ H+VO_?= &W16)_PE_A[_
M *"]K_WW1_PE_A[_ *"]K_WW0!MT5B?\)?X>_P"@O:_]]T?\)?X>_P"@O:_]
M]T ;=%8G_"7^'O\ H+VO_?='_"7^'O\ H+VO_?= &W16)_PE_A[_ *"]K_WW
M1_PE_A[_ *"]K_WW0!MT5B?\)?X>_P"@O:_]]T?\)?X>_P"@O:_]]T ;=%8G
M_"7^'O\ H+VO_?='_"7^'O\ H+VO_?= &W16)_PE_A[_ *"]K_WW1_PE_A[_
M *"]K_WW0!MT5B?\)?X>_P"@O:_]]T?\)?X>_P"@O:_]]T ;=%8G_"7^'O\
MH+VO_?='_"7^'O\ H+VO_?= &W16)_PE_A[_ *"]K_WW1_PE_A[_ *"]K_WW
M0!MT5B?\)?X>_P"@O:_]]T?\)?X>_P"@O:_]]T ;=%8G_"7^'O\ H+VO_?='
M_"7^'O\ H+VO_?= &W16)_PE_A[_ *"]K_WW1_PE_A[_ *"]K_WW0!MT5B?\
M)?X>_P"@O:_]]T?\)?X>_P"@O:_]]T ;=%8G_"7^'O\ H+VO_?='_"7^'O\
MH+VO_?= &W16)_PE_A[_ *"]K_WW1_PE_A[_ *"]K_WW0!MT5B?\)?X>_P"@
MO:_]]T?\)?X>_P"@O:_]]T ;=%8G_"7^'O\ H+VO_?='_"7^'O\ H+VO_?=
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M^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\
M?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\
MA5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_
M ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H
M1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#
MD?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?
M]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@
MG_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:Z
MZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\
MH 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\
MA5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_
M ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>
M"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\
M:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?
M]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?
M^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\
M?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\
MH 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB
M@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H
M1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>
M"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\
M:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@
MG_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/
M^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\
M?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\
MA5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_
M ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H
M1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#
MD?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?
M]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@
MG_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:Z
MZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\
MH 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\
MA5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_
M ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>
M"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\
M:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?
M]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?
M^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\
M?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\
MH 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB
M@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H
M1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>
M"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\
M:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@
MG_H 1?\ ?U_\:/\ A5W@G_H 1?\ ?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/
M^%7>"?\ H 1?]_7_ ,:ZZB@#D?\ A5W@G_H 1?\ ?U_\:/\ A5W@G_H 1?\
M?U_\:ZZB@#D?^%7>"?\ H 1?]_7_ ,:/^%7>"?\ H 1?]_7_ ,:ZZB@#D?\
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MNO[1<@!@@\O)]\UU)&"0: $HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH \\M?^2_3_P#7C_[**]2KRVU_Y+]/_P!>/_LHKU*D
M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.O\ A0!@?\+,\'?]!RU_[^#_ !H_X69X._Z#EK_W\'^-;_\ PAGAK_H!:?\
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M._Z#EK_W\'^-;_\ PAGAK_H!:?\ ^ Z_X4?\(9X:_P"@%I__ (#K_A0!@?\
M"S/!W_0<M?\ OX/\:/\ A9G@[_H.6O\ W\'^-;__  AGAK_H!:?_ . Z_P"%
M'_"&>&O^@%I__@.O^% &!_PLSP=_T'+7_OX/\:/^%F>#O^@Y:_\ ?P?XUO\
M_"&>&O\ H!:?_P" Z_X4?\(9X:_Z 6G_ /@.O^% &!_PLSP=_P!!RU_[^#_&
MC_A9G@[_ *#EK_W\'^-;_P#PAGAK_H!:?_X#K_A1_P (9X:_Z 6G_P#@.O\
MA0!@?\+,\'?]!RU_[^#_ !H/Q+\'CKKEJ/\ MH/\:W_^$-\-#_F!:?\ ^ Z_
MX5YW\)/#FBW^F:LUWI5G.RWK*IDA5L#)X'% '2_\+,\'?]!RU_[^#_&C_A9G
M@[_H.6O_ '\'^-;_ /PAGAK_ * 6G_\ @.O^%'_"&>&O^@%I_P#X#K_A0!@?
M\+,\'?\ 0<M?^_@_QH_X69X._P"@Y:_]_!_C6_\ \(9X:_Z 6G_^ Z_X4?\
M"&>&O^@%I_\ X#K_ (4 8'_"S/!W_0<M?^_@_P :/^%F>#O^@Y:_]_!_C6__
M ,(9X:_Z 6G_ /@.O^%'_"&>&O\ H!:?_P" Z_X4 8'_  LSP=_T'+7_ +^#
M_&C_ (69X._Z#EK_ -_!_C6__P (9X:_Z 6G_P#@.O\ A1_PAGAK_H!:?_X#
MK_A0!@?\+,\'?]!RU_[^#_&C_A9G@[_H.6O_ '\'^-;_ /PAGAK_ * 6G_\
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M_P :/^%F>#O^@Y:_]_!_C6__ ,(9X:_Z 6G_ /@.O^%'_"&>&O\ H!:?_P"
MZ_X4 8'_  LSP=_T'+7_ +^#_&C_ (69X._Z#EK_ -_!_C6__P (9X:_Z 6G
M_P#@.O\ A1_PAGAK_H!:?_X#K_A0!@?\+,\'?]!RU_[^#_&C_A9G@[_H.6O_
M '\'^-;_ /PAGAK_ * 6G_\ @.O^%'_"&>&O^@%I_P#X#K_A0!@?\+,\'?\
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M&>&O^@%I_P#X#K_A0!@?\+,\'?\ 0<M?^_@_QH_X69X._P"@Y:_]_!_C6_\
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M^_@_QH_X69X._P"@Y:_]_!_C6_\ \(9X:_Z 6G_^ Z_X4?\ "&^&O^@%I_\
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M  H P/\ A9G@[_H.6O\ W\'^-'_"S/!W_0<M?^_@_P :W_\ A#/#7_0"T_\
M\!U_PH_X0SPU_P! +3__  '7_"@# _X69X._Z#EK_P!_!_C1_P +,\'?]!RU
M_P"_@_QK?_X0SPU_T M/_P# =?\ "C_A#/#7_0"T_P#\!U_PH P/^%F>#O\
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MX0SPU_T M/\ _ =?\* ,#_A9G@[_ *#EK_W\'^-'_"S/!W_0<M?^_@_QK?\
M^$,\-?\ 0"T__P !U_PH_P"$,\-?] +3_P#P'7_"@# _X69X._Z#EK_W\'^-
M'_"S/!W_ $'+7_OX/\:W_P#A#/#7_0"T_P#\!U_PH_X0SPU_T M/_P# =?\
M"@# _P"%F>#O^@Y:_P#?P?XT?\+,\'?]!RU_[^#_ !K?_P"$,\-?] +3_P#P
M'7_"C_A#/#7_ $ M/_\  =?\* ,#_A9G@[_H.6O_ '\'^-'_  LSP=_T'+7_
M +^#_&M__A#/#7_0"T__ ,!U_P */^$,\-?] +3_ /P'7_"@# _X69X._P"@
MY:_]_!_C1_PLSP=_T'+7_OX/\:W_ /A#/#7_ $ M/_\  =?\*/\ A#/#7_0"
MT_\ \!U_PH P/^%F>#O^@Y:_]_!_C1_PLSP=_P!!RU_[^#_&M_\ X0SPU_T
MM/\ _ =?\*/^$,\-?] +3_\ P'7_  H P/\ A9G@[_H.6O\ W\'^-'_"S/!W
M_0<M?^_@_P :W_\ A#/#7_0"T_\ \!U_PH_X0SPU_P! +3__  '7_"@# _X6
M9X._Z#EK_P!_!_C1_P +,\'?]!RU_P"_@_QK?_X0SPU_T M/_P# =?\ "C_A
M#/#7_0"T_P#\!U_PH P/^%F>#O\ H.6O_?P?XT?\+,\'?]!RU_[^#_&M_P#X
M0SPU_P! +3__  '7_"C_ (0SPU_T M/_ / =?\* ,#_A9G@[_H.6O_?P?XT?
M\+,\'?\ 0<M?^_@_QK?_ .$,\-?] +3_ /P'7_"C_A#/#7_0"T__ ,!U_P *
M /.?#^NZ9KGQUEN=-NX[B)K(@,C YPHS7L5>3Z;IMCIOQ[EBLK2&WC%CD+$@
M4#*C/2O6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "N9^(7_(AZM_UQ_K735S/Q"_Y$/5O^N/\ 6@!GPW_Y)QH'_7FE
M=37+?#?_ ))QH'_7FE=30 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 =J\R^#'_(*UG_K^;^9KTWM7F7P8_Y!6L_]
M?S?S- 'IM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!YEX)_Y*OXQ_WO_9J]-KS+P3_R5?QC_O?^
MS5Z;0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 >91_\G 3?]> _] %>FUYE'_R<!-_UX#_T 5Z;0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S
M/Q"_Y$/5O^N/]:Z:N9^(7_(AZM_UQ_K0 SX;_P#).- _Z\TKJ:Y;X;_\DXT#
M_KS2NIH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH .U>9?!C_ )!6L_\ 7\W\S7IO:O,O@Q_R"M9_Z_F_F: /3:**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#S+P3_P E7\8_[W_LU>FUYEX)_P"2K^,?][_V:O3: "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#S*/\ Y. F_P"O ?\ H KTVO,H_P#DX";_ *\!_P"@"O3: "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M* "BBN.L?'4U]X[G\-KH-ZD$2%OM[@B-B . "/?U[4 =C1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-_,T >FT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% 'F7@G_DJ_C'_>_]FKTVO,O!/_)5_&/^]_[-
M7IM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!YE'_R<!-_UX#_T 5Z;7F4?_)P$W_7@/_0!7IM !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 1DXKM+"RATW3[>RM@1!!&(T![ # KEK[POK\^LZ-+9Z^UGIEC&$GM8@1YY
MQSVQ78T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7,_$+_ )$/5O\ KC_6NFKF?B%_R(>K?]<?ZT ,^&__
M "3C0/\ KS2NIKEOAO\ \DXT#_KS2NIH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH .U>9?!C_D%:S_U_-_,UZ;VK
MS+X,?\@K6?\ K^;^9H ]-HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** /,O!/_)5_&/\ O?\ LU>F
MUYEX)_Y*OXQ_WO\ V:O3: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC_A>O@W_ )^9/^^#_A0!Z;17F7_"]?!O_/S)_P!\'_"C_A>O@W_GYD_[X/\
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M\+U\&_\ /S)_WP?\* /3:*\R_P"%Z^#?^?F3_O@_X4?\+U\&_P#/S)_WP?\
M"@#TVBO,O^%Z^#?^?F3_ +X/^%'_  O7P;_S\R?]\'_"@#TVBN/\+_$K0/%V
MH/9:9,SS(NX@J1Q784 %%%% !1110 5S/Q"_Y$/5O^N/]:Z:N9^(7_(AZM_U
MQ_K0 SX;_P#).- _Z\TKJ:Y;X;_\DXT#_KS2NIH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH .U>9?!C_ )!6L_\
M7\W\S7IO:O,O@Q_R"M9_Z_F_F: /3:*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S+P3_P E7\8_
M[W_LU>FUYEX)_P"2K^,?][_V:O3: "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S*/\ Y. F_P"O ?\
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MVM[> -$)&7!7GG(..QKM-8^&9\$^-?#RR:9/K=A<.$DA#+^_EP244$CM@\T
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M_HGVI?FO_P 571_#?_DG&@?]>:5U- 'F?_"?^,_^B?:E^:__ !5'_"?^,_\
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M?S?S- "_\)_XS_Z)]J7YK_\ %4?\)_XS_P"B?:E^:_\ Q5>F44 >9_\ "?\
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M_HGVI?FO_P 51_PG_C/_ *)]J7YK_P#%5Z910!YG_P )_P",_P#HGVI?FO\
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M>F44 >9_\)_XS_Z)]J7YK_\ %4?\)_XS_P"B?:E^:_\ Q5>F44 >9_\ "?\
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M_P#&?_1/M2_-?_BJ],HH \S_ .$_\9_]$^U+\U_^*H_X3_QG_P!$^U+\U_\
MBJ],HH \S_X3_P 9_P#1/M2_-?\ XJC_ (3_ ,9_]$^U+\U_^*KTRB@#S/\
MX3_QG_T3[4OS7_XJC_A/_&?_ $3[4OS7_P"*KTRB@#S/_A/_ !G_ -$^U+\U
M_P#BJ/\ A/\ QG_T3[4OS7_XJO3** /,_P#A/_&?_1/M2_-?_BJ/^$_\9_\
M1/M2_-?_ (JO3** /,_^$_\ &?\ T3[4OS7_ .*H_P"$_P#&?_1/M2_-?_BJ
M],HH \S_ .$_\9_]$^U+\U_^*H_X3_QG_P!$^U+\U_\ BJ],HH \S_X3_P 9
M_P#1/M2_-?\ XJC_ (3_ ,9_]$^U+\U_^*KTRB@#S/\ X3_QG_T3[4OS7_XJ
MC_A/_&?_ $3[4OS7_P"*KTRB@#S/_A/_ !G_ -$^U+\U_P#BJ/\ A/\ QG_T
M3[4OS7_XJO3** /,_P#A/_&?_1/M2_-?_BJ/^$_\9_\ 1/M2_-?_ (JO3**
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M?_1/M2_-?_BJ],HH \6\+:OJ>K_'&2?4M&GTV8V1!BE(R %&.A[U[37F4?\
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M!_9JTL@8!NV('I\S\5XA6M+XGUJ;0(]"DU&9M+B;<EL<;5//M[FLF@ HHHH
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M%% !1110 4444 %%%% !1110 4444 ':O,O@Q_R"M9_Z_F_F:]-[5YE\&/\
MD%:S_P!?S?S- 'IM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!YEX)_Y*OXQ_P![_P!FKTVO,O!/
M_)5_&/\ O?\ LU>FT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% 'F4?_ "<!-_UX#_T 5Z;7F4?_ "<!
M-_UX#_T 5Z;0 4444 %-=0\;(>C BG4AX!H \BU#]GSP_J.HW-[)JNHJ\\AD
M*KLP"?3BJW_#-_AS_H+ZE_XY_A7HDVJW23.H?@-@4S^U[O\ OT >??\ #-_A
MS_H+ZE_XY_A1_P ,W^'/^@OJ7_CG^%>@_P!KW?\ ?H_M>[_OT >??\,W^'/^
M@OJ7_CG^%'_#-_AS_H+ZE_XY_A7H/]KW?]^C^U[O^_0!Y]_PS?X<_P"@OJ7_
M (Y_A1_PS?X<_P"@OJ7_ (Y_A7H/]KW?]^C^U[O^_0!Y]_PS?X<_Z"^I?^.?
MX4?\,W^'/^@OJ7_CG^%>@_VO=_WZ/[7N_P"_0!Y]_P ,W^'/^@OJ7_CG^%'_
M  S?X<_Z"^I?^.?X5Z#_ &O=_P!^C^U[O^_0!R_A?X):+X5UM-4M=2OI944J
M$DVXY^@K,N_V>/#UW>SW+ZMJ(::1I"!LP"3GTKT2PU&XGN@CME<5!)JMTLK@
M/P&(% 'GG_#-_AS_ *"^I?\ CG^%'_#-_AS_ *"^I?\ CG^%>@_VO=_WZ/[7
MN_[] 'GW_#-_AS_H+ZE_XY_A1_PS?X<_Z"^I?^.?X5Z#_:]W_?H_M>[_ +]
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M#'_(*UG_ *_F_F:]-[5YE\&/^05K/_7\W\S0!Z;1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117CWQ&\7^-[6*_FT
MFS.D:58S11_:[A<2W!8X.P'(*YH ]AHJCHL\EUH=A<3-OEEMXW=O4E02:O4
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M^&\_GR('34XVE+O_ +6,XYKVK3_A!9Q?#23PO=W)>>5_.:=1TDZC'L*YVS\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;4ZB@!OV.P_YYM1]CL/^>;4ZG;&QG'% $?V.P_YYM1]CL/\ GFU.I0I;H,T
M,^QV'_/-J/L=A_SS:GD$'!%)0 W['8?\\VH^QV'_ #S:G44 -^QV'_/-J/L=
MA_SS:G44 -^QV'_/-J/L=A_SS:G4H!/2@!GV.P_YYM1]CL/^>;4ZB@!OV.P_
MYYM1]CL/^>;4ZB@!OV.P_P">;4?8[#_GFU.HH ;]CL/^>;4?8[#_ )YM3J*
M&_8[#_GFU'V.P_YYM3J* &_8[#_GFU'V.P_YYM3J* &_8[#_ )YM1]CL/^>;
M4ZB@!OV.P_YYM1]CL/\ GFU.HH L6,%M%*3"A#8[UH50LO\ 6GZ5?H ****
M"BBB@ KF?B%_R(>K?]<?ZUTU<S\0O^1#U;_KC_6@!GPW_P"2<:!_UYI74URW
MPW_Y)QH'_7FE=30 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 =J\R^#'_ ""M9_Z_F_F:]-[5YE\&/^05K/\ U_-_
M,T >FT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% 'F7@G_DJ_C'_>_P#9J]-KS+P3_P E7\8_[W_L
MU>FT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'F4?\ R<!-_P!> _\ 0!7IM>91_P#)P$W_ %X#_P!
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M ,0ZOI+I/IT>C>5)=1-F.1P&R 1P2,BN7TP-:>$_ VLW"LVEV4S&Y(&1'E<
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M 32/_ P?X4?;_BW_ - 32/\ P,'^%>F44 >9_;_BW_T!-(_\#!_A1]O^+?\
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M 'F?V_XM_P#0$TC_ ,#!_A1]O^+?_0$TC_P,'^%>F44 >9_;_BW_ - 32/\
MP,'^%'V_XM_] 32/_ P?X5Z910!YG]O^+?\ T!-(_P# P?X4?;_BW_T!-(_\
M#!_A7IE% 'F?V_XM_P#0$TC_ ,#!_A1]O^+?_0$TC_P,'^%>F44 >9_;_BW_
M - 32/\ P,'^%'V_XM_] 32/_ P?X5Z910!YG]O^+?\ T!-(_P# P?X4?;_B
MW_T!-(_\#!_A7IE% 'F?V_XM_P#0$TC_ ,#!_A1]O^+?_0$TC_P,'^%>F44
M>9_;_BW_ - 32/\ P,'^%'V_XM_] 32/_ P?X5Z910!YG]O^+?\ T!-(_P#
MP?X4?;_BW_T!-(_\#!_A7IE% 'F?V_XM_P#0$TC_ ,#!_A1]O^+?_0$TC_P,
M'^%>F44 >9_;_BW_ - 32/\ P,'^%'V_XM_] 32/_ P?X5Z910!YG]O^+?\
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MYOYFO3>U>9?!C_D%:S_U_-_,T >FT444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'F7@G_ )*OXQ_W
MO_9J]-KS+P3_ ,E7\8_[W_LU>FT %%%% !1110 4444 %%%% !1110 4444
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M 6_[2N_^>OZ4?VE=_P#/7]*J5G:IKEAHTEJE[(R-=/LBVKG)_I0!N?VE=_\
M/7]*/[2N_P#GK^E5",&HI;FW@:-)IXHFD.(P[ %SZ#UH T/[2N_^>OZ4?VE=
M_P#/7]*J44 6_P"TKO\ YZ_I1_:5W_SU_2L35=;L=%^R_;7=?M,OE1;4W9;&
M>?2KY("[B0!C.30!<_M*[_YZ_I1_:5W_ ,]?TJA!<0740EMYHYHST>-@P/XB
MI* +?]I7?_/7]*/[2N_^>OZ54KGM0\:Z/IUVUJ?MEU(GW_L5NTP0^C%>A]J
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M\4V?QD6V\0:P]Q)<V33/;1$K#$00  N<?C7L] !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'F4?\ R<!-_P!> _\
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M>L7WAOX9V]R)([F2XE,5G"$V[6R>I[]S71QZOK^A>(=-LM;O(-0MM3Q'%)#
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M@P7Y['M7H$MM;W#1M/!'*T1W1EU!V'U'I7,Z5I6IZ9XTU*Z^QJ^GWOS?:/-
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M0 4444 %%%% !VKS+X,?\@K6?^OYOYFO3>U>9?!C_D%:S_U_-_,T >FT444
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MT 9=%:G]CK_S]K_WS1_8Z_\ /VO_ 'S0!ET5J?V.O_/VO_?-']CK_P _:_\
M?- &716I_8Z_\_:_]\T?V.O_ #]K_P!\T 9=%:G]CK_S]K_WS1_8Z_\ /VO_
M 'S0!ET5J?V.O_/VO_?-']CK_P _:_\ ?- &716I_8Z_\_:_]\T?V.O_ #]K
M_P!\T 9=%:G]CK_S]K_WS1_8Z_\ /VO_ 'S0!ET5J?V.O_/VO_?-']CK_P _
M:_\ ?- &716I_8Z_\_:_]\T?V.O_ #]K_P!\T )H?_'VWTKH:R].L!:SEQ.'
MR.@&*U* "BBB@ HHHH *YGXA?\B'JW_7'^M=-7,_$+_D0]6_ZX_UH 9\-_\
MDG&@?]>:5U-<M\-_^2<:!_UYI74T %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 ':O,O@Q_P @K6?^OYOYFO3>U>9?
M!C_D%:S_ -?S?S- 'IM%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!YEX)_Y*OXQ_WO\ V:O3:\R\
M$_\ )5_&/^]_[-7IM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!YE'_ ,G 3?\ 7@/_ $ 5Z;7F4?\
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M76?A6ULYYXUG%U,D2A957 8@;N>H&<T =#13'=1 \D;JZ["RLIR&XZCVKF_
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M-_,T >FT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_0[7PWHL&E6+2M;PLS*93EOF8L<GZFH--\+Z;IESJ\T8DF&JLK7,<QW*<#&
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M 'XD_P :],HH \S_ .$=^*?_ $-.D_\ ?B3_ !H_X1WXI_\ 0TZ3_P!^)/\
M&O3** /,_P#A'?BG_P!#3I/_ 'XD_P :/^$=^*?_ $-.D_\ ?B3_ !KTRB@#
MS/\ X1WXI_\ 0TZ3_P!^)/\ &C_A'?BG_P!#3I/_ 'XD_P :],HH \S_ .$=
M^*?_ $-.D_\ ?B3_ !H_X1WXI_\ 0TZ3_P!^)/\ &O3** /,_P#A'?BG_P!#
M3I/_ 'XD_P :/^$=^*?_ $-.D_\ ?B3_ !KTRB@#S/\ X1WXI_\ 0TZ3_P!^
M)/\ &C_A'?BG_P!#3I/_ 'XD_P :],HH \S_ .$=^*?_ $-.D_\ ?B3_ !H_
MX1WXI_\ 0TZ3_P!^)/\ &O3** /,_P#A'?BG_P!#3I/_ 'XD_P :/^$=^*?_
M $-.D_\ ?B3_ !KTRB@#S/\ X1WXI_\ 0TZ3_P!^)/\ &C_A'?BG_P!#3I/_
M 'XD_P :],HH \S_ .$=^*?_ $-.D_\ ?B3_ !H_X1WXI_\ 0TZ3_P!^)/\
M&O3** /,_P#A'?BG_P!#3I/_ 'XD_P :/^$=^*?_ $-.D_\ ?B3_ !KTRB@#
MS/\ X1WXI_\ 0TZ1_P!^)/\ &LK0_AW\0O#L,\6G>)M*5)Y/,?=#)]ZO8:*
M/,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_W
MXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I
M/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^
M$=^*?_0TZ3_WXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_Q
MH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I/_?B
M3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*
M?_0TZ3_WXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1
MWXI_]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I/_?B3_&O
M3** /,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*?_0T
MZ3_WXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1WXI_
M]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I/_?B3_&O3**
M/,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_W
MXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I
M/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^
M$=^*?_0TZ3_WXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_Q
MH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I/_?B
M3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*
M?_0TZ3_WXD_QH_X1WXI_]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1
MWXI_]#3I/_?B3_&O3** /,_^$=^*?_0TZ3_WXD_QH_X1WXI_]#3I'_?B3_&O
M3** /'K#X=_$+3-8OM5MO$VE"ZO?]<3#)@\YXK5_X1WXI_\ 0TZ3_P!^)/\
M&O3** /,_P#A'?BG_P!#3I/_ 'XD_P :/^$=^*?_ $-.D_\ ?B3_ !KTRB@#
MS/\ X1WXI_\ 0TZ3_P!^)/\ &C_A'?BG_P!#3I/_ 'XD_P :],HH \S_ .$=
M^*?_ $-.D_\ ?B3_ !H_X1WXI_\ 0TZ3_P!^)/\ &O3** /,_P#A'?BG_P!#
M3I/_ 'XD_P :/^$=^*?_ $-.D_\ ?B3_ !KTRB@#S/\ X1WXI_\ 0TZ3_P!^
M)/\ &C_A'?BG_P!#3I/_ 'XD_P :],HH \S_ .$=^*?_ $-.D_\ ?B3_ !H_
MX1WXI_\ 0TZ3_P!^)/\ &O3** /,_P#A'?BG_P!#3I/_ 'XD_P :/^$=^*?_
M $-.D_\ ?B3_ !KTRB@#S/\ X1WXI_\ 0TZ3_P!^)/\ &C_A'?BG_P!#3I/_
M 'XD_P :],HH \S_ .$=^*?_ $-.D_\ ?B3_ !H_X1WXI_\ 0TZ3_P!^)/\
M&O3** /,_P#A'?BG_P!#3I/_ 'XD_P :/^$=^*?_ $-.D_\ ?B3_ !KTRB@#
MS/\ X1WXI_\ 0TZ3_P!^)/\ &C_A'?BG_P!#3I/_ 'XD_P :],HH \S_ .$=
M^*?_ $-.D_\ ?B3_ !H_X1WXI_\ 0TZ3_P!^)/\ &O3** /,_P#A'?BG_P!#
M3I/_ 'XD_P :/^$=^*?_ $-.D_\ ?B3_ !KTRB@#S/\ X1WXI_\ 0TZ3_P!^
M)/\ &C_A'?BG_P!#3I/_ 'XD_P :],HH \S_ .$=^*?_ $-.D_\ ?B3_ !H_
MX1WXI_\ 0TZ3_P!^)/\ &O3** /,_P#A'?BG_P!#3I/_ 'XD_P :/^$=^*?_
M $-.D_\ ?B3_ !KTRB@#S/\ X1WXI_\ 0TZ3_P!^)/\ &C_A'?BG_P!#3I/_
M 'XD_P :],HH \S_ .$=^*?_ $-.D_\ ?B3_ !H_X1WXI_\ 0TZ3_P!^)/\
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M8O[@H RZ*U/)B_N"CR8O[@H RZ*U/)B_N"CR8O[@H RZ*U/)B_N"CR8O[@H
MRZ*U/)B_N"CR8O[@H RZ*U/)B_N"CR8O[@H RZ*U/)B_N"CR8O[@H RZ*U/)
MB_N"CR8O[@H RZ*U/)B_N"CR8O[@H RZ*U/)B_N"CR8O[@H RZ*U/)B_N"CR
M8O[@H RZ*U/)B_N"CR8O[@H RZ*U/)B_N"CR8O[@H RZ*U/)B_N"CR8O[@H
MRZ*U/)B_N"CR8O[@H RZ*U/)B_N"CR8O[@H J67^M/TJ_35C1#E5 -.H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
,* "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img38651418_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img38651418_8.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &@ F # 2(  A$! Q$!_\0
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M<B/'<W-Z)7VJ<JGS*0$SV 'UH Y+Q?I5GK?[2V@Z?J$"3VDEB&DB<95]BS.
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MG#."/D&.>W8XS6[X@^*UK8>#=$UC2;)KV\UQA'8VCMM^?.&W'_9;Y>.I(^M
M'HM,,L8F6$R()64LJ;AN*C ) ]!D?F*X'2_$OCJP\3V.E^*/#UK-:7R_+?:-
M',\=LWI+NSCGOP.<\X->>^'9_&DW[0&NK'+HSZG':[+D3-,8%M]T)(B_B#<K
MUXR6H ^@Z*\O/CWQ7XF\1ZQI_@G3-*DM='?RI[C4G<>>^2-L87&.5.">.,\9
MJ;3_ (O65Q\-+[Q5<V1CNK&3[//9!^LV0% ;'0[@<XXYZXH [K6];T[PYH\^
MK:M<?9[&#;YDNQGV[F"CA02>2!P*FTW4;75]-MM1L9?-M+F,2Q2;2NY2,@X(
M!'XUX;X[\0>.-6^#]W?ZYI&E1:7J2P/$;25Q-;J94=&D5L@@@ <$$;AD=:]5
M^''_ "3;PY_V#X?_ $$4 =/17 :?XZOT^*.M^%=9BM(;2VM?M=G/&C*SQ@ G
M=EB"0">@'W37/?#WXRW'B>3Q VLVUI;0Z?:-?0>0K*S1*3NW;F.3]SD8Y)H
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M^>.1TYS0!Z-=W4-C9SW=P^R""-I9&P3M51DG Y/ KA?^%V_#S_H8?_)*X_\
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MH WZ*YW_ (2+6/\ H2M:_P# BR_^2*/^$BUC_H2M:_\  BR_^2* .BHKG?\
MA(M8_P"A*UK_ ,"++_Y(H_X2+6/^A*UK_P "++_Y(H Z*BN=_P"$BUC_ *$K
M6O\ P(LO_DBC_A(M8_Z$K6O_  (LO_DB@#HJ*YW_ (2+6/\ H2M:_P# BR_^
M2*/^$BUC_H2M:_\  BR_^2* .BHKG?\ A(M8_P"A*UK_ ,"++_Y(H_X2+6/^
MA*UK_P "++_Y(H Z*FR1K+$\;?==2IQZ&N?_ .$BUC_H2M:_\"++_P"2*/\
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M\HQ;H]XDQ&SJ5;#H2< \,*[;P-\--&\ 37LNE7-_,UXJ+)]JD1@-N<8VJO\
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MH *P-5_Y&_P__N7/_H*5OU@:K_R-_A__ '+G_P!!2@#?HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#G?#O_(P^+O\ L*1?^D=M715SOAW_ )&'Q=_V
M%(O_ $CMJZ*@ KG;'_DHNN_]@NP_]&7==%7.V/\ R477?^P78?\ HR[H Z*B
MBB@ HHHH **** "BBB@ HHHH *P-5_Y&_P /_P"Y<_\ H*5OU@:K_P C?X?_
M -RY_P#04H WZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML/&]A9/;Z+!*X9&CMK,^<$\L.K[SV.>OM7NU6]D2MPHHHJ1A6!JO_(W^'_\
M<N?_ $%*WZP-5_Y&_P /_P"Y<_\ H*4 ;]%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 45R/CF::%+'RI9(\E\[&*Y^[Z5QW
MVV[_ .?NX_[^M_C7'5Q:IS<;'+5Q2IR<;'K]%>0?;;O_ )^[C_OZW^-'VV[_
M .?NX_[^M_C6?U]?RF?UU=CU^BO(/MMW_P _=Q_W];_&C[;=_P#/W<?]_6_Q
MH^OK^4/KJ[&QXN\9:#IGQ!\/076H(CV;3?:?E)$7F( NXCIS^5>C*RNH92"I
M&01T(KY?\1>%3?>*(91=D?V@[,Y<;BI4 GGOFN^MY[BVMHH([JX"1($4>:W0
M# [UI/&0BDTKW-)XN,4FM;GL=%>0?;;O_G[N/^_K?XT?;;O_ )^[C_OZW^-9
M_7U_*9_75V/7Z*\@^VW?_/W<?]_6_P :/MMW_P _=Q_W];_&CZ^OY0^NKL>O
MT5YIX;NKF3Q%9(]S,REFRK2$@_*?>O2ZZJ%;VL;VL=%&K[6-[!1116QL%%%%
M '#:S_R&+K_>'\A5&KVL_P#(8NO]X?R%4:^-Q'\:?J_S/IJ/\./H@HHHK(T"
MBBB@ HHHH **** "BBB@#I?"O^KNOJO]:Z*N=\*_ZNZ^J_UKHJ^JR[_=H_/\
MV?/XW^/+^N@4445VG*%%%% !1110!SOAW_D8?%W_ &%(O_2.VKHJYWP[_P C
M#XN_["D7_I';5T5 !7.V/_)1==_[!=A_Z,NZZ*N=L?\ DHNN_P#8+L/_ $9=
MT =%1110 5B^+;6:\\*:E!;W,=M*T)VSRRF-8\<[BPY&*VJY[QS9'4?!6J6:
MM"K31;5,TOEH#D8RW89J9;,J/Q(YCX<ZIJ5[>20-JOA>\M8H\2_V8&$S/T#-
MD 'ZUW.N3W-KH.H7%GL^TQ6\CQ>9C;N"DC.>V:\ML]*\9:?XHL+V#1/#%M=1
MVIA6""Z*>8F1ER ,G&/UKT;Q'J=C8Z'<1ZA)9>;/;N$MKF=8UG.WE<DC@YQ^
M-5/X28?$<7X:UGQ/JGB:PU2YTU(=.N@;;8]HHE4*F3(7'(!;( SBO3Z\/\/:
M!JL=R]UH7BC1]-O&7=!HUE=^?"Q'.ULD\?05[5:&X:TA-TB)<%!YBH<J&QS@
M^F:I["ZDU%%%2,*P-5_Y&_P__N7/_H*5OU@:K_R-_A__ '+G_P!!2@#?HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .-\>_<
ML/K)_P"RUQ==IX]^Y8?63_V6N+KQL7_&?]=#R<5_%84445S'.(Q(0E5W,!P,
MXS5'[7J/_0,_\CK5^BFG;H-.W0P[I=3N-1L;D:> ML7)!G7G< *N_:]1_P"@
M9_Y'6K]%4YWZ%.=^A%;R321[IX/)?/W=X;]14M%%20%%%%(#6\,_\C)9?[S?
M^@FO4*\O\,_\C)9?[S?^@FO4*]7 _P -^IZ6"^!^H4445VG8%%%% '#:S_R&
M+K_>'\A5&KVL_P#(8NO]X?R%4:^-Q'\:?J_S/IJ/\./H@HHHK(T"BBB@ HHH
MH **** "BBB@#I?"O^KNOJO]:Z*N=\*_ZNZ^J_UKHJ^JR[_=H_/\V?/XW^/+
M^N@4445VG*%%%% !1110!SOAW_D8?%W_ &%(O_2.VKHJYWP[_P C#XN_["D7
M_I';5T5 !7.V/_)1==_[!=A_Z,NZZ*N=L?\ DHNN_P#8+L/_ $9=T =%1110
M 5C>+(&N?"NHPI'9N7A(Q>G$('<O[#K^%;-9?B/1QX@\/7NEF7ROM$>T/C.#
MG(R.XR.12DKICCNCSSX<Z#;:5K\=W:ZUINM0W%NR"X#'SHBN,K&"QS'R.>O2
MNG\<:AX/L39?\)581W6_?Y&^S,^WINZ X[5F^"_ VKZ+KC:CJ]Y9NL7FB"&T
MB**#(06)]!\HP.U;WB\>(([1;O1M6L-.@MT>2Z:[MS+E0,Y&#QC!IR>B%%:L
MYSPOK'PXNO$%O#H.E0P:BP;RY%TUHB..?F*C'%>CUY3X,\7>(-4UNU74=9MG
MM99FA$/]FM"[L$W Y)X&.?>O5J;V%U$+J&"E@">@)ZTGF1^9Y>]=^,[<\X^E
M<UXBMH/^$E\.710>?]J9 Y)X78QQ7.6WDG5[3!3_ (2#^W)/._YZ^1\V<]_+
MV;<=NG>DM?Z]/\QO17_KK_D>E5@:K_R-_A__ '+G_P!!2M+4K6]NH42RU V3
MALEQ$LF1Z8-<W)8ZE:^,]":]U<WBE+G"FW6/'RKW% '8T444 %%%% !1110
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M?^D=M714 %<[8_\ )1==_P"P78?^C+NNBKG;'_DHNN_]@NP_]&7= '14444
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MW_WPO_Q5>>45T?4*)R_VGB/+[CT(^.M+P<178/\ N+_\56$WC.]W'&JVX&>
M=.Z?^1JYJJ9TG32<G3K0D_\ 3!?\*EX&ET_,J.9UNK_ P_'OC_Q4FO1QVVKR
MPVT:*T36R>2)#W)&YL\\8S_.N_TCQQK$^CVDM[J-O%<M&#(AL-Q!^OFC^0KG
M/[(TS_H'6?\ WX7_  H_LC3/^@=9_P#?A?\ "H6 2;;V-99K)Q26C]#T'3?&
M\21O]OG:Y;/RF"V$8 ]\R-FKW_"=:7_SQN_^^%_^*KS>"UM[4$6]O%"&Y(C0
M+G\JEK18&EU,7F=>^C_ ]#_X3K2_^>-W_P!\+_\ %4?\)UI?_/&[_P"^%_\
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MC?'OW+#ZR?\ LM<77:>/?N6'UD_]EKBZ\;%_QG_70\G%?Q6%%%%<QSA1110
M4444 %%%% !1110!K>&?^1DLO]YO_037J%>7^&?^1DLO]YO_ $$UZA7JX'^&
M_4]+!? _4****[3L"BBB@#AM9_Y#%U_O#^0JC5[6?^0Q=?[P_D*HU\;B/XT_
M5_F?34?X<?1!11161H%%%% !1110 4444 %%%% '2^%?]7=?5?ZUT5<[X5_U
M=U]5_K715]5EW^[1^?YL^?QO\>7]= HHHKM.4**** "BBB@#G?#O_(P^+O\
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M$_\ T+C?^!D7^-'V#Q/_ -"XW_@9%_C1]0Q/\@?6Z/\ ,.HIOV#Q/_T+C?\
M@9%_C1]@\3_]"XW_ (&1?XT?4,3_ "!];H_S#J*;]@\3_P#0N-_X&1?XT?8/
M$_\ T+C?^!D7^-'U#$_R!];H_P PZBF_8/$__0N-_P"!D7^-'V#Q/_T+C?\
M@9%_C1]0Q/\ ('UNC_,=/X5_U=U]5_K715QFC3>(M-682>&9&WD$;;R'MGWK
M3_MG7O\ H5I__ V'_P"*KZ+!0E3H1C)6?_!/&Q4XSK.4=CH**Y_^V=>_Z%:?
M_P #8?\ XJC^V=>_Z%:?_P #8?\ XJNHYSH**QM&UJXU*^OK*[TV2QGM%C8J
M\J2;@^[&"I/]VMF@ HHHH YWP[_R,/B[_L*1?^D=M715SOAW_D8?%W_84B_]
M([:NBH *YFR_Y*9K7_8)L?\ T;<UTU<S9?\ )3-:_P"P38_^C;F@&=-1110
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M7D]CX.U*XU'Q7>BRG@U P*FF3R,4 9HMK%><9[9[5!X1\-ZK'KNG2Z;I5WH
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MUK_P'LO_ )'H_P"$=UC_ *'76O\ P'LO_D>@#HJ*YW_A'=8_Z'76O_ >R_\
MD>C_ (1W6/\ H==:_P# >R_^1Z .BHKG?^$=UC_H==:_\![+_P"1Z/\ A'=8
M_P"AUUK_ ,![+_Y'H Z*BN=_X1W6/^AUUK_P'LO_ )'H_P"$=UC_ *'76O\
MP'LO_D>@#HJ*YW_A'=8_Z'76O_ >R_\ D>C_ (1W6/\ H==:_P# >R_^1Z .
MBHKG?^$=UC_H==:_\![+_P"1Z/\ A'=8_P"AUUK_ ,![+_Y'H Z*BN=_X1W6
M/^AUUK_P'LO_ )'H_P"$=UC_ *'76O\ P'LO_D>@#HJ*YW_A'=8_Z'76O_ >
MR_\ D>C_ (1W6/\ H==:_P# >R_^1Z .BHKG?^$=UC_H==:_\![+_P"1Z/\
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M *'76O\ P'LO_D>@#HJ*YW_A'=8_Z'76O_ >R_\ D>C_ (1W6/\ H==:_P#
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M$:1@ 1JJ@;8U[5K4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUCY&_=T8_P 76@#U>BO,=0\:>,KKQVGAGP[9Z*S/I4=^9;X2A8R2 V=AR1R
M !G)!SQ3)_''C/5=2UU?"^FZ/+8Z Y@NGO6D62ZF0$R+$%.%P00-V>QSS@ '
MJ-%>5W_Q1U:\@\$3>&],LY&\2>>CPWCM^Y>,JIPZ_P *L6).TDA> ":N>'_'
M?B'[9XKTKQ%IVFMJ>@P+< V,YB@E5DW@%I3\HQ@EB0 ">..0#TBBO(/!?Q4U
MK6/'=GX<U1_#]T+J!V+Z0TI^SR*F_:SL2C\ CY"1G^+CG5^!?_)-T_Z_9_\
MT*@#TJBO-]3\8>,-4\5:WHW@S3M(<:(B?:7U)WS-(ZEE6,*0!T(^8X]Q5+QU
M\5;_ ,,/H^GBTL-+U2\MOM5T=4:2:&V'(V#R 2Y+!OF'& ..> #U6BO!/$7C
M;_A.OAQHM_)%%'=6_B6WMI_)W>6[!6.]-WS!2"" >1TKH;'4)-)^+'Q,U&&T
MDO);6PM9DMXSAI2L"D*.#UQCH?H: /6J*\E^'7Q/UOQ5K-I:W[>'I[>ZC;(L
M)FAGMI%7=AXIFW2#'&8PP!SS@&O6J "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ K$\8>'O^$K\*:AH?VK[+]K0+YWE[]F&#?=R,
M]/6MNB@#D=2\#_VC=>$I_P"T?+_X1]PV/(S]HPJK_>^7[OOUK$OOA7>&\U9-
M%\676E:/K$IEU#3TM4DWLQ/F>6Y(,88'' /XC 'I-% '&Q?#ZTM/$WAK5+&Z
M,%KH5I):QVACW&0,I7)?=P><]#FI=+\!V=IK'B>\OW@U*UUV:*5[.>V!2/R\
MX!R2'Y(/08Q76T4 <??_  _L)O$/AO4M-^S:9;Z)+/+]DMK1528RJH/W2 I&
MWK@YJ&Y^'%IJ&O>*[Z_O7EMO$-O# ]ND>UH/+0*&#Y.3D!AE>#ZUVU% '$>%
MO ^M:)J%K/JOC._U6WLH/(M;18A;Q 8VYD"L?-('0MR#S7-S_!>_;1-1\/VW
MC.Y@T&ZF,\5C]A1O+;>K#<Y;<P&.@V\X/KGUNB@#DK/P1]D\<6GB3^T-_P!G
MTE=,^S^3C=AL[]V[CZ8_&LO5_AM?R:YJFI>&_%=SH:ZN/]/@6U2=9&QC<A)!
M0X)Y'.3D$5Z#10!PR_#*QM)?"*Z;>/;VOAR2618Y(_,:X+XR6;(P<@GH1SP!
M3K_X<PZEKGBF_GU*01:_91VC11Q8:':H&X-D[LXSC KMZ* /--%^%>H:;K'A
M[4KWQ6]\VAAHK>'^STAC$)3;L 5LANI+$G/''&3TW@GPG_PAVD7-A]M^V>?>
M2W6_RO+V[\?+C)Z8ZUTM% '":[\/]0N?$MWKWAOQ/-H-W?PB&^"VJW"S;0 K
M ,1L8 8R/PQSENI_#>:XBT.YTSQ-J%IK>D(\<>IW(%V\ROG<) Y^;DG'. #C
M'3'>T4 <!?\ PVN=2\)6^CWOB:]N[M-02_FO;I#)O9<_(B;@(U] #@5HKX&'
M_"6>(M;.JW$8UFUCMMEL#%);[5"[UD#=>,C@8]ZZZB@#SC3?A??KXHTK6M>\
M5S:Q_9*E;-6LDBE']WS)@2T@')YZDYSR0?1Z** "J.LZ=_:^A:AIGF^5]LMI
M+?S-N[9O4KG&1G&>F:O44 <'>?#;[7X&\/\ AK^UMG]D7,-Q]H^S9\WR]W&W
M=\N=W7)Z5%JWPWU"7Q!J>I>'_%MYH<6K;#J$$-NLAD9>-T;D@QDC/(R<G/M7
MH-% '"^(OA[<ZGJ&B:GHWB.ZTO5-)@:W2[FB%VTJ$8.\.1ENO)SG/3IC*_X5
M!(WASQ3I4WB26>77YX9WNI;4%HV1PYR P#9/IMQ7I]% '*^*?!$'B;1-/M/M
MTUE?Z:Z365]"H+12J, [3U'0D9'0<UGZ3\.YX+O5=5USQ!-K&MWUFUBMXULL
M*00D?=6)3C.>2<\^V23W5% 'G]S\,?M'PVTSPA_:^W[#,DOVO[-G?M=FQLW\
M?>QU/2J^L_"NXU'Q#KFH6?B>>PM-<B$5_;+9QR.X"E0%D;E5Z9 '/3/3'I%%
M '":5\.6T[5O"E^^KB8Z!926>P6VWSPRE0V=YVX!Z<YQVK;\9>$[;QEH!TV>
MXEM9HY%N+6ZB^]!,N=K@=^IR.,@GD'D=!10!P]EX"U"XAU2/Q5XKO]<%_:FT
M\M8Q;0Q(>K")25WYZ-BF^&/ >L:'?V3ZAXSU#4;#3XC%9V*Q"W0+C \S:Q\W
M QC=T(_"NZHH \U_X5-_Q2']@_VW_P QC^U//^R_^0]N_P#\>S^%7O%G@#5_
M$%W?-8>+[JQLM0B$=U87-JMY <# ,:N1Y?J=O?GC%=Y10!F>'=#MO#7AZRT:
MS>1X+2/RU>4Y9N<DG\2:TZ** .9UGPC_ &MXU\/^(OMWE?V0)A]G\K=YOF+M
M^]N&W'T.:R[CX9V=_?\ B^74+UYK;Q&L :%(MC6YB'!#$G<<X/0=.]=U10!Q
M?A;P9K>C:C%=ZSXROM82VMQ;VUL(A;Q*.FYU5CYC8QAFY^O&.6F^"E^WA^]\
M.6_C2YAT&68S6]B;%&\IMX8;GW;G  / *C.&[8/KM% '*:?X+^P^/#XG_M#?
MG2ETW[-Y..C*V_=N_P!GICOUK%U/X8WS:OJ]UX?\5W6BVFLDOJ-HMJDPD8Y#
M,C$@QD@G)&3DYST ]%HH X@_#>R@OO![Z?=M;6OAKSMD+Q[VG\P+DELC:<@D
M\')/05%J?PTBU75?%UY/JDBQ^(;:& QQPX-N8U4 [MWS9*@XP/3WKO** /.-
M#^&&H:9XBT'6;WQ4]_)H\4EM'!]@2&/R"FU44(?E(RQ+'=GY1QCGHO OA+_A
M"O#:Z1]M^V8FDE\WRO+^\<XQD]/K72T4 <#K7P\U&;Q#J&L>&O%4^@3:I&J7
MZ+:K.)2HPK+D@H0">1SSD8IVK?#B>>;1M0T?Q-?V&M:7"UN-1N4%V\\3 Y$@
M<C<<DD'H,GCICO** ."O_AO/J/A73=(NO$E[=7-KJ,>H37MVIE:5ESE54L-B
M\\ $X]\YJ\G@4#Q1XGUDZM<QC7;>*#;:@PRVVQ FY) 3SQD<#'O77T4 ><Z5
M\,+^/Q7I>NZ_XJEUF32HC'9@V4<,GH/,E!+2 #)^;G))SRP/HU%% !1110 4
..444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img38651418_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img38651418_9.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (" R4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:!;(6&Y 6&1D5G_$/P1X_P##WAI;WQ+XH_M*P-PB"#^T)YOG(.#M=0.QY]Z
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M:G!!(PMTN$:5652>4SGC'I7'?!+Q9K?B[PSJ%YKM[]KGBO/*1_*2/"[%.,(
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MCY'!('&X;3P*[C1_!=Z? ]WX?\4ZY<:T]XC)),^!Y8(X"D\D@\Y;//:NRHH
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M-JC!WJIYP>GYUCWWPW^*FL:8VA:KXTL)]&?:)-REI64$$9/EACR.[]J]NHH
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MBMT$:$F8H3@< X//KB@#V;Q'XS\.^$DC;7-5ALS)RB$,[L/4*H+8]\5-X?\
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M7!W<$G@'N:[GP5K.E:5\.(-2O/%KZM8QO)NU:]5XF?YSQB0EN#\H'?'%>4^
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MWPZT*ZN[B6XN);56DEF<N[G)Y)/)->>?%SP-X2T;X5O=:;IMG:W%JT(MIXD
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MS SE<=AN56QVS4'PETC3O&/CWQ?J7B>S@O[^&9=D-TH=5W.X;Y#P=NU%''%
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M>;N5<#=G>O?(QCM7J_P[^#4?@/Q')K#ZW_:#&W:%(_LGE;"Q4[L[V[ C&.]
M'/>,_B!XK\3^-9O!O@$&,VS%;F[3 8E>'.X\(BDXSU)''4 X6I?\+6^%<MGJ
M^HZTVL6,LPCDA-U)<(2>=A#@%2<'!7_ZQT?V>+NTBU;Q);WTD::S,\9VR, [
M@%]X'KAB,X]17IGB#XH>'/#OB&TT*9[B[O[DA?+LT$GEL2 JMR,$YX ST[<9
M .8^,WC"YLOAGIM]H]W<V4VJ30M')%(T4BQE"YY!!'\(/UKC)/ /Q<M]$.KO
MXVE$<=O]I:)M7N=X 7<005VYQ[X]ZN?'L7'B'QQX7\*V3K]HD4E0Q(4-*X0%
ML9X&PGO@4U_@Q\2-53[)K7C9);%OOHU]<3C_ +X8 '\Z -?PEX^\8:Q\&KZ^
MLK2;4]>M[LV4,JQAB5*JV\@=2H8C_ODG/-<QKC_$/X?Z#HWB^^\6WD]Q>S*)
MM+NBY6/<I?:RL<=!@@!2I/'K7L-I!H'PC^'X269ELK0%GD(S)<2MZ#^\3P!V
M ]!FO*M"TG6_C?XL3Q#KJ-;>%[*0B"VR<28/W%]<X&Y_P'L >_:==_;],M+W
MRVC^T0I+L;JNY0<'\ZPO$7Q#\*>%+M;36M9BMKD@-Y2H\C@'H2$!(_&NE50J
MA5 "@8 '05XU8^(K2Y^(.O+X"\'K?ZMO,>HZI>WS+&#N(. Q;Y<CHN,A>F *
M /4=!\2:/XGL#>Z+J$5Y;AMK,F05/HRG!!^HKQCX0>(=:U/P+XUN+_6-0NY[
M>WW023W+R-$?*D.5).1R >/2E_9\$L?B;QA'*L:.'C#I#P@8/)PH]!SCVK,^
M"?\ R3SQ[_U['_T5)0!W'P&UJ_U/P!J%[K&IW-V\6HR+Y]Y.TA1!%$<;F)P!
MDGTY-=)!\5_ MQJ8TZ/Q':FX+;02KK&3_P!="NS]:\(T>\NK3]FO6Q;%E$^N
M"&9E.,(8XB?P) 'XUJ1^#]6UWX9V%AIGPOMA-+;Q30ZTNJV_FR,<,7(.&PP)
M^0GY<^HH ]!^/FKZCH_@2QN=*U"ZL9GU*-#+:S-$Q4Q2G&5(.,@''L*["R\0
MV&C>!=*U77-2CMXFLH"\]P_+N4!^K,>3W)KQ_P")]KJ]C\ ?#-GKT+0ZE;W\
M<,J-(LA 6.<+\RD@_*%/6LWXC275[K7PZTEK%K^S.FVLB69N!"MQ(Q"E-YX7
M(51G_:H ]Q\._$'PKXKN6MM%UF&YN%!;R2CQN0.I"N 3^%.\1>//"_A.9(=;
MUB&UF==PB"M(^/7:@) _"O'M6\&^+;SQ7H>MZ'\.8/#LEA*K3?9=3MV690P(
M^52H'&X'@Y#<]*V/&'@'7[3XDWGBZQ\/Z=XHLKN-5>QO&7=$0JKD!N#]W@\\
M$\=Z /3_  [XS\.^+%D.AZK#>-&,O& 4=1ZE6 ;'OBMVO(/AUKWA1?&=QI(\
M&'PQXFE1B8F&X,N Q53QM&!NP !@5Z_0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %,F5WAD6)Q'(5(5RN[:<<''>GT4 >(6/P"UC3+J:ZT_P"(=]:7
M$^?-EM[5XVDYS\Q68$\\UW_@7P?K'A3[?_:WBV^U_P"T^7Y?VL/^XV[LXW2/
M][<.F/NCK7844 >;7GP?L+OXH1^,C?[8UF6X>P^SY#2JN V_=Q\P#8V]<^M=
MKXB\/Z?XIT*YT?4XB]K<+@[3AE(.0RGL0<&M2B@#QRT^ <7G6]OJOBS4M0T6
MV??#IS HJ^V=Y ST.U0?<5TWCCX:)XQU70;R/4Q8)I#96%;;S XW*0 =PV_=
MQT/6N]HH *XCX:_#S_A7FFWUG_:G]H?:IA+O^S^5MP,8QN;-=O10!Q_Q'\"_
M\+ \/6^D_P!H_8/)NUN?-\CS<X1UVXW+_?SG/:NIL;;['86UKOW^3$L>[&,X
M &<?A4]% &!XP\*6_C'0GTNXO;RS!8.LMK*5(/N.C#GH?T->=?\ "B;R]\FU
MUKQYJ^H:7$P*V;*P  Z %I& XXR%KV2B@#C_ !=\.=(\5^$;7P\2]E#9;/L<
MD0SY.U=H&#]X8X(S^-<'>?L^OJ&DP6U[XSO[JZ@8+!+/"7CBB .8TC,G&3M.
M=W\/3FO;** //?&WPLA\:Q>'(;C5#!!I"LDB"#<;A3Y8(SN&SB/WZ^U8"_ 6
M*YU&U_M;Q9JFI:1:']Q83Y^1?[N_<0!Q@[5'X5[#10!P7Q'^&:>/['3+6/4Q
MIB6#.5"VWFA@0H  W+C&VG>-/AQ_PE_BG0M:_M7[)_93J_D_9_,\W#A_O;AM
MZ8Z&N[HH X36/AQ_:WQ-TSQE_:OE?841/LGV?=OV[OX]PQ][T/2CQ7\-_P#A
M)_'.@^)?[6^S?V2\3?9_L^_S=DOF?>W#;GIT-=W10!YWXT^$UIXGUY/$&FZO
M=:'K0 #75L,[\# ) *D-CC((XJQX(^&O_")WUUJ-YXAU/5[^Y4K))-(R(<]6
MV[B2WN2<=J[RB@#R.\^"E^FH7-QH?C[6]-AN&+21%GD)]BPD4D#ISDUUW@+X
M>Z9X!L+B*SFFN;JZ8-<W4V-SD9P !T R?4\GFNNHH J:IIEGK.EW.FW\(FM+
MF,QRQGC(/OV/O7D]K\!$MVDLCXPU5M!=]YTU<JK'_:(;:?\ OD'Z5['10!YQ
MH/PI_L3X;:QX0_MKSO[2E>3[7]EV^7N5%QLWG/W/4=:6'X2VX^'%OX1N-;O/
M]'E>5;NV!AW%F)PR;B&'/0G\J]&HH \<'P*NKZ2"'7_'6K:KIL+ADM'# #'H
M6D8#CC@5T7COX70^,E\/QVVI#3(-&#+'$MMYH93Y>%'S#&!'COUKT&B@"AK>
MCVNOZ)>:3>JQMKN)HGVG! /<>XZCZ5Y+#^S\$L+G3I?&.HR:<VYH+01E8HY"
M.'9=^&(Z\!<XKVFB@#R7Q+X4_P"$*_9]U;0_MOVSR$+>=Y7E[MTP;[N3Z^M<
MAX&^$S^*_ASI=[;>*-1TRWOO--]9IEXIRLSJ#MW  [5 Y!Z5]!7EE:ZA:26E
M[;0W-M(,/#-&'1AUY4\&DL;"STRSCL["T@M+6/.R&",1HN22<*.!DDG\: .<
M3X?:-#\/I?!MN)8K"2(HT@(,A8G=O)Z$[N?3MTK \)_"1=!TK4M(U77[G6=)
MO(# ME(ACCA!;=E1O8!L\Y&.>:]*HH \87X"7$2?88/'6K1Z+YF\6 4XZYSD
M.%SGG.SK7>ZWX T?7O!D7AF]:YDMX5'DW$DI>9'&</N/4\GVP<5U5% 'B[?
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MC_R477?^P78?^C+NNBH YW_A&=2_Z'/7_P#OBS_^1Z/^$9U+_H<]?_[XL_\
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M^+/_ .1ZZ*B@#G?^$9U+_H<]?_[XL_\ Y'H_X1G4O^ASU_\ [XL__D>NBHH
MYW_A&=2_Z'/7_P#OBS_^1Z/^$9U+_H<]?_[XL_\ Y'KHJ* .=_X1G4O^ASU_
M_OBS_P#D>C_A&=2_Z'/7_P#OBS_^1ZZ*B@#G?^$9U+_H<]?_ .^+/_Y'H_X1
MG4O^ASU__OBS_P#D>NBHH YW_A&=2_Z'/7_^^+/_ .1Z/^$9U+_H<]?_ .^+
M/_Y'KHJ* .=_X1G4O^ASU_\ [XL__D>C_A&=2_Z'/7_^^+/_ .1ZZ*B@#G?^
M$9U+_H<]?_[XL_\ Y'H_X1G4O^ASU_\ [XL__D>NBHH YW_A&=2_Z'/7_P#O
MBS_^1Z/^$9U+_H<]?_[XL_\ Y'KHJ* .=_X1G4O^ASU__OBS_P#D>C_A&=2_
MZ'/7_P#OBS_^1ZZ*B@#G?^$9U+_H<]?_ .^+/_Y'H_X1G4O^ASU__OBS_P#D
M>NBHH YW_A&=2_Z'/7_^^+/_ .1Z/^$9U+_H<]?_ .^+/_Y'KHJ* .=_X1G4
MO^ASU_\ [XL__D>C_A&=2_Z'/7_^^+/_ .1ZZ*B@#G?^$9U+_H<]?_[XL_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% '.^'?\ D8?%W_84B_\
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M:QI%X TQ(U"J$; 48'WC0!UE%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '.^'
M?^1A\7?]A2+_ -([:NBKG?#O_(P^+O\ L*1?^D=M714 %%%% !1110!SMC_R
M477?^P78?^C+NNBKG;'_ )*+KO\ V"[#_P!&7==%0 4444 %%%% !1110 44
M44 %%%% !1110 5ROPX_Y$/3/]UO_0C755ROPX_Y$/3/]UO_ $(T =51110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!SOAW_D8?%W_84B_]([:NBKG?#O\ R,/B
M[_L*1?\ I';5T5 !1110 4444 <[8_\ )1==_P"P78?^C+NNBKG;'_DHNN_]
M@NP_]&7==%0 4444 %%%% !1110 4444 %%%% !1110 5ROPX_Y$/3/]UO\
MT(UU5<K\./\ D0],_P!UO_0C0!U5%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'.^'?^1A\7?]A2+_ -([:NBKG?#O_(P^+O\ L*1?^D=M714 %%%% !1110!S
MMC_R477?^P78?^C+NNBKG;'_ )*+KO\ V"[#_P!&7==%0 4444 %%%% !111
M0 4444 %%%% !1110 5ROPX_Y$/3/]UO_0C755ROPX_Y$/3/]UO_ $(T =51
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!SOAW_D8?%W_84B_]([:NBKG?#O\
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MX;(J> =,5%"J$;@#'\1H ZNBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ [5S4^H>+5N)%AT:P>(,0C-<L"1V)&VNEHH Y;^TO&/\ T!-/_P#
MIO\ XFJ2>)O%+ZW)I0T.Q^T1VXN#_I+8VEMO]WKFNVKEH/\ DJ%W_P!@E/\
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MKU]:GU >*P\F>&W"7)V@'&,=*F]I/T*M>/S/HS1H+ZVT>UAU.Y6YO43$TR#
M=O4"KU87@UKUO!VE-J._[68!YF_K[9_#%;<DB1(7D=41>2S' %:3TDS..L4.
MHK/37M(DE\J/5+)I.FU9U)_+-:'6I*"BBB@ HHHH *Y7X<?\B'IG^ZW_ *$:
MZJN5^''_ "(>F?[K?^A&@#JJ*** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ_R(>F?[K?\ H1H ZJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&8*I8] ,FJ?\
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M:_WF_P"^31_:MK_>;_ODUA4=J/8Q#V\CJ000".AI:;'_ *M/H*=7*=84444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@!DW^HD_W3_*N8'2NGF_U$G^Z?Y5S Z5T4-F<V(W04445N<X4444 %%%
M% !1110 4444 %%%% !1110 4=J*.U '41_ZM/H*=38_]6GT%.K@/104444
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MN;5?"UX=0:VGM99%4L+AY-P$F?3##\J]]\2^*-,\)Z9]OU.1EC)VJJ+N9SZ
M5AZ9\3?#NLZ1?:A:,YDLHC+);RILDV@9X!J=+M_?_7S*ULE]QL^#M.N-)\(:
M987?_'Q#" X]#DG'ZUSWC6'QD^K1MX?TC1[NT$0W27H&X-DY'/;I76Z)JL6N
M:+::G C)%<IO56Z@4[6;6:^T6\M;=_+FEA9$;T)%55O=M[ZDT[:+H>)0>)?%
M]Q=SVT5EX/>2W4O-ATP@'4DYKV[1Y)9=&LY)Q")6A4N(#E,XYV^U?.T=CK&G
MWDVEVWA*YBN[BQ-C(0"0[DC,N?PKZ%T"RETWP_I]C,09;>W2-R/4#!JE\/\
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M\._\C#XN_P"PI%_Z1VU=%0 4444 %%%% '.V/_)1==_[!=A_Z,NZZ*N=L?\
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MIVJV&KVWVC3[N*YBZ;HVS3O=-]6+:R6Q<HHHI#"BBB@ KE?AQ_R(>F?[K?\
MH1KJJY7X<?\ (AZ9_NM_Z$: .JHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HIKNL<;.[!549)/85E?\)3H?\ T$X/SH UZ*Q_^$JT+_H)P?G1_P )5H7_
M $%+?_OJ@#8HK'_X2K0O^@G!^=6+37=+OYQ!:WL4LI&0JGF@#0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH 9-_J)/]T_RKF!TKIYO]1)_NG^5<P.E=%#
M9G-B-T%%%%;G.%%%% !1110 4444 %%%% !1110 4444 %':BCM0!U$?^K3Z
M"G4V/_5I]!3JX#T4%%%% !1110!SOAW_ )&'Q=_V%(O_ $CMJZ*N=\._\C#X
MN_["D7_I';5T5 !1110 4444 <[8_P#)1==_[!=A_P"C+NNBKG;'_DHNN_\
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M "BBB@ HHHH **** "N6^'W_ "*4/_7:7_T,UU-<M\/O^12A_P"NTO\ Z&:
M.IHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$]E]W_!/4?\ A.M#_P">LW_?DT?\)UH?_/6;_OR:\NHH_LVCYA_;6)[+[O\
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MH*=7 >B@HHHH **** .=\._\C#XN_P"PI%_Z1VU=%7.^'?\ D8?%W_84B_\
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M_P!([:NBKG?#O_(P^+O^PI%_Z1VU=%0 4444 %%%% '.V/\ R477?^P78?\
MHR[KHJYVQ_Y*+KO_ &"[#_T9=UT5 !1110 4444 %%%% !1110 4444 %%,E
MFB@3?-*D:^KL /UIR.LBAD8,IZ$'(- "UROPX_Y$/3/]UO\ T(UU5<K\./\
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M_P"_0_QH_P"$F'_0&U3_ +]#_&O1Z*/;2#V$3SC_ (28?] ;5/\ OT/\:/\
MA)A_T!M4_P"_0_QKT>BCVT@]A$\X_P"$F'_0&U3_ +]#_&C_ (28?] ;5/\
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MYP65;+:&42.-RJI4 8.!VI+_ "_X(,ZJBFH@C147[J@ <YIU !1110 4444
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MBBB@ HHHH YVQ_Y*+KO_ &"[#_T9=UT5<[8_\E%UW_L%V'_HR[KHJ "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH JZG81ZI
MIMQ8RR21QSH49HSA@#Z&L*7P%HL\&BPRI*\>D8^SJ6'S8&/FXY]>U=/10M'?
M^M Z6_K4YRX\%Z?<7^KWC3W0FU2$03%7'RJ !\O''3WJAH?PYL] N;:2UUK6
M'BM_N02SJ8_Q 45V5%"TV!Z[G':I\.=-O]8EU6TOK_3+N;_7-9R!1)[D$'FK
MT?@RQ6^TF\EN[V>;2T983+(#N)ZEN.3^5='10M-@>NYC>)?#L'BC26TVYN[N
MWA9@6-K($9O8D@\5F^&_ =GX8N4EM-4U.:-$*+!/*IC&>^ HYKJZ*%IL#U5F
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 07MJM]8W%H[N
MB3QM&S(<, 1CCWKG)?A_HD^F:1I\HF>#2Y?-A!899LY^;CG]*ZJBA::_UH!S
M\_@^PGU74-1::Y6>]M?LC[7&$3G[O'!Y]ZRM&^&MCH=Q;26NM:R8K=]RP/.A
MC/L0%Z5VM%"TV!Z[G(:S\/--U36&U:WO+[3;Z08DDLY OF?[P(/-6;?P38PW
M^EWLM[?7,^FJXA::0'<6QDMQR>*Z:BA:; ]=S*\0Z%#XCTB33;BZNK:&3[[6
MSA&(],D'BL7PY\/;'PQ=136>JZI)'$"%MYI5,?([@*/YUU]%"TU0/5684444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A_\(M8'6=0U1WG>
MXOH! X9AM5!GA>..M;E%)I,+G)#X=Z*GAF#0(VN8[.&<7&5<;W8'/S''(JO?
M_#33[W6KK54U?5[6XN<"3[/.JC Z 94UVM%/K</(YK5O ^EZUHMKIU[)<NUK
M@PW7F 3*1WW8Z_A56V\ P1:;?65QK6K7<=Y%Y+F:5247_9^7K77T4;W\P6EO
M(JZ;I\.EZ;;V%ON\F! B;CS@>M<6_P *--;5)]276];2[G;+R+<)GZ#*<"N^
MHH>KYGN"T5EL16L M;6* .[B-0NYSEC]:EHHH;OJ"5@HHHH **** "BBB@ H
MHHH **** .=\._\ (P^+O^PI%_Z1VU=%7.^'?^1A\7?]A2+_ -([:NBH ***
M* "BBB@#G;'_ )*+KO\ V"[#_P!&7==%7.V/_)1==_[!=A_Z,NZZ*@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"M-_Y_M?_P#![>?_ !VNBHH YW_A"M-_Y_M?_P#![>?_ !VC_A"M-_Y_M?\
M_![>?_':Z*B@#G?^$*TW_G^U_P#\'MY_\=H_X0K3?^?[7_\ P>WG_P =KHJ*
M .=_X0K3?^?[7_\ P>WG_P =H_X0K3?^?[7_ /P>WG_QVNBHH YW_A"M-_Y_
MM?\ _![>?_':/^$*TW_G^U__ ,'MY_\ ':Z*B@#G?^$*TW_G^U__ ,'MY_\
M':/^$*TW_G^U_P#\'MY_\=KHJ* .=_X0K3?^?[7_ /P>WG_QVC_A"M-_Y_M?
M_P#![>?_ !VNBHH YW_A"M-_Y_M?_P#![>?_ !VC_A"M-_Y_M?\ _![>?_':
MZ*B@#G?^$*TW_G^U_P#\'MY_\=H_X0K3?^?[7_\ P>WG_P =KHJ* .=_X0K3
M?^?[7_\ P>WG_P =H_X0K3?^?[7_ /P>WG_QVNBHH YW_A"M-_Y_M?\ _![>
M?_':/^$*TW_G^U__ ,'MY_\ ':Z*B@#G?^$*TW_G^U__ ,'MY_\ ':/^$*TW
M_G^U_P#\'MY_\=KHJ* .=_X0K3?^?[7_ /P>WG_QVC_A"M-_Y_M?_P#![>?_
M !VNBHH YW_A"M-_Y_M?_P#![>?_ !VC_A"M-_Y_M?\ _![>?_':Z*B@#G?^
M$*TW_G^U_P#\'MY_\=H_X0K3?^?[7_\ P>WG_P =KHJ* .=_X0K3?^?[7_\
MP>WG_P =H_X0K3?^?[7_ /P>WG_QVNBHH YW_A"M-_Y_M?\ _![>?_':/^$*
MTW_G^U__ ,'MY_\ ':Z*B@#G?^$*TW_G^U__ ,'MY_\ ':/^$*TW_G^U_P#\
M'MY_\=KHJ* .=_X0K3?^?[7_ /P>WG_QVC_A"M-_Y_M?_P#![>?_ !VNBHH
MYW_A"M-_Y_M?_P#![>?_ !VC_A"M-_Y_M?\ _![>?_':Z*B@#G?^$*TW_G^U
M_P#\'MY_\=H_X0K3?^?[7_\ P>WG_P =KHJ* .=_X0K3?^?[7_\ P>WG_P =
MH_X0K3?^?[7_ /P>WG_QVNBHH YW_A"M-_Y_M?\ _![>?_':/^$*TW_G^U__
M ,'MY_\ ':Z*B@#G?^$*TW_G^U__ ,'MY_\ ':/^$*TW_G^U_P#\'MY_\=KH
MJ* .=_X0K3?^?[7_ /P>WG_QVC_A"M-_Y_M?_P#![>?_ !VNBHH YW_A"M-_
MY_M?_P#![>?_ !VC_A"M-_Y_M?\ _![>?_':Z*B@#G?^$*TW_G^U_P#\'MY_
M\=H_X0K3?^?[7_\ P>WG_P =KHJ* .=_X0K3?^?[7_\ P>WG_P =H_X0K3?^
M?[7_ /P>WG_QVNBHH YW_A"M-_Y_M?\ _![>?_':/^$*TW_G^U__ ,'MY_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img38651418_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img38651418_10.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &]! 4# 2(  A$! Q$!_\0
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MVW[I;;T)'! ]*T/'2W'@[PMIFF0^-KBRMIKHF[O]0NI)K^2/(RL.U"2>3_=
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MR[MA'#*X![9YQP* /7J*^>? OB/Q3\3/$&DZ3<ZM<6-EHEOOU"2TO&22](;
MR5()S\H)Z?>.<L!6YXDNO$&H_'R'P[I_B&_TZQN+)3*L,I(50I9BBG*ASMQN
MQQG- 'M5%>/Z!J6L^$/C+'X*NM;OM9TO4+8SV[W\GF30L%9N7/)_U;#TY' K
M&^&]IKGC76_$2ZCXMUZ&QTZ__=16UZRLY+-\I8Y(0!0-HQUH ]YHKYXU'Q_;
M:]XXUZVU_P ::KX:TS3I3;V$.FB0-*RLREW**V1\N2#_ '@!T-:7AWQ_XJUK
MX2^(SITTFH:UI<RQ0WB19DEA8_?VXY8*&[9Z=QR >ZT5\R:%XW<7FDS:=XZU
M:#4_,4:A:^))V:TD_O!&56"#.1\V,9ZC%=A\7_$FL:1XNTN&[N];L/"CP;I;
MG1F$<KRDMQO/'&%X]">M 'M=<SX.\3:GXEAOGU+PW=Z(UO/Y<:W);,RX^\-R
M+Q^=<7\(?$4VIZIJME'XL76M,51):QWK/]NB&1G?N4!EYP2&/('3-<_X'\=:
MMI/PZ\:Z[?7MUJ$]C=!+87<SRA&8A%')X7<P) Q0![U17AHTKQ8?AG_PGC>.
M-8_M?[+]O%N)!]DV?>V>5C&=O?IGM5/QUX^UO4_AKX,\0Z;=3V%[>73+,EM,
MT:R.A*D'!Y4LI.#V- 'OU%>&^-/^$C^'WB;PM?Q>+=6U$ZC=>5>6]W(# QRF
M=D8 500QXQD>M>Y4 <9X9\>_\)%XU\0>'?[-^S_V0Y7[1Y^_S?F*_=VC;T]3
M79U\_>&-#O=?^,7CJTM];O=*M_/=IY+!@DS_ +P[5#D':,Y)QSP!5W0[WQ3J
M#^-_ #Z[?7-[IL1ET[45E9)\JPPK.#N.[*@]>K=>* /=**\%N_B7?3? 2SD@
MO9_^$AGG&E^9'(?.WJ<EL]=Q0+SUR]>S>&]/NM*\-Z=8WUW-=W<,"K//-(7:
M23&6)8DD\Y[]* -2BO%-5GU[5_V@+OP[;>(]2T_39+)6D2WF/RKY:D^6#E58
MG'S8SR:H>%K;Q+JOC[Q%X(G\::VNF:?NE6X68&Z;Y@%7S2"0/FYQ_=XQF@#W
M2ZF>WLYYHXFF>.-G6->KD#( ^M<++\1]0L_AIJ'BW4_"MUI]Q:3+'_9US*T;
M.I=$#;FC! ^<_P /\-<]\+/$>M:AX8\6V&I:E/>RZ2\D<%U*Q\W&U^K=3@KG
M).>>M<I!JFH:O^S!X@N=3O[J]N/MJ+YMS,TC;1-!@98DXY- '2Q?&[Q%+9+?
MK\,=6:Q9/,^TI+(8RG7<&\G!&.^:]$\$^,]/\=>'UU73TDBVR&*:&3[T;@ D
M<=1@@@^_X5X6OQ$^(WA3P'HT<FC:;:Z-/;)!9Z@T;2';M^5FVR$!L<X*]CQ7
MI?PYT6V^&_PONM1NK^&]1T?499;=MT978,!#CGA1^)H I>)OCC9^'/&TN@G1
MVN+6WFCAN+\7.T1E@"WR[#G:,\9&=IKTG7=4&C>'=2U<1>>+*TEN1&'V^9L0
MMC.#C..N#7RSIVK^%[_X=^+#KFJ*GB75KK[7%']GD8[D)9?F"E06+R#KT/->
MN^'?$?\ PDO[.VIS.^ZYM-(NK.?GG<D+ $^Y7:?QH S['XX^(M3LUO+#X9:I
M=VK9Q-!-)(AQP?F$..*[3P/\2-/\<:7?SV]I-:7EA_Q\6DQR5R#@@XY!VD=,
M@CITSXIX6\<?$#P=\-+:ZT[0M/E\/))($O949V#%SG<%D! W' )4#I7HGPB\
M.26OA[6O%5SJ5M>W6O!IF-M]Q/OD@Y PVYCD=L8H S]-^.NO:S;M<:7\-M2O
MH%<HTEK</*H; ."5A(S@@X]Q7>>!?&&L>*_M_P#:WA*^T#[-Y?E_:R_[_=NS
MC=&GW=HZ9^\.E>*?";5?B18^%;J+P?X?TW4-/-Z[22W4@5A+L3*C,J<;0IZ=
MSSZ>Z>";[Q=?:9<2>,=+M-.O5FQ#':L&5H]HY.'?G.>X^E '3T444 %%%% !
M1110 5P'B7P-J>L_%'PYXGMY[1;+3$VS1R.PD8Y8_* I!^\.I%=_10!P'B7P
M-J>L_%'PYXGMY[1;+3$VS1R.PD8Y8_* I!^\.I%,^(G@+5/$VKZ'KNAWUI!J
M>DR[XX[U6,+_ #!N< D<CTYSVQ7H5% 'E>E^ /%J?%.R\9ZOJ6DW)\EH[F&
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M$O(VXQE#W]*] HH X'QGX"O]5\3:=XL\.:C%8Z]8IY8%PI:&=.?E;'(X9AD
M\'M@&H-$\!:U>>-XO&'C*_L;C4+6+RK.UT]7$$(YYRW)/S-P>YZ\"O1:* /-
M;7P-XFT3XH:CXBT>]TIM+U62,WD5TLGG(@(+!-HQNX."3CGD547X?^+_  QJ
MVLOX*U;2HM/U:0RO#J"/OMG.<F,H#DC)QGVSG&:]5HH \ZU;X?:M=_"2\\*#
M7)=1U6Y,;O>ZE.[*6$J.0#\Q50$P!SS]369KWPPUK5/#G@?3H+K3UFT$I]J9
MY'"O@)G9A#G[IZXKUBB@#S_XB>!=3\7>(/"E_83VD<6D7337 G=@S*7B/RX4
MY/[L]<=J] HHH \G@^'GC'PK<ZQ;>"]8TN'2=4D,A2^202VC,,$QE 02!TSZ
M#ZUKZKX/\51_#=?#>CZ\+K49\K>:EJ=Q(7*-]X)PQ&?N@=AGOS7H-% 'CQ^#
ME]X9U;0-7\$WUM#>V,?EWJWKNJ78ZL3M5B-V2,=AMQTK'\26FIWG[2-JNE7L
M5EJ"6 DCDD0R1Y$;95AP2I&1Z\YKWFL9O"FB/XJ3Q,UEG6$C\I;CS7X7!&-N
M=O0GM0!R7AGP'K?_  G<OC/Q=?V-QJ:P^1:V]@K>3"N,9!8 ]"W'^T>:G^&O
M@;4_!MWXBEU&>TE74KL3P_9W9BJY8_-N48/S#IFN_HH \QG\!>*/#OBS5]:\
M$:CI<<6L'?=6NIH^U),D[D* YY9B >.3UK2L_ 6L1^ [G1KKQAJ[ZQ._G?VF
MMS)F)^RK\V=G&",C.2>.,=Y10!XUJ_PQ\9>+;>QTSQ+J'AXV=JZE]0M8'-],
MH&/F9AC)'IWP3FNI\2>$O$S:S9ZKX5UY81! ()=+U*21[.90, E03@XZX'8'
M(YSWE% 'FW@KX<7^D>,K[Q9KDVF)J%Q%Y26FDQ&.WC!QD_, 23M'YD\]JW@W
MX5W&F>%?$F@^()[:6#6)BZM:.Q*#'!^91A@<'N.*]2HH \A'P]^( \,?\(;_
M ,)%HY\/E?*^U&"3[6(<YV;?NX[=<XXS5SQE\*KC4O"OAO0?#TUM#!I$X=C=
MNP+CN?E4_,3DGH.:]2HH X#XE>!M3\97?AV73I[2)=-NS/-]H=E++E3\NU3D
M_*>N*[^BB@#R2T^'OC71?'7B'Q/HFJ:.C:A*QBMKH2.DB,Q/[S !5AQ@KGO6
M_P##_P !WOAJ_P!6UW7=0BO==U5]T[PJ1'&,YVKG!//L.@&..>\JMJ.GVNJZ
M;<Z??1"6UN8VBFC)(W*PP1D<CZB@#Y[T7PG;:A^T5?65G)YVD:9=-J3HI)C2
M4A3M';(D('T0CM7T;6'X;\'Z!X1@EAT+38[-9B#(0S.SXZ99B20,GC/>MR@#
M@(O VIQ_&B?QD9[3^SI+00"(.WF[MBKTVXQD>M'AKP-J>C?%'Q'XGN)[1K+4
MTVPQQNQD4Y4_,"H ^Z>A-=_10!YMX&^'VK>&;;Q9'>W%E(=8E9[?R7<[00_W
M\J,?>'3/>LJP^%>N6OP6U3P:]UIQU&[NEF259'\D*)(VY.S.<(>WI7KU% ')
MVO@N&Y^&=IX1UH1RA+%+:5XCD!U PZ$@=" 1D=J\^@^&/CVV^&^H>#%U/1I+
M6:Y5X)FGE4I%N+.I C/5@IQGNW->VT4 <CHOPW\*Z;HEC97/A[1[J>"!(Y;B
M6QC=I7  +$E<G)R:Y3P_\,-<\/VOC?2H+O3SI&MV\Z6*>8X:%V#*FX;, ;6P
M2"?NCBO6:* .+\!^"Y?#_P .H_#&N"UNL^<LZPDM&ZNQ./F /0^E8GP_^'OB
M#P/?:U8+?V5SX=O-[6R&1Q-&_121LQR.#@]@?:O3Z* /!_#?PU^+7A'3I+#0
M_$VAVEK)*9F3!DRY !.7@)Z*/RKT7P-IOCVPFO3XSUNPU&-U3[,+5 I0\[LX
MC3KQZ]*[.B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^HKNZ^7[J]U#P_?>'VT_Q7I?C>![A1;6%S"L\\6<$8#;FB/ '# @XXXKZ@H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\S^+/\
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MNO'!SD=:[.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFFVEP<YF@M$C<Y]P,UJ444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML/C'_H8=%_\ !-)_\DUT5% '._8?&/\ T,.B_P#@FD_^2:/L/C'_ *&'1?\
MP32?_)-=%10!SOV'QC_T,.B_^":3_P"2:/L/C'_H8=%_\$TG_P DUT5% '._
M8?&/_0PZ+_X)I/\ Y)H^P^,?^AAT7_P32?\ R37144 <[]A\8_\ 0PZ+_P""
M:3_Y)H^P^,?^AAT7_P $TG_R37144 <[]A\8_P#0PZ+_ .":3_Y)H^P^,?\
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M_P#I'<UT5 !1110 V0$QL%QNQQFO)]4\/^)]7O3;7/\ PCUI;?:1()8XPLH
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MCYCY_P!X\ULT45Z!W!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9"T<;= !U8^PK2T:[EOM(MKF?9YLD8+[.F<<XJ5K=E/2WF3ZA_R#;K_KB_\
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M#FO<ZT:M$SO[P4445)05Q&M_\E=\+?\ 7G>?R6NWKB-;_P"2N^%O^O.\_DM
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M%DTGF-&N"WJ:TZ*E:*R*>NY6U #^SKKC_EB_\C7-_#G_ )%?_MN_]*Z74/\
MD&W7_7%_Y&N:^'/_ "*__;=_Z4 =;1110 4444 %%%% !1110 4444 %%<]J
MGC/1]-F-LLQN[P?\NMM\\A_"LSS_ !=XA_U$*:+9-TD?/V@?\!/% '3ZEJ^G
MZ1;F?4+N.WB'\3FN:;Q?J6L-Y7AO27E4_=O;D8@/Y'-6]-\#:79W O+PR:A?
M][B<G)_X"./TKI418UVHH5?0#% ''IX,O-582^)=4ENU/WK*(X@_EFEU32/#
M%L8+1[E-/$*D+%&<<'UKL:Y?7;SP?!?[=:NK*.ZQ]V:3!Q4RBIJTMB914E:1
MR?A*31=1M$O;W41!<QW<B)&IP"J/A3T[@"O4U8.H93E2,@UPT6H_#GS4$5]I
MF\L-H67O^==O"8S"AB(,94;2.F*4*<8?"K"A3C#X58?1115EA1110 4444 %
M%,DE2)-TCJJCN3BLNY\4Z%9Y^TZK:Q8Z[I * ->BN8?X@>&S_P >^H1W1](#
MNJNWCV-CBV\/ZW<^ABM@1_.@#KZ*X_\ X27Q%<_\>?AR6//3[4"G\J3SO']Q
MP;/1K=#W69RW\J .QI"0.I%<?_8/BN[_ -?XD>TS_P ^\:MC\Q2CP1=3?\?_
M (EO[OUWJJY_*@#6U^_LM-M?.E@CEE?*J, GI7.> Y+&VL(M'>!3)'N9)&4?
M-DD_UJ+4?#GAS2U>.+48K>^QDF>8_,/3!JMX+O-'D,>I2ZG;H6RL<+/AL@XY
M'X5RS=;VR2^$YI.M[5)?">E]!BBD!#*"#D'D&EKJ.D**** "BBB@ HHHH **
M** "BBB@#G?&_P#R+T/_ &%-._\ 2R&NBKG?&_\ R+T/_84T[_TLAKHJ "BB
MB@#G;'_DHNN_]@NP_P#1EW715SMC_P E%UW_ +!=A_Z,NZZ*@ K,\11W<OA^
M^2Q)^TM"P3'4G':M.N=\30ZBJ?;+;5VL;>*)_,4*#DD<'GTJ)ZQL5#>YY9X3
MLU7Q'I@TC3=4MM2C)_M&:X V,<<_UKW6O(=&U;58O%=E8W?C)[H2H)#'Y485
M@1P"0,YKUZM7\*^9G]M_(**3<N[;D;NN*-P!QD9/:I*%KB-;_P"2N^%O^O.\
M_DM=O7$:W_R5WPM_UYWG\EH [>BBB@ HHHH **** "BBB@ HHHH *XO5=:O?
M$.H2:%X>?:B'%Y?C[L0[JI_O=:;JFJ7OBK4)=$T.0Q6<9VWM^.@'=$/<UU&D
MZ39Z+I\=E91!(T'/JQ[DGUH CT30[+0;!;6RCP.KN?O2-W8GU-:5%% !1110
M 4444 %%%% !1110 4444 %%%% !117 >(/$6H)JTUO;RF&.%MN .I]:RK5H
MTE=F56JJ:NSOZ*Q?#.J2ZIIF^<?O$.TM_>]ZY;QUKWBKP_>0RV0L6LKB9((@
M[D.&/KQTJHS4DFNII!J<>9'H=%>9Z_XP\1:!:Z5978T^*]O=Q>Z=R(4&1@9Q
M[U9U3QEJ&@/H":E<6)CO'<37$;DQ[1C!!JUJ[>=OF/\ RN>AT5PNF>.DU/QA
MJ-E:SV]QIMM:B59HVSD\Y'Z52\'>/K_6O$TUCJ$$<5M/'YMFRGEQG_ZU$?>:
M2ZJX/2[?30]'HK.UN\O;#2YKBPM5N;A1E8V) /UQ7):=\09Y? 4_B&^LXTGC
M8HL,9)!8$X'Z4K[^0[/3S.^HKS[2/&FOW6H2Z5>Z=9IJ,D'GVH21MC*1G#'M
MU%6O#OBS6;CQ3<>']=LK2*ZCC$H>T<LH!&<'-4E=V_K3<F^E_P"M=OS.WHKF
M=9\>:)H6H/8WDKB=%#E5&>#WJ*S^(&AZI<M:65UF=HB\9/W6X[5-]+HJUMSJ
MZ*\IO?'NK1Z3I!M9[1I;V?RFGD;"+U[_ (5K^'O'-Y=:%K5UJ44&[3,XG@8F
M.7C/!--Z)OM_7ZA;5+O_ %^AW]%><>%/'6IZG;ZS'J=O'%=6L1G@53]Y-N1_
M2LG1OB-KLUWI[SI8W$-[,T7D1.3+& <9(_&G;6W]:BOI?^NYZ[17E-EXXUO4
M?$M[9+?:3:PV]T81'<2E9'4-C@8ZUZJ,X&>M)?"I=P>DG$6BBB@ HHHH ***
M* "N=\3?\AGPE_V%V_\ 2.YKHJYWQ-_R&?"7_87;_P!([F@#HJ*** .=\1?\
MC#X1_P"PI+_Z1W-=%7.^(O\ D8?"/_84E_\ 2.YKHJ "BBB@"IJ%E!>VQ6>!
M9MAWHK#^(=*\3GN)[F_+VGAI(WM+H_:Y)(L;@6^7;Q7NDH=H7$9PY!VGWKQF
MXA\67EY)%(\5N+*ZW;5(9K@%N,CVQ4KX_P"OZ^7H5]D]>A5;S244J8EEAP5'
M!7(KQ3Q?X6\.Z)?)92'4KZ4@22!I'98U)P#U]:]OLS(UE TP D*#<!V.*\O^
M)RZ#<:A-'>3S6U[#;J^8V/[Y2V N!UYISLJE_,5/6%O(ZKX?Q6%MI%S::?).
M\<$Y1C,Q)S@=,GI76UQOPTDL'\,;;**6)TDVSB4DMOP.N?;%=E6D]_N_(B&P
M4445!17U#_D&W7_7%_Y&N:^'/_(K_P#;=_Z5TNH?\@VZ_P"N+_R-<U\.?^17
M_P"V[_TH ZVBBB@ HHHH *Q9_%WAVVGD@GUJQCEC8JZ-, 5([&MJO,?&NFZ?
M_P )$S&PM2SQ!F/E+ECD\GCK65:K[*/,T95:OLX\S1VUKXKT"]N8[:UUBRFF
MD.$C24$L?85HW=[:V$!GN[B*"(=7D8*!^)KR/2=-_P")K;_V7#:VU]D^5,85
M.PXZX^E=M:>!8)+@7>MWL^I77?<Q6(_]L\XI4*RJQNE8*-555=(;<>-_M4IM
MO#^G3ZC.?NRE2L'_ 'V*B_X1O7M>^;Q!JA@MV^]8VN-O_?P8-=?;VT%I$(K>
M&.&,=%C4*/R%2UL:F9I?A[2]'B6.SM$7'\;?,_\ WT>:TZ** "BBB@ K*UC^
MR;6$W>H6D$A' +Q*S'\ZOW5W;V5NUQ=31PQ+U>1@H'XFN%U#4;SQC,8])T^1
MM/@R6NIB4W-Z*IZCWJ*CDH-QW(J.2BW'<9X$@T6TTR2SN[>U^T?:99@\D2_=
M9B1R?05ULWB70;,;9M6L80.,-,HQ^M<5X;\/IKN9YLFR5VC8HV"64X(_.NP@
M\(:%!C_B702_]=D#_P ZSP\YRA>:U(H2G*-YHK2^.O#Z?ZJ\%S_U[_/G\JJ-
M\0;1FVV^C:W,W9ELCM_.NCBTG38/]3I]I'_N0J/Y"K:JJ#"J /0"MS8X_P#X
M2?Q#<_\ 'CX=;GI]I8Q_TH^T^/+GA]-TVT'JER7/ZBNQHH X_P#L3QA=<R>)
MA9^T5JC_ ,Z/^$)N[C_D(>(;NYSUP@CS^1KL** .1C^&WAY7$DD=W+)W+74F
M/RS6I;>$]$M<>781MC_GI\_\ZVJ* *J:;81?ZNRMD_W8E']*L*BH,(H4>@&*
M=10 4444 %%%% &;>:!IE_.9KFU220\;C4">%=%C8,EA$I!R,"MFB@!% 50H
MZ 8%+110 4444 %%%% !1110 4444 %%%% '.^-_^1>A_P"PIIW_ *60UT5<
M[XW_ .1>A_["FG?^ED-=%0 4444 <[8_\E%UW_L%V'_HR[KHJYVQ_P"2BZ[_
M -@NP_\ 1EW714 %97B1[9/#UZ;N,R0>4V]1Z8K5K-U^Z2ST*\GD@$ZK$Q,9
MZ-QWJ*GPLJ'Q(\@T"X\,QZQIEE86LKVY/F&\Y;#'^#/L:]QKQ/PQXAMVNK&S
MDT^T!>8R110.I*9]<=:]LK9_"OZZ(S^U_7=G$>(=-M7URU731,=5DE\QV65B
M(UQU89QBLF_C-S:Z]JTLTHOK&8>1B0@(0HXQT-=4?!&D'59M2!O%NI6W.RW+
M#\,9Z>U3W/A+2KO4?MLJ2^86#,JRD(Y'&2O0U$=+?U;;;Y*WS+D[M_U??_,9
MJ-MK6H:3:-I>HBRF**SL8P^>/>N-BLM;L_BWX<&L:H+XM9W?EXB5-G STZUZ
M@H"J% P , 5Q.M_\E=\+?]>=Y_):'N2MCMZ***!A1110 4444 %%%% !7'>(
M=6NM7U$^&M$DVS-_Q^72\BW3N/\ >Z<59\3Z_<0S1Z)HP$NK70P#U$"_WFK1
M\.Z!;^']/$$9,D[G=/.WWI&]2: +.D:3:Z+IL5E9QA8T')[L>Y)J]110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %8FI^&++4[CSVS'(?O%>];,C;(
MV?&=H)Q7&?\ ">M_T#O_ ")_]:L*TZ25JAC6G32M4.LL;&#3K5;>W7:B_K7.
M>.O#U_X@M=/CL?*W07D<S^8V/E'7%:V@:T=;MI9C!Y/EOMQNSGBL+Q'\1+/P
MUJ!M+NQO&Y"K(D1*L3V!QS5PE!J+C\OD:TVG&\-K#O&&G:Y?V,-EI^E:??0M
M%ME^TR["IQP5.*YB#X::H+;0+>Y:&XBM)I9+A'DSM#8PJ^N*Z6Y^(VGVNFVE
MQ+9W@N+LGR;7R6\PX.,XZU;'C:T5],CFMKB&74'9(XY(RK KC.0?K6L5:7G?
M\>P-^[;I9_\ #G+ZAX"U:WUK6+G0X;2&"[MDBB4R;<')W9X]#4%O\+[_ $>[
MT.]TR=9)[8[;I9)"!MP<[?SKO(_$UG)XDN=$PXN+>$3.2.-IS_A5+P_XZTOQ
M%K-WIEIO$UL,DLN PSC(]:4.EOZ2O^&HY];_ --I?Y%W3?#&GZ+#<_V>DJR3
M@[O,G9QD_4G%<I9> ]0/P]NM#NWB2[:5I8BC97.21G\Z[G5-4MM'L)+V[+"&
M,9.Q=Q_*LVP\9:-J/AZ7789G6QC!+-(FT\>U+35^2^6N@]5;U^_0Y"P\,^+D
MOIM9GBLDU*&V^S6D:S93&W&XG'7@'%6? 7A_Q1HVJW%QK=G8N]R2TUVEP7<G
ML N.!6UIWQ"T/4X;IX?M8:W7>T3P,'9<9RJ]35CP_P"-M)\1W<MI:BYAN8QN
M,5S"8V(]0#5*]_E_P?S)=K?U\C"UCP9J.H>+=3U)8[9[>XLA#%O/(<9[8XZU
MEV?P^UBV;P^WEVBM8P&.X*O@D[2...>M=7KOCFPT754TM;>YN[TJ&:*"(OM4
M]SBIK'QC97FM+I312PW+0"=5D4KE?Q[\5,4N6RV_X?\ S94F^O\ 6R_1'#VW
MPVU9M.T.SO$MFCM;GS+E1*>4P>G'N*DD\!>(K?1=3T*Q^RC3[JY5HV,F&6+'
MS \=<UVNG>,M-U"SU&]5F2UL'*22L, X]*K6_P 1/#]SH4NKQS3?9HY/*P8C
MO9O0+WIMWW_J]K?D@UO_ %NK_P"9RX^&VIZ/K"7.CS)+#+9/;W FD(.X@ 8J
M+3_AOJNE)H][9I;+J5O<.;DF3*M&S#I[XKO_  ]XHTWQ-;236#2 QG#QRH4=
M?3(-;-/5/^O7]2=&K?UV/)K#P=XGTOQ)?7::1I5W!<W9E666X(=%+9Z8ZUZP
MN=HSU[TM%)/W5'L-ZRY@HHHH **** "BBB@ KG?$W_(9\)?]A=O_ $CN:Z*N
M=\3?\AGPE_V%V_\ 2.YH Z*BBB@#G?$7_(P^$?\ L*2_^D=S715SOB+_ )&'
MPC_V%)?_ $CN:Z*@ HHHH 9-N\A]K;6VG!]*\"MK?7YO$,\=E;7D\LMT0]R)
M\J%#?ICTKWZ10T;*3@$8S7B,*:-8>))+*S\;W]KYER6:*$N(RY;E>F.M*/\
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M];UQ()8+*Z:,1+(A0MA<'@UZ+111T2716%U;?4****0PHHHH **** "BBB@
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M1G\QFRG3!KS\+"LIWG>QPX:%53]^]C6HHHKT3O"BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[T_X8745YX0$T6_89WQO4J>W8UUFH?\ (-NO^N+_ ,C7-?#G_D5_^V[_ -*
M.MHHH/ R: .4\<WTAT^'1;4G[5J<@@.WJD9X9_PKH=-L8]-TZWLX@ L,87@=
M2!R?QKE/#P/B'Q7>^('RUK; VUB3T*G[Y_[Z%=K0 5Y5<Z3J_C#Q9>QVVL;=
M,LI#B7RL@N>"G7MZUUOC#6)[>&'1]-^;4]0)CC _@3^)O; -:VA:/#H6D0V,
M/S;!EW/61^['W-)I-68FDU9F'HWA35=*NX'.LK) AR\:P[=_XYKKJ**$DE9
MDEH@HHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .=\;_\ (O0_]A33
MO_2R&NBKG?&__(O0_P#84T[_ -+(:Z*@ HHHH YVQ_Y*+KO_ &"[#_T9=UT5
M<[8_\E%UW_L%V'_HR[KHJ "L'Q19Z=_9TVHWMDMR]O"X4$=B.16]7-^.-1O]
M-\,W,MAIWVYRI5H^, 'J2.XJ*GPEPUD>7>%+S28]8LW.BVB74KYB$+*613]*
M]UKPWP=9W4VOZ=<V'AR"V?&ZYFDF1P,C^%0<K7N5;/X5_78R^T_ZZL**C\^'
MS?*\U/,_N;AG\J:]U;I*(GGC60]%+ $_A4%$U<1K?_)7?"W_ %YWG\EKM7DC
MC&7=5'^T<5Q&L21R?%SPML=6Q9WGW3GLM '<T444 %5M0OH-,L)[VZ?9!"I=
MV]!5FN+\3,?$'B*R\-1'-NH%S>X/#1@XV'ZY!H G\%V,\XNO$.H)MO-0;<J-
M_P LD'  ^H -=;38T6*-8T&%4!0/0"G4 %%%% !1110 4444 %%%% !1110
M45SESX[\.V<DD<]\4,?#YB? _'%2V/C+0]2NDMK6[:25_NCRF&?Q(H WJ***
M "BBB@ HHHH **** "BBD+*O5@/J: %HJ,W$(ZRQC_@0I/M5N/\ EO%_WV*
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MZGJ-OI6G3WURVV*%"Q]3@=![U;KA[UCXR\4+IT9)T?3762X8=)9>J@>PP<T
M6O".G7%Y<3^)M37_ $N]_P!0A_Y90_PX]"0>:ZZD50JA5   P .U+0 4444
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MUJ7_ 'YP?Z5U]% ')CP!8?Q7M\_^](/\*7_A7^D_Q27+?5__ *U=710!RO\
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M<9#:7=N[2DN+I2'8X'.#78UK/<SCL%%%%045]0_Y!MU_UQ?^1KFOAS_R*_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1"7E^]-*WWI&/<GO58;G]G[^Y6'YO9^_N:J(L:*B !5& !V%.HHK<V"BBB@
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M:W?M#/TKPYI6C(HM+1!(/^6SC=(?JQYK5HHKJ.D**** "BBB@ HHHH ****
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M.8&60Y..PK<JJ3DX)SW*IN3BN;<****T+"BBB@ HHHH **** "BBB@ HHHH
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M56E!I1ZFS;>(=95A#;SAFD^1%<<)GC/X5U>A>$K?3)VO[V5K_5)/]9<R]1[
M= *Y?0M3\,Z:5GU34((KU2<1R.!@=C73?\+ \+?]!FU_[^"M,(IJ%Y/<TPJG
MR7D]SI:*YK_A8'A;_H,VO_?P4?\ "P/"W_09M?\ OX*ZCI.EHKFO^%@>%O\
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M#I:*YEOB%X512QUFUP/^F@H7X@^%74,-9M<'_IH* .FHKFO^%@>%O^@S:_\
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M[PP89]JT: ,_^P='_P"@38_^ R?X4?V#H_\ T";'_P !D_PK0HH S_[!T?\
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M_P"D=S715SOB+_D8?"/_ &%)?_2.YKHJ "BBB@ HHHH **** "BBB@ HHHH
MY3Q4XLM9T;5)PWV.V:3S652VW< !P/>G^#5:0:I>JK+!<WCO%D8W*<<XKJ"
M1@C- &!Q1'0):_UZ_P"84444 %%%% !1110 5SOC=6;PK>!5+-MZ 9/6NBHH
M[ 9MZUNGAV0W>_R!;C?M'.,=JY3P0]V-4N$U83BX(S:>9DCROZ<8KO:*%HVP
M>JL<QK:,?&&A,$) 6;) X' KE[N00:?JFB21R'4+C4/.B0(3N0N"#GIT%>GT
MF!G.!FDD.^MU_6_^93T[3X["%@"S22'<[,<G/^%7:**INY*5E8****0PHHHH
M Y[Q9XEA\/6"Y21Y[@E(E1"V#ZG%5M#&FP^$IF\]IXB"T\@C9=S>P(SZ5U6,
MT8I6T:[COJO(\_\  [W8U.1-5%QYYC)M/,.1Y.>Y]<ULZ\K'Q+H[!&(#\D#W
MKIZ*J^J?8GH_,\SNIEM8=3T>:.0W\]TIC 0D,"3@YZ<9KO-+TU;*%'8LT[1(
MDC,<]!5_ SG S2THZ*WI^"L.6KOZ_CJ%%%% !1110 5A^)[RR@TUH+N_N++S
M@0LL ;<,?0&MRD(##! /UI-75AIV=SD?"[*O@R<W496(/( X4AI5[.1UR:S?
M!+W(U>1=2%QS"#8^9DCRL\9_VNM>@XHJK^\Y"^S8YCQ&C'Q!X?*HQ N\D@=/
ME/6N?U:9=/N/$UG<HYGU'FU4(3Y@V@8R.G->CTA )R0*FVEO7\2E*VOI^!E:
M%IBV-G'(^\SR1IOW'.W Q@5K4453=V0E96"BBBD,*CG,H@?R<>;CY<],U)12
M:NK CS*TT_5[#QGI[W-N))I5<RS 9W#=QS["KOC5[K^V(?[,$^Y$/V[R\A?*
MQS]3C.*] HI]O(=]6^YG0&"3P\IMPQA-M\FX<XV\9]ZXEHY(O#5C=O&YAMKM
MGF7:<X. #BO1Z,4?:YEY?@[B^SROS_%6.+T6VAUW5]5O5\S[!*VP<%=Y!!S@
MUV8   '04H  P!@44=$D&[;9SOC?_D7H?^PIIW_I9#715SOC?_D7H?\ L*:=
M_P"ED-=%0 4444 <[8_\E%UW_L%V'_HR[KHJYVQ_Y*+KO_8+L/\ T9=UT5 !
M6-XL+#PKJ6U58^0_##(Z&MFF21)-&T<BAD88(/0U,X\T6BHNTDSQCP-JBFXT
MR!O&LSOM -AY,@ X^[G&.*]JJA#HFF6\BR16,*.O1@O(J_6CE=$)684445(P
MKS.ZF6SAU31YXY#?7%RIC 0G<"3@YZ<9KTRDP,YP,TK:_P!>3_0:=E_7G_F0
M6$3P:?;Q2??2-5;Z@58HHJF[NY*5E8****0PHHHH **** .7U%&_X3?3V"-M
MV<D#CO53QVUWBT32!*=5W939P-G.<GT]J[.BDU[J78:?O-F/X8>WDT"V-OYF
MW!W>8/FW9YS^.:Y-K:>71-8V1O\ N[I9&7'WE&<_6O1**<M6WW_S3_04=$E_
M6S7ZG"Z8T/B#Q$L]KYHM8K58Y6VE,DKC;R*[:"%+:".&,81%"J/84\ #H *6
MG?2W];M_J*W]?)+] HHHI#"BBB@ KE/&/B>'2(4T]=_VB[!7<(V8(O<G ],U
MU=&!2:N-.QRJKIEKX$$:2RRVJ1!1(J$,S<8.,9ZXJGX#:\$EW'K F&ICG]X<
MCR^V#]:[4X YZ49'7BJOJWW)MHD<S>(Q^(%FP5L?87&['&=_K7+0O_Q*[30?
M+D_M*+4A*Z;#PN\G=GIT(KT\D#DXH^7[W'UI+3^O.Y3=_P"O)K]2M96$=DK;
M2S.YR[N<DU:HHH$@HHHH **** *>J7=O96$DMU,\,9^7S$!++GTQ7*^"2OV[
M5O+EDNK3*E+R92'DZY4YY.*[8@$8/(I  !@  4+1MC>UCS>SEE'C ,XN?[%:
MX<0YSCS?XLC^[TQ72^.59O#%P%4LV5X49/WA728HH6T5V_SN+[3?<XC4[R+1
MO%,EY?!Q!-8>7&P0M\V1\O%:/A'2#;Z-8370<3QJX5"> &8D<>M=*0#U -+1
M'1?UY_Y@]0HHHH **** "F3&00OY6/,Q\N>F:?12:N@1YE!I^L6/C+3I;FW$
MD\WF&68#.5SQS["K_C9[O^U;<:4)_-52;S9D+Y6.?J<9Q7?44^B\AWU;[F;9
MF"3P]&;8,83;_)O'.-O?WKB6BD3PO;W31N8K:\:25=ISMP!TKTBC%%_>YEY?
M@[B7P\K_ *NK'%Z/!#K^MZI>)YGV"3]WG!7S#P>AKLU4*H4= ,"@  8 P*6C
M9)(-W=A1110 4444 %<[XF_Y#/A+_L+M_P"D=S715SOB;_D,^$O^PNW_ *1W
M- '14444 <[XB_Y&'PC_ -A27_TCN:Z*N=\1?\C#X1_["DO_ *1W-=%0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5YK>^/K^Q^)2:-)''_9I)1I.X(&:]*KR_7OAWJNK:AK
M5VDL"27#[K1MQRO(Z^G&:F[4DRK)Q:&Z-\2[NXUW5S>1(-,MK9KB K]Y@"!3
M'\9^+H-'B\4S6UC_ &2[X-NI;S%3)^;Z\59MOAM<Q:@(W>$6#Z:UI(0?GW%L
MYQ57_A#?&-QHD7ABXEL1I"2<W*R$RLF3QMQCO5)6LNNGYN]_56%=-MO;_@*W
MXG1:#XMN=7\9W>G!4%FEO'+&>_S+FNTKBM"\(WFD>-+O4=T1L7MXX8L-\_RK
MCD5VM/3ECZ?JR5>[OY?DOU"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG?\ A-]'_P">&M?^".]_^-4?\)OH_P#SPUK_ ,$=[_\ &JZ*B@#G?^$WT?\
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MO_QJNBHH YW_ (3?1_\ GAK7_@CO?_C5'_";Z/\ \\-:_P#!'>__ !JNBHH
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MOH__ #PUK_P1WO\ \:KHJ* .=_X3?1_^>&M?^".]_P#C5'_";Z/_ ,\-:_\
M!'>__&JZ*B@#G?\ A-]'_P">&M?^".]_^-4?\)OH_P#SPUK_ ,$=[_\ &JZ*
MB@#G?^$WT?\ YX:U_P"".]_^-4?\)OH__/#6O_!'>_\ QJNBHH YW_A-]'_Y
MX:U_X([W_P"-4?\ ";Z/_P \-:_\$=[_ /&JZ*B@#G?^$WT?_GAK7_@CO?\
MXU1_PF^C_P#/#6O_  1WO_QJNBHH YW_ (3?1_\ GAK7_@CO?_C5'_";Z/\
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J:[K_ (9BL+;5";?46GE:?2[F!$3[+.N2TD:K]YU'7O7:44 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>18
<FILENAME>tsha-20230930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-11-14T16:15:08.0125+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity" xlink:href="tsha-20230930.xsd#StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical" xlink:href="tsha-20230930.xsd#StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="tsha-20230930.xsd#Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements" xlink:href="tsha-20230930.xsd#DisclosureAstellasAgreements" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:href="tsha-20230930.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails" xlink:href="tsha-20230930.xsd#DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:href="tsha-20230930.xsd#DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" xlink:href="tsha-20230930.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#DisclosureLeasesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#DisclosureAstellasAgreementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails" xlink:href="tsha-20230930.xsd#DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails" xlink:href="tsha-20230930.xsd#DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock" xlink:href="tsha-20230930.xsd#DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#DisclosureWarrantsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails" xlink:href="tsha-20230930.xsd#DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails" xlink:href="tsha-20230930.xsd#DisclosureWarrantsScheduleOfWarrantLiabilityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails" xlink:href="tsha-20230930.xsd#DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#DisclosureNetLossPerCommonShareAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureStrategicReprioritizationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails" xlink:href="tsha-20230930.xsd#DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureRetirementPlanAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm" xlink:type="simple"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiStrategyHoldingsLlcMember" xlink:label="tsha_SsiStrategyHoldingsLlcMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares" xlink:label="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_SsiStrategyHoldingsLlcMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiStrategyHoldingsLlcMember" xlink:label="tsha_SsiStrategyHoldingsLlcMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts" xlink:label="tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_SsiStrategyHoldingsLlcMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" xlink:label="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ResearchAndDevelopmentLicenseExpense" xlink:label="tsha_ResearchAndDevelopmentLicenseExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentOfShelfRegistrationCosts" xlink:label="tsha_PaymentOfShelfRegistrationCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement" xlink:label="tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceCostsForPreFundedWarrantLiability" xlink:label="tsha_IssuanceCostsForPreFundedWarrantLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ResearchAndDevelopmentLicenseNotYetPaid" xlink:label="tsha_ResearchAndDevelopmentLicenseNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="tsha_ResearchAndDevelopmentLicenseExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="tsha_PaymentOfShelfRegistrationCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="tsha_IssuanceCostsForPreFundedWarrantLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="tsha_ResearchAndDevelopmentLicenseNotYetPaid" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestrictedCash" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasMember" xlink:label="tsha_AstellasMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AstellasMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock" xlink:label="tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SalesAgreementMember" xlink:label="tsha_SalesAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SalesAgentMember" xlink:label="tsha_SalesAgentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasMember" xlink:label="tsha_AstellasMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AggregateOfferingPriceFromSaleOfCommonStock" xlink:label="tsha_AggregateOfferingPriceFromSaleOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiStrategyHoldingsLlcMember" xlink:label="tsha_SsiStrategyHoldingsLlcMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfSalePricePerShareOfCommonStock" xlink:label="tsha_PercentageOfSalePricePerShareOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_CommonStockSharesIssuedAndSold" xlink:label="tsha_CommonStockSharesIssuedAndSold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SalesAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="tsha_SalesAgentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AstellasMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_AggregateOfferingPriceFromSaleOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_SsiStrategyHoldingsLlcMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_PercentageOfSalePricePerShareOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_CommonStockSharesIssuedAndSold" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SignificantAccountingPoliciesLineItems" xlink:label="tsha_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SignificantAccountingPoliciesTable" xlink:label="tsha_SignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:label="us-gaap_AccountingStandardsUpdate201912Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment" xlink:label="tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DerecognizedBuildToSuitLeaseLiability" xlink:label="tsha_DerecognizedBuildToSuitLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances" xlink:label="tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CumulativeEarningsDeficit" xlink:label="us-gaap_CumulativeEarningsDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="tsha_SignificantAccountingPoliciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tsha_SignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201912Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="tsha_DerecognizedBuildToSuitLeaseLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CumulativeEarningsDeficit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails">
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SignificantAccountingPoliciesLineItems" xlink:label="tsha_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SignificantAccountingPoliciesTable" xlink:label="tsha_SignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember" xlink:label="srt_RestatementAdjustmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="tsha_SignificantAccountingPoliciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tsha_SignificantAccountingPoliciesTable" xlink:to="srt_RestatementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tsha_SignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementAdjustmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiWarrants" xlink:label="tsha_SsiWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrants" xlink:label="tsha_PreFundedWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="tsha_SsiWarrants" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="tsha_PreFundedWarrants" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LaboratoryEquipmentMember" xlink:label="tsha_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tsha_LaboratoryEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AssetsCapitalizedAsFinanceLeasesMember" xlink:label="tsha_AssetsCapitalizedAsFinanceLeasesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset" xlink:label="tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tsha_AssetsCapitalizedAsFinanceLeasesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AssetImpairmentCharges" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DallasLeaseMember" xlink:label="tsha_DallasLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PegasusParkLLCMember" xlink:label="tsha_PegasusParkLLCMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DallasLeaseAmendmentMember" xlink:label="tsha_DallasLeaseAmendmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperationsCommencedDate1" xlink:label="us-gaap_OperationsCommencedDate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DurhamLeaseMember" xlink:label="tsha_DurhamLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_OnSiteGenerationLeaseMember" xlink:label="tsha_OnSiteGenerationLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" xlink:label="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit" xlink:label="us-gaap_EscrowDeposit"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_DallasLeaseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_PegasusParkLLCMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_DallasLeaseAmendmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperationsCommencedDate1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_DurhamLeaseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_OnSiteGenerationLeaseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_EscrowDeposit" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SecuritiesPurchaseAgreementMember" xlink:label="tsha_SecuritiesPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_UpfrontPayment" xlink:label="tsha_UpfrontPayment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasMember" xlink:label="tsha_AstellasMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasSecuritiesPurchaseAgreementMember" xlink:label="tsha_AstellasSecuritiesPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasPrivatePlacementMember" xlink:label="tsha_AstellasPrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AbeonaRettAgreementMember" xlink:label="tsha_AbeonaRettAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_FairValueOfSharesTransferredValue" xlink:label="tsha_FairValueOfSharesTransferredValue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_GiantAxonalNeuropathyAgreementMember" xlink:label="tsha_GiantAxonalNeuropathyAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TransactionPrice" xlink:label="tsha_TransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DifferenceOfMarketValuePaid" xlink:label="tsha_DifferenceOfMarketValuePaid"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ProbabilityOfAnOptionExercise" xlink:label="tsha_ProbabilityOfAnOptionExercise"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SecuritiesPurchaseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_UpfrontPayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AstellasMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AstellasSecuritiesPurchaseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="tsha_AstellasPrivatePlacementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AbeonaRettAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_FairValueOfSharesTransferredValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_GiantAxonalNeuropathyAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SharePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_TransactionPrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_DifferenceOfMarketValuePaid" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_ProbabilityOfAnOptionExercise" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_Revenues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenueCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenueNoncurrent" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseForRettMember" xlink:label="tsha_LicenseForRettMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TransactionPrice" xlink:label="tsha_TransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasMember" xlink:label="tsha_AstellasMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseForGanMember" xlink:label="tsha_LicenseForGanMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AbeonaRettAgreementMember" xlink:label="tsha_AbeonaRettAgreementMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_LicenseForRettMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_TransactionPrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AstellasMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_LicenseForGanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AbeonaRettAgreementMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFacilityMember" xlink:label="tsha_TermLoanFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" xlink:label="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDateRangeStart1" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeStart1"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" xlink:label="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDateRangeEnd1" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeEnd1"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" xlink:label="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_NumberOfDistinctAndActiveClinicalStage" xlink:label="tsha_NumberOfDistinctAndActiveClinicalStage"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfPrepaymentPremium" xlink:label="tsha_PercentageOfPrepaymentPremium"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfPrepaymentOfFacility" xlink:label="tsha_PercentageOfPrepaymentOfFacility"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfAnnualDefaultInterestRate" xlink:label="tsha_PercentageOfAnnualDefaultInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseLongTermDebt" xlink:label="us-gaap_InterestExpenseLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ProceedsFromTermLoan" xlink:label="tsha_ProceedsFromTermLoan"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="tsha_TermLoanFacilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDateRangeStart1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDateRangeEnd1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tsha_NumberOfDistinctAndActiveClinicalStage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tsha_PercentageOfPrepaymentPremium" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tsha_PercentageOfPrepaymentOfFacility" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tsha_PercentageOfAnnualDefaultInterestRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseLongTermDebt" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tsha_ProceedsFromTermLoan" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AbeonaRettAgreementMember" xlink:label="tsha_AbeonaRettAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" xlink:label="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_UTSouthwesternAgreementMember" xlink:label="tsha_UTSouthwesternAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" xlink:label="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_QueensAgreementMember" xlink:label="tsha_QueensAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementForCLN7Member" xlink:label="tsha_LicenseAgreementForCLN7Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AbeonaCLN1AgreementsMember" xlink:label="tsha_AbeonaCLN1AgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" xlink:label="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AbeonaTherapeuticsIncMember" xlink:label="tsha_AbeonaTherapeuticsIncMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" xlink:label="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentsToAcquireLicenseRight" xlink:label="tsha_PaymentsToAcquireLicenseRight"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementRegulatoryMilestonesPayment" xlink:label="tsha_LicenseAgreementRegulatoryMilestonesPayment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementCommercialMilestonesPayment" xlink:label="tsha_LicenseAgreementCommercialMilestonesPayment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AdditionalMilestonePayments" xlink:label="tsha_AdditionalMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentOfLicenseFee" xlink:label="tsha_PaymentOfLicenseFee"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" xlink:label="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_MilestoneFeePaid" xlink:label="tsha_MilestoneFeePaid"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentOfOneTimeUpfrontLicenseFee" xlink:label="tsha_PaymentOfOneTimeUpfrontLicenseFee"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_RegulatoryRelatedMilestonesObligationPayable" xlink:label="tsha_RegulatoryRelatedMilestonesObligationPayable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" xlink:label="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_RegulatoryMilestoneFeePaid" xlink:label="tsha_RegulatoryMilestoneFeePaid"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_UpfrontPayment" xlink:label="tsha_UpfrontPayment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" xlink:label="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable" xlink:label="tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable" xlink:label="tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AbeonaRettAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_UTSouthwesternAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_QueensAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_LicenseAgreementForCLN7Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AbeonaCLN1AgreementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AbeonaTherapeuticsIncMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PaymentsToAcquireLicenseRight" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAgreementRegulatoryMilestonesPayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAgreementCommercialMilestonesPayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_AdditionalMilestonePayments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PaymentOfLicenseFee" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_MilestoneFeePaid" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PaymentOfOneTimeUpfrontLicenseFee" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_RegulatoryRelatedMilestonesObligationPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_RegulatoryMilestoneFeePaid" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_UpfrontPayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_CertainEmployeesAndConsultantsMember" xlink:label="tsha_CertainEmployeesAndConsultantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_EmployeeStockPurchasePlansMember" xlink:label="tsha_EmployeeStockPurchasePlansMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PresidentAndChiefExecutiveOfficerMember" xlink:label="tsha_PresidentAndChiefExecutiveOfficerMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TwoThousandTwentyStockIncentivePlanMember" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_CancelledOptionsMember" xlink:label="tsha_CancelledOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationAwardTrancheFourMember" xlink:label="tsha_ShareBasedCompensationAwardTrancheFourMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember" xlink:label="tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" xlink:label="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PerformanceAndMarketBasedStockOptionsMember" xlink:label="tsha_PerformanceAndMarketBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_MarketBasedStockOptionsMember" xlink:label="tsha_MarketBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="tsha_CertainEmployeesAndConsultantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_EmployeeStockPurchasePlansMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="tsha_PresidentAndChiefExecutiveOfficerMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyStockIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_CancelledOptionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="tsha_ShareBasedCompensationAwardTrancheFourMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_PerformanceAndMarketBasedStockOptionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_MarketBasedStockOptionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TwoThousandTwentyStockIncentivePlanMember" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyStockIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SecuritiesPurchaseAgreementMember" xlink:label="tsha_SecuritiesPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiInvestorsMember" xlink:label="tsha_SsiInvestorsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrantsMember" xlink:label="tsha_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiStrategyHoldingsLlcMember" xlink:label="tsha_SsiStrategyHoldingsLlcMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiWarrantsMember" xlink:label="tsha_SsiWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember" xlink:label="tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts" xlink:label="tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital" xlink:label="tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceOfFairValueWarrant" xlink:label="tsha_IssuanceOfFairValueWarrant"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ClassOfWarrantOrRightVestedAndExercisable" xlink:label="tsha_ClassOfWarrantOrRightVestedAndExercisable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightUnissued" xlink:label="us-gaap_ClassOfWarrantOrRightUnissued"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_BeneficialOwnershipLimitationNoticePeriod" xlink:label="tsha_BeneficialOwnershipLimitationNoticePeriod"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage" xlink:label="tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentsToInvestorsAsLiquidatedDamages" xlink:label="tsha_PaymentsToInvestorsAsLiquidatedDamages"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage" xlink:label="tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ProceedsFromIssuanceOfCommonStockNet" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockNet"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SecuritiesPurchaseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="tsha_SsiInvestorsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tsha_PreFundedWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_SsiStrategyHoldingsLlcMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SsiWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_SharePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_IssuanceOfFairValueWarrant" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_ClassOfWarrantOrRightVestedAndExercisable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightUnissued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_BeneficialOwnershipLimitationNoticePeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_PaymentsToInvestorsAsLiquidatedDamages" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_ProceedsFromIssuanceOfCommonStockNet" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_CommonStockAndWarrantsFairValueDisclosure" xlink:label="tsha_CommonStockAndWarrantsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrantsMember" xlink:label="tsha_PreFundedWarrantsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_CommonStockAndWarrantsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tsha_PreFundedWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_WarrantLiabilityFairValueDisclosure" xlink:label="tsha_WarrantLiabilityFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiWarrantsMember" xlink:label="tsha_SsiWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceOfWarrantLiability" xlink:label="tsha_IssuanceOfWarrantLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrantsMember" xlink:label="tsha_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ChangeInFairValueOfWarrants" xlink:label="tsha_ChangeInFairValueOfWarrants"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_WarrantLiabilityFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tsha_SsiWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_IssuanceOfWarrantLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tsha_PreFundedWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_ChangeInFairValueOfWarrants" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiWarrantsMember" xlink:label="tsha_SsiWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SsiWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_MeasurementInputTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputSharePriceMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="us-gaap_RegistrationPaymentArrangementArrangementDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SecuritiesPurchaseAgreementMember" xlink:label="tsha_SecuritiesPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrantsMember" xlink:label="tsha_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_RegistrationPaymentArrangementArrangementDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:to="tsha_SecuritiesPurchaseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tsha_PreFundedWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrantsMember" xlink:label="tsha_PreFundedWarrantsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="tsha_PreFundedWarrantsMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis" xlink:label="us-gaap_RestructuringPlanAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ExitAndDisposalActivitiesMember" xlink:label="tsha_ExitAndDisposalActivitiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_RestructuringPlanAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringPlanDomain" xlink:to="tsha_ExitAndDisposalActivitiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringPlanAxis" xlink:to="us-gaap_RestructuringPlanDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RestructuringPlanAxis" xlink:to="us-gaap_RestructuringPlanDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_SeveranceCosts1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedSeveranceBalance" xlink:label="tsha_AccruedSeveranceBalance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="us-gaap_EmployeeSeveranceMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SeveranceCostRecorded" xlink:label="tsha_SeveranceCostRecorded"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="tsha_AccruedSeveranceBalance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_EmployeeSeveranceMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="tsha_SeveranceCostRecorded" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_SeveranceCosts1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ClosingDateThroughNovember132024Member" xlink:label="tsha_ClosingDateThroughNovember132024Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TrinityTermLoansMember" xlink:label="tsha_TrinityTermLoansMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TrinityTermLoanAgreementMember" xlink:label="tsha_TrinityTermLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TrinityLendersMember" xlink:label="tsha_TrinityLendersMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_November132024ThroughNovember132025Member" xlink:label="tsha_November132024ThroughNovember132025Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="us-gaap_DebtInstrumentInterestRateTerms"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_November132025ThroughButExcludingTheMaturityDateMember" xlink:label="tsha_November132025ThroughButExcludingTheMaturityDateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_InterestRatePeriod" xlink:label="tsha_InterestRatePeriod"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_InterestRateExtensionPeriod" xlink:label="tsha_InterestRateExtensionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfPrepaymentPremium" xlink:label="tsha_PercentageOfPrepaymentPremium"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_EndOfTermPaymentPercentage" xlink:label="tsha_EndOfTermPaymentPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfAnnualDefaultInterestRate" xlink:label="tsha_PercentageOfAnnualDefaultInterestRate"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="tsha_ClosingDateThroughNovember132024Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="tsha_TrinityTermLoansMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TrinityTermLoanAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="tsha_TrinityLendersMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="tsha_November132024ThroughNovember132025Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateTerms" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="tsha_November132025ThroughButExcludingTheMaturityDateMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_LineOfCreditFacilityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_InterestRatePeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_VariableRateAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_InterestRateExtensionPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_PercentageOfPrepaymentPremium" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_EndOfTermPaymentPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_PercentageOfAnnualDefaultInterestRate" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>tsha-20230930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-11-14T16:15:08.3474+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="tsha-20230930.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:href="tsha-20230930.xsd#Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:href="tsha-20230930.xsd#Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" xlink:href="tsha-20230930.xsd#Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity" xlink:href="tsha-20230930.xsd#StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical" xlink:href="tsha-20230930.xsd#StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="tsha-20230930.xsd#Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperations" xlink:href="tsha-20230930.xsd#Role_DisclosureOrganizationAndDescriptionOfBusinessOperations" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="tsha-20230930.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurements" xlink:href="tsha-20230930.xsd#DisclosureFairValueMeasurements" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponents" xlink:href="tsha-20230930.xsd#Role_DisclosureBalanceSheetComponents" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeases" xlink:href="tsha-20230930.xsd#DisclosureLeases" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements" xlink:href="tsha-20230930.xsd#DisclosureAstellasAgreements" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBank" xlink:href="tsha-20230930.xsd#Role_DisclosureLoanWithSiliconValleyBank" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreements" xlink:href="tsha-20230930.xsd#Role_DisclosureResearchCollaborationAndLicenseAgreements" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:href="tsha-20230930.xsd#Role_DisclosureStockBasedCompensation" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrants" xlink:href="tsha-20230930.xsd#DisclosureWarrants" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShare" xlink:href="tsha-20230930.xsd#Role_DisclosureNetLossPerCommonShare" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:href="tsha-20230930.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:href="tsha-20230930.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritization" xlink:href="tsha-20230930.xsd#Role_DisclosureStrategicReprioritization" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlan" xlink:href="tsha-20230930.xsd#Role_DisclosureRetirementPlan" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:href="tsha-20230930.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="tsha-20230930.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="tsha-20230930.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:href="tsha-20230930.xsd#DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables" xlink:href="tsha-20230930.xsd#Role_DisclosureBalanceSheetComponentsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesTables" xlink:href="tsha-20230930.xsd#DisclosureLeasesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsTables" xlink:href="tsha-20230930.xsd#DisclosureAstellasAgreementsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankTables" xlink:href="tsha-20230930.xsd#Role_DisclosureLoanWithSiliconValleyBankTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:href="tsha-20230930.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsTables" xlink:href="tsha-20230930.xsd#DisclosureWarrantsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables" xlink:href="tsha-20230930.xsd#Role_DisclosureNetLossPerCommonShareTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationTables" xlink:href="tsha-20230930.xsd#DisclosureStrategicReprioritizationTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails" xlink:href="tsha-20230930.xsd#DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:href="tsha-20230930.xsd#DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:href="tsha-20230930.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" xlink:href="tsha-20230930.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#DisclosureLeasesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaseCostDetails" xlink:href="tsha-20230930.xsd#DisclosureLeasesScheduleOfLeaseCostDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateDetails" xlink:href="tsha-20230930.xsd#DisclosureLeasesSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails" xlink:href="tsha-20230930.xsd#DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails" xlink:href="tsha-20230930.xsd#DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#DisclosureAstellasAgreementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails" xlink:href="tsha-20230930.xsd#DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails" xlink:href="tsha-20230930.xsd#DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock" xlink:href="tsha-20230930.xsd#DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#DisclosureWarrantsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails" xlink:href="tsha-20230930.xsd#DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails" xlink:href="tsha-20230930.xsd#DisclosureWarrantsScheduleOfWarrantLiabilityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails" xlink:href="tsha-20230930.xsd#DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#DisclosureNetLossPerCommonShareAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureStrategicReprioritizationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails" xlink:href="tsha-20230930.xsd#DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureRetirementPlanAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="tsha-20230930.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="73.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="74.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="75.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="76.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="77.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentQuarterlyReport" order="78.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="79.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:label="us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCash" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DerivativeLiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermDebtCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ChangeInFairValueOfWarrantLiability" xlink:label="tsha_ChangeInFairValueOfWarrantLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="tsha_ChangeInFairValueOfWarrantLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiStrategyHoldingsLlcMember" xlink:label="tsha_SsiStrategyHoldingsLlcMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares" xlink:label="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_10"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_11"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_SsiStrategyHoldingsLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_10" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding_11" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiStrategyHoldingsLlcMember" xlink:label="tsha_SsiStrategyHoldingsLlcMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts" xlink:label="tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_SsiStrategyHoldingsLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_CounterpartyNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" xlink:label="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ResearchAndDevelopmentLicenseExpense" xlink:label="tsha_ResearchAndDevelopmentLicenseExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentOfShelfRegistrationCosts" xlink:label="tsha_PaymentOfShelfRegistrationCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement" xlink:label="tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceCostsForPreFundedWarrantLiability" xlink:label="tsha_IssuanceCostsForPreFundedWarrantLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ResearchAndDevelopmentLicenseNotYetPaid" xlink:label="tsha_ResearchAndDevelopmentLicenseNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_5"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="tsha_ResearchAndDevelopmentLicenseExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="tsha_PaymentOfShelfRegistrationCosts" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="tsha_IssuanceCostsForPreFundedWarrantLiability" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="tsha_ResearchAndDevelopmentLicenseNotYetPaid" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestrictedCash" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperations" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponents" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeases" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasMember" xlink:label="tsha_AstellasMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AstellasMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBank" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreements" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:label="tsha_ResearchCollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrants" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_WarrantsNoteDisclosureTextBlock" xlink:label="tsha_WarrantsNoteDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="tsha_WarrantsNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShare" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritization" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" xlink:label="us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlan" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AssetsHeldForSalePolicyTextBlock" xlink:label="tsha_AssetsHeldForSalePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_WarrantsPolicyPolicyTextBlock" xlink:label="tsha_WarrantsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="tsha_AssetsHeldForSalePolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="tsha_WarrantsPolicyPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" xlink:label="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:label="tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" xlink:label="tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" xlink:label="tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SummaryOfTransactionPriceAllocationTableTextBlock" xlink:label="tsha_SummaryOfTransactionPriceAllocationTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="tsha_SummaryOfTransactionPriceAllocationTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock" xlink:label="tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" order="5.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock" xlink:label="tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfWarrantLiabilityTableTextBlock" xlink:label="tsha_ScheduleOfWarrantLiabilityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock" xlink:label="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock" xlink:label="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="tsha_ScheduleOfWarrantLiabilityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock" xlink:label="tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SalesAgreementMember" xlink:label="tsha_SalesAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SalesAgentMember" xlink:label="tsha_SalesAgentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasMember" xlink:label="tsha_AstellasMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AggregateOfferingPriceFromSaleOfCommonStock" xlink:label="tsha_AggregateOfferingPriceFromSaleOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiStrategyHoldingsLlcMember" xlink:label="tsha_SsiStrategyHoldingsLlcMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfSalePricePerShareOfCommonStock" xlink:label="tsha_PercentageOfSalePricePerShareOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_CommonStockSharesIssuedAndSold" xlink:label="tsha_CommonStockSharesIssuedAndSold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SalesAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="tsha_SalesAgentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AstellasMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="srt_ProductOrServiceAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_AggregateOfferingPriceFromSaleOfCommonStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_SsiStrategyHoldingsLlcMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_PercentageOfSalePricePerShareOfCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="srt_CounterpartyNameAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_CommonStockSharesIssuedAndSold" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SignificantAccountingPoliciesTable" xlink:label="tsha_SignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SignificantAccountingPoliciesLineItems" xlink:label="tsha_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:label="us-gaap_AccountingStandardsUpdate201912Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment" xlink:label="tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DerecognizedBuildToSuitLeaseLiability" xlink:label="tsha_DerecognizedBuildToSuitLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances" xlink:label="tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CumulativeEarningsDeficit" xlink:label="us-gaap_CumulativeEarningsDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="tsha_SignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesTable" xlink:to="tsha_SignificantAccountingPoliciesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201912Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="tsha_DerecognizedBuildToSuitLeaseLiability" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CumulativeEarningsDeficit" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SignificantAccountingPoliciesTable" xlink:label="tsha_SignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SignificantAccountingPoliciesLineItems" xlink:label="tsha_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember" xlink:label="srt_RestatementAdjustmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesTable" xlink:to="srt_RestatementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="tsha_SignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementAdjustmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesTable" xlink:to="tsha_SignificantAccountingPoliciesLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NetIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiWarrants" xlink:label="tsha_SsiWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrants" xlink:label="tsha_PreFundedWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="tsha_SsiWarrants" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="tsha_PreFundedWarrants" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PrepaidResearchAndDevelopmentContracts" xlink:label="tsha_PrepaidResearchAndDevelopmentContracts"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PrepaidClinicalTrial" xlink:label="tsha_PrepaidClinicalTrial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PrepaidBonus" xlink:label="tsha_PrepaidBonus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_PrepaidResearchAndDevelopmentContracts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_PrepaidClinicalTrial" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_DeferredOfferingCosts" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PrepaidInsurance" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_PrepaidBonus" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LaboratoryEquipmentMember" xlink:label="tsha_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tsha_LaboratoryEquipmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AssetsCapitalizedAsFinanceLeasesMember" xlink:label="tsha_AssetsCapitalizedAsFinanceLeasesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset" xlink:label="tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="tsha_AssetsCapitalizedAsFinanceLeasesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AssetImpairmentCharges" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedResearchAndDevelopmentCurrent" xlink:label="tsha_AccruedResearchAndDevelopmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LeaseLiabilityCurrent" xlink:label="tsha_LeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedClinicalTrialCurrent" xlink:label="tsha_AccruedClinicalTrialCurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedSeverance" xlink:label="tsha_AccruedSeverance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedPropertyPlantAndEquipmentCurrent" xlink:label="tsha_AccruedPropertyPlantAndEquipmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_AccruedResearchAndDevelopmentCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_LeaseLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_AccruedClinicalTrialCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_AccruedSeverance" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="tsha_AccruedPropertyPlantAndEquipmentCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DallasLeaseMember" xlink:label="tsha_DallasLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PegasusParkLLCMember" xlink:label="tsha_PegasusParkLLCMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DallasLeaseAmendmentMember" xlink:label="tsha_DallasLeaseAmendmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperationsCommencedDate1" xlink:label="us-gaap_OperationsCommencedDate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DurhamLeaseMember" xlink:label="tsha_DurhamLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_OnSiteGenerationLeaseMember" xlink:label="tsha_OnSiteGenerationLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" xlink:label="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit" xlink:label="us-gaap_EscrowDeposit"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_DallasLeaseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_CounterpartyNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_PegasusParkLLCMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_DallasLeaseAmendmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperationsCommencedDate1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_DurhamLeaseMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_OnSiteGenerationLeaseMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_EscrowDeposit" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaseCostDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_VariableLeaseCost" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:label="us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:label="tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:label="tsha_FinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_12"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability_13"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="tsha_FinanceLeaseLiabilityPaymentsDueAfterYearFour" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability_12" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiability_13" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SecuritiesPurchaseAgreementMember" xlink:label="tsha_SecuritiesPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_UpfrontPayment" xlink:label="tsha_UpfrontPayment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasMember" xlink:label="tsha_AstellasMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasSecuritiesPurchaseAgreementMember" xlink:label="tsha_AstellasSecuritiesPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasPrivatePlacementMember" xlink:label="tsha_AstellasPrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AbeonaRettAgreementMember" xlink:label="tsha_AbeonaRettAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_FairValueOfSharesTransferredValue" xlink:label="tsha_FairValueOfSharesTransferredValue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_GiantAxonalNeuropathyAgreementMember" xlink:label="tsha_GiantAxonalNeuropathyAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TransactionPrice" xlink:label="tsha_TransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DifferenceOfMarketValuePaid" xlink:label="tsha_DifferenceOfMarketValuePaid"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ProbabilityOfAnOptionExercise" xlink:label="tsha_ProbabilityOfAnOptionExercise"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SecuritiesPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_UpfrontPayment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AstellasMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AstellasSecuritiesPurchaseAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="tsha_AstellasPrivatePlacementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AbeonaRettAgreementMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_FairValueOfSharesTransferredValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_GiantAxonalNeuropathyAgreementMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_SharePrice" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_TransactionPrice" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_DifferenceOfMarketValuePaid" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_ProbabilityOfAnOptionExercise" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_Revenues" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenue" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenueCurrent" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseForRettMember" xlink:label="tsha_LicenseForRettMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TransactionPrice" xlink:label="tsha_TransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasMember" xlink:label="tsha_AstellasMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseForGanMember" xlink:label="tsha_LicenseForGanMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AbeonaRettAgreementMember" xlink:label="tsha_AbeonaRettAgreementMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_LicenseForRettMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_TransactionPrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AstellasMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_LicenseForGanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AbeonaRettAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFacilityMember" xlink:label="tsha_TermLoanFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" xlink:label="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDateRangeStart1" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeStart1"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" xlink:label="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDateRangeEnd1" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeEnd1"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" xlink:label="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_NumberOfDistinctAndActiveClinicalStage" xlink:label="tsha_NumberOfDistinctAndActiveClinicalStage"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfPrepaymentPremium" xlink:label="tsha_PercentageOfPrepaymentPremium"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfPrepaymentOfFacility" xlink:label="tsha_PercentageOfPrepaymentOfFacility"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfAnnualDefaultInterestRate" xlink:label="tsha_PercentageOfAnnualDefaultInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseLongTermDebt" xlink:label="us-gaap_InterestExpenseLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ProceedsFromTermLoan" xlink:label="tsha_ProceedsFromTermLoan"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="tsha_TermLoanFacilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDateRangeStart1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDateRangeEnd1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tsha_NumberOfDistinctAndActiveClinicalStage" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tsha_PercentageOfPrepaymentPremium" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tsha_PercentageOfPrepaymentOfFacility" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tsha_PercentageOfAnnualDefaultInterestRate" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseLongTermDebt" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="tsha_ProceedsFromTermLoan" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebt" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AbeonaRettAgreementMember" xlink:label="tsha_AbeonaRettAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" xlink:label="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:label="tsha_ResearchCollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_UTSouthwesternAgreementMember" xlink:label="tsha_UTSouthwesternAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" xlink:label="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_QueensAgreementMember" xlink:label="tsha_QueensAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementForCLN7Member" xlink:label="tsha_LicenseAgreementForCLN7Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AbeonaCLN1AgreementsMember" xlink:label="tsha_AbeonaCLN1AgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" xlink:label="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AbeonaTherapeuticsIncMember" xlink:label="tsha_AbeonaTherapeuticsIncMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" xlink:label="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentsToAcquireLicenseRight" xlink:label="tsha_PaymentsToAcquireLicenseRight"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementRegulatoryMilestonesPayment" xlink:label="tsha_LicenseAgreementRegulatoryMilestonesPayment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementCommercialMilestonesPayment" xlink:label="tsha_LicenseAgreementCommercialMilestonesPayment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AdditionalMilestonePayments" xlink:label="tsha_AdditionalMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentOfLicenseFee" xlink:label="tsha_PaymentOfLicenseFee"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" xlink:label="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_MilestoneFeePaid" xlink:label="tsha_MilestoneFeePaid"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentOfOneTimeUpfrontLicenseFee" xlink:label="tsha_PaymentOfOneTimeUpfrontLicenseFee"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_RegulatoryRelatedMilestonesObligationPayable" xlink:label="tsha_RegulatoryRelatedMilestonesObligationPayable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" xlink:label="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_RegulatoryMilestoneFeePaid" xlink:label="tsha_RegulatoryMilestoneFeePaid"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_UpfrontPayment" xlink:label="tsha_UpfrontPayment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" xlink:label="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable" xlink:label="tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable" xlink:label="tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AbeonaRettAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tsha_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_UTSouthwesternAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_QueensAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_LicenseAgreementForCLN7Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AbeonaCLN1AgreementsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_AbeonaTherapeuticsIncMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PaymentsToAcquireLicenseRight" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAgreementRegulatoryMilestonesPayment" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAgreementCommercialMilestonesPayment" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_AdditionalMilestonePayments" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PaymentOfLicenseFee" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_MilestoneFeePaid" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_PaymentOfOneTimeUpfrontLicenseFee" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_RegulatoryRelatedMilestonesObligationPayable" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_RegulatoryMilestoneFeePaid" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_UpfrontPayment" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_CertainEmployeesAndConsultantsMember" xlink:label="tsha_CertainEmployeesAndConsultantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PresidentAndChiefExecutiveOfficerMember" xlink:label="tsha_PresidentAndChiefExecutiveOfficerMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TwoThousandTwentyStockIncentivePlanMember" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationAwardTrancheFourMember" xlink:label="tsha_ShareBasedCompensationAwardTrancheFourMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_EmployeeStockPurchasePlansMember" xlink:label="tsha_EmployeeStockPurchasePlansMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" xlink:label="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_CancelledOptionsMember" xlink:label="tsha_CancelledOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember" xlink:label="tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PerformanceAndMarketBasedStockOptionsMember" xlink:label="tsha_PerformanceAndMarketBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_MarketBasedStockOptionsMember" xlink:label="tsha_MarketBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="tsha_CertainEmployeesAndConsultantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="tsha_PresidentAndChiefExecutiveOfficerMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyStockIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="tsha_ShareBasedCompensationAwardTrancheFourMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_EmployeeStockPurchasePlansMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_CancelledOptionsMember" order="5.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="6.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember" order="7.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="8.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_PerformanceAndMarketBasedStockOptionsMember" order="9.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="10.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" order="11.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="tsha_MarketBasedStockOptionsMember" order="12.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TwoThousandTwentyStockIncentivePlanMember" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="tsha_TwoThousandTwentyStockIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" order="5.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_21"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" order="5.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_21" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SecuritiesPurchaseAgreementMember" xlink:label="tsha_SecuritiesPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiInvestorsMember" xlink:label="tsha_SsiInvestorsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrantsMember" xlink:label="tsha_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiStrategyHoldingsLlcMember" xlink:label="tsha_SsiStrategyHoldingsLlcMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiWarrantsMember" xlink:label="tsha_SsiWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember" xlink:label="tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts" xlink:label="tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital" xlink:label="tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceOfFairValueWarrant" xlink:label="tsha_IssuanceOfFairValueWarrant"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ClassOfWarrantOrRightVestedAndExercisable" xlink:label="tsha_ClassOfWarrantOrRightVestedAndExercisable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightUnissued" xlink:label="us-gaap_ClassOfWarrantOrRightUnissued"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_BeneficialOwnershipLimitationNoticePeriod" xlink:label="tsha_BeneficialOwnershipLimitationNoticePeriod"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage" xlink:label="tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentsToInvestorsAsLiquidatedDamages" xlink:label="tsha_PaymentsToInvestorsAsLiquidatedDamages"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage" xlink:label="tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ProceedsFromIssuanceOfCommonStockNet" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SecuritiesPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="tsha_SsiInvestorsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="srt_CounterpartyNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tsha_PreFundedWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="tsha_SsiStrategyHoldingsLlcMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SsiWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="dei_LegalEntityAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_SharePrice" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_IssuanceOfFairValueWarrant" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_ClassOfWarrantOrRightVestedAndExercisable" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightUnissued" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_BeneficialOwnershipLimitationNoticePeriod" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_PaymentsToInvestorsAsLiquidatedDamages" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_ProceedsFromIssuanceOfCommonStockNet" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_CommonStockAndWarrantsFairValueDisclosure" xlink:label="tsha_CommonStockAndWarrantsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrantsMember" xlink:label="tsha_PreFundedWarrantsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_CommonStockAndWarrantsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tsha_PreFundedWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_WarrantLiabilityFairValueDisclosure" xlink:label="tsha_WarrantLiabilityFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiWarrantsMember" xlink:label="tsha_SsiWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceOfWarrantLiability" xlink:label="tsha_IssuanceOfWarrantLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrantsMember" xlink:label="tsha_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ChangeInFairValueOfWarrants" xlink:label="tsha_ChangeInFairValueOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_WarrantLiabilityFairValueDisclosure" xlink:label="tsha_WarrantLiabilityFairValueDisclosure_3"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_WarrantLiabilityFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tsha_SsiWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_IssuanceOfWarrantLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tsha_PreFundedWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_ChangeInFairValueOfWarrants" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="tsha_WarrantLiabilityFairValueDisclosure_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiWarrantsMember" xlink:label="tsha_SsiWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="tsha_SsiWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputSharePriceMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="us-gaap_RegistrationPaymentArrangementArrangementDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SecuritiesPurchaseAgreementMember" xlink:label="tsha_SecuritiesPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrantsMember" xlink:label="tsha_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_RegistrationPaymentArrangementArrangementDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:to="tsha_SecuritiesPurchaseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="tsha_PreFundedWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrantsMember" xlink:label="tsha_PreFundedWarrantsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="tsha_PreFundedWarrantsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis" xlink:label="us-gaap_RestructuringPlanAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ExitAndDisposalActivitiesMember" xlink:label="tsha_ExitAndDisposalActivitiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_RestructuringPlanAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringPlanDomain" xlink:to="tsha_ExitAndDisposalActivitiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringPlanAxis" xlink:to="us-gaap_RestructuringPlanDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_SeveranceCosts1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_RestructuringCostAndReserveLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedSeveranceBalance" xlink:label="tsha_AccruedSeveranceBalance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="us-gaap_EmployeeSeveranceMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SeveranceCostRecorded" xlink:label="tsha_SeveranceCostRecorded"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedSeveranceBalance" xlink:label="tsha_AccruedSeveranceBalance_3"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="tsha_AccruedSeveranceBalance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_EmployeeSeveranceMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="tsha_SeveranceCostRecorded" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_RestructuringCostAndReserveLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_SeveranceCosts1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="tsha_AccruedSeveranceBalance_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ClosingDateThroughNovember132024Member" xlink:label="tsha_ClosingDateThroughNovember132024Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TrinityTermLoansMember" xlink:label="tsha_TrinityTermLoansMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TrinityTermLoanAgreementMember" xlink:label="tsha_TrinityTermLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TrinityLendersMember" xlink:label="tsha_TrinityLendersMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_November132024ThroughNovember132025Member" xlink:label="tsha_November132024ThroughNovember132025Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="us-gaap_DebtInstrumentInterestRateTerms"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_November132025ThroughButExcludingTheMaturityDateMember" xlink:label="tsha_November132025ThroughButExcludingTheMaturityDateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_InterestRatePeriod" xlink:label="tsha_InterestRatePeriod"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_InterestRateExtensionPeriod" xlink:label="tsha_InterestRateExtensionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfPrepaymentPremium" xlink:label="tsha_PercentageOfPrepaymentPremium"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_EndOfTermPaymentPercentage" xlink:label="tsha_EndOfTermPaymentPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfAnnualDefaultInterestRate" xlink:label="tsha_PercentageOfAnnualDefaultInterestRate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="tsha_ClosingDateThroughNovember132024Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="tsha_TrinityTermLoansMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="tsha_TrinityTermLoanAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="tsha_TrinityLendersMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="tsha_November132024ThroughNovember132025Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateTerms" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="tsha_November132025ThroughButExcludingTheMaturityDateMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_LineOfCreditFacilityAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_InterestRatePeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_VariableRateAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_InterestRateExtensionPeriod" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_StatementScenarioAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_PercentageOfPrepaymentPremium" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_EndOfTermPaymentPercentage" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="tsha_PercentageOfAnnualDefaultInterestRate" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>20
<FILENAME>tsha-20230930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-11-14T16:15:13.2195+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ProceedsFromTermLoan" xlink:label="tsha_ProceedsFromTermLoan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseForGanMember" xlink:label="tsha_LicenseForGanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" xlink:label="tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AbeonaTherapeuticsIncMember" xlink:label="tsha_AbeonaTherapeuticsIncMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceOfFairValueWarrant" xlink:label="tsha_IssuanceOfFairValueWarrant"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AssetsCapitalizedAsFinanceLeasesMember" xlink:label="tsha_AssetsCapitalizedAsFinanceLeasesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock" xlink:label="tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeSeveranceMember" xlink:label="us-gaap_EmployeeSeveranceMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_MilestoneFeePaid" xlink:label="tsha_MilestoneFeePaid"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" xlink:label="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TrinityTermLoanAgreementMember" xlink:label="tsha_TrinityTermLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasSecuritiesPurchaseAgreementMember" xlink:label="tsha_AstellasSecuritiesPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ClosingDateThroughNovember132024Member" xlink:label="tsha_ClosingDateThroughNovember132024Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage" xlink:label="tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_CommonStockAndWarrantsFairValueDisclosure" xlink:label="tsha_CommonStockAndWarrantsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PrepaidClinicalTrial" xlink:label="tsha_PrepaidClinicalTrial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ExitAndDisposalActivitiesMember" xlink:label="tsha_ExitAndDisposalActivitiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ResearchAndDevelopmentLicenseExpense" xlink:label="tsha_ResearchAndDevelopmentLicenseExpense"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_WarrantsNoteDisclosureTextBlock" xlink:label="tsha_WarrantsNoteDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember" xlink:label="tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfPrepaymentOfFacility" xlink:label="tsha_PercentageOfPrepaymentOfFacility"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DurhamLeaseMember" xlink:label="tsha_DurhamLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_CancelledOptionsMember" xlink:label="tsha_CancelledOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ChangeInFairValueOfWarrants" xlink:label="tsha_ChangeInFairValueOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrantsMember" xlink:label="tsha_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" xlink:label="us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset" xlink:label="tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_QueensAgreementMember" xlink:label="tsha_QueensAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SalesAgentMember" xlink:label="tsha_SalesAgentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:label="us-gaap_AccountingStandardsUpdate201912Member"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" xlink:label="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock" xlink:label="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfSalePricePerShareOfCommonStock" xlink:label="tsha_PercentageOfSalePricePerShareOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_November132025ThroughButExcludingTheMaturityDateMember" xlink:label="tsha_November132025ThroughButExcludingTheMaturityDateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SummaryOfTransactionPriceAllocationTableTextBlock" xlink:label="tsha_SummaryOfTransactionPriceAllocationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfWarrantLiabilityTableTextBlock" xlink:label="tsha_ScheduleOfWarrantLiabilityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" xlink:label="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceOfWarrantLiability" xlink:label="tsha_IssuanceOfWarrantLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SignificantAccountingPoliciesTable" xlink:label="tsha_SignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_November132024ThroughNovember132025Member" xlink:label="tsha_November132024ThroughNovember132025Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_EndOfTermPaymentPercentage" xlink:label="tsha_EndOfTermPaymentPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="us-gaap_DebtInstrumentInterestRateTerms"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CumulativeEarningsDeficit" xlink:label="us-gaap_CumulativeEarningsDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDateRangeStart1" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeStart1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_InterestRatePeriod" xlink:label="tsha_InterestRatePeriod"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" xlink:label="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasPrivatePlacementMember" xlink:label="tsha_AstellasPrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SignificantAccountingPoliciesLineItems" xlink:label="tsha_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:label="us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TransactionPrice" xlink:label="tsha_TransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LaboratoryEquipmentMember" xlink:label="tsha_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AdditionalMilestonePayments" xlink:label="tsha_AdditionalMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" xlink:label="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="us-gaap_RestructuringCostAndReserveAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement" xlink:label="tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EscrowDeposit" xlink:label="us-gaap_EscrowDeposit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDateRangeEnd1" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeEnd1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_InterestRateExtensionPeriod" xlink:label="tsha_InterestRateExtensionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_WarrantLiabilityFairValueDisclosure" xlink:label="tsha_WarrantLiabilityFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ProbabilityOfAnOptionExercise" xlink:label="tsha_ProbabilityOfAnOptionExercise"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiStrategyHoldingsLlcMember" xlink:label="tsha_SsiStrategyHoldingsLlcMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DallasLeaseAmendmentMember" xlink:label="tsha_DallasLeaseAmendmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" xlink:label="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:label="us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" xlink:label="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_CertainEmployeesAndConsultantsMember" xlink:label="tsha_CertainEmployeesAndConsultantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementCommercialMilestonesPayment" xlink:label="tsha_LicenseAgreementCommercialMilestonesPayment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" xlink:label="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrants" xlink:label="tsha_PreFundedWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentOfOneTimeUpfrontLicenseFee" xlink:label="tsha_PaymentOfOneTimeUpfrontLicenseFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember" xlink:label="srt_RestatementAdjustmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts" xlink:label="tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AssetsHeldForSalePolicyTextBlock" xlink:label="tsha_AssetsHeldForSalePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_WarrantsPolicyPolicyTextBlock" xlink:label="tsha_WarrantsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PerformanceAndMarketBasedStockOptionsMember" xlink:label="tsha_PerformanceAndMarketBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_UpfrontPayment" xlink:label="tsha_UpfrontPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_GiantAxonalNeuropathyAgreementMember" xlink:label="tsha_GiantAxonalNeuropathyAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceCostsForPreFundedWarrantLiability" xlink:label="tsha_IssuanceCostsForPreFundedWarrantLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_RegulatoryRelatedMilestonesObligationPayable" xlink:label="tsha_RegulatoryRelatedMilestonesObligationPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentOfShelfRegistrationCosts" xlink:label="tsha_PaymentOfShelfRegistrationCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember" xlink:label="tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ChangeInFairValueOfWarrantLiability" xlink:label="tsha_ChangeInFairValueOfWarrantLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AbeonaRettAgreementMember" xlink:label="tsha_AbeonaRettAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TwoThousandTwentyStockIncentivePlanMember" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock" xlink:label="tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_CommonStockSharesIssuedAndSold" xlink:label="tsha_CommonStockSharesIssuedAndSold"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseForRettMember" xlink:label="tsha_LicenseForRettMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiInvestorsMember" xlink:label="tsha_SsiInvestorsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentOfLicenseFee" xlink:label="tsha_PaymentOfLicenseFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TrinityTermLoansMember" xlink:label="tsha_TrinityTermLoansMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DerecognizedBuildToSuitLeaseLiability" xlink:label="tsha_DerecognizedBuildToSuitLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SalesAgreementMember" xlink:label="tsha_SalesAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperationsCommencedDate1" xlink:label="us-gaap_OperationsCommencedDate1"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFacilityMember" xlink:label="tsha_TermLoanFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationAwardTrancheFourMember" xlink:label="tsha_ShareBasedCompensationAwardTrancheFourMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedSeveranceBalance" xlink:label="tsha_AccruedSeveranceBalance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedClinicalTrialCurrent" xlink:label="tsha_AccruedClinicalTrialCurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" xlink:label="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment" xlink:label="tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedSeverance" xlink:label="tsha_AccruedSeverance"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:label="tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:label="us-gaap_RegistrationPaymentArrangementArrangementDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares" xlink:label="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SecuritiesPurchaseAgreementMember" xlink:label="tsha_SecuritiesPurchaseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AstellasMember" xlink:label="tsha_AstellasMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentsToInvestorsAsLiquidatedDamages" xlink:label="tsha_PaymentsToInvestorsAsLiquidatedDamages"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances" xlink:label="tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementForCLN7Member" xlink:label="tsha_LicenseAgreementForCLN7Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DifferenceOfMarketValuePaid" xlink:label="tsha_DifferenceOfMarketValuePaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PegasusParkLLCMember" xlink:label="tsha_PegasusParkLLCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" xlink:label="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_RegulatoryMilestoneFeePaid" xlink:label="tsha_RegulatoryMilestoneFeePaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedPropertyPlantAndEquipmentCurrent" xlink:label="tsha_AccruedPropertyPlantAndEquipmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PresidentAndChiefExecutiveOfficerMember" xlink:label="tsha_PresidentAndChiefExecutiveOfficerMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" xlink:label="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable" xlink:label="tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_EmployeeStockPurchasePlansMember" xlink:label="tsha_EmployeeStockPurchasePlansMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:label="tsha_ResearchCollaborationAndLicenseAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_NumberOfDistinctAndActiveClinicalStage" xlink:label="tsha_NumberOfDistinctAndActiveClinicalStage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ClassOfWarrantOrRightVestedAndExercisable" xlink:label="tsha_ClassOfWarrantOrRightVestedAndExercisable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" xlink:label="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementRegulatoryMilestonesPayment" xlink:label="tsha_LicenseAgreementRegulatoryMilestonesPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" xlink:label="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_MarketBasedStockOptionsMember" xlink:label="tsha_MarketBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfAnnualDefaultInterestRate" xlink:label="tsha_PercentageOfAnnualDefaultInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:label="tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock" xlink:label="tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts" xlink:label="tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ResearchAndDevelopmentLicenseNotYetPaid" xlink:label="tsha_ResearchAndDevelopmentLicenseNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AggregateOfferingPriceFromSaleOfCommonStock" xlink:label="tsha_AggregateOfferingPriceFromSaleOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" xlink:label="tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TrinityLendersMember" xlink:label="tsha_TrinityLendersMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedResearchAndDevelopmentCurrent" xlink:label="tsha_AccruedResearchAndDevelopmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_FairValueOfSharesTransferredValue" xlink:label="tsha_FairValueOfSharesTransferredValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_BeneficialOwnershipLimitationNoticePeriod" xlink:label="tsha_BeneficialOwnershipLimitationNoticePeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringPlanAxis" xlink:label="us-gaap_RestructuringPlanAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AbeonaCLN1AgreementsMember" xlink:label="tsha_AbeonaCLN1AgreementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentsToAcquireLicenseRight" xlink:label="tsha_PaymentsToAcquireLicenseRight"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PercentageOfPrepaymentPremium" xlink:label="tsha_PercentageOfPrepaymentPremium"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_UTSouthwesternAgreementMember" xlink:label="tsha_UTSouthwesternAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiWarrantsMember" xlink:label="tsha_SsiWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightUnissued" xlink:label="us-gaap_ClassOfWarrantOrRightUnissued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PrepaidBonus" xlink:label="tsha_PrepaidBonus"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SeveranceCostRecorded" xlink:label="tsha_SeveranceCostRecorded"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_OnSiteGenerationLeaseMember" xlink:label="tsha_OnSiteGenerationLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock" xlink:label="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiWarrants" xlink:label="tsha_SsiWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital" xlink:label="tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LeaseLiabilityCurrent" xlink:label="tsha_LeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage" xlink:label="tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" xlink:label="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:label="tsha_FinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ProceedsFromIssuanceOfCommonStockNet" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_DallasLeaseMember" xlink:label="tsha_DallasLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable" xlink:label="tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="us-gaap_TypeOfRestructuringDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain" xlink:label="srt_RestatementDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseLongTermDebt" xlink:label="us-gaap_InterestExpenseLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PrepaidResearchAndDevelopmentContracts" xlink:label="tsha_PrepaidResearchAndDevelopmentContracts"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock and pre-funded warrants from private placement, net of placement agent commissions and other offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Common Stock And Prefunded Warrants From Private Placement Net Of Placement Agent Commissions And Other Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of common stock and prefunded warrants from private placement net of placement agent commissions and other offering costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">TSHA-120</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Acquisition Of Worldwide Rights For T S H A120 For Treatment Of Giant Axonal Neuropathy [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Acquisition of worldwide rights for TSHA 120 for treatment of giant axonal neuropathy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding, Weighted Average Remaining Contractual Life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of headcount reduced</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring and Related Cost, Number of Positions Eliminated, Period Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restructuring Cost And Reserve [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award vesting period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other non-current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted, Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options grants in period intrinsic value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ProceedsFromTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from term loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ProceedsFromTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Term Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ProceedsFromTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from term loan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unvested RSUs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseForGanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option to obtain license for GAN</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseForGanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License For GAN [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseForGanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License For GAN</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, expiration date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Forfeitures</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeitures</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Cancelled In Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award number of shares available for grant cancelled in period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">OperatingLeaseLiability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Supplemental Cash Flow Information Related to Operating Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Supplemental Cash Flow Information Related To Operating Leases [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule Of Supplemental Cash Flow Information Related To Operating Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License and inventory purchase agreement sales related milestones payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License And Inventory Purchase Agreement Sales Related Milestones Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License and inventory purchase agreement sales related milestones payment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AbeonaTherapeuticsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Abeona</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AbeonaTherapeuticsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Abeona Therapeutics Inc [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AbeonaTherapeuticsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Abeona Therapeutics Inc.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfFairValueWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of SSI warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfFairValueWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of fair value warrant.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfFairValueWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Fair Value Warrant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfFairValueWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of fair value warrant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AssetsCapitalizedAsFinanceLeasesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets Capitalized As Finance Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AssetsCapitalizedAsFinanceLeasesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Capitalized as Finance Leases [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AssetsCapitalizedAsFinanceLeasesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Assets capitalized as finance leases.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of Individual [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability, net of current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease liabilities, non-current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Accrued Severance Activity Recorded</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued Severance Activity Recorded [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of accrued severance activity table text block.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance, lease liabilities, non-current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Instrument, Unamortized Discount, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unamortized debt discount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unamortized Discount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeSeveranceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Severance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeSeveranceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Severance [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_MilestoneFeePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone fee paid.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_MilestoneFeePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Fee Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_MilestoneFeePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone fee paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of clinical materials and reimbursement incurred development costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Of Clinical Materials And Reimbursement Incurred Development Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase of clinical materials and reimbursement incurred development costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders' (deficit) equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, commencement date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Commencement Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award commencement date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding. Stock Options, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding. Stock Options, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding performance and market-based options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, options, weighted-average grant date fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TrinityTermLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trinity Term Loan Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TrinityTermLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trinity Term Loan Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TrinityTermLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Trinity Term Loan Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock reserved for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AstellasSecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Astellas Securities Purchase Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AstellasSecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Astellas Securities Purchase Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AstellasSecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Astellas Securities Purchase Agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum number of shares employees may purchase during offering period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Current portion of Term Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan, current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Current Maturities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Long-Term Debt, Current Maturities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ClosingDateThroughNovember132024Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Closing Date through November 13, 2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ClosingDateThroughNovember132024Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Closing Date through November 13, 2024 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ClosingDateThroughNovember132024Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Closing Date through November 13, 2024.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average discount rate - Operating leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease extend term of contract</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Renewal Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan with Silicon Valley Bank</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Property Plant and Equipment Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization And Description Of Business Operations [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization And Description Of Business Operations [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Organization and description of business operations.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable at September 30, 2023, Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Options expired, Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement, Tranche Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options expired , Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options expired in period intrinsic value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Impairment of assets held for sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of long-lived assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Impairment, Long-Lived Asset, Held-for-Use, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease liabilities, current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lender Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, maturity date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments to investors as additional liquidated damages percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Investors As Additional Liquidated Damages Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments to investors as additional liquidated damages percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Term Loan, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, plant and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, plant and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_CommonStockAndWarrantsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock and warrants fair value disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_CommonStockAndWarrantsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock and Warrants Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_CommonStockAndWarrantsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock and warrants fair value disclosure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at September 30, 2023, Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PrepaidClinicalTrial_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid clinical trial</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PrepaidClinicalTrial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Clinical Trial</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PrepaidClinicalTrial_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid clinical trial.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance lease liabilities, current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants to purchase share of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease, option to extend description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Option to Extend</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ExitAndDisposalActivitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exit and Disposal Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ExitAndDisposalActivitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exit And Disposal Activities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ExitAndDisposalActivitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exit and disposal activities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ResearchAndDevelopmentLicenseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development license expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ResearchAndDevelopmentLicenseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development License Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ResearchAndDevelopmentLicenseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and development license expense.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_WarrantsNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants note disclosure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_WarrantsNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Note Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_WarrantsNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Construction in Progress</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Construction in Progress [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under ESPP</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">August 2023 Private Placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">August Two Thousand And Twenty Three Private Placement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">August two thousand and twenty three private placement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Leases [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unvested RSAs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining lease term (in years) - Finance leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfPrepaymentOfFacility_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of prepayment of facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfPrepaymentOfFacility_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Prepayment Of Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfPrepaymentOfFacility_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of prepayment of facility.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease term of contract</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, options, compensation cost not yet recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DurhamLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Durham Lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DurhamLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Durham Lease [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DurhamLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Durham lease.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Replacement restricted units granted, Number of Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares awarded</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement Units Grants In Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award equity instruments other than options replacement units grants in period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_CancelledOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cancelled Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_CancelledOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cancelled Options [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_CancelledOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cancelled options.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from common stock issuances under ESPP</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of cash flow information:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Restricted Stock Awards Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstsanding performance and market-based RSU's</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Nonvested, Number of Shares, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Nonvested, Number of Shares, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on held for sale assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on held for sale assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Disposition of Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gain (Loss) on Disposition of Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under ESPP, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares of common stock issued under ESPP</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ChangeInFairValueOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ChangeInFairValueOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Fair Value of Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ChangeInFairValueOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value of warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Revenues, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Accounting Policies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Prepaid Expenses and Other Current Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeveranceCosts1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Severance paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeveranceCosts1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Severance and termination-related costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeveranceCosts1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Severance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement, Tranche One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adoption Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, plan modification, incremental cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, basis spread on variable rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research And Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of payroll deductions of employee's compensation during offering period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Offering Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-Funded Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pre Funded Warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre Funded Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Stock Option Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASSETS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock, net of sales commissions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net proceeds from issuance of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gross proceeds from issuance of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Strategic Reprioritization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Integration, Restructuring and Other Related Costs [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Available for grant ending of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Available for grant beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating lease landlord square feet manufacturing facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Subject to or Available for Operating Lease, Number of Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Expected Term [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.00001 par value per share; 200,000,000 shares authorized and 186,960,193 and 63,207,507 issued and outstanding as of September 30, 2023 and December 31, 2022, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization and Description of Business Operations [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization And Description Of Business Operations [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Organization and description of business operations.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment charges to construction in process and finance lease right of use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Charge On Construction In Progress And Finance Lease Right Of Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Impairment Charge On Construction In Progress And Finance Lease Right Of Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_QueensAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Queens Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_QueensAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Queens Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_QueensAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Queen's agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Noncash Income (Expense), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncash Income (Expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Granted In Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award number of shares available for grant granted in period..</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Decrease in revenue previously recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and Fixtures</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture and Fixtures [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SalesAgentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales Agents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SalesAgentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sales Agent [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SalesAgentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sales agent.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Payment Arrangement, Noncash Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201912Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU 2019-12</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201912Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2019-12 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preclinical activities period under sponsored research agreements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preclinical Activities Period Under Sponsored Research Agreements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Preclinical activities period under sponsored research agreements.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Tax Expense (Benefit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provision for income taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, vesting rights percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of assumptions used to estimate fair value of warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Assumptions Used To Estimate Fair Value Of Warrants [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Assumptions Used To Estimate Fair Value Of Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU 2016-02</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfSalePricePerShareOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of gross sales price per share of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfSalePricePerShareOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Sale Price Per Share Of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfSalePricePerShareOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of sale price per share of common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_November132025ThroughButExcludingTheMaturityDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">November 13, 2025 through, but excluding, the Maturity Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_November132025ThroughButExcludingTheMaturityDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">November 13, 2025 through, but excluding, the Maturity Date [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_November132025ThroughButExcludingTheMaturityDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">November 13, 2025 through, but excluding, the Maturity Date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets Held for Sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: imputed interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SummaryOfTransactionPriceAllocationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Allocation for Transaction Price to the Three Performance Obligations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SummaryOfTransactionPriceAllocationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Transaction Price Allocation [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SummaryOfTransactionPriceAllocationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary Of Transaction Price Allocation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfWarrantLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Warrant Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfWarrantLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Warrant Liability [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfWarrantLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of warrant liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, Aggregate Intrinsic Value, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, Aggregate Intrinsic Value, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale-related milestones per licensed product and royalties on net sales of licensed products payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale Related Milestones Per Licensed Product And Royalties On Net Sales Of Licensed Products Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sale-related milestones per licensed product and royalties on net sales of licensed products payable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Pre-Funded Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Warrant Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of warrant liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Term Debt, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Significant accounting policies table.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other non-current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">January 1, 2022 until September 30, 2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan From January One Twenty Twenty Two Until September Thirty Twenty Twenty Two [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan from january one twenty twenty two until september thirty twenty twenty two.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share-based payment award, options granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted, Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_November132024ThroughNovember132025Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">November 13, 2024 through November 13, 2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_November132024ThroughNovember132025Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">November 13, 2024 through November 13, 2025 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_November132024ThroughNovember132025Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">November 13, 2024 through November 13, 2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Additional Paid in Capital, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Through August 13, 2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan Through August Thirteen Twenty Twenty Three [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan through august thirteen twenty twenty three.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at September 30, 2023, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_EndOfTermPaymentPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">End of term payment percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_EndOfTermPaymentPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">End of term payment percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate terms description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate Terms</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' (deficit) equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Lease Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Aggregate principal amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum borrowing capacity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CumulativeEarningsDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CumulativeEarningsDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Earnings (Deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeStart1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, maturity start date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeStart1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date Range, Start</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_InterestRatePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest rate period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_InterestRatePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest rate period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">October 1, 2022 until March 31, 2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan From October One Twenty Twenty Two Until March Thirty One Twenty Twenty Three [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan from october one twenty twenty two until march thirty one twenty twenty three.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AstellasPrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Astellas Private Placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AstellasPrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Astellas Private Placement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AstellasPrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Astellas Private Placement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Significant accounting policies line items.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowOperatingActivitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per common share, basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Transaction Price Allocation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Transaction Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Transaction price.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies - Note 13</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Laboratory equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AdditionalMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AdditionalMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Milestone Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AdditionalMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional Milestone payments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Effect of the Adoption of ASC 842 on Statement of Operations and Cash Flows</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">January 1, 2022 until March 31, 2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan From January One Twenty Twenty Two Until March Thirty One Twenty Twenty Three [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan from january one twenty twenty two until march thirty one twenty twenty three.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PerformanceSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PerformanceSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, plant and equipment in accounts payable and accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property And Equipment In Accounts Payable And Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Property and equipment in accounts payable and accrued expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringCostAndReserveAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at September 30, 2023, Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan adjustments and amendments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Plan Adjustments And Amendments In Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award number of shares available for grant plan adjustments and amendments in period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of warrants in connection with private placement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Warrants In Connection With Private Placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of warrants in connection with private placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">All Award Types</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options cancelled or forfeited, Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Or Forfeited In Period Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options cancelled or forfeited in period intrinsic value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating cash flows for operating leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EscrowDeposit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount required to place in escrow account</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EscrowDeposit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Escrow Deposit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per common share, diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeEnd1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, maturity end date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDateRangeEnd1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date Range, End</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_InterestRateExtensionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest rate extension period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_InterestRateExtensionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest rate extension period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_WarrantLiabilityFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_WarrantLiabilityFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at September 30, 2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_WarrantLiabilityFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at January 1, 2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_WarrantLiabilityFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Liability Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_WarrantLiabilityFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant liability fair value disclosure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ProbabilityOfAnOptionExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Probability of option exercise</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ProbabilityOfAnOptionExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Probability Of An Option Exercise</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ProbabilityOfAnOptionExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Probability of Option Exercise</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SsiStrategyHoldingsLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SSI Strategy Holdings LLC</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SsiStrategyHoldingsLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">SSI Strategy Holdings LLC [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SsiStrategyHoldingsLlcMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">SSI Strategy Holdings LLC.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award requisite service vesting period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DallasLeaseAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Dallas lease amendment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DallasLeaseAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dallas Lease Amendment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DallasLeaseAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dallas Lease Amendment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum licensed product to develop obtain regulatory approval for and commercialize</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Licensed Product To Develop Obtain Regulatory Approval For And Commercialize</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum licensed product to develop obtain regulatory approval for and commercialize.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets held for sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset, Held-for-Sale, Not Part of Disposal Group, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Asset, Held-for-Sale, Not Part of Disposal Group, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Principal Debt Payments on Loan Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of fully diluted common stock shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Fully Diluted Common Stock Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of fully diluted common stock shares outstanding.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_CertainEmployeesAndConsultantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Certain Employees and Consultants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_CertainEmployeesAndConsultantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Certain Employees And Consultants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_CertainEmployeesAndConsultantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Certain employees and consultants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Restructuring And Related Costs [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principles of Consolidation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementCommercialMilestonesPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement commercial milestones payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementCommercialMilestonesPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Commercial Milestones Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementCommercialMilestonesPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement commercial milestones payment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum construction allowance provided by landlord per rentable square foot.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum Construction Allowance Provided By Landlord Per Rentable Square Foot</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum construction allowance provided by landlord per rentable square foot</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-funded warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre Funded Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pre funded warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentOfOneTimeUpfrontLicenseFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of one-time upfront license fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentOfOneTimeUpfrontLicenseFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment Of One Time Upfront License Fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentOfOneTimeUpfrontLicenseFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment of one-time upfront license fee.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RestatementAdjustmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASC 842 Adjustments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RestatementAdjustmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: imputed interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment of sales commissions and other offering costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment Of Sales Commissions And Other Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of sales commissions and other offering cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share-based payment award, RSU/RSA granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted units/stock granted, Number of Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of research and development license</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire in Process Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RestatementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revision of Prior Period [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AssetsHeldForSalePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets Held for Sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AssetsHeldForSalePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets Held for Sale [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AssetsHeldForSalePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Assets held for sale.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_WarrantsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_WarrantsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_WarrantsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PerformanceAndMarketBasedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance and Market-based Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PerformanceAndMarketBasedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance And Market-Based Stock Options [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PerformanceAndMarketBasedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance and market-based stock options.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringAndRelatedActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring and Related Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Retirement Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_UpfrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_UpfrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upfront Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_UpfrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront payment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested, Weighted Average Grant Date Fair Value per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable at September 30, 2023, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_GiantAxonalNeuropathyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option Agreement for GAN</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_GiantAxonalNeuropathyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Giant Axonal Neuropathy Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_GiantAxonalNeuropathyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Giant axonal neuropathy agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceCostsForPreFundedWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance costs for pre-funded warrant liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceCostsForPreFundedWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Costs For Pre-funded Warrant Liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceCostsForPreFundedWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance costs for pre-funded warrant liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_RegulatoryRelatedMilestonesObligationPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Regulatory related milestones obligation payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_RegulatoryRelatedMilestonesObligationPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Regulatory Related Milestones Obligation Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_RegulatoryRelatedMilestonesObligationPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Regulatory related milestones obligation payable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred revenue, net of current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue recorded within long-term liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentOfShelfRegistrationCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment of shelf registration costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentOfShelfRegistrationCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment Of Shelf Registration Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentOfShelfRegistrationCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment of shelf registration costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, compensation cost not yet recognized, weighted-average period of recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance and Market-based Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance and Market-based Restricted Stock Units [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance and market-based restricted stock units.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at September 30, 2023, Weighted Average Remaining Contractual Life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares authorized for issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Research, Collaboration and License Agreements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Astellas Agreements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate gross proceeds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Private Placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ChangeInFairValueOfWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value of warrant liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ChangeInFairValueOfWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Fair Value of Warrant Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ChangeInFairValueOfWarrantLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value of warrant liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AbeonaRettAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rett Research and Development Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AbeonaRettAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Abeona Rett Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AbeonaRettAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Abeona Rett agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization and Description of Business Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Stock Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TwoThousandTwentyStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty stock incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Fair Value Method to Allocate Net Proceeds Received from Sale of Common Stock and Pre-funded Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Fair Value Method To Allocate Net Proceeds Received From Sale Of Common Stock And Warrants [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of fair value method to allocate net proceeds received from sale of common stock and warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 3</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value of warrant liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of warrant liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrant liability fair value adjustment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Adjustment of Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_CommonStockSharesIssuedAndSold_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock shares issued and sold</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_CommonStockSharesIssuedAndSold_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Issued And Sold</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_CommonStockSharesIssuedAndSold_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock shares issued and sold.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseForRettMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option to obtain license for Rett</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseForRettMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License For RETT [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseForRettMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License For RETT</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SsiInvestorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">SSI investors.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SsiInvestorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">SSI Investors [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SsiInvestorsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SSI Investors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of noncash investing and financing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Options cancelled or forfeited, Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Existing Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TwoThousandTwentyEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty equity incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average common shares outstanding, basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentOfLicenseFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License fee payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentOfLicenseFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment Of License Fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentOfLicenseFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment of license fee.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Restricted Stock Units Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TrinityTermLoansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trinity Term Loans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TrinityTermLoansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trinity Term Loans [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TrinityTermLoansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Trinity Term Loans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DerecognizedBuildToSuitLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derecognized build to suit lease liablility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DerecognizedBuildToSuitLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derecognized Build To Suit Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DerecognizedBuildToSuitLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Derecognized Build To Suit Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future minimum remianing lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sales Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sales Agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued professional and consulting fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accrued Expense And Other Current Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in accrued expense and other current liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperationsCommencedDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease commencement date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperationsCommencedDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operations Commenced Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan Facility [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan facility.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationAwardTrancheFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement, Tranche Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationAwardTrancheFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Award Tranche Four [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationAwardTrancheFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation award tranche four.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anti-dilutive securities excluded from computation of diluted net loss per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedSeveranceBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accrued severance balance as of September 30, 2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedSeveranceBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accrued severance balance as of December 31, 2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedSeveranceBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Severance Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedSeveranceBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued severance balance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">SSI Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Date of incorporation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, Date of Incorporation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedClinicalTrialCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued clinical trial</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedClinicalTrialCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Clinical Trial Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedClinicalTrialCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued clinical trial current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Expense and Other Current Labilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued Expense And Other Current Labilities Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of accrued expense and other current labilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">PIPE Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Total Stock-Based Compensation Expense for Stock Options, ESPP, RSAs and RSUs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable at Sepember 30, 2023, Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derecognized build to suite lease asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derecognized Build To Suit Lease Asset Presented In Property Plant Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Derecognized Build To Suit Lease Asset Presented In Property Plant Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedSeverance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued severance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedSeverance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Severance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedSeverance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued Severance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Supplemental Information Related to Remaining Lease Term and Discount Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Supplemental Information Related To Remaining Lease Term And Discount Rate [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of supplemental information related to remaining lease term and discount rate.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License and inventory purchase agreement regulatory related milestones payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License And Inventory Purchase Agreement Regulatory Related Milestones Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License and inventory purchase agreement regulatory related milestones payment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RegistrationPaymentArrangementArrangementDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Registration Payment Arrangement, Arrangement [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock upon vesting and settlement of restricted stock unit shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Upon Vesting And Settlement Of Restricted Stock Unit Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon vesting and settlement of restricted stock units, net, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities Purchase Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Purchase Agreement Member</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Securities purchase agreement member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SecuritiesPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Purchase Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AstellasMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Astellas</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AstellasMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Astellas [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AstellasMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Astellas [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentsToInvestorsAsLiquidatedDamages_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments to investors as liquidated damages.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentsToInvestorsAsLiquidatedDamages_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Investors As Liquidated Damages</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentsToInvestorsAsLiquidatedDamages_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments to investors as liquidated damages</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share-based payment award, RSU/RSA granted, weighted average grant date fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted units/stock granted, Weighted Average Grant Date Fair Value per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringPlanDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restructuring Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringPlanDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Plan [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accrued Expense And Other Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in accrued expense and other liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred rent liabiilities and tenant improvement allowances</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Rent Liabiilities And Tenant Improvement Allowances</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred Rent Liabiilities And Tenant Improvement Allowances</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, expiration period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recently Adopted Accounting Pronouncements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementForCLN7Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License Agreement for CLN7</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementForCLN7Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement For C L N7 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementForCLN7Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement for CLN7.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Gross, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Gross, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Gross, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, plant and equipment, gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Market-based Stock Options vested during period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options cancelled or forfeited, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DifferenceOfMarketValuePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Difference of market value paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DifferenceOfMarketValuePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Difference Of Market Value Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DifferenceOfMarketValuePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Difference of market value paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options were exercised during the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PegasusParkLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pegasus Park, LLC.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PegasusParkLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pegasus Park L L C [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PegasusParkLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pegasus Park L L C</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of entitled to receive additional shares on fully diluted basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Common Stock Shares Entitled To Receive Additional Shares On Fully Diluted Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of common stock shares entitled to receive additional shares on fully diluted basis.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leases [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_RegulatoryMilestoneFeePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Regulatory milestone fee paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_RegulatoryMilestoneFeePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Regulatory Milestone Fee Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_RegulatoryMilestoneFeePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Regulatory milestone fee paid.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedPropertyPlantAndEquipmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued property, plant and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedPropertyPlantAndEquipmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Property Plant And Equipment Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedPropertyPlantAndEquipmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued property, plant, and equipment current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PresidentAndChiefExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RA Session II</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PresidentAndChiefExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">President And Chief Executive Officer [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PresidentAndChiefExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">President and chief executive officer.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PresidentAndChiefExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Former President and Chief Executive Officer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of automatic increase every year in common stock shares reserved for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Automatic Increase Every Year In Common Stock Shares Reserved For Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of automatic increase every year in common stock shares reserved for future issuance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement sales-related milestones maximum amount payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Sales Related Milestones Maximum Amount Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement sales-related milestones maximum amount payable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average discount rate - Finance leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Term Loan, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding, Measurement Input</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants, measurement input</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_EmployeeStockPurchasePlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Stock Purchase Plan (ESPP)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_EmployeeStockPurchasePlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plans [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_EmployeeStockPurchasePlansMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock purchase plans.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ResearchCollaborationAndLicenseAgreementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research Collaboration And License Agreements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ResearchCollaborationAndLicenseAgreementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research, collaboration and license agreements.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Nonvested, Weighted Average Grant Date Fair Value per Share, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Nonvested, Weighted Average Grant Date Fair Value per Share, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_NumberOfDistinctAndActiveClinicalStage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of distinct and active clinical stage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_NumberOfDistinctAndActiveClinicalStage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Distinct And Active Clinical Stage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_NumberOfDistinctAndActiveClinicalStage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of distinct and active clinical stage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities and Other Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term in years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.00001 par value per share; 10,000,000 shares authorized and no shares issued and outstanding as of September 30, 2023 and December 31, 2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of Individual [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitment fee percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ClassOfWarrantOrRightVestedAndExercisable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of warrant or right vested and exercisable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ClassOfWarrantOrRightVestedAndExercisable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Vested and Exercisable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ClassOfWarrantOrRightVestedAndExercisable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of warrant or right vested and exercisable shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise price of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Exercise price of warrants per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, unvested RSU/RSA granted, compensation cost not yet recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Common Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Clinical, regulatory and commercial milestones to be received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Clinical Regulatory And Commercial Milestones To Be Received</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Clinical, regulatory and commercial milestones to be received.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents - money market funds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementRegulatoryMilestonesPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement regulatory milestones payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementRegulatoryMilestonesPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Regulatory Milestones Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementRegulatoryMilestonesPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement regulatory milestones payment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">April 1, 2023 until December 31, 2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan From April One Twenty Twenty Three Until December Thirty One Twenty Twenty Three [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan from april one twenty twenty three until december thirty one twenty twenty three.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_MarketBasedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Market based stock options.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_MarketBasedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Market Based Stock Options [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_MarketBasedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Market-based Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfAnnualDefaultInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of annual default interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfAnnualDefaultInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Annual Default Interest Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfAnnualDefaultInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of annual default interest rate.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, options grant date fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options grants in period grant date fair value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Market value of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Share Price [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Price Volatility [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Liability Payments Due After Year Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease liability payments due after year four.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Restricted Cash, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Share Based Compensation Available for Grant under Incentive Plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Available For Grant [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of share based compensation available for grant.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable lease cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incurred placement agent commissions and other issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incurred Placement Agent Commissions And Other Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Incurred placement agent commissions and other issuance costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Term Debt, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ResearchAndDevelopmentLicenseNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of research and development license not yet paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ResearchAndDevelopmentLicenseNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development License Not Yet Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ResearchAndDevelopmentLicenseNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and development license not yet paid.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid insurance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Insurance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AggregateOfferingPriceFromSaleOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate offering price from sale of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AggregateOfferingPriceFromSaleOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Aggregate Offering Price From Sale Of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AggregateOfferingPriceFromSaleOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Aggregate offering price from sale of common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Minimum Commitments Under Company's Operating and Finance Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating And Finance Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee, operating and finance lease, liability, maturity .</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Purchase price per share of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TrinityLendersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trinity Lenders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TrinityLendersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trinity Lenders [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TrinityLendersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Trinity Lenders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total principal payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets obtained in exchange for lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Previously ASC 842</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Previously Reported [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prime Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prime Rate [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of common stock price purchased through payroll deductions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research And Development Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AccruedResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_FairValueOfSharesTransferredValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of shares transferred, Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_FairValueOfSharesTransferredValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Of Shares Transferred Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_FairValueOfSharesTransferredValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value of shares transferred value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Impairment loss on sale of assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement, Tranche Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_BeneficialOwnershipLimitationNoticePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Beneficial ownership limitation notice period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_BeneficialOwnershipLimitationNoticePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Beneficial Ownership Limitation Notice Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_BeneficialOwnershipLimitationNoticePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Beneficial ownership limitation notice period (in days)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based payment award, terms of award issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contribution to retirement savings plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable at September 30, 2023, Weighted Average Remaining Contractual Life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringPlanAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restructuring Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestructuringPlanAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring Plan [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cancelled or forfeited, Weighted Average Grant Date Fair Value per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share-based payment award, options granted, exercise price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current borrowing capacity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AbeonaCLN1AgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Abeona CLN1 Agreements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AbeonaCLN1AgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Abeona CLN1 Agreements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AbeonaCLN1AgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Abeona C L N1 Agreements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AbeonaCLN1AgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Abeona CLN1 agreements.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Quarterly Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Quarterly Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants associated with loan facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss) Available to Common Stockholders, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentsToAcquireLicenseRight_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash payment to acquire license agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentsToAcquireLicenseRight_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire License Right</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PaymentsToAcquireLicenseRight_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments to acquire license right.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cancelled or forfeited, Number of Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options expired, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfPrepaymentPremium_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of prepayment premium</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfPrepaymentPremium_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Prepayment Premium</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PercentageOfPrepaymentPremium_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of prepayment premium</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_UTSouthwesternAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">UT Southwestern Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_UTSouthwesternAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">U T Southwestern Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_UTSouthwesternAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">UT southwestern agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other income (expense), net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SsiWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">SSI Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SsiWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">SSI Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SsiWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SSI Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightUnissued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Unissued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightUnissued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering costs not yet paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash impairment charge</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Impairment Charges</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Asset Impairment Charges, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' (deficit) equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PrepaidBonus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid bonus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PrepaidBonus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Bonus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PrepaidBonus_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid bonus.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SeveranceCostRecorded_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Severance recorded</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SeveranceCostRecorded_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Severance Cost Recorded</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SeveranceCostRecorded_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Severance cost recorded.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense):</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance Lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_OnSiteGenerationLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">On-site generation lease.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_OnSiteGenerationLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">On Site Generation Lease [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_OnSiteGenerationLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">On Site Generation Lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average common shares outstanding, diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Non-cash lease expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Assumptions Used To Estimate Fair Value Of SSI Warrant Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Assumptions Used To Estimate Fair Value Of SSI Warrant Liability [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of assumptions used to estimate fair value of SSI warrant liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase price per share of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SsiWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SSI Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SsiWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">SSI Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_SsiWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">SSI warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining lease term (in years) - Operating leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allocated to shares, deduction to Additional paid-In capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Allocated to Shares, deduction to Additional paid-In capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Allocated to Shares, deduction to Additional paid-In capital.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liabilities, current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Liability Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease liability current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase or decrease in beneficial ownership limitation percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase or Decrease in Beneficial Ownership Limitation Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase or decrease in beneficial ownership limitation percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, Weighted Average Exercise Price, Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, Weighted Average Exercise Price, Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Through December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan Through December Thirty One Twenty Twenty One [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan through december thirty one twenty twenty one.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Calculation of Basic and Diluted Net Loss Per Common Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_FinanceLeaseLiabilityPaymentsDueAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_FinanceLeaseLiabilityPaymentsDueAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Liability Payments Due After Year Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_FinanceLeaseLiabilityPaymentsDueAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance lease liability payments due after year four.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockNet_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from issuance of common stock and pre-funded warrants from private placement, net of sales commissions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from issuance of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Common Stock Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance of common stock net.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DallasLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Dallas lease.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DallasLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dallas Lease [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_DallasLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dallas Lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of property, plant and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement regulatory related milestones maximum amount payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Regulatory Related Milestones Maximum Amount Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement regulatory related milestones maximum amount payable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfRestructuringDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Type of Restructuring [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RestatementDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revision of Prior Period [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exit fee recorded as debt discount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unamortized Discount, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Vested, Number of Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance and market-based restricted stock units of other option vested during period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Employee-related Liabilities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee-related Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents and restricted cash at the beginning of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents and restricted cash at the end of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Revenue, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred revenue recorded within current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Long-Term Debt, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense related to term loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Long-Term Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PrepaidResearchAndDevelopmentContracts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PrepaidResearchAndDevelopmentContracts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Research And Development Contracts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tsha_PrepaidResearchAndDevelopmentContracts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid research and development contracts.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts" xlink:to="tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" xlink:to="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:to="us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ProceedsFromTermLoan" xlink:to="tsha_ProceedsFromTermLoan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LicenseForGanMember" xlink:to="tsha_LicenseForGanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" xlink:to="tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" xlink:to="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AbeonaTherapeuticsIncMember" xlink:to="tsha_AbeonaTherapeuticsIncMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_IssuanceOfFairValueWarrant" xlink:to="tsha_IssuanceOfFairValueWarrant_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AssetsCapitalizedAsFinanceLeasesMember" xlink:to="tsha_AssetsCapitalizedAsFinanceLeasesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock" xlink:to="tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeSeveranceMember" xlink:to="us-gaap_EmployeeSeveranceMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_MilestoneFeePaid" xlink:to="tsha_MilestoneFeePaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" xlink:to="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TrinityTermLoanAgreementMember" xlink:to="tsha_TrinityTermLoanAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AstellasSecuritiesPurchaseAgreementMember" xlink:to="tsha_AstellasSecuritiesPurchaseAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ClosingDateThroughNovember132024Member" xlink:to="tsha_ClosingDateThroughNovember132024Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" xlink:to="tsha_OrganizationAndDescriptionOfBusinessOperationsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage" xlink:to="tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_CommonStockAndWarrantsFairValueDisclosure" xlink:to="tsha_CommonStockAndWarrantsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PrepaidClinicalTrial" xlink:to="tsha_PrepaidClinicalTrial_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ExitAndDisposalActivitiesMember" xlink:to="tsha_ExitAndDisposalActivitiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ResearchAndDevelopmentLicenseExpense" xlink:to="tsha_ResearchAndDevelopmentLicenseExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_WarrantsNoteDisclosureTextBlock" xlink:to="tsha_WarrantsNoteDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember" xlink:to="tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PercentageOfPrepaymentOfFacility" xlink:to="tsha_PercentageOfPrepaymentOfFacility_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_DurhamLeaseMember" xlink:to="tsha_DurhamLeaseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_CancelledOptionsMember" xlink:to="tsha_CancelledOptionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockPlans" xlink:to="us-gaap_ProceedsFromStockPlans_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ChangeInFairValueOfWarrants" xlink:to="tsha_ChangeInFairValueOfWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="us-gaap_SeveranceCosts1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesCurrent" xlink:to="us-gaap_DerivativeLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PreFundedWarrantsMember" xlink:to="tsha_PreFundedWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock" xlink:to="us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" xlink:to="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset" xlink:to="tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_QueensAgreementMember" xlink:to="tsha_QueensAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SalesAgentMember" xlink:to="tsha_SalesAgentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201912Member" xlink:to="us-gaap_AccountingStandardsUpdate201912Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" xlink:to="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock" xlink:to="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PercentageOfSalePricePerShareOfCommonStock" xlink:to="tsha_PercentageOfSalePricePerShareOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_November132025ThroughButExcludingTheMaturityDateMember" xlink:to="tsha_November132025ThroughButExcludingTheMaturityDateMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SummaryOfTransactionPriceAllocationTableTextBlock" xlink:to="tsha_SummaryOfTransactionPriceAllocationTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ScheduleOfWarrantLiabilityTableTextBlock" xlink:to="tsha_ScheduleOfWarrantLiabilityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" xlink:to="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_IssuanceOfWarrantLiability" xlink:to="tsha_IssuanceOfWarrantLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SignificantAccountingPoliciesTable" xlink:to="tsha_SignificantAccountingPoliciesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" xlink:to="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_November132024ThroughNovember132025Member" xlink:to="tsha_November132024ThroughNovember132025Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" xlink:to="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_EndOfTermPaymentPercentage" xlink:to="tsha_EndOfTermPaymentPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateTerms" xlink:to="us-gaap_DebtInstrumentInterestRateTerms_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CumulativeEarningsDeficit" xlink:to="us-gaap_CumulativeEarningsDeficit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDateRangeStart1" xlink:to="us-gaap_DebtInstrumentMaturityDateRangeStart1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_InterestRatePeriod" xlink:to="tsha_InterestRatePeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" xlink:to="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AstellasPrivatePlacementMember" xlink:to="tsha_AstellasPrivatePlacementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SignificantAccountingPoliciesLineItems" xlink:to="tsha_SignificantAccountingPoliciesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="us-gaap_CashFlowOperatingActivitiesLesseeAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TransactionPrice" xlink:to="tsha_TransactionPrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LaboratoryEquipmentMember" xlink:to="tsha_LaboratoryEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AdditionalMilestonePayments" xlink:to="tsha_AdditionalMilestonePayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" xlink:to="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PerformanceSharesMember" xlink:to="us-gaap_PerformanceSharesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" xlink:to="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_RestructuringCostAndReserveAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement" xlink:to="tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EscrowDeposit" xlink:to="us-gaap_EscrowDeposit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDateRangeEnd1" xlink:to="us-gaap_DebtInstrumentMaturityDateRangeEnd1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_InterestRateExtensionPeriod" xlink:to="tsha_InterestRateExtensionPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_WarrantLiabilityFairValueDisclosure" xlink:to="tsha_WarrantLiabilityFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ProbabilityOfAnOptionExercise" xlink:to="tsha_ProbabilityOfAnOptionExercise_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SsiStrategyHoldingsLlcMember" xlink:to="tsha_SsiStrategyHoldingsLlcMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_DallasLeaseAmendmentMember" xlink:to="tsha_DallasLeaseAmendmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" xlink:to="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:to="us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" xlink:to="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_CertainEmployeesAndConsultantsMember" xlink:to="tsha_CertainEmployeesAndConsultantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LicenseAgreementCommercialMilestonesPayment" xlink:to="tsha_LicenseAgreementCommercialMilestonesPayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" xlink:to="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PreFundedWarrants" xlink:to="tsha_PreFundedWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PaymentOfOneTimeUpfrontLicenseFee" xlink:to="tsha_PaymentOfOneTimeUpfrontLicenseFee_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts" xlink:to="tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AssetsHeldForSalePolicyTextBlock" xlink:to="tsha_AssetsHeldForSalePolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_WarrantsPolicyPolicyTextBlock" xlink:to="tsha_WarrantsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PerformanceAndMarketBasedStockOptionsMember" xlink:to="tsha_PerformanceAndMarketBasedStockOptionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="us-gaap_RestructuringAndRelatedActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_UpfrontPayment" xlink:to="tsha_UpfrontPayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_GiantAxonalNeuropathyAgreementMember" xlink:to="tsha_GiantAxonalNeuropathyAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_IssuanceCostsForPreFundedWarrantLiability" xlink:to="tsha_IssuanceCostsForPreFundedWarrantLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_RegulatoryRelatedMilestonesObligationPayable" xlink:to="tsha_RegulatoryRelatedMilestonesObligationPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PaymentOfShelfRegistrationCosts" xlink:to="tsha_PaymentOfShelfRegistrationCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="srt_CumulativeEffectPeriodOfAdoptionAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember" xlink:to="tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ChangeInFairValueOfWarrantLiability" xlink:to="tsha_ChangeInFairValueOfWarrantLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AbeonaRettAgreementMember" xlink:to="tsha_AbeonaRettAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TwoThousandTwentyStockIncentivePlanMember" xlink:to="tsha_TwoThousandTwentyStockIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock" xlink:to="tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_CommonStockSharesIssuedAndSold" xlink:to="tsha_CommonStockSharesIssuedAndSold_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LicenseForRettMember" xlink:to="tsha_LicenseForRettMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SsiInvestorsMember" xlink:to="tsha_SsiInvestorsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TwoThousandTwentyEquityIncentivePlanMember" xlink:to="tsha_TwoThousandTwentyEquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PaymentOfLicenseFee" xlink:to="tsha_PaymentOfLicenseFee_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TrinityTermLoansMember" xlink:to="tsha_TrinityTermLoansMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_DerecognizedBuildToSuitLeaseLiability" xlink:to="tsha_DerecognizedBuildToSuitLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SalesAgreementMember" xlink:to="tsha_SalesAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities" xlink:to="tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperationsCommencedDate1" xlink:to="us-gaap_OperationsCommencedDate1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanFacilityMember" xlink:to="tsha_TermLoanFacilityMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationAwardTrancheFourMember" xlink:to="tsha_ShareBasedCompensationAwardTrancheFourMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AccruedSeveranceBalance" xlink:to="tsha_AccruedSeveranceBalance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AccruedClinicalTrialCurrent" xlink:to="tsha_AccruedClinicalTrialCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" xlink:to="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="srt_CumulativeEffectPeriodOfAdoptionDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment" xlink:to="tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AccruedSeverance" xlink:to="tsha_AccruedSeverance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock" xlink:to="tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" xlink:to="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RegistrationPaymentArrangementArrangementDomain" xlink:to="us-gaap_RegistrationPaymentArrangementArrangementDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares" xlink:to="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SecuritiesPurchaseAgreementMember" xlink:to="tsha_SecuritiesPurchaseAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AstellasMember" xlink:to="tsha_AstellasMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PaymentsToInvestorsAsLiquidatedDamages" xlink:to="tsha_PaymentsToInvestorsAsLiquidatedDamages_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringPlanDomain" xlink:to="us-gaap_RestructuringPlanDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" xlink:to="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances" xlink:to="tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LicenseAgreementForCLN7Member" xlink:to="tsha_LicenseAgreementForCLN7Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_DifferenceOfMarketValuePaid" xlink:to="tsha_DifferenceOfMarketValuePaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PegasusParkLLCMember" xlink:to="tsha_PegasusParkLLCMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" xlink:to="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_RegulatoryMilestoneFeePaid" xlink:to="tsha_RegulatoryMilestoneFeePaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AccruedPropertyPlantAndEquipmentCurrent" xlink:to="tsha_AccruedPropertyPlantAndEquipmentCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PresidentAndChiefExecutiveOfficerMember" xlink:to="tsha_PresidentAndChiefExecutiveOfficerMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" xlink:to="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable" xlink:to="tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_EmployeeStockPurchasePlansMember" xlink:to="tsha_EmployeeStockPurchasePlansMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ResearchCollaborationAndLicenseAgreementsAbstract" xlink:to="tsha_ResearchCollaborationAndLicenseAgreementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_NumberOfDistinctAndActiveClinicalStage" xlink:to="tsha_NumberOfDistinctAndActiveClinicalStage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ClassOfWarrantOrRightVestedAndExercisable" xlink:to="tsha_ClassOfWarrantOrRightVestedAndExercisable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" xlink:to="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LicenseAgreementRegulatoryMilestonesPayment" xlink:to="tsha_LicenseAgreementRegulatoryMilestonesPayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" xlink:to="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_MarketBasedStockOptionsMember" xlink:to="tsha_MarketBasedStockOptionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PercentageOfAnnualDefaultInterestRate" xlink:to="tsha_PercentageOfAnnualDefaultInterestRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:to="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock" xlink:to="tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts" xlink:to="tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ResearchAndDevelopmentLicenseNotYetPaid" xlink:to="tsha_ResearchAndDevelopmentLicenseNotYetPaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AggregateOfferingPriceFromSaleOfCommonStock" xlink:to="tsha_AggregateOfferingPriceFromSaleOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TrinityLendersMember" xlink:to="tsha_TrinityLendersMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrimeRateMember" xlink:to="us-gaap_PrimeRateMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AccruedResearchAndDevelopmentCurrent" xlink:to="tsha_AccruedResearchAndDevelopmentCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_FairValueOfSharesTransferredValue" xlink:to="tsha_FairValueOfSharesTransferredValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_BeneficialOwnershipLimitationNoticePeriod" xlink:to="tsha_BeneficialOwnershipLimitationNoticePeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringPlanAxis" xlink:to="us-gaap_RestructuringPlanAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AbeonaCLN1AgreementsMember" xlink:to="tsha_AbeonaCLN1AgreementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PaymentsToAcquireLicenseRight" xlink:to="tsha_PaymentsToAcquireLicenseRight_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PercentageOfPrepaymentPremium" xlink:to="tsha_PercentageOfPrepaymentPremium_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_UTSouthwesternAgreementMember" xlink:to="tsha_UTSouthwesternAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SsiWarrantsMember" xlink:to="tsha_SsiWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightUnissued" xlink:to="us-gaap_ClassOfWarrantOrRightUnissued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PrepaidBonus" xlink:to="tsha_PrepaidBonus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SeveranceCostRecorded" xlink:to="tsha_SeveranceCostRecorded_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_OnSiteGenerationLeaseMember" xlink:to="tsha_OnSiteGenerationLeaseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock" xlink:to="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_SsiWarrants" xlink:to="tsha_SsiWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital" xlink:to="tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LeaseLiabilityCurrent" xlink:to="tsha_LeaseLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage" xlink:to="tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" xlink:to="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="tsha_FinanceLeaseLiabilityPaymentsDueAfterYearFour_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_ProceedsFromIssuanceOfCommonStockNet" xlink:to="tsha_ProceedsFromIssuanceOfCommonStockNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_DallasLeaseMember" xlink:to="tsha_DallasLeaseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable" xlink:to="tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_TypeOfRestructuringDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseLongTermDebt" xlink:to="us-gaap_InterestExpenseLongTermDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tsha_PrepaidResearchAndDevelopmentContracts" xlink:to="tsha_PrepaidResearchAndDevelopmentContracts_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>21
<FILENAME>tsha-20230930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-11-14T16:15:07.9163+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:href="tsha-20230930.xsd#Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails2" xlink:href="tsha-20230930.xsd#DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails2" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails3" xlink:href="tsha-20230930.xsd#DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails3" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" xlink:href="tsha-20230930.xsd#Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails4" xlink:href="tsha-20230930.xsd#DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails4" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="tsha-20230930.xsd#Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:href="tsha-20230930.xsd#DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:href="tsha-20230930.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" xlink:href="tsha-20230930.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaseCostDetails" xlink:href="tsha-20230930.xsd#DisclosureLeasesScheduleOfLeaseCostDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails" xlink:href="tsha-20230930.xsd#DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails" xlink:href="tsha-20230930.xsd#Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails" xlink:type="simple"/>
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCash" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermDebtNoncurrent" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DerivativeLiabilitiesCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LongTermDebtCurrent" order="5" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:label="us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails3">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="tsha_ChangeInFairValueOfWarrantLiability" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpense" order="3" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ChangeInFairValueOfWarrantLiability" xlink:label="tsha_ChangeInFairValueOfWarrantLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails4">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiability" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" order="0" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="tsha_ResearchAndDevelopmentLicenseExpense" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="6" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="tsha_IssuanceCostsForPreFundedWarrantLiability" order="7" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="tsha_PaymentOfShelfRegistrationCosts" order="7" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="8" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockPlans" order="8" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="9" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" order="9" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="10" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="11" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="12" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="13" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" order="14" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="15" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="17" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts" xlink:label="tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_ResearchAndDevelopmentLicenseExpense" xlink:label="tsha_ResearchAndDevelopmentLicenseExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IssuanceCostsForPreFundedWarrantLiability" xlink:label="tsha_IssuanceCostsForPreFundedWarrantLiability"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PaymentOfShelfRegistrationCosts" xlink:label="tsha_PaymentOfShelfRegistrationCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:label="us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" xlink:label="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="tsha_SsiWarrants" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="tsha_PreFundedWarrants" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_SsiWarrants" xlink:label="tsha_SsiWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PreFundedWarrants" xlink:label="tsha_PreFundedWarrants"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="tsha_PrepaidResearchAndDevelopmentContracts" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="tsha_PrepaidClinicalTrial" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_DeferredOfferingCosts" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidInsurance" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="tsha_PrepaidBonus" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="5" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PrepaidResearchAndDevelopmentContracts" xlink:label="tsha_PrepaidResearchAndDevelopmentContracts"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PrepaidClinicalTrial" xlink:label="tsha_PrepaidClinicalTrial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_PrepaidBonus" xlink:label="tsha_PrepaidBonus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" weight="-1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="tsha_AccruedResearchAndDevelopmentCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="tsha_AccruedSeverance" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="tsha_LeaseLiabilityCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="tsha_AccruedPropertyPlantAndEquipmentCurrent" order="5" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="tsha_AccruedClinicalTrialCurrent" order="6" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="7" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="8" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedResearchAndDevelopmentCurrent" xlink:label="tsha_AccruedResearchAndDevelopmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedSeverance" xlink:label="tsha_AccruedSeverance"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LeaseLiabilityCurrent" xlink:label="tsha_LeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedPropertyPlantAndEquipmentCurrent" xlink:label="tsha_AccruedPropertyPlantAndEquipmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_AccruedClinicalTrialCurrent" xlink:label="tsha_AccruedClinicalTrialCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaseCostDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_VariableLeaseCost" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_OperatingLeaseCost" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="5" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="tsha-20230930.xsd#tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:label="tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="1" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="3" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>22
<FILENAME>tsha-20230930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-11-14T16:15:08.0711+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://tayshagtx.com/20230930" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2023" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:tsha="http://tayshagtx.com/20230930" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" namespace="http://fasb.org/srt/2023"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tsha-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tsha-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tsha-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tsha-20230930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited" id="Role_StatementCondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails2" id="DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails2">
        <link:definition>100020 - Disclosure - Leases - Schedule of Future Minimum Commitments Under Company's Operating and Finance Leases (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical" id="Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>100030 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails3" id="DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails3">
        <link:definition>100040 - Disclosure - Leases - Schedule of Future Minimum Commitments Under Company's Operating and Finance Leases (Details) 3</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" id="Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited">
        <link:definition>100050 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails4" id="DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails4">
        <link:definition>100060 - Disclosure - Leases - Schedule of Future Minimum Commitments Under Company's Operating and Finance Leases (Details) 4</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity" id="StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity">
        <link:definition>100070 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical" id="StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical">
        <link:definition>100080 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" id="Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited">
        <link:definition>100090 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperations" id="Role_DisclosureOrganizationAndDescriptionOfBusinessOperations">
        <link:definition>100100 - Disclosure - Organization and Description of Business Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100110 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurements" id="DisclosureFairValueMeasurements">
        <link:definition>100120 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponents" id="Role_DisclosureBalanceSheetComponents">
        <link:definition>100130 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeases" id="DisclosureLeases">
        <link:definition>100140 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements" id="DisclosureAstellasAgreements">
        <link:definition>100150 - Disclosure - Astellas Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBank" id="Role_DisclosureLoanWithSiliconValleyBank">
        <link:definition>100160 - Disclosure - Loan with Silicon Valley Bank</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreements" id="Role_DisclosureResearchCollaborationAndLicenseAgreements">
        <link:definition>100170 - Disclosure - Research, Collaboration and License Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
        <link:definition>100180 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrants" id="DisclosureWarrants">
        <link:definition>100190 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShare" id="Role_DisclosureNetLossPerCommonShare">
        <link:definition>100200 - Disclosure - Net Loss Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100210 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100220 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritization" id="Role_DisclosureStrategicReprioritization">
        <link:definition>100230 - Disclosure - Strategic Reprioritization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlan" id="Role_DisclosureRetirementPlan">
        <link:definition>100240 - Disclosure - Retirement Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
        <link:definition>100250 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100260 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>100270 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsTables" id="DisclosureFairValueMeasurementsTables">
        <link:definition>100280 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables" id="Role_DisclosureBalanceSheetComponentsTables">
        <link:definition>100290 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesTables" id="DisclosureLeasesTables">
        <link:definition>100300 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsTables" id="DisclosureAstellasAgreementsTables">
        <link:definition>100310 - Disclosure - Astellas Agreements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankTables" id="Role_DisclosureLoanWithSiliconValleyBankTables">
        <link:definition>100320 - Disclosure - Loan with Silicon Valley Bank (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
        <link:definition>100330 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsTables" id="DisclosureWarrantsTables">
        <link:definition>100340 - Disclosure - Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables" id="Role_DisclosureNetLossPerCommonShareTables">
        <link:definition>100350 - Disclosure - Net Loss Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationTables" id="DisclosureStrategicReprioritizationTables">
        <link:definition>100360 - Disclosure - Strategic Reprioritization (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails" id="Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails">
        <link:definition>100370 - Disclosure - Organization and Description of Business Operations - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" id="DisclosureSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100380 - Disclosure - Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails" id="DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails">
        <link:definition>100390 - Disclosure - Significant Accounting Policies - Summary of Effect of the Adoption of ASC 842 on Statement of Operations and Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" id="DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails">
        <link:definition>100400 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail" id="Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail">
        <link:definition>100410 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail" id="Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail">
        <link:definition>100420 - Disclosure - Balance Sheet Components - Schedule of Property, Plant and Equipment Net (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails" id="Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails">
        <link:definition>100430 - Disclosure - Balance Sheet Components - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" id="Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
        <link:definition>100440 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" id="DisclosureLeasesAdditionalInformationDetails">
        <link:definition>100450 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaseCostDetails" id="DisclosureLeasesScheduleOfLeaseCostDetails">
        <link:definition>100460 - Disclosure - Leases - Schedule of Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateDetails" id="DisclosureLeasesSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateDetails">
        <link:definition>100470 - Disclosure - Leases - Supplemental Information Related to Remaining Lease Term and Discount Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails" id="DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails">
        <link:definition>100480 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails" id="DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails">
        <link:definition>100490 - Disclosure - Leases - Schedule of Future Minimum Commitments Under Company's Operating and Finance Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails" id="DisclosureAstellasAgreementsAdditionalInformationDetails">
        <link:definition>100500 - Disclosure - Astellas Agreements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails" id="DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails">
        <link:definition>100510 - Disclosure - Astellas Agreements - Summary of Allocation for Transaction Price to the Three Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails" id="Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails">
        <link:definition>100520 - Disclosure - Loan with Silicon Valley Bank - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails" id="Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails">
        <link:definition>100530 - Disclosure - Loan with Silicon Valley Bank - Schedule of Future Principal Debt Payments on Loan Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails" id="Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails">
        <link:definition>100540 - Disclosure - Research, Collaboration and License Agreements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" id="Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
        <link:definition>100550 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails" id="DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails">
        <link:definition>100560 - Disclosure - Stock-Based Compensation - Schedule of Share Based Compensation Available for Grant under Incentive Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock" id="DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock">
        <link:definition>100570 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value Time Based Vesting of Stock Options, Performance and Service-based Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails" id="Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails">
        <link:definition>100580 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails" id="Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails">
        <link:definition>100590 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails" id="Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails">
        <link:definition>100600 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Awards Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails" id="Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails">
        <link:definition>100610 - Disclosure - Stock-Based Compensation - Schedule of Total Stock-Based Compensation Expense for Stock Options, ESPP, RSAs and RSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails" id="DisclosureWarrantsAdditionalInformationDetails">
        <link:definition>100620 - Disclosure - Warrants - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails" id="DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails">
        <link:definition>100630 - Disclosure - Warrants - Schedule of Fair Value Method to Allocate Net Proceeds Received from Sale of Common Stock and Pre-funded Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails" id="DisclosureWarrantsScheduleOfWarrantLiabilityDetails">
        <link:definition>100640 - Disclosure - Warrants - Schedule of Warrant Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails" id="DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails">
        <link:definition>100650 - Disclosure - Warrants - Schedule Of Assumptions Used To Estimate Fair Value Of Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails" id="DisclosureNetLossPerCommonShareAdditionalInformationDetails">
        <link:definition>100660 - Disclosure - Net Loss Per Common Share - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails" id="Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails">
        <link:definition>100670 - Disclosure - Net Loss Per Common Share - Schedule of Calculation of Basic and Diluted Net Loss Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" id="Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails">
        <link:definition>100680 - Disclosure - Net Loss Per Common Share - Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" id="Role_DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>100690 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails" id="Role_DisclosureStrategicReprioritizationAdditionalInformationDetails">
        <link:definition>100700 - Disclosure - Strategic Reprioritization - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails" id="DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails">
        <link:definition>100710 - Disclosure - Strategic Reprioritization - Summary of Accrued Severance Activity Recorded (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails" id="Role_DisclosureRetirementPlanAdditionalInformationDetails">
        <link:definition>100720 - Disclosure - Retirement Plan - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" id="DisclosureSubsequentEventsAdditionalInformationDetails">
        <link:definition>100730 - Disclosure - Subsequent Events - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="tsha_AccruedSeveranceBalance" name="AccruedSeveranceBalance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_November132025ThroughButExcludingTheMaturityDateMember" name="November132025ThroughButExcludingTheMaturityDateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_ChangeInFairValueOfWarrants" name="ChangeInFairValueOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_TrinityTermLoanAgreementMember" name="TrinityTermLoanAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_CancelledOptionsMember" name="CancelledOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_AccruedClinicalTrialCurrent" name="AccruedClinicalTrialCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_OnSiteGenerationLeaseMember" name="OnSiteGenerationLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock" name="ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_OrganizationAndDescriptionOfBusinessOperationsTable" name="OrganizationAndDescriptionOfBusinessOperationsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage" name="IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts" name="PaymentOfSalesCommissionsAndOtherOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" name="PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="tsha_AssetsHeldForSalePolicyTextBlock" name="AssetsHeldForSalePolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_EndOfTermPaymentPercentage" name="EndOfTermPaymentPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_NumberOfDistinctAndActiveClinicalStage" name="NumberOfDistinctAndActiveClinicalStage" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage" name="PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_EmployeeStockPurchasePlansMember" name="EmployeeStockPurchasePlansMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_PaymentOfShelfRegistrationCosts" name="PaymentOfShelfRegistrationCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_ResearchAndDevelopmentLicenseExpense" name="ResearchAndDevelopmentLicenseExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" name="AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_PaymentsToAcquireLicenseRight" name="PaymentsToAcquireLicenseRight" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_WarrantLiabilityFairValueDisclosure" name="WarrantLiabilityFairValueDisclosure" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_PresidentAndChiefExecutiveOfficerMember" name="PresidentAndChiefExecutiveOfficerMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember" name="PerformanceAndMarketBasedRestrictedStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_AbeonaTherapeuticsIncMember" name="AbeonaTherapeuticsIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived" name="ClinicalRegulatoryAndCommercialMilestonesToBeReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_FinanceLeaseLiabilityPaymentsDueAfterYearFour" name="FinanceLeaseLiabilityPaymentsDueAfterYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_RegulatoryMilestoneFeePaid" name="RegulatoryMilestoneFeePaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_ResearchAndDevelopmentLicenseNotYetPaid" name="ResearchAndDevelopmentLicenseNotYetPaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_AccruedResearchAndDevelopmentCurrent" name="AccruedResearchAndDevelopmentCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts" name="IncurredPlacementAgentCommissionsAndOtherIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_PreFundedWarrants" name="PreFundedWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset" name="ConstructionInProgressAndFinanceLeaseRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances" name="DeferredRentLiabiilitiesAndTenantImprovementAllowances" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock" name="ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_PercentageOfPrepaymentPremium" name="PercentageOfPrepaymentPremium" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember" name="TermLoanThroughAugustThirteenTwentyTwentyThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable" name="LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_SeveranceCostRecorded" name="SeveranceCostRecorded" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_SalesAgentMember" name="SalesAgentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_TransactionPrice" name="TransactionPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock" name="ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_PrepaidBonus" name="PrepaidBonus" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" name="SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_LicenseForGanMember" name="LicenseForGanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_FairValueOfSharesTransferredValue" name="FairValueOfSharesTransferredValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_PegasusParkLLCMember" name="PegasusParkLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_AdditionalMilestonePayments" name="AdditionalMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_ScheduleOfWarrantLiabilityTableTextBlock" name="ScheduleOfWarrantLiabilityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_RegulatoryRelatedMilestonesObligationPayable" name="RegulatoryRelatedMilestonesObligationPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" name="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_LicenseAgreementForCLN7Member" name="LicenseAgreementForCLN7Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_SsiWarrantsMember" name="SsiWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_PrepaidClinicalTrial" name="PrepaidClinicalTrial" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_November132024ThroughNovember132025Member" name="November132024ThroughNovember132025Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_PrepaidResearchAndDevelopmentContracts" name="PrepaidResearchAndDevelopmentContracts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_CommonStockSharesIssuedAndSold" name="CommonStockSharesIssuedAndSold" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="tsha_LeaseLiabilityCurrent" name="LeaseLiabilityCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" name="LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_SsiWarrants" name="SsiWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_TermLoanFacilityMember" name="TermLoanFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_PercentageOfAnnualDefaultInterestRate" name="PercentageOfAnnualDefaultInterestRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_WarrantsNoteDisclosureTextBlock" name="WarrantsNoteDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_ProbabilityOfAnOptionExercise" name="ProbabilityOfAnOptionExercise" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems" name="OrganizationAndDescriptionOfBusinessOperationsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_UTSouthwesternAgreementMember" name="UTSouthwesternAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable" name="LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_PaymentOfOneTimeUpfrontLicenseFee" name="PaymentOfOneTimeUpfrontLicenseFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_PercentageOfSalePricePerShareOfCommonStock" name="PercentageOfSalePricePerShareOfCommonStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" name="PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" name="MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock" name="ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_SalesAgreementMember" name="SalesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding" name="PercentageOfFullyDilutedCommonStockSharesOutstanding" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="tsha_CommonStockAndWarrantsFairValueDisclosure" name="CommonStockAndWarrantsFairValueDisclosure" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock" name="ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" name="PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_SummaryOfTransactionPriceAllocationTableTextBlock" name="SummaryOfTransactionPriceAllocationTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_LicenseAgreementCommercialMilestonesPayment" name="LicenseAgreementCommercialMilestonesPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" name="PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_PreFundedWarrantsMember" name="PreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_LicenseForRettMember" name="LicenseForRettMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" name="ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_AggregateOfferingPriceFromSaleOfCommonStock" name="AggregateOfferingPriceFromSaleOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock" name="ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_LicenseAgreementRegulatoryMilestonesPayment" name="LicenseAgreementRegulatoryMilestonesPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts" name="ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_MilestoneFeePaid" name="MilestoneFeePaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_ClosingDateThroughNovember132024Member" name="ClosingDateThroughNovember132024Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" name="MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" name="LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" name="IncreaseDecreaseInAccruedExpenseAndOtherLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_DallasLeaseMember" name="DallasLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment" name="DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_CertainEmployeesAndConsultantsMember" name="CertainEmployeesAndConsultantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_SignificantAccountingPoliciesLineItems" name="SignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_UpfrontPayment" name="UpfrontPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_DurhamLeaseMember" name="DurhamLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_MarketBasedStockOptionsMember" name="MarketBasedStockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" name="TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_ExitAndDisposalActivitiesMember" name="ExitAndDisposalActivitiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities" name="IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_SsiStrategyHoldingsLlcMember" name="SsiStrategyHoldingsLlcMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_TrinityLendersMember" name="TrinityLendersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" name="TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_AstellasMember" name="AstellasMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_PerformanceAndMarketBasedStockOptionsMember" name="PerformanceAndMarketBasedStockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_AccruedSeverance" name="AccruedSeverance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_AstellasPrivatePlacementMember" name="AstellasPrivatePlacementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement" name="IssuanceOfWarrantsInConnectionWithPrivatePlacement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_IssuanceCostsForPreFundedWarrantLiability" name="IssuanceCostsForPreFundedWarrantLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_ShareBasedCompensationAwardTrancheFourMember" name="ShareBasedCompensationAwardTrancheFourMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_TrinityTermLoansMember" name="TrinityTermLoansMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_PaymentOfLicenseFee" name="PaymentOfLicenseFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_QueensAgreementMember" name="QueensAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_DerecognizedBuildToSuitLeaseLiability" name="DerecognizedBuildToSuitLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember" name="AugustTwoThousandAndTwentyThreePrivatePlacementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares" name="IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_ClassOfWarrantOrRightVestedAndExercisable" name="ClassOfWarrantOrRightVestedAndExercisable" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="tsha_AstellasSecuritiesPurchaseAgreementMember" name="AstellasSecuritiesPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_TwoThousandTwentyEquityIncentivePlanMember" name="TwoThousandTwentyEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" name="TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_GiantAxonalNeuropathyAgreementMember" name="GiantAxonalNeuropathyAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_PaymentsToInvestorsAsLiquidatedDamages" name="PaymentsToInvestorsAsLiquidatedDamages" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" name="PropertyAndEquipmentInAccountsPayableAndAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" name="LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_ProceedsFromIssuanceOfCommonStockNet" name="ProceedsFromIssuanceOfCommonStockNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" name="TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_InterestRatePeriod" name="InterestRatePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_InterestRateExtensionPeriod" name="InterestRateExtensionPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_SignificantAccountingPoliciesTable" name="SignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_ChangeInFairValueOfWarrantLiability" name="ChangeInFairValueOfWarrantLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_DallasLeaseAmendmentMember" name="DallasLeaseAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_TwoThousandTwentyStockIncentivePlanMember" name="TwoThousandTwentyStockIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_ResearchCollaborationAndLicenseAgreementsAbstract" name="ResearchCollaborationAndLicenseAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_ProceedsFromTermLoan" name="ProceedsFromTermLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_AssetsCapitalizedAsFinanceLeasesMember" name="AssetsCapitalizedAsFinanceLeasesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_AbeonaCLN1AgreementsMember" name="AbeonaCLN1AgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_BeneficialOwnershipLimitationNoticePeriod" name="BeneficialOwnershipLimitationNoticePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_IssuanceOfWarrantLiability" name="IssuanceOfWarrantLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_SsiInvestorsMember" name="SsiInvestorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_AbeonaRettAgreementMember" name="AbeonaRettAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_DifferenceOfMarketValuePaid" name="DifferenceOfMarketValuePaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_PercentageOfPrepaymentOfFacility" name="PercentageOfPrepaymentOfFacility" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_IssuanceOfFairValueWarrant" name="IssuanceOfFairValueWarrant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital" name="AllocatedToSharesDeductionToAdditionalPaidInCapital" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="tsha_LaboratoryEquipmentMember" name="LaboratoryEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_WarrantsPolicyPolicyTextBlock" name="WarrantsPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" name="TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="tsha_AccruedPropertyPlantAndEquipmentCurrent" name="AccruedPropertyPlantAndEquipmentCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" name="ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699848464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Nov. 14, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TSHA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Taysha Gene Therapies, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001806310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-3199512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3000 Pegasus Park Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Ste 1430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">612-0000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,960,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.00001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699981296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 164,278<span></span>
</td>
<td class="nump">$ 87,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">5,529<span></span>
</td>
<td class="nump">8,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent', window );">Assets held for sale</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">171,807<span></span>
</td>
<td class="nump">96,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">2,637<span></span>
</td>
<td class="nump">2,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">11,169<span></span>
</td>
<td class="nump">14,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">9,852<span></span>
</td>
<td class="nump">10,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">304<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">195,769<span></span>
</td>
<td class="nump">126,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">7,520<span></span>
</td>
<td class="nump">10,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">13,638<span></span>
</td>
<td class="nump">18,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">18,759<span></span>
</td>
<td class="nump">33,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Warrant liability</a></td>
<td class="nump">140,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">180,451<span></span>
</td>
<td class="nump">62,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">2,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term loan, net</a></td>
<td class="nump">38,548<span></span>
</td>
<td class="nump">37,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, net of current portion</a></td>
<td class="nump">19,101<span></span>
</td>
<td class="nump">20,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">3,832<span></span>
</td>
<td class="nump">4,130<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">244,883<span></span>
</td>
<td class="nump">125,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies - Note 13</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' (deficit) equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.00001 par value per share; 10,000,000 shares authorized and no shares issued and outstanding as of September 30, 2023 and December 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.00001 par value per share; 200,000,000 shares authorized and 186,960,193 and 63,207,507 issued and outstanding as of September 30, 2023 and December 31, 2022, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">511,632<span></span>
</td>
<td class="nump">402,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(560,748)<span></span>
</td>
<td class="num">(401,441)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' (deficit) equity</a></td>
<td class="num">(49,114)<span></span>
</td>
<td class="nump">949<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' (deficit) equity</a></td>
<td class="nump">$ 195,769<span></span>
</td>
<td class="nump">$ 126,276<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482309/360-10-15-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699033552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">186,960,193<span></span>
</td>
<td class="nump">63,207,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">186,960,193<span></span>
</td>
<td class="nump">63,207,507<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801698989504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 4,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">11,791<span></span>
</td>
<td class="nump">$ 16,774<span></span>
</td>
<td class="nump">44,096<span></span>
</td>
<td class="nump">$ 78,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">8,589<span></span>
</td>
<td class="nump">8,683<span></span>
</td>
<td class="nump">23,328<span></span>
</td>
<td class="nump">30,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">20,996<span></span>
</td>
<td class="nump">25,457<span></span>
</td>
<td class="nump">68,040<span></span>
</td>
<td class="nump">108,481<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(16,250)<span></span>
</td>
<td class="num">(25,457)<span></span>
</td>
<td class="num">(56,193)<span></span>
</td>
<td class="num">(108,481)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ChangeInFairValueOfWarrantLiability', window );">Change in fair value of warrant liability</a></td>
<td class="num">(100,456)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,456)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income</a></td>
<td class="nump">1,109<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,471)<span></span>
</td>
<td class="num">(1,078)<span></span>
</td>
<td class="num">(4,285)<span></span>
</td>
<td class="num">(2,493)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="num">(100,837)<span></span>
</td>
<td class="num">(1,070)<span></span>
</td>
<td class="num">(103,114)<span></span>
</td>
<td class="num">(2,455)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (117,087)<span></span>
</td>
<td class="num">$ (26,527)<span></span>
</td>
<td class="num">$ (159,307)<span></span>
</td>
<td class="num">$ (110,936)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share, basic</a></td>
<td class="num">$ (0.93)<span></span>
</td>
<td class="num">$ (0.65)<span></span>
</td>
<td class="num">$ (1.88)<span></span>
</td>
<td class="num">$ (2.79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share, diluted</a></td>
<td class="num">$ (0.93)<span></span>
</td>
<td class="num">$ (0.65)<span></span>
</td>
<td class="num">$ (1.88)<span></span>
</td>
<td class="num">$ (2.79)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic</a></td>
<td class="nump">125,700,799<span></span>
</td>
<td class="nump">40,937,808<span></span>
</td>
<td class="nump">84,630,796<span></span>
</td>
<td class="nump">39,761,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted</a></td>
<td class="nump">125,700,799<span></span>
</td>
<td class="nump">40,937,808<span></span>
</td>
<td class="nump">84,630,796<span></span>
</td>
<td class="nump">39,761,764<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ChangeInFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ChangeInFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801696311088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' (Deficit) Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Private Placement</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Private Placement</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Private Placement</div>
</th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 95,383<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 331,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (235,649)<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,473,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="text">Accounting Standards Update 2016-02 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 14,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">11,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares', window );">Issuance of common stock upon vesting and settlement of restricted stock units, net, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">628,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under ESPP</a></td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under ESPP, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(110,936)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110,936)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2022</a></td>
<td class="nump">10,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">357,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(346,363)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,175,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2022</a></td>
<td class="nump">$ 32,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(319,836)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,020,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="text">Accounting Standards Update 2016-02 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 4,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares', window );">Issuance of common stock upon vesting and settlement of restricted stock units, net, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under ESPP</a></td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under ESPP, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(26,527)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,527)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2022</a></td>
<td class="nump">10,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">357,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(346,363)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,175,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">402,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(401,441)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">63,207,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,207,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 5,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,117,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares', window );">Issuance of common stock upon vesting and settlement of restricted stock units, net, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">566,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under ESPP</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under ESPP, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(159,307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159,307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2023</a></td>
<td class="num">$ (49,114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">511,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(560,748)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Sep. 30, 2023</a></td>
<td class="nump">186,960,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,960,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2023</a></td>
<td class="num">$ (37,114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(443,661)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,432,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">2,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,412,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares', window );">Issuance of common stock upon vesting and settlement of restricted stock units, net, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under ESPP</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under ESPP, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(117,087)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117,087)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2023</a></td>
<td class="num">$ (49,114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 511,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (560,748)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Sep. 30, 2023</a></td>
<td class="nump">186,960,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,960,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock upon vesting and settlement of restricted stock unit shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147477123/405-50-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 72: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699769824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts', window );">Payment of sales commissions and other offering cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 392<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Offering costs</a></td>
<td class="nump">$ 7,098<span></span>
</td>
<td class="nump">$ 7,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of sales commissions and other offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699967280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (159,307)<span></span>
</td>
<td class="num">$ (110,936)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">1,005<span></span>
</td>
<td class="nump">810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ResearchAndDevelopmentLicenseExpense', window );">Research and development license expense</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">5,937<span></span>
</td>
<td class="nump">13,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liability</a></td>
<td class="nump">100,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IssuanceCostsForPreFundedWarrantLiability', window );">Issuance costs for pre-funded warrant liability</a></td>
<td class="nump">2,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="nump">908<span></span>
</td>
<td class="nump">1,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">581<span></span>
</td>
<td class="nump">616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">4,008<span></span>
</td>
<td class="nump">1,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(1,065)<span></span>
</td>
<td class="num">(3,217)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(4,260)<span></span>
</td>
<td class="num">(8,576)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(11,847)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(56,901)<span></span>
</td>
<td class="num">(103,102)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment', window );">Purchase of research and development license</a></td>
<td class="num">(3,500)<span></span>
</td>
<td class="num">(4,250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(3,852)<span></span>
</td>
<td class="num">(18,310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(7,342)<span></span>
</td>
<td class="num">(22,560)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of sales commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts', window );">Proceeds from issuance of common stock and pre-funded warrants from private placement, net of placement agent commissions and other offering costs</a></td>
<td class="nump">140,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PaymentOfShelfRegistrationCosts', window );">Payment of shelf registration costs</a></td>
<td class="num">(387)<span></span>
</td>
<td class="num">(319)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from common stock issuances under ESPP</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(253)<span></span>
</td>
<td class="num">(709)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">140,641<span></span>
</td>
<td class="nump">10,865<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">76,398<span></span>
</td>
<td class="num">(114,797)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">90,517<span></span>
</td>
<td class="nump">151,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">166,915<span></span>
</td>
<td class="nump">36,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">164,278<span></span>
</td>
<td class="nump">34,306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">2,637<span></span>
</td>
<td class="nump">2,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">3,665<span></span>
</td>
<td class="nump">1,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses', window );">Property, plant and equipment in accounts payable and accrued expenses</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">3,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Offering costs not yet paid</a></td>
<td class="nump">423<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement', window );">Issuance of warrants in connection with private placement</a></td>
<td class="nump">252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of sales commissions</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in accrued expense and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_IssuanceCostsForPreFundedWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance costs for pre-funded warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_IssuanceCostsForPreFundedWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of warrants in connection with private placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PaymentOfShelfRegistrationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of shelf registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PaymentOfShelfRegistrationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of common stock and prefunded warrants from private placement net of placement agent commissions and other offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property and equipment in accounts payable and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ResearchAndDevelopmentLicenseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and development license expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ResearchAndDevelopmentLicenseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801704346224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business Operations<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Description of Business Operations</a></td>
<td class="text"><p id="note_1organization_description_business_" style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 1&#8212;Organization and Descr</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">iption of Business Operations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Taysha Gene Therapies, Inc. (the &#8220;Company&#8221; or &#8220;Taysha&#8221;) was originally formed under the laws of the State of Texas on September 20, 2019 (&#8220;Inception&#8221;). Taysha converted to a Delaware corporation on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">February 13, 2020</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, which had no impact to the Company&#8217;s par value or issued and authorized capital structure.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Taysha is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Sales Agreement</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 5, 2021, the Company entered into a Sales Agreement (the &#8220;Sales Agreement&#8221;) with SVB Securities LLC (f/k/a SVB Leerink LLC) and Wells Fargo Securities, LLC (collectively, the &#8220;Sales Agents&#8221;), pursuant to which the Company may issue and sell, from time to time in its sole discretion, shares of its common stock having an aggregate offering price of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">150.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million through the Sales Agents. In March 2022, the Company amended the Sales Agreement to, among other things, include Goldman Sachs &amp; Co. LLC as an additional Sales Agent. The Sales Agents may sell common stock by any method permitted by law deemed to be an &#8220;at-the-market offering&#8221; as defined in Rule 415(a)(4) of the Securities Act, including sales made directly on or through the Nasdaq Global Select Market or any other existing trade market for the common stock, in negotiated transactions at market prices prevailing at the time of sale or at prices related to prevailing market prices, or any other method permitted by law. Any shares of the Company&#8217;s common stock will be issued pursuant to the Company&#8217;s shelf registration statement on Form S-3 (File No. 333-260069) (the &#8220;Shelf Registration Statement&#8221;), which the Securities and Exchange Commission (&#8220;SEC&#8221;) declared effective on October 14, 2021; however the Company&#8217;s use of the Shelf Registration Statement will be limited for so long as the Company is subject to General Instruction I.B.6 of Form S-3, which limits the amounts that the Company may sell under the Shelf Registration Statement and in accordance with the Sales Agreement. The Sales Agents are entitled to receive </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the gross sales price per share of common stock sold under the Sales Agreement. In April 2022, the Company sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,000,000</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock under the Sales Agreement and received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11.6</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in net proceeds. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> other shares of common stock have been issued and sold pursuant to the Sales Agreement as of September 30, 2023.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Liquidity and Capital Resources</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to ASC 205, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Presentation of Financial Statements</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company is required to and does evaluate at each annual and interim period whether there are conditions or events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. In its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, the Company concluded that due to inherent uncertainties in the Company&#8217;s forecast, and after considering both quantitative and qualitative factors that were known or reasonably knowable as of the date that such condensed consolidated financial statements were issued, there were conditions present in the aggregate that raised substantial doubt about the Company&#8217;s ability to continue as a going concern.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Following the closing of the Private Placement (as defined below) in August 2023 (see Note 10), the Company has concluded that after considering both qualitative and quantitative factors, there are no longer conditions present in the aggregate that raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The Company has sufficient liquidity to satisfy its obligations for at least twelve months following the date of the issuance of these condensed consolidated financial statements. Accordingly, the Company has concluded that there is no longer substantial doubt about the Company&#8217;s ability to continue as a going concern.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has incurred operating losses since inception and expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As of September 30, 2023, the Company had an accumulated deficit of </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">560.7</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">million. Losses are expected to continue as the Company continues to invest in its research and development activities. Future capital requirements will depend on many factors, including the timing and extent of spending on research and development and the market acceptance of the Company&#8217;s products. As of September 30, 2023, the Company had cash and cash equivalents of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">164.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which the Company believes will be sufficient to fund its planned operations for a period of at least twelve months from the date of issuance of these condensed consolidated financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801700192400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 2&#8212;Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) as determined by the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X and are consistent in all material respects with those included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 28, 2023 (the &#8220;2022 Annual Report&#8221;). In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The consolidated balance sheet as of December 31, 2022, is derived from audited financial statements, however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in the Company&#8217;s 2022 Annual Report.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Principles of Consolidation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying interim condensed consolidated financial statements include the accounts of Taysha and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The most significant estimates and assumptions in the Company&#8217;s financial statements relate to the determination of the fair value of the common stock prior to the initial public offering ("IPO") (as an input into stock-based compensation), estimating manufacturing accruals and accrued or prepaid research and development expenses, the measurement of impairment of long-lived assets, the fair value of the warrant liability, and the allocation of consideration received in connection with the Astellas Transactions (as defined below) at contract inception. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#8217;s future results of operations will be affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There have been no changes in the Company&#8217;s significant accounting policies as disclosed in Note 2 to the audited consolidated financial statements included in the 2022 Annual Report, except as described below.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash and cash equivalents consist of funds held in a standard checking account, a standard savings account and a money market fund. The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Assets Held for Sale</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assets and liabilities are classified as held for sale when all of the following criteria for a plan of sale have been met: (1) management, having the authority to approve the action, commits to a plan to sell the assets; (2) the assets are available for immediate sale, in their present condition, subject only to terms that are usual and customary for sales of such assets; (3) an active program to locate a buyer and other actions required to complete the plan to sell the assets have been initiated; (4) the sale of the assets is probable and is expected to be completed within one year; (5) the assets are being actively marketed for a price that is reasonable in relation to their current fair value; and (6) actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or the plan will be withdrawn. When all of these criteria have been met, the assets and liabilities are classified as held for sale in the balance sheet. Assets classified as held for sale are reported at </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the lower of their carrying value or fair value less costs to sell. The Company recorded a partial impairment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million during the three months ended September 30, 2023 in connection with the classification of certain assets to assets held for sale. Depreciation and amortization of assets ceases upon designation as held for sale.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Warrants</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s specific terms and applicable authoritative guidance in FASB ASC 480, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (&#8220;ASC 480&#8221;) and ASC 815,</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> Derivatives and Hedging</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#8217;s own common shares and whether the warrant holders could potentially require &#8220;net cash settlement&#8221; in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period while the warrants are outstanding.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to remeasurement at each balance sheet date until the warrants are exercised or expire, and any change in fair value is recognized in the Company&#8217;s condensed consolidated statement of operations.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Comprehensive Loss</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Comprehensive loss is equal to net loss as presented in the accompanying condensed consolidated statements of operations.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), as amended, with guidance regarding the accounting for and disclosure of leases. This update requires lessees to recognize the liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheets. This update also requires lessees and lessors to disclose key information about their leasing transactions.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2022</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">adopted</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> ASU 2016-02 using the modified retrospective approach and utilizing the effective date as its date of initial application.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The Company has retrospectively changed its previously issued condensed consolidated financial statements as of September 30, 2022 as presented within the Company&#8217;s September 30, 2022 Quarterly Report on Form 10-Q to reflect the adoption of ASC 842 on January 1, 2022. The condensed consolidated financial statements for the three and nine months ended September 30, 2022 presented herein differ from the Company&#8217;s condensed consolidated financial statements included in the Company&#8217;s September 30, 2022 Quarterly Report on Form 10-Q as those condensed consolidated financial statements were prepared using the former accounting standard referred to as ASC Topic 840, Leases.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company elected the following practical expedients, which must be elected as a package and applied consistently to all of its leases at the transition date (including those for which the entity is a lessee or a lessor): i) the Company did not reassess whether any expired or existing contracts are or contain leases; ii) the Company did not reassess the lease classification for any expired or existing leases (that is, all existing leases that were classified as operating leases in accordance with ASC 840 are classified as operating leases, and all existing leases that were classified as capital leases in accordance with ASC 840 are classified as finance leases); and iii) the Company did not reassess initial direct costs for any existing leases. For leases that existed prior to the date of initial application of ASC 842 (which were previously classified as operating leases), a lessee may elect to use either the total lease term measured at lease inception under ASC 840 or the remaining lease term as of the date of initial application of ASC 842 in determining the period for which to measure its incremental borrowing rate. In transition to ASC 842, the Company utilized the remaining lease term of its leases in determining the appropriate incremental borrowing rates.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The adoption of this standard resulted in the recognition of operating lease right-of-use assets and operating lease liabilities of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18.4</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">19.1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, on the Company&#8217;s condensed consolidated balance sheet at adoption relating to its operating leases. The lease liabilities were determined based on the present value of the remaining minimum lease payments. Upon adoption of ASC 842, the Company also (i) derecognized the build-to-suit lease asset of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million previously presented in property, plant and equipment, (ii) derecognized the build-to-suit lease liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, and (iii) eliminated $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of deferred rent liabilities and tenant improvement allowances as of January 1, 2022, as these liabilities are reflected in the operating lease right-of-use assets. In adopting ASU 2016-02, the Company recorded a total one-time adjustment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million to the opening balance of accumulated deficit as of January 1, 2022, related to the de-recognition of the build-to-suit lease asset and related build-to-suit lease obligation. The adoption </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">did not</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> have a material impact on accumulated deficit and on the condensed consolidated statements of operations and cash flows.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations and statement of cash flows for the nine months ended September 30, 2022 (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:54.498%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:12.366%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre ASC 842 Nine Months Ended<br/>September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASC 842 Adjustments</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">After ASC 842 Nine Months Ended<br/>September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_c235bfe5-b369-4c89-8e3c-24a2b2c671cb;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed</span></span></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Consolidated Statement of Operations</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating expenses:</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">77,308</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,154</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">78,462</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other income (expense):</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3,002</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">509</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,493</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">110,291</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">645</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">110,936</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed Consolidated Statement of Cash Flows</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Depreciation expense</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">808</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">810</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Non-cash lease expense</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,031</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,031</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;&#160;Accrued expenses and other current liabilities</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7,753</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">823</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8,576</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash flows from financing activities</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,144</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">435</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">709</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Supplemental disclosure of noncash investing and financing activities:</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Right-of-use assets obtained in exchange for lease liabilities</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">23,035</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">23,035</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations for the three months ended September 30, 2022 (in thousands):</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:54.498%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:12.366%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre ASC 842 Three Months Ended<br/>September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASC 842 Adjustments</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">After ASC 842 Three Months Ended<br/>September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_3d5ea955-cb63-460e-9ac4-0cc91b6e0847;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed</span></span></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Consolidated Statement of Operations</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating expenses:</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16,391</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">383</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16,774</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other income (expense):</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,241</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">163</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,078</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26,307</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">220</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26,527</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
        </table></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801702669808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 3&#8212;Fair Value Measurements</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following tables present information about the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values (in thousands):</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.487%;"></td>
        <td style="width:1%;"></td>
        <td style="width:11.149%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.263%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.525%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.263%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.525%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.263%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.525%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assets:</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;&#160;&#160;Cash equivalents &#8211; money market funds</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">150,514</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">150,514</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">150,514</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">150,514</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Liabilities:</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant liability</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;&#160;&#160;SSI Warrants</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">701</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">701</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;&#160;&#160;Pre-funded warrants</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">139,833</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">139,833</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total liabilities</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">140,534</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">139,833</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">701</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company classifies its money market funds, which are valued based on quoted market prices in an active market with no valuation adjustment, as Level 1 assets within the fair value hierarchy.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company uses the Black-Scholes-Merton option pricing model to determine the fair value of the SSI Warrants (as defined below). The Company classifies its Pre-Funded Warrants (as defined below), which are valued using quoted prices of similar financial instruments in the market, as Level 2 liabilities. S</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ee Note 10 for additional information on the SSI Warrants and the Pre-Funded Warrants.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801702079056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 4&#8212;Balance Sheet Components</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br/>2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid research and development</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,672</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4,840</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid clinical trial</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,392</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,119</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Deferred offering costs</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">724</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">724</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid insurance</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">337</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">388</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">404</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">466</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total prepaid expenses and other current assets</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,529</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8,537</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property, plant and equipment, net consisted of the following (in thousands):	</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br/>2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,091</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,091</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Laboratory equipment</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,868</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,868</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,115</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,115</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">864</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">898</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Construction in progress</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6,874</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9,633</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13,812</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16,605</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accumulated depreciation</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,643</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,642</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property, plant and equipment, net</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11,169</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">14,963</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In November 2022, the Company recognized a non-cash impairment charge of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">36.4</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the manufacturing facility asset group, of which $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million relates to construction in progress and finance lease right-of-use assets. The impairment charge was estimated using a discounted cash flow model and recorded in the consolidated statements of operations for the year ended December 31, 2022. Property, plant and equipment, net includes </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> mi</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">llion and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of assets capitalized as finance leases as of September 30, 2023 and December 31, 2022, respectively.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Depreciation expense w</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">as $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the three months ended September 30, 2023 and 2022, respectively. Depreciation expense was</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> milli</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">on and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.8</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the nine months ended September 30, 2023 and 2022, respectively.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the three months ended September 30, 2023, the Company committed to a plan to sell specific pieces of equipment originally intended for use in the Company&#8217;s manufacturing facility in Durham, NC. The Company determined that this equipment met the requirements to be classified as held for sale. The sale is expected to be completed within one year. During the three and nine</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">months </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ended September 30, 2023, the Company recorded an impairment loss of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which was the difference between the carrying value and fair value less cost to sell.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued expenses and other current liabilities consisted of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br/>2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued research and development</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,699</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8,190</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued compensation</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,745</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,519</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lease liabilities, current portion</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,538</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,521</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued clinical trial</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,359</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,473</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued severance</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">992</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,463</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued professional and consulting fees</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">579</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">390</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued property, plant and equipment</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">45</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,081</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">681</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">650</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total accrued expenses and other current liabilities</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13,638</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18,287</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801705360544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 5&#8212; Leases</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company leases certain office, laboratory, and manufacturing space.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Dallas Lease</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On January 11, 2021, the Company entered into a lease agreement (the &#8220;Dallas Lease&#8221;) with Pegasus Park, LLC, a Delaware limited liability company (the &#8220;Dallas Landlord&#8221;), pursuant to which the Company will lease approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15,000</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square feet of office space at 3000 Pegasus Park Drive, Dallas, Texas 75247 (the &#8220;Office Space&#8221;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Dallas Lease commenced on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">May 27, 2021</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, and has a term of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ten years</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company has an option to extend the term of the Dallas Lease for one additional period of five years.</span></span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Dallas Landlord has the right to terminate the Dallas Lease, or the Company&#8217;s right to possess the Office Space without terminating the Dallas Lease, upon specified events of default, including the Company&#8217;s failure to pay rent in a timely manner and upon the occurrence of certain events of insolvency with respect to the Company.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Dallas Lease Expansion</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On December 14, 2021, the Company amended the Dallas Lease (the &#8220;Dallas Lease Amendment&#8221;) with the Dallas Landlord, pursuant to which the Company will lease approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18,000</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square feet of office space adjacent to the Office Space at 3000 Pegasus Park Drive, Dallas, Texas 75247 (the &#8220;Expansion Premises&#8221;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The Dallas Lease Amendment commenced on July 1, 2022, and has a term of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ten years</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is obligated to pay operating costs and utilities applicable to the Expansion Premises. Total future minimum lease payments under the Dallas Lease Amendment over the initial </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10-year</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> term are approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. The Company will be responsible for costs of constructing interior improvements within the Expansion Premises that exceed a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">40.00</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per rentable square foot construction allowance provided by the Dallas Landlord.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has a right of first refusal with respect to certain additional office space on the 15</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;">th</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> floor at 3000 Pegasus Park Drive, Dallas, Texas 75247 before the Dallas Landlord accepts any offer for such space.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Durham Lease</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On December 17, 2020, the Company entered into a lease agreement (the &#8220;Durham Lease&#8221;) with Patriot Park Partners II, LLC, a Delaware limited liability company (the &#8220;Durham Landlord&#8221;), pursuant to which the Company agreed to lease approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">187,500</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> square feet of a manufacturing facility located at 5 National Way, Durham, North Carolina (the &#8220;Facility&#8221;). The Durham Lease commenced on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">April 1, 2021</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and is expected to have a term of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">fifteen years and six months</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Company has two options to extend the term of the Durham Lease, each for a period of an additional </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">five years</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company was not required to provide a security deposit in connection with its entry into the Durham Lease. The Company will be responsible for constructing interior improvements within the Facility. The Company was required to place $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in an escrow account which will be released when the improvements are substantially complete. The escrow funds are recorded as restricted cash on the condensed consolidated balance sheet as of September 30, 2023. The Durham Landlord has the right to terminate the Durham Lease upon specified events of default, including the Company&#8217;s failure to pay rent in a timely manner and upon the occurrence of certain events of insolvency with respect to the Company.</span></p><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Summary of all lease costs recognized under ASC 842</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the lease costs recognized under ASC 842 and other information pertaining to the Company&#8217;s operating leases for the three and nine months ended September 30, 2023 and 2022 (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:36.628%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.314%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.314%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.223%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.937%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.764%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.817%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="5" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Three Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating lease cost</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">696</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">794</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,088</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,079</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Variable lease cost</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">243</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">229</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">729</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">617</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total lease cost</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">939</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,817</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,696</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Supplemental information related to the remaining lease term and discount rate are as follows:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:54.052%;"></td>
        <td style="width:1.545%;"></td>
        <td style="width:1%;"></td>
        <td style="width:22.212%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:18.19%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted average remaining lease term (in years) &#8211; Finance leases</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.13</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.88</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted average remaining lease term (in years) &#8211; Operating leases</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10.97</span></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11.45</span></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted average discount rate &#8211; Finance leases</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10.52</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10.51</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted average discount rate &#8211; Operating leases</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.79</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.72</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:11pt;font-family:'Calibri',sans-serif;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Supplemental cash flow information related to the Company&#8217;s operating leases are as follows (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:52.723%;"></td>
        <td style="width:1%;"></td>
        <td style="width:20.627%;"></td>
        <td style="width:1%;"></td>
        <td style="width:2.022%;"></td>
        <td style="width:1%;"></td>
        <td style="width:20.627%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating cash flows for operating leases</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,109</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">847</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023, future minimum commitments under ASC 842 under the Company&#8217;s operating and finance leases were as follows (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:51.682%;"></td>
        <td style="width:1%;"></td>
        <td style="width:22.389%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:21.927999999999997%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Year Ending December 31,</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Finance</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">686</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">114</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,810</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">454</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,910</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">454</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,485</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">399</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,577</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Thereafter</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">19,721</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total lease payments</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">31,189</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,421</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10,895</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">242</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total lease liabilities</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20,294</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,179</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_3e78f387-05e6-4d7c-88d4-c13b0a4b78ec;"><span style="-sec-ix-hidden:F_dbeee014-7927-4ce5-8253-ba65a26dca89;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lease liabilities, current</span></span></span></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,193</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">345</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b7b24932-76e0-4234-83dc-e0defb7581aa;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lease liabilities, non-current</span></span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">19,101</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">834</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1ede665f-e147-4c30-a4ac-9f4f220b3eda;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total lease liabilities</span></span></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20,294</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,179</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699036192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Astellas Agreements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Astellas Agreements</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 8&#8212;Research, Collaboration and License Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">UT Southwestern Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 19, 2019, the Company entered into a research, collaboration and license agreement (&#8220;UT Southwestern Agreement&#8221;) with the Board of Regents of the University of Texas System on behalf of The University of Texas Southwestern Medical Center (&#8220;UT Southwestern&#8221;). Under the UT Southwestern Agreement, UT Southwestern is primarily responsible for preclinical development activities with respect to licensed products for use in certain specified indications (up to investigational new drug application-enabling studies), and the Company is responsible for all subsequent clinical development and commercialization activities with respect to the licensed products. UT Southwestern will conduct such preclinical activities for a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">two-year</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> period under mutually agreed upon sponsored research agreements that were entered into beginning in April 2020. During the initial research phase, the Company has the right to expand the scope of specified indications under the UT Southwestern Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the UT Southwestern Agreement, the Company obtained an exclusive, worldwide, royalty-free license under certain patent rights of UT Southwestern and a non-exclusive, worldwide, royalty-free license under certain know-how of UT Southwestern, in each case to make, have made, use, sell, offer for sale and import licensed products for use in certain specified indications. Additionally, the Company obtained a non-exclusive, worldwide, royalty-free license under certain patents and know-how of UT Southwestern for use in all human uses, with a right of first refusal to obtain an exclusive license under certain of such patent rights and an option to negotiate an exclusive license under other of such patent rights. The Company is required to use commercially reasonable efforts to develop, obtain regulatory approval for, and commercialize at least </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> licensed product.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 2, 2020, the Company amended the UT Southwestern Agreement to include the addition of another licensed product and certain indications, and a right of first refusal to the Company over certain patient dosing patents. No additional consideration was transferred in connection with this amendment. In March 2022, the Company and UT Southwestern mutually agreed to revise the payment schedules and current performance expectations of the current sponsored research agreements under the UT Southwestern Agreement and defer payments by fifteen months.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The UT Southwestern Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last valid claim of a licensed patent in such country for such licensed product. After the initial research term, the Company may terminate the agreement, on an indication-by-indication and licensed product-by-licensed product basis, at any time upon specified written notice to UT Southwestern. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In November 2019, as partial consideration for the license rights granted under the UT Southwestern Agreement, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,179,000</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of its common stock, or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of its then outstanding fully-diluted common stock, to UT Southwestern. The Company does not have any future milestone or royalty obligations to UT Southwestern under the UT Southwestern Agreement other than costs related to maintenance of patents.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Abeona CLN1 Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In August 2020, the Company entered into license and inventory purchase agreements (collectively, the &#8220;Abeona Agreements&#8221;) with Abeona Therapeutics Inc. (&#8220;Abeona&#8221;) for worldwide exclusive rights to certain intellectual property rights and know-how relating to the research, development and manufacture of ABO-202, an AAV-based gene therapy for CLN1 disease (also known as infantile Batten disease). Under the terms of the Abeona Agreements, the Company made initial cash payments to Abeona of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the license fee and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for purchase of clinical materials and reimbursement for previously incurred development costs in October 2020. In exchange for the license rights, the Company recorded an aggregate of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within research and development expenses in the consolidated statements of operations for the year ended December 31, 2020, since the acquired license or acquired inventory do not have an alternative future use. The Company is obligated to make up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in regulatory-related milestones and up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in sales-related milestones per licensed CLN1 product. The Company will also pay an annual earned royalty in the high single digits on net sales of any licensed CLN1 products. The license agreement with Abeona (the &#8220;Abeona License Agreement&#8221;) expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the Abeona License Agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the Abeona License Agreement for convenience upon specified prior written notice to Abeona.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2021, a regulatory milestone was triggered in connection with this agreement and therefore the Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within research and development expenses in the consolidated statements of operations for the year ended December 31, 2021. The milestone fee was paid in January 2022 and classified as an investing cash outflow in the condensed consolidated statements of cash flows for the nine months ended September 30, 2022. No additional milestone payments were made or triggered in connection with this agreement during the nine months ended September 30, 2023.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Abeona Rett Agreement</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 29, 2020, the Company entered into a license agreement (the &#8220;Abeona Rett Agreement&#8221;) with Abeona pursuant to which the Company obtained an exclusive, worldwide, royalty-bearing license, with the right to grant sublicenses under certain patents, know-how and materials originally developed by the University of North Carolina at Chapel Hill, the University of Edinburgh and Abeona to research, develop, manufacture, have manufactured, use, and commercialize licensed products for gene therapy and the use of related transgenes for Rett syndrome.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Subject to certain obligations of Abeona, the Company is required to use commercially reasonable efforts to develop at least one licensed product and commercialize at least one licensed product in the United States.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the Abeona Rett Agreement, the Company paid Abeona a one-time upfront license fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which was recorded in research and development expenses in the consolidated statements of operations for the year ended December 31, 2020, since the acquired license does not have an alternative future use. The Company is obligated to pay Abeona up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in regulatory-related milestones and up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in sales-related milestones per licensed Rett product and high single-digit royalties on net sales of licensed Rett products. Royalties are payable on a licensed product-by-licensed product and country-by-country basis until the latest of the expiration or revocation or complete rejection of the last licensed patent covering such licensed product in the country where the licensed product is sold, the loss of market exclusivity in such country where the product is sold, or, if no licensed product exists in such country and no market exclusivity exists in such country, ten years from first commercial sale of such licensed product in such country.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Abeona Rett Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the agreement for convenience upon specified prior written notice to Abeona.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2022, the Company&#8217;s clinical trial application (&#8220;CTA&#8221;) filing for TSHA-102 for the treatment of Rett Syndrome was approved by Health Canada and therefore triggered a regulatory milestone payment in connection with the Abeona Rett Agreement. The Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within research and development expenses in the condensed consolidated statements of operations for the nine months ended September 30, 2022. The $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million regulatory milestone fee was paid in July 2022. In May 2023, the Company dosed the first patient with TSHA-102 in the Phase 1/2 REVEAL trial evaluating the safety and preliminary efficacy of TSHA-102 in adult patients with Rett syndrome and therefore triggered a milestone payment in connection with the Abeona Rett Agreement. The Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">within research and development expenses in the condensed consolidated statements of operations for the nine months ended September 30, 2023. This milestone fee was paid in August 2023 and classified as an investing cash outflow in the condensed consolidated statements of cash flows for the nine months ended September 30, 2023. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> additional milestone payments were made or triggered in connection with the Abeona Rett Agreement during the nine months ended September 30, 2023.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Acquisition of Worldwide Rights for TSHA-120 for the treatment of GAN</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2021, the Company acquired the exclusive worldwide rights to a clinical-stage AAV9 gene therapy program, now known as TSHA-120, for the treatment of GAN. TSHA-120 is an intrathecally dosed AAV9 gene therapy currently being evaluated in a clinical trial for the treatment of GAN. The trial is being conducted by the National Institutes of Health (&#8220;NIH&#8221;) in close collaboration with a leading patient advocacy group focused on finding treatments and cures for GAN. TSHA-120 has received rare pediatric disease and orphan drug designations from the U.S. Food and Drug Administration for the treatment of GAN. The worldwide rights were acquired through a license agreement, effective March 29, 2021, between Hannah&#8217;s Hope Fund for Giant Axonal Neuropathy, Inc. (&#8220;HHF&#8221;) and the Company (the &#8220;GAN Agreement&#8221;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the terms of the GAN Agreement, in exchange for granting the Company the exclusive worldwide rights to TSHA-120, HHF received an upfront payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and will be eligible to receive clinical, regulatory and commercial milestones totaling up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">19.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, as well as a low, single-digit royalty on net sales upon commercialization of the product. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> additional milestone payments were made or triggered in connection with the GAN Agreement during the nine months ended September 30, 2023.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">License Agreement for CLN7</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2022, the Company entered into a license agreement with UT Southwestern (the &#8220;CLN7 Agreement&#8221;) pursuant to which the Company obtained an exclusive worldwide, royalty-bearing license with right to grant sublicenses to develop, manufacture, use, and commercialize licensed products for gene therapy for CLN7, a form of Batten Disease. In connection with the CLN7 Agreement, the Company paid a one-time upfront license fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. The Company recorded the upfront license fee in research and development expense in the condensed consolidated statements of operations since the acquired license does not have an alternative future use. The Company is obligated to pay UT Southwestern up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.7</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in regulatory-related milestones and up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in sales-related milestones, as well as a low, single-digit royalty on net sales upon commercialization of the product. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> additional milestone payments were made or triggered in connection with the CLN7 Agreement during the nine months ended September 30, 2023.</span></p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AstellasMember', window );">Astellas</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Astellas Agreements</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 6&#8212;Astellas Agreements</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 21, 2022 (the &#8220;Effective Date&#8221;), the Company entered into the Option Agreement (the &#8220;Option Agreement&#8221;) with Audentes Therapeutics, Inc. (d/b/a Astellas Gene Therapy)(&#8220;Astellas&#8221;), pursuant to which the Company granted to Astellas an exclusive option to obtain an exclusive, worldwide, royalty and milestone-bearing right and license (A) to research, develop, make, have made, use, sell, offer for sale, have sold, import, export and otherwise exploit, or, collectively, exploit, the product known, as of the Effective Date, as TSHA-120 (the &#8220;120 GAN Product&#8221;), and any backup products with respect thereto for use in the treatment of Giant Axonal Neuropathy (&#8220;GAN&#8221;) or any other gene therapy product for use in the treatment of GAN that is controlled by Taysha or any of its affiliates or with respect to which the Company or any of its affiliates controls intellectual property rights covering the exploitation thereof, or a GAN Product, and (B) under any intellectual property rights controlled by Taysha or any of its affiliates with respect to such exploitation (the &#8220;GAN Option&#8221;). Subject to certain extensions, the GAN Option was exercisable from the Effective Date through a specified period of time following Astellas&#8217; receipt of (i) the formal minutes from the Type B end-of-Phase 2 meeting between Taysha and the FDA in response to the Company&#8217;s meeting request sent to the FDA on September 19, 2022 for the 120 GAN Product (the &#8220;Type B end-of-Phase 2 Meeting&#8221;), (ii) all written feedback from the FDA with respect to the Type B end-of-Phase 2 Meeting, and (iii) all briefing documents sent by Taysha to the FDA with respect to the Type B end-of-Phase 2 Meeting.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the Option Agreement, the Company also granted to Astellas an exclusive option to obtain an exclusive, worldwide, royalty and milestone-bearing right and license (A) to exploit any Rett Product (as defined below), and (B) under any intellectual property rights controlled by Taysha or any of its affiliates with respect to such exploitation (the &#8220;Rett Option,&#8221; and together with the GAN Option, each, an &#8220;Option&#8221;). Subject to certain extensions, the Rett Option is exercisable from the Effective Date through a specified period of time following Astellas&#8217; receipt of (i) certain clinical data from the female pediatric trial and (ii) certain specified data with respect to TSHA-102, such period, the Rett Option Period, related to (i) the product known, as of the Effective Date, as TSHA-102 and any backup products with respect thereto for use in the treatment of Rett syndrome, and (ii) any other gene therapy product for use in the treatment of Rett syndrome that is controlled by Taysha or any of its affiliates or with respect to which the Company or any of its affiliates controls intellectual property rights covering the exploitation thereof (a &#8220;Rett Product&#8221;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The parties have agreed that, if Astellas exercises an Option, the parties will, for a specified period, negotiate a license agreement in good faith on the terms and conditions outlined in the Option Agreement, including payments by Astellas of a to be determined upfront payment, certain to be determined milestone payments, and certain to be determined royalties on net sales of GAN Products and/or Rett Products, as applicable.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the Rett Option Period, the Company has agreed to (A) not solicit or encourage any inquiries, offers or proposals for, or that could reasonably be expected to lead to, a Change of Control (as defined in the Option Agreement), or (B) otherwise initiate a process for a potential Change of Control, in each case, without first notifying Astellas and offering Astellas the opportunity to submit an offer or proposal to the Company for a transaction that would result in a Change of Control. If Astellas fails or declines to submit any such offer within a specified period after the receipt of such notice, the Company will have the ability to solicit third party bids for a Change of Control transaction. If Astellas delivers an offer to the Company for a transaction that would result in a Change of Control, the Company and Astellas will attempt to negotiate in good faith the potential terms and conditions for such potential transaction that would result in a Change of Control for a specified period, which period may be shortened or extended by mutual agreement.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As partial consideration for the rights granted to Astellas under the Option Agreement, Astellas paid the Company an upfront payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million (the &#8220;Upfront Payment&#8221;). Astellas or any of its affiliates shall have the right, in its or their discretion and upon written notice to the Company, to offset the amount of the Upfront Payment (in whole or in part, until the full amount of the Upfront Payment has been offset) against (a) any payment(s) owed to Taysha or any of its affiliates (or to any third party on behalf of the Company) under or in connection with any license agreement entered into with respect to any GAN Product or Rett Product, including, any upfront payment, milestone payment or royalties owed to Taysha or any of its affiliates (or to any third party on behalf of the Company) under or in connection with any such license agreement or (b) any amount owed to Taysha or any of its affiliates in connection with a Change of Control transaction with Astellas or any of its affiliates. As further consideration for the rights granted to Astellas under the Option Agreement, the Company and Astellas also entered into the Astellas Securities Purchase Agreement (as defined below).</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Astellas Securities Purchase Agreement</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 21, 2022, the Company entered into a securities purchase agreement with Astellas (the &#8220;Astellas Securities Purchase Agreement&#8221; and, together with the Option Agreement, the &#8220;Astellas Transactions&#8221;), pursuant to which the Company agreed to issue and sell to Astellas in a private placement (the &#8220;Astellas Private Placement&#8221;), an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7,266,342</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares (the &#8220;Astellas Private Placement Shares&#8221;), of its common stock, for aggregate gross proceeds of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Astellas Private Placement closed on October 24, 2022. Pursuant to the Astellas Securities Purchase Agreement, in connection with the Astellas Private</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Placement, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Astellas has the right to designate one individual to attend all meetings of the Board in a non-voting observer capacity. The Company also granted Astellas certain registration rights with respect to the Astellas Private Placement Shares.</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Accounting Treatment</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In October 2022, upon closing of the Astellas Private Placement and transferring the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7,266,342</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares to Astellas, the Company recorded the issuance of shares at fair value. Fair value of the shares transferred to Astellas was calculated in accordance with ASC 820, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair Value Measurement </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">by analyzing the Company&#8217;s stock price for a short period of time prior to and after the transaction date as traded on the NASDAQ. The NASDAQ trading data is considered an active market and a Level 1 measurement under ASC 820. The fair value was determined to be approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13.95</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million or $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.92</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share. The $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16.1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million difference between the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million paid by Astellas and the fair market value of shares issued was allocated to the transaction price of the Option Agreement.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company determined that the Option Agreement falls within the scope of ASC 606, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> as the development of TSHA-102 for the treatment of Rett Syndrome and TSHA-120 for the treatment of GAN are considered ordinary activities for the Company. In accordance with ASC 606, the Company evaluated the Option Agreement and identified three separate performance obligations: (1) option to obtain licensing right to GAN, (2) option to obtain licensing right to Rett and (3) performance of research and development activities in the Rett development plan. The transaction price is determined to be $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">36.1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which is comprised of the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million Upfront Payment and the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16.1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million allocated from the Astellas Private Placement.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">To determine the standalone selling price (&#8220;SSP&#8221;) of the Rett and GAN options, which the Company concluded to be material rights, the Company utilized the probability-weighted expected return (&#8220;PWERM&#8221;) method. The PWERM method contemplates the probability and timing of an option exercise. At contract inception, the Company estimated that the probability of exercise was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% for each of the GAN and Rett options. The SSP of the Rett research and development activities was estimated using an expected cost plus margin approach. The standalone selling prices of the material rights and Rett research and development activities were then used to proportionately allocate the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">36.1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million transaction price to the three performance obligations. The $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">36.1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million transaction price was recorded as deferred revenue on the condensed consolidated balance sheet at the inception of the Astellas Transactions.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the allocation of the transaction price to the three performance obligations at contract inception (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.653%;"></td>
        <td style="width:1.02%;"></td>
        <td style="width:1.02%;"></td>
        <td style="width:29.288%;"></td>
        <td style="width:1.02%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Transaction Price Allocation</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Option to obtain license for Rett</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,485</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Option to obtain license for GAN</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,317</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rett research and development activities</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">28,257</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">36,059</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Revenue allocated to the material rights will be recognized at a point in time when each option period expires or when a decision is made by Astellas to exercise or not exercise each option. Revenue from the Rett research and development activities will be recognized as activities are performed using an input method, according to the costs incurred as related to the total costs expected to be incurred to satisfy the performance obligation. The transfer of control occurs over this time period and is a reliable measure of progress towards satisfying the performance obligation.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the three and six months ended June 30, 2023, the Company determined that the total estimated costs to be incurred to satisfy the performance obligation associated with Rett research and development activities had increased from the cost estimate used for the year ended December 31, 2022, and the three months ended March 31, 2023. The cumulative impact of this change would have resulted in a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million decrease related to revenue previously recognized based on prior cost estimates. Subsequent changes during the three months ended September 30, 2023 to total estimated costs were not material, and did not have a material impact on cumulative revenue earned.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company recognized revenue of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.4</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million from Rett research and development activities for the three and nine months ended September 30, 2023, respectively. In September 2023, Astellas provided written notice of its decision not to exercise the GAN Option. The Company recognized revenue of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million from the GAN Option during the three and nine months ended September 30, 2023.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023, the Company recorded deferred revenue of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18.8</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within current liabilities and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within long-term liabilities in the accompanying consolidated balance sheet. The Company will recognize revenues for these performance obligations as they are satisfied.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_AstellasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_AstellasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801705463728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan with Silicon Valley Bank<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Loan with Silicon Valley Bank</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 7&#8212;Loan with Silicon Valley Bank	</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 12, 2021 (the &#8220;Closing Date&#8221;), the Company entered into a Loan and Security Agreement (the &#8220;Term Loan Agreement&#8221;), by and among the Company, the lenders party thereto from time to time (the &#8220;Lenders&#8221;) and Silicon Valley Bank, as administrative agent and collateral agent for the Lenders (&#8220;Agent&#8221;). The Term Loan Agreement provided for (i) on the Closing Date, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">40.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million aggregate principal amount of term loans available through </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2021</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, (ii) from </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 1, 2022</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> until </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30, 2022</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, an additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million term loan facility available at the Company&#8217;s option upon having </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> distinct and active clinical stage programs, determined at the discretion of the Agent, at the time of draw, (iii) from </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">October 1, 2022</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> until </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, an additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million term loan facility available at the Company&#8217;s option upon having </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> distinct and active clinical stage programs, determined at the discretion of the Agent, at the time of draw and (iv) from </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">April 1, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> until </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, an additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million term loan facility available upon approval by the Agent and the Lenders (collectively, the &#8220;Term Loans&#8221;). The Company drew $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in term loans on the Closing Date and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in term loans in December 2021. The Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">t draw on the two additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million tranches prior to expiration on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30, 2022</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 31, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The interest rate applicable to the Term Loans was the greater of (a) the WSJ (&#8220;Wall Street Journal&#8221;) Prime Rate plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.75</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% or (b) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.00</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% per annum. The Term Loans were interest only from the Closing Date through August 31, 2024, after which the Company was required to pay equal monthly installments of principal through </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">August 1, 2026</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the maturity date.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Term Loans could have been prepaid in full through August 12, 2023, with payment of a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.00</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% prepayment premium, after which they could be prepaid in full with no prepayment premium. An additional final payment of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the amount of Terms Loans advanced by the Lenders (&#8220;Exit Fee&#8221;) was due upon prepayment or repayment of the Term Loans in full. The Exit Fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million was recorded as debt discount and has also been fully accrued within non-current liabilities as of September 30, 2023. The debt discount was being accreted using the effective interest method over the term of the Term Loans within interest expense in the condensed consolidated statements of operations.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The obligations under the Term Loan Agreement were secured by a perfected security interest in all of the Company&#8217;s assets except for intellectual property and certain other customarily excluded property pursuant to the terms of the Term Loan Agreement. There were no financial covenants and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> warrants associated with the Term Loan Agreement. The Term Loan Agreement contained various covenants that limited the Company&#8217;s ability to engage in specified types of transactions without the consent of the Lenders which included, among others, incurring or assuming certain debt; merging, consolidating or acquiring all or substantially all of the capital stock or property of another entity; changing the nature of the Company&#8217;s business; changing the Company&#8217;s organizational structure or type; licensing, transferring or disposing of certain assets; granting certain types of liens on the Company&#8217;s assets; making certain investments; and paying cash dividends.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Term Loan Agreement also contained customary representations and warranties, and also included customary events of default, including payment default, breach of covenants, change of control, and material adverse effects. The Company was in compliance with all covenants under the Term Loan Agreement as of September 30, 2023. Upon the occurrence of an event of default, a default interest rate of an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% per annum could have been applied to the outstanding loan balances, and the Lenders could have declared all outstanding obligations immediately due and payable and exercised all of its rights and remedies as set forth in the Term Loan Agreement and under applicable law.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">During the three and nine months ended September 30, 2023, the Company recognized interest expense related to the Term Loan </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> mi</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">llion and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively. During the three and nine months ended September 30, 2022, the Company recognized interest expense related to the Term Loan of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Future principal debt payments on the loan payable as of September 30, 2023 are as follows (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:83.83%;"></td>
        <td style="width:1.801%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.369%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Year Ending December 31,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6,667</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20,000</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13,333</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total principal payments</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">40,000</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unamortized debt discount</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,452</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Term Loan, net</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">38,548</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Term Loan is considered long-term debt because it has been refinanced on a long-term basis, subsequent to September 30, 2023 but before the issuance of these condensed consolidated financial statements, using the proceeds of the Trinity Term Loan Agreement (as defined in Note 16).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On March 10, 2023, Silicon Valley Bank, based in Santa Clara, California, was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) as receiver. On March 27, 2023, First Citizens Bank purchased the remaining assets, deposits and loans of Silicon Valley Bank. As a result, the portion of the Company&#8217;s term loans previously held by Silicon Valley Bank is now held by Silicon Valley Bank as a division of First-Citizen&#8217;s Bank &amp; Trust Company. The remaining portion of the Company&#8217;s term loans are still held by SVB Capital, which is currently in bankruptcy proceedings.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801700345600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research, Collaboration and License Agreements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ResearchCollaborationAndLicenseAgreementsAbstract', window );"><strong>Research Collaboration And License Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Research, Collaboration and License Agreements</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 8&#8212;Research, Collaboration and License Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">UT Southwestern Agreement</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 19, 2019, the Company entered into a research, collaboration and license agreement (&#8220;UT Southwestern Agreement&#8221;) with the Board of Regents of the University of Texas System on behalf of The University of Texas Southwestern Medical Center (&#8220;UT Southwestern&#8221;). Under the UT Southwestern Agreement, UT Southwestern is primarily responsible for preclinical development activities with respect to licensed products for use in certain specified indications (up to investigational new drug application-enabling studies), and the Company is responsible for all subsequent clinical development and commercialization activities with respect to the licensed products. UT Southwestern will conduct such preclinical activities for a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">two-year</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> period under mutually agreed upon sponsored research agreements that were entered into beginning in April 2020. During the initial research phase, the Company has the right to expand the scope of specified indications under the UT Southwestern Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the UT Southwestern Agreement, the Company obtained an exclusive, worldwide, royalty-free license under certain patent rights of UT Southwestern and a non-exclusive, worldwide, royalty-free license under certain know-how of UT Southwestern, in each case to make, have made, use, sell, offer for sale and import licensed products for use in certain specified indications. Additionally, the Company obtained a non-exclusive, worldwide, royalty-free license under certain patents and know-how of UT Southwestern for use in all human uses, with a right of first refusal to obtain an exclusive license under certain of such patent rights and an option to negotiate an exclusive license under other of such patent rights. The Company is required to use commercially reasonable efforts to develop, obtain regulatory approval for, and commercialize at least </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> licensed product.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On April 2, 2020, the Company amended the UT Southwestern Agreement to include the addition of another licensed product and certain indications, and a right of first refusal to the Company over certain patient dosing patents. No additional consideration was transferred in connection with this amendment. In March 2022, the Company and UT Southwestern mutually agreed to revise the payment schedules and current performance expectations of the current sponsored research agreements under the UT Southwestern Agreement and defer payments by fifteen months.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The UT Southwestern Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last valid claim of a licensed patent in such country for such licensed product. After the initial research term, the Company may terminate the agreement, on an indication-by-indication and licensed product-by-licensed product basis, at any time upon specified written notice to UT Southwestern. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In November 2019, as partial consideration for the license rights granted under the UT Southwestern Agreement, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,179,000</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of its common stock, or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of its then outstanding fully-diluted common stock, to UT Southwestern. The Company does not have any future milestone or royalty obligations to UT Southwestern under the UT Southwestern Agreement other than costs related to maintenance of patents.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Abeona CLN1 Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In August 2020, the Company entered into license and inventory purchase agreements (collectively, the &#8220;Abeona Agreements&#8221;) with Abeona Therapeutics Inc. (&#8220;Abeona&#8221;) for worldwide exclusive rights to certain intellectual property rights and know-how relating to the research, development and manufacture of ABO-202, an AAV-based gene therapy for CLN1 disease (also known as infantile Batten disease). Under the terms of the Abeona Agreements, the Company made initial cash payments to Abeona of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for the license fee and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million for purchase of clinical materials and reimbursement for previously incurred development costs in October 2020. In exchange for the license rights, the Company recorded an aggregate of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within research and development expenses in the consolidated statements of operations for the year ended December 31, 2020, since the acquired license or acquired inventory do not have an alternative future use. The Company is obligated to make up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in regulatory-related milestones and up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in sales-related milestones per licensed CLN1 product. The Company will also pay an annual earned royalty in the high single digits on net sales of any licensed CLN1 products. The license agreement with Abeona (the &#8220;Abeona License Agreement&#8221;) expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the Abeona License Agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the Abeona License Agreement for convenience upon specified prior written notice to Abeona.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In December 2021, a regulatory milestone was triggered in connection with this agreement and therefore the Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within research and development expenses in the consolidated statements of operations for the year ended December 31, 2021. The milestone fee was paid in January 2022 and classified as an investing cash outflow in the condensed consolidated statements of cash flows for the nine months ended September 30, 2022. No additional milestone payments were made or triggered in connection with this agreement during the nine months ended September 30, 2023.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Abeona Rett Agreement</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On October 29, 2020, the Company entered into a license agreement (the &#8220;Abeona Rett Agreement&#8221;) with Abeona pursuant to which the Company obtained an exclusive, worldwide, royalty-bearing license, with the right to grant sublicenses under certain patents, know-how and materials originally developed by the University of North Carolina at Chapel Hill, the University of Edinburgh and Abeona to research, develop, manufacture, have manufactured, use, and commercialize licensed products for gene therapy and the use of related transgenes for Rett syndrome.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Subject to certain obligations of Abeona, the Company is required to use commercially reasonable efforts to develop at least one licensed product and commercialize at least one licensed product in the United States.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the Abeona Rett Agreement, the Company paid Abeona a one-time upfront license fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which was recorded in research and development expenses in the consolidated statements of operations for the year ended December 31, 2020, since the acquired license does not have an alternative future use. The Company is obligated to pay Abeona up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in regulatory-related milestones and up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in sales-related milestones per licensed Rett product and high single-digit royalties on net sales of licensed Rett products. Royalties are payable on a licensed product-by-licensed product and country-by-country basis until the latest of the expiration or revocation or complete rejection of the last licensed patent covering such licensed product in the country where the licensed product is sold, the loss of market exclusivity in such country where the product is sold, or, if no licensed product exists in such country and no market exclusivity exists in such country, ten years from first commercial sale of such licensed product in such country.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Abeona Rett Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the agreement for convenience upon specified prior written notice to Abeona.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2022, the Company&#8217;s clinical trial application (&#8220;CTA&#8221;) filing for TSHA-102 for the treatment of Rett Syndrome was approved by Health Canada and therefore triggered a regulatory milestone payment in connection with the Abeona Rett Agreement. The Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within research and development expenses in the condensed consolidated statements of operations for the nine months ended September 30, 2022. The $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million regulatory milestone fee was paid in July 2022. In May 2023, the Company dosed the first patient with TSHA-102 in the Phase 1/2 REVEAL trial evaluating the safety and preliminary efficacy of TSHA-102 in adult patients with Rett syndrome and therefore triggered a milestone payment in connection with the Abeona Rett Agreement. The Company recorded $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">within research and development expenses in the condensed consolidated statements of operations for the nine months ended September 30, 2023. This milestone fee was paid in August 2023 and classified as an investing cash outflow in the condensed consolidated statements of cash flows for the nine months ended September 30, 2023. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> additional milestone payments were made or triggered in connection with the Abeona Rett Agreement during the nine months ended September 30, 2023.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Acquisition of Worldwide Rights for TSHA-120 for the treatment of GAN</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2021, the Company acquired the exclusive worldwide rights to a clinical-stage AAV9 gene therapy program, now known as TSHA-120, for the treatment of GAN. TSHA-120 is an intrathecally dosed AAV9 gene therapy currently being evaluated in a clinical trial for the treatment of GAN. The trial is being conducted by the National Institutes of Health (&#8220;NIH&#8221;) in close collaboration with a leading patient advocacy group focused on finding treatments and cures for GAN. TSHA-120 has received rare pediatric disease and orphan drug designations from the U.S. Food and Drug Administration for the treatment of GAN. The worldwide rights were acquired through a license agreement, effective March 29, 2021, between Hannah&#8217;s Hope Fund for Giant Axonal Neuropathy, Inc. (&#8220;HHF&#8221;) and the Company (the &#8220;GAN Agreement&#8221;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the terms of the GAN Agreement, in exchange for granting the Company the exclusive worldwide rights to TSHA-120, HHF received an upfront payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and will be eligible to receive clinical, regulatory and commercial milestones totaling up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">19.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, as well as a low, single-digit royalty on net sales upon commercialization of the product. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> additional milestone payments were made or triggered in connection with the GAN Agreement during the nine months ended September 30, 2023.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">License Agreement for CLN7</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2022, the Company entered into a license agreement with UT Southwestern (the &#8220;CLN7 Agreement&#8221;) pursuant to which the Company obtained an exclusive worldwide, royalty-bearing license with right to grant sublicenses to develop, manufacture, use, and commercialize licensed products for gene therapy for CLN7, a form of Batten Disease. In connection with the CLN7 Agreement, the Company paid a one-time upfront license fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. The Company recorded the upfront license fee in research and development expense in the condensed consolidated statements of operations since the acquired license does not have an alternative future use. The Company is obligated to pay UT Southwestern up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.7</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in regulatory-related milestones and up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in sales-related milestones, as well as a low, single-digit royalty on net sales upon commercialization of the product. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> additional milestone payments were made or triggered in connection with the CLN7 Agreement during the nine months ended September 30, 2023.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ResearchCollaborationAndLicenseAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research, collaboration and license agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ResearchCollaborationAndLicenseAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org//808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801704294880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 9&#8212;Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On July 1, 2020, the Company&#8217;s board of directors approved the 2020 Equity Incentive Plan (&#8220;Existing Plan&#8221;) which permits the granting of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;) and other stock-based awards to employees, directors, officers and consultants. As of September 16, 2020, the approval date of the New Plan (as defined below), no additional awards will be granted under the Existing Plan. The terms of the Existing Plan will continue to govern the terms of outstanding equity awards that were granted prior to approval of the New Plan.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On September 16, 2020, the Company&#8217;s stockholders approved the 2020 Stock Incentive Plan (&#8220;New Plan&#8221;), which became effective upon the execution of the underwriting agreement in connection with the IPO. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The number of shares of common stock reserved for issuance under the New Plan automatically increases on January 1 of each year, for a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ten years</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, from </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 1, 2021</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, continuing through </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 1, 2030</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company&#8217;s board of directors.</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> On January 1, 2023, the Company&#8217;s board of directors increased the number of shares of common stock reserved for issuance under the New Plan by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3,160,375</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Furthermore, on September 16, 2020, the Company&#8217;s stockholders approved the Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which became effective upon the execution of the underwriting agreement in connection with the IPO. The maximum number of shares of common stock that may be issued under the ESPP will not exceed </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">362,000</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock, plus </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the number of shares of common stock that are automatically added on January 1st of each year for a period of up to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ten years</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, commencing on the first January 1 following the IPO and ending on (and including) </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 1, 2030</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, in an amount equal to the lesser of (i) one percent (</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year, and (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">724,000</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock.</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">were added to the ESPP in 2021. On January 1, 2022 and 2023, the Company&#8217;s board of directors</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">incre</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ased the number of shares of common stock reserved for issuance under the ESPP by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">384,739</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">632,075</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> respectively. The Company has issued an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">141,393</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock under the ESPP as of September 30, 2023.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The number of shares available for grant under the Company&#8217;s incentive plans were as follows:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.21%;"></td>
        <td style="width:1.18%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.943%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.743%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.18%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.743%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Existing</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">New</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Plan</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Plan</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Available for grant - December 31, 2022</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,067,682</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,067,682</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Plan adjustments and amendments</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">667,828</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3,828,203</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3,160,375</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Grants</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,241,357</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,241,357</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Forfeitures</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">667,828</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,918,614</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3,586,442</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Available for grant - September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,573,142</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,573,142</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock Options</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the three months ended September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">50,000</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock under the New Plan were awarded with a weighted-average grant date fair value per sh</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">are of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.50</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. For the nine months ended September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,520,471</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock under the New Plan were awarded with a weighted-average grant date fair value per share of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.64</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The stoc</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">k options vest over </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_a612bde1-69ec-4545-8cd9-0a74e9778ed1;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">one</span></span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">four years</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> and have a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ten-year</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> contractual term.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following weighted-average assumptions were used to estimate the fair value of time-based vesting stock options that were granted during the three and nine months ended September 30, 2023 and 2022:</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:53.008%;"></td>
        <td style="width:1.003%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.349%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.003%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.93%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.003%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.349%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.003%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.352%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Three Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4.22</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.61</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.16</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6.1</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">81</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">81</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">76</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes time-based vesting stock option activity, during the nine months ended September 30, 2023:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.18%;"></td>
        <td style="width:1.001%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.674%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.221%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.893%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.001%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.674%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.221%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.133%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Aggregate</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Remaining</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Intrinsic</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Stock</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Exercise</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Contractual</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Options</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Price</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Life (in years)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Outstanding at December 31, 2022</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6,158,078</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11.84</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8.9</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">62</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options granted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,520,471</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.90</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options cancelled or forfeited</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,013,500</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10.88</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options expired</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">857,557</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">22.26</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Outstanding at September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,807,492</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.89</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8.9</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6,851</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options exercisable at September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,036,300</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18.48</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.5</span></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">49</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The aggregate intrinsic value in the above table is calculated as the difference between the fair value of the Company&#8217;s common stock at the respective reporting date and the exercise price of the stock options. As of September 30, 2023, the total unrecognized compensation related to unvested time-based vesting stock option awards granted was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, which the Company expects to recognize over a weighted-average period of approximately</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.1</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> y</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ears. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> stock options were exercised during the period.</span></p><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Performance Stock Options</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2023, the Company issued options to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">70,235</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock to employees under the New Plan that contain performance-based vesting conditions, subject to continued employment through each anniversary and achievement of the performance c</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">onditions. The grant date fair value of these awards was not material. As of September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">58,346</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of the shares subject to the performance-based options were outstanding, all of which vested during the period. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> stock options were exercised during the period.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In May 2023, the Company issued options to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,166,653</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock to employees under the New Plan that contain both service and performance-based vesting conditions with a weighted average grant date fair value per share of</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.50</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. T</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">he stock options have a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10-year</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> contractual term and vest over </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.6</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years if a combination of clinical, regulatory and financing performance conditions are achieved. As of September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> compensation expense was recorded related to the awards as achievement of the performance conditions was not considered probable. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following assumptions were used to estimate the fair value of performance and service-based stock options that were granted during the nine months ended September 30, 2023:</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.449%;"></td>
        <td style="width:0.998%;"></td>
        <td style="width:1%;"></td>
        <td style="width:17.552999999999997%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the nine months ended September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4.02</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6.0</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">81</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Market-based Stock Options</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2023, the Company issued options to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">70,233</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of common stock to employees under the New Plan that contain a market-based vesting condition, subject to continued employment through each anniversary and achievement of the market c</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ondition. The grant date fair value of the stock options that contain market-based vesting conditions was not material. As of September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">58,344</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of the shares subject to the stock options that contain a market-based vesting condition were outstanding, and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> options vested during the period.</span></p><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Restricted Stock Units</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">81,236</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> RSUs to employees under the New Plan. </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">T</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">he RSUs are subject to a service-based vesting condition. The service-based RSUs vest in equal annual installments over a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">four-year</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> period. The Company at any time may accelerate the vesting of the RSUs. Such shares are not accounted for as out</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">standing until they vest.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s default tax withholding method for RSUs granted prior to 2023 is the sell-to-cover method, in which shares with a market value equivalent to the tax withholding obligation are sold on behalf of the holder of the RSUs upon vesting and settlement to cover the tax withholding liability and the cash proceeds from such sales are remitted by the Company to taxing authorities. For RSUs granted in 2023, the Company&#8217;s tax withholding policy allows the RSU holder to choose to either pay cash to the Company for the tax withholding obligation or elect the net withholding method, in which shares with a market equivalent to the tax withholding obligation are withheld and the net shares are issued to the RSU holder.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">251,296</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> RSUs to the former President and Chief Executive officer of the Company in connection with his resignation from the Company and Board of Directors. The RSUs vested immediately.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s RSU activity for the nine months ended September 30, 2023 was as follows:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.02%;"></td>
        <td style="width:1.161%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.370000000000001%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.621%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.829999999999998%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Grant Date</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Number</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">of Shares</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">per Share</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonvested at December 31, 2022</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,257,844</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6.52</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Restricted units granted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">332,532</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.06</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">556,989</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4.78</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cancelled or forfeited</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">658,343</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.18</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonvested at September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">375,044</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6.63</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023, the total unrecognized compensation related to unvested RSUs granted was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which is expected to be amortized on a straight-line basis over a weighted-average period of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.9</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years.</span></p></div><p style="text-indent:0;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Performance and Market-based Restricted Stock Units</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2023, the Company issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">81,233</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> RSUs to employees under the New Plan that contain a combination of performance and market-based vesting conditions, subject to continued employment through each anniversary and achievement of market and performance conditions. The grant date fair value of the RSUs that contain performance and market-based vesting conditions was not material. As of September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">34,673</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of the RSUs were unvested and still outstanding and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">34,671</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> RSUs vested and were settled during the period.</span></p><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Restricted Stock Awards</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s former President and Chief Executive Officer, was awarded </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">769,058</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> RSAs under the Existing Plan on July 1, 2020, which vested over a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three-year</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> term, subject to continuous employment. The fair value of these RSAs at the grant date of July 1, 2020, was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.28</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share. On March 2, 2023, the Company&#8217;s former President and Chief Executive Officer resigned from the Board of Directors, therefore cancelling any remaining unvested tranches.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s RSA activity for the nine months ended September 30, 2023 was as follows:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.02%;"></td>
        <td style="width:1.161%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.370000000000001%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.621%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.829999999999998%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Grant Date</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Number</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">of Shares</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">per Share</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonvested at December 31, 2022</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">85,494</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.28</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Restricted stock granted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">64,120</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.28</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cancelled or forfeited</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">21,374</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.28</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonvested at September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Employee Stock Purchase Plan</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2022, the Company&#8217;s board of directors authorized the first offering under the ESPP. Under the ESPP, eligible employees may purchase shares of Taysha common stock through payroll deductions at a price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the lower of the fair market values of the stock as of the beginning or the end of six-month offering periods. An employee&#8217;s payroll deductions under the ESPP are limited to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the employee&#8217;s compensation and employees may not purchase more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,800</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of shares of Taysha common stock during any offering period. During the nine months ended September 30, 2023 and 2022, stock-based compensation expense related to the ESPP was not material.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Stock-based Compensation Expense</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the total stock-based compensation expense for the stock options, ESPP, RSAs and RSUs recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and 2022 (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.225%;"></td>
        <td style="width:1.905%;"></td>
        <td style="width:1%;"></td>
        <td style="width:15.741999999999999%;"></td>
        <td style="width:1%;"></td>
        <td style="width:2.807%;"></td>
        <td style="width:1%;"></td>
        <td style="width:11.772%;"></td>
        <td style="width:1%;"></td>
        <td style="width:2.506%;"></td>
        <td style="width:1%;"></td>
        <td style="width:14.138%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.764%;"></td>
        <td style="width:1%;"></td>
        <td style="width:14.138%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Three Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development expense</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">705</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,001</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,524</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,894</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,335</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,469</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4,413</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8,046</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,040</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4,470</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,937</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13,940</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801704276000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_WarrantsNoteDisclosureTextBlock', window );">Warrants</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 10&#8212;Warrants</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Pre-Funded Warrants</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On August 14, 2023, the Company entered into a Securities Purchase Agreement (the &#8220;August 2023 Purchase Agreement&#8221;) with certain institutional and other accredited investors (the &#8220;Purchasers&#8221;), pursuant to which the Company agreed to sell and issue to the Purchasers in a private placement transaction (the &#8220;August 2023 Private Placement&#8221;) (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">122,412,376</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares (the &#8220;PIPE Shares&#8221;) of the Company&#8217;s common stock, and (ii) with respect to certain Purchasers, pre-funded warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">44,250,978</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company&#8217;s common stock (the &#8220;Pre-Funded Warrants&#8221;) in lieu of shares of the Company&#8217;s common stock. The purchase price per share of common stock was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.90</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share (the &#8220;Purchase Price&#8221;), and the purchase price for the Pre-Funded Warrants was the Purchase Price minus $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per Pre-Funded Warrant.</span></p><p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Pre-Funded Warrants have a per share exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, subject to proportional adjustments in the event of stock splits or combinations or similar events. The Pre-Funded Warrants will not expire until exercised in full. The Pre-Funded Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation; provided, however, that a holder may increase or decrease the beneficial ownership limitation by giving </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">61</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> days&#8217; notice to the Company, but not to any percentage in excess of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">19.99</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%. The Pre-Funded Warrants will only be exercisable upon receipt of stockholder approval of an increase in the authorized shares of the Company&#8217;s common stock (the &#8220;Stockholder Approval&#8221;), which the Company will first seek to obtain at a special meeting of stockholders scheduled to be held on November 15, 2023. If the Company does not obtain Stockholder Approval by December 31, 2023, it is required to pay liquidated damages of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the aggregate purchase price paid by each holder of Pre-Funded Warrants. For any subsequent failure to obtain Stockholder Approval, the Company is required to pay an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% as liquidated damages.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The closing of the August 2023 Private Placement occurred on August 16, 2023 (the &#8220;Closing&#8221;). The total gross proceeds to the Company at the Closing were approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">150.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, and after deducting placement agent commissions and offering expenses payable by the Company, net proceeds were approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">140.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million. The Company used the with-and-without method to allocate the total gross proceeds by first allocating the portion of the proceeds equal to the fair value of the Pre-Funded Warrants on the Closing date with the remaining proceeds allocated to the PIPE Shares on a residual basis.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company concluded that the Pre-Funded Warrants do not meet the criteria for equity classification under the guidance of ASC 815 as the Company does not have sufficient authorized and unissued shares to satisfy the warrants if exercised. The Company recorded the Pre-Funded Warrants as liabilities at their fair value. This liability is subject to remeasurement at each balance sheet date and any change in fair value is recognized in the Company&#8217;s condensed consolidated statement of operations. The Company incurred $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9.7</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of placement agent commissions and other issuance costs in connection with the August 2023 Private Placement. The placement agent commissions and other issuance costs were allocated between the PIPE Shares and the Pre-Funded Warrants on a systematic basis. The Company allocated $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million to the PIPE Shares which was recorded as a deduction to Additional paid-in capital. The remaining $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million allocated to the Pre-Funded Warrants were recorded within general and administrative expense in the consolidated statements of operations for the nine months ended September 30, 2023. The issuance costs allocated to the Pre-Funded Warrants have been added back to net loss when deriving cash flows used in operations, and have been classified as a financing cash outflow in the condensed consolidated statement of cash flows for the nine months ended September 30, 2023.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company measured the fair value of the PIPE Shares and Pre-Funded Warrants based on the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.90</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share Purchase Price. </span><span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company used the relative fair value method to allocate the net proceeds received from the sales of the PIPE Shares and the Pre-Funded Warrants on the condensed consolidated balance sheet as follows (in thousands):</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:60.997%;"></td>
        <td style="width:4.503%;"></td>
        <td style="width:1%;"></td>
        <td style="width:32.501000000000005%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Purchase Price Allocation</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PIPE Shares</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">110,127</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-Funded Warrants</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">39,826</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">149,953</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company remeasured the fair value of the Pre-Funded Warrants using the closing price of the Company&#8217;s common stock on the Nasdaq Global Market as of September 30, 2023 of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.16</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per common share. The Company recorded a fair value adjustment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">100.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">SSI Warrants</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In April 2023, the Company entered into a securities purchase agreement (the &#8220;SSI Securities Purchase Agreement&#8221;), with two affiliates of SSI Strategy Holdings LLC (&#8220;SSI&#8221;), named therein (the &#8220;SSI Investors&#8221;) pursuant to which the Company agreed to issue and sell to the SSI Investors in a private placement (the &#8220;SSI Private Placement&#8221;), </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">705,218</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of its common stock (the &#8220;SSI Shares&#8221;) and warrants (the &#8220;SSI Warrants&#8221;) to purchase an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">525,000</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> shares of the Company&#8217;s common stock (the &#8220;Warrant Shares&#8221;). SSI provides certain consulting services to the Company. Each SSI Warrant has an exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.7090</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per Warrant Share, which was the closing price of the Company&#8217;s common stock on the Nasdaq Global Market on April 4, 2023. The SSI Warrants issued in the SSI Private Placement provide that the holder of the SSI Warrants will not have the right to exercise any portion of its SSI Warrants until the achievement of certain clinical and regulatory milestones related to the Company&#8217;s clinical programs. The SSI Private Placement closed on April 5, 2023. Gross proceeds of the SSI Private Placement were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company concluded that the SSI Warrants do not meet the criteria for equity classification under the guidance of ASC 815 due to settlement provisions that permit the holder to receive a variable number of shares in the event of a specified fundamental transaction as well as provisions that permit the holder to participate in dividends. As the SSI Warrants do not meet the criteria for equity classification, the Company recorded the warrants as liabilities at their fair value. This liability is subject to remeasurement at each balance sheet date until the warrants are exercised or expire, and any change in fair value is recognized in the Company&#8217;s condensed consolidated statement of operations.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company determined the fair value of the SSI Warrants at issuance was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million using the Black-Scholes-Merton option pricing model. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following assumptions were used to estimate the fair value of the warrants at issuance:</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.853%;"></td>
        <td style="width:2.092%;"></td>
        <td style="width:1%;"></td>
        <td style="width:15.054%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.46</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.2</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">81</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Market value of common stock</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.71</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The fair value adjustment as of September 30, 2023 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million using the Black-Scholes-Merton option pricing model with probability weights applied to each of the SSI Warrants where vesting is contingent upon the achievement of certain clinical and regulatory milestones related to the Company&#8217;s clinical programs. As of September 30, 2023, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">200,000</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> of the SSI Warrants have vested and are exercisable. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> warrants were exercised during the period.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company estimated the fair value of the SSI Warrant liability using the following assumptions as of September 30, 2023:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:72.285%;"></td>
        <td style="width:4.901%;"></td>
        <td style="width:1%;"></td>
        <td style="width:20.812%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.46</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4.8</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">81</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Market value of common stock</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.16</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the Company&#8217;s warrant liability (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.499%;"></td>
        <td style="width:3.962%;"></td>
        <td style="width:1%;"></td>
        <td style="width:28.538999999999998%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Warrant Liability</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Balance at January 1, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Issuance of SSI Warrants</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">252</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Issuance of Pre-Funded Warrants</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">39,826</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Change in fair value</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">100,456</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Balance at September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">140,534</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_WarrantsNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants note disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_WarrantsNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699064704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Common Share</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 11&#8212;Net Loss Per Common Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Since the Company had a net loss in all periods presented, basic and diluted net loss per common share are the same.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In August 2023, the Company issued liability-classified Pre-Funded Warrants with a nominal exercise price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.001</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> per share (see Note 10). In accordance with ASC 260 </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Earnings Per Share, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">shares issuable for little to no cash consideration should be included in the number of outstanding shares used to calculate basic earnings per share as long as all conditions necessary for exercise are met. As the Company does not have enough authorized shares to satisfy the warrants, the requirement that all conditions necessary for exercise are not met, and the Pre-Funded Warrants are not included in the calculation of basic net loss per share for the three and nine months ended September 30, 2023.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table represents the calculation of basic and diluted net loss per common share (in thousands, except share and per share data):</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.158%;"></td>
        <td style="width:1.484%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.954%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.384%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.954%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.183%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.851%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.183%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.851%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Three Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">117,087</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26,527</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">159,307</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">110,936</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted-average shares of common stock outstanding used to compute net loss per common share, basic and diluted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">125,700,799</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">40,937,808</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">84,630,796</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">39,761,764</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss per common share, basic and diluted</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.93</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.65</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.88</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.79</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following common stock equivalents outstanding as of September 30, 2023 and 2022 were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti&#8209;dilutive:</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.96%;"></td>
        <td style="width:1.16%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.36%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.16%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.36%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br/>2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br/>2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unvested RSUs</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">409,717</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,257,844</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unvested RSAs</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">149,614</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Stock options</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8,090,835</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4,547,733</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SSI Warrants</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">525,000</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-Funded Warrants</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">44,250,978</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">53,276,530</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,955,191</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801704344176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 12&#8212;Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are provided if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets. There is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> provision for income taxes because the Company has incurred operating losses and capitalized certain items for income tax purposes since its inception and maintains a full valuation allowance against its net deferred tax assets. The reported amount of income tax expense for the period differs from the amount that would result from applying the federal statutory tax rate to net loss before taxes primarily because of the change in valuation allowance.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023, there were no material changes to either the nature or the amounts of the uncertain tax positions previously determined for the year ended December 31, 2022.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699871920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 13&#8212;Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Litigation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company is not a party to any material legal proceedings and is not aware of any pending or threatened claims. From time to time, the Company may be subject to various legal proceedings and claims that arise in the ordinary course of its business activities.</span></p><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Commitments</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In the normal course of business, the Company enters into contracts that contain a variety of indemnifications with its employees, licensors, suppliers and service providers. The Company&#8217;s maximum exposure under these arrangements is unknown at September 30, 2023. The Company does not anticipate recognizing any significant losses relating to these arrangements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801702154704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Reprioritization<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock', window );">Strategic Reprioritization</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 14 &#8211; Strategic Reprioritization</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In March 2022, the Company implemented changes to the Company&#8217;s organizational structure as well as a broader operational cost reduction plan to enable the Company to focus on specific clinical-stage programs for GAN and Rett syndrome. Substantially all other research and development activities have been paused to increase operational efficiency.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with prioritization of programs, the Company reduced headcount by approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">35</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% across all functions in March 2022. In accordance with ASC 420,</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> Exit and Disposal Activities,</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the Company recorded one-time severance and termination-related costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million in the condensed consolidated statements of operations for the nine months ended September 30, 2022, primarily within research and development expenses. Throughout the first quarter of 2023, the Company further reduced headcount and recorded additional one-time severance and termination related costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.7</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million within research and development and general and administrative expenses.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company expects payment of these costs to be complete by March 31, 2024. The amount of accrued severance recorded as of September 30, 2023 is as follows (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.8%;"></td>
        <td style="width:4.122%;"></td>
        <td style="width:1%;"></td>
        <td style="width:27.078%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued severance balance as of December 31, 2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,463</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Severance recorded</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,691</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Severance paid</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3,162</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued severance balance as of September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">992</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire description for costs incurred to effect a business combination that have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801704276000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Retirement Plan</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 15 &#8211; Retirement Plan</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In July 2021, the Company adopted a 401(k) retirement savings plan that provides retirement benefits to all full-time employees. Eligible employees may</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> contribute a percentage of their annual compensation, subject to Internal Revenue Service limitations. The Company contributed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million to the 401(k) retirement savings plan for the three months ended September 30, 2023 and 2022, respectively. The Company contributed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million to the 401(k) retirement savings plan for the nine months ended September 30, 2023 and 2022, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801704339584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Note 16&#8211; Subsequent Events</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 13, 2023 (the &#8220;Trinity Closing Date&#8221;), the Company entered into a Loan and Security Agreement (the &#8220;Trinity Term Loan Agreement&#8221;), by and among the Company, the lenders party thereto from time to time (the &#8220;Trinity Lenders&#8221;) and Trinity Capital Inc., as administrative agent and collateral agent for the Trinity Lenders (&#8220;Trinity&#8221;). The Trinity Term Loan Agreement provides for, on the Trinity Closing Date, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">40.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million aggregate principal amount of term loans (collectively, the &#8220;Trinity Term Loans&#8221;). The Company drew the Trinity Term Loans in full on the Trinity Closing Date.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The interest rate applicable to the Trinity Term Loans is the greater of (a) the WSJ Prime Rate plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4.50</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% or (b) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">12.75</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% per annum. The Trinity Term Loans are interest only from the Trinity Closing Date through </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">36 months</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> from the Trinity Closing Date, which may be extended to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">48 months</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> from the Trinity Closing Date upon the satisfaction of certain milestones set forth in the Trinity Term Loan Agreement, after which the Company is required to pay equal monthly installments of principal through </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">November 13, 2028</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (the &#8220;Maturity Date&#8221;).</span></span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Trinity Term Loans may be prepaid in full (i) from the Trinity Closing Date through November 13, 2024, with payment of a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.00</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% prepayment premium, (ii) from November 13, 2024 through November 13, 2025, with payment of a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% prepayment premium, and (iii) from November 13, 2025 through, but excluding, the Maturity Date, with payment of a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% prepayment premium.  On the Trinity Closing Date, the Company paid to Trinity a commitment fee of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.00</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the original principal amount of the Trinity Term Loans. Upon repayment in full of the Trinity Term Loans, the Company will pay to Trinity an end of term payment equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.00</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of the original principal amount of the Trinity Term Loans.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The obligations under the Trinity Term Loan Agreement are secured by a perfected security interest in all of the Company&#8217;s assets except for certain customarily excluded property pursuant to the terms of the Trinity Term Loan Agreement. There are no financial covenants and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> warrants associated with the Trinity Term Loan Agreement. The Trinity Term Loan Agreement contains various covenants that limit the Company&#8217;s ability to engage in specified types of transactions without the consent of Trinity and the Trinity Lenders which include, among others, incurring or assuming certain debt; merging, consolidating or acquiring all or substantially all of the capital stock or property of another entity; changing the nature of the Company&#8217;s business; changing the Company&#8217;s organizational structure or type; licensing, transferring or disposing of certain assets; granting certain types of liens on the Company&#8217;s assets; making certain investments; and paying cash dividends.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Trinity Term Loan Agreement also contains customary representations and warranties, and also includes customary events of default, including payment default, breach of covenants, change of control, and material adverse effects. Upon the occurrence of an event of default, a default interest rate of an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% per annum may be applied to the outstanding loan balances, and the Trinity Lenders may declare all outstanding obligations immediately due and payable and exercise all of its rights and remedies as set forth in the Trinity Term Loan Agreement and under applicable law.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The proceeds of the Trinity Term Loans were used to repay the Company&#8217;s obligations under the Term Loan Agreement with Silicon Valley Bank in full. The Term Loan Agreement with Silicon Valley Bank was terminated concurrently with entry into the Trinity Term Loan Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801698977792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) as determined by the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X and are consistent in all material respects with those included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 28, 2023 (the &#8220;2022 Annual Report&#8221;). In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The consolidated balance sheet as of December 31, 2022, is derived from audited financial statements, however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in the Company&#8217;s 2022 Annual Report.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Principles of Consolidation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The accompanying interim condensed consolidated financial statements include the accounts of Taysha and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The most significant estimates and assumptions in the Company&#8217;s financial statements relate to the determination of the fair value of the common stock prior to the initial public offering ("IPO") (as an input into stock-based compensation), estimating manufacturing accruals and accrued or prepaid research and development expenses, the measurement of impairment of long-lived assets, the fair value of the warrant liability, and the allocation of consideration received in connection with the Astellas Transactions (as defined below) at contract inception. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#8217;s future results of operations will be affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash and cash equivalents consist of funds held in a standard checking account, a standard savings account and a money market fund. The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Assets Held for Sale</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Assets Held for Sale</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assets and liabilities are classified as held for sale when all of the following criteria for a plan of sale have been met: (1) management, having the authority to approve the action, commits to a plan to sell the assets; (2) the assets are available for immediate sale, in their present condition, subject only to terms that are usual and customary for sales of such assets; (3) an active program to locate a buyer and other actions required to complete the plan to sell the assets have been initiated; (4) the sale of the assets is probable and is expected to be completed within one year; (5) the assets are being actively marketed for a price that is reasonable in relation to their current fair value; and (6) actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or the plan will be withdrawn. When all of these criteria have been met, the assets and liabilities are classified as held for sale in the balance sheet. Assets classified as held for sale are reported at </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">the lower of their carrying value or fair value less costs to sell. The Company recorded a partial impairment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million during the three months ended September 30, 2023 in connection with the classification of certain assets to assets held for sale. Depreciation and amortization of assets ceases upon designation as held for sale.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_WarrantsPolicyPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Warrants</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s specific terms and applicable authoritative guidance in FASB ASC 480, </span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (&#8220;ASC 480&#8221;) and ASC 815,</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> Derivatives and Hedging</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#8217;s own common shares and whether the warrant holders could potentially require &#8220;net cash settlement&#8221; in a circumstance outside of the Company&#8217;s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period while the warrants are outstanding.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to remeasurement at each balance sheet date until the warrants are exercised or expire, and any change in fair value is recognized in the Company&#8217;s condensed consolidated statement of operations.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Comprehensive Loss</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Comprehensive loss is equal to net loss as presented in the accompanying condensed consolidated statements of operations.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), as amended, with guidance regarding the accounting for and disclosure of leases. This update requires lessees to recognize the liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheets. This update also requires lessees and lessors to disclose key information about their leasing transactions.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2022</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, the Company </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">adopted</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> ASU 2016-02 using the modified retrospective approach and utilizing the effective date as its date of initial application.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> The Company has retrospectively changed its previously issued condensed consolidated financial statements as of September 30, 2022 as presented within the Company&#8217;s September 30, 2022 Quarterly Report on Form 10-Q to reflect the adoption of ASC 842 on January 1, 2022. The condensed consolidated financial statements for the three and nine months ended September 30, 2022 presented herein differ from the Company&#8217;s condensed consolidated financial statements included in the Company&#8217;s September 30, 2022 Quarterly Report on Form 10-Q as those condensed consolidated financial statements were prepared using the former accounting standard referred to as ASC Topic 840, Leases.</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">  </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company elected the following practical expedients, which must be elected as a package and applied consistently to all of its leases at the transition date (including those for which the entity is a lessee or a lessor): i) the Company did not reassess whether any expired or existing contracts are or contain leases; ii) the Company did not reassess the lease classification for any expired or existing leases (that is, all existing leases that were classified as operating leases in accordance with ASC 840 are classified as operating leases, and all existing leases that were classified as capital leases in accordance with ASC 840 are classified as finance leases); and iii) the Company did not reassess initial direct costs for any existing leases. For leases that existed prior to the date of initial application of ASC 842 (which were previously classified as operating leases), a lessee may elect to use either the total lease term measured at lease inception under ASC 840 or the remaining lease term as of the date of initial application of ASC 842 in determining the period for which to measure its incremental borrowing rate. In transition to ASC 842, the Company utilized the remaining lease term of its leases in determining the appropriate incremental borrowing rates.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The adoption of this standard resulted in the recognition of operating lease right-of-use assets and operating lease liabilities of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18.4</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">19.1</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, respectively, on the Company&#8217;s condensed consolidated balance sheet at adoption relating to its operating leases. The lease liabilities were determined based on the present value of the remaining minimum lease payments. Upon adoption of ASC 842, the Company also (i) derecognized the build-to-suit lease asset of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26.3</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million previously presented in property, plant and equipment, (ii) derecognized the build-to-suit lease liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26.5</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million, and (iii) eliminated $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million of deferred rent liabilities and tenant improvement allowances as of January 1, 2022, as these liabilities are reflected in the operating lease right-of-use assets. In adopting ASU 2016-02, the Company recorded a total one-time adjustment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million to the opening balance of accumulated deficit as of January 1, 2022, related to the de-recognition of the build-to-suit lease asset and related build-to-suit lease obligation. The adoption </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">did not</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> have a material impact on accumulated deficit and on the condensed consolidated statements of operations and cash flows.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations and statement of cash flows for the nine months ended September 30, 2022 (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:54.498%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:12.366%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre ASC 842 Nine Months Ended<br/>September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASC 842 Adjustments</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">After ASC 842 Nine Months Ended<br/>September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_c235bfe5-b369-4c89-8e3c-24a2b2c671cb;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed</span></span></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Consolidated Statement of Operations</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating expenses:</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">77,308</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,154</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">78,462</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other income (expense):</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3,002</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">509</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,493</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">110,291</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">645</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">110,936</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed Consolidated Statement of Cash Flows</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Depreciation expense</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">808</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">810</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Non-cash lease expense</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,031</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,031</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;&#160;Accrued expenses and other current liabilities</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7,753</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">823</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8,576</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash flows from financing activities</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,144</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">435</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">709</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Supplemental disclosure of noncash investing and financing activities:</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Right-of-use assets obtained in exchange for lease liabilities</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">23,035</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">23,035</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations for the three months ended September 30, 2022 (in thousands):</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:54.498%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:12.366%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre ASC 842 Three Months Ended<br/>September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASC 842 Adjustments</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">After ASC 842 Three Months Ended<br/>September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_3d5ea955-cb63-460e-9ac4-0cc91b6e0847;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed</span></span></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Consolidated Statement of Operations</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating expenses:</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16,391</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">383</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16,774</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other income (expense):</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,241</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">163</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,078</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26,307</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">220</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26,527</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
        </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_WarrantsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_WarrantsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801702193776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Summary of Effect of the Adoption of ASC 842 on Statement of Operations and Cash Flows</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations and statement of cash flows for the nine months ended September 30, 2022 (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:54.498%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:12.366%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre ASC 842 Nine Months Ended<br/>September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASC 842 Adjustments</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">After ASC 842 Nine Months Ended<br/>September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_c235bfe5-b369-4c89-8e3c-24a2b2c671cb;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed</span></span></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Consolidated Statement of Operations</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating expenses:</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">77,308</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,154</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">78,462</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other income (expense):</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3,002</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">509</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,493</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">110,291</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">645</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">110,936</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed Consolidated Statement of Cash Flows</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Depreciation expense</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">808</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">810</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Non-cash lease expense</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,031</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,031</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;&#160;Accrued expenses and other current liabilities</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7,753</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">823</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8,576</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cash flows from financing activities</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,144</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">435</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">709</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Supplemental disclosure of noncash investing and financing activities:</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Right-of-use assets obtained in exchange for lease liabilities</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">23,035</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">23,035</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations for the three months ended September 30, 2022 (in thousands):</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:54.498%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:12.366%;"></td>
          <td style="width:1%;"></td>
          <td style="width:1.322%;"></td>
          <td style="width:1%;"></td>
          <td style="width:11.584999999999999%;"></td>
          <td style="width:1%;"></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre ASC 842 Three Months Ended<br/>September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ASC 842 Adjustments</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">After ASC 842 Three Months Ended<br/>September 30, 2022</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_3d5ea955-cb63-460e-9ac4-0cc91b6e0847;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Condensed</span></span></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Consolidated Statement of Operations</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating expenses:</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16,391</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">383</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16,774</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other income (expense):</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest expense</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,241</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">163</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,078</span></p></td>
          <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
         <tr style="height:10pt;">
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26,307</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">220</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26,527</span></p></td>
          <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-12<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801702038704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following tables present information about the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values (in thousands):</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.487%;"></td>
        <td style="width:1%;"></td>
        <td style="width:11.149%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.263%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.525%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.263%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.525%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.263%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.525%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Assets:</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;&#160;&#160;Cash equivalents &#8211; money market funds</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">150,514</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">150,514</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">150,514</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">150,514</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Liabilities:</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Warrant liability</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;&#160;&#160;SSI Warrants</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">701</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">701</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;&#160;&#160;Pre-funded warrants</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">139,833</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">139,833</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total liabilities</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">140,534</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">139,833</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">701</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801702550256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br/>2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid research and development</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,672</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4,840</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid clinical trial</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,392</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,119</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Deferred offering costs</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">724</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">724</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Prepaid insurance</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">337</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">388</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">404</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">466</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total prepaid expenses and other current assets</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,529</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8,537</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property Plant and Equipment Net</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property, plant and equipment, net consisted of the following (in thousands):	</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br/>2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,091</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,091</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Laboratory equipment</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,868</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,868</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,115</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,115</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">864</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">898</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Construction in progress</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6,874</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9,633</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13,812</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">16,605</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accumulated depreciation</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,643</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,642</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Property, plant and equipment, net</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11,169</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">14,963</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock', window );">Schedule of Accrued Expense and Other Current Labilities</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued expenses and other current liabilities consisted of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.08%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.622%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.837%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br/>2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31,<br/>2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued research and development</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,699</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8,190</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued compensation</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,745</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,519</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lease liabilities, current portion</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,538</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,521</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued clinical trial</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,359</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,473</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued severance</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">992</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,463</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued professional and consulting fees</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">579</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">390</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued property, plant and equipment</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">45</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,081</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">681</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">650</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total accrued expenses and other current liabilities</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13,638</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18,287</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of accrued expense and other current labilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699109712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the lease costs recognized under ASC 842 and other information pertaining to the Company&#8217;s operating leases for the three and nine months ended September 30, 2023 and 2022 (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:36.628%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.314%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.314%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.223%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.937%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.764%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.817%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="5" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Three Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating lease cost</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">696</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">794</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,088</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,079</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Variable lease cost</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">243</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">229</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">729</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">617</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total lease cost</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">939</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,817</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,696</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock', window );">Schedule of Supplemental Information Related to Remaining Lease Term and Discount Rate</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Supplemental information related to the remaining lease term and discount rate are as follows:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:54.052%;"></td>
        <td style="width:1.545%;"></td>
        <td style="width:1%;"></td>
        <td style="width:22.212%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:18.19%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">December 31, 2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted average remaining lease term (in years) &#8211; Finance leases</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.13</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.88</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted average remaining lease term (in years) &#8211; Operating leases</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10.97</span></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11.45</span></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted average discount rate &#8211; Finance leases</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10.52</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10.51</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted average discount rate &#8211; Operating leases</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.79</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.72</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock', window );">Schedule of Supplemental Cash Flow Information Related to Operating Leases</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Supplemental cash flow information related to the Company&#8217;s operating leases are as follows (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:52.723%;"></td>
        <td style="width:1%;"></td>
        <td style="width:20.627%;"></td>
        <td style="width:1%;"></td>
        <td style="width:2.022%;"></td>
        <td style="width:1%;"></td>
        <td style="width:20.627%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating cash flows for operating leases</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,109</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">847</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Commitments Under Company's Operating and Finance Leases</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023, future minimum commitments under ASC 842 under the Company&#8217;s operating and finance leases were as follows (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:51.682%;"></td>
        <td style="width:1%;"></td>
        <td style="width:22.389%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:21.927999999999997%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Year Ending December 31,</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Operating</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Finance</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">686</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">114</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,810</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">454</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,910</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">454</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,485</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">399</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,577</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Thereafter</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">19,721</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total lease payments</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">31,189</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,421</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10,895</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">242</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total lease liabilities</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20,294</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,179</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_3e78f387-05e6-4d7c-88d4-c13b0a4b78ec;"><span style="-sec-ix-hidden:F_dbeee014-7927-4ce5-8253-ba65a26dca89;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lease liabilities, current</span></span></span></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,193</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">345</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_b7b24932-76e0-4234-83dc-e0defb7581aa;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Lease liabilities, non-current</span></span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">19,101</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">834</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1ede665f-e147-4c30-a4ac-9f4f220b3eda;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total lease liabilities</span></span></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20,294</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,179</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, operating and finance lease, liability, maturity .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Supplemental Cash Flow Information Related To Operating Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of supplemental information related to remaining lease term and discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801702191408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Astellas Agreements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_SummaryOfTransactionPriceAllocationTableTextBlock', window );">Summary of Allocation for Transaction Price to the Three Performance Obligations</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the allocation of the transaction price to the three performance obligations at contract inception (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.653%;"></td>
        <td style="width:1.02%;"></td>
        <td style="width:1.02%;"></td>
        <td style="width:29.288%;"></td>
        <td style="width:1.02%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Transaction Price Allocation</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Option to obtain license for Rett</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,485</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Option to obtain license for GAN</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,317</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Rett research and development activities</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">28,257</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">36,059</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_SummaryOfTransactionPriceAllocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary Of Transaction Price Allocation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_SummaryOfTransactionPriceAllocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801702125872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan with Silicon Valley Bank (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Principal Debt Payments on Loan Payable</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Future principal debt payments on the loan payable as of September 30, 2023 are as follows (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:83.83%;"></td>
        <td style="width:1.801%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.369%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Year Ending December 31,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6,667</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">20,000</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13,333</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total principal payments</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">40,000</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unamortized debt discount</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,452</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Term Loan, net</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">38,548</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801698980992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock', window );">Schedule of Share Based Compensation Available for Grant under Incentive Plans</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The number of shares available for grant under the Company&#8217;s incentive plans were as follows:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.21%;"></td>
        <td style="width:1.18%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.943%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.743%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.18%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.743%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Existing</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">New</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Plan</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Plan</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Available for grant - December 31, 2022</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,067,682</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,067,682</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Plan adjustments and amendments</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">667,828</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3,828,203</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3,160,375</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Grants</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,241,357</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,241,357</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Forfeitures</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">667,828</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,918,614</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3,586,442</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Available for grant - September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,573,142</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,573,142</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s RSU activity for the nine months ended September 30, 2023 was as follows:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.02%;"></td>
        <td style="width:1.161%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.370000000000001%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.621%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.829999999999998%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Grant Date</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Number</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">of Shares</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">per Share</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonvested at December 31, 2022</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,257,844</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6.52</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Restricted units granted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">332,532</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.06</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">556,989</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4.78</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cancelled or forfeited</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">658,343</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.18</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonvested at September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">375,044</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6.63</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023, the total unrecognized compensation related to unvested RSUs granted was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> million which is expected to be amortized on a straight-line basis over a weighted-average period of approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.9</span></span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> years.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of Restricted Stock Awards Activity</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company&#8217;s RSA activity for the nine months ended September 30, 2023 was as follows:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.02%;"></td>
        <td style="width:1.161%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.370000000000001%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.621%;"></td>
        <td style="width:1%;"></td>
        <td style="width:12.829999999999998%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Grant Date</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Number</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">of Shares</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">per Share</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonvested at December 31, 2022</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">85,494</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.28</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Restricted stock granted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Vested</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">64,120</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.28</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Cancelled or forfeited</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">21,374</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.28</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Nonvested at September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Total Stock-Based Compensation Expense for Stock Options, ESPP, RSAs and RSUs</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the total stock-based compensation expense for the stock options, ESPP, RSAs and RSUs recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and 2022 (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.225%;"></td>
        <td style="width:1.905%;"></td>
        <td style="width:1%;"></td>
        <td style="width:15.741999999999999%;"></td>
        <td style="width:1%;"></td>
        <td style="width:2.807%;"></td>
        <td style="width:1%;"></td>
        <td style="width:11.772%;"></td>
        <td style="width:1%;"></td>
        <td style="width:2.506%;"></td>
        <td style="width:1%;"></td>
        <td style="width:14.138%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.764%;"></td>
        <td style="width:1%;"></td>
        <td style="width:14.138%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Three Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Research and development expense</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">705</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,001</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,524</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,894</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,335</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,469</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4,413</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8,046</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,040</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4,470</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,937</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">13,940</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following weighted-average assumptions were used to estimate the fair value of time-based vesting stock options that were granted during the three and nine months ended September 30, 2023 and 2022:</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:53.008%;"></td>
        <td style="width:1.003%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.349%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.003%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.93%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.003%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.349%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.003%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.352%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Three Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4.22</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.61</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.16</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.5</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6.1</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">81</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">81</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">76</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes time-based vesting stock option activity, during the nine months ended September 30, 2023:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.18%;"></td>
        <td style="width:1.001%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.674%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.221%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.893%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.001%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.674%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.221%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.133%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Aggregate</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Remaining</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Intrinsic</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Stock</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Exercise</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Contractual</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Options</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Price</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Life (in years)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Outstanding at December 31, 2022</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6,158,078</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">11.84</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8.9</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">62</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options granted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,520,471</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.90</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options cancelled or forfeited</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,013,500</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">10.88</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options expired</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">857,557</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">22.26</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Outstanding at September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,807,492</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.89</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8.9</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6,851</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Options exercisable at September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,036,300</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">18.48</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">7.5</span></span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">49</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following assumptions were used to estimate the fair value of performance and service-based stock options that were granted during the nine months ended September 30, 2023:</span><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.449%;"></td>
        <td style="width:0.998%;"></td>
        <td style="width:1%;"></td>
        <td style="width:17.552999999999997%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the nine months ended September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4.02</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">6.0</span></span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">81</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of share based compensation available for grant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801702692880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock', window );">Schedule of Fair Value Method to Allocate Net Proceeds Received from Sale of Common Stock and Pre-funded Warrants</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company used the relative fair value method to allocate the net proceeds received from the sales of the PIPE Shares and the Pre-Funded Warrants on the condensed consolidated balance sheet as follows (in thousands):</span><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:60.997%;"></td>
        <td style="width:4.503%;"></td>
        <td style="width:1%;"></td>
        <td style="width:32.501000000000005%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Purchase Price Allocation</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PIPE Shares</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">110,127</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-Funded Warrants</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">39,826</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">149,953</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ScheduleOfWarrantLiabilityTableTextBlock', window );">Schedule of Warrant Liability</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table summarizes the Company&#8217;s warrant liability (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.499%;"></td>
        <td style="width:3.962%;"></td>
        <td style="width:1%;"></td>
        <td style="width:28.538999999999998%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Warrant Liability</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Balance at January 1, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Issuance of SSI Warrants</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">252</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Issuance of Pre-Funded Warrants</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">39,826</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Change in fair value</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">100,456</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Balance at September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">140,534</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock', window );">Schedule Of Assumptions Used To Estimate Fair Value Of Warrants</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following assumptions were used to estimate the fair value of the warrants at issuance:</span><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.853%;"></td>
        <td style="width:2.092%;"></td>
        <td style="width:1%;"></td>
        <td style="width:15.054%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.46</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5.2</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">81</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Market value of common stock</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.71</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company estimated the fair value of the SSI Warrant liability using the following assumptions as of September 30, 2023:</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:72.285%;"></td>
        <td style="width:4.901%;"></td>
        <td style="width:1%;"></td>
        <td style="width:20.812%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.46</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4.8</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">81</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Market value of common stock</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3.16</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of assumptions used to estimate fair value of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of fair value method to allocate net proceeds received from sale of common stock and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ScheduleOfWarrantLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ScheduleOfWarrantLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801705222672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Calculation of Basic and Diluted Net Loss Per Common Share</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following table represents the calculation of basic and diluted net loss per common share (in thousands, except share and per share data):</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.158%;"></td>
        <td style="width:1.484%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.954%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.384%;"></td>
        <td style="width:1%;"></td>
        <td style="width:9.954%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.183%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.851%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.183%;"></td>
        <td style="width:1%;"></td>
        <td style="width:8.851%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Three Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">For the Nine Months Ended September 30,</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">117,087</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">26,527</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">159,307</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">110,936</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Weighted-average shares of common stock outstanding used to compute net loss per common share, basic and diluted</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">125,700,799</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">40,937,808</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">84,630,796</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">39,761,764</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Net loss per common share, basic and diluted</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.93</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">0.65</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1.88</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2.79</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following common stock equivalents outstanding as of September 30, 2023 and 2022 were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti&#8209;dilutive:</span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.96%;"></td>
        <td style="width:1.16%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.36%;"></td>
        <td style="width:1%;"></td>
        <td style="width:1.16%;"></td>
        <td style="width:1%;"></td>
        <td style="width:13.36%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:8pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br/>2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">September 30,<br/>2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unvested RSUs</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">409,717</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,257,844</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Unvested RSAs</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">149,614</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Stock options</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">8,090,835</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">4,547,733</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SSI Warrants</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">525,000</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-Funded Warrants</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">44,250,978</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">53,276,530</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5,955,191</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699899616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Reprioritization (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock', window );">Summary of Accrued Severance Activity Recorded</a></td>
<td class="text"><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company expects payment of these costs to be complete by March 31, 2024. The amount of accrued severance recorded as of September 30, 2023 is as follows (in thousands):</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.8%;"></td>
        <td style="width:4.122%;"></td>
        <td style="width:1%;"></td>
        <td style="width:27.078%;"></td>
        <td style="width:1%;"></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As of September 30, 2023</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued severance balance as of December 31, 2022</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1,463</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Severance recorded</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2,691</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Severance paid</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">3,162</span></p></td>
        <td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;">
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accrued severance balance as of September 30, 2023</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">$</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">992</span></p></td>
        <td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of accrued severance activity table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801700507088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business Operations - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 05, 2021</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems', window );"><strong>Organization and Description of Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 13,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,640,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (560,748,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (401,441,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164,278,000<span></span>
</td>
<td class="nump">$ 34,306,000<span></span>
</td>
<td class="nump">$ 87,880,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_SalesAgreementMember', window );">Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems', window );"><strong>Organization and Description of Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_CommonStockSharesIssuedAndSold', window );">Common stock shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_SalesAgreementMember', window );">Sales Agreement | Sales Agents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems', window );"><strong>Organization and Description of Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PercentageOfSalePricePerShareOfCommonStock', window );">Percentage of gross sales price per share of common stock</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_SalesAgreementMember', window );">Sales Agreement | Sales Agents | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems', window );"><strong>Organization and Description of Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_AggregateOfferingPriceFromSaleOfCommonStock', window );">Aggregate offering price from sale of common stock</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AggregateOfferingPriceFromSaleOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate offering price from sale of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AggregateOfferingPriceFromSaleOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_CommonStockSharesIssuedAndSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock shares issued and sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_CommonStockSharesIssuedAndSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization and description of business operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PercentageOfSalePricePerShareOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of sale price per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PercentageOfSalePricePerShareOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_SalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_SalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=tsha_SalesAgentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=tsha_SalesAgentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801700450896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of assets held for sale</a></td>
<td class="nump">$ 616<span></span>
</td>
<td class="nump">$ 616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">9,852<span></span>
</td>
<td class="nump">9,852<span></span>
</td>
<td class="nump">$ 10,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">20,294<span></span>
</td>
<td class="nump">20,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment', window );">Derecognized build to suite lease asset</a></td>
<td class="nump">26,300<span></span>
</td>
<td class="nump">26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_DerecognizedBuildToSuitLeaseLiability', window );">Derecognized build to suit lease liablility</a></td>
<td class="nump">26,500<span></span>
</td>
<td class="nump">26,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances', window );">Deferred rent liabiilities and tenant improvement allowances</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CumulativeEarningsDeficit', window );">Accumulated Deficit</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASU 2016-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Change in Accounting Principle, Accounting Standards Update, Adoption Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted', window );">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 18,400<span></span>
</td>
<td class="nump">$ 18,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">$ 19,100<span></span>
</td>
<td class="nump">$ 19,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Rent Liabiilities And Tenant Improvement Allowances</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derecognized Build To Suit Lease Asset Presented In Property Plant Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_DerecognizedBuildToSuitLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derecognized Build To Suit Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_DerecognizedBuildToSuitLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant accounting policies line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147477123/405-50-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-5<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-5<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date accounting standards update was adopted, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147477123/405-50-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-5<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-5<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-4<br><br>Reference 42: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 250<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -SubTopic 20<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480530/250-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeEarningsDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative earnings (deficits) for relevant time periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeEarningsDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801695483088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Summary of Effect of the Adoption of ASC 842 on Statement of Operations and Cash Flows (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 11,791<span></span>
</td>
<td class="nump">$ 16,774<span></span>
</td>
<td class="nump">$ 44,096<span></span>
</td>
<td class="nump">$ 78,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,471)<span></span>
</td>
<td class="num">(1,078)<span></span>
</td>
<td class="num">(4,285)<span></span>
</td>
<td class="num">(2,493)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(117,087)<span></span>
</td>
<td class="num">(26,527)<span></span>
</td>
<td class="num">(159,307)<span></span>
</td>
<td class="num">(110,936)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">1,005<span></span>
</td>
<td class="nump">810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">908<span></span>
</td>
<td class="nump">1,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,576)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (253)<span></span>
</td>
<td class="num">(709)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Accounting Standards Update 2016-02 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Accounting Standards Update 2016-02 [Member]<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,241)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,002)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110,291)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,753)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,144)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">ASC 842 Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (220)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(645)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(823)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,035<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in accrued expense and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147477123/405-50-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 72: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801695385728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">$ 150,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_SsiWarrants', window );">SSI Warrants</a></td>
<td class="nump">701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PreFundedWarrants', window );">Pre-funded warrants</a></td>
<td class="nump">139,833<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">140,534<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents - money market funds</a></td>
<td class="nump">150,514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">150,514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents - money market funds</a></td>
<td class="nump">150,514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PreFundedWarrants', window );">Pre-funded warrants</a></td>
<td class="nump">139,833<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">139,833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_SsiWarrants', window );">SSI Warrants</a></td>
<td class="nump">701<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">$ 701<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre funded warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_SsiWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>SSI warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_SsiWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699422912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PrepaidResearchAndDevelopmentContracts', window );">Prepaid research and development</a></td>
<td class="nump">$ 2,672<span></span>
</td>
<td class="nump">$ 4,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PrepaidClinicalTrial', window );">Prepaid clinical trial</a></td>
<td class="nump">1,392<span></span>
</td>
<td class="nump">2,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="nump">724<span></span>
</td>
<td class="nump">724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">337<span></span>
</td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">466<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other current assets</a></td>
<td class="nump">$ 5,529<span></span>
</td>
<td class="nump">$ 8,537<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PrepaidClinicalTrial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid clinical trial.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PrepaidClinicalTrial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PrepaidResearchAndDevelopmentContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid research and development contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PrepaidResearchAndDevelopmentContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480341/340-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801700324960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Property, Plant and Equipment Net (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 13,812<span></span>
</td>
<td class="nump">$ 16,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(2,643)<span></span>
</td>
<td class="num">(1,642)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">11,169<span></span>
</td>
<td class="nump">14,963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">2,091<span></span>
</td>
<td class="nump">2,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tsha_LaboratoryEquipmentMember', window );">Laboratory Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">2,868<span></span>
</td>
<td class="nump">2,868<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">864<span></span>
</td>
<td class="nump">898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 6,874<span></span>
</td>
<td class="nump">$ 9,633<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tsha_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=tsha_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801789982224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 1,005<span></span>
</td>
<td class="nump">$ 810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Non-cash impairment charge</a></td>
<td class="nump">$ 36,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset', window );">Impairment charges to construction in process and finance lease right of use assets</a></td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Impairment loss on sale of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tsha_AssetsCapitalizedAsFinanceLeasesMember', window );">Assets Capitalized As Finance Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment Charge On Construction In Progress And Finance Lease Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=tsha_AssetsCapitalizedAsFinanceLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=tsha_AssetsCapitalizedAsFinanceLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699969296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_AccruedResearchAndDevelopmentCurrent', window );">Accrued research and development</a></td>
<td class="nump">$ 5,699<span></span>
</td>
<td class="nump">$ 8,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">2,745<span></span>
</td>
<td class="nump">2,519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_LeaseLiabilityCurrent', window );">Lease liabilities, current portion</a></td>
<td class="nump">1,538<span></span>
</td>
<td class="nump">1,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_AccruedClinicalTrialCurrent', window );">Accrued clinical trial</a></td>
<td class="nump">1,359<span></span>
</td>
<td class="nump">1,473<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_AccruedSeverance', window );">Accrued severance</a></td>
<td class="nump">992<span></span>
</td>
<td class="nump">1,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional and consulting fees</a></td>
<td class="nump">579<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_AccruedPropertyPlantAndEquipmentCurrent', window );">Accrued property, plant and equipment</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">2,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">681<span></span>
</td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total accrued expenses and other current liabilities</a></td>
<td class="nump">$ 13,638<span></span>
</td>
<td class="nump">$ 18,287<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AccruedClinicalTrialCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued clinical trial current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AccruedClinicalTrialCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AccruedPropertyPlantAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued property, plant, and equipment current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AccruedPropertyPlantAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AccruedResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AccruedResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AccruedSeverance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Severance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AccruedSeverance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_LeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease liability current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_LeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699534000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 14, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jan. 11, 2021 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 17, 2020 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Future minimum remianing lease payments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,189<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_DurhamLeaseMember', window );">Durham Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits', window );">Number of operating lease landlord square feet manufacturing facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperationsCommencedDate1', window );">Operating lease commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Lease, option to extend description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Company has two options to extend the term of the Durham Lease, each for a period of an additional five years.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease extend term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Amount required to place in escrow account | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_PegasusParkLLCMember', window );">Pegasus Park L L C | Dallas Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits', window );">Number of operating lease landlord square feet manufacturing facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperationsCommencedDate1', window );">Operating lease commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 27,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Lease, option to extend description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Company has an option to extend the term of the Dallas Lease for one additional period of five years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_PegasusParkLLCMember', window );">Pegasus Park L L C | Dallas Lease Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits', window );">Number of operating lease landlord square feet manufacturing facility</a></td>
<td class="nump">18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term of contract</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Future minimum remianing lease payments | $</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_PegasusParkLLCMember', window );">Pegasus Park L L C | Dallas Lease Amendment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot', window );">Maximum construction allowance provided by landlord per rentable square foot</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum construction allowance provided by landlord per rentable square foot.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperationsCommencedDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the operations of the entity commenced, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperationsCommencedDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of units (items of property) under operating lease arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_DurhamLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_DurhamLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_PegasusParkLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_PegasusParkLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_DallasLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_DallasLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_DallasLeaseAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_DallasLeaseAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699174528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 696<span></span>
</td>
<td class="nump">$ 794<span></span>
</td>
<td class="nump">$ 2,088<span></span>
</td>
<td class="nump">$ 2,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="nump">729<span></span>
</td>
<td class="nump">617<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 939<span></span>
</td>
<td class="nump">$ 1,023<span></span>
</td>
<td class="nump">$ 2,817<span></span>
</td>
<td class="nump">$ 2,696<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801702506304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Information Related to Remaining Lease Term and Discount Rate (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years) - Finance leases</a></td>
<td class="text">3 years 1 month 17 days<span></span>
</td>
<td class="text">3 years 10 months 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years) - Operating leases</a></td>
<td class="text">10 years 11 months 19 days<span></span>
</td>
<td class="text">11 years 5 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate - Finance leases</a></td>
<td class="nump">10.52%<span></span>
</td>
<td class="nump">10.51%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate - Operating leases</a></td>
<td class="nump">7.79%<span></span>
</td>
<td class="nump">7.72%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699845440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Cash Flow, Operating Activities, Lessee [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows for operating leases</a></td>
<td class="nump">$ 2,109<span></span>
</td>
<td class="nump">$ 847<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801700442256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Future Minimum Commitments Under Company's Operating and Finance Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">2,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">2,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">2,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">2,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">19,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">31,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(10,895)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">20,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">$ 1,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued Liabilities and Other Liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">$ 19,101<span></span>
</td>
<td class="nump">$ 20,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">20,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">1,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(242)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">1,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities, current</a></td>
<td class="nump">$ 345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued Liabilities and Other Liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance, lease liabilities, non-current</a></td>
<td class="nump">$ 834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other Liabilities, Noncurrent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 1,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease liability payments due after year four.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801695651120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Astellas Agreements - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 21, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,960,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,960,193<span></span>
</td>
<td class="nump">63,207,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ProbabilityOfAnOptionExercise', window );">Probability of option exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Decrease in revenue previously recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue recorded within current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,759<span></span>
</td>
<td class="nump">$ 33,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue recorded within long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember', window );">TSHA-120</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_UpfrontPayment', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_AbeonaRettAgreementMember', window );">Rett Research and Development Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_GiantAxonalNeuropathyAgreementMember', window );">Option Agreement for GAN</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AstellasMember', window );">Astellas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_UpfrontPayment', window );">Upfront payment</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_TransactionPrice', window );">Transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AstellasMember', window );">Astellas | Astellas Securities Purchase Agreement | Astellas Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">7,266,342<span></span>
</td>
<td class="nump">7,266,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Aggregate gross proceeds</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_FairValueOfSharesTransferredValue', window );">Fair value of shares transferred, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_TransactionPrice', window );">Transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_DifferenceOfMarketValuePaid', window );">Difference of market value paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AstellasMember', window );">Astellas | TSHA-120</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_UpfrontPayment', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_TransactionPrice', window );">Transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AstellasMember', window );">Astellas | TSHA-120 | Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_TransactionPrice', window );">Transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AstellasMember', window );">Astellas | Rett Research and Development Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_TransactionPrice', window );">Transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_DifferenceOfMarketValuePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference of market value paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_DifferenceOfMarketValuePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_FairValueOfSharesTransferredValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of shares transferred value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_FairValueOfSharesTransferredValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ProbabilityOfAnOptionExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Probability of Option Exercise</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ProbabilityOfAnOptionExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_TransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_TransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_UpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_UpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_AbeonaRettAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_AbeonaRettAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_GiantAxonalNeuropathyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_GiantAxonalNeuropathyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_AstellasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_AstellasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_AstellasSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_AstellasSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=tsha_AstellasPrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=tsha_AstellasPrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699967616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Astellas Agreements - Summary of Allocation for Transaction Price to the Three Performance Obligations (Details) - Astellas - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_TransactionPrice', window );">Transaction Price Allocation</a></td>
<td class="nump">$ 36,100<span></span>
</td>
<td class="nump">$ 36,059<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AstellasMember', window );">Option to obtain license for Rett</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_TransactionPrice', window );">Transaction Price Allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AstellasMember', window );">Option to obtain license for GAN</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_TransactionPrice', window );">Transaction Price Allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AstellasMember', window );">Rett Research and Development Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_TransactionPrice', window );">Transaction Price Allocation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,257<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_TransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_TransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_AstellasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_AstellasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_LicenseForRettMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_LicenseForRettMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_LicenseForGanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_LicenseForGanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_AbeonaRettAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_AbeonaRettAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801689591920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan with Silicon Valley Bank - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 12, 2021 </div>
<div>USD ($) </div>
<div>Program</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">Aug.  01,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest rate</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PercentageOfPrepaymentOfFacility', window );">Percentage of prepayment of facility</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants associated with loan facility</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent', window );">Exit fee recorded as debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PercentageOfAnnualDefaultInterestRate', window );">Percentage of annual default interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseLongTermDebt', window );">Interest expense related to term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember', window );">Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=tsha_TermLoanFacilityMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Current borrowing capacity</a></td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember', window );">Through December 31, 2021 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember', window );">January 1, 2022 until September 30, 2022 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateRangeStart1', window );">Debt instrument, maturity start date</a></td>
<td class="text">Jan.  01,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateRangeEnd1', window );">Debt instrument, maturity end date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_NumberOfDistinctAndActiveClinicalStage', window );">Number of distinct and active clinical stage | Program</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ProceedsFromTermLoan', window );">Proceeds from term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember', window );">January 1, 2022 until March 31, 2023 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateRangeEnd1', window );">Debt instrument, maturity end date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ProceedsFromTermLoan', window );">Proceeds from term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember', window );">October 1, 2022 until March 31, 2023 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateRangeStart1', window );">Debt instrument, maturity start date</a></td>
<td class="text">Oct.  01,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateRangeEnd1', window );">Debt instrument, maturity end date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_NumberOfDistinctAndActiveClinicalStage', window );">Number of distinct and active clinical stage | Program</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember', window );">April 1, 2023 until December 31, 2023 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateRangeStart1', window );">Debt instrument, maturity start date</a></td>
<td class="text">Apr.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateRangeEnd1', window );">Debt instrument, maturity end date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember', window );">Through August 13, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PercentageOfPrepaymentPremium', window );">Percentage of prepayment premium</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_NumberOfDistinctAndActiveClinicalStage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of distinct and active clinical stage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_NumberOfDistinctAndActiveClinicalStage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PercentageOfAnnualDefaultInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of annual default interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PercentageOfAnnualDefaultInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PercentageOfPrepaymentOfFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of prepayment of facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PercentageOfPrepaymentOfFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PercentageOfPrepaymentPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of prepayment premium</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PercentageOfPrepaymentPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ProceedsFromTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from term loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ProceedsFromTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateRangeEnd1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Latest date the outstanding debt instruments are required to be repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateRangeEnd1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateRangeStart1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earliest date the outstanding debt instruments are required to be repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateRangeStart1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest paid or due on all long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (b)<br> -Subparagraph (1)<br> -Publisher SEC<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=tsha_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=tsha_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699098960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Loan with Silicon Valley Bank - Schedule of Future Principal Debt Payments on Loan Payable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 6,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">13,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total principal payments</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="num">(1,452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term Loan, net</a></td>
<td class="nump">$ 38,548<span></span>
</td>
<td class="nump">$ 37,967<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801691423296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research, Collaboration and License Agreements - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>Product</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 29, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,960,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,960,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,207,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,791,000<span></span>
</td>
<td class="nump">$ 16,774,000<span></span>
</td>
<td class="nump">$ 44,096,000<span></span>
</td>
<td class="nump">$ 78,462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember', window );">TSHA-120</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_AdditionalMilestonePayments', window );">Additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_UpfrontPayment', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived', window );">Clinical, regulatory and commercial milestones to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_LicenseAgreementForCLN7Member', window );">License Agreement for CLN7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_AdditionalMilestonePayments', window );">Additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PaymentOfOneTimeUpfrontLicenseFee', window );">Payment of one-time upfront license fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable', window );">License agreement regulatory related milestones maximum amount payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable', window );">License agreement sales-related milestones maximum amount payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_UTSouthwesternAgreementMember', window );">UT Southwestern Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements', window );">Preclinical activities period under sponsored research agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize', window );">Minimum licensed product to develop obtain regulatory approval for and commercialize | Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,179,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding', window );">Percentage of fully diluted common stock shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AbeonaCLN1AgreementsMember', window );">Abeona CLN1 Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PaymentOfLicenseFee', window );">License fee payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts', window );">Purchase of clinical materials and reimbursement incurred development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="nump">$ 7,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AbeonaCLN1AgreementsMember', window );">Abeona CLN1 Agreements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment', window );">License and inventory purchase agreement regulatory related milestones payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment', window );">License and inventory purchase agreement sales related milestones payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AbeonaTherapeuticsIncMember', window );">Abeona | Rett Research and Development Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_AdditionalMilestonePayments', window );">Additional milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PaymentOfOneTimeUpfrontLicenseFee', window );">Payment of one-time upfront license fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_RegulatoryMilestoneFeePaid', window );">Regulatory milestone fee paid</a></td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_AbeonaTherapeuticsIncMember', window );">Abeona | Maximum | Rett Research and Development Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_RegulatoryRelatedMilestonesObligationPayable', window );">Regulatory related milestones obligation payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable', window );">Sale-related milestones per licensed product and royalties on net sales of licensed products payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AdditionalMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AdditionalMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Clinical, regulatory and commercial milestones to be received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License agreement regulatory related milestones maximum amount payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License agreement sales-related milestones maximum amount payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License and inventory purchase agreement regulatory related milestones payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License and inventory purchase agreement sales related milestones payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum licensed product to develop obtain regulatory approval for and commercialize.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PaymentOfLicenseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of license fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PaymentOfLicenseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PaymentOfOneTimeUpfrontLicenseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of one-time upfront license fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PaymentOfOneTimeUpfrontLicenseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of fully diluted common stock shares outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preclinical activities period under sponsored research agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase of clinical materials and reimbursement incurred development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_RegulatoryMilestoneFeePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Regulatory milestone fee paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_RegulatoryMilestoneFeePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_RegulatoryRelatedMilestonesObligationPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Regulatory related milestones obligation payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_RegulatoryRelatedMilestonesObligationPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale-related milestones per licensed product and royalties on net sales of licensed products payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_UpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_UpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_LicenseAgreementForCLN7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_LicenseAgreementForCLN7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_UTSouthwesternAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_UTSouthwesternAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_AbeonaCLN1AgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_AbeonaCLN1AgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_AbeonaTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_AbeonaTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_AbeonaRettAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_AbeonaRettAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801689832240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 16, 2020</div></th>
<th class="th"><div>Jul. 01, 2020</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Feb. 28, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jan. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Percentage of common stock price purchased through payroll deductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate', window );">Percentage of payroll deductions of employee's compensation during offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares employees may purchase during offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,040,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,470,000<span></span>
</td>
<td class="nump">$ 5,937,000<span></span>
</td>
<td class="nump">$ 13,940,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tsha_EmployeeStockPurchasePlansMember', window );">Employee Stock Purchase Plan (ESPP)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="nump">724,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">632,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">384,739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-based payment award, expiration date</a></td>
<td class="text">Jan.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance', window );">Percentage of automatic increase every year in common stock shares reserved for future issuance</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward', window );">Share-based payment award, terms of award issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the number of shares of common stock that are automatically added on January 1st of each year for a period of up to ten years, commencing on the first January 1 following the IPO and ending on (and including) January 1, 2030, in an amount equal to the lesser of (i) one percent (1.0%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year, and (ii) 724,000 shares of common stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Number of shares of common stock issued under ESPP</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tsha_EmployeeStockPurchasePlansMember', window );">Employee Stock Purchase Plan (ESPP) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance</a></td>
<td class="nump">362,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Performance and market-based restricted stock units of other option vested during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">556,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based payment award, compensation cost not yet recognized, weighted-average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based payment award, RSU/RSA granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstsanding performance and market-based RSU's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,257,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Share-based payment award, unvested RSU/RSA granted, compensation cost not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based payment award, RSU/RSA granted, weighted average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based payment award, options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,520,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Share-based payment award, options granted, exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Share-based payment award, options, compensation cost not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based payment award, compensation cost not yet recognized, weighted-average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options were exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding performance and market-based options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,807,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,807,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,158,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Performance and market-based restricted stock units of other option vested during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstsanding performance and market-based RSU's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based payment award, RSU/RSA granted, weighted average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Number of shares of common stock issued under ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,073<span></span>
</td>
<td class="nump">68,320<span></span>
</td>
<td class="nump">73,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan | Restricted Stock Awards | Former President and Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based payment award, RSU/RSA granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">769,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Award requisite service vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember', window );">New Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,160,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate', window );">Share-based payment award, commencement date</a></td>
<td class="text">Jan.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-based payment award, expiration date</a></td>
<td class="text">Jan.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance', window );">Percentage of automatic increase every year in common stock shares reserved for future issuance</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward', window );">Share-based payment award, terms of award issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The number of shares of common stock reserved for issuance under the New Plan automatically increases on January 1 of each year, for a period of ten years, from January 1, 2021, continuing through January 1, 2030, by 5% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company&#8217;s board of directors.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember', window );">New Plan | Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based payment award, RSU/RSA granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember', window );">New Plan | Performance and Market-based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Performance and market-based restricted stock units of other option vested during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based payment award, RSU/RSA granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstsanding performance and market-based RSU's</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember', window );">New Plan | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based payment award, options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,520,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based payment award, options, weighted-average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember', window );">New Plan | Stock Options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember', window );">New Plan | Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember', window );">New Plan | Performance Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based payment award, options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,166,653<span></span>
</td>
<td class="nump">70,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based payment award, options, weighted-average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options were exercised during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding performance and market-based options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember', window );">New Plan | Market-based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share-based payment award, options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding performance and market-based options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Market-based Stock Options vested during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of automatic increase every year in common stock shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award commencement date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on offering date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the equity-based award expires, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tsha_EmployeeStockPurchasePlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tsha_EmployeeStockPurchasePlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=tsha_PresidentAndChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=tsha_PresidentAndChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tsha_MarketBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tsha_MarketBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801690981200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Share Based Compensation Available for Grant under Incentive Plans (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Available for grant beginning of period</a></td>
<td class="nump">1,067,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod', window );">Plan adjustments and amendments</a></td>
<td class="nump">3,160,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod', window );">Grants</a></td>
<td class="num">(5,241,357)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod', window );">Forfeitures</a></td>
<td class="nump">3,586,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Available for grant ending of period</a></td>
<td class="nump">2,573,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember', window );">Existing Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod', window );">Plan adjustments and amendments</a></td>
<td class="num">(667,828)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod', window );">Forfeitures</a></td>
<td class="nump">667,828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember', window );">New Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Available for grant beginning of period</a></td>
<td class="nump">1,067,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod', window );">Plan adjustments and amendments</a></td>
<td class="nump">3,828,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod', window );">Grants</a></td>
<td class="num">(5,241,357)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod', window );">Forfeitures</a></td>
<td class="nump">2,918,614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Available for grant ending of period</a></td>
<td class="nump">2,573,142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award number of shares available for grant cancelled in period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award number of shares available for grant granted in period..</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award number of shares available for grant plan adjustments and amendments in period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=tsha_TwoThousandTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=tsha_TwoThousandTwentyStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801695292608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value Time Based Vesting of Stock Options, Performance and Service-based Stock Options (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.22%<span></span>
</td>
<td class="nump">3.61%<span></span>
</td>
<td class="nump">2.16%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">81.00%<span></span>
</td>
<td class="nump">81.00%<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699810656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Stock Option Activity (Details) - Stock Options<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding. Stock Options, Beginning Balance | shares</a></td>
<td class="nump">6,158,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted, Stock Options | shares</a></td>
<td class="nump">2,520,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options cancelled or forfeited, Stock Options | shares</a></td>
<td class="num">(2,013,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options expired, Stock Options | shares</a></td>
<td class="num">(857,557)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding. Stock Options, Ending Balance | shares</a></td>
<td class="nump">5,807,492<span></span>
</td>
<td class="nump">6,158,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options exercisable at September 30, 2023, Stock Options | shares</a></td>
<td class="nump">1,036,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Weighted Average Exercise Price, Beginning balance | $ / shares</a></td>
<td class="nump">$ 11.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options cancelled or forfeited, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">10.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Options expired, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">22.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Weighted Average Exercise Price, Ending balance | $ / shares</a></td>
<td class="nump">5.89<span></span>
</td>
<td class="nump">$ 11.84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable at September 30, 2023, Weighted Average Exercise Price | $ / shares</a></td>
<td class="nump">$ 18.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, Weighted Average Remaining Contractual Life</a></td>
<td class="text">8 years 10 months 24 days<span></span>
</td>
<td class="text">8 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable at September 30, 2023, Weighted Average Remaining Contractual Life</a></td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, Aggregate Intrinsic Value, Beginning Balance | $</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, Aggregate Intrinsic Value, Ending Balance | $</a></td>
<td class="nump">6,851<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable at Sepember 30, 2023, Aggregate Intrinsic Value | $</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801700556752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Restricted Stock Units Activity (Details) - Restricted Stock Units<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, Number of Shares, Beginning Balance | shares</a></td>
<td class="nump">1,257,844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted units/stock granted, Number of Shares | shares</a></td>
<td class="nump">332,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested, Number of Shares | shares</a></td>
<td class="num">(556,989)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancelled or forfeited, Number of Shares | shares</a></td>
<td class="num">(658,343)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, Number of Shares, Ending Balance | shares</a></td>
<td class="nump">375,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested, Weighted Average Grant Date Fair Value per Share, Beginning Balance | $ / shares</a></td>
<td class="nump">$ 6.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted units/stock granted, Weighted Average Grant Date Fair Value per Share | $ / shares</a></td>
<td class="nump">1.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, Weighted Average Grant Date Fair Value per Share | $ / shares</a></td>
<td class="nump">4.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancelled or forfeited, Weighted Average Grant Date Fair Value per Share | $ / shares</a></td>
<td class="nump">5.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested, Weighted Average Grant Date Fair Value per Share, Ending Balance | $ / shares</a></td>
<td class="nump">$ 6.63<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699174976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Restricted Stock Awards Activity (Details) - Restricted Stock Awards - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2020</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, Number of Shares, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64,120)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancelled or forfeited, Number of Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,374)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested, Weighted Average Grant Date Fair Value per Share, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted units/stock granted, Weighted Average Grant Date Fair Value per Share</a></td>
<td class="nump">$ 5.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, Weighted Average Grant Date Fair Value per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancelled or forfeited, Weighted Average Grant Date Fair Value per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801695295888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Total Stock-Based Compensation Expense for Stock Options, ESPP, RSAs and RSUs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 2,040<span></span>
</td>
<td class="nump">$ 4,470<span></span>
</td>
<td class="nump">$ 5,937<span></span>
</td>
<td class="nump">$ 13,940<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">705<span></span>
</td>
<td class="nump">2,001<span></span>
</td>
<td class="nump">1,524<span></span>
</td>
<td class="nump">5,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1,335<span></span>
</td>
<td class="nump">$ 2,469<span></span>
</td>
<td class="nump">$ 4,413<span></span>
</td>
<td class="nump">$ 8,046<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801700698768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 16, 2023</div></th>
<th class="th"><div>Aug. 14, 2023</div></th>
<th class="th"><div>Apr. 05, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,960,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,960,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,207,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,589<span></span>
</td>
<td class="nump">$ 8,683<span></span>
</td>
<td class="nump">$ 23,328<span></span>
</td>
<td class="nump">$ 30,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Warrant liability fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tsha_PreFundedWarrantsMember', window );">Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Warrant liability fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement | Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PaymentsToInvestorsAsLiquidatedDamages', window );">Payments to investors as liquidated damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage', window );">Payments to investors as additional liquidated damages percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tsha_SsiWarrantsMember', window );">SSI Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IssuanceOfFairValueWarrant', window );">Issuance of fair value warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ClassOfWarrantOrRightVestedAndExercisable', window );">Class of warrant or right vested and exercisable shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Warrant liability fair value adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightUnissued', window );">Warrants Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Securities Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_BeneficialOwnershipLimitationNoticePeriod', window );">Beneficial ownership limitation notice period (in days)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">61 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage', window );">Increase or decrease in beneficial ownership limitation percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross proceeds from issuance of common stock</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ProceedsFromIssuanceOfCommonStockNet', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">$ 140,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Securities Purchase Agreement | Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price per share of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts', window );">Incurred placement agent commissions and other issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital', window );">Allocated to shares, deduction to Additional paid-In capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember', window );">August 2023 Private Placement | Securities Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,412,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember', window );">August 2023 Private Placement | Securities Purchase Agreement | Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,250,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price per share of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=tsha_SsiStrategyHoldingsLlcMember', window );">SSI Strategy Holdings LLC | Private Placement | Securities Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">705,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Aggregate gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allocated to Shares, deduction to Additional paid-In capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_BeneficialOwnershipLimitationNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Beneficial ownership limitation notice period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_BeneficialOwnershipLimitationNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ClassOfWarrantOrRightVestedAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right vested and exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ClassOfWarrantOrRightVestedAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase or decrease in beneficial ownership limitation percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incurred placement agent commissions and other issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_IssuanceOfFairValueWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of fair value warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_IssuanceOfFairValueWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to investors as additional liquidated damages percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PaymentsToInvestorsAsLiquidatedDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to investors as liquidated damages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PaymentsToInvestorsAsLiquidatedDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ProceedsFromIssuanceOfCommonStockNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of common stock net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ProceedsFromIssuanceOfCommonStockNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightUnissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrants or rights which entitle the entity to receive future services in exchange for the unvested, forfeitable warrants or rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightUnissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=tsha_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=tsha_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_SsiWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_SsiWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=tsha_SsiStrategyHoldingsLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=tsha_SsiStrategyHoldingsLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699111408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Warrants - Schedule of Fair Value Method to Allocate Net Proceeds Received from Sale of Common Stock and Pre-funded Warrants (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_CommonStockAndWarrantsFairValueDisclosure', window );">Common stock and warrants fair value disclosure</a></td>
<td class="nump">$ 149,953<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">PIPE Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_CommonStockAndWarrantsFairValueDisclosure', window );">Common stock and warrants fair value disclosure</a></td>
<td class="nump">110,127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tsha_PreFundedWarrantsMember', window );">Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_CommonStockAndWarrantsFairValueDisclosure', window );">Common stock and warrants fair value disclosure</a></td>
<td class="nump">$ 39,826<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_CommonStockAndWarrantsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock and warrants fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_CommonStockAndWarrantsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=tsha_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=tsha_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801705248096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Schedule of Warrant Liability (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_ChangeInFairValueOfWarrants', window );">Change in fair value</a></td>
<td class="nump">$ 100,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_WarrantLiabilityFairValueDisclosure', window );">Balance at September 30, 2023</a></td>
<td class="nump">140,534<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tsha_SsiWarrantsMember', window );">SSI Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IssuanceOfWarrantLiability', window );">Issuance of Warrants</a></td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tsha_PreFundedWarrantsMember', window );">Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_IssuanceOfWarrantLiability', window );">Issuance of Warrants</a></td>
<td class="nump">$ 39,826<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_ChangeInFairValueOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_ChangeInFairValueOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_IssuanceOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_IssuanceOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_WarrantLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant liability fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_WarrantLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=tsha_SsiWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=tsha_SsiWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=tsha_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=tsha_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801699435808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Warrants - Schedule Of Assumptions Used To Estimate Fair Value Of Warrants (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>yr</div>
</th>
<th class="th">
<div>Apr. 05, 2023 </div>
<div>USD ($) </div>
<div>yr</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">3.46<span></span>
</td>
<td class="nump">3.46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input | yr</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Market value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input | $</a></td>
<td class="nump">3.16<span></span>
</td>
<td class="nump">0.71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801702632480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Net Loss Per Common Share - Additional Information (Details)<br></strong></div></th>
<th class="th">
<div>Aug. 14, 2023 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tsha_PreFundedWarrantsMember', window );">Pre-Funded Warrants | Securities Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=tsha_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=tsha_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tsha_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tsha_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801702644544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share - Schedule of Calculation of Basic and Diluted Net Loss Per Common Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss</a></td>
<td class="num">$ (117,087)<span></span>
</td>
<td class="num">$ (26,527)<span></span>
</td>
<td class="num">$ (159,307)<span></span>
</td>
<td class="num">$ (110,936)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic</a></td>
<td class="nump">125,700,799<span></span>
</td>
<td class="nump">40,937,808<span></span>
</td>
<td class="nump">84,630,796<span></span>
</td>
<td class="nump">39,761,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted</a></td>
<td class="nump">125,700,799<span></span>
</td>
<td class="nump">40,937,808<span></span>
</td>
<td class="nump">84,630,796<span></span>
</td>
<td class="nump">39,761,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share, basic</a></td>
<td class="num">$ (0.93)<span></span>
</td>
<td class="num">$ (0.65)<span></span>
</td>
<td class="num">$ (1.88)<span></span>
</td>
<td class="num">$ (2.79)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share, diluted</a></td>
<td class="num">$ (0.93)<span></span>
</td>
<td class="num">$ (0.65)<span></span>
</td>
<td class="num">$ (1.88)<span></span>
</td>
<td class="num">$ (2.79)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801698903696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Common Share - Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="nump">53,276,530<span></span>
</td>
<td class="nump">5,955,191<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Unvested RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="nump">409,717<span></span>
</td>
<td class="nump">1,257,844<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Unvested RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="nump">8,090,835<span></span>
</td>
<td class="nump">4,547,733<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">SSI Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="nump">525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=tsha_PreFundedWarrantsMember', window );">Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="nump">44,250,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=tsha_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=tsha_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801705366496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801700486736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Reprioritization - Additional Information (Details) - Exit and Disposal Activities - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost And Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent', window );">Percentage of headcount reduced</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and termination-related costs</a></td>
<td class="nump">$ 2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=tsha_ExitAndDisposalActivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=tsha_ExitAndDisposalActivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801700270528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Reprioritization - Summary of Accrued Severance Activity Recorded (Details) - Employee Severance<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_AccruedSeveranceBalance', window );">Accrued severance balance as of December 31, 2022</a></td>
<td class="nump">$ 1,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_SeveranceCostRecorded', window );">Severance recorded</a></td>
<td class="nump">2,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance paid</a></td>
<td class="num">(3,162)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_AccruedSeveranceBalance', window );">Accrued severance balance as of September 30, 2023</a></td>
<td class="nump">$ 992<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_AccruedSeveranceBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued severance balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_AccruedSeveranceBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_SeveranceCostRecorded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Severance cost recorded.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_SeveranceCostRecorded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801703538048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Contribution to retirement savings plan</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139801696785440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Nov. 13, 2023</div></th>
<th class="th"><div>Aug. 12, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug.  01,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants associated with loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PercentageOfAnnualDefaultInterestRate', window );">Percentage of annual default interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember', window );">Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Trinity Term Loan Agreement | Trinity Term Loans | Trinity Lenders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Aggregate principal amount</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateTerms', window );">Interest rate terms description</a></td>
<td class="text">The interest rate applicable to the Trinity Term Loans is the greater of (a) the WSJ Prime Rate plus 4.50% or (b) 12.75% per annum. The Trinity Term Loans are interest only from the Trinity Closing Date through 36 months from the Trinity Closing Date, which may be extended to 48 months from the Trinity Closing Date upon the satisfaction of certain milestones set forth in the Trinity Term Loan Agreement, after which the Company is required to pay equal monthly installments of principal through November 13, 2028 (the &#8220;Maturity Date&#8221;).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Percentage of interest rate</a></td>
<td class="nump">12.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_InterestRatePeriod', window );">Interest rate period</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_InterestRateExtensionPeriod', window );">Interest rate extension period</a></td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">Nov. 13,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_EndOfTermPaymentPercentage', window );">End of term payment percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants associated with loan facility</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PercentageOfAnnualDefaultInterestRate', window );">Percentage of annual default interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Trinity Term Loan Agreement | Trinity Term Loans | Trinity Lenders | Closing Date through November 13, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PercentageOfPrepaymentPremium', window );">Percentage of prepayment premium</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Trinity Term Loan Agreement | Trinity Term Loans | Trinity Lenders | November 13, 2024 through November 13, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PercentageOfPrepaymentPremium', window );">Percentage of prepayment premium</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Trinity Term Loan Agreement | Trinity Term Loans | Trinity Lenders | November 13, 2025 through, but excluding, the Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tsha_PercentageOfPrepaymentPremium', window );">Percentage of prepayment premium</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Trinity Term Loan Agreement | Trinity Term Loans | Trinity Lenders | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_EndOfTermPaymentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End of term payment percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_EndOfTermPaymentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_InterestRateExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate extension period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_InterestRateExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_InterestRatePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_InterestRatePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PercentageOfAnnualDefaultInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of annual default interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PercentageOfAnnualDefaultInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tsha_PercentageOfPrepaymentPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of prepayment premium</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tsha_PercentageOfPrepaymentPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tsha_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tsha_TrinityTermLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tsha_TrinityTermLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=tsha_TrinityTermLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=tsha_TrinityTermLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=tsha_TrinityLendersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=tsha_TrinityLendersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=tsha_ClosingDateThroughNovember132024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=tsha_ClosingDateThroughNovember132024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=tsha_November132024ThroughNovember132025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=tsha_November132024ThroughNovember132025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=tsha_November132025ThroughButExcludingTheMaturityDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=tsha_November132025ThroughButExcludingTheMaturityDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>tsha-20230930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:tsha="http://tayshagtx.com/20230930"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="tsha-20230930.xsd" xlink:type="simple"/>
    <context id="C_4232a358-a09c-4ded-8c53-c1c79684fc22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_245eca74-de86-4efc-a7d0-3ed028ab318b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="C_2db1cf9d-e412-454a-abb7-673182786e9b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_9758b5a2-ae6e-4588-8d02-3e34f18b2c5c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_c89eb35b-aaf3-4ca8-943d-735991153287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:SsiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_19b223c2-858d-4c13-823b-7fac0db24551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_4c88705b-93a0-4d16-a99d-3dbf7a0c78c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_6c73f75e-0143-4c42-88c1-9f83877c234e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-16</startDate>
            <endDate>2020-09-16</endDate>
        </period>
    </context>
    <context id="C_ebb6d69e-99d0-4437-b8b8-87ca448aa0d2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_c883f68e-7f40-4df1-9893-6348c141e5e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_afb7066a-ec3f-492c-abdf-4728d171d8a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_5e5e45fa-c545-46e3-838a-10c5bb7a8a1d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_268fe9ab-86f1-47ea-8103-b41a53f40e03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_b15937e2-c5c7-42c8-90fd-354de23b40f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_2d977a75-9f73-4edb-9392-84ff074a6057">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tsha:AssetsCapitalizedAsFinanceLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_2c7a64a4-5c6c-45c0-a89a-29ee6d67a457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_3643e8c7-ca2c-41ba-88d7-153c48cfb65c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_7c39cbeb-fc40-4194-9257-c31ad0395ba2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_7b13f58d-8442-4d48-a92e-3e9c2f531ffc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TrinityTermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">tsha:TrinityLendersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TrinityTermLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-13</startDate>
            <endDate>2023-11-13</endDate>
        </period>
    </context>
    <context id="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_52565164-9ede-4417-8be6-ba6aecffc735">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="C_7e3ec4c7-5cbb-4cfd-9e66-965a4caa80c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-14</startDate>
            <endDate>2023-08-14</endDate>
        </period>
    </context>
    <context id="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="C_5142e56d-a1ef-405d-ada4-47c2a8ad2e32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:UTSouthwesternAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="C_f346f496-91c4-40a5-b151-c5aa7e20a131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_99018103-c6e5-46d7-86c2-6f53ea9bbe0b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tsha:AugustTwoThousandAndTwentyThreePrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-14</instant>
        </period>
    </context>
    <context id="C_80322908-dd6f-45f1-92a0-5b56754ba105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_6310a863-a521-49ae-9a54-5fdd0104f020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_40e64b85-0bd6-43d7-85ac-e8176005098e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="C_24c41917-d26a-4624-8e85-a10244e4a9a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="C_b930a776-4755-4d30-be4d-477d007415b3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_b1703001-53ce-4fd2-a321-a0b32037899b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_1fb76a57-582e-46ab-b8bd-4287ba306f26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_9e4fa149-1f8c-4521-8d30-073662fd12c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_173d420c-3a82-453d-854d-b15fa055eec3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="C_d38e6bea-f6ec-49da-b364-707ab055ad3c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_fe9c5e2c-7fc2-459d-a948-657f1b1df93e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_04ff6dd0-0334-40e9-88c7-2032acec21a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:SsiStrategyHoldingsLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="C_ded5d2d0-56e4-4b8d-b636-71c37d47e597">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="C_3dc1a85a-2423-47a1-852c-f4579e03847b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_fc047aed-6e3c-4d6e-8708-d9135d555669">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_8d03e9bb-23a1-464b-940a-dd1c8ec2a91b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-17</instant>
        </period>
    </context>
    <context id="C_15407518-9c8f-475c-9932-cccfb6f73f94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tsha:AstellasPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AstellasSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="C_788446ba-8777-48e6-8377-1f4a2176149f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_513161af-679d-453e-bcb3-fe06753ed420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_5fe22845-b517-4024-bf3c-a463c9c5382c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_0169fb3b-514c-413b-8951-2aa1318d1f3e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2023-11-14</instant>
        </period>
    </context>
    <context id="C_27149336-d352-41a8-8d0e-18408512989e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_dbe9d225-ee5e-4b8b-b0c9-9b23ae056e8c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_e15af869-8ce3-412a-8b1c-4c46b2d2bba7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_d4e0f467-0a9d-4677-822d-01e528375bf1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_c9c85128-8f32-4f62-b33e-e8c28c2b5969">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="C_27aa3cc4-7b79-4c00-b3a7-7e63aea84451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="C_224db9b6-cf69-4025-8ace-07a34716e87d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_7ff33646-2760-47df-b89c-a551eb67ee08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_ef3c29aa-a25c-41d7-ad90-3c2283143f19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_41f81af9-f063-4fcb-9aee-fe6cb9bc2fc8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-21</startDate>
            <endDate>2022-10-21</endDate>
        </period>
    </context>
    <context id="C_151eb485-8164-452f-8e8d-d530d960d3b9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_de722255-5e4d-4b90-b918-c5cb3d32e39a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">tsha:ClosingDateThroughNovember132024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TrinityTermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">tsha:TrinityLendersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TrinityTermLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-13</startDate>
            <endDate>2023-11-13</endDate>
        </period>
    </context>
    <context id="C_f6908048-c889-4f93-869e-3dd5fb923ea5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:PerformanceAndMarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_dbe2a760-59ec-4506-ae61-53a963aae53f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_d6b67c53-c7b5-4cb3-a237-27c8b3f18659">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_312a5395-35e7-4a3b-845a-3e7f7d95509c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="C_a8165939-afd1-4d28-97a4-17ac213a88aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_3d602e83-3144-42f0-b3b2-264b04cf5dbb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_14267a27-65cc-48af-8835-a0a763940651">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_80f023fb-4c4f-4913-a8f0-25a04332f88c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_5effed74-1ac1-4896-81fb-36ffc78da0fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_41509e45-2fbe-49bb-bd92-c66a85232c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_ba166f8a-c9a3-4db9-b638-31d38de73008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_bcabd00a-3c24-4571-bd95-b51d333d5e34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_3c5342a3-7cee-4f48-b5b3-8beff925816b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:PerformanceAndMarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_0b1daf03-1138-4ea7-94f2-9e77213ae909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_349ea30b-6a31-4c2d-af3c-94a43b0e6e4e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_c50b3cb1-c0e2-4765-8d8d-617b504675a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_84a4182e-9ee0-43f3-b998-badcbf3028a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b4dd4b5f-778b-4ec9-8faf-8068d96c92af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_6ea481f7-b42d-41cf-8579-8896b25d1f78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_9f8d2f91-99fe-4b86-b976-930ef584b76d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:LicenseAgreementForCLN7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_3253dca9-a154-4e6e-add3-61c9afd96cb4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_ec26563e-4690-407e-a176-41017d5c4238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_27463c1c-a3d9-4df6-9af4-17d723f972fa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="C_5f9fb3b0-fe97-419b-bdc6-be3820e2ea68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_23bd83df-eede-42ec-9c51-05585993a9e0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:PresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-01</endDate>
        </period>
    </context>
    <context id="C_95c66cb1-2fc7-4423-a36f-6e539db9b9ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="C_d239af67-cf01-4921-a72c-010606f8efdb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_a19561be-07c5-4bcb-9000-74a3fb2fa74a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_7f6e1c72-16bb-483e-8cd7-a7a20b74ede0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:MarketBasedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="C_01b23b59-342a-4659-a799-48ef1e2fa7a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_c46c3bce-3fb6-4de8-b570-c0f54c0a4d18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_fe9362b3-8b1b-412f-a9cb-c0083a836950">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="C_162c443b-2d6f-4ca9-a115-4b08a2c7a8c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_9ddff924-68e1-4fa1-9bb2-4276e2baedd2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="C_f899ecab-1c91-4d92-99fb-b948b9803592">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_2a31a044-252b-446e-9552-0e90214b5729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tsha:AugustTwoThousandAndTwentyThreePrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-14</instant>
        </period>
    </context>
    <context id="C_997ec0ed-2c41-4632-ae98-d747ae5dbab5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">tsha:ExitAndDisposalActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_09805d8b-419c-40f4-b6d8-e5976d919ebd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_10334e6e-f910-467c-a8bf-bccc2eb4ec31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TrinityTermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">tsha:TrinityLendersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TrinityTermLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-13</startDate>
            <endDate>2023-11-13</endDate>
        </period>
    </context>
    <context id="C_f438b467-3326-45e8-9282-1549429f210e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_b0d18d87-5486-439a-b80d-f6f9cd2a928a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-16</startDate>
            <endDate>2020-09-16</endDate>
        </period>
    </context>
    <context id="C_3fe65adb-4ffe-4988-98fd-276d9f0de168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="C_c3b5bdf8-5491-4876-b736-c28be19cc6fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_773e89ba-c62d-4d26-a9c3-69efc4d4d04e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:LicenseAgreementForCLN7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_f91f76fc-5e39-4eee-9c56-7105b8b287f2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_f938f988-ce4c-4a96-9c9e-d18ca55eb075">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_15353d77-7cae-498e-95ff-53e56b3c8df9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_afe869c3-1801-4581-a6f5-b8768beaf0e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:LicenseAgreementForCLN7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_33b1b61d-afdf-4871-8372-0ac5c4985bb3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-14</instant>
        </period>
    </context>
    <context id="C_a3d12033-f85a-468b-8d86-8048a97ad7ff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">tsha:November132024ThroughNovember132025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TrinityTermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">tsha:TrinityLendersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TrinityTermLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-13</startDate>
            <endDate>2023-11-13</endDate>
        </period>
    </context>
    <context id="C_52fa6299-e193-4168-a292-1d334991839a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PegasusParkLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DallasLeaseAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-14</instant>
        </period>
    </context>
    <context id="C_0d813ec3-e8bb-4190-af8b-be115e142cd4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_aa7f77ea-a48d-42e3-9e4f-5074456c1eb3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-05</instant>
        </period>
    </context>
    <context id="C_2e51a9e4-9e0b-4c3b-97d0-34a783d596e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_bafc0748-9e47-4fe0-8057-f224262368a9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-05</instant>
        </period>
    </context>
    <context id="C_b0061a32-1c5e-4190-b750-44c408af1f14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_7b453598-4699-4830-9fe7-728f5848fb84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_29c4a552-4734-47bc-be8c-3e643d34d362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_a36762fa-d31c-45ad-af2e-461829666801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_dbdfd311-3825-4ad7-b403-58287d7548a7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_386cd9a0-f7f8-4dec-8608-31eb57cc80ff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_90d0d226-40ec-4b9a-8519-b099afecfa5a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">tsha:ExitAndDisposalActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_02cd1c3a-1c6e-4efe-a03e-b7815be0c062">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tsha:SalesAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-05</instant>
        </period>
    </context>
    <context id="C_e2ae4188-b729-4bb9-a810-c77a789712b1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:MarketBasedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_3d08f4c0-b2de-4b5c-a77e-bed99023b07d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_9be26314-5dbf-4dea-ac67-93410907efad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_29b5ff44-bd12-407c-9c1b-ed72f20b73c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_0f464446-8753-4ba1-9363-45ea238784a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_aa916425-81f6-46a9-9211-8a2744be8acf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_49ea514f-2749-4ec3-b1be-bc456b767a33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_2d3969b3-1904-49b7-9987-89bee52040f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_879840b7-9535-4ff6-b76f-43c8c0b8f843">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tsha:AstellasPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AstellasSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-21</instant>
        </period>
    </context>
    <context id="C_f73dfe04-8e13-4f73-9796-2fc971735968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_e679b79d-3341-4675-987e-dcc562289f26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_d2c65442-11b0-4704-bbf6-bea92b060507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tsha:AssetsCapitalizedAsFinanceLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_2453238f-62d1-4664-a753-3e1fa2683010">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_8bc60dc0-3547-4346-8f8c-627b12b9404c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:UTSouthwesternAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_ecf42b20-4d10-4df6-8173-984ab0bc4b7a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-29</instant>
        </period>
    </context>
    <context id="C_a5a9cdf2-731c-430f-9ea7-2e1cfb949e8a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tsha:SalesAgentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-05</startDate>
            <endDate>2021-10-05</endDate>
        </period>
    </context>
    <context id="C_be79abbe-9cb7-450a-89c0-09810beac69c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_bda073bb-c8f5-46f9-ba1e-59d7b6cce834">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_1004e87a-1fce-46e3-ac6d-39787b2f2454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tsha:AstellasPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AstellasSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="C_aca6a365-8b8d-47ba-b0c6-cb825ca992cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_7f2b298a-2b65-407d-9b6b-4e8ad3ab3b4a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="C_8e476623-2cf0-4fe3-b12e-9c905fead252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_8ef3dae4-92a8-4848-bc8b-7d6ee1d2bca5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:SsiStrategyHoldingsLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="C_2ac01888-0938-41c1-b387-fb08d1afdae5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-05</instant>
        </period>
    </context>
    <context id="C_5248d7d9-3cd0-4735-865f-dda80ba32b79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_d73f002d-37aa-4ddd-8f3a-08970ba84984">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_9cb3becb-0241-4438-9d16-a477e9cdad37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_9eccec65-aa13-4b7b-8210-aa887edfcc29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PegasusParkLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DallasLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-11</instant>
        </period>
    </context>
    <context id="C_fb426d7d-a58c-4a86-b783-cad0e1d55c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="C_11f479fa-8bc0-462f-aae7-eb345d89a6d2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SsiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_31bb6c1a-64e4-43f2-ac13-da2509eeeef2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_f36491bb-eacf-4acf-ac52-472ebe8b3169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-16</startDate>
            <endDate>2023-08-16</endDate>
        </period>
    </context>
    <context id="C_c21847ad-1728-4953-9228-368c4f2998f2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tsha:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_6a80be52-6387-4afd-9538-c38ccf4297dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:MarketBasedStockOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_e42d8932-a6cb-47d7-883a-506fc278ba6a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_41099a59-f81f-47bf-96a8-c4997b89b7b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanThroughAugustThirteenTwentyTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_3e6ad8f3-e3b2-4766-81e6-638c50b9a854">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">tsha:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_8da9a80f-388d-49d3-9c46-6ca3616d641d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_29b986aa-0e5f-4fce-8696-e82fa25305c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SsiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-05</startDate>
            <endDate>2023-04-05</endDate>
        </period>
    </context>
    <context id="C_0263ef18-95c0-4f1d-a160-663af20e3c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_6fdb1bde-2709-45b1-a9e2-787a87ee5614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_e6e5f371-c876-4258-be9b-7f8411f4ff7e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_451c5407-a741-4c7e-bd00-1970b0bc0851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_4bcd5e18-554d-46bd-8387-2b416ade3f02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-14</instant>
        </period>
    </context>
    <context id="C_4c721f5c-334b-4fe7-802b-653db955a9ef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-14</startDate>
            <endDate>2023-08-14</endDate>
        </period>
    </context>
    <context id="C_715ad203-ffe8-49ff-9388-adf38b8f0cef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_d374b9c6-f352-4efa-81b7-539cd0b063c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_6aeab603-0bae-4f76-9690-07fdf336dce4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TrinityTermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">tsha:TrinityLendersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TrinityTermLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-13</instant>
        </period>
    </context>
    <context id="C_cf8b3b2d-3381-4c33-97b3-0a49e5fa0576">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:GiantAxonalNeuropathyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_27c18364-0175-4f13-b9fc-bed49be4dac2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">tsha:ExitAndDisposalActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_63dd2c50-f529-4540-bf31-b0caef7db5c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_467bb9bb-f5c8-46b2-9e83-49a77c2c5e47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-05</instant>
        </period>
    </context>
    <context id="C_18d9db4b-0220-483d-b698-33462a0d1d11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_f2bd8525-6258-4ee1-bf3e-0b623f59864b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b40906ab-540f-4d66-babc-185d6edc1657">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_5a369e84-71ee-4265-82bd-b5c3255f95c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_58fa74f2-e180-43b6-b5c7-e1e48ea4adbf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_d41a29de-53a9-4a5a-96ba-31f6e55605f3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_865be14a-e277-45f2-b305-9aa13e3a0315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PegasusParkLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DallasLeaseAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-14</startDate>
            <endDate>2021-12-14</endDate>
        </period>
    </context>
    <context id="C_8267f30d-8810-477f-a104-32649ca7a65d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_fd17c3d9-bde3-44a4-b00f-89b6c9cd0d15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_51f1008f-8fa9-4508-a0ff-0b2d61656244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="C_f5f51dd5-7ef2-471d-bd94-707e6e8d06e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_cd7537ff-48e9-472a-86b6-01bf17d9a102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_56aba35a-c830-45c9-adb0-37ddf0bc7d62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-12</instant>
        </period>
    </context>
    <context id="C_2baf5077-feb2-430c-8618-bc9ab6c792fa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_220cf9fa-9710-4b12-8b10-b837e62d8c09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_8786aa0e-05e3-4061-9f46-80d5e9b63b63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_1247712d-baca-4aef-85fb-e3036cdde096">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_73e2f837-a7da-4610-a8b8-b300a337c6b9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_5ff63508-7308-4b13-b74d-9cf9982f8736">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:PegasusParkLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DallasLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-11</startDate>
            <endDate>2021-01-11</endDate>
        </period>
    </context>
    <context id="C_407b4a6b-c691-4b3a-9a19-64936d532af0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_4747c8da-f859-4b04-947f-581d35ec592c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">tsha:PresidentAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="C_7a0ba426-b372-4bb2-a6ce-f8a55df6817b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_f72dceba-fcca-4fdd-bb14-6b5646b92d1e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-01</endDate>
        </period>
    </context>
    <context id="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_4e3d744a-95f2-48c1-8ae4-8a48d4233bb0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tsha:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_c880fb70-98ec-4743-b3ec-50abce55fb61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_287d5758-9445-46a9-a9b4-4f0e72d6bc05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:LicenseForRettMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_36b0de8a-1c04-40e9-bda7-6a7e96088f0e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_d3115968-7432-4bb2-8241-e0b51c3126b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_5bdf589d-7a91-4625-927d-1d6ee35dde2c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_247c1361-9891-4d77-8855-fdadd0f3d730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-12</startDate>
            <endDate>2021-08-12</endDate>
        </period>
    </context>
    <context id="C_afb73dc0-9840-43ad-9af7-f5a3c969493a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_dd649981-9002-4b1a-8b61-880d7062b373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_85b1368b-9750-457e-87f0-e98f7d80ece8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_3826a1af-5558-42d4-951c-d3a6f47c100b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="C_5d53cb28-f1c8-45d3-aaa3-c5feece6f465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_72ee41ab-a948-4033-acce-533b6eca774e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:GiantAxonalNeuropathyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_c061af20-6853-41e3-a4ad-c8a519ad7164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="C_9b53dc51-ef56-4848-a5a0-e8634b747a3a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0ed2ccbf-6260-463b-bb8f-3005a6425089">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:PerformanceAndMarketBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="C_5d0c08dd-ca08-469f-b519-b8ead4c58f61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_6b959717-546d-4082-a216-54b72a00c5df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_eda542a6-c47a-464c-9bfb-8cc6ae934ce2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaCLN1AgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="C_07daf6b0-f34a-4741-b184-8a1f541a9c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:SsiWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_7a6e813a-84dc-4c50-933b-18e61eccc073">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_ffe2668b-14a2-48c0-b393-270f102a3ad6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:LicenseForGanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_c8ed76c8-0f36-44af-8fd2-f083fa2a50c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="C_386d4b0c-dbb1-4cd6-9f1e-31bdfd623c2f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AstellasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">tsha:AstellasPrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AstellasSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-21</startDate>
            <endDate>2022-10-21</endDate>
        </period>
    </context>
    <context id="C_c6f58321-0fb7-430f-a653-4f529d5145cb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_f68841e2-9812-4928-9cd8-bc1e4d7385dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">tsha:AbeonaTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:AbeonaRettAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="C_6de550d8-31ef-460a-ab24-a8f077bb2101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tsha:DurhamLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-17</startDate>
            <endDate>2020-12-17</endDate>
        </period>
    </context>
    <context id="C_3cb6925a-8272-4205-b6cf-61f911a340b6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="C_d99997ac-c0d1-4216-92e6-c6f95f327fe8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">tsha:TwoThousandTwentyStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_df655a6c-a1e2-4b8b-b36e-5e7362c2c0fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">tsha:November132025ThroughButExcludingTheMaturityDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TrinityTermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">tsha:TrinityLendersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TrinityTermLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-13</startDate>
            <endDate>2023-11-13</endDate>
        </period>
    </context>
    <context id="C_81a7b536-c0bb-453e-bcc6-30eb806c1470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="C_860f05e5-09f2-4dfd-b455-5e8e3432983f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_10cb884e-9a48-40ed-b56b-6772d0af148c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_89723ac2-2fad-4cb4-b5fc-51a86fd96b12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="C_e482ef1c-238b-4c33-805a-cf73ba22ae2b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tsha:EmployeeStockPurchasePlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-16</instant>
        </period>
    </context>
    <context id="C_5063c218-0805-481c-bd11-cdcf2eae0406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001806310</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tsha:TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">tsha:TermLoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Product">
        <measure>tsha:Product</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_Program">
        <measure>tsha:Program</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_Y">
        <measure>utr:Y</measure>
    </unit>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_669a90f6-b4ec-40ad-8075-b945710aa163">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_47737c52-79d8-4291-b3bf-6af71ead65de">0001806310</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_b232171e-663f-4173-a902-2f5bad93ae1b">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_d9c132d3-6f22-4bd6-86e3-44211bb85b64">false</dei:AmendmentFlag>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      id="F_8d3f62bc-18eb-44df-b73a-6f99476c53f5"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      id="F_3ce03d57-ef16-429a-a038-f0a3ac29261c"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      id="F_097186ba-8243-4d01-97b1-6cb2253b2a70"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      id="F_a4badc19-7056-4e60-a745-d3a4681c7b4e"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      id="F_95731e73-590b-4d8b-bc53-eed7708f5dfe">http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201602Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      id="F_c235bfe5-b369-4c89-8e3c-24a2b2c671cb">http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201602Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      id="F_3d5ea955-cb63-460e-9ac4-0cc91b6e0847">http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201602Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      id="F_3e78f387-05e6-4d7c-88d4-c13b0a4b78ec">http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      id="F_dbeee014-7927-4ce5-8253-ba65a26dca89">http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      id="F_b7b24932-76e0-4234-83dc-e0defb7581aa">http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      id="F_1ede665f-e147-4c30-a4ac-9f4f220b3eda">http://fasb.org/us-gaap/2023#Liabilities</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_d41a29de-53a9-4a5a-96ba-31f6e55605f3"
      id="F_a612bde1-69ec-4545-8cd9-0a74e9778ed1">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_1811ec9d-7a62-451e-b167-8fc8560b0f2a">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_23da2b02-760e-4e0a-a02b-0d62def5a1fe">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_d808408d-889e-470b-bf3a-703b9cc96c1f">2023-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_e15c83b8-e4a1-4a64-b2a6-20fe6c9f20d7">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_5bd1b79b-7ef7-47c5-b390-c0c6a1149b2e">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_5a96f874-6ccf-4b34-9b43-0454dbc5d85a">001-39536</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_36905c67-dbc8-4d28-8990-65859ba549e3">Taysha Gene Therapies, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_42275103-565c-4753-9996-ab1ab09a8ddd">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_41411fb5-b11b-4224-9bdd-d6ea6af65aac">84-3199512</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_fe28bd1c-1768-4a19-a257-7ae67ca39894">3000 Pegasus Park Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_1e2b55da-abbc-439e-9d8d-5dc6025a4fda">Ste 1430</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_0ff203f1-29ec-4990-98d4-361d09e61d56">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_706fb4a4-ad08-4324-a6e5-a9d8fc5f6db6">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_f55b937b-e844-4403-a79a-6b02b9aa7553">75247</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_dd5ff52b-6924-40ef-acad-e65d677378d7">214</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_814e30f2-b437-4ec1-8769-740eb0fd9e53">612-0000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_4bcf1e44-afab-4225-b330-5e9fe504000a">Common stock, par value $0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_1ab6b6fd-45e9-4ae5-8d26-d6dbbf07331a">TSHA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_f8206ca9-8837-45d1-92c6-d8acd4ee5b6d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_8ddc9340-9209-40ca-9d53-39e7e757b4f0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_70f293f3-52de-4a74-b597-ebaa51ddec10">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_56244417-4b22-4705-a811-bcea4329d3d3">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_6b1eacc8-82a2-4a60-b67a-c5a02d5564ec">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_b351223b-c321-4de7-afcc-dfe1198bba5d">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_b5f207b5-1520-44f7-aaa4-fd533a6858e4">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_858f396a-50e0-4a4d-b854-de38cb95f54f">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_0169fb3b-514c-413b-8951-2aa1318d1f3e"
      decimals="INF"
      id="F_22945b03-662c-4fe1-9de9-011a9666b5f4"
      unitRef="U_shares">186960193</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_15ddbf0d-21c4-415b-9991-37ec94b0fbfe"
      unitRef="U_USD">164278000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_31674c0c-21fa-4b6e-ae39-443a6e1d8be7"
      unitRef="U_USD">87880000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_75996035-61d2-4821-833b-0c58bd10425d"
      unitRef="U_USD">5529000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_f74ca653-af62-421c-8518-87f1ac38df19"
      unitRef="U_USD">8537000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_f6caa6d9-d16b-4f09-a760-8459ccbdd436"
      unitRef="U_USD">2000000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_46b96967-3b31-4b3b-a053-fa23482a59f0"
      unitRef="U_USD">171807000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_db0ca990-edb6-4ef7-bf22-f4966f754f99"
      unitRef="U_USD">96417000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCash
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_a0853b86-abbe-4155-8e06-6d4924b4aa1e"
      unitRef="U_USD">2637000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_085f986a-ff34-47de-abbf-557f20913a92"
      unitRef="U_USD">2637000</us-gaap:RestrictedCash>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_a667b4e7-6f89-4066-801e-5abe9affcb6e"
      unitRef="U_USD">11169000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_c1dd473d-e057-4378-bf1b-8de620b88b86"
      unitRef="U_USD">14963000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_cabb8c6b-b662-42f3-bf9f-eb6d9d58a380"
      unitRef="U_USD">9852000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_0bfc2d4d-598b-4e1c-a83d-7bba78b8bd65"
      unitRef="U_USD">10943000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_523d635d-bfb5-4877-aeb9-ea2aede93404"
      unitRef="U_USD">304000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_77fd5254-4e8e-44da-ade3-96655dbb8fd3"
      unitRef="U_USD">1316000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_dcb9023a-132d-45cf-bf57-83f9474795a5"
      unitRef="U_USD">195769000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_1d873396-95ad-42c6-9863-f8a67b62f905"
      unitRef="U_USD">126276000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_75e48267-20bb-4a4e-92ed-ec10182c92ef"
      unitRef="U_USD">7520000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_a62514ed-7be2-4824-9e9d-6ebaf608b137"
      unitRef="U_USD">10946000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_d47dbf94-8283-4328-87a4-6fcd75a0f2c8"
      unitRef="U_USD">13638000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_1136a7b8-b05b-447b-b461-448420a540a7"
      unitRef="U_USD">18287000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:DeferredRevenueCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_f67d38ff-5222-4773-b6f3-0c42db10d3f4"
      unitRef="U_USD">18759000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_f0408399-ca7c-4999-96e1-3cbf5c1ca791"
      unitRef="U_USD">33557000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_fbc87160-e8bc-4339-bcf8-d20235315b99"
      unitRef="U_USD">140534000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_14a644b0-d99c-49fb-a69c-ec5c82063ffe"
      unitRef="U_USD">180451000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_99825810-0138-4b0d-8493-92647b6e8e6b"
      unitRef="U_USD">62790000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_6fc2bb24-873e-4eee-8768-b11cf3b06858"
      unitRef="U_USD">2951000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_1956e90a-b275-432d-a248-0a545b61e23a"
      unitRef="U_USD">38548000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_7263d603-aec5-40c5-9daf-56de9c9d822b"
      unitRef="U_USD">37967000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_64cd877a-6e08-4a0e-b6fc-49bffff0a119"
      unitRef="U_USD">19101000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_dba9101b-bd7e-4a05-8513-05c5a8980b68"
      unitRef="U_USD">20440000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_0d289983-16d8-42ef-9651-3c2e3cafdeeb"
      unitRef="U_USD">3832000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_ebfa3254-6994-463a-8db8-6be1dc69da59"
      unitRef="U_USD">4130000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_6ac3a5e8-b769-4439-984c-473f715c2cb8"
      unitRef="U_USD">244883000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_c41cd85e-4f4a-420e-9717-9c37e9b3483b"
      unitRef="U_USD">125327000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="INF"
      id="F_18f43d51-a909-4b10-b990-e8e95f35a0ab"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="INF"
      id="F_a9edb114-de90-49fa-9e3a-13fa2e86b99c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="INF"
      id="F_5e4a0cec-1fb2-4b9d-9374-3c95b602f8e8"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="INF"
      id="F_9de760de-3176-4582-bd75-3989f6338ebc"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="INF"
      id="F_26ca3392-06b8-41e1-a55c-210252de804e"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="INF"
      id="F_b76e2daf-6d3c-433a-976f-80e2676c6913"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="INF"
      id="F_a4e30397-0645-42c0-be86-565adf9aa787"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="INF"
      id="F_4d1e9ec7-a060-4aa8-9180-d8abaca8e543"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="INF"
      id="F_03fc1444-8fc0-442a-b159-297b0205b043"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="INF"
      id="F_634b014f-1d38-4f58-9965-997121637b3b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="INF"
      id="F_d737af77-16b3-4eac-a0d1-7fc542c6ff43"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="INF"
      id="F_05a0ad2d-859d-48b3-9640-e08fbf2dc9ae"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="INF"
      id="F_2096f63e-70b2-4d91-a9e4-a5a00b63f58e"
      unitRef="U_shares">186960193</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="INF"
      id="F_18b69774-1835-4c02-a390-832ab16f694c"
      unitRef="U_shares">186960193</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="INF"
      id="F_f0fe94df-9de1-4c48-8c26-ceb67a0c416c"
      unitRef="U_shares">63207507</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="INF"
      id="F_fec9abe7-7f8b-4238-b6cb-0f0741e7d1a3"
      unitRef="U_shares">63207507</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_2f08af14-7baa-4e97-aeaa-7b57d6881df0"
      unitRef="U_USD">2000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_0794c31b-52d0-4ae5-86f9-882cf32e9d8f"
      unitRef="U_USD">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_756362b7-eae4-4441-b8c8-684048d00b88"
      unitRef="U_USD">511632000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_1e78b8ba-4c3a-456a-b576-974149fd9c2c"
      unitRef="U_USD">402389000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_532218c7-701e-476b-82ef-ec8a4b9af634"
      unitRef="U_USD">-560748000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_44ed63cc-932f-4d59-8586-cc06a62bde37"
      unitRef="U_USD">-401441000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_9cc6d0b9-6aa1-4606-b475-fe11cd657e39"
      unitRef="U_USD">-49114000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_0d5ef7bc-f1c9-4d4f-aa01-3b4bd3dcec8c"
      unitRef="U_USD">949000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_724b5420-1017-4a63-9196-976db7103450"
      unitRef="U_USD">195769000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_e39afbab-292a-4a0a-802c-ec3c2c4ca1d2"
      unitRef="U_USD">126276000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_d3f935ef-5c7e-4417-b5a3-ef94426e939f"
      unitRef="U_USD">4746000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_61040eb4-8df7-402e-9bd3-0f4084a85eeb"
      unitRef="U_USD">11847000</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_c7b69474-4270-4630-b457-c371e39046f5"
      unitRef="U_USD">11791000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_2f30d144-cecf-4a30-ab31-27e7289a5b8d"
      unitRef="U_USD">16774000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_c291665c-07d6-4e59-97d0-b0668321b76b"
      unitRef="U_USD">44096000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_8568d068-c982-475f-871a-a3ec512af048"
      unitRef="U_USD">78462000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_90970647-97d1-44b8-94a5-bba40fc8c29d"
      unitRef="U_USD">8589000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_7b6663e9-865a-4fe9-8426-948b85b7e7ff"
      unitRef="U_USD">8683000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_85a29c59-75e0-4711-a2cb-e1ec1f724d40"
      unitRef="U_USD">23328000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_5bcf15b7-3b24-491e-be29-8478daa0db7f"
      unitRef="U_USD">30019000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_6bb73656-a6a7-4c11-8daa-d0a6001f465a"
      unitRef="U_USD">616000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_c5359fef-6386-431f-b78e-672155e33ae3"
      unitRef="U_USD">616000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:OperatingExpenses
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_2aa2eb03-5fd3-4d57-aa62-c40745819e81"
      unitRef="U_USD">20996000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_674be32a-e6ed-4810-afa2-cebe183d104b"
      unitRef="U_USD">25457000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_cc16bb60-9c78-4f1b-8587-6c2206b4bcac"
      unitRef="U_USD">68040000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_91a47dd0-f6ba-4c94-9ef1-51d972f38914"
      unitRef="U_USD">108481000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_65e5a731-578a-4bc7-b7f2-6e62ae4adc03"
      unitRef="U_USD">-16250000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_a7913c2e-9e2c-42f2-bfa4-9df11dc5e8ad"
      unitRef="U_USD">-25457000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_e6c4ada4-ffd7-48e6-aa27-e988671cd5de"
      unitRef="U_USD">-56193000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_71fc9dc5-95b1-4656-acf9-8304984f67a8"
      unitRef="U_USD">-108481000</us-gaap:OperatingIncomeLoss>
    <tsha:ChangeInFairValueOfWarrantLiability
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_81185aa5-d2d6-4545-917e-e94ddd6ec9a0"
      unitRef="U_USD">100456000</tsha:ChangeInFairValueOfWarrantLiability>
    <tsha:ChangeInFairValueOfWarrantLiability
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_2b8c8c91-6b9f-45e6-b034-0eda67b694e4"
      unitRef="U_USD">100456000</tsha:ChangeInFairValueOfWarrantLiability>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_7e567cfd-d8c8-4333-81b6-7fc8dd0e6104"
      unitRef="U_USD">1109000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_9467724f-f364-4651-ada0-aaccb8210d85"
      unitRef="U_USD">9000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_e41c13ed-f08c-4920-af7a-71dfdc0ba9c8"
      unitRef="U_USD">1651000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_3e968b7b-3af7-4393-bb08-59a27c7f1c81"
      unitRef="U_USD">50000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestExpense
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_3961148e-55ac-4d20-91ae-317f7de1dbd4"
      unitRef="U_USD">1471000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_af8dcb54-7b45-4690-811b-0b9f21f83be2"
      unitRef="U_USD">1078000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_8307644d-0844-4884-8eca-b8d9af5ae0ab"
      unitRef="U_USD">4285000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_ee87c7a4-4018-4087-b9ce-4fa689efdd4a"
      unitRef="U_USD">2493000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_67727ba1-005b-4240-a52f-f4ade1ad886d"
      unitRef="U_USD">-19000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_8d73978e-711a-46d9-813b-5ab7ceff193b"
      unitRef="U_USD">-1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_6eeefc68-1f79-45eb-9d7a-93cf4d507d51"
      unitRef="U_USD">-24000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_b42c7c68-9bb8-444e-80f3-e4e841ca39c6"
      unitRef="U_USD">-12000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_54a4ee3c-f8c7-4dd4-840a-992452bd3947"
      unitRef="U_USD">-100837000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_04492d99-14f9-424d-bc69-a05668e4b5c2"
      unitRef="U_USD">-1070000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_e83acb7a-12a1-42b0-816a-1cbc0509d69b"
      unitRef="U_USD">-103114000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_9e948b5d-feb7-4dcb-8dc7-ceb5b40dfede"
      unitRef="U_USD">-2455000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_68c18e4a-0ff0-4635-a8b1-1de6ad26042e"
      unitRef="U_USD">-117087000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_5dff1b59-dce7-4937-a51d-d8cd95793ebf"
      unitRef="U_USD">-26527000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_0d39384e-21ec-4ef9-9b6e-0d4d8d30e462"
      unitRef="U_USD">-159307000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_c2309640-3e8f-4eda-bf0d-c452cb4a330f"
      unitRef="U_USD">-110936000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="2"
      id="F_d16815ad-6ed6-40a0-8708-77310476a397"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="2"
      id="F_58dd17d7-d881-47e3-977e-1de7aad46548"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="2"
      id="F_f187561b-c0ba-4b98-81e6-3e8ccfe2796a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="2"
      id="F_43ffbf65-0f47-4091-8959-7d635eeb885c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="2"
      id="F_edf095de-9690-4f04-8dac-4bd468720e1a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.88</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="2"
      id="F_6c287adb-251a-4814-b95c-4e522ec91cb6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.88</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="2"
      id="F_df3ac2f0-ece8-458e-a283-e3d1a4ffe8a7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="2"
      id="F_f1bf78d7-9991-4fba-9e10-b6f3c4b5f761"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="0"
      id="F_319e7abb-49da-4c62-a75d-e30f0c60d9f6"
      unitRef="U_shares">125700799</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="0"
      id="F_175b9d31-cc92-4b57-95be-04e35e6bb13a"
      unitRef="U_shares">125700799</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="0"
      id="F_ae971ffc-4b1a-48b6-84f7-9fbbf7f0960d"
      unitRef="U_shares">40937808</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="0"
      id="F_8d6bb7e4-e0fb-4df8-8f6d-c564dad1f02d"
      unitRef="U_shares">40937808</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="0"
      id="F_d9500cb0-23b5-4125-a2c9-d9b807ec79a4"
      unitRef="U_shares">84630796</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="0"
      id="F_c351466c-2e45-4880-883b-eba6e5595d59"
      unitRef="U_shares">84630796</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="0"
      id="F_121480ee-cef5-437f-8cd7-425543be0d51"
      unitRef="U_shares">39761764</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="0"
      id="F_bf8c0978-cfb5-41bb-bf11-e564fd85183a"
      unitRef="U_shares">39761764</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_4232a358-a09c-4ded-8c53-c1c79684fc22"
      decimals="INF"
      id="F_91e0a81a-4ef7-48c5-ab09-be18f287abbd"
      unitRef="U_shares">64432637</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_4232a358-a09c-4ded-8c53-c1c79684fc22"
      decimals="-3"
      id="F_ae6a9fca-094c-4d04-8088-d4b83f224a6b"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_aca6a365-8b8d-47ba-b0c6-cb825ca992cc"
      decimals="-3"
      id="F_4452fb35-7d7a-4be8-99f2-983830de2db7"
      unitRef="U_USD">406546000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_c061af20-6853-41e3-a4ad-c8a519ad7164"
      decimals="-3"
      id="F_2d524c56-72b9-43ab-a678-a3f51ff5e115"
      unitRef="U_USD">-443661000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3dc1a85a-2423-47a1-852c-f4579e03847b"
      decimals="-3"
      id="F_a61c0b39-753b-453f-8362-4e2b848daa64"
      unitRef="U_USD">-37114000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_dbe2a760-59ec-4506-ae61-53a963aae53f"
      decimals="-3"
      id="F_0a1ec276-4e42-4c98-8cc5-ebb819db0b48"
      unitRef="U_USD">2040000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_3ce377be-a989-4def-b2f2-ff85c0ebbdf5"
      unitRef="U_USD">2040000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_5bdf589d-7a91-4625-927d-1d6ee35dde2c"
      decimals="-3"
      id="F_ef56d5ad-b2f9-4f84-a669-e8e9f453530e"
      unitRef="U_USD">7098000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_f938f988-ce4c-4a96-9c9e-d18ca55eb075"
      decimals="INF"
      id="F_67525041-61d2-43a6-a471-65029dd0e62e"
      unitRef="U_shares">122412376</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_f938f988-ce4c-4a96-9c9e-d18ca55eb075"
      decimals="-3"
      id="F_ec5cdc7d-6a7b-4c96-b1b5-37378f7dbf58"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_7ff33646-2760-47df-b89c-a551eb67ee08"
      decimals="-3"
      id="F_2e5b9d19-2d9b-4b3b-bd7e-88a842607a41"
      unitRef="U_USD">103028000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_5bdf589d-7a91-4625-927d-1d6ee35dde2c"
      decimals="-3"
      id="F_fb361efa-b3bb-42a4-a00e-615471240d07"
      unitRef="U_USD">103029000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <tsha:IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares
      contextRef="C_b4dd4b5f-778b-4ec9-8faf-8068d96c92af"
      decimals="INF"
      id="F_d5581a3e-ddde-4c46-8c13-3a99401eea4f"
      unitRef="U_shares">82780</tsha:IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_b4dd4b5f-778b-4ec9-8faf-8068d96c92af"
      decimals="INF"
      id="F_cf49e83d-ce08-434c-8282-ece2bbac5af7"
      unitRef="U_shares">32400</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_dbe2a760-59ec-4506-ae61-53a963aae53f"
      decimals="-3"
      id="F_cf402109-f2b8-4588-812d-e6c66a1397b9"
      unitRef="U_USD">18000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_712f9ad1-8672-43ea-925c-6320828288d6"
      unitRef="U_USD">18000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:NetIncomeLoss
      contextRef="C_80322908-dd6f-45f1-92a0-5b56754ba105"
      decimals="-3"
      id="F_5cb4be66-8f17-43a4-a1ab-16d81f69a578"
      unitRef="U_USD">-117087000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_c79d2388-ad6d-4db8-ba09-68adc1e19542"
      unitRef="U_USD">-117087000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d"
      decimals="INF"
      id="F_ec2b1cf2-93b2-4c19-9ce5-aac324c6483f"
      unitRef="U_shares">186960193</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d"
      decimals="-3"
      id="F_1f8d6d1e-e706-47d7-add7-b121a57132e3"
      unitRef="U_USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_451c5407-a741-4c7e-bd00-1970b0bc0851"
      decimals="-3"
      id="F_52e0f445-8819-4520-83ae-c602747258bc"
      unitRef="U_USD">511632000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_715ad203-ffe8-49ff-9388-adf38b8f0cef"
      decimals="-3"
      id="F_bb26db7d-e201-4aec-bd5c-ec01db683938"
      unitRef="U_USD">-560748000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_a3f6648f-0304-461b-a2a7-0dfa9cd32806"
      unitRef="U_USD">-49114000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_14267a27-65cc-48af-8835-a0a763940651"
      decimals="INF"
      id="F_b7647c69-c66a-439a-a54b-50487d18e91c"
      unitRef="U_shares">41020086</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_14267a27-65cc-48af-8835-a0a763940651"
      decimals="-3"
      id="F_1e273e5b-2af3-4b2d-980d-159f5e4841b0"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_9758b5a2-ae6e-4588-8d02-3e34f18b2c5c"
      decimals="-3"
      id="F_ca04e855-ba3d-422f-b2f3-1344f1d7fe0c"
      unitRef="U_USD">352342000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_8267f30d-8810-477f-a104-32649ca7a65d"
      decimals="-3"
      id="F_78f8ab95-76f1-425e-9356-9036a8aa561d"
      unitRef="U_USD">-319836000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_41509e45-2fbe-49bb-bd92-c66a85232c95"
      decimals="-3"
      id="F_738c8aa2-35ed-4da3-a346-570a39ce537e"
      unitRef="U_USD">32507000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_ba166f8a-c9a3-4db9-b638-31d38de73008"
      decimals="-3"
      id="F_f092634b-0dc1-4baf-8cb1-ba718f161ef0"
      unitRef="U_USD">4470000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_7a0f86ca-38ba-4e89-85c6-de25686d925c"
      unitRef="U_USD">4470000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <tsha:IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares
      contextRef="C_3d08f4c0-b2de-4b5c-a77e-bed99023b07d"
      decimals="INF"
      id="F_e86c035c-0741-4d27-b8e1-9e067cb59022"
      unitRef="U_shares">82780</tsha:IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_3d08f4c0-b2de-4b5c-a77e-bed99023b07d"
      decimals="INF"
      id="F_3e7a11d6-653c-4e91-9ee4-b8acdff9479a"
      unitRef="U_shares">73073</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_ba166f8a-c9a3-4db9-b638-31d38de73008"
      decimals="-3"
      id="F_5ed5df10-3d03-4fbc-924c-ca9555abb8d1"
      unitRef="U_USD">253000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_6c8c0c4c-8265-4227-81f6-cf7ec7a17d66"
      unitRef="U_USD">253000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:NetIncomeLoss
      contextRef="C_e679b79d-3341-4675-987e-dcc562289f26"
      decimals="-3"
      id="F_3ce63c2b-3541-4724-ab34-6b0335a6f147"
      unitRef="U_USD">-26527000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_6ec593cc-adb0-437b-8a2d-4afc86c50270"
      unitRef="U_USD">-26527000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_c9c85128-8f32-4f62-b33e-e8c28c2b5969"
      decimals="INF"
      id="F_9adad259-62c8-42ad-8d35-9374f31f431f"
      unitRef="U_shares">41175939</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_c9c85128-8f32-4f62-b33e-e8c28c2b5969"
      decimals="-3"
      id="F_78549080-1f45-4587-abcd-da03ec440a1f"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_c8ed76c8-0f36-44af-8fd2-f083fa2a50c3"
      decimals="-3"
      id="F_a38e3bde-a3cb-4a80-bfed-00b04f5f3410"
      unitRef="U_USD">357065000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3fe65adb-4ffe-4988-98fd-276d9f0de168"
      decimals="-3"
      id="F_21a425e7-67ff-435d-a0c3-a8d96dc5ef37"
      unitRef="U_USD">-346363000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf"
      decimals="-3"
      id="F_2a66cd98-1ea7-4481-8d2d-fa78055cab7a"
      unitRef="U_USD">10703000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_f91f76fc-5e39-4eee-9c56-7105b8b287f2"
      decimals="INF"
      id="F_3d3fc4c3-34d6-412a-95bf-ebb31da9c77e"
      unitRef="U_shares">63207507</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_f91f76fc-5e39-4eee-9c56-7105b8b287f2"
      decimals="-3"
      id="F_638275d2-3b3b-40a1-a735-f7bdca51b3cd"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0263ef18-95c0-4f1d-a160-663af20e3c36"
      decimals="-3"
      id="F_a118a347-68b6-4270-9076-baeae49cf0c9"
      unitRef="U_USD">402389000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_ec26563e-4690-407e-a176-41017d5c4238"
      decimals="-3"
      id="F_24c6658e-9abe-4a8e-afdd-b66b64f6219a"
      unitRef="U_USD">-401441000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_6e41b5cb-7e8b-4f6e-a526-52292b6f524b"
      unitRef="U_USD">949000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_cd7537ff-48e9-472a-86b6-01bf17d9a102"
      decimals="-3"
      id="F_e2274d8d-81d9-40d0-bd6b-dbb6999cacd9"
      unitRef="U_USD">5937000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_b117104d-2695-47b4-8d2f-00538cbe7da5"
      unitRef="U_USD">5937000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_15353d77-7cae-498e-95ff-53e56b3c8df9"
      decimals="-3"
      id="F_fcbf2112-69b8-407b-a111-0675939965bd"
      unitRef="U_USD">7138000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_7a6e813a-84dc-4c50-933b-18e61eccc073"
      decimals="INF"
      id="F_a05fec02-19ee-479a-bd6c-43e4f4f66ccb"
      unitRef="U_shares">123117594</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_7a6e813a-84dc-4c50-933b-18e61eccc073"
      decimals="-3"
      id="F_7dcddb0e-4499-4ff1-8966-bad198fca9ee"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_ef3c29aa-a25c-41d7-ad90-3c2283143f19"
      decimals="-3"
      id="F_ce5d1263-0d28-4ec0-8170-b6083df0a74d"
      unitRef="U_USD">103238000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_15353d77-7cae-498e-95ff-53e56b3c8df9"
      decimals="-3"
      id="F_aab15f8c-32a7-4d5d-ab59-63692fa24821"
      unitRef="U_USD">103239000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <tsha:IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares
      contextRef="C_80f023fb-4c4f-4913-a8f0-25a04332f88c"
      decimals="INF"
      id="F_dbbf366c-922c-423c-98c9-a7193d184e9e"
      unitRef="U_shares">566772</tsha:IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_80f023fb-4c4f-4913-a8f0-25a04332f88c"
      decimals="INF"
      id="F_5fff56f2-a334-4186-8c84-335ceb1d2cd6"
      unitRef="U_shares">68320</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_cd7537ff-48e9-472a-86b6-01bf17d9a102"
      decimals="-3"
      id="F_18b4aaa3-fc8d-4b33-946e-940d7561ec89"
      unitRef="U_USD">68000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_ac13f7df-08f7-4bd1-9086-a387e64f22d1"
      unitRef="U_USD">68000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:NetIncomeLoss
      contextRef="C_5effed74-1ac1-4896-81fb-36ffc78da0fd"
      decimals="-3"
      id="F_602ff705-4908-4cdb-b685-9f4b221c4958"
      unitRef="U_USD">-159307000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_e17f26a4-8403-4913-acc9-f4195536d693"
      unitRef="U_USD">-159307000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d"
      decimals="INF"
      id="F_2f2b23aa-bcee-4609-a6d6-0b68e09bb60f"
      unitRef="U_shares">186960193</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d"
      decimals="-3"
      id="F_1b1a9296-e7de-4bda-88d6-29054364b4fe"
      unitRef="U_USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_451c5407-a741-4c7e-bd00-1970b0bc0851"
      decimals="-3"
      id="F_9b18d519-cc79-442d-9895-fe8a6e78dabb"
      unitRef="U_USD">511632000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_715ad203-ffe8-49ff-9388-adf38b8f0cef"
      decimals="-3"
      id="F_81822b0a-7381-4728-a8f2-1b02c2aa0994"
      unitRef="U_USD">-560748000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_671e9f7c-c1cd-42c0-815c-5f97752ef047"
      unitRef="U_USD">-49114000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_5d0c08dd-ca08-469f-b519-b8ead4c58f61"
      decimals="INF"
      id="F_f917292d-1f6e-41d6-9d61-1db2f29eb211"
      unitRef="U_shares">38473945</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_f5f51dd5-7ef2-471d-bd94-707e6e8d06e9"
      decimals="-3"
      id="F_2ab44f11-bde7-4e23-8b87-42eb75870a30"
      unitRef="U_USD">331032000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_58fa74f2-e180-43b6-b5c7-e1e48ea4adbf"
      decimals="-3"
      id="F_f60ab6bc-6913-45ed-89c3-b012a781ca82"
      unitRef="U_USD">-235649000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_9b53dc51-ef56-4848-a5a0-e8634b747a3a"
      decimals="-3"
      id="F_c4eb95b3-f277-4e48-8c23-b641e606525d"
      unitRef="U_USD">95383000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_407b4a6b-c691-4b3a-9a19-64936d532af0"
      decimals="-3"
      id="F_fa7558f3-5f31-4426-966c-430558c10cc6"
      unitRef="U_USD">222000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_6ea481f7-b42d-41cf-8579-8896b25d1f78"
      decimals="-3"
      id="F_8d0bd0cc-4058-4055-8376-7dd14f1f98ef"
      unitRef="U_USD">222000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_c6f58321-0fb7-430f-a653-4f529d5145cb"
      decimals="-3"
      id="F_386ec145-d68f-4a6b-ab04-0262a71b72a4"
      unitRef="U_USD">14172000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_bdc5d700-5afb-4b92-9dd9-0022136564e1"
      unitRef="U_USD">14172000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <tsha:IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares
      contextRef="C_513161af-679d-453e-bcb3-fe06753ed420"
      decimals="INF"
      id="F_c02fb7f1-86b9-4328-8f9a-39f207af2944"
      unitRef="U_shares">628921</tsha:IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares>
    <tsha:PaymentOfSalesCommissionsAndOtherOfferingCosts
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_3f830d23-6081-449a-8198-53f31072473c"
      unitRef="U_USD">392000</tsha:PaymentOfSalesCommissionsAndOtherOfferingCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_513161af-679d-453e-bcb3-fe06753ed420"
      decimals="INF"
      id="F_66551b7f-ac42-463f-8663-f1091fa16ece"
      unitRef="U_shares">2000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_513161af-679d-453e-bcb3-fe06753ed420"
      decimals="-3"
      id="F_fa2c3941-a7af-432a-828f-fc96606a4d57"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_c6f58321-0fb7-430f-a653-4f529d5145cb"
      decimals="-3"
      id="F_3c3916af-bc97-43e6-82fd-ec5314cc5ff7"
      unitRef="U_USD">11608000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_4f2ce7d4-94e0-4a86-8098-16113b2b9dd4"
      unitRef="U_USD">11609000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_513161af-679d-453e-bcb3-fe06753ed420"
      decimals="INF"
      id="F_7b6d6fc9-9c42-4324-a3b0-9e16e6174073"
      unitRef="U_shares">73073</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_c6f58321-0fb7-430f-a653-4f529d5145cb"
      decimals="-3"
      id="F_2e7213ce-75e3-4dd4-a32c-aa913e1c7ccd"
      unitRef="U_USD">253000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_75afba98-b57f-4edd-ba55-f0ac6aa3d2f0"
      unitRef="U_USD">253000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:NetIncomeLoss
      contextRef="C_09805d8b-419c-40f4-b6d8-e5976d919ebd"
      decimals="-3"
      id="F_8870923a-7441-4a52-8394-efb7b99c1de4"
      unitRef="U_USD">-110936000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_0d8c8ad6-e492-4034-ad01-e393946676a5"
      unitRef="U_USD">-110936000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_c9c85128-8f32-4f62-b33e-e8c28c2b5969"
      decimals="INF"
      id="F_33fcad05-de5d-4d3c-a9c5-2c7e51260ea0"
      unitRef="U_shares">41175939</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_c9c85128-8f32-4f62-b33e-e8c28c2b5969"
      decimals="-3"
      id="F_5ac1013c-825e-449d-aa55-443355e81b33"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_c8ed76c8-0f36-44af-8fd2-f083fa2a50c3"
      decimals="-3"
      id="F_bdf1f50e-44a6-4abe-aaac-5384dc313f77"
      unitRef="U_USD">357065000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3fe65adb-4ffe-4988-98fd-276d9f0de168"
      decimals="-3"
      id="F_51b6efcd-e00d-40c4-a1fe-9646f51c8313"
      unitRef="U_USD">-346363000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf"
      decimals="-3"
      id="F_c3351ec4-4b2b-42d2-a900-114c81007b38"
      unitRef="U_USD">10703000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_a8f13be1-9ac3-4366-a3cb-8cd85e878cde"
      unitRef="U_USD">-159307000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_cf14486d-60f7-4423-92cb-624f800b7786"
      unitRef="U_USD">-110936000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_ac3543b8-054f-470c-be45-20f46b568a11"
      unitRef="U_USD">1005000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_2e3e62f6-4587-4a82-afc8-d6e70feef072"
      unitRef="U_USD">810000</us-gaap:Depreciation>
    <tsha:ResearchAndDevelopmentLicenseExpense
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_ec81b5dd-6c8d-49cd-80c9-8d15542f9df0"
      unitRef="U_USD">3500000</tsha:ResearchAndDevelopmentLicenseExpense>
    <tsha:ResearchAndDevelopmentLicenseExpense
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_3cd03697-6cbb-440d-b3c8-e5aa4a1db120"
      unitRef="U_USD">1250000</tsha:ResearchAndDevelopmentLicenseExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_50be4c4e-ad13-491a-b1e5-4f75b10d68fa"
      unitRef="U_USD">5937000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_d0af85d4-502b-4705-952b-1ab53124e74f"
      unitRef="U_USD">13940000</us-gaap:ShareBasedCompensation>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_3a2234f1-c3bb-4230-b5ab-471df8866120"
      unitRef="U_USD">100456000</us-gaap:FairValueAdjustmentOfWarrants>
    <tsha:IssuanceCostsForPreFundedWarrantLiability
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_89d01131-8c58-42e0-aae8-de3e7acbe780"
      unitRef="U_USD">2567000</tsha:IssuanceCostsForPreFundedWarrantLiability>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_cb9216d1-e445-414a-b62b-c5e82b1e7006"
      unitRef="U_USD">616000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_2a4cbf84-38b4-4097-ba9b-344536bcfe08"
      unitRef="U_USD">908000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_0a40be2a-b01a-4995-b3f2-13f0f57fcb0a"
      unitRef="U_USD">1031000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_d3e93223-37cf-4c5b-8370-91b71a86d321"
      unitRef="U_USD">-581000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_2bf6ebbd-8c52-49e8-9044-3f9286967d90"
      unitRef="U_USD">-616000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_3a0b7ae6-8fbc-4fd0-9efc-bc0ef8cacc49"
      unitRef="U_USD">-4008000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_c3711008-9715-4711-bba6-ed0ce7e880e4"
      unitRef="U_USD">-1980000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_72b69ce4-5dc5-4c6d-ae8b-c1eb2c6ef119"
      unitRef="U_USD">-1065000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_12bd5b97-dda6-469a-b427-2c6f1a219834"
      unitRef="U_USD">-3217000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <tsha:IncreaseDecreaseInAccruedExpenseAndOtherLiabilities
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_daefd5d1-3650-42ae-a456-2445664e9d01"
      unitRef="U_USD">-4260000</tsha:IncreaseDecreaseInAccruedExpenseAndOtherLiabilities>
    <tsha:IncreaseDecreaseInAccruedExpenseAndOtherLiabilities
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_b7493215-6611-4436-bffd-648fdfdf9218"
      unitRef="U_USD">-8576000</tsha:IncreaseDecreaseInAccruedExpenseAndOtherLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_b2f247d0-3a3e-44d7-9ac1-ac2c59f91279"
      unitRef="U_USD">-11847000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_f923c27d-9bcb-44b1-a9e8-a69cfde3f9dc"
      unitRef="U_USD">-56901000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_ee24f4f5-8066-418e-9ca6-041ef6501c7f"
      unitRef="U_USD">-103102000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_33adfbf0-8320-4e36-b0ec-700db2be9c04"
      unitRef="U_USD">3500000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_9df576c6-8a25-46a7-b71c-c74d6b94e265"
      unitRef="U_USD">4250000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_3822ff4f-b161-40cc-9e8e-ffdbd257cf0a"
      unitRef="U_USD">3852000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_d9c9171b-335c-478d-8f65-f12d54a264f3"
      unitRef="U_USD">18310000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_457f81a8-0704-4590-8ade-de67edcb9934"
      unitRef="U_USD">-10000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_8a90202c-5864-410a-9a0f-1e6436d2dcc0"
      unitRef="U_USD">-7342000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_7297cdc0-46ee-4a50-acd6-cdb712d53546"
      unitRef="U_USD">-22560000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_e4a1b2e4-47b8-4d64-b1c4-3c83e7ace361"
      unitRef="U_USD">11640000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <tsha:ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_f6719ec0-e481-4793-b5c9-45b758b0d328"
      unitRef="U_USD">140713000</tsha:ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_15353d77-7cae-498e-95ff-53e56b3c8df9"
      decimals="-3"
      id="F_a36333de-2991-485a-96a1-e452857b0e8b"
      unitRef="U_USD">500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <tsha:PaymentOfShelfRegistrationCosts
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_243e989a-2a08-458b-bfc9-70c41dca1e78"
      unitRef="U_USD">387000</tsha:PaymentOfShelfRegistrationCosts>
    <tsha:PaymentOfShelfRegistrationCosts
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_3ad40c31-0a13-46e2-b989-a483a474aa30"
      unitRef="U_USD">319000</tsha:PaymentOfShelfRegistrationCosts>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_f44d5adf-7855-446d-874c-d5af70f58645"
      unitRef="U_USD">68000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_8e3499f3-ae51-4be1-8ea8-277bf5826e57"
      unitRef="U_USD">253000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_6cdee9b1-c7c2-4945-9a79-8b8b301c7833"
      unitRef="U_USD">-253000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_a876e13c-4e0c-482e-b7e1-ca083d9b7b65"
      unitRef="U_USD">-709000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_94aa1965-bdfc-49d3-8b5d-14578e1ed543"
      unitRef="U_USD">140641000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_4551e776-589a-4939-9547-431a966ee5bb"
      unitRef="U_USD">10865000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_4d8a88b0-deaf-4121-a678-850668ae5b8b"
      unitRef="U_USD">76398000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_d3ab6378-b5a1-4510-af6f-4d311b35f792"
      unitRef="U_USD">-114797000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_db78b6e7-4cfd-4893-b96e-0060aeedd2df"
      unitRef="U_USD">90517000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_9b53dc51-ef56-4848-a5a0-e8634b747a3a"
      decimals="-3"
      id="F_a196705b-24e7-4d2d-a79f-4719228267a5"
      unitRef="U_USD">151740000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_9167cfc2-13a8-4f3e-86d9-2e511cad4b0c"
      unitRef="U_USD">166915000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf"
      decimals="-3"
      id="F_1aab7023-08ef-402a-ad8e-9f187961494c"
      unitRef="U_USD">36943000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_8fd1f4b2-8169-4a53-8e2f-43374888436b"
      unitRef="U_USD">164278000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf"
      decimals="-3"
      id="F_289d1fed-2dbb-4d96-9a18-383e078d6167"
      unitRef="U_USD">34306000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_81c769e7-92a5-4058-9071-c70e30025a84"
      unitRef="U_USD">2637000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf"
      decimals="-3"
      id="F_d9795842-a4fd-45e8-8cfb-56b35208f408"
      unitRef="U_USD">2637000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_2988e45c-a2e3-493f-b3dd-0fab2d86b5cd"
      unitRef="U_USD">166915000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_b9455bc6-4ca8-486d-acfd-2f4903aaa2bf"
      decimals="-3"
      id="F_4d7c2e03-4e54-4de7-873e-24fcc668aff2"
      unitRef="U_USD">36943000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_f87fad18-9ba2-4b81-9f5c-5a8b086d50b3"
      unitRef="U_USD">3665000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_23bfd193-c5b7-4e88-9141-771abc883787"
      unitRef="U_USD">1758000</us-gaap:InterestPaidNet>
    <tsha:PropertyAndEquipmentInAccountsPayableAndAccruedExpenses
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_1118f970-9f92-4a21-88da-c38997bcfe46"
      unitRef="U_USD">45000</tsha:PropertyAndEquipmentInAccountsPayableAndAccruedExpenses>
    <tsha:PropertyAndEquipmentInAccountsPayableAndAccruedExpenses
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_a6271304-1072-4ba1-acb0-3e34c9360022"
      unitRef="U_USD">3366000</tsha:PropertyAndEquipmentInAccountsPayableAndAccruedExpenses>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_3feb8c27-1871-4673-be19-9f34cd933a03"
      unitRef="U_USD">23035000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_0cef183d-4e88-4274-95f8-f63ebda51c1b"
      unitRef="U_USD">423000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_3666aa39-b5ee-44f9-a45b-7b16788934de"
      unitRef="U_USD">40000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <tsha:IssuanceOfWarrantsInConnectionWithPrivatePlacement
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_90bf28ad-5fa2-4c2b-9e33-073988f58120"
      unitRef="U_USD">252000</tsha:IssuanceOfWarrantsInConnectionWithPrivatePlacement>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_c7ac8d7e-9c38-40d2-b72a-2bc13be41a09">&lt;p id="note_1organization_description_business_" style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 1&#x2014;Organization and Descr&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;iption of Business Operations&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Taysha Gene Therapies, Inc. (the &#x201c;Company&#x201d; or &#x201c;Taysha&#x201d;) was originally formed under the laws of the State of Texas on September 20, 2019 (&#x201c;Inception&#x201d;). Taysha converted to a Delaware corporation on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;February 13, 2020&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, which had no impact to the Company&#x2019;s par value or issued and authorized capital structure.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Taysha is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Sales Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On October 5, 2021, the Company entered into a Sales Agreement (the &#x201c;Sales Agreement&#x201d;) with SVB Securities LLC (f/k/a SVB Leerink LLC) and Wells Fargo Securities, LLC (collectively, the &#x201c;Sales Agents&#x201d;), pursuant to which the Company may issue and sell, from time to time in its sole discretion, shares of its common stock having an aggregate offering price of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;150.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million through the Sales Agents. In March 2022, the Company amended the Sales Agreement to, among other things, include Goldman Sachs &amp;amp; Co. LLC as an additional Sales Agent. The Sales Agents may sell common stock by any method permitted by law deemed to be an &#x201c;at-the-market offering&#x201d; as defined in Rule 415(a)(4) of the Securities Act, including sales made directly on or through the Nasdaq Global Select Market or any other existing trade market for the common stock, in negotiated transactions at market prices prevailing at the time of sale or at prices related to prevailing market prices, or any other method permitted by law. Any shares of the Company&#x2019;s common stock will be issued pursuant to the Company&#x2019;s shelf registration statement on Form S-3 (File No. 333-260069) (the &#x201c;Shelf Registration Statement&#x201d;), which the Securities and Exchange Commission (&#x201c;SEC&#x201d;) declared effective on October 14, 2021; however the Company&#x2019;s use of the Shelf Registration Statement will be limited for so long as the Company is subject to General Instruction I.B.6 of Form S-3, which limits the amounts that the Company may sell under the Shelf Registration Statement and in accordance with the Sales Agreement. The Sales Agents are entitled to receive &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of the gross sales price per share of common stock sold under the Sales Agreement. In April 2022, the Company sold &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock under the Sales Agreement and received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;11.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million in net proceeds. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; other shares of common stock have been issued and sold pursuant to the Sales Agreement as of September 30, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Liquidity and Capital Resources&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The accompanying condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Pursuant to ASC 205, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Presentation of Financial Statements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, the Company is required to and does evaluate at each annual and interim period whether there are conditions or events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. In its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, the Company concluded that due to inherent uncertainties in the Company&#x2019;s forecast, and after considering both quantitative and qualitative factors that were known or reasonably knowable as of the date that such condensed consolidated financial statements were issued, there were conditions present in the aggregate that raised substantial doubt about the Company&#x2019;s ability to continue as a going concern.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Following the closing of the Private Placement (as defined below) in August 2023 (see Note 10), the Company has concluded that after considering both qualitative and quantitative factors, there are no longer conditions present in the aggregate that raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. The Company has sufficient liquidity to satisfy its obligations for at least twelve months following the date of the issuance of these condensed consolidated financial statements. Accordingly, the Company has concluded that there is no longer substantial doubt about the Company&#x2019;s ability to continue as a going concern.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company has incurred operating losses since inception and expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As of September 30, 2023, the Company had an accumulated deficit of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;560.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;million. Losses are expected to continue as the Company continues to invest in its research and development activities. Future capital requirements will depend on many factors, including the timing and extent of spending on research and development and the market acceptance of the Company&#x2019;s products. As of September 30, 2023, the Company had cash and cash equivalents of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;164.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million which the Company believes will be sufficient to fund its planned operations for a period of at least twelve months from the date of issuance of these condensed consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <dei:EntityIncorporationDateOfIncorporation
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_f9b7a97f-fbb2-4a5b-951e-a927b9786181">2020-02-13</dei:EntityIncorporationDateOfIncorporation>
    <tsha:AggregateOfferingPriceFromSaleOfCommonStock
      contextRef="C_02cd1c3a-1c6e-4efe-a03e-b7815be0c062"
      decimals="INF"
      id="F_2c1a4810-7ad2-4c9f-8fb6-459690e2cd27"
      unitRef="U_USD">150000000</tsha:AggregateOfferingPriceFromSaleOfCommonStock>
    <tsha:PercentageOfSalePricePerShareOfCommonStock
      contextRef="C_a5a9cdf2-731c-430f-9ea7-2e1cfb949e8a"
      decimals="3"
      id="F_cb9936d2-313e-4e73-84fb-3704ff8825d2"
      unitRef="U_pure">0.03</tsha:PercentageOfSalePricePerShareOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_27463c1c-a3d9-4df6-9af4-17d723f972fa"
      decimals="INF"
      id="F_a6b031af-6166-451a-ade4-6a9e309b03f1"
      unitRef="U_shares">2000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_27463c1c-a3d9-4df6-9af4-17d723f972fa"
      decimals="-5"
      id="F_50f767fb-5a9b-4648-bf50-e3882c45f0ef"
      unitRef="U_USD">11600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <tsha:CommonStockSharesIssuedAndSold
      contextRef="C_9cb3becb-0241-4438-9d16-a477e9cdad37"
      decimals="INF"
      id="F_9172715e-dfd4-4173-8966-b56cbe7dae9d"
      unitRef="U_shares">0</tsha:CommonStockSharesIssuedAndSold>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-5"
      id="F_85839cb4-c79d-4408-a126-af3ab10ff1fd"
      unitRef="U_USD">-560700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-5"
      id="F_2b9f3ef3-84fb-4c64-a094-814dda0a4976"
      unitRef="U_USD">164300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_55e3016b-4944-4093-a164-41e899a2cc36">&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 2&#x2014;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) as determined by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X and are consistent in all material respects with those included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 28, 2023 (the &#x201c;2022 Annual Report&#x201d;). In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The consolidated balance sheet as of December 31, 2022, is derived from audited financial statements, however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in the Company&#x2019;s 2022 Annual Report.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The accompanying interim condensed consolidated financial statements include the accounts of Taysha and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The most significant estimates and assumptions in the Company&#x2019;s financial statements relate to the determination of the fair value of the common stock prior to the initial public offering ("IPO") (as an input into stock-based compensation), estimating manufacturing accruals and accrued or prepaid research and development expenses, the measurement of impairment of long-lived assets, the fair value of the warrant liability, and the allocation of consideration received in connection with the Astellas Transactions (as defined below) at contract inception. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#x2019;s future results of operations will be affected.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;There have been no changes in the Company&#x2019;s significant accounting policies as disclosed in Note 2 to the audited consolidated financial statements included in the 2022 Annual Report, except as described below.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Cash and cash equivalents consist of funds held in a standard checking account, a standard savings account and a money market fund. The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Assets Held for Sale&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Assets and liabilities are classified as held for sale when all of the following criteria for a plan of sale have been met: (1) management, having the authority to approve the action, commits to a plan to sell the assets; (2) the assets are available for immediate sale, in their present condition, subject only to terms that are usual and customary for sales of such assets; (3) an active program to locate a buyer and other actions required to complete the plan to sell the assets have been initiated; (4) the sale of the assets is probable and is expected to be completed within one year; (5) the assets are being actively marketed for a price that is reasonable in relation to their current fair value; and (6) actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or the plan will be withdrawn. When all of these criteria have been met, the assets and liabilities are classified as held for sale in the balance sheet. Assets classified as held for sale are reported at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;the lower of their carrying value or fair value less costs to sell. The Company recorded a partial impairment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million during the three months ended September 30, 2023 in connection with the classification of certain assets to assets held for sale. Depreciation and amortization of assets ceases upon designation as held for sale.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s specific terms and applicable authoritative guidance in FASB ASC 480, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; (&#x201c;ASC 480&#x201d;) and ASC 815,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#x2019;s own common shares and whether the warrant holders could potentially require &#x201c;net cash settlement&#x201d; in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period while the warrants are outstanding.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to remeasurement at each balance sheet date until the warrants are exercised or expire, and any change in fair value is recognized in the Company&#x2019;s condensed consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Comprehensive loss is equal to net loss as presented in the accompanying condensed consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), as amended, with guidance regarding the accounting for and disclosure of leases. This update requires lessees to recognize the liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheets. This update also requires lessees and lessors to disclose key information about their leasing transactions.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, the Company &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; ASU 2016-02 using the modified retrospective approach and utilizing the effective date as its date of initial application.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; The Company has retrospectively changed its previously issued condensed consolidated financial statements as of September 30, 2022 as presented within the Company&#x2019;s September 30, 2022 Quarterly Report on Form 10-Q to reflect the adoption of ASC 842 on January 1, 2022. The condensed consolidated financial statements for the three and nine months ended September 30, 2022 presented herein differ from the Company&#x2019;s condensed consolidated financial statements included in the Company&#x2019;s September 30, 2022 Quarterly Report on Form 10-Q as those condensed consolidated financial statements were prepared using the former accounting standard referred to as ASC Topic 840, Leases.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company elected the following practical expedients, which must be elected as a package and applied consistently to all of its leases at the transition date (including those for which the entity is a lessee or a lessor): i) the Company did not reassess whether any expired or existing contracts are or contain leases; ii) the Company did not reassess the lease classification for any expired or existing leases (that is, all existing leases that were classified as operating leases in accordance with ASC 840 are classified as operating leases, and all existing leases that were classified as capital leases in accordance with ASC 840 are classified as finance leases); and iii) the Company did not reassess initial direct costs for any existing leases. For leases that existed prior to the date of initial application of ASC 842 (which were previously classified as operating leases), a lessee may elect to use either the total lease term measured at lease inception under ASC 840 or the remaining lease term as of the date of initial application of ASC 842 in determining the period for which to measure its incremental borrowing rate. In transition to ASC 842, the Company utilized the remaining lease term of its leases in determining the appropriate incremental borrowing rates.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The adoption of this standard resulted in the recognition of operating lease right-of-use assets and operating lease liabilities of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;18.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;19.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively, on the Company&#x2019;s condensed consolidated balance sheet at adoption relating to its operating leases. The lease liabilities were determined based on the present value of the remaining minimum lease payments. Upon adoption of ASC 842, the Company also (i) derecognized the build-to-suit lease asset of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million previously presented in property, plant and equipment, (ii) derecognized the build-to-suit lease liability of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, and (iii) eliminated $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million of deferred rent liabilities and tenant improvement allowances as of January 1, 2022, as these liabilities are reflected in the operating lease right-of-use assets. In adopting ASU 2016-02, the Company recorded a total one-time adjustment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million to the opening balance of accumulated deficit as of January 1, 2022, related to the de-recognition of the build-to-suit lease asset and related build-to-suit lease obligation. The adoption &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;did not&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; have a material impact on accumulated deficit and on the condensed consolidated statements of operations and cash flows.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations and statement of cash flows for the nine months ended September 30, 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:54.498%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:11.584999999999999%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:12.366%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:11.584999999999999%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Pre ASC 842 Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ASC 842 Adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;After ASC 842 Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_c235bfe5-b369-4c89-8e3c-24a2b2c671cb;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Condensed&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;Consolidated Statement of Operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Operating expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;77,308&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,154&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;78,462&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Other income (expense):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3,002&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;509&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;110,291&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;645&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;110,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Condensed Consolidated Statement of Cash Flows&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Depreciation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;808&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Non-cash lease expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,031&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,031&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&#160;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8,576&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Cash flows from financing activities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;435&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;709&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Supplemental disclosure of noncash investing and financing activities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;23,035&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;23,035&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations for the three months ended September 30, 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:54.498%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:11.584999999999999%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:12.366%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:11.584999999999999%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Pre ASC 842 Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ASC 842 Adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;After ASC 842 Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_3d5ea955-cb63-460e-9ac4-0cc91b6e0847;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Condensed&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;Consolidated Statement of Operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Operating expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;16,391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;383&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;16,774&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Other income (expense):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,241&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;163&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26,307&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;220&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26,527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_927d9dad-f597-44a8-8bc7-af4da5721662">&lt;p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) as determined by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X and are consistent in all material respects with those included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 28, 2023 (the &#x201c;2022 Annual Report&#x201d;). In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The consolidated balance sheet as of December 31, 2022, is derived from audited financial statements, however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in the Company&#x2019;s 2022 Annual Report.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_b4b9d143-84fb-47e9-b7f5-9ee642750d02">&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The accompanying interim condensed consolidated financial statements include the accounts of Taysha and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_9419a0a0-b27b-464c-bc3c-c46914e44ae6">&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The most significant estimates and assumptions in the Company&#x2019;s financial statements relate to the determination of the fair value of the common stock prior to the initial public offering ("IPO") (as an input into stock-based compensation), estimating manufacturing accruals and accrued or prepaid research and development expenses, the measurement of impairment of long-lived assets, the fair value of the warrant liability, and the allocation of consideration received in connection with the Astellas Transactions (as defined below) at contract inception. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially from these estimates. To the extent there are material differences between the estimates and actual results, the Company&#x2019;s future results of operations will be affected.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_5d115043-0b83-4040-94d6-7b540af6bb38">&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Cash and cash equivalents consist of funds held in a standard checking account, a standard savings account and a money market fund. The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_18d5e842-6af5-4e2c-819d-c685028e7ccc">&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Assets Held for Sale&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Assets and liabilities are classified as held for sale when all of the following criteria for a plan of sale have been met: (1) management, having the authority to approve the action, commits to a plan to sell the assets; (2) the assets are available for immediate sale, in their present condition, subject only to terms that are usual and customary for sales of such assets; (3) an active program to locate a buyer and other actions required to complete the plan to sell the assets have been initiated; (4) the sale of the assets is probable and is expected to be completed within one year; (5) the assets are being actively marketed for a price that is reasonable in relation to their current fair value; and (6) actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or the plan will be withdrawn. When all of these criteria have been met, the assets and liabilities are classified as held for sale in the balance sheet. Assets classified as held for sale are reported at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;the lower of their carrying value or fair value less costs to sell. The Company recorded a partial impairment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million during the three months ended September 30, 2023 in connection with the classification of certain assets to assets held for sale. Depreciation and amortization of assets ceases upon designation as held for sale.&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-5"
      id="F_f90d1bd6-ef0b-4a0f-acf8-948c611a2632"
      unitRef="U_USD">600000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <tsha:WarrantsPolicyPolicyTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_a95962eb-2365-4517-8e27-a238692e1277">&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s specific terms and applicable authoritative guidance in FASB ASC 480, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; (&#x201c;ASC 480&#x201d;) and ASC 815,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#x2019;s own common shares and whether the warrant holders could potentially require &#x201c;net cash settlement&#x201d; in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period while the warrants are outstanding.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to remeasurement at each balance sheet date until the warrants are exercised or expire, and any change in fair value is recognized in the Company&#x2019;s condensed consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;</tsha:WarrantsPolicyPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_95925d93-dce1-4762-b13b-39e08c63f329">&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Comprehensive loss is equal to net loss as presented in the accompanying condensed consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_5c97f90a-3058-44e8-9525-bd2462761b67">&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), as amended, with guidance regarding the accounting for and disclosure of leases. This update requires lessees to recognize the liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheets. This update also requires lessees and lessors to disclose key information about their leasing transactions.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, the Company &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; ASU 2016-02 using the modified retrospective approach and utilizing the effective date as its date of initial application.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; The Company has retrospectively changed its previously issued condensed consolidated financial statements as of September 30, 2022 as presented within the Company&#x2019;s September 30, 2022 Quarterly Report on Form 10-Q to reflect the adoption of ASC 842 on January 1, 2022. The condensed consolidated financial statements for the three and nine months ended September 30, 2022 presented herein differ from the Company&#x2019;s condensed consolidated financial statements included in the Company&#x2019;s September 30, 2022 Quarterly Report on Form 10-Q as those condensed consolidated financial statements were prepared using the former accounting standard referred to as ASC Topic 840, Leases.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company elected the following practical expedients, which must be elected as a package and applied consistently to all of its leases at the transition date (including those for which the entity is a lessee or a lessor): i) the Company did not reassess whether any expired or existing contracts are or contain leases; ii) the Company did not reassess the lease classification for any expired or existing leases (that is, all existing leases that were classified as operating leases in accordance with ASC 840 are classified as operating leases, and all existing leases that were classified as capital leases in accordance with ASC 840 are classified as finance leases); and iii) the Company did not reassess initial direct costs for any existing leases. For leases that existed prior to the date of initial application of ASC 842 (which were previously classified as operating leases), a lessee may elect to use either the total lease term measured at lease inception under ASC 840 or the remaining lease term as of the date of initial application of ASC 842 in determining the period for which to measure its incremental borrowing rate. In transition to ASC 842, the Company utilized the remaining lease term of its leases in determining the appropriate incremental borrowing rates.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The adoption of this standard resulted in the recognition of operating lease right-of-use assets and operating lease liabilities of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;18.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;19.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively, on the Company&#x2019;s condensed consolidated balance sheet at adoption relating to its operating leases. The lease liabilities were determined based on the present value of the remaining minimum lease payments. Upon adoption of ASC 842, the Company also (i) derecognized the build-to-suit lease asset of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million previously presented in property, plant and equipment, (ii) derecognized the build-to-suit lease liability of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, and (iii) eliminated $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million of deferred rent liabilities and tenant improvement allowances as of January 1, 2022, as these liabilities are reflected in the operating lease right-of-use assets. In adopting ASU 2016-02, the Company recorded a total one-time adjustment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million to the opening balance of accumulated deficit as of January 1, 2022, related to the de-recognition of the build-to-suit lease asset and related build-to-suit lease obligation. The adoption &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;did not&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; have a material impact on accumulated deficit and on the condensed consolidated statements of operations and cash flows.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations and statement of cash flows for the nine months ended September 30, 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:54.498%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:11.584999999999999%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:12.366%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:11.584999999999999%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Pre ASC 842 Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ASC 842 Adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;After ASC 842 Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_c235bfe5-b369-4c89-8e3c-24a2b2c671cb;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Condensed&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;Consolidated Statement of Operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Operating expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;77,308&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,154&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;78,462&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Other income (expense):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3,002&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;509&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;110,291&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;645&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;110,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Condensed Consolidated Statement of Cash Flows&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Depreciation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;808&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Non-cash lease expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,031&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,031&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&#160;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8,576&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Cash flows from financing activities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;435&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;709&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Supplemental disclosure of noncash investing and financing activities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;23,035&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;23,035&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations for the three months ended September 30, 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:54.498%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:11.584999999999999%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:12.366%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:11.584999999999999%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Pre ASC 842 Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ASC 842 Adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;After ASC 842 Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_3d5ea955-cb63-460e-9ac4-0cc91b6e0847;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Condensed&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;Consolidated Statement of Operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Operating expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;16,391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;383&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;16,774&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Other income (expense):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,241&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;163&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26,307&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;220&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26,527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_afb73dc0-9840-43ad-9af7-f5a3c969493a"
      id="F_32c9359a-e9a8-4fc7-a3f3-73b9d5a4cf3b">2022-12-31</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
      contextRef="C_afb73dc0-9840-43ad-9af7-f5a3c969493a"
      id="F_46c772b8-901a-425a-a18f-7a5729cc8b31">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_afb73dc0-9840-43ad-9af7-f5a3c969493a"
      decimals="-5"
      id="F_5064d37c-f65f-43ed-a30f-9dc78f71328a"
      unitRef="U_USD">18400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_afb73dc0-9840-43ad-9af7-f5a3c969493a"
      decimals="-5"
      id="F_f1ad92e5-323d-4469-bc63-af3e27764c73"
      unitRef="U_USD">19100000</us-gaap:OperatingLeaseLiability>
    <tsha:DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-5"
      id="F_ef560271-daf5-4c83-ba76-a434a2c5cb46"
      unitRef="U_USD">26300000</tsha:DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment>
    <tsha:DerecognizedBuildToSuitLeaseLiability
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-5"
      id="F_4cfa970f-9fb6-4a11-866e-79f2fa23e7ce"
      unitRef="U_USD">26500000</tsha:DerecognizedBuildToSuitLeaseLiability>
    <tsha:DeferredRentLiabiilitiesAndTenantImprovementAllowances
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-5"
      id="F_87360ca5-9820-40f4-8bf6-5b50b1dc069c"
      unitRef="U_USD">700000</tsha:DeferredRentLiabiilitiesAndTenantImprovementAllowances>
    <us-gaap:CumulativeEarningsDeficit
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-5"
      id="F_c58b3dc9-f3ef-4622-a70c-4d76ce3c11bc"
      unitRef="U_USD">200000</us-gaap:CumulativeEarningsDeficit>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_afb73dc0-9840-43ad-9af7-f5a3c969493a"
      id="F_a1660a95-a59c-43e9-bd21-a30eff4d9fc6">false</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_c511b058-9aab-427d-a0c3-2c7e503df1dd">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations and statement of cash flows for the nine months ended September 30, 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:54.498%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:11.584999999999999%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:12.366%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:11.584999999999999%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Pre ASC 842 Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ASC 842 Adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;After ASC 842 Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_c235bfe5-b369-4c89-8e3c-24a2b2c671cb;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Condensed&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;Consolidated Statement of Operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Operating expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;77,308&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,154&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;78,462&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Other income (expense):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3,002&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;509&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;110,291&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;645&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;110,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Condensed Consolidated Statement of Cash Flows&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Depreciation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;808&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Non-cash lease expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,031&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,031&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Changes in operating assets and liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&#160;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7,753&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8,576&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Cash flows from financing activities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;435&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;709&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Supplemental disclosure of noncash investing and financing activities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;23,035&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;23,035&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the effect of the adoption of ASC 842 on the condensed consolidated statement of operations for the three months ended September 30, 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:54.498%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:11.584999999999999%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:12.366%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:1.322%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
          &lt;td style="width:11.584999999999999%;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Pre ASC 842 Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ASC 842 Adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;After ASC 842 Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_3d5ea955-cb63-460e-9ac4-0cc91b6e0847;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Condensed&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;Consolidated Statement of Operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Operating expenses:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;16,391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;383&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;16,774&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Other income (expense):&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,241&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;163&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;"&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26,307&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;220&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26,527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_f346f496-91c4-40a5-b151-c5aa7e20a131"
      decimals="-3"
      id="F_0c3cbcb6-e7be-4991-a71a-8453f7433904"
      unitRef="U_USD">77308000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4"
      decimals="-3"
      id="F_2eaca8fc-a0bc-42bf-a128-6e64e8767352"
      unitRef="U_USD">1154000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_25e4f396-b102-4c1e-9d6e-0541930e7646"
      unitRef="U_USD">78462000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:InterestExpense
      contextRef="C_f346f496-91c4-40a5-b151-c5aa7e20a131"
      decimals="-3"
      id="F_f6dffa40-0c32-4fbe-85f9-ed28585ebbbb"
      unitRef="U_USD">3002000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4"
      decimals="-3"
      id="F_8f99f1c8-108f-4efd-b95d-924ad1840e81"
      unitRef="U_USD">-509000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_565fa6c7-c51e-4d4e-9cf6-f02285b5fd27"
      unitRef="U_USD">2493000</us-gaap:InterestExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_f346f496-91c4-40a5-b151-c5aa7e20a131"
      decimals="-3"
      id="F_0b44acad-ca44-4c4d-8390-f1f26da3dd37"
      unitRef="U_USD">-110291000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4"
      decimals="-3"
      id="F_1ee04bcc-ecfc-4678-97f4-bc18f57e0359"
      unitRef="U_USD">-645000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_1405e0d8-7b7b-4b9f-8c3f-6c8cb4df9a8c"
      unitRef="U_USD">-110936000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="C_f346f496-91c4-40a5-b151-c5aa7e20a131"
      decimals="-3"
      id="F_6b881678-78da-47bf-89bc-3cab1cbd41bf"
      unitRef="U_USD">808000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4"
      decimals="-3"
      id="F_070e5678-9cbb-48e6-b503-fb3a4a7867d8"
      unitRef="U_USD">2000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_740ab599-5810-43c9-af41-b0a28cab4d86"
      unitRef="U_USD">810000</us-gaap:Depreciation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4"
      decimals="-3"
      id="F_104598ce-7836-4445-96d1-b50be7e52cb4"
      unitRef="U_USD">1031000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_6b7ee46e-fc16-4038-a00b-50ace86de29b"
      unitRef="U_USD">1031000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <tsha:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities
      contextRef="C_f346f496-91c4-40a5-b151-c5aa7e20a131"
      decimals="-3"
      id="F_38039a88-ff71-46ef-b55e-de573c2a5496"
      unitRef="U_USD">-7753000</tsha:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities>
    <tsha:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities
      contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4"
      decimals="-3"
      id="F_632def47-773a-4ac7-98ef-bf2a2e475fb8"
      unitRef="U_USD">-823000</tsha:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities>
    <tsha:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_24f0400d-537f-404c-9de6-1cbc6c1b84c6"
      unitRef="U_USD">-8576000</tsha:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="C_f346f496-91c4-40a5-b151-c5aa7e20a131"
      decimals="-3"
      id="F_2c0e4160-8b0b-448a-a9c0-9d421acfca20"
      unitRef="U_USD">-1144000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4"
      decimals="-3"
      id="F_0d22f4cc-c0c7-416b-ab27-3b9415eb1583"
      unitRef="U_USD">435000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_0aa3a5c6-1c01-4cc9-91ac-779f2b019912"
      unitRef="U_USD">-709000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="C_0d813ec3-e8bb-4190-af8b-be115e142cd4"
      decimals="-3"
      id="F_5ddb2696-3923-4b84-8a7e-e8d33e5a7cdc"
      unitRef="U_USD">23035000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_de38802d-cd6c-4295-af22-413d0de6e65d"
      unitRef="U_USD">23035000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_10334e6e-f910-467c-a8bf-bccc2eb4ec31"
      decimals="-3"
      id="F_67d63899-1bb0-484d-8c87-edd6e26ab89e"
      unitRef="U_USD">16391000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_e42d8932-a6cb-47d7-883a-506fc278ba6a"
      decimals="-3"
      id="F_a8839044-1d15-42a1-a604-d9b04a324017"
      unitRef="U_USD">383000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_79cf2757-ba9f-463d-8cee-2a4a9e0b7300"
      unitRef="U_USD">16774000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:InterestExpense
      contextRef="C_10334e6e-f910-467c-a8bf-bccc2eb4ec31"
      decimals="-3"
      id="F_f2c4878a-58ef-44a3-a1ed-5fdf63bf69cf"
      unitRef="U_USD">1241000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_e42d8932-a6cb-47d7-883a-506fc278ba6a"
      decimals="-3"
      id="F_441b8914-31de-46e0-b2ae-78b47d20ebb8"
      unitRef="U_USD">-163000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_53592727-a99d-406b-8b02-1866c7e7bad2"
      unitRef="U_USD">1078000</us-gaap:InterestExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_10334e6e-f910-467c-a8bf-bccc2eb4ec31"
      decimals="-3"
      id="F_1336323d-b76c-4b3a-8e14-2f0da68361b3"
      unitRef="U_USD">-26307000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_e42d8932-a6cb-47d7-883a-506fc278ba6a"
      decimals="-3"
      id="F_d8871b70-d164-4464-88df-3861fd4f35fb"
      unitRef="U_USD">-220000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_83e95a2f-690d-4082-a718-d1692630f49c"
      unitRef="U_USD">-26527000</us-gaap:NetIncomeLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_add60778-1e81-4881-a327-cc2241132f20">&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 3&#x2014;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following tables present information about the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:48.487%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:11.149%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.263%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.525%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.263%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.525%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.263%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.525%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&#160;&#160;Cash equivalents &#x2013; money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;150,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;150,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;150,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;150,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&#160;&#160;SSI Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;701&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;701&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&#160;&#160;Pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;139,833&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;139,833&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;140,534&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;139,833&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;701&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company classifies its money market funds, which are valued based on quoted market prices in an active market with no valuation adjustment, as Level 1 assets within the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company uses the Black-Scholes-Merton option pricing model to determine the fair value of the SSI Warrants (as defined below). The Company classifies its Pre-Funded Warrants (as defined below), which are valued using quoted prices of similar financial instruments in the market, as Level 2 liabilities. S&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ee Note 10 for additional information on the SSI Warrants and the Pre-Funded Warrants.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_e62f40d1-1418-450e-8660-ffe3d7eb2546">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following tables present information about the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy used to determine such fair values (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:48.487%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:11.149%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.263%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.525%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.263%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.525%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.263%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.525%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&#160;&#160;Cash equivalents &#x2013; money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;150,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;150,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;150,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;150,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Warrant liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&#160;&#160;SSI Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;701&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;701&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&#160;&#160;Pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;139,833&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;139,833&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;140,534&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;139,833&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;701&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_89723ac2-2fad-4cb4-b5fc-51a86fd96b12"
      decimals="-3"
      id="F_e7edd8bc-f81b-463b-b2ba-a0a7e604a8ac"
      unitRef="U_USD">150514000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_f438b467-3326-45e8-9282-1549429f210e"
      decimals="-3"
      id="F_105d961a-c975-4b67-90db-d51b37abc001"
      unitRef="U_USD">150514000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_ae0e6e94-6d42-449a-98d1-1d5e970a3352"
      unitRef="U_USD">150514000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_29c4a552-4734-47bc-be8c-3e643d34d362"
      decimals="-3"
      id="F_e6b0c43d-20da-4899-8de8-f434e8ba1db5"
      unitRef="U_USD">150514000</us-gaap:AssetsFairValueDisclosure>
    <tsha:SsiWarrants
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_32f283cd-7278-4c51-828f-eb0a08917984"
      unitRef="U_USD">701000</tsha:SsiWarrants>
    <tsha:SsiWarrants
      contextRef="C_8e476623-2cf0-4fe3-b12e-9c905fead252"
      decimals="-3"
      id="F_adef2980-a607-4f66-9666-720b5ae81d21"
      unitRef="U_USD">701000</tsha:SsiWarrants>
    <tsha:PreFundedWarrants
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_7895aff2-9e30-462d-a8c1-35ce88cc9ddc"
      unitRef="U_USD">139833000</tsha:PreFundedWarrants>
    <tsha:PreFundedWarrants
      contextRef="C_8786aa0e-05e3-4061-9f46-80d5e9b63b63"
      decimals="-3"
      id="F_b899e91f-c1b0-4747-b7ea-7db78bb8e7cc"
      unitRef="U_USD">139833000</tsha:PreFundedWarrants>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_422d3738-e8fd-4f6d-acac-153378794476"
      unitRef="U_USD">140534000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_8786aa0e-05e3-4061-9f46-80d5e9b63b63"
      decimals="-3"
      id="F_14081e8d-b4f6-4ead-b1ff-24985a8fd61c"
      unitRef="U_USD">139833000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="C_8e476623-2cf0-4fe3-b12e-9c905fead252"
      decimals="-3"
      id="F_a2b849af-155e-449c-b892-48385f907fad"
      unitRef="U_USD">701000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_3ae8ed67-8a3c-4455-9074-07d573d42104">&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 4&#x2014;Balance Sheet Components&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Prepaid expenses and other current assets consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.08%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.622%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.837%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.622%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.837%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Prepaid research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,672&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4,840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Prepaid clinical trial&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Deferred offering costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;724&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;724&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Prepaid insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;337&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;404&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;466&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,529&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Property, plant and equipment, net consisted of the following (in thousands):	&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.08%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.622%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.837%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.622%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.837%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,091&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,091&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,868&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,868&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,115&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,115&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;898&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6,874&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;9,633&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;13,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;16,605&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,643&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,642&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;11,169&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;14,963&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In November 2022, the Company recognized a non-cash impairment charge of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;36.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million for the manufacturing facility asset group, of which $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million relates to construction in progress and finance lease right-of-use assets. The impairment charge was estimated using a discounted cash flow model and recorded in the consolidated statements of operations for the year ended December 31, 2022. Property, plant and equipment, net includes &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; mi&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;llion and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million of assets capitalized as finance leases as of September 30, 2023 and December 31, 2022, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Depreciation expense w&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;as $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million for the three months ended September 30, 2023 and 2022, respectively. Depreciation expense was&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; milli&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;on and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million for the nine months ended September 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;During &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;the three months ended September 30, 2023, the Company committed to a plan to sell specific pieces of equipment originally intended for use in the Company&#x2019;s manufacturing facility in Durham, NC. The Company determined that this equipment met the requirements to be classified as held for sale. The sale is expected to be completed within one year. During the three and nine&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;months &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ended September 30, 2023, the Company recorded an impairment loss of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million which was the difference between the carrying value and fair value less cost to sell.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued expenses and other current liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.08%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.622%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.837%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.622%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.837%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,699&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8,190&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,745&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,519&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Lease liabilities, current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,538&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued clinical trial&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,473&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued severance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;992&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,463&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued professional and consulting fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;579&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;390&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued property, plant and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,081&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;13,638&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;18,287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_2369e6a5-30c7-4416-a984-cb053cab1a04">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Prepaid expenses and other current assets consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.08%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.622%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.837%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.622%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.837%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Prepaid research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,672&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4,840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Prepaid clinical trial&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Deferred offering costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;724&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;724&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Prepaid insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;337&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;404&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;466&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,529&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <tsha:PrepaidResearchAndDevelopmentContracts
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_c6e26e63-0620-4844-8c3c-c4462846eccc"
      unitRef="U_USD">2672000</tsha:PrepaidResearchAndDevelopmentContracts>
    <tsha:PrepaidResearchAndDevelopmentContracts
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_2b122f53-2bae-46e6-9423-085632cb0960"
      unitRef="U_USD">4840000</tsha:PrepaidResearchAndDevelopmentContracts>
    <tsha:PrepaidClinicalTrial
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_22d35b4c-559f-40ed-b4a2-4881ece7845d"
      unitRef="U_USD">1392000</tsha:PrepaidClinicalTrial>
    <tsha:PrepaidClinicalTrial
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_a8d3ec45-efdc-4da1-a8d0-9c6358ad666b"
      unitRef="U_USD">2119000</tsha:PrepaidClinicalTrial>
    <us-gaap:DeferredOfferingCosts
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_c45924eb-0db3-4d45-a2fc-72c3078a347f"
      unitRef="U_USD">724000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_b9ed8917-1320-4149-80cc-6f80b391a557"
      unitRef="U_USD">724000</us-gaap:DeferredOfferingCosts>
    <us-gaap:PrepaidInsurance
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_2b395e23-5869-4831-830d-a234750a5b26"
      unitRef="U_USD">337000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_7b59eb06-c1ea-43ef-ab5e-8145e8017b79"
      unitRef="U_USD">388000</us-gaap:PrepaidInsurance>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_10164f86-8c37-434a-93af-4c6cb534b172"
      unitRef="U_USD">404000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_800baabb-e847-4919-9ad5-b49b9c571c88"
      unitRef="U_USD">466000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_7aabf20f-97e3-49ad-bc47-85dcf25c0c62"
      unitRef="U_USD">5529000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_c08eb56c-c799-4a6b-9040-03fa2ab7c993"
      unitRef="U_USD">8537000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_02046928-70ff-4d0f-bd3e-a0ddb14d1c86">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Property, plant and equipment, net consisted of the following (in thousands):	&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.08%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.622%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.837%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.622%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.837%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,091&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,091&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,868&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,868&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,115&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,115&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;898&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6,874&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;9,633&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;13,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;16,605&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,643&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,642&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;11,169&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;14,963&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_2d3969b3-1904-49b7-9987-89bee52040f5"
      decimals="-3"
      id="F_05d1a5b2-d61f-4a33-b46b-3680e91d32c3"
      unitRef="U_USD">2091000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_afb7066a-ec3f-492c-abdf-4728d171d8a0"
      decimals="-3"
      id="F_9edeb595-b3ed-40be-8110-5cc727cf5e4c"
      unitRef="U_USD">2091000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_c21847ad-1728-4953-9228-368c4f2998f2"
      decimals="-3"
      id="F_ac532878-9a7a-4593-a0c9-e54996995090"
      unitRef="U_USD">2868000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_3e6ad8f3-e3b2-4766-81e6-638c50b9a854"
      decimals="-3"
      id="F_f3b25d27-36e5-4c57-8db6-14e2ab630206"
      unitRef="U_USD">2868000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_31bb6c1a-64e4-43f2-ac13-da2509eeeef2"
      decimals="-3"
      id="F_e94707b8-fd3d-4834-b6c6-d0b5ef4ca0e8"
      unitRef="U_USD">1115000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_a8165939-afd1-4d28-97a4-17ac213a88aa"
      decimals="-3"
      id="F_b5a8cc82-8f4c-45e9-88a8-2c04a716e819"
      unitRef="U_USD">1115000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_2db1cf9d-e412-454a-abb7-673182786e9b"
      decimals="-3"
      id="F_2ec41ad1-ea9d-4566-bf61-5a5db2f5ac3e"
      unitRef="U_USD">864000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_c880fb70-98ec-4743-b3ec-50abce55fb61"
      decimals="-3"
      id="F_97837f61-722f-4f99-984f-2653be955b92"
      unitRef="U_USD">898000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_63dd2c50-f529-4540-bf31-b0caef7db5c3"
      decimals="-3"
      id="F_dfe9e20d-3dc9-41c5-b78c-5c9a3a3304a4"
      unitRef="U_USD">6874000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_49ea514f-2749-4ec3-b1be-bc456b767a33"
      decimals="-3"
      id="F_2e9457ae-6c2c-4435-85a5-162205f60ab6"
      unitRef="U_USD">9633000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_aadc76bd-44ce-47be-840d-c3bdae021f34"
      unitRef="U_USD">13812000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_27cb081f-b114-4278-998c-bfd26533d88b"
      unitRef="U_USD">16605000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_dc7f2e6a-0510-4477-87ca-42e63cfcd496"
      unitRef="U_USD">2643000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_466dfb04-14cc-4ccc-8e5f-efa43f9abddb"
      unitRef="U_USD">1642000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_5df56936-5d93-4a8b-b666-b697bb5ff012"
      unitRef="U_USD">11169000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_75d6ee6c-5a31-4e08-8d84-06365d5f1c41"
      unitRef="U_USD">14963000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetImpairmentCharges
      contextRef="C_7f2b298a-2b65-407d-9b6b-4e8ad3ab3b4a"
      decimals="-5"
      id="F_08015c26-338f-43e7-9eb0-1947514a1dd0"
      unitRef="U_USD">36400000</us-gaap:AssetImpairmentCharges>
    <tsha:ConstructionInProgressAndFinanceLeaseRightOfUseAsset
      contextRef="C_3826a1af-5558-42d4-951c-d3a6f47c100b"
      decimals="-5"
      id="F_9b4f9619-281e-43ed-b73f-ecdb7631ee19"
      unitRef="U_USD">26300000</tsha:ConstructionInProgressAndFinanceLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_2d977a75-9f73-4edb-9392-84ff074a6057"
      decimals="-5"
      id="F_b0082228-dfef-4e74-9eae-0727e7ba1e2c"
      unitRef="U_USD">1100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_d2c65442-11b0-4704-bbf6-bea92b060507"
      decimals="-5"
      id="F_c9c1fcab-ded5-445b-b7be-add53d2c0ebc"
      unitRef="U_USD">1300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-5"
      id="F_a3da04ba-90c1-4593-b200-860c31ea7ad0"
      unitRef="U_USD">300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-5"
      id="F_b460b74c-d46e-41b3-b29b-f8c50ae4c655"
      unitRef="U_USD">300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-5"
      id="F_8debac72-7b6b-415c-bb23-7cc945c177c6"
      unitRef="U_USD">1000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-5"
      id="F_18bb08a0-0cd9-4c01-bcff-f807769e4ba0"
      unitRef="U_USD">800000</us-gaap:Depreciation>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-5"
      id="F_733ba1af-f372-4ab7-b40f-940ae31a87b0"
      unitRef="U_USD">-600000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-5"
      id="F_15debbcd-1453-42d4-9d27-8298598e41c6"
      unitRef="U_USD">-600000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <tsha:ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_da9dc036-0cca-44b3-9b49-c355a08a1e1c">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued expenses and other current liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.08%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.622%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.837%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.622%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.837%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,699&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8,190&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,745&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,519&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Lease liabilities, current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,538&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued clinical trial&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,473&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued severance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;992&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,463&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued professional and consulting fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;579&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;390&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued property, plant and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,081&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;13,638&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;18,287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</tsha:ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock>
    <tsha:AccruedResearchAndDevelopmentCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_ab37fa38-8476-4e50-9dcf-1400cdaee42c"
      unitRef="U_USD">5699000</tsha:AccruedResearchAndDevelopmentCurrent>
    <tsha:AccruedResearchAndDevelopmentCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_fddf0e6a-7fc7-41ec-b427-65b84206155c"
      unitRef="U_USD">8190000</tsha:AccruedResearchAndDevelopmentCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_38fb16cd-6005-4872-9c94-a35bc6798d71"
      unitRef="U_USD">2745000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_da6da6ea-e2c5-427e-bf64-ae9ba08281ab"
      unitRef="U_USD">2519000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <tsha:LeaseLiabilityCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_41186d13-85e0-430c-9c34-c40820da46c8"
      unitRef="U_USD">1538000</tsha:LeaseLiabilityCurrent>
    <tsha:LeaseLiabilityCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_c46ca0ac-16a8-447c-9ced-42a511b3970c"
      unitRef="U_USD">1521000</tsha:LeaseLiabilityCurrent>
    <tsha:AccruedClinicalTrialCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_8c36c8bb-8cac-4d86-8491-dd9031fc1ed7"
      unitRef="U_USD">1359000</tsha:AccruedClinicalTrialCurrent>
    <tsha:AccruedClinicalTrialCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_5e77389f-ee99-4be5-8258-f9506fd9c639"
      unitRef="U_USD">1473000</tsha:AccruedClinicalTrialCurrent>
    <tsha:AccruedSeverance
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_ee31d2a3-b349-4fc8-ada3-84d8559def74"
      unitRef="U_USD">992000</tsha:AccruedSeverance>
    <tsha:AccruedSeverance
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_c6ec0734-a0bf-4f0a-96e6-9256fe4e300e"
      unitRef="U_USD">1463000</tsha:AccruedSeverance>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_dfcf3534-99e3-4d49-8205-597bdfc52299"
      unitRef="U_USD">579000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_9716097f-524a-4316-bb74-897da6dfbae8"
      unitRef="U_USD">390000</us-gaap:AccruedProfessionalFeesCurrent>
    <tsha:AccruedPropertyPlantAndEquipmentCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_99c387af-9fe3-40fe-a20a-dfbbdbfea3af"
      unitRef="U_USD">45000</tsha:AccruedPropertyPlantAndEquipmentCurrent>
    <tsha:AccruedPropertyPlantAndEquipmentCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_106b3755-2cf8-4abe-b701-222072f6e1ef"
      unitRef="U_USD">2081000</tsha:AccruedPropertyPlantAndEquipmentCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_8362be7c-dfa9-4bcc-9d80-9efc2de29f71"
      unitRef="U_USD">681000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_87602525-d00c-4ae3-a2bc-809d3d0c369d"
      unitRef="U_USD">650000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_1af54469-7bbb-4755-9ba9-1fd046c001d9"
      unitRef="U_USD">13638000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="-3"
      id="F_9c574ba1-4fb0-4c05-89af-7438838090b1"
      unitRef="U_USD">18287000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_f717141a-ce61-4066-a3f9-5b84c5da78f9">&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 5&#x2014; Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company leases certain office, laboratory, and manufacturing space.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Dallas Lease&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On January 11, 2021, the Company entered into a lease agreement (the &#x201c;Dallas Lease&#x201d;) with Pegasus Park, LLC, a Delaware limited liability company (the &#x201c;Dallas Landlord&#x201d;), pursuant to which the Company will lease approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;15,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; square feet of office space at 3000 Pegasus Park Drive, Dallas, Texas 75247 (the &#x201c;Office Space&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Dallas Lease commenced on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;May 27, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, and has a term of approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;. The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Company has an option to extend the term of the Dallas Lease for one additional period of five years.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Dallas Landlord has the right to terminate the Dallas Lease, or the Company&#x2019;s right to possess the Office Space without terminating the Dallas Lease, upon specified events of default, including the Company&#x2019;s failure to pay rent in a timely manner and upon the occurrence of certain events of insolvency with respect to the Company.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Dallas Lease Expansion&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On December 14, 2021, the Company amended the Dallas Lease (the &#x201c;Dallas Lease Amendment&#x201d;) with the Dallas Landlord, pursuant to which the Company will lease approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;18,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; square feet of office space adjacent to the Office Space at 3000 Pegasus Park Drive, Dallas, Texas 75247 (the &#x201c;Expansion Premises&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; The Dallas Lease Amendment commenced on July 1, 2022, and has a term of approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company is obligated to pay operating costs and utilities applicable to the Expansion Premises. Total future minimum lease payments under the Dallas Lease Amendment over the initial &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;10-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; term are approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million. The Company will be responsible for costs of constructing interior improvements within the Expansion Premises that exceed a $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;40.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per rentable square foot construction allowance provided by the Dallas Landlord.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company has a right of first refusal with respect to certain additional office space on the 15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;min-width:fit-content;"&gt;th&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; floor at 3000 Pegasus Park Drive, Dallas, Texas 75247 before the Dallas Landlord accepts any offer for such space.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Durham Lease&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On December 17, 2020, the Company entered into a lease agreement (the &#x201c;Durham Lease&#x201d;) with Patriot Park Partners II, LLC, a Delaware limited liability company (the &#x201c;Durham Landlord&#x201d;), pursuant to which the Company agreed to lease approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;187,500&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; square feet of a manufacturing facility located at 5 National Way, Durham, North Carolina (the &#x201c;Facility&#x201d;). The Durham Lease commenced on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;April 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and is expected to have a term of approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;fifteen years and six months&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;. The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Company has two options to extend the term of the Durham Lease, each for a period of an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company was not required to provide a security deposit in connection with its entry into the Durham Lease. The Company will be responsible for constructing interior improvements within the Facility. The Company was required to place $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million in an escrow account which will be released when the improvements are substantially complete. The escrow funds are recorded as restricted cash on the condensed consolidated balance sheet as of September 30, 2023. The Durham Landlord has the right to terminate the Durham Lease upon specified events of default, including the Company&#x2019;s failure to pay rent in a timely manner and upon the occurrence of certain events of insolvency with respect to the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Summary of all lease costs recognized under ASC 842&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the lease costs recognized under ASC 842 and other information pertaining to the Company&#x2019;s operating leases for the three and nine months ended September 30, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:36.628%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.314%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.314%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.223%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.937%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.764%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.817%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="5" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;696&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;794&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,088&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,079&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Variable lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;243&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;229&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;729&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;939&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,817&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,696&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Supplemental information related to the remaining lease term and discount rate are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:54.052%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.545%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:22.212%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:18.19%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted average remaining lease term (in years) &#x2013; Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.13&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.88&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted average remaining lease term (in years) &#x2013; Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;10.97&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;11.45&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted average discount rate &#x2013; Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;10.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;10.51&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted average discount rate &#x2013; Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7.79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7.72&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11pt;font-family:'Calibri',sans-serif;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Supplemental cash flow information related to the Company&#x2019;s operating leases are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:52.723%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:20.627%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:2.022%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:20.627%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,109&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;847&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of September 30, 2023, future minimum commitments under ASC 842 under the Company&#x2019;s operating and finance leases were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.682%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:22.389%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:21.927999999999997%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Year Ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Operating&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Finance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;686&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;114&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;454&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,910&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;454&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,485&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;399&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,577&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;19,721&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;31,189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,421&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;10,895&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;242&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;20,294&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_3e78f387-05e6-4d7c-88d4-c13b0a4b78ec;"&gt;&lt;span style="-sec-ix-hidden:F_dbeee014-7927-4ce5-8253-ba65a26dca89;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Lease liabilities, current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_b7b24932-76e0-4234-83dc-e0defb7581aa;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Lease liabilities, non-current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;19,101&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;834&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_1ede665f-e147-4c30-a4ac-9f4f220b3eda;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;20,294&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits
      contextRef="C_9eccec65-aa13-4b7b-8210-aa887edfcc29"
      decimals="0"
      id="F_837a0ae3-728a-4fcc-84a9-9fd898dbbc68"
      unitRef="U_sqft">15000</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits>
    <us-gaap:OperationsCommencedDate1
      contextRef="C_5ff63508-7308-4b13-b74d-9cf9982f8736"
      id="F_93803869-f59b-4751-b83f-114b385d74b1">2021-05-27</us-gaap:OperationsCommencedDate1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_9eccec65-aa13-4b7b-8210-aa887edfcc29"
      id="F_67318a11-065a-44bb-bdb0-57150b9c493f">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="C_5ff63508-7308-4b13-b74d-9cf9982f8736"
      id="F_c9528032-3fe9-48d1-9bed-510d99603420">Company has an option to extend the term of the Dallas Lease for one additional period of five years.</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits
      contextRef="C_52fa6299-e193-4168-a292-1d334991839a"
      decimals="0"
      id="F_95c70711-0670-4936-ab63-2ed50fda6347"
      unitRef="U_sqft">18000</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_52fa6299-e193-4168-a292-1d334991839a"
      id="F_fe587f63-d525-48bd-954b-5674456790c7">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_52fa6299-e193-4168-a292-1d334991839a"
      id="F_ccba435e-1d9f-4298-8ef0-508f801381b7">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_52fa6299-e193-4168-a292-1d334991839a"
      decimals="-5"
      id="F_f5b112a4-c288-49fb-913d-76a817c57c19"
      unitRef="U_USD">6000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <tsha:MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot
      contextRef="C_865be14a-e277-45f2-b305-9aa13e3a0315"
      decimals="2"
      id="F_b2fdf68b-9e21-473c-ad50-e513b5d4def7"
      unitRef="U_sqft">40</tsha:MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot>
    <us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits
      contextRef="C_8d03e9bb-23a1-464b-940a-dd1c8ec2a91b"
      decimals="0"
      id="F_496bb1f4-1d99-480b-9594-1f154bb2824e"
      unitRef="U_sqft">187500</us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits>
    <us-gaap:OperationsCommencedDate1
      contextRef="C_6de550d8-31ef-460a-ab24-a8f077bb2101"
      id="F_d50a21c1-6d0c-4e4a-b934-f5cf8d12b3ba">2021-04-01</us-gaap:OperationsCommencedDate1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_8d03e9bb-23a1-464b-940a-dd1c8ec2a91b"
      id="F_c7467d0a-c9ed-424a-aa67-e01809c2f821">P15Y6M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="C_b1703001-53ce-4fd2-a321-a0b32037899b"
      id="F_46146595-d4bb-4171-badd-5fb0d6f94c41">Company has two options to extend the term of the Durham Lease, each for a period of an additional five years.</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_8d03e9bb-23a1-464b-940a-dd1c8ec2a91b"
      id="F_6cd6e812-ab5d-410e-b800-5168832d9a44">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:EscrowDeposit
      contextRef="C_a36762fa-d31c-45ad-af2e-461829666801"
      decimals="-5"
      id="F_e2de3653-a2c0-4345-9d18-51575bed0434"
      unitRef="U_USD">2600000</us-gaap:EscrowDeposit>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_e56107ae-a440-4c05-9381-5e2e21c989fc">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the lease costs recognized under ASC 842 and other information pertaining to the Company&#x2019;s operating leases for the three and nine months ended September 30, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:36.628%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.314%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.314%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.223%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.937%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.764%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.817%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="5" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Arial;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;696&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;794&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,088&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,079&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Variable lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;243&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;229&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;729&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;939&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,817&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,696&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_a75347cc-611d-4750-b8d1-5c7569e4db08"
      unitRef="U_USD">696000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_0fd5dec8-a695-4393-9983-91d65cb4ca61"
      unitRef="U_USD">794000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_42d01fdf-6b34-4ef3-b296-21bbee7fa212"
      unitRef="U_USD">2088000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_78980256-de87-4f7a-9094-5ad955ffffc7"
      unitRef="U_USD">2079000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_d4ada43a-1a88-4526-a086-6787e3edb350"
      unitRef="U_USD">243000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_f9898f54-3e9a-449b-b8df-3ecb4e0c2ab4"
      unitRef="U_USD">229000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_3f7f45fa-77b1-4df8-b3ab-713c348dc01a"
      unitRef="U_USD">729000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_a461db72-1637-4da1-9c9e-70739719790a"
      unitRef="U_USD">617000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_12b7cb8e-3eb8-42fe-9af2-f56967239780"
      unitRef="U_USD">939000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_fd5e0ba5-fd72-4e33-ab1d-16d671c23eab"
      unitRef="U_USD">1023000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_57468358-1da4-4c90-a076-95e98a7dae96"
      unitRef="U_USD">2817000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_4059405f-0136-463d-bcfa-61ee2620b8fb"
      unitRef="U_USD">2696000</us-gaap:LeaseCost>
    <tsha:ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_12657e78-4713-4243-8997-a5add12171fe">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Supplemental information related to the remaining lease term and discount rate are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:54.052%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.545%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:22.212%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:18.19%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted average remaining lease term (in years) &#x2013; Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.13&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.88&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted average remaining lease term (in years) &#x2013; Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;10.97&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;11.45&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted average discount rate &#x2013; Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;10.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;10.51&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted average discount rate &#x2013; Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7.79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7.72&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</tsha:ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      id="F_603d8ed2-1fa8-464f-a77c-5d5c345f286f">P3Y1M17D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      id="F_16b8fcaf-0b5b-4a93-89e4-dd8a09f46b63">P3Y10M17D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      id="F_0851ca30-2c62-4879-8e3d-307dd918935b">P10Y11M19D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      id="F_48705012-0381-466b-a22a-8040b0385853">P11Y5M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="4"
      id="F_3c2a6ed8-9a88-4ffd-a9ab-4f97af601e7c"
      unitRef="U_pure">0.1052</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="4"
      id="F_7276c2d4-2a66-431a-8af5-e20bf562e06c"
      unitRef="U_pure">0.1051</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="4"
      id="F_40fffc75-286d-406a-8ca1-b5a835a71559"
      unitRef="U_pure">0.0779</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="4"
      id="F_08cb5bd0-8592-4b07-a817-ee77973312f8"
      unitRef="U_pure">0.0772</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <tsha:ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_958f357b-0c54-4045-9498-f6bdf656b147">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Supplemental cash flow information related to the Company&#x2019;s operating leases are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:52.723%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:20.627%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:2.022%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:20.627%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,109&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;847&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</tsha:ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_a8aa0785-6a4e-4860-8fd1-3d8e25cee974"
      unitRef="U_USD">2109000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_ea846e0a-8e17-4aff-885f-1cb5dbf545a1"
      unitRef="U_USD">847000</us-gaap:OperatingLeasePayments>
    <tsha:LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_89fdf85e-f685-46d5-953b-5c3508977aca">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of September 30, 2023, future minimum commitments under ASC 842 under the Company&#x2019;s operating and finance leases were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:51.682%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:22.389%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:21.927999999999997%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Year Ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Operating&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Finance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;686&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;114&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;454&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,910&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;454&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,485&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;399&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,577&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;19,721&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;31,189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,421&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;10,895&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;242&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;20,294&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_3e78f387-05e6-4d7c-88d4-c13b0a4b78ec;"&gt;&lt;span style="-sec-ix-hidden:F_dbeee014-7927-4ce5-8253-ba65a26dca89;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Lease liabilities, current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_b7b24932-76e0-4234-83dc-e0defb7581aa;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Lease liabilities, non-current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;19,101&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;834&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_1ede665f-e147-4c30-a4ac-9f4f220b3eda;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;20,294&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</tsha:LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_31dc40f7-a309-4b33-8ed1-10b53b240e43"
      unitRef="U_USD">686000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_6fb4f3e1-6d52-4780-8a4b-dad7ba6adee6"
      unitRef="U_USD">114000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_94844b45-35c7-41e3-83ce-1e6ef9b0e088"
      unitRef="U_USD">2810000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_fa9e1c51-a22e-4db6-9998-aea499400f68"
      unitRef="U_USD">454000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_1d6b035c-99df-4eb3-a7ec-9e80854d058d"
      unitRef="U_USD">2910000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_f3ae3c9e-8b63-48fb-8815-73396a8f880c"
      unitRef="U_USD">454000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_bc9fcae9-ceca-4412-85c0-1392a85d482e"
      unitRef="U_USD">2485000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_c6c8e510-87df-4106-a963-c15073ae182b"
      unitRef="U_USD">399000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_53588910-8b07-4942-a952-2fd6fe1ef52d"
      unitRef="U_USD">2577000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <tsha:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_e8c897f3-7a50-46d8-b36f-f37a4b9c96d8"
      unitRef="U_USD">19721000</tsha:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_d173bea5-d699-4e18-990a-0004f74d2af4"
      unitRef="U_USD">31189000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_e94173e3-cd36-466a-926b-823479c3a80c"
      unitRef="U_USD">1421000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_276af2f8-7fb2-463f-8d61-dc522f2b3a13"
      unitRef="U_USD">10895000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_4cc208aa-37a0-475e-9eb2-bc84a4d61b89"
      unitRef="U_USD">242000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_6ac980d4-e064-4ef7-a808-9748a5e22176"
      unitRef="U_USD">20294000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_dd7de99e-4e39-4968-88c2-fd3c4b3804f3"
      unitRef="U_USD">1179000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_e53b50fd-82bf-4967-a769-c5cca9a57140"
      unitRef="U_USD">1193000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_b29d2a7d-7132-4237-a9b3-194c173e1e38"
      unitRef="U_USD">345000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_05d86439-b904-452a-8371-c74e0f4fe7e1"
      unitRef="U_USD">19101000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_accc5487-7c3e-4059-bfbd-8a1c1752c012"
      unitRef="U_USD">834000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_90c4cc56-e66f-4080-93b1-9c96a6558b3d"
      unitRef="U_USD">20294000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_e87e6cd1-f653-4e33-a409-920e9c8263c7"
      unitRef="U_USD">1179000</us-gaap:FinanceLeaseLiability>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="C_e6e5f371-c876-4258-be9b-7f8411f4ff7e"
      id="F_873fc97c-d77d-4b49-9fc3-6f4208731867">&lt;p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 6&#x2014;Astellas Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On October 21, 2022 (the &#x201c;Effective Date&#x201d;), the Company entered into the Option Agreement (the &#x201c;Option Agreement&#x201d;) with Audentes Therapeutics, Inc. (d/b/a Astellas Gene Therapy)(&#x201c;Astellas&#x201d;), pursuant to which the Company granted to Astellas an exclusive option to obtain an exclusive, worldwide, royalty and milestone-bearing right and license (A) to research, develop, make, have made, use, sell, offer for sale, have sold, import, export and otherwise exploit, or, collectively, exploit, the product known, as of the Effective Date, as TSHA-120 (the &#x201c;120 GAN Product&#x201d;), and any backup products with respect thereto for use in the treatment of Giant Axonal Neuropathy (&#x201c;GAN&#x201d;) or any other gene therapy product for use in the treatment of GAN that is controlled by Taysha or any of its affiliates or with respect to which the Company or any of its affiliates controls intellectual property rights covering the exploitation thereof, or a GAN Product, and (B) under any intellectual property rights controlled by Taysha or any of its affiliates with respect to such exploitation (the &#x201c;GAN Option&#x201d;). Subject to certain extensions, the GAN Option was exercisable from the Effective Date through a specified period of time following Astellas&#x2019; receipt of (i) the formal minutes from the Type B end-of-Phase 2 meeting between Taysha and the FDA in response to the Company&#x2019;s meeting request sent to the FDA on September 19, 2022 for the 120 GAN Product (the &#x201c;Type B end-of-Phase 2 Meeting&#x201d;), (ii) all written feedback from the FDA with respect to the Type B end-of-Phase 2 Meeting, and (iii) all briefing documents sent by Taysha to the FDA with respect to the Type B end-of-Phase 2 Meeting.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Under the Option Agreement, the Company also granted to Astellas an exclusive option to obtain an exclusive, worldwide, royalty and milestone-bearing right and license (A) to exploit any Rett Product (as defined below), and (B) under any intellectual property rights controlled by Taysha or any of its affiliates with respect to such exploitation (the &#x201c;Rett Option,&#x201d; and together with the GAN Option, each, an &#x201c;Option&#x201d;). Subject to certain extensions, the Rett Option is exercisable from the Effective Date through a specified period of time following Astellas&#x2019; receipt of (i) certain clinical data from the female pediatric trial and (ii) certain specified data with respect to TSHA-102, such period, the Rett Option Period, related to (i) the product known, as of the Effective Date, as TSHA-102 and any backup products with respect thereto for use in the treatment of Rett syndrome, and (ii) any other gene therapy product for use in the treatment of Rett syndrome that is controlled by Taysha or any of its affiliates or with respect to which the Company or any of its affiliates controls intellectual property rights covering the exploitation thereof (a &#x201c;Rett Product&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The parties have agreed that, if Astellas exercises an Option, the parties will, for a specified period, negotiate a license agreement in good faith on the terms and conditions outlined in the Option Agreement, including payments by Astellas of a to be determined upfront payment, certain to be determined milestone payments, and certain to be determined royalties on net sales of GAN Products and/or Rett Products, as applicable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;During the Rett Option Period, the Company has agreed to (A) not solicit or encourage any inquiries, offers or proposals for, or that could reasonably be expected to lead to, a Change of Control (as defined in the Option Agreement), or (B) otherwise initiate a process for a potential Change of Control, in each case, without first notifying Astellas and offering Astellas the opportunity to submit an offer or proposal to the Company for a transaction that would result in a Change of Control. If Astellas fails or declines to submit any such offer within a specified period after the receipt of such notice, the Company will have the ability to solicit third party bids for a Change of Control transaction. If Astellas delivers an offer to the Company for a transaction that would result in a Change of Control, the Company and Astellas will attempt to negotiate in good faith the potential terms and conditions for such potential transaction that would result in a Change of Control for a specified period, which period may be shortened or extended by mutual agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As partial consideration for the rights granted to Astellas under the Option Agreement, Astellas paid the Company an upfront payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million (the &#x201c;Upfront Payment&#x201d;). Astellas or any of its affiliates shall have the right, in its or their discretion and upon written notice to the Company, to offset the amount of the Upfront Payment (in whole or in part, until the full amount of the Upfront Payment has been offset) against (a) any payment(s) owed to Taysha or any of its affiliates (or to any third party on behalf of the Company) under or in connection with any license agreement entered into with respect to any GAN Product or Rett Product, including, any upfront payment, milestone payment or royalties owed to Taysha or any of its affiliates (or to any third party on behalf of the Company) under or in connection with any such license agreement or (b) any amount owed to Taysha or any of its affiliates in connection with a Change of Control transaction with Astellas or any of its affiliates. As further consideration for the rights granted to Astellas under the Option Agreement, the Company and Astellas also entered into the Astellas Securities Purchase Agreement (as defined below).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Astellas Securities Purchase Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On October 21, 2022, the Company entered into a securities purchase agreement with Astellas (the &#x201c;Astellas Securities Purchase Agreement&#x201d; and, together with the Option Agreement, the &#x201c;Astellas Transactions&#x201d;), pursuant to which the Company agreed to issue and sell to Astellas in a private placement (the &#x201c;Astellas Private Placement&#x201d;), an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7,266,342&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares (the &#x201c;Astellas Private Placement Shares&#x201d;), of its common stock, for aggregate gross proceeds of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Astellas Private Placement closed on October 24, 2022. Pursuant to the Astellas Securities Purchase Agreement, in connection with the Astellas Private&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Placement, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Astellas has the right to designate one individual to attend all meetings of the Board in a non-voting observer capacity. The Company also granted Astellas certain registration rights with respect to the Astellas Private Placement Shares.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Accounting Treatment&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In October 2022, upon closing of the Astellas Private Placement and transferring the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7,266,342&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares to Astellas, the Company recorded the issuance of shares at fair value. Fair value of the shares transferred to Astellas was calculated in accordance with ASC 820, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Fair Value Measurement &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;by analyzing the Company&#x2019;s stock price for a short period of time prior to and after the transaction date as traded on the NASDAQ. The NASDAQ trading data is considered an active market and a Level 1 measurement under ASC 820. The fair value was determined to be approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;13.95&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million or $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.92&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per share. The $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;16.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million difference between the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million paid by Astellas and the fair market value of shares issued was allocated to the transaction price of the Option Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company determined that the Option Agreement falls within the scope of ASC 606, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; as the development of TSHA-102 for the treatment of Rett Syndrome and TSHA-120 for the treatment of GAN are considered ordinary activities for the Company. In accordance with ASC 606, the Company evaluated the Option Agreement and identified three separate performance obligations: (1) option to obtain licensing right to GAN, (2) option to obtain licensing right to Rett and (3) performance of research and development activities in the Rett development plan. The transaction price is determined to be $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;36.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million which is comprised of the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million Upfront Payment and the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;16.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million allocated from the Astellas Private Placement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;To determine the standalone selling price (&#x201c;SSP&#x201d;) of the Rett and GAN options, which the Company concluded to be material rights, the Company utilized the probability-weighted expected return (&#x201c;PWERM&#x201d;) method. The PWERM method contemplates the probability and timing of an option exercise. At contract inception, the Company estimated that the probability of exercise was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% for each of the GAN and Rett options. The SSP of the Rett research and development activities was estimated using an expected cost plus margin approach. The standalone selling prices of the material rights and Rett research and development activities were then used to proportionately allocate the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;36.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million transaction price to the three performance obligations. The $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;36.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million transaction price was recorded as deferred revenue on the condensed consolidated balance sheet at the inception of the Astellas Transactions.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the allocation of the transaction price to the three performance obligations at contract inception (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.653%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;"&gt;&lt;/td&gt;
        &lt;td style="width:29.288%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Transaction Price Allocation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Option to obtain license for Rett&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,485&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Option to obtain license for GAN&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Rett research and development activities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;28,257&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;36,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Revenue allocated to the material rights will be recognized at a point in time when each option period expires or when a decision is made by Astellas to exercise or not exercise each option. Revenue from the Rett research and development activities will be recognized as activities are performed using an input method, according to the costs incurred as related to the total costs expected to be incurred to satisfy the performance obligation. The transfer of control occurs over this time period and is a reliable measure of progress towards satisfying the performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;During the three and six months ended June 30, 2023, the Company determined that the total estimated costs to be incurred to satisfy the performance obligation associated with Rett research and development activities had increased from the cost estimate used for the year ended December 31, 2022, and the three months ended March 31, 2023. The cumulative impact of this change would have resulted in a $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million decrease related to revenue previously recognized based on prior cost estimates. Subsequent changes during the three months ended September 30, 2023 to total estimated costs were not material, and did not have a material impact on cumulative revenue earned.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company recognized revenue of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;9.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million from Rett research and development activities for the three and nine months ended September 30, 2023, respectively. In September 2023, Astellas provided written notice of its decision not to exercise the GAN Option. The Company recognized revenue of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million from the GAN Option during the three and nine months ended September 30, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of September 30, 2023, the Company recorded deferred revenue of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;18.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million within current liabilities and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million within long-term liabilities in the accompanying consolidated balance sheet. The Company will recognize revenues for these performance obligations as they are satisfied.&lt;/span&gt;&lt;/p&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <tsha:UpfrontPayment
      contextRef="C_41f81af9-f063-4fcb-9aee-fe6cb9bc2fc8"
      decimals="-5"
      id="F_9e14ae18-f2a5-4d76-95e4-2edd9b70d236"
      unitRef="U_USD">20000000</tsha:UpfrontPayment>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_879840b7-9535-4ff6-b76f-43c8c0b8f843"
      decimals="0"
      id="F_4538443d-15bb-4d72-8170-f6925356956f"
      unitRef="U_shares">7266342</us-gaap:CommonStockSharesIssued>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_386d4b0c-dbb1-4cd6-9f1e-31bdfd623c2f"
      decimals="-5"
      id="F_f762dc07-d5b8-43c2-876e-79afd877fcd8"
      unitRef="U_USD">30000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_1004e87a-1fce-46e3-ac6d-39787b2f2454"
      decimals="0"
      id="F_24f53afe-d516-4da1-a031-5a59442c2c5e"
      unitRef="U_shares">7266342</us-gaap:CommonStockSharesIssued>
    <tsha:FairValueOfSharesTransferredValue
      contextRef="C_15407518-9c8f-475c-9932-cccfb6f73f94"
      decimals="-4"
      id="F_7972229e-0f27-420b-9fa6-aabfb04446da"
      unitRef="U_USD">13950000</tsha:FairValueOfSharesTransferredValue>
    <us-gaap:SharePrice
      contextRef="C_1004e87a-1fce-46e3-ac6d-39787b2f2454"
      decimals="2"
      id="F_a2aee87b-b2e0-4f2c-8138-a759608ecded"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.92</us-gaap:SharePrice>
    <tsha:TransactionPrice
      contextRef="C_15407518-9c8f-475c-9932-cccfb6f73f94"
      decimals="-5"
      id="F_e5814aad-872e-4425-b94c-8072ef5fd8d7"
      unitRef="U_USD">16100000</tsha:TransactionPrice>
    <tsha:DifferenceOfMarketValuePaid
      contextRef="C_15407518-9c8f-475c-9932-cccfb6f73f94"
      decimals="-5"
      id="F_388de720-b97b-47d3-9012-a646047fbdb8"
      unitRef="U_USD">30000000</tsha:DifferenceOfMarketValuePaid>
    <tsha:TransactionPrice
      contextRef="C_be79abbe-9cb7-450a-89c0-09810beac69c"
      decimals="-5"
      id="F_123427fc-7bea-4119-985d-77a0949900d6"
      unitRef="U_USD">36100000</tsha:TransactionPrice>
    <tsha:UpfrontPayment
      contextRef="C_be79abbe-9cb7-450a-89c0-09810beac69c"
      decimals="-5"
      id="F_c2a9e23e-289d-42ab-8e28-3c62a2fb2533"
      unitRef="U_USD">20000000</tsha:UpfrontPayment>
    <tsha:TransactionPrice
      contextRef="C_7a0ba426-b372-4bb2-a6ce-f8a55df6817b"
      decimals="-5"
      id="F_dc0fac12-b1cb-4cc9-b7ec-07d8a42e7cb8"
      unitRef="U_USD">16100000</tsha:TransactionPrice>
    <tsha:ProbabilityOfAnOptionExercise
      contextRef="C_24c41917-d26a-4624-8e85-a10244e4a9a4"
      decimals="2"
      id="F_3b9f8e35-53a3-4faf-95f7-6fd46a129f18"
      unitRef="U_pure">0.50</tsha:ProbabilityOfAnOptionExercise>
    <tsha:TransactionPrice
      contextRef="C_ded5d2d0-56e4-4b8d-b636-71c37d47e597"
      decimals="-5"
      id="F_4db9ea2c-969c-4901-ad4f-a411aea34860"
      unitRef="U_USD">36100000</tsha:TransactionPrice>
    <us-gaap:DeferredRevenue
      contextRef="C_9ddff924-68e1-4fa1-9bb2-4276e2baedd2"
      decimals="-5"
      id="F_b5dbb0b5-6bf3-4776-96b7-aba1ec52ce4b"
      unitRef="U_USD">36100000</us-gaap:DeferredRevenue>
    <tsha:SummaryOfTransactionPriceAllocationTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_6473d355-9a3c-4637-88ed-eacff20a89e8">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the allocation of the transaction price to the three performance obligations at contract inception (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.653%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;"&gt;&lt;/td&gt;
        &lt;td style="width:29.288%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.02%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Transaction Price Allocation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Option to obtain license for Rett&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,485&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Option to obtain license for GAN&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Rett research and development activities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;28,257&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;36,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</tsha:SummaryOfTransactionPriceAllocationTableTextBlock>
    <tsha:TransactionPrice
      contextRef="C_287d5758-9445-46a9-a9b4-4f0e72d6bc05"
      decimals="-3"
      id="F_0adfb1f0-7878-46af-a10d-0556f1a58ba3"
      unitRef="U_USD">5485000</tsha:TransactionPrice>
    <tsha:TransactionPrice
      contextRef="C_ffe2668b-14a2-48c0-b393-270f102a3ad6"
      decimals="-3"
      id="F_5b9b4855-88ba-4a21-9d78-daf26ab1a611"
      unitRef="U_USD">2317000</tsha:TransactionPrice>
    <tsha:TransactionPrice
      contextRef="C_9be26314-5dbf-4dea-ac67-93410907efad"
      decimals="-3"
      id="F_83fd814f-4f75-4132-8b02-1706cc4a83da"
      unitRef="U_USD">28257000</tsha:TransactionPrice>
    <tsha:TransactionPrice
      contextRef="C_e6e5f371-c876-4258-be9b-7f8411f4ff7e"
      decimals="-3"
      id="F_be7c5311-2478-47b3-8300-5817643b6f41"
      unitRef="U_USD">36059000</tsha:TransactionPrice>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_c883f68e-7f40-4df1-9893-6348c141e5e9"
      decimals="-5"
      id="F_48083b02-7224-4cbf-8374-765028641971"
      unitRef="U_USD">3100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_40e64b85-0bd6-43d7-85ac-e8176005098e"
      decimals="-5"
      id="F_52fd2d46-5af0-4d7c-85d7-f88525ce9b3c"
      unitRef="U_USD">3100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:Revenues
      contextRef="C_d6b67c53-c7b5-4cb3-a237-27c8b3f18659"
      decimals="-5"
      id="F_7aca2aeb-936b-4f85-8e28-aca07621984d"
      unitRef="U_USD">2400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_5248d7d9-3cd0-4735-865f-dda80ba32b79"
      decimals="-5"
      id="F_bdedd799-28be-400a-83db-6f87a49ac62b"
      unitRef="U_USD">9500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_cf8b3b2d-3381-4c33-97b3-0a49e5fa0576"
      decimals="-5"
      id="F_a4a114f3-11e0-45d7-85d2-f80ec8981104"
      unitRef="U_USD">2300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_72ee41ab-a948-4033-acce-533b6eca774e"
      decimals="-5"
      id="F_aad91a8a-04c4-48a6-95d4-5d2448e68c11"
      unitRef="U_USD">2300000</us-gaap:Revenues>
    <us-gaap:DeferredRevenueCurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-5"
      id="F_0c3c38b8-4255-440b-bb01-c60a43b2abfe"
      unitRef="U_USD">18800000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-5"
      id="F_dd6c2d76-f911-40c2-b21b-f2f39f138cdb"
      unitRef="U_USD">3000000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_9e335a34-b9cb-4ffe-b076-01db55fd8b7e">&lt;p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 7&#x2014;Loan with Silicon Valley Bank	&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On August 12, 2021 (the &#x201c;Closing Date&#x201d;), the Company entered into a Loan and Security Agreement (the &#x201c;Term Loan Agreement&#x201d;), by and among the Company, the lenders party thereto from time to time (the &#x201c;Lenders&#x201d;) and Silicon Valley Bank, as administrative agent and collateral agent for the Lenders (&#x201c;Agent&#x201d;). The Term Loan Agreement provided for (i) on the Closing Date, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;40.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million aggregate principal amount of term loans available through &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, (ii) from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;January 1, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; until &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, an additional $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million term loan facility available at the Company&#x2019;s option upon having &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; distinct and active clinical stage programs, determined at the discretion of the Agent, at the time of draw, (iii) from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;October 1, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; until &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;March 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, an additional $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million term loan facility available at the Company&#x2019;s option upon having &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; distinct and active clinical stage programs, determined at the discretion of the Agent, at the time of draw and (iv) from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;April 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; until &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, an additional $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million term loan facility available upon approval by the Agent and the Lenders (collectively, the &#x201c;Term Loans&#x201d;). The Company drew $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million in term loans on the Closing Date and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million in term loans in December 2021. The Company did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;t draw on the two additional $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million tranches prior to expiration on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;March 31, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The interest rate applicable to the Term Loans was the greater of (a) the WSJ (&#x201c;Wall Street Journal&#x201d;) Prime Rate plus &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% or (b) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% per annum. The Term Loans were interest only from the Closing Date through August 31, 2024, after which the Company was required to pay equal monthly installments of principal through &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;August 1, 2026&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, the maturity date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Term Loans could have been prepaid in full through August 12, 2023, with payment of a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% prepayment premium, after which they could be prepaid in full with no prepayment premium. An additional final payment of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of the amount of Terms Loans advanced by the Lenders (&#x201c;Exit Fee&#x201d;) was due upon prepayment or repayment of the Term Loans in full. The Exit Fee of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million was recorded as debt discount and has also been fully accrued within non-current liabilities as of September 30, 2023. The debt discount was being accreted using the effective interest method over the term of the Term Loans within interest expense in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The obligations under the Term Loan Agreement were secured by a perfected security interest in all of the Company&#x2019;s assets except for intellectual property and certain other customarily excluded property pursuant to the terms of the Term Loan Agreement. There were no financial covenants and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; warrants associated with the Term Loan Agreement. The Term Loan Agreement contained various covenants that limited the Company&#x2019;s ability to engage in specified types of transactions without the consent of the Lenders which included, among others, incurring or assuming certain debt; merging, consolidating or acquiring all or substantially all of the capital stock or property of another entity; changing the nature of the Company&#x2019;s business; changing the Company&#x2019;s organizational structure or type; licensing, transferring or disposing of certain assets; granting certain types of liens on the Company&#x2019;s assets; making certain investments; and paying cash dividends.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Term Loan Agreement also contained customary representations and warranties, and also included customary events of default, including payment default, breach of covenants, change of control, and material adverse effects. The Company was in compliance with all covenants under the Term Loan Agreement as of September 30, 2023. Upon the occurrence of an event of default, a default interest rate of an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% per annum could have been applied to the outstanding loan balances, and the Lenders could have declared all outstanding obligations immediately due and payable and exercised all of its rights and remedies as set forth in the Term Loan Agreement and under applicable law.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;During the three and nine months ended September 30, 2023, the Company recognized interest expense related to the Term Loan &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; mi&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;llion and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively. During the three and nine months ended September 30, 2022, the Company recognized interest expense related to the Term Loan of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Future principal debt payments on the loan payable as of September 30, 2023 are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:83.83%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.801%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.369%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Year Ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;20,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;13,333&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total principal payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Unamortized debt discount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Term Loan, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;38,548&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Term Loan is considered long-term debt because it has been refinanced on a long-term basis, subsequent to September 30, 2023 but before the issuance of these condensed consolidated financial statements, using the proceeds of the Trinity Term Loan Agreement (as defined in Note 16).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On March 10, 2023, Silicon Valley Bank, based in Santa Clara, California, was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) as receiver. On March 27, 2023, First Citizens Bank purchased the remaining assets, deposits and loans of Silicon Valley Bank. As a result, the portion of the Company&#x2019;s term loans previously held by Silicon Valley Bank is now held by Silicon Valley Bank as a division of First-Citizen&#x2019;s Bank &amp;amp; Trust Company. The remaining portion of the Company&#x2019;s term loans are still held by SVB Capital, which is currently in bankruptcy proceedings.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_01b23b59-342a-4659-a799-48ef1e2fa7a6"
      decimals="-5"
      id="F_305658ad-cc4a-4d04-8822-de0863c817c7"
      unitRef="U_USD">40000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_7b453598-4699-4830-9fe7-728f5848fb84"
      id="F_ebc49b91-cc3c-456e-9fc8-80a4549b14aa">2021-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDateRangeStart1
      contextRef="C_5f9fb3b0-fe97-419b-bdc6-be3820e2ea68"
      id="F_40de76cc-5eea-4bea-8808-f7256b2b0e85">2022-01-01</us-gaap:DebtInstrumentMaturityDateRangeStart1>
    <us-gaap:DebtInstrumentMaturityDateRangeEnd1
      contextRef="C_5f9fb3b0-fe97-419b-bdc6-be3820e2ea68"
      id="F_33d58575-c7a2-4f31-a252-7df69f54faba">2022-09-30</us-gaap:DebtInstrumentMaturityDateRangeEnd1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_56aba35a-c830-45c9-adb0-37ddf0bc7d62"
      decimals="-5"
      id="F_5b54960e-87fb-4fb6-9540-bb2e3b647840"
      unitRef="U_USD">20000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <tsha:NumberOfDistinctAndActiveClinicalStage
      contextRef="C_5f9fb3b0-fe97-419b-bdc6-be3820e2ea68"
      decimals="INF"
      id="F_05b502fe-b6a9-4a90-957f-a48ea434b728"
      unitRef="U_Program">3</tsha:NumberOfDistinctAndActiveClinicalStage>
    <us-gaap:DebtInstrumentMaturityDateRangeStart1
      contextRef="C_247c1361-9891-4d77-8855-fdadd0f3d730"
      id="F_4e2b5bee-826b-493d-b99c-9dd3bcf9c671">2022-10-01</us-gaap:DebtInstrumentMaturityDateRangeStart1>
    <us-gaap:DebtInstrumentMaturityDateRangeEnd1
      contextRef="C_247c1361-9891-4d77-8855-fdadd0f3d730"
      id="F_74c17aae-e175-466a-a98d-62ce7f9ecde6">2023-03-31</us-gaap:DebtInstrumentMaturityDateRangeEnd1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_0f464446-8753-4ba1-9363-45ea238784a0"
      decimals="-5"
      id="F_32dbd640-5a09-4dcc-a8b7-fa7325f2204b"
      unitRef="U_USD">20000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <tsha:NumberOfDistinctAndActiveClinicalStage
      contextRef="C_247c1361-9891-4d77-8855-fdadd0f3d730"
      decimals="INF"
      id="F_71607e46-d1b1-4d45-953f-d0571982c6da"
      unitRef="U_Program">3</tsha:NumberOfDistinctAndActiveClinicalStage>
    <us-gaap:DebtInstrumentMaturityDateRangeStart1
      contextRef="C_5e5e45fa-c545-46e3-838a-10c5bb7a8a1d"
      id="F_7a6603fa-161f-4ac0-bb94-a0111fc2ab27">2023-04-01</us-gaap:DebtInstrumentMaturityDateRangeStart1>
    <us-gaap:DebtInstrumentMaturityDateRangeEnd1
      contextRef="C_5e5e45fa-c545-46e3-838a-10c5bb7a8a1d"
      id="F_2a77a0a5-3c25-46fb-8da5-d899817ad0ec">2023-12-31</us-gaap:DebtInstrumentMaturityDateRangeEnd1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_268fe9ab-86f1-47ea-8103-b41a53f40e03"
      decimals="-5"
      id="F_33a7b2ad-6de7-4631-82af-167a1d8aea1a"
      unitRef="U_USD">20000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="C_b40906ab-540f-4d66-babc-185d6edc1657"
      decimals="-5"
      id="F_729672f8-c8b8-4d4f-9d5e-35093ff52314"
      unitRef="U_USD">30000000.0</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="C_6b959717-546d-4082-a216-54b72a00c5df"
      decimals="-5"
      id="F_18890225-77c5-45b5-8696-84e8fe413800"
      unitRef="U_USD">10000000.0</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <tsha:ProceedsFromTermLoan
      contextRef="C_3d602e83-3144-42f0-b3b2-264b04cf5dbb"
      decimals="0"
      id="F_01b256c4-a4a8-4575-89ef-9fc46082381b"
      unitRef="U_USD">0</tsha:ProceedsFromTermLoan>
    <tsha:ProceedsFromTermLoan
      contextRef="C_5063c218-0805-481c-bd11-cdcf2eae0406"
      decimals="0"
      id="F_81e44b8f-cf66-4880-bc6b-c92745c5202e"
      unitRef="U_USD">0</tsha:ProceedsFromTermLoan>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_2c7a64a4-5c6c-45c0-a89a-29ee6d67a457"
      decimals="-5"
      id="F_f82a132f-2eec-465f-873d-8b6ae88eeb63"
      unitRef="U_USD">20000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_6fdb1bde-2709-45b1-a9e2-787a87ee5614"
      decimals="-5"
      id="F_4ca15537-a718-4d7b-9db2-61ce1c8a2972"
      unitRef="U_USD">20000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentMaturityDateRangeEnd1
      contextRef="C_3d602e83-3144-42f0-b3b2-264b04cf5dbb"
      id="F_77742d47-ad35-4962-a738-44d717d3790f">2022-09-30</us-gaap:DebtInstrumentMaturityDateRangeEnd1>
    <us-gaap:DebtInstrumentMaturityDateRangeEnd1
      contextRef="C_5063c218-0805-481c-bd11-cdcf2eae0406"
      id="F_91282fb7-95ea-463f-8b13-233507214c33">2023-03-31</us-gaap:DebtInstrumentMaturityDateRangeEnd1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_2453238f-62d1-4664-a753-3e1fa2683010"
      decimals="4"
      id="F_f9bdbb9e-61c7-4f1c-97c2-f4ab0216728b"
      unitRef="U_pure">0.0375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_ebb6d69e-99d0-4437-b8b8-87ca448aa0d2"
      decimals="INF"
      id="F_b1e85a80-3c3e-4cee-a941-cfae7b344b49"
      unitRef="U_pure">0.0700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_349ea30b-6a31-4c2d-af3c-94a43b0e6e4e"
      id="F_0056571b-d3cb-4081-bc28-5988ed7bc695">2026-08-01</us-gaap:DebtInstrumentMaturityDate>
    <tsha:PercentageOfPrepaymentPremium
      contextRef="C_41099a59-f81f-47bf-96a8-c4997b89b7b2"
      decimals="4"
      id="F_00a6c529-90fe-4571-ab9f-ed121ecd3bc0"
      unitRef="U_pure">0.0100</tsha:PercentageOfPrepaymentPremium>
    <tsha:PercentageOfPrepaymentOfFacility
      contextRef="C_349ea30b-6a31-4c2d-af3c-94a43b0e6e4e"
      decimals="3"
      id="F_e5329074-01c5-4b18-b666-ba1c3fea4941"
      unitRef="U_pure">0.075</tsha:PercentageOfPrepaymentOfFacility>
    <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-5"
      id="F_e3d7ae0a-fe18-40a5-8bfb-2d77ae36a79a"
      unitRef="U_USD">3000000</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_ebb6d69e-99d0-4437-b8b8-87ca448aa0d2"
      decimals="-3"
      id="F_10f90984-82f8-4822-86cd-82487fe33831"
      unitRef="U_USD">0</us-gaap:WarrantsAndRightsOutstanding>
    <tsha:PercentageOfAnnualDefaultInterestRate
      contextRef="C_349ea30b-6a31-4c2d-af3c-94a43b0e6e4e"
      decimals="2"
      id="F_d02d091d-d93a-45f0-bd1f-967fdc6f9ce9"
      unitRef="U_pure">0.05</tsha:PercentageOfAnnualDefaultInterestRate>
    <us-gaap:InterestExpenseLongTermDebt
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-5"
      id="F_c98a9017-2b11-4950-aaec-7c4a5305ca07"
      unitRef="U_USD">1400000</us-gaap:InterestExpenseLongTermDebt>
    <us-gaap:InterestExpenseLongTermDebt
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-5"
      id="F_dac8474d-466d-4f62-ba5b-e30167d402f8"
      unitRef="U_USD">4200000</us-gaap:InterestExpenseLongTermDebt>
    <us-gaap:InterestExpenseLongTermDebt
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-5"
      id="F_55528caa-1777-4e8a-b308-67b5c7f7dab2"
      unitRef="U_USD">1100000</us-gaap:InterestExpenseLongTermDebt>
    <us-gaap:InterestExpenseLongTermDebt
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-5"
      id="F_1a9b1afa-67cc-4ee5-a583-3a1b272f1381"
      unitRef="U_USD">2500000</us-gaap:InterestExpenseLongTermDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_f2451d69-ce4e-464f-965f-c679f4bfb06f">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Future principal debt payments on the loan payable as of September 30, 2023 are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:83.83%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.801%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.369%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Year Ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;20,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;13,333&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total principal payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;40,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Unamortized debt discount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,452&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Term Loan, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;38,548&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_82ffae77-c327-4bbc-8534-fa00a1d2c793"
      unitRef="U_USD">6667000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_ffc8c6dc-b8a2-4be0-a0d7-1b4b05220337"
      unitRef="U_USD">20000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_01ec527c-c98d-4bf3-807a-baec23eaa47c"
      unitRef="U_USD">13333000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_7bcb53c4-d7a2-4c05-9b20-14ddc5859e91"
      unitRef="U_USD">40000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_79767910-1412-48cd-b3da-351edff13bf8"
      unitRef="U_USD">1452000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_ac945a17-d09a-4e8c-adaa-74ab90cfda76"
      unitRef="U_USD">38548000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_08c3790e-b980-43ee-a82d-e811b3fa3289">&lt;p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 8&#x2014;Research, Collaboration and License Agreements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;UT Southwestern Agreement&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On November 19, 2019, the Company entered into a research, collaboration and license agreement (&#x201c;UT Southwestern Agreement&#x201d;) with the Board of Regents of the University of Texas System on behalf of The University of Texas Southwestern Medical Center (&#x201c;UT Southwestern&#x201d;). Under the UT Southwestern Agreement, UT Southwestern is primarily responsible for preclinical development activities with respect to licensed products for use in certain specified indications (up to investigational new drug application-enabling studies), and the Company is responsible for all subsequent clinical development and commercialization activities with respect to the licensed products. UT Southwestern will conduct such preclinical activities for a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;two-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; period under mutually agreed upon sponsored research agreements that were entered into beginning in April 2020. During the initial research phase, the Company has the right to expand the scope of specified indications under the UT Southwestern Agreement.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In connection with the UT Southwestern Agreement, the Company obtained an exclusive, worldwide, royalty-free license under certain patent rights of UT Southwestern and a non-exclusive, worldwide, royalty-free license under certain know-how of UT Southwestern, in each case to make, have made, use, sell, offer for sale and import licensed products for use in certain specified indications. Additionally, the Company obtained a non-exclusive, worldwide, royalty-free license under certain patents and know-how of UT Southwestern for use in all human uses, with a right of first refusal to obtain an exclusive license under certain of such patent rights and an option to negotiate an exclusive license under other of such patent rights. The Company is required to use commercially reasonable efforts to develop, obtain regulatory approval for, and commercialize at least &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; licensed product.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On April 2, 2020, the Company amended the UT Southwestern Agreement to include the addition of another licensed product and certain indications, and a right of first refusal to the Company over certain patient dosing patents. No additional consideration was transferred in connection with this amendment. In March 2022, the Company and UT Southwestern mutually agreed to revise the payment schedules and current performance expectations of the current sponsored research agreements under the UT Southwestern Agreement and defer payments by fifteen months.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The UT Southwestern Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last valid claim of a licensed patent in such country for such licensed product. After the initial research term, the Company may terminate the agreement, on an indication-by-indication and licensed product-by-licensed product basis, at any time upon specified written notice to UT Southwestern. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In November 2019, as partial consideration for the license rights granted under the UT Southwestern Agreement, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,179,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of its common stock, or &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of its then outstanding fully-diluted common stock, to UT Southwestern. The Company does not have any future milestone or royalty obligations to UT Southwestern under the UT Southwestern Agreement other than costs related to maintenance of patents.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Abeona CLN1 Agreements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In August 2020, the Company entered into license and inventory purchase agreements (collectively, the &#x201c;Abeona Agreements&#x201d;) with Abeona Therapeutics Inc. (&#x201c;Abeona&#x201d;) for worldwide exclusive rights to certain intellectual property rights and know-how relating to the research, development and manufacture of ABO-202, an AAV-based gene therapy for CLN1 disease (also known as infantile Batten disease). Under the terms of the Abeona Agreements, the Company made initial cash payments to Abeona of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million for the license fee and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million for purchase of clinical materials and reimbursement for previously incurred development costs in October 2020. In exchange for the license rights, the Company recorded an aggregate of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million within research and development expenses in the consolidated statements of operations for the year ended December 31, 2020, since the acquired license or acquired inventory do not have an alternative future use. The Company is obligated to make up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million in regulatory-related milestones and up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million in sales-related milestones per licensed CLN1 product. The Company will also pay an annual earned royalty in the high single digits on net sales of any licensed CLN1 products. The license agreement with Abeona (the &#x201c;Abeona License Agreement&#x201d;) expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the Abeona License Agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the Abeona License Agreement for convenience upon specified prior written notice to Abeona.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In December 2021, a regulatory milestone was triggered in connection with this agreement and therefore the Company recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million within research and development expenses in the consolidated statements of operations for the year ended December 31, 2021. The milestone fee was paid in January 2022 and classified as an investing cash outflow in the condensed consolidated statements of cash flows for the nine months ended September 30, 2022. No additional milestone payments were made or triggered in connection with this agreement during the nine months ended September 30, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Abeona Rett Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On October 29, 2020, the Company entered into a license agreement (the &#x201c;Abeona Rett Agreement&#x201d;) with Abeona pursuant to which the Company obtained an exclusive, worldwide, royalty-bearing license, with the right to grant sublicenses under certain patents, know-how and materials originally developed by the University of North Carolina at Chapel Hill, the University of Edinburgh and Abeona to research, develop, manufacture, have manufactured, use, and commercialize licensed products for gene therapy and the use of related transgenes for Rett syndrome.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Subject to certain obligations of Abeona, the Company is required to use commercially reasonable efforts to develop at least one licensed product and commercialize at least one licensed product in the United States.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In connection with the Abeona Rett Agreement, the Company paid Abeona a one-time upfront license fee of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million which was recorded in research and development expenses in the consolidated statements of operations for the year ended December 31, 2020, since the acquired license does not have an alternative future use. The Company is obligated to pay Abeona up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million in regulatory-related milestones and up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million in sales-related milestones per licensed Rett product and high single-digit royalties on net sales of licensed Rett products. Royalties are payable on a licensed product-by-licensed product and country-by-country basis until the latest of the expiration or revocation or complete rejection of the last licensed patent covering such licensed product in the country where the licensed product is sold, the loss of market exclusivity in such country where the product is sold, or, if no licensed product exists in such country and no market exclusivity exists in such country, ten years from first commercial sale of such licensed product in such country.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Abeona Rett Agreement expires on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last royalty term of a licensed product. Either party may terminate the agreement upon an uncured material breach of the agreement or insolvency of the other party. The Company may terminate the agreement for convenience upon specified prior written notice to Abeona.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In March 2022, the Company&#x2019;s clinical trial application (&#x201c;CTA&#x201d;) filing for TSHA-102 for the treatment of Rett Syndrome was approved by Health Canada and therefore triggered a regulatory milestone payment in connection with the Abeona Rett Agreement. The Company recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million within research and development expenses in the condensed consolidated statements of operations for the nine months ended September 30, 2022. The $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million regulatory milestone fee was paid in July 2022. In May 2023, the Company dosed the first patient with TSHA-102 in the Phase 1/2 REVEAL trial evaluating the safety and preliminary efficacy of TSHA-102 in adult patients with Rett syndrome and therefore triggered a milestone payment in connection with the Abeona Rett Agreement. The Company recorded $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;within research and development expenses in the condensed consolidated statements of operations for the nine months ended September 30, 2023. This milestone fee was paid in August 2023 and classified as an investing cash outflow in the condensed consolidated statements of cash flows for the nine months ended September 30, 2023. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; additional milestone payments were made or triggered in connection with the Abeona Rett Agreement during the nine months ended September 30, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Acquisition of Worldwide Rights for TSHA-120 for the treatment of GAN&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In March 2021, the Company acquired the exclusive worldwide rights to a clinical-stage AAV9 gene therapy program, now known as TSHA-120, for the treatment of GAN. TSHA-120 is an intrathecally dosed AAV9 gene therapy currently being evaluated in a clinical trial for the treatment of GAN. The trial is being conducted by the National Institutes of Health (&#x201c;NIH&#x201d;) in close collaboration with a leading patient advocacy group focused on finding treatments and cures for GAN. TSHA-120 has received rare pediatric disease and orphan drug designations from the U.S. Food and Drug Administration for the treatment of GAN. The worldwide rights were acquired through a license agreement, effective March 29, 2021, between Hannah&#x2019;s Hope Fund for Giant Axonal Neuropathy, Inc. (&#x201c;HHF&#x201d;) and the Company (the &#x201c;GAN Agreement&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Under the terms of the GAN Agreement, in exchange for granting the Company the exclusive worldwide rights to TSHA-120, HHF received an upfront payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and will be eligible to receive clinical, regulatory and commercial milestones totaling up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;19.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, as well as a low, single-digit royalty on net sales upon commercialization of the product. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; additional milestone payments were made or triggered in connection with the GAN Agreement during the nine months ended September 30, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;License Agreement for CLN7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In March 2022, the Company entered into a license agreement with UT Southwestern (the &#x201c;CLN7 Agreement&#x201d;) pursuant to which the Company obtained an exclusive worldwide, royalty-bearing license with right to grant sublicenses to develop, manufacture, use, and commercialize licensed products for gene therapy for CLN7, a form of Batten Disease. In connection with the CLN7 Agreement, the Company paid a one-time upfront license fee of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million. The Company recorded the upfront license fee in research and development expense in the condensed consolidated statements of operations since the acquired license does not have an alternative future use. The Company is obligated to pay UT Southwestern up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million in regulatory-related milestones and up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million in sales-related milestones, as well as a low, single-digit royalty on net sales upon commercialization of the product. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; additional milestone payments were made or triggered in connection with the CLN7 Agreement during the nine months ended September 30, 2023.&lt;/span&gt;&lt;/p&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <tsha:PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements
      contextRef="C_8bc60dc0-3547-4346-8f8c-627b12b9404c"
      id="F_f7b63a28-c457-4eae-9f82-f4c3ae43af69">P2Y</tsha:PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements>
    <tsha:MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize
      contextRef="C_8bc60dc0-3547-4346-8f8c-627b12b9404c"
      decimals="INF"
      id="F_6db483e6-b714-424b-9970-81878f495a48"
      unitRef="U_Product">1</tsha:MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_5142e56d-a1ef-405d-ada4-47c2a8ad2e32"
      decimals="0"
      id="F_724cf76a-a7e0-4608-b438-ad2e26678ce3"
      unitRef="U_shares">2179000</us-gaap:CommonStockSharesIssued>
    <tsha:PercentageOfFullyDilutedCommonStockSharesOutstanding
      contextRef="C_5142e56d-a1ef-405d-ada4-47c2a8ad2e32"
      decimals="2"
      id="F_3a200027-7c12-437a-be39-e883c1c446d7"
      unitRef="U_pure">0.20</tsha:PercentageOfFullyDilutedCommonStockSharesOutstanding>
    <tsha:PaymentOfLicenseFee
      contextRef="C_fe9362b3-8b1b-412f-a9cb-c0083a836950"
      decimals="-5"
      id="F_cf5a9166-2a0a-43e0-bb05-c0c038e7021b"
      unitRef="U_USD">3000000.0</tsha:PaymentOfLicenseFee>
    <tsha:PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts
      contextRef="C_fb426d7d-a58c-4a86-b783-cad0e1d55c63"
      decimals="-5"
      id="F_67df01a7-b473-4c29-8b39-af011792cac0"
      unitRef="U_USD">4000000.0</tsha:PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_d38e6bea-f6ec-49da-b364-707ab055ad3c"
      decimals="-5"
      id="F_6b902e6a-fa9c-48bd-b78a-bda0bf06949c"
      unitRef="U_USD">7000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <tsha:LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment
      contextRef="C_eda542a6-c47a-464c-9bfb-8cc6ae934ce2"
      decimals="INF"
      id="F_08843b8f-1043-4250-8502-dea516eadb19"
      unitRef="U_USD">26000000.0</tsha:LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment>
    <tsha:LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment
      contextRef="C_eda542a6-c47a-464c-9bfb-8cc6ae934ce2"
      decimals="INF"
      id="F_95f9c2f9-6e45-4bcc-941f-af4cf4f31662"
      unitRef="U_USD">30000000.0</tsha:LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_386cd9a0-f7f8-4dec-8608-31eb57cc80ff"
      decimals="-5"
      id="F_c1ef85d0-2862-494d-9d82-14437214b218"
      unitRef="U_USD">3000000</us-gaap:ResearchAndDevelopmentExpense>
    <tsha:PaymentOfOneTimeUpfrontLicenseFee
      contextRef="C_fc047aed-6e3c-4d6e-8708-d9135d555669"
      decimals="-5"
      id="F_3d2cf173-5f11-40a5-8eaa-e5f706ccd103"
      unitRef="U_USD">3000000.0</tsha:PaymentOfOneTimeUpfrontLicenseFee>
    <tsha:RegulatoryRelatedMilestonesObligationPayable
      contextRef="C_ecf42b20-4d10-4df6-8173-984ab0bc4b7a"
      decimals="INF"
      id="F_47e60a4b-7e5f-41a5-9501-4462406da6fc"
      unitRef="U_USD">26500000</tsha:RegulatoryRelatedMilestonesObligationPayable>
    <tsha:SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable
      contextRef="C_ecf42b20-4d10-4df6-8173-984ab0bc4b7a"
      decimals="INF"
      id="F_faed1faa-b08e-4697-9b17-89ee6a88490a"
      unitRef="U_USD">30000000.0</tsha:SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_b930a776-4755-4d30-be4d-477d007415b3"
      decimals="-5"
      id="F_7505dfd7-ab06-4e36-a8ed-0339a4418699"
      unitRef="U_USD">1000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <tsha:RegulatoryMilestoneFeePaid
      contextRef="C_f68841e2-9812-4928-9cd8-bc1e4d7385dd"
      decimals="-5"
      id="F_7c88b796-fca6-4ce3-aea7-8eeb24e4c6c5"
      unitRef="U_USD">1000000.0</tsha:RegulatoryMilestoneFeePaid>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_85b1368b-9750-457e-87f0-e98f7d80ece8"
      decimals="-5"
      id="F_4eafcc20-9b15-4aee-ab71-281b01b14af5"
      unitRef="U_USD">3500000</us-gaap:ResearchAndDevelopmentExpense>
    <tsha:AdditionalMilestonePayments
      contextRef="C_85b1368b-9750-457e-87f0-e98f7d80ece8"
      decimals="INF"
      id="F_f732e8d9-a4d6-47e5-a8cf-a9047f355f5f"
      unitRef="U_USD">0</tsha:AdditionalMilestonePayments>
    <tsha:UpfrontPayment
      contextRef="C_a19561be-07c5-4bcb-9000-74a3fb2fa74a"
      decimals="-5"
      id="F_82d0f882-b02b-4552-ab7f-f4a4d27dcbb2"
      unitRef="U_USD">5500000</tsha:UpfrontPayment>
    <tsha:ClinicalRegulatoryAndCommercialMilestonesToBeReceived
      contextRef="C_c50b3cb1-c0e2-4765-8d8d-617b504675a8"
      decimals="-5"
      id="F_ad1c0d18-7f9f-4d9a-968f-21112e098464"
      unitRef="U_USD">19300000</tsha:ClinicalRegulatoryAndCommercialMilestonesToBeReceived>
    <tsha:AdditionalMilestonePayments
      contextRef="C_c46c3bce-3fb6-4de8-b570-c0f54c0a4d18"
      decimals="INF"
      id="F_3d8f05e2-660c-4da4-9319-4b22454ef055"
      unitRef="U_USD">0</tsha:AdditionalMilestonePayments>
    <tsha:PaymentOfOneTimeUpfrontLicenseFee
      contextRef="C_afe869c3-1801-4581-a6f5-b8768beaf0e4"
      decimals="-5"
      id="F_3fcb6dc6-ca1b-425b-87e5-dc7555cf5645"
      unitRef="U_USD">300000</tsha:PaymentOfOneTimeUpfrontLicenseFee>
    <tsha:LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable
      contextRef="C_9f8d2f91-99fe-4b86-b976-930ef584b76d"
      decimals="-5"
      id="F_aac0c73c-c07c-402b-a7f3-6b00f720197c"
      unitRef="U_USD">7700000</tsha:LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable>
    <tsha:LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable
      contextRef="C_9f8d2f91-99fe-4b86-b976-930ef584b76d"
      decimals="-5"
      id="F_34e74be1-b72a-4b9e-91b9-3a2228f40ce3"
      unitRef="U_USD">7500000</tsha:LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable>
    <tsha:AdditionalMilestonePayments
      contextRef="C_773e89ba-c62d-4d26-a9c3-69efc4d4d04e"
      decimals="INF"
      id="F_2d9d7810-8c55-4a2b-8f1e-9f4b73be551f"
      unitRef="U_USD">0</tsha:AdditionalMilestonePayments>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_81d1ce0d-774d-4a7c-8a8a-114d528712a9">&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 9&#x2014;Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On July 1, 2020, the Company&#x2019;s board of directors approved the 2020 Equity Incentive Plan (&#x201c;Existing Plan&#x201d;) which permits the granting of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards (&#x201c;RSAs&#x201d;), restricted stock units (&#x201c;RSUs&#x201d;) and other stock-based awards to employees, directors, officers and consultants. As of September 16, 2020, the approval date of the New Plan (as defined below), no additional awards will be granted under the Existing Plan. The terms of the Existing Plan will continue to govern the terms of outstanding equity awards that were granted prior to approval of the New Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On September 16, 2020, the Company&#x2019;s stockholders approved the 2020 Stock Incentive Plan (&#x201c;New Plan&#x201d;), which became effective upon the execution of the underwriting agreement in connection with the IPO. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The number of shares of common stock reserved for issuance under the New Plan automatically increases on January 1 of each year, for a period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, continuing through &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;January 1, 2030&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company&#x2019;s board of directors.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; On January 1, 2023, the Company&#x2019;s board of directors increased the number of shares of common stock reserved for issuance under the New Plan by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3,160,375&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Furthermore, on September 16, 2020, the Company&#x2019;s stockholders approved the Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;), which became effective upon the execution of the underwriting agreement in connection with the IPO. The maximum number of shares of common stock that may be issued under the ESPP will not exceed &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;362,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock, plus &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;the number of shares of common stock that are automatically added on January 1st of each year for a period of up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, commencing on the first January 1 following the IPO and ending on (and including) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;January 1, 2030&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, in an amount equal to the lesser of (i) one percent (&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year, and (ii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;724,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;were added to the ESPP in 2021. On January 1, 2022 and 2023, the Company&#x2019;s board of directors&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;incre&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ased the number of shares of common stock reserved for issuance under the ESPP by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;384,739&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;632,075&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; respectively. The Company has issued an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;141,393&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock under the ESPP as of September 30, 2023.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The number of shares available for grant under the Company&#x2019;s incentive plans were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.21%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.943%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.743%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.743%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Existing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;New&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;Available for grant - December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,067,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,067,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Plan adjustments and amendments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;667,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3,828,203&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3,160,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Grants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,241,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,241,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Forfeitures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;667,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,918,614&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3,586,442&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;Available for grant - September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,573,142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,573,142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Stock Options&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the three months ended September 30, 2023, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;50,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock under the New Plan were awarded with a weighted-average grant date fair value per sh&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;are of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;. For the nine months ended September 30, 2023, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,520,471&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock under the New Plan were awarded with a weighted-average grant date fair value per share of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.64&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;. The stoc&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;k options vest over &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_a612bde1-69ec-4545-8cd9-0a74e9778ed1;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;four years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; and have a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ten-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; contractual term.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following weighted-average assumptions were used to estimate the fair value of time-based vesting stock options that were granted during the three and nine months ended September 30, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.008%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.003%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:8.349%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.003%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:8.93%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.003%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:8.349%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.003%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.352%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes time-based vesting stock option activity, during the nine months ended September 30, 2023:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.18%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.001%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.674%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.221%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:8.893%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.001%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.674%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.221%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.133%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Aggregate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Remaining&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Intrinsic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Exercise&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Contractual&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Life (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6,158,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;11.84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,520,471&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Options cancelled or forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,013,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;10.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Options expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;857,557&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;22.26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Outstanding at September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,807,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Options exercisable at September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,036,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;18.48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The aggregate intrinsic value in the above table is calculated as the difference between the fair value of the Company&#x2019;s common stock at the respective reporting date and the exercise price of the stock options. As of September 30, 2023, the total unrecognized compensation related to unvested time-based vesting stock option awards granted was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;9.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, which the Company expects to recognize over a weighted-average period of approximately&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; y&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ears. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; stock options were exercised during the period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Performance Stock Options&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In February 2023, the Company issued options to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;70,235&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock to employees under the New Plan that contain performance-based vesting conditions, subject to continued employment through each anniversary and achievement of the performance c&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;onditions. The grant date fair value of these awards was not material. As of September 30, 2023, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;58,346&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; of the shares subject to the performance-based options were outstanding, all of which vested during the period. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; stock options were exercised during the period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In May 2023, the Company issued options to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,166,653&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock to employees under the New Plan that contain both service and performance-based vesting conditions with a weighted average grant date fair value per share of&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;. T&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;he stock options have a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;10-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; contractual term and vest over &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.6&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; years if a combination of clinical, regulatory and financing performance conditions are achieved. As of September 30, 2023, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; compensation expense was recorded related to the awards as achievement of the performance conditions was not considered probable. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following assumptions were used to estimate the fair value of performance and service-based stock options that were granted during the nine months ended September 30, 2023:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.449%;"&gt;&lt;/td&gt;
        &lt;td style="width:0.998%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:17.552999999999997%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the nine months ended September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Market-based Stock Options&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In February 2023, the Company issued options to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;70,233&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of common stock to employees under the New Plan that contain a market-based vesting condition, subject to continued employment through each anniversary and achievement of the market c&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;ondition. The grant date fair value of the stock options that contain market-based vesting conditions was not material. As of September 30, 2023, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;58,344&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; of the shares subject to the stock options that contain a market-based vesting condition were outstanding, and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; options vested during the period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Restricted Stock Units&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In February 2023, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;81,236&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; RSUs to employees under the New Plan. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;T&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;he RSUs are subject to a service-based vesting condition. The service-based RSUs vest in equal annual installments over a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;four-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; period. The Company at any time may accelerate the vesting of the RSUs. Such shares are not accounted for as out&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;standing until they vest.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s default tax withholding method for RSUs granted prior to 2023 is the sell-to-cover method, in which shares with a market value equivalent to the tax withholding obligation are sold on behalf of the holder of the RSUs upon vesting and settlement to cover the tax withholding liability and the cash proceeds from such sales are remitted by the Company to taxing authorities. For RSUs granted in 2023, the Company&#x2019;s tax withholding policy allows the RSU holder to choose to either pay cash to the Company for the tax withholding obligation or elect the net withholding method, in which shares with a market equivalent to the tax withholding obligation are withheld and the net shares are issued to the RSU holder.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In March 2023, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;251,296&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; RSUs to the former President and Chief Executive officer of the Company in connection with his resignation from the Company and Board of Directors. The RSUs vested immediately.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s RSU activity for the nine months ended September 30, 2023 was as follows:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.02%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.161%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.370000000000001%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.621%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.829999999999998%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Grant Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Number&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;of Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Nonvested at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,257,844&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Restricted units granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;332,532&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.06&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;556,989&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4.78&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Cancelled or forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;658,343&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Nonvested at September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;375,044&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6.63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of September 30, 2023, the total unrecognized compensation related to unvested RSUs granted was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million which is expected to be amortized on a straight-line basis over a weighted-average period of approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Performance and Market-based Restricted Stock Units&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In February 2023, the Company issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;81,233&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; RSUs to employees under the New Plan that contain a combination of performance and market-based vesting conditions, subject to continued employment through each anniversary and achievement of market and performance conditions. The grant date fair value of the RSUs that contain performance and market-based vesting conditions was not material. As of September 30, 2023, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;34,673&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; of the RSUs were unvested and still outstanding and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;34,671&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; RSUs vested and were settled during the period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s former President and Chief Executive Officer, was awarded &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;769,058&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; RSAs under the Existing Plan on July 1, 2020, which vested over a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;three-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; term, subject to continuous employment. The fair value of these RSAs at the grant date of July 1, 2020, was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.28&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per share. On March 2, 2023, the Company&#x2019;s former President and Chief Executive Officer resigned from the Board of Directors, therefore cancelling any remaining unvested tranches.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s RSA activity for the nine months ended September 30, 2023 was as follows:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.02%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.161%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.370000000000001%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.621%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.829999999999998%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Grant Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Number&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;of Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Nonvested at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;85,494&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Restricted stock granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;64,120&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Cancelled or forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;21,374&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Nonvested at September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In February 2022, the Company&#x2019;s board of directors authorized the first offering under the ESPP. Under the ESPP, eligible employees may purchase shares of Taysha common stock through payroll deductions at a price equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of the lower of the fair market values of the stock as of the beginning or the end of six-month offering periods. An employee&#x2019;s payroll deductions under the ESPP are limited to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of the employee&#x2019;s compensation and employees may not purchase more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,800&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; of shares of Taysha common stock during any offering period. During the nine months ended September 30, 2023 and 2022, stock-based compensation expense related to the ESPP was not material.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the total stock-based compensation expense for the stock options, ESPP, RSAs and RSUs recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:27.225%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.905%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:15.741999999999999%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:2.807%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:11.772%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:2.506%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:14.138%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.764%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:14.138%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,524&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,894&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,335&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,469&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4,413&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8,046&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4,470&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,937&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;13,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
      contextRef="C_5a369e84-71ee-4265-82bd-b5c3255f95c4"
      id="F_044dd7b4-b7b6-4116-bb1b-2501bb774ab5">The number of shares of common stock reserved for issuance under the New Plan automatically increases on January 1 of each year, for a period of ten years, from January 1, 2021, continuing through January 1, 2030, by 5% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by the Company&#x2019;s board of directors.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_6c73f75e-0143-4c42-88c1-9f83877c234e"
      id="F_c8bff56c-f5a0-4f15-a300-4270ad65d7bb">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate
      contextRef="C_6c73f75e-0143-4c42-88c1-9f83877c234e"
      id="F_811c04e3-6044-4824-b0f5-27ef92ac1590">2021-01-01</tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_6c73f75e-0143-4c42-88c1-9f83877c234e"
      id="F_85805a2b-5890-424c-a868-8ce7ae5a3ee7">2030-01-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <tsha:PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance
      contextRef="C_6c73f75e-0143-4c42-88c1-9f83877c234e"
      decimals="2"
      id="F_ca7b195d-5fe4-4a77-a7b0-f3b4001641bd"
      unitRef="U_pure">0.05</tsha:PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_95c66cb1-2fc7-4423-a36f-6e539db9b9ac"
      decimals="INF"
      id="F_70fc3ac3-ec7c-4ce6-b3c2-7d1ed4b8e70f"
      unitRef="U_shares">3160375</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_e482ef1c-238b-4c33-805a-cf73ba22ae2b"
      decimals="INF"
      id="F_c443ee12-c63f-47fc-8024-eb9c47806e6c"
      unitRef="U_shares">362000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
      contextRef="C_224db9b6-cf69-4025-8ace-07a34716e87d"
      id="F_6d2392a4-2e92-4073-91a6-acd3bdbe3270">the number of shares of common stock that are automatically added on January 1st of each year for a period of up to ten years, commencing on the first January 1 following the IPO and ending on (and including) January 1, 2030, in an amount equal to the lesser of (i) one percent (1.0%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year, and (ii) 724,000 shares of common stock.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_b0d18d87-5486-439a-b80d-f6f9cd2a928a"
      id="F_93913759-339e-43a6-b0f5-b2ef8cc2ebaf">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="C_b0d18d87-5486-439a-b80d-f6f9cd2a928a"
      id="F_c3f63bcf-2195-4d8b-a6ba-64acae60e270">2030-01-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <tsha:PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance
      contextRef="C_b0d18d87-5486-439a-b80d-f6f9cd2a928a"
      decimals="INF"
      id="F_19834e73-31b5-4cd8-a5df-5dff8faa7a10"
      unitRef="U_pure">0.010</tsha:PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_245eca74-de86-4efc-a7d0-3ed028ab318b"
      decimals="INF"
      id="F_4b6edc71-84b7-41cd-b992-34375e44fbda"
      unitRef="U_shares">724000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_b0d18d87-5486-439a-b80d-f6f9cd2a928a"
      decimals="INF"
      id="F_7d9ce19d-cb20-49ce-8993-0e92c98d6fb4"
      unitRef="U_shares">0</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_173d420c-3a82-453d-854d-b15fa055eec3"
      decimals="INF"
      id="F_eb9cea34-8c57-4cc6-adcb-4e5a64a16b56"
      unitRef="U_shares">384739</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_27aa3cc4-7b79-4c00-b3a7-7e63aea84451"
      decimals="INF"
      id="F_d63320a1-c624-4bba-b4cc-32260ccb7a29"
      unitRef="U_shares">632075</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_224db9b6-cf69-4025-8ace-07a34716e87d"
      decimals="INF"
      id="F_439c6df3-dd2e-4501-bd56-ecc7704781df"
      unitRef="U_shares">141393</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <tsha:ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_5b430549-cff9-4b87-9faa-ca1ed412727f">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The number of shares available for grant under the Company&#x2019;s incentive plans were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.21%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.943%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.743%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.18%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.743%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Existing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;New&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;Available for grant - December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,067,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,067,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Plan adjustments and amendments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;667,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3,828,203&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3,160,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Grants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,241,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,241,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Forfeitures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;667,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,918,614&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3,586,442&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;Available for grant - September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,573,142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,573,142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</tsha:ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_1247712d-baca-4aef-85fb-e3036cdde096"
      decimals="INF"
      id="F_16b83f56-ee4d-42ba-8e7b-b0ac17442d8a"
      unitRef="U_shares">1067682</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02"
      decimals="INF"
      id="F_29239a0c-2cce-46e0-8a1b-a14c2327eefe"
      unitRef="U_shares">1067682</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod
      contextRef="C_3cb6925a-8272-4205-b6cf-61f911a340b6"
      decimals="INF"
      id="F_305d9063-3756-4628-8783-0f8c5edb5976"
      unitRef="U_shares">-667828</tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod>
    <tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod
      contextRef="C_5a369e84-71ee-4265-82bd-b5c3255f95c4"
      decimals="INF"
      id="F_6a4e7de2-3176-46cf-890b-615dd16717a4"
      unitRef="U_shares">3828203</tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod>
    <tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="INF"
      id="F_a90d80df-0545-447d-8c10-bad0056a4f92"
      unitRef="U_shares">3160375</tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod>
    <tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod
      contextRef="C_5a369e84-71ee-4265-82bd-b5c3255f95c4"
      decimals="INF"
      id="F_9ae8cd8e-eb97-4348-8a74-9b9667968c68"
      unitRef="U_shares">-5241357</tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod>
    <tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="INF"
      id="F_3e98dfce-b73a-4341-8b06-32fc3704fc0d"
      unitRef="U_shares">-5241357</tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod>
    <tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod
      contextRef="C_3cb6925a-8272-4205-b6cf-61f911a340b6"
      decimals="INF"
      id="F_24445621-9051-4f72-86ff-e0510b94845b"
      unitRef="U_shares">-667828</tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod>
    <tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod
      contextRef="C_5a369e84-71ee-4265-82bd-b5c3255f95c4"
      decimals="INF"
      id="F_7336a14f-f695-47f6-9b55-4440eec3b7a0"
      unitRef="U_shares">-2918614</tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod>
    <tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="INF"
      id="F_346614ba-edb7-4ddc-a844-f6c5f496ee40"
      unitRef="U_shares">-3586442</tsha:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_d99997ac-c0d1-4216-92e6-c6f95f327fe8"
      decimals="INF"
      id="F_fc5b9f4c-b248-4ce9-be9f-35b909b679f4"
      unitRef="U_shares">2573142</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="INF"
      id="F_f63bb8c8-5528-4f8f-8206-854c4b5a15b7"
      unitRef="U_shares">2573142</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_2baf5077-feb2-430c-8618-bc9ab6c792fa"
      decimals="INF"
      id="F_c07ef100-f7c1-466a-adb3-dfa899e6caad"
      unitRef="U_shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_2baf5077-feb2-430c-8618-bc9ab6c792fa"
      decimals="2"
      id="F_c5649c61-a48a-4659-b5b7-39b113b1a5f1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_d3115968-7432-4bb2-8241-e0b51c3126b8"
      decimals="INF"
      id="F_731f2365-3848-4d1b-afe5-404f5104b3ed"
      unitRef="U_shares">2520471</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_d3115968-7432-4bb2-8241-e0b51c3126b8"
      decimals="2"
      id="F_b00d0845-adcf-484c-900c-ce2544f029b6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_b15937e2-c5c7-42c8-90fd-354de23b40f1"
      id="F_875d8156-3d37-434c-9b8a-7f56cb5ffa59">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_d3115968-7432-4bb2-8241-e0b51c3126b8"
      id="F_312d1777-ef8a-4a65-a06e-f5ea03e43202">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      id="F_7a2b4a43-50d5-4243-8fdf-fe26aa1014d3">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following weighted-average assumptions were used to estimate the fair value of time-based vesting stock options that were granted during the three and nine months ended September 30, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.008%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.003%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:8.349%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.003%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:8.93%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.003%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:8.349%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.003%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.352%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_36b0de8a-1c04-40e9-bda7-6a7e96088f0e"
      decimals="4"
      id="F_778c79f4-e0b4-4c7e-be9b-aacd1addbb3f"
      unitRef="U_pure">0.0422</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      decimals="4"
      id="F_d58bfebb-55bb-4253-a3c7-fdaeed25cc8a"
      unitRef="U_pure">0.0361</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_fe9c5e2c-7fc2-459d-a948-657f1b1df93e"
      decimals="4"
      id="F_a35153de-a83e-4db4-9dd1-1ac32fac46bc"
      unitRef="U_pure">0.0216</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_36b0de8a-1c04-40e9-bda7-6a7e96088f0e"
      id="F_5919e379-74b8-4f9d-805a-04a6e5a6d81a">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      id="F_ad93611b-bde7-41f4-b0af-2e50b256875d">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_fe9c5e2c-7fc2-459d-a948-657f1b1df93e"
      id="F_7cf7c32a-22c0-416f-a645-1c6f48e9b569">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_36b0de8a-1c04-40e9-bda7-6a7e96088f0e"
      decimals="2"
      id="F_eff53df5-8d7d-4873-a09a-58536314888d"
      unitRef="U_pure">0.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      decimals="2"
      id="F_7abbe73f-5fbb-49f1-8d41-44ff756ced2a"
      unitRef="U_pure">0.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_fe9c5e2c-7fc2-459d-a948-657f1b1df93e"
      decimals="2"
      id="F_63a3daa1-201c-47b4-94ce-0a0cac92a2a0"
      unitRef="U_pure">0.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      id="F_9cba1451-0750-413c-a25c-9a0d0c394c1e">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes time-based vesting stock option activity, during the nine months ended September 30, 2023:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.18%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.001%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.674%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.221%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:8.893%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.001%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.674%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.221%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.133%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Aggregate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Remaining&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Intrinsic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Exercise&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Contractual&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Life (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6,158,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;11.84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,520,471&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Options cancelled or forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,013,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;10.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Options expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;857,557&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;22.26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Outstanding at September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,807,492&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Options exercisable at September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,036,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;18.48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;49&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_788446ba-8777-48e6-8377-1f4a2176149f"
      decimals="INF"
      id="F_9db26c3b-6f6b-4751-af43-0e92afc3be1b"
      unitRef="U_shares">6158078</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_788446ba-8777-48e6-8377-1f4a2176149f"
      decimals="2"
      id="F_77951a1e-5482-4e1d-850a-7962789f0982"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">11.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_220cf9fa-9710-4b12-8b10-b837e62d8c09"
      id="F_af3cd7ba-e05f-40e4-ba35-06176b75865d">P8Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_788446ba-8777-48e6-8377-1f4a2176149f"
      decimals="-3"
      id="F_7302ca05-e560-4f4a-bcfb-2ab45a74cdf4"
      unitRef="U_USD">62000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      decimals="INF"
      id="F_f5ccf08d-492b-49c5-9624-8441d3992bb6"
      unitRef="U_shares">2520471</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      decimals="2"
      id="F_48d3424f-ab2f-4d59-86d7-66b2e2eaefa5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.9</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      decimals="INF"
      id="F_9eb403a9-f954-492f-9261-bf194727bd91"
      unitRef="U_shares">2013500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      decimals="2"
      id="F_78561fe5-81b4-4544-8f9f-1fa606ad7e37"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">10.88</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      decimals="0"
      id="F_a8275811-58ee-40cc-8d56-262178add0bd"
      unitRef="U_shares">857557</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      decimals="2"
      id="F_6cbace24-952c-4590-999a-928014ab4e35"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">22.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f"
      decimals="INF"
      id="F_cda1acf1-71d4-48b9-b6c6-5d2212ffbe14"
      unitRef="U_shares">5807492</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f"
      decimals="2"
      id="F_0b46072b-b662-4b6a-bacc-8c175937769a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      id="F_47e9a754-2128-4a13-bec3-c725ac21efba">P8Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f"
      decimals="-3"
      id="F_cd732caa-daf5-4004-8a70-6e1769a37675"
      unitRef="U_USD">6851000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f"
      decimals="INF"
      id="F_33375baf-5846-46f8-8182-da4bd82cf3c0"
      unitRef="U_shares">1036300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f"
      decimals="2"
      id="F_8fd7cc89-ab28-464a-ad5e-0d7534f28630"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">18.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      id="F_e4433fbe-0311-42a3-a453-25b04f0d771d">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f"
      decimals="-3"
      id="F_6c944c98-a1e3-4e7c-a695-02e757115cb7"
      unitRef="U_USD">49000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_860f05e5-09f2-4dfd-b455-5e8e3432983f"
      decimals="-5"
      id="F_d8eb2b5d-2d7f-447d-a284-910280d82cae"
      unitRef="U_USD">9300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      id="F_51994655-e561-4c91-b3e6-8bcc8f9c77da">P2Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7"
      decimals="INF"
      id="F_40cc1e49-de9b-493d-9638-d9b0e66c4575"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_52565164-9ede-4417-8be6-ba6aecffc735"
      decimals="INF"
      id="F_4366ab82-5bc5-4ad3-b4fc-966a19a7b594"
      unitRef="U_shares">70235</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_5d53cb28-f1c8-45d3-aaa3-c5feece6f465"
      decimals="INF"
      id="F_0b095a16-bb51-469e-bac3-cb7b1430501a"
      unitRef="U_shares">58346</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_e15af869-8ce3-412a-8b1c-4c46b2d2bba7"
      decimals="INF"
      id="F_9bcdc1d8-fc35-460e-8f69-6070085bfc38"
      unitRef="U_USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_dbe9d225-ee5e-4b8b-b0c9-9b23ae056e8c"
      decimals="INF"
      id="F_7ded1995-fb1a-4f9b-b4c4-7ca816586446"
      unitRef="U_shares">2166653</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_dbe9d225-ee5e-4b8b-b0c9-9b23ae056e8c"
      decimals="2"
      id="F_be8357b0-4587-4bae-972f-78976bb522fc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_dbe9d225-ee5e-4b8b-b0c9-9b23ae056e8c"
      id="F_5e82dde4-59d1-4047-a357-96aca8a7b34e">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_dbe9d225-ee5e-4b8b-b0c9-9b23ae056e8c"
      id="F_22fa820d-3d2f-466d-b4bc-62a8bbf469e9">P3Y7M6D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_e15af869-8ce3-412a-8b1c-4c46b2d2bba7"
      decimals="INF"
      id="F_c548c0eb-85a0-48e3-8555-731cfa758f04"
      unitRef="U_USD">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_3253dca9-a154-4e6e-add3-61c9afd96cb4"
      id="F_dcd68353-2aff-4023-9797-c3cbd527cb36">&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following assumptions were used to estimate the fair value of performance and service-based stock options that were granted during the nine months ended September 30, 2023:&lt;/span&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.449%;"&gt;&lt;/td&gt;
        &lt;td style="width:0.998%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:17.552999999999997%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the nine months ended September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_3253dca9-a154-4e6e-add3-61c9afd96cb4"
      decimals="4"
      id="F_6b2cb829-2808-4c57-a375-bd1ad9fe190c"
      unitRef="U_pure">0.0402</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_3253dca9-a154-4e6e-add3-61c9afd96cb4"
      id="F_bccf195d-fd23-45bf-95fb-08ca81f9be31">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_3253dca9-a154-4e6e-add3-61c9afd96cb4"
      decimals="2"
      id="F_4c9c53d5-963e-469d-8bda-229b60f625c7"
      unitRef="U_pure">0.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_7f6e1c72-16bb-483e-8cd7-a7a20b74ede0"
      decimals="INF"
      id="F_8620624e-17da-4c8c-85af-7d82979ce453"
      unitRef="U_shares">70233</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_e2ae4188-b729-4bb9-a810-c77a789712b1"
      decimals="INF"
      id="F_90f6b43a-e351-4fa3-9b34-ccd55bcf6a4c"
      unitRef="U_shares">58344</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="C_6a80be52-6387-4afd-9538-c38ccf4297dd"
      decimals="INF"
      id="F_bde5fe73-360a-4cb7-a9d3-311248741367"
      unitRef="U_shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_51f1008f-8fa9-4508-a0ff-0b2d61656244"
      decimals="INF"
      id="F_5ef62eef-db65-4279-acc9-aedd1661906e"
      unitRef="U_shares">81236</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_51f1008f-8fa9-4508-a0ff-0b2d61656244"
      id="F_3fb623fe-c601-4a61-b82d-5aebf1893c8c">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_4747c8da-f859-4b04-947f-581d35ec592c"
      decimals="INF"
      id="F_c189d623-fd4c-4136-921a-f234127238d2"
      unitRef="U_shares">251296</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_1bfa979e-1bd8-4626-9c61-6b2757b3cf55">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s RSU activity for the nine months ended September 30, 2023 was as follows:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.02%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.161%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.370000000000001%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.621%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.829999999999998%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Grant Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Number&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;of Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Nonvested at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,257,844&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Restricted units granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;332,532&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.06&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;556,989&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4.78&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Cancelled or forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;658,343&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Nonvested at September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;375,044&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;6.63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of September 30, 2023, the total unrecognized compensation related to unvested RSUs granted was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million which is expected to be amortized on a straight-line basis over a weighted-average period of approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_f2bd8525-6258-4ee1-bf3e-0b623f59864b"
      decimals="INF"
      id="F_eac1036b-58b0-4014-ab92-f24ed3c9abab"
      unitRef="U_shares">1257844</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_f2bd8525-6258-4ee1-bf3e-0b623f59864b"
      decimals="2"
      id="F_c91fb5c4-2014-4ca6-be80-7d3a9caf42e2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb"
      decimals="INF"
      id="F_a9e1b30a-b560-4be5-afe7-1d84ae889784"
      unitRef="U_shares">332532</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb"
      decimals="2"
      id="F_dd1a5808-56b6-40f4-970e-5d4f3a51894f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb"
      decimals="INF"
      id="F_0092c5b1-d2c9-4efc-ba24-f09ec584d456"
      unitRef="U_shares">556989</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb"
      decimals="2"
      id="F_ec3de5d6-682f-455f-a45e-e9644ded3d15"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb"
      decimals="INF"
      id="F_88fc5d72-16b1-4c7e-8167-c8148f43b068"
      unitRef="U_shares">658343</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb"
      decimals="2"
      id="F_2a3268ff-8777-478b-a3b6-ea18755d8523"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_dbdfd311-3825-4ad7-b403-58287d7548a7"
      decimals="INF"
      id="F_8e5fa4b7-e01c-411c-926e-39f3c8207093"
      unitRef="U_shares">375044</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_dbdfd311-3825-4ad7-b403-58287d7548a7"
      decimals="2"
      id="F_dc46b9b9-89f2-4452-9846-80d04c25dbf8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_dbdfd311-3825-4ad7-b403-58287d7548a7"
      decimals="-5"
      id="F_3a84d598-f8e3-47e9-aa0c-c3d53f5cddad"
      unitRef="U_USD">2000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_d239af67-cf01-4921-a72c-010606f8efdb"
      id="F_8ef19aa3-dad1-4a34-a2af-ff5b088b180d">P0Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_0ed2ccbf-6260-463b-bb8f-3005a6425089"
      decimals="INF"
      id="F_6f8fc3cc-0e3d-483c-a765-a49670c5ce14"
      unitRef="U_shares">81233</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_3c5342a3-7cee-4f48-b5b3-8beff925816b"
      decimals="INF"
      id="F_041f60e2-5000-4d9d-909f-7d803317e271"
      unitRef="U_shares">34673</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_f6908048-c889-4f93-869e-3dd5fb923ea5"
      decimals="INF"
      id="F_3c995765-6a60-464a-a96e-54d9a29982ec"
      unitRef="U_shares">34671</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_23bd83df-eede-42ec-9c51-05585993a9e0"
      decimals="INF"
      id="F_3f8b0414-16e0-4760-a42b-8bc0896b75f0"
      unitRef="U_shares">769058</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="C_23bd83df-eede-42ec-9c51-05585993a9e0"
      id="F_0ea41303-bbd6-43d5-8791-899ecdb91403">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_f72dceba-fcca-4fdd-bb14-6b5646b92d1e"
      decimals="INF"
      id="F_3705bb68-b4ac-4d76-9982-2d1f87da63c7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_cd100d8d-8db1-484f-9fe9-adb0ac60bd8c">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company&#x2019;s RSA activity for the nine months ended September 30, 2023 was as follows:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.02%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.161%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.370000000000001%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.621%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:12.829999999999998%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Grant Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Number&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;of Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Nonvested at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;85,494&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Restricted stock granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;64,120&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Cancelled or forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;21,374&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Nonvested at September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_84a4182e-9ee0-43f3-b998-badcbf3028a8"
      decimals="INF"
      id="F_baf52c9e-a14d-4bdd-905b-639280de3cfd"
      unitRef="U_shares">85494</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_84a4182e-9ee0-43f3-b998-badcbf3028a8"
      decimals="2"
      id="F_7d6926f9-f179-44a8-97ad-5a126c5175be"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_d374b9c6-f352-4efa-81b7-539cd0b063c1"
      decimals="INF"
      id="F_7fb42317-be3b-4916-874c-7a048b1116d9"
      unitRef="U_shares">64120</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_d374b9c6-f352-4efa-81b7-539cd0b063c1"
      decimals="2"
      id="F_9fa4fb33-bde1-4d38-83e9-1e4ead293315"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_d374b9c6-f352-4efa-81b7-539cd0b063c1"
      decimals="INF"
      id="F_60c88455-64ea-4fb9-89bc-86bceffa8e23"
      unitRef="U_shares">21374</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_d374b9c6-f352-4efa-81b7-539cd0b063c1"
      decimals="2"
      id="F_2ebcd611-920e-4511-9bbc-981bb0ed5390"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="C_312a5395-35e7-4a3b-845a-3e7f7d95509c"
      decimals="2"
      id="F_58e6230e-e16d-41d4-9a62-83511e9f243c"
      unitRef="U_pure">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
      contextRef="C_81a7b536-c0bb-453e-bcc6-30eb806c1470"
      decimals="2"
      id="F_3ff8bf16-ebe9-4e92-96d2-4d64a17f9cf6"
      unitRef="U_pure">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="C_81a7b536-c0bb-453e-bcc6-30eb806c1470"
      decimals="INF"
      id="F_bf81007a-ec6c-4394-8292-e99d299bd523"
      unitRef="U_shares">1800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_346dd76b-f298-49c0-83c5-6be343195470">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the total stock-based compensation expense for the stock options, ESPP, RSAs and RSUs recorded in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:27.225%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.905%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:15.741999999999999%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:2.807%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:11.772%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:2.506%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:14.138%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.764%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:14.138%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,524&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,894&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,335&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,469&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4,413&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8,046&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4,470&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,937&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;13,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_73e2f837-a7da-4610-a8b8-b300a337c6b9"
      decimals="-3"
      id="F_498bdc8f-e0af-4b50-a40a-52f6fbadcebe"
      unitRef="U_USD">705000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_2e51a9e4-9e0b-4c3b-97d0-34a783d596e7"
      decimals="-3"
      id="F_7c89e4cd-f286-4a2f-ac78-6a8899e031ea"
      unitRef="U_USD">2001000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_aa916425-81f6-46a9-9211-8a2744be8acf"
      decimals="-3"
      id="F_d247639d-b0d8-4a28-8c89-0e4a8d089911"
      unitRef="U_USD">1524000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_151eb485-8164-452f-8e8d-d530d960d3b9"
      decimals="-3"
      id="F_35952651-37ca-4e79-b99a-8f9f79108572"
      unitRef="U_USD">5894000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_bcabd00a-3c24-4571-bd95-b51d333d5e34"
      decimals="-3"
      id="F_231da254-44d4-4020-a098-211c63c63b5e"
      unitRef="U_USD">1335000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c3b5bdf8-5491-4876-b736-c28be19cc6fb"
      decimals="-3"
      id="F_eb2456b7-99da-44ea-9a16-eb7cd4866c9a"
      unitRef="U_USD">2469000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_27149336-d352-41a8-8d0e-18408512989e"
      decimals="-3"
      id="F_089f4fb2-ec6d-4603-8ec9-4ef87980e922"
      unitRef="U_USD">4413000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_5fe22845-b517-4024-bf3c-a463c9c5382c"
      decimals="-3"
      id="F_9a114797-0c3e-44b6-8e1b-c4e022b4696d"
      unitRef="U_USD">8046000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_80380664-e109-425c-be9e-6eb7569a998b"
      unitRef="U_USD">2040000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_02a96fa6-4090-4dbf-9fe3-0ce88c786c04"
      unitRef="U_USD">4470000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_9e843bfb-178a-4cb0-acee-511e37195f6d"
      unitRef="U_USD">5937000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_93f71f9a-7fde-44ed-9a51-4058464d90b7"
      unitRef="U_USD">13940000</us-gaap:AllocatedShareBasedCompensationExpense>
    <tsha:WarrantsNoteDisclosureTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_660d0472-e7f0-4e21-8b02-9aa2d9fcf00e">&lt;p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 10&#x2014;Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On August 14, 2023, the Company entered into a Securities Purchase Agreement (the &#x201c;August 2023 Purchase Agreement&#x201d;) with certain institutional and other accredited investors (the &#x201c;Purchasers&#x201d;), pursuant to which the Company agreed to sell and issue to the Purchasers in a private placement transaction (the &#x201c;August 2023 Private Placement&#x201d;) (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;122,412,376&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares (the &#x201c;PIPE Shares&#x201d;) of the Company&#x2019;s common stock, and (ii) with respect to certain Purchasers, pre-funded warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;44,250,978&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock (the &#x201c;Pre-Funded Warrants&#x201d;) in lieu of shares of the Company&#x2019;s common stock. The purchase price per share of common stock was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.90&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per share (the &#x201c;Purchase Price&#x201d;), and the purchase price for the Pre-Funded Warrants was the Purchase Price minus $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per Pre-Funded Warrant.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Pre-Funded Warrants have a per share exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;, subject to proportional adjustments in the event of stock splits or combinations or similar events. The Pre-Funded Warrants will not expire until exercised in full. The Pre-Funded Warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the holder thereof immediately following such exercise would exceed a specified beneficial ownership limitation; provided, however, that a holder may increase or decrease the beneficial ownership limitation by giving &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;61&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; days&#x2019; notice to the Company, but not to any percentage in excess of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;19.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%. The Pre-Funded Warrants will only be exercisable upon receipt of stockholder approval of an increase in the authorized shares of the Company&#x2019;s common stock (the &#x201c;Stockholder Approval&#x201d;), which the Company will first seek to obtain at a special meeting of stockholders scheduled to be held on November 15, 2023. If the Company does not obtain Stockholder Approval by December 31, 2023, it is required to pay liquidated damages of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of the aggregate purchase price paid by each holder of Pre-Funded Warrants. For any subsequent failure to obtain Stockholder Approval, the Company is required to pay an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% as liquidated damages.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The closing of the August 2023 Private Placement occurred on August 16, 2023 (the &#x201c;Closing&#x201d;). The total gross proceeds to the Company at the Closing were approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;150.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million, and after deducting placement agent commissions and offering expenses payable by the Company, net proceeds were approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;140.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million. The Company used the with-and-without method to allocate the total gross proceeds by first allocating the portion of the proceeds equal to the fair value of the Pre-Funded Warrants on the Closing date with the remaining proceeds allocated to the PIPE Shares on a residual basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company concluded that the Pre-Funded Warrants do not meet the criteria for equity classification under the guidance of ASC 815 as the Company does not have sufficient authorized and unissued shares to satisfy the warrants if exercised. The Company recorded the Pre-Funded Warrants as liabilities at their fair value. This liability is subject to remeasurement at each balance sheet date and any change in fair value is recognized in the Company&#x2019;s condensed consolidated statement of operations. The Company incurred $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;9.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million of placement agent commissions and other issuance costs in connection with the August 2023 Private Placement. The placement agent commissions and other issuance costs were allocated between the PIPE Shares and the Pre-Funded Warrants on a systematic basis. The Company allocated $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;7.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million to the PIPE Shares which was recorded as a deduction to Additional paid-in capital. The remaining $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million allocated to the Pre-Funded Warrants were recorded within general and administrative expense in the consolidated statements of operations for the nine months ended September 30, 2023. The issuance costs allocated to the Pre-Funded Warrants have been added back to net loss when deriving cash flows used in operations, and have been classified as a financing cash outflow in the condensed consolidated statement of cash flows for the nine months ended September 30, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company measured the fair value of the PIPE Shares and Pre-Funded Warrants based on the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.90&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per share Purchase Price. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company used the relative fair value method to allocate the net proceeds received from the sales of the PIPE Shares and the Pre-Funded Warrants on the condensed consolidated balance sheet as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:60.997%;"&gt;&lt;/td&gt;
        &lt;td style="width:4.503%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:32.501000000000005%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;PIPE Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;110,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;39,826&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;149,953&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company remeasured the fair value of the Pre-Funded Warrants using the closing price of the Company&#x2019;s common stock on the Nasdaq Global Market as of September 30, 2023 of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.16&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per common share. The Company recorded a fair value adjustment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million in the condensed consolidated statements of operations for the three and nine months ended September 30, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;SSI Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In April 2023, the Company entered into a securities purchase agreement (the &#x201c;SSI Securities Purchase Agreement&#x201d;), with two affiliates of SSI Strategy Holdings LLC (&#x201c;SSI&#x201d;), named therein (the &#x201c;SSI Investors&#x201d;) pursuant to which the Company agreed to issue and sell to the SSI Investors in a private placement (the &#x201c;SSI Private Placement&#x201d;), &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;705,218&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of its common stock (the &#x201c;SSI Shares&#x201d;) and warrants (the &#x201c;SSI Warrants&#x201d;) to purchase an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;525,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock (the &#x201c;Warrant Shares&#x201d;). SSI provides certain consulting services to the Company. Each SSI Warrant has an exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.7090&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per Warrant Share, which was the closing price of the Company&#x2019;s common stock on the Nasdaq Global Market on April 4, 2023. The SSI Warrants issued in the SSI Private Placement provide that the holder of the SSI Warrants will not have the right to exercise any portion of its SSI Warrants until the achievement of certain clinical and regulatory milestones related to the Company&#x2019;s clinical programs. The SSI Private Placement closed on April 5, 2023. Gross proceeds of the SSI Private Placement were $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company concluded that the SSI Warrants do not meet the criteria for equity classification under the guidance of ASC 815 due to settlement provisions that permit the holder to receive a variable number of shares in the event of a specified fundamental transaction as well as provisions that permit the holder to participate in dividends. As the SSI Warrants do not meet the criteria for equity classification, the Company recorded the warrants as liabilities at their fair value. This liability is subject to remeasurement at each balance sheet date until the warrants are exercised or expire, and any change in fair value is recognized in the Company&#x2019;s condensed consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company determined the fair value of the SSI Warrants at issuance was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million using the Black-Scholes-Merton option pricing model. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following assumptions were used to estimate the fair value of the warrants at issuance:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.853%;"&gt;&lt;/td&gt;
        &lt;td style="width:2.092%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:15.054%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Market value of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The fair value adjustment as of September 30, 2023 was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million using the Black-Scholes-Merton option pricing model with probability weights applied to each of the SSI Warrants where vesting is contingent upon the achievement of certain clinical and regulatory milestones related to the Company&#x2019;s clinical programs. As of September 30, 2023, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;200,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; of the SSI Warrants have vested and are exercisable. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; warrants were exercised during the period.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company estimated the fair value of the SSI Warrant liability using the following assumptions as of September 30, 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:72.285%;"&gt;&lt;/td&gt;
        &lt;td style="width:4.901%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:20.812%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Market value of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the Company&#x2019;s warrant liability (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.499%;"&gt;&lt;/td&gt;
        &lt;td style="width:3.962%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:28.538999999999998%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Warrant Liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Balance at January 1, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Issuance of SSI Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;252&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Issuance of Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;39,826&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Change in fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;100,456&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Balance at September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;140,534&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</tsha:WarrantsNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_99018103-c6e5-46d7-86c2-6f53ea9bbe0b"
      decimals="INF"
      id="F_dca234d0-7ab3-4204-aee3-e219a877dd9d"
      unitRef="U_shares">122412376</us-gaap:CommonStockSharesIssued>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_2a31a044-252b-446e-9552-0e90214b5729"
      decimals="INF"
      id="F_6d64e9cb-5361-4f7f-be80-03390b7d980a"
      unitRef="U_shares">44250978</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_2a31a044-252b-446e-9552-0e90214b5729"
      decimals="2"
      id="F_e10476e5-3e7d-40c0-9c61-0a3322037830"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.9</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_2a31a044-252b-446e-9552-0e90214b5729"
      decimals="3"
      id="F_2cfe4120-7260-46ab-b8a3-2fcb7a189a3a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_4bcd5e18-554d-46bd-8387-2b416ade3f02"
      decimals="INF"
      id="F_9fa7aad7-ef2b-4312-8a6a-330d87d8e3d5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <tsha:BeneficialOwnershipLimitationNoticePeriod
      contextRef="C_4c721f5c-334b-4fe7-802b-653db955a9ef"
      id="F_18c6d9d3-5fc2-4723-8163-dae66a1f360c">P61D</tsha:BeneficialOwnershipLimitationNoticePeriod>
    <tsha:IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage
      contextRef="C_4c721f5c-334b-4fe7-802b-653db955a9ef"
      decimals="4"
      id="F_221f66fb-5761-4f79-8c67-7eb7a0d9efeb"
      unitRef="U_pure">0.1999</tsha:IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage>
    <tsha:PaymentsToInvestorsAsLiquidatedDamages
      contextRef="C_7e3ec4c7-5cbb-4cfd-9e66-965a4caa80c9"
      decimals="3"
      id="F_61f98c13-4d3d-4f94-8a0f-358138df5a16"
      unitRef="U_pure">0.02</tsha:PaymentsToInvestorsAsLiquidatedDamages>
    <tsha:PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage
      contextRef="C_7e3ec4c7-5cbb-4cfd-9e66-965a4caa80c9"
      decimals="3"
      id="F_a4cb185d-28ca-4bad-92d9-4e492bea0bd2"
      unitRef="U_pure">0.02</tsha:PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_f36491bb-eacf-4acf-ac52-472ebe8b3169"
      decimals="-5"
      id="F_d22af962-d34a-4ffb-add8-e07ea27c280d"
      unitRef="U_USD">150000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <tsha:ProceedsFromIssuanceOfCommonStockNet
      contextRef="C_f36491bb-eacf-4acf-ac52-472ebe8b3169"
      decimals="-5"
      id="F_0f3e8848-1fcc-40a1-b57a-9fcf25eb07b2"
      unitRef="U_USD">140300000</tsha:ProceedsFromIssuanceOfCommonStockNet>
    <tsha:IncurredPlacementAgentCommissionsAndOtherIssuanceCosts
      contextRef="C_d4e0f467-0a9d-4677-822d-01e528375bf1"
      decimals="-5"
      id="F_41e180ee-8a45-4875-85d9-495940c58fc5"
      unitRef="U_USD">9700000</tsha:IncurredPlacementAgentCommissionsAndOtherIssuanceCosts>
    <tsha:AllocatedToSharesDeductionToAdditionalPaidInCapital
      contextRef="C_d4e0f467-0a9d-4677-822d-01e528375bf1"
      decimals="-5"
      id="F_d206a09b-ffd9-472c-ac06-578e4202e871"
      unitRef="U_USD">7100000</tsha:AllocatedToSharesDeductionToAdditionalPaidInCapital>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_d4e0f467-0a9d-4677-822d-01e528375bf1"
      decimals="-5"
      id="F_a0329215-34db-4a54-9c85-fe1d51ef9bff"
      unitRef="U_USD">2600000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_33b1b61d-afdf-4871-8372-0ac5c4985bb3"
      decimals="2"
      id="F_dcd9f868-b16c-41ca-826b-ecbef21aa376"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.9</us-gaap:SharesIssuedPricePerShare>
    <tsha:ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_73cb2e9a-dda9-4648-8f59-ab366784501e">&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company used the relative fair value method to allocate the net proceeds received from the sales of the PIPE Shares and the Pre-Funded Warrants on the condensed consolidated balance sheet as follows (in thousands):&lt;/span&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:60.997%;"&gt;&lt;/td&gt;
        &lt;td style="width:4.503%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:32.501000000000005%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;PIPE Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;110,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;39,826&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;149,953&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</tsha:ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock>
    <tsha:CommonStockAndWarrantsFairValueDisclosure
      contextRef="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d"
      decimals="0"
      id="F_5c1e9a69-7edc-4c24-ab6f-c035026066b8"
      unitRef="U_USD">110127</tsha:CommonStockAndWarrantsFairValueDisclosure>
    <tsha:CommonStockAndWarrantsFairValueDisclosure
      contextRef="C_18d9db4b-0220-483d-b698-33462a0d1d11"
      decimals="0"
      id="F_85a4b906-424e-4f1b-8bc3-3a81ef27b5cd"
      unitRef="U_USD">39826</tsha:CommonStockAndWarrantsFairValueDisclosure>
    <tsha:CommonStockAndWarrantsFairValueDisclosure
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="0"
      id="F_40b47110-7cab-4a6b-ad06-57193de9e760"
      unitRef="U_USD">149953</tsha:CommonStockAndWarrantsFairValueDisclosure>
    <us-gaap:SharePrice
      contextRef="C_3bc2a0ec-e010-4eea-9039-dc57eaff573d"
      decimals="INF"
      id="F_f3bfb88f-d97f-4f4d-b9dc-61fb97f2dda9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.16</us-gaap:SharePrice>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_4c88705b-93a0-4d16-a99d-3dbf7a0c78c1"
      decimals="-5"
      id="F_ae683f19-777c-4950-8fde-d848579831ef"
      unitRef="U_USD">100000000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_4e3d744a-95f2-48c1-8ae4-8a48d4233bb0"
      decimals="-5"
      id="F_8f01855d-d36c-4cbd-9a22-1ea34f1bbc91"
      unitRef="U_USD">100000000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_8ef3dae4-92a8-4848-bc8b-7d6ee1d2bca5"
      decimals="INF"
      id="F_5d58a253-d764-42fa-a51a-a7b5e04c5c95"
      unitRef="U_shares">705218</us-gaap:CommonStockSharesIssued>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_8ef3dae4-92a8-4848-bc8b-7d6ee1d2bca5"
      decimals="INF"
      id="F_009c671d-3943-4277-b882-29cc6d06b526"
      unitRef="U_shares">525000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_8ef3dae4-92a8-4848-bc8b-7d6ee1d2bca5"
      decimals="4"
      id="F_eb9e77d5-bd11-4912-bc15-78c94dfa8e81"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.709</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_04ff6dd0-0334-40e9-88c7-2032acec21a2"
      decimals="-5"
      id="F_9c23db95-f09f-4806-8e98-390571f046ca"
      unitRef="U_USD">500000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <tsha:IssuanceOfFairValueWarrant
      contextRef="C_29b986aa-0e5f-4fce-8696-e82fa25305c3"
      decimals="-5"
      id="F_e14584b4-87ee-4409-b56c-0595f1011bed"
      unitRef="U_USD">300000</tsha:IssuanceOfFairValueWarrant>
    <tsha:ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_ed0ea81d-6850-4959-b3b5-ba8a15aba4e8">&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following assumptions were used to estimate the fair value of the warrants at issuance:&lt;/span&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.853%;"&gt;&lt;/td&gt;
        &lt;td style="width:2.092%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:15.054%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Market value of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.71&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company estimated the fair value of the SSI Warrant liability using the following assumptions as of September 30, 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:72.285%;"&gt;&lt;/td&gt;
        &lt;td style="width:4.901%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:20.812%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Market value of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</tsha:ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_bafc0748-9e47-4fe0-8057-f224262368a9"
      decimals="2"
      id="F_a2bde128-4913-43fd-9365-e650a9f7688d"
      unitRef="U_pure">3.46</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_467bb9bb-f5c8-46b2-9e83-49a77c2c5e47"
      decimals="1"
      id="F_608a22a1-b921-4091-ac09-3a38c787c736"
      unitRef="U_Y">5.2</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_2ac01888-0938-41c1-b387-fb08d1afdae5"
      decimals="0"
      id="F_6a907542-f134-4de2-a429-46a613e8d902"
      unitRef="U_pure">81</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_aa7f77ea-a48d-42e3-9e4f-5074456c1eb3"
      decimals="2"
      id="F_f05c1ca2-d0e8-45b9-9427-4ef1e769d039"
      unitRef="U_USD">0.71</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="C_07daf6b0-f34a-4741-b184-8a1f541a9c89"
      decimals="-5"
      id="F_90942d6b-1d82-44f4-927e-a784cc8d5170"
      unitRef="U_USD">500000</us-gaap:FairValueAdjustmentOfWarrants>
    <tsha:ClassOfWarrantOrRightVestedAndExercisable
      contextRef="C_11f479fa-8bc0-462f-aae7-eb345d89a6d2"
      decimals="INF"
      id="F_eff766fe-7d24-414d-a9fe-f1dbf3198e6f"
      unitRef="U_shares">200000</tsha:ClassOfWarrantOrRightVestedAndExercisable>
    <us-gaap:ClassOfWarrantOrRightUnissued
      contextRef="C_11f479fa-8bc0-462f-aae7-eb345d89a6d2"
      decimals="INF"
      id="F_9323706a-7e4f-451c-ba3c-f851db29f254"
      unitRef="U_shares">0</us-gaap:ClassOfWarrantOrRightUnissued>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_f73dfe04-8e13-4f73-9796-2fc971735968"
      decimals="2"
      id="F_563d603f-fd5f-4510-8b9b-f83866df9231"
      unitRef="U_pure">3.46</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_7c39cbeb-fc40-4194-9257-c31ad0395ba2"
      decimals="1"
      id="F_0af00a57-f31c-49a9-907a-6dc414640b6b"
      unitRef="U_Y">4.8</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_19b223c2-858d-4c13-823b-7fac0db24551"
      decimals="0"
      id="F_82183d37-b260-4b1e-a526-763f11253614"
      unitRef="U_pure">81</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="C_3643e8c7-ca2c-41ba-88d7-153c48cfb65c"
      decimals="2"
      id="F_d02f8e22-dd3c-40d2-bea2-8f52e37cc3a0"
      unitRef="U_USD">3.16</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <tsha:ScheduleOfWarrantLiabilityTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_6adfa201-5aa0-4a89-b87c-34b201e2d341">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table summarizes the Company&#x2019;s warrant liability (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.499%;"&gt;&lt;/td&gt;
        &lt;td style="width:3.962%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:28.538999999999998%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;Warrant Liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Balance at January 1, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Issuance of SSI Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;252&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Issuance of Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;39,826&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Change in fair value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;100,456&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Balance at September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;140,534&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</tsha:ScheduleOfWarrantLiabilityTableTextBlock>
    <tsha:IssuanceOfWarrantLiability
      contextRef="C_c89eb35b-aaf3-4ca8-943d-735991153287"
      decimals="-3"
      id="F_360a56ab-c147-4bc6-934e-c16805a65db0"
      unitRef="U_USD">252000</tsha:IssuanceOfWarrantLiability>
    <tsha:IssuanceOfWarrantLiability
      contextRef="C_4e3d744a-95f2-48c1-8ae4-8a48d4233bb0"
      decimals="-3"
      id="F_fe75c879-3d63-447c-aaa4-89174bd92cd3"
      unitRef="U_USD">39826000</tsha:IssuanceOfWarrantLiability>
    <tsha:ChangeInFairValueOfWarrants
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_bccdaa89-7fa4-4946-b426-5471a12dacc3"
      unitRef="U_USD">100456000</tsha:ChangeInFairValueOfWarrants>
    <tsha:WarrantLiabilityFairValueDisclosure
      contextRef="C_10cb884e-9a48-40ed-b56b-6772d0af148c"
      decimals="-3"
      id="F_87050d92-85c6-472a-926d-8c94251f13d0"
      unitRef="U_USD">140534000</tsha:WarrantLiabilityFairValueDisclosure>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_e99a3168-daf5-4006-a2ed-551d0b1be580">&lt;p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 11&#x2014;Net Loss Per Common Share&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Since the Company had a net loss in all periods presented, basic and diluted net loss per common share are the same.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In August 2023, the Company issued liability-classified Pre-Funded Warrants with a nominal exercise price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; per share (see Note 10). In accordance with ASC 260 &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Earnings Per Share, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;shares issuable for little to no cash consideration should be included in the number of outstanding shares used to calculate basic earnings per share as long as all conditions necessary for exercise are met. As the Company does not have enough authorized shares to satisfy the warrants, the requirement that all conditions necessary for exercise are not met, and the Pre-Funded Warrants are not included in the calculation of basic net loss per share for the three and nine months ended September 30, 2023.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table represents the calculation of basic and diluted net loss per common share (in thousands, except share and per share data):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.158%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.484%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.954%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.384%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.954%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.183%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:8.851%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.183%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:8.851%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;117,087&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26,527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;159,307&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;110,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted-average shares of common stock outstanding used to compute net loss per common share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;125,700,799&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;40,937,808&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;84,630,796&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;39,761,764&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Net loss per common share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following common stock equivalents outstanding as of September 30, 2023 and 2022 were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti&#x2011;dilutive:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.96%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.36%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.36%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Unvested RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;409,717&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,257,844&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Unvested RSAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;149,614&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8,090,835&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4,547,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;SSI Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;525,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;44,250,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;53,276,530&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,955,191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_4bcd5e18-554d-46bd-8387-2b416ade3f02"
      decimals="INF"
      id="F_494d45c3-1c3b-4eeb-9b97-a559a832fff6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_db55f184-d6f5-4bb1-a6a8-7122da3db1f6">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following table represents the calculation of basic and diluted net loss per common share (in thousands, except share and per share data):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.158%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.484%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.954%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.384%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:9.954%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.183%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:8.851%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.183%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:8.851%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the Three Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;For the Nine Months Ended September 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;117,087&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;26,527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;159,307&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;110,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Weighted-average shares of common stock outstanding used to compute net loss per common share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;125,700,799&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;40,937,808&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;84,630,796&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;39,761,764&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Net loss per common share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-3"
      id="F_d620a975-1bf2-46ee-b718-bf841f9258f1"
      unitRef="U_USD">-117087000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-3"
      id="F_21930559-da14-408b-bb10-b57b7658875b"
      unitRef="U_USD">-26527000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-3"
      id="F_60dd379e-dd60-4ea1-8c80-47dc65114a56"
      unitRef="U_USD">-159307000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-3"
      id="F_61f744e5-c040-4b5e-88d3-6f82aee57848"
      unitRef="U_USD">-110936000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="0"
      id="F_f0e19d0e-973d-471e-8bd1-62593a06683a"
      unitRef="U_shares">125700799</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="0"
      id="F_77d85fe1-0860-40cc-b34a-bb703da4b9f7"
      unitRef="U_shares">125700799</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="0"
      id="F_b29869cd-c405-40a1-b461-7f876c38a7df"
      unitRef="U_shares">40937808</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="0"
      id="F_ffd36926-beb1-42fd-9892-92e36a3816c0"
      unitRef="U_shares">40937808</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="0"
      id="F_83d65c74-80fe-4fff-ad14-97437a144015"
      unitRef="U_shares">84630796</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="0"
      id="F_4a989680-1761-4e33-b95a-e7f8bafdbc26"
      unitRef="U_shares">84630796</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="0"
      id="F_30e720ce-214f-44db-8806-4ed0d201775c"
      unitRef="U_shares">39761764</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="0"
      id="F_7be8fcd7-7c59-4cfb-8e6a-52b1a145ec7e"
      unitRef="U_shares">39761764</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="2"
      id="F_4b1e48fa-2e7b-4157-b2d6-d311db92b78d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="2"
      id="F_f38e8912-1bef-41c6-b39b-abe65bc91437"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="2"
      id="F_7cb4c5b4-3656-4f78-9817-80a9884e1da8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="2"
      id="F_1b2ecd13-6f62-40dd-8291-89dab0c89a57"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="2"
      id="F_327a0837-f826-4449-89ef-21b26d32257b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.88</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="2"
      id="F_8b2e7849-1f95-4750-82d4-9ce74305e8b9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.88</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="2"
      id="F_34837c66-aade-49a2-88b2-e74a12b606e1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="2"
      id="F_3bee20d9-e0b1-467e-9f91-872428bb850f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_1854a085-665c-40d3-99ba-5ad9598829ec">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The following common stock equivalents outstanding as of September 30, 2023 and 2022 were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti&#x2011;dilutive:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.96%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.36%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:13.36%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Unvested RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;409,717&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,257,844&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Unvested RSAs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;149,614&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;8,090,835&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4,547,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;SSI Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;525,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Pre-Funded Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;44,250,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;text-indent:10pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;53,276,530&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5,955,191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_29b5ff44-bd12-407c-9c1b-ed72f20b73c9"
      decimals="INF"
      id="F_3faafbe7-b0d6-416a-a578-460283a0e7bb"
      unitRef="U_shares">409717</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_dd649981-9002-4b1a-8b61-880d7062b373"
      decimals="INF"
      id="F_99f8134e-c5cf-4325-992a-f6b09f1a9c35"
      unitRef="U_shares">1257844</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_bda073bb-c8f5-46f9-ba1e-59d7b6cce834"
      decimals="INF"
      id="F_4355b4b2-668c-4a46-b1c5-5dd36c437081"
      unitRef="U_shares">149614</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_9e4fa149-1f8c-4521-8d30-073662fd12c2"
      decimals="INF"
      id="F_4e9be5b3-30f1-44e9-8cea-2d372e4b7b02"
      unitRef="U_shares">8090835</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_1fb76a57-582e-46ab-b8bd-4287ba306f26"
      decimals="INF"
      id="F_2c025c7d-fdf2-4f8d-8346-50e4a15c6022"
      unitRef="U_shares">4547733</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_162c443b-2d6f-4ca9-a115-4b08a2c7a8c0"
      decimals="INF"
      id="F_931188a6-db0b-4cdf-af73-04625b9fef8f"
      unitRef="U_shares">525000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_8da9a80f-388d-49d3-9c46-6ca3616d641d"
      decimals="INF"
      id="F_46a463ef-4f08-435b-a55c-b97ca7ba5b7b"
      unitRef="U_shares">44250978</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="INF"
      id="F_83d6761d-0fb0-4fae-a9e6-5b817794c6b2"
      unitRef="U_shares">53276530</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="INF"
      id="F_3f728cb0-5ee1-40cb-9ac6-474e48dc2b86"
      unitRef="U_shares">5955191</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_5fc1b327-691b-4706-8eed-9e5be6834808">&lt;p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 12&#x2014;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are provided if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets. There is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; provision for income taxes because the Company has incurred operating losses and capitalized certain items for income tax purposes since its inception and maintains a full valuation allowance against its net deferred tax assets. The reported amount of income tax expense for the period differs from the amount that would result from applying the federal statutory tax rate to net loss before taxes primarily because of the change in valuation allowance.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of September 30, 2023, there were no material changes to either the nature or the amounts of the uncertain tax positions previously determined for the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="INF"
      id="F_a4954892-c11a-4875-972e-16d839175703"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_4f12cb32-4aa9-4d4a-9590-adf4c1e7c3b5">&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 13&#x2014;Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Litigation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company is not a party to any material legal proceedings and is not aware of any pending or threatened claims. From time to time, the Company may be subject to various legal proceedings and claims that arise in the ordinary course of its business activities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt;Commitments&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In the normal course of business, the Company enters into contracts that contain a variety of indemnifications with its employees, licensors, suppliers and service providers. The Company&#x2019;s maximum exposure under these arrangements is unknown at September 30, 2023. The Company does not anticipate recognizing any significant losses relating to these arrangements.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_04e72515-9aa7-40ae-a650-a0b6688b4c62">&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 14 &#x2013; Strategic Reprioritization&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In March 2022, the Company implemented changes to the Company&#x2019;s organizational structure as well as a broader operational cost reduction plan to enable the Company to focus on specific clinical-stage programs for GAN and Rett syndrome. Substantially all other research and development activities have been paused to increase operational efficiency.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In connection with prioritization of programs, the Company reduced headcount by approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;35&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% across all functions in March 2022. In accordance with ASC 420,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"&gt; Exit and Disposal Activities,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; the Company recorded one-time severance and termination-related costs of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million in the condensed consolidated statements of operations for the nine months ended September 30, 2022, primarily within research and development expenses. Throughout the first quarter of 2023, the Company further reduced headcount and recorded additional one-time severance and termination related costs of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million within research and development and general and administrative expenses.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company expects payment of these costs to be complete by March 31, 2024. The amount of accrued severance recorded as of September 30, 2023 is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.8%;"&gt;&lt;/td&gt;
        &lt;td style="width:4.122%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:27.078%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued severance balance as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,463&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Severance recorded&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,691&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Severance paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3,162&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued severance balance as of September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;992&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
      contextRef="C_27c18364-0175-4f13-b9fc-bed49be4dac2"
      decimals="2"
      id="F_3eba7946-471b-4d74-b856-416807851a50"
      unitRef="U_pure">0.35</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent>
    <us-gaap:SeveranceCosts1
      contextRef="C_90d0d226-40ec-4b9a-8519-b099afecfa5a"
      decimals="-5"
      id="F_4c3e1801-e577-4b29-a599-062037a4ee7c"
      unitRef="U_USD">2600000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="C_997ec0ed-2c41-4632-ae98-d747ae5dbab5"
      decimals="-5"
      id="F_152a82aa-5bbc-4089-bd39-831236f18a97"
      unitRef="U_USD">2700000</us-gaap:SeveranceCosts1>
    <tsha:ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_1abc8484-0280-4c88-95e6-c95fb3103ffd">&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Company expects payment of these costs to be complete by March 31, 2024. The amount of accrued severance recorded as of September 30, 2023 is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.8%;"&gt;&lt;/td&gt;
        &lt;td style="width:4.122%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
        &lt;td style="width:27.078%;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;As of September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued severance balance as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1,463&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Severance recorded&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2,691&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Severance paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3,162&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#ffffff;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;"&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Accrued severance balance as of September 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #000000;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;992&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:#cff0fc;word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</tsha:ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock>
    <tsha:AccruedSeveranceBalance
      contextRef="C_d73f002d-37aa-4ddd-8f3a-08970ba84984"
      decimals="-3"
      id="F_58a9ed5f-bba5-45df-9481-6e64e22d0f10"
      unitRef="U_USD">1463000</tsha:AccruedSeveranceBalance>
    <tsha:SeveranceCostRecorded
      contextRef="C_fd17c3d9-bde3-44a4-b00f-89b6c9cd0d15"
      decimals="-3"
      id="F_f886e981-890b-4f09-b3ce-79130facf450"
      unitRef="U_USD">2691000</tsha:SeveranceCostRecorded>
    <us-gaap:SeveranceCosts1
      contextRef="C_fd17c3d9-bde3-44a4-b00f-89b6c9cd0d15"
      decimals="-3"
      id="F_d3bf96ca-0d01-4425-95d1-d3ae4863accd"
      unitRef="U_USD">-3162000</us-gaap:SeveranceCosts1>
    <tsha:AccruedSeveranceBalance
      contextRef="C_6310a863-a521-49ae-9a54-5fdd0104f020"
      decimals="-3"
      id="F_bfa06cbc-dc73-4017-b668-ee4b3eb4df36"
      unitRef="U_USD">992000</tsha:AccruedSeveranceBalance>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_a36a7b3d-d478-4641-b0ae-17573cb23e2e">&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 15 &#x2013; Retirement Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;In July 2021, the Company adopted a 401(k) retirement savings plan that provides retirement benefits to all full-time employees. Eligible employees may&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; contribute a percentage of their annual compensation, subject to Internal Revenue Service limitations. The Company contributed $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million to the 401(k) retirement savings plan for the three months ended September 30, 2023 and 2022, respectively. The Company contributed $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million to the 401(k) retirement savings plan for the nine months ended September 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_f899ecab-1c91-4d92-99fb-b948b9803592"
      decimals="-5"
      id="F_ef8a227a-9353-4d92-b4d5-b20388fafc46"
      unitRef="U_USD">100000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_b0061a32-1c5e-4190-b750-44c408af1f14"
      decimals="-5"
      id="F_c0c9a06b-e51f-47ff-93bf-2281c4171ed9"
      unitRef="U_USD">100000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      decimals="-5"
      id="F_1c0c965a-2945-4150-9576-b311c52789dc"
      unitRef="U_USD">300000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_0b1daf03-1138-4ea7-94f2-9e77213ae909"
      decimals="-5"
      id="F_9c900c96-dc88-4bfe-ae1b-7f8b43e1383f"
      unitRef="U_USD">700000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017"
      id="F_fb48c0fe-5b00-4bf3-9f98-0d54ea11d3b6">&lt;p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;Note 16&#x2013; Subsequent Events&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;On November 13, 2023 (the &#x201c;Trinity Closing Date&#x201d;), the Company entered into a Loan and Security Agreement (the &#x201c;Trinity Term Loan Agreement&#x201d;), by and among the Company, the lenders party thereto from time to time (the &#x201c;Trinity Lenders&#x201d;) and Trinity Capital Inc., as administrative agent and collateral agent for the Trinity Lenders (&#x201c;Trinity&#x201d;). The Trinity Term Loan Agreement provides for, on the Trinity Closing Date, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;40.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; million aggregate principal amount of term loans (collectively, the &#x201c;Trinity Term Loans&#x201d;). The Company drew the Trinity Term Loans in full on the Trinity Closing Date.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The interest rate applicable to the Trinity Term Loans is the greater of (a) the WSJ Prime Rate plus &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;4.50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% or (b) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;12.75&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% per annum. The Trinity Term Loans are interest only from the Trinity Closing Date through &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;36 months&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; from the Trinity Closing Date, which may be extended to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;48 months&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; from the Trinity Closing Date upon the satisfaction of certain milestones set forth in the Trinity Term Loan Agreement, after which the Company is required to pay equal monthly installments of principal through &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;November 13, 2028&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; (the &#x201c;Maturity Date&#x201d;).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Trinity Term Loans may be prepaid in full (i) from the Trinity Closing Date through November 13, 2024, with payment of a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;3.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% prepayment premium, (ii) from November 13, 2024 through November 13, 2025, with payment of a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% prepayment premium, and (iii) from November 13, 2025 through, but excluding, the Maturity Date, with payment of a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% prepayment premium.  On the Trinity Closing Date, the Company paid to Trinity a commitment fee of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;1.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of the original principal amount of the Trinity Term Loans. Upon repayment in full of the Trinity Term Loans, the Company will pay to Trinity an end of term payment equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% of the original principal amount of the Trinity Term Loans.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The obligations under the Trinity Term Loan Agreement are secured by a perfected security interest in all of the Company&#x2019;s assets except for certain customarily excluded property pursuant to the terms of the Trinity Term Loan Agreement. There are no financial covenants and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; warrants associated with the Trinity Term Loan Agreement. The Trinity Term Loan Agreement contains various covenants that limit the Company&#x2019;s ability to engage in specified types of transactions without the consent of Trinity and the Trinity Lenders which include, among others, incurring or assuming certain debt; merging, consolidating or acquiring all or substantially all of the capital stock or property of another entity; changing the nature of the Company&#x2019;s business; changing the Company&#x2019;s organizational structure or type; licensing, transferring or disposing of certain assets; granting certain types of liens on the Company&#x2019;s assets; making certain investments; and paying cash dividends.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The Trinity Term Loan Agreement also contains customary representations and warranties, and also includes customary events of default, including payment default, breach of covenants, change of control, and material adverse effects. Upon the occurrence of an event of default, a default interest rate of an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;% per annum may be applied to the outstanding loan balances, and the Trinity Lenders may declare all outstanding obligations immediately due and payable and exercise all of its rights and remedies as set forth in the Trinity Term Loan Agreement and under applicable law.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt;The proceeds of the Trinity Term Loans were used to repay the Company&#x2019;s obligations under the Term Loan Agreement with Silicon Valley Bank in full. The Term Loan Agreement with Silicon Valley Bank was terminated concurrently with entry into the Trinity Term Loan Agreement.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_6aeab603-0bae-4f76-9690-07fdf336dce4"
      decimals="INF"
      id="F_cda83925-daf9-4916-95ca-6cd7296f9e1b"
      unitRef="U_USD">40000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateTerms
      contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd"
      id="F_d2c96810-1873-4afd-8b0d-e60ae2d68ff3">The interest rate applicable to the Trinity Term Loans is the greater of (a) the WSJ Prime Rate plus 4.50% or (b) 12.75% per annum. The Trinity Term Loans are interest only from the Trinity Closing Date through 36 months from the Trinity Closing Date, which may be extended to 48 months from the Trinity Closing Date upon the satisfaction of certain milestones set forth in the Trinity Term Loan Agreement, after which the Company is required to pay equal monthly installments of principal through November 13, 2028 (the &#x201c;Maturity Date&#x201d;).</us-gaap:DebtInstrumentInterestRateTerms>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_7b13f58d-8442-4d48-a92e-3e9c2f531ffc"
      decimals="4"
      id="F_bf8c5ab5-ecc1-4808-b14a-0a5f92ae0670"
      unitRef="U_pure">0.045</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_6aeab603-0bae-4f76-9690-07fdf336dce4"
      decimals="INF"
      id="F_bfe80533-da64-492e-ab39-b873b42da718"
      unitRef="U_pure">0.1275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <tsha:InterestRatePeriod
      contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd"
      id="F_ac428606-dfd5-45a7-b41f-fbd4b9f940aa">P36M</tsha:InterestRatePeriod>
    <tsha:InterestRateExtensionPeriod
      contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd"
      id="F_dc455359-a684-4d81-a4a8-4314226f3ebb">P48M</tsha:InterestRateExtensionPeriod>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd"
      id="F_45818241-e07b-4c41-b3b3-78ad2d89da69">2028-11-13</us-gaap:DebtInstrumentMaturityDate>
    <tsha:PercentageOfPrepaymentPremium
      contextRef="C_de722255-5e4d-4b90-b918-c5cb3d32e39a"
      decimals="4"
      id="F_6f1c9bf3-a0d8-4d54-9c1a-ea88d47a38eb"
      unitRef="U_pure">0.03</tsha:PercentageOfPrepaymentPremium>
    <tsha:PercentageOfPrepaymentPremium
      contextRef="C_a3d12033-f85a-468b-8d86-8048a97ad7ff"
      decimals="2"
      id="F_20037e57-5782-46c6-b3f7-8b793cb60ea6"
      unitRef="U_pure">0.02</tsha:PercentageOfPrepaymentPremium>
    <tsha:PercentageOfPrepaymentPremium
      contextRef="C_df655a6c-a1e2-4b8b-b36e-5e7362c2c0fb"
      decimals="2"
      id="F_fec0b5ad-5b1f-47ca-ba40-7d455f4cb73b"
      unitRef="U_pure">0.01</tsha:PercentageOfPrepaymentPremium>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd"
      decimals="4"
      id="F_eed2b33f-2fe3-43f7-a7a0-b80a3dcdc9ed"
      unitRef="U_pure">0.01</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <tsha:EndOfTermPaymentPercentage
      contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd"
      decimals="4"
      id="F_8186d173-79fa-49bc-a52c-3a11add28542"
      unitRef="U_pure">0.05</tsha:EndOfTermPaymentPercentage>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="C_6aeab603-0bae-4f76-9690-07fdf336dce4"
      decimals="INF"
      id="F_d2346482-df09-4bea-8dc2-472cbcca3c20"
      unitRef="U_USD">0</us-gaap:WarrantsAndRightsOutstanding>
    <tsha:PercentageOfAnnualDefaultInterestRate
      contextRef="C_5ff42a86-3c0a-43b6-b4d3-d8ff970e8ddd"
      decimals="2"
      id="F_23baa426-7a97-4b6d-8358-0e95ea38bf82"
      unitRef="U_pure">0.05</tsha:PercentageOfAnnualDefaultInterestRate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>95
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M(5@YH 74^S53E-S=Z$\#_:>@U?]02P,$%     @ -H)N5ZY=>R#Z @  #0H
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MP \&E;L-ZN?FS7/]*+,%?PKFX%@&3=3&: -/>N#8'47!^RZ2\2"B-$KL1HA
MX<'5BV)J]WT$"0^O<'_T'G,1I)=$(8M"_XP\!Q?+G8[L6?(X2J8=Y4D"]:'G
M!.HCSPG41YX1:'CTYKV0U;+YY*&!]:8T^Q>LW=7NL\J;YF."=?V.W4P8<GW*
M;F;[CR:']/MO..]$M<Q*37*Y@*'H=033K?:?1?8G1JV;]_X/RAA5-(<K*5)9
MU0#X_T(I\WA2#]!]G!K_"U!+ P04    "  V@FY7.*RDTTD+   FA   &
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M)'I\[SD"59-0F@>E^5!: *6%4%J$HK7G4>,\B5YZ]ODTR0%U>@9@68XIGL-
M-2:4YD)I'I3F$UFRRELW@&:&4%J$HK6KW+A,\G\E,_5+T_MD"JHSH327R$)S
M0IV)*/^AH3Z4%D!I(906H6CM:=-83?(F6I-T\9KZZ-ZMAII-*,V#TOPN&S>
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M,\7,._%(!CFMN;F6FZ_0YN,"3"77[B_9M+Z!1]):&UFV8(R@9*+YTH=6AQT
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MW++ .0_*.N!Y+J79&O:"[I=#_!M02P,$%     @ -H)N5]+>-EM4"   =B@
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M<VAE970X+GAM;+U9VW+;.!+]%91F-F57R;K:GDE\J;(]<39;F<1C9S,/6_L
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ML7>M8>1'('$ZG1Y,CM%+O][?9!T6==L5U38=:PY8YWT'$)3P;Q^3A309JUA
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M  !N-0  &    'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;,5;6W,;-Y9^UZ]
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MH #O*<JB=F;:UNNMB&6Z.M$EN(#7DME@%V08GY:L8"X'QUI)\)GI$8=>1XQ
M0$E>UQRL6[1OR?]K9$4(7KNEBLK9IH6^6K@[<VMJ+&O4U(&[RC5)>-)-X'[3
M=6?.-7C4D"+_:&TMH4:!R#(5\*D24;AU5Y;-_U7#^85K2^QF%-4K 51^;RLI
M")+7?9V0V*'D!T24'0'QT#V/@)()K:"AJ[19!$T"-J9"[A*1X%O$C#9H K&6
M+F*K3_K>+S0S;RFN%XYPTMT1V/EVXNW4ZAJ ?J0NRU)V#IPH9,#*ZP U1""Y
MY!JL36D!G+I)<+V6ZTA]AM' PEO?V"4#,$DJ\"Z2X^8.81X@/[M*\!V?Q31A
MX%+?&&72+HQS'A7F*J#D0L/_9S,*7U)/S38!QWJ9U(3G3;!Q:?7$EK:Q@=34
M^J)TOJU9&/!%X$X[[UHCNY"M8C3L]*==[)@O*S(\0K-E %D_QZF/HU]"?NE\
MHWR6K'?K88>[[H [<G12+LL2$F2R6H*M6UVV24PXSA+W4:\6-Y2?":Q<@ /H
M!CNLV@GJ!SP_,RQ7;__=A_?[!ZJGB5T\MFH)3K"*B1Q2K3UE=( Z>/>#?I20
MUL,/VAE<5+0$OZ\1=$%R^H+%8()=SC**&LXJ;%;@6.E6[$-1W9(@ED:3M2,8
M6ZC+UO%;Z:KY8<EP*?;O[U#&G:YKLD=TC?M^LCAPTA5)EYR. <%R 4G#,'6)
M@<ILX-0E$G=90EV?\NCL<14SDQ*&FJP#<D/R5:IB"1S,2F)2H'2WDU"!(%K'
MKI2_2&Y2,8$_J@97P\U*UAA@@_(+4;@%AK@6K@L6:W[<U9XXL89D@3T%?[VK
M]*0D*(? XC.V+MHE/(^ I1\<79(=="/)E8 @Y$0J.BEA(.3)XK^WTWF(I@FZ
M3:$(Q3.,LCF^%MVR8>'J*2W)0T]@ ^J@%$>YPU*!N:+:E%1"N5+$]:ZM"T90
M.*(44<S_4M\#/,C54X$%"KRPZ5H!9I$X,5^X+".RAO=.E9D0,@R_$]/<$?CR
MBJXE.QSTM\=[VQ"695I&=R_>1W4?L@!L)7!)=<77&H%/S.LZ(U1.%0L-A-P)
M.#E:Y05]I$B^+)@K82 M2H22K 9X6DI,A>O#O PL^4*1(4V +VH[B0%TI*ZT
M%Z3@#V^1>>!03#C=*>B#R>Z$TIH3&WP<F=*4O+\FQK@;@'9,<1/@BF3OYS>]
MOL4M'^^)40'RE;F'+]0WJ.2(L&!_4&Q"$,\5V,+.%_"STH(OVOO6Q-)36BB
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M'^VUQK?IH*44-31&J(9I6)V.SZ/CBY36NP5_"MB8O3$C3Y9*?:.7#^7I."1
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M*>*94.==6G*LSH?*TES.K5B7)IIMY#/+?+>_"W:[4E7C8(YU#@UCNTQP1)O
MQALM V_Q8-- ;.E<06>NB%-_EE)7%=(S%.*,P+I*$4\$N@+I%F+0.J_V@ YA
M$I@''M' .J!NF_?:(O4MM:G.X*XK+3=2(OV/+.J=U173-1)H#$Q,NPLP5I5
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M2E2H&,0A67I[<>171#FJY4/7^)H7Z^,%>.SN]#'ND!0@_@2DCR)>BJ\PZT)
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M[S2;L(#]1NG-P512-4>'#F3DLF(Z&)!N^M<U^*9;.?)=T&'7:76*7,X-_<&
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MXUSYCZ Y%EG-&-U?YXD;^,3 R *  F925&>R*@^$0<+9K:Y_+$I8_%*4H$;
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MJOS*Y8HN9+478>EBY_^<K_%;%;/%68BQ%=>.!=T>2J17J'76H2MRH)X[\=>
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M1IR"ZJFSI0@ %H$7_M]5]WM<TZB(%CX-1U](+V2.@M24/H0L A@&VVD!BK)
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M "WBQ[F22$R:@.]3BYQ.+Z2@_<7N\I]02P,$%     @ -H)N5VK\5,E;#@
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M"FE,$BMA4 ]#P],W!"I5R!]/Q<7XK X:NO%@Q/+H0HY@C1+C0N<%&8JXI6@
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MS;-*E^$1G?9X>- )?EEKP"53*UQ%GED<A6ZN?N--R0_L+(WW)N>7&R51H.D
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MX[1/=/V,KB=6K?W3=:$L/H3]L,!_'J#= =Q?*KSJFHDST/V7F?T/4$L#!!0
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MP]?0_V>M7L7:S_2[\0C](7QX=Q[W^U=P."!\U?!-V"3GTL3'X'.$&U.40F]
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M6(. <98_O'[$@SB$>K&29NFA#1#4"(+6V96LT>]ZE;=-)PM"*5AT2CTF'FQ
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M"#BPLY&VNU?FP8M/LB N[W"RFSUX9WO.<1FG_T<MTK0;\:Y;[T/#GJ4_0R"
M]8&AQ^?U/[/?\3DW.3-JVY6F5"/.I_C\7V5!X>1,%(Z>GRR8/\7FAA"M4D"
M?Z4SG$8R8[8$F=UXV,^$GYH-]IU-[LPLS]:EM.[]B>=P<8^3Z_ "3.O9&$8T
M+@KH$B:I8#!5N1H%]D0[>> :>RSK>BV]UJ;2K1E?B6<=X70BU?';#3E4$5@
M^954RY4RN95KU79Z3D)^M83'::Z8Q%A@+ J5'48^]ST4;8,6OEAKU,G2YA2G
M(#37(-(!CZ!!$P//\%+H80<G4IWZ@P>JV$,'0O)3N>$J#^XWPV&/*YVI*:#I
M K,-K<;7=B"8QH>W>RS. _W;.J4,W*AL1 K;ODLWR3.Z<Y]MG*=V*,$2E2"<
M0)_#=MPS;GJ<)<B0S]C?%^M_9'?V?J<Q.^2!G_ZJDCTBIZ#)I'9CJE;!';ZY
M68AEH =@_\[AZAZPCW%OP,[H ]3#^GZ=8N'@_17/LU3FRF=L%-ULAJ+!!#UR
MDG;%-74:?#D<0L8].ZC602D4XN"M86>FP@GD&4(BIKK#:H\\KL>,PM%X[BBL
M@2]N H#JTE05@PEH0?&[6&V<NSD&[-/-Z9R15;I;CBZ"]#!)&1ZLBE+N9LC!
M8)S5:BQO(BC%0[TV![@:S#^\95U1X5N[1V9UA-:,QKS;S\7%&\U')Q?'\S @
MQ15PZ<7QQ%\:^=?PJ* 8^=+LB=EMZ[6ONI67)^^H,D/ZW/965L]CGLGGXW<D
M_5RPYA=2Z$RE<WK?6A&-E#>YHUK*!_=&UV><LO;4%UOE'E:< P %\/BV]Z,Z
MM=%9>E2;(PN=O*-.)F -3\^.9T'#4;AV&B7T&57AJP4XZ><S2*QN2Q[7#/13
M-VZ;9+_Y:6M+.LD@9(O>0\(9^7E@$%:E/HO32<BC8W95T' HIS,S;KDQ;[L7
M!,FMMJJR$1<@:LN6/-58N3RN_<N27W5L"F:V%SP6E=]=@T6' XQIIE!'-,5I
M7X'T9P33(+]#8ORY %+W'HPCHB1I\H;['1R5)KK>)6[4%O%@]6@K?/>[3?QV
M7]]39IGI==0"!-_U.8J.?F3[R@$>BM#!8K\018B@9[;G[8'\"CS !6U;QM4T
M;N<?2H#3VJC-"4>"_67]4WCI8:5SK^4K%/E/*NT'Y(D0HT#1#B\/KL%-/6L_
M(8'X)P#ASB)ZK7:!P[/=:PZN@F17L60W,?<?@F0''T)(^#=:+@\^[GH!ZAMQ
M?CZ:C2\0QT>3TSE>N!C-SZ8''RC%0THR$ (#1PKD^Q[?850VO#LE!F(V&D,S
M.Q2GXQ?P;3J:OYB)X<%/?LHS$)/)>#1],8%'!N)L?DK_\=J+V1D\^!3YZ'V.
M]VB=@UAU;MH S0AX3A@KN1$36;2Q#!8M4-#)+T'*Y4'G@,T+](VX((5,\=-D
M?/"3*8Z(%H>3?XRRV?0EZ&T\F_#?@RMW/MO=L/<8]?)@X5Y4"R\>M8?K_EPY
MQK^!.!^=G\Y(>1=3]W]T>DXJC)P76TK7H76D=18=H*'G<U@^GYTB43#:\."F
M@;+*UQ[=L4\!ZD7R_)H*T2S2WAW SWKJ"K/$;H2MH+ZX >G*U[<=$;U*I^!1
MP)S[]W]$B6Z[_Y] P2>B\$PL>+SH?PP&D[/1#.+T&S&[F/'7\_/Y<Z!@,IK.
M,<XG9S/Z-CZ_Z$+!%'88GY/S3J=C_G\V.IW"I;[A[4GT&Z]<56OZ)1N=O!4U
M_]PK7 V_EEOP;\3:Q_FG=C_*:JT+K,57L!2*F--#+A?\E]J4](NQI:EKD]/'
MC9)01N$#<!]_"."_X ;A-X1O_@U02P,$%     @ -H)N5R2XQW]8!    PL
M !D   !X;"]W;W)K<VAE971S+W-H965T,C4N>&ULQ59-;]LX$+W[5Q!J4#B
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M;ZF@K %^SZ4TW<0&Z.^]BV]02P,$%     @ -H)N5XJ<TL,Z P  70<  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C8N>&ULC55-;]LX$+W[5PS4HFB!;/3E
M-*EC&XC3#;9  P1QVAZ*'BAI9!&A2)6DXOK?[Y"2%67A>GN1..3,F_=(SG"^
M5?K15(@6?M5"FD506=O,PM#D%=;,G*H&):V42M?,DJDWH6DTLL('U2),HNA]
M6#,N@^7<S]WIY5RU5G")=QI,6]=,[U8HU'81Q,%^XIYO*NLFPN6\81M<H_W2
MW&FRP@&EX#5*PY4$C>4BN(IGJZGS]PY?.6[-: Q.2:;4HS,^%8L@<H108&X=
M J/?$UZC$ Z(:/SL,8,AI0L<C_?H-UX[:<F8P6LEOO'"5HO@(H "2]8*>Z^V
M_V"OY\SAY4H8_X5M[QL%D+?&JKH/)@8UE]V?_>KWX4\"DCX@\;R[1)[E1V;9
M<J[5%K3S)C0W\%)]-)'CTAW*VFI:Y11GES>,:_C*1(MPB\RT&FG'K8&W#RP3
M:-[-0TM9G&^8]XBK#C'Y#>('N%725@;^E@46+^-#8C=03/845\E1P#4VIY!&
M)Y!$27H$+QTDIQXO_7_)'[G)A7*J#7R_RHS5=$M^'-+<04X/0[K*F9F&Y;@(
MJ#0,ZB<,EF]>Q>^CRR.$IP/AZ3'TY9HJL6@%@BKAADLF<\X$7!F#=%!,%O"9
MLXP+;CG)Z$^Q &9AI-05 -QCWFK-Y096S'!S2.=1)H=U/E0(I1)4W@[9^GL#
M?EE:X+)K'+X",^H*8,G]6M4-D[LWKRZ2^/S20#FH8L^JQ$A5/5)5.E5/SZKT
MH"ISJGPLEP7/F46?3> 3"K=YSAA%5QPUTWFU@]80M%54SA8U51E2D\JKD2\5
M!)<4KUI#\.;=;$*WTF*=H1ZNYN1!65+PV6>+^W_2_]-)=UZSR34S%>#/EA.P
M+S6_"_$EU$KBCFI;/U(O+EM* Z\A/HM.SN+IBY$/2"Z?1Y,_]1M=E-GD&].:
MT1'M]WDW6:\_03_K<I]'\2&4;F5RI_$OQY)V;KN/B=,/)Q=I.GC^Q^YW:'RP
MQ'=*?-.7?/=Q'8=#)12.6EZ->N,;NX%<M=)VW6^8'=Z.JZYE/KMW#\\MTQLN
M#5V3DD*CT_.S '37S#O#JL8WT$Q9:L=^6-'[A]HYT'JIE-T;+L'PHB[_!5!+
M P04    "  V@FY7N,FGSDT$   7"P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970R-RYX;6RM5MMNXS80??=7#-2@2  ANLM2:AO(;;$%=ML@V;8/11]H:6P3
M*XE:DHJ3O^^0LF47=80LL ^F*)%SY@QY9CRSK9!?U091PTM=-6KN;+1NKSQ/
M%1NLF;H4+3:TLA*R9II>Y=I3K4166J.Z\D+?3[V:\<99S.RW![F8B4Y7O,$'
M":JK:R9?;[ 2V[D3./L/CWR]T>:#MYBU;(U/J/]H'R2]>0-*R6ML%!<-2%S-
MG>O@ZB8U^^V&/SENU=$<3"1+(;Z:EU_+N>,;0EAAH0T"H\<SWF)5&2"B\6V'
MZ0PNC>'Q?(_^P<9.L2R9PEM1_<5+O9D[F0,EKEA7Z4>Q_8B[>!*#5XA*V1&V
M_=YDZD#1*2WJG3$QJ'G3/]G+[AR.##+_#8-P9Q!:WKTCR_*.:;:82;$%:783
MFIG84*TUD>.-N90G+6F5DYU>W+"*-07"DU7 K:A;T6"C%9Q_8<L*U<7,T^3&
M;/:*'>1-#QF^ 9G#9]'HC8+[IL3RO_8>T1LXAGN.-^$HX!.VEQ#Y+H1^&(W@
M14/,D<6+WA7S(U9,8PEW7!654)U$!7]?+Y66I)A_3H7?H\>GT4T67:F6%3AW
M*$T4RF=T%C__%*3^+R/<XX%[/(:^>**L++L*0:S@06++> GW+Y2BBFBSIH3?
M]08EW'92TC7"M5*HU:D@1MV<#F+O#X_]">NOV/ECUA\4@K)6F5,EFK0!5J*B
M].?-&LYY0U]$I\A875Q-Z'(UUDO",#=\A\7N)7 G>W^& )/%QOHK\9DJ25L;
M;V<0NNDTI&?L9K$_&!04#B]8!5IR&@,WRD/:&@3YY Y72%0-,9H80H50Q'@:
MQN8W0/"&E&!5$D53B+)LTA]L[,<0I^GDB]"$W+[[1,X@<9,PIV?F)H0X(H5D
MD$+R'5*@,BWU*SR0M+6E<?^MX_TQ_8;ZE )&T=]20._&A7;P@WL_+C243C_F
MZC\A5=J-J.@BZE:*9ZQM43(7[N?!_CGYQ)9",BWDZX$&+65IUH\34] Z3:"'
MY8!TD/3CY$,G&ZXIY6TD*_ZB;?IG:0Q9;JP;*@-=__]!Y(G)FM85I&XVC2%W
MTRB:!)&;!2$$J9OZR>2Z*+JZZRM*B71R!6?6_-QH-8[@@F8!S4*XF+SC.,\@
M(*JI$4X0NWD:C2DG'923OELY1%AV.!21$S6$#IE77',\64=&/9U6T=[E2-94
M?'#Z@Q2U=SI23!(WS?L,#7)_,"A(0D2SO\70G<8)C0F5$JO18Z;N0+\5TFX/
M*-<S,X;! >]_Q2G):8RGT;!%$:V^^.14N&@M/:R1!E<D04(G8Q.#.1YJ0<QQ
MK)".*YGF$!WQ;\=$!C8:/PMVY2W- D@3?U?>V/==%$DTHI3(S"1SP^QTE?..
MFI4:Y=JV9.:6NT;W?<OP=>CZKOMFY["];QD_,[FF0@T5KLC4OYQ229-]&]:_
M:-':UF<I-#52=KJASA6EV4#K*R'T_L4X&'KAQ;]02P,$%     @ -H)N5\K=
M5?70!   APT  !D   !X;"]W;W)K<VAE971S+W-H965T,C@N>&ULG5==;]LV
M%'WWK[A0URX!/%N294MR; .)LV %DC6(TQ;#L =:HFVADJB25-SLU^^2E&6Y
ML=6L#Y+X<7GN(>_A)379,OY%;"B5\"U+<S&U-E(6XWY?1!N:$=%C!<VQ9\5X
M1B16^;HO"DY)K =E:=^U[5$_(TENS2:Z[9[/)JR4:9+3>PZBS#+"GZ]HRK93
MR[%V#0_)>B-50W\V*<B:+JC\6-QSK/5KE#C):"X2E@.GJZEUZ8RO?&6O#3XE
M="L:95 S63+V157>QU/+5H1H2B.I$ A^GNB<IJD"0AI?*TRK=JD&-LL[]!L]
M=YS+D@@Z9^GG)):;J158$-,5*5/YP+9_T&H^0X47L53H-VPK6]N"J!229=5@
M9) EN?F2;]4ZO&: 6PUP-6_C2+.\)I+,)IQM@2MK1%,%/54]&LDEN0K*0G+L
M37"<G-U2G)* LT>R3*DXG_0E@JJN?E0!7!D ]P1 "'<LEQL!O^<QC0_']Y%,
MS<C=,;IR6P$7M.C!P.Z":[N#%KQ!/<.!QANTS_#ORZ60'$7PS[$Y&@CO.(3:
M&&-1D(A.+52^H/R)6K-W;YR1?=%"T*L)>FWHLP5NM+A,*; 5:+(P9T(>8]F*
M<YSEXX;"BJ6X]Y)\#5)%N=J R;^X*A*[4^TS0I\"MUG$UCEVQ5!B/#E<+N80
M>"Z0/ :&UAR2W*0"M:<*RB5N? W---B<907)G]^]"5S'OQ" V8.C+1JD)@XX
M6!O*#:=4P^)P"ID1$54B I2 I-D2G>UTH VQX,)9DN-85@IL$>?CSJ/&:6KP
MN^$WE<,_E9O3=AWM1KNH2YT/A^SU(L$O, I'^/9##]]NUPX"\_7#SB=<5[W&
M#7O70S0W!!^?D>-W'IDDZ2%@. CQ[7258P45.+[^*D<M"AO6"AN^6F&+LBA2
MBFE5D7C?B.4#38G$5<% /M"LBJK1XR/EF8[ =2(B5N82'M#TF$)_P*/INZDC
MOO>M0L5K_V:5Y,Y_O/./44'Q<'Q$)6\Q[AR1S36-JA:G:T+Z6>=I]$6>,+;K
M$\Z4RIXIX>(<M)2="[A)<I)'=*?C0<\9X"L(?A[QP_=[P[%[H0^.T_.&+U$/
MYWZ"%2(,77BKOPZ\?2W*"R9^SP\1!C^(UJ+ 4:W T<\I<$[$!FXP?J>TN*=F
M$ODQU;7Z/IX7#TA$BL1*D6@1Y0\SVZ$<7R2J_YV'&MFG)FCRYPO7*E<XMLHA
M@>>W90R_CI?_ZGC=E++$J=VAI+,R4^N0)5*MG("/^HRH5N97T0B6VJT[;9X.
M7"N)XX&[%%I#+[9Z%U:&9U;QC!H\#\\R4VN/J>*_.MQ;6]H>X+]P=ZN(JN$'
M>6>_*M6*F!CC.1*H<\1Q/-7@Z;QO@S?4U2%6PWUUA%4O&,(@#%75Q^K0]\T&
M=B_P%$1R9(69!IRPZ[O.OJ=QVA3DV:P'LG*"$ \<SW4ZMU2(,21942JU)SF"
M4#R5SC")=(-P".=8=''9S@^P4CSGDC21B9&?W77U<8C > S>?F_2Q;LLY^A;
M&828.#'#'3'*6?Y;;1BBI!T(!MZK_1Y5?K]Q.<XH7^M?  $Z"YI[<MU:_V5<
MFLOUWMS\HMP1ODYR@4Q6.-3N^7C<<7/M-Q7)"GW57C*)%W==W."?$N7* /M7
MC,E=13FH_[UF_P%02P,$%     @ -H)N5PA[UKGC @  708  !D   !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&ULC55-;]LP#+WW5Q!>,;1 4+M.TJ\E =)N
MW7;H&C39=AAV4&S&%BI+GL0T77_]*-E-,RP-=HGUP??X2)',8&7LO2L1"1XK
MI=TP*HGJBSAV68F5<$>F1LTW"V,K0;RU1>QJBR(/H$K%:9*<Q)60.AH-PMG$
MC@9F24IJG%APRZH2]O<E*K,:1L?1\\&=+$KR!_%H4(L"ITA?ZXGE7;QFR66%
MVDFCP>)B&(V/+RY[WCX8?).X<AMK\)',C;GWF\_Y,$J\(%28D6<0_'G *U3*
M$[&,7RUGM';I@9OK9_;K$#O',A<.KXSZ+G,JA]%9!#DNQ%+1G5E]PC:>ON?+
MC'+A%U:M;1)!MG1DJA;,"BJIFZ]X;//P/X"T!:1!=^,HJ'PO2(P&UJS >FMF
M\XL0:D"S.*G]HTS)\JUD'(W&CC@CPL&XL(B<;7)P,!-SA>YP$!-[\'9QUK)=
M-FSI*VSG<&,TE0X^Z!SSO_$Q*UO+2Y_E7:8[":=8'T$WZ4":I-T=?-UUN-W
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MM2)5O:.JB9&%>[NLI:&7D!NF]/1$90_0?B+I.UY/[ 7-8W;Q#U!+ P04
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M60R=?^WPC>/6'-C@,DF4>G*++]G,"YP@%)A:Q\#H\XQW*(0C(AF_6DZO"^F
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M;KJ-:]X8<+K]^:NZA6XDS<5? R.X:EKTAEO4D?E2E"2F"TN%7D'Y$[66/_V
M?>?G(2TA80$D+(2$14"PWASPNCG@F>A+%:>HUCHM8L9+UL@\)*P1<ZZPD+#
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MLFF[F!8U[78Q[<*%DV#58&:;I/OW.S8$Y8-&N=A-8N/SOG[.P1^,-T(^JQQ
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MZ(&X\^,)BX?JC8]%Z^K1E @<<XW@)1F0&3E8#K.#CGTT5O)0'?&Q:%TEFK*
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M#9G0#\#W6K&'&]U ?4YW]1]02P,$%     @ -H)N5T#(!;#K @  C0D  !D
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M++DH-I#?/Z9I_O*A2'!XV>/-_P%02P,$%     @ -H)N5V4 YO=_ P  ;0\
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MU<#MJ'[O-9HC6-W'';M&XR;T%@S47H72*)3&4#1;,,9>#=SVZG<.>-S0H\.
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MJ>K<K3I&YN71-9<&#\*RN<*K"B@;@.\74IJ7CCT-F\M/_!=02P,$%     @
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M+4"U$-4B5(LIK9.5P[;68BBOM=A>?J4*QG3^5$5@74NQV!S:._1J5)))#/D
MC@U)5--1S4 U<[A?#:%=],YBH/W:J.:@FHMJ'JKYJ!:@6HAJ$:K%E-8-P+;$
M8GC873->#<#59:F.S3ZT#@/5=%0S4,ULM)ZC1'O9A]98H)J#:BZJ>:CFHUJ
M:B&J1:@64UHW^[0V^^2%&,WQP>_*9U&62F=*0]^9HOVPO0Y!;\:AY1>HIJ.:
M@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD6H%E-:-P?;.HWA\.<X8#A$RSQ034<U
M ]5,5+-0S48U!]5<5/-0S4>U -5"5(M0+::T;E:V91[50^DVX[$W$I)[1V<>
MJ>FH9J":B6H6JMFHYJ":VVBR&PFA'?JH%J!:B&H1JL64U@VRM@9C**_!..8,
M/CEU=(:AA1BH9J":B6H6JMFHYJ":.^PI8.F[XX#7LZ#:=YS41\<7H%J(:A&J
MQ936#:FVQF+X2HW%'[_;F5P^.K/0^@E4,U#-1#4+U6Q4<U#-134/U7Q4"X;[
M]3J]YS"':+<1JL64U@VVMGYB^%K]Q/9TDG8W<ET.FTYZXVS_?/#>;[I/\HZ/
M3BJT/@+53%2S4,U&-0?57%3S4,U'M0#50E2+4"VFM&Z<M946PX,J+;:5%7]V
M3A4MPD U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4*UF-*ZB=@680Q_DB*,
M(5J$@6HZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):A&HQI76R\JPMPCB3%V%\
MEM969'?3]"&IPU!VRUMY%\?&(*KIJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ
M4:/M'A73+OIFBF*JWV[$M6469_(RBR_)5/3=TWLA\OW[_*PN'95]2Z:K>Y]5
MN3<7F_J+['YO\4(:BV@%!JKIJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJT=FA
M]4,QU>\Z%D^+1R%*/2F3VYN9R!_$)S&=%LHX6\[+^I2DG6>K+;W[^G:0UQ^T
MD].]YS^JUY;:\[RM7CM]S[OJM=?WO*]>!ZOG3]OAW-XLD@<1)/E#6NU>3\5]
M-;3!N]'YB9*G#X_;'\IL\?ZD>G?NLK+,9JN'CR*9B+Q>H/K]?9:5FQ_J#IZS
M_+?5R[_]/U!+ P04    "  V@FY70M0ND.48  "F@ $ &0   'AL+W=O<FMS
M:&5E=',O<VAE970U,RYX;6S-W6MSVEB"QO&OHO+LS*2KTK8DKLXDKNI8]UNG
MDNW=%UO[0H%CFVI ;B'B>&L^_$I"MC@@CB']W_%634W'&/V.A.%!$H\.[Q^R
M_/?5G1"%]GTQ7ZX^G-T5Q?V[BXO5Y$XLTM5Y=B^6Y6]NLGR1%N6/^>W%ZCX7
MZ;1>:#&_,'5]>+%(9\NSJ_?U;9_RJ_?9NIC/EN)3KJW6BT6:/WX4\^SAPYEQ
M]G3#Y]GM75'=<''U_CZ]%5]$\=O]I[S\Z>)9F<X68KF:94LM%S<?SGXQWB7C
M<;5 ?8__F(F'U=:_M6I3OF;9[]4/_O3#F5ZMD9B+25$1:?F?;^):S.>55*['
M'PUZ]CQFM>#VOY]TI][X<F.^IBMQG<W_<S8M[CZ<C<^TJ;A)U_/B<_;@B6:#
M!I4WR>:K^O^UA^:^^IDV6:^*;-$L7*[!8K;<_#?]WCP06PL8PP,+F,T"YNX"
M_0,+])H%>CL+F(<6Z#<+](\=8= L,#AV@6&SP'!W@<&!!4;- J-C1Q@W"XR/
M7>"R6>!R9X'#?SC]Z2^G'SN&\?S'WOMK'USDZ<]M'/WW-I[^X,;N7_SP(D]_
M<J/^FU]LGK[U<]]*B_3J?9X]:'EU_]*K_E&_@.KERZ?\;%F]UK\4>?G;6;E<
M<?6ER":___RQ?+5,M>ML44;(*JU?A#]KOTRGL^J?Z5SSEYM4J7[QQA)%.INO
M?BKO\ML72WOS;S^]ORC*5:G BTDSK+49UCPPK*'%V;*X6VGV<BJF'<N[ZN5[
M+RT?J)>_5"Q_43Z$SX^C^?0X?C25X!=Q?ZX9P[>:J9MZQ_I<JQ</UO-S33<.
M+FZI%X_31ZVW6;K7L;2M7MH17\\U<WQP<>?XQ<VN/^41CUQ//SBZ]]*FY^>J
M;?>/'[UKY8,_M_+AGQL]>N%9DRZ?GS5=H\?JQ2TQ>7[HND9/CA_=5+R$>L]1
MU*N]WJ$'XR[-A=811;_D>;J\%>4>1J%]?-2V[_<I?:QO_N4AS:?:?T4EJ?F%
M6*S^NV-[/F[&[W>/7^U5O5O=IQ/QX:S<;5J)_)LXN_K;7XRA_H^N%S2)621F
MDYA#8BZ)>23FDUA 8B&)1206DU@"85+R])^3IZ_2KSZ)?%*F2'ELHV4WVB1;
M+,K4655[1MI]/IL([7Z=3^[JP"GN\FQ]>Z?=IX]Y-I^7AQ73=7W4LNH*'.6P
MIP8.B5DD9I.8L\$N:ZPZ4OUVI9^/!^\OOFT'"3FB1V(^B04D%I)81&(QB240
M)@7)X#E(!B<$R7Y&5+>*Q?T\>Q3B[ZLJ:=J]G.DZGRUORWO<B/H?]^5_LJY#
MFX_*=3@U54C,(C&;Q)Q!1ZH8NZE"CNB1F$]B 8F%)!:16$QB"81)J3)\3I6A
M,E7B]/MLL5YHR_7BJ\BK#%E5AT"KYRA9:8OT\7DGY80D48Y[:I*0F$5B-HDY
M&VRPE23&6-=WDH0<T2,QG\0"$@M)+"*QF,02").29/2<)"-EDFS.]GZMCV2D
MG0_QO?JWZ,H(I7AJ1I"816(VB3DDYFZPX5;@F'I?UW<SQR,']?<'[?='^X,&
M^_<;7/9&>_<+]^]G]"X[MB(BMR(FL03"I!?N^/F%.U:^<.WFG5ZK7\':IZ>W
M^D_S=*F]L;]\^M3U(<Q')7KJ:Y?$+!*S2<PA,9?$/!+S22P@L9#$(A*+22R!
M,"E.+I_CY/*5/VJY)).'Q"P2LTG,(3&7Q#P2\TDL(+&0Q"(2BTDL@3 I>0R]
M+9SHREV9Z^V/5YH!IMI-EFLWZV)=QLULM5JGRTGGP4AC;Q]]C\S^WE[DM7H=
M3HT,5+-1S4$U%]4\5/-1+4"U$-6BCF?YL&?JHYWSU3$Z:M(Q:F_<'_4NGT>5
M7_%;%3-#?=:AVHMHSCK<-WL1:;47\;8Z[S#+-[L>A\]2OL ;NO8HTKSK ]AK
M]:(GYP"IV:CFH)J+:AZJ^:@6H%J(:A&JQ:B64)J<*6:;*2:0*=.TZ-Z-4.-U
MLZVNMFFFWNNL<ZJ%DX.%U&Q4<U#-134/U7Q4"U M1+4(U6)42RA-#I:VA&HH
MFV8[%8YT7615[WVBS9:37%2G7,4WD3_6>QSE;7)9K/E8]N2#FEY'.4$W=@]I
MT,(IJMFHYJ":BVH>JOFH%J!:B&H1JL6HEE":G#AM^=105M)4NS*%R!=U::S^
M61TB9(GN&M4L5+-1S4$U%]4\5/-1+7CA25W<B?V^TFZYNKA+RZ=Z^>[X_#:;
MSN>/6CJ=EB^%\E[E?O@Z+=]LC551-R?3R=WFC;=Z8TV;,P;5;];W6I&5KY;E
MYDS VWH8L9S4-:BE5JW,S2POE6>Q).;S[*&Z0_5;_].O6KJ<:F(Y;99Y4_U8
MONG/U]4M/[5+OJV/"=Y6;_YI^;]%MBY?K^*/=3JOUZ'$YF*UVFSWF]E/I26J
M-:UV*K0WQKG^UY^JWU3W*[*B7*CS44KO9]7O-@]3MBY61?J\9I:8B'J17O.X
M5%;Y)YN(^A[E8UAN1?D@50_%VWJKWLS*]1B9_;>ZKA_X6YQWO@60SY@(U6)4
M2RA-?@MH:\.&NC><O/1*J9*_?$VLE]/R;M7'_9UO 8.]$WA[Y\71NB^JV:CF
MH)J+:AZJ^:@6=#R)C+[1N^SM%'K042-4BU$MH30Y&]KRKZ%N_QY1_='^J34=
MX<Y80%N^J&:AFHUJ#JJYJ.:AFH]J :J%J!:A6HQJ":7).=-6@XW1*W>"#+1*
MC&H6JMFHYJ":BVH>JOFH%J!:B&H1JL6HEE":'$1MU=E0=YWW#H;2=7&7Y;/_
M:<ZH*\^"C?<[#$.SHQ^$EIE1S48U!]5<5/-0S4>U -5"5(M0+4:UA-+D\&B+
MS8:RO7CU6:R*?#8IRJS8'"_]MIP5G7,SJ*&3]T;0CC*JV:CFH)J+:AZJ^:@6
MH%J(:A&JQ:B64)H\K5M;5S;U5SXL,LD6YS6J6:AFHYJ#:BZJ>:CFHUJ :B&J
M1:@6HUI":7(0M2UJ4UUS_B3R>A+.\LBG_E!OD>:_BZ+I#>3M;L_F Z-UM=M3
M'4-EQ5UU,'5?9]:W\F[E79H)(@XWKM6K<G(DH25L5+-1S4$U%]4\5/-1+6BT
M[</VP6!X.;[<^= )'35"M1C5$DJ3P\9LP^:'Z]72O!&3;%5HRZS0'D51AM D
MNUU6YVG>:@_U)-MB^G/Z3>15F;(M:S1WJY;OS!ZR37J-:A:JV:CFH)J+:AZJ
M^:@6O/!*,'1ML9DJVNQKT_2QZUQ"B*Y1A&HQJB64)N=2V\XVU>UL12Y]_O+;
MQ><OOVBWY6%9T3DG^$<U?G*TH(5L5+-1S4$U%]4\5/-1+6@TZ=.(GCGHF;N[
M-6C5&M5B5$LH38Z/MFIM*GM\5[]63<I54Z6\5QU0E6GR]\[3QNH13LX04K-0
MS48U!]7<1I->6:.!WN_OS(F%CNJC6G#D-H3HJ!&JQ1W;8)B#T7AW(Q)J6/F%
MWQ9L377!5K'?L%XV9T5V=B"..]+IC AT@EY4LU#-1C4'U=Q&D^?-TSOFS4.'
M]5$M.'8C0G38"-5B5$LH34Z2MHYKJNNXQQ^!M"=!M*>3(/5OZJO2M9MTEFO?
MTOFZL\>B7HF3(P3M[**:C6H.JKFHYJ&:CVI!HXVWW\?/]>%NR*!=7%2+42VA
M-#EDVBZN><0\O=JO]P>_6$2]_,GY@%9I4<U&-0?57%3S4,U'M0#50E2+4"U&
MM832Y!QIJ[3F^+7+*^@4PZAFH9J-:@ZJN:CFH9J/:@&JA:@6H5J,:@FER4'4
MUG)-=2U7<=2TJ::LE)_;H%5=5+-0S48U!]5<5/-0S4>UH-&VSVJ: U/OCXS=
M R*TA8MJ,:HEE"9_,VS;PNVI)PT^/C^J^?]$/IFMQ--W-XI\<R%15[*HASTU
M65#-0C4;U1Q4<U'-0S4?U8)&,XRM:-'/=VMNZ)@1JL6HEE":'"MMI[;WPS,3
M-['RXY\"J8<^.5K0#BVJV:CFH)K;:-L?H%SVNCX%0H?U42TX=B-"=-@(U6)4
M2RA-#@ZS#8[_M_U8]9J=G"MH/Q;5;%1S4,U%-0_5?%0+7G@EF)LI]S1C4Y/5
MA@=+LNAJ1:@6HUI":7(XM279W@LEV<VL@<UQT8/(Q?,QT?.U/_6<@0>O_U$/
M<'+&H$595+-1S4$U%]4\5/-1+6BT[1V<O5T;M".+:C&J)90FIT?;D>TIJWB;
MCNPQ%=GL\,?3ZB%.S@]2LU#-1C4'U=Q&DZZJ&^NC_J6Y>^Q##NNC6G#L1H3H
ML!&JQ1T;,32JS1COU&2I8>77?EN3[:EKLI]W9T^I/P3N?HFC)5=4LU#-1C4'
MU5Q4\U#-1[4 U4)4BU M1K6$TN1$:>NRO>$K-U!Z:%46U2Q4LU'-0347U3Q4
M\U$M0+40U2)4BU$MH30YB-I*;4]=J?U73I^B7I63(PEMYZ*:C6H.JKFHYJ&:
MCVI!HTF'%WW#W#N%@M9N42U&M832Y*QI:[<]]0RVP&7&ZA%.CA"T5XMJ-JHY
MJ.:BFH=J/JH%J!:B6H1J<6]_BNCQH'^Y>\$R-:@<(6UAMO?#A5GP,D/U2IR<
M,AMM^R*RP;FY<XK+0L>T4<U!-1?5/%3S42U M1#5(E2+42VA-"ED^FVKMJ]N
MU5YOOF*L/M7;%0_JQ4^-!U2S4,U&-0?57%3S4,U'M0#50E2+4"U&M832Y!AI
M6[1]XY7/\?;1+BVJ6:AFHYJ#:BZJ>:CFHUJ :B&J1:@6HUI":7(0F6T0J;N(
MS->HJ@<Y.6S0@BVJV:CFH)K;:-+L:&9_K[:/#NIW##KJZ:.=[SX-.NXV'/?V
MSK<>IT7H)L2HEE":_()NFZQ]=9/5U$U=L_]8SXI'S5]67Z$]^]9\\^D_M0-E
ME?(W3I8ORA?XIW*59M/ZS,FRW#.YFXD;S?XN)NM:^?7F9C81>6<"H/575+-0
MS48U!]5<5/-0S4>U -5"5(M0+4:UA-+D=&J;LOW^:Q_WD"W$:U2S4,U&-0?5
M7%3S4,U'M0#50E2+4"U&M832Y"!J:[O]'Y[=]HA9\=7XR2$SV-_I'5[J@]V/
M@=!1;51S4,U%-:_C\34'AGFY,U>CCXX:H%J(:A&JQ:B64)H<#&W[MJ^>K':S
MEY&+\@AJ-2N$5HU0S8E2%=G4%38U?'(HJ%>SM[F&M',O VW0HIJ#:BZJ>:CF
MHUJ :B&J1:@6HUI":7*8M W:OKI!FXB'^M1+9UR@C5=4LU#-1C4'U5Q4\U#-
M1[4 U4)4BU M1K6$TN0(:8NQ_=>>C[:/]F91S4(U&]4<5'-1S4,U']4"5 M1
M+4*U&-422I.#J*W7]M7UVNOM3X6; :;:399K-^MB769/]4EQ5=GOS!BT-8MJ
M%JK9J.:@FHMJ'JKYJ!:@6HAJ47]_JMQ>>=_>:""?CXK181-*D^)CT!9G!S\\
M':WX?C_+-SLUA\^NO, ;^L$3(M?J14^-"U2S4<U!-1?5/%3S42U M1#5(E2+
M42VA-#E3VA;MX(?GHJTZ;*+<&:EOJR[KZ<P4-1^DRW--TXVWFF;JIM$9+6@O
M%M5L5'-0S44U#]5\5 M0+42U"-5B5$LH38X6LXV6'YZM=FMWY6"PJ'$I6'IZ
M9["@'5A4LU'-0347U3Q4\U$M0+40U2)4BU$MH30Y6-I^[D#=S_TD\JJ46UUS
MG-UHZ;K(%F663+39<I*+,FXT\4WDC_7!3'F;W,5O*OJGGGQIUNARZX!3/]=W
MCC:OU>M]<N*@G5M4<U#-134/U7Q4"U M1+4(U6)42RA-3IRV<SM05NE4NS*%
MR!?U)3_US^H0(=M_UZAFH9J-:@ZJN:CFH9J/:L$+3^I_OQ/:\J5KUZ0WRJ<G
M=W,I6S6;^U,]HWT;3N?SQ^>WXA)<:N6^^CHMWY"-2A?IY*Y^:WY;D^G65U 4
M8KDY UG^*L\6[7)OZY,'U1F)93%;KC<SR>?9^O9.OD]/?ZM]?=0&?ZVU<NV*
MK$CG+V]DMC7Y='FC)2:B7J)G/$'EPST1]>_+[1/+:;EGL=F&>A/F8E4^2OOC
MI"MMD3YJ7X4V%55.E'^ :;6"E5A]$)TN'__VE[%IC/ZQTKYF57R4RTYGY5A%
MEJ_..R.??(9$J!:C6D)I<N2W[>:!NMW\_,3NN.3KMVJ>OLZ$1TO-J&:AFHUJ
M#JJYJ.:AFH]J :J%J!:A6HQJ":7)V=(6I >O/3WQ "U2HYJ%:C:J.:CFHIJ'
M:CZJ!:@6HEJ$:C&J)90F!U%;KAZHR]6;,'GYN@PU<W*<H$5K5+-?>,#Z!RL2
M#KH>+JIYJ.:C6H!J(:I%J!:C6D)I<G2TI>J!>K;A/W?UIQH_.5#0PC2JV8..
MB5\-L[=SX:2##NJBFH=J/JH%J!:B6H1J,:HEE":G1]N$'JB;T%MG5W:_(B&6
M9BH__M0+6H]&-0O5;%1S4,U%-0_5?%0+4"U$M0C58E1+*$T*GF';H1[JKWSJ
M98A.7XQJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%J)90FAQ$;?%ZJ&Y&_RN_&4J]
M*B='$EK81C4;U1Q4<U'-0S4?U8)&DR[/Z@]'QLY,I>B@$:K%J)90FIPU9ILU
M/]S$/N)<C1H_.3W05C:JV</]J7.K<S4[4^<ZZ* NJGFHYJ-:@&HAJD6H%J-:
M0FER>K1UZZ&Z;@U\KYQZA),C!*U9HYJ-:@ZJN8VV^[:\$V\>.JB/:L%QFQ"B
M@T:H%J-:0FER-K3%Z*&RA;=]'G=S?O;7^LBD.P3(>N UJEFH9J.:@VHNJGFH
MYJ-:@&HAJD6H%J-:0FERI+3%V^'@M<_0HBU=5+-0S48U!]5<5/-0S4>U -5"
M5(M0+4:UA-+D(&I;ND/U_,!_=KH=-7]RS* =7%2S4<U!-1?5/%3S42UXX>FL
MF-XI1%<D0K48U1)*DS.E+=P.U?U11:9L/M-9*<_$HC5<5+-0S48U!]7<1ML^
M!S'0];WOB$,']5$MZ-@$<V#J_?V/:- Z+:K%J)90FAP,;9UV^,-UVB88WFH/
M8G9[5T;#S^DWD5>S7]114<^@H]VDLUS[EL[7G5>>JP<_.3C0NBVJV:CFH)K;
M:(:Q];+3SP>[N8&V;5$M:+2QM '#_FYHH"U:5(M1+:$T.33:%NWPZ!:M=/:U
M_#E.O\\6ZT5G&*!-652S4,U&-0?57%3S4,U'M0#50E2+4"U&M832I' 9M4W9
MT6LW94=H4Q;5+%2S4<U!-1?5/%3S42U M1#5(E2+42VA-#F(VJ;L2-V4/?8B
M935S<IR@+5=4LU'-0347U3Q4\U$M>.%I>_A2\1!=CPC58E1+*$V.#K.-#G7Q
M576 -%L>.D!2HR<'"5IX134;U1Q4<U'-0S4?U0)4"U$M0K48U1)*D\.E[<6.
M>J]]@(369E'-0C4;U1Q4<U'-0S4?U0)4"U$M0K48U1)*DX.H+>&.E(V\XP^0
MR)K@-:I9J&:CFH-J+JIYJ.:C6O#"T]:H#Y ZDX-<C0C58E1+*$U.CK9K.SIZ
MDMOMZY%?K/*KV9.3!&W0HIJ-:@ZJN:CFH9J/:@&JA:@6H5J,:@FER?'2-FA'
MKSW/[0CMV**:A6HVJCFHYJ*:AVH^J@6H%J):A&HQJB64)@=16[L=_7#M]J@J
MOYH_.6;0XNT+FZZH?=OHBCBHYJ*:AVH^J@6H%J):A&HQJB64)F=*V]@=_=G&
MKJK*K\9/3A2TD3O:G[+6-(;#X6#G,GN[XXXCW>SM-%H==.U<5/-0S4>U -5"
M5(M0+4:UA-+D8&A;N2-U*_?HT[%H#Q?5K!<VL;?9I]!&VB);%G<K;:A-T\?N
M?0RT@XMJ+JIYJ.:C6H!J(:I%J!:C6D)I4I2,VP[N6%FM^S^^*D@]^*D!A&I6
MHZFOE;'1,1U4<U'-0S4?U0)4"U$M0K48U1)*D\.E[=6.U07%S:<\3\<J#R(7
MFO@N\LELU<XI6W_WY<$]&/4 )P<(VKA%-1O5'%1S4<U#-1_5@D8;;K\G[%Q[
MB X8H5J,:@FER>EAMNGQPIRR57HTNR:3[<]VQ/?JW]T['&BQ%M4L5+-1S4$U
M%]4\5/-1+6@T95Z@;5E4BU$MH30Y+]JV[/B(662/F40V.UP[40]Q<GZ@?5A4
MLU'-035WO#\'ZV#<Z^]\HYF'#NJC6G#<)H3HH!&JQ:B64)H<#FV#=:RN F[U
MT*2O_WJQB*9V3TX$4K-0S48U!]5<5/-0S4>U -5"5(M0+4:UA-+D?&E[KN/7
MGE-VC#9B4<U"-1O5'%1S4<U#-1_5 E0+42U"M1C5$DJ3@ZAMQ(Y_>$[9(THC
M:OSDD$';KJAF-]INLV3WFWC005U4\U#-1[4 U4)4BU M1K6$TN3T:&NL8W67
M$SF'@E994<U"-1O5'%1SQQUSR(Y[_?[N.12TMHIJP7&;$**#1J@6HUI":7(X
MM'W4L;J/>OC$R='?$ZH>X>1L0$NIJ&:CFH-J+JIYJ.:C6C#>[P_O?3Z#ME91
M+4:UA-(V\7&QNA.BL-(BO7J_$/FMN!;S^4J;9.ME40VR=:N6BYLR7HQWOYAG
M%WNW6\8[Q^BXW37>^5VW!\:[L+[]HAWVZOU]>BO*@+J=E6DT%S?E*NCGU<6)
M>=5=>_JAR.X_G!EGVM>L*+)%_<\[D4Y%7MVA_/U-EA5//U0#/&3Y[_5F7OTO
M4$L#!!0    ( #:";E?A84#NDP,  -8-   9    >&PO=V]R:W-H965T<R]S
M:&5E=#4T+GAM;,5778_C)A3]*\B55JW4&1L[_L@TL93,;MN1NJMHH[8/51^(
M31)W;'"!)#/_OA?LL3.*S:C9E?8E <R]Y]S+A0.S$Q>/<D^I0D]5R>3<V2M5
MW[FNS/:T(O*6UY3!ERT7%5'0%3M7UH*2W!A5I>M[7N16I&!..C-C*Y'.^$&5
M!:,K@>2AJHAX7M*2G^8.=EX&/A>[O=(#;CJKR8ZNJ?J]7@GHN9V7O*@HDP5G
M2-#MW%G@NR6>:@,SXX^"GN19&^E0-IP_ZLY#/G<\S8B6-%/:!8&_([VG9:D]
M 8]_6Z=.AZD-S]LOWG\VP4,P&R+I/2__+'*UGSN)@W*Z)8=2?>:G7VD;4*C]
M9;R4YA>=VKF>@[*#5+QJC8%!5;#FGSRUB3@S\/&(@=\:^(9W V18OB>*I#/!
M3TCHV>!--TRHQAK(%4ROREH)^%J G4K7BF>/-TN(*T?WO(+%EL2DZP:MH0+R
M0TD1WZ+UG@B*!J8MCJ0HR09F086@7P1A"AU83@5Z8!EE.N5H51(FT??OJ8*Y
M\H>9JX"XAG>SEN2R(>F/D)RBCYRIO40?P'/^VMZ%@+NH_9>HE[[5X9K6MRCP
M?D2^YP=(ZN"DQ6W0)3,P;H,QM]K14#(7 A*SHU#-"FV>T?F\%7DVPXL3$3GZ
MZS=PB1X4K>3?0WEJ\"?#^'H'W\F:9'3NP!:55!RID[[[#D?>3Y;H)EUT$YOW
M]/52[\Q2;^BN8*Q@.UTD-14%SX=H-XY#XUB?$\<4>U$<)?[,/0XP"CM&H961
M+BQ$\G]@F^@<2D18C@@T<],=8A)>, D@/4$<#C.).B:1E8DI_$' Z +P)O0G
M. CC8<2X0XRMB' F;6FA#A>5V\#&EW&&2329C&0\Z5"3_UT#D.XW"R"YH..'
M<8#'Z$P[.E,KG0]/A50:7%?"$*[5_,K]@KW^;/6^\7G0$OC* 9Z)!_[:&[#U
M^&I#1%&<^,EP*6"_)^-_R8YHK<^!K;C]H8^MIV[Z":X>8_5G-[UV??H3&T^^
M=0%:->/: 'L!P'8%^ )-PI=28!4EW&L!MHO!-;OB4B8"*$W?"T;(]#*![3HQ
MKDSX4B/LTH1[E<!VF7AK*P[(P10G$9Z, /=Z@.V"<*T^M6[?%BCW[*I=4;$S
M#PJ),GY@JKEU=Z/=HV717-7[Z<V+YR,14*@2E70+IMYM#.BB>40T'<5K<W'?
M< 7/ -/<P\.+"CT!OF\Y5R\=#= ]Y=+_ %!+ P04    "  V@FY7<ZRUW;0#
M  #G$   &0   'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6S%6&UOVS80_BL'
M#1@VH(G>'"5.;0.VE:(%6LR(V^S#T ^,=+:)2*)&TG;\[TM2LB*ELA:C N8/
MEDC>\XCW\'C4:;1G_$EL$"4\ITDFQM9&ROS6MD6TP92(2Y9CID96C*=$JB9?
MVR+G2&(#2A/;<YS 3@G-K,G(]"WX9,2V,J$9+CB(;9H2?IAAPO9CR[6.'?=T
MO9&ZPYZ,<K+&)<IO^8*KEEVQQ#3%3%"6 <?5V)JZMZ'K:8"Q>*"X%[5[T*X\
M,O:D&Y_BL>7H&6&"D=041%UV.,<DT4QJ'O^6I%;U3 VLWQ_9/QCGE3./1."<
M)7_36&[&UHT%,:[(-I'W;/\12X>N-%_$$F'^85_:.A9$6R%96H+5#%*:%5?R
M7 I1 [C7)P!>"?#>"O!+@/\*X/DG (,2,##*%*X8'4(BR63$V1ZXME9L^L:(
M:=#*?9KI=5]*KD:IPLG)4K+HZ6*FE(MASE(53H*8!;F I8JQ>)L@L!5,A0J,
M7 \(^*9M)8,[(:D2'N$#H1P>2+)%^*IB @JV!U3CV5JCS4/@KP+_#A;(3<!F
M$0+)8E@BW]$(+QX-KF$,?X0H"4W$GR-;*G?UI.VH=&U6N.:=<,V'+RR3&P%W
M68QQ"W[>C1]VX&TE<Z6U=]1ZYG42+C&_!-]Y!Y[C^6WS^35X^':XU^&-7T6.
M;_@&79%S7*>VU>F$ZWQV*W(2X=A2"4NH$$!K\OMO;N"\;Y.F3[*P)[*&;(-*
MMH%A]T_)MB'\N$4:&V[*.<G6J'*JA-D!ZG8+<C#=TSWA,?SS65'")XFI^-ZF
M^Z!/W?LD"WLB:^A^5>E^U1FN]U0\7:PX(M!,HN*7P%7R:A.P('(=PZ0/SMW$
MN70&>M?LZMJTV_F!V[0+V^T\-ZCL&AX%E4=!IT=WS[DZ/'4N1IXJK^" A+?N
MQ&Z>JP(( :0FW[6%P2\SA-T,0<G@%@R**28'T;'LUY5(UV\3:<<2M<\2*@]M
M"A4DP\8*W;A._?=J5>?G0\(VR/6)*+BI'+SI=+!^F/YG2NZD.C<U]$D6]D36
MD'!823C\GU/RL$_=^R0+>R)KZ.XZ+R^?3E])N9OI7 U+MI]RO/,JQX=]/;8I
M4.WMW.TIQW<3G:U/][2"D_,(^YI'4S#O13"OCWS?S7*V6M[Y9T%?,RATLFL5
M8(I\;2II 1';9K(H4*K>JEJ?FAKU5?]<5_&FLGRA*3X!?"%\355%EN!*4:J#
M2[W6\**J+AJ2Y:;.?&125:WF=H,D1JX-U/B*,7ELZ =4WS8F/P!02P,$%
M  @ -H)N5S&*+;S3!   $A8  !D   !X;"]W;W)K<VAE971S+W-H965T-38N
M>&ULM9AM;^(X$,>_BI6K3KL2)7%((/0 "=I=W4J[VJI<=U^<[H5)!HB:Q)QM
M2I'NPY^=I$E(0@AT^P;RX!G/;\9V_O9H1]D37P,(]!(&$1]K:R$V-[K.W36$
MA'?I!B+Y9DE92(2\92N=;Q@0+S8* ]TTC+X>$C_2)J/XV3V;C.A6!'X$]PSQ
M;1@2MI]!0'=C#6NO#Q[\U5JH!_IDM"$KF(-XW-PS>:=G7CP_A(C[-$(,EF-M
MBF]N34,9Q"U^^+#CA6ND4!:4/JF;+]Y8,U1$$( KE LB_Y[A%H) >9)Q_)LZ
MU;(^E6'Q^M7[YQA>PBP(AUL:_/0]L1YKCH8\6))M(![H[D](@6SESZ4!CW_1
M+FUK:,C=<D'#U%A&$/I1\D]>TD04#*QC!F9J8+8UZ*4&O1@TB2S&NB."3$:,
M[A!3K:4W=1'G)K:6-'ZDRC@73+[UI9V8S 5UGZYG,A$>NJ6A'!V<Q/F]1G,Y
M9+QM (@N4=P,?=_$KZ8J];[8HP]W((@?\(^J=:$%1U=(1WQ-&'#D1^@Q\@7O
MR(?R^J\UW7(2>7RD"QF_BD)WTUAG2:SFD5B'Z!N-Q)JC3Y$'7HW];;,]-AL<
MZ#)Q6?;,U^S-S$:/<]AT4<_H(-,P>^AQ?H<^7'TLPB=_=:$V.[X#5SK&L6.S
MK>,#A%XV 'IQ3[UC",H1JAD 4\9(M (Y906:[5&QW3W9QX^G.\(\]/=7Z1)]
M$1#R?^J*FO1OU?>OEJD;OB$NC#6Y#G%@SZ!-?O\-]XT_ZM+VBYP=I,K*4F4U
M>9]\WPHNY-#UHU7W<+QWT Q6?A3)-S)% 8E<0/\=+_XLZ<>.^U$+[?.DCVW'
M&#@C_;E(VQC/A;1V1FLWTZ93>26'@0"O4YKA37AV!<^T3<,:X!)>8P 7XO4S
MO'XK/%<5*PCDJ*8,R<_B$OPS:?L5VFO3P#W;,$JXC0%=B#O(< >M<.%EX[/S
M^ 95/L<>V/:@A-<8P(5X3H;G7#PU/\6/6\U+IX*J9J4U-$NHU7;E^7M ,<PH
MABV+!,SU.5G(CR\12'YEY.*Z )9]:LXIW[ 2*S9Z_5YE=#:&=F'YL)'+$*-M
M 3OH9RR^Y)2</@.38A)]2A("Z)[Y+A17VT56U?SC6*LLDNZ=8AIPU[%*26B.
M\M(L%,08/F_-/9&)T]BI^C,+W$9W6*9NC.I2:C.G-M^T%+\Y"4GWN'<P![I.
M^6O;'.:E:<B%&&X4+]4E^LW<O2JW:7;-?IG[/405SE45;BVK6DS]=#5O/>^M
M:@[LKE.9 =:)Y>&0+==0N)V(:K&BO[G:=A7!Z5J50?X>H@OGJ@N?D%V-Q7X
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M$#2,+]= /&"J@7R_I%2\WJ@.LF/@R?]02P,$%     @ -H)N5_ :8^=U P
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MJ+JIK =&EJXO>Y"&NCSWN*5&')5=0._74IKG@=V@;>V3?P%02P,$%     @
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M!BH!8GY+"#]UI(/F2\GL/U!+ P04    "  V@FY7O?%MNLD,  "GJ   &0
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MV[*=G_>NV^Y6N]Z/^2:<JT^#<M^:J^Q1#:[__C=[;/VCK5J1F(_$*!)C2"Q
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MS?4G(]I+KITH7MF+Y8DK?4W98:[_"U 8 [V?<:YV$W-7]7\:T1]02P,$%
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M.I=8F"K?MG)B9.[<_D$:?#O<T-X]4#8 ]U=2FOW$)JC_8,3_ %!+ P04
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MN?#RZYCR1+)<?V"R8%*R5!^N@2+AZ@&XOV1,/IZH;U;J;Y3F_P%02P,$%
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M)F6AC-U"!V>+&VB,25DH8[<0@3FM,29EH8S90EL+XMO/'>\OI"QTRKT2M+U
MW@?%F)2%3KO]V>W%_N*\4'-M5/$=_L)#>2[+_-Z)YJ/;.Y:DS9Z/>5V67Z#L
MSL"(K-CL\=[L3[_X!U!+ P04    "  V@FY7L 4 O38"   <*@  &@   'AL
M+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=I+;J- %(7AK5@L(+CNBZ059]23
M3*-L #GEAV(;1-%*LONVG(%]4 ]Z$G%&J$!<?C'XA(#'EWQHQWUW*KM]7Q:?
MQ\.IK*K=./:_ZKJL=_G8EKNNSZ?SD4TW'-OQO!RV==^NW]MMKF6YC'JXG5$]
M/=[.7+Q^]?E_)G:;S7Z=?W?K/\=\&O\QN/[HAO>RRWFL%J_ML,WCJJH_#]?=
MI;YLTMUY<K5X?EM5P_-;JNJY@P2"9/X@A2"=/\@@R.8/<@CR^8,"@F+^H :"
MFOF#[B'H?OZ@!PAZF#\H+5'&)4'2!&L"K1-RG0B\3@AV(A [(=F)P.R$:"<"
MM1.RG0C<3@AW(I [(=V)P.Z$>"<"O07U%@*]!?46 KUE\K!-H+>@WD*@MZ#>
M0J"WH-Y"H+>@WD*@MZ#>0J"WH-Y"H+>@WD*@MZ+>2J"WHMY*H+>BWDJ@MTY>
MEA#HK:BW$NBMJ+<2Z*VHMQ+HK:BW$NBMJ+<2Z*VHMQ+H;:BW$>AMJ+<1Z&VH
MMQ'H;:BW$>AMDY?=!'H;ZFT$>AOJ;01Z&^IM!'H;ZFT$>AOJ;01Z.^KM!'H[
MZNT$>COJ[01Z.^KM!'H[ZNT$>OOD8R6!WHYZ.X'>CGH[@=Z.>CN!WHYZ.X'>
M@7H'@=Z!>@>!WH%Z!X'>@7H'@=Z!>@>!WH%Z!X'>,?G9A$#O0+V#0.] O8-
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MY_\IZ[USFS^.'Y]E9YO^+9^-_YH\?P%02P$"% ,4    "  V@FY7!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( #:";E=@2A$Y[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( #:";E>97)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M-H)N5SZN3R(3!@  OB   !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( #:";E<?-W4>&08  !8:   8
M          " @58.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M    "  V@FY7KEU[(/H"   -"@  &               @(&E%   >&PO=V]R
M:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ -H)N5TQU)K>Z!0  J!H
M !@              ("!U1<  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+
M 0(4 Q0    ( #:";E<XK*3320L  ":$   8              " @<4=  !X
M;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  V@FY7!'HF KD"
M  !%"   &               @(%$*0  >&PO=V]R:W-H965T<R]S:&5E=#8N
M>&UL4$L! A0#%     @ -H)N5]+>-EM4"   =B@  !@              ("!
M,RP  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( #:";E<N
M!#:I% H  !P:   8              " @;TT  !X;"]W;W)K<VAE971S+W-H
M965T."YX;6Q02P$"% ,4    "  V@FY7:81K#^$1  !N-0  &
M    @($'/P  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @
M-H)N5[(5%<#X P  <0D  !D              ("!'E$  'AL+W=O<FMS:&5E
M=',O<VAE970Q,"YX;6Q02P$"% ,4    "  V@FY7H75H'1,&   2#P  &0
M            @(%-50  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4
M Q0    ( #:";E>CV&'LA@@  -$8   9              " @9=;  !X;"]W
M;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ -H)N5Q)T&_A(&@
MK&(  !D              ("!5&0  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6Q02P$"% ,4    "  V@FY75F@C$(,*  "]&P  &0              @('3
M?@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( #:";E=J
M_%3)6PX  -,S   9              " @8V)  !X;"]W;W)K<VAE971S+W-H
M965T,34N>&UL4$L! A0#%     @ -H)N5W [$*&'#P  YC(  !D
M     ("!'Y@  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #:";E<KF)[A>00  %\*   9              "
M@7;!  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ -H)N
M5Y%4(,[K @  !0<  !D              ("!)L8  'AL+W=O<FMS:&5E=',O
M<VAE970R,BYX;6Q02P$"% ,4    "  V@FY7787I 20'  "#$P  &0
M        @(%(R0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0
M   ( #:";E<$M.%@*1(  $\X   9              " @:/0  !X;"]W;W)K
M<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ -H)N5R2XQW]8!    PL
M !D              ("! ^,  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q0
M2P$"% ,4    "  V@FY7BIS2PSH#  !=!P  &0              @(&2YP
M>&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( #:";E>XR:?.
M300  !<+   9              " @0/K  !X;"]W;W)K<VAE971S+W-H965T
M,C<N>&UL4$L! A0#%     @ -H)N5\K=5?70!   APT  !D
M ("!A^\  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    "  V
M@FY7"'O6N>,"  !=!@  &0              @(&.]   >&PO=V]R:W-H965T
M<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( #:";E<L%.CXR0(  .\%   9
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M970S-"YX;6Q02P$"% ,4    "  V@FY7%(-JL!<%   Q(P  &0
M    @($*#@$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    (
M #:";E<$$P?,? 0  )(5   9              " @5@3 0!X;"]W;W)K<VAE
M971S+W-H965T,S8N>&UL4$L! A0#%     @ -H)N5Z3\ZF@S"   Y4(  !D
M             ("!"Q@! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"
M% ,4    "  V@FY7+I G5[0#   4$0  &0              @(%U( $ >&PO
M=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( #:";E="6 Y-!0,
M (((   9              " @6 D 0!X;"]W;W)K<VAE971S+W-H965T,SDN
M>&UL4$L! A0#%     @ -H)N5_:(NO_P P  (10  !D              ("!
MG"<! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    "  V@FY7
MU[1AV%,$  !3&   &0              @('#*P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0Q+GAM;%!+ 0(4 Q0    ( #:";E=I%-,I>@,  *H*   9
M      " @4TP 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%
M  @ -H)N5UKW%:LH!@  LRL  !D              ("!_C,! 'AL+W=O<FMS
M:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    "  V@FY70,@%L.L"  "-"0
M&0              @(%=.@$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+
M 0(4 Q0    ( #:";E>IY-I$O (  #,(   9              " @7\] 0!X
M;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ -H)N5Z*R)(.-
M @  "P8  !D              ("!<D ! 'AL+W=O<FMS:&5E=',O<VAE970T
M-BYX;6Q02P$"% ,4    "  V@FY7JE&'[N\$  "7&P  &0
M@($V0P$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( #:"
M;E=\SN:QM0D  /AQ   9              " @5Q( 0!X;"]W;W)K<VAE971S
M+W-H965T-#@N>&UL4$L! A0#%     @ -H)N5V4 YO=_ P  ;0\  !D
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M=#4S+GAM;%!+ 0(4 Q0    ( #:";E?A84#NDP,  -8-   9
M  " @6:) 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @
M-H)N5W.LM=VT P  YQ   !D              ("!,(T! 'AL+W=O<FMS:&5E
M=',O<VAE970U-2YX;6Q02P$"% ,4    "  V@FY7,8HMO-,$   2%@  &0
M            @($;D0$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4
M Q0    ( #:";E?P&F/G=0,  &\+   9              " @266 0!X;"]W
M;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ -H)N5_2=FMY> P
MY@L  !D              ("!T9D! 'AL+W=O<FMS:&5E=',O<VAE970U."YX
M;6Q02P$"% ,4    "  V@FY7Q6RVJ\$#   U$0  &0              @(%F
MG0$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( #:";E>]
M\6VZR0P  *>H   9              " @5ZA 0!X;"]W;W)K<VAE971S+W-H
M965T-C N>&UL4$L! A0#%     @ -H)N5Y*4K^JQ @  =0@  !D
M     ("!7JX! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #:";E<4+*A?'@0  #(6   9              "
M@1Z^ 0!X;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ -H)N
M5T5 VA(M @  KP0  !D              ("!<\(! 'AL+W=O<FMS:&5E=',O
M<VAE970V-RYX;6Q02P$"% ,4    "  V@FY7/ < )>0"  !L"   &0
M        @('7Q $ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0
M   ( #:";E=0WX\_M@(  *@&   9              " @?+' 0!X;"]W;W)K
M<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @ -H)N5XN 3>VF @  ] <
M !D              ("!W\H! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q0
M2P$"% ,4    "  V@FY7^C.T$DX&  "O)   &0              @(&\S0$
M>&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    ( #:";E=4K1A,
M5 ,  - 5   -              "  4'4 0!X;"]S='EL97,N>&UL4$L! A0#
M%     @ -H)N5Y>*NQS     $P(   L              ( !P-<! %]R96QS
M+RYR96QS4$L! A0#%     @ -H)N5WP]_6%7!0  (R\   \
M ( !J=@! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( #:";E>P!0"]-@(
M !PJ   :              "  2W> 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( #:";E?ART;(_0$  #TI   3              "
M 9O@ 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !/ $\ H!4  ,GB 0
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>237</ContextCount>
  <ElementCount>362</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>82</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100030 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100050 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100070 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' (Deficit) Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100080 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100090 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Organization and Description of Business Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperations</Role>
      <ShortName>Organization and Description of Business Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Astellas Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements</Role>
      <ShortName>Astellas Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Loan with Silicon Valley Bank</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBank</Role>
      <ShortName>Loan with Silicon Valley Bank</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Research, Collaboration and License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreements</Role>
      <ShortName>Research, Collaboration and License Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Net Loss Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShare</Role>
      <ShortName>Net Loss Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Strategic Reprioritization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritization</Role>
      <ShortName>Strategic Reprioritization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Retirement Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlan</Role>
      <ShortName>Retirement Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponents</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeases</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Astellas Agreements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsTables</Role>
      <ShortName>Astellas Agreements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Loan with Silicon Valley Bank (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankTables</Role>
      <ShortName>Loan with Silicon Valley Bank (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBank</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrants</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Net Loss Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables</Role>
      <ShortName>Net Loss Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShare</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Strategic Reprioritization (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationTables</Role>
      <ShortName>Strategic Reprioritization (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritization</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Organization and Description of Business Operations - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails</Role>
      <ShortName>Organization and Description of Business Operations - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Significant Accounting Policies - Summary of Effect of the Adoption of ASC 842 on Statement of Operations and Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails</Role>
      <ShortName>Significant Accounting Policies - Summary of Effect of the Adoption of ASC 842 on Statement of Operations and Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail</Role>
      <ShortName>Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Balance Sheet Components - Schedule of Property, Plant and Equipment Net (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail</Role>
      <ShortName>Balance Sheet Components - Schedule of Property, Plant and Equipment Net (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Balance Sheet Components - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails</Role>
      <ShortName>Balance Sheet Components - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Leases - Schedule of Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaseCostDetails</Role>
      <ShortName>Leases - Schedule of Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Leases - Supplemental Information Related to Remaining Lease Term and Discount Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateDetails</Role>
      <ShortName>Leases - Supplemental Information Related to Remaining Lease Term and Discount Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails</Role>
      <ShortName>Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100490 - Disclosure - Leases - Schedule of Future Minimum Commitments Under Company's Operating and Finance Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails</Role>
      <ShortName>Leases - Schedule of Future Minimum Commitments Under Company's Operating and Finance Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100500 - Disclosure - Astellas Agreements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails</Role>
      <ShortName>Astellas Agreements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Astellas Agreements - Summary of Allocation for Transaction Price to the Three Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails</Role>
      <ShortName>Astellas Agreements - Summary of Allocation for Transaction Price to the Three Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Loan with Silicon Valley Bank - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails</Role>
      <ShortName>Loan with Silicon Valley Bank - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100530 - Disclosure - Loan with Silicon Valley Bank - Schedule of Future Principal Debt Payments on Loan Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails</Role>
      <ShortName>Loan with Silicon Valley Bank - Schedule of Future Principal Debt Payments on Loan Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100540 - Disclosure - Research, Collaboration and License Agreements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails</Role>
      <ShortName>Research, Collaboration and License Agreements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100550 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100560 - Disclosure - Stock-Based Compensation - Schedule of Share Based Compensation Available for Grant under Incentive Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Share Based Compensation Available for Grant under Incentive Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100570 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value Time Based Vesting of Stock Options, Performance and Service-based Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock</Role>
      <ShortName>Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value Time Based Vesting of Stock Options, Performance and Service-based Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100580 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100590 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100600 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Awards Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Restricted Stock Awards Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100610 - Disclosure - Stock-Based Compensation - Schedule of Total Stock-Based Compensation Expense for Stock Options, ESPP, RSAs and RSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Total Stock-Based Compensation Expense for Stock Options, ESPP, RSAs and RSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100620 - Disclosure - Warrants - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails</Role>
      <ShortName>Warrants - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100630 - Disclosure - Warrants - Schedule of Fair Value Method to Allocate Net Proceeds Received from Sale of Common Stock and Pre-funded Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails</Role>
      <ShortName>Warrants - Schedule of Fair Value Method to Allocate Net Proceeds Received from Sale of Common Stock and Pre-funded Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100640 - Disclosure - Warrants - Schedule of Warrant Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails</Role>
      <ShortName>Warrants - Schedule of Warrant Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>100650 - Disclosure - Warrants - Schedule Of Assumptions Used To Estimate Fair Value Of Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails</Role>
      <ShortName>Warrants - Schedule Of Assumptions Used To Estimate Fair Value Of Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>100660 - Disclosure - Net Loss Per Common Share - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails</Role>
      <ShortName>Net Loss Per Common Share - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>100670 - Disclosure - Net Loss Per Common Share - Schedule of Calculation of Basic and Diluted Net Loss Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails</Role>
      <ShortName>Net Loss Per Common Share - Schedule of Calculation of Basic and Diluted Net Loss Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>100680 - Disclosure - Net Loss Per Common Share - Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails</Role>
      <ShortName>Net Loss Per Common Share - Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>100690 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>100700 - Disclosure - Strategic Reprioritization - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails</Role>
      <ShortName>Strategic Reprioritization - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>100710 - Disclosure - Strategic Reprioritization - Summary of Accrued Severance Activity Recorded (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails</Role>
      <ShortName>Strategic Reprioritization - Summary of Accrued Severance Activity Recorded (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>100720 - Disclosure - Retirement Plan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails</Role>
      <ShortName>Retirement Plan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="tsha-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>100730 - Disclosure - Subsequent Events - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails</Role>
      <ShortName>Subsequent Events - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="tsha-20230930.htm">tsha-20230930.htm</File>
    <File>tsha-20230930.xsd</File>
    <File>tsha-20230930_cal.xml</File>
    <File>tsha-20230930_def.xml</File>
    <File>tsha-20230930_lab.xml</File>
    <File>tsha-20230930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img38651418_0.jpg</File>
    <File>img38651418_1.jpg</File>
    <File>img38651418_10.jpg</File>
    <File>img38651418_2.jpg</File>
    <File>img38651418_3.jpg</File>
    <File>img38651418_4.jpg</File>
    <File>img38651418_5.jpg</File>
    <File>img38651418_6.jpg</File>
    <File>img38651418_7.jpg</File>
    <File>img38651418_8.jpg</File>
    <File>img38651418_9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="673">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="32">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>101
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tsha-20230930.htm": {
   "nsprefix": "tsha",
   "nsuri": "http://tayshagtx.com/20230930",
   "dts": {
    "inline": {
     "local": [
      "tsha-20230930.htm"
     ]
    },
    "schema": {
     "local": [
      "tsha-20230930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "tsha-20230930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "tsha-20230930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "tsha-20230930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tsha-20230930_pre.xml"
     ]
    }
   },
   "keyStandard": 273,
   "keyCustom": 89,
   "axisStandard": 27,
   "axisCustom": 0,
   "memberStandard": 32,
   "memberCustom": 45,
   "hidden": {
    "total": 16,
    "http://fasb.org/us-gaap/2023": 12,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 237,
   "entityCount": 1,
   "segmentCount": 82,
   "elementCount": 606,
   "unitCount": 8,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 673,
    "http://xbrl.sec.gov/dei/2023": 32
   },
   "report": {
    "R1": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited",
     "longName": "100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical",
     "longName": "100030 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited",
     "longName": "100050 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_f899ecab-1c91-4d92-99fb-b948b9803592",
      "name": "us-gaap:Revenues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f899ecab-1c91-4d92-99fb-b948b9803592",
      "name": "us-gaap:OperatingExpenses",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity",
     "longName": "100070 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity",
     "shortName": "Condensed Consolidated Statements of Stockholders' (Deficit) Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_9b53dc51-ef56-4848-a5a0-e8634b747a3a",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_9b53dc51-ef56-4848-a5a0-e8634b747a3a",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical",
     "longName": "100080 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_0b1daf03-1138-4ea7-94f2-9e77213ae909",
      "name": "tsha:PaymentOfSalesCommissionsAndOtherOfferingCosts",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0b1daf03-1138-4ea7-94f2-9e77213ae909",
      "name": "tsha:PaymentOfSalesCommissionsAndOtherOfferingCosts",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
     "longName": "100090 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperations",
     "longName": "100100 - Disclosure - Organization and Description of Business Operations",
     "shortName": "Organization and Description of Business Operations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies",
     "longName": "100110 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurements",
     "longName": "100120 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponents",
     "longName": "100130 - Disclosure - Balance Sheet Components",
     "shortName": "Balance Sheet Components",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeases",
     "longName": "100140 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements",
     "longName": "100150 - Disclosure - Astellas Agreements",
     "shortName": "Astellas Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e6e5f371-c876-4258-be9b-7f8411f4ff7e",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R14": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBank",
     "longName": "100160 - Disclosure - Loan with Silicon Valley Bank",
     "shortName": "Loan with Silicon Valley Bank",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreements",
     "longName": "100170 - Disclosure - Research, Collaboration and License Agreements",
     "shortName": "Research, Collaboration and License Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R16": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensation",
     "longName": "100180 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrants",
     "longName": "100190 - Disclosure - Warrants",
     "shortName": "Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "tsha:WarrantsNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "tsha:WarrantsNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShare",
     "longName": "100200 - Disclosure - Net Loss Per Common Share",
     "shortName": "Net Loss Per Common Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxes",
     "longName": "100210 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
     "longName": "100220 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritization",
     "longName": "100230 - Disclosure - Strategic Reprioritization",
     "shortName": "Strategic Reprioritization",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlan",
     "longName": "100240 - Disclosure - Retirement Plan",
     "shortName": "Retirement Plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSubsequentEvents",
     "longName": "100250 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "100260 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "longName": "100270 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsTables",
     "longName": "100280 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables",
     "longName": "100290 - Disclosure - Balance Sheet Components (Tables)",
     "shortName": "Balance Sheet Components (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesTables",
     "longName": "100300 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsTables",
     "longName": "100310 - Disclosure - Astellas Agreements (Tables)",
     "shortName": "Astellas Agreements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "tsha:SummaryOfTransactionPriceAllocationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "tsha:SummaryOfTransactionPriceAllocationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankTables",
     "longName": "100320 - Disclosure - Loan with Silicon Valley Bank (Tables)",
     "shortName": "Loan with Silicon Valley Bank (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
     "longName": "100330 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "tsha:ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "tsha:ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsTables",
     "longName": "100340 - Disclosure - Warrants (Tables)",
     "shortName": "Warrants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "tsha:ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "tsha:WarrantsNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "tsha:ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "tsha:WarrantsNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables",
     "longName": "100350 - Disclosure - Net Loss Per Common Share (Tables)",
     "shortName": "Net Loss Per Common Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationTables",
     "longName": "100360 - Disclosure - Strategic Reprioritization (Tables)",
     "shortName": "Strategic Reprioritization (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "tsha:ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "tsha:ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
     "longName": "100370 - Disclosure - Organization and Description of Business Operations - Additional Information (Details)",
     "shortName": "Organization and Description of Business Operations - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
     "longName": "100380 - Disclosure - Significant Accounting Policies - Additional Information (Details)",
     "shortName": "Significant Accounting Policies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_f899ecab-1c91-4d92-99fb-b948b9803592",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R37": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
     "longName": "100390 - Disclosure - Significant Accounting Policies - Summary of Effect of the Adoption of ASC 842 on Statement of Operations and Cash Flows (Details)",
     "shortName": "Significant Accounting Policies - Summary of Effect of the Adoption of ASC 842 on Statement of Operations and Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_f899ecab-1c91-4d92-99fb-b948b9803592",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0b1daf03-1138-4ea7-94f2-9e77213ae909",
      "name": "tsha:IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "div",
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails",
     "longName": "100400 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail",
     "longName": "100410 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail)",
     "shortName": "Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "tsha:PrepaidResearchAndDevelopmentContracts",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "tsha:PrepaidResearchAndDevelopmentContracts",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail",
     "longName": "100420 - Disclosure - Balance Sheet Components - Schedule of Property, Plant and Equipment Net (Detail)",
     "shortName": "Balance Sheet Components - Schedule of Property, Plant and Equipment Net (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails",
     "longName": "100430 - Disclosure - Balance Sheet Components - Additional Information (Details)",
     "shortName": "Balance Sheet Components - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_f899ecab-1c91-4d92-99fb-b948b9803592",
      "name": "us-gaap:Depreciation",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7f2b298a-2b65-407d-9b6b-4e8ad3ab3b4a",
      "name": "us-gaap:AssetImpairmentCharges",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
     "longName": "100440 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "shortName": "Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "tsha:AccruedResearchAndDevelopmentCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "tsha:AccruedResearchAndDevelopmentCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
     "longName": "100450 - Disclosure - Leases - Additional Information (Details)",
     "shortName": "Leases - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8d03e9bb-23a1-464b-940a-dd1c8ec2a91b",
      "name": "us-gaap:PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits",
      "unitRef": "U_sqft",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaseCostDetails",
     "longName": "100460 - Disclosure - Leases - Schedule of Lease Cost (Details)",
     "shortName": "Leases - Schedule of Lease Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_f899ecab-1c91-4d92-99fb-b948b9803592",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f899ecab-1c91-4d92-99fb-b948b9803592",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateDetails",
     "longName": "100470 - Disclosure - Leases - Supplemental Information Related to Remaining Lease Term and Discount Rate (Details)",
     "shortName": "Leases - Supplemental Information Related to Remaining Lease Term and Discount Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails",
     "longName": "100480 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details)",
     "shortName": "Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails",
     "longName": "100490 - Disclosure - Leases - Schedule of Future Minimum Commitments Under Company's Operating and Finance Leases (Details)",
     "shortName": "Leases - Schedule of Future Minimum Commitments Under Company's Operating and Finance Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
     "longName": "100500 - Disclosure - Astellas Agreements - Additional Information (Details)",
     "shortName": "Astellas Agreements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_24c41917-d26a-4624-8e85-a10244e4a9a4",
      "name": "tsha:ProbabilityOfAnOptionExercise",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails",
     "longName": "100510 - Disclosure - Astellas Agreements - Summary of Allocation for Transaction Price to the Three Performance Obligations (Details)",
     "shortName": "Astellas Agreements - Summary of Allocation for Transaction Price to the Three Performance Obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_ded5d2d0-56e4-4b8d-b636-71c37d47e597",
      "name": "tsha:TransactionPrice",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_287d5758-9445-46a9-a9b4-4f0e72d6bc05",
      "name": "tsha:TransactionPrice",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:SummaryOfTransactionPriceAllocationTableTextBlock",
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails",
     "longName": "100520 - Disclosure - Loan with Silicon Valley Bank - Additional Information (Details)",
     "shortName": "Loan with Silicon Valley Bank - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_349ea30b-6a31-4c2d-af3c-94a43b0e6e4e",
      "name": "us-gaap:DebtInstrumentMaturityDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_349ea30b-6a31-4c2d-af3c-94a43b0e6e4e",
      "name": "tsha:PercentageOfPrepaymentOfFacility",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails",
     "longName": "100530 - Disclosure - Loan with Silicon Valley Bank - Schedule of Future Principal Debt Payments on Loan Payable (Details)",
     "shortName": "Loan with Silicon Valley Bank - Schedule of Future Principal Debt Payments on Loan Payable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
     "longName": "100540 - Disclosure - Research, Collaboration and License Agreements - Additional Information (Details)",
     "shortName": "Research, Collaboration and License Agreements - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c46c3bce-3fb6-4de8-b570-c0f54c0a4d18",
      "name": "tsha:AdditionalMilestonePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
     "longName": "100550 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_312a5395-35e7-4a3b-845a-3e7f7d95509c",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_312a5395-35e7-4a3b-845a-3e7f7d95509c",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails",
     "longName": "100560 - Disclosure - Stock-Based Compensation - Schedule of Share Based Compensation Available for Grant under Incentive Plans (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Share Based Compensation Available for Grant under Incentive Plans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_9c728cb2-6a71-4e2d-8092-19c35d0a4b02",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock",
     "longName": "100570 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value Time Based Vesting of Stock Options, Performance and Service-based Stock Options (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value Time Based Vesting of Stock Options, Performance and Service-based Stock Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_36b0de8a-1c04-40e9-bda7-6a7e96088f0e",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_36b0de8a-1c04-40e9-bda7-6a7e96088f0e",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails",
     "longName": "100580 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_788446ba-8777-48e6-8377-1f4a2176149f",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_44490c2c-0f57-4d56-bc50-19d98eb2bbe7",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails",
     "longName": "100590 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Units Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Restricted Stock Units Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_f2bd8525-6258-4ee1-bf3e-0b623f59864b",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_d239af67-cf01-4921-a72c-010606f8efdb",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
     "longName": "100600 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Awards Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Restricted Stock Awards Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_84a4182e-9ee0-43f3-b998-badcbf3028a8",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_d374b9c6-f352-4efa-81b7-539cd0b063c1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails",
     "longName": "100610 - Disclosure - Stock-Based Compensation - Schedule of Total Stock-Based Compensation Expense for Stock Options, ESPP, RSAs and RSUs (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Total Stock-Based Compensation Expense for Stock Options, ESPP, RSAs and RSUs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_f899ecab-1c91-4d92-99fb-b948b9803592",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_73e2f837-a7da-4610-a8b8-b300a337c6b9",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
     "longName": "100620 - Disclosure - Warrants - Additional Information (Details)",
     "shortName": "Warrants - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_4c88705b-93a0-4d16-a99d-3dbf7a0c78c1",
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "tsha:WarrantsNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails",
     "longName": "100630 - Disclosure - Warrants - Schedule of Fair Value Method to Allocate Net Proceeds Received from Sale of Common Stock and Pre-funded Warrants (Details)",
     "shortName": "Warrants - Schedule of Fair Value Method to Allocate Net Proceeds Received from Sale of Common Stock and Pre-funded Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "tsha:CommonStockAndWarrantsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "tsha:WarrantsNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_10cb884e-9a48-40ed-b56b-6772d0af148c",
      "name": "tsha:CommonStockAndWarrantsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "tsha:WarrantsNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails",
     "longName": "100640 - Disclosure - Warrants - Schedule of Warrant Liability (Details)",
     "shortName": "Warrants - Schedule of Warrant Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "tsha:ChangeInFairValueOfWarrants",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:ScheduleOfWarrantLiabilityTableTextBlock",
       "div",
       "tsha:WarrantsNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "tsha:ChangeInFairValueOfWarrants",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:ScheduleOfWarrantLiabilityTableTextBlock",
       "div",
       "tsha:WarrantsNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails",
     "longName": "100650 - Disclosure - Warrants - Schedule Of Assumptions Used To Estimate Fair Value Of Warrants (Details)",
     "shortName": "Warrants - Schedule Of Assumptions Used To Estimate Fair Value Of Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_f73dfe04-8e13-4f73-9796-2fc971735968",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "tsha:WarrantsNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f73dfe04-8e13-4f73-9796-2fc971735968",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "tsha:WarrantsNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails",
     "longName": "100660 - Disclosure - Net Loss Per Common Share - Additional Information (Details)",
     "shortName": "Net Loss Per Common Share - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_4bcd5e18-554d-46bd-8387-2b416ade3f02",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R65": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
     "longName": "100670 - Disclosure - Net Loss Per Common Share - Schedule of Calculation of Basic and Diluted Net Loss Per Common Share (Details)",
     "shortName": "Net Loss Per Common Share - Schedule of Calculation of Basic and Diluted Net Loss Per Common Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_f899ecab-1c91-4d92-99fb-b948b9803592",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f899ecab-1c91-4d92-99fb-b948b9803592",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails",
     "longName": "100680 - Disclosure - Net Loss Per Common Share - Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)",
     "shortName": "Net Loss Per Common Share - Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
     "longName": "100690 - Disclosure - Income Taxes - Additional Information (Details)",
     "shortName": "Income Taxes - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fc9bbbfd-8b86-4d90-a4d1-630d8f667017",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails",
     "longName": "100700 - Disclosure - Strategic Reprioritization - Additional Information (Details)",
     "shortName": "Strategic Reprioritization - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "C_27c18364-0175-4f13-b9fc-bed49be4dac2",
      "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_27c18364-0175-4f13-b9fc-bed49be4dac2",
      "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails",
     "longName": "100710 - Disclosure - Strategic Reprioritization - Summary of Accrued Severance Activity Recorded (Details)",
     "shortName": "Strategic Reprioritization - Summary of Accrued Severance Activity Recorded (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "C_d73f002d-37aa-4ddd-8f3a-08970ba84984",
      "name": "tsha:AccruedSeveranceBalance",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock",
       "div",
       "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_d73f002d-37aa-4ddd-8f3a-08970ba84984",
      "name": "tsha:AccruedSeveranceBalance",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "tsha:ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock",
       "div",
       "us-gaap:BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails",
     "longName": "100720 - Disclosure - Retirement Plan - Additional Information (Details)",
     "shortName": "Retirement Plan - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "C_f899ecab-1c91-4d92-99fb-b948b9803592",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f899ecab-1c91-4d92-99fb-b948b9803592",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
     "longName": "100730 - Disclosure - Subsequent Events - Additional Information (Details)",
     "shortName": "Subsequent Events - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "C_ebb6d69e-99d0-4437-b8b8-87ca448aa0d2",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_6aeab603-0bae-4f76-9690-07fdf336dce4",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tsha-20230930.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "tsha_PerformanceAndMarketBasedRestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PerformanceAndMarketBasedRestrictedStockUnitsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance and Market-based Restricted Stock Units",
        "label": "Performance and Market-based Restricted Stock Units [Member]",
        "documentation": "Performance and market-based restricted stock units."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate - Operating leases",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r602"
     ]
    },
    "tsha_IncurredPlacementAgentCommissionsAndOtherIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "IncurredPlacementAgentCommissionsAndOtherIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incurred placement agent commissions and other issuance costs",
        "label": "Incurred Placement Agent Commissions And Other Issuance Costs",
        "documentation": "Incurred placement agent commissions and other issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee Operating Lease Liability Payments Due After Year Four",
        "documentation": "Lessee operating lease liability payments due after year four."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RestatementAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementAdjustmentMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASC 842 Adjustments",
        "label": "Revision of Prior Period, Adjustment [Member]"
       }
      }
     },
     "auth_ref": [
      "r168",
      "r169",
      "r170",
      "r183",
      "r184",
      "r202",
      "r401",
      "r402",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r637",
      "r638"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_SsiWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "SsiWarrants",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SSI Warrants",
        "label": "SSI Warrants",
        "documentation": "SSI warrants."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndWarrantsTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Method to Allocate Net Proceeds Received from Sale of Common Stock and Pre-funded Warrants",
        "label": "Schedule Of Fair Value Method To Allocate Net Proceeds Received From Sale Of Common Stock And Warrants [Table Text Block]",
        "documentation": "Schedule of fair value method to allocate net proceeds received from sale of common stock and warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money Market Funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "us-gaap_RestructuringPlanDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringPlanDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Plan",
        "label": "Restructuring Plan [Domain]",
        "documentation": "Identification of the individual restructuring plans."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term in years",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "tsha_PaymentOfOneTimeUpfrontLicenseFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PaymentOfOneTimeUpfrontLicenseFee",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment of one-time upfront license fee",
        "label": "Payment Of One Time Upfront License Fee",
        "documentation": "Payment of one-time upfront license fee."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "tsha_PresidentAndChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PresidentAndChiefExecutiveOfficerMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RA Session II",
        "label": "President And Chief Executive Officer [Member]",
        "documentation": "President and chief executive officer.",
        "verboseLabel": "Former President and Chief Executive Officer"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of common stock price purchased through payroll deductions",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate",
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "tsha_AbeonaTherapeuticsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AbeonaTherapeuticsIncMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Abeona",
        "label": "Abeona Therapeutics Inc [Member]",
        "documentation": "Abeona Therapeutics Inc."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, options grant date fair value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value",
        "documentation": "Share based compensation arrangement by share based payment award options grants in period grant date fair value."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_RegulatoryMilestoneFeePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "RegulatoryMilestoneFeePaid",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Regulatory milestone fee paid",
        "label": "Regulatory Milestone Fee Paid",
        "documentation": "Regulatory milestone fee paid."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "tsha_AdditionalMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AdditionalMilestonePayments",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional milestone payments",
        "label": "Additional Milestone Payments",
        "documentation": "Additional Milestone payments."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_CancelledOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "CancelledOptionsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancelled Options",
        "label": "Cancelled Options [Member]",
        "documentation": "Cancelled options."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_FinanceLeaseLiabilityPaymentsDueAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFour",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finance Lease Liability Payments Due After Year Four",
        "documentation": "Finance lease liability payments due after year four."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantCancelledInPeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeitures",
        "terseLabel": "Forfeitures",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Cancelled In Period",
        "documentation": "Share based compensation arrangement by share based payment award number of shares available for grant cancelled in period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails": {
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Current portion of Term Loan",
        "terseLabel": "Term loan, current portion",
        "label": "Long-Term Debt, Current Maturities",
        "totalLabel": "Long-Term Debt, Current Maturities, Total",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total",
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r136",
      "r575"
     ]
    },
    "tsha_ScheduleOfWarrantLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ScheduleOfWarrantLiabilityTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Warrant Liability",
        "label": "Schedule Of Warrant Liability [Table Text Block]",
        "documentation": "Schedule of warrant liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property Plant And Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r355",
      "r357",
      "r358",
      "r359",
      "r365",
      "r367",
      "r368",
      "r369",
      "r508"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets Held for Sale",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r95"
     ]
    },
    "tsha_RegulatoryRelatedMilestonesObligationPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "RegulatoryRelatedMilestonesObligationPayable",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Regulatory related milestones obligation payable",
        "label": "Regulatory Related Milestones Obligation Payable",
        "documentation": "Regulatory related milestones obligation payable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate - Finance leases",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r602"
     ]
    },
    "tsha_ClinicalRegulatoryAndCommercialMilestonesToBeReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ClinicalRegulatoryAndCommercialMilestonesToBeReceived",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical, regulatory and commercial milestones to be received",
        "label": "Clinical Regulatory And Commercial Milestones To Be Received",
        "documentation": "Clinical, regulatory and commercial milestones to be received."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_LicenseAgreementForCLN7Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "LicenseAgreementForCLN7Member",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License Agreement for CLN7",
        "label": "License Agreement For C L N7 [Member]",
        "documentation": "License agreement for CLN7."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r296",
      "r301",
      "r407",
      "r459",
      "r587",
      "r588",
      "r593",
      "r594",
      "r595"
     ]
    },
    "tsha_PreFundedWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PreFundedWarrants",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-funded warrants",
        "label": "Pre Funded Warrants",
        "documentation": "Pre funded warrants."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_CommonStockSharesIssuedAndSold": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "CommonStockSharesIssuedAndSold",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock shares issued and sold",
        "label": "Common Stock Shares Issued And Sold",
        "documentation": "Common stock shares issued and sold."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based payment award, options granted, exercise price per share",
        "terseLabel": "Options granted, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r325"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r296",
      "r301",
      "r407",
      "r458",
      "r593",
      "r594",
      "r595"
     ]
    },
    "tsha_SsiWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "SsiWarrantsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SSI Warrants [Member]",
        "label": "SSI Warrants [Member]",
        "terseLabel": "SSI Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "tsha_ResearchAndDevelopmentLicenseNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ResearchAndDevelopmentLicenseNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of research and development license not yet paid",
        "label": "Research And Development License Not Yet Paid",
        "documentation": "Research and development license not yet paid."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease payments",
        "terseLabel": "Future minimum remianing lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_AccruedResearchAndDevelopmentCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AccruedResearchAndDevelopmentCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued research and development",
        "label": "Accrued Research And Development Current",
        "documentation": "Accrued research and development current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options expired, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r167",
      "r277"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r407",
      "r460",
      "r587",
      "r588",
      "r593",
      "r594",
      "r595"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_PrepaidClinicalTrial": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PrepaidClinicalTrial",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid clinical trial",
        "label": "Prepaid Clinical Trial",
        "documentation": "Prepaid clinical trial."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options cancelled or forfeited, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r327"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "tsha_PercentageOfPrepaymentPremium": {
     "xbrltype": "percentItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PercentageOfPrepaymentPremium",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of prepayment premium",
        "label": "Percentage Of Prepayment Premium",
        "documentation": "Percentage of prepayment premium"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anti-dilutive securities excluded from computation of diluted net loss per share",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock reserved for future issuance",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year Three",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r167",
      "r277"
     ]
    },
    "tsha_ConstructionInProgressAndFinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ConstructionInProgressAndFinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment charges to construction in process and finance lease right of use assets",
        "label": "Impairment Charge On Construction In Progress And Finance Lease Right Of Use Asset",
        "documentation": "Impairment Charge On Construction In Progress And Finance Lease Right Of Use Asset"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_November132025ThroughButExcludingTheMaturityDateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "November132025ThroughButExcludingTheMaturityDateMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "November 13, 2025 through, but excluding, the Maturity Date",
        "label": "November 13, 2025 through, but excluding, the Maturity Date [Member]",
        "documentation": "November 13, 2025 through, but excluding, the Maturity Date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r167",
      "r277"
     ]
    },
    "tsha_November132024ThroughNovember132025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "November132024ThroughNovember132025Member",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "November 13, 2024 through November 13, 2025",
        "label": "November 13, 2024 through November 13, 2025 [Member]",
        "documentation": "November 13, 2024 through November 13, 2025"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Term Loan, net",
        "terseLabel": "Term loan, net",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "tsha_DeferredRentLiabiilitiesAndTenantImprovementAllowances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "DeferredRentLiabiilitiesAndTenantImprovementAllowances",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred rent liabiilities and tenant improvement allowances",
        "label": "Deferred Rent Liabiilities And Tenant Improvement Allowances",
        "documentation": "Deferred Rent Liabiilities And Tenant Improvement Allowances"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "tsha_PrepaidResearchAndDevelopmentContracts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PrepaidResearchAndDevelopmentContracts",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid research and development",
        "label": "Prepaid Research And Development Contracts",
        "documentation": "Prepaid research and development contracts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PerformanceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PerformanceSharesMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Stock Options",
        "documentation": "Share-based payment arrangement awarded for meeting performance target."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Defined Benefit Plans Disclosures [Table]",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r46",
      "r47",
      "r48",
      "r49"
     ]
    },
    "tsha_SeveranceCostRecorded": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "SeveranceCostRecorded",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance recorded",
        "label": "Severance Cost Recorded",
        "documentation": "Severance cost recorded."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "tsha_LeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "LeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities, current portion",
        "label": "Lease Liability Current",
        "documentation": "Lease liability current."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_TermLoanThroughAugustThirteenTwentyTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "TermLoanThroughAugustThirteenTwentyTwentyThreeMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Through August 13, 2023",
        "label": "Term Loan Through August Thirteen Twenty Twenty Three [Member]",
        "documentation": "Term loan through august thirteen twenty twenty three."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "tsha_LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "LicenseAgreementSalesRelatedMilestonesMaximumAmountPayable",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement sales-related milestones maximum amount payable",
        "label": "License Agreement Sales Related Milestones Maximum Amount Payable",
        "documentation": "License agreement sales-related milestones maximum amount payable."
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual",
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "LicenseAndInventoryPurchaseAgreementRegulatoryRelatedMilestonesPayment",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License and inventory purchase agreement regulatory related milestones payment",
        "label": "License And Inventory Purchase Agreement Regulatory Related Milestones Payment",
        "documentation": "License and inventory purchase agreement regulatory related milestones payment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property Plant and Equipment Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional and consulting fees",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grants",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Granted In Period",
        "documentation": "Share based compensation arrangement by share based payment award number of shares available for grant granted in period.."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r603"
     ]
    },
    "tsha_SalesAgentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "SalesAgentMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales Agents",
        "label": "Sales Agent [Member]",
        "documentation": "Sales agent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and Fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
        "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
        "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total",
        "negatedLabel": "Accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r138",
      "r477"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income Tax Expense (Benefit), Total",
        "terseLabel": "Provision for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r123",
      "r185",
      "r186",
      "r208",
      "r356",
      "r366",
      "r482"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "tsha_TermLoanFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "TermLoanFacilityMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan",
        "label": "Term Loan Facility [Member]",
        "documentation": "Term loan facility."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_TransactionPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "TransactionPrice",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Transaction Price Allocation",
        "terseLabel": "Transaction price",
        "label": "Transaction Price",
        "documentation": "Transaction price."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancelled or forfeited, Weighted Average Grant Date Fair Value per Share",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "tsha_PercentageOfAnnualDefaultInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PercentageOfAnnualDefaultInterestRate",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of annual default interest rate",
        "label": "Percentage Of Annual Default Interest Rate",
        "documentation": "Percentage of annual default interest rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Term Loan, net",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r107",
      "r272",
      "r287",
      "r587",
      "r588",
      "r726"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding, Weighted Average Remaining Contractual Life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "tsha_ProbabilityOfAnOptionExercise": {
     "xbrltype": "percentItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ProbabilityOfAnOptionExercise",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Probability of option exercise",
        "label": "Probability Of An Option Exercise",
        "documentation": "Probability of Option Exercise"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assumptions used to estimate fair value of warrants.",
        "label": "Schedule Of Assumptions Used To Estimate Fair Value Of Warrants [Table Text Block]",
        "terseLabel": "Schedule Of Assumptions Used To Estimate Fair Value Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercisable at September 30, 2023, Weighted Average Remaining Contractual Life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "tsha_WarrantsNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "WarrantsNoteDisclosureTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants note disclosure.",
        "label": "Warrants Note Disclosure [Text Block]",
        "terseLabel": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "LicenseAgreementRegulatoryRelatedMilestonesMaximumAmountPayable",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement regulatory related milestones maximum amount payable",
        "label": "License Agreement Regulatory Related Milestones Maximum Amount Payable",
        "documentation": "License agreement regulatory related milestones maximum amount payable."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_LicenseForGanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "LicenseForGanMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option to obtain license for GAN",
        "label": "License For GAN [Member]",
        "documentation": "License For GAN"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_PrepaidBonus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PrepaidBonus",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid bonus",
        "label": "Prepaid Bonus",
        "documentation": "Prepaid bonus."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at September 30, 2023, Weighted Average Remaining Contractual Life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "tsha_SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "SaleRelatedMilestonesPerLicensedProductAndRoyaltiesOnNetSalesOfLicensedProductsPayable",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale-related milestones per licensed product and royalties on net sales of licensed products payable",
        "label": "Sale Related Milestones Per Licensed Product And Royalties On Net Sales Of Licensed Products Payable",
        "documentation": "Sale-related milestones per licensed product and royalties on net sales of licensed products payable."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_PegasusParkLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PegasusParkLLCMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pegasus Park, LLC.",
        "label": "Pegasus Park L L C [Member]",
        "terseLabel": "Pegasus Park L L C"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_OrganizationAndDescriptionOfBusinessOperationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "OrganizationAndDescriptionOfBusinessOperationsLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization and Description of Business Operations [Line Items]",
        "label": "Organization And Description Of Business Operations [Line Items]",
        "documentation": "Organization and description of business operations."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_FairValueOfSharesTransferredValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "FairValueOfSharesTransferredValue",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of shares transferred, Value",
        "label": "Fair Value Of Shares Transferred Value",
        "documentation": "Fair value of shares transferred value."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_UTSouthwesternAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "UTSouthwesternAgreementMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "UT Southwestern Agreement",
        "label": "U T Southwestern Agreement [Member]",
        "documentation": "UT southwestern agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r244",
      "r245",
      "r570",
      "r668"
     ]
    },
    "tsha_PercentageOfSalePricePerShareOfCommonStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PercentageOfSalePricePerShareOfCommonStock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of gross sales price per share of common stock",
        "label": "Percentage Of Sale Price Per Share Of Common Stock",
        "documentation": "Percentage of sale price per share of common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "terseLabel": "Warrants, measurement input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "tsha_PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PurchaseOfClinicalMaterialsAndReimbursementIncurredDevelopmentCosts",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of clinical materials and reimbursement incurred development costs",
        "label": "Purchase Of Clinical Materials And Reimbursement Incurred Development Costs",
        "documentation": "Purchase of clinical materials and reimbursement incurred development costs."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_AccruedClinicalTrialCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AccruedClinicalTrialCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued clinical trial",
        "label": "Accrued Clinical Trial Current",
        "documentation": "Accrued clinical trial current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer Equipment",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ScheduleOfAccruedSeveranceActivityRecordedTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Accrued Severance Activity Recorded",
        "label": "Schedule Of Accrued Severance Activity Recorded [Table Text Block]",
        "documentation": "Schedule of accrued severance activity table text block."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ScheduleOfSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Supplemental Information Related to Remaining Lease Term and Discount Rate",
        "label": "Schedule Of Supplemental Information Related To Remaining Lease Term And Discount Rate [Table Text Block]",
        "documentation": "Schedule of supplemental information related to remaining lease term and discount rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r351",
      "r352",
      "r510",
      "r653",
      "r654",
      "r655",
      "r704",
      "r732"
     ]
    },
    "tsha_MarketBasedStockOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "MarketBasedStockOptionsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market based stock options.",
        "label": "Market Based Stock Options [Member]",
        "terseLabel": "Market-based Stock Options"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize": {
     "xbrltype": "integerItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "MinimumLicensedProductToDevelopObtainRegulatoryApprovalForAndCommercialize",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum licensed product to develop obtain regulatory approval for and commercialize",
        "label": "Minimum Licensed Product To Develop Obtain Regulatory Approval For And Commercialize",
        "documentation": "Minimum licensed product to develop obtain regulatory approval for and commercialize."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "tsha_SalesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "SalesAgreementMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales Agreement",
        "label": "Sales Agreement [Member]",
        "documentation": "Sales Agreement."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "LicenseAndInventoryPurchaseAgreementSalesRelatedMilestonesPayment",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License and inventory purchase agreement sales related milestones payment",
        "label": "License And Inventory Purchase Agreement Sales Related Milestones Payment",
        "documentation": "License and inventory purchase agreement sales related milestones payment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Diluted, Total",
        "terseLabel": "Net loss per common share, diluted",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r177",
      "r178",
      "r180",
      "r181",
      "r183",
      "r193",
      "r196",
      "r197",
      "r198",
      "r202",
      "r402",
      "r403",
      "r468",
      "r481",
      "r581"
     ]
    },
    "tsha_PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements": {
     "xbrltype": "durationItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PreclinicalActivitiesPeriodUnderSponsoredResearchAgreements",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preclinical activities period under sponsored research agreements",
        "label": "Preclinical Activities Period Under Sponsored Research Agreements",
        "documentation": "Preclinical activities period under sponsored research agreements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "General and Administrative Expense, Total",
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r544"
     ]
    },
    "tsha_PercentageOfFullyDilutedCommonStockSharesOutstanding": {
     "xbrltype": "percentItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PercentageOfFullyDilutedCommonStockSharesOutstanding",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of fully diluted common stock shares outstanding",
        "label": "Percentage Of Fully Diluted Common Stock Shares Outstanding",
        "documentation": "Percentage of fully diluted common stock shares outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease term of contract",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "tsha_LicenseAgreementCommercialMilestonesPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "LicenseAgreementCommercialMilestonesPayment",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement commercial milestones payment",
        "label": "License Agreement Commercial Milestones Payment",
        "documentation": "License agreement commercial milestones payment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease extend term of contract",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "tsha_CommonStockAndWarrantsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "CommonStockAndWarrantsFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock and warrants fair value disclosure",
        "label": "Common Stock and Warrants Fair Value Disclosure",
        "documentation": "Common stock and warrants fair value disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_SummaryOfTransactionPriceAllocationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "SummaryOfTransactionPriceAllocationTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Allocation for Transaction Price to the Three Performance Obligations",
        "label": "Summary Of Transaction Price Allocation [Table Text Block]",
        "documentation": "Summary Of Transaction Price Allocation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "tsha_PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PercentageOfAutomaticIncreaseEveryYearInCommonStockSharesReservedForFutureIssuance",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of automatic increase every year in common stock shares reserved for future issuance",
        "label": "Percentage Of Automatic Increase Every Year In Common Stock Shares Reserved For Future Issuance",
        "documentation": "Percentage of automatic increase every year in common stock shares reserved for future issuance."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term (in years) - Operating leases",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r446",
      "r602"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Purchase price per share of common stock",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Funded Warrants",
        "documentation": "Pre Funded Warrants.",
        "label": "Pre Funded Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r25",
      "r130",
      "r148",
      "r149",
      "r150",
      "r168",
      "r169",
      "r170",
      "r174",
      "r184",
      "r186",
      "r203",
      "r227",
      "r234",
      "r291",
      "r350",
      "r351",
      "r352",
      "r362",
      "r363",
      "r385",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r401",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r453",
      "r492",
      "r493",
      "r494",
      "r510",
      "r561"
     ]
    },
    "tsha_ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ScheduleOfAssumptionsUsedToEstimateFairValueOfSsiWarrantLiabilityTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Assumptions Used To Estimate Fair Value Of SSI Warrant Liability",
        "label": "Schedule Of Assumptions Used To Estimate Fair Value Of SSI Warrant Liability [Table Text Block]",
        "documentation": "Schedule of assumptions used to estimate fair value of SSI warrant liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r168",
      "r169",
      "r170",
      "r174",
      "r184",
      "r186",
      "r227",
      "r234",
      "r350",
      "r351",
      "r352",
      "r362",
      "r363",
      "r385",
      "r388",
      "r389",
      "r392",
      "r401",
      "r492",
      "r494",
      "r510",
      "r732"
     ]
    },
    "tsha_LicenseForRettMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "LicenseForRettMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option to obtain license for Rett",
        "label": "License For RETT [Member]",
        "documentation": "License For RETT"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RegistrationPaymentArrangementArrangementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RegistrationPaymentArrangementArrangementDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Payment Arrangement, Arrangement [Domain]",
        "documentation": "Identifies and describes the contingent obligation arising from a commitment made to the recipient of the entity's financial instruments to endeavor (a) to file a registration statement for the resale of those financial instrument (demand or \"piggyback\" rights granted to the recipient) or for the resale of equity shares that are issuable upon exercise or conversion of those financial instruments and (b) for the registration statement to be declared effective by the Securities and Exchange Commission within a specified grace period."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62"
     ]
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "PIPE Shares",
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r606",
      "r607",
      "r608",
      "r610",
      "r611",
      "r612",
      "r613",
      "r653",
      "r654",
      "r704",
      "r729",
      "r732"
     ]
    },
    "tsha_LicenseAgreementRegulatoryMilestonesPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "LicenseAgreementRegulatoryMilestonesPayment",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement regulatory milestones payment",
        "label": "License Agreement Regulatory Milestones Payment",
        "documentation": "License agreement regulatory milestones payment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionIntegrationRestructuringAndOtherRelatedCostsTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritization"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Strategic Reprioritization",
        "label": "Business Acquisition, Integration, Restructuring and Other Related Costs [Text Block]",
        "documentation": "The entire description for costs incurred to effect a business combination that have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "tsha_ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ScheduleOfAccruedExpenseAndOtherCurrentLabilitiesTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expense and Other Current Labilities",
        "label": "Schedule Of Accrued Expense And Other Current Labilities Table [Text Block]",
        "documentation": "Schedule of accrued expense and other current labilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in Progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting",
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702"
     ]
    },
    "tsha_MilestoneFeePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "MilestoneFeePaid",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone fee paid.",
        "label": "Milestone Fee Paid",
        "terseLabel": "Milestone fee paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "tsha_AggregateOfferingPriceFromSaleOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AggregateOfferingPriceFromSaleOfCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate offering price from sale of common stock",
        "label": "Aggregate Offering Price From Sale Of Common Stock",
        "documentation": "Aggregate offering price from sale of common stock."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ProceedsFromIssuanceOfCommonStockAndPrefundedWarrantsFromPrivatePlacementNetOfPlacementAgentCommissionsAndOtherOfferingCosts",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock and pre-funded warrants from private placement, net of placement agent commissions and other offering costs",
        "label": "Proceeds From Issuance Of Common Stock And Prefunded Warrants From Private Placement Net Of Placement Agent Commissions And Other Offering Costs",
        "documentation": "Proceeds from issuance of common stock and prefunded warrants from private placement net of placement agent commissions and other offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_PaymentsToAcquireLicenseRight": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PaymentsToAcquireLicenseRight",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payment to acquire license agreement",
        "label": "Payments To Acquire License Right",
        "documentation": "Payments to acquire license right."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Interest Expense, Total",
        "negatedLabel": "Interest expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r111",
      "r151",
      "r207",
      "r427",
      "r546",
      "r614",
      "r731"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual",
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r660",
      "r715"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and Administrative Expense",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r130",
      "r148",
      "r149",
      "r150",
      "r168",
      "r169",
      "r170",
      "r174",
      "r184",
      "r186",
      "r203",
      "r227",
      "r234",
      "r291",
      "r350",
      "r351",
      "r352",
      "r362",
      "r363",
      "r385",
      "r387",
      "r388",
      "r389",
      "r390",
      "r392",
      "r401",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r453",
      "r492",
      "r493",
      "r494",
      "r510",
      "r561"
     ]
    },
    "tsha_SignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "SignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant accounting policies line items.",
        "label": "Significant Accounting Policies [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_IncreaseDecreaseInAccruedExpenseAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "IncreaseDecreaseInAccruedExpenseAndOtherLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Increase Decrease In Accrued Expense And Other Liabilities",
        "documentation": "Increase decrease in accrued expense and other liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting",
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.00001 par value per share; 200,000,000 shares authorized and 186,960,193 and 63,207,507 issued and outstanding as of September 30, 2023 and December 31, 2022, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r474",
      "r603"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r580"
     ]
    },
    "tsha_ClosingDateThroughNovember132024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ClosingDateThroughNovember132024Member",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Closing Date through November 13, 2024",
        "label": "Closing Date through November 13, 2024 [Member]",
        "documentation": "Closing Date through November 13, 2024."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails": {
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r522"
     ]
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Stock Awards Activity",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "tsha_MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "MaximumConstructionAllowanceProvidedByLandlordPerRentableSquareFoot",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum construction allowance provided by landlord per rentable square foot.",
        "label": "Maximum Construction Allowance Provided By Landlord Per Rentable Square Foot",
        "terseLabel": "Maximum construction allowance provided by landlord per rentable square foot"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, expiration period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding",
        "periodStartLabel": "Balance, shares",
        "periodEndLabel": "Balance, shares",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r75",
      "r522",
      "r540",
      "r732",
      "r733"
     ]
    },
    "tsha_DallasLeaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "DallasLeaseMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dallas lease.",
        "label": "Dallas Lease [Member]",
        "terseLabel": "Dallas Lease"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_UpfrontPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "UpfrontPayment",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upfront payment",
        "label": "Upfront Payment",
        "documentation": "Upfront payment."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "DerecognizedBuildToSuitLeaseAssetPresentedInPropertyPlantEquipment",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derecognized build to suite lease asset",
        "label": "Derecognized Build To Suit Lease Asset Presented In Property Plant Equipment",
        "documentation": "Derecognized Build To Suit Lease Asset Presented In Property Plant Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r39",
      "r114",
      "r116",
      "r117",
      "r118"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "tsha_CertainEmployeesAndConsultantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "CertainEmployeesAndConsultantsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Certain Employees and Consultants",
        "label": "Certain Employees And Consultants [Member]",
        "documentation": "Certain employees and consultants."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_DurhamLeaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "DurhamLeaseMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Durham Lease",
        "label": "Durham Lease [Member]",
        "documentation": "Durham lease."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price of warrants",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Exercise price of warrants per share",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r290"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt, Type",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contribution to retirement savings plan",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research, Collaboration and License Agreements",
        "terseLabel": "Astellas Agreements",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r115",
      "r125"
     ]
    },
    "us-gaap_CumulativeEarningsDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CumulativeEarningsDeficit",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Cumulative Earnings (Deficit)",
        "documentation": "Amount of cumulative earnings (deficits) for relevant time periods."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, vesting rights percentage",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r261"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateTerms",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate terms description",
        "label": "Debt Instrument, Interest Rate Terms",
        "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails2": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfFairValueMethodToAllocateNetProceedsReceivedFromSaleOfCommonStockAndPrefundedWarrantsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, maturity date",
        "label": "Debt Instrument, Maturity Date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r586",
      "r707"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Operating Activities, Lessee [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total",
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r456"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails2": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total lease liabilities",
        "totalLabel": "Total lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancelled or forfeited, Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total",
        "terseLabel": "Net loss",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r146",
      "r147",
      "r156",
      "r163",
      "r173",
      "r185",
      "r186",
      "r204",
      "r210",
      "r214",
      "r216",
      "r222",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r374",
      "r377",
      "r378",
      "r403",
      "r412",
      "r469",
      "r479",
      "r509",
      "r542",
      "r559",
      "r560",
      "r583",
      "r600",
      "r601",
      "r615",
      "r644",
      "r671"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based payment award, RSU/RSA granted",
        "terseLabel": "Restricted units/stock granted, Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Common Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r199",
      "r200",
      "r201"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based payment award, RSU/RSA granted, weighted average grant date fair value",
        "terseLabel": "Restricted units/stock granted, Weighted Average Grant Date Fair Value per Share",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Calculation of Basic and Diluted Net Loss Per Common Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstsanding performance and market-based RSU's",
        "periodStartLabel": "Nonvested, Number of Shares, Beginning Balance",
        "periodEndLabel": "Nonvested, Number of Shares, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r330"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r456"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Nonvested, Weighted Average Grant Date Fair Value per Share, Beginning Balance",
        "periodEndLabel": "Nonvested, Weighted Average Grant Date Fair Value per Share, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r330"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails2": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liabilities, current",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r135",
      "r163",
      "r222",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r376",
      "r379",
      "r380",
      "r412",
      "r603",
      "r671",
      "r716",
      "r717"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r456"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested, Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "terseLabel": "Performance and market-based restricted stock units of other option vested during period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r167",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r428",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r650"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested, Weighted Average Grant Date Fair Value per Share",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "terseLabel": "Offering costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r100"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r633",
      "r647"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r263",
      "r289",
      "r454",
      "r578",
      "r579"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r456"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, plan modification, incremental cost",
        "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost",
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense):",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails2": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability, net of current portion",
        "verboseLabel": "Operating lease liabilities, non-current",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails": {
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Debt Instrument, Unamortized Discount, Total",
        "negatedLabel": "Unamortized debt discount",
        "label": "Debt Instrument, Unamortized Discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r66",
      "r674"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r239",
      "r545"
     ]
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of headcount reduced",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated, Period Percent",
        "documentation": "The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares authorized for issuance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Available for grant ending of period",
        "periodStartLabel": "Available for grant beginning of period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense), net",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "us-gaap_EscrowDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EscrowDeposit",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount required to place in escrow account",
        "label": "Escrow Deposit",
        "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r571"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total",
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r100",
      "r475",
      "r496",
      "r501",
      "r507",
      "r523",
      "r603"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Options expired, Stock Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r456"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Options cancelled or forfeited, Stock Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r327"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, options, weighted-average grant date fair value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, Aggregate Intrinsic Value, Beginning Balance",
        "periodEndLabel": "Outstanding, Aggregate Intrinsic Value, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r617"
     ]
    },
    "us-gaap_TypeOfAdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfAdoptionMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Domain]",
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r173",
      "r174",
      "r175",
      "r176",
      "r188",
      "r220",
      "r221",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r236",
      "r350",
      "r351",
      "r352",
      "r360",
      "r361",
      "r362",
      "r363",
      "r370",
      "r371",
      "r372",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r410",
      "r411",
      "r414",
      "r415",
      "r416",
      "r417",
      "r425",
      "r426",
      "r430",
      "r431",
      "r432",
      "r433",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r465",
      "r466",
      "r467",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r545"
     ]
    },
    "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets held for sale",
        "label": "Asset, Held-for-Sale, Not Part of Disposal Group, Current",
        "totalLabel": "Asset, Held-for-Sale, Not Part of Disposal Group, Current, Total",
        "documentation": "Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r603"
     ]
    },
    "us-gaap_RestructuringPlanAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringPlanAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Plan",
        "label": "Restructuring Plan [Axis]",
        "documentation": "Information by individual restructuring plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r72",
      "r73",
      "r106",
      "r107",
      "r167",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r428",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r650"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r284",
      "r428",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r650"
     ]
    },
    "tsha_TrinityTermLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "TrinityTermLoansMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trinity Term Loans",
        "label": "Trinity Term Loans [Member]",
        "documentation": "Trinity Term Loans"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares",
        "terseLabel": "Market-based Stock Options vested during period",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_AstellasMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AstellasMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Astellas",
        "label": "Astellas [Member]",
        "documentation": "Astellas [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r44",
      "r45",
      "r63",
      "r64",
      "r66",
      "r69",
      "r98",
      "r99",
      "r167",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r284",
      "r428",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r650"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails": {
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankScheduleOfFuturePrincipalDebtPaymentsOnLoanPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total principal payments",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r107",
      "r286"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaseCostDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease cost",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r441",
      "r602"
     ]
    },
    "tsha_TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "TermLoanFromAprilOneTwentyTwentyThreeUntilDecemberThirtyOneTwentyTwentyThreeMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "April 1, 2023 until December 31, 2023",
        "label": "Term Loan From April One Twenty Twenty Three Until December Thirty One Twenty Twenty Three [Member]",
        "documentation": "Term loan from april one twenty twenty three until december thirty one twenty twenty three."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold Improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at September 30, 2023, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r338"
     ]
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Date of incorporation",
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "IncreaseDecreaseInAccruedExpenseAndOtherCurrentLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other current liabilities",
        "label": "Increase Decrease In Accrued Expense And Other Current Liabilities",
        "documentation": "Increase decrease in accrued expense and other current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ExitAndDisposalActivitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ExitAndDisposalActivitiesMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exit and Disposal Activities",
        "label": "Exit And Disposal Activities [Member]",
        "documentation": "Exit and disposal activities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease",
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r602"
     ]
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBank"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan with Silicon Valley Bank",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r162",
      "r259",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r275",
      "r282",
      "r283",
      "r285"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r217",
      "r464",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r574",
      "r592",
      "r604",
      "r634",
      "r669",
      "r670",
      "r675",
      "r728"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Restricted Cash, Total",
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r640",
      "r649",
      "r725",
      "r727"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease cost",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r602"
     ]
    },
    "tsha_TrinityLendersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "TrinityLendersMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trinity Lenders",
        "label": "Trinity Lenders [Member]",
        "documentation": "Trinity Lenders"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "tsha_SsiStrategyHoldingsLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "SsiStrategyHoldingsLlcMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SSI Strategy Holdings LLC",
        "label": "SSI Strategy Holdings LLC [Member]",
        "documentation": "SSI Strategy Holdings LLC."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r163",
      "r222",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r376",
      "r379",
      "r380",
      "r412",
      "r520",
      "r582",
      "r616",
      "r671",
      "r716",
      "r717"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r344",
      "r353"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r87"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscountNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exit fee recorded as debt discount",
        "label": "Debt Instrument, Unamortized Discount, Noncurrent",
        "documentation": "Amount of debt discount to be amortized after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r66"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r217",
      "r464",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r574",
      "r592",
      "r604",
      "r634",
      "r669",
      "r670",
      "r675",
      "r728"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at September 30, 2023, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at September 30, 2023, Stock Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "tsha_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities Purchase Agreement",
        "label": "Securities Purchase Agreement Member",
        "documentation": "Securities purchase agreement member.",
        "verboseLabel": "Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r87",
      "r160"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercisable at September 30, 2023, Stock Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r338"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Tranche One",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Earnings Per Share, Basic, Total",
        "terseLabel": "Net loss per common share, basic",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r177",
      "r178",
      "r180",
      "r181",
      "r183",
      "r190",
      "r193",
      "r196",
      "r197",
      "r198",
      "r202",
      "r402",
      "r403",
      "r468",
      "r481",
      "r581"
     ]
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Severance paid",
        "terseLabel": "Severance and termination-related costs",
        "label": "Severance Costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "tsha_ChangeInFairValueOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ChangeInFairValueOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value",
        "label": "Change in Fair Value of Warrants",
        "documentation": "Change in fair value of warrants."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "TermLoanFromJanuaryOneTwentyTwentyTwoUntilSeptemberThirtyTwentyTwentyTwoMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January 1, 2022 until September 30, 2022",
        "label": "Term Loan From January One Twenty Twenty Two Until September Thirty Twenty Twenty Two [Member]",
        "documentation": "Term loan from january one twenty twenty two until september thirty twenty twenty two."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_GiantAxonalNeuropathyAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "GiantAxonalNeuropathyAgreementMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option Agreement for GAN",
        "label": "Giant Axonal Neuropathy Agreement [Member]",
        "documentation": "Giant axonal neuropathy agreement."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_AccruedSeverance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AccruedSeverance",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued severance",
        "label": "Accrued Severance",
        "documentation": "Accrued Severance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Share-Based Payment Arrangement, Noncash Expense, Total",
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "tsha_PerformanceAndMarketBasedStockOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PerformanceAndMarketBasedStockOptionsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance and Market-based Stock Options",
        "label": "Performance And Market-Based Stock Options [Member]",
        "documentation": "Performance and market-based stock options."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "IssuanceOfCommonStockUponVestingAndSettlementOfRestrictedStockUnitShares",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock upon vesting and settlement of restricted stock unit shares.",
        "label": "Issuance Of Common Stock Upon Vesting And Settlement Of Restricted Stock Unit Shares",
        "terseLabel": "Issuance of common stock upon vesting and settlement of restricted stock units, net, shares"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "auth_ref": [
      "r131",
      "r168",
      "r169",
      "r170",
      "r173",
      "r174",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r202",
      "r229",
      "r230",
      "r363",
      "r397",
      "r401",
      "r402",
      "r403",
      "r433",
      "r452",
      "r453",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r504"
     ]
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on held for sale assets",
        "terseLabel": "Loss on held for sale assets",
        "label": "Gain (Loss) on Disposition of Assets",
        "totalLabel": "Gain (Loss) on Disposition of Assets, Total",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r648"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Tranche Three",
        "label": "Share-Based Payment Arrangement, Tranche Three [Member]",
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r263",
      "r289",
      "r454",
      "r577",
      "r579"
     ]
    },
    "tsha_ShareBasedCompensationAwardTrancheFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ShareBasedCompensationAwardTrancheFourMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Tranche Four",
        "label": "Share Based Compensation Award Tranche Four [Member]",
        "documentation": "Share based compensation award tranche four."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_OnSiteGenerationLeaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "OnSiteGenerationLeaseMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "On-site generation lease.",
        "label": "On Site Generation Lease [Member]",
        "terseLabel": "On Site Generation Lease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liability",
        "label": "Derivative Liability, Current",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]"
       }
      }
     },
     "auth_ref": [
      "r131",
      "r168",
      "r169",
      "r170",
      "r173",
      "r174",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r202",
      "r229",
      "r230",
      "r363",
      "r397",
      "r401",
      "r402",
      "r403",
      "r433",
      "r452",
      "r453",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r504"
     ]
    },
    "tsha_AstellasPrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AstellasPrivatePlacementMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Astellas Private Placement",
        "label": "Astellas Private Placement [Member]",
        "documentation": "Astellas Private Placement."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_TrinityTermLoanAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "TrinityTermLoanAgreementMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trinity Term Loan Agreement",
        "label": "Trinity Term Loan Agreement [Member]",
        "documentation": "Trinity Term Loan Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders' (deficit) equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r108",
      "r476",
      "r603",
      "r651",
      "r661",
      "r708"
     ]
    },
    "tsha_IssuanceOfWarrantsInConnectionWithPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "IssuanceOfWarrantsInConnectionWithPrivatePlacement",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of warrants in connection with private placement.",
        "label": "Issuance Of Warrants In Connection With Private Placement",
        "terseLabel": "Issuance of warrants in connection with private placement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Tranche Two",
        "label": "Share-Based Payment Arrangement, Tranche Two [Member]",
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "TermLoanFromJanuaryOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January 1, 2022 until March 31, 2023",
        "label": "Term Loan From January One Twenty Twenty Two Until March Thirty One Twenty Twenty Three [Member]",
        "documentation": "Term loan from january one twenty twenty two until march thirty one twenty twenty three."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_IssuanceCostsForPreFundedWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "IssuanceCostsForPreFundedWarrantLiability",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance costs for pre-funded warrant liability",
        "label": "Issuance Costs For Pre-funded Warrant Liability.",
        "documentation": "Issuance costs for pre-funded warrant liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Stock Units Activity",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based payment award, options granted",
        "terseLabel": "Options granted, Stock Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r325"
     ]
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Impairment loss on sale of assets",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value."
       }
      }
     },
     "auth_ref": [
      "r648"
     ]
    },
    "tsha_PaymentOfLicenseFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PaymentOfLicenseFee",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License fee payment",
        "label": "Payment Of License Fee",
        "documentation": "Payment of license fee."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "auth_ref": [
      "r130",
      "r171",
      "r180",
      "r188",
      "r227",
      "r234",
      "r350",
      "r351",
      "r352",
      "r362",
      "r363",
      "r385",
      "r387",
      "r388",
      "r390",
      "r391",
      "r392",
      "r396",
      "r399",
      "r401",
      "r402",
      "r451"
     ]
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "auth_ref": [
      "r130",
      "r171",
      "r180",
      "r188",
      "r227",
      "r234",
      "r350",
      "r351",
      "r352",
      "r362",
      "r363",
      "r385",
      "r387",
      "r388",
      "r390",
      "r391",
      "r392",
      "r396",
      "r399",
      "r401",
      "r402",
      "r451"
     ]
    },
    "tsha_QueensAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "QueensAgreementMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Queens Agreement",
        "label": "Queens Agreement [Member]",
        "documentation": "Queen's agreement."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]"
       }
      }
     },
     "auth_ref": [
      "r130",
      "r171",
      "r180",
      "r188",
      "r227",
      "r234",
      "r350",
      "r351",
      "r352",
      "r362",
      "r363",
      "r385",
      "r387",
      "r388",
      "r390",
      "r391",
      "r392",
      "r396",
      "r399",
      "r401",
      "r402",
      "r451"
     ]
    },
    "tsha_ClassOfWarrantOrRightVestedAndExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ClassOfWarrantOrRightVestedAndExercisable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of warrant or right vested and exercisable.",
        "label": "Class Of Warrant Or Right Vested and Exercisable",
        "terseLabel": "Class of warrant or right vested and exercisable shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_DerecognizedBuildToSuitLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "DerecognizedBuildToSuitLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derecognized build to suit lease liablility",
        "label": "Derecognized Build To Suit Lease Liability",
        "documentation": "Derecognized Build To Suit Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, commencement date",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Commencement Date",
        "documentation": "Share based compensation arrangement by share based payment award commencement date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of noncash investing and financing activities:",
        "label": "Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_AugustTwoThousandAndTwentyThreePrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AugustTwoThousandAndTwentyThreePrivatePlacementMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "August 2023 Private Placement",
        "label": "August Two Thousand And Twenty Three Private Placement [Member]",
        "documentation": "August two thousand and twenty three private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows for operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r438",
      "r444"
     ]
    },
    "tsha_TwoThousandTwentyEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "TwoThousandTwentyEquityIncentivePlanMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Existing Plan",
        "terseLabel": "2020 Equity Incentive Plan",
        "label": "Two Thousand Twenty Equity Incentive Plan [Member]",
        "documentation": "Two thousand twenty equity incentive plan."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_AstellasSecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AstellasSecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Astellas Securities Purchase Agreement",
        "label": "Astellas Securities Purchase Agreement [Member]",
        "documentation": "Astellas Securities Purchase Agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r169",
      "r170",
      "r203",
      "r464",
      "r505",
      "r511",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r522",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r541",
      "r543",
      "r544",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r561",
      "r609"
     ]
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledOrForfeitedInPeriodIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options cancelled or forfeited, Aggregate Intrinsic Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Or Forfeited In Period Intrinsic Value",
        "documentation": "Share based compensation arrangement by share based payment award options cancelled or forfeited in period intrinsic value."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ProceedsFromIssuanceOfCommonStockNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ProceedsFromIssuanceOfCommonStockNet",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Proceeds from issuance of common stock and pre-funded warrants from private placement, net of sales commissions",
        "terseLabel": "Net proceeds from issuance of common stock",
        "label": "Proceeds From Issuance Of Common Stock Net",
        "documentation": "Proceeds from issuance of common stock net."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Commitments Under Company's Operating and Finance Leases",
        "label": "Lessee, Operating And Finance Lease, Liability, Maturity [Table Text Block]",
        "documentation": "Lessee, operating and finance lease, liability, maturity ."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award requisite service vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period",
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "tsha_PaymentsToInvestorsAsLiquidatedDamages": {
     "xbrltype": "percentItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PaymentsToInvestorsAsLiquidatedDamages",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to investors as liquidated damages.",
        "label": "Payments To Investors As Liquidated Damages",
        "terseLabel": "Payments to investors as liquidated damages"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "SSI Warrants",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r606",
      "r607",
      "r610",
      "r611",
      "r612",
      "r613"
     ]
    },
    "tsha_PropertyAndEquipmentInAccountsPayableAndAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PropertyAndEquipmentInAccountsPayableAndAccruedExpenses",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment in accounts payable and accrued expenses",
        "label": "Property And Equipment In Accounts Payable And Accrued Expenses",
        "documentation": "Property and equipment in accounts payable and accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentMaturityDateRangeEnd1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentMaturityDateRangeEnd1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, maturity end date",
        "label": "Debt Instrument, Maturity Date Range, End",
        "documentation": "Latest date the outstanding debt instruments are required to be repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering costs not yet paid",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r31"
     ]
    },
    "tsha_AllocatedToSharesDeductionToAdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AllocatedToSharesDeductionToAdditionalPaidInCapital",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allocated to shares, deduction to Additional paid-In capital",
        "label": "Allocated to Shares, deduction to Additional paid-In capital",
        "documentation": "Allocated to Shares, deduction to Additional paid-In capital."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "TermLoanThroughDecemberThirtyOneTwentyTwentyOneMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Through December 31, 2021",
        "label": "Term Loan Through December Thirty One Twenty Twenty One [Member]",
        "documentation": "Term loan through december thirty one twenty twenty one."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "tsha_ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Supplemental Cash Flow Information Related to Operating Leases",
        "label": "Schedule Of Supplemental Cash Flow Information Related To Operating Leases [Table Text Block]",
        "documentation": "Schedule Of Supplemental Cash Flow Information Related To Operating Leases"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_InterestRatePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "InterestRatePeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate period",
        "documentation": "Interest rate period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "tsha_LaboratoryEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "LaboratoryEquipmentMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Laboratory Equipment",
        "label": "Laboratory Equipment [Member]",
        "documentation": "Laboratory equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' (deficit) equity",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfRestructuringDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Type of Restructuring [Domain]",
        "documentation": "Identification of the types of restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r238",
      "r241",
      "r242"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, compensation cost not yet recognized, weighted-average period of recognition",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "us-gaap_EmployeeSeveranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeSeveranceMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Severance",
        "label": "Employee Severance [Member]",
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_AbeonaCLN1AgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AbeonaCLN1AgreementsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Abeona CLN1 Agreements",
        "verboseLabel": "Abeona CLN1 Agreements",
        "label": "Abeona C L N1 Agreements [Member]",
        "documentation": "Abeona CLN1 agreements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Depreciation, Total",
        "terseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r41"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock Options",
        "terseLabel": "Stock Options",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_WarrantsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "WarrantsPolicyPolicyTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants policy.",
        "label": "Warrants Policy [Policy Text Block]",
        "terseLabel": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants issued",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "verboseLabel": "Warrants to purchase share of common stock",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r290"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Expected term (in years)",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r706"
     ]
    },
    "tsha_DallasLeaseAmendmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "DallasLeaseAmendmentMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dallas lease amendment.",
        "label": "Dallas Lease Amendment [Member]",
        "terseLabel": "Dallas Lease Amendment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r89"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r602"
     ]
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating lease landlord square feet manufacturing facility",
        "label": "Property Subject to or Available for Operating Lease, Number of Units",
        "documentation": "The number of units (items of property) under operating lease arrangements."
       }
      }
     },
     "auth_ref": [
      "r666",
      "r712"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants associated with loan facility",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_InterestRateExtensionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "InterestRateExtensionPeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate extension period",
        "documentation": "Interest rate extension period"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "TermLoanFromOctoberOneTwentyTwentyTwoUntilMarchThirtyOneTwentyTwentyThreeMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "October 1, 2022 until March 31, 2023",
        "label": "Term Loan From October One Twenty Twenty Two Until March Thirty One Twenty Twenty Three [Member]",
        "documentation": "Term loan from october one twenty twenty two until march thirty one twenty twenty three."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_AccruedPropertyPlantAndEquipmentCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AccruedPropertyPlantAndEquipmentCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued property, plant and equipment",
        "label": "Accrued Property Plant And Equipment Current",
        "documentation": "Accrued property, plant, and equipment current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r463",
      "r647"
     ]
    },
    "tsha_SignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "SignificantAccountingPoliciesTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant accounting policies table.",
        "label": "Significant Accounting Policies [Table]",
        "terseLabel": "Significant Accounting Policies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock, net of sales commissions",
        "verboseLabel": "Net proceeds from issuance of common stock",
        "label": "Gross proceeds from issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "tsha_ChangeInFairValueOfWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ChangeInFairValueOfWarrantLiability",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of warrant liability",
        "label": "Change in Fair Value of Warrant Liability",
        "documentation": "Change in fair value of warrant liability."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_PercentageOfPrepaymentOfFacility": {
     "xbrltype": "percentItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PercentageOfPrepaymentOfFacility",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of prepayment of facility",
        "label": "Percentage Of Prepayment Of Facility",
        "documentation": "Percentage of prepayment of facility."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails4": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: imputed interest",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Expected volatility",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r706"
     ]
    },
    "tsha_ProceedsFromTermLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ProceedsFromTermLoan",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from term loan",
        "label": "Proceeds From Term Loan",
        "documentation": "Proceeds from term loan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Components",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value per share",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails4": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total lease liabilities",
        "totalLabel": "Total lease liabilities",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r436",
      "r448"
     ]
    },
    "tsha_TwoThousandTwentyStockIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "TwoThousandTwentyStockIncentivePlanMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Plan",
        "label": "Two Thousand Twenty Stock Incentive Plan [Member]",
        "documentation": "Two thousand twenty stock incentive plan."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r621"
     ]
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputSharePriceMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market value of common stock",
        "label": "Measurement Input, Share Price [Member]",
        "documentation": "Measurement input using share price of saleable stock."
       }
      }
     },
     "auth_ref": [
      "r706"
     ]
    },
    "tsha_ResearchCollaborationAndLicenseAgreementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ResearchCollaborationAndLicenseAgreementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Research Collaboration And License Agreements [Abstract]",
        "documentation": "Research, collaboration and license agreements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r294",
      "r295",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r595"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails4": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease liabilities, current",
        "label": "Finance Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "terseLabel": "Other",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r626",
      "r645"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Risk-free interest rate",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r706"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease, option to extend description",
        "label": "Lessee, Operating Lease, Option to Extend",
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "us-gaap_DeferredOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredOfferingCosts",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred offering costs",
        "label": "Deferred Offering Costs",
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r665"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercisable at Sepember 30, 2023, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesSupplementalInformationRelatedToRemainingLeaseTermAndDiscountRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term (in years) - Finance leases",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r446",
      "r602"
     ]
    },
    "tsha_AssetsCapitalizedAsFinanceLeasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AssetsCapitalizedAsFinanceLeasesMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets Capitalized As Finance Leases",
        "label": "Assets Capitalized as Finance Leases [Member]",
        "documentation": "Assets capitalized as finance leases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Restructuring And Related Costs [Table]",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails3": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails4": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OperatingLeaseLiability",
        "totalLabel": "Total lease payments",
        "label": "Finance Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate gross proceeds",
        "label": "Proceeds from Issuance of Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReplacementUnitsGrantsInPeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Replacement restricted units granted, Number of Shares",
        "verboseLabel": "Number of shares awarded",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement Units Grants In Period",
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options replacement units grants in period."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_IssuanceOfFairValueWarrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "IssuanceOfFairValueWarrant",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of SSI warrants",
        "documentation": "Issuance of fair value warrant.",
        "label": "Issuance of Fair Value Warrant",
        "terseLabel": "Issuance of fair value warrant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails3": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDateRangeStart1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentMaturityDateRangeStart1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, maturity start date",
        "label": "Debt Instrument, Maturity Date Range, Start",
        "documentation": "Earliest date the outstanding debt instruments are required to be repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "tsha_BeneficialOwnershipLimitationNoticePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "BeneficialOwnershipLimitationNoticePeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Beneficial ownership limitation notice period.",
        "label": "Beneficial Ownership Limitation Notice Period",
        "terseLabel": "Beneficial ownership limitation notice period (in days)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies - Note 13",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r68",
      "r472",
      "r521"
     ]
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r622"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum number of shares employees may purchase during offering period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee",
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "tsha_IssuanceOfWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "IssuanceOfWarrantLiability",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of Warrants",
        "terseLabel": "Issuance of Pre-Funded Warrants",
        "label": "Issuance Of Warrant Liability",
        "documentation": "Issuance of warrant liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails4": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance, lease liabilities, non-current",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Expense",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Axis]",
        "documentation": "Information by amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r173",
      "r174",
      "r175",
      "r176",
      "r188",
      "r220",
      "r221",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r236",
      "r350",
      "r351",
      "r352",
      "r360",
      "r361",
      "r362",
      "r363",
      "r370",
      "r371",
      "r372",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r410",
      "r411",
      "r414",
      "r415",
      "r416",
      "r417",
      "r425",
      "r426",
      "r430",
      "r431",
      "r432",
      "r433",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r465",
      "r466",
      "r467",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStrategicReprioritizationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost And Reserve [Line Items]",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243"
     ]
    },
    "tsha_SsiInvestorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "SsiInvestorsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SSI investors.",
        "label": "SSI Investors [Member]",
        "terseLabel": "SSI Investors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock under ESPP",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r74",
      "r75",
      "r100"
     ]
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Type [Axis]",
        "documentation": "Information by type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r238",
      "r241",
      "r242"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unvested RSAs",
        "terseLabel": "Restricted Stock Awards",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingStandardsUpdateExtensibleList",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "documentation": "Indicates amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r173",
      "r174",
      "r175",
      "r220",
      "r221",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r236",
      "r350",
      "r351",
      "r352",
      "r362",
      "r363",
      "r370",
      "r371",
      "r372",
      "r382",
      "r383",
      "r384",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r410",
      "r411",
      "r414",
      "r415",
      "r416",
      "r417",
      "r425",
      "r426",
      "r430",
      "r431",
      "r432",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r656"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]",
        "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r173",
      "r187",
      "r228",
      "r364"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails3": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_InterestExpenseLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseLongTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Interest Expense, Long-Term Debt, Total",
        "terseLabel": "Interest expense related to term loan",
        "label": "Interest Expense, Long-Term Debt",
        "documentation": "Aggregate amount of interest paid or due on all long-term debt."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r126",
      "r127"
     ]
    },
    "us-gaap_OperationsCommencedDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperationsCommencedDate1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease commencement date",
        "label": "Operations Commenced Date",
        "documentation": "Date the operations of the entity commenced, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_AbeonaRettAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AbeonaRettAgreementMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rett Research and Development Activities",
        "label": "Abeona Rett Agreement [Member]",
        "documentation": "Abeona Rett agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingStandardsUpdate201602Member",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASU 2016-02",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842)."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r74",
      "r75",
      "r100",
      "r510",
      "r561",
      "r569",
      "r615"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total",
        "terseLabel": "Weighted average common shares outstanding, diluted",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r198"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails3": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r158",
      "r159"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total",
        "terseLabel": "Weighted average common shares outstanding, basic",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r198"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Accounts Payable, Current, Total",
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r603"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails3": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "tsha_DifferenceOfMarketValuePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "DifferenceOfMarketValuePaid",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Difference of market value paid",
        "label": "Difference Of Market Value Paid",
        "documentation": "Difference of market value paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails3": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other Noncash Income (Expense), Total",
        "negatedLabel": "Other",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive Loss",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r317",
      "r345",
      "r346",
      "r349",
      "r597"
     ]
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current borrowing capacity",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r246",
      "r247",
      "r248",
      "r249",
      "r294",
      "r311",
      "r340",
      "r341",
      "r342",
      "r461",
      "r462",
      "r489",
      "r512",
      "r513",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r572",
      "r573",
      "r584",
      "r591",
      "r596",
      "r605",
      "r608",
      "r667",
      "r673",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r169",
      "r170",
      "r203",
      "r464",
      "r505",
      "r511",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r522",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r541",
      "r543",
      "r544",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r561",
      "r609"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumCommitmentsUnderCompanysOperatingAndFinanceLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid insurance",
        "label": "Prepaid Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r576",
      "r585",
      "r664"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue",
        "terseLabel": "Revenues",
        "label": "Revenues",
        "totalLabel": "Revenues, Total",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r163",
      "r205",
      "r206",
      "r209",
      "r212",
      "r213",
      "r217",
      "r218",
      "r219",
      "r222",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r412",
      "r469",
      "r671"
     ]
    },
    "tsha_IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "IncreaseOrDecreaseInBeneficialOwnershipLimitationPercentage",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase or decrease in beneficial ownership limitation percentage.",
        "label": "Increase or Decrease in Beneficial Ownership Limitation Percentage",
        "terseLabel": "Increase or decrease in beneficial ownership limitation percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Employee-related Liabilities, Current, Total",
        "terseLabel": "Accrued compensation",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r210",
      "r214",
      "r216",
      "r583"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r246",
      "r247",
      "r248",
      "r249",
      "r311",
      "r462",
      "r489",
      "r512",
      "r513",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r572",
      "r573",
      "r584",
      "r591",
      "r596",
      "r605",
      "r673",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents - money market funds",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r627",
      "r646"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r246",
      "r247",
      "r248",
      "r249",
      "r294",
      "r311",
      "r340",
      "r341",
      "r342",
      "r461",
      "r462",
      "r489",
      "r512",
      "r513",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r572",
      "r573",
      "r584",
      "r591",
      "r596",
      "r605",
      "r608",
      "r667",
      "r673",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r246",
      "r247",
      "r248",
      "r249",
      "r311",
      "r462",
      "r489",
      "r512",
      "r513",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r572",
      "r573",
      "r584",
      "r591",
      "r596",
      "r605",
      "r673",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ScheduleOfShareBasedCompensationAvailableForGrantTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share Based Compensation Available for Grant under Incentive Plans",
        "label": "Schedule Of Share Based Compensation Available For Grant [Table Text Block]",
        "documentation": "Schedule of share based compensation available for grant."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expense",
        "totalLabel": "Other Nonoperating Income (Expense), Total",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' (deficit) equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r78",
      "r79",
      "r91",
      "r524",
      "r540",
      "r562",
      "r563",
      "r603",
      "r616",
      "r651",
      "r661",
      "r708",
      "r732"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetail",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total prepaid expenses and other current assets",
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "tsha_OrganizationAndDescriptionOfBusinessOperationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "OrganizationAndDescriptionOfBusinessOperationsTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization And Description Of Business Operations [Table]",
        "label": "Organization And Description Of Business Operations [Table]",
        "documentation": "Organization and description of business operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59",
      "r60"
     ]
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityLenderDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Lender [Domain]",
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r650"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Aggregate principal amount",
        "terseLabel": "Maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization and Description of Business Operations",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r104",
      "r502",
      "r503"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r161"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r144",
      "r163",
      "r222",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r375",
      "r379",
      "r412",
      "r603",
      "r671",
      "r672",
      "r716"
     ]
    },
    "us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireInProcessResearchAndDevelopment",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of research and development license",
        "label": "Payments to Acquire in Process Research and Development",
        "documentation": "The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lender Name [Axis]",
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r650"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r89",
      "r109",
      "r133",
      "r146",
      "r147",
      "r150",
      "r163",
      "r173",
      "r177",
      "r178",
      "r180",
      "r181",
      "r185",
      "r186",
      "r194",
      "r204",
      "r210",
      "r214",
      "r216",
      "r222",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r403",
      "r412",
      "r480",
      "r542",
      "r559",
      "r560",
      "r583",
      "r614",
      "r671"
     ]
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r11",
      "r53"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options were exercised during the period",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r25",
      "r100"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of payroll deductions of employee's compensation during offering period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Offering Date",
        "documentation": "Discount rate from fair value on offering date that participants pay for shares."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Adopted Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-cash lease expense",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r648"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Income (Loss) Available to Common Stockholders, Basic, Total",
        "terseLabel": "Net loss",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r177",
      "r178",
      "r180",
      "r181",
      "r190",
      "r191",
      "r195",
      "r198",
      "r204",
      "r210",
      "r214",
      "r216",
      "r583"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of shares issued",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock, shares",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r74",
      "r75",
      "r100",
      "r506",
      "r561",
      "r569"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrimeRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrimeRateMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prime Rate",
        "label": "Prime Rate [Member]",
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_AccruedSeveranceBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AccruedSeveranceBalance",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStrategicReprioritizationSummaryOfAccruedSeveranceActivityRecordedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Accrued severance balance as of September 30, 2023",
        "periodStartLabel": "Accrued severance balance as of December 31, 2022",
        "label": "Accrued Severance Balance",
        "documentation": "Accrued severance balance."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingStandardsUpdate201912Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingStandardsUpdate201912Member",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASU 2019-12",
        "label": "Accounting Standards Update 2019-12 [Member]",
        "documentation": "Accounting Standards Update 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r363"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Decrease in revenue previously recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r292"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock under ESPP, shares",
        "verboseLabel": "Number of shares of common stock issued under ESPP",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r74",
      "r75",
      "r100"
     ]
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Note Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockPlans",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from common stock issuances under ESPP",
        "label": "Proceeds from Stock Plans",
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt, Type",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r43"
     ]
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r455",
      "r457"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity",
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightUnissued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightUnissued",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Unissued",
        "terseLabel": "Warrants Exercised",
        "documentation": "The number of warrants or rights which entitle the entity to receive future services in exchange for the unvested, forfeitable warrants or rights."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Deferred Revenue, Current",
        "totalLabel": "Deferred Revenue, Current, Total",
        "verboseLabel": "Deferred revenue recorded within current liabilities",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total accrued expenses and other current liabilities",
        "terseLabel": "Accrued expenses and other current liabilities",
        "label": "Accrued Liabilities and Other Liabilities",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      },
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Impairment of assets held for sale",
        "terseLabel": "Impairment of long-lived assets",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "totalLabel": "Impairment, Long-Lived Asset, Held-for-Use, Total",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r40",
      "r94"
     ]
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenueNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred Revenue, Noncurrent, Total",
        "label": "Deferred Revenue, Noncurrent",
        "verboseLabel": "Deferred revenue, net of current portion",
        "terseLabel": "Deferred revenue recorded within long-term liabilities",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Summary of Effect of the Adoption of ASC 842 on Statement of Operations and Cash Flows",
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r35",
      "r36"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, options, compensation cost not yet recognized",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r703"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, basis spread on variable rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, unvested RSU/RSA granted, compensation cost not yet recognized",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r703"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price",
        "label": "Share Price",
        "verboseLabel": "Purchase price per share of common stock",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, terms of award issuance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award",
        "documentation": "Description of terms of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitment fee percentage",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r458",
      "r459",
      "r460",
      "r587",
      "r588",
      "r593",
      "r594",
      "r595"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding. Stock Options, Beginning Balance",
        "periodEndLabel": "Outstanding. Stock Options, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Outstanding performance and market-based options",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r321",
      "r322"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Additional Paid in Capital, Total",
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r603",
      "r730"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, Weighted Average Exercise Price, Beginning balance",
        "periodEndLabel": "Outstanding, Weighted Average Exercise Price, Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r321",
      "r322"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercisable at September 30, 2023, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of warrant liability",
        "terseLabel": "Change in fair value of warrant liability",
        "verboseLabel": "Warrant liability fair value adjustment",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r5"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lease Cost",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r407",
      "r458",
      "r459",
      "r460",
      "r587",
      "r588",
      "r593",
      "r594",
      "r595"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r342"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type",
        "label": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r140",
      "r163",
      "r204",
      "r211",
      "r215",
      "r222",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r375",
      "r379",
      "r412",
      "r471",
      "r534",
      "r603",
      "r616",
      "r671",
      "r672",
      "r716"
     ]
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash impairment charge",
        "label": "Asset Impairment Charges",
        "totalLabel": "Asset Impairment Charges, Total",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r40"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, $0.00001 par value per share; 10,000,000 shares authorized and no shares issued and outstanding as of September 30, 2023 and December 31, 2022",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r473",
      "r603"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Principal Debt Payments on Loan Payable",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r288"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueTimeBasedVestingOfStockOptionsPerformanceAndServicebasedStock",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockAwardsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment award, expiration date",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date",
        "documentation": "Date the equity-based award expires, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "us-gaap_DeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Deferred Revenue",
        "totalLabel": "Deferred Revenue, Total",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Previously ASC 842",
        "label": "Previously Reported [Member]"
       }
      }
     },
     "auth_ref": [
      "r131",
      "r168",
      "r170",
      "r173",
      "r174",
      "r177",
      "r178",
      "r186",
      "r202",
      "r363",
      "r397",
      "r401",
      "r402",
      "r433",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r504",
      "r632",
      "r635",
      "r636",
      "r637",
      "r657",
      "r662",
      "r663",
      "r705",
      "r713",
      "r714"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r522"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "terseLabel": "Preferred stock, shares outstanding",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r522",
      "r540",
      "r732",
      "r733"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance",
        "totalLabel": "Property, Plant and Equipment, Gross, Total",
        "terseLabel": "Property, plant and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r137",
      "r478"
     ]
    },
    "tsha_EndOfTermPaymentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "EndOfTermPaymentPercentage",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "End of term payment percentage",
        "documentation": "End of term payment percentage"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r188",
      "r312",
      "r624",
      "r625",
      "r658"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Research and Development Expense, Total",
        "label": "Research and Development Expense",
        "terseLabel": "Research And Development Expense",
        "verboseLabel": "Research and development",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r354",
      "r724"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfAssumptionsUsedToEstimateFairValueOfWarrantsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessOperationsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "tsha_AssetsHeldForSalePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AssetsHeldForSalePolicyTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets Held for Sale",
        "label": "Assets Held for Sale [Policy Text Block]",
        "documentation": "Assets held for sale."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Property, plant and equipment, net",
        "terseLabel": "Property, plant and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r470",
      "r478",
      "r603"
     ]
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted, Aggregate Intrinsic Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value",
        "documentation": "Share based compensation arrangement by share based payment award options grants in period intrinsic value."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_PaymentOfSalesCommissionsAndOtherOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PaymentOfSalesCommissionsAndOtherOfferingCosts",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of sales commissions and other offering costs.",
        "label": "Payment Of Sales Commissions And Other Offering Costs",
        "terseLabel": "Payment of sales commissions and other offering cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "documentation": "The net amount of nonoperating interest income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Total Stock-Based Compensation Expense for Stock Options, ESPP, RSAs and RSUs",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r188",
      "r312",
      "r624",
      "r658"
     ]
    },
    "tsha_PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis": {
     "xbrltype": "percentItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PercentageOfCommonStockSharesEntitledToReceiveAdditionalSharesOnFullyDilutedBasis",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of entitled to receive additional shares on fully diluted basis",
        "label": "Percentage Of Common Stock Shares Entitled To Receive Additional Shares On Fully Diluted Basis",
        "documentation": "Percentage of common stock shares entitled to receive additional shares on fully diluted basis."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfEffectOfTheAdoptionOfAsc842OnStatementOfOperationsAndCashFlowsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_WarrantLiabilityFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "WarrantLiabilityFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsScheduleOfWarrantLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Liability",
        "periodEndLabel": "Balance at September 30, 2023",
        "periodStartLabel": "Balance at January 1, 2023",
        "label": "Warrant Liability Fair Value Disclosure",
        "documentation": "Warrant liability fair value disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreements",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsSummaryOfAllocationForTransactionPriceToTheThreePerformanceObligationsDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value per share",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r288"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureFairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r407"
     ]
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]",
        "documentation": "Indicates (true false) whether accounting standards update was adopted."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r128",
      "r129",
      "r172",
      "r220",
      "r221",
      "r223",
      "r224",
      "r225",
      "r231",
      "r232",
      "r236",
      "r360",
      "r370",
      "r371",
      "r381",
      "r382",
      "r383",
      "r393",
      "r394",
      "r404",
      "r410",
      "r411",
      "r413",
      "r414",
      "r415",
      "r425",
      "r430",
      "r431",
      "r432",
      "r449",
      "r465",
      "r466",
      "r490",
      "r491"
     ]
    },
    "tsha_EmployeeStockPurchasePlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "EmployeeStockPurchasePlansMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Purchase Plan (ESPP)",
        "label": "Employee Stock Purchase Plans [Member]",
        "documentation": "Employee stock purchase plans."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_NumberOfDistinctAndActiveClinicalStage": {
     "xbrltype": "integerItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "NumberOfDistinctAndActiveClinicalStage",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureLoanWithSiliconValleyBankAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of distinct and active clinical stage",
        "label": "Number Of Distinct And Active Clinical Stage",
        "documentation": "Number of distinct and active clinical stage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureNetLossPerCommonShareScheduleOfCommonStockEquivalentsOutstandingExcludedFromComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unvested RSUs",
        "terseLabel": "Restricted Stock Units",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PaymentsToInvestorsAsAdditionalLiquidatedDamagesPercentage",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to investors as additional liquidated damages percentage.",
        "label": "Payments To Investors As Additional Liquidated Damages Percentage",
        "terseLabel": "Payments to investors as additional liquidated damages percentage"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_PaymentOfShelfRegistrationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "PaymentOfShelfRegistrationCosts",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of shelf registration costs",
        "label": "Payment Of Shelf Registration Costs",
        "documentation": "Payment of shelf registration costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date",
        "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r128",
      "r129",
      "r220",
      "r221",
      "r223",
      "r224",
      "r225",
      "r231",
      "r232",
      "r233",
      "r236",
      "r360",
      "r370",
      "r371",
      "r372",
      "r381",
      "r382",
      "r383",
      "r384",
      "r393",
      "r394",
      "r395",
      "r398",
      "r404",
      "r410",
      "r411",
      "r413",
      "r414",
      "r415",
      "r425",
      "r430",
      "r431",
      "r432",
      "r449",
      "r465",
      "r466",
      "r490",
      "r491",
      "r632"
     ]
    },
    "tsha_AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "AcquisitionOfWorldwideRightsForTSHA120ForTreatmentOfGiantAxonalNeuropathyMember",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureAstellasAgreementsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureResearchCollaborationAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TSHA-120",
        "label": "Acquisition Of Worldwide Rights For T S H A120 For Treatment Of Giant Axonal Neuropathy [Member]",
        "documentation": "Acquisition of worldwide rights for TSHA 120 for treatment of giant axonal neuropathy."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseForStockOptionsESPPRsasAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantPlanAdjustmentsAndAmendmentsInPeriod",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/DisclosureStockbasedCompensationScheduleOfShareBasedCompensationAvailableForGrantUnderIncentivePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan adjustments and amendments",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Plan Adjustments And Amendments In Period",
        "documentation": "Share based compensation arrangement by share based payment award number of shares available for grant plan adjustments and amendments in period."
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureStockBasedCompensationScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options expired , Aggregate Intrinsic Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Intrinsic Value",
        "documentation": "Share based compensation arrangement by share based payment award options expired in period intrinsic value"
       }
      }
     },
     "auth_ref": []
    },
    "tsha_ResearchAndDevelopmentLicenseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://tayshagtx.com/20230930",
     "localname": "ResearchAndDevelopmentLicenseExpense",
     "crdr": "debit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development license expense",
        "label": "Research And Development License Expense",
        "documentation": "Research and development license expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersDeficitEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total",
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r315"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total",
        "negatedLabel": "Purchase of property, plant and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsAdditionalInformationDetails",
      "http://tayshagtx.com/20230930/taxonomy/role/Role_DisclosureBalanceSheetComponentsScheduleOfPropertyPlantAndEquipmentNetDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(c)",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "270",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-12"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "270",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-13"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482804/825-20-50-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482804/825-20-50-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482309/360-10-15-4"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "SubTopic": "20",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "326",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-3"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "326",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-3"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-4"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//808/tableOfContent"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-3"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-2"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715/tableOfContent"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-5"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-5"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r636": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r637": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r638": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r639": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//210/tableOfContent"
  },
  "r640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480341/340-10-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r684": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r685": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r688": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r689": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r691": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r692": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r693": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r696": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r697": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r698": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r699": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r703": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r704": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r707": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r708": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r709": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r710": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r711": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r712": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-13"
  },
  "r713": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r714": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r715": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r716": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r717": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r718": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r719": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r720": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r721": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r722": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r723": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r724": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r729": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r730": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r732": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r733": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>102
<FILENAME>0000950170-23-063734-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-063734-xbrl.zip
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M5%M6( /:5QGR=">@/1#X7Q+J_CM.QV\KP8)BE>"NE$/^Z_OL)R1.4Z>G'Y"
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M/!]5-Q 'A7V0M+ZE%(7Z1$9II)9+<6W'B8K+YLI8; 91WUA=.SR9>N,:05)
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MC 2$H3LS?[,RL[(Z^%>,];."DP4D$(S_VV6U_4O.88!-)\#=[+ 7X-_8TW]
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M_ _$=\)\KBC<R.$(/U0Q9W*Y?>$Q))5>PB)<9;5\M9GOT-?@WGR!6P="U&2
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MN$0]U)[ 6<>N04O<&&XKK=PN?:1S43E6_^OGWH\6$0LS%%EM^;?#93RDM1N
M Y]"0UL$T=S]EZ36!QA4\8!:%ZL+W3R"F(M.5^P.<9T^3<X0<T ]R5ORN>6#
M=>]<,V)U57([N>_=$N%3X6JQO]?ES_X1H):;0V6K*3>6H+TMWD"[I_1]13>H
MHRT9:;--?8[*#>A_GG0P3KT@T[H4D_B!Q5YS&5T9W61MH[RE$M["*#K<+F<7
M4,SL<[)^.; O8ZI*9T76LNBTUX972^Y+MVSJ@(F(C[<Z86LGP_QXCZD./A5]
M/Q8TMX.5=4!&5_*4?7)T?9 R,'[5AG>D8C"8->8#B25MU-4/9S"(N"B--9W"
MG!>578Y0*,S4Q6E5EK*K[51=\(#/X1M%,P>FB$>=7XIOT+W#^E TK:G8/Q#L
MU#\JQNKF7CH16W/!G3;D$2"50?I8.#S:JV(H+L7M'LMS3C8OR:2(HXR7EP:?
M>3Y5N)$.<4]TP0,&J,XJ>,\H'B"N*D/'),^<&$!@8J8>]NL+EU/OGI#@E#"/
MI-X-J**1=* #AJ2EN[1ONEPL))V7"[T<$7#:Q:Z1<:'!77KUJD)]LZ>_A:2V
MU[*O(;]T3):5P>.G$&Y%ST:S"TL6!YX%YWXIN^5.+CE%1%:^;!OC]I;MV>I@
M9/BL:Z[V>YM5'Q$[$MHU/7\[TINJ8M3]8:D;,SBX.V*L!)$47,C #U9K\*4W
M2#V+U:@W<A=(3;@5Z)IYZ)@>ZNS$-ATY9"?@^4E7 #ZJM!2C8!B@.K:N?Q/[
M5C^[Z&*@ARI+C66&PO*S"3CY$Z[49-!$LI\1O%35W__?04Z%ZR1$* /QNSLC
MXXJ;86!4@AL$HY)N/'!Z'C[*V(G:6U@ELK?ZF_ S8;T<JJX\*&T,$K-BP?$N
MWC[POP;Q"X+IO,7@.*H@!PQ_-J=PN&)T!S8%#,8@Q9"M#51=&1-:L2!G;P%:
M &$!FE3*W@(TV$KRK&C0)$;/E6Y+=&F!"PS8L(2 #4'8<!RTRK:%-BP6MI)=
MCSNYP$58&\<")RR-@YKLK0*CQUCN!+)LHZ@9Z]Q:)7:5P3@.;@M?F@/OZ=<%
M8[==,':#&V*LW^&!9Z[*OZP5&R&L5NO7W5MRID!8&IG\ @>K]?Y+^OW2RWQ:
M^M!0B6S#.O[A[1<>.BOS<PJ7GX)\30;?HU$#%QFK[FU#UN&!?823]Y-QXJ@N
M5>? TOR;J.[?N^'\MZ7O41JUT9R=_&)XG5%;*_B\&->\BO'O:!A04[_4I_0=
MYO4I$STS@;6VHC7X-)ERWM+HO"I_F=ETDN^ZJGO2CS=6!U)K<;ENY*MOM<;P
M@)ZT][8ZT??V>__C-=2%!\;K(/7;T?G:!7@ O1*T@KN;]=VH:?]UR/44=56?
MX=-SZK(+[].W>+:\IV34$P" R!U(>;^>0#R(&F:*I8_8K5X#B\E$G>X4=GC@
MX1,'6Y,E\M8(HDY_<F5 I1D[NMV!A)=#Q(W(E7FE. ^($' 4ON*6,3/WI3C_
MPODGXHBAN-461;XJ1G!LT:]FA_Z"-(E!0DI&PAB-X@=A3:77]\"(8E8G<.-/
M;KC8P1^@+LSP[N&1P9I#=P.V-;XV8NLPF6_^*9#2HH/*\2R.#)F)?[^WFGX1
MPN*X_F8/7+OSUB,-CQF9,R-[SR;O@>LJ><PHD*0 ]D_VZ 3M@1NSDZ30,KXZ
MT+*]1T=R#]PADO'5K4?J)")[=-+^'T&FUM+[O'QEFUSH(/K/>/W_DD2'-4H9
MAS^W?_GSL?\)2(/W)\UI64CB4%HZEC]WN 8$W_=_ %!+ P04    "  V@FY7
M2#<Y(L/_  #O;P$ $0   &EM9S,X-C4Q-#$X7S$N:G!G[+P%5%S;EBZ\"01"
ML)#@3B@"P=V=X </KL&A4KA+"@D0)&B X.Y.< @2W(-#X1ZD$MRI^KFMY]S;
MM_OO]_IUW_?&W8PYQK8U]_S6FG/-;^Y:&^0<<A5XHBBK( N@/   E/L_ +D
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ME$.PJSB1.(G15(*^3K;WA&,S_O23=<EOSY3-NC2_GJQ7'Z<()TI4^';(2Q$
M!OX *H,HMTYJ=[-70VL<G?"03<!F0'F^ B"*^ZVE^E?DX](2V$CV#PTD8+K
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ME4+L%Q8.W4AK@567Q>F]__&.^Z^5+%M]6<[.R(N84Y,C7IS%TC=@^NGE+-I
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M),@\[KQ[D$!6>/MK'M4KP';E;)\8$<ATYSO5(&I9=8\\Y/<<_6]%" =\U9!
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M6;&TUF00QP^/3(_=$$XR-42)2BY7#='WY=/6OWEUP:+2X$-Z4F&1]#[9_^;
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M&@;9RK%^+A*H=FL_S0:[= M!SQ,_TR#Z)GD=EM%OQ/)NS'Z=6 _%QR)^N8R
MU24H"D-;Q>]2B^]R$?<Y"7O7A-:DUO:+?5*:;^.-B"_U18MKWM%96?4N7_-=
M";>QC<Z#*ZDS3W]FKG><7Q T.GHR@)?%3$KBU\.-GG<T52$Z[;/C*3!ZS588
MPP!9P"PKU7F?"\-7,N5AH8:P5A;7.Q>E-B+&K3<3//61"Q)F"UNC^FNM^3=9
MM$8+GYPZ^XK'):A4UY8(?R'0;.&%W;GJM:Q0&XG-,0HX#1)HJX>+C1CQ^[]
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M;%BEHM[':?N3XL*9ZZG+S(UCVD7/CE\ACKJ:Q9;^-O)]]T8.<ABI92OXZ'%
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MI*U(A6$@ =&*([CU7@ERV[\N1(Z12!4"H$S#;0U:00!+^!/(&?4>!Q_2S""
MT*%_4_:O*$/]\2:>9(VTD7Q<>]DZ]XVP\6?6GFSM.IT/=^>W7W^\06?"R:GT
M[,@R]R\$BE&_)^E" #__=N9/-")W+PW:O_ <_C.-*)/*.N"?6 ;]-'3?,0PE
M[1# STS_F[)_1=G-W%#0ZE,(WK4?._A$52T<!]Q=E 6>^ BZ!(JY.[Q))NX>
M>E<];N0;RPT3PII*=V5K[49_(Q=%-X"GR.R%T9JPVT@S0J]$M0VAFW[:1S$S
M$^&3MF@BO/@<(^W_T\/R/X<RDJXF6.Q+T*Y^- *0(_R9)J>83'.7:?V.M;!S
M[;HQS1/R6PW?[/+%-W+17@4!)UJ_GA'\0CA/)$3>4A1GLE?0;U8Y<ST\^D[:
M[F?-^3F3'M\#3^N );JR9AS;W3N&+7O5Y4L_Y:#S<7K84YPXNO79%G\Q';O(
MZ^F=?_MY_,=_5#;M@Q<DJO!&U0L>MQON".#/38\:ET-OT\0@^-W,(L$$P9&"
MK@'P_)W<[<'X;TTA#:!O!?]$5>"AA1[&'<)?U2$ 7]"V4]-Y.EQ)A]A%B$M_
MN43C@J9,DEA#^?3M_POY@JA?_.XYQO6;*>W5#@7'S %\"ERH.[.E?K;!.WZ.
M9X&V&ANS%CKVX?;;JK35)(@/SC1++-0#[);O*L>2F+]>_6&0:VI6AYTA85*F
ME1&L\@+7+HK3;4!AJF)/[N%JJ#!#X;>\CJ?Y;)\T@%/*7 R,DKNTAF*4']4H
M\]>L<#W\J"J'$TW ;-T+E%8#6"I2TE_IPK!*:()?5ODMO8\MP,U>SJM  &5B
MRV=+IS<K"6.?:WZ+]^D:[!\UXM\@1MD[T7CDM&QY45'0P"(^O'=*OFL@:[V:
M<CC3F2/^:0A3>K8=5=$68.D9)-^"H"K([4A5?C]YZ\2>:V/'>4=#5.QMND%Q
M^#MO>YGNP;O. @!U \F&'A/$Y*O;X@'AW.:E">ON4G45W]?YCY_D? KJY8@^
M2@U^TU4D^8#AX[0"X<WFF=X29(^CR72R-"(^C];5(Z.3LCNZ:Q"FV7TC'$ )
M<^L G$8U"(7!;-<# 9:9YJC+7NHL<1UC@Q%L\S=O[=Q[X3#ZI1LC0H@JQ(N[
M78-3R9V'P,G^"-K^LMWW\BGI8NL[E/!&G_T+7.(-_C0\Q8SJ.]  [UKU_")P
M*XCV3#'.@ZUHU/_J/-LHSDB6REN/#.78H#0%DWPQV;*$:%O5XC+&_WU&5Q[8
MY,8=%067530Z)CLJ,)VU598I@Q@]]FDSAK+D\R$G#UT/R;*Q-\'7*=OW[F.0
M&::T.]\]].IP*XH+9.?A/5R;2XJK=*[2N@%# "8>6XSW/J:I#'2QMR4]6C7Q
M$3$)VH#AV(DL^'B"'!P>1RNQIZ+UL(9H)@>ARC)&*17]F+;M/_)-&->A+[%B
M%F<*,GE"%QEM*]6%'A*R>-8/R$JZ[>V5PZDF/!^9&Q=9:$QWK W,;&[41KU(
M63#GZGUE\A ?^XZY&*?B4&3"WBEES6Y1_8R7X/;U.<KJS&.YR=/KE8P52#^@
MG5%:?JUU=K;36WVXGVN0*'M<_+KR]6#N_KKSX%+0<N,]2XJ<\!4<TNW.LV46
M2WFAX)DZ1Z-2L\PH#F[[$WHI';\0OV$?$>:@X\$/TW.[EL8W8\"L6-AGT3H]
MUE#VTMG[4HD!AU\(HP</P](29L,[KDX.2'2O V@GN?II%H2NP7&$/4E[%PYU
MU)<F/H+N+-'ZI O;? _-TS</YV:S0S3B],WJ.:7O)'!%^F-V)"V%SP& P 9)
MX)T/%3,+'X:*$W,55;QN/IQO4ZGQ>%$%%I5\U<P"@Z&T)KU-6B$'3MQ9Z-H$
MMZ'AXGXJI =O]@>IOG#?/%J58MJIMFWF2J)9P4#+MA]/X8NAF)Y0&LI*\=A[
M==:A[B4YR2)9'<?:V_%\[RK-,S.-OP4XN<7R#DR]0S!M&5WEOT@[R;HP#8(\
MNI![1VB"MK8VT!9%)CT**/%7"AM^UM^INC0)3.MP9F-+J^&>77"[M:S&^OD1
M)?ZL%[\ G8\84FW^H$3;GS=K%F&6P%\3IU:9XO3'DG.(D,=%6<7MNB];;^5M
M=:H@U24AW\ B&[E<]U'/*F8:=#K_S(-SR:US7:$='^.9C[.CQB.K%>V'VEKF
MD:^J1HKHFL(,'TAV%'3JOB9'HRIX2+6"EF)1E!O"HZNH;2DB)!98061$LK>J
MP9?#5/0T?HH&0DGJX+]BAH:1 .R:%8OB45/+/I[Q8GS&;5&5XGVE'=\N;[5:
MV>/9]?R:ZCWEBPVZM/7HYDM_Y"GFFF5AR:K2EL]J:7T<KTZP*B4C<=TJ:]@\
ML!N!==]'B.+_@!$L7Q*YZ;(F5.S5QU$4S34FH@K)6EERSY274EF9Q)#QCE$V
M*OO(HI^@EHG2ZL]:4/"<A#KQS+US?S=D7L5-.,A3NOB0U0V<Z(KM=A?58=Q'
M<)J%]$![E&T_RY_CML6Y3 "JF7$Y)GQ1>'OA$TF^N7 <[]=^ML+Q4OX>WU?O
M1R8_FNAW)P )04<'[VGHZY5N=2? LWD&XU[7)FG<X6AHQZG1(16NG @-%_;9
M%D11WH2SC3EZ-!'-6S1ZK5PW*8:RO?[T>>;VAY5>#G2@T317R$U ( U/+:.F
MWZCC;)JFS,[4#4O;THM905'^_9N(O"6Y&UWT&\5>!=RJ$)K:QT)-E9LJ+]G&
MD^W8&OJ+^IZ-[W\E17US_T,B-28K'[8I?S>&E:2M'CE$KP W9HG_-)23K;'(
MAIASWJN\CUM^]>#F"Z9'U2Q4_D9)IN3+&^TX\L]',/RS1F+='L1IA=&AJ[J]
MLC5,7'6XGGW/*-#)[1?TMYFWH4( KXN+2)MRKF./E?R%W@<-VY2S?;/G;3^:
M_$P];]HMKNP7)L/#"*.__';'SGPZ)=C2U,O#BKZ21O<B@3'RCD,7G9M8)B"^
MI(-/F2( [#"5T'^'B2_7)7($2(G;W&UTTU*W/+^Y>MM%(/I<QXBA<LU_33]O
M*PNRUCU2PC-9KLP8P,;H.G^P]S)YB-*R-V+W;IK!G,ZC6XJ"J"C30SH=J4$<
MIQRDVPD\L3%H6EM13\KF95TU[/LHNF_=E:@.2?)MML5DY*<6^3'-YP\:9-VM
ME06X/"OM&4</ LC&0NJAO^@NII:QJOI;1-HSN\?R=#<B(DHJVDCH'?P!O],B
MBMS/O8?FT;+4L\XAU>U'DNO,1Z  .H&MB0; (!QW=E#0PL6VV4G3YM7'WM#4
MLB?O/(,FT=?$,=Y&K9X5?ZYY,6J]=UI]<E5"-%F^_$*CBL)-_<WBWER]CPS=
M<?'GOUHS($T?$, 1GRP"T%&]T/C2Q_P4Q:AG$T-53P!"$ PM?M+]_.)ARZ6&
MMR[,)K(_"$[>JQJ7S9O4P%+ BU3EO/,N8%U0VD>6&G((0(WQ:BQ&JU;C,A\T
M7Q+<";Z1<)@*"[VWQ=&30#+B*@W7!RW27O$X\/SQ[-EH#M\"Q:V'CWY-;8D[
M'=TJ^%.80-:?[50E\2T(@(;Q/5M8=,O"$<OT-5*WE^"IT]EX9^)X./8%7PB[
MZ6[X :W[[-73U.,]QG50YP]7\3V;>:)#C+ KV8MP2.8>(7BP//43 J#8ID\)
M\ONC^7N7-*Q_W!_X=_?_0]W71/]LZ!MOI)<[6'+$N9UV)6=OMSFV6K&_MM!R
MD6+- O4-*]\VVU$LH15  *YZJ06BIEQPKA,$P%6<B10(0CCM-PWPH?2U8A7\
M!-2SXS,*7FG5;[L(VH??ZN[!K:A\X%D.<J'RNORS^6^:&:\<*>ZBP]Y&,+/?
MY:4VO) Q(^WW9O@?77[)5O\/7O#Y=W=4]X>1=8)10Z4>O ]/ (T_TN3M%/W)
M2^ [AAK>)7+6YVA[JQ?(S)!H_@./!U,4M>!.VW<\7DNL@]=5?*IH1Q=UK[R&
MBKG+?)08^5'KF'X+I@%R<RJNM/#V*.6U-=\VAXTOY8@U-)H\!?F#* 836[6L
MVH^>G0MVFY/58!7IW?=5=%7["(CX .IKQ"@JVB#H1Y$0UJ[SF\3FKTU!+D 9
M[\M4%7NE!MOO4,N.HL,S#@Q9FPQQ@E)M<IOQ2TU-513-=BF2GIDDG)4D![U
M2< N?ZG?J&UZ;.W ?T2IQO=RFBS;%^[RH8/^X5=J38)SU.H;,K2.^&[\P1*'
M/)T!A69\6"[$AY-:NEVVN[>$HP;O=VN^0$7=<%%M[M+:VTS# XT*,RSS.^+A
MNWI(Q3VSQ'DQ*TO2,5O*&@MW7H;LOKC7^=)GYBUEF?_,,==Y,V[M;FVA%E_
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M7:%SF:%$ GM)SOG&AW?BG1XO3+\\YH%6%+I1\S*7Q)S7[5W-7[.49?@(X!%
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MG$)J%B!&6Y<I\X:0DB>52-7K;E_3Y3("N,0J! '@;JT=>#52F:[BH;VXJ8L
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M]>6GW0!S7"-](T>1I.^?2- G&;#'U?:]/T!0L4VJ@(Q*NU01A7??E<#*;MG
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M(Y6[;[E-43P&'I%A^9[W"#0#&ON?T]P_K>->Y*8VWR^M]LG'TDEBGHZG.$;
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MP+O1:Q?7XX%LJI"EHQE\+XQ4*SUIZF-%%-]S)V,3QKN?'#N,>['$PQ+4M_!
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M_*#5#A9^OWBU>0;:V!*YW:]DE7SE*G4-O.D[[?_!EF]&7/^EWW_>]*2P=;_
M6FZ+0+F1X-T69F")__>(^.5T_L='.>?E*&[Q!\X&HBW?V.CZK[+_OR+OY\^+
MU.0:2(J\D5=+KSB'PEXH(Q0?T;WOLT_6!I*"@O]LO8#_+V;]]&"$X+;1Q9%/
MR>-YXMN-4JP,9/PE)_'_;Q)##<^Q$]QDLQ."]S(+/T84_');6W?%>=<!"W7X
M>]<OB']3>QE0=JR,JY,&&-^_J(3>,O9]@;B $54=F]V+R3&*!X8>._7PP_0:
M;4?VB8QQI,E:%G++L="%L#A!SX/\!O9A5^/6EMMW*KP.RC5U^<LQ,5$6O%$N
M&,P!^FQKYJV"UT5ENA)8\51!PFQ-._;]DJ[1:RJ*( D)>T<;$U#2NG/*6VST
MJ HUA B@XX@&*R?W#%R:L=I/4Y6986)(6C[DEC-"U58(>LYN"K>%3W:[V?&;
M!U]Q#T(V!1^U0>>ZI"B"K2C9<DGAQ=.YQ(?;LCHS.&;<HVP)@ASZK6%9DP3M
M*1AQ#$0V3(66 _MH 480AP."%[;M72';Z+S4Y.MAB?-6\)J5W#!C:.:,/%YE
M$&R;3Y.^@>Z63!MULBLP]#'%[WADV67.>YG8"&H0?5>:^.-S=GC0EUF?'BPW
M"_)%=1O[6U./\_>:!H#MO)"(6FEBXK,O"(=*BFU.5EPMQWNZ$C1?L.^%ZA*$
M1$96.!*3A7Q!&%+F0%3N%E%DEUF]7RQ+MIO^I3U*XJZ?E"2BE@*5-W\0X/Z;
M"!"J/(3@D3<:,.L[/CV1S\-[;*NGJNC[E-TPRT!<^!B0)<AL!&RRF3=(,DC\
MMM_8NFVGW1>?1G()N9NJ'9E!,%2Z)-4@HJ&:* %$U1N4=)[ CCP"-@H?<BH>
M4*:DV.QD9<>YVVR'%S7Q22:2C" T  $)/K41.:G5\]['R"E#22>#W#3:P :X
M-&B%]S:,,=XL+0Y55?!E:V/,T#X*M3=6P<T?"!]= SRHVV>%W\*N8 /M#20C
M"+?MW":7E*(6,H4S_U7O9[CM9,E"T#WYB#F.@]['>5H1&\UJPU.:^ 2?"\!3
M5=;3^2S(*B,HPSF^GV8"2F_H@/$G8,HS9*86F9X]V6W,7A_AMI>[RA4(?AN:
MG/ Z-8 N^3'PY:= YVO#E+2W.3)/4!6*$(YBJZ<:!8^_#J(ZV/P[%0PX3I8V
M)-VZCZS!;/=OL&-'P5MM>(L2'W/=IX*3:2"724'\F JI+J^#A*T/S#,&NTBN
M+ODVIX4K2B&H#@%*BAE395 5[3:[VY-B^!F!NH0AW*_ Y"*\O'VZ)'$WK5.6
MZ[A#-Y^:^F^]>1J_:$-Z;$):?M3JW/=D<#F.T90FR469WE!Y7WH37TFD@R8)
M@*\%'@9Y,W9IQ=$&+1.3:%ZL-DFC.BPL4^2UKV3=S?IOL'/\GTV8*O,41<SA
M<P(?4H;+MOC-\#]*UNI^]7WGF7-02%KWQA)PYNH]U5$+6FE3/XX\S6MV^C)N
MUF5E@_].1]]@W%CSYG]WD1W$+H]%9N!8)#KDL.HH?=?OE6WDI(0M'#9[?X5C
M'SD/O; O@:L#MX;&"4Y9*.UFDYELA*T8 \ [^PR9(CWI$(246J2U%FMF)<@?
MW+Y.1&K%/^_02/-R+XU>T(%.Z+S?J'!\9D8HG76=D0%.5B%+5YP2F4P@1>64
MPDT]$0_4=.J]3XGFO'+N:E@..Y!*XG-I8->Y.A+&#66Y/-"%Q$^^%BJM^O"E
M8*1H[L!U"FI.W_+I+-K69S5F]8I^MS!Q?H+43>A1=W&C+?36,X/T"!2&EUB=
MXMA2MF:OQ>?T>%H&S,*S72H'"T?669@\)S42"QH[HT#4X55\*9@D V<+DK70
MW=>$9^!$LX]KKYJT.&N9BFCCG)!I X(D)$AE5M$(> 5)[/;*(;95%+$NEZF9
MNI/N&=O;!66!^DYAA+="R9A(WQWP(-&^\UT;"MJ"4*)_=LD+U1Y4JAOD@B>,
M?#!BS+$BB2GB&$DNC\K+V]Y!W)A;O^N]9CMNMCO6XV)H;]"[^U24RNR$K]NW
MRP^K9G_"B[CM"3I@"YL)@.!DP;A3K7+U/V<Y!PT7,%/*N;GL&#)TXTEV>K:3
MWH_ H\!$LH#L,F=E6YR);T!/&NO&J2T'TT(0/MUZ]?51#.8 '.;\I,FV)W\'
MI=?AL.:T3GS'=FL:10;79&&F3J#B,_$YD5N$ (,O@,G6Z^"P!3?Z>/B(\5S&
M1#2[(L[-LBAFV1,4*<E.[$F\@DS<:@H?<5J:UF;_L3&WR_&57,'4QV9SV@FX
M4ETJ=GSX9:OTHFYI^!2$*%>K5^YH(LE7N'HR=J\BT7@UK5UH)L=Q)#\LC9VA
M)]@WS$_7I\).@Q_SNT]&T]S3S)Q"!962YH6E[,40'^=O633N;3R\4SI2#SDB
ME<VCCQ-P]!19H]BI:30*W&TQL":;-1SQ))YE8CAXO+L0O.%8!M[>=FLT+H@T
M+ZE\1K35(+@0$JWYD&R8Y<%KI07ZK4-R*27U82]V[=JJW.2[#[$^,)!=@BB.
MILQ&[,<FB JY& M$NP@."M5I#7@73DQ]*/U<-M0.:S$G9&J'F5.BC-T?KVQQ
MH*+<T7F>20@8/)/2_8(<]]#?S8C"*\V"-5W[3?4\:7!7'G9C6N#CLF(=-DI&
MC$Y4^"4:;';^(WV>VD\E02/N"J+#)(,*5=Z:CFC<4#A"YMP48Y%36N]/:.UT
M$(>JNM!GA6.D3&*W:01&)!@VP\*R&#H[Q1GA^+T9[UP0DZ]$4Q07FI]!\A\4
MED,5<"5[T]EC]]/$3ADPB2*3I#E!P7,]8N0<G_7Y*Q*9]83+4G1UM#L$%AN2
MFTE*#6?PH!K%YL+X@HR.<+HT-EDS!KHZ'?"[AF1IGLU[^,-K<1B%,3GKL+>X
M3P;6[1\,(E/EEJ2(0@$# \S*CRNBD*H]6K^*_2?,^:E@HG[I,76YRO96^_V0
ME_3P'"UQ,=? \95_BJ8^*<%0S5>CZD<:D=1O[S-X->IUZZ)'V((6>+DZF$;2
MYK:D6@O/6H3-W:I1E,_<7O9!^C4"TE3J='$!-.\Q&E"DWA4D1<?"PRARN0)2
M4QK= ZDI-\)M:GE67(%_QT\4'87JL!WA>;*_J\5GCQ5S_H11)RCKM-!"9Y*Y
M N&D0Q,B4<."]30K@ ?JF-RHJETX]1$'[^@0**_R\$3HFK\"[T[>)MVD55-\
MSH-@1_/L/.3%\T77@N/8%&<3N7#M(?E+NBUCH8<=UC9+32FJ:OM/9+!G0K=!
M-/13)Z$._:<$[>L'Z[%5X P/%[MG]Y(Y)F6(L. C7FT]4JR@]DYQY.OA9H'[
M; E[?0S;+D#<"LTID2W;1ZLA1I#L?$XO0F6PA3P4!PC"%YB3],9D%V;3GLOY
MI7$EK8&Y(F-L)?>([U=C^$##> MEM??" SDO*?:;1E9Z1@XOE5=Z(^>>=)C@
M&<^25]N!)4/9D562:D;=Y^K1QT_UIX])[Q=FZ'1E54=,=M36M )LO>PO-017
MHM[$$.^&@:<9*_9N!VIOSW>/=^ \6\*C,2H.V;ZC)M,G@@C8$UXQU2?)/=_O
M4@L:E=6)EWLX(FYM_'P;OG/O+C5GU/-':OH:]#)$/:IE>RQ!E$HCG 5"7(P?
MKH&2JXFL1&,8BK'QP9,7ON$&,)%V7$3+,%L,!_5ZS,-@8=1QYS?3\V><Q96$
MKTZ\)0X&##[[K%@/N#!ZIQN&J PV@.MA3JX)L-Y2[E1'DV,^9KFFUCDG).4Z
M[6RQ=+LRX*43$DT<D#?'Y*!OOF7&7)W;)0@.%CXVAF0R%70_94.,B:%6UV\!
M+KS\R#%ZM$^4ZO=BBOPM'5$YQ]0_[Q0R&X3QQ%S9!@0O,S*$@&EBZ#R1^/+
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M<B;,E42/75A2]WDFI:+$VC,YB!L%L3W#7!87X>,'7\O,DYLO2'Y9 ;LS;]M
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MT!L7"E:AH/N43Q/S:GOPV81?HJC>?I@@H&876>5 _P/M7\C^?<""_U\A^S^
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M32O23TE+K1.\+;@UEWQ_++\.GI"_CS#Q_(0%A&2K/M_U9[L%AL70X.N0O[?
M3TWG[ >MV>.G;Z!?7JT'PRJ=S"7??JB,>92&2_9-!&M7SS#9EVW*W<RB3\HF
M6C2 8D?\ ]F3 3N.5>H_^NG"+.OM5A1)?K+<@7-P'7^$1TU90*][I3GTYWB;
MA-NCM$NI)=EN8#T_9-"+T6UG%/ 35(;Q]Y/20OM6-CZ*?A.5_N+P]*_MC\/Y
MYQ->+;'U[7:,Y$*JS].&<E#)OO)PU'Y3-N^,DR/?_C/#U&9RTOK:E83$H$;#
MTGV_39Q%VQI"3!'20?<Y)H2XNC8 R23>.[CH6]9@2":3Q%S8NA.2&:\@L9%E
M$6XNT!+?E_VH_4O_5^BIU'LA,^-(C>C^6/VXWTI<8PJ,P0L;&<#)!7<O7- :
MN4P-(WR)_H(9-PC13;&!0HVL"-^7IS.\\,.28!'H8636U/V*":G:M*@_]NZ:
MW^=SAU8I[B+;VA)^3&RXVO!FKNJMR5A% 1?WHL[SG2(\;FB^J$P?6S!O+[%D
M%>J4_UKF"6,M]!V4W<:V3 #8C_<2S3PC#F24_- 7I*1V%]?7H2FC"4?/7B:5
MYM%]S@=_DIR/_24Q9HN#L*VA1U475<)LUL1*5J6S/'5F&O+>.3[8)C^O>XBH
MZ@.7,;X&/T<ZW#P<0AJ)^EF8H$^K\NRY[W;YG=TL-V=2^3U#V+.'AUJ2+"CU
M;2Z<K3;N2(PNLKV+%D8RIS,M,%?[[?2HA99<:(TX[C>NS;+H]ROH3..H=#\S
M0?.$*#1+SJ2]3 =>9L26A0I=REWM7H!),N88 Z<$W ,R&GP=J)&!&\:V^/Z+
MZIHWY0M>-*EWDE@QLY3C'F#1D7!/,*Z0/@RUT\ERG2LZ3CR =+" 3 Y4.J(1
MIG6?="@YSUZO/^114:/K<=)58%Y3AMT"D:),[W:&$. ^![!I9UV3B0[O?K[5
MLCL75IQXMFOHMN"(-]%+DVWZN:#.)W9+Y#FFTZ*Q8*/ STL7%D+(Q;'5!,Q&
MRL7KX[4$4K5:M%9B&2SL3*FNC6+9*!>:HN QJ#XXZ6WSR^W 1/1HN2^ \#R'
M5@8".MUOZOKMR<WYN1GFTU'G]WM,'D8BR6CSJ.P6Z.UN0HNU5BU ;V1F?"49
MA6F/V\UDK0@#M>@U(SQ/O[%3)/]\K0V"PTJ,X#]])3W+?MD);\]I[_ZVON<Y
MDJ8OT5N[0N[-G&+SK"M';X*G9K_2JC8;296D\<JUC9J-0TM!$JQH_IBFGQAJ
M<9TMVJ&E\7MEYO@RHBKV3_OGK*$O9,0I@_@&3USFT*5P:R3_ P2,9K5Q+*=B
MZ:Y8+;5.WB.]/.V''4F>#T(D3T2P#HX-PS%E<$74Y5 V>1*8:AN1:=PQGNR)
M=YR7+V$[TY2+I4?&2<MH65;C?)=-SO/!$<ZPXC6CZ<;QN_@$IUB]*3+ZQ1,L
MD&O]X@ME^"Z)FJS/:T/753^(":8 Y>&A:?"WS[PA/4]CQ"Z#5.B9]DC[&T:A
M%E"3U] =P7M'G6]T=[*A(?WC#^RD-,>J7"RM\TT.IMD;X%9)QV'=PR_QQ[_C
M;YW%?>@VV(CD@RN67OF&][4%1#@=[S!$<PA5"B51/4U]&_4A;VS!<8AN%/#1
MIUJ[N%=4B5%:X_$G:)L]:,SBUVX2GN^XRK;Z^=7 T?0P8.;K\;HS-\-J1W'K
MFIE3OT8IIMD\;$BKZWK:8*ZR<KW>MRA.38&2N(#)%F?)MB9;% R>ARY)S%4U
MW@+T]IWT4R);FAT?I6P31"HKOYM]Y[;R;66Y!6!8/V?3PGT#D%705?Z(L2R1
MC+#&HA^U2K#$=^IO+,].UU()&)J\/1D#?:JHCAZ%KGG29+Q >,8UVHK*"ZKD
M09'JOZO8;U J^J]#),%B@MD%5+]\+="/:@MA[1IA^P<F7U$%/6TF670?/\ +
MFQG&&=_ CCFK !\S5SD2M%@)TL@IYR5J<2EB]NC<I6KX_8^6R[X/_. LEX#[
MOLIB)>7V33J86O<J03UU*-.._'P^'=URJX+U!FZ83-"4Z#@&/&3<E(S:&6S;
M.]F;S9.-_:GQQE/X.]GGCSK#JYX"[$3:H X=<WJ1&FIP6  J6SQ.-'XOH.X:
M;A()^BWFMY=M()C5<6'3J(N>BV_L@*S6A,@H%2]"WOAXN8T(F;R8J(S[6 8"
MI? 4KIS>A=JT81AFZH9</GSI$:KQRIQWII&B=-'+,/7L PX.8[&'"J"/*[A&
MQ]RXKX<U"+,9ZD(EPN;ZF9EN1B_E3Y52+E5SND;/HZX7"YP@NF99OM>KL21G
M%IB!M0H-/\>SY\U'BR5)/<$O;@&XM)XDR'9,?4@&R]!->IERFW0M )!K]W/U
M*>ZWGFJD2DGRK2#BEI".VRV5]6XVY\)9Y*K!:\>D^8EW:TBR=.3<D--MT%ND
M,X:/+95PU,^Y*,!/1N;J84Z0MDFX>(G1LMFHIR<10?VX2"A"73"5(Y+]*/N:
M"^=E%%K3P,_'\#J7[TK: 2FK 9FRJC-(Y/TK_^3<'I)*HF^4Z?MK_%$IS'B^
MOZTF'JZ\$GEE5U6=7K*?XDC]VO'+7RS#498$.4>7ZR7!#.!,HRQ[:<RK(+(8
MMF9C-%>1( 1<S!'R]_L]'5\MSD,N0GJ;C?T&"D? I^X_JABDTIX1MQ;@DF;>
M J2H.\53W^\]F[<:3_W+WOC36=T6/[NSV?.AT<&Y[44M@@WVC>S&[XKE]O1=
MNSU(PBRMF^W3M;W23H<?HVP.%(I!J>QKR0I,/!8,<&7>I.6:/J97E:]DQAL*
MZVB_NR\P#/?0'F0<0W QXQ#T7/B<_M2D6M.WMQET<L>. +O+].M@TJY5<^HN
M,CDVF&ZWM\@'6X1#=:QLG:)-J8C#P_GF/^_F'V+5CA&<RA@674E..'0R7/&W
M33O6K':HJDY;IRXVJQB^[E:*@^E@,H BI%.<F#\CNJ$-?P*!G%VR76WIHI%^
M9AW(>[@KB1 >5/'(.,[RU*,7#W?G-57>B.96=WSVYO3\RX,FX9"8M6IBW_H2
M^QN:+HPGLJ_:/BJ;8Z:Z<XXRP"8Q;ITC[2^!'C4_R\[/(_/VU66RNX2M<2EM
M[RJ]W]HPR5>YL9$U3 A 6LU*T+E$E^ X.=;IW=G#OM74,D_[W_T_-=DC7'K.
M/TH@VR$X5VI35RY%R^-.=J)%?\*O?(U??#!D60F)4T2HO@B6<AN/@ID,@1_(
M,*$F$3M:/QO.?662U,A/]6Q>#XQYXB4\$&?$UB-)V<RY#Y?DJ EOK*$RW3:8
M:S9&V7V>]^N_7 ])$)C_O.XQR(4CKXG9J8&*[;D478E-U^0:<DT:+\B4,P K
M*1]C5D+B7<PV@GS?5,)J]FX!Q!)YYT^YT3_G 5#^R^OY^MB)DD6$E,T!20HR
M![_1(I):CJHMNN<&/.5.++/4KLX['62D42M4(%3"\#0[:UPN>VOERP&-A5T:
M.6Q(HV&JQN"]$E/%/8-XV_75Y<R-E@MM$$294AOKOYHI*-*7N&Q'GM)7$NGC
MM4<]\D*S7I7M:V*<T57N8] !2:%A@#+@S,R!$BNIO-)!;43N;328\ J*C3+&
M]:I(6AX&%H+A4HDO,)$KO+K]B,[PZDW/V01[[Q?M:W$G1KVW@("C,SYCO);K
M/-6FGC8H9<L?0-O[ZM:ALVO*[,0YAVWWWP2J@S\1"(7&//#$2OC0SZQI#Z/I
M;LL)D[%!+KX[]5'G/8DNSEA\X\%7;N5QWJ.-U1?W\:Q&(3]0IJMWF>C$[)$3
M ^&HCD.:^6=UJ$L)A'7T'K,!;B8?Z1@<V_5;997N:G/<R1ZY/*G]14UX]6[B
M)^*71NP^UWEUDC(V,>[#3)H^O)18?YCE4 ;I)"FK1KMP=<O\;02+WI3UM(T>
MQ4?\GO&7]Y6Z95WBH)_06<T1%LB OK6:Y5^+]KQ^# QF4F)DBO0C= N$3/U-
MM$G.<N;2<TW0&]H)7UVKIHRE+.)U+D\6W^#P&:,'JBM0X;Y;@,27;16ZW+1Y
MP6-P9L3R?%*FLG5EI9W1GQ)K?-L?%\V<LN9S0(GAUYYZ^T4GAN-/<6'\G]2U
MOR\S-V*N77>B:NU6'+Q\<6JVO',B.&9$L\P?4PZ["']FX;E/$+A>OIZYXNW2
M7:-XMS0[6BB2"CN4^A4-QT#Z= 9^ 7E%<W):2J9KLX= '\9[ACL^E$8JO'>/
MIF^.!C6_(Z617K6?-S((=F7\@-6#Z[$2-,=XD4*)M=%F$>;K&8 T88(,,+,V
M14WV^Z8:BR0-IO'NB#F3.DHRM0S7/,V/ E;DZ#$,NBB'Y8BB:9N&%'?N6AEY
M&X^W%:GR8G]HY06V,GY,^=-OW]!@"O@C9,1=+9G#?6X!<*JP= 7QPE<%RCC2
M'_"XM2#S(F7 ZRP(3EB&L1GTYYWE+ZE/FG_59E<U2?-VNUCUO<030,+E9_;)
MN*T\B%]&$NTM3_[+]!4QB21'(N^(0+IX_T@#<;LS7<MY&\'I$RZ<D:O'J%HD
M6CS"?9G.Q(Z^\N+3_-[:XXW*)Z\BP7#%,;&@H F[3A',R[F,IM *#-^\ZJ23
MV^^KWS0CA^3:!"GCJ>'L#U39"NA/GG!A$[:KU>QRUK<I_%QX-O$\?;M20'4=
M.KS;R82Y?#I1@AH,19I),9&\TE#UV&%=ZBY<_SA_N+',5C;(/;>92RJ-3@N6
M4:Z&66B@.K]4LFYUEV\;IM6W+XSEQN4\!LEDJZUC=9?3>_9>J_8RRS?-^CYT
ML:..9W^,=Q([74V(%?@\H80S<&'M[[BE>8DRX'NY&@UY,(Z.'Q)G9NBL;^X(
ML_EA.%&O))1.2MSP1XWE@4J \8'OP[MZ?"*Y7ZJXME31"TGLP&2=Q/),!YOT
M>RL=&[O')C#$>))A$RJB"3:>%HTFY']T"VA+5Q<=F<'[,H_9@\9SJ>H5&%5[
MET$6&,Z>@T+[),2HM"F\M>F=%:)'1<X:),,\,XJXDD3GA%K.N-6 H-Y64GP%
M;&IRLW6$T4^['PNFT+(# .=/-YFYJ@D%1N:"%<UW%KA&6V+, C-YLSS+HS<3
M/NGX6?'Z"8Y_9$$2W3MC7N?^]+"T_B7.27=YJO%5#.M4$?F&6M"L2=)]MA_O
M<!A+M[:=[[F:M][%QVS]*C]=#Y)[3[7O8C%E+Q1U_3>M1J2N!W_?<M!9.%N"
M<2V3(+P73,3G*YD+2[=I:TS6G[-,-'/X.>1 HK2G3SN&Y3I?##"Z;KEI@U+M
MP/A6 1^K5O8^;&.YGH:W1"%_IADM2^H>X7&VL,7A;W08=F#\UKK([<2R&='@
M")&:76X/B!!4(F?/\$D6SCZ#XAD32@LZ>[?)DFC.OI%%U<'.!S,BPSPK4VXL
M$:AON^"W7[L5*$.Z]Y4A2 L<>^_Q 3 )+'O)1[ENBN+]Q+===LM4>2X"Q<N^
M,JKE"04\6'/(#:.O,DHNT@=:"#4FS?)ZR,\XPEUHP87]S"'W8/O^$U5"\REE
MP*6+] KDM))#J%&T8,J[-S#?T)STM?=;_^M2T%><+G.(KV'R%2T*KGOU8N;@
M;7JU6P?>G^;:A"2]- \"P^;%)?]*8I^Q]CR[3HY)Z\E&GS>NUH(OT0=6PR]I
M/Q22?6,B%E9$[2>NQDK87?#&>'CT-%.^2!K=5F=/[E[/ *:K<7J9[TU?R:,)
M!^BO%T[C[<I;;<DYWVZ+IYX':8- M:)W0)@=5IS"$<UA#O!73'L#G\*-4K*7
MASVE%4G/#@O ,+=Q[_&)&UJH<4!/E6'/X:+=7JGY"ZNX9XD_%,C#D^OE>WV\
M#2OO)E%"!H1Z_VU$M?=UTC:U326=:;K;%2:IDC51A7]_2NZ/VL;S"'@ IW)8
MJR'4+%9[*=UPO5>X*S_S#41W"U@=RPU-$VS?;0S=3"<#;,,"11VYZJ"J.^EA
MM+"?O<KYJ2&A%%L E"JD8,-XP2_KLDE^)8-R2W5RN 7N#\8%%0@>F-#VQ<18
MB2UL++79<^$,-AR$^G,U8B U,"&?:SZ5MI8XD\?/ZAP4V%6<;X%'J@O?!KTL
MS49K@E=;,39VJTRVJEP:E$TI2$FL:2(I<M!3+#JFBLJ[O%S29T'J:UCH*SUW
M]= OH'C!9*&/U6Z2/<E_MT62A,"YE06=2>X]RQ>YPA]CSCBQ,NF60V7K<2K@
M>(C\W>7XE\?+%E\FR4MTGU(;)+CR!4QCM)5&AAG2:YAV,G[?QU$>JA]ON[)*
MD;E1>S$K/\"/8^\OWC#).F73$%E9?74N-[F;6RTX."-SH__/'@64PFATVS%3
M1;#ODGOWLNSL?PY32'L-1#V'$[<,FGJ>%*5U(S)SZ%G0"=E3EU+22E@1[5[M
M34+'\S%6%W-WDH!2Y_]JEK!Z]1QS5%Q5(0)N)_NG,F%P,HE2F(@H 7]HU70P
M?L4, L'P<H989T\T4C>V?'P>-\@T*5UWU"S11X0V#[H+ZAL"5.A8"&ILN1>1
MB19!TB%3-0PX7-A:OR=AC3%Z[)A2-??&,R PXCHH-ZFEJ#:1L<DA_F3.'#;G
MI\VT^CP52>(/9+T-F^Z0R2+Y0[,?SMY087SZ\%V+A@**-=H,[:P.TQ6<Q;+2
MQVC=<3K<+"CAQ&68I2FU:,WLR4=U[4?KEQIUP2U##'I'Y_\2/.;LJ)IHD_[1
M*@S4++0@@Y_/C]/0RZK>,>1#>7(#2@IKS&L]:AP5T/=HPNED#]JONW4+V,XX
M9"]!_62)#'[V_UJ^$[ @"=J-:NB4W7VB(B-L4ESF8ZQ5;X.0*MO.^W,-H^#!
M#+R-CV_5L_9SG<3^<G"GQKS>?=G7RGE@A?42AM/CC)E;8?16GFIL5W?G.9W:
M&QLR8!&3CH>3UHHNC*-\NL7%P[8A)$_9>5L^9NC=E4PME32H 0^#U-19ZD1C
M8T5&:E2I&C+V:3G7)G#'X]3^9)C04O,M[9T;SL:F*9%)_)LAK_P,%-'KYS"F
M,)=MV+BH]UV"^N!K&S+XU >RN[E'=(]U[^_^KY$I1\'D';/KNSG0&)J7%C%G
MS()VE6-?>$L26!>6'#V>'(KM#8$ZWAK_>^F 3HY^XN]/-T(SJ0W=]NE]-MV_
MBXMJ8X>"DISL2:#<<6QXSMHTN1DLN=L K35[J.'YA/V[D"7'"E9XRX[YHE';
M\L=C"-G2UEQ&8QJ"<\I*""&?L?6G]HEZ;P(I5X?K9*!$Y T84]%_PS/I=/6F
MPN[#%N)9M@.<FDPJ?9YE/T&<0&MF#)_Q@6#F;%S.BIG6U)I6Q=ICS@8I]\7R
M/L;G>QOW\,D/Q=;HE)8G.[#O9(VOS0KWM6$_PC-:1K)TP++&J"05KS<US&WC
MS_L/$N_H )3/:_J09RCJ1J\U&/S-&O<E0^S36?XG8W,0PP=/)3=XA^6%G7VR
MX03'QEPXHPZ^Q$@'"F18 9*7^>RY []^DK 7U>3P!BLV(2Y"L#TD6$MR75\9
M$X"\!8CL$2,8;H/)_*D3.Z(:DMSXSM]C'RRY2-2&!_WJ,]]U&$0!1U4FJZ=5
MGJBDH]X0TS2=&<<7CF=MG_:_&SV/4Y 7U,<2 ,E<:[Z#+A.)5NGV98.F<MNF
M9AUP2Q#IZ\XU@>F_/TI>EE1SSW+EDLK?*7<SR, 2"ZKH^N-IXD"AF<@<MN?K
M'T5(>3[*]9O=DR'[8X*[?IPAJQLQOMRNE28P?J/)U4EW=:)0_B1%W@*!'L%/
MN.2@%Q>D5=#M3E*T7@#Q7)^W')ROD>ZP.2.UQ.7AA]BS8.=^F_V@7S9=HILB
MVJ!X<$C:$MU, [%%C_CLSZ5?0W^6JG;:BGYM]^\9L'FH#;UI9N(&]Z=F9&WL
ML=FWZ>\:& <;X;,E/1-2362P-G)^GIBX,P9=@M+!'^?+1R7WCUIGO6$[3%T;
M]:?!M73T..9L!#Z8TZ&8FV\!_(5.8;3[=>Q@\==SZJ93@J47W#%6U, Q[]"E
M:D;.:DU0H_R]14R4F8J/NN'+=HJ^4\]W3UHMCQQU0HY(TJMO[M:9[@H/&4^"
MJ3><A9.5;KD,5#*=&;1ER$TGL^\_#=Q(?8NUECS;4'F%5ZFZ(IU%OS-(W[Y#
MT95U7=PL](YSM^+(QH:6C4V2,TYP24>!6;3B2A"=%NVPZS9.OLW,+.91771"
M:,2X_"+7\N\[VF'FK#LU48;F_ A_@1C-KE@U\WKS0($E36.Z,''WK[8 OK86
MB=2*!X@M\^R3-N@+C'MUX"9QC?N &IIL%UEJJOR'HSB9+&Y)P"7Y"%"75OT+
MD:V B:^:#::O6I#;RK%D(XQ$(Z,KC*7)0QC!Z2JTC,QK47?B%N>;:M]R!$X?
M&!5V5T4K%^20IAQV3K].WGO+N/%NN3UNT35.V%#&&E6^]A)5$W8,)M5T(*)_
MMOIKL1U[K?5<[ZI_/3LDXY]Y C$I*PZ004-_IC2M[$F.*<<?1WYYOS7X]*[:
M]=:O[J*MZZY2.-2 A'>*3OBZ(\$4FQG%<;&ESP>YH7ELA1$_( <"6 :,KZM]
M9F^!NTH):PEC?PL8S+DO/N5>]-3WFX(_>>82LV&_@7NT*X45)WGPI*F@!+'=
MYC"6X_<@=?:O6)3M,-N'KSUTC/&EN:39QQ;X\_;@!OV3E,QLC\1B,['"S<+/
MDR\I]YCJV%G\'L3-'#N\P3CU7( ^ODYE(M2,&WW'\DU)N'ZM^%4D.U&V\%+S
M':#H.P8,H.=$)_[#@!J*0(3T'0,^^8<!O2=6:^[TG/@ F R3C?11J9N>>B\X
MN&NEFR(O\ 2X+,G[=\F@[U\QAM7&5]0S,O1GQB[3CONI5BE6 >Q<26+KNV/.
MX<U%WB>46,,(#!]#3IA'-MGLQP\?:S7LS-D2F!3Z\EC<6,@2$? +TC YV2:,
M4RE,T%V67N-5M?Y*>DG*<^66^C)LX9G@3)MV5_-Y9>"#%']? ,%6&T=LRGAX
M@T_92A!;*M*$=K'(&>!1-\W,S/@C(X_J,T5=U\0>E_(='Q5"/8Z*HKSBZ&E>
M?_\2]@.K\:L:YWX<]ZQM+@E_MS]AVC^E; %JL(77L7Z#9P>?EZ&B5N(\4):T
MZ*VO/,8'28JS##4@#+!V79T?W7L?IDJA<DV96,\81T+ZVJ]BZDZ6@5#+?1;1
MYF13A5]_7FGF(8R''Z<GWWO1"E"D!69'R3\YML"QZY3]FG&,&3?Y.FWI#JDG
MU"/0/FJ7B)5"[TRV2W$!^5'_<U9#>UT8L/YBLFN71?[89*Y^+L9_4O[PD9W%
MZ0/P!>\F=F--M T:U)U#;M>6;CU[[/.N :YZN0$B&%H.QC_1-1,/E%$JAEFL
MA,66;\^Q$AKEO=;"YQE4Z0V42C95';PF..HS3AF*/$Z,EK5?K'27Z#[W3#RL
M/1Z;P-1<ZJ<AH0SM\;_7>N:TN1L;BWI\@LO:7_.R$*DZXP]=$03*^CS#E.3M
M2(TVI?"F5A4MFL7.AKQL/%3N/E%*SCS=ROC9B)Y-]UR[7+XWA/=KVN$AA3HW
MZSG'\P)G3QL)E_E9N*<N&)4$J^]-3?952NOW?+H"L6_SB >H,=;LWPST'_>N
MH]0(8">_;R;J4 =[DA5F.S3:O^;-?K&$0</OAY^YD,)AC(-]VUPXDVX'3'89
M.7&-X/M]>(AM>E\YMSHIKLBT]<M",=?+GFF2D]"B*\L)]_8":-%F)PN\Y=55
M.EOPJ,5W.IP?'\ $Z>/L&R$#'\"D[AJ:T--(M%;>&_XO4+[L)=/ UQ+$V.L^
MC,X^4:V7LOG18(H6G99M@&(AD$0^_6H3IV'NYI%M!G4#@L<#D5I5SNJ4.J71
M=+3$L9.ZCM4S;BYQ4F5!@.E30<=^3#-^L3M(_5N&O'KXC9.*^>+Y5L]&B/FK
M%;.70SU=5#(N4&1T2R6?4PD-=3/->S+V:-_8OFQ)HL_@W41$/* <4(690U)W
MK;;BBC6[#!.'+D1'9*P<U@23W#'F"FI1<@#P8:ZGSI.+]B%)D?&X^)A09S+*
M]7UP_;7@RO'.9*</VK-/$DZVDHHV.XNL81C0^9$#CUKYE)B.#F4'L?.9L)_*
M&!;8=J&^RCPY:YN+EU$O7K+U:(H[8*I\+8>.(8M(EAT4GHXZ,I&G@YD,WG#>
M A]#ABY^-3<T)$03$_/^3:0,\%;1>UB_X#DD@4.)M5,R='H#1AF&UUP]2Q.R
M;TMI,.'9>[,L<O@)=T]+.G%K&+L*8X+DBT=6&>RHARUK?YWA3?9--8[M2N$R
MEQR$E*[5B';[*J%]/?WY4)_N!$Y8^AN_]WQOT<0#2=+]E49OB$+65XB.Y27&
MN#E7^YLF_7]*M9M =:%D#-3Z75DA(NOW0U['8&/A$KF$4F(=4[0-QNSWZ*MH
M4 3B>4TOT\.%&31$/+Q_7%@)W5^?>5/':Q^;^>%\?&L,5ETS*&9HG!;<.,+]
M0'/Z5%B5/&1$\"EPY>TO^@=,"G=:N:98^6X$/9Q7%_VBR32;_H1;0U"H'F![
M[[A2PQD4IS8 >#M%R'CEPEQ5ZZ:KJS-@!^A3KCW#'TD;+&1?2>!DXSB)VT](
MB:Z>3LI RL:+AIQ*[1"%A!V[[MP!CQPZ<ZTV2@^RH<.=#VL=7+O-6:9F+8AM
M]YA'O*SKGO(8U3[,8'E.%$PB_-.FT1SUY^NLG.@O<_&8$C33:9:][TB%IA#M
MWD=E4UP[<O/6@/UL+>$A@!!U>:,*B;8X001<T\D:8Z21LL*].?>JW1V,7:DJ
MC3^&_#'[\>,ID.OYJ/Q*[A9(G$+.77ODW (J$--;(-QRDOTZJUJEV:E,_9WH
M.SG'[(@#' >S:B4!/!_P6=<#K!UOBX%8\EO@5?WD_O&>C5KV)?9$H[0\!^>X
M9@EG#>U%U/[.G\N*1:6^LR6P@_R MT7LBD\H]2R-0.710"99X'P&6S>C ,M:
M'/<V <!UQZ[_JXW[QPW/G2@0/ETFO/M1NJ[YZ]=P'7\I/S)X57(Q>D?34R6R
MT"GNP4[I6^";:H_\*9G\F!2PZ]X5>4$:?O5RB;DC[&HIPD!/H)N=G/JR-)=I
M(+YX>; 0U=P?RS#@/3 ;3]R4]Z9LGN^L8?KU8>'\H):0MY6SL]>6J>RZ'><>
MY*V9XN.25--3.=V8FX:=-[< G:;7+?!Z]1;(3PJ4E1\(..3<"3A9E;^)MD=9
M!&;SY*C,T/0AXM:G3OPF?WV[!3S'S.D4;P$H[47H28TWVN(J\F+Y&@:Y&XZ
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MCR(M"YR_'($2\L; ;J6_(.S#X>'DXRI1'P;HW.&>4PW/5;O7."3E,$ (SS6
M0GZ]X4K^%JB^$Y0J!*NB=LDF*/GPXY&:""'[1%/:E\0,D(G7=GL+CWXRG$4X
M"S>S'V6NS-FAL3E#D!M]$5:N;(,ZK[[UO&52L<76I VZU(5%) >*K _+GWPG
MV'R'F5G]]N-(L02:YFU%[O5A._54NDK[LG/%)VYQP-78 [0GB_3MGXS?[?D\
M11>PT-,]C,.YS?TQ;!Y2/R$:74,(^ZOY9%8L07-USYW,[!MC3>JKU*?^!XM[
M(0I@K2U$;'%5B<DVM3#/;#-9)&NBMU!&HZE-;Y;*AA[&]4[#V<V>DO3T#C@
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M=Z>MJ24#.M-R*:C0+KH\2\]N-D3'^I=C/^'?E$'!+KI!V>T]2F#X;1S,G*Y
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M42_8E1.\!?+"E6^!'I&<JV0S*DJLL>OP0?EC@<TNS*/D6R#)]I(T)F#SS40
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M-#2W?W Z,+FX:6!2IM2+^8^X"_M_>W<V"RU^%>;+<1<*'K? I'3&W9+\FR/
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MT+(_E&S>CSW3?C:9\SD4Q^OLI*3' :_2WPPNV)_E,9BGNLX]X/]HYP,$J>2
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MQ[/:8(]J"D=#ZI$NPIXYO9A8GHGF4=76BHI:#.2& %W\U?N>J5[1XA[3JM&
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M8YDU-[PY8+YWE/9UWYR7J#32T=P@G11\Q?;VT.FIQKG848/<'ZZ,Y=B1#VQ
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M1'F:)_85ZLT)UC.\+9;N%_)<N=-X>&[9BG#>ZCCM5[Y==O"? =3>W#C6H^/
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MRQ.'>- (;Q\*+3'6#8+5U%3TN5$(THT>?(YI(.1 BX\<3X)+O,RK&+G/)<?
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M%EK0J"S#!/M'7@6_P:\L\9M;.5B[6QE8?,EBJ29D"IX"*KCI3(PGO$Z ;
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MUTT,D*,U)#7;V3OB4*4\B[PWM:Y>RPRJDF>;I K3 E6/=  W7"Z[4< .? C
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M0'U!AGGPE<8)+18UKONJC*<WQ,6B+T(%1+JNKD:#[H0Y7FQF:2R1700&O"\
M4GL5C5*(.WG'OC[9%,X#.9^)4*5JSM_,3.RD,/GZRO[S"+'*I_83O1>]IV*P
M9F:Y$61\SC_Q!W'U90W&6>P*L9&WT-Y@]KC>G_HEQOCRBMW6JL9VESAD-PC"
M3R3[MVS_:>WX<8]N]81D]P"WPV +*&I3O\G!,_QR%UFVX6C"8,T@YJZ_7'Y)
M1KS%@OG]U*K!Z(D'J'A%I 3>9H1M[,87E.USO'2A5D'VX\M]$JH$ %UIPN2R
MG6"K -VX<K8-@H6O:V_0N6G 3<5WGXL\^;@34J\IAW@F?+/,^)-#UH4K4TY<
MZ-N<FK>Y[XO>4Z','-"O :61)KW80&VBX3D%!WYQ!Z1_0UJHWRC/]T ]].(F
M=BN\R,@Y\@G7-A^H6[RW,T@C/U*6-:_P*6Q<B5E3")E[3)<KG;JCD48TI3PO
M  2KY1WQJ7ERQRIUC#7Z')*V#ZT?*#VOJF8A@,CW;T$^8NV8%-T)LJDUY;!T
M0;/:P@ON?JS>O[)XD4-$>Y&_C%/P5=W[93X/'S>NM^ 8::G,3WLC_G;""@C9
MA%$"@#A3K5>6>,_CRK"F6$4;^GD\)"<CZ/3/CB5-R?5TNF7)@]('BZ8^;E?4
M%/$7-4,$7SE 0]8^Q2UT"^BMW>*<QB5*3T^B;Y(P@L,4 4: 1+D3*5D6+5F2
MI#L%8$3@Q=")>FD,&#O9C%^^:J0YE6BSTE!C*#1H06=],&%^AC_=@7YX?^E<
M*=;U8<\R5V>5/N^G%1>R/G8S^V.HCMBU5:C\\:ZC[R(MQ3^Z@.],Z*0 -CPN
M./.SP";0U<EV:G,6?V/S[RN[UHU*5%^,UT779E_9;>C=F3L^HV.WVQ =43KO
MZ% ?WS'#9 .2-EO]4)2/E_"M7C1UR:+8[]5SDK ^EQ@5D,W4X-FC/_=3@MH,
M/N%9V; 9$+TWO)_<)#6,)29HV.65MV^[56<$88UQAD.N*, -H9Y)=WULQN)Z
M2/GCNE8"D)_/:A%-)H-'Y5GP/=VB4/!\3K].>SB]L,- ()0-J$D#R(&:K$SK
MN*.C S]F>_I_?%C ?*=P>QR/-#(U6.&#+Q/L9(/)85WY;9O+#WP*"W)@1G9"
M%+QU2Z4.38+-N/G&.XX]\0(M#>F5DO5H=*2GD63LZ6[A@F>3I-7>@:?U.1H#
M1$+4PAO$3(T)@#5Z?#C7252?;V9W%>+PCL6L(>?(Z 0#[:NRE_<X4EWL9^F-
M\,>PC".W8[UN3IH>?\GS?.3UO=:6^,81J[=ZD#>X[)EEN*&EN<3P,)X4->D&
MI0UW=(<SC<[7ZIAD5=UM]-UO>[8H&/:QBMO[I5?7LN[H\6)?KXGPH^O[^5$J
M'J4;GZ*S%UJ,T-6/IZMUOFKXG[X6_)]NAXG828=[9N^(S&B>'6()5LY$Z-P5
M["AS.@5S]5+&:@?O7NX1.@*K4!N[M;V/&_#3GFBNTL[F34!=4 R;:%$Y+"7=
MI'"E+GDB)5FHLCW?54 ^E[V)4VFM46EJ+4<C?Q</02V8]Z,/W D =PJ^JQ=L
M,FDJ1RIW#<9B7  >3&%U3)CV.8!Q[=4SC\5GXWQ8%O0P6_J-G)52HZ7!SK"*
MMSN>=*\:)^L,RXMZA+G70GMN4[BDC*_J1M^'J%VJ+([#>U94)FC*3?&/3?NZ
M+4-ES8<= GSF\.JA;[[XE?8ORQP(#VEQM8PL>011G1Q)I'=,+T4Q)#F;D@MQ
M15I1^XY;B8N?&!W0O/%;XO6COAO]9Q]_Z#:H'[UL_KN6TZT:2ORC=5=Z]VK=
MA=\69BR+(I%Q'BH2)6F\5GH#(ZUB49OG]L_L*NRO]%6OJ/D2@,;\C*]%_X[6
M!OS+1 %\/&J; $3J$@"*=\2^!RR.V#\^1@!6\^9RTF@\\2?].?!>L.L[W&\)
MP)0!_+T3L?OY<!1& ,@\J_?O$&MU$+$4NH<E-DDIS/WX(\OPG5Z.E61B^[5>
M!R4 M6S+!("Y,(S($OB$)+$'G;U?1@""9;%X<;6_,/V%Z2],_W<P<=1;<)7T
ME>)@5%3FYDL<NL7.'.J5D<I9/=?J2QKI@+QK&HOF#3_OM>=PR;N4X;5M4/X6
MV7-54L;]F0HO,E7N?0G/8][[5JI )*YV,Q_[_\^%?V'Z"]-?F/[KF R3_0N&
M894$X/[-(F0O!:H'Z@WU%YDAN[PGA(OK4LW??J%FL3GTO[-K'(3!_P%02P,$
M%     @ -H)N5RB#9C%J7   ;N8  !$   !I;6<S.#8U,30Q.%\R+FIP9^Q=
M!UQ42=)_)%% $"2(1 $5B8(@2G  )8MD!DFCHD0!D1P'04 0& $!)4L.DB1G
M0:+DG$%RSADF?..*:6_WUMOS=KW[''_M-!WJ=?>KKOY7=74/J@?U#C@B+2XE
M#F!@ @ &^A^ Z@<N P</', ]@',0%Q?WT*&#> 2DAPGP\0DH28X2D=(<IZ.E
M.4Y-3<_$<9J>@8V1FIJ9[PS;62X>'AZZTQ>%+G +<ISCX7Y/!./0H4,$^ 3'
M#A\^QGV"^@3WO_Q!O0:(#V*N'3B#A<$ 8!)C8!%CH"H!.G0[<3!^^0#['PQ,
M+&R< [@'#^'AHPOD' $P,;"P,+&Q<'"PL=&YCNA\ )L8A^0$E\B!HPHW<1G,
M2+D?^+TXR"B:64ZFV+K,=.[6?9=#>.04QRB/GSQUFOD,"P_O>;X+%_DO7Q$3
MEY"4DE925E$%JUU7U[E]1U=/W\#0W,+2RMK&UL[UH9N[QR-/+_^ IX%!P<^>
MAT3'Q,;%)R0F);_*RL[)S<LO**QX4UE575-;][:MO:.SJ[NGMV]D=&Q\8G)J
M>F9V975M?6-S:WMG]WV_,  LC(^?W^P7,;I?F-C86-BX[_N%@6G]O@ Q-LX)
MK@,D(@JX-\V.,G _.$@JZO<BL_P0XSG%9;);]UOQR)EX1DZNO._:+SW[MHZY
M_*F>?>K8YW[U 018&.B7AT4,@(#-% ')Q1?<,D56HQ=X=?8XAA%E>[,!TB@
MIHH"'#IG@3A$L"ER&+$AL:E5M@?=ZM2*=CX#O=./ O)0@*/"?B98/PH/TFN%
M A90P+#RIVR5/F;,X/UZ=!^S5:R\?A+]2?0GT9]$?Q+]2?0GT?\:HN<X7IYP
MZ1V7[?>X&M*\!NE 6N8D0FN\(SW67K( /6UE8YUEP[QVB3.0E=GAI9 281Q2
MA9_A;PYD.43;*P'+2$LWC4(/N$W=-I2_(NJP#RM22 .Q!D[V#40!M*G(G90.
M0$&,]$<-& &CLC>S:0@=14X<Y;DL@&_</*:9D^<CJ&1M3-- 2V1+_\0$K/&@
M%IZB,4H']PPNDVY:[O9QN'AS)!3?*%P=.X)9V*;I/E&"--"^/.5CS#M7P,;D
MHB&S[:Y-B9N@2;OQ8I2.N-?&Y+7F8-"MJ;MF4?47U\FJ]/WJ1B&/_&U<FGI'
MVV.$H\&:IHR^K!*CXH\='4WO)/:\F<IY&J%3R?_D8A2&H-ZHGEBX QU7CNDS
MJ2F"A8UJUN0VWCN=V8^6NBA/$,8^&S]&[_6ZI91!?S<DEN+N7<ZS&%XWG>7V
M3K?/><TQW;&WOD.?I.1"I,V,Y>)14[B F!C@UW.7[=.0UM'3\'8\YZ>:*@CE
M.1Y[_C@2QO&<:8"1?*#,\Z4<YER(;D#B7 K4GJQ(J/DM]<9XV_8;Y5<K[G'Q
M!G9,F8/2_I[:=RX<Q+T; FP<'[<TI57O@^2&QJLW)D%\\:Y<DG?$5XWTY+C=
M!C]MRV3B4/N.)7WXPIP:E("GUAC.'>+;8L)YK*A@KOL8@AGS_$K"H_F:R,1M
M<1MV<+#?24+A7;!,U/;C:RLTS_,SGH8G$%%Y<].)LJHYBV#?/KZ*$#HJNITC
M%)=XR-2B[!XM!N/IC2@B^30]K6Y!D83A'7Y3#UKDX8*U*^6VZU46'?*X83(K
M1)5'9LUF7MEH&,^[WA<UN:1+6\*J)[-"X9FVP7RC9#FE3Z/HYN0Y]QXA,S6[
M87C083YD/M&<5K"GPV7CD9(SZ7J*\]=ZQFBNPT2$J4C!&,:@2G9U8GN374MO
MSK<B_"0]NZ.I-M95W:MS_OK\B.3^X<2WDF56TL#,QF&]:VT1V*5%O@?"<Z_0
M@;C6R>R*'X\2\*\:[IH5%>7XDQ?0W3[XC-EF;\!<:]+#>/21*;X1>-.\?V'D
MQF.#P8TJP(('S)K4.(9?(FK#\^SN_,+H#1)[U_Q:(6',5QR"(J,P_%ER5\CY
M8"LP459#GE;<I6)Y7+G1.<]4!W8H;W$Z:1*M2LL[7XG+\C:G9D?7*H+,!QJ9
MVC)V(L3K0#Z<WL] KKRX-,?I)299Z !H;:@.<@&PZ&RP@57+ZP>;S6QNMFG/
M*GK'$B.?"Z4DI'.ML/$A*5<:G$[*G"_*LNC9PST3488P!#IH>;L7CDDEVUP;
M'>JGIR01'K^]"[[GR^2CB8E%L*:F?MH[6\N&I6\0.VS#!1)8I=F]400EFCEJ
M2$&=3, "&S6I<.:93L/L6JK9;6!-5(?J]6J &H+6SG!(=-/,O6C-Z7_LPS Y
MI9I]WER=_'IPX@7*VJC#LZS-QG"QT3(R&:926J^NIJI#^$(M@Y-.3_F\'*1&
MPJ_U#5=F:#0;W2O'Z<RO2((G8K4DINE5%PX.P4;2\V;:Z)\4+NAJO7818B6O
M5T7SWHCOFHR, "O7 ^33,IZA6 )J>=PH!<V:1W"%\ZZF>D9D>7T;1B_9[B6]
M9A] 6H;,K! R^[06M/4J4YPO)YS7B3?K<A8(8<6M*&62(YYI9!6]4>"6*T>,
M)$^=!9BCO7[8D/II=1WL (U5R[W9Z2(#[AKL+Z_*%NG;&Z9;C=I1F%[,/VP@
M_"B24T>6\*<+@UWOBE6'WM56.S!SY<8E1VO+5 140M9>,E3.7]?M#G6ALV12
M=KB013A+7SD3-]NA# &"H\+4? \YTRR(2 >WU3=U;7";#34#'O1"&;7=[WA?
M$)VE7B6-,(KL=F DS$KI-32P/AG7F51KTT&# C3;YI#$N=TFC(5\UN?S_.*K
M(BCHQ]*E 4'9D1(*Y?;%4Z5Y[A<QCVXZ S<?S UE7#JF-:1IX[1[<<* WEU5
M\KKO/:X6>Y4'RQ-3-T)@GI8R_::C+A+T?'-:EN[/#>+53@:&L9+BY0/0"'VL
M9@>L.(-=WQ?I5/U4]OYYH#,A]-OCZXU:*RC P\*(DT@FL4\$QV>BX/!144P2
M\W:L5"D4@-<GF;:HE[7"$:-_^DD1$SWSU+1MTKMM<U.FF5/I*<.SR1[,P83W
MB*:$\4F&;%Q'_/:$]0KM;X$9@^G-MD,\1MQ3"89HM=A[%2=;O8[5E0M.%ME$
M^Q[T9W["I'\V.0; F^2%8LR$!,Z4YMF^Y"2ZGAIJ.B-,(_BJAL"8*2W1B_NZ
M+Y#.TZ*V'3QJ/)1*<+M7@X-$] +;A52+;:NV#"V92KNXC;*5RTP/#R ,,Y9S
M2T:D8D/?\,D(A9Z?S(Q,VL3=;4'//Q6+F;0TGCG;=..JDOHH;E$J :)XPT[
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M:B^5!XN'I:[W#>7IC2 $AX8IL4^X(!?XJ",-@0DY9\[8)]?K1JG<6[&FYD4
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M<!R9!YNW(3\]"O:Q?#I/W0:/6ZYWT.N-4^BB"1\)-G\LD*03=!%L89)6PIW
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MQU/(9IZP=-[?+8-9&#-,I,+Z."8O>Y*T">T1E8CHK#!>+HZL?VXR_^"=T(
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M/D/AV3>L!"ZL. Z4L6?P'\< CBA CX_CUN[=)JX%+\#U]5DIW(>I#E4LFEF
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M?@E7[$O\8!S>P%&8VVAZ\K"48?$]#R(2YTR+BXF#ZS[.VD R5 H_G8?O)AM
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MY_32X&=XMK715?([@#DI8/GGO27B3/'*!%K>W=SM98_9 ;JN;3"%S9"A<0%
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M*W2\WJ.F*A+//A/D<F5,LR,">3JO2_8!T?C/#LH-Z'>#5CMLK;U_[N_\1L!
MC+'H7:EM23D]_0G0E<" !=_\44[A)XE6(+E6KJ4SQ(E5@QZ(XROMCNOKNB9F
M+1RK_%0V#$O"S.67G1TML<SQFP(?I=U7MPO\;N+**UL9MVP0KTXR]!1RC_3N
M!GAO<KFZ%Q,I'[EC3][/ODT9)JPF<X;X09+9,FEZ_;6<+M8DT22N1.,++W3(
M];I.1'KT-W]18S-"%]>H2<6<<N498G5G6 "+F ?]](L%[>I=D8/@Z'[\8\\=
MX"255E[!IY_:B99.(EX"Z,/U7AEZR\A,43==/V4L JGJC,XW?EF '59S]B+H
MMMD;T]WL.UGM,6O./2)L9GK!;42F.CTNDZ3XK3SH]?QZD@EI?U2IYVT/^XD'
MRH:3I/:KHP> [.41;7*E0HB>R9CI;)7/6?'';L*!"O>4V%X/3;.P)NAXC&I=
M[L<5EE4X*WK:.8E@$C',FXBJ?-?FUV@[%ZYGK,:<(_$J483;/586-I"9-[ES
M]L3/GL1ZZ61<,OFO__WY1[XU/V.V [3H8F<<1Y94;KIR'3LWDZT;59>YI*17
M<PVT75,<X\^2JE^/,:Q?[=X!QD_Y"S7[;PF3@9_'$PC@+_T(\*N44PE>J-N&
M5-1S%(=/1!'-H_L7<;R6&S.PQ7B5]83BK4_@SZT(<\?(*ZW;DSQN)MG&*0P+
M)[URS%LFJ&64%&S@F-GULS80BJA1LGZ-.&#+X0>OZ&_C7#EN8'EH]J U=\IP
M;J"*,.CPB-!DS,T$L(:>TY9(MO$(XK5X]IMZCYR$2>RG$4V>Z6]LLS8O#1+N
ML&U.=I.:JS2D&!;<2C)*;)Q6PCSG*[I'H_4@S"\C<[;*#,&?4S[,'+B X[3N
MXU,#@?=V)[D3%0Z?>^DW['0B9LK<.(OFR]$8B+@KJ?USQ5<2MF$6XIJG;]^2
MS2R10+CND3V3;-;-TA3+4+R@^^[!.VZJ8!M<=;G?@VT%360_/]/ .BT?GSR/
M&LO=V-[X;_QZMG/^2-MIME?L#[QINL\0J>]$#$ -1<=HNZ>3IZ#BI)T?]%,4
M=6&CU.2S)FQ[]25W--R8M'CXWAEV+*J-*JCY*4]D1HAH 4DR/^Y2LR#/3*]T
M'OGP?>*E O ^?1E;WVY32K1;O7[.]LX[S1]_H)DMR"))]5G*AX'WZFZ]&&HY
M;'0K?@>0@NVCYJK&BJ6GD3>EWZP7,78:JUP(S=X!J@K)9XUV "0"-KUKI767
M?P#V9\+(IN,]U[V1X1\?-B>2D0_.+VH;>WFJ]YU>13@/J9)U=_&V!N J4@TR
M]JJ5TC.=OF=QP>0]5)?;/5A(8WD!'\3.5$V69@>Q69=@5\6MXX9JFROG_) 9
M^TAY^%D?[E:U*+(T5.F G>,!3;!4'NS=J(!>Q;$1[#%!AG&6:$;.D3S&+<>N
MO5(2?RQT1FZZDQ9>E&BNY-I6FR2(T?PED(._D?1;EC5LYTR[;HA;2RS*,2$-
MM/;BI[KU"]1Z).?-"EMVT2TYGC?44Q9?"'$8D:&XJC)K"-YOND0^UDBR,(6B
M!5S/B5$AS4O4W)'>UG4'_,$L^DQ)03"D1W8_68$G24_14#^(46^&44MVK?B'
M*1-Z_]@HAA V1(DLM?H$^*:%M0I'QTX)3;V)#5C;T&?JR]]OHH[/_.+5U-_V
ME'-O4A;HZP(-8+'RK8TF?R6M2UC>OEKXU>JU7C-1>@5V\%^OJ4!%FKH?F?C0
MK#')RD/E>X PTD3_VJA)] 7MAG9  /8> KS7EB@\#DDMK"A!?"WF6HC>O(J-
M@2WFB!U/R#2=C6^]U=OF 14X:M9^XZ.,H 3Q#,_X?KZ#!_ZKUG[/N[[[O'R$
MYT%TW-4=@%WC6-0GH@(E_1^*A#F8[.9)"CN 3PJ ^C4;KF#&XL1JA=6/5Z6/
M<FUV'"0*_32I/[Y?-#A>QUA3&BC!OZ7D%],DF,MQCQHV#H+GS69@4C2J?)*$
MFYX_;8X5JHAN YW>SU,Z/>XKO(;TMSJ3Y!A68K"O5^'O^=>HY_R>E+ZIJ Y6
MK_8&K>3Z68>5_56P'@7I[1?#?YUJ?B-U0E\4?Y+G\5)%;%8BV>2=I1LT[WD"
MOYC;50?[ZNE4H>^1W]+II#4P':0@TQHHVU<1/'/X0W6%UY(Z$C%SQ ]=3K)+
M^?FP-3TI79I3R$5LX]::'M]DP![KI*-H]B$%#': ?WJ4^Q]%1 7=6?+M6S^L
M.7_04\A<E/<@W\O5"&VRG#_M8J8@!>HC- /Q;5H+ E.:3_R9I^"?Z5>R?A=_
M%W\7?Q?_'8N9''=C,MFN:?XOK^"AL3(()0GXZ%"-W>S8Z%$"F/_RK*VO&4^C
MTR;ZRY/Y=]/OIM]-OYM^-U5&D]YG,[E-2J=-OC/\'U!+ P04    "  V@FY7
MM;^:EC9"  "[=@  $0   &EM9S,X-C4Q-#$X7S,N:G!G[;P%7%5=NC^^#^&1
M$*24!@EIZ8X#*BT2TB!(=S>(!PQ 4EJ1DD8$I!M$&I0.Z>80TEWG_ ^^UCOC
M.S/WWIG[G_N;%S[K<_;>:ZUGQ5/?9ZVU-^(38@JX*"<E*P6 4   A/P'$*/
M#>#\N7/@<^CGP6 P!L9Y3&S""]A86-@D^ 2XA!2D5)04I.3DU'37&*AI6&G)
MR1GYF5@Y.'EX>*@8!$4%N$2N<?-PG1$!86!@8&-A$U^X0,QUA?P*UW_Y#_$.
MP#N/PHTJCPJB 5#P0*AX($0C0(7L)SKHRQ_P]0^$@HJ&?@Y\'@,3"UF@Y"*
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MNQUVFQP1P*A0YBE:/F3]&!IBO)SG'WV'+Y-$FWGQR#7P,.C83!4!)$?#3A&
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MC0[\NI.W]!91_Q!;#K3UMET6_'HE!P+ \Z.=EF1F3*GL1-9F1!VK)8.V1EK
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M+N,R&]M[?5,16*Y/GUK<P/.[)X[U1/D=0X1'GI\/C86L33B@4R%Z^>3H3FK
M55GA>*1M[//!Y !01WYRA(Q9<5*&*JSX JR>2 @+.$<\?G?\P9-QV2('SW22
M"6U/N<>BC?A6XE_ 6J)M%V]:I&#F1I_6Q2X[&(EU?4!*PV[HQ5])63J%!1*?
MPI!B5746+@N$377TA"*Y.!/V_(]"/YZ=K\+(_U4ZJW7U-Y-VNT\?/4$ <W?D
M8=_7:=[_2@"J<E'AXC&34L@8.,2^9-R<:@NM](@?_MBJM;/.ETJ_)UX  4SG
MWY%#ZM%SD6>_ZG.:7?F#J.*0?=S>YY1WD5ZVG_B+9_\?@CB8X<9;JY=ML-K:
MX"[[K=<C$VVD3P2:Q:E-2ZVM(]Z/MLKFT9,PN#1^I'U@[:3;7%U+PS4>8U7W
M=NHTWL+K9H+ 9-7"RI")M?L][0N8('-RA^-U[@?K_*BNJR<P'E#!KW"$S <B
M>4X )ZW/.-RHV5%S1[F_3YW/%?<:!OD3"J3M 103H>MT9TNL1,Q9:B!QP)6P
M^"<":+.Y5^?/@GF0U<+RT0W'L]C?9=O[/]42-9IL#2U0@#U_@"9OPI>QQPW;
MJ;_-S$X&38]LQ=E:"#_[OC],'$ORM]D;.UL& =A^+NL,%*O8GBVBA'2<3A]V
MH_S->K\A2G*I] Q+-Z''Z_1^V?;YKOP>&N%O%*TYM]"YL)UW* Z1T0R.CJZV
M16\#;W7I(H,3&E=K7AN)(.J5YY[[>6[Z?3Q>WBI:T^6A-M=-)P;9,<HGO*,?
M.!_!* =Z#USYPV3"/O0.W7*E#ZDLM_;:7%D:\>']?3#\[%ERQ%??)2=/&'#.
MH#\Q".[-Q+4]:WOF_6H3HYE?ISQ1 BB> 'P"#XTCM+K4117$?F)PABSC+>Q+
M1CW2=Q0L2)ZG:=+9:_Z&VO#FMGY#;3>%.Y?>MA3N$=;>A&RW0=;#593%\0XO
M(@.SL\T&R?OS_\;A\(HX,ARF+^NIVZ'597/3!I_XLM6&((!7I%O<^5/20SMF
M.) #J_Y>I,5:P*7[98_)UJC2V6B]&W8RP+'(N&#WW!<5U.M_)ED =4X ;P1N
M:O^5*[RP=04)F601P/U D0 H+ (Z29-V9H;"6OWA'@RG6XP_\B,"@7_U4Z:;
MG*CA^&:G/8H_=$IP54>R-_=*57]M VND,#C<L#R</T*\"SS96VK].?GMH[8R
M#;RY>)Y@&$2=;H@J:TFHNC*Z<7-XDB?,):GXQOWLRDGBK?<QLRO!L+BE'1WC
MXKY&V<R2@ G%J%X,#,@$*T:;&-+RI9[-E-I<75'@GK#@M2GY['-SOFF@3TZM
MNG,[D/ <HDY+QR:Q.AO3/3?.)L*",5G[&$>!&(E]0J%L "?]Z10@' _8U&=I
MW=55L+-SLV/MCI<G=SQG+,KQCCRL^8T&[?2H1U-G+(&VK@3]D[3N<9%PKAQ!
MDW?JM+@1;X9)J!)<^H$V.LUWG;*BP+)%"M\S_]B"5HENZ--,5KDW.A$M!V':
MOU\-D@PC:3M3 W$<4\POBYN6[(D/!&40 ,WD%---R5'G<CKRUZ%!\*OIR6AJ
MF&<QK_AW#/EGU/K?BEK_,*G@$^++ "Y74SJZ]AW#CW;8X(1 +A.KRI48"MG%
M.EAO KD$EZ-6&-*4":HI7\\"<-['_-YE_,F0?QY#6L*-4 7I=E"S,XK32EM]
MS-:\V(=.F'H:+\;0%26^,0<]1.K6RRS!\[BH)PH*OUMX1O\MKAJFU]S\+3H;
M>)I0IO!0HCUKL6[&',1-U_+0Z'8+%>?)D<HA&P(0G4, +=#WZ2D^-%LZ<*\V
M!!"* )[<A_TG^I?N<+ZFTY,$\#[T?;7>5Z[VVN_MBNEGA^@]$HE!VODMZ&S=
MM'3$Y/:$XHG;";,V,OJ2J?Y5!B,*.WT=K#KI8/U >:[L9#\2 5 @ ,R80""H
MS>YPG0$N#"?T^,/YIY2'=GE -B<WLLV3S_\]^DHT]R2VY\3&H$_D?R5-FF4I
MFB?*Z6\KDSJB3=3]']!..\7C9*[$&P4[/;OPFB5\8[>QRR7]EBTL4?Y8-J-2
MEMY4[5['P]>W"= #I^X]4!M20L$'Z.+/HGNGC_L8,L=EKD>>WA;W"]<KKV.&
M!@AY*^;*BY_/RGJE>N_' 2(9&27YB\#:V5955!%A $I#]EGHI6("6XH*&WIU
MAK!_!DAS1=_">\G_S!"?PASX&D35'T#KP\1&<Y6U:&A9P%)V^S5B"5:UJ "H
M6V/0^+EVL0%3O_I"2:T&1S;=WIE*]OW#&^:OG2RT79IF]!0R1]J<'Q.]F%99
MEK[%24*<$Z6$[N6%):RUD#C1>]XD?BU&9A:SEQS&*@Z+\#P:^/V)Q*M1,</$
MV.-=)F>OC0""<YJ;B;)?MK*MYT1JI*^ )>!7D6X"PU!><+DYZ?<&_-]Z!^>?
M;5*LS&NIJ@?33[NWIN[XO_!'75JV6F%22=!BE+A;E%!EJU1<5%Y;H>-E'B>K
MDQ*XHX#ZWO5(4R<HMVA\3U1-+!&^FY.^N.<I6A=M18EQO,7/B@#N:*RL<)VD
M$+*IY!6>X#U^K7\3J6A>5PW^NP=C962 "'NPB@6E9+!3&Q*L/8@F#DF[DKXT
M+(R;GPN0)4*KHL*.Q[&\1<5*F&F^J.JO7K2JM=^:/ XYU.C9T="[3/29/7W-
M0#NLN+2T8-L?:;/&[-K#D!:N?#+:FTK2!6H)==I$ #Y&NY!U*@$/N]/FDZQO
MM95/LT^[6N" M^)Q2R>E#@)PJ&,6*8///E#;\2;\5I'J#GSSK^E2C22-G4"G
MP,APH/K^]'S=/ME6:@=TC7]>7[I'>B]S'T)U /H'6U0F@WVIIZRLP;$7-8]S
M=Z ,V:SD+; (N4?9EIC3E[K*7YK(3V7,O[P,-WL!S\\_/$3J[%_FIB[##?X=
M\T3(9$/>Q<[9CM>6I!?454*9]SQ9 O.T5J_.?SRK6<?:='H# YNWHL(N;[1T
M;ZABEHSL.',KU0CJ#%?[O*,.':::/(%,)2" 4<C9M%-R?B'"Q[^O.*_7)4GU
M6[;_7M?9O(.#K>W6DMI#0D[[#C6*D-R0WD< N =73HO.IA[T>]+*I^&G"* !
M?AYJC0"^\-N]N1F^=)+U:7(<$NTE2@@UAD(W$,!#JG^\Y:H$-+P4'6/*+YJ\
MDI4G8H?S1I50-/W->MD) ;:4V6IJ1X==T@DJ+K@WF$IN+*6Z:Y<3VH4 3F(1
M0*F@6,&<P=21\J,EG2AE> 8[TH0@@ @$L%>_&T;[K4;83Q5PWW@0NXM%W3M2
MGR>$9@?!H0A@KN[TK;=1:T/]3BJXMXPQ]?26_O89&7H$L/IHA5**$C>=6"RZ
M0I)JV1 !)"& 0W8$8$VEN<6QX<WT!J>AQ7+B+UN@]$YVY].I*1-Z9OYJZLU=
M$GCMH]TC#6]"SGK\)FPK<DL.(BD@LT=?YW&]RON6&"R]_!R.J/BRLS,\O_9&
M?R^Q)/:ZY(Q6Y5RMT'&PR9)D?<9J?J.E./@<?8!U=J<X,4TE*<#,'[4V3#QV
M>GIY16&L#_]BM+@,V]@II#GMIF8_<S F8.V +OQI[5GP)0@,&2'_ST]W_>N2
M>+V?1)= ,OI_H18JBV(WV\Y*=(S@&IUF=._Y-&85=-.Q>GO09S#=LW,LZH&,
M*(R0@:3]R;,X@TT2?%0$/T8 BU+I_\5W 7Y+F/MN@W'W::Q&L]A2V(I%>M'0
MCHSWIWI']$;TWYL65?HM4+NN^XFO)-T*#-*0CI6L"^4U<RT+5U,UCE"= NG"
M,\J8+D0YYF64SBK>2VF5(]:]7W7#X_Y.)__]&J<1'Z%V@QA.CL>M#]55ZODO
M-$F!!';F'KBTC.CH#4OFM='7?*X,?IOV'%^AH"O*-S!:H-5^C.F"KZ]OH @G
M$5(K5F2=K\WY"<!"F3+]5-LC0:C[Z<^-_9ME%[TY *&D56'<LM-'JX.32.5.
M@O+>[WQQ7-%U^T$TRU@]X:8$W69:GUE[2/RY^]@)J=DM]S4X11,VAS)>S)B^
MA0\&7L_&V.;><^^7(1-@) .F'!XZU1/&=2:][LC6N2L8N& E[P'SJ;?M\>F@
MP[XX_Y(^^JZ7O0+@G.]M0?8AS 6E&F/A5H8XMM60DR>NDZQ5EI:^>-^(GL[8
M]<=^$4QJ_1>Y)*AG7Q&U4(B=KKJ,OK!A.)9ZE=8ZSX?O5O:BE!/>?3<HS#(J
M?:?TJ%K]J;>CW0BQ^LS6V+NY9^KB]H_.9YTC,U,7-4?-U\EQ*SY6T;TY..IV
M6%^O4%NQ%.;)9KN:GTPPHBOI@$&'06._#,7374U/RWEE.6*:;D3S/D*81AL?
M 51!D_:-7Z\QRSN$OKNW\[K9:BF"UCG.MP\^,B.[NCKO-V.,=S]XT4?@L%;7
MA[N8'"1.$4+4*KW7E\,0>_KZZN6G\W;;]Y,*K4G&J^8Z^;W7D]RFU=;82F[V
M34=U964F>?&/:#Z=9PSL/?\^S3:/\*3.C616D! T(L]J?W/K(XTT*791%4#H
M&>&IJJ0_/#8F;X<^AO\1H[&@A=KT!KP;3+OY1GZ:V5W]HUF<_#.&4@)Y.@4"
M+H^VB/:Q4"%88DE\ST3+N52S]!N>M#KR?F&=99QM=IS6GP-O79@.540[[79S
M!(!5QCRI&:M3V77M,<MG.ATNY@4)$3?K^4%7E,2I7=I:ZFH@MXKK2@9LXMNR
MJDW7%BX1=- F/S['.<?9HL31$IF8X2,4L!"H,B.(]\&FX/U;81U@ZH@<KZ5&
MK.*"5*_'^LTAV2P>#BNRV'8+QP(R>ZY7@LUP+B&3&@5EEMSG+H*D6Z=VMS0
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MX45'8XPJ3*?0<]Q#D:$<5HX^+!*T 5UK=!!A9Y8OYC@? 8AM/;""\TC WR"
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ME34&G<ZB%B>XD Z2L?=&7Z=Z@?KKI()+VKD\M_21=A$H3$9/NN-C-V^E,Q8
M\^3ETV](,^L7RWY\1[VX%:'L'M]=G333=]?7M<NSJ_ZLOP/?<'T4W/%$4%>L
M%>GNO5_(/R_>6;YS89$R%(I5A1 4' U'+YB@F]RYLTBG'M76CM^AH_*(H$Z
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M:;>-H0:'UE\17_]7H#^^T\. \5YX">I*0%*6&0[V2Z\G"[M.+L@%_&4#'IC
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M34%RN<J6Q$EL7<V\(<CPX"'_64<NT0A,&C\+F'FW:(_K&K)3#YJR69'33O%
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MC/$]E7+5;7*_G=P3GO80<X]%A0*[BI+DJ,X5U= #"4$A9?P4,YM!I0^'$X_
M#S8QA#:4VD:,2/:#5RD. H//\=(N6\I6>N]!&MH3O)^E(4,)NUQ+R8PWG*:*
M6+6B&&-9?1?NKM#[C!KA- @?YT5!^M[&R^M>$AI>< 4SS2^$ D?-J NCW/<"
M@+@ G)H;Z454Y_R1U9\!D%)TG_;WQ2>I!C(!'0V^!!Z?GCM7WKE*__"=3A+U
M4:W#:2'B!@U<R=3G!5'D'?RN=<Y1#(MG.TH9SGB@DAJ<02^A)63N)WD'ZF'D
M9&2"V,4HS-!AFA\?A:YCA#_NHG4\OU GA%)0,U0"YUI7,W%96>T(6B;CGL:
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M'DDAOYL37L5::D&DHG8Q+S+. #\IE/KYV+$=);7Z@/%PY QXZ1WW"^ 7P"^
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MU#\JM8?-4&X1<KZ.-H_?<@F\;!('>=0)?JDM.I9"&BPNG&\\T_0)6W=)_?+
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MSE&WMJOPW?7EZT[:GS_B'')+,9VZ-V*$03QX>@_'2U$G/-D*IZ;$!.0OB$A
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MR/\+(<W[7UV2=#O):ZGRRD/?4N''!-$&GQZ .Y/86^WY3-TQ$Z,B&OY'Y]A
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MW4S'^_WM=XE8@?2*O1GBN#,$5&\[+7"D/+*UET2ZT8M.'@B8*RV0<]2HD98
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M76T\+9/VCH?MH>/KU8:-DE!62,96XY0AIA28 0IC)DLG\)WYN$A<E8-RN.3
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M"%M-(HU\+[:L?HN/? %8M>E//RX$5=A..(:S=3-2#?2N7 /L*C<\#2I#?/U
M2X.7YFB=6O@#ZPB?:N)X2CK6&''A' PA7VH?,\/5(.=QXV?F-XY.U7%.E-D=
M9XC5Q$_ U"L>4PIPPCQR'(40B4$@YDWY\99"'A;CU%2*G38=Q[)VM5O\;)NX
M+&%)7KT<^B$V+*EKMK1CL*;7T)JPB>3R;&CQ<2<?@$E4*HZ4');G,((]U3$X
M-B$=S_W[_%/O>L4V+ /6F L#^'U?+)#++E'"_:=80GH:IDV__TQ7/??(1,_7
M[!QM#;$O509O"TW]W!-6T#-/.HH%4"BU<8T)G],=L9"8_C ,%ARQQSQ"!S96
MX OW#RP:/P5AK]=+HB/UQ[4-*!@XVP'D.2\!"AGZ^YY1;BT,T59[>A-'3Q[P
M@.7!!3(?=R)Z1NM2]X^3T43K24*=*Q:1TJ*9Z*.*A)FG&-)6E ^3;G=*2CVY
M[2;Q'4.UU= X-W,?;3_)CM0$V[8'U? HY^BG&@];>F<BXC/O_AK%YT&K,AA&
M+LT:0/?"0'P*8^]5(O7[?Z(?!G:^M:Z$^N!E70/N#8+.5F63O0JKEMJ9@29W
MU<A4'<P8=7J%E7MZ#9:T0^=I?X'I*E_71.=6A[#W+LL5,3?FDO%C7I>M;!H4
MPS"8\=U/:H>J,E]_633D+;NS,TD#67I$&]H>G8I:EQ@M&"D(T7!2EC9>_IK-
MX]N5N 1ZRQ*",UZW(QR@0D,BNR,:H%3UQCBOT?=/7FA*6A\650:ZIY[JNBY-
MPT+@/0L91%XY7,5OY=FKQ#:0 9)0['$5'M)Q0M[5%LLH*]NJIK;&2O&).M=/
MX$H47F$5H<G"N[#0/')F.9G)#7J^F=YXQ^8LF,Z)78"4LW*K_+'P@"&8>1-M
M@ ':/1*J0F"7\S%8)MDCE2FQNLGHA"NBJ6'9,D"H]K*N U/&DV"+;Q9T_7@M
M.93 1VB5<<=W&#83YB_-70-/[%^!UV'D^O7>9-'EA_VU>D)0:MI/3O&;"ZPJ
M*YQH#B5-_"T#&?;]X3K>I@*[,^.Z[)*'GPF6ZUO,&!VB+CK<A@#O3KFZFS^D
M(]H+IS<3P>_G.2YFB,KR$N\3G2CR]P+9E:=V'5\:M<<4UB*&EI3&CA[-W&'X
M(M<Q\CIS2C7W5*M;IXV[?;(B'3' YS#]9F:I;? 1@$$WC_1(36M4RA*ZL9-O
M)\$;,U;[S?"-<K*5I4Z_0ZX[ZWP EUVSPN"%8^UPE7<P5,<T*3;IW4709?J1
M8Z;[V4D%\WGG65U1I%N6KDH$0S\4BD!:2+4PV(Q\EU831FR&7-CJLK_2&_H5
M]0M;L7-O)U&.,:>;1'W.H#+XL#$8 04/-M\3>!![FM8JMF&L$VMVF?AYVG8I
MR"^=*I*UC6O$5[(0?- U*)77):$P=]E%G;ZK*K<+DA-#,T]N4*NY/DPB\[G]
MS*.?>$QQ)IFA$;\QE_29WOY(& ],S_?94D8&*]N7I.SY7S&=KG"'M;HWHQ<J
MU$4H22(0%=C]\";6NY=D.$O5;9]7F>*:&+^ER^>F1F$SSPY#P"17[,A-#Z2#
M9^<-N Z)H2-FXY'2^$93, W+BM//2.3@N3"3 Y2G\.!YQEG"G"*_'&/R2-0#
MQ,6S,H@->-R4])DEJ_RM<I(@+L[SH3COR7/9,(/HOJ[4ULAO&5IW+Z,?T?T8
M5GSFK^UV:FBZO]M4HOK)EMX$:NF_ZGJ\]L;&TF)8@%3!Q@@LJS4)([_,*5EX
M+FP\[P8B?AE)&91+NQCK#?#/R 5'OFJN@8>&5]01T$N?Z$Q]%^&58[?"=W1.
M[ZEQ@/3AZR*XC\Z''L\/V_+L0*%AY/T6:SS9J_7V>9B5E;GD@D-J"9,<[.!T
MU+R9X#!-E:;8W)E5\:- 5#OQW$V(PE!3TSI^1,@,$D"A!VV8KO:)%K #!(1!
M=,#4!;)#X+GR54_)@&_]0=(Y]"MZ0S?? =B9S3.*FWV_?9+GB/*!#6__XW+G
M]XU,-5JFOC*MH5_/1.*+^A-'@. &&H&7,Y[$C/&_$.WAOJ+%F\UKH94\SQ6Y
MR([.<_"+-[;& P0^G+5'^9J6ZB.!GNFJ(>F?M+8_X*6\BGMF7>>"I$(TY-MF
M"R=,N/=^8CH@9(M,8>'XE3K?HI*%TRU!%@%R-R4Q1,X;;M[&W3=272&(<6UD
M7LM.?O9L/S52J 5RYQ7?;U7HF@4[NT@?TN( K0/ER,%*;VCH+S].7+@@.P>(
M&#(83BY1HBQN  E7DPP3%REA%(^/Z02O<#3#J_%[53)FC54?!;]UO,<"D))Y
M'[JX=)^-8FO&PF1JD_+VR*  (/LLRTN#Y[\56OGW2F"G<3QB![R+<^+JE*)#
M)^V[][9:>G[>%&S9=!4#O[%(G$@'G*1S?8<LN>E#1EO*K@$+1+^=@E^OO@9\
M\M2]!K31_'9@OKB2_R;2'[.\!CS=K;P&^/*=CET#B#X/7@7/F5Z=FF)RR5Y_
MAO5=T2BD7A(UMU_NMZ.5+G@C^<YHW"'G2Y#>WPIN'["<&E.;'O)N7@-..J\!
MT2S[S=SMZ\:3UX"]X-^.PAYN_C>+_RF+JK]B@97^UR\DM/FUGP:1]/60")H:
MDVG=D;=ELQ+(\Z%08IV)V)%=<M.[B8W^Q,':@.M^O$FP_D:F?R/.*'Z1AHG%
MW\B4]]?B_+8#Y!7[US+%_JTX &]WJE79OY5)]F_$^6\:_TWC_P\TB/_VF=G:
MS#4@C%\-HZ*, 8P>W0>!0-Q6 D$^%(W]%1,WXV+_J]'_;QK_3>._/(T_W[<R
ML?V;;H7M-^E)=.H5^9QIG-+LS6T9W_>OCNV5#<H0]I]0,[,VV[ %J)4*EKYX
M(H?D@J___BV*1$@)I,#2 VIMO#ZX^3CGA^%Y9\#C,9VVSH5Y2K_@=A@'-I0*
MN,USN:3T'VAB^*.P1F5KC1!'1HA\\>\=L70BZHZIK_;S?NLH1V539FH&VKLM
M\_=-M'? GFKUF%N]3?0#QUO!,_?Y?J)I%W6@!N=$$+#&;_UR;]=J5WYI. EF
M^0T"4*;P?[I)7R2;<:*\[KS5D2IUI\&YW"7AEQ'?*]+)T=^E_6V8^BU.\QB;
M=$X+?5:S$$4Z_$W.;Z6E5'*WQ0 >99!_1[#_B<Q_VQ0(69J3U;S).@R3D^;T
MHYYK[[>Z]N\9%&6NM?XU9XUGE%@?^-G,8E"4%NR(G/_#5OROTC1^DQ/46?_V
MCY?<'^]XW@8T_E9WT1;0@9T2<#MR>Y1"+9Y9>4 27YB'$HMF.O<:D$U^LPBQ
M8VODKP%2K#=+[Y:*MCO)4Q*!;RHM"9UL= YA>E?/$N4H+M/)?BVQ7.YSG NQ
M''3*GB_JLBZ-A)V!PMZEL[VW>:<;ITC )I [K-SWS?G')(,I([CL3>2.@=I[
MU<G(G-EA=]J)[\R-K!& /9DA_(O]V*M32K\_ +FR]XLB6;KO+OR8W]@ILO,@
M+G.V'R<4V:6C-?N*:K8#W'"&C!#<7#<"E?Z5;@VH[M1!>)#G/JNM8X6,E49?
M*HLL_X7BXTGHT';#B=.LWB\1S)U[.4,D:]CB8E>,S.*Y1"Q605=@I9MKR>T_
M*5#]NRJ0L-4D,-%GL'N08K%^R^H48J *>24ZUCG&GHXI=EQZ+7@ZBA?Z#P?2
MT#PQD)N8'6+DOS<H%45)UHT@"X:96:,&50:WA#@MB%M8LX9Q<]WMF8.$L%J/
M;637/D!..O+^14+]>>;)76&H^&X%=UO_\Q'ZHH\L+B4=]K$F=5 Y<K]_:X$W
MM>JXIO^$5"H* (6_GU,3@3O_<!HM"2)[F">6,K>:@/;'M70.C/DU!'#XAU/*
M6C8,^X;5;'W1_-,G'AN\^[Z!&TOI_RXBO]2:(4:,;D>.Y,\A&G].65P[O5OA
M-N.U!Y7I<ULGKK]Z"^$^<V2DK_LG1+/X<1HR?PWH]HZ)O<V?\-7"UNCPU]=[
M9-\"A*[^SJ\$>R1^GEIW>:9W=4Q$.A5]TWH__?:)K,1DR#-N\O[!VNH0KHUL
M.&#A7_7SKQZ2$O&/W:[@<\"#OY.K7 ME*2,@PQ3S Q:./<+6TJ@MCA/;V;".
MS?<?ABZQR25H^[>"/3;@^,?0(QB\%KS (H:2-_W;7Q^$>[=XZV2"5I_'*(IR
MB!WFXOUG^<_8/V&_M[/@-#-,04/(^'1^.E#+;1RO0X&DH0!@_W>7EW\'(<,9
M103V5<'[$#9N/$B6W>'VXB"Z#U-V,J5B8>;L@>8B=KA/UP>P"F#Y>Z)O#E55
MZZ(?<ZTV/"'TTN9IX?JQ6FOS3QJI>#6-9]$K<XE<Y>Z.'.'?SZ$G81VV5^='
M[DZD>J\F(R7RFV#@3[S>BTOQ'C>W?UZK*0OB/Q_T7P/>_F\Z1'\MA@9Y80;Y
MQ%-VJ[8^QL*UY7XDA0AZAJKI/^UJHN_/AL'U9ZIJ:$JXRYF]*OE.[L>@> ?4
MC7NL3&#'7$!W=!3G[^\ +*H86CA,J=A6 _E%A3\DQ_-6370C%/E/+)32]'DH
M7O#GN<W4>Q^A>0)/F%Y+WL[NW#;=.#XQN\V-*8\H*L9]!Y$ )/XCQ.K[F#L9
MO:DR3(8ZWZEMW29VT:OF(NBIB-E_J.MN& 90CV'*CF6J2EZ[E2WWXV<O*:GD
M82X)Z!^9P#>!6Z,VQJE40"VW7(T0' S3^!3]:KJNV#8_6B/'^;Y>!811':_O
M/VNY6?P YH"F0&[+]0\D3>@=?MVJF:#$*OI[T%=M*2@BSH+:^O-7F_GYDIT@
MF31ISN,1[OHJ92F35^4!,)\&>WL7P05*P/_JU!F>* (>7^6B]6Q#J1-;UEVF
M.QPCL@93_XSWII1(#VUN:<SPQ-@3WT+N#;%PK6&)'&T,VV#_8WVY.IW.CZ]U
MI4K,P4B/,:]'[UG4MG!1B8TT5H3TKE1R\^R:L-Y5H77Y\+.)B0/K&O /U.4:
MB=KR<G ?++YO>V\<S=<N1A&7'R=+'@&8_P<.QUSHGG6[3^LG,0LPT(J\:D"]
M2PQZ^Q^[;+X50?#');D!F>3DI1UOECL_1MQQ5>D57-EP/#$.8B.CHWCI"HQR
M86/J=Q-K+83._OE7<O_+_.6VUM'4:QG2O8L<>OKYQ3 =(8N7FOEC;PZ<#ZW[
MB*S%N;OJ<.Z")F+$E5&8D;DUZZV9&/WP903?APNMBO4VJHG:E7W2!H[W]]K,
M86"0OZJ'B=CHGJ_"4HG0(">%:(K>=-;P$ZHNEA7CVQS/M34"\ "Y9/P_*V&R
M^5LF' @^:&W&I?F+T5^?(F8X;LG1#LQ%K.U(*13]V$K76L^6A!\-3K--\V1]
M+S?SW7]Q2^FU\Y W60Q,M!BH_F-N0^9Y:KU6><FM07+* ,:L'^5L^PV1PB#:
M4X@APFP<FCLQK_6PKHP:QZGC7GR"6BM WF'IH,37#"ZLM@-5&JP)#1M7IQ2!
M3!Z>9ZY1I7EA;A^H[AM)!)DT#Y7/T9JGVR?71?$K.N%+60A/V&8S8T2RRL"5
MY'K"%062LP9JJPT?"3N078S$M_E@9!":T%KW"?K93>]W&6./K@':][CU2M"?
MA+ &-MHXJ\8OY/.C67H;D.>SLJF>#B[#6\, SI]1+JINYM(^/2:\".@2HH*[
MUO"IPS34J+SLWO*.]"T[&Z1GY*X[OT\YDZ1JQ"T9XX( "NYM)5TKHRA&M[(K
MIM'*VBQ9[8-L5B\_UX<#C_W5OP.NDK!ZI(<.;Y)HX5.K25#.]E+"^*ZR('<?
M?HAT+[!Z'R\ 21;,_1EXWE*83IG<-GI>7\/!1B8_9*:VV&I%%G(LP9,S_0[N
ML"NU1M%$/G# _U5LQ-D8D=*@7&A8L*W>XU1,-4[]$ NG2@@K%"U]NTNKVG#N
MM?)R70WQCG7[B6#"$YP8-!L]=']+*61J:2XXZ7B3^@U$1$#L7A7Z)Y2/?D/T
M;.]#Y>&0R/.8S25M[=E%7MJ[9[=_5#=0IZC/Q/ZR"H2\!*!A/J RPU-_!C6R
M9^Z,V H'UX :([;U@-A&-=JCTBMLB*AZDP\9I=$F OM)]<PFJ0F*T+6?'6 .
M!:=VG1WZL]=A6$+FYPV3HC^GC^_JO,C'?<L8@\K?AX2Z&QKKJD_5K=2%:K8P
M:S34F)OK?>T79Q7?DKOK^W22[W"!K#?=J)/AO DQ/Q=[,B-VI3VL9EEA8S ?
MZBS27CRW,!>7.)WF"HK!NN^];-6\0&Z3ZCU<DM<L9#[^;<,Q\^X!M1&:)4M4
M?;1BS]<U?^M6WCE3E, G37_S83Q2V=N -:)-TSM2"L6&R"V:9IWX@F^CH*K$
MP73]I*4@9L6%ER.J$+TQ-Q::C>I-BGG5@A!#AC0&05E 0%_+.T3:J)3Q4I:%
M)HBHK\A8SXZB[GND#Q>K A?+QRA2I9<J$"P[G68)A>/B76&BK96F2?8DM L:
MEV]#CK89VA N5$FVP?P ?J$ N2R0GJQ5M07RSEB1R@%*Z(8E#A M/@MA)C3C
ME;U9)7;[,PM.4$(E-GXT([%[$3BHZ\2@#I'(:"5H:;?%%K&6\"8ZWU][M!7:
MTG;R_A%(,R =<+!AJH59BQ!FX%(U.% 9%RJ1"F>K3GU7/?1U:V0PR&@^NM@4
M#-+#&!]_<D(FG?DH.=A*A3Z<GEHAAI "BR7P(RZD43R:$)*>(B,]NT2&M+8I
M+M:>^[2_Y!BC2(]($_</U*\!']0TJR8KJ8ZX!H([&J/62)NF?UD%<)JLF]RO
MV1_#"&5SPGL+G\XRJ,E>4GG>>>G0ZQRTI66Z17\-")=Z]ME6PG*IVC!:&@0R
M)KRE7F6:.KJ:(QL*<T9Q 8W)C"7<"^/I3&5\E/4+,Q\1]+/BL+G&&FS4YI".
M6*(RAE01;!^ZCGW<GB7<N>.52RKY<NQHZQI  6QCNB&5HWW55P.>WD6B:<R?
MMKPO0V-)+)M_JL'@51;Y"L*M@><934N3J@6MW;%I^KZCL!PSXYC8I4LEM8FC
MHOA/$L&_N,MI%^,(C'*^U:#WC3=M)10SB;$Y=NE1)ZNRX,6+-MCH+6.SBV<^
M:* LB6US7A>(Z?V@CSB[%T-5LNS\ALJ23T8KC1Y&)H>WR@L"-*>Z&BL>A'5[
M6-/1HII5N11;@[J;L\O 8RR2)QY+I"]BQ>E.RI7V55?F(U$J/N'QO$=6\VR*
MTD\7K0+$#*\!Y!LD(.'S"Q4X@_:!:!_0FA7:M/8!J;LO-:55!F1^.#G3Z8'4
M'C<P&2YS]1:?^5)"RSHA"]6 P]C16:Y=*6</APK#K4&.H[$"A$1"I1_<OV$F
M&J >!IZA>V\Q&783M4_'A)9K(QZ*WP]ZU[ B1^O]L.U3'OA,E>8<J 6WMZSQ
MLDKXZ;#**?"$$AT8]*:-:MU*!:K6;:T+9S^H6 W]EO(J#]<\-SYFKBR_>G^W
MB+D*Y3.]_.&R,;CJ<1]'QA-/;U=-\-V7""'C!RI,.LAO]ZIK>AWR>1KO9M8K
M&0 &3HN$9Q'>KZ/?LI[KE+@O][ZCTPAL3#R]#<7+*3GU[$4:-X.#-.'TF]PC
M0'?>]4GYK^]HT53CFP94\Y]0.Z+J%BP_MMO<Z7XUQ,FC-UYE=#7HRD@9N^@J
M-,1\W4;?]@>E!0X!G*[N8_!BO2H6>,LPM]$O7[S^P5/;Y\85TS(\3GC8(\%'
MM7EPP0KGW0:Q-;:JY#D4S28>? ],)>UK8A4O*8<]1*LRO(#M7P;7Q_)$C0@^
M/!R_*W9 *.M)BQ8N*3KETJD>@PD7TO$@N21#$BX#5Z9 #.#EU0#!.A79.S8T
M5TSP"E]Y/]<2._H/ZL;Z/7QG]S1)/>[3X03.5[YL+HJ54O*YU0:%Y-M*./^<
MW+:<9MM5$I?:)ZB(U1KCW;O0+319936SR8A(//!*6PP\K/!=-^$;=1]Z?NHN
MM'$X<Z([!"^O=/2:?8,5-# BDX2EM-23O(^I#.,](JKQ8;M=KS%;-2C RN@H
M.W\$76!:V*3WR%ORXMZUC.&LTUMJC";%Z95G8_E6<.JW%+E'O.&)V4Q\V+,S
M>=A )I"Y1Q)EO0!50[?BJT\=OE@:GV=K?6\FI'J_ Q?G2@CK^S,4<./JT3,/
M4($::5W^BI;L?9M>VOAM5PTCH$1P>^B>N\\"Q:/,].BNAV4CC?E..'']^))A
MPCX&^Z2?I.B)Z=]@#'MLZ'A_^I\UX<G)P"9'J,!*Z@D'<G!?::;R1)NE!$F5
M!JZ[)<:P.(D(P'(MA%S/ -RE5+]_$G4D#=E)#*O(;4W.LHCZ:62I2&IW$L4.
M3^P1=0%Z5]3DG;I3*51\*OQ.+6PN3A&C++X1:."M&WRAZHKV,;VSY;SQA>V)
MUU/D6'6I:^9[N4>E?,$7UI^?E=AX"QE8KH:[?3=/.?8X,%_(FGT;]/[UC49G
MP*^,KP&=THZ.1QQU]V:[W)DA7C3[*2,8"ZC+U;V,;OKV;KU#'G8-$6_/'U*#
M V_B!@_0)]8UAQ4-70:BQZ1!P**T5Y7T)+L^]>*EWKS1?@XH$E/--INP;,WZ
MKZ0O(M\+[J4#EMW\'-<Z:\"]=$=$ESHSR@3])]4@OU[IK_)H*/\ARQT[&1H(
MI=%IWIO:-INV::8"V+G#)'^3>H4$.F@(A 0+>!T:NTQH)%.@WYB_&G/1!01+
MG6!7Q02BYY14@[I2QVT1R%<^%CY;7OI%"<(;R:R,@4$W-YWQV=-C/FRCP>(Y
M?66_>F"8PSODG;<7@YF+RQ;"6_N]W/;:]/H/]1)3XU;"F L;!V!\91M7PN,@
MMT@@G5 D4+C6+5M1)Q(WJQ^P/&58;GL-0")Y5K/?V;1-$#TW]JY0%.# Z3N2
M)5\_$:6/WLW#/-Y$'@N@&*3YY\5T'3U*;KTVK%I+WV!X@WE4MY_2NZ5V=Q#B
M>CN-?O)X6/>\7PVCXW.JUB=XZGXA?.Q C>CG2VG B-M.*[UZWSBPKM9J-W<J
M:E0S<2'NF:?L*"S]Z&&$BA<;%_$W+%HV5_@HK@Q!?(Z^K#G&>&=3B9"FV1]Z
MW^M38LP' +_18<TFL.2;E!I*&M1UEM1@:2_K=Q7L]JE-G4J>-<I:;,M8..?]
M4;3_EG8[YD5==5-SG0^'Q40^=VD4GEX"UES\&X;.*W%X;22(U(ZSH# -]-BA
M+4;']I@5NYV3=@ '+X +W-X[Q!+.?<%7O-6E&"%&;7B^]?9KOD5\_0.LF6&)
MB(9%EKL][!%\;M*2IHU3]J_P4)(MU=_'R -K$_"9MM2T]]M:"\#A=;'$7XOF
MO8ZW0,+UN2O:3JZP.X0#91I@-=W)"_%2@ZT33)],'KG\K5*.F.]H%M:WU$>K
M 6+@U4G2_$$4'P70GV5R_H#:647&?A<NBJ4M+]8KF#C?#&%F\BN<P%$ID2]4
M%#6971\/FV-@3)F[D,G:S#NUZ#V;# X)*B],ILZPY;;G,TM.]]3KY_I*2]<G
M_,EG:8%RW9\-!H<]J==-F:K"34!>66E'![)5+S*N!O 78'RSR?<5YDN *"K$
MCB,O+KW?T/ :^$>E,IANF?E]TQ'&N"()Z7Z5AI[9L=!.7Q7*4<ML>:K] X1L
M410Y7FW!VM^]4B-L2G^!!YL*TB0/.@]N5)?3Z)OKJ[/9\ 9%\U7N+$]> ZH/
M/_+T6]&#*=)&\AQ-\"<0 9Q&*B6G)]V)^M-V#<VOXXLN-\J7IX7&?]Y.[.]
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M,^>J8]J5_1BCF&=+$R'3!2K0E_WXH":NJ9FU\"+FB9S4&T\3)HQ.-,KO]35
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M"U!]D0=P-1GQ<ZO7H:%YK?@@.B?'+'WY4%6TIR&]U 08^GKB7H"9@] ^F_[
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M)^E6_(630/\TE*5&A5OJ7!SR8&\.%#1]!K/Z_.9:/3W <HAK6.U5*YS)">X
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MCG%I)<515QA&Q2@/Q@@.!RJR^"G>PV5^0N;12U_4EY,G)DMM&6G<E'&CG<3
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M[T5%=@BRGHO$LIO?U<.T-/;-9-S=,%ZSOQ"Q? %:55+9-]TMT269T%K*QGO
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MI\4T]<PEU#ZJGE4L]Y9?D)O;!;^1_XX-]F-OO5V,L#71..P^&:.!^*:7Y!^
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MA)/QP9P/ ?$F3Z,]KSTV\*#/4>F<'W!RVMP7]5B;YS:.FM:*)$F*S+L(3<H
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MI[NG[WW3,U?FS>O-5]_'*7:MO=:JJG_]:]4^0"8AB\ =&0EI"0 &%@!@H#\
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MV2Y_LHXK3!2O]/909?&FOON9.Z*/ &)E5WWN;>1>I!?\BWFK)P_B;JK,E$2
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MBN?8M<9P/M;.4W[X8 $>VGA=$L^A8E/\9/^>4\I1&QQ@_\SIL]8F:[L7QM[
MV=SIX3TIXK78"^%#*=1"-DGXE&2O>']3T^S>7,/UZC>]S::4\9C25#X"<H"A
M14-IWODMD_MTP*DK96@Y5\KG;A3&J)YYK4,LTOA!<?E,RX28;;\)E>8TM'.V
M6&/.AF+KC,//=7#V<&2:D7I(6N/OA\-#VU.?@9?IU*T5^G>J)5@'QQ#>"S7)
ME^E91)FS=H)LW 7.UF:FBQXV#&Z+>?K K](QV;/&,WE<K/MPYF>% '3_9-N@
M.7P6R51V#\=O5\.7%DXH &]X6-O3HZ6_OSE :$U$'%?M0:8XK@+,OV.3%(F5
M<\?G_$215Y#?5/,V20*GRKM%_S #X5I%(#'=/@<"R B.$12!%I!N&"SI8"FJ
MQ;<7+MJ@">B?O7_V_KOT<B116]/S=+DK,<C\G<$S*\:FI!SQJX" P !MXA=2
M,?O450B =51PES/</GO;,QDP<3"LK9^C+3,\+3#_^TX,_C5:_FJ"E;5(@^@-
M5>W$B _I,9-5?03227X-_P:;7_FYO'[9I7(,$]=7S(VS7<&XAP 9(@*NHO"_
M?E/5E0"3/7J6=K7B&H=*8) =NRLP) -4BSN]F*>I:[KF5QN_LNGLWYU1PY#L
M#\>#9KG+@EC]V0!YLY6^]*BZZLABLT;R(Q:RX?)>-7@_]H4H]PRT*F7=<<[9
M;MBLZ9,32D8*DWWOEB5A5!.+9Y//")K2EW;D([ZMA3+JM+P=>0#&AP7A1_&"
M<\Y8J5\8UH=,@8A828T\=757,*W*QAT,5A+:O[ KNU1I_79RQH<*A.Z67\S+
M%S@-4)B&#K<<5((YH104:\KHU.YZ%P*$_]G[9^^_2R_QD^@:%=(5TG).FM\A
M*2IGN@(N<LS+O3GF';U5O&%Q B+=+TE5^^C@WD*37-M3RX49."4?2Y.]A^>B
MJXGG*[8#UY51F*[>>.6Y%CNY6U&:Q>&T\9BZ@6BLU+$14]1C?70 )7EV[L_H
MH/) +3I$-(*;V0,KKR #29KN"2[LH ==CE2P(74.^SE9PM:S")HP4I/8L4AE
M^?_R+.R_M44G*<JR ICK2=19_'0(*:>*HR-,XHG\.>R8/L[Z)SO"&.VS7KLY
M>JEH7EX(3P$%6!]@$^'A#Z1BDQ9S(V3JSHIXYT,A+@J.<>\7G8$?#DT_$/]*
M<92!DI_OX'2[V4(%YC#:N![VEKPQA[5D(-6! !Z/>J#S2U@//M6/A@#$0')(
M$('0?.BQT(H$,ZB98!74Y?,@*[-SZ"+K)O+R3WE_ROLOE,=QXNI]F$FQZZ_T
MMSBB,#?79FC&.?=IUP_W$95!"MVV/4]!86D>O"NO:0>.5J\+[FO%Q7"_2O\V
M( :XZ034;+S;[DM3[%GJ]E';F+)$]Q#Q*3]?!O81&?9R1PG&HW6U92K:& (E
M]9;K93W)]"8T0I6T&:>L5\RD=M<;I&F%>^IM^E>QZWGMN >]BCS;SY4MKLBJ
MJS\6]C_F*TP)8.HL3[=>]N'8QH]+#1'UDU07(+B1D]I:9QZ1(CMT2%95*,03
M!IQA?4A(9<D=8KJ+R-^E_S@ D>K'^[:K<T:%^&_9HKW%6UH58*N*^Y7NH&$6
M>SRZ3'[IP.3.P_1M2$IA?J8*@"1,;PYDA=#]/]/>23-T(3IJ0.'J"[%2O_%K
M1,/1M%"P%_UP!PYUS*!'^;8Y3!$.']);^(C7O%A'T CR#V2_>+[+=@06'PAJ
MYAS!II_0NZV#UNV<-@4@0*J*T>KNJVF9W?&6T8<<C3S,!V92!F$O![M/+P3'
MH"OUX_CAT,5^R\$0!-!KBNWPIAMMDG/?T.M]_2:= ?XZ.M)PYT"C>E.Y36(>
MO,%4C@G>VF\YK&YBO[UNN3Z! !/98/S:0%"+*P3P!EV=+:FHI2OEKLN//_ L
MNWEHAP[M/0#?0("S30@04+*4?C ' 1;2P<UNJKA>,@F)7D9F#3\T@  _J1!Y
MJ35/!+Y=N/T* 78F A0E1PO<@_YQ<?Y'^NV4)LWC0CN1W^R[-TO9>U-8V:-S
M\F4DMFU$MZNH_^ICWS[C-8EG#PK+$'%?$B&?A@F(-ZV"GQ$"W(\(APY2@ ";
ML-4[GV(JS7>TH2%6RO"_I%PA[K >JND]"//6\/C">2Z"_7*"QZ+ JE9=[0(1
M!Z_A$RF.-H=P/8VW.PK\'DP=A>@V'5S^K]>524RQ@1EU6@AO,N!P3X3:!TG)
MDK0) KC2$UPTUGX9>2,V<N?$..()IO_.MJ4E("8NCIH!Y>%:WT-I5!0,]2+F
M^EOJ(D*$AC0?%XXV$AE1N2]57D$3XSY859F;,=C;=Q:'S^,@0)HCU,N5RHK"
M=VYS01LI+1>[_\;=ZG$WXD=<[^S6AYG6\,<W@;B)@]XH3/9)I\OQ*O.^JGHC
M<9D0U-V690@07'-EV1P?HN8YJ+I.18]]#CZZ%:Q>F7!U)9A@TYE[>B)W[Q-?
M2HREW>XY5+C_<?:U0,M&QDW15&Z@2EP,-ZUVZK9R5BG(K/;FE"*.8FH/ @@@
MK6D=2T68_&VW)+5_$NYF4?J/C^>>H"&1KXJ]E.OBO P;WS_=IBV<?/96<93B
MB7Z6%6/0A"G'>\K9]$'-J<N1(=>,U@959CE&8S4E68:N@.[*\^-)X:6\) GU
M<A_Y:U =H_8>=+WSKT& EN>53;]=^AT)'4-/^'[?BTIL%%5E-R<)X-MDP9&6
MDT']ZW/+;Z6)/SM_W<GQ1FH2=27LID]<^A<'_QA+L%V+25KWUFI,%&-27"AD
M5C@>PM[(V2ZCT5G+MCNMM]][H/M:^)Y,A$9J1VRW@%5EHW/$H&NT9K2Q45^S
M5+?(@8Y@;%ZGH6 LB"8@1GNN)PO&SH6=W[KU_>!*=8-3:P;FU;>]7K!=ZSAI
MX4K ,M/KP/"H%]=<HY(<"2TV+,V>]WFIHC Y*$=/%E2,P;"B,)H37+KAZLHV
MPQY-:D(G1*\8_V(2N9O4F&C[):L#YT300YJTYTD]IB<D,=N$ =07/7!I9XY>
MC^0;@E?JWE<G/XX=,(W!,Q@*LZ6,>,8]H"DFE:VQHBJF@*<J <!EP/J@H 7<
M3B(T#\&^)15!,7+EV>Z^.5+ZD;8H2,%1+Z("#+1O]H]72-);LFXM&N>]J6B,
MP1# Z11*I.*PC74+6>A@RCON'!@WB(Y%GIX6_)%JT)$0!:AGS0L" !#@,WYS
M19-\]\(QCSZH5>@4H4ST(9@1^A"J!(+#1\K)62&,L_R+OPGC<%BJ$"!RX1*Y
M4-7UY]\ZA8)36:<0!+FG1;OEM5XJX*_540P6^P"MA'CKRPZ%Y+N<9OA4A)G[
M[6JN#:Z=<NIR7QY:&Y=7FM0&&*D93-T3)N*_5DV_U.'MOH7;!=%"@.6BP?RR
M>Z.QVPZWGM@W&UG0<+8T+K1)8?Q5" +@2=XPDQF#?<^%8B' D>J&BN(0\]+9
MKN1)6B@$0 O2@  97I&K$.!&E>*PSB7R"FD2+ \!.M53%27Y&X,FRBD&/1[]
M4H(*Z)?"]5S$28_W*?0Z0#R;+;\<K_@;X>YCDM1MW*3)/&NS^(_OGD=O'AS%
MJHG$YGU_6H&;G4J"UN%>1"[;?6D'\G.5023:=U9K(YT1TKUEN?P(4'!AAA)C
M':&"$HO>VH)MT['"T;?*<:>\O'19U0+V?Y!<P?+T%]G=\U7-195!W-0F-3LJ
M?2P3,L\WQ[I;E60T>K'\=?4]*P.]<M-^JX+3%T.>@^0MSD;9HD8$;;EP:L><
M=[2.H73*,0$^W$-?=CI-1):NVSPM"I[A7,OMA]6R,[TJ=C#PO;N1WS7\I50.
M<.%0% =P?]44^>OLF%D;Y)^U[PACQHB'.W9O(BD_Q:[J=FY'FQ8Z.LN3Q!^?
MWW .NHRTR\N5_N.E/K?TR)95QP\0P >TB:8WI4>[<O"5M*QED>(*=B(S'CII
M5Z#H3Z&7! 4#BN)X^^3VOWVQ*+@0UNX]XK-AQ4Y 3SMV:TO;Q@J]K'GB89@9
M1[J1_W70"><)]XU)<TY!MRRY+2-+I7-V;E@#H_*N L@>_#RR7.2V_6OR\=?H
MC6NW)&>UO,D,\-+- ,5/ SF<*,^/V#9+Y/]RDV GT@76NOFZR-ZRZ;#67V1S
M>(5@[5/T#_?[SW1\RDA!3QZ]QJ68%4HJ'E#B#%11Z5&JI^+X4I_+&YU2KZ@E
M7?GQ]"S?/"M_1YJR+/?E+U9)67+1ECX,J"<T!S2!M6VEI9V6IGDCN>GLK"AN
M[?E'N1BB=YDY\\.GX5[NYE&(+ZS44:7@6I $&*.^/-H'5>^)!6EA<Y2'3Q"4
M5]QL:SYF*'6'&V\DTUL^GI&+ER5A=^%6KF%I?<%_,K$U7Y_*Q6/'2<9=&F!A
MXV")*\NH0T7X&2X*^YG*6@3[%PZ8Z;],@8C;<:<I1Q0"6^'=MW&)9N2AO5>8
M<H"\N&-\,CC/TRW9V5'KX2=9VH/<FFA6XBS21+1 )=E%TT#A01Z\VLSMNY;)
M LVSP\6.']9<E*/K-0JZ:T0R,%!16GO?-842[QMWG^2_LF'MST:!KK5OKU$^
M;KH1>Y'G>G8%"I>)+K:JED ZR?NQFI3UQ,-=65O!SL"V3Z-<AR3*O/PA%%5A
M^6_ZN/+,;[U;EI1/,Y"]>[&<>\]H8R6G#* QWNA=EL^]:R:*DW[%<PVAC<2"
M?.@=GY!N3G"]XK&^KO]T!E'1!B4.G12F_F#WD.00(&CW/6B(];]W.-XRF$]<
MGE"O, PK-O(2*+,MPSFZN(E07SC$NH6Q^OP)%'(KU+/6>8,VN@[ES!=8W+\]
M(W4\S<W1>U-]E+AP$7Q5N5ZNWY60#]U ?4X!O]Q\QE841T<4U^GC-58D4/B+
M? T!9L'5BK.;'R' G4%HC!#]@GHEVAI_V.)[&FC>)BAYQGGBY<6X^.@KMG/D
MU=*MG)6LT\@GH=>W& N_MG+RO.=?P(M_'<[AQSU#YT-JE/,+%Y6 .!QFOMKQ
M^)9BQ9+X2&.VKN#U6TSCC;)O19>&FQF-/T.O?=^']A0V2AA Y*N,;3SCK"^U
MD"^:T1:NJ'K"]RINBMK$)IMG6I+RY&G-X2E^+>M@[571&QZTAS>E>=LH;1D8
M'M]B<N V5M6,-'*RABPZRGUKMG0%4/<W_=LAP"LCBBJTMGR]<%%W8S=TSQX&
M MNYMZP^0D'Y Q:3&NWO)MO-[!K[@NW12&.WI<]HDRM_"<L*1,3&-3@!![27
M'I_A?GD&%'V_W3V&;,3CG$+&V:'8*H#,G?J,X^H/G:\S=MQ .015W,4-' 00
MUCKO^PVO0*^]+/MR$Z&CW]K\S#*$KLS^Q.\W94RD1S):XENR^D10BNV67B1H
MA7=CX0%=>3IYW+_$;S6N<@A @0T!ZF^MGI=71UY>1MX.[:B2#88].D+?ILNJ
M$F#YOP%E_#\.E @8>KHR)(A>#,AY#;,L,2GHK@(2\C62X_4VO-L63:KP6A\R
M\QG=/;/\EH4J)4R'8)ZD"!&!'Y2&=BC/M>5)GDO4B5)OQDC;H<1+K="N&V20
M.^QZ3/ 8.N1_R+8]<"@>HFS&MDGKDUJV>FG !^LK:I:R2@I6@9G][0NUWT^E
MWE)G8HZ1Y C@@O1EQ%[OGU#SI==FW=+!-.IYFR 8[Z8.3=PPV .$<,!? W,O
MW1-<C$$/.NB^4(!_H\)GB_5 C+R-_=9\R@&:0\6"+R' SF?X414^9J&-"M "
MQ:T'EPYHR 0"?!"Z.H7AQ,/\%/EU-_VB&YH%A2=0G$P)'42"FP$Y<=&*%; G
M[>W1M]*':??-N?SU"@0H$\915-BM@^ZV7@CP$G2V^2_TD%]3B(&_2BXC.)HT
M7$&;Z\ Y=D04\E'_%9\8_%T^ :QMR4HUTUNML+8<X)R9#1BUA#]2@ +AFXU?
M,>VN<:&59:$+H1+K\;^N8<OL^N$ \+U4<5RUH'=XIV4^+:OB(T([05#05/6B
M6A1/O*20FKGON^I,G[8Q7YU;OV6:WN$=)/\?^$*;?.K?:([^PX=(A-+9I8X%
M9>BHO/F9TXFJ?UD?+<9H(OBB*5W'$G_?J=O8#U,(6Z<FUIEJ(NM]\O+YN:EU
M4O&!23(>!"@-D>\]I9Y0+K9@V5%#'%S6S'[]WLC( *7;.$J$?"PA9\MH0C%M
MA.33:6!_)K(6*^G;0 <?_Z^?D22_P8"BCHZXE1U-QT$%W6@E%[OO*9FEEM^Q
M9D9ELK:5L1-O >M'T@?GNVQN%%I %K]T;F)[\',F$U;W^]/*S(N-KX_/#[:&
MGL5YCVRC[4B5EN1J&L2)4I4YZ.3FIN4A9MH5]N;,]3I\4'8.E!+E<5'(14J4
M&,,.:#-P'^(?OPC:???EE,_**D UT=95E0=5,]18<*H3L!A](/$F+BC/=5<P
MK9HJ(_I%C<,LW/@;( -@03(4QHC@##/T2,N!(OH/L)5P$6?J /B2@[ <+BJB
M0:Z-7EX( 'UT#HWA7IO39R\!.4'N>!:'&'DU 3ENJ!1HEHI;]7>_N:\>?'D-
MEF0\N$0"^U3OQ2U["T* Z+YK, PT57KH061WI)_WE;2NQ=<C90Q746]IX[?L
M'E/O357H2/P'=A+PD9#:RW'&RY$SZ/ZI?_:K'*C8QA@L2 7-@:_&!WYF)(5\
MJ83ZRT2CBN+F'H;Z,I=H8#%=*G =2%F?4WWD RQ4#P(IZ.13C(Y7U0HP55Y&
M?M[<S(+RCH]_\,0-/1)[>D[/HKS=!CT6CI<H*T*1A-]@-7R*<(ALAT!BQ#9S
M%.^@*K07GR>XQJ),3:PF\CU:W6J$^^II:=?O1T\&'AKD)SZ:0^)D<IRY9D91
MB]%M3L.@CB\KP<9(1$Q_*85C/\>B1V_/(".XN1JM^I]-F/[; .YW6"%F1 A=
M2:3U/_N^'UW6M]-0='SC84EE8<SG*DK]PG#U^=[N5VOW3S>U;Q 8.C3]^T4,
MAR7%(0".L@(L0X!"X4_K_+O'J%B^;1'>6+D8U4BBWF]2GFHD3?)/4CN+0"?F
M,\QYV/']-Y&Z55X9$&"("'20_(U?[B&!W3Y!$6[XW!\:8$VA./:7PA?%UY5'
MMR>2TU@W1PG@KS]1S<^@C;"6BP$*<Z&3+OWK]9_8J @4(-D@P +'_[90O4<K
M-7,K:%^JRF87SZ[]FAO^:%$(YM-(?+2'TD27,6B>=GLHN1-$K)<ICJM./_C+
M0@%>>#&HNP.T#]*:^NMV'I-TRD:[$>6%K@*LIXQ;6+!/U5NOA(]SA.JVD>K+
MWN[\'I>SO?UAF^!W%\A!N9V)T'<_1'XWZZ?B]M_>"8C^[ 3SG]WUTVL,WWV;
M_<-;HZ,*\/]30K%S&F?(M<O(-%3>_,Z&%GUA@.]$DO0RD8N"39ZCN]HSM=6O
M1>=;DG!2PK4C$3\DX;?O23NRG'PH4\&;J/BI_#67&Y'NFM.ENN:2R/U+HP[I
MEOV:(7:>J;K='?#@]%26#\F#V[I((H$A2ZEEC6/W;YAC<?J#]KX*@(\!R*0S
M$/*3E?J5*(F"U 2@**3L>$'A2D]0]N+* S5)5?%)/H#YT8>(5(3-47,(&CFD
M_\YX\:\2,Y2UIF?U9KMMK- &.((L[Z/'>,=E;NV+ZLM>XA$+P6VA;JLV^;81
M[EO%':I_G/%Z_&F4<TPVM.V$ID4E=.=VY<K+:N1*[3!4JW*FU=!,YB1=S_<;
MXN7@_DUQ[!]IBOPYY1&41-=IG\XRD'XZ-I7>S"YXAYS\A-S:H4?D,R@X3_+.
M$XUOIZ8%?_P@]E=U@AG&3TVZ2V1V*D</Q^9RTY/@]J;GC<*6A#?EJUU-3\(8
M:FEM,*U5=#)-(H6R&O0OA5]*0_,]"' 3EKXB>4,I2 V=,1!80OZHS'@'MR7)
M:P.K(OVYDXJZ+ 1 Q@H6VJ2 3FSLC3DTDT7J2#_%@@ ]O6 .+Z.$DT=- F^N
MV9/_4YG9/XE<VLV;2AG#&X$ '^&6Y:^0(, JE#(2"RW!'-'>0K//8S90.(5&
M[LVG RQ3P?[U_-($\!V*NZ#/0E#,HKT<_K4B5YV/UO7=/.G/S;BA 2Z''/;H
M@=#J7Y5$ZP!]5Y+SV*UC3<^6MRA=(/BC$9D%)U++<R=G=:BFR 2O(<#F[XX9
MZ&7NHE#J@*)#[07[VZP&^4OA)LE?VJ9'];-M,;K^VQKI7\_!Z_\WL1R.LN^]
M9'$@@.#"[*!MR);0$NP1Q<^6'_JZ18)](<!7(J&N".D76 5&H(V9ZZ2!7\1D
MJ^9?J\F5?EBF.%HMM: . <0JPUZVZ6JN;F1T"5\EYW]4G]SZN%A./J:'X9$=
M<+@1<":$LX#FB>PM+M24="G570].M9IOHE\L8?\8OU"GSWL42%WO<$)A>#N\
M]W6]QGF.;4BJ/&+PXQRE+Q)J]IE@WGS)A(I!]!FW-2G=]ED4E&V8F?_37Q55
MX903V:6JU3# F=7IIPP@E@O1\.N(;VM%+79#RB5^EC4=US1 32[V^=FAC.\%
MT.?A[QLE@24RD0OHYU#344<!^Q854N6EVOPI !+U%W@;>HS'SX;/*?2U +DA
MH=D^\=O]O=/3J]'\D! \"2#O#S*O_['F$[CI-/C[;X# !A;E"6:258K84];5
MI,CC5'E.V"-(F?;T,/1S4Y5:.)=P;XT?%\>BO$LV2U-'J<(WGC19A/'A$> =
MVZ:#I?]P(W0  4251I6]+D$+X,#</_Z"6D7U0XNJF41#&^9S!WX_NIS7G=4I
M?@XGW%0^'F%J)6;;\7?G!_+XK7VT=8,7'/CS)?4$CC_Z4-R6&%2&6I3N+35.
M-9?D),&'L,9&81DNY.$]F^C4(AL+<P5-OXCJ6LW'T;D?)6D\I!>T*:["2W;4
MP!)M<<Z>'PH!A)S<Z^&YYAH=1FWF&O?/"YW</+6]F-$08F9%[Z2BYNZ6H\"E
M1\]8;JQ]K4BBW"@!G-6N8H9<\D77EJS[PI<JFW"QTFWK"J_D7]\;T^/ 3U ;
MX&R8;=]X=;MK1L$R/1!FZL;-'Q(J.;S/<6D[HAX<-MP1^C[6KYR!]&@;:TFE
MJ@RUUZ FNI>]"608,;]8,IHY+M;6;Y?:AL6CH&+/O2-,/+SSHL+J>'/&1#MQ
MY:ZM 1?+BH]3RC&?*L6E;/'<NM1#VPVW_8#"UQ^Q6%\;H<8;<-WDQ884@99"
M)]*V-^0;I&Q%G]C0Q$U-O<BF"J*E7M.XX/=-#MGYR.:G-(W&LQ?OZ2KKF4#)
M*TGTA'#75IKRE .FX''P[MZIRVB.WX9AW!(K@M)25 TX"!X(DX8_Q- ;Y>1V
MOM98ISLA,M%8CF"RC7Z; 1\E<"Q%JBY@LR0['L\JL#RM+;G!8:^Y9X@=M9@Q
M_\H&;9?'N)7,^?[(0=;AV(>W'%P$>RC85:YBN_$T0LS/O@2V*E_(4]Z:PWX=
M9\H,1&I.8B(W4KW?Z!+^"<X/B5O(EW+5N$2JH33E9 AV83K)9K1J.#C!V<"%
MB;V5_"SHW>;5AP0GO%:NVJ>?$W4?U$6Y,ZZSTTDR=+9B1+ZE</:^0X&^S:;1
M;@0!C#1*[M=)/5<W.D["?F-+XBW?'.LW==_G\8S.B!I'=+7L/9+Z<(W9!T1!
MJDC\:9*XUY^.+)S,;._PS?:HQ[>*JS+UN^WY".:HD6<OU:_7U<33K21S5.#'
MB)Q/V:@#9X@LKG ];>1Q+\X'-5P>WG4S%M2!E7V!BO;5,':-MA[((+K(0*G:
M\UA0\#5CD;>!]T5GF[513>3YN'<ODGK%W[]GN42^T.*\<, !9(6:;6U,W5=G
M#><?.P%/T:'.]?)Q07V,QLK[2H//?36?GZZC/)?&^_1^FLN$F1O^I)>[Z$4R
MWM:8\8=F_"2"&)TWX4DU@0$*@$Q8E'H9Q8@/5TDU'UJO%J/VC,6J*GHO;F$'
M_:844F9/H9);K)P?F(0O.(;H>=R*W'%W6%DI25@:L).6H6I#)?Q6SH;Q]DFH
MK/MRE&1T76,VND//5VF> SDY?/ \F*3.>^">[-2ZB3L1R)4V$]7;<"O,\S/B
M^[&J\1BWKDQ+O85;Q^ $5J?(1+/(KB3RVIS^HQRMW-BF"&-Q[5<TB<8,/*O'
MW!=X_=V+UW%?'I2[+45WW!7%Z$\X$10E/[JCR@8,HJRJI2X$F23K2B]IFSQ^
M9&G,W::(0T^YZ.EP2P=G.:-0T11COF>[F+K$9ZJ1@V[,?]A*SDO^(3#CRYFY
M"_W^4@C)Z^FICX]3R0>FB.#A!EFW$52'.:YW4$KQ]1E([B/%6I'NL4CT,HFR
MT0-'Q\=(ULXY(WN<W)RI$MO[:&*!N]E8#$NI;PH#X!" #:*=[F9 UF)9[OX^
M8[T2>(ZJ.JJ;D;\']L2G8\-'_HG'6#L(S6+]?/)M7<V^?.4=L)DU,R86OTMW
M 5[@-%=.#)]$O!)R-8X7$*,&*]?VIN@FSX*D GFNAQ2UUL*X0,-"_=VL)@0P
MGQV\0(T86,UF);V+* _'T]I[F@$KCS,M^DYG7M[."4>[W\#SN2J;7:LU.JOR
M<913BG'LY[&W&*IVI>L^8L-[@?0K3-XWCG#^NR)J\$Z?/<9I;^Y?)! [45>^
MU:Z.," G&C=D[Q$TBZJB@E_$>F/?A([),!^:IS-C.?BE*N)AL6'5W8:5?@/-
MQ#  F4@QQ>,"T8>7^!_XQLA]__W'UWLW [**(A<DM^?@Y[\( 46=1-%H1-2]
MSS?GUXO5.9=W@O=>$GAQ5HV(LE7LN4T6H??!M)&/*43RO_$,D8_C<B:7O^6(
M!5\5.NIOO9\O>=.00_^B \&W%)>'-N]3RHD.5GNXLM*'(X0.UX0+=>Q0-8/*
MIX,P\RF+:4W)X^,VI6^UQL2DO0>8XLO@42RU4*:XTM/DTNG@G4Y*+/1"LP4E
M>O,$W4ZHJHY!6SGI%V/?GU5Z!V0E"W(FUE7JHPTQI--@?H?].#D3H!D\%K8U
M0O.1%V#9&BRQ?^@JF)FG%?H"&S=P?ZMIF JVVXKQN!'YKA]OF+U3L)DAQEC*
M"0?K/ Z=:Z3A2U;3KEVX"2+22*W*50CP15KHH'#EN;^:KUT'FAM1P#7<W8H#
MK^"U]]V.3K5'G7R*U6,E_),VM*,8E:'JR9)L_>T/%!_,%5/DOXY[PH+UE!C8
MH0G"(#B@7H, S;N6\K3@9"C]\U)['A;S+LGZ04/RZM>!ZG4_J41,>ZX>V:/M
MCEAM7!B"6 @@!R7&'_*_&RLK#HC_T(4__<J"]O9,:5@8VUWH=$3^>CORNU"5
M*@5XO;^X);L7 KR+ 2VH/OQ3VM](NR,5C&M#'=L@X5/)+@CK.QJK,EB0$\KJ
MYA)J5Y%PW+%@J?NV8>6%0[IE90$NL4UW$F[%N_:X$%:JVR=1(E2E+![. HRO
MXTF6/,Q>;;/>:[# 4;%"C'%\&97#P2>)!,"]!W!&]S,PMSFDC36I4N<?P\3%
M'1.2OR)V_:%<85#0?3=^'D/<^*ZID3OHDCSDE_QA9VVK9F1%2C[W?[V\"\PS
MD)O^HKCDS^.UZ& ??7>$X@_KXD. T.^>4/GNK-RL/Z7]5AJ)X>M)DQ0^EZOD
MY*P?P/=7GJT6^*1\I<_IY#$5>=Y\\;@-N  Q-%LN7Z<X'%?N!+F5R?':K9=L
M &,R25J"66F*X.4*!. WN17JBN3^5B(2DC\J%D#JXG5]7:8W,D*2$TW%AL.0
M3PB/V>^^JD)<&_S(>;.:+JLV1+N'5KPV$AXI/-9;7L"^ NL2.2?9(\M"-4#C
M1-E54G*#XNL*[1:8P[T;[-9[!0HWT'&KF1ZW6'^3-_E&E)2:K4B:L2 J?+ -
M0%8XEM1KAC&9YQO.K W476OJ,&.@>8V+VBE/TVJKLF)HO1*V:II,1I "V@A+
MS[L<_BZ8,S3':L%F],"Z+68M9G&/-1\-71NWP+A;Z1EO[)"!?>WT6H?'7&YN
ML0-G09VV9[ ^]8')\^FZ%4HZ6I[K]@6 N*)/5ORZ )%BYO/U:)K#M^*7=_J*
MV((WQ04$R"PPAWWTPQG9@T(G7?)?;BR_S>*?G?\+G1:UD4QJRM* ,D,F?;UF
MH,-F4WK&Z@0G[>MJL6%.DAQM'IK*-_06]V-P*BU3$J69<F*$9]LCWT;["/."
M_K4,^?^]D\0X<7(Q,K5.2%E91<&K"PJ'+4D%?RT'%(=K2X-G#V^[4C?<!9U
MQ3.-A%YS; *,>EG7O&%+.40\K4ZBZI^3/K*'OJKQ(.T.N,'E?UP@ZWZ;>1Y^
MF%CCSL<:@^E4=Z4V.\U9TE6-6'0O:@#].4L2"?)&#.LHHN'$9;C.,=(%%'\_
M#) +@V_2+Z9RLK**7V<_245V5%:3$&\)L-[CV+1Y6,J<94Y[LERGIGR?BVO1
M5*IK(0'>^6;;@D/"(KM>5^V*K_IUQP7J_3F&_5DX."(]%.Y6,L_QR"BA%MK;
M<_,?3V!7%GR(.(TAO"#.M.4XDD361L'- "/:S7CLOXWUA/X1/WOV_+RH*TU
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M"!_8/I/0/99NK$, R&U#$:LDI_YD09$ A #W?OXF!/G86PD?G(PX1,-B7 C
MZ;( ?D1D3P"P- BD%HXW@YT 9#%GGDX_&WA&HN<$@%*J=7Z/LXH ((+_M$F5
MNK!]1&-VVH5;\3*(/Z\-C [U=L0'FL'P(#CV)BD9[M(@&6SHV20>3XO)Q3/;
M!B-6%4X;%D:&G2  ?U89["=5U%C!Z IE+@)PY;/U,1;2%8<US: Y_?02_ 0'
M7C0G +^OR? 7ZE^H_PTU;0>"++9^J8@ 5 ?C'&'X<_/4M#^>_VM55E[HQ/8T
M47QJB<Q<DJV2Z,;%5%ZCEMX%5S4N\?\I /[?;+9?J'^A_H7Z%^I_&M0N?XD:
M=D*ZB?A+U&ZJ-.BY"$C'-K.Y;KYI(YW<UJ+=G7?0V5!YN 8!>"'5;KUW9O2T
M BY86^#EG[[YLTHU! !)A9X\ 2I/L9!9HW/QYP:I84.4!@2@Q8, G 5:?C:7
M],\M,?]G=<5AKRK+$  U40@!()K$"8- /QEL^.>F^&TF_:DVR$^Z9%'1_F0P
MK=^W1.FIB7^NZQ?L7[!_P?X%^Q?L_QSV;B;M1OWC.LR$^5O9+:7PM)[ GI:5
MLU)6G58&!6O5BB[==0\^5H;.2=B\+.>Y*9FK(C+QCS_A_8-/A6W;83^$V,E.
M?/(]9#Y#Y0A @FL6;#+-^/9?O9E$YK K'@S>.3L!V_B!2(7K;5H]0MO@KY@-
MGL#D=J6)UBK_3OL_/BE!L&\EV.Z3[9.T)MG&SZV0G;LX&_PAOM_JS=]L)^VG
M7;5'8%PZ\?S^ F2/R.J-U4_<WT6!/YS<(.<0WZZ.(S;B]LO2ZC+#K7=XU^?W
MNX^&0*J_'7#*#T$V^D6*R\R1"%QB# C?.%*?]E<G8R@9IT)9"<!+HPH"8-V/
MZ_=U^:D_9='J_9U&"ZBOD8$ "%IW0;9AW\?7JI:M*$Y'!7P1?(@X<-B;^IMD
MHOQ%9LJIG_NV<)X P(E.'>/9O:F_>./OHL8?32*IV! "P,=]ZM8M8*7NXS_?
M0F!#S^-UNDYC$RM[2[UG\]2GB-/MP/O+26-#?WG\\=00JA>,9[Z605,W*E 3
MKVFTE$\LP7-.=K'9W[$(<[Z.-A0'\2G1#[U6$UVK]D5,;2W3%QC/:>R!FM7"
M2+]@(VG/SNO7/*MT))9T>736-4%]#R<R_+Z,>BFDZ?.U8;8<4RJG<4FIX+TL
MBM6"AB<Q;]A:A$!-SZSH,57=$?N6^I^<2'?US<]/51B\K7BFJ04:53D:(K/6
M<)L"QU2*TSE,3CU.==^9-:G^.M3QB?%;;)Y;C\S07X*8:OR\T(T+JLH\PKLL
M.X[Z_=D( 'R=_LM!:0Q9A#!-8^7:$]=WVVQWT,Q,3OD#OH\#%<^*=-X^>&YS
MU@(1["%8Y0P]^6'AN^(L,@+E7Q05ZDHS;1I9$N"=%GARN<=?&)3]']U^\3W4
M0^8P=@4]M2I73*QMOKE%'A,."B0_W-]4XXKY?=U,@S4QTM(8!V^+F;KQMW+A
M+VYH2F0V1;LS#?W6+',*V$2GA28MO7)%:$K%7 ^#@S;#/2%@3Z&LQ'B<;[C2
M\>UU9( VO]CGS%%IHH#(;W@P]BO4)ZOW74'&@7;B:W7EYX?W0.D+OI.F_UKC
M';>^9+2.=$P5G2[#JO"9ZR+] 8S827-,B2,+>]S7SM+2[B3R6)7"R<2YIHO_
MY=&4\D^S@-6CA<P?%_$2!,"/ #R&Z_TG=V9V"4 X@G$S &SQU?QSH8Z?Z*<*
MI"!%Y1DR9;#9ZAXMDZEW6%NYX\$/<\_HA@O*Q5Q:2#6.2F/P@@%782R#88*H
MHJYVZ?F=I"FU-JO&:!I%X_N_L]^W^NUN\DHX_=QJM15GXUA>I1M'([T7E_=9
MA\%0O)R]8M>'-*O"0HO5PUM<Y:6M/4+SSR.!??9_1_,>PNP=CK6YFFAHJ8HZ
M&4,Z;8XEVV!!D<!,SL=&N?<Z<*SOX)VT+G,VL7/EU:]PO;VLRK37QW^'K7_2
M8Q/2[GLG+:-8+M&>C2C]PA/;PC-YP_M^*EZZ888?/!.F[K]ZK%X'OJK&4O1N
M*@1E/^4T_CU78KICY,/^60I\TF<LJ+MX<9KC38_[UR>HB(,+/B 77!@CT9=A
M"[$*S'EJ$11)X8M$O624S[!%WT?@'.=!MXI(_>^M*QZ1H32.4RJSJY<-O<?B
M54;Y8WC[AZ06.,G7C-Y09R/6CFCLSV?U5["=IPRPR4 ",$3BZ_1G[#_\T.F_
M=5#UD_NK=U@.X(7UA)7 )L$;:E18%P(@L*AVZO"ERPKJ7$()P(Z^-.W1[O5U
MN[^8L-H"9$V:0U"SH,X#S,L/GW*0D\4\T0&!XX,QBL<.&:Q#[HZR)\N5F)X&
M V=Y M!=4HO-1R)1!L Z\[N0I1 H-LDW^:;VF49S9.R;4N_";D5S1Z/$_+)X
M.KLI[<C =@XMR'7@.UZPO\A;O(4;7#$B+E3N;C=R%?3JTE.I=+_E'&SI(K67
MUC!4QO&1OV"Z'/I"??-972'* :VQ3-\A[*&CJT>V?8F+RZ4^L3OQ[,S=_".%
MF.IRU]Q514;C#&;VN=B#=V)\7U.TSDK$UN**SAB$5D\MY8TV9HC$=9C=*7<Q
M_<R%27=MI]>X!U49D]EF<.!6'A6<=&[GWZQ.T*'T 2N=#$\'*AJYM.GQ'1AP
MSVTH.J=ZY=N=%Z)U4EAZ'?Q\R):T6I7RJT4GB@!P2!_LJB?TG9&.3Z+>1=S8
MSZ)5Q7H@];SN8+I*'.^C=)[8?GS-$3'IZ7QY1:%U.WARHKDXPI1/X_%,"V ^
MT>PV)+YO'09CE(%7VLEYE119.,6@R.QNK5"G@\V.9&7%Z2NH)-CX1P*Y_C@W
M[UVX20U[*ZXYDBOD?FCJNE[;<N(XM;$"B_:J(4,%I$B,;(M?>O_ R!L5C9P6
M'5KD?D6T6<VN4147C!S9XHW)"IVTX0\T!HR#<3P3HC@9<)1,@9C[ADGOE9/%
MVGL/JJO@X=SBF(/,\U%(.-7LETN+#ROTGZH="+&6VN.9+-; 9/!*<X:5]=$
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M1(:W;Z2^K&27R!Y6I[QI[O>@.@XX3.)YXN^JQC!\MTR&@T-'N>'-M+<UV[3
MNT+NVO/YID@[XHU+C^DE!:AD%R>EB029]/8M57CIWVS<C&DK3U6S^>YF,1DJ
M8\ PLZ'8D79XX&ZFK!>E%:HAQ+;>(;&Y$0E\MWL7]VYM^)W4_%21ZRM1R9CV
M,;=^4TG-\E2V,1ZV&0/6HR%0T;NH=VN#'(KS4Q_%Y^Y+OE1M',]_Y$$5S6;
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MTI[@%. <5K08FU0%0X<*H,]@;30:8^?[7NFZ*:];]#RC ''59M%(M652/RG
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M!N[O..,L N X2P "XC;]$-M#9)F_%\;XLV3(U"%L/O?8:OMXCVAE'MV/YR0
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M]WV[;KXM6NRJ&A\^+_G/(0SZ%I?5_E('R+&Z*Y]%)0FK1<-H2@X(Q$-?[^E
M/2ZA)S YU-EU_Q80*C#'D$\LF-'8:8%&]9DW70.S[)\8=OJG# '#41+W$;<
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M6N .'O<HEK5%%$R8UXP OXT!TN 7.Q(3YN,O-!P)O$=^*(9C)@D2/\^GV-:
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M[/>QW6\[=JA8"RH7=%KLN.H:/J=97M.DZ)[40]SY]CFN:?=^[B=)*F]E#XE
M.*5%,^7D^F3<IMHX6)[T=<-XB=<VH<>;EUBVW [VW1X3302ML^9!-RI%UN<Q
M"TV+!7.Y\H8*+ L-ZRA25"EKPUB)MR%371)5-O!XR!WZE [%,KPWYD]^ZLX1
M7N<&#IX+GM-\M>0G26#:Q\B#.2K4?'92?J;"X9T;@'?GI_NZ,.Y13V;4\%2&
M6^;*>2BD<-=;=J5D#ZSX)KCT]++Q^[B';=N0QKA]S*ZZFW9K@H"_T0:D?U]
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M@4(=A"NP7B#8.:HHM%A1<8+?W<XUQ^"2^T5SV >IU<@<,0RDCO*S 2M+M"*
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MG'T<II^YR-#Y?D>S;$N^5?1)R5SK$AZO':#LR1GK".(Q8F5/M8HBPZOKYB]
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M_D#A1OQ<L*&K+7?!4D@9$B;?-G__-4^^QC_C\!@!X")WO,\,?@+:>MPDW61
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MGQ2>+[2FC'!4#,W+IK3 Q_8VGM!]7;\@EBJ[Y8B5E!I6/B@M6Q]C9QOB'3D
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M-#\#/30EHD"LI'@DR>HM?1 +0]NZ#H0&#C6N:!"W6#%-LNARMI]VH,KWM@T
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MQBTM+R4J)R0F+OHO"!8A(2$),0D]*2F]Z$/FAZ+_G]M=%T!)@(V-PX6#]0C
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M:PAKTUNQ)#VK+UODL:S,B--H%W'>W*V3V^V(/T>3&CO5['R-'+B[H6(SC0S
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MI]7SBB1Z",BZ#IWJOW7(1KZ_SE/3FF!XY,;@]^+9CVW\S9MU<KD'@P' ^1U
MAI[H[1 P)8OZT0N9BF^SH?9A+3+!'^S@]VT+@\VWPU20.0,I<O1!(EM.>C$Q
MD9NCH?VOD74VKEV C7'5))8*M>[_LK_Z8@E+?NO!'*%NS-_J- AB^?=_JV@3
M#/:\^&AIY;U'C/:;SWBP^RM]?0[N)#TQ9F2C([< W;0&';)27T-1C7%N]7=
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MRR(Y>73)PH( /W)4DS.T+PW^@3F1=DV(;M%A3(K5^ZK;F1-!,A^=SUE,L*,
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MIZB&/;JKMY3R10YH1P-56SW,\M#@.^6][FQOAPPS]5^>'YEB\GQFN5!*]^F
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M<T4EZ[EGMHENMF)X8M!0RIKR&=AI"*,W.Z+',,YY4":)6XCX#'FZ$LI(D?Z
M)=K,DC-\9=_X\[+/EO!)6^74K=)9/  X#L 1&*HT152-%USYLK#3"^73+J%,
M*,';#(@39/*,-B&28CF6-U3?]\^&SV'[Z\[5O @"U9>OL<D.V&","88L7/G
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M@BLV<W[HDK\F*@GA5"I+%9+"@TJB;4):,X$L!D6%&8YEN7&Z\J*G?15::9R
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M$9-B(46 "AT)*';P%AEE9&Y.;A113)ARRW'7(S^C+\R(4@&:FX 8ZQHQ*8$
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M'\MO^<U^"NRYPWO:BM1ZV"5:P^9FL!6))\@QK5!R6 =B$VS3XK;B[6-@74>
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M*5=!(:V910++Y*G2SLKB\G-*ZZZZ@L3F7$=NK# H:9)R&#$A R" /#=&.6W
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M<R)<I_M==]5OX%'06'.L\S1F WBDL$,N,8L49LYX;Z0GJ2\\FD^#>#GWZEY
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M\5WF9U>PWAQO34+\VI9O\Q&'S>13/D\I/MH7<60_VYS>>\\6_(/>@H03DIQ
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MH[A=-=5/NM5?2?4K38S[VP?=O?0M4&]-QRLEZ@"V*]");DW"[6D\J,@ M]?
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M",\\NZ"GS634?CQL)CZ&#&/E _+6R4UW8/SN[,8'M!W0=D#;E=3_#06 BQ4
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MA <0?EP<7@0-B\I3*(Y$EU,58!4CZ,<I@F8<OF1=E0^^O\-Y0"O.-WX^76P
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M<H54\P#-]A 0)-4\G//AR:"):XEKC]8TB6N/-T(1T277!AHF^E(C%#00F53
M, =CH_$*MP[R^9K2>XI0*$(AU1P@YP_;; \!05)-BE"&8=#4G>H LF0O6P[
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M4"9[<%Q&T"':A*5P+[?6^^^3$M^S/I,\DSR3/),\'P#&),\DSU\.GQ&Q)..
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MG&XJ:.I[%_65Q20M,5^^OTZ^>W0O/Y;Q&YBW095\5/1[;-Y&UMKQ(!%R=1)
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MA^A [<QGZ8BLOM1>6T2>2O4Y9!2@$O?@$VH((4FADE%.;C4@D#&)P# !,LY
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MF*ZPHY4S-5:6=;!P1E0Q#*KH&T%2,#)+BA(H2CAF8^X;0>)8,DN*$G8:)=C
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MOGX2'<MP#*SWR)UA_=/N 7V#>@#XW=T9HLX@=QRSFSN#R"Q+4DF"5-F XB*
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M&3*Y+A%W N")<(+*DBAMA&"EV#DN^2U3F.X'E,BLS-,Y_93VF+IG^P!I#Q"
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MCSKJ>=<\=PP3T+Y<<@[*6#(P"XN0?G1"2D6-8=\U-7534G'I=YQND@QO03.
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MF3:A4UI,JH2>A4$W!-LEOJBV3OAMFA!^1>_FK>*@O8IK;F3I)5:(X5P@SIU
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M\C=HF8VX][0;^O186^"R%(@X01 7\ _(<8F,H903PJBG.^T.O)%::V^1T*)
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MU&:^6JB%J=0\4W%38CO@^>6V9.?]OF1JE?D@BA^B*(:K9LVP4YD.6Q6_"UL
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M1FR_9-X[\NX74:[8*_^.IR9[LF7NT](M LX%[5<'"F9F#71>K 8S";[35FW
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M7R#ME*0: T_C_3#UH6 8H$"'08 ERVH%SD>TX]NKH-6&5^"C[]QRU6,"CIC
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MB542>RLV-2SY8?/VH#W?&8CF8I3:ORZ2\[OJL3K$TGM',(8XVQ!+/UJ" :1
M*Q-)&='MI3$0PZDA0"VLMS$88>*^-G3?M[CW'E'O=.I_Z3!OOS1C;]6GAG7?
MIW7_['(<3-.@HH-I>CK3Q&AAA<ISPEW4V'$Z$*LH(YQSJG@L @L[INF^V[Q/
M9)KXB.KA@.[A^L!'$\=]MJ6>^DX/0?3>$8G]1-1N[G[W[,(_%#GOL\_@0$8>
M?J97%-P&Y< Q-GB"RCE2>DU)&:+C/O R[J=*<\+'EI0\6AW,8F\DY-%AHWD
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M[<BW#F5@:M>^6I"7U^>K?I<0<"CLOM]2'(!T -([ 2F-/@=0TL0494ZD* 6
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M<AY69X\)WSQ\+&^J;D5/<MZK8K_/C@)/49O@Q^]:P@/.#CB[VQ28J\)Q+PG
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M0*.,007VB#[0']74[=<-*D>,]NODP4'DE!P*? PP/<#T=PC3QCF72ZV(<B(
MY.8 V-%ZH@T#?ROGCC+^:/[6WD%:BS[G%WRO"-VK':IC<\M8\*$H\D@"D[BS
M)"@QTCA2 L?BG%H1?'_<LINR"I]]/VE(4GE8DLKC5%D:DE2>H/$]=1*H0$$
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M87[LHE2:O"118TZ)LI&4A='$R;)45I=66;X=M5P9GG?Q/4H^B1-^.A\OS^_
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M@PC!ER21SG)F-+<..\^=LFM"\IU8_;NEJ@))RNKFQZ+VXD DYG2C]@G0E"2
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MAN/+F(V&)27;">%@B4WF)03P!K/AU+:C45^T_MX5P!*YNDW+:=)AWJN[K8J
M+>\(#^9(B*D-"SGP-[_^DJFVJB7FZUKDVS;GTZUMV;PH8S6-O/;W[CZ9L^K1
MK$W:?<H':4?KV>?5H5"Q8Y@%><[MM--2BX5TY_=R*&WQHM?>L63ZUP3Y)C[9
M$.>6.<\!3.-606X1_$8Y7A!_14@Z&7;1@WI=J1)9.88:_6S5OFU9+!_,S&QP
M%1Z]P1AY\_[=@RWA9]M-#<QY",IQ\+-R8HD0\)GR; PJ,'$.[ _K-N)GPC(P
M/C5'BD3PLVA.H=+<1UYX1H5(1GA^W=2X,B-65>*+R2377.1W_^URP])XD>7B
M8Q:<=ZG]OB^LEG$ +./,:/D8^'+$X.I8MS;B-<ELE>.]>8)E.S+M"EN6.&4!
MPL'HKKO",@#\W)>J.PN]:,Q(\MW;P\3Y7'I7M&:SSJC'K59Z'-[PVJ4DI$=)
M6(QX(@)9AN$[JK -4@#?;$Q8D5ZQI$1$8 GE$1N<(JT]N.1),ZV4I^S*6UGC
M#7<[;[CKO/%J>;K[?4N*3?\%[/:E_](/WEDV%UA"]W7WH$<NU5E7=_<X[*4)
M\>"[@B<+((2XI@!". E$54R&6D^$V9C&\B/LU75-N2_NM!4>(+'Y%R_!O%B/
MY&2# [5.8'X6"O82Y4U%_>&S)71T)8J'P6USXZESM;M"S$?B/:&QR.$7H4T&
M-.Z1U5(C[:.R$11<C!N34N\-;?=AORMH.WCF8_@PF,]='EFTT5OEB!$!B11Y
M#B,I!+_!*#'',2:2$Q<>#+"KXX!?+"R9-W,CYA7X/Y?_#;SY9K0Q'OB/N7WT
M>CQYW2;CWLQMI%T-"^YY:/VGA2_0UFC>;D^N.H[CT6J?P*N@.?PN= <YAW$4
M[&1N+K;6XC V0/#-YX"7G%O,@/\;8M=GYNJ$P1WB((-#$.[JW8HM?;9Y;/^[
M@9Z%1=XYB+NS^X\.;Q1.GEG/4/0YA>PC^)+,4Z0"B8&[/)-Q([L!OJ*4N1R7
M)J\0YY2!CR$3DE$P$YQQQFZ,%EN!DM_M12[<^A%$V9QU?SWSL>6<_!F1^(RI
MGD/*G"5+5.B*)*]GDQR._#S.-5OCG82(7LUCF/,PT6)TTO5H[X?W[Y\X0M0.
M>>B2U;?#5!MMG -_1JGUN"<LO@MGYOJ9^,U'^/-Q@97G'(Q\0I&7+"&NDD<:
M@PL:G?%<:2RCW&P*"TYJ3,0CRK0#@&,,93<"^:28LY3:2-W./("W[0Z^2QVV
M@6EU/IX '<+#P4S2,]B"@X"RZVQ[5ET,9\TC.84R4&:HY8A&0Q''N1LKL1)9
M'Y@++C*J-@(2E/*LI23P@#2Y;$H@#>1!6%G&%9%1JW#4L= [V40MV.13G^NQ
M3AM"=YIT:9MU_4R7D<Z-0&=7Z_0XVV^8(:#B#6+,1,09['P;CW(@\]I[&IW=
M,%]</GX4M$*"YZP[,Q8YC0-*,AD?J#54VQ+N/)QPI^^B?G,?ZZJ-UU4@/HV'
MP_'713$(Z-TV:1F7?MG/^4=P&8:S_)M?'BLTSY)DSN>C;B8W(@1U9*6S2'+K
M;90X;H&J>_-JB5\=!._6;1=:VY8IYM1R[C(P[GK>=JX_X.?/]2_M?)*++FI3
M_7Q<1ATQ.A>.,L2( ['(#0ZM" G!_Y-.UBI+'B06>XYXM6W8>]]4\:=?[A#9
MZOSV6T-;5_W-;PQN9;S]N:X?C+0]8V7N9 Q>$93KEA$G/B!GP"QE'&R4R'ER
M86.F .4"'$S%P=;/K!S!I[$J8,1BP,#%CA&]X9\\?3!%47ZP_L=A1#N/2Q)4
M,#X2$Y!OQV7 #T@;PQ &+\T;'61R&Z?\[V7KY U^TX9"7K;EOIV5W8G#(NC3
M7K0(^>2(3_.#\G!X9=5S2>C5HKJF/:W[.+=QVI 5F$#=O-.->'\WU_2' O^]
M>N&UBMW2:W#>:U"77H/'W&MP=YS2YO!Z)="[2RBVR'=TR<0<AX^6\7Q4"NQ?
M[R6RP3NP:H65W!+IA+RN]8EB@5/L$;.:(BY80%IP,)R)2!8+$:/?&,^PAV2B
MYF>*F9YK_:PNCXNC@F2,8DOR03J.N'-@$P)?(4:IQ-X[9>G&J2JJK&7><Z2<
M,L"%&"/'K$(J2F:CU9P+LG^.DHR>X=XGI^&U+KJTY_#:B*/<'7*>@\P1K$^?
M)O'3_$3'<;$@.")>AL10"#0"0&&"7! 21>^5PEQI$C92#/?*,#V)*[.E7QDG
M9\STO8G%#7KVFD:UUXX>;3W;&>HONPOJ"\<9%MS 3J?<#@S<5Y.G2GJ;ZV<(
M551M<,>/'/OL"J+]>0RS89PGEC=C^U]L/<Q'W &F_IK/(7W,/_S@F<_3J2_9
M>A3$+FAXU4QTA;LV7,^K,WX760KG'6F;>:JI>=Z[PYI/YKYT/EWU'].6F/.G
MSQ>;%_8\YY-_=;G[S*1=#T!=7GZ^' WMY7@VA4=\B^'7[G$$XP'^:?&!M@7R
M11.?-_'"3D#A+.C0GI7L[OULL098Q-*S_%(WM:N']?3R^>(>*Q?"E6%)J?:Q
MW PH^2E3\=^GX3O7D0'1=[GL+M>P@>%L5S?;W:+4[A:U4V+==UWPPV0;BYQW
M0)//MV_G#&?]G[FK]BB@.7BE]M^O.3#8A2V>=\&+_(OMD/8E3MI2BKFH=N*[
M37AO=?SUCH(=VP-$M^#%K4T [A[MN&'W"K&?@MA VOS7MC+_! G_L%X.]]V7
MQ1'T(@9]$8-"[((YQXTY<$61@+Y(0"%V@9OC)WPA]M,0N_BS?=V90NRC!OMY
M3')!EX&XF%9M_^MJ8=WU;VOV8WWF5-5^A>0[>]4] K,>[E9!K9,@=D&M@EH%
MM0IJ'1:Q"VKU$K4^YA-<!;8.1))N<=[;NHR[>N\>")O\P[?O/FWA=UIKO[?2
MH&ZO7FRI!4*K1QR[XRGWD[&CV:0G/!"Q>^*.QGTF[:%0\>[&TA7B/AUEVY*P
M'D%+-VJB,/;A,_;>Z5BPM[#HX6'O#Y"V9X= B'2:I7SJ(^;I3M19I*-RR&'K
MB>*<!KW1V8%0KA2AL(W66\1M3$B+Y%!DF$D?0L1&/E;GN>L' AY^2N0,2W4F
M-;WQG$@!BP(6NP2+HN(*UQX>UQZNBJ.&,F.Q1]3[B+B,&.D\G]L2[BFC*L84
M-SI!>T6U=Q1)JPCB$92=QH8B8CP3 5ON,"TJKH#%DT5 YP'L54*UG[\_U@ ]
MU_9@]21;>^O3"I!VTZ_"OV;-M!O1FGL.@'R/0OOC?M,.>Y>5/MHL=R;NB</0
MD^>/>V.S[ U,CJR3*<,B&"P98DI(L*"H1EIIAG#27L3@A%$;[6^8=])089&F
MBB).L4!.^H0D2880RSAV<C?#T6XQGS*PO[C"]1>C\&*)ZF^6S:MO-[$:8+/_
M\PS=UOT$+"U-]8XLK2.!N'5V?AS._:5HZ**ABX8^, U]N#I16AY5B!0QHK).
M!-6F#7:@WT0(1"JB[$8CV!^957P0.O&6.56@",\HOKD#4T&3@B;''EDO7%NX
M]EAUH#4X:!P2PH(+Q+D*2'N"D;,!8P$:,AGZ\!YQAZT#;YO56-"D[Z'W>;JC
MA-X?"UQ:<;QGA+T4OO4AGWWB:'.Z50&EZ+@P]E$R=H'CPK6'Q[4EX;D;Q];8
MJ'W0,0_@5H@SKI'.H^R,,^"A&JF]U+T-[K9?8MA];E.<T=Q27ZA21W8@V<UC
MQKJBH8N&/CRN+1IZ1R5)T>B0?$1.,9LU-$':88D839XIS)/'H;>AYZ*A3TA#
MERKP PI%@X2F6.=Y:*7BNW_FU6ZR7[<W7-H[\0^%SKML;=4;$^UPC2+*.1>2
M$F2P((@G19&6*:$(/V)GN.;"];9.^_<\?7(X? RSJ(]%V7?I)%9PZ*EP:.^4
M+NJVL'E1MX>E;A5CTA*>4))&(*Z21,:)7 C'<9[N[93%O<T2/**ZI6>&Z#-)
M>%&X!8D."(F*#BZ<?YJ<?[@ZF'$)BL99%(-3B(?@D=6<@TKV(G$C8^0;.K@W
M>8!'U,'L3&AYQOFN>KX4'=SKXO3#CS?WLC/VAW@QG;?&QFUK;%:JU'MG(NTF
M2;D.371 ,S:%\2RS1#&2=LO&=Z%U'\VDDZYV_^ZFG9#V[H^([)W611L45C]=
M;7"X3G/RPIG$/7*4:\1]-,A%DQ"#7V/CI((_7G>:@X%_RGKD,;C*G!*)#(T2
M>9F,2(RJ%/7!=$2E9T*Q,[(S[[AHV ([IQRE+DJW=Y0^4NX_8*4KF7/::R0$
M!:6;=$*:8HFTX)X[88EP:F/2!O9.:QZ1L5E1XY@3Q=(AJ10-V";"M2]*MRC=
M'0>EX?N\\W]9;!1P1IS4'GX.]9=[4(+<.F'R46/%U\:/WDK [M+\J.?U%%;A
M;R3IA^G8_UF]N\A<W&P[8-.;E5:K^[YU ^5 2O73=W91[G43=UKC7TW/(_Q_
M$F/U&7Y_WE01B!"VQ/O/JN,Z-^6QBHE@C)+RX,9):9$-CJ&0K#8F2F_MQKDI
MZFP26"F4HJ.(,^R1ED0CYXUUTBM#D]V9%IH+4]<3:)$7_>MDW#0/5D "G\$>
MW*A]>L&<5?=BU3C!)GP&YH0598P!O1<[MLWW:(<5?(V36-E,,^#<K_7TO+)5
MMQXP$RQH._LISC-9P4YCE6P]J;[8X2Q6%W"OYKQ7+PYOG5_ZWXY,W(3DQDN"
MP'ZS(&["@ 'G%&+&$<(<L2*1_HG;?\VYZ$7'1.T?7P(+O08.^F=FH#51_ =\
M&\.'*5S0O$LO6E/!OAP/AW;2M ]]5C5@=L%J\:J\TEND%0]$SV5U4"U4R:@>
MG9PF48PDRJ1 3&??).2)2BD*\%)X$@1SQ^*&)@F,$&&D1HHS8&T'_*TI)RAB
M)XAGA$JWNR#B(VH2<&4H/N.*])M!GU*9'"=^.XP#UER D>03XII[9#  LH]4
M<)XP-6YC\L7^F;PG^"UO+@#OA7@,JH\@ EDD>K6L/ZMQMZG5E]A,JS%LXD-5
MQS77"S71H_H;.J\#N'[/7_\_*PEU(1(D#?R%YVZ^V@>#L%4\&J5T#*0W_MMX
M%)?.[-I_>K&Z:CK>P6ZMQ5WF6*25")H(B5A@;5,JP"('5J5*0GHG4K+"7,<B
M!TC$5*3("P^?H5X#?J6 F. A4N8XSO;GCK"H_?)/X-EZ]*D#(K*&$9GMGH?9
M) ?HFCCJ"S^E\6Q2749 NR4_70][]8F_\ERZ<]#(H* ?A\] 0P6BP/^(*?LL
M%DP\BV5$242+602EAC>Z>M];Y[G;^<Q=Y[-7WR[J27OQHFJZ_TP&_T&9QPZ"
MQ?*W66//[+":QLGGP6KP,-1?=L=KRE+'+6=(X "N X7O= H)7%\JK268\,"N
M\QKGW&!//<))Y))_0$3G!4;$!*/!978NJ@U>\^<QS(9QGMW8@*XVD#NWI;*%
MU+%BT\P^=[_[F./A'V$-OPWAPF=5!(OH(@=0)V!,W3>@2NB11%2S&97 8!Q_
M!>3?=!OL%1T[/V,&U,]Z,JN*S]F;R*[(BD<!?@3\(:)6\ELK*-^W\UT6MM'T
MW$Z[NWWJNBE5(/3YLJO0;D;*NWCF[87P#7U^:Y"\+Z5UM\;B[YP#NA_K'N2[
M+K);;7)K6\,C.YN.%PG!O!Q@I[SZ?#D:VLOQ; J/^!;#K]WC",8#_-/B SY[
M3!=-?-[$"POJ*2[(T.:QNWL_VW;LXTO=U*X>UM/+YXM[W'#\HWNL8 .,]4^9
MBC<E2^?K@^O87:Z[PS5ZP+C9T;UVNRZSJUN= KG,@ EZKWO=<FA)_W@7LUWV
M=US RJV@K7>$8U<%,3^ 9+>FP7M\L/4IB7L/)?&(I 5"YK_^GV?RV2GR],-*
M&.Z[+Q];"^[OG>'V:M-PZ\T8L9[LTA$C3R%VP:*]8M';[$,6*.JU=!3SM*\[
M4\S3)U()] E4P@^UM^D)U^]':=R_6<03[-6RKKU_NW7$&%6(75"K_ZA%"VH=
MDB 5U"JHU9^M*;960:V"6CTC=D&MOJ)6L;4.19!ZU;/S^M"NTVK8^4?=_(E2
M3@_6F3URC7PNMRF=.8^T+<S>27LH5#S <:@_0-J>G0Q32OO<)RV7N'/$O8JY
MAYI#UOI ; C.L;0Q:TLZ'**VB'C,<SL7@URP"DFKHI%8ZX3CSDYC+ ][K90Q
M9^A\#<CY9@Z<?P!NKIT%NYBM'/="=/6\%[_EO!<?T'YU=MD[;CS%V-&?BMHK
M:J^HO0-3>R?=2+HP=L'>_1.WL.B)8N_ANAQ!:)>B<T@(^,*I8,@RKU *-L9
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M'=H'A:RR%#O%8XCX$+I_M)T.3Z'UAZT^KR+"1IN/W7<Y[)[7TP:'M_<WW'9
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MV_7PY$%VJT65]9&=DV^I8>_2C*/-)<'_NE:,S?-^26K/9K<_V:#Z(^EQ*-4
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M3LY:B\!FLAZ=G<^2=J#U.2(R G J0$_+J0/M[<%:ETZ)A*\#)V4N:!82BC&
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MOQ]2<<5T6PVCJJ79BG&4$7^ZR;MI/II^BZRTW+MJ&77WK&!)LZ-C:^I3!$L
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M5!_;?TQ_@TU$>8M_4!0+ *!6PA_DJ@D+?L9TA@LI,#QXRO-A:! ,<;.WOF#
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MJS\**L>IPNMV%5Z!/;?#F_11=^>1>:/JK9M4BYGST+I;N=@4A1Z-VIDJO*8
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M\!XA+V1>+E7\ND4RQCF_P-"JA(%B6(7"RUF1  A#0]#[+)G"Z#+PJZZFJ,I
MVN ?A51K3>9MN#'1##9K.)1&$A&8\'/)14+!L_@* V55">8,MCDLY7&%JQT9
M\R!R,:T!3S=%X+(X]*BY8F@&H6=QS]QJJ1@D5NCX+@-[XS$WM1P61VG"8BG<
M*):NX-L<HIN6IF=DP#""O?^8?FI"4^_R##X"__R) IOPOYC/,@AM+V';_V2
M2<+I9W8_S&W_],MW2$)'(:$_PVZO,)Z*>B%=%XE"8EE?3<X-D&.>). !4>R8
MY/CD](WAVN;L4;[F%F#^W;=,G<B]S6H @*"J3EKU]CB#WSO4X?;'Z:;C1\G(
MNZWQ5$_%[O%\D<*DI$-8I2283 L%6_]T7)K!31QIA:;%I!< 0HWMB'$OBICI
MVZ83<%?*(-EB%S:%*6P;U(<I$[@GX@Q42,1B,XIX*I.4>WQ3,YPV,TR T]H^
MP-*;W._O<>;]](L]]\>]RPVX.J<)50X=_$7@N0W*3$%53B1 [1$V25%KWNLV
M%E\ @C<6\-CS6H?DM[PD %7=:0QJ"GCE7J2ACX_(=:O*]=EYN5[I8_4*8-*_
MU[Q:(7Y*N[.(=H>DZTK#F$U#B6]I]P\7(M,8Y?JM9!S[5K(\FX<VY\R+8]@6
M9@@[0C@1"QW+=OS4"GD4;&VE*)")*06S$]=BKN_8C,LH9&"A RX]$7,\\3C,
M5OI^:J ]W]^#>%S[[#K!QW^?R8(..O%G+N"168T.'&4U-/NBCZ7APZ7*Q7S@
MJ&*7PCN*2;;=89(=9B*>MY6*2W"+5)XGXRD,^Q7/+_E5_?HGX\^/G9SY@/GW
M?5DY:+3(XG$2NB$@;CLTF9N$(8L\Z;,D\M+8L4PG3<6/1(M6]3E_=9J<@U+/
MY<?T)$FJM12M.M'8[>JS5N]?T&N^96CH^;B?_7"E2A"KP8^_(@VDSN1KJ4T=
M^/4Q_HPQD)5$7U/A?WW2[JK89Y<#PM7"]$QI9W'WI!)@?)4CEL#\B]IX05BD
M7->@_^J7KT87HGJPW=ID4U,R]:[29KY>E4T".HX'_%8</E[.<GX%F E>\4V*
MU^IUEFG.S9^;&T#X<KZLY:M:+CG&!YMYH"()]>R?=I5\8WJ32IY[U3QC3^FW
M>JWOS\.?<1+WI>:KR]RY9=LWN,ZZP35V,#>#F[QT^V&CHN/>YBML!/+A#-9N
M(_^D2\:FZ;[%=,/DXE\Q:/70-637\*.,97$>Z9AG7V;>F*H =].EC' -'V>#
MC<K8/&]6T),MW!KS7(6":)]MI9B.QD:-II#V26."<?,3#[?%_>R /TT2?3RE
MX5[((RF\E,4Q]YCKB91%;F@Q7_JNM&UAIM;6H:D(G-0T;<&<@'/F"B%8F#J<
MF6$4F#$/W2AT!^&8S2#,KTIC[@WJ.H.@KG-=X^:9ZQ^J&=61J($G!4@FFO(?
M6JC3K0#:U%OP*2".J>_=F A7QRBU3Q=5I&'HRPA@1!AAEZK4C%CL))(%D>68
M*4]2=SL5*Q56D#@"SY.EPUR7NRPVS10>$?M)E A36-[PD*=_1-R<YQP(4]@S
M_V#\,=-&GX(<3Q93+'EV1SPQL=Z-/EPQ\;F/(-J]?5XQ&@#R:/KGQ7$ES0DG
M3B,_X<P4I@70QO98Y F+"8=+-_0=GB3;.2^W@$.W39K;PD)89@8_70.*G)GE
MVZ,*M#P)SOV'B,F^G (UHP=5UYT<'>J$]IA=XC%BL?MH'S)2!N(1'R_=3^>=
MB9WX_M%1G'+33^*$B20 I&-: </"<2:E&SLR=D7J;+$3^XYE<D!.C'LV(*J(
M2Q9QSV5>*@!BF6YJVN8#'D%%T:%PT0,HD_$@HP<-*1TGV? ADX@/F^C/'9\'
ML2.8<(.0N;YK@0,#^Q1Y(YTDMAUIRT/00GR2!=(H-I0/G\#UJ>0JJZ@.35-)
M3HQGU]) >!T-Q.=V^HQ/H"5'EUC_F-7X_[7.KQ";6\-:0B[*)7%<&F"_7GQ]
M:70B:-3\@LBA%%,#DMEHQIFZ?U6L)95HKJB4.L]5L6'+93,WWL&<9$2HV_P.
MZ:G&5<%&Q#U9O :AXDCGB0@)F294O4A6&;PHUL1CL< :-2J;G/7IM9#4I<)R
MR\]@K(NU!,=($?5@+;WJ'3"DZNF]4AQ;O:5,0V[; 6>1XSFH$6T&B,ACL6TZ
M89CR-'&WP%$:1I%,>,RL)++4/5&4QBR.W#".0M/QHBU2@[<@?(4DFDB:21@!
M[OUW2LXJU)\HK"42F/4OVM&SX>[EF>9\_YG;.(2[*<_$DLLCD[3$3"( XC&3
MGI4R-TA3D+DX9;8=6HEK!984T::DQ:;I6]RQ0=(\R5P+['4<>"9SW<0U0YY:
MJ>5.DO9#DJ8)A*XQ*TU]/=(;7E=@[Y#TJDK[2B(Q$)8,YU?/1J=:*.J^QYD=
MN1Y(+0ALY 4^BQT+Y-@.PDALT4'<!9F.1-+WYT:.2]*/4*=&262BK#&!=<YN
MG$K&I16S( UCUY&6$SKI(1HOC432G@JYPNUTZ@TX2_:JU'%]_\-S0Z:Q&R8F
MB+T'4 $W@,.B- J9*3R0;,L23KP-7^^@:I&B3OY[#=_Y[@+I9R8O?[>7[W=<
MC^V,&6K*)C>_F:J/A?&AO% ;W'+T!G^!JD#-7O+Z2Y45V!3F35Y2"YZW?"75
MW\3KESLX;;%1#I+:<N/WDBM+I_OC71DG9P#92/OL?,4762W47>V%O3<AI5]!
MK35T\PO]6C6&'-5553?\V=B' 3DA-_FN=[_X=W5S^S)Z4?OAJMD(^.K)?$9<
ME4/^&7#X-4D-E?ZO%$\-_;)1JQOO,5YL#*!]L<*EWYF/+IX"SYXU_99VK='L
MV !&(GCH1+;' #)$S(TL'Z!LPIF?B,"._#0"M+%U=L(ECWT &&;,P6E+ ?E&
M/BA9,TA%ZCB^2.26T_8[V,"/Z1L0Y&SU&T^(U>$/Q8O\:UE5Y27,,,@$_&5U
M=3,X<7T?1]><[^]V/ I%T4'7,Y#%,R1P7H+4(9=SWJ,Z07XP(P>1!2''[="@
M [5)]V[X>F,'M+S1%0QLM6M+$.TB=>SYSAX8,289!]O.CZ,>80/F#RV362&>
M:'+",J9@TC>YM(4?INE6XRPO35V; ^!Q$I,S%W 1!OH<!I GC0)3AD*(;=@?
MK]X7R$:*:I#BIK)>?89%1I&HQV)/47@S/3C5APG[-66)(BPN]\IR37\YHX8-
MQ.'W@K^D7_WC]+^,3Q5:KL^TY_+UL;5>B],P\7CL,9DD%L.^G"RV7,Y,[J61
MS:4)*'A3@H+8<E(O!%ES71L;"X6,1[9DCHP2._4<*TV3[TO0K[S.ZE/X8"X^
M%G_G588KA%-LW92PUKU.I\^]D>OTG[%+R(OXY=$)E Q-SP%]PGT7@ +(!8^=
MB,6@H6+7%CRPMEJ_W@4H[%=)IRM-@ZP/A&XJ4M<#!<N>!Z-G25Y*=?*UV -G
M55_-5DV617[5=;_;9<<QUHN,IS\JJ/N.[Q/7#GW39R(56!C. [!'5LK26+@Q
M^/"NR?F/V##*RNG+AR+(WN[J*-95V]5Q'(OI^#H<U&*7S5C*B"3O^T(TTQUA
M=9,C6$H5X0*K?#]B)1+7\QPO8MP/00^)T&+<Y2$(B^7:MI\Z,MYR6'Y(K-[A
M)V&"R-.1+S<\&OGJNNGB07^=:IL$6*[IY @O@Y4J"WA9+2DZ@"U\BMV@L//Y
M9P:1L_8:&O>ZAE7RW^NL4F*\!,F&?X)#1G,*6A7;EO(\;VFJ.Y?M?C6JZX56
M:+L6DV80,Q>YD&,G=E@0<F&+, ++O'7 ^N->P1_84!,F$5=C:$>1LIO1I.#]
M  RN&+;*9./9")M1N/!);(A!-*V9_F&(<'[-AXS'&7Y4IW$'2-*&"EZ.E:EM
MO.-%]O*&:&E3IMR9;JO2T=KR(\/^?FHE$1Z]<%. I16>RZ+$XDSR,!1NP)U0
M;ME<(0/;MCV/>=(5V/[ 9'%DA2SQDM@1CBV=B ]L;@?L/Z:?<'5H.N&G1;9>
M',I]=.;FZ-W'9?OQ^"-^_0S$LY'/+?';*YC>\0NF;9I.(+V >4%H,]=/, <C
M#5@8!Y&3@.LI^=;I('>$99O@R*:A!Q;1#V,6"C"0H>EB[P$N@C0]O&#:U_%%
M/$6IQ.,9D,Q]HNDUHCDSXC6VVD Z>-"G*FP],&S'+ZJI3,S8XX)Y,67')9S%
MW#59(,"?2=TD#IQM'9KZGL?]A'%+@GC'(*JQXTM0J8'CVXF=F&G\\*(Z\L2W
M7:(Z-XR/WSO4Z\-_@@6 ^YLK.28:Z[:Q1BHI#_FX1%-*8<>.DS([Q4IQ5* \
MX&"O0Q.492*22&Y5E]_%K]AU!OBW IOZ-2=_78/>WZ2\?:3O.NMO/0'KK[+<
MC;+* &53=^@=YX$[H>W<^-N2&@@UPM^>Y>V[8RCXEQE<B]YN7_@+S%AJSR";
M)RM_^,=C/"/;".!>^\(*P*..4A#J*$ZP/#!A#K<L+H0=>NY6(]I;QY;>%>)C
MBFOP26OG@XNY=]QB/JHO&>'Q\Z-ZW&4,X](]V]HVU]_-O<%3BQISF:2@;"0\
MZ "P1-W@FA2G]E0#&WAW&FVK*2ZO:XG-N[\E<JD2A9HH8;*N8?)43SC=ETA@
MV@^\#)X/FZU>8XML?9B,RJ[>*X+=X.DH!GON5MBBW$A!E$&*J3;I0L+/*]4H
M_+BTI+ =UW?!WQ)(R^?&DH,#E0 ^#>PD3A+N)/;6T?)=3@+_06W)5S5V2,4/
MJS^N5]A&&%V([12A_>=]%*0')=D&Z8MRW-K1N-1?CO)<@CSA7B#_Z";B^-W-
MAB^![5 ;%[ 5RG7=$U0J+*0*N3U[2[7B4:VBS[ @+VN[0F.D_&HIU9:!H==<
M=W'%43<=%;'1HW;N.G@A=J;RJ: \6 3<IS.=G4@]HP&SP*_7%;;.Q8-VF*'U
M G]N-KJ0\>JUL9"H,L'3[+I+-C=@\W>ZFQ1)A86#F\VIU;Y/=(HB*([D*U[9
MJ@MT3PO5PAH^" ;^6K7KSG0.9<&I$_<^+17K/O0;=]V\Q3<F0,)TOX;E2O!L
MBEQJG/94MA,CJ-DL_:,[*U'Z\;5QAN+5G[5V]?(,'MAD?^W1KS"]_&O_[JRX
M .5,YR&O:4T!)]+?>7T. \'4RD+44UON:X+3?:.8UV6W61OCA4UYE]C1L=!5
MK#396EM@-V&5RXOWZKW3OU=>- =60J9\G:]F^BI<J@;9MW]"U@C8@R@\C8J8
MZ:;TZI?%JBIS]4;L!EZAV>/B K:HQ%[LV.I->R0$]!+<M!+)BFCWJ-$,!L.;
M'S=RO=3UO2ZJQV5.;2?FW+5]%O (>PO[@H6.%S)31I[D3ABGX8\['?W T F5
M3[]5<]T_Z3Y4@.CII-(TIT&43JB.>TE8.Z!!:;<-SY;>8+LL%CX()B!')$@V
MI/>(/B;.%@LIT**#K1%KV6A+RF3$G^4W6*FLEHTAPH)^HNNI=5-AO%U2&\/;
MG';3S0J/]U(G<WXY*>6A4@8;GT@I]H-_ ">(^#%JA>)"T98]YGNW*[1C<0C;
MG0*\@K$8?X>5EU?&K[SXVD1P-*Z[S9V7("!-6VG59%OIWY7NB8W I;I21277
MH<I1[=Z;U: ]Z^[$W@8KS\U:$S\SJJ*'_E2R]O!]BW_:_X0;8"$(+_\3<#I
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MH+F0,R6)ZA_J8$-(]"@QQ B_$5F-D< F2(=@ H#5C-*ZEI@OI=1&U[D,[KS
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MC$-U2JSY+-G3R8<<*U4) ZBB6&8J&P,NQ<V_L#8UPI*^U/Q;1URW\UN +-R
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M(;;Q"Z,>R!E=GM2F136NE>61[I'4,$JNY0F@#"409=R2I1%ZZ/82!!N]!+U
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M,$,K]1K<WLQ$J\)@:@"I7*2E *-4)\OH7R$G_/WS)U7[@6=.""H$.IJ)P'8
ME9@LS!L_?SA]$;S^<*H&0B<U@.:;;;3 3X#U@2=#+;\YX]29LD3\H2GX.C @
M*:C)LO:3X([#0+),=!B 5@:G=9:98B:5P(-#72Y4U9)I0*M#>T\S<K]@(ON(
M6Y^HN^4X'%A>^$K7&P /U;G)PH1KE6@NGF/[;FEJI<AIP]]1FTKZEZGK"9;
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M^-%X$'R9XV[TKF+D>? S2>\IA:RS"ELP?A95A7^*J(0EHSP)$G@F*Y8+.%>
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M4\:J[:?UK)85Z_^?RO0<7A%\R@"I4*Y[IKZ5*;X#C$U+4H#@?M^#/-W+@"B
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MUI\SD2!/&9XR^@%!I@RK.U7H/YYQ XR"9$';QFIZ*"1H2&*O7KJ.B+:]MB'
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M*K.@RY)K"CQS%I7SN2XLM%Q=U\LEHK3,W7#T+:[4M;*WB;L#',5R'J69'CK
MP(M*BF3SVROLD34(3F,<)0U0PEDSC6H?NA=5:T4MO6'1HM'O124'8DYA8<"
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M\8RLLAT,@D5-SO(IEG!P$#ZB?[#>7PK%)20P@)A6P63!5&</*OYB@)C*AG7
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M8096]4R?E$)F4A8X]%E[3IJ7JR5)0V=HJ/Y\_]Q(Q;3R;B((HWQQD3?Y!^@
M=8D"+%1WN$G]:FBMCN[&]8+=RJ>A-#7JMES#6E@<,'&I7& MP8W!/V16);9,
M6^U-5GOFCV 2 6YK\E--S*VNTWI-468),'-?9^6F2^[[=,D'6F=U@V5!RH1R
MI*+V5"@'IM)"N@Q/%81!5MW@U)9)2UMMW'Q6FT#6T8W/@"Q0@CT'%EHAO[1S
M$L#&K%@,M&Q?RH*:1N=%:94??(3]AC5))L.?MFZKG3]O)9MUK70K)6C-&*T0
M5*/<=O;3XD )$IWQ74O3O]+(+?U>91-V*397UN.4UD--X51X L7H.37P[U3L
M/(5L',&P02-M2G''^&]J\DJYL2JNQL,-.'61FVHWUPF(ZAE&I.*(S!3EI5_
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MJ.5FT],03JK8[3NFOU*6AU:3($:J><T7O9&G#L[UP,T"#,D)%XS'PD?S@9!
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M 3;51,3UL1!CEC255E:@?&< "RL CC!FRL$JN;_I@>YL@VP*]>MI&(L!XHZ
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MR&SL_2S^+@ZHN')<I*9B04:-Z^7!K*P6/TR$U;L()]!=L4JX\+T93-%D!G_
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MD%X+FY_3R'/WX-IJD16*:.14]G-D]2TD, BGA<?^B9$_0O@ 5\^5ZZY2(8V
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MTXM. +_47?T$T]=?MVXX6"[P1<=WY@L7=XX;@KL>%K<8NLEG6IV$+AY.;\(
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M4,$5?.N S(^>PU[#;,GAN)J URN!\3R0?SK+]&,T&X).V 8$QCT;\]P'&PX
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MFZE33K _O*5L:0U;*MM;RW["I8/BA(AE=XA/D]56NJTWQ+D;NGZ *C;Y143
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M"@_ZJ0FRMI_Z"HS.20,MZ22O-ML@VJ&,_\TI=Q;6L^"W5U?B^W!9<\!^<?R
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M$_YN6"*J2_2<W-#$< 3H)EL?K[66-W/EJ8CL;JR6VB<L,"LP&NJHO1*%*[@
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MY3121M*+;]%B':6Q$WI9W9>K/U(X.3<A\1O#54R^RR?L%KUU9"VF.[S;LC*
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M8L4(;^04L3)%K+P![*>(%0,W98I8,75GIH@54W?FS4:L+*+$"=B-2/J?,$8
M3:FP3'SU>'__$#LQ*$X/<1KK"VHY5+U!^,7/RV4<TT9 /PX_D> <-UJ%_I]
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MM;8^.<9FQ) N]:LW]&:;M>/#8YUEC^WVYF/9WL3_D9V*!6Q6+>BF6UX3<"-
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M(\3)K%BH-EB,@91 8^QH$,I4J^8:SKK1HR>O-,#B50RT6 \G8"' 0ZRV(+W
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MP=N>M+8J\Y2;/9S]Q2,+GD1\NAZA_Z#G1\DE*_1$:D5BKA_OP!N[H6S-)S"
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MX;W)3=&YW^)4-VP)%SY]2]RM0W\N-W&4/6T:D3?Y/]O1/0\C-*KG; \ $&+
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MD6B6Q.#)S]CUMSV!]M;M0BW48]X#R.[N/4CT2Y&DF$*L.?< 7JL\DE[GF6!
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M',&!&"S(/"&%D\?5Q^-&.5:KEU?6R_EN[43!\L8M%%T5%5U+1=$_XP+L!:!
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MGM!?/ "S!T_+'55%^8OU+;>15\'.8U<A%(8M7Z*>Q75_.FUME%^*LWJ'$)[
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M$OMI;7E3K^MUAVHN!=AT\GJW^)[+,R  4L<L:[,] >H\:BALTV=W0V6;@Y4
MX/=?@C#89MO^EQE):()2LH* SKV)$@94 T;J;/%^P/P:ZS-O!S)]#5A9> /T
M,L]W=^:6MJ=(V;M;\39 (=6SQ:&S]XX^TS"C/?=A265Z8A9CO8+&]*1D4Q>P
MF! B:+BWI(*G$ 'H^$TO!T&.6+ *+%4Y&AP*F,>2QZFIQCII-5 UY+E$UX3$
MRT2",$'&I6QA,0]]O/P*J]PRDH;IXU8M,R0\C "_$O=NB3;I_,8S]%3(=:#8
M8NXK@&OFG&=J6F;&= C^13R5X?SA-5V0^RP#4;:PU^EB^CKLE5Z<G@YR#=:W
MH7:XN5*HY>3W85SW!WL4BI:-)D;@<YFLT(7=3XN,X 0TW@8A&IKO8BJB0U!3
MX/)TZZ<+*ZMQYE;<2LR[D]IW[&@PYJYC10.Y<.I !@</7B!J#BSA#5V$%@I
MS-JARNH7R8QP;B>I;$6LI4W/ 2+%(FX#RD8A9]^_W8T,!&F*$Q>=54L]0 ^<
M@M=4!,ALH*H(=ZBS'$;KTA?V@!.372V>HBM:-CQQ_^T>W46)BW?.?QZME1),
M#PC@\E:*2%7!,[70C&(?QE+;#0[/79LJZ$NS(CEH,T'M4Y:)%O<;2M//<93M
M^!H1!DW@,;Y64CP"^54>-X#KGK5KN?]\IE(\"+(FBO>,:.Y$LR>*_T 5;G/_
M/[(DQ92)903%NUP>1F]H>A6NHBV%B.\R@A3.VSAZ#GQHM_? C0<#;#QO66 C
M1]:0!X"K8R41"?G,,4@4X+^%GS%C-@,[I@C#KJ5QF#T[A4ECE?.EA2%<&B+$
M47%[_F?,Q55"04[-=P]B!K\W4#3,YA<#9.F>T\<T=XSUG X@5G"S#:# T?E5
M$"S^$OFZ$PP"[LN<[%+!OR-<A!T@+&T-$69\+6@AT)GQ;<U;UVL20E-]*4R<
M(06Z5=Q^,7FJ&Y<R2.YW,?7\1?BK%P?@6+[CQTDO3Q=^2'D!U@SJM(*$),@'
M4H">)2<2.S:EW.AJ[A=7AIK(@=QK-143<N=$3:.;MK"#[N@NBJ7EG&:]@K(2
M T"%8C1E(DA/7QDVDAY5)4VJ4<=E%&-(1YINYDG>*QL=:)ZL)O)%%:NVOE.,
M(*7S>QD(T\R<]@K+H>PA7\VL?LG2311#F*X?)G^>!J?;-7J:]$GHPPJJ%-LT
MS@=0Y:ZRW\BQ'6(*.11&EQ&SCXJD/0":AD7-6#>E3D2;RDX^Y7XWIZ52.5FK
MNL7-$-Z-MRK_1I\.<*8'@U\5JYT8 W3#._:: -= < 7"H?<%"[INXV!%%^LU
MA9S>8WR0#="NWAL?P?A+]T6?$TR8IM(W^T])$0G!%UG%D11%PA5\&W-8<<4Z
MLNI'"2?L#2$>0?EF1$GHR-,K\&AC>@GI[[[*5>T?@^ DWPF:KE-N+0E?QM"-
M*2G)[PJ$PY("VG;=$WR(2EG=Z;/F"W5:HUX(&+DO3!]&V:X>G%$JTT4>H!4_
M^?W]Q?)^JI(JY[1(>QS""5L;<KQX3?D""_@KO@Z.]@<V!!7);SD'<A'RS3#&
MU>RR"X!QFU<%:H"FK2^']@!E@IKZMQG&8* XS&,4C9LM'^HV<&Y=[5+!&U=H
MUTGY$U)1KE]NK2?)Z-I]RI(@I$DR7_V>!:)Z]"I,Z9/X8!!"A-O.:!JKQ.T[
MD5:):8IVSK\4_-5/P0K\B-SHAD[6_T#^7Y_>\N4K]L3@#^$*+<&,%&0P\M:E
M&")-=*#JAJ/O*J)B55H7R?S9"QB<[)=1C/!V?;$<-$$L44>H.4(%A /<_Z9Z
M@W,R*R8H2-6\/&HLD&]H:NQ=;,M8(:0XQRB=TT.(O[+T[3Y[_ ^Z2I?1(C;G
MIEC%H.80823[;,RYSE&I;0/7PV=1[)/D]PP0(]?@?]IZ8;;VU([EKI7.\).2
M!U.0(9$<(7V#O_OB2MBK <EG$7F[FX\OG%\FXMU7X2Y#]RG ?T'OE7[%WSEA
M@I1G1-$6C5W<W\KMZU8(RRIM2NW@!@D;H3O77NSK_WG_PWO^?Q_(SE.UU7Q%
MBI#8_T<XA=E[\?_[43*T,C[\US_/?O[S^]F'GW_"?__YI]G']_\\^]/[?U;P
M$O#;"*"Z)%*7AW[5>[I+\460G][/1']8$1E9R=]^P-]^G 'R-$QW\$R9P]VA
M[PQ71N.DZUT 43ARHBWB)R^4!C#&0S3"_F*M[$:YR?3)B2R$N@V6\JWEL/[\
MW6IS->?K.!=RR)E@%9,P+TW"XFN?A)+3>&]%^,45\:@F(]*LG2$[&YWJKT+5
MIYY/A5E%9;%%U=5VYP4Q'G8KOD,^4<SB7!E2()HU7-P345^]-EN&BI96,$<N
M6UH--C-L;U+.<%+((B0F?T1>EQ+@UU.H2Y,=.?E7Y+ KUF!S4OI63F9N_BVC
M_.8SYW)8:@8O"!)-<<IRLVJ172,:69&]M."0YC_QO4=1=8B8@TZGFRB$W'Z1
MNVXA(4AXLB15G1(O";MOKM-?ITH,2,<)@];>!.OR$J;6/Z/%,?19-*^QT23G
ML\L0_T3U-_UDO=JW2&?'HL)-=JG<9$0*.]UF+6XGVWIOEG"O)U&%_U>V=S(Z
ML3@\-52;W[\&Z>8L2U*^M<2ZP%!":N5M*8^^F@LFY(5S(8K-S*QDE*R,%IBG
MJG.Q$&05H^7(WV4L-=SQ'X(H2]C;(&U3+[,X#%(H#@/+^A5^LI!JI:GBM4K1
M/04M6),"KFW,>PCXSY^LF/1(BR Q9V=@3W'9GJ13G^#RCH^2>T]N+'<H^9&%
M.9=!LO+8WZ@77X1^W^1:5>PCB!*@"GCYCK(Y;6K!QE"@.13:Y_;4I2TTVO1#
ME5=84K&,^_%NWR::N@[LN#<T +Y=7@;?9^EA6P!,5<K]OI,67MUU=5"V4'\_
M0N[CQ_<??O[PT4+[H_L' K3>??AX8EK(5]*4ORD5<WVLWW)+F?\RX*=!7OHH
M[G0/ *%_O^/+.XJQ;9<H3U(.MY[] 35; QM#WLHD>'^B6$.T5-8O:>:G/QUL
M?R8,B O!DR!3HKF2O#SM*YJ)_6*-?FO#D4$I"KXO7@&+3J0K]G>TR2+RBU>2
M4W7F$+*I!!M!?K4EB_-KZ;U*T^$3#>FZ7\][>21RFLH>(=])LNY]\;;T*:;+
M/P>0^([>KT!HEWJO+CT)EM1@[6_$/7"WJM/##.-^?BH)R:V+*AU#\5K1@)6$
MUV6+CH%Y&VN@^QN,$ZU7[]E)LUFG 1(3YXQ%*P@"5E\@+53EU]V%"77]XMSH
MUO6.['Q=H@2/[>&AQW)X"/_G5YK Y063-Y*\\-P1*MBSX":2B] >E/R^\NFI
M6"Q')O"+^*042^3<)#-R.\!$EG.7E_RA7MC$>_G8!$@Z1"@63G!=*SQ/DFPK
M(#$!JW 97?!)W?*-HJ)75+_*X;+CW*B4]G(A!.9D&A$JY1BNL=1H,Z,^##4C
M"VSYJ&<$,227$5'\S=YAB[513S] I?5H<U199'_<1#F].6 P5P5U#412>ST:
M<O_G@%T.G&F6WY)$&/P[Q>%[B(B7"G"&Z(C0Y"?]\WM[WMX_OWL_DK?W:"VZ
M>7M!L0&,=76GD]D85NZVL>MF@#V%+E]GG3<O[#O)AF>J++0S;Y3P^FI;<+&&
M$#W"%O%?HE%I#\RA@%'UA"@  K%A!_SR8BWW( ".M69["D-:(/011QY@>\M,
M0OY[L\[JY#0M._$+KQ@[I[>\6U>6Z4WTC'OJAY\^OO_XI^4FCK*GS2<HGURQ
M#(KWEAOZQ8.*W?0-TB#ZGU2*(_GP$];[_8FD@NN,//*+"E6,9_SWE"C>+B'!
MAID#UEM]U]'.8>:A]"GTF ^'Z:EYQ<XB/@^27<2_T<7Z.N*&:?!,?8&1A!U$
MWZQ</B3HTB^4^1B3@-WGM+53)GA>^L354LQ@=P-V[Y"?[+0Y$RU9W\AO\K^#
M()=4=EI["'T)4TA]OOJA/FP+_^I7_G'-Z?R%!-M=)M*L^0*@+B'GW:C6K;G<
MC)B,B.!$!"M7#H1LN_7BM\4:@ZT>%M;A"2Z]U/R?%KT%@ADLY)P\?KH&=VG&
MI!'N77Q#I6C3\%%;G+3%(PN>7.5(#3,GK#@=W$[;U]^8H.&\2:X5+SL>NTV
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M:[J8J_7C^X_O\SXE9KK=R:DE%V95.F&E@H/G$UK3M$-"(14:.\\HU&D$JY5
M\J'^.=W%=!6@</QG1F6F\'P+R'LB?;<6T^/0J1#H-1>ALN,-.8@IR(QH4<1%
MUQ!F1DHM16;%GB(S<B$LLT\><UO:/.XLWJ=>G#J=QT_T*0C#KWHJ"^E03B;1
M=7K4T!-7>1\WI\XWQ/B*]"XE/#E8*Z/Y(_M\-.WN2.>?@&WM:IS(7H'XR:C3
MV6WL3J,2UDP1V,/PI7SRDF#59S'NX;_L(784X&*0G_/EZ59[LP>YTEYA!:J\
M<Z%Z9*K^",Q.5&=V_,L>_":OO?5NO195D8]3UK6;UR(/A0SIM= XS2HZ3WL=
M,2H@OZ;4<6]B"X++]V* 9.M\ NJJ#X(%L>NQL%D^^R[!]+2[72.15L$(RE7\
MYJ8XKP9'43']2K2OB"ODZ*\M4S!<!=PRY@885Y7&V^O("RVD;4B*B&U'D.:D
M16=U4CMW\UD1O^S2&V#R]WH"]@=UTZT W>.Q]1*:#2ZO3+,O)=<_A'$Y$;^<
M?H]-^7I;=G!)*V?*?RW*LA8]9\3D3!K&#=D)L0E8T$SLP&-%@;!Z+!,)(4F2
M;<7OW!SM!@."UG$:D8LD#;;%#O1YVV>5/R,F5N70N,^7&77V*DR#AG28PD3-
MB!:G,-F#&0SG-.\*\"D+F+^,[K,@O89"&2L-.$T&Y!$XP")*. _"L"X'ZN28
M2TPL)RJR"NV0., F 'F"])T#?CE1KF2%C*EDWA^G7'FF@)?_&J2;LRQ)HRV-
M+:W88H^MDU5*KM&*"CA(OU.LL',84<QF+E\F) R=R[5U&20KCZEN':NL5Y6.
M(DH$557[AW0GK@8;0P.U *]IDE"JDW2*NX:J&CKO!P:!7G"YUTL_U"EJ9*RV
MRPQR6 G$.@!#-:;;P,-H]JDK*=>B(#\SDK>0@[$US. ,?Z0$X"%<%9]P:SRQ
MB/"(]'(PQ E+S2H%=E[L8T'R<FE540.'?M"N'\3?J!<O7Z*>F7)_.EE%COK
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M9\ IG2!$[AL) 5(</C^6AGR*LK_=IH3<Q6SQ2)9#M:%!LHXV "\^R4X?&R.
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MWC%AKV/F<M5*2;\A)XV0%5NFOS7EQ'-AB/;@)>"DSX6ENE9?LF804K<XA+/
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MW%\YBS\>8>Y2C]?F'-RS_UTY#Q(?8?(5XTJ# S?[?L:^] J-M#0<!#BE" 5
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M 9JOK]A%%N6WX1)SB5[B @3G<,?^.]]#\':4(R8/(66 ];#45$F29YHKHC\
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M8@ZH0?5D10Z1(1 I72&UG601:)7_0$-Q0W2)DGTM>761!)=$HIJ>-?L-57/
M-G"@=[;YF89I'VW.)B?1$*.RTL=EYC2FXRK,-K =V;_@E7H/*42N*)]OZ=,9
M="DQZ@BQ),@'GP+V@I"]K!2R+N*52T7)%8]48P_A3N ';8B*A[H<YD3)\0:
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MMPV[ ]%KO-A$:;Z?QV3QP2:^Y_]D_SG<IRP&"N1(P1\^8U'(S^?,H-@;,%8
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MMK.Q3S$'JD/S0EI8ITKD6$=6Y(B.]KX5EC)YG*WR*J(%FQXIG\B;[U"8BZP
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MA6^+<*F9%N4D _N\;)BLN@FW^,DM0E.CA7<KU1-YBT 5CW.XKLW&J6J;2=R
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M);P.'-NCU04-R>;@=>U//R+ $8"6:]CW<.NR'U;X'R='/>HS&=]E$$G>LPJ
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MQ^<&AH:8D:)&H70>6EM.SVG!KIS S0*G2.5P$M_%/ND@@QLLL6NW_6A@*DP
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MNVCQ_0$7:_W6W?E!979OXFA/<@F67XL('KIWR-,>_^.;OWQ$)=T+1_WQ']]
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MC_AA22EN'W/<0K!%SAXS<),2/>Z)S/*(EX3H,7"U'"0I290[(EN.G)0L"I[
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M6GY=2>*07%N(2RDSRS\9\Z._,U82067+[RRQP5(<T;;\<E-_(64$PBV_WZ1
M:%GQ]#&N.!F/'OEV[\>+QH0<VJ].T0,XE&]"0^HR]/<VH/R!"JH!/ Y-J"9U
MA="<U]_F^X3S?<+Y/N%\46SLBV+V7D\2<O&<+-7R_'05)2EM8KV&G.\%:;T7
M1*'JT3D6ZAG*7()?:4X2N*KHV5Q<D6BY@081_#B)+[J,,&=R3NYH8F(ZIR'.
M]CD/;\Q@NLVP,(^W_?9RV_74G"TU9TN9F:9@?68446MU,BPO!;$N\>*ADCB,
M??CPRDEVMT'T=7KO'MZ%;@R@AKT&^?_?A56MX&*?YC_$)SJ GD<%6]0]QN
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MNPQ#J,U&=I:,SK&\VN!P.WJI6<C:QS[N[60-5_<YVAO*S'8]V&X813)$T:;
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M><H.AP"?CAL77XH+1.MH!5" H>Y=05>ZX2 H$+&";::XOPV>6-N;S'JMJ]\
M*G8%O 6Z>KH%YRM"2RN5'$3[!MYYHM+#F+6B=7&"1S&77@A#<A#35E1\HM+#
M&+&K, /8LB)]"=8)^SZOM'*X!,NE*X\19<_ZZ$@O'F-!-J@[VP0'1MTPO'*2
MW6T0?249B$T$IU;EKYQ9-8N%F_JO^,)[[NOB6(KB_;7OQ:6[7&C'K1KK%F'I
M!:)+]PF ,;96$V3X-D/O=!69%RA-QT\Q L]0VF)4S-,)C\D)V6:)W:F),CE*
M!/FD%B?B2+/4$(;<2CD+A^66D8?RJF\A9SC!OX!#*_708T!K+\4J/>EU8D.)
M 0R97B?FZS"0J3('E^0!JK[U5Q"\@L]1F.[8Y1TZ#&?:2HM/67H8@U<9<>'Z
M:]1S<<M1#%Q3]@1%>YN^@O";?6_>GL8Q=149DQ3O;_A*WD99+]NF/HRAZ\B8
MHG!WA57/Q4!=;.!YB$)]CX&4S8.'')=^N0$,EJ*>TF.BU'24%N-6"1[3"P\D
M>E_#1:_@[-%/79:,.I8IZR<Y6;DQM#O?*A*E/ ]'8U9'9A4,0IOSK "[DRG8
MLR?![&+<2CRE3HJ#"NA8CPCWG> 198;Z48@O#"0^2D;R!3/Y>@QOV.KV!D;1
MX.9PS$,4NEW$M];/E#7F3H77RYQ5D5N++^\_&+@(P\A:I_%- 4=FHE_>_V@,
MW<,L9=<%U! ?[1+UDKYA1?'JSQE*4N!;#I=\V(N6N33SWWBB30SCS'ET$KQL
M.5@#BO4E\MY80EW%\2Q/\1R6/2\%Q5&Y,H]+6EX68@2^O @<Q^3,/-9G>26)
MX1GS(F#LRI=]HNB6U^/HQIE=POF6 SF6SARHW$GK;O3D.%(\3<%R^ ;E0WJ^
M@-(2,Q]S5$.PQ>]Q&X'K &QYP6CVY5)JH&R,]U+MXD+K,1N(U]I/'']4"=\K
MB%\B4TR; 9AN4/ LL@K5)?:4+EZ+RO4/SY\SP$-R<3U#IT1/:0C"=BTZ.(#V
M:U*4+%5A9VND85#6ZZ(C+2R"/@#&*.>K@LS66,, N'7A2*4N\QI'ZJA(L4A2
M@%[5J1XP2A:>Y^=3J563F5BIB8ZO#+12#V5'47;Y[0E ?9FS=OM]*?ISP?Q.
M(SU6S7KQLB"8VFRL9^5E'^ZJT2W>5T,.+O,1S19[D]MJ(/HI>TE\SW?BXY.#
M*UNED?L[@W!Z>QW$GTA 2[_<U!0#D8<D.NJX51!OG=#_$ZMT]#A!%/A>OL6'
MWF--W=>VRVH+Y55^43.VCC6N"C9=17"S?(G0Z> 5G.\/+N7/]<VB\?)(FR?4
M?T@#7(^Q_XHJ\@6.2]^S.(TUD*T \OOV0POM:G0J/Z',W'@^0#,[3 LSFF1;
MM%HH^W)I?=*MFE8+Y5_N9&J)=U9.KY!LB?30(F#[?13B'>]I!P][R5V29,"C
MR@JYM3I(W3\R/S_I+3>_17'@??4]L$(51I/;*%X__7/Q_L,/Z%\Q<-+\C/B+
M[R ["9V.'D 61P<GW1T9:Z#X$UJ4>>0"X"6W\"2.5@ =H9>;-E-1E;M09W5+
M^@(@;BN0IB)23&VLKHJ)X\>_.D&&##W,PUB3Y]X!_'L27?Q.RN@C\IH =$+]
M=!AJ""_(7B[5P#HU4 9B;7<F?9K<1MG7K_T-9 V !>NS$_\.4LPCCX[?5JS<
MYLIH@F+_4OC7X $SS!\<O'D#L>LG1'C8';1L5?G[I+_YZ>XJ2])H#^+*9[@"
MKR#,P JXT1:>9Q@[F-0@&J99$$$S5ZL_:R#MNG"B%C10*&RWTD\HNQ@(I;%^
MLKD5$.CM=4<%^CXI*W $L/0B*\];6[U,+.XN'0(I,X)V3-=J/<XDS8_V8L;U
M[-9Q$_&DV@N54L=K ]8!G)>6ZD-YGWX=:)IKQG*PAG";5GMSVS5I.9;#!1K*
MK9R\W=NG5CM%>2NV:_NE+6>[OA:TA#/=\NH1<CN'D&??<L2&VCZX00?+<1UV
M*^$<BH; U@PSO;>J5!UTLKSPR=#J032\93G,XV@+ACM@"'PMT1CTF*;EI64&
M/5D*A&8MAW<<F5>[B)8O25]=(1;/M[SRS] F0SW)8(:RNP8^SYNPO.S/H&@R
M\T &J6-S(<!RDEF4EE^Y'&B[)MH,4G_D<N ^)?Q87DQC:"#/TI,&*>EPN8"V
MB[Y87.QA9&1)A2 &=6N9<:WY*=OOG1AMX0%.J(/?PE[6I@VZCM8[@ OW/H(8
MWWY&!M5+X&]QCV2^!SWF/>A[N")A N Z(?<7/1V=V&Z^[3S?=C;QMO-\PW:^
M83M?5>VX(^B]:Z/ONNIIA_O%"44VPE,SHR_73=#'3C9*+,T0FV\(S#<$YK3W
M(=/>S5@&/8$>I4 :Y=.9$[E5[D!S(O?HMDW-S)P39>=$61/3WN9<3./RLH9*
MWQPOA+""__ERBB/<1TZ(0M-/?N"[4?BK$P3@^,D)?[>A2NHU>$GO0FA"9WAE
M&5XS4DLM-0OJ9#"<O82&FLBMA:38KEM*8PUDWT?A%JK#/:((;5O,*I:4QNH<
M?G!L)(2WCHM30N@>)TI+[6Q*#:]PFRL'<;V+HVR[NP8NQF:]\Z'UO S!^BO\
M\#'_+_R1C['<0-J7@.?KIK76(7SPXW#CAWNDGU:<[+SY^VS_*8KCZ*L?;J^<
M _P+>HV)+)(R0VB8XJ].[*,=9.6D;,$@--13S72/2>"5,6VT,D!O,_9'8E/-
MK, @]ZR9^NT%6N#_RPDSE"'25&/KK]%SF/K!$SBD-677:B*P+:GY@G9=^ME)
MT1WOXS5<"R%UVNB@8>$^PY/7CKA#X3P?%2LG]@FCEFZ%#G1/J1.G[Z57L=YW
MD 5=NFD$$1MR055\PKP%O0F]CLN)>PZRF(M#[ <D%#'23!-28CT5?449 @\9
M&F^Y@4>ZU _==!%Z"Q?Y4JY@7]_%4:PM,7U!L.=0AX-%MLV2% ,%0-AA-:3&
M,<3"+K*-^UC8U"&T:XD[%"@!28JL)QP[]1Y!["*/U!D#=AA ^_0^.8F?/!UB
MX'C+L&XIBFE"1G=U]7 KN%!I 7#(JUG!?^W];$^2)7:'@>E:;DJ>%B>MUD<#
M0_R&0PO8=9U7TEAF:9(ZH0?ED,($S"[:>?HY=/91G*(K3]?%L]\"!5K%1QB$
M@Q8AM)'A5KMQLJ"A,WAL1.^H82'*[]^\'5 H%)V4U\5)F0(\JX?*DMI5G9)R
MIR7B2FJG.Z+%"#0T+ZJ<N_<M#]BS0P1T<"ZC#B<[$G'*+Z+$""Q'AQ=F.,-'
MTOU_4?#=LV[0R3GE+<>-[KYO%<-M>LTM1X7E?&^P$D6E60X/S=%?AX;$6);#
M(F@8D9G+\KP\Z>U-50SGHG!E[GNLR,]%H425S'.]9GERX@!2*1C/N2A@.XIE
M(ZIW48#1C HZOY;P?'?AQ@65\2ROM=A)DRF)3%\4L'TT61[.OBBX!/E055#=
M\OJ5 JPH%:V_*+C$/8J".0.6E_?LZ5"DYR#,N'5);+"\YFEGU%CY$I87,Q7=
M#CCY&I;7(.V'4CU[Q/(:HQ(BR,Y0L;UV:&==Q<F#&:0VZ+1PD\G"&:7:I]EP
M"67YE#A=QHF3P5;$G*,2G4$/0>9=^#[=RK_-T@P_ !&Z_@&)VDOY/FFR#%%_
M^!.RJ29X&WRBMY5+T2T<2#Y(5J4YDN#'O/*56@%TF/700?\6TNX$_P(.[3Y?
M[V'-AN(N?("L!L_HP2OX'(7ICG53L/N8IH. 5FK]-5(Q]W*H24P9>66431H/
MICUE^@I:V$=H32_VR$H4RI%N==&\<E?,[&Y22^V8$\SSKLGINM$7@%TWB=P;
M )3&)IB;8CG._??R"\@74PXER1:X@.R> 7"LS(D+2+T8"K[<-+F F&^7:Q]M
M(V>0>&24.L'48"(:4DKC9A]S=$*P18&FJ>$C8+<IC9=-&RVB.U!M4&SJ0D9P
MPZN-A[4 TN807,%A45I7K5XF+DY>E,H]/3!E0T7(B;\7Q:@9VR!4YH6*^>6H
M^>6H(5^.XJT ^BB1B=M_'8F@XMXCE:3FW\=$B2(_I[_-#S6-]U#38PS<(,^=
MQ)F4^-SW"*!]X#TCM\W3 3WV@5^ES/?7TT9*4M9]AE,V)W%3@!P\ZSC(_!R;
MZ<^QW4'R]J!ZE^:^>%^4L:>P>I@S 69U5G8?#9.H1#_TKL$K"*(#HJO(\& :
MK"(]E6F1Y_53E*6[KR"!IE H8*BR.Z@SGMT_,C_!1YCEYK<H#KROO@?R;#7T
M4N[3/Q?O/_R W\P%3IJG^OWB.\@<0H>>!Y#%T<%)=XP2W:H_,9;) S<>ILG3
M^+NR!2F&+38&[S&.O,Q-UU'!HLL7>+0,5V";!6C(X^)PB*-7)X#P03Z^BO9[
M$*/GLOP_B068%(ZN;,;_.P.0& &1(#=4_=IB-3Z<]-7]P]^X[RY2.FBQ._?[
M*'Q*(_?WIYT3@^0N23+@44U(<FO%!W,(R?N3?<,[F1-;#U*X[#8+@N.U'V0I
M\,Z@H)>2ZSZ.8ES7.Q [!Y"EOIO 79D'++GY(,B>H7 38A>8MXY6P 7(E*N\
M9@5,81U%?%>!![N:CZB;?Q':6D=XNXM!H1SP-D><"[/#8$KMI-L_^P&T+:(0
MGJAR4D14'*O[8#2?]IU.-+.ZJY/)BMFJCY0K3)1)1G/5/+G<E ^\G:5_49NI
MHZ'P!D*!+4[RG^'1(8:+@6]% '__DL4)R"]VX=A"W1B_BA**9T#!L*8=5KH<
M4U3:G04?PN5_=/RVT4!NHUSD0^\N?(73@PKFL>U'/NF>%0A0@%%*&_0<>=29
M/CD!2I=0.TGVH.J5#KJ [N_!\V$31^B^@9 *HG92Z,ZCKO7R)?"WV)U1Y/*3
M/7D2_951C1;O?.U W#K((=T7'9T ^4F7X0/(%[W2[&6SA#&_@;XTP/J):"Q&
M:W6NG9Q9&>+9:J'LR^7>5SNPUT_II_5;1Y] 81438>HVT A&ZADG%H&F/!6*
MP<9]AQQL;F0UW'5:$J/ISC@9_FE8V_)_>>D"Y:/@$O%Z2Y$2"O#7DYJDF=%2
MX"C)!B5GM<+^MH- %*XZ.I8",&3>0NU><8_< $N![Y=@4%=H0\3N+05=(G[?
M+![ C)9;#M:PS]/3+1W+815*P:ASH5"Z@Z6@=<I-K?8?3@:&I9@I.WVISA.Q
M]*XASZ!N)I58"L(H]J3*1!G+UV'XS;MV?+(4RWZ;#R7'R5*L5&TZG(PLR^];
M#Z4]N=EBEN,ZK#84.EU:BG _'<E*%QP"L%<0OT2Z(1O']=8I[='R:@SCJ %*
M1,)2;%4H $I>JZ6(C2[_BI)S+7\381SEH';1+5^2826$G;YM^5L,@T(KE8%N
M^?,-HP+-3)NW_,V'08%FYOI;_DS$&%JX>6'!\N<DA@54Q>T+V]^I&-K/QKGT
M,<AS%I?CVSC/ K?]P8M1C(B^%W%L?TU#^R)P[@B-\EZ'K?@+W&$J\9V/A!WP
ME;N#54(]'PH[0#W4Q;%R4>8#9"_^IULO\P&R [#MJW@EF//AL0.8'6\7EJ':
M^;BHU%DJ>&6P1-_6E*)1T9>YJUD"/^BI4UL];!PO_ 3/'T@!(,=%ON:F%K_F
ME'9;(YJ6F[O0\U]]+W,"]/8?7F?$'SO_L(YP5/1(+7,L.X*Z*]\@1GFM-_M#
M$!T!2+!*#I,L2!UF=2VA?AHJHOP*A<H/M\R:D\TV.@JCHCCX.?=_=6(/*19W
M!^!!D5EK4F8$#1-\#)R06M:;TD@92Z^_1NM=E"5.Z*V_0AUQO/DC@Y)S%Z*<
M!:C&T7?IC"W16R.PC**PC28:2,SQ0FP)-[<P9;( N:W>2H=,N3MO9X[Z.%DG
MGXZG)L79!:N&,TM%3*O(##PE.!XRM(++39Z6M,C2'32S_J36MU3_G;GZ_US]
M7X"_RYSOEK9,&)L NX^.C2N.#M!D/*+="7D'$5V'7&A02BMK/Q/H:=*$$%%L
MNT>@I]9J_5Q%E] TG5B1_K[CZSM6,-BTWD+'D[K5T1JGY%:H%MX&G'J!,7VI
M84I[8D+1H",I[K.S,T6)D]MI,3;Q&WK8>W070G6PA68!^S$L9A>5SZTDO@>P
M5KK:^6!S\P;<#)UZEIN-[X*8?FP2[6J.?5@[*\,S7\_3]FF$X8ZQ^-31]11+
M[:SWL'7E'/RTO!B $IOB5^#=1O%MED*M@RX00GAI.XK\.)8\]3"&2* 7=/L*
M16T,#9/,26$;E\TVYJR$@"UT(CWTA/QM@WQ*%V0O_'/X2WL:-V\'/Z^&E9<)
M8^&D9'QUY7JYLG8;98S=6:K_T%3S'28X* SU-?K%-;0T):;487 3I9Y&_(G%
M"+BH'ET9(Y11(KQ5EYF'2)$P DS</H,\-;+(T@B%'5UH*L4 ?O'F%<1']*3\
M77AVTU'47AGJ*^J"@&BX( #>\D HG]$(^Y%;3DF$T-O3"5P#]&_5 M086\][
M$&GLN_!LCAGH.?339/7TS'NVCM%'B[\3'55P[9#K+/;#;;Z;%K>+J6J!Z@GM
M-II*]8)S&:#@0//ILQ/_#E+,."3@&0?L#L-,22P+A?)+C/('[@H+ZI<X2I0'
MJQA?TA$NK;-@3AI37.GM35QMZI&"N B_ 70]&G@+N!W"C?+F#64&0H&$[-W9
MUE%(P? JH;:H750!H;N)3,$\9A9^]'PYWJN6?=(G]._3,OOS!->US*!!'FPL
MDLMT!^+US@D+7D4+ KP[@6/Y&)_7$4P\271NF# Y@M9:_\&=LK4Z^4G[UO'C
M7YT@4WN>%_VFNI?-9/6U:@VM>M6X K("A\#)/2;8O&QBK70U^](R);V(HS"1
MYV_\O)8?]@:@OSI!?2049E6M$V4^/25(18PZKC[2187.TP>(7_UB.SF;\4,4
MON(M$D\N64<$+GF(TG^!= 7<:!NBW+:ZHN.=9 ;]MDV@YHQT&\7%KU [FHD\
M,A'F^(FP+-59H#S$40U+Z7&FI!&Y&RIS,Q_]\U9!6XE7G@$\.K;M[T\I6%L_
MJ>?/0IPB**H#M\QOV;2!G$;*.[499O2=FD?/E-0!_L\*Y.^:E%@-Z<>B?6M*
MH$GN#Z.;\LKIF]+B%/<P*O'/7A(W]O&\5P.D'_ ^-R7H4.HTNL]]&T?[W/^#
M8PC+S08@$W.([ V13TX)PH(=FK>GH)B5_#$0^]&_IR.',<#CUG?*^JRJHG_D
MY$:QSE/BB4+IUMX5&,:TIGYG2B9T([S19&O5%C3K4SH?#^A8F>%4LT:H/(+E
M;_T1:RHT'HOEII?6ZAE8#A8Y%;MB*)GB!!>"%.V!W#:2EL/!K)M >6?K0CBE
M\S9^SZJCW'E4>MT 2]>!]PAI\SJ_[2"T]=49.I8"<(J7"-0CJ L:1;-9#I-$
MQ8/&KB=25\!RZ)27(B"9%1?Q'CRA;D$=BY9E;SD8:FHD-$P(=8QJ*?;< @WE
M#BI]4K<4,*E]@'0X8-66L!0S%9X>X=H70[RQ;=3S*@K</;6"&I8_22[K[J$7
M\; <J&'.\!U*B5B*,^^,WBQ)8BD(HQP@..=?RZ%5L3O4:\M8^G1]%8,E%:&1
M\D)V*@!3HOJ=;:;>""YA-:5E+.?K035L2V@LAY*J43N4_K'\57NU4J^Z2)'M
MX \A\JVHBNT0FA7(;%>3*M"W]8W'84RMEC[AU[HJ4;;7-AM*45 <R9?.MO*;
MWA ESXI5L/4!TU&4!ZT06XGMK#*Z'"<:0=!+9]-Q+8QFL;T">UL?WAU:15 J
M K6K_)4HS\JB4WJ(2-K.I3-R-R72M:YC@;;2IZ&-BKB.8EMTJD-90C_KDDZ1
M(@5R- 3SFX2_6?8*JPIIL1)*'U*_*#5T5D[@O.1IB;&]^D8/OZNLPUJLT<=9
M#@;9CDDU!4O(9[$89QL@5J(M$SLN=@V&.;ZV4Y)^F)E\I.B/;%G><H5L36T:
M2P"HU7XK@&<1&"& +URLN%P66Q-01K%WQ"R<]W/&VABLW[OB<[E<2A,UIG4(
M&'>SEJH57:[.'!'7YS02J%17+M,<BY19II%*5I>+,\=XC%@<2NGK<I5F][B"
M2!RK<G8)M%+OM_U #V:@T0RR"_;*&K9"9\6_RVL,\P%GE"LY[ +BY6)<K"_+
MK.W]-!*M,'FY8!?KA-$0 :$6,R\78[ZG8<9>T_7H^4&IAV V%WJ44B]79'8&
MC+(>0O79RS69?0!CR@BCX'NY(/-Q7V9!1(O(E^C.9_PQW<:$6O;E0B@]S%_&
M0G0Y*3+KY)<WD@<]M?_']V=+ :?Z._X3\2_%]!LKDCK'9.=LT[?OW&C_??D^
M+/SU6Q1&^V/^Y5,-1.SH.X.+FP_]ZO@!RG>^C6)L6#Z'$)]&0:OD&J2PT6F-
MT*W-?WS3GL(W#4X#;RF (WG?:'A\F1BX#O)UI#12]FBO3#WX!F&RO76\:DTH
M\$Z!%3>9TD,D9YJH-3$% T\)CE9)]+:24 T2[W,ZH%-]D:2-E;+Q-8"CIO)N
M"Y&>@PZGPNDU'@4T.+6S_G?B.5*':%UX_\Z2- <Z]!;P'Q[^89"WXE708SRJ
M^#_U+-SQ &Q_VGBLJO().M Z__B\@7?]W)>_:#^C&OZ.DU&^=A-><@J,0,(P
M%Q-7JH=8B4-^K3]UXM0,]ISX<R)F</;%/9YA!NQS??D)7J]0<E"R?;TF4GA#
M*?YFZ)0)B<K9Z=?R6M 36AK"85MI]=Z/^>*$8(OLB[6M:S3"47J0 JFYE7\3
M>H:',1=)DNWS .\S;+2.;I+4W]>SX=;^/D>U2!:&4-;N0#3K=!2)D/A[N-54
M@IQSH$L-'!77U/AJY2>_W\8 W,&M"JY_FB?TJ45+^+MSZ,NLT!?Q 9C6!)MM
MYOA<Q_B<65H!I=6A(C?7J%8Y5/MC:07B=TT$LT=5"5G\NGQ*%V1=,MA8?(!*
M,+]G 3?,!TWDN"YB]&N$GA -H,T\M@"WOJP!4$:A1B(,]/8ZLL]H59;(B6B4
MUO-ALZ/Y:^E3PZ.X+ULVH^507EQDR2#L)Z!>R';T'!VQ+SIB$/[$4_O\;*O)
M^F:@<],<<#)E VB?Q"[]K<C1JO%;_%+A2!CS*OX._+#;>'&Y%?S/EU9P[@S?
MFG%SXKF%FT(#+SU.[/+@'%=3 P?],K1:=*C?F>-F<]QLCIOID7KB<TN#R#WI
M2R8"-L?&5//8;11O@(^>+*9=1ASR2Q,$[/0X_-" D;XT0<"TV2[MVW)S<'#P
MM<YKQ:#G84MO481^-18+"'_>CKCKI'FB***-[&@=/''^^0E"6V-L]MN$0RM<
MYM=-!%;EPX^*[4MY"J8(,,$:U(&R+!E3A)I@1^J 6I8,$Z&V01]_>3^M+$3A
M?5P#Y#V)FN RZ,7;=&"[!-NYTKL"R+D$?W\5A=B7F3D!BL)_4)V]W(.2"0+.
M/RP*SEYY%KEZ B>X/'11'WL=NE R0<U>XZL[.!L_3'RW>!9A:'.E]3W]!=6(
M9S F*L-_SQA4JAONR[@X/ITNNP^/D<37C4$,'WW&!(G]P5DY=?_>EP^35.Y\
M6V*QW<:XIL0H^':G9]JF3',R(U@L[0\:GUIHV&,3<PG ^;K6?%W+<.S-5"K$
M]"W++PC-%[3F"UHVXFJFAB$F[RF]F=6L-C>OA61>X("5_^:UD$L%'*W:G\FK
M,=^-LY3CQ1,ORZMUE[H\=EQ=-!EADP2 D&5:+-#\>+&F'9F=-E*LCM*7C,US
MN^E9(Y5)K\4ZS6\BC[I"TEFSQ3+-+R:/NDS2&;>E5VJV&0S<E%#";+5"2AV'
M4SL^&FK9B<G67*IH7'>8Y/)<;+VB<4M[]<DV+I=*J0MM7JH1\Y3+%;Q8[X^6
M%>R4REPNU>RGT&02MO/@R@6971/BRS)"%G:Y++,G8K0%D4D +Y=G]D",MCR<
M;/,R/V#V-1BQL:"$\FI-9N^"(=X%D<3X<M%FQX(F8_HLF;Y<D4%]"<96C5U!
MOHU]Q,.XY7/HI\E</O:BR\?>_)'!Q;\+(6-D.'"Q3'<@7N^<L)"FARA\Q1IP
MF!I,TM^?R\TRQI_+S9*)G,O-#BRES1/XZ$JB]7D3H9T+TX['C;G)KHT;6Y^W
M"MHS=\[HZ)Y38!7 AME;>DKDD@XJJZ=G9D%4=A\[>:05+,+;X#4T/JK7@/2Q
M#Y\TJY:$F1EIP+K(TF?5XC0W9/,61Y8^JQ:GEK%JWLI($6?5LEBQQWSY:+./
M?!S[<RYSTL7%-Y<YF<N<S,I&UFUH>>V-N?;)7/O$1ERGIG;:_N&Y((IA"T3P
M,L^%4@Q;HW-'\5Q I5^<K[YN' _X7$3%5&D0<)<,46#%O!/UQ!90VH$_5PDQ
M:OVD??Q#U!&9UV^D,,!<7,2HQ9/RR ]2<H1D)DXE#QMC/"=BSXG84TH,FA.Q
MYT3L.1';."TQ)V+/B=CF<..<B#TG8D\58,/L+2,2L642L.?$:SWL<F%YBG/B
MM<&+,R=>&[PX<^*UD<MBQ1XS)U[/B=?Z4R+GQ.LY\7I6-B)N0LL3?^?$ZSGQ
MVD9<IZ9VYL1KPQ=H3KPV?XWFQ.L1$Z_GA&O3I6!.N)[F LX)U]->OSGA>MKK
M-R=<3WCQYH1KJ83K=90Z ;D1JNH>)@!*0^VM\N3FZ?%QE3@)-!E7299,+2>[
MFGCU#CN(7_WB(>ISA@PP&?!?*#7=C;:A_R?D1[S V&LLEC.K\EL:(GIW(>0W
MR$E0>)#(W1=D,K)I63WFW%I=N;5JV/!,K[=P4?T5'0GC.77PH$LDOE",M$QR
ML<[FR#$SDY?=1T_>'8#6RP[N/]?@%031 =%5H,K+PN/VU#"A7T (#90 4K7P
M]G[H(_V0^J] 9$IB?;6;D$-NNG6KDKE161YG'3+&K739+%^'@3;91O*&X/9D
M.=("9JF <FA%1"\,+*:WG[_/6@[::!N7<J5A>=:$-#<+&EECP#:>*^AD$OSF
MQ#BFL/ \/Y_%7;B)XGV.VK1<./7 )ES/!SB;TV_6\%\)M&>0IXII.<N.(G\P
M0.^1?ENN#)Y!_D(I<#/(6#Y('C.H7J&0+[8QP)\E$BS82=7!)8G3VB+ GTX+
M '_X<A5E(61H**'I$46+"3X@:K.12%R!0QNC-CG$$Z]<7PT'112H7VYJC,MP
MP)';:B#Z*G"29+DI%- R7B&G/,^%Q.FD8QK1?A^%V ^.-^?D+DDR0+M92FNM
MP^>'XR7(C(A"R 9,7P^YK5ZTF4K\O%U/8A/@?K>-7K_W@)_3"?]Q(@_^\.4F
M3%$E&A*,9W]6MV<D_AV.:D4Q>5>CM=*P=I6I$7I8;).'* 4G2X3C5!?M;8HF
M8\5_&!UT7,LJC>66E">,783=1\<DLI?$]WPG/CXY.&<=%XEB3(#:7@?Q)Q*0
M(;'<U,Q,=C4-?D<=01*HZCP_R- QZF2?<DN#<+OITUG,O:;91@.1C['_"L7Q
M,7!<^FF!TWCP[?$>;)T@WP0)8DEJ88HF9S(MJX>R7?XQ!K<9.E27FR!]JZ<U
M-48-W+RY00;INXVC/=HVLK1P7-TX<>B'V^01Q+F7ZT@>@%6J:\ OJC39GI"/
M"6R/_XP"#Q%P'[A,XXW>WA0982P*O;U*2/F2<=Y([_GET8F7,;:C/)QT5G(A
M_T1#[:D,T$6VS9)T_35:[Z(L<4(/6MWKKW"W.*YA/R"TX?082,L>&KD > E2
M$NA,[H0N-*?:]%'W5*'.I@AK?@<&VHV5AKMR@@!XGXZE@!0-I41:8E1=M2<*
M;PM<&)<G;O3VNHC'5+"HS1N8PF0W;R!V_22GJOICQ0/O95B+.Y8RQ7<70N:-
M@5<)[6*+/;W[O9\DR.D/]1?.*R[%'(?72)JOXTCJ5'B9"K".<EZ^!EZ&#X;K
MZ!3L>71\[RZ\<@Y^BN)7! 7>81CS4J6Z)4DI9*MJ4ZARS LF)K(.O;4RBHAR
MEE]/@7 4 D=P84EVUL *%68+[]_0]D"B=U(9%$9@]S%%I3Y##F7%%IA]E''.
M)R@T&]_UG6#Y%8I/LO,/]_[>SP]5#U&:[Y7GQ34E.ZM4Z3%P$K",KT'^K[N0
M208DP$7Q[2V1]_L,I\XA4"3IK:/*K[]([OT_,M]#NOK:V<//$;<EP9[#4GK:
M.,Z^S :_QVC&G"EJ!SFIXT2]GT+/$N=3#X"X10GUTYT+U#$?!&4'B29D6)KF
MQDOH0!!)9E0,@51@1,H9,_NBD9TKRX_V8B:6_%$'CYIG8:D("J5I4 "R7#O1
MLBU.BIN0%6$I%AV3*QJ,PTA?L%<#"64]-#*QR8)H,4*\E(K&E2"!% 9[H1+-
M>*@CUDHML%P_B:>XU#&B!9HL!8N1)X%0.=_W[)4H?DY=>08AGU,N#!F*(41-
M'+%4@$9,/6D<[+CJWSYV['2AHFZA,Y)@+.=.;@8-USJWEZV4^>[.4X(LO_G8
MRZ5"3T:R'#4YN[1/<I3E0(H9;*-LT$,@;896E)=QT;PVI57%I\Z=#,_'$#A-
ME;=Z)Q<J+9,^=::CA)$N$2,FUS$R.8<HZ6XZ5F?\1'0B#8',5-56/9MVB"KG
MD^,8P9#($%A-E8<ZICQ;7HY=CMT8;I A<)H:J_7*1[>\;KP"1KL_*XFE%*Q)
M<ENG.P.65[F7WQNX=Q&&*"T_2<2X=R-*3\Y%10+H4$E<VBB1NRAW(U,L.?="
M2L"4>G9>0?P231<RSBV4$K+9-R%[,:9$[J(\%4PKM_L5G1++BSK#T[$4O1I4
MPG919U%)V 3O*9507M1IJT/4J7'SJ01-Z;EADJ<NL3M8)5Z#GAIT5B ^E=2N
M++7/(-U%\#!:GDLA$"58*^ ">*;"H>(\2%<###U:"G%H9+Y-K):Q&=51:9?'
M&U"7"%?+=EK;%IV2G>>BJ(8719VK@,Y50(VJ JJS-ME<?%"L^*#Y!IG$]F9Y
MIK)IET^-\J?-5R[G*Y=C**H> ?1+@6B^_C1?,#$@->I2,L[[9EH,E3UMAONJ
M^,V][[SX ;JL.WN>E!U&VM@*^IQ$NLV^D-D7,KL1!G,CC%:CG5N"M:T,2(0P
M6AOK6.GET=^A6R=W8:48J253N<TGH.N__&BF745W20EA,82Q?L 9*]#\C5,S
MSC:SUV7V*>CT*= +"\S>A-F;()WS?&Z,#.%+,,IO/HA+X5)<+QT]G7,:.-_,
MO<02"+TL3FA&#W(]/;<Y;T+/N,RT!=3;>SRKY#E!UZ1NDM3?.RD@,-3$W'X=
M"RZU7 FRHTS/O= ;:&:Y\!:<Y+:F.)5&=PJK=[@NLS1)G1 5H/L,'"3T".6[
M\) )>UU90VB88IL&Q$),[Q^C@P'DK_SD]]L8P#T;;J4@25=0V3(UD,0 !DP/
M@<V0?VIS$V1G#E88$:QH\PBZ9NRB.]P@WDM)"J&C =/!Q31^C0)H,2$S5&I&
MY+X&3.I4@D9J/F?==)\I.AJ-%^Q,FQ^+&>/^F9R=9SG+\2W".G0R!M@% D<3
M5Q;(]DKF'(P;U/=-9T![$>JGK4C&[R6ZP#M6&;4PBM*/GRBGCTL,%9B:]#M9
MWCH_!(Y1ZU='(.4!I/=1@FIF%/?$T,Q/Q37NPDT4[_$')Q8TF:0O?P6V14VZ
M*"S*GM2I.OV3Z3:6'47'E>93W*[?<P,L9Z#BCYCB_YQ*MG,;18X;FMI<72"2
M_V@T(3#)[60*7^A/)->2-MT_O-Y/.9QYN]IQ=U7#F\)G_%K:XAS('4NW'2GL
M%);>NNWU$PRSN5]\*C1O/VU<BE6\!/:BVM'D/L7)^$:%Y;[X^=K_X*^>,B-J
M_1Z\L+<(S'PYPH2M^N*\VL-#JDZ96%/T807_\X7CU3PMS)43N%E0P//)27QW
M$7K7"%'@$;M.S/>IS_/2FW0(_UT(%QJ@15B\0M21%*RC6A6S711 KDWPNE%F
M)#N*CIQ-@'88X"W@GNEL0?4V(W[<I983PYJFW!CF3+(0M3,ZY:9)'<4 7R=K
MU<AM#2"Z %20[+*U[OU6YE@LK5TL/Y;(8">IL"Q/[5" '%T+6I[#((,=1;%:
M_O1N'X0J+3[&D[O&6O@GA8[* KXZ 4K6K@D9];1T=@S(%R!-8_\%-J)L%Q,[
M(,SA]S$B@Y^.Y $8 ?PAOVB A3FA@R@9R =GS[ZRR>VF):L(PNBCW%NLLIY#
M/TU63\_,^TWL/L:LQQRE[T_[8A]E(4TDU8RMG^EEF%T?D]_L#T%T! "3L<0V
M&I-P>GM]MY"9!#?;&)MX-(<-9*V9V5$RJ=P+@Z 5-;2:R59,B\;ZT/8(!Q.^
MYJ@OT47RJ)KT#476F^4K8/SV>#]LW4.#ED*!PA[R_N<$%#4;*\8A8(C P.3Q
M:IT[A@@-3!8CH:1+.R,$>:!W[;R!Q(;[C-5TA.MZL7IH< ]4Y*!" &$"/H$0
M;'PN\:W6NH5/8!GJNHDZZ3',-6VB]X3RZ<'6=U>@F)W_9[Y(%@@B-F4R-X5Z
M-]Q>14F**JQ 6N-7KI-9J*LN7VE)%Z8I@.OG(0K+9(7'*,$KE]P$_MX/T9\?
M<2U@^%\74-W'*D;6>CV9,8%$+/C)'T'WBC\&3LB(29+;ZB;ZA.3"A990[K]@
M;XCB_75/#J',N>)/;JW,HW[SYJ<X*3HY1(D3G#"B>]9Y773(,4 I5Z$+L+31
M;J:V6^FV,61VF+-#=E\U?C%^)&'-3H7XI#<M!TU:\9+#(0*(7Q*0YTJ^.K%S
MM>^EX42_=4\!])( DM@BSC9$RWW5*M4]%>8Q,-11&XQZC'_*]GLG/BXW"]>-
M,^!57%4HJN,*N @4;S[:]SS:4ZSS-NZ?G #]'\DJIS75?<1I8B1Z_"3TTO9.
M3(,PYFF-WG[V;<QN@FX9@J4\B^4'MEHK+*E6LR=*K4]20^2&TW0)Z-7<!KR0
M+&M]LF=^$6\C"^Y]YY4SB+O,)10D46VPVUX>;-I.&C,PY!IVQ#R=]E8\^Q[.
MM3_%4)C=#V:Z'\P01]5>+GOSYE1:9':^'=Q*45F!U,\+_F/WL@5Y*==@ U?:
M*S*,L"^\FBW/>R765\-IK2#L*@KS^_<0=$1=L?7&B,H8X)6+C_5&S#N-/0?5
M48<YVJ/TL5RC(,DNF5<X&5!F!*U.J7-63$XD"KJE1,90-<DD3FL3A#^=)@=_
M^+)"90^)/IKV7T<BZ+/SYN\S\O.CYW\?$R6"#[CYM[$0\D,V0HV_Z][YI=1^
MW4CJJUHM/^5T4+GD [600K,43(H&1$ 1=)'M(+0=?6?H6 I KTV^ 935V58\
M86EN2Q?C.9'D%<E]T=K<C>PE 7]D<-2;5U3ZS(83;FM.R%G+R!N@M=9QNCDG
MA9DO0&^O@7@D+,O-%61^/[UU7/S8)@-V:G-#2+]'W!LSX>=V&^D@\N0":'S[
MT7.8'(#K;WS@$>EFMU46NKZ"F@4%1)P4K'=QE&UW#]$KWHW>_PA;_X5^,T"P
MIPX.B<(M5-?[:_#"%TM*8V4 KV.XQ:=']$#R?02W.3J@E);Z51LOMX;:7#_I
M3-<2J>E86@#NQ/C@68HXQ4]";J?%9_N2WH4H'H&HX59,I#8?2JX$'GWD]-#/
MK&>>'3;#WNOTX9.VT^+D_RF*X^@K"EDY!_B7]"BQ(U.'T##%7Z&\(9VP@B+(
M9'9"0PWD/L;^'I/ 3!YLM]+/]4QRR6T-L"E8QC*IJ6J]EYNN?&NBV4ZS%#%
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M>E/;X$-?#!%,M7\TX$JD> %HVP7XT;T7\HQ_?%;9.6SA/B"2=,4W!('S7)Y
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MGZ3')#WNK?0 :ZTV_^1ZDH'13H ^KUJ([TU97)J4LSN#7M5W8G.='IT<J-D
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MM] M,KYMSUU=B]3.C5'=4R"9P8#MEQJ3E[BI6QNU8W;AFXE;\P\HOT]BU[T
M(1"RL-VULIM"2_M6N_#:,/QQ3P=+ANPB3&.]UM1R!IL'!014LCQSG2#6PM(6
M^,J]]L!]PX"Q<]WJH DG9[RN2S-O:KMA^EMN]I]<?T' -A6RQ80+>K"<<?#
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MIC\)A-X&:2J=+0Y;]Z)<&BWK).$F"7=?)=S+7#$QOD?=#TF\<;B%\H]!64"
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M<?2A,,SRA2P<)=*M;TJS%NA<I=&SA#^P%<4_&L,%@012]']+*L5^(7^@-V9
M/%GT9:ZO9/6PV)BR*%T&,,8NXD1M7L8W=(<)KW%M[ KB\@1@0<K0&-L5U[U=
MI,2/4CW')-<!XO\H@Y0Q$DC0CPY2A#TT&L)#WO*N<0A0Q-4RL&E5&6(5N[2T
M'J?8>?>"C*+-0L#)35'A7@_N[ZN\::_#,-AFVC\(4FO@4!E,0W*+W3IRN])A
M/\5,US7N\%;I-_<R(S<<SD5>*<NM'U9^^_@#<NJNUT7*MYDTX*0![ZT&?'%V
M/CS5M],B$)NGP7X(8W.V4:O'8K^6?N\+S)H3J^)956E08((LF,[Q=([O[3EV
M98+#!2#%CI'5\KD$A81!NWB\*<6U4Q\*5Y6%)'DS]9U.L.]R2?%YDA/4)1D)
M:"Y51E8O]?NA1LJ]M_H EEF5FL1BI</6.,2MSQ01S#E6@36"31(S8RG\F>\M
M.GAP/(,+MQ6:FFR1[A*8*<1P8S< TYH+FW2P$S:%K6/"K,)\2X2P&.:7]M"X
M*C'1]/<-8&VDS-B4!77&SK<\W-ZO/1R*ELY:?.[3&0.M#I+^VZ),SN'OE=GP
MC8(/;C&T+;)OM7QF&Q.='_OHK@*,[+6P"*RRY!N3:)]$^[T5[01>!"EW7C0E
M%^#])#G3 8KX5G-%$O:!PX6EY.!@DE,:J '*@-JG3-Q3]HILFRXFC0#.?)/4
M/L#0$E#<&J5,P^2KCIH*J_"I_@_V=$&1 ?Y7)6T*I"V]C1MC]0W.QMW8N>4=
M<:ASA(NF+#$Y%\QIY_G.Q);8%7A!78&YW2Y'5<"-Q1XPY+OJ2Y7:=4H*\,D5
MAS708RZ-7<W=;BZ3))PDX;V5A!2F.?? AV$V?8I[NS=)83$<X;X ;<S/XKI
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MG>RIX@N*>$4P^^BHL/ N3)6 BX&N0FPCK#RI6TT$72%ZJ-M</8G^@9VR4>'
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M;D+"4LHPM+[$>Q%+S6PO%4Z\2VD3I$/:U*-8ZX?YD1R[@^C/8+X1"!%7</M
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MH$67[6'TZ.CQ *37[/8:!:^KFK65!%]#,+654##XW>31Y%U-HN@>>U<$S1Z
MK.@)/H>0,OS[H\FIR9.K<6(B=8VD^"M-(A\KOF)?#84H-_,)N?/M!;7*EX:I
M<W!\^6LZX],9OZ]G_"TX>4CA@)O^-7=X&]YQ)_2,:-UDA0T'F.0;?5II2Q<'
M7_JJD9XO/93??8G0%Y-2GKE&VNNFQ$\O#<'PY"N\O2#MG$M#F*0BRS@([KN*
MJRJZTF!GJBK(A,O=4+*XSG8T,D+R4KXV4@W8GR4L6.JNM]T<;+(=W?(BH](
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MPN[2N^D=^'Z>B*ZCJW]%V!R&4BDZ2><HR11CXVAT>?XJ6>FT@9MW"X-)^+4
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M$8<'L82N6"PZ%88R9?<0\ZU[4+54F .ZU@9 9<#916F/E<KQX9P:Z3@N16S
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M&.I1Y5L> /R0YU2F<+"8VEI2]ORYWXG$V-F0U]HX<+82&YHBE6>>2JZJ?Y4
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M>/T ;MC8WZ_[--6W7J\JN_0)ENZ!_K+9+YB67_#DJ_ +[-IM?)GOC+V$OW=
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MP?QJY3WN5"3&[(&KN%W+T6]S0=S/$3=]33AQK8&/Y37B*OF]3:]D(J?&6OB
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M!9Q:#Q-8[KKF2#XU]DUECFRU:*ILV5+:F]K<8PR:=EG:4H!=2<257%W95Y4
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M5$,;>QE1+08+X?;&I0&Y#[9T64.71*EG5I8FK9!CY9\2O%>[9-,X$ A12M6
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M2Q%?LAU^*XK#4A=L5A VMLUU6=EA'GDH>P=#PX>X].LD7_?X[^$IL]P(M<^
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M: >=7 UYN^AJ!=PKC$1R#!0!PW=!%*$"<Y+ZLS>7AZKDV(P'0JR[$*BBR2R
M\QA$3[#OK*R8W??"''A:U Y$N4%XF8J#=6, 8%@/EYK[ESJE/#[;YRG9Y]^G
M9)^9F\ZZVK$+DWWD/!@H4S/I7NPR8Q*"(GF]NC9I"[R\>&IB$'5@,-0I)L0#
MF)H79DF VB4MEU00%CZ^3K1I8IB#TO+SIV-L'@* 5_9YLD8#=?5O&%BVB!TR
MF;/MG%4/'MG'5#XJ._TY*A<HLRB2"F&M94\8#0A$QMC"=VP$>9,;C1?#.[OU
MD/" 8*@O"1F[N="VY=F"O 4CBH3*4.1=QQVX9A HZR"9VM_QS&C:^^:RGT-
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MXXNF">+;,@?/K.$#9PTL%-*U1Y?WSP!>V%LJLCZP:*27!\D/D4.M5L8%;S@
M-B2\ <Z!A5LR@V'O^"X5"S:(EX9<GI6'")8!. ,R$:PD'%TDC=)U9032V&19
MQ'XC!?A#D_N C^%(9#;R?"C\/>OIU4LZ?\')%9.1QOHL,TR=ONQO$+*A>-57
M?M(E7NL[ *1W8FU[]6P=XIC6K7VG'"&&]48V:G,*^\N[.RZ%??^K2&&_H!V;
MC=(+W,W/8'5>_M.HE#U!&@-V0G9";IW$A$T;D9X$T\#NA2N!8O17_:!=3E(
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MX2UG-,#HN-Z\1?U)GYL++: YE[,<'0G702T%ZSV2S:(;X>%NC'%:ZM%%2)R
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MMX?/0YI LW21R)&T'6"V 1[6E0ZZ-)T7(=-..#**-AO[&XK:=:M0*T7<::3
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MC#SOU6>U5T]JLWZI4>CC&'/6^W4(<_=%C_F4>19#)E*=0'EAEHU+PD.?JLY
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MB@ZXE3C]+L;"+$D-UT=*Y4T0S_DIRC!AS!1OMH!-MH''BL2M4\G(PE3S"=M
M'1CT;4%[4$(>%O1#%\/]A!B3'76AK$:(NR [77#@Y58(>YXP[;$SV\]'AP<B
M^+EC/* T3K/W2TDJ48,D"0< -"4+Q8VL4+9&\>&8:CBR\\@B>>W BY62NBP$
MM4$BW>&Z.SGU$V)RG#*5:=JJ$/'8L@K6M53F,I^XX]%/_1CW!G7LP?I0)7G
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M7#=4HG9<5)&/K\J;@ML25YZLW:-$$<A,OJ_[\.#Y !/@^A_JIY]P@AY]\70
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M1(9@/2\[QH)LM(R[<K%.Z+(_.T7!+#76,T!)%AONEO"$7B8-M6&UGFM0ZF@
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M/@L'RG,#)CM(O:YST<'=T_[(\M3F50/7$I^<4Y@TK.]V$T7[!2SI)E/=;K/
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M96V,K1GC>2D3&LT.N]9*#Q.7J8&!7X4@8O!V?)5*$L.Y( (4IXMA.+PA'$9
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M48Q=E^)>[5/Z3D71>_QZC"C"36>M<XZ>Y6%EL=%J8S".@H;Z@.B\=='JTP2
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M0F@8C6*$W1QR1.$OQ)CNDJ KJGQ*E<FE_6IXR5BXL9^06U0"]BWE" \I.9F
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MVX?.,*UU,L"%^TG6H9=RGH%K8<,5;H<N(CKD%6XJ'BU-M42U1I.+-"UJXC+
MIH71F)J;8]MO=ZI;35*B*'9GF9,0]N(+N0Y'4):8GYDEQ-*L\$MW*F4-2%E:
MX;"@MT7[*0=<3QW53%R&VF4^X6RKUB=98N80RQ+ETQP^SJ%>M4!.:A[,/9HG
M@8LR(Z$5>@,[$#X;NU.+N[BFH)AI]\._EO!D0@ZTM%2KSS$*@[,(6\!>^$&
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ML%N_.3V,T(INZ]W[ONAWA(U!+?L<:]U_N>I^S!42!>YI<8*#&8U&] 4L _)
M)Q&X !.4@4GB8]]C=&5E/ Q<'Z0(+7TT;(3Z@+;#E-U@7D()"#D>V@B6(^HN
M$I;EP)ORR7%Y#J,DY<?*SQ/0O9+&)4-8J4,6L+S;@D#FB[^D\,#C#C(2=BYP
M"C;H-&%#^^TQ; LY\V1^%&X2>JT1=PO%W0!FCU3-)E&H B/#(:B,* 8SR$U0
MT3$Y*4\01(6RO"@].I=[A1/KAYBAH(390(;@T:3Z*M)X%BTCM3!H/=Y(/ZZ\
M%HPM^!>8^H01K!U>0CY!-33*V=K;4@=S-<^L^,92[L4G5"\>P5^HJVK!IK5;
MEV;"JS[A%RCU?E7K0.AB%/ZU9QX57M>;>X9SBZO$Z\VYQW'ZZY \;3+%?V"]
MW<\U")9L+Y,C]&4)U7/7F$FE-JG"<U.I3PQ]YDNIBTZWW_H?QJWL-=\[IU?G
MSYI(73_!?6($]PL(+".YC62:*[F;AC[S*_^<9M?IV]V/^L2C)Q :N75&$,?4
M)G".&*O%T)<&\G=GJ[%W^ B>[]YVXW &T/?^1=M;C=W]W4<NVCEL[+[=-=#
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MIV XP J-F9(4CK2@DL0T@E.:J!122ZL\W0I!QB-N#-53)$GI+8=Y%W@:.,=
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M?/C&BKUR-OR/0H#(SKT46>3:W[MU]VMKD?F:NE]]"34@[*D ,&)S%MN\D>
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M]WN&+YQO!Q,R9$6],TB 8G")&)-IEF\-6S7]H.39FU8M?\3R;U!+ 0(4 Q0
M   ( #:";E>;$+I(SET  ,BS   1              "  0    !I;6<S.#8U
M,30Q.%\P+FIP9U!+ 0(4 Q0    ( #:";E=(-SDBP_\  .]O 0 1
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M-3$T,3A?-"YJ<&=02P$"% ,4    "  V@FY7;ZLQ&@0F  !N/@  $0
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M-3$T,3A?.2YJ<&=02P$"% ,4    "  V@FY7&XKT]8F( @"XA24 $0
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M   /              "  <B("@!T<VAA+65X,S)?,BYH=&U02P4&     !8
,%@!Q!0  ;HX*

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
